PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bautista-Caro, MB; de Miguel, E; Peiteado, D; Plasencia-Rodriguez, C; Villalba, A; Monjo-Henry, I; Puig-Kroger, A; Sanchez-Mateos, P; Martin-Mola, E; Miranda-Carus, ME				Bautista-Caro, Maria-Belen; de Miguel, Eugenio; Peiteado, Diana; Plasencia-Rodriguez, Chamaida; Villalba, Alejandro; Monjo-Henry, Irene; Puig-Kroger, Amaya; Sanchez-Mateos, Paloma; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia			Increased frequency of circulating CD19+CD24(hi) CD38(hi) B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naive for biological agents	PLOS ONE			English	Article							GUT INFLAMMATION; MICROBIOTA; DISEASE; SPONDYLOARTHRITIS; PERMEABILITY; EXPRESSION; BARRIER; TNF	Our objective was to study the frequency of circulating CD19+CD24(hi) CD38(hi) B cells (Breg) in AS patients. To this end, peripheral blood was drawn from AS patients naive for TNF blockers (AS/nb) (n = 42) and healthy controls (HC) (n = 42). Six patients donated blood for a second time, 6 months after initiating treatment with anti-TNF alpha drugs. After isolation by Ficoll-Hypaque, PBMCs were stained with antibodies to CD3, CD4, CD19, CD24, and CD38, and examined by cytometry. For functional studies, total CD19+ B cells were isolated from PBMCs of 3 HC by magnetical sorting. Breg-depleted CD19+ B cells were obtained after CD19+ CD24(hi)CD38(hi) B cells were removed from total CD19+ cells by cytometry. Total CD19+ B cells or Breg-depleted CD19+ B cells were established in culture and stimulated through their BCR. Secretion of IFN. was determined by ELISA in culture supernatants. When compared with HC, AS/nb patients demonstrated a significantly increased frequency of Breg cells, which was independent of disease activity. Anti-TNF alpha drugs induced a significant reduction of circulating Breg numbers, which were no longer elevated after six months of treatment. Functional in vitro studies showed that the secretion of IFN. was significantly higher in Breg-depleted as compared with total CD19+ B cells, indicating that Breg can downmodulate B cell pro-inflammatory cytokine secretion. In summary, an increased frequency of circulating CD19+ CD24 hi CD38 hi B cells is observed in AS/nb patients, that is not related with disease activity; anti-TNF alpha drugs are able to downmodulate circulating Breg numbers in AS.	[Bautista-Caro, Maria-Belen; de Miguel, Eugenio; Peiteado, Diana; Plasencia-Rodriguez, Chamaida; Villalba, Alejandro; Monjo-Henry, Irene; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia] Hosp Univ La Paz IdiPAZ, Dept Rheumatol, Madrid, Spain; [Puig-Kroger, Amaya; Sanchez-Mateos, Paloma] Hosp Gen Univ Gregorio Maranon, Lab Inmunooncol, Madrid, Spain	Hospital Universitario La Paz; General University Gregorio Maranon Hospital	Miranda-Carus, ME (corresponding author), Hosp Univ La Paz IdiPAZ, Dept Rheumatol, Madrid, Spain.	mariaeugenia.miranda@salud.madrid.org	Puig, Amaya/B-6164-2015; Sanchez-Mateos, Paloma/E-8931-2013; Miranda-Carus, Maria-Eugenia/S-7403-2019	Puig, Amaya/0000-0003-2943-9757; Monjo Henry, Irene/0000-0002-3252-8016	Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (MINECO/ISCIII) [FIS PI-16/01189, RD12/0009/0012, RD16/0012/0012]; COnsejeria de Educacion de la Comunidad de Madrid/Fondo Europeo de Desarrollo Regional RAPHYME [S2010/BMD-2350]; Roche Pharmaceuticals	Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (MINECO/ISCIII); COnsejeria de Educacion de la Comunidad de Madrid/Fondo Europeo de Desarrollo Regional RAPHYME; Roche Pharmaceuticals(Roche Holding)	This work was supported by Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (MINECO/ISCIII) grant numbers FIS PI-16/01189, RD12/0009/0012 and RD16/0012/0012 (RIER, RETICS Program) (http://www.idi.mineco.gob.es/portal/site/MICINN, http://www.isciii.es), by COnsejeria de Educacion de la Comunidad de Madrid/Fondo Europeo de Desarrollo Regional RAPHYME, grant number S2010/BMD-2350 (www.madrimasd.org) and by an unrestricted research grant from Roche Pharmaceuticals (www.roche.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus C, 2012, CURR OPIN RHEUMATOL, V24, P351, DOI 10.1097/BOR.0b013e3283534df4; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Cantaert T, 2012, ARTHRITIS RHEUM-US, V64, P1859, DOI 10.1002/art.34364; Chen M, 2016, DNA CELL BIOL, V35, P88, DOI 10.1089/dna.2015.3046; Cypers H, 2016, ANN RHEUM DIS, V75, P1357, DOI 10.1136/annrheumdis-2015-208025; Demetter P, 2002, J PATHOL, V198, P517, DOI 10.1002/path.1235; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Fonseca-Camarillo G, 2015, CYTOKINE, V75, P389, DOI 10.1016/j.cyto.2015.04.009; Furuzawa-Carballeda J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4245; Gibson PR, 2004, GUT, V53, P1724, DOI 10.1136/gut.2004.047092; Gill T, 2015, CURR OPIN RHEUMATOL, V27, P319, DOI 10.1097/BOR.0000000000000187; Hindryckx P, 2011, ANN RHEUM DIS, V70, P2044, DOI 10.1136/ard.2010.149229; Jones-Hall YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119441; Jones-Hall YL, 2016, INTERSECTION TNF IBD, V7, P58; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; MARTINEZGONZALEZ O, 1994, BRIT J RHEUMATOL, V33, P644; Matsushita T, 2016, RHEUMATOLOGY, V55, P263, DOI 10.1093/rheumatology/kev331; Mauri C, 2015, INT IMMUNOL, V27, P479, DOI 10.1093/intimm/dxv038; Mavropoulos A, 2016, ARTHRITIS RHEUMATOL, V68, P494, DOI 10.1002/art.39437; MIELANTS H, 1991, J RHEUMATOL, V18, P1542; Nova-Lamperti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep20044; Ochoa-Reparaz J, 2010, GUT MICROBES, V1, P103, DOI 10.4161/gmic.1.2.11515; Rigoni R, 2016, J EXP MED, V213, P355, DOI 10.1084/jem.20151116; Rosenbaum JT, 2011, ARTHRITIS RHEUM-US, V63, P3195, DOI 10.1002/art.30558; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Rosser EC, 2014, MOL IMMUNOL, V62, P296, DOI 10.1016/j.molimm.2014.01.014; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Silverman GJ, 2003, ARTHRITIS RES THER, V5, pS1, DOI 10.1186/ar1010; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Todd SK, 2014, RHEUMATOLOGY, V53, P1693, DOI 10.1093/rheumatology/keu136; Turina MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0413-4; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Watson AJM, 2012, ANN NY ACAD SCI, V1258, P1, DOI 10.1111/j.1749-6632.2012.06523.x	34	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180726	10.1371/journal.pone.0180726	http://dx.doi.org/10.1371/journal.pone.0180726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683133	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200062
J	Molaei, A; Lakzian, A; Haghnia, G; Astaraei, A; Rasouii-Sadaghiani, M; Ceccherini, MT; Datta, R				Molaei, Ali; Lakzian, Amir; Haghnia, Gholamhosain; Astaraei, Alireza; Rasouii-Sadaghiani, MirHassan; Ceccherini, Maria Teresa; Datta, Rahul			Assessment of some cultural experimental methods to study the effects of antibiotics on microbial activities in a soil: An incubation study	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SULFONAMIDE ANTIBIOTICS; VETERINARY ANTIBIOTICS; EXTRACTION METHOD; ACTIVATED-SLUDGE; RESISTANCE GENES; ORGANIC-MATTER; SULFADIAZINE; MANURE; DIVERSITY	Oxytetracycline (OTC) and sulfamethoxazole (SMX) are two of most widely used antibiotics in livestock and poultry industry. After consumption of antibiotics, a major portion of these compounds is excreted through the feces and urine of animals. Land application of anti-biotictreated animal wastes has caused increasing concern about their adverse effects on ecosystem health. In this regard, inconsistent results have been reported regarding the effects of antibiotics on soil microbial activities. This study was conducted based on the completely randomized design to the measure microbial biomass carbon, cumulative respiration and iron (III) reduction bioassays. Concentrations of OTC and SMX including 0, 1, 10, 25, 50, and 100 mg./kg were spiked in triplicate to a sandy loam soil and incubated for 21 days at 25 degrees C. Results showed that the effects of OTC and SMX antibiotics on cumulative respiration and microbial biomass carbon were different. SMX antibiotic significantly affected soil microbial biomass carbon and cumulative respiration at different treatments compared to control with increasing incubation time. OTC antibiotic, on the other hand, negatively affected cumulative respiration compared to control treatment throughout the incubation period. Although OTC antibiotic positively affected microbial biomass carbon at day one of incubation, there was no clear trend in microbial biomass carbon between different treatments of this antibiotic after that time period. Nevertheless, sulfamethoxazole and oxytetracycline antibiotics had similar effects on iron (III) reduction such that they considerably affected iron (III) reduction at 1 and 10 mg./kg, and iron (III) reduction was completely inhibited at concentrations above 10 mg./kg. Hence, according to our results, microbial biomass carbon and cumulative respiration experiments are not able alone to exhibit the effect of antibiotics on soil microbial activity, but combination of these two experiments with iron (III) reduction test could well display the effects of sulfamethoxazole (SMX) and oxytetracycline (OTC) antibiotics on soil biochemical activities.	[Molaei, Ali; Lakzian, Amir; Haghnia, Gholamhosain; Astaraei, Alireza] Ferdowsi Univ Mashhad, Fac Agr, Dept Soil Sci, Mashhad, Iran; [Rasouii-Sadaghiani, MirHassan] Urmia Univ, Fac Agr, Dept Soil Sci, Orumiyeh, Iran; [Ceccherini, Maria Teresa] Univ Florence, Dept Agrifood & Environm Sci, Florence, Italy; [Datta, Rahul] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Geol & Soil Sci, Brno, Czech Republic	Ferdowsi University Mashhad; Urmia University; University of Florence; Mendel University in Brno	Lakzian, A (corresponding author), Ferdowsi Univ Mashhad, Fac Agr, Dept Soil Sci, Mashhad, Iran.	lakzian@um.ac.ir	Ceccherini, Maria Teresa/J-7847-2019; ASTARAEI, ALI REZA/AAF-6672-2022; Lakzian, Amir/AAH-2645-2021; Datta, Rahul/J-9495-2014; ASTARAEI, ALI REZA/AFJ-9621-2022	Ceccherini, Maria Teresa/0000-0002-4261-7514; ASTARAEI, ALI REZA/0000-0001-6156-8570; Lakzian, Amir/0000-0003-3972-5802; Datta, Rahul/0000-0001-9001-2555; ASTARAEI, ALI REZA/0000-0001-6156-8570; Rasouli-Sadaghiani, MirHassan/0000-0001-9804-4076	Ferdowsi University of Mashhad, Department Of Soil Science, Iran; Mendel University in Brno, Department of Geology and Soil Science, Zemidilska, Brno, Czech Republic	Ferdowsi University of Mashhad, Department Of Soil Science, Iran; Mendel University in Brno, Department of Geology and Soil Science, Zemidilska, Brno, Czech Republic	This work was supported by the Ferdowsi University of Mashhad, Department Of Soil Science, Iran and the Mendel University in Brno, Department of Geology and Soil Science, Zemidilska 3, 613 00 Brno, Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black C.A., 1965, METHODS SOIL ANAL, P653; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Chander Y, 2005, J ENVIRON QUAL, V34, P1952, DOI 10.2134/jeq2005.0017; Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128; Drillia P, 2005, J HAZARD MATER, V122, P259, DOI 10.1016/j.jhazmat.2005.03.009; Elsgaard L, 2001, ENVIRON TOXICOL CHEM, V20, P1656, DOI [10.1897/1551-5028(2001)020&lt;1656:EARAOL&gt;2.0.CO;2, 10.1002/etc.5620200806]; Fang H, 2016, SCI TOTAL ENVIRON, V572, P1203, DOI 10.1016/j.scitotenv.2016.08.038; Gutierrez IR, 2010, J SOIL SEDIMENT, V10, P537, DOI 10.1007/s11368-009-0168-8; Haluschak P, 2006, CANADA MANITOBA SOIL, P3; Hammesfahr U, 2011, J PLANT NUTR SOIL SC, V174, P614, DOI 10.1002/jpln.201000322; Hammesfahr U, 2011, EUR J SOIL BIOL, V47, P61, DOI 10.1016/j.ejsobi.2010.10.004; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; ISERMEYER H., 1952, Zeitschrift fur Pflanzenernahrung, Dungung und Bodenkunde, V56, P26, DOI 10.1002/jpln.19520560107; Kahle M, 2007, CHEMOSPHERE, V68, P1224, DOI 10.1016/j.chemosphere.2007.01.061; Kotzerke A, 2008, ENVIRON POLLUT, V153, P315, DOI 10.1016/j.envpol.2007.08.020; Kreuzig R, 2003, FRESEN ENVIRON BULL, V12, P550; Kumar K, 2004, J ENVIRON QUAL, V33, P250, DOI 10.2134/jeq2004.0250; Liu B, 2015, EUR J SOIL BIOL, V68, P69, DOI 10.1016/j.ejsobi.2015.01.002; Liu W, 2012, PLANT SOIL ENVIRON, V58, P295, DOI 10.17221/430/2011-PSE; Ma TT, 2016, EUR J SOIL BIOL, V76, P53, DOI 10.1016/j.ejsobi.2016.07.004; Mojica ERE, 2011, ENCY ENV HLTH, P97, DOI DOI 10.1016/B978-0-444-52272-6.00338-X; Nelson KL, 2011, WORLD J MICROB BIOT, V27, P659, DOI 10.1007/s11274-010-0504-6; Park JY, 2016, ENVIRON POLLUT, V213, P561, DOI 10.1016/j.envpol.2016.01.089; Pfeiffer C., 1998, Umweltwissenschaften und Schadstoff-Forschung, V10, P147; Reichel R, 2013, SOIL BIOL BIOCHEM, V62, P82, DOI 10.1016/j.soilbio.2013.03.007; Schmitt H, 2004, ENVIRON SCI TECHNOL, V38, P1148, DOI 10.1021/es034685p; SPARLING GP, 1990, SOIL BIOL BIOCHEM, V22, P301, DOI 10.1016/0038-0717(90)90104-8; SPARLING GP, 1988, SOIL BIOL BIOCHEM, V20, P337, DOI 10.1016/0038-0717(88)90014-4; [汤玮婧 TANG Wei-jing], 2009, [湖北农业科学, Hubei Agricultural Sciences], V48, P70; Thiele-Bruhn S, 2005, CHEMOSPHERE, V59, P457, DOI 10.1016/j.chemosphere.2005.01.023; Thiele-Bruhn S, 2005, ENVIRON TOXICOL CHEM, V24, P869, DOI 10.1897/04-166R.1; Thiele-Bruhn S, 2003, J PLANT NUTR SOIL SC, V166, P145, DOI 10.1002/jpln.200390023; Toth JD, 2011, SOIL BIOL BIOCHEM, V43, P2470, DOI 10.1016/j.soilbio.2011.09.004; Vaclavik E, 2004, CHEMOSPHERE, V56, P667, DOI 10.1016/j.chemosphere.2004.02.018; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Welp G, 1995, IRON, P296; Westergaard K, 2001, SOIL BIOL BIOCHEM, V33, P2061, DOI 10.1016/S0038-0717(01)00134-1; Widenfalk A, 2008, ENVIRON POLLUT, V152, P576, DOI 10.1016/j.envpol.2007.07.003; ZELLES L, 1986, ECOTOX ENVIRON SAFE, V12, P53, DOI 10.1016/0147-6513(86)90006-0; Zhang YY, 2016, SCI TOTAL ENVIRON, V571, P479, DOI 10.1016/j.scitotenv.2016.07.014; Zielezny Y, 2006, SOIL BIOL BIOCHEM, V38, P2372, DOI 10.1016/j.soilbio.2006.01.031	41	27	29	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180663	10.1371/journal.pone.0180663	http://dx.doi.org/10.1371/journal.pone.0180663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683144	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200057
J	Roberts, JJ; Fausch, KD; Schmidt, TS; Walters, DM				Roberts, James J.; Fausch, Kurt D.; Schmidt, Travis S.; Walters, David M.			Thermal regimes of Rocky Mountain lakes warm with climate change	PLOS ONE			English	Article							UNITED-STATES; ICE COVER; NUTRIENT LIMITATION; NATIONAL-PARK; COLORADO; TRENDS; TEMPERATURES; SENSITIVITY; SENTINELS; PHENOLOGY	Anthropogenic climate change is causing a wide range of stresses in aquatic ecosystems, primarily through warming thermal conditions. Lakes, in response to these changes, are experiencing increases in both summer temperatures and ice-free days. We used continuous records of lake surface temperature and air temperature to create statistical models of daily mean lake surface temperature to assess thermal changes in mountain lakes. These models were combined with downscaled climate projections to predict future thermal conditions for 27 high-elevation lakes in the southern Rocky Mountains. The models predict a 0.25 degrees C.decade(-1) increase in mean annual lake surface temperature through the 2080s, which is greater than warming rates of streams in this region. Most striking is that on average, ice-free days are predicted to increase by 5.9 days.decade(-1), and summer mean lake surface temperature is predicted to increase by 0.47 degrees C.decade(-1). Both could profoundly alter the length of the growing season and potentially change the structure and function of mountain lake ecosystems. These results highlight the changes expected of mountain lakes and stress the importance of incorporating climate- related adaptive strategies in the development of resource management plans.	[Roberts, James J.; Schmidt, Travis S.] US Geol Survey, Colorado Water Sci Ctr, Ft Collins, CO 80526 USA; [Roberts, James J.; Walters, David M.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Fausch, Kurt D.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Colorado State University	Roberts, JJ (corresponding author), US Geol Survey, Colorado Water Sci Ctr, Ft Collins, CO 80526 USA.; Roberts, JJ (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA.	jroberts@usgs.gov	Schmidt, Travis S/I-3416-2018	Schmidt, Travis S/0000-0003-1400-0637	United States Geological Survey; Mendenhall Postdoctoral Fellowship Program	United States Geological Survey(United States Geological Survey); Mendenhall Postdoctoral Fellowship Program	This work was funded by the United States Geological Survey, who provided JJR funding through the Mendenhall Postdoctoral Fellowship Program. Colorado Parksand Wildlife also provided funding to KDF. The funder provided support in the form of salaries for authors JJR, DMW, TSS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Alder JR, 2011, GEOSCI MODEL DEV, V4, P69, DOI 10.5194/gmd-4-69-2011; Austin JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029021; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Baron JS, 2009, GLOBAL CHANGE BIOL, V15, P1777, DOI 10.1111/j.1365-2486.2009.01847.x; Baron JS, 2000, FRESHWATER BIOL, V43, P463, DOI 10.1046/j.1365-2427.2000.00517.x; Bergstrom AK, 2005, LIMNOL OCEANOGR, V50, P987, DOI 10.4319/lo.2005.50.3.0987; Campbell DH, 2000, WATER RESOUR RES, V36, P37, DOI 10.1029/1999WR900283; Clow DW, 2010, J CLIMATE, V23, P2293, DOI 10.1175/2009JCLI2951.1; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Domis LND, 2013, FRESHWATER BIOL, V58, P463, DOI 10.1111/fwb.12053; Dunham J, 2005, RMRSGTR150WWW USDA F; Edenhofer O., 2014, CONTRIBUTION WORKING; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Fang X, 2004, ECOL MODEL, V172, P39, DOI 10.1016/S0304-3800(03)00285-0; Fang X, 2012, WATER QUAL RES J CAN, V47, P375, DOI 10.2166/wqrjc.2012.031; Fang X, 2009, LIMNOL OCEANOGR, V54, P2359, DOI 10.4319/lo.2009.54.6_part_2.2359; Gauthier J, 2014, FRESHWATER BIOL, V59, P998, DOI 10.1111/fwb.12322; Giorgetta M.E.M., 2003, REPORTMAX PLANCK INS, DOI DOI 10.17617/2.995269; Granados Ignacio, 2000, Journal of Limnology, V59, P109; Hampton SE, 2017, ECOL LETT, V20, P98, DOI 10.1111/ele.12699; Hartman MD, 2014, BIOGEOCHEMISTRY, V119, P85, DOI 10.1007/s10533-014-9950-9; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; HOSTETLER S.W., 2011, 20111238 US GEOL SUR; Hostetler SW, 1999, J AM WATER RESOUR AS, V35, P1625, DOI 10.1111/j.1752-1688.1999.tb04241.x; Isaak DJ, 2012, CLIMATIC CHANGE, V113, P499, DOI 10.1007/s10584-011-0326-z; Isaak DJ, 2016, P NATL ACAD SCI USA, V113, P4374, DOI 10.1073/pnas.1522429113; Isaak DJ, 2015, GLOBAL CHANGE BIOL, V21, P2540, DOI 10.1111/gcb.12879; Jankowski T, 2006, LIMNOL OCEANOGR, V51, P815, DOI 10.4319/lo.2006.51.2.0815; Kao YC, 2015, J GREAT LAKES RES, V41, P423, DOI 10.1016/j.jglr.2015.03.012; Lapierre JF, 2015, GLOBAL CHANGE BIOL, V21, P4425, DOI 10.1111/gcb.13031; Leppi JC, 2012, CLIMATIC CHANGE, V112, P997, DOI 10.1007/s10584-011-0235-1; Letcher BH, 2004, CAN J FISH AQUAT SCI, V61, P2288, DOI [10.1139/f04-214, 10.1139/F04-214]; Lindenmayer DB, 2010, P NATL ACAD SCI USA, V107, P21957, DOI 10.1073/pnas.1015696107; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Markensten H, 2010, ECOL APPL, V20, P752, DOI 10.1890/08-2109.1; Mast MA, 2014, ENVIRON SCI TECHNOL, V48, P14258, DOI 10.1021/es502461k; McGuire CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044370; Metcalf JL, 2012, MOL ECOL, V21, P5194, DOI 10.1111/mec.12028; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; Mohseni O, 1998, WATER RESOUR RES, V34, P2685, DOI 10.1029/98WR01877; Mohseni O, 1999, WATER RESOUR RES, V35, P3723, DOI 10.1029/1999WR900193; Muths E, 2014, BIOL CONSERV, V172, P200, DOI 10.1016/j.biocon.2014.02.034; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nijssen B, 2001, CLIMATIC CHANGE, V50, P143, DOI 10.1023/A:1010616428763; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Oyler JW, 2015, GEOPHYS RES LETT, V42, P153, DOI 10.1002/2014GL062803; Parker BR, 2008, P NATL ACAD SCI USA, V105, P12927, DOI 10.1073/pnas.0806481105; Peeters F, 2007, GLOBAL CHANGE BIOL, V13, P1898, DOI 10.1111/j.1365-2486.2007.01412.x; Penaluna BE, 2015, PLOS ONE, P10; Preston DL, 2016, GEOPHYS RES LETT, V43, P5553, DOI 10.1002/2016GL069036; Read JS, 2014, ECOL MODEL, V291, P142, DOI 10.1016/j.ecolmodel.2014.07.029; Roberts JJ, 2013, GLOBAL CHANGE BIOL, V19, P1383, DOI 10.1111/gcb.12136; Sadro S, 2012, ECOSYSTEMS, V15, P363, DOI 10.1007/s10021-011-9515-x; Scavia D, 2014, J GREAT LAKES RES, V40, P226, DOI 10.1016/j.jglr.2014.02.004; Schmid M, 2014, CLIMATIC CHANGE, V124, P301, DOI 10.1007/s10584-014-1087-2; Schneider P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040846; SCHNEIDER P, 1985, GEOPHYS RES LETT, V2010, P37, DOI DOI 10.1029/2010GL045059; Serreze MC, 1999, WATER RESOUR RES, V35, P2145, DOI 10.1029/1999WR900090; Sharma S, 2011, PLOS ONE, V6; Sharma S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25061; Shuter BJ, 2013, CAN J FISH AQUAT SCI, V70, P982, DOI 10.1139/cjfas-2012-0437; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stowell SML, 2015, CAN J FISH AQUAT SCI, V72, P1565, DOI 10.1139/cjfas-2015-0009; Straile D, 2015, ECOLOGY, V96, P2794, DOI 10.1890/14-0839.1.sm; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; Wedekind C, 2010, CONSERV BIOL, V24, P1418, DOI 10.1111/j.1523-1739.2010.01534.x; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER; Williamson CE, 2010, HYDROBIOLOGIA, V648, P73, DOI 10.1007/s10750-010-0147-5; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273; Williamson CE, 2009, SCIENCE, V323, P887, DOI 10.1126/science.1169443; Winslow LA, 2015, GEOPHYS RES LETT, V42, P355, DOI 10.1002/2014GL062325; Wolfe AP, 2003, GEOBIOLOGY, V1, P153, DOI 10.1046/j.1472-4669.2003.00012.x	75	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179498	10.1371/journal.pone.0179498	http://dx.doi.org/10.1371/journal.pone.0179498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683083	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200006
J	Hu, JL; Li, ZF; Hong, L; Bao, CJ; Zhang, Z; Zhang, HY; He, H; Wang, XC; Liu, WD; Peng, ZH; Shi, LM; Zhu, FC				Hu, Jianli; Li, Zhifeng; Hong, Lei; Bao, Changjun; Zhang, Zhong; Zhang, Hongying; He, Hao; Wang, Xiaochen; Liu, Wendong; Peng, Zhihang; Shi, Limin; Zhu, Fengcai			Preliminary fast diagnosis of severe fever with thrombocytopenia syndrome with clinical and epidemiological parameters	PLOS ONE			English	Article							SYNDROME VIRUS; SFTS VIRUS; SHANDONG PROVINCE; BUNYAVIRUS; TICKS; TRANSMISSION; ANIMALS	Objectives To identify specific clinical and epidemiological parameters for clinical diagnosis of SFTSV infection with relatively higher accuracy. Methods 231 suspected cases of SFTS were reported by various medical institutions from 2011 to 2013 in Jiangsu Province, China. They were followed with SFTSV diagnosis tests and interview-administered questionnaires about demographic characteristics, clinical symptoms and epidemiological exposure factors. Univariate and multivariable logistic regression analysis were used to examine the diagnostic value of these parameters. Results SFTSV infection occurred only from April to October annually and usually in hilly areas of specific regions. Three prediction models of SFTSV infection were constructed. Model 3 with clinical and epidemiological parameters combined the benefits of both Model 1and Model 2, which was optimal and had an overall accuracy of 80.2%. Independent indicators for clinical diagnosis of SFTSV infection in Model 3 were as follows: lymphadenopathy (P = 0.01), leucopenia (P<0.01), age >50 years (P = 0.01), tick bites (P<0.01), raising domestic animals in the residential areas (P<0.01) and farming (P = 0.03). Conclusions Our results show that using a combination of clinical and epidemiological parameters may be a feasible strategy to provide preliminary fast diagnosis as differentiating SFTSV infection from SFTS-like diseases, thus reducing the risk of misdiagnosis.	[Hu, Jianli; Li, Zhifeng; Bao, Changjun; Wang, Xiaochen; Liu, Wendong; Zhu, Fengcai] Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Li, Zhifeng] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Hong, Lei; Zhang, Zhong; Zhang, Hongying; Shi, Limin] Nanjing Municipal Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [He, Hao] Gulou Dist Ctr Dis Control & Prevent, Dept Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Peng, Zhihang] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Nanjing University; Nanjing Medical University	Bao, CJ (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	bao2000_cn@163.com			Natural Science Foundation of China [81373055, 81601794]; Jiangsu Province Science & Technology Demonstration Project for Major Emerging Infectious Diseases Control and Prevention [BE2015714]; Jiangsu Provincial Nature Science Foundation [BK20161584]; Jiangsu Provincial Key Medical Discipline of Epidemiology [ZDXKA2016008]; 10th Summit of Six Top Talents of Jiangsu Province [2013-WSN-061]; Jiangsu Provincial Medical Youth Talent [ZDRCA2016032, QNRC2016545]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science & Technology Demonstration Project for Major Emerging Infectious Diseases Control and Prevention; Jiangsu Provincial Nature Science Foundation; Jiangsu Provincial Key Medical Discipline of Epidemiology; 10th Summit of Six Top Talents of Jiangsu Province; Jiangsu Provincial Medical Youth Talent	Our research was supported by Natural Science Foundation of China (No. 81373055 and No. 81601794), Jiangsu Province Science & Technology Demonstration Project for Major Emerging Infectious Diseases Control and Prevention (No.BE2015714), Jiangsu Provincial Nature Science Foundation (No. BK20161584), Jiangsu Provincial Key Medical Discipline of Epidemiology (ZDXKA2016008), the 10th Summit of Six Top Talents of Jiangsu Province (No. 2013-WSN-061) and Jiangsu Provincial Medical & Youth Talent (No. ZDRCA2016032 & QNRC2016545). All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Ding F, 2013, CLIN INFECT DIS, V56, P1682, DOI 10.1093/cid/cit100; Ding SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111736; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Jiang Xiao-lin, 2012, Chinese Journal of Virology, V28, P252; Jiao YJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004092; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Jin C, 2012, P NATL ACAD SCI USA, V109, P10053, DOI 10.1073/pnas.1120246109; Kang Kai, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P106; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Li Yi-fan, 2011, Journal of Traffic and Transportation Engineering, V11, P36; Li ZF, 2014, J CLIN VIROL, V60, P185, DOI 10.1016/j.jcv.2014.03.020; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09679; Liu Li, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P168; Liu Y., 2012, CHIN J PREMED, V46, P500; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Lu QB, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.07.012; Luo LM, 2015, EMERG INFECT DIS, V21, P1770, DOI 10.3201/eid2110.150126; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Park S.U., 2013, INT J CHEM, V2, P10, DOI DOI 10.3201/EID2011.140888; Shimada S, 2015, VIROLOGY, V482, P19, DOI 10.1016/j.virol.2015.03.010; Shimojima M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0412-3; Sun Y, 2012, AASRI PROC, V3, P694, DOI 10.1016/j.aasri.2012.11.110; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Vynograd N, 2014, ARCH IMMUNOL THER EX, V62, P445, DOI 10.1007/s00005-014-0316-8; Wang SW, 2015, AM J TROP MED HYG, V92, P684, DOI 10.4269/ajtmh.14-0008; Xie YT, 2015, LANCET INFECT DIS, V15, P145, DOI 10.1016/S1473-3099(14)70891-6; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209; Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345	34	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180256	10.1371/journal.pone.0180256	http://dx.doi.org/10.1371/journal.pone.0180256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678811	gold, Green Published, Green Submitted			2022-12-27	WOS:000405272200043
J	Perez, LG; Martinez, DR; Decamp, AC; Pinter, A; Berman, PW; Francis, D; Sinangil, F; Lees, C; Greene, K; Gao, HM; Nitayaphan, S; Rerks-Ngarm, S; Kaewkungwal, J; Pitisuttithum, P; Tartaglia, J; O'Connell, RJ; Robb, ML; Michael, NL; Kim, JH; Gilbert, P; Montefiori, DC				Perez, Lautaro G.; Martinez, David R.; Decamp, Allan C.; Pinter, Abraham; Berman, Phillip W.; Francis, Donald; Sinangil, Faruk; Lees, Carter; Greene, Kelli; Gao, Hongmei; Nitayaphan, Sorachai; Rerks-Ngarm, Supachai; Kaewkungwal, Jaranit; Pitisuttithum, Punnee; Tartaglia, James; O'Connell, Robert J.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Gilbert, Peter; Montefiori, David C.			V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; VACCINE EFFICACY; IN-VITRO; TYPE-1 INFECTION; PLASMA VIRUS; FACTOR-H; BINDING; CELLS; CD55	Non-neutralizing IgG to the V1V2 loop of HIV-1 gp120 correlates with a decreased risk of HIV-1 infection but the mechanism of protection remains unknown. This V1V2 IgG correlate was identified in RV144 Thai trial vaccine recipients, who were primed with a canarypox vector expressing membrane-bound gp120 (vCP1521) and boosted with vCP1521 plus a mixture gp120 proteins from clade B and clade CRF01_AE (B/E gp120). We sought to determine whether the mechanism of vaccine protection might involve antibody-dependent complement activation. Complement activation was measured as a function of complement component C3d deposition on V1V2-coated beads in the presence of RV144 sera. Variable levels of complement activation were detected two weeks post final boosting in RV144, which is when the V1V2 IgG correlate was identified. The magnitude of complement activation correlated with V1V2-specific serum IgG and was stronger and more common in RV144 than in HIV-1 infected individuals and two related HIV-1 vaccine trials, VAX003 and VAX004, where no protection was seen. After adjusting for gp120 IgA, V1V2 IgG, gender, and risk score, complement activation by case-control plasmas from RV144 correlated inversely with a reduced risk of HIV-1 infection, with odds ratio for positive versus negative response to TH023-V1V2 0.42 (95% CI 0.18 to 0.99, p = 0.048) and to A244-V1V2 0.49 (95% CI 0.21 to 1.10, p = 0.085). These results suggest that complement activity may have contributed in part to modest protection against the acquisition of HIV-1 infection seen in the RV144 trial.	[Perez, Lautaro G.; Martinez, David R.; Greene, Kelli; Gao, Hongmei; Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC 27708 USA; [Decamp, Allan C.; Gilbert, Peter] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Pinter, Abraham] Publ Hlth Res Inst, Newark, NJ USA; [Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Francis, Donald; Sinangil, Faruk; Lees, Carter] Global Solut Infect Dis, San Francisco, CA USA; [Nitayaphan, Sorachai; O'Connell, Robert J.] Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Bangkok, Thailand; [Kaewkungwal, Jaranit; Pitisuttithum, Punnee] Fac Trop Med, Mahidol, Thailand; [Tartaglia, James] Sanofi Pasteur, Dept Res & Dev, Swiftwater, PA USA; [O'Connell, Robert J.; Robb, Merlin L.; Michael, Nelson L.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	Duke University; Fred Hutchinson Cancer Center; University of California System; University of California Santa Cruz; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; Sanofi-Aventis; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); International Vaccine Institute	Montefiori, DC (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	david.montefiori@duke.edu	martinez, david/GQI-0849-2022		Bill & Melinda Gates Foundation [1032144]; National Institutes of Health, USA [Y1-AI2 642-12]; U.S. Department of Defense [W81XWH-07-2-0067]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, R01AI046283, P01AI088610] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill & Melinda Gates Foundation, Grant #1032144; the National Institutes of Health, USA, Grant #Y1-AI2 642-12 and the U.S. Department of Defense, Grant #W81XWH-07-2-0067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. James Tartagliais employed by Sanofi Pasteur. Dr. Tartaglia was involved in providing RV144 plasmas for our study. We received no funding from Sanofi Pasteur for the work described in our manuscript.	Aasa-Chapman MMI, 2005, J VIROL, V79, P2823, DOI 10.1128/JVI.79.5.2823-2830.2005; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Edlefsen PT, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003973; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; GRAS G, 1993, BLOOD, V81, P1808; HEYMAN B, 1990, J EXP MED, V172, P665, DOI 10.1084/jem.172.2.665; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; JUNE RA, 1991, AIDS, V5, P269, DOI 10.1097/00002030-199103000-00004; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; KAYMAN SC, 1994, J VIROL, V68, P400, DOI 10.1128/JVI.68.1.400-410.1994; Li SYS, 2014, J CLIN INVEST, V124, P3879, DOI 10.1172/JCI75539; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; McMichael AJ, 2012, NAT IMMUNOL, V13, P423, DOI 10.1038/ni.2264; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; MONTEFIORI DC, 1993, J VIROL, V67, P2699, DOI 10.1128/JVI.67.5.2699-2706.1993; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; MONTEFIORI DC, 1992, CLIN EXP IMMUNOL, V90, P383; MONTEFIORI DC, 1994, J INFECT DIS, V170, P429, DOI 10.1093/infdis/170.2.429; MONTEFIORI DC, 1994, VIROLOGY, V205, P82, DOI 10.1006/viro.1994.1622; Montefiori DC, 1996, SYMPOSIUM IN IMMUNOLOGY V, P31; Nesargikar PN, 2012, EUR J MICROBIOL IMMU, V2, P103, DOI 10.1556/EuJMI.2.2012.2.2; PINTER C, 1995, AIDS RES HUM RETROV, V11, P577, DOI 10.1089/aid.1995.11.577; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBINSON WE, 1990, VIROLOGY, V175, P600, DOI 10.1016/0042-6822(90)90449-2; ROBINSON WE, 1990, J VIROL, V64, P5301, DOI 10.1128/JVI.64.11.5301-5305.1990; ROBINSON WE, 1991, J VIROL, V65, P4169, DOI 10.1128/JVI.65.8.4169-4176.1991; ROBINSON WE, 1988, LANCET, V1, P790; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Saifuddin M, 1997, J GEN VIROL, V78, P1907, DOI 10.1099/0022-1317-78-8-1907; Stoiber H, 1996, J EXP MED, V183, P307, DOI 10.1084/jem.183.1.307; Stoiber H, 2008, VACCINE, V26, P3046, DOI 10.1016/j.vaccine.2007.12.003; Sullivan BL, 1996, J IMMUNOL, V157, P1791; Sullivan BL, 1998, VIROLOGY, V248, P173, DOI 10.1006/viro.1998.9289; Thurman JM, 2013, J CLIN INVEST, V123, P2218, DOI 10.1172/JCI65861; Tomaras GD, 2014, VACCINES, V2, P15, DOI 10.3390/vaccines2010015; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x; TREMBLAY M, 1990, J EXP MED, V171, P1791, DOI 10.1084/jem.171.5.1791; Willey S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-16; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Yu QG, 2010, CELL MOL IMMUNOL, V7, P334, DOI 10.1038/cmi.2010.8; Zhou JT, 1996, VIROLOGY, V226, P13, DOI 10.1006/viro.1996.0623; Zolla-Pazner S, 2010, PLOS ONE, V9; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629	51	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180720	10.1371/journal.pone.0180720	http://dx.doi.org/10.1371/journal.pone.0180720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678869	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200085
J	Reyes-Gibby, CC; Melkonian, SC; Wang, J; Yu, RK; Shelburne, SA; Lu, C; Gunn, GB; Chambers, MS; Hanna, EY; Yeung, SCJ; Shete, S				Reyes-Gibby, Cielito C.; Melkonian, Stephanie C.; Wang, Jian; Yu, Robert K.; Shelburne, Samuel A.; Lu, Charles; Gunn, Gary Brandon; Chambers, Mark S.; Hanna, Ehab Y.; Yeung, Sai-Ching J.; Shete, Sanjay			Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE C677T; ORAL MUCOSITIS; FUNCTIONAL MODULES; PATHWAY ANALYSIS; RISK-FACTORS; DNA-DAMAGE; TOXICITY; CHEMOTHERAPY; ASSOCIATION; POLYMORPHISMS	Mucositis is a complex, dose-limiting toxicity of chemotherapy or radiotherapy that leads to painful mouth ulcers, difficulty eating or swallowing, gastrointestinal distress, and reduced quality of life for patients with cancer. Mucositis is most common for those undergoing highdose chemotherapy and hematopoietic stem cell transplantation and for those being treated for malignancies of the head and neck. Treatment and management of mucositis remain challenging. It is expected that multiple genes are involved in the formation, severity, and persistence of mucositis. We used Ingenuity Pathway Analysis ((IPA), a novel networkbased approach that integrates complex intracellular and intercellular interactions involved in diseases, to systematically explore the molecular complexity of mucositis. As a first step, we searched the literature to identify genes that harbor or are close to the genetic variants significantly associated with mucositis. Our literature review identified 27 candidate genes, of which ERCC1, XRCC1, and MTHFR were the most frequently studied for mucositis. On the basis of this 27-gene list, we used IPA to generate gene networks for mucositis. The most biologically significant novel molecules identified through IPA analyses included TP53, CTNNB1, MYC, RB1, P38 MAPK, and EP300. Additionally, uracil degradation II ((reductive) and thymine degradation pathways ((p = 1.06(-08)) were most significant. Finally, utilizing 66 SNPs within the 8 most connected IPA-derived candidate molecules, we conducted a genetic association study for oral mucositis in the head and neck cancer patients who were treated using chemotherapy and/or radiation therapy ((186 head and neck cancer patients with oral mucositis vs. 699 head and neck cancer patients without oral mucositis). The top ranked gene identified through this association analysis was RB1 ((rs2227311, p-value = 0.034, odds ratio = 0.67). In conclusion, gene network analysis identified novel molecules and biological processes, including pathways related to inflammation and oxidative stress, that are relevant to mucositis development, thus providing the basis for future studies to improve the management and treatment of mucositis in patients with cancer.	[Reyes-Gibby, Cielito C.; Melkonian, Stephanie C.; Yeung, Sai-Ching J.] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA; [Wang, Jian; Yu, Robert K.; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Wang, Jian; Shelburne, Samuel A.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Lu, Charles] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Gunn, Gary Brandon] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Chambers, Mark S.; Hanna, Ehab Y.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Reyes-Gibby, CC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA.	creyes@mdanderson.org	Yeung, Sai-Ching/AAI-6178-2021; Yeung, Sai-Ching/AAP-8079-2020	Yeung, Sai-Ching/0000-0001-5170-0822; Gunn, G. Brandon/0000-0001-8197-0380	National Institutes of Health [R01 DE022891, R25 DA026120, R03 CA192197]; Barnhart Family Distinguished Professorship in Targeted Therapy; National Cancer Institute (MD Anderson Cancer Center Support Grant) [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R03CA192197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnhart Family Distinguished Professorship in Targeted Therapy; National Cancer Institute (MD Anderson Cancer Center Support Grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health (www.nih.gov) through grants R01 DE022891 (CCRandSS), R25 DA026120 (SS), and R03 CA192197 (JW). This research was also supported in part by the Barnhart Family Distinguished Professorship in Targeted Therapy (SS) and by National Cancer Institute grant P30 CA016672 (MD Anderson Cancer Center Support Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Aragues R, 2007, PLOS COMPUT BIOL, V3, P1761, DOI 10.1371/journal.pcbi.0030178; Askland K, 2012, HUM GENET, V131, P373, DOI 10.1007/s00439-011-1082-x; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Banklau Chumphorn, 2010, Hematol Oncol Stem Cell Ther, V3, P103; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barasch A, 2003, ORAL ONCOL, V39, P91, DOI 10.1016/S1368-8375(02)00033-7; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bektas-Kayhan K, 2012, ASIAN PAC J CANCER P, V13, P5251, DOI 10.7314/APJCP.2012.13.10.5251; Belinky F, 2015, DATABASE J BIOL DATA, V2015; Ben-Ari Fuchs S, 2016, OMICS, V20, P139, DOI 10.1089/omi.2015.0168; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booth D, 2015, SCIENCE, V348, P99, DOI 10.1126/science.1260722; Boso V, 2014, PHARMACOGENOMICS, V15, P1845, DOI [10.2217/pgs.14.127, 10.2217/PGS.14.127]; Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7; Bowen Joanne M, 2011, J Support Oncol, V9, P161, DOI 10.1016/j.suponc.2011.04.009; Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808; Chen XW, 2012, PEDIATR HEMAT ONCOL, V29, P303, DOI 10.3109/08880018.2012.657767; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; Cho HJ, 2010, CANCER GENET CYTOGEN, V198, P40, DOI 10.1016/j.cancergencyto.2009.12.004; Coleman EA, 2015, SUPPORT CARE CANCER, V23, P841, DOI 10.1007/s00520-014-2406-x; Cowling VH, 2007, CELL CYCLE, V6, P2625, DOI 10.4161/cc.6.21.4880; Crook JM, 2011, J CLIN ONCOL, V29, P362, DOI 10.1200/JCO.2010.31.7305; De Mattia E, 2009, EUR J CANCER, V45, P1333, DOI 10.1016/j.ejca.2008.12.004; den Hoed MAH, 2015, PHARMACOGENOMICS J, V15, P248, DOI 10.1038/tpj.2014.63; Deng CX, 2003, HUM MOL GENET, V12, pR113, DOI 10.1093/hmg/ddg082; Deorukhkar A, 2010, BIOCHEM PHARMACOL, V80, P1904, DOI 10.1016/j.bcp.2010.06.039; Dogan M, 2012, ASIAN PAC J CANCER P, V13, P1553, DOI 10.7314/APJCP.2012.13.4.1553; Dumontet C, 2010, BONE MARROW TRANSPL, V45, P1316, DOI 10.1038/bmt.2009.335; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Elsea CR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002355; Erculj N, 2012, LEUKEMIA LYMPHOMA, V53, P1096, DOI 10.3109/10428194.2011.639880; Ersland KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031687; Etienne-Grimaldi MC, 2007, PHARMACOGENOMICS, V8, P1561, DOI 10.2217/14622416.8.11.1561; Fidlerova J, 2012, PHARMACOL REP, V64, P1234, DOI 10.1016/S1734-1140(12)70919-2; Fidlerova J, 2010, CANCER CHEMOTH PHARM, V65, P661, DOI 10.1007/s00280-009-1071-0; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gemmati D, 2007, HAEMATOLOGICA, V92, P478, DOI 10.3324/haematol.10587; Georgiou M, 2012, HIPPOKRATIA, V16, P215; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Harris Debra J, 2006, Ther Clin Risk Manag, V2, P251, DOI 10.2147/tcrm.2006.2.3.251; Herzog H, 1996, GENOME RES, V6, P858, DOI 10.1101/gr.6.9.858; High KP, 2002, AM J CLIN NUTR, V76, P1358, DOI 10.1093/ajcn/76.6.1358; HOFFBRAND AV, 1993, BRIT J HAEMATOL, V83, P643, DOI 10.1111/j.1365-2141.1993.tb04704.x; Huang PH, 2015, ONCOTARGET, V6, P20746, DOI 10.18632/oncotarget.5234; Imanishi J, 2000, J BIOCHEM-TOKYO, V127, P525, DOI 10.1093/oxfordjournals.jbchem.a022636; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KIM BD, 1976, J BIOL CHEM, V251, P6909; Kleibl Z, 2009, NEOPLASMA, V56, P303, DOI 10.4149/neo_2009_04_303; Kotnik BF, 2011, EUR J CLIN PHARMACOL, V67, P993, DOI 10.1007/s00228-011-1046-z; Lalla Rajesh V, 2008, Dent Clin North Am, V52, P61, DOI 10.1016/j.cden.2007.10.002; Lambros MP, 2015, EVID-BASED COMPL ALT, V2015; Langford A, 2010, J HEALTH COMMUN, V15, P92, DOI 10.1080/10810730.2010.525296; Li H, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/265895; Liu XC, 2014, ONCOLOGIST, V19, P426, DOI 10.1634/theoncologist.2013-0231; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Ma HW, 2004, BIOINFORMATICS, V20, P1870, DOI 10.1093/bioinformatics/bth167; McCarthy GM, 1998, ORAL ONCOL, V34, P484, DOI 10.1016/S1368-8375(98)00068-2; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mitteer RA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13961; Montassier E, 2015, ALIMENT PHARM THER, V42, P515, DOI 10.1111/apt.13302; Muurling T, 2014, OTOL NEUROTOL, V35, P1, DOI 10.1097/MAO.0000000000000254; Naidu MUR, 2004, NEOPLASIA, V6, P423, DOI 10.1593/neo.04169; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Ozawa Manabu, 2016, BMC Res Notes, V9, P250, DOI 10.1186/s13104-016-2038-y; Ozdemir N, 2012, LEUKEMIA RES, V36, P565, DOI 10.1016/j.leukres.2011.10.012; Peterson DE, 2009, ANN ONCOL, V20, P174, DOI 10.1093/annonc/mdp165; Peterson DE, 2004, SEMIN ONCOL, V31, P35, DOI 10.1053/j.seminoncol.2004.04.006; Pratesi N, 2011, RADIOTHER ONCOL, V99, P356, DOI 10.1016/j.radonc.2011.05.062; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reed E, 2005, CLIN CANCER RES, V11, P6100, DOI 10.1158/1078-0432.CCR-05-1083; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Ren JH, 2014, INT J RADIAT BIOL, V90, P256, DOI 10.3109/09553002.2014.873558; Reyes-Gibby CC, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0348-7; Reyes-Gibby CC, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0058-0; Reyes-Gibby CC, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0167-x; Robien K, 2006, BONE MARROW TRANSPL, V37, P799, DOI 10.1038/sj.bmt.1705330; Rocha V, 2009, LEUKEMIA, V23, P545, DOI 10.1038/leu.2008.323; Rosenthal DI, 2014, CANCER-AM CANCER SOC, V120, P1975, DOI 10.1002/cncr.28672; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sanoff HK, 2008, SEMIN COLON RECTAL S, V19, P226, DOI 10.1053/j.scrs.2008.09.007; Schochet PZ, 2008, 20084018 NCEE US DEP; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Song HL, 2006, CANCER RES, V66, P10220, DOI 10.1158/0008-5472.CAN-06-2222; Sonis S, 2007, ORAL ONCOL, V43, P289, DOI 10.1016/j.oraloncology.2006.03.014; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stamatiou GA, 2013, OTOL NEUROTOL, V34, P961, DOI 10.1097/MAO.0b013e3182898272; Tantawy AAG, 2010, BLOOD COAGUL FIBRIN, V21, P28, DOI 10.1097/MBC.0b013e32833135e9; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Teo YL, 2015, TARGET ONCOL, V10, P429, DOI 10.1007/s11523-014-0349-2; Thomas F, 2011, BRIT J CANCER, V105, P1654, DOI 10.1038/bjc.2011.442; Ulrich CM, 2001, BLOOD, V98, P231, DOI 10.1182/blood.V98.1.231; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; van den Blink B, 2001, J IMMUNOL, V166, P582, DOI 10.4049/jimmunol.166.1.582; van Erp NP, 2009, J CLIN ONCOL, V27, P4406, DOI 10.1200/JCO.2008.21.7679; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Venkatesh GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089079; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097523; Weaver DA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-18; Yeoh ASJ, 2007, MOL CANCER THER, V6, P2319, DOI 10.1158/1535-7163.MCT-07-0113; Yomade O, 2013, ANN HEMATOL, V92, P1071, DOI 10.1007/s00277-013-1734-0; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932	116	16	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180396	10.1371/journal.pone.0180396	http://dx.doi.org/10.1371/journal.pone.0180396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678827	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200061
J	Woywod, C; Gruber, FX; Engh, RA; Fla, T				Woywod, Clemens; Gruber, Franz X.; Engh, Richard A.; Fla, Tor			Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; BLAST CRISIS; CML PATIENTS; MATHEMATICAL-MODELS; DRUG-RESISTANCE; TYROSINE KINASE; STEM-CELLS; CANCER; EMERGENCE; MESYLATE	Targeted inhibition of the oncogenic BCR-ABL1 fusion protein using the ABL1 tyrosine kinase inhibitor imatinib has become standard therapy for chronic myelogenous leukemia (CML), with most patients reaching total and durable remission. However, a significant fraction of patients develop resistance, commonly due to mutated ABL1 kinase domains. This motivated development of second-generation drugs with broadened or altered protein kinase selectivity profiles, including dasatinib and nilotinib. Imatinib-resistant patients undergoing treatment with second-line drugs typically develop resistance to them, but dynamic and clonal properties of this response differ. Shared, however, is the observation of clonal competition, reflected in patterns of successive dominance of individual clones. We present three deterministic mathematical models to study the origins of clinically observed dynamics. Each model is a system of coupled first-order differential equations, considering populations of three mutated active stem cell strains and three associated pools of differentiated cells; two models allow for activation of quiescent stem cells. Each approach is distinguished by the way proliferation rates of the primary stem cell reservoir are modulated. Previous studies have concentrated on simulating the response of wild-type leukemic cells to imatinib administration; our focus is on modelling the time dependence of imatinib-resistant clones upon subsequent exposure to dasatinib or nilotinib. Performance of the three computational schemes to reproduce selected CML patient profiles is assessed. While some simple cases can be approximated by a basic design that does not invoke quiescence, others are more complex and require involvement of non-cycling stem cells for reproduction. We implement a new feedback mechanism for regulation of coupling between cycling and noncycling stem cell reservoirs that depends on total cell populations. A bifurcation landscape analysis is also performed for solutions to the basic ansatz. Computational models reproducing patient data illustrate potential dynamic mechanisms that may guide optimization of therapy of drug resistant CML.	[Woywod, Clemens; Fla, Tor] Univ Tromso, Dept Chem, Ctr Theoret & Computat Chem, N-9037 Tromso, Norway; [Gruber, Franz X.; Engh, Richard A.] Univ Tromso, Dept Chem, NORSTRUCT, N-9037 Tromso, Norway; [Fla, Tor] Univ Tromso, Dept Math, N-9037 Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Woywod, C (corresponding author), Univ Tromso, Dept Chem, Ctr Theoret & Computat Chem, N-9037 Tromso, Norway.	clemens.woywod@ch.tum.de	woywod, clemens/Q-2939-2017	woywod, clemens/0000-0002-3407-1486; Engh, Richard/0000-0002-6207-0560	Research Council of Norway [179568/V30]; Tromso Research Foundation [A32542]; Kreftforeningen [PK01-2009-0541]; Publication Fund of UiT The Arctic University of Norway	Research Council of Norway(Research Council of Norway); Tromso Research Foundation; Kreftforeningen; Publication Fund of UiT The Arctic University of Norway	This work was supported by Research Council of Norway (Grant Nr 179568/V30), URL: http://www.forskningsradet.no/en/Home_page/ 1177315753906, Received Funding: CW, Role: Funding position; Tromso Research Foundation (supported by Trond Mohn, Grant Nr. A32542), URL:http://www.tfstiftelse.no, Received funding: CW, Role: Funding position; and Kreftforeningen (Grant Nr. PK01-2009-0541), URL:http://kreftforeningen.no, Received funding: RAE, FXG, Role: Funding position (FXG). The publication charges for this article have been funded by a grant from the Publication Fund of UiT The Arctic University of Norway.	Abbott LH, 2006, BRIT J CANCER, V95, P1136, DOI 10.1038/sj.bjc.6603310; [Anonymous], 2010, MATL VERS 7 11 0; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Berezansky L, 2005, COMPUT MATH APPL, V49, P549, DOI 10.1016/j.camwa.2004.07.015; Brown G, 2012, LEUKEMIA RES, V36, P14, DOI 10.1016/j.leukres.2011.10.010; Catlin SN, 2005, BLOOD, V106, P2688, DOI 10.1182/blood-2005-03-1240; Chereda B, 2015, ANN HEMATOL, V94, pS107, DOI 10.1007/s00277-015-2325-z; Clapp GD, 2015, CANCER RES, V75, P4053, DOI 10.1158/0008-5472.CAN-15-0611; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Dormand J.R., 1980, J COMPUT APPL MATH, V6, P19, DOI [10.1016/0771-050X(80)90013-3, DOI 10.1016/0771-050X(80)90013-3]; Doumic-Jauffret M, 2010, B MATH BIOL, V72, P1732, DOI 10.1007/s11538-009-9500-0; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Drummond MW, 2009, LEUKEMIA, V23, P1199, DOI 10.1038/leu.2009.43; Ernst T, 2008, HAEMATOLOGICA, V93, P186, DOI 10.3324/haematol.11993; Fla T, 2013, SPRINGER P MATH STAT, V35, P221; Fla T, 2015, MATH METHOD APPL SCI, V38, P3392, DOI 10.1002/mma.3345; Foo J, 2010, J THEOR BIOL, V263, P179, DOI 10.1016/j.jtbi.2009.11.022; Foo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000557; Foo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000503; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Ghanima W, 2004, EUR J HAEMATOL, V72, P441, DOI 10.1111/j.1600-0609.2004.00257.x; Glauche I, 2007, BRIT J CANCER, V96, P677, DOI 10.1038/sj.bjc.6603603; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; Gruber FX, 2006, LEUKEMIA, V20, P2057, DOI 10.1038/sj.leu.2404400; Gruber FX, 2012, LEUKEMIA, V26, P172, DOI 10.1038/leu.2011.187; Gruber FX, 2009, QUANTITATIVE UNDERST; Gruber FXE, 2005, LEUKEMIA, V19, P2159, DOI 10.1038/sj.leu.2403983; Ha KJ, 2007, ATMOS RES, V86, P330, DOI 10.1016/j.atmosres.2007.07.002; Haeno H, 2009, P NATL ACAD SCI USA, V106, P16616, DOI 10.1073/pnas.0908107106; Han L, 2010, ANN HEMATOL, V89, P861, DOI 10.1007/s00277-010-0948-7; Higashi T, 2004, AM J HEMATOL, V76, P275, DOI 10.1002/ajh.20096; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hochhaus A, 2007, SEMIN HEMATOL, V44, pS15, DOI 10.1053/j.seminhematol.2006.12.002; Horn M, 2008, CELLS TISSUES ORGANS, V188, P236, DOI 10.1159/000118786; Ito T, 2013, INT J HEMATOL, V98, P641, DOI 10.1007/s12185-013-1318-8; Jackson RC, 2014, CANCER CHEMOTH PHARM, V74, P765, DOI 10.1007/s00280-014-2556-z; Kantarjian HM, 2006, ANN INTERN MED, V145, P913, DOI 10.7326/0003-4819-145-12-200612190-00008; Kim PS, 2008, B MATH BIOL, V70, P1994, DOI 10.1007/s11538-008-9336-z; Kim PS, 2008, B MATH BIOL, V70, P728, DOI 10.1007/s11538-007-9276-z; Kim PS, 2007, J THEOR BIOL, V246, P33, DOI 10.1016/j.jtbi.2006.12.012; Kim PS, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000095; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Komarova NL, 2009, CANCER RES, V69, P4904, DOI 10.1158/0008-5472.CAN-08-1959; Komarova NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004423; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Korfi K, 2015, ANN ONCOL, V26, P1180, DOI 10.1093/annonc/mdv110; Leder K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027682; Lenaerts T, 2010, HAEMATOL-HEMATOL J, V95, P900, DOI 10.3324/haematol.2009.015271; MacLean AL, 2014, P NATL ACAD SCI USA, V111, P3883, DOI 10.1073/pnas.1317072111; Mauro MJ, 2004, LEUKEMIA RES, V28, pS71, DOI 10.1016/j.leukres.2003.10.017; Merante S, 2005, HAEMATOLOGICA, V90, P979; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Michor F, 2007, TRENDS PHARMACOL SCI, V28, P197, DOI 10.1016/j.tips.2007.03.003; Michor F, 2007, STEM CELLS, V25, P1114, DOI 10.1634/stemcells.2006-0638; Mustjoki S, 2013, LEUKEMIA, V27, P1520, DOI 10.1038/leu.2013.19; Olshen A, 2014, HAEMATOLOGICA, V99, P1701, DOI 10.3324/haematol.2013.085977; Paquin D, 2011, B MATH BIOL, V73, P1082, DOI 10.1007/s11538-010-9553-0; Roeder I, 2008, J MOL MED, V86, P17, DOI 10.1007/s00109-007-0241-y; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; Roeder I, 2006, CURR OPIN HEMATOL, V13, P222, DOI 10.1097/01.moh.0000231418.08031.48; Roeder I, 2009, B MATH BIOL, V71, P602, DOI 10.1007/s11538-008-9373-7; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Shieh MP, 2011, CLIN MED INSIGHTS-ON, V5, P185, DOI 10.4137/CMO.S6416; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Tang M, 2011, BLOOD, V118, P1622, DOI 10.1182/blood-2011-02-339267; Tomasetti C, 2010, P NATL ACAD SCI USA, V107, P16766, DOI 10.1073/pnas.1007726107; Ursan LD, 2015, J MANAG CARE SPEC PH, V21, P114; Weissman I., 2015, PHILOS T R SOC LON B, V370, P1680, DOI DOI 10.1098/RSTB.2014.0364; Wodarz D, 2005, SEMIN CANCER BIOL, V15, P506, DOI 10.1016/j.semcancer.2005.07.002; Wodarz D, 2008, MED HYPOTHESES, V70, P128, DOI 10.1016/j.mehy.2007.03.040	75	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179700	10.1371/journal.pone.0179700	http://dx.doi.org/10.1371/journal.pone.0179700			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678800	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200023
J	Spaans, F; Kao, CK; Morton, JS; Quon, AL; Sawamura, T; Tannetta, DS; Sargent, IL; Davidge, ST				Spaans, Floor; Kao, Cindy K.; Morton, Jude S.; Quon, Anita L.; Sawamura, Tatsuya; Tannetta, Dionne S.; Sargent, Ian L.; Davidge, Sandra T.			Syncytiotrophoblast extracellular vesicles impair rat uterine vascular function via the lectin-like oxidized LDL receptor-1	PLOS ONE			English	Article							MULTICOLOR FLOW-CYTOMETRY; NITRIC-OXIDE; ENDOTHELIAL-CELLS; RESISTANCE ARTERIES; OXIDATIVE STRESS; OX-LDL; LOX-1; MICROPARTICLES; DYSFUNCTION; PLASMA	Syncytiotrophoblast extracellular vesicles (STBEVs) are placenta derived particles that are released into the maternal circulation during pregnancy. Abnormal levels of STBEVs have been proposed to affect maternal vascular function. The lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a multi-ligand scavenger receptor. Increased LOX-1 expression and activation has been proposed to contribute to endothelial dysfunction. As LOX-1 has various ligands, we hypothesized that, being essentially packages of lipoproteins, STBEVs are able to activate the LOX-1 receptor thereby impairing vascular function via the production of superoxide and decreased nitric oxide bioavailability. Uterine arteries were obtained in late gestation from Sprague-Dawley rats and incubated for 24h with or without human STBEVs (derived from a normal pregnant placenta) in the absence or presence of a LOX-1 blocking antibody. Vascular function was assessed using wire myography. Endothelium-dependent maximal vasodilation to methylcholine was impaired by STBEVs (MCh E-max: 57.7 +/- 5.9% in STBEV-incubated arteries vs. 77.8 +/- 2.9% in controls, p< 0.05). This was prevented by co-incubation of STBEV-incubated arteries with LOX-1 blocking antibodies (MCh E-max: 78.8 +/- 4.3%, p<0.05). Pre-incubation of the vessels with a nitric oxide synthase inhibitor (L-NAME) demonstrated that the STBEV-induced impairment in vasodilation was due to decreased nitric oxide contribution (Delta AUC 12.2 +/- 11.7 in STBEV-arteries vs. 86.5 +/- 20 in controls, p<0.05), which was abolished by LOX-1 blocking antibody (Delta AUC 98.9 +/- 17, p<0.05). In STBEV-incubated vessels, LOX-1 inhibition resulted in an increased endothelial nitric oxide synthase expression (p<0.05), to a level similar to control vessels. The oxidant scavenger, superoxide dismutase, did not improve this impairment, nor were vascular superoxide levels altered. Our data support an important role for STBEVs in impairment of vascular function via activation of LOX-1 and reduced nitric oxide mediated vasodilation. Moreover, we postulate that the LOX-1 pathway could be a potential therapeutic target in pathologies associated with vascular dysfunction during pregnancy.	[Spaans, Floor; Kao, Cindy K.; Morton, Jude S.; Quon, Anita L.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Spaans, Floor; Kao, Cindy K.; Morton, Jude S.; Quon, Anita L.; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Sawamura, Tatsuya] Shinshu Univ, Sch Med, Dept Physiol, Asahi Ku, Matsumoto, Nagano, Japan; [Tannetta, Dionne S.; Sargent, Ian L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; Shinshu University; University of Oxford; University of Alberta	Davidge, ST (corresponding author), Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada.; Davidge, ST (corresponding author), Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.; Davidge, ST (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	sandra.davidge@ualberta.ca		Davidge, Sandra/0000-0002-5559-4905	Canadian Institutes of Health Research (CIHR) [MOP142320]; Women and Children's Health Research Institute (WCHRI) through generosity of the Stollery Children's Hospital Foundation; Lois Hole Hospital for Women; Medical Research Council Programme [MR/J003360/1]; Post graduate Fellowship award from Alberta Innovates-Health Solutions (AIHS) [PF 201400457]; Dr. Kaobya Clinical Investigator Program of Alberta Health Services (AHS); MRC [MR/J003360/1] Funding Source: UKRI; Medical Research Council [MR/J003360/1] Funding Source: researchfish; Alberta Innovates [201400457] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute (WCHRI) through generosity of the Stollery Children's Hospital Foundation; Lois Hole Hospital for Women; Medical Research Council Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Post graduate Fellowship award from Alberta Innovates-Health Solutions (AIHS); Dr. Kaobya Clinical Investigator Program of Alberta Health Services (AHS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Alberta Innovates	This study was funded by grants from Canadian Institutes of Health Research (CIHR; MOP142320), by the Women and Children's Health Research Institute (WCHRI) through the generosity of the Stollery Children's Hospital Foundation and supporters of the Lois Hole Hospital for Women, and by the Medical Research Council Programme grant MR/J003360/1. Dr. Spaans was funded by a Post graduate Fellowship award from Alberta Innovates-Health Solutions (AIHS; PF 201400457), and Dr. Kaobya Clinical Investigator Program of Alberta Health Services (AHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106540; Buchwalow IB, 2002, FASEB J, V16, P500, DOI 10.1096/fj.01-0842com; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen XP, 2007, VASC PHARMACOL, V47, P1, DOI 10.1016/j.vph.2007.01.004; Chen Y, 2012, INT J GYNECOL OBSTET, V119, P234, DOI 10.1016/j.ijgo.2012.07.010; Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Cominacini L, 2001, J BIOL CHEM, V276, P13750, DOI 10.1074/jbc.M010612200; Dragovic RA, 2015, METHODS, V87, P64, DOI 10.1016/j.ymeth.2015.03.028; Dragovic RA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113266; Eichhorn B, 2009, CARDIOVASC RES, V82, P493, DOI 10.1093/cvr/cvp089; English FA, 2013, AM J HYPERTENS, V26, P279, DOI 10.1093/ajh/hps035; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gohner C, 2015, AM J REPROD IMMUNOL, V73, P582, DOI 10.1111/aji.12367; Goulopoulou S, 2015, TRENDS MOL MED, V21, P88, DOI 10.1016/j.molmed.2014.11.009; Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006; Kertesz Z, 2000, PLACENTA, V21, P150, DOI 10.1053/plac.1999.0476; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Lok CAR, 2008, HYPERTENS PREGNANCY, V27, P344, DOI 10.1080/10641950801955733; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Morton JS, 2012, HYPERTENSION, V59, P1014, DOI 10.1161/HYPERTENSIONAHA.112.191825; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Pirillo A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152786; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Ryoo S, 2011, ATHEROSCLEROSIS, V214, P279, DOI 10.1016/j.atherosclerosis.2010.10.044; Sakamoto N, 2009, J CELL PHYSIOL, V220, P706, DOI 10.1002/jcp.21818; Sankaralingam S, 2009, HYPERTENSION, V53, P270, DOI 10.1161/HYPERTENSIONAHA.108.122630; Sawamura T, 2012, CURR OPIN LIPIDOL, V23, P439, DOI 10.1097/MOL.0b013e32835688e4; Shin HK, 2004, CIRCULATION, V109, P1022, DOI 10.1161/01.CIR.0000117403.64398.53; van der Post JAM, 2011, SEMIN THROMB HEMOST, V37, P146, DOI 10.1055/s-0030-1270342; Van Wijk MJ, 2001, BRIT J OBSTET GYNAEC, V108, P967; VanWijk MJ, 2002, AM J OBSTET GYNECOL, V187, P1686, DOI 10.1067/mob.2002.127905; Welter H, 2004, REPROD FERT DEVELOP, V16, P689, DOI 10.1071/RD03103; Xu L, 2015, J CELL MOL MED, V19, P92, DOI 10.1111/jcmm.12463; Xu X, 2007, THROMB VASC BIOL, V27, P871, DOI DOI 10.1161/01.ATV.0000259358.31234.37; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180364	10.1371/journal.pone.0180364	http://dx.doi.org/10.1371/journal.pone.0180364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672042	Green Submitted, gold, Green Published			2022-12-27	WOS:000405268500047
J	Thothathiri, M; Evans, DG; Poudel, S				Thothathiri, Malathi; Evans, Daniel G.; Poudel, Sonali			Verb bias and verb-specific competition effects on sentence production	PLOS ONE			English	Article							SYNTACTIC FLEXIBILITY; LANGUAGE PRODUCTION; VISUAL SCENE; COMPREHENSION; EXPERIENCE; CONSTRAINTS; INFORMATION; RESOLUTION; PATTERNS; REFLECT	How do speakers choose between structural options for expressing a given meaning? Overall preference for some structures over others as well as prior statistical association between specific verbs and sentence structures ("verb bias") are known to broadly influence language use. However, the effects of prior statistical experience on the planning and execution of utterances and the mechanisms that facilitate structural choice for verbs with different biases have not been fully explored. In this study, we manipulated verb bias for English doubleobject (DO) and prepositional-object (PO) dative structures: some verbs appeared solely in the DO structure (DO-only), others solely in PO (PO-only) and yet others equally in both (Equi). Structural choices during subsequent free-choice sentence production revealed the expected dispreference for DO overall but critically also a reliable linear trend in DO production that was consistent with verb bias (DO-only > Equi > PO-only). Going beyond the general verb bias effect, three results suggested that Equi verbs, which were associated equally with the two structures, engendered verb-specific competition and required additional resources for choosing the dispreferred DO structure. First, DO production with Equi verbs but not the other verbs correlated with participants' inhibition ability. Second, utterance duration prior to the choice of a DO structure showed a quadratic trend (DO-only < Equi > PO-only) with the longest durations for Equi verbs. Third, eye movements consistent with reimagining the event also showed a quadratic trend (DO-only < Equi > PO-only) prior to choosing DO, suggesting that participants used such recall particularly for Equi verbs. Together, these analyses of structural choices, utterance durations, eye movements and individual differences in executive functions shed light on the effects of verb bias and verb-specific competition on sentence production and the role of different executive functions in choosing between sentence structures.	[Thothathiri, Malathi; Evans, Daniel G.; Poudel, Sonali] George Washington Univ, Dept Speech Language & Hearing Sci, Washington, DC 20052 USA	George Washington University	Thothathiri, M (corresponding author), George Washington Univ, Dept Speech Language & Hearing Sci, Washington, DC 20052 USA.	malathi@gwu.edu		Thothathiri, Malathi/0000-0002-6449-405X; Evans, Daniel/0000-0003-3809-157X				Abutalebi J, 2013, CORTEX, V49, P905, DOI 10.1016/j.cortex.2012.08.018; Barr DJ, 2008, J MEM LANG, V59, P457, DOI 10.1016/j.jml.2007.09.002; Brandt SA, 1997, J COGNITIVE NEUROSCI, V9, P27, DOI 10.1162/jocn.1997.9.1.27; Branigan HP, 2007, COGNITION, V104, P163, DOI 10.1016/j.cognition.2006.05.006; Coyle JM, 2008, PSYCHON B REV, V15, P967, DOI 10.3758/PBR.15.5.967; Ferreira VS, 2013, Q J EXP PSYCHOL, V66, P1548, DOI 10.1080/17470218.2012.753924; Ferreira VS, 1996, J MEM LANG, V35, P724, DOI 10.1006/jmla.1996.0038; Fine AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077661; Gahl S, 2004, LANGUAGE, V80, P748, DOI 10.1353/lan.2004.0185; Garnsey SM, 1997, J MEM LANG, V37, P58, DOI 10.1006/jmla.1997.2512; Hwang H, 2014, LANG COGN NEUROSCI, V29, P1115, DOI 10.1080/23273798.2013.875212; Jaeger TF, 2010, COGNITIVE PSYCHOL, V61, P23, DOI 10.1016/j.cogpsych.2010.02.002; Kaschak MP, 2007, MEM COGNITION, V35, P925, DOI 10.3758/BF03193466; Konopka AE, 2012, J MEM LANG, V66, P143, DOI 10.1016/j.jml.2011.08.003; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Luk G, 2012, LANG COGNITIVE PROC, V27, P1479, DOI 10.1080/01690965.2011.613209; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Myachykov A, 2013, Q J EXP PSYCHOL, V66, P1601, DOI 10.1080/17470218.2012.754910; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; Pernet CR, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00606; Pettigrew C, 2016, Q J EXP PSYCHOL, V69, P2431, DOI 10.1080/17470218.2015.1121282; Snedeker J, 2004, COGNITIVE PSYCHOL, V49, P238, DOI 10.1016/j.cogpsych.2004.03.001; Stallings LM, 1998, J MEM LANG, V39, P392, DOI 10.1006/jmla.1998.2586; Thothathiri M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00404; Thothathiri M, 2015, P NATL ACAD SCI USA, V112, P15456, DOI 10.1073/pnas.1514711112; TRUESWELL JC, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P155; Twomey KE, 2016, COGNITION, V153, P124, DOI 10.1016/j.cognition.2016.05.001; van de Velde M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01174; Vandierendonck A, 2010, PSYCHOL BULL, V136, P601, DOI 10.1037/a0019791; Wells JB, 2009, COGNITIVE PSYCHOL, V58, P250, DOI 10.1016/j.cogpsych.2008.08.002; Wilson MP, 2009, J MEM LANG, V60, P368, DOI 10.1016/j.jml.2008.09.005; Wonnacott E, 2008, COGNITIVE PSYCHOL, V56, P165, DOI 10.1016/j.cogpsych.2007.04.002	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180580	10.1371/journal.pone.0180580	http://dx.doi.org/10.1371/journal.pone.0180580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA2JX	28672009	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500072
J	Zhou, SD; Du, XX; Xie, JX; Wang, J				Zhou, Shida; Du, Xinxing; Xie, Junxia; Wang, Jun			Interleukin-6 regulates iron-related proteins through c-Jun N-terminal kinase activation in BV2 microglial cell lines	PLOS ONE			English	Article							PARKINSONS-DISEASE; INTRACEREBRAL HEMORRHAGE; SIGNALING PATHWAYS; FACTOR-ALPHA; EXPRESSION; MODEL; INFLAMMATION; NEURONS; STRESS; NEURODEGENERATION	Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic (DA) neurons in the substantia nigra (SN) and subsequent DA depletion in the striatum. Microglia activation and nigral iron accumulation play important roles in the pathogenesis of PD. Activated microglia show increased iron deposits. However, the relationship between microglia activation and iron accumulation remains unclear. In the present study, we aimed to determine how iron levels affect interleukin-6 (IL-6) synthesis, and the effect of IL-6 on cellular iron metabolism in BV2 microglial cells. IL-6 mRNA was up-regulated after FAC treatment for 12 h in BV2 cells. Iron regulatory protein 1 (IRP1) and divalent metal transporter 1 (DMT1) were up-regulated and iron exporter ferroportin 1 (FPN1) was down-regulated in BV2 cells after 24 h of IL-6 treatment. Phosphorylated JNK increased significantly compared to the control after BV2 cells were treated with IL-6 for 1 h. Pretreatment with SP600125 attenuated the up-regulation of IRP1 and DMT1 and down-regulation of FPN1 (compared to IL-6-treated group). These results suggest that iron load could increase IL-6 mRNA expression in BV2 cells. Further, IL-6 likely up-regulates IRP1 and DMT1 expression and down-regulates FPN1 expression in BV2 microglial cells through JNK signaling pathways.	[Zhou, Shida; Xie, Junxia; Wang, Jun] Qingdao Univ, Coll Med, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao, Peoples R China; [Zhou, Shida; Xie, Junxia; Wang, Jun] Qingdao Univ, Coll Med, State Key Disciplines Physiol, Qingdao, Peoples R China; [Du, Xinxing] Qingdao Univ, Coll Med, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Xie, JX; Wang, J (corresponding author), Qingdao Univ, Coll Med, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao, Peoples R China.; Xie, JX; Wang, J (corresponding author), Qingdao Univ, Coll Med, State Key Disciplines Physiol, Qingdao, Peoples R China.	jxiaxie@public.qd.sd.cn; junwangqdu@163.com		Zhou, Shida/0000-0002-9493-9072	National Natural Science Foundation of China [31571054, 81430024]; Excellent InnovativeTeam of Shandong Province; Taishan Scholars Construction Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent InnovativeTeam of Shandong Province; Taishan Scholars Construction Project	z This work was supported by the National Natural Science Foundation of China (31571054, 81430024), Excellent InnovativeTeam of Shandong Province and Taishan Scholars Construction Project to JW and JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414; Chuang JY, 2014, INT J MOL SCI, V15, P545, DOI 10.3390/ijms15010545; Coffey ET, 2014, NAT REV NEUROSCI, V15, P285, DOI 10.1038/nrn3729; Du F, 2011, GLIA, V59, P936, DOI 10.1002/glia.21166; Ferrer I, 2001, J NEURAL TRANSM, V108, P1383, DOI 10.1007/s007020100015; Ferrer I, 2001, J NEURAL TRANSM, V108, P1397, DOI 10.1007/s007020100016; Gayle DA, 2002, DEV BRAIN RES, V133, P27, DOI 10.1016/S0165-3806(01)00315-7; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GOOSSEN B, 1990, EMBO J, V9, P4127, DOI 10.1002/j.1460-2075.1990.tb07635.x; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gozzelino R, 2012, CELL HOST MICROBE, V12, P693, DOI 10.1016/j.chom.2012.10.011; Hare DJ, 2016, BRAIN, V139, P1026, DOI 10.1093/brain/aww022; Hua Y., 2017, INT J HEMATOL, P1; Jiang H, 2010, CELL RES, V20, P345, DOI 10.1038/cr.2010.20; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; Lee Y, 2015, BRAIN RES, V1627, P233, DOI 10.1016/j.brainres.2015.09.029; Maria Erta AQ, 2011, INT J BIOL SCI, V8, P1254; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Nagatsu T, 2000, CHANGES CYTOKINES NE, P265; Ni W, 2015, EXP NEUROL, V272, P128, DOI 10.1016/j.expneurol.2015.02.035; Nunez MT, 2012, BIOMETALS, V25, P761, DOI 10.1007/s10534-012-9523-0; Oh ES, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.051207; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Qin XY, 2016, JAMA NEUROLOGY, V73; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Song N, 2010, FREE RADICAL BIO MED, V48, P332, DOI 10.1016/j.freeradbiomed.2009.11.004; Wang G, 2012, PROG NEUROBIOL, V98, P207, DOI 10.1016/j.pneurobio.2012.06.003; Wang J, 2013, BBA-MOL BASIS DIS, V1832, P618, DOI 10.1016/j.bbadis.2013.01.021; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Yao L, 2016, J CELLULAR BIOCH, V118; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang K, 2011, NEUROPHARMACOLOGY, V61, P329, DOI 10.1016/j.neuropharm.2011.04.021; Zhang W, 2014, MOL NEUROBIOL, V49, P1153, DOI 10.1007/s12035-013-8586-4	38	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180464	10.1371/journal.pone.0180464	http://dx.doi.org/10.1371/journal.pone.0180464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672025	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500055
J	Ellinas, C; Allan, N; Johansson, A				Ellinas, Christos; Allan, Neil; Johansson, Anders			Dynamics of organizational culture: Individual beliefs vs. social conformity	PLOS ONE			English	Article							MODEL; SCIENCE; NETWORKS; BALANCE; POWER; TIME	The complex nature of organizational culture challenges our ability to infer its underlying dynamics from observational studies. Recent computational studies have adopted a distinctly different view, where plausible mechanisms are proposed to describe a wide range of social phenomena, including the onset and evolution of organizational culture. In this spirit, this work introduces an empirically-grounded, agent-based model which relaxes a set of assumptions that describes past work-(a) omittance of an individual's strive for achieving cognitive coherence; (b) limited integration of important contextual factors-by utilizing networks of beliefs and incorporating social rank into the dynamics. As a result, we illustrate that: (i) an organization may appear to be increasingly coherent in terms of its organizational culture, yet be composed of individuals with reduced levels of coherence; (ii) the components of social conformity D peer-pressure and social rank D are influential at different aggregation levels.	[Ellinas, Christos] Univ Bristol, Engn Math, Bristol, Avon, England; [Ellinas, Christos; Allan, Neil] Syst Consult Ltd, Bradford On Avon, England; [Allan, Neil; Johansson, Anders] Univ Bristol, Syst IDC, Bristol, Avon, England	University of Bristol; University of Bristol	Ellinas, C (corresponding author), Univ Bristol, Engn Math, Bristol, Avon, England.; Ellinas, C (corresponding author), Syst Consult Ltd, Bradford On Avon, England.	ce12183@bristol.ac.uk		Ellinas, Christos/0000-0001-5146-6554	Engineering and Physical Sciences Research Council (EPSRC), UK [EP/G037353/1]; EPSRC Doctoral Prize fellowship; Systemic Consult Ltd; Engineering and Physical Sciences Research Council [1224532] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC), UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Doctoral Prize fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Systemic Consult Ltd; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	CE was partially funded by the Engineering and Physical Sciences Research Council (EPSRC), UK (http://www.epsrc.ac.uk/) under the grant EP/G037353/1, an EPSRC Doctoral Prize fellowship and Systemic Consult Ltd (http://www.systemicconsult.com/). Systemic Consult Ltd provided support in the form of salaries for authors CE and NA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2009, OXFORD HDB ANAL SOCI; Antal T, 2006, PHYSICA D, V224, P130, DOI 10.1016/j.physd.2006.09.028; Ashworth M. J., 2007, Computational & Mathematical Organization Theory, V13, P89, DOI 10.1007/s10588-006-9000-9; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; Barabasi AL, 2012, NATURE, V489, P507, DOI 10.1038/nature11486; Blondel VD, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0046-0; Borgatti SP, 2003, J MANAGE, V29, P991, DOI 10.1016/S0149-2063(03)00087-4; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Bresman H, 2013, ORGAN SCI, V24, P1120, DOI 10.1287/orsc.1120.0783; Bunderson JS, 2011, ORGAN SCI, V22, P1182, DOI 10.1287/orsc.1100.0590; Bunderson JS, 2010, ORGAN SCI, V21, P609, DOI 10.1287/orsc.1090.0483; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Castellano C, 2000, PHYS REV LETT, V85, P3536, DOI 10.1103/PhysRevLett.85.3536; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; Chatman JA, 2016, RES ORG BEHAV; Cramton CD, 2014, ORGAN SCI, V25, P1056, DOI 10.1287/orsc.2013.0885; Cronin KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep18634; Earley PC, 2000, ACAD MANAGE J, V43, P26, DOI 10.2307/1556384; ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382; Festinger L., 1962, THEORY COGNITIVE DIS; Fioretti G, 2013, ORGAN RES METHODS, V16, P227, DOI 10.1177/1094428112470006; Fleming P, 2014, ACAD MANAG ANN, V8, P237, DOI 10.1080/19416520.2014.875671; Gavetti G, 2015, ORGAN SCI, V26, P1263, DOI 10.1287/orsc.2015.0987; Ghosh A, 2015, ORGAN SCI, V26, P622, DOI 10.1287/orsc.2014.0922; Goel S, 2015, MANAGEMENT SCI; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Guerra B, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056105; Hanaki N, 2007, MANAGE SCI, V53, P1036, DOI 10.1287/mnsc.1060.0625; HOFSTEDE G, 1980, ORGAN DYN, V9, P42, DOI 10.1016/0090-2616(80)90013-3; Holme P, 2015, FRONT PHYS-LAUSANNE, V3, DOI 10.3389/fphy.205.00078; Kopecki D, 2013, BLOOMBERG NEWS; Kovanen L, 2013, P NATL ACAD SCI USA, V110, P18070, DOI 10.1073/pnas.1307941110; Kozlowski SW, 2013, ADVANCING MULTILEVEL; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lewis H, 2014, ENGAGING RISK; Macy MW, 2002, ANNU REV SOCIOL, V28, P143, DOI 10.1146/annurev.soc.28.110601.141117; Marvel SA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198701; MCADAM D, 1986, AM J SOCIOL, V92, P64, DOI 10.1086/228463; MCADAM D, 1993, AM J SOCIOL, V99, P640, DOI 10.1086/230319; Mitchell TR, 2001, ACAD MANAGE REV, V26, P530, DOI 10.2307/3560240; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Omar N, 2015, PROC ECON FINANC, V31, P367, DOI 10.1016/S2212-5671(15)01211-3; Rodriguez N., 2015, ARXIV150901502; Roe RA, 2008, EUR PSYCHOL, V13, P37, DOI 10.1027/1016-9040.13.1.37; Ruan ZY, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.218702; Schaefer Steve, 2012, FORBES; Schein E. H., 2010, ORG CULTURE LEADERSH, V4th; Schilke O, 2015, P NATL ACAD SCI USA, V112, P12950, DOI 10.1073/pnas.1517057112; Takaguchi T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036115; Vancouver JB, 2012, ORGAN RES METHODS, V15, P602, DOI 10.1177/1094428112449655; Viswanatha A, 2013, LONDON WHALE FINE RE; Wallace J., 1999, INT J PUBLIC SECT MA, V12, P548, DOI [DOI 10.1108/09513559910305339, 10.1108/09513559910305339]; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; Watts DJ, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0015; Willinger W, 2002, P NATL ACAD SCI USA, V99, P2573, DOI 10.1073/pnas.012583099; Yamanoi J, 2013, COMPUT MATH ORGAN TH, V19, P516, DOI 10.1007/s10588-012-9139-5; ZALESNY MD, 1987, ACAD MANAGE J, V30, P240, DOI 10.2307/256272	63	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180193	10.1371/journal.pone.0180193	http://dx.doi.org/10.1371/journal.pone.0180193			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665960	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608700069
J	Lin, KY; Cheng, CY; Li, CW; Yang, CJ; Tsai, MS; Liu, CE; Lee, YT; Tang, HJ; Wang, NC; Lin, TY; Lee, YC; Lin, SP; Huang, YS; Zhang, JY; Ko, WC; Cheng, SH; Hung, CC				Lin, Kuan-Yin; Cheng, Chien-Yu; Li, Chia-Wen; Yang, Chia-Jui; Tsai, Mao-Song; Liu, Chun-Eng; Lee, Yuan-Ti; Tang, Hung-Jen; Wang, Ning-Chi; Lin, Te-Yu; Lee, Yi-Chien; Lin, Shih-Ping; Huang, Yu-Shan; Zhang, Jun-Yu; Ko, Wen-Chien; Cheng, Shu-Hsing; Hung, Chien-Ching		Taiwan HIV Study Grp	Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; HEPATITIS-B-VIRUS; TREATMENT RESPONSE; CELL COUNT; INFECTION; PREVALENCE; ADULTS; CARE	Objectives The international and national HIV treatment guidelines in 2016 have focused on scaling up access to combination antiretroviral therapy (cART). We aimed to assess the trends and treatment outcomes of late cART initiation in Taiwan. Methods Between June 2012 and May 2016, we retrospectively included antiretroviral-naive HIV-positive adults who initiated cART. Late initiation was defined as when cART was initiated in patients with a CD4 count <200 cells/mm(3) or having experienced AIDS-defining illnesses. The treatment outcomes were assessed up to 6 months after starting cART. Results We included 3655 HIV-positive patients, and the majority of the patients were male (95.4%) with a median age of 31 years and initiated non-nucleoside reverse-transcriptase inhibitor-containing regimens (87.0%). The median CD4 count at cART initiation increased from 207 cells/mm 3 in 2012 to 298 cells/mm 3 in 2016, and the overall proportion of late cART initiation decreased from 49.1% in 2012 to 29.0% in 2016 (P for trend <0.001). Late cART initiation mainly resulted from late presentation for HIV care and was associated with older age (per 1-year increase, adjusted odds ratio [AOR], 1.05; 95% CI, 1.04-1.06), HBsAg seropositivity (AOR, 1.31; 95% CI, 1.04-1.64), HIV care in central and southern Taiwan, initiating cART in earlier year, non-intravenous drug users (AOR, 1.96; 95% CI, 1.33-2.86), and negative hepatitis C serostatus (AOR, 1.47; 95% CI, 1.04-2.08). Compared with non-late initiators, late initiators had a higher rate of all-cause mortality (1.7% vs. 0.3%) and regimen modification due to virological failure (7.1% vs. 2.6%). The predicting factors of all-cause mortality were late cART initiation (adjusted hazard ratio [AHR], 5.40; 95% CI, 2.14-13.65) and older age (AHR, 1.06; 95% CI, 1.03-1.10). Conclusions While the proportion of late cART initiation decreased over time in Taiwan, late initiation remained in a substantial proportion of HIV-positive patients. The late initiators had higher risk for poor outcomes. The need for strategies to earlier detection of HIV infection and expediting cART initiation should be highlighted, especially among the older population.	[Lin, Kuan-Yin] Natl Taiwan Univ Hosp, Dept Med, Jin Shan Branch, New Taipei, Taiwan; [Cheng, Chien-Yu; Cheng, Shu-Hsing] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Internal Med, Taoyuan, Taiwan; [Cheng, Chien-Yu] Natl Yang Ming Univ, Sch Publ Hlth, Taipei, Taiwan; [Li, Chia-Wen; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Li, Chia-Wen; Ko, Wen-Chien] Natl Cheng Kung Univ, Dept Med, Med Coll, Tainan, Taiwan; [Yang, Chia-Jui; Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Yang, Chia-Jui] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Liu, Chun-Eng] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan; [Lee, Yuan-Ti] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, Yuan-Ti] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Wang, Ning-Chi; Lin, Te-Yu] Triserv Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Wang, Ning-Chi; Lin, Te-Yu] Natl Def Med Ctr, Taipei, Taiwan; [Lee, Yi-Chien] Ditmanson Med Fdn, Chia Yi Christian Hosp, Dept Internal Med, Chiayi, Taiwan; [Lin, Shih-Ping] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Huang, Yu-Shan] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Zhang, Jun-Yu] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan; [Cheng, Shu-Hsing] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Tri-Service General Hospital; National Defense Medical Center; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Cheng, SH (corresponding author), Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Internal Med, Taoyuan, Taiwan.; Cheng, SH (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.; Hung, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Hung, CC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Hung, CC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei, Taiwan.; Hung, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Hung, CC (corresponding author), China Med Univ, Taichung, Taiwan.	shuhsingcheng@gmail.com; hcc0401@ntu.edu.tw	cheng, chien-yu/M-1108-2019; Wang, Ning-Chi/GLT-7544-2022; Lee, Yuan-Ti/ABH-7837-2020; Ko, Wen-Chien/ABG-4316-2020	cheng, chien-yu/0000-0002-1886-0370; Lee, Yuan-Ti/0000-0003-4577-4379; Ko, Wen-Chien/0000-0001-7497-149X; Lin, Kuan-Yin/0000-0001-6877-5345; Huang, Yu-Shan/0000-0002-9047-5709	Taiwan Centers for Disease Control [MOHW103-CDC-C-114-000405]	Taiwan Centers for Disease Control	The authors would like to thank Taiwan Centers for Disease Control for research grant support (grant number MOHW103-CDC-C-114-000405 to C.-C. H.). The funding source played no role in study design and conduct, data collection, analysis or interpretation, writing of the manuscript, or the decision to submit it for publication. The authors also thank all study members participating in the Taiwan HIV Study Group: Hsin-Yun Sun, Sui-Yuan Chang, Pei-Ying Wu, Jun-Yu Zhang, Hsi-Yen Chang, Wen-Chun Liu, Yi-Ching Su, and Chien-Ching Hung , National Taiwan University Hospital, Taipei; Ning-Chi Wang and Te-Yu Lin, Tri-Service General Hospital and National Defense Medical Center, Taipei; Kuan-Yin Lin, National Taiwan University Hospital Jin-Shan Branch, New Taipei City; Chia-Jui Yang, and Mao-Song Tsai, Far Eastern Memorial Hospital, New Taipei City; Yi-Chieh Lee, Lotung Poh-Ai Hospital, Lo-Hsu Foundation, I-Lan; Chien-Yu Cheng and Shu-Hsing Cheng, Tao-Yuan General Hospital, Ministry of Health and Welfare, Tao-Yuan; Yu-Shan Huang, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu; Yuan-Ti Lee and Chia-Chun Lin, Chung Shan Medical University Hospital, Taichung; Shih-Ping Lin, Chia-Yin Hsieh, and Hsiu-Wen Wang, Taichung Veterans General Hospital, Taichung; Mao-Wang Ho, China Medical University Hospital, Taichung; Chun-Eng Liu and Yu-Lin Lee, Changhua Christian Hospital, Changhua; Yi-Chien Lee, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi; Hung-Jen Tang and Huei-Chun Ku, Chi Mei Medical Center, Tainan; Chia-Wen Li, Nan-Yao Lee, and Wen-Chien Ko, National Cheng Kung University Hospital, Tainan; Po-Liang Lu and Yen-Hsu Chen, Kaohsiung Medical University Hospital, Kaohsiung; Hsi-Hsun Lin, E-Da Hospital, Kaohsiung; Wen-Chi Huang and Chen-Hsiang Lee, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung; Tun-Chieh Chen, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung.; The authors would like to thank Taiwan Centers for Disease Control for research grant support (grant number MOHW103-CDC-C-114-000405 to C.-C. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control, 2013, GUID DIAGN TREATM HI; Centers for Disease Control R. O. C. (Taiwan), 2014, STAT COMM DIS SURV R; Chang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep35779; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Edwards JK, 2015, CLIN INFECT DIS, V61, P1189, DOI 10.1093/cid/civ463; Ford N, 2015, CLIN INFECT DIS, V60, P1128, DOI 10.1093/cid/ciu1138; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Harwood RH, 2014, AGE AGEING, V43, P308, DOI 10.1093/ageing/afu016; Huang SM, 2016, INT J STD AIDS, V27, P890, DOI 10.1177/0956462415600570; Kiertiburanakul S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18804; Lahuerta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037125; Lai CC, 2016, J ANTIMICROB CHEMOTH, V71, P226, DOI 10.1093/jac/dkv284; Lai CC, 2012, J ANTIMICROB CHEMOTH, V67, P1254, DOI 10.1093/jac/dkr601; Lesko CR, 2013, CLIN INFECT DIS, V57, P1027, DOI 10.1093/cid/cit421; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Lourenco L, 2015, HIV MED, V16, P337, DOI 10.1111/hiv.12212; Ministry of Health and Welfare R. O. C. (Taiwan), 2008, DENS MED RES TAIW; Ministry of the Interior R. O. C. (Taiwan), 2016, ED LEV TABL TAIW; Mutimura E, 2015, AIDS, V29, P67, DOI 10.1097/QAD.0000000000000520; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Perez-Molina JA, 2012, J ANTIMICROB CHEMOTH, V67, P312, DOI 10.1093/jac/dkr478; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Tsai MS, 2013, J INFECT DIS, V208, P1184, DOI 10.1093/infdis/jit299; UNAIDS/WHO, 2013, REP GLOB AIDS EP; UNAIDS/WHO, 2016, GLOB AIDS UPD; UNAIDS/WHO, 2016, CONGUID UANT DRU; UNAIDS/ WHO, 2013, HIV AS PAC; UNAIDS/ WHO, 2014, 90 90 90 AMB TREATM; UNAIDS/ WHO, 2013, CONGUID UANT DRU; UNAIDS/ WHO, 2010, ANT THER HIV INF AD; World Bank, 2016, COUNTR LEND GROUPS; Wright ST, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19463; Wu PY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171596	35	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179870	10.1371/journal.pone.0179870	http://dx.doi.org/10.1371/journal.pone.0179870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665938	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700042
J	Rudolf, G; Tul, N; Verdenik, I; Volk, M; Brezigar, A; Vokac, NK; Jersin, N; Prosenc, B; Srsen, TP; Peterlin, B				Rudolf, Gorazd; Tul, Natasa; Verdenik, Ivan; Volk, Marija; Brezigar, Anamarija; Vokac, Nadja Kokalj; Jersin, Natasa; Prosenc, Bernarda; Srsen, Tanja Premru; Peterlin, Borut			Impact of prenatal screening on the prevalence of Down syndrome in Slovenia	PLOS ONE			English	Article							MATERNAL AGE; TRENDS	Objectives To evaluate the impact of prenatal screening and genetic testing for trisomy 21 (T21) on the prevalence of T21 in Slovenia. Design and setting Data about all prenatally and postnatally confirmed cases of T21 in Slovenia between 1981 and 2012 were collected retrospectively from all genetic laboratories in Slovenia. The expected number of babies with T21 according to maternal age was calculated. Main outcome measures The primary outcomes measures were number of fetuses and newborn infants with T21 diagnosed prenatally and postnatally and the impact of advances in screening and genetic diagnostics on the prevalence of newborns with T21 in Slovenia. Results Despite a significantly increased mean maternal age from 25.4 years in year 1981 to 30.3 years in year 2012 the prevalence of newborn infants with T21 was 0.51 per 1000 births compared to 0.55 per 1000 births, respectively. The prevalence of prenatally diagnosed cases increased from 0.03 per 1000 births to 2.06 per 1000. The detection rate of T21 in year 2012 was 78,9%. The total number of prenatal invasive procedures (chorionic villous sampling and amniocenteses) carried out during that period was rising until 2002, since when it is stable at around 7%. Conclusion The advancement and implementation of screening tests and prenatal diagnostic procedures in Slovenia caused an important improvement in the efficiency of the prenatal detection of T21.	[Rudolf, Gorazd; Volk, Marija; Prosenc, Bernarda; Peterlin, Borut] Univ Med Ctr Ljubljana, CIMG, Ljubljana, Slovenia; [Tul, Natasa; Verdenik, Ivan; Jersin, Natasa; Srsen, Tanja Premru] Univ Med Ctr Ljubljana, Div Gynaecol & Obstet, Dept Perinatol, Ljubljana, Slovenia; [Brezigar, Anamarija] Medgen, Outpatient Clin Med Genet, Ljubljana, Slovenia; [Vokac, Nadja Kokalj] Univ Med Ctr Maribor, Lab Med Genet, Maribor, Slovenia	University Medical Centre Ljubljana; University Medical Centre Ljubljana; University of Maribor	Rudolf, G (corresponding author), Univ Med Ctr Ljubljana, CIMG, Ljubljana, Slovenia.	gorazd.img@gmail.com	Verdenik, Ivan/G-9618-2012; Premru-Srsen, Tanja/AGK-8909-2022	Premru-Srsen, Tanja/0000-0003-2597-0188				Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Cocchi G, 2010, BIRTH DEFECTS RES A, V88, P474, DOI 10.1002/bdra.20666; Crombag NMTH, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-437; Ekelund CK, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2547; Gidiri M, 2007, BJOG-INT J OBSTET GY, V114, P458, DOI 10.1111/j.1471-0528.2007.01266.x; Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94; Merilainen A, 2014, CLIN MED INSIGHTS-RE, V8, P45, DOI 10.4137/CMRH.S14958; Metneki J, 2005, EUR J EPIDEMIOL, V20, P525, DOI 10.1007/s10654-005-4261-z; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Morris JK, 2009, BMJ-BRIT MED J, V339, pb3794, DOI DOI 10.1136/BMJ.B3794; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033	11	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180348	10.1371/journal.pone.0180348	http://dx.doi.org/10.1371/journal.pone.0180348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665986	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700002
J	Shin, S; Kim, J; Kim-Wanner, SZ; Bonig, H; Cho, SR; Kim, S; Choi, JR; Lee, KA				Shin, Saeam; Kim, Juwon; Kim-Wanner, Soo-Zin; Boenig, Halvard; Cho, Sung Ran; Kim, Sinyoung; Choi, Jong Rak; Lee, Kyung-A			A novel association between relaxin receptor polymorphism and hematopoietic stem cell yield after mobilization	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BLOOD PROGENITOR CELLS; ACUTE HEART-FAILURE; PERIPHERAL-BLOOD; HEALTHY DONORS; VOLUNTEER DONORS; CONTROLLED-TRIAL; POPULATION; COUNT; TRANSPLANTATION	Mobilization of hematopoietic stem cells (HSCs) from the bone marrow to the peripheral blood is a complex mechanism that involves adhesive and chemotactic interactions of HSCs as well as their bone marrow microenvironment. In addition to a number of non-genetic factors, genetic susceptibilities also contribute to the mobilization outcome. Identification of genetic factors associated with HSC yield is important to better understand the mechanism behind HSC mobilization. In the present study, we enrolled 148 Korean participants (56 healthy donors and 92 patients) undergoing HSC mobilization for allogeneic or autologous HSC transplantation. Among a total of 53 polymorphisms in 33 candidate genes, one polymorphism (rs11264422) in relaxin/insulin-like family peptide receptor 4 (RXFP4) gene was significantly associated with a higher HSC yield after mobilization in Koreans. However, in a set of 101 Europeans, no association was found between circulating CD34+ cell counts and rs11264422 genotype. Therefore, we suggest that the ethnic differences in subjects' genetic background may be related to HSC mobilization. In conclusion, the relaxin-relaxin receptor axis may play an important role in HSC mobilization. We believe that the results of the current study could provide new insights for therapies that use relaxin and HSC populations, as well as a better understanding of HSC regulation and mobilization at the molecular level.	[Shin, Saeam; Kim, Sinyoung; Choi, Jong Rak; Lee, Kyung-A] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Shin, Saeam] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Juwon] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea; [Kim-Wanner, Soo-Zin; Boenig, Halvard] German Red Cross Blood Serv BaWuHe, Frankfurt, Germany; [Boenig, Halvard] Johann Wolfgang Goethe Med Univ, Inst Transfus Med & Immune Hematol, Frankfurt, Germany; [Boenig, Halvard] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Cho, Sung Ran] Ajou Univ, Sch Med, Dept Lab Med, Suwon, South Korea	Yonsei University; Yonsei University Health System; Hallym University; Yonsei University; University of Washington; University of Washington Seattle; Ajou University	Lee, KA (corresponding author), Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea.	KAL1119@yuhs.ac	Cho, Sung-Ran/AAK-9950-2021; Bönig, Halvard/AAG-3029-2021	Bönig, Halvard/0000-0003-0088-2675; Kim, Sinyoung/0000-0002-2609-8945; Shin, Saeam/0000-0003-1501-3923; Lee, Kyung-A/0000-0001-5320-6705	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120030]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A120030, http://www.htdream.kr/, KAL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2011, PLOS GENET, V7; Ameen RM, 2008, CLIN LYMPHOMA MYELOM, V8, P106, DOI 10.3816/CLM.2008.n.012; Ben Nasr M, 2011, TRANSPL P, V43, P635, DOI 10.1016/j.transproceed.2011.01.016; Benboubker L, 2001, BRIT J HAEMATOL, V113, P247, DOI 10.1046/j.1365-2141.2001.02717.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bitto A, 2013, CLIN SCI, V125, P575, DOI 10.1042/CS20130105; Boels K, 2003, BRIT J PHARMACOL, V140, P932, DOI 10.1038/sj.bjp.0705521; Bogunia-Kubik K, 2009, BONE MARROW TRANSPL, V44, P273, DOI 10.1038/bmt.2009.30; Cohen KS, 2013, BLOOD; Cottler-Fox M, 2006, BLOOD REV, V20, P43, DOI 10.1016/j.blre.2005.06.001; De La Rubia J, 2002, J HEMATOTH STEM CELL, V11, P705, DOI 10.1089/15258160260194857; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gupta R, 2011, CIRC-CARDIOVASC INTE, V4, P2, DOI 10.1161/CIRCINTERVENTIONS.110.960716; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Koenigsmann M, 2004, TRANSFUSION, V44, P777, DOI 10.1111/j.0041-1132.2004.03321.x; Komeno Y, 2006, BIOL BLOOD MARROW TR, V12, P408, DOI 10.1016/j.bbmt.2005.11.007; Kong M, 2013, INT J IMMUNOGENET, V40, P120, DOI 10.1111/j.1744-313X.2012.01141.x; Lenk J, 2013, BIOL BLOOD MARROW TR, V19, P1517, DOI 10.1016/j.bbmt.2013.07.018; Lentner C, 1982, GEIGY SCI TABLES; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Martin-Antonio B, 2011, HAEMATOL-HEMATOL J, V96, P102, DOI 10.3324/haematol.2010.026401; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Okada Y, 2012, J HUM GENET, V57, P161, DOI 10.1038/jhg.2012.2; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Okada Y, 2010, HUM MOL GENET, V19, P2079, DOI 10.1093/hmg/ddq080; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Pavone V, 2006, BONE MARROW TRANSPL, V37, P719, DOI 10.1038/sj.bmt.1705298; Platzbecker U, 2005, TRANSFUSION, V45, P11, DOI 10.1111/j.1537-2995.2005.04107.x; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Schulz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121859; Segal MS, 2012, BLOOD, V119, P629, DOI 10.1182/blood-2011-04-346007; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Szmigielska-Kaplon A, 2014, BIOL BLOOD MARROW TR, V20, P986, DOI 10.1016/j.bbmt.2014.03.019; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teipel R, 2015, TRANSFUSION, V55, P2855, DOI 10.1111/trf.13239; Tietjens J, 2016, HEART, V102, P95, DOI 10.1136/heartjnl-2014-306786; To LB, 2011, BLOOD, V118, P4530, DOI 10.1182/blood-2011-06-318220; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vasu S, 2008, BLOOD, V112, P2092, DOI 10.1182/blood-2008-03-143677; Wang TF, 2008, BIOL BLOOD MARROW TR, V14, P1305, DOI 10.1016/j.bbmt.2008.09.002; Wang XL, 2015, STEM CELL RES, V15, P14, DOI 10.1016/j.scr.2015.04.004; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779	44	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179986	10.1371/journal.pone.0179986	http://dx.doi.org/10.1371/journal.pone.0179986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666004	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700049
J	Agostinete, RR; Duarte, JP; Valente-dos-Santos, J; Coelho-e-Silva, MJ; Tavares, OM; Conde, JM; Fontes-Ribeiro, CA; Condello, G; Capranica, L; Caires, SU; Fernandes, RAMA				Agostinete, Ricardo R.; Duarte, Joao P.; Valente-dos-Santos, Joao; Coelho-e-Silva, Manuel J.; Tavares, Oscar M.; Conde, Jorge M.; Fontes-Ribeiro, Carlos A.; Condello, Giancarlo; Capranica, Laura; Caires, Suziane U.; Fernandes, Ro A. Mulo A.			Bone tissue, blood lipids and inflammatory profiles in adolescent male athletes from sports contrasting in mechanical load	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MINERAL DENSITY; RESISTANCE EXERCISE; ADIPOSE-TISSUE; CALCIUM INTAKE; CHILDREN; IMPACT; RISK; PARTICIPATION; FITNESS	Exploring the effect of non-impact and impact sports is particular relevant to understand the interaction between skeletal muscle and bone health during growth. The current study aimed to compare total and regional bone and soft-tissue composition, in parallel to measurements of blood lipid and inflammatory profiles between adolescent athletes and non-athletes. Anthropometry, biological maturity, dual energy X-ray absorptiometry (DXA) scans, training load and lipid and inflammatory profiles were assessed in a cross-sectional sample of 53 male adolescents (20 non-athletes, 15 swimmers and 18 basketball players) aged 12-19 years. Multiple comparisons between groups were performed using analysis of variance, covariance and magnitude effects (ES-r and Cohen's d). The comparisons of controls with other groups were very large for high-sensitivity C-reactive protein (d range: 2.17-2.92). The differences between sports disciplines, regarding tissue outputs obtained from DXA scan were moderate for all variables except fat tissue (d = 0.4). It was possible to determine small differences (ES-r = 0.17) between controls and swimmers for bone area at the lower limbs (13.0%). In parallel, between swimmers and basketball players, the gradient of the differences was small (ES-r range: 0.15-0.23) for bone mineral content (24.6%), bone area (11.3%) and bone mineral density (11.1%) at the lower limbs, favoring the basketball players. These observations highlight that youth male athletes presented better blood and soft tissues profiles with respect to controls. Furthermore, sport-specific differences emerged for the lower limbs, with basketball players presenting higher bone mineral content, area and density than swimmers.	[Agostinete, Ricardo R.; Caires, Suziane U.; Fernandes, Ro A. Mulo A.] Sao Paulo State Univ UNESP, Dept Phys Educ, Lab Invest Exercise LIVE, Sao Paulo, Brazil; [Agostinete, Ricardo R.; Caires, Suziane U.; Fernandes, Ro A. Mulo A.] Sao Paulo State Univ UNESP, Dept Phys Therapy, Postgrad Program Phys Therapy, Sao Paulo, Brazil; [Duarte, Joao P.; Valente-dos-Santos, Joao; Coelho-e-Silva, Manuel J.] Univ Coimbra, CIDAF UID DTP 04213 2016, Fac Sport Sci & Phys Educ, Coimbra, Portugal; [Duarte, Joao P.] Portuguese Fdn Sci & Technol SFRH BD 101083 2014, Lisbon, Portugal; [Valente-dos-Santos, Joao] Portuguese Fdn Sci & Technol SFRH BPD 100470 2014, Lisbon, Portugal; [Valente-dos-Santos, Joao; Fontes-Ribeiro, Carlos A.] Univ Coimbra, Inst Biomed Imaging & Life Sci IBILI, Coimbra, Portugal; [Valente-dos-Santos, Joao] Lusofona Univ Humanities & Technol, Fac Phys Educ & Sport, Lisbon, Portugal; [Tavares, Oscar M.] Inst Politecn Coimbra, Sch Hlth & Technol, Dept Med Imaging & Radiat Therapy, Coimbra, Portugal; [Conde, Jorge M.] Inst Politecn Coimbra, Coimbra, Portugal; [Fontes-Ribeiro, Carlos A.] Univ Coimbra, Fac Med, Inst Pharmacol & Expt Therapeut, Coimbra, Portugal; [Condello, Giancarlo; Capranica, Laura] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Fernandes, Ro A. Mulo A.] Sao Paulo State Univ UNESP, Inst Biosci, Postgrad Program Kinesiol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Coimbra; Universidade de Coimbra; Lusofona University; Instituto Politecnico de Coimbra (IPC); Instituto Politecnico de Coimbra (IPC); Universidade de Coimbra; Foro Italico University of Rome; Universidade Estadual Paulista	Coelho-e-Silva, MJ (corresponding author), Univ Coimbra, CIDAF UID DTP 04213 2016, Fac Sport Sci & Phys Educ, Coimbra, Portugal.	mjcesilva@hotmail.com	Condello, Giancarlo/AAC-8365-2020; Ribeiro, Carlos A Fontes/B-7729-2018; Coelho-e-Silva, Manuel J/V-1645-2017; Silva, Manuel Coelho E/O-2604-2019; Agostinete, Ricardo/N-7874-2016; Laura, Capranica/AFW-3460-2022; Valente-dos-Santos, Joao/ABE-3220-2020; Fernandes, Rômulo A/G-3114-2012	Condello, Giancarlo/0000-0001-5092-3258; Ribeiro, Carlos A Fontes/0000-0002-9707-4895; Coelho-e-Silva, Manuel J/0000-0003-4512-7331; Silva, Manuel Coelho E/0000-0003-4512-7331; Agostinete, Ricardo/0000-0001-8420-7225; Valente-dos-Santos, Joao/0000-0003-0980-0269; Fernandes, Rômulo A/0000-0003-1576-8090; Capranica, Laura/0000-0003-3073-7655; Marques Duarte, Joao Pedro/0000-0002-7536-9780; Tavares, Oscar/0000-0002-1437-0307; Conde, Jorge/0000-0002-2225-8569	Sao Paulo Research Foundation (FAPESP) [2013/06963-5, 2015/13543-8, 2016/06920-2]; JPD [SFRH/BD/101083/2014]; JVdS [SFRH/ BPD/100470/2014]; Portuguese Foundation for Science and Technology; Portuguese Foundation for Science and Technology [uid/dtp/04213/2016]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); JPD; JVdS; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This study was supported by the Sao Paulo Research Foundation (FAPESP,Process 2013/06963-5,2015/13543-8 and 2016/06920-2). JPD (SFRH/BD/101083/2014) and JVdS(SFRH/ BPD/100470/2014) were partially supported by the Portuguese Foundation for Science and Technology. CIDAF is registered in Portuguese Foundation for Science and Technology: uid/dtp/04213/2016. No other current funding sources for this study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio M, 2002, SCAND J MED SCI SPOR, V12, P179, DOI 10.1034/j.1600-0838.2002.00250.x; Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005; Agostinete RR, 2016, J CLIN DENSITOM, V19, P375, DOI 10.1016/j.jocd.2016.04.006; American Heart Association, 2014, CHILDR CHOL; Bellew James W, 2006, Pediatr Phys Ther, V18, P19, DOI 10.1097/01.pep.0000200952.63544.16; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cohen J, 1988, STAT POWER ANAL SOCI, V2nd; Quiterio ALD, 2011, J STRENGTH COND RES, V25, P3439, DOI 10.1519/JSC.0b013e318216003b; Dollman J, 2005, BRIT J SPORT MED, V39, P892, DOI 10.1136/bjsm.2004.016675; Ducher G, 2006, J BONE MINER METAB, V24, P484, DOI 10.1007/s00774-006-0710-3; Dyson K, 1997, MED SCI SPORT EXER, V29, P443, DOI 10.1097/00005768-199704000-00004; European Commission, 2008, EU PHYS ACT GUID REC; European Commission Expert Group on Health-enhancing Physical Activity, 2015, EXP GROUP HLTH ENH P; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Gillam G., 1985, NSCA J, V6, P44; Goodpaster BH, 2005, EXERC SPORT SCI REV, V33, P150; Harvey N, 2010, NAT REV RHEUMATOL, V6, P99, DOI 10.1038/nrrheum.2009.260; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Horowitz JF, 2003, TRENDS ENDOCRIN MET, V14, P386, DOI 10.1016/S1043-2760(03)00143-7; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Katzmarzyk PT, 1998, PEDIATR EXERC SCI, V10, P378, DOI 10.1123/pes.10.4.378; Kavey REW, 2006, CIRCULATION, V114, P2710, DOI 10.1161/CIRCULATIONAHA.106.179568; Kelley GA, 2006, ATHEROSCLEROSIS, V184, P207, DOI 10.1016/j.atherosclerosis.2005.04.005; Lipnowski S, 2012, PAED CHILD HEALT-CAN, V17, P209, DOI 10.1093/pch/17.4.209; McGuigan MR, 2008, PEDIATR EXERC SCI, V20, P333, DOI 10.1123/pes.20.3.333; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Molgaard C, 2001, OSTEOPOROSIS INT, V12, P887, DOI 10.1007/s001980170042; Naghii MR, 2011, INT J OCCUP MED ENV, V24, P380, DOI 10.2478/s13382-011-0044-9; Nemet D, 2002, PEDIATRICS, V110, P681, DOI 10.1542/peds.110.4.681; Nordstrom A, 2005, J BONE MINER RES, V20, P202, DOI 10.1359/JBMR.041012; Nordstrom P, 1998, J BONE MINER RES, V13, P1141, DOI 10.1359/jbmr.1998.13.7.1141; Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008; Pfeiffer KA, 2006, J ADOLESCENT HEALTH, V39, P523, DOI 10.1016/j.jadohealth.2006.03.005; Pyne DB, 2014, INT J SPORT NUTR EXE, V24, P351, DOI 10.1123/ijsnem.2014-0047; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; RUIZ JC, 1995, J BONE MINER RES, V10, P675; Seabra A, 2016, J SPORT SCI, V34, P1822, DOI 10.1080/02640414.2016.1140219; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tambalis K, 2009, ANGIOLOGY, V60, P614, DOI 10.1177/0003319708324927; Tanaka H, 2009, SPORTS MED, V39, P377, DOI 10.2165/00007256-200939050-00004; Tenforde AS, 2011, PM&R, V3, P861, DOI 10.1016/j.pmrj.2011.05.019; Trost SG, 1997, PREV MED, V26, P257, DOI 10.1006/pmed.1996.0137; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a; Wiebe PN, 2002, PEDIATR EXERC SCI, V14, P345, DOI 10.1123/pes.14.4.345; Williams CL, 2002, CIRCULATION, V106, P143, DOI 10.1161/01.CIR.0000019555.61092.9E; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yang PF, 2011, J MUSCULOSKEL NEURON, V11, P8; Zribi A, 2014, J CLIN DENSITOM, V17, P156, DOI 10.1016/j.jocd.2013.04.001	50	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180357	10.1371/journal.pone.0180357	http://dx.doi.org/10.1371/journal.pone.0180357			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662190	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300144
J	Lakon, CM; Wang, C; Butts, CT; Jose, R; Hipp, JR				Lakon, Cynthia M.; Wang, Cheng; Butts, Carter T.; Jose, Rupa; Hipp, John R.			Cascades of emotional support in friendship networks and adolescent smoking	PLOS ONE			English	Article							SOCIAL SUPPORT; SUBSTANCE USE; PHYSIOLOGICAL PROCESSES; PARENTAL INFLUENCES; CIGARETTE-SMOKING; PEER INFLUENCE; HEALTH; ADJUSTMENT; BEHAVIORS; SELECTION	Social support from peers and parents provides a key socialization function during adolescence. We examine adolescent friendship networks using a Stochastic Actor-Based modeling approach to observe the flow of emotional support provision to peers and the effect of support from parents, while simultaneously modeling smoking behavior. We utilized one school (n = 976) from The National Longitudinal Study of Adolescent to Adult Health (AddHealth) Study. Our findings suggest that emotional support is transacted through an interdependent contextual system, comprised of both peer and parental effects, with the latter also having distal indirect effects from youths' friends' parents.	[Lakon, Cynthia M.] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Program Publ Hlth, Irvine, CA 92697 USA; [Wang, Cheng] Notre Dame Univ, Dept Sociol, Notre Dame, IN USA; [Butts, Carter T.] Univ Calif Irvine, Dept Sociol, Dept Stat, Irvine, CA USA; [Butts, Carter T.] Univ Calif Irvine, EECS, Irvine, CA USA; [Jose, Rupa] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Hipp, John R.] Univ Calif Irvine, Dept Criminol, Dept Law & Soc, Irvine, CA USA; [Hipp, John R.] Univ Calif Irvine, Dept Sociol, Irvine, CA USA	University of California System; University of California Irvine; University of Notre Dame; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Lakon, CM (corresponding author), Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Program Publ Hlth, Irvine, CA 92697 USA.	clakon@uci.edu			Cascades of Network Structure Function [1 R21 DA031152-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031152] Funding Source: NIH RePORTER	Cascades of Network Structure Function; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by Grant #1 R21 DA031152-01A1, Cascades of Network Structure & Function: Pathways to Adolescent Substance Use. National Institute on Drug Abuse (http://sci-hub.io/https://www.drugabuse.gov/), administered through the Program in Public Health at the University of California Irvine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott-Chapman J, 2008, J YOUTH STUD, V11, P611, DOI 10.1080/13676260802191938; Bandura Albert, 1977, SOCIAL LEARNING THEO; BARBER BK, 1992, J MARRIAGE FAM, V54, P69, DOI 10.2307/353276; Baumrind D., 1991, J EARLY ADOLESC, V11, P56, DOI [DOI 10.1177/0272431691111004, 10.1177/0272431691111004]; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; BIGLAN A, 1995, J BEHAV MED, V18, P315, DOI 10.1007/BF01857657; Bowlby J., 1969, ATTACHMENT AND LOSS; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; Burg MM., 1994, ANN BEHAV MED, V16, P109, DOI 10.1093/abm/16.2.109; CAUCE AM, 1986, AM J COMMUN PSYCHOL, V14, P607, DOI 10.1007/BF00931339; CAUCE AM, 1982, AM J COMMUN PSYCHOL, V10, P417, DOI 10.1007/BF00893980; Chuang YC, 2005, J HEALTH SOC BEHAV, V46, P187, DOI 10.1177/002214650504600205; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Colarossi LG, 2003, SOC WORK RES, V27, P19, DOI 10.1093/swr/27.1.19; Colarossi LG, 2001, SOC WORK RES, V25, P233, DOI 10.1093/swr/25.4.233; CONRAD KM, 1992, BRIT J ADDICT, V87, P1711; Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380; Engels RCME, 2004, J ADOLESCENCE, V27, P531, DOI 10.1016/j.adolescence.2004.06.006; ENNETT ST, 1994, J PERS SOC PSYCHOL, V67, P653, DOI 10.1037/0022-3514.67.4.653; Ennett ST, 2006, J RES ADOLESCENCE, V16, P159, DOI 10.1111/j.1532-7795.2006.00127.x; ENNETT ST, 1993, J HEALTH SOC BEHAV, V34, P226, DOI 10.2307/2137204; FURMAN W, 1992, CHILD DEV, V63, P103, DOI 10.2307/1130905; GREENBERG MT, 1983, J YOUTH ADOLESCENCE, V12, P373, DOI 10.1007/BF02088721; Harris KM, 2009, NATL LONGITUDINAL ST; Hartup W, 1983, HDB CHILD PSYCHOL SO; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Henderson A, 1991, MEANING MEASUREMENT, P85; House J.S., 1985, SOCIAL SUPPORT HLTH, P83, DOI DOI 10.1016/0883-0355(88)90010-9; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453; Hombrados-Mendieta MI, 2012, J COMMUNITY PSYCHOL, V40, P645, DOI 10.1002/jcop.20523; KANDEL DB, 1978, J PERS SOC PSYCHOL, V36, P306, DOI 10.1037/0022-3514.36.3.306; Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037/0012-1649.36.3.366; Kirke DM, 2004, J PRIM PREV, V26, P3; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Lakon CM, 2015, J YOUTH ADOLESCENCE, V44, P1767, DOI 10.1007/s10964-014-0187-7; Malecki CK, 2003, SCHOOL PSYCHOL QUART, V18, P231, DOI 10.1521/scpq.18.3.231.22576; Marshal MP., 2000, APPL DEV SCI, V4, P80, DOI [DOI 10.1207/S1532480XADS0402_3, 10.1207/S1532480XADS0402_3]; Maxwell KA, 2002, J YOUTH ADOLESCENCE, V31, P267, DOI 10.1023/A:1015493316865; Mercken L, 2010, SOC NETWORKS, V32, P72, DOI 10.1016/j.socnet.2009.02.005; NEWCOMB MD, 1988, J ABNORM PSYCHOL, V97, P64, DOI 10.1037/0021-843X.97.1.64; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ripley R., 2017, MANUAL SIENA VERSION; Rubin KH, 2004, J EARLY ADOLESCENCE, V24, P326, DOI 10.1177/0272431604268530; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; Scholte RHJ, 2005, MERRILL PALMER QUART, V51, P258, DOI 10.1353/mpq.2005.0019; Simons-Morton B, 2004, HEALTH PSYCHOL, V23, P612, DOI 10.1037/0278-6133.23.6.612; Simpkins SD, 2013, J RES ADOLESCENCE, V23, P537, DOI 10.1111/j.1532-7795.2012.00836.x; Snijders T. A. B., 2011, SAGE HDB SOCIAL NETW, P501; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; Stanton-Salazar RD, 2005, YOUTH SOC, V36, P379, DOI 10.1177/0044118X04267814; Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210; Steuber TL, 2006, ADDICT BEHAV, V31, P133, DOI 10.1016/j.addbeh.2005.04.010; Stice E, 2004, J ABNORM PSYCHOL, V113, P155, DOI 10.1037/0021-843X.113.1.155; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Umberson D, 2010, ANNU REV SOCIOL, V36, P139, DOI 10.1146/annurev-soc-070308-120011; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WILLS TA, 1989, J BEHAV MED, V12, P321, DOI 10.1007/BF00844927; Wills TA, 1996, J PERS SOC PSYCHOL, V71, P937, DOI 10.1037/0022-3514.71.5.937; WILLS TA, 1995, J PERS SOC PSYCHOL, V68, P901, DOI 10.1037/0022-3514.68.5.901	61	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180204	10.1371/journal.pone.0180204	http://dx.doi.org/10.1371/journal.pone.0180204			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662121	gold, Green Published			2022-12-27	WOS:000404608300125
J	Ma, Y; Wang, YH; Xu, ZH; Wang, YJ; Fallon, JK; Liu, F				Ma, Yan; Wang, Yuhua; Xu, Zhenghong; Wang, Yongjun; Fallon, John K.; Liu, Feng			Extreme low dose of 5-fluorouracil reverses MDR in cancer by sensitizing cancer associated fibroblasts and down-regulating P-gp	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; CHEMOTHERAPY; GLYCOPROTEIN; CELLS; INHIBITION; SECRETION; EFFICACY; IMPROVES	We conducted a prospective, meaningful study of extreme low dose of 5-fluorouracil (5FU) as a metronomic agent targeting cancer associated fibroblasts (CAFs) to reverse Multidrug resistance (MDR) by sensitizing cancer associated fibroblasts and down-regulating P-glycoprotein (P-gp). The combination of 5FU and Taxol inhibited resistant KB-8-5 tumor growth by 79% and H460/Tax-R tumor growth by 55%. The inhibition was significant for both tumor types compared with Taxol treatment alone (p<0.001 and p = 0.0067, respectively). Nevertheless, the low -dose 5FU (2.2 mg/kg compared to the therapeutic dose of 50-150 mg/kg) showed negligible tumor inhibitory effect. The tumor growth inhibition study on resistant tumors demonstrated that the continuous administration of low dose 5FU with Taxol significantly inhibited the tumor growth. The treatment overcomes drug resistance in tumors by down -regulating multi -drug resistance transporter protein (P-gp), and more importantly, by eliminating CAFs recruited by resistant tumors. Compared with traditional metronomic chemotherapy, 5FU as metronomic agent targeting CAFs can avoid the disadvantages resulted from the concomitant administration of antiangiogenetic drug. The approach has good translational potential for clinical trials when treating stroma-rich drug resistant tumors.	[Ma, Yan; Wang, Yuhua; Xu, Zhenghong; Wang, Yongjun; Fallon, John K.; Liu, Feng] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Ma, Yan] Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou, Guangdong, Peoples R China; [Wang, Yongjun] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Guangzhou University of Chinese Medicine; Shenyang Pharmaceutical University	Ma, Y; Wang, YH (corresponding author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA.; Ma, Y (corresponding author), Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou, Guangdong, Peoples R China.	mygzhtcm@163.com; yhw_albert@163.com		Fallon, John/0000-0003-1848-0121	National Cancer Institute National Institutes of Health [5R01CA149387]; National Nature Science Foundation of China [81403109]; Science and Technology Planning Project of Guangdong Province [2014A020210021]; NATIONAL CANCER INSTITUTE [R01CA149387] Funding Source: NIH RePORTER	National Cancer Institute National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: 1. National Cancer Institute National Institutes of Health (5R01CA149387), Feng Liu; 2. National Nature Science Foundation of China (81403109), Yan Ma; 3. Science and Technology Planning Project of Guangdong Province (2014A020210021), Yan Ma.	Benasso M, 1997, SEMIN ONCOL, V24, pS46; Binkhathlan Z, 2013, CURR CANCER DRUG TAR, V13, P326, DOI 10.2174/15680096113139990076; Blansfield JA, 2008, CLIN CANCER RES, V14, P270, DOI 10.1158/1078-0432.CCR-07-1562; Brenda PN, 2000, CLIN BREAST CANCER, V1, P136; Browder T, 2000, CANCER RES, V60, P1878; Callaghan R, 2014, DRUG METAB DISPOS, V42, P623, DOI 10.1124/dmd.113.056176; Cristiane CD, 2000, FOOD CHEM TOXICOL, V48, P3120; Cruz JJ, 2008, CANCER TREAT REV, V34, P268, DOI 10.1016/j.ctrv.2007.12.004; Han EKH, 2000, EUR J CANCER, V36, P1565, DOI 10.1016/S0959-8049(00)00145-3; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Johnson LM, 2013, CANCER BIOL THER, V14, P90, DOI 10.4161/cbt.22636; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kinugasa Y, 2014, STEM CELLS, V32, P145, DOI 10.1002/stem.1556; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; PIWNICAWORMS D, 1993, CANCER RES, V53, P977; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Yan M, 2014, MOL PHARM, V11, P2623	19	10	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180023	10.1371/journal.pone.0180023	http://dx.doi.org/10.1371/journal.pone.0180023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662182	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300089
J	Clark, DP; Badea, CT				Clark, Darin P.; Badea, Cristian T.			Hybrid spectral CT reconstruction	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; IMAGE-RECONSTRUCTION; MATERIAL DECOMPOSITION; TUMOR VASCULATURE; NOISE-REDUCTION; MOUSE MODEL; MICRO-CT; ALGORITHM; IODINE; ACQUISITION	Current photon counting x-ray detector (PCD) technology faces limitations associated with spectral fidelity and photon starvation. One strategy for addressing these limitations is to supplement PCD data with high-resolution, low-noise data acquired with an energy-integrating detector (EID). In this work, we propose an iterative, hybrid reconstruction technique which combines the spectral properties of PCD data with the resolution and signal-to-noise characteristics of EID data. Our hybrid reconstruction technique is based on an algebraic model of data fidelity which substitutes the EID data into the data fidelity term associated with the PCD reconstruction, resulting in a joint reconstruction problem. Within the split Bregman framework, these data fidelity constraints are minimized subject to additional constraints on spectral rank and on joint intensity-gradient sparsity measured between the reconstructions of the EID and PCD data. Following a derivation of the proposed technique, we apply it to the reconstruction of a digital phantom which contains realistic concentrations of iodine, barium, and calcium encountered in small-animal micro-CT. The results of this experiment suggest reliable separation and detection of iodine at concentrations >= 5 mg/ml and barium at concentrations >= 10 mg/ml in 2-mm features for EID and PCD data reconstructed with inherent spatial resolutions of 176 mu m and 254 mu m, respectively (point spread function, FWHM). Furthermore, hybrid reconstruction is demonstrated to enhance spatial resolution within material decomposition results and to improve low-contrast detectability by as much as 2.6 times relative to reconstruction with PCD data only. The parameters of the simulation experiment are based on an in vivo micro-CT experiment conducted in a mouse model of soft-tissue sarcoma. Material decomposition results produced from this in vivo data demonstrate the feasibility of distinguishing two K-edge contrast agents with a spectral separation on the order of the energy resolution of the PCD hardware.	[Clark, Darin P.; Badea, Cristian T.] Duke Univ, Med Ctr, Dept Radiol, Ctr In Vivo Microscopy, Durham, NC 27710 USA	Duke University	Badea, CT (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Ctr In Vivo Microscopy, Durham, NC 27710 USA.	cristian.badea@duke.edu	Badea, Cristian T/M-3323-2019; Badea, Cristian/B-6681-2011	Badea, Cristian T/0000-0002-1850-2522; Badea, Cristian/0000-0002-1850-2522	National Institutes of Health, National Cancer Institute [R01CA196667]; NATIONAL CANCER INSTITUTE [R01CA196667] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All work was performed at Duke University Medical Center's Center for In Vivo Microscopy (http://www.civm.duhs.duke.edu/), a National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering national Biomedical Technology Resource Center (P4 EB015897; https://www.nibib.nih.gov/; CTB). The work was also supported by the National Institutes of Health, National Cancer Institute (R01CA196667; https://www.cancer.gov/; CTB). These funding sources had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This work was made possible by the loan of a PILATUS3 CdTe 300K photon counting x-ray detector from Dectris AG of Baden-Dattwil, Switzerland (https://www.dectris.com/). Dectris AG reviewed this manuscript prior to its initial submission to PLOSONE, but had no direct role in the study design or the analysis methods employed.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; Aly HA, 2014, IEEE T IMAGE PROCESS, V23, P2596, DOI 10.1109/TIP.2014.2316641; Anderson NG, 2010, EUR RADIOL, V20, P2126, DOI 10.1007/s00330-010-1768-9; Ashton JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088129; Ashton JR, 2014, CONTRAST MEDIA MOL I, V9, P161, DOI 10.1002/cmmi.1557; Badea C, 2008, MED IMAGING; Ballabriga R, 2006, 2006 IEEE NUCL SCI S; Bennett JR, 2014, IEEE T BIO-MED ENG, V61, P246, DOI 10.1109/TBME.2013.2279673; Bhavane R, 2013, CIRC-CARDIOVASC IMAG, V6, P285, DOI 10.1161/CIRCIMAGING.112.000119; Boll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025692; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chen Y, 2017, PHYS MED BIOL, V62, P2103, DOI 10.1088/1361-6560/aa5c24; Chen Y, 2014, IEEE T MED IMAGING, V33, P2271, DOI 10.1109/TMI.2014.2336860; Chen Y, 2011, EUR J RADIOL, V80, pE42, DOI 10.1016/j.ejrad.2010.07.003; Clark D, 2016, SPIE MED IMAGING; Clark D, 2016, SPIE MED IMAGING; Clark DP, 2015, PROC SPIE, V9412, DOI 10.1117/12.2081249; Clark DP, 2015, MED PHYS, V42, P6317, DOI 10.1118/1.4931407; Clark DP, 2014, PHYS MED BIOL, V59, P6445, DOI 10.1088/0031-9155/59/21/6445; Clark DP, 2013, PHYS MED BIOL, V58, P1683, DOI 10.1088/0031-9155/58/6/1683; Cormode DP, 2010, RADIOLOGY, V256, P774, DOI 10.1148/radiol.10092473; Donath T, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/6/062001; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Elad M, 2002, IEEE T IMAGE PROCESS, V11, P1141, DOI 10.1109/TIP.2002.801126; Elbakri IA, 2002, IEEE T MED IMAGING, V21, P89, DOI 10.1109/42.993128; Farsiu S, 2004, IEEE T IMAGE PROCESS, V13, P1327, DOI 10.1109/TIP.2004.834669; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Galigekere RR, 2003, IEEE T MED IMAGING, V22, P1202, DOI 10.1109/TMI.2003.817787; Gang GJ, 2016, PROC SPIE, V9783, DOI 10.1117/12.2216387; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Gutjahr R, 2016, INVEST RADIOL, V51, P421, DOI 10.1097/RLI.0000000000000251; Hansen N, 2004, INT C PAR PROBL SOLV; Hermosillo G, 2002, INT J COMPUT VISION, V50, P329, DOI 10.1023/A:1020830525823; Jawak SD, 2013, ADV REMOTE SENSING, V2013; Johnson T, 2011, DUAL ENERGY CT CLINI; Kim K, 2015, IEEE T MED IMAGING, V34, P748, DOI 10.1109/TMI.2014.2380993; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kraft P, 2009, IEEE T NUCL SCI, V56, P758, DOI 10.1109/TNS.2008.2009448; Kraft P, 2009, J SYNCHROTRON RADIAT, V16, P368, DOI 10.1107/S0909049509009911; Lai RJ, 2014, J SCI COMPUT, V58, P431, DOI 10.1007/s10915-013-9740-x; Lawson CL., 1995, SOLVING LEAST SQUARE; Leng SA, 2011, MED PHYS, V38, P4946, DOI 10.1118/1.3609097; Loeliger T, 2012, NUCL SCI S MED IM C; Long Y, 2010, IEEE T MED IMAGING, V29, P1839, DOI 10.1109/TMI.2010.2050898; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; McCollough CH, 2004, MED PHYS, V31, P2423, DOI 10.1118/1.1769632; Moding EJ, 2013, INT J RADIAT ONCOL, V85, P1353, DOI 10.1016/j.ijrobp.2012.09.027; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Ouadah S, 2015, SPIE MED IMAGING; Radicci V, INT WORKSH RAD IM DE; Rigie DS, 2015, PHYS MED BIOL, V60, P1741, DOI 10.1088/0031-9155/60/5/1741; Rubinstein R, 2008, EFFICIENT IMPLEMENTA; Schlifske D, 2016, SPIE MED IMAGING; Schlomka JP, 2008, PHYS MED BIOL, V53, P4031, DOI 10.1088/0031-9155/53/15/002; Schmidt TG, 2011, MED PHYS, V38, P5657, DOI 10.1118/1.3641749; Schmidt TG, 2009, MED PHYS, V36, P3018, DOI 10.1118/1.3148535; Shaw C, 2014, CONE BEAM COMPUTED T, DOI DOI 10.1201/B16465; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Siewerdsen JH, 2004, MED PHYS, V31, P3057, DOI 10.1118/1.1758350; Szczykutowicz TP, 2010, PHYS MED BIOL, V55, P6411, DOI 10.1088/0031-9155/55/21/005; Taguchi K, 2013, MED PHYS, V40, DOI 10.1118/1.4820371; Touch M, 2016, PHYS MED BIOL, V61, P6132, DOI 10.1088/0031-9155/61/16/6132; VANDERVORST HA, 1992, SIAM J SCI STAT COMP, V13, P631, DOI 10.1137/0913035; Vivone G, 2015, IEEE T GEOSCI REMOTE, V53, P2565, DOI 10.1109/TGRS.2014.2361734; Wang AS, 2015, MED PHYS, V42, P2699, DOI 10.1118/1.4914378; Wang J, 2006, IEEE T MED IMAGING, V25, P1272, DOI 10.1109/TMI.2006.882141; Xu Q, 2012, IEEE T MED IMAGING, V31, P1682, DOI 10.1109/TMI.2012.2195669; Xu Q, 2012, IEEE T BIO-MED ENG, V59, P1711, DOI 10.1109/TBME.2012.2192119; Zeng D, 2016, IEEE T BIO-MED ENG, V63, P1044, DOI 10.1109/TBME.2015.2476371; Zhang YB, 2017, IEEE T MED IMAGING, V36, P142, DOI 10.1109/TMI.2016.2600249; Zhang Y, 2016, IEEE T COMPUT IMAG, V2, P510, DOI 10.1109/TCI.2016.2609414	75	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180324	10.1371/journal.pone.0180324	http://dx.doi.org/10.1371/journal.pone.0180324			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683124	Green Submitted, Green Published, gold			2022-12-27	WOS:000405335200023
J	Deng, PY; Li, X; Wei, Y; Liu, J; Chen, M; Xu, YM; Dong, B; Zhu, LQ; Cheri, LM				Deng, Peiying; Li, Xue; Wei, Yi; Liu, Juan; Chen, Meng; Xu, Yamei; Dong, Bin; Zhu, Lingqun; Chai, Limin			The herbal decoction modified Danggui Buxue Tang attenuates immune-mediated bone marrow failure by regulating the differentiation of T lymphocytes in an immune-induced aplastic anemia mouse model	PLOS ONE			English	Article							RADIX-ASTRAGALI; NITRIC-OXIDE; CELLS; PATHOPHYSIOLOGY; MECHANISMS; EXPRESSION; RESPONSES; GAMMA; HETEROGENEITY; RHIZOMA	Angelicae Sinensis, Radix Astragali and Rhizoma Coptidis are all herbs of modified Danggui Buxue Tang (DGBX) and are extensively applied herbs in traditional Chinese medicine for the treatment of anemia and inflammation. In this study, immune-induced AA mice were used as an animal model, and the immunosuppressive agent, Ciclosporin A (CsA), was used as a positive control. Multiple pro-inflammatory cytokines were examined by bead based multiplex flow cytometry. The T-cell subsets were assessed using a fluorescence activated cell sorter (FACS). Western blot analysis was used to estimate the protein expression levels of specific transcription factors for T helper cells (Th1, Th2 and Th17) and key molecules of the Janus-activated kinase (Jak)/signal transducer and activator of transcription (Stat3) signaling pathway. DGBX treatment could significantly increase the production of whole blood cells in peripheral blood (PB); inhibit the expansion of Th1 and Th17 cells; increase the differentiation of Th2 and Tregs cells; regulate the expression levels of T-bet, GATA-3, RORy and proinflammatory cytokines; and decrease the expression levels of key molecules in the Jak/Stat signaling pathway. These results indicate that DGBX can regulate the differentiation of T lymphocytes, resulting in immunosuppressive and hematogenic functions on AA mice. DGBX might be a good candidate for inclusion in a randomized study for AA with more data on the possible side effects and doses used in humans. Ultimately, it may be used for applications of traditional medicine against AA in modern complementary and alternative immunosuppressive therapeutics.	[Deng, Peiying; Li, Xue; Wei, Yi; Dong, Bin; Zhu, Lingqun; Chai, Limin] Beijing Univ Chinese Med, Minist Educ, Key Lab Chinese Internal Med, Beijing, Peoples R China; [Deng, Peiying; Li, Xue; Wei, Yi; Dong, Bin; Zhu, Lingqun; Chai, Limin] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China; [Liu, Juan; Xu, Yamei] Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Hematol & Oncol, Beijing, Peoples R China; [Chen, Meng] Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Cheri, LM (corresponding author), Beijing Univ Chinese Med, Minist Educ, Key Lab Chinese Internal Med, Beijing, Peoples R China.; Cheri, LM (corresponding author), Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China.	liminchai@hotmail.com			National Natural Science Foundation of China [81373583]; Fundamental Research Funds for Beijing University of Chinese medicine [2015-JYB-XJQ002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Beijing University of Chinese medicine	This work was supported by National Natural Science Foundation of China 81373583 (http://wwtiv.nsfc.gov.cri), Fundamental Research Funds for Beijing University of Chinese medicine 2015-JYB-XJQ002 (http./Armwbum.eduLn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2016, FOOD FUNCT, V7, P1380, DOI [10.1039/c5fo01531f, 10.1039/C5FO01531F]; [Anonymous], 2006, [No title captured]; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bin Dong JL, 2014, J BEIJING U TRADITIO, V37; Bloom ML, 2004, EXP HEMATOL, V32, P1163, DOI 10.1016/j.exphem.2004.08.006; Brodsky RA, 2005, LANCET, V365, P1647, DOI 10.1016/S0140-6736(05)66515-4; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chen Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep11638; Choi YY, 2013, J ETHNOPHARMACOL, V149, P506, DOI 10.1016/j.jep.2013.07.008; de Latour RP, 2010, BLOOD, V116, P4175, DOI 10.1182/blood-2010-01-266098; Fagerlie SR, 2004, J IMMUNOL, V173, P3863, DOI 10.4049/jimmunol.173.6.3863; Gao QT, 2006, PLANTA MED, V72, P1227, DOI 10.1055/s-2006-947186; Giannakoulas NC, 2004, BRIT J HAEMATOL, V124, P97, DOI 10.1046/j.1365-2141.2003.04729.x; Gong AGW, 2016, PLANTA MED, V82, P418, DOI 10.1055/s-0035-1558332; Hoyer KK, 2009, BLOOD, V113, P389, DOI 10.1182/blood-2008-04-153346; Iizuka N, 2000, CANCER LETT, V158, P35, DOI 10.1016/S0304-3835(00)00496-1; Ishikawa S, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7262054; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Juan Liu CZ, 2013, J BEIJING U TRADITIO, V36; Kordasti S, 2012, BLOOD, V119, P2033, DOI 10.1182/blood-2011-08-368308; Kotsianidis I, 2009, LEUKEMIA, V23, P510, DOI 10.1038/leu.2008.333; Li J., 2016, STEM CELLS INT, V2016, P6, DOI DOI 10.1016/J.ENGGE0.2016.03.006; Liu TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13982; Miyara M, 2011, IMMUNOL CELL BIOL, V89, P346, DOI 10.1038/icb.2010.137; Munoz J, 2014, ONCOLOGIST, V19, P536, DOI 10.1634/theoncologist.2013-0407; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NISTICO A, 1994, ANN INTERN MED, V120, P463, DOI 10.7326/0003-4819-120-6-199403150-00003; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Qiu CL, 2014, CELL PHYSIOL BIOCHEM, V33, P784, DOI 10.1159/000358652; Quan GH, 2015, INT J MOL SCI, V16, P29496, DOI 10.3390/ijms161226179; Remppis A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/194896; Shi J, 2012, BLOOD, V120, P1624, DOI 10.1182/blood-2011-11-390708; Shin JS, 2016, J PHARMACOL EXP THER, V358, P20, DOI 10.1124/jpet.115.231043; Solomou EE, 2007, BLOOD, V110, P1603, DOI 10.1182/blood-2007-01-066258; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Yan Y, 2013, J PHARMACEUT BIOMED, V80, P192, DOI 10.1016/j.jpba.2013.03.008; Yang M, 2009, J ETHNOPHARMACOL, V124, P87, DOI 10.1016/j.jep.2009.04.007; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470; Young NS, 2010, BIOL BLOOD MARROW TR, V16, pS119, DOI 10.1016/j.bbmt.2009.09.013; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI12687; Zeng Y, 2015, CLIN EXP IMMUNOL, V180, P361, DOI 10.1111/cei.12605; Zhang B, 2016, J CLIN INVEST, V126, P975, DOI 10.1172/JCI79196; Zhou B, 2014, J CLIN INVEST, V124, P553, DOI 10.1172/JCI69804; Zhou K, 2016, INFLAMMATION, V39, P1558, DOI 10.1007/s10753-016-0391-6; Zierau O, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/	49	15	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180417	10.1371/journal.pone.0180417	http://dx.doi.org/10.1371/journal.pone.0180417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683082	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200033
J	Hata, T; Asano, Y; Yoshihara, K; Kimura-Todani, T; Miyata, N; Zhang, XT; Takakura, S; Aiba, Y; Koga, Y; Sudo, N				Hata, Tomokazu; Asano, Yasunari; Yoshihara, Kazufumi; Kimura-Todani, Tae; Miyata, Noriyuki; Zhang, Xue-Ting; Takakura, Shu; Aiba, Yuji; Koga, Yasuhiro; Sudo, Nobuyuki			Regulation of gut luminal serotonin by commensal microbiota in mice	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CENTRAL-NERVOUS-SYSTEM; ENTEROCHROMAFFIN CELLS; INTESTINAL MICROBIOTA; INTRALUMINAL PRESSURE; VISCERAL SENSITIVITY; RELEASE; 5-HYDROXYTRYPTAMINE; MUCOSA; BRAIN	Gut lumen serotonin (5-hydroxytryptamine: 5-HT) contributes to several gastrointestinal functions such as peristaltic reflexes. 5-HT is released from enterochromaffin (EC) cells in response to a number of stimuli, including signals from the gut microbiota. However, the specific mechanism by which the gut microbiota regulates 5-HT levels in the gut lumen has not yet been clarified. Our previous work with gnotobiotic mice showed that free catecholamines can be produced by the deconjugation of conjugated catecholamines; hence, we speculated that deconjugation by bacterial enzymes may be one of the mechanisms whereby gut microbes can produce free 5-HT in the gut lumen. In this study, we tested this hypothesis using germ-free (GF) mice and gnotobiotic mice recolonized with specific pathogen-free (SPF) fecal flora (EX-GF). The 5-HT levels in the lumens of the cecum and colon were significantly lower in the GF mice than in the EX-GF mice. Moreover, these levels were rapidly increased, within only 3 days after exposure to SPF microbiota. The majority of 5-HT was in an unconjugated, free form in the EX-GF mice, whereas approximately 50% of the 5-HT was found in the conjugated form in the GF mice. These results further support the current view that the gut microbiota plays a crucial role in promoting the production of biologically active, free 5-HT. The deconjugation of glucuronide-conjugated 5-HT by bacterial enzymes is likely one of the mechanisms contributing to free 5-HT production in the gut lumen.	[Hata, Tomokazu; Asano, Yasunari; Yoshihara, Kazufumi; Kimura-Todani, Tae; Miyata, Noriyuki; Zhang, Xue-Ting; Takakura, Shu; Sudo, Nobuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka, Japan; [Aiba, Yuji; Koga, Yasuhiro] Tokai Univ Med, Dept Infect Dis, Isehara, Kanagawa, Japan	Kyushu University; Tokai University	Sudo, N (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka, Japan.	nobuyuki@med.kyushu-u.ac.jp		Sudo, Nobuyuki/0000-0002-7935-878X; Asano, Yasunari/0000-0002-6180-3494	Ministry of Education, Culture, Sports, Science, and Technology in Japan [25293054, 25293167, 16H05278, 16K15413, 16H06404]	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was totally supported by Grants-in-Aid for General Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (25293054, https://kaken. nii.ac.ip/d/p/25293054.ja.html; 25293167, https:// kaken.ni.acdpid/p/25293167.1a.html; 16H05278, https://kaken.nii.ac.jd/p/16H05278.ja.html; 16K15413, https://kaken.nii.ac.jp/d/p/16K15413.ja. htm;; 16H06404, https://kaken.nii.ac.jp/d/p/16H06404.ja.html: NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012; Bertrand PP, 2010, AUTON NEUROSCI-BASIC, V153, P47, DOI 10.1016/j.autneu.2009.08.002; Bertrand PP, 2004, NEUROGASTROENT MOTIL, V16, P511, DOI 10.1111/j.1365-2982.2004.00572.x; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BULBRING E, 1959, J PHYSIOL-LONDON, V146, P18; BULBRING E, 1958, J PHYSIOL-LONDON, V140, P381; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Forsythe P, 2010, BRAIN BEHAV IMMUN, V24, P9, DOI 10.1016/j.bbi.2009.05.058; Fujimiya M, 1997, HISTOCHEM CELL BIOL, V108, P105, DOI 10.1007/s004180050151; Gershon MD, 2004, ALIMENT PHARM THER, V20, P3, DOI 10.1111/j.1365-2036.2004.02180.x; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; Grundy D, 2008, EUR REV MED PHARMACO, V12, P63; HAZENBERG MP, 1988, FEMS MICROBIOL LETT, V54, P9; ILETT KF, 1990, PHARMACOL THERAPEUT, V46, P67, DOI 10.1016/0163-7258(90)90036-2; Kerckhoffs APM, 2012, AM J PHYSIOL-GASTR L, V302, pG1053, DOI 10.1152/ajpgi.00153.2011; Kirkup AJ, 2001, AM J PHYSIOL-GASTR L, V280, pG787, DOI 10.1152/ajpgi.2001.280.5.G787; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x; Nishino R, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12110; O'Hara JR, 2004, AM J PHYSIOL-GASTR L, V287, pG998, DOI 10.1152/ajpgi.00090.2004; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Rodriguez MJ, 2001, CELL TISSUE RES, V304, P215, DOI 10.1007/s004410100361; Selwyn FP, 2016, DRUG METAB DISPOS, V44, P262, DOI 10.1124/dmd.115.067504; Shibata O, 1988, Masui, V37, P428; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sudo N, 1997, J IMMUNOL, V159, P1739; Toda T, 2009, XENOBIOTICA, V39, P323, DOI 10.1080/00498250802651984; Tsukamoto K, 2007, AM J PHYSIOL-REG I, V293, pR64, DOI 10.1152/ajpregu.00856.2006; URIBE A, 1994, GASTROENTEROLOGY, V107, P1259, DOI 10.1016/0016-5085(94)90526-6; Verbeuren TJ, 1989, PERIPHERAL ACTIONS 5, P1; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; YONEDA S, 1983, LIFE SCI, V33, P935, DOI 10.1016/0024-3205(83)90749-X; Zeng FN, 2010, GASTROENTEROLOGY, V138, P1491, DOI 10.1053/j.gastro.2009.11.048	38	101	103	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180745	10.1371/journal.pone.0180745	http://dx.doi.org/10.1371/journal.pone.0180745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683093	Green Submitted, Green Published, gold			2022-12-27	WOS:000405335200065
J	Kessel, KA; Hesse, J; Straube, C; Zimmer, C; Schmidt-Graf, F; Schlegel, J; Meyer, B; Combs, SE				Kessel, Kerstin A.; Hesse, Josefine; Straube, Christoph; Zimmer, Claus; Schmidt-Graf, Friederike; Schlegel, Juergen; Meyer, Bernhard; Combs, Stephanie E.			Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma	PLOS ONE			English	Article							STEREOTAXIC RADIOTHERAPY; GRADE GLIOMAS; GLIOBLASTOMA; VALIDATION; RESECTION; MANAGEMENT; OUTCOMES; SURGERY; THERAPY	Introduction For about 30 years, researchers developed prognostic scores and searched for prognostic factors to predict outcomes for cancer patients. The Combs Prognostic Score for re-irradiation in recurrent glioma was recently validated and results showed that the score is a significant (p < .001) and reliable predictor for patients undergoing re-irradiation (re-RT). We sought to enhance the score and generated a novel scoring approach, taking into account the information on resection of recurrent tumors, KPS, and tumor volume. Patients and methods The prognostic score was generated based on 209 patients treated between 2002 and 2016 for recurrent glioma at the department of radiation oncology at the Klinikum rechts der Isar, Munich. To further enhance the previously validated Combs Prognostic Score, which uses the prognostic factors primary histology, time between primary RT and re-RT, and age, we added KPS, tumor volume (PTV) and re-resection into the scoring scheme. Results The median follow-up time was 3.5 months. 67.5% were WHO IV gliomas with a median OS after re-RT of 7.9 months, 17.7% were WHO III gliomas with an OS of 11.3 months and 14.8% were WHO I/II gliomas with an OS of 14.7 months. Multivariate analyses confirmed the prognostic factors KPS (p < .001) and showed a tendency to significance for tumor volume (p = .067) and re-resection (p = .064). The new prognostic score demonstrated a high significance (p < .001). Conclusion The New Combs Prognostics Score is a significant and useful tool to predict the overall effect of re-RT in patients with recurrence gliomas. This modified score offers an even better way to classify patients in clinical routine and prospective clinical trials investigating re-irradiation.	[Kessel, Kerstin A.; Hesse, Josefine; Straube, Christoph; Combs, Stephanie E.] TUM, Dept Radiat Oncol, Munich, Germany; [Kessel, Kerstin A.; Combs, Stephanie E.] Helmholtz Zentrum Munchen, Inst Innovat Radiotherapy iRT, Neuherberg, Germany; [Zimmer, Claus] TUM, Dept roradiol, Munich, Germany; [Schmidt-Graf, Friederike] TUM, Dept Neurol, Munich, Germany; [Schlegel, Juergen] TUM, Dept Neuropathol, Munich, Germany; [Meyer, Bernhard] TUM, Dept Neurosurg, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Kessel, KA (corresponding author), TUM, Dept Radiat Oncol, Munich, Germany.; Kessel, KA (corresponding author), Helmholtz Zentrum Munchen, Inst Innovat Radiotherapy iRT, Neuherberg, Germany.	Kerstin.Kessel@tum.de		Eitz, Kerstin A./0000-0002-6544-8151; Schlegel, Jurgen/0000-0002-5544-2717				Adeberg S, 2015, IMPACT DELAYS INITIA, V15, P987; Amichetti Maurizio, 2011, Cancers (Basel), V3, P4061, DOI 10.3390/cancers3044061; Brandes AA, 2010, NEURO-ONCOLOGY, V12, P283, DOI 10.1093/neuonc/nop050; Combs SE, 2005, J NEURO-ONCOL, V74, P167, DOI 10.1007/s11060-004-2463-y; Combs SE, 2013, ACTA ONCOL, V52, P147, DOI 10.3109/0284186X.2012.692882; Combs SE, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-167; Fogh SE, 2010, J CLIN ONCOL, V28, P3048, DOI 10.1200/JCO.2009.25.6941; Hayes J, 2016, MOL ONCOL, V10, P1296, DOI 10.1016/j.molonc.2016.06.004; Hayes J, 2015, MOL ONCOL, V9, P704, DOI 10.1016/j.molonc.2014.11.004; Kessel KA, 2017, ACTA ONCOL, V56, P422, DOI 10.1080/0284186X.2016.1276621; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; LAING RW, 1993, RADIOTHER ONCOL, V27, P22, DOI 10.1016/0167-8140(93)90040-F; Lee J, 2016, YONSEI MED J, V57, P824, DOI 10.3349/ymj.2016.57.4.824; Mallick S, 2016, J EGYPT NATL CANCER, V28, P199, DOI 10.1016/j.jnci.2016.07.001; Nieder C, 2016, ANTICANCER RES; Niyazi M, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-128; Palmer JD, 2015, J NEURO-ONCOL, V124, P215, DOI 10.1007/s11060-015-1825-y; Reifenberger G, 2016, NAT REV CLIN ONCOL; Ringel F, 2016, NEURO-ONCOLOGY, V18, P96, DOI 10.1093/neuonc/nov145; Sana J, 2014, CARCINOGENESIS, V35, P2756, DOI 10.1093/carcin/bgu212; Scholtyssek F, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-161; Shepherd SF, 1997, INT J RADIAT ONCOL, V37, P393, DOI 10.1016/S0360-3016(96)00455-5; Taunk NK, 2016, EXPERT REV ANTICANC, V16, P347, DOI 10.1586/14737140.2016.1143364; Thon N, 2016, J NEUROL; Torcuator RG, 2010, J NEURO-ONCOL, V97, P401, DOI 10.1007/s11060-009-0034-y; Uppstrom TJ, 2016, CLIN NEUROL NEUROSUR, V151, P18, DOI 10.1016/j.clineuro.2016.09.013; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572	27	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180457	10.1371/journal.pone.0180457	http://dx.doi.org/10.1371/journal.pone.0180457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678889	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200065
J	Monte-Ordono, J; Toro, JM				Monte-Ordono, Julia; Toro, Juan M.			Early positivity signals changes in an abstract linguistic pattern	PLOS ONE			English	Article							GRAMMAR; LANGUAGE; BRAIN; ERP; VIOLATIONS; REVEALS	The extraction of abstract structures from speech (or from gestures in the case of sign languages) has been claimed to be a fundamental mechanism for language acquisition. In the present study we registered the neural responses that are triggered when a violation of an abstract, token-independent rule is detected. We registered ERPs while presenting participants with trisyllabic CVCVCV nonsense words in an oddball paradigm. Standard stimuli followed an ABB rule (where A and B are different syllables). Importantly, to distinguish neural responses triggered by changes in surface information from responses triggered by changes in the underlying abstract structure, we used two types of deviant stimuli. Phoneme deviants differed from standards only in their phonemes. Rule deviants differed from standards in both their phonemes and their composing rule. We observed a significant positivity as early as 300 ms after the presentation of deviant stimuli that violated the abstract rule (Rule deviants). The amplitude of this neural response was correlated with participants' performance in a behavioral rule learning test. Differences in electrophysiological responses observed between learners and non-learners suggest that individual differences in an abstract rule learning task might be related to how listeners select relevant sources of information.	[Monte-Ordono, Julia; Toro, Juan M.] Univ Pompeu Fabra, Barcelona, Spain; [Toro, Juan M.] ICREA, Barcelona, Spain	Pompeu Fabra University; ICREA	Toro, JM (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.; Toro, JM (corresponding author), ICREA, Barcelona, Spain.	juanmanuel.toro@upf.edu	Toro, Juan M/F-3933-2010	Toro, Juan M/0000-0002-5336-5658	European Research Council (ERC) Starting Grant [312519]; Spanish Ministerio de Economo Aagrant [PSI 2013-44992-P]	European Research Council (ERC) Starting Grant(European Research Council (ERC)); Spanish Ministerio de Economo Aagrant	This research was supported by the European Research Council (ERC) Starting Grant agreement n. 312519, and Spanish Ministerio de Economo Aagrant PSI 2013-44992-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlmann J, 2006, J COGNITIVE NEUROSCI, V18, P1829, DOI 10.1162/jocn.2006.18.11.1829; Basirat A, 2014, COGNITION, V132, P137, DOI 10.1016/j.cognition.2014.03.013; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Chomsky N., 1957, SYNTACTIC STRUCTURES; Choudhary KK, 2009, NEUROPSYCHOLOGIA, V47, P3012, DOI 10.1016/j.neuropsychologia.2009.05.009; Christiansen MH, 2012, LANG COGNITIVE PROC, V27, P231, DOI 10.1080/01690965.2011.606666; Cornella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043604; Crespo-Bojorque P, 2016, J COMP PSYCHOL, V130, P97, DOI 10.1037/com0000027; De Diego Balaguer Ruth, 2007, PLoS One, V2, pe1175, DOI 10.1371/journal.pone.0001175; Diaz B, 2008, P NATL ACAD SCI USA, V105, P16083, DOI 10.1073/pnas.0805022105; DUTOIT T, 1996, MBROLA PROJECT SET H; Endress AD, 2009, TRENDS COGN SCI, V13, P348, DOI 10.1016/j.tics.2009.05.005; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Ferguson B, 2016, SCI REP-UK, V6, DOI 10.1038/srep25434; Friederici AD, 2002, P NATL ACAD SCI USA, V99, P529, DOI 10.1073/pnas.012611199; Friederici Angela D, 2004, Curr Neurol Neurosci Rep, V4, P466, DOI 10.1007/s11910-004-0070-0; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Honrubia-Serrano M. L, 2005, N400 CATEGORY EXEMPL; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Leone-Fernandez B, 2012, BRAIN LANG, V120, P127, DOI 10.1016/j.bandl.2010.12.006; Marcus GF, 2007, PSYCHOL SCI, V18, P387, DOI 10.1111/j.1467-9280.2007.01910.x; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mehler J, 2003, LINGUE LINGUAGGIO, V2, P203; Mueller JL, 2012, P NATL ACAD SCI USA, V109, P15953, DOI 10.1073/pnas.1204319109; Paavilainen P, 2001, PSYCHOPHYSIOLOGY, V38, P359, DOI 10.1017/S0048577201000920; Paavilainen P, 2013, INT J PSYCHOPHYSIOL, V88, P109, DOI 10.1016/j.ijpsycho.2013.03.015; Petersson KM, 2012, BRAIN LANG, V120, P83, DOI 10.1016/j.bandl.2010.08.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pulvermuller F, 2003, NEUROIMAGE, V20, P159, DOI 10.1016/S1053-8119(03)00261-1; Rabagliati H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040517; Rossi S, 2013, BRAIN LANG, V127, P404, DOI 10.1016/j.bandl.2013.02.009; Rossi S, 2011, J COGNITIVE NEUROSCI, V23, P1752, DOI 10.1162/jocn.2010.21547; Saffran JR, 2007, COGNITION, V105, P669, DOI 10.1016/j.cognition.2006.11.004; Silva-Pereyra J, 2003, CLIN NEUROPHYSIOL, V114, P2469, DOI 10.1016/S1388-2457(03)00248-7; Sun F, 2012, ACTA MATER, V60, P6631, DOI 10.1016/j.actamat.2012.08.032; Tabullo A, 2013, BRAIN RES, V1527, P149, DOI 10.1016/j.brainres.2013.05.022; Tabullo A, 2011, BRAIN RES, V1373, P131, DOI 10.1016/j.brainres.2010.12.023; Toro JM, 2008, PSYCHOL SCI, V19, P137, DOI 10.1111/j.1467-9280.2008.02059.x; Toro JM, 2011, J EXP PSYCHOL LEARN, V37, P493, DOI 10.1037/a0022056	41	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180727	10.1371/journal.pone.0180727	http://dx.doi.org/10.1371/journal.pone.0180727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678863	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200086
J	Almarzouki, AF; Brown, CA; Brown, RJ; Leung, MHK; Jones, AKP				Almarzouki, Abeer F.; Brown, Christopher A.; Brown, Richard J.; Leung, Matthew H. K.; Jones, Anthony K. P.			Negative expectations interfere with the analgesic effect of safety cues on pain perception by priming the cortical representation of pain in the midcingulate cortex	PLOS ONE			English	Article							PLACEBO ANALGESIA; PATIENT EXPECTATIONS; ATTENTIONAL BIASES; QUESTIONNAIRE-III; EVOKED-POTENTIALS; FEAR-AVOIDANCE; MODULATION; PERSPECTIVE; LOCALIZATION; EXPERIENCE	It is well known that the efficacy of treatment effects, including those of placebos, is heavily dependent on positive expectations regarding treatment outcomes. For example, positive expectations about pain treatments are essential for pain reduction. Such positive expectations not only depend on the properties of the treatment itself, but also on the context in which the treatment is presented. However, it is not clear how the preceding threat of pain will bias positive expectancy effects. One hypothesis is that threatening contexts trigger fearful and catastrophic thinking, reducing the pain-relieving effects of positive expectancy. In this study, we investigated the disruptive influence of threatening contexts on positive expectancy effects while 41 healthy volunteers experienced laser-induced heat pain. A threatening context was induced using pain-threatening cues that preceded the induction of positive expectancies via subsequent pain-safety cues. We also utilised electroencephalography (EEG) to investigate potential neural mechanisms underlying these effects. Lastly, we used the Fear of Pain Questionnaire to address whether the disruptive effect of negative contexts on cued pain relief was related to the degree of fear of pain. As predicted, participants responded less to pain-safety cues (i.e., experienced more pain) when these were preceded by pain-threatening cues. In this threatening context, an enhancement of the N2 component of the laser-evoked potential was detected, which was more pronounced in fearful individuals. This effect was localised to the midcingulate cortex, an area thought to integrate negative affect with pain experience to enable adaptive behaviour in aversive situations. These results suggest that threatening contexts disrupt the effect of pain relief cues via an aversive priming mechanism that enhances neural responses in the early stages of sensory processing.	[Almarzouki, Abeer F.] King Abdulaziz Univ, Dept Physiol, Fac Med, Jeddah, Saudi Arabia; [Brown, Christopher A.] Univ Liverpool, Dept Psychol Sci, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England; [Brown, Richard J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Leung, Matthew H. K.] Royal Bolton NHS Fdn Trust, Bolton, England; [Jones, Anthony K. P.] Univ Manchester, Salford Royal NHS Fdn Trust, Div Neurosci & Cognit Psychol, Human Pain Res Grp, Salford, Lancs, England	King Abdulaziz University; University of Liverpool; University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester	Almarzouki, AF (corresponding author), King Abdulaziz Univ, Dept Physiol, Fac Med, Jeddah, Saudi Arabia.	Afmalmarzouki@kau.edu.sa		Almarzouki, Abeer F/0000-0001-8090-5341; Brown, Christopher/0000-0003-1414-2635; Jones, Anthony/0000-0001-6944-9365; Brown, Richard/0000-0003-3961-2023	King Abdul-Aziz University scholarship scheme	King Abdul-Aziz University scholarship scheme	The study has been funded by King Abdul-Aziz University scholarship scheme.	Asmundson GJG, 2007, J PAIN, V8, P11, DOI 10.1016/j.jpain.2006.05.008; Atlas LY, 2012, NEUROSCI LETT, V520, P140, DOI 10.1016/j.neulet.2012.03.039; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Bentley DE, 2004, CLIN NEUROPHYSIOL, V115, P1846, DOI 10.1016/j.clinph.2004.03.010; Bialosky JE, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-19; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Brown CA, 2008, PAIN, V139, P324, DOI 10.1016/j.pain.2008.04.028; Brown CA, 2008, PAIN, V135, P240, DOI 10.1016/j.pain.2007.05.022; Brown CA, 2010, PAIN, V150, P428, DOI 10.1016/j.pain.2010.04.017; Buchel C, 2014, NEURON, V81, P1223, DOI 10.1016/j.neuron.2014.02.042; Clark JA, 2008, CLIN NEUROPHYSIOL, V119, P2870, DOI 10.1016/j.clinph.2008.09.022; Crombez G, 1999, J PSYCHOSOM RES, V47, P403, DOI 10.1016/S0022-3999(99)00046-X; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; Gandhi R, 2009, J ARTHROPLASTY, V24, P716, DOI 10.1016/j.arth.2008.05.016; Huneke NTM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078278; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2005, NEUROSCIENCE, V131, P199, DOI 10.1016/j.neuroscience.2004.10.035; Iles R, EXTRACRANIAL LOCALIZ; Jones A, 2013, PLACEBO AND PAIN: FROM BENCH TO BEDSIDE, P37, DOI 10.1016/B978-0-12-397928-5.00005-2; Judge A, 2011, OSTEOARTHR CARTILAGE, V19, P659, DOI 10.1016/j.joca.2011.03.009; Keogh E, 2003, PAIN, V104, P85, DOI 10.1016/S0304-3959(02)00468-2; Keogh E, 2001, J ANXIETY DISORD, V15, P299, DOI 10.1016/S0887-6185(01)00065-2; Lantz G, 1997, ELECTROEN CLIN NEURO, V102, P414, DOI 10.1016/S0921-884X(96)96551-0; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; Lorenz R, 2005, BRAIN BEHAV IMMUN, V19, P283, DOI 10.1016/j.bbi.2005.03.010; Martini M, 2015, EUR J NEUROSCI, V41, P498, DOI 10.1111/ejn.12807; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Morton DL, 2010, NEUROPSYCHOLOGIA, V48, P1958, DOI 10.1016/j.neuropsychologia.2010.03.016; Ohara S, 2004, PAIN, V110, P318, DOI 10.1016/j.pain.2004.04.009; Osman A, 2002, J BEHAV MED, V25, P155, DOI 10.1023/A:1014884704974; Pagnoni G, 2014, PHYS LIFE REV, V11, P555, DOI 10.1016/j.plrev.2014.05.006; Petersen GL, 2014, PAIN, V155, P1426, DOI 10.1016/j.pain.2014.04.016; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Smeets RJEM, 2008, CLIN J PAIN, V24, P305, DOI 10.1097/AJP.0b013e318164aa75; Stancak A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00552; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wager TD, 2006, BRAIN BEHAV IMMUN, V20, P219, DOI 10.1016/j.bbi.2006.01.007; Wager TD, 2005, PAIN, V115, P225, DOI 10.1016/j.pain.2005.03.018; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003; Wiech K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00046; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010	44	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180006	10.1371/journal.pone.0180006	http://dx.doi.org/10.1371/journal.pone.0180006			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665973	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700051
J	Bae, JH; Hwang, AR; Kim, CY; Yu, HG; Koh, HJ; Yang, WI; Chang, HR; Lee, SC				Bae, Jeong Hun; Hwang, Ah Reum; Kim, Chan Yun; Yu, Hyeong Gon; Koh, Hyoung Jun; Yang, Woo Ick; Chang, Hae Ran; Lee, Sung Chul			Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats	PLOS ONE			English	Article							MACULAR DEGENERATION; GROWTH; VEGF; ANTIFUNGAL; ANGIOGENESIS; EXPRESSION; CANCER; TRIAMCINOLONE; TRAFFICKING; ACTIVATION	Choroidal neovascularization (CNV) is a major cause of severe visual loss in patients with age-related macular degeneration (AMD). Recently, itraconazole has shown potent and dose-dependent inhibition of tumor-associated angiogenesis. We evaluated the anti-angiogenic effect of itraconazole in a rat model of laser-induced CNV. After laser photocoagulation in each eye to cause CNV, right eyes were administered intravitreal injections of itraconazole; left eyes received balanced salt solution (BSS) as controls. On day 14 after laser induction, fluorescein angiography (FA) was used to assess abnormal vascular leakage. Flattened retinal pigment epithelium (RPE)-choroid tissue complex was stained with Alexa Fluor 594-conjugated isolectin B4 to measure the CNV area and volume. Vascular endothelial growth factor receptor 2 (VEGFR2) mRNA and protein expression was determined 1, 4, 7, and 14 days after intravitreal injection by quantitative RT-PCR or Western blot. VEGF levels were analyzed by enzyme-linked immunosorbent assay (ELISA). Intravitreal itraconazole significantly reduced leakage from CNV as assessed by FA and CNV area and volume on flat mounts compared with intravitreal BSS (p = 0.002 for CNV leakage, p< 0.001 for CNV area and volume). Quantitative RT-PCR showed significantly lower expression of VEGFR2 mRNA in the RPE-choroid complexes of itraconazole-injected eyes than those of BSS-injected eyes on days 7 and 14 (p = 0.003 and p = 0.006). Western blots indicated that VEGFR2 was downregulated after itraconazole treatment. ELISA showed a significant difference in VEGF level between itraconazole-injected and BSS-injected eyes on days 7 and 14 (p = 0.04 and p = 0.001). Our study demonstrated that intravitreal itraconazole significantly inhibited the development of laser-induced CNV in rats. Itraconazole had anti-angiogenic activity along with the reduction of VEGFR2 and VEGF levels. Itraconazole may prove beneficial for treating CNV as an alternative or adjunct to other therapies.	[Bae, Jeong Hun; Chang, Hae Ran] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Med Res Inst,Dept Ophthalmol, Seoul, South Korea; [Bae, Jeong Hun; Hwang, Ah Reum; Kim, Chan Yun; Koh, Hyoung Jun; Lee, Sung Chul] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Yu, Hyeong Gon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Yang, Woo Ick] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Yonsei University Health System	Lee, SC (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	sunglee@yuhs.ac		Koh, Hyoung Jun/0000-0002-5932-8516; , Sung Chul/0000-0001-9438-2385; Kim, Chan Yun/0000-0002-8373-9999	Medical Research Funds from Kangbuk Samsung Hospital; Samsung Biomedical Research Institute [SMX1132251]	Medical Research Funds from Kangbuk Samsung Hospital(Samsung); Samsung Biomedical Research Institute(Samsung)	This work was supported by Medical Research Funds from Kangbuk Samsung Hospital (https://www.kbsmc.co.kr/) and Samsung Biomedical Research Institute grant #SMX1132251 (http://www.smc.or.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab BT, 2011, CANCER RES, V71, P6764, DOI 10.1158/0008-5472.CAN-11-0691; Antonarakis ES, 2013, ONCOLOGIST, V18, P163, DOI 10.1634/theoncologist.2012-314; Barouch Fina C., 2004, International Ophthalmology Clinics, V44, P23, DOI 10.1097/00004397-200404430-00005; Blinder KJ, 2003, AM J OPHTHALMOL, V136, P407, DOI 10.1016/S0002-9394(03)00223-X; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Del Carratore R, 2012, BIOMED PHARMACOTHER, V66, P312, DOI 10.1016/j.biopha.2011.11.004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frey T, 2009, J BIOL CHEM, V284, P16882, DOI 10.1074/jbc.M109.007609; Fu YL, 2007, INVEST OPHTH VIS SCI, V48, P5184, DOI 10.1167/iovs.07-0469; Goktas S, 2014, OPHTHALMIC RES, V52, P170, DOI 10.1159/000366283; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kim SJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P596, DOI 10.1001/archophthalmol.2010.69; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Lin CH, 2013, BRIT J PHARMACOL, V168, P920, DOI 10.1111/j.1476-5381.2012.02227.x; Liu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057473, 10.1371/journal.pone.0050719, 10.1371/journal.pone.0064143]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyzogubov VV, 2012, BBA-MOL CELL RES, V1823, P1264, DOI 10.1016/j.bbamcr.2012.05.017; Nacev BA, 2011, J BIOL CHEM, V286, P44045, DOI 10.1074/jbc.M111.278754; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Oshima Y, 2004, J CELL PHYSIOL, V201, P393, DOI 10.1002/jcp.20110; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; SCHULMAN JA, 1991, INT OPHTHALMOL, V15, P21, DOI 10.1007/BF00150975; Shi W, 2010, ACS MED CHEM LETT, V1, P155, DOI 10.1021/ml1000068; Shi YY, 2011, GRAEF ARCH CLIN EXP, V249, P1667, DOI 10.1007/s00417-011-1699-4; Surace EM, 2006, MOL THER, V13, P573, DOI 10.1016/j.ymthe.2005.10.010; Takahashi H, 2006, J OCUL PHARMACOL TH, V22, P213, DOI 10.1089/jop.2006.22.213; Takata S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09898; Thompson JT, 2006, AM J OPHTHALMOL, V141, P629, DOI 10.1016/j.ajo.2005.11.050; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085	40	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180482	10.1371/journal.pone.0180482	http://dx.doi.org/10.1371/journal.pone.0180482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666022	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700011
J	De Pasquale, C; Conti, D; Pistorio, ML; Fatuzzo, P; Veroux, M; Di Nuovo, S				De Pasquale, Concetta; Conti, Daniela; Pistorio, Maria Luisa; Fatuzzo, Pasquale; Veroux, Massimiliano; Di Nuovo, Santo			Comparison of the CBA-H and SF-36 for the screening of the psychological and behavioural variables in chronic dialysis patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEMODIALYSIS-PATIENTS; RENAL-FAILURE; DISEASE; SYMPTOMS; PATTERN	The aim of the study was to perform an analysis of the emotional reactions, perception of stressful life and behavioural changes related to Haemodialysis (HD) in order to identify those variables that can improve lifestyle and the adherence to treatment. Some psychometric assessment, such as the Cognitive Behavioural Assessment, Hospital Form, (CBA-H) and the Health Survey (SF-36), which provides two indexes: the Physical Component Score (PCS) and the Mental Component Score (MCS), are suitable to assess a patient's psychological and behavioural style and their health-related quality of life. The study involved 37 Italian out-patients with end-stage renal disease under HD therapy. We calculated the Spearman correlation between variables of CBA-H, SF-36, age and time on HD. We also performed a multivariate linear regression using the CBA-H variables as predictors and PCS and MCS as dependent variables. From the CBA-H, 95% of participants self-reported psychological characteristics comparable to Type A personality, which identifies an anxious, hyperactive and hostile subject. Physical limitations were found to be directly proportional to the time on dialysis (r(s) = -0.42). The condition of perceived stress worsens the state of mental health (r(s) = -0.68) and general health perception (r(s) = -0.44). The condition of vital exhaustion correlates both the PCS and the MCS (p<0.01) with possible outcomes of physical and mental illness. The psychological wellbeing of a dialyzed patient could be due to the combination of several factors, including life parameters, the positive perception of psychosocial outcomes, and the perceived quality of life. A multidisciplinary team (neurologists, psychiatrists, psychologists, and nurses) is essential to plan effective psychological and psychotherapeutic interventions to improve a mind-body integration.	[De Pasquale, Concetta; Pistorio, Maria Luisa; Veroux, Massimiliano] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Vasc Surg & Organ Transplant Unit, Catania, Italy; [De Pasquale, Concetta; Di Nuovo, Santo] Univ Catania, Dept Educ Sci, Catania, Italy; [Conti, Daniela] Sheffield Hallam Univ, Fac Arts Comp Engn & Sci, Sheffield, S Yorkshire, England; [Fatuzzo, Pasquale] Univ Catania, Dept Med & Paediat Sci, Catania, Italy	University of Catania; University of Catania; Sheffield Hallam University; University of Catania	Conti, D (corresponding author), Sheffield Hallam Univ, Fac Arts Comp Engn & Sci, Sheffield, S Yorkshire, England.	d.conti@shu.ac.uk	Conti, Daniela/J-5197-2019; Di Nuovo, Santo/K-7760-2019; de pasquale, concetta/AAG-8431-2020; Veroux, Massimiliano/K-4821-2018	Conti, Daniela/0000-0001-5308-7961; Di Nuovo, Santo/0000-0001-6086-7624; de pasquale, concetta/0000-0003-4692-0980; Veroux, Massimiliano/0000-0002-2780-6421	European Union's H research and innovation program under the MSCA-Individual Fellowship [703489]	European Union's H research and innovation program under the MSCA-Individual Fellowship	The work of Daniela Conti was partially supported by the European Union's H2020 research and innovation program under the MSCA-Individual Fellowship grant agreement no. 703489. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAM HS, 1971, AM J PSYCHIAT, V127, P1199, DOI 10.1176/ajp.127.9.1199; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Balestroni G, 2015, MONALDI ARCH CHEST D, V74; De Pasquale C, 2014, TRANSPL P, P2199; De Pasquale C, 2016, TRANSPL P, P319; De Pasquale C, 2011, TRANSPL P, P1045; De Pasquale C, 2012, TRANSPL P, P1876; Fornaro M, 2013, J AFFECT DISORDERS, V148, P375, DOI 10.1016/j.jad.2013.01.002; FRIEDMAN M, 1959, JAMA-J AM MED ASSOC, V169, P1286, DOI 10.1001/jama.1959.03000290012005; Friedman M, 1974, TYPE BEHAV YOUR HEAR, P26; Friedman M., 1996, TYPE BEHAV ITS DIAGN; Fujisawa M, 2000, UROLOGY, V56, P201, DOI 10.1016/S0090-4295(00)00623-3; Ghadam MS, 2016, GLOB J HLTH SCI, V8, P121; Lahousen T, 2016, NORD J PSYCHIAT, V70, P24, DOI 10.3109/08039488.2015.1041156; Lee SY, 2004, J PSYCHOSOM RES, V57, P5, DOI 10.1016/S0022-3999(03)00528-2; LEVY NB, 1979, PSYCHOTHER PSYCHOSOM, V31, P260, DOI 10.1159/000287338; LIVESLEY WJ, 1982, J PSYCHOSOM RES, V26, P581, DOI 10.1016/0022-3999(82)90072-1; Masoud Rayyani., 2014, ASIAN J NURSING ED R, V4, P165; Petticrew MP, 2012, AM J PUBLIC HEALTH, V102, P2018, DOI 10.2105/AJPH.2012.300816; Poorgholami Farzad, 2015, Glob J Health Sci, V8, P165, DOI 10.5539/gjhs.v8n7p165; Poppe C, 2013, NEPHROL DIAL TRANSPL, V28, P116, DOI 10.1093/ndt/gfs151; Prihodova L, 2014, TRANSPLANTATION, V97, P1139, DOI 10.1097/01.TP.0000441092.24593.1e; Sanavio E, 2013, PSYCHO COMMUNITY HEA, V2, P362, DOI DOI 10.5964/PCH.V2I3.61; SENSKY T, 1993, PSYCHOTHER PSYCHOSOM, V59, P56, DOI 10.1159/000288649; Soponaru C, 2016, ARCH MED SCI D CIVIL, P16; van Dijk S, 2012, PSYCHOSOM MED, V74, P854, DOI 10.1097/PSY.0b013e31826aff0b; WARE JE, 2000, HLTH SURVEY MANUAL I; WILLIAMS RB, 1980, PSYCHOSOM MED, V42, P539, DOI 10.1097/00006842-198011000-00002; WRIGHT RG, 1966, ANN INTERN MED, V64, P611, DOI 10.7326/0003-4819-64-3-611; Zotti AM, 2010, CBA H COGNITIVE BEHA	30	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180077	10.1371/journal.pone.0180077	http://dx.doi.org/10.1371/journal.pone.0180077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28666025	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000404608700060
J	Garcia-Recio, M; Cladera, A; Bento, L; Dominguez, J; de Gracia, SR; Sartori, F; Del Campo, R; Garcia, L; Ballester, C; Gines, J; Bargay, J; Sampol, A; Gutierrez, A				Garcia-Recio, Marta; Cladera, Antonia; Bento, Leyre; Dominguez, Julia; de Gracia, Silvia Ruiz; Sartori, Francesca; Del Campo, Raquel; Garcia, Lucia; Ballester, Carmen; Gines, Jordi; Bargay, Joan; Sampol, Antonia; Gutierrez, Antonio			Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience	PLOS ONE			English	Article							B-CELL LYMPHOMA; PRIMARY CNS LYMPHOMA; NON-HODGKIN-LYMPHOMA; HIGH-RISK PATIENTS; RITUXIMAB ERA; THERAPY; TRIAL; METHOTREXATE; LEUKEMIA; RELAPSE	Central nervous system (CNS) lymphomatosis is a fatal complication of aggressive non-Hodgkin lymphoma (NHL). In lymphoblastic or Burkitt lymphoma, without specific CNS prophylaxis the risk of CNS relapse is 20-30%. DLBCL has a lower risk of relapse (around 5%) but several factors increase its incidence. There is no consensus or trials to conclude which is the best CNS prophylaxis. Best results seem to be associated with the use of intravenous (iv) high-dose methotrexate (HDMTX) but with a significant toxicity. Other options are the administration of intrathecal (IT) MTX, cytarabine or liposomal cytarabine (ITLC). Our aim is to analyze the experience of the centers of the Balearic Lymphoma Group (BLG) about the toxicity and efficacy of ITLC in the prophylaxis and therapy of CNS lymphomatosis. We retrospectively reviewed cases from 2005 to 2015 (n = 58) treated with ITLC. Our toxicity results were: 33% headache, 20% neurological deficits, 11% nausea, 9% dizziness, 4% vomiting, 4% fever, 2% transient blindness and 2% photophobia. In the prophylactic cohort (n = 26) with a median follow-up of 55 months (17-81) only 3 CNS relapses (11%) were observed (testicular DLBCL, Burkitt and plasmablastic lymphoma, with a cumulative incidence of 8%, 14% and 20% respectively). In the treatment cohort (n = 32), CSF complete clearance was obtained in 77% cases. Median OS was 6 months (0-16). Death causes were lymphoma progression (19 patients, 79%), treatment toxicity (2 patients) and nonrelated (3 patients, 12%). Toxicity profile was good especially when concomitant dexamethasone was administered. In the prophylactic cohort the incidence of CNS relapse in DLBCL group was similar to previously reported for HDMTX and much better than IT MTX. A high number of ITLC injections was associated with better rates of CSF clearance, clinical responses, PFS and lower relapses. Survival is still poor in CNS lymphomatosis and new therapeutic approaches are still needed.	[Garcia-Recio, Marta; Bento, Leyre; de Gracia, Silvia Ruiz; Sartori, Francesca; Garcia, Lucia; Ballester, Carmen; Sampol, Antonia; Gutierrez, Antonio] Son Espases Univ Hosp, Hematol Dept, Palma de Mallorca, Balearic Island, Spain; [Cladera, Antonia; Dominguez, Julia; Del Campo, Raquel; Bargay, Joan] Hosp Son Llatzer, Hematol Dept, Palma de Mallorca, Balearic Island, Spain; [Gines, Jordi] Son Espases Univ Hosp, Pharm Dept, Palma de Mallorca, Balearic Island, Spain	Hospital Universitari Son Espases; Hospital Universitari Son Llatzer; Hospital Universitari Son Espases	Gutierrez, A (corresponding author), Son Espases Univ Hosp, Hematol Dept, Palma de Mallorca, Balearic Island, Spain.	antoniom.gutierrez@ssib.es	Gutiérrez, Antonio/AAL-9381-2021; Llàtzer, Son/ABG-1829-2020; garcia, lucia/GXV-8296-2022	Llàtzer, Son/0000-0002-6739-3916; 				Abramson JS, 2010, CANCER-AM CANCER SOC, V116, P4283, DOI 10.1002/cncr.25278; Bassan R, 2015, HAEMATOLOGICA, V100, P786, DOI 10.3324/haematol.2014.123273; Bhojwani D, 2008, LEUKEMIA LYMPHOMA, V49, P1427, DOI 10.1080/10428190802220527; Boehme V, 2009, BLOOD, V113, P3896, DOI 10.1182/blood-2008-10-182253; Chamberlain MC, 2016, J NEURO-ONCOL, V126, P545, DOI 10.1007/s11060-015-1994-8; Cheah CY, 2014, BRIT J CANCER, V111, P1072, DOI 10.1038/bjc.2014.405; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Corazzelli G, 2012, BRIT J HAEMATOL, V156, P234, DOI 10.1111/j.1365-2141.2011.08947.x; Doolittle ND, 2008, BLOOD, V111, P1085, DOI 10.1182/blood-2007-07-101402; Ferreri AJM, 2009, HEMATOL ONCOL, V27, P61, DOI 10.1002/hon.881; Gonzalez-Barca E, 2016, ANN HEMATOL, V95, P893, DOI 10.1007/s00277-016-2648-4; Guirguis HR, 2012, BRIT J HAEMATOL, V159, P39, DOI 10.1111/j.1365-2141.2012.09247.x; HRYNIUK WM, 1969, J CLIN INVEST, V48, P2140, DOI 10.1172/JCI106181; Jahn F, 2015, ONCOLOGY-BASEL, V89, P137, DOI 10.1159/000380913; Jun GT, 2009, COMMON TERMINOLOGY C, P829; Jurczak W, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0520-3; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krawczyk K, 2013, POL ARCH MED WEWN, V123, P589, DOI 10.20452/pamw.1968; Kumar A, 2012, CANCER-AM CANCER SOC, V118, P2944, DOI 10.1002/cncr.26588; Kumiega Beata, 2013, Przegl Lek, V70, P187; McMillan A, 2013, BRIT J HAEMATOL, V163, P168, DOI 10.1111/bjh.12509; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pui CH, 2009, SEMIN ONCOL, V36, pS2, DOI 10.1053/j.seminoncol.2009.05.002; Schuitema I, 2015, J INT NEUROPSYCH SOC, V21, P1; Siegal T, 2012, BLOOD REV, V26, P97, DOI 10.1016/j.blre.2011.12.001	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179595	10.1371/journal.pone.0179595	http://dx.doi.org/10.1371/journal.pone.0179595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665999	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700036
J	Hanes, MS; Moremen, KW; Cummings, RD				Hanes, Melinda S.; Moremen, Kelley W.; Cummings, Richard D.			Biochemical characterization of functional domains of the chaperone Cosmc	PLOS ONE			English	Article							MOLECULAR CHAPERONE; ENDOPLASMIC-RETICULUM; T-SYNTHASE; O-GLYCOSYLATION; BINDING-SITES; IN-VITRO; PROTEIN; O-FUCOSYL-TRANSFERASE-1; GLYCOSYLTRANSFERASES; IDENTIFICATION	Cosmc is an endoplasmic reticulum chaperone necessary for normal protein O-GalNAc glycosylation through regulation of T-synthase, its single client. Loss-of-function of Cosmc results in expression of the Tn antigen, which is associated with multiple human diseases including cancer. Despite intense interest in dysregulated expression of the Tn antigen, little is known about the structure and function of Cosmc, including domain organization, secondary structure, oligomerization, and co-factors. Limited proteolysis experiments show that Cosmc contains a structured N-terminal domain (Cosmc Delta 256), and biochemical characterization of Cosmc Delta 256 reveals wild type chaperone activity. Interestingly, CosmcE152K, which shows loss of function in vivo, exhibits wild type-like activity in vitro. Cosmc and CosmcE152K heterogeneously oligomerize and form monomeric, dimeric, trimeric, and tetrameric species, while Cosmc Delta 256 is predominantly monomeric as characterized by chemical crosslinking and blue native page electrophoresis. Additionally, Cosmc selectively binds divalent cations in thermal shift assays and metal binding is abrogated by the Cosmc Delta 256 truncation, and perturbed by the E152K mutation. Therefore, the N-terminal domain of Cosmc mediates T-synthase binding and chaperone function, whereas the C-terminal domain is necessary for oligomerization and metal binding. Our results provide new structure-function insight to Cosmc, indicate that Cosmc behaves as a modular protein and suggests points of modulation or regulation of in vivo chaperone function.	[Hanes, Melinda S.; Cummings, Richard D.] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Georgia; University of Georgia	Cummings, RD (corresponding author), Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	rcummin1@bidmc.harvard.edu	Moremen, Kelley/AAD-4661-2019		National Institutes of Health Grants: National Institute of General Medical Sciences [GM068559]; National Cancer Institute [CA183215]; National Institute of General Medical Sciences [P41GM103390, P01GM107012]; National Institutes of Health Grants [GM068559, CA183215, P41GM103390, P01GM107012]; NATIONAL CANCER INSTITUTE [F32CA183215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, P41GM103390, R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health Grants: National Institute of General Medical Sciences; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants: National Institute of General Medical Sciences (www.nigms.nih.gov) GM068559 (to R. D. C.), National Cancer Institute (www.cancer.gov) CA183215 (to M. S. H.), and National Institute of General Medical Sciences P41GM103390 and P01GM107012 (to K.W.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate members of the Cummings laboratory for critical discussions. This work was supported, in whole or in part, by National Institutes of Health Grants GM068559 (to R. D. C.), CA183215 (to M. S. H.), P41GM103390 and P01GM107012 (to K.W.M.).	Arakawa T, 2010, J PHARM SCI-US, V99, P1674, DOI 10.1002/jps.21974; Aryal RP, 2014, J BIOL CHEM, V289, P11630, DOI 10.1074/jbc.M114.555870; Aryal RP, 2012, J BIOL CHEM, V287, P15317, DOI 10.1074/jbc.M111.312587; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; Babor M, 2005, PROTEINS, V59, P221, DOI 10.1002/prot.20431; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Breton C, 2002, BIOCHEM SOC SYMP, V69, P23; Carugo O, 2003, PROTEIN ENG, V16, P637, DOI 10.1093/protein/gzg088; Cha JY, 2013, PLANT PHYSIOL BIOCH, V70, P368, DOI 10.1016/j.plaphy.2013.05.039; Chang D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113684, 10.1371/journal.pone.0113596]; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fontana Angelo, 2012, Methods Mol Biol, V896, P297, DOI 10.1007/978-1-4614-3704-8_20; Formosa T., 2013, BIOCHIM BIOPHYS ACTA, V1819, P247; Gloster TM, 2014, CURR OPIN STRUC BIOL, V28, P131, DOI 10.1016/j.sbi.2014.08.012; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Hashimoto K, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035007; Hashimoto K, 2010, J MOL BIOL, V399, P196, DOI 10.1016/j.jmb.2010.03.059; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Jinek M, 2006, NAT STRUCT MOL BIOL, V13, P945, DOI 10.1038/nsmb1144; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Ju Tongzhong, 2013, Methods Mol Biol, V1022, P15, DOI 10.1007/978-1-62703-465-4_2; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; KAO PN, 1986, J BIOL CHEM, V261, P8085; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Koide T, 1999, J BIOL CHEM, V274, P34523, DOI 10.1074/jbc.274.49.34523; Kudelka MR, 2016, P NATL ACAD SCI USA, V113, P14787, DOI 10.1073/pnas.1612158114; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Mallett TC, 1998, BIOCHEMISTRY-US, V37, P8790, DOI 10.1021/bi9803630; MOSCKOVITZ R, 1988, J BIOL CHEM, V263, P1017; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; Narimatsu Y, 2011, FEBS LETT, V585, P1276, DOI 10.1016/j.febslet.2011.04.010; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Park C, 2001, PROTEIN ENG, V14, P939, DOI 10.1093/protein/14.11.939; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stephens B, 2013, PROG MOL BIOL TRANSL, V115, P375, DOI 10.1016/B978-0-12-394587-7.00009-9; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Subedi GP, 2015, HIGH YIELD EXPRESSIO; Sun QA, 2011, J BIOL CHEM, V286, P11529, DOI 10.1074/jbc.M110.173591; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Vandersall-Nairn AS, 1998, GLYCOBIOLOGY, V8, P1183, DOI 10.1093/glycob/8.12.1183; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Won HS, 2004, J MOL BIOL, V341, P893, DOI 10.1016/j.jmb.2004.06.046	59	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180242	10.1371/journal.pone.0180242	http://dx.doi.org/10.1371/journal.pone.0180242			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665962	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700076
J	Madejon, P; Maranon, T; Navarro-Fernandez, CM; Dominguez, MT; Alegre, JM; Robinson, B; Murillo, JM				Madejon, Paula; Maranon, Teodoro; Navarro-Fernandez, Carmen M.; Dominguez, Maria T.; Alegre, Jose M.; Robinson, Brett; Murillo, Jose M.			Potential of Eucalyptus camaldulensis for phytostabilization and biomonitoring of traceelement contaminated soils	PLOS ONE			English	Article							TRACE-ELEMENTS; HEAVY-METALS; DEGRADED SOILS; MINE TAILINGS; POPULUS-ALBA; ACCUMULATION; PHYTOREMEDIATION; POLLUTION; CADMIUM; PLANTS	Soil pollution by trace elements (TEs) from mining and industrial activity is widespread and presents a risk to humans and ecosystems. The use of trees to immobilize TEs (phytostabilization) is a low-cost and effective method of soil remediation. We aimed to determine the chemical composition of leaves and flower buds of Eucalyptus camaldulensis in seven sites along the Guadiamar River valley (SW Spain), an area contaminated by a mine-spill in 1998. E. camaldulensis trees in the spill-affected area and adjacent non affected areas were growing on a variety of soils with pH from 5.6 to 8.1 with low concentration of plant nutrients. The spill affected soils contained up to 1069 mg kg(-1) of As and 4086 mg kg(-1) of Pb. E. camaldulensis tolerated elevated TE concentrations in soil and, compared to other species growing in the same environment, had low TE concentrations in the aerial portions. Besides tolerance to soil contamination, E. camaldulensis had low bioaccumulation coefficients for soil contaminants. TE concentrations in the aboveground portions were below levels reported to be toxic to plants or ecosystems. Flower buds had even lower TE concentrations than leaves. Despite the relatively low concentration of TEs in leaves they were significantly correlated with the soil extractable (0.01 M CaCl2) Cd, Mn and Zn (but not Cu and Pb). The general features of this tree species: tolerance to impoverished and contaminated soils, fast growth and deep root system, and low transfer of TEs from soil to aboveground organs makes it suitable for phytostabilization of soils contaminated by TEs. In addition, eucalyptus leaves could be used for biomonitoring the soil extractability of Cd, Mn and Zn but not Cu or Pb.	[Madejon, Paula; Maranon, Teodoro; Navarro-Fernandez, Carmen M.; Dominguez, Maria T.; Alegre, Jose M.; Murillo, Jose M.] IRNAS, Seville, Spain; [Robinson, Brett] Lincoln Univ, Dept Soil & Phys Sci, Canterbury, New Zealand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Lincoln University - New Zealand	Madejon, P (corresponding author), IRNAS, Seville, Spain.	pmadejon@irnase.csic.es	Domínguez, María T./K-6081-2014; Dominguez, Maria T./AAV-4787-2020; Maranon, Teodoro/K-6648-2014; MADEJON, PAULA/K-1237-2014; Robinson, Brett/F-1208-2010	Domínguez, María T./0000-0002-7348-9543; Dominguez, Maria T./0000-0002-7348-9543; Maranon, Teodoro/0000-0002-7751-9316; MADEJON, PAULA/0000-0002-8641-8293; Robinson, Brett/0000-0003-0322-0255	European Union Seventh Framework Programme (FP7) [603498]; Spanish Ministry of Economy and Competitiveness project RESTECO [CGL-2014-52858-R]	European Union Seventh Framework Programme (FP7); Spanish Ministry of Economy and Competitiveness project RESTECO	This work has been funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n 603498 (RECARE), and by the Spanish Ministry of Economy and Competitiveness, project RESTECO (CGL-2014-52858-R).	Adriano D.C., 2001, TRACE ELEMENTS TERRE, VSecond; Aguilar J, 2004, ENVIRON POLLUT, V132, P395, DOI 10.1016/j.envpol.2004.05.028; Aguilar J, 1999, CRITERIOS ESTA NDARE; Ali H, 2013, CHEMOSPHERE, V91, P869, DOI 10.1016/j.chemosphere.2013.01.075; [Anonymous], 2013, INT J FORESTRY RES, DOI DOI 10.1155/2013/463030; Arenas J. M, 2003, GUADIAMAR GREEN CORR; Arriagada CA, 2007, J ENVIRON MANAGE, V84, P93, DOI 10.1016/j.jenvman.2006.05.005; Baker AJM, 2000, PHYTOREMEDIATION OF, P85; Baoeva K, 2014, INT J PHYTOREMEDIAT, V16, P347; BARGAGLI R, 1998, TRACE ELEMENTS TERRE; Bolan NS, 2011, ADV AGRON, V112, P145, DOI 10.1016/B978-0-12-385538-1.00004-4; Bowen H. J. M., 1979, Environmental chemistry of the elements.; Bren L. J., 1991, Australian Forestry, V54, P9; Cabrera F, 1999, SCI TOTAL ENVIRON, V242, P117, DOI 10.1016/S0048-9697(99)00379-4; CAC (Consejeria de Agricultura y Comercio), 1992, JUNT EXTR; Carbonell AA, 1998, SCI TOTAL ENVIRON, V217, P189, DOI 10.1016/S0048-9697(98)00195-8; Chaney RL, 2017, ADV BOT RES, V83, P189, DOI 10.1016/bs.abr.2016.12.006; Ciadamidaro L, 2014, J ENVIRON MANAGE, V132, P329, DOI 10.1016/j.jenvman.2013.11.010; Coleman CM, 2005, J CHEM ECOL, V31, P1669, DOI 10.1007/s10886-005-5919-4; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Davidson J., 1993, P REG EXP CONS EUC O, V1, P35; Demolon A., 1952, GUIDE ETUDE EXPT SOL; Deng THB, 2016, PLANT SOIL, V404, P35, DOI 10.1007/s11104-016-2825-1; Dominguez MT, 2016, GEODERMA, V261, P133, DOI 10.1016/j.geoderma.2015.07.008; Dominguez MT, 2008, ENVIRON POLLUT, V152, P50, DOI 10.1016/j.envpol.2007.05.021; Dominguez MT, 2012, PLANT SOIL, V357, P407, DOI 10.1007/s11104-012-1214-7; Dominguez MT, 2010, WATER AIR SOIL POLL, V205, P305, DOI 10.1007/s11270-009-0075-z; Doumas P, 2016, REGIONAL ENV CHANGE, P1; ERNST WHO, 1992, ACTA BOT NEERL, V41, P229, DOI 10.1111/j.1438-8677.1992.tb01332.x; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fine P, 2013, INT J PHYTOREMEDIAT, V15, P585, DOI 10.1080/15226514.2012.723061; Flege A, 2000, LAND RECONS, V1, P291; Freitas P, 1970, PHYS CHEM METHODS SO; GEE GW, 1979, SOIL SCI SOC AM J, V43, P1004, DOI 10.2136/sssaj1979.03615995004300050038x; Grimalt JO, 1999, SCI TOTAL ENVIRON, V242, P3, DOI 10.1016/S0048-9697(99)00372-1; Hazelton P., 2007, Interpreting soil test results: what do all the numbers mean?; Heckenroth A, 2016, J ENVIRON MANAGE, V183, P850, DOI 10.1016/j.jenvman.2016.09.029; Hesse P. R., 1971, TXB SOIL CHEM ANAL; Houba VJG, 2000, COMMUN SOIL SCI PLAN, V31, P1299, DOI 10.1080/00103620009370514; Kabata-Pendias A., 1992, Trace elements in soils and plants.; King DJ, 2008, SCI TOTAL ENVIRON, V406, P35, DOI 10.1016/j.scitotenv.2008.07.054; Lambers H, 2015, TRENDS PLANT SCI, V20, P83, DOI 10.1016/j.tplants.2014.10.007; Lepp NW, 2007, J ENVIRON QUAL, V36, P1123, DOI 10.2134/jeq2006.0218; Macklin MG, 2006, GEOMORPHOLOGY, V79, P423, DOI 10.1016/j.geomorph.2006.06.024; Madejon P, 2007, CHEMOSPHERE, V67, P20, DOI 10.1016/j.chemosphere.2006.10.008; Madejon P, 2004, ENVIRON POLLUT, V132, P145, DOI 10.1016/j.envpol.2004.03.015; Madejon P, 2013, INT J PHYTOREMEDIAT, V15, P602, DOI 10.1080/15226514.2012.723062; Madejon P, 2003, SCI TOTAL ENVIRON, V307, P239, DOI 10.1016/S0048-9697(02)00609-5; Madejon P, 2009, INT J PHYTOREMEDIAT, V11, P542, DOI 10.1080/15226510902717572; Madejon P, 2006, ENVIRON POLLUT, V143, P1, DOI 10.1016/j.envpol.2005.11.008; Madejon P, 2016, J ENVIRON MANAGE, V169, P18, DOI 10.1016/j.jenvman.2015.11.050; Markert BA, 2003, TRACE METALS OTHER, V6, P3; Meeinkuirt W, 2016, SCIENCEASIA, V42, P83, DOI 10.2306/scienceasia1513-1874.2016.42.083; Meeinkuirt W, 2012, INT J PHYTOREMEDIAT, V14, P925, DOI 10.1080/15226514.2011.636403; Meers E, 2007, ENVIRON EXP BOT, V60, P57, DOI 10.1016/j.envexpbot.2006.06.008; Meindl GA, 2013, ENVIRON POLLUT, V177, P78, DOI 10.1016/j.envpol.2013.02.017; Mendez Monica O., 2008, Reviews in Environmental Science and Bio/Technology, V7, P47, DOI 10.1007/s11157-007-9125-4; Mengel K, 1987, PRINCIPLES PLANT NUT, V4th, DOI DOI 10.1093/AOB/MCH063; Mleczek M, 2009, ENVIRON EXP BOT, V66, P289, DOI 10.1016/j.envexpbot.2009.02.010; Mok HF, 2013, INT J PHYTOREMEDIAT, V15, P615, DOI 10.1080/15226514.2012.723063; Moreno-Jimenez E, 2012, J HAZARD MATER, V201, P52, DOI 10.1016/j.jhazmat.2011.11.013; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Navarro A, 2016, BIOENERG RES, V9, P208, DOI 10.1007/s12155-015-9677-z; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Panagos P, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/158764; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pietrini F, 2015, J ENVIRON MANAGE, V162, P221, DOI 10.1016/j.jenvman.2015.07.053; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Reichman SM, 2004, PLANT SOIL, V258, P341, DOI 10.1023/B:PLSO.0000016564.14512.eb; Reimann C, 1998, CHEM ELEMENTS ENV FA, DOI DOI 10.1017/S0016756800264613; Reuter D.J., 1997, PLANT ANAL INTERPRET, P83; Robinson BH, 2000, PLANT SOIL, V227, P301, DOI 10.1023/A:1026515007319; SECF, 2010, SIT BOSQ SECT FOR ES; STONE C, 1994, J APPL ECOL, V31, P604, DOI 10.2307/2404151; Teh T, 2016, PEDOSPHERE, V26, P431, DOI 10.1016/S1002-0160(15)60055-8; Dominguez MT, 2010, EUR J FOREST RES, V129, P47, DOI 10.1007/s10342-008-0253-3; Terrab A, 2004, J AGR FOOD CHEM, V52, P3441, DOI 10.1021/jf035352e; Terrab A, 2003, J SCI FOOD AGR, V83, P637, DOI 10.1002/jsfa.1341; TOMLINSON DL, 1980, HELGOLANDER MEERESUN, V33, P566, DOI 10.1007/BF02414780; Turnbull J.W., 2002, EUCALYPTUS GENUS EUC, P52; Wahsha M, 2012, J GEOCHEM EXPLOR, V123, P19, DOI 10.1016/j.gexplo.2012.07.004; Wolterbeek B, 2002, ENVIRON POLLUT, V120, P11, DOI 10.1016/S0269-7491(02)00124-0; Wong MH, 2003, CHEMOSPHERE, V50, P775, DOI 10.1016/S0045-6535(02)00232-1; Wu G, 2010, J HAZARD MATER, V174, P1, DOI 10.1016/j.jhazmat.2009.09.113; Xie QQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136606; Zuur A, 2009, MIXED EFFECTS MODELS	88	22	24	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180240	10.1371/journal.pone.0180240	http://dx.doi.org/10.1371/journal.pone.0180240			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666017	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608700075
J	Williams, GA; Guichard, AC; An, JH				Williams, Gary A.; Guichard, AnaMarie C.; An, JungHa			The effects of name and religious priming on ratings of a well-known political figure, President Barack Obama	PLOS ONE			English	Article							PREJUDICE; GOD	Priming with race-typed names and religious concepts have been shown to activate stereotypes and increase prejudice towards out-groups. We examined the effects of name and religious word priming on views of a specific and well-known person, President Barack Obama. We predicted that politically conservative participants primed with President Obama's middle name (Hussein) would rate him more negatively and be more likely to view him as a Muslim than those not shown his middle name. We also examined whether conservatives primed with concrete religious words would rate President Obama more negatively and be more likely to view him as Muslim than those primed with other word types. Furthermore, we predicted that those who mis-identify President Obama as Muslim would rate him more negatively than would those who view him as Christian. The results provided mixed support for these hypotheses. Conservatives primed with President Obama's middle name rated him significantly more negatively than did those in the control condition. This effect was not found for politically liberal or moderate participants. Name priming did not significantly affect views of President Obama's religious affiliation. Although not statistically significant, conservatives primed with abstract religious words tended to rate President Obama more negatively than did those primed with other word types. Religious word priming significantly influenced views of President Obama's religious affiliation; interestingly, participants primed with abstract religious words were more likely to think President Obama is Muslim than were those primed with religious agent or non-religious words. As predicted, participants who thought president Obama was Muslim rated him significantly more negatively than did those who thought he was Christian. Overall, our results provide some evidence that ethnic name and religious word priming can significantly influence opinions, even with a well-known and specific person.	[Williams, Gary A.; Guichard, AnaMarie C.] Calif State Univ Stanislaus, Dept Psychol & Child Dev, Turlock, CA 95382 USA; [An, JungHa] Calif State Univ Stanislaus, Dept Math, Turlock, CA 95382 USA	California State University System; California State University Stanislaus; California State University System; California State University Stanislaus	Williams, GA (corresponding author), Calif State Univ Stanislaus, Dept Psychol & Child Dev, Turlock, CA 95382 USA.	gwilliams1@csustan.edu		Williams, Gary/0000-0003-1592-9288				Agerstrom J, 2012, BASIC APPL SOC PSYCH, V34, P359, DOI 10.1080/01973533.2012.693438; Alibeli MA, 2012, INT J HUMANIT SOC SC, V2, P21; [Anonymous], 2010, Am Psychol, V65, P493, DOI 10.1037/a0020168; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Calfano BR, 2009, POLIT RES QUART, V62, P329, DOI 10.1177/1065912908319605; Carpusor AG, 2006, J APPL SOC PSYCHOL, V36, P934, DOI 10.1111/j.0021-9029.2006.00050.x; CNN/ Opinion Research Corporation International, 2015, CNN ORC INT POLL DAT; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cotton JL, 2014, J MANAGE PSYCHOL, V29, P405, DOI 10.1108/JMP-03-2012-0086; Domke D, 2007, J ECUMENICAL STUD, V42, P54; Fetzer Institute, 2003, 2003 BRIED MULT MEAS; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Greenwald AG, 2009, ANAL SOC ISS PUB POL, V9, P241, DOI 10.1111/j.1530-2415.2009.01195.x; Johnson MK, 2012, PSYCHOL RELIG SPIRIT, V4, P154, DOI 10.1037/a0025107; Johnson MK, 2010, SOC PSYCHOL PERS SCI, V1, P119, DOI 10.1177/1948550609357246; Kalkan KO, 2009, J POLIT, V71, P847, DOI 10.1017/S0022381609090756; Kauff M, 2013, J COMMUNITY APPL SOC, V23, P536, DOI 10.1002/casp.2143; Kauff M, 2013, PERS SOC PSYCHOL B, V39, P305, DOI 10.1177/0146167212473160; King EB, 2006, J APPL SOC PSYCHOL, V36, P1145, DOI 10.1111/j.0021-9029.2006.00035.x; LaBouff JP, 2012, INT J PSYCHOL RELIG, V22, P1, DOI 10.1080/10508619.2012.634778; Luguri JB, 2012, PSYCHOL SCI, V23, P756, DOI 10.1177/0956797611433877; Macrae CN, 2002, J EXP SOC PSYCHOL, V38, P186, DOI 10.1006/jesp.2001.1496; Milem J.F, 2005, AAC U MAKING EXCELLE; Pew Research Center, 2011, RELIG NEWS ISLAM WAS; Pew Research Center, 2014, MOST ID POL AM LIV D; Pew Research Center, 2012, MED REL 2012 CAMP PR; Preston JL, 2013, PERS SOC PSYCHOL B, V39, P1471, DOI 10.1177/0146167213499937; Public Policy Polling, 2015, TRUMP SUPP THINK OB; Quinn KA, 2005, J PERS SOC PSYCHOL, V88, P467, DOI 10.1037/0022-3514.88.3.467; Ramsay JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147178; Ritter RS, 2013, J SCI STUD RELIG, V52, P494, DOI 10.1111/jssr.12042; Sabato Jr Antonio, 2016, SAYS HES ABSOLUTELY; Stryker R, 2016, COMMUN MONOGR, V83, P535, DOI 10.1080/03637751.2016.1201207; Waismel-Manor I, 2013, POLIT BEHAV, V35, P621, DOI 10.1007/s11109-012-9210-4; Wenger J. L., 2003, J PSYCHOL CHRISTIANI, V22, P223	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180676	10.1371/journal.pone.0180676	http://dx.doi.org/10.1371/journal.pone.0180676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EZ3KB	28665980	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700024
J	Bellettiere, J; Winkler, EAH; Chastin, SFM; Kerr, J; Owen, N; Dunstan, DW; Healy, GN				Bellettiere, John; Winkler, Elisabeth A. H.; Chastin, Sebastien F. M.; Kerr, Jacqueline; Owen, Neville; Dunstan, David W.; Healy, Genevieve N.			Associations of sitting accumulation patterns with cardio-metabolic risk biomarkers in Australian adults	PLOS ONE			English	Article							MEASURED SEDENTARY TIME; PHYSICAL-ACTIVITY; CARDIOMETABOLIC BIOMARKERS; BREAKS; BEHAVIOR; ADJUSTMENT; DISEASE	Background High amounts of time spent sitting can increase cardiovascular disease risk and are deleteriously associated cardio-metabolic risk biomarkers. Though evidence suggests that accruing sitting time in prolonged periods may convey additional risk, verification using high-quality measures is needed. We examined this issue in adults from the Australian Diabetes, Obesity and Lifestyle Study, using accurate measures of sitting accumulation. Methods In 2011/12, 739 adults aged 36 to 89 years (mean +/- SD 58 +/- 10 years) wore activPAL3 (TM) monitors (which provide accurate objective measures of sitting); 678 provided >= 4 valid days of monitor data and complete cardio-metabolic biomarker and confounder data. Multivariable linear regression models examined associations of sitting time, sitting time accrued in >= 30 minute bouts (prolonged sitting time), and three measures of sitting accumulation patterns with cardio-metabolic risk markers: body mass index (BMI), waist circumference, blood pressure, high- and low- density lipoprotein (HDL and LDL) cholesterol, triglycerides, glycated haemoglobin (HbA1c), fasting plasma glucose (FPG) and 2-hour post-load glucose (PLG). Interactions tests examined whether associations of sitting time with biomarkers varied by usual sitting bout duration. Results Adjusted for potential confounders, greater amounts of sitting time and prolonged sitting time were significantly (p<0.05) deleteriously associated with BMI, waist circumference, HDL cholesterol, and triglycerides. Total sitting time was also significantly associated with higher PLG. Sitting accumulation patterns of frequently interrupted sitting (compared to patterns with relatively more prolonged sitting) were significantly beneficially associated with BMI, waist circumference, HDL cholesterol, triglycerides, PLG, and with FPG. Effect sizes were typically larger for accumulation patterns than for sitting time. Significant interactions (p<0.05) showed that associations of sitting time with HDL, triglycerides and PLG became more deleterious the longer at a time sitting was usually accumulated. Conclusions Adding to previous evidence reliant on low-quality measures, our study showed that accumulating sitting in patterns where sitting was most frequently interrupted had significant beneficial associations with several cardio-metabolic biomarkers and that sitting for prolonged periods at a time may exacerbate some of the effects of sitting time. The findings support sedentary behavior guidelines that promote reducing and regularly interrupting sitting.	[Bellettiere, John] Joint Doctoral Program Publ Hlth Epidemiol, San Diego, CA USA; [Bellettiere, John] San Diego State Univ, Grad Sch Publ Hlth, Ctr Behav Epidemiol & Community Hlth, San Diego, CA 92182 USA; [Winkler, Elisabeth A. H.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Chastin, Sebastien F. M.; Dunstan, David W.; Healy, Genevieve N.] Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Chastin, Sebastien F. M.] Univ Ghent, Dept Movement & Sport Sci, Fac Med & Hlth Sci, Ghent, East Flanders, Belgium; [Kerr, Jacqueline] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Owen, Neville; Dunstan, David W.; Healy, Genevieve N.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Owen, Neville] Swinburne Univ Technol, Melbourne, Vic, Australia; [Dunstan, David W.] Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Vic, Australia; [Healy, Genevieve N.] Curtin Univ, Sch Physiotherapy, Perth, WA, Australia	California State University System; San Diego State University; University of Queensland; Glasgow Caledonian University; Ghent University; University of California System; University of California San Diego; Baker Heart and Diabetes Institute; Swinburne University of Technology; Australian Catholic University; Curtin University	Bellettiere, J (corresponding author), Joint Doctoral Program Publ Hlth Epidemiol, San Diego, CA USA.; Bellettiere, J (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, Ctr Behav Epidemiol & Community Hlth, San Diego, CA 92182 USA.	jbellettiere@ucsd.edu	Bellettiere, John/AAC-6092-2020; Winkler, Elisabeth/AAD-7153-2022; Dunstan, David Wayne/E-8473-2010; Chastin, Sebastien/ABF-1455-2020; Healy, Genevieve/A-7408-2008	Bellettiere, John/0000-0002-7167-3048; Winkler, Elisabeth/0000-0003-1452-6102; Dunstan, David Wayne/0000-0003-2629-9568; Chastin, Sebastien/0000-0003-1421-9348; Healy, Genevieve/0000-0001-7093-7892	National Health and Medical Research Council of Australia [566940, 1000986, 1003960, 1078360, 108029]; Victorian Government's OIS Program; Victorian Government's OIS Programme; National Health and Medical Research Council [NHMRC] [233200]; Australian Government Department of Health and Ageing; Abbott Australasia Pty Ltd; Alphapharm Pty Ltd; AstraZeneca; Bristol-Myers Squibb; City Health Centre-Diabetes Service Canberra; Department of Health and Community Services Northern Territory; Department of Health and Human Services Tasmania; Department of Health New South Wales; Department of Health Western Australia; Department of Health South Australia; Department of Human Services Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia; Estate of the Late Edward Wilson; GlaxoSmithKline; Jack Brockhoff Foundation; Janssen-Cilag; Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme; Novartis Pharmaceuticals; Novo Nordisk Pharmaceuticals; Pfizer Pty Ltd; Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital; Sydney; Sanofi Aventis and Sanofi Synthelabo	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's OIS Program; Victorian Government's OIS Programme; National Health and Medical Research Council [NHMRC](National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Abbott Australasia Pty Ltd(Abbott Laboratories); Alphapharm Pty Ltd; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); City Health Centre-Diabetes Service Canberra; Department of Health and Community Services Northern Territory; Department of Health and Human Services Tasmania; Department of Health New South Wales; Department of Health Western Australia; Department of Health South Australia; Department of Human Services Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia(Eli Lilly); Estate of the Late Edward Wilson; GlaxoSmithKline(GlaxoSmithKline); Jack Brockhoff Foundation; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme(Merck & Company); Novartis Pharmaceuticals(Novartis); Novo Nordisk Pharmaceuticals(Novo Nordisk); Pfizer Pty Ltd(Pfizer); Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital; Sydney; Sanofi Aventis and Sanofi Synthelabo	This work was supported by: National Health and Medical Research Council of Australia [Program Grant #566940 to NO; Centre of Research Excellence Grant #1000986 to GNH, NO, DWD with salary support to EW; Senior Principal Research Fellowship #1003960 to NO; Senior Research Fellowship #1078360 to DWD; Career Development Fellowship #108029 to GNH]; and, the Victorian Government's OIS Program (to NO and DWD). The Australian Diabetes, Obesity and Lifestyle study (AusDiab), co-coordinated by the Baker IDI Heart and Diabetes Institute, was supported in part by the Victorian Government's OIS Programme, and gratefully acknowledges the generous support given by the National Health and Medical Research Council [NHMRC grant #233200], Australian Government Department of Health and Ageing, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service Canberra, Department of Health and Community Services Northern Territory, Department of Health and Human Services Tasmania, Department of Health New South Wales, Department of Health Western Australia, Department of Health South Australia, Department of Human Services Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian & FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis and Sanofi Synthelabo. The funders of this study had no role in the data analysis or interpretation of the results.	Australian Government, 2014, AUSTR PHYS ACT SED B; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Barr E. L. M., 2005, AUSDIAB 2005 AUSTR D; Barreira TV, 2015, GAIT POSTURE, V42, P70, DOI 10.1016/j.gaitpost.2015.04.008; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Carson V, 2014, PREV MED, V65, P23, DOI 10.1016/j.ypmed.2014.04.005; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Chastin SFM, 2015, MEAS PHYS EDUC EXERC, V19, P138, DOI 10.1080/1091367X.2015.1050592; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Chastin SF, 2015, MEASUREMENT PHYS ED; Chief Medical Officers of England, 2011, REP PHYS ACT HLTH 4; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Dempsey P., 2015, HEAR LUNG CIRC, V24, pS127, DOI [DOI 10.1016/J.HLC.2015.06.033, 10.1016/j.hlc.2015.06.033]; Dempsey PC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0797-4; Dempsey PC, 2016, DIABETOLOGIA DIABETO; Dunstan D., 2016, SEDENTARY BEHAV HLTH; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Falconer CL, 2015, MED SCI SPORT EXERC, V1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Giles GG, 1996, DIETARY QUESTIONNAIR; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119140; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Healy GN, 2015, EUR HEART J; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Henson J, 2015, DIABETES CA IN PRESS; Keadle SK, 2017, AM J PREV MED, V52, P541, DOI 10.1016/j.amepre.2016.11.010; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118078; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Larsen RN, 2014, NUTR METAB CARDIOVAS, V24, P976, DOI 10.1016/j.numecd.2014.04.011; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lyden K, 2012, MED SCI SPORT EXER, V44, P2243, DOI 10.1249/MSS.0b013e318260c477; Page A, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0032-9; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Qi QB, 2015, CIRCULATION, V132, P1560, DOI 10.1161/CIRCULATIONAHA.115.016938; Scheers T, 2013, MED SCI SPORT EXER, V45, P481, DOI 10.1249/MSS.0b013e31827563ba; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Tanamas SK, 2013, AUSDIAB 2012 AUSTR D, P1; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; van der Berg JD, 2016, DIABETOLOGIA; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Young DR, 2016, CIRCULATION, V134, pE262, DOI 10.1161/CIR.0000000000000440	47	90	91	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180119	10.1371/journal.pone.0180119	http://dx.doi.org/10.1371/journal.pone.0180119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662164	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300106
J	Webster, L; Groskreutz, D; Grinbergs-Saull, A; Howard, R; O'Brien, JT; Mountain, G; Banerjee, S; Woods, B; Perneczky, R; Lafortune, L; Roberts, C; McCleery, J; Pickett, J; Bunn, F; Challis, D; Charlesworth, G; Featherstone, K; Fox, C; Goodman, C; Jones, R; Lamb, S; Moniz-Cook, E; Schneider, J; Shepperd, S; Surr, C; Thompson-Coon, J; Ballard, C; Brayne, C; Burns, A; Clare, L; Garrard, P; Kehoe, P; Passmore, P; Holmes, C; Maidment, I; Robinson, L; Livingston, G				Webster, Lucy; Groskreutz, Derek; Grinbergs-Saull, Anna; Howard, Rob; O'Brien, John T.; Mountain, Gail; Banerjee, Sube; Woods, Bob; Perneczky, Robert; Lafortune, Louise; Roberts, Charlotte; McCleery, Jenny; Pickett, James; Bunn, Frances; Challis, David; Charlesworth, Georgina; Featherstone, Katie; Fox, Chris; Goodman, Claire; Jones, Roy; Lamb, Sarah; Moniz-Cook, Esme; Schneider, Justine; Shepperd, Sasha; Surr, Claire; Thompson-Coon, Jo; Ballard, Clive; Brayne, Carol; Burns, Alistair; Clare, Linda; Garrard, Peter; Kehoe, Patrick; Passmore, Peter; Holmes, Clive; Maidment, Ian; Robinson, Louise; Livingston, Gill			Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations	PLOS ONE			English	Review							MINI-MENTAL-STATE; QUALITY-OF-LIFE; TASK-FORCE CONSENSUS; ALZHEIMERS-DISEASE; NEUROPSYCHIATRIC SYMPTOMS; COGNITIVE IMPAIRMENT; CLINICAL-TRIAL; ADAS-COG; THERAPY; ATROPHY	Background There are no disease-modifying treatments for dementia. There is also no consensus on disease modifying outcomes. We aimed to produce the first evidence-based consensus on core outcome measures for trials of disease modification in mild-to-moderate dementia. Methods and findings We defined disease-modification interventions as those aiming to change the underlying pathology. We systematically searched electronic databases and previous systematic reviews for published and ongoing trials of disease-modifying treatments in mild-to-moderate dementia. We included 149/22,918 of the references found; with 81 outcome measures from 125 trials. Trials involved participants with Alzheimer's disease (AD) alone (n = 111), or AD and mild cognitive impairment (n = 8) and three vascular dementia. We divided outcomes by the domain measured (cognition, activities of daily living, biological markers, neuropsychiatric symptoms, quality of life, global). We calculated the number of trials and of participants using each outcome. We detailed psychometric properties of each outcome. We sought the views of people living with dementia and family carers in three cities through Alzheimer's society focus groups. Attendees at a consensus conference (experts in dementia research, disease-modification and harmonisation measures) decided on the core set of outcomes using these results. Recommended core outcomes were cognition as the fundamental deficit in dementia and to indicate disease modification, serial structural MRIs. Cognition should be measured by Mini Mental State Examination or Alzheimer's Disease Assessment Scale-Cognitive Subscale. MRIs would be optional for patients. We also made recommendations for measuring important, but non-core domains which may not change despite disease modification. Limitations Most trials were about AD. Specific instruments may be superseded. We searched one database for psychometric properties. Interpretation This is the first review to identify the 81 outcome measures the research community uses for disease-modifying trials in mild-to-moderate dementia. Our recommendations will facilitate designing, comparing and meta-analysing disease modification trials in mild-to-moderate dementia, increasing their value.	[Webster, Lucy; Howard, Rob; Livingston, Gill] UCL, Div Psychiat, London, England; [Groskreutz, Derek] UCL, Div Psychol & Language Sci, London, England; [Grinbergs-Saull, Anna; Pickett, James] Alzheimers Soc, London, England; [O'Brien, John T.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Mountain, Gail] Univ Sheffield, ScHARR, Sheffield, S Yorkshire, England; [Banerjee, Sube] Brighton & Sussex Med Sch, Ctr Dementia Studies, Brighton, E Sussex, England; [Woods, Bob] Bangor Univ, Dementia Serv Dev Ctr Wales, Bangor, Gwynedd, Wales; [Perneczky, Robert] Imperial Coll London, Sch Publ Hlth, Fac Med, London, England; [Perneczky, Robert] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany; [Perneczky, Robert] Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Lafortune, Louise; Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England; [Roberts, Charlotte] Int Consortium Hlth Outcomes Measurement, London, England; [McCleery, Jenny] Oxford Hlth NHS Fdn Trust, Oxford, England; [Bunn, Frances; Goodman, Claire] Univ Hertfordshire, Ctr Res Primary & Community Care, Hatfield, Herts, England; [Challis, David] Univ Manchester, Personal Social Serv Res Unit, Manchester, Lancs, England; [Charlesworth, Georgina] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Featherstone, Katie] Cardiff Univ, Sch Healthcare Sci, Cardiff, S Glam, Wales; [Fox, Chris] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Jones, Roy] Univ Bath, Res Inst Care Older People RICE, Bath, Avon, England; [Lamb, Sarah] Univ Warwick, Warwick Clin Trials Res Unit, Warwick, England; [Moniz-Cook, Esme] Univ Hull, Fac Hlth & Social Care, Kingston Upon Hull, N Humberside, England; [Schneider, Justine] Univ Nottingham, Inst Mental Hlth, Nottingham, England; [Shepperd, Sasha] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Surr, Claire] Leeds Beckett Univ, Sch Hlth & Community Studies, Leeds, W Yorkshire, England; [Thompson-Coon, Jo; Clare, Linda] Univ Exeter, PenCLAHRC, Sch Med, Exeter, Devon, England; [Ballard, Clive] Kings Coll London, Wolfson Ctr Age Related Dis, London, England; [Burns, Alistair] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England; [Clare, Linda] Univ Exeter, Sch Psychol, Exeter, Devon, England; [Garrard, Peter] St Georges Univ London, Neurosci Res Ctr, London, England; [Kehoe, Patrick] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Passmore, Peter] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Holmes, Clive] Univ Southampton, Sch Med, Southampton, Hants, England; [Maidment, Ian] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham, W Midlands, England; [Robinson, Louise] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Livingston, Gill] North Thames CLAHRC, London, England; [Livingston, Gill] Camden & Islington NHS Fdn Trust, London, England	University of London; University College London; University of London; University College London; University of Cambridge; University of Sheffield; University of Brighton; University of Sussex; Bangor University; Imperial College London; University of Munich; Technical University of Munich; University of Munich; University of Cambridge; University of Hertfordshire; University of Manchester; University of London; University College London; Cardiff University; University of East Anglia; University of Bath; University of Warwick; University of Hull; University of Nottingham; University of Oxford; Leeds Beckett University; University of Exeter; University of London; King's College London; University of Manchester; University of Exeter; St Georges University London; University of London; King's College London; University of Bristol; Queens University Belfast; University of Southampton; Aston University; Newcastle University - UK	Livingston, G (corresponding author), UCL, Div Psychiat, London, England.; Livingston, G (corresponding author), North Thames CLAHRC, London, England.; Livingston, G (corresponding author), Camden & Islington NHS Fdn Trust, London, England.	g.livingston@ucl.ac.uk	Webster, Lucy/ABG-3101-2020; Perneczky, Robert/AAJ-2550-2020; Lafortune, Louise/AAJ-9257-2020; Coon, Jo Thompson/C-7923-2017; Challis, David/B-9262-2008; Brayne, Carol/AAA-4285-2020; Bunn, Frances/I-8108-2015; Kehoe, Patrick/P-8760-2018	Lafortune, Louise/0000-0002-9018-1217; Coon, Jo Thompson/0000-0002-5161-0234; Challis, David/0000-0002-6464-2286; Brayne, Carol/0000-0001-5307-663X; Howard, Robert/0000-0002-3071-2338; Moniz-Cook, Esme/0000-0002-7232-4632; Schneider, Justine/0000-0002-5863-7747; O'Brien, John/0000-0002-0837-5080; Charlesworth, Georgina/0000-0002-5278-1756; Bunn, Frances/0000-0002-5885-918X; Holmes, Clive/0000-0003-1999-6912; Clare, Linda/0000-0003-3989-5318; Shepperd, Sasha/0000-0001-6384-8322; Ballard, Clive/0000-0003-0022-5632; Livingston, Gill/0000-0001-6741-5516; Burns, Alistair/0000-0002-9837-0645; Garrard, Peter/0000-0001-8268-9718; Goodman, Claire/0000-0002-8938-4893; Kehoe, Patrick/0000-0002-7542-1139; Pickett, James/0000-0002-2657-0795; Banerjee, Sube/0000-0002-8083-7649; Webster, Lucy/0000-0001-9152-4990; Lamb, Sarah/0000-0003-4349-7195; Fox, Chris/0000-0001-9480-5704; Featherstone, Katie/0000-0003-4999-8425; Surr, Claire/0000-0002-4312-6661; Maidment, Ian/0000-0003-4152-9704; Perneczky, Robert/0000-0003-1981-7435	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula; EPSRC [EP/J017175/1, EP/K021931/1] Funding Source: UKRI; MRC [MR/N025881/1, MC_PC_13088, G0801370] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K021931/1, EP/J017175/1] Funding Source: researchfish; Medical Research Council [G0801370, MC_PC_13088, MR/N025881/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1067, NIHR-RP-011-043, 15/62/02, NF-SI-0611-10084, NF-SI-0515-10103] Funding Source: researchfish	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	GL was (in part) supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. JTC is funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Apostolova LG, 2015, ALZHEIMERS DEMENT, V11, P139, DOI 10.1016/j.jalz.2015.01.001; Banerjee S, 2006, J NEUROL NEUROSUR PS, V77, P146, DOI 10.1136/jnnp.2005.072983; Banerjee S, 2007, ALZHEIMERS DEMENT, V3, P166, DOI 10.1016/j.jalz.2007.04.384; Banerjee S, 2009, INT J GERIATR PSYCH, V24, P15, DOI 10.1002/gps.2090; Brookmeyer R, 2016, ALZHEIMERS DEMENT, V12, P225, DOI 10.1016/j.jalz.2016.01.004; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Deardorff WJ, 2015, DRUG AGING, V32, P537, DOI 10.1007/s40266-015-0273-x; Department oHaPMsO, 2013, G8 DEM SUMM DECL; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Duits FH, 2016, ALZHEIMERS DEMENT, V12, P154, DOI 10.1016/j.jalz.2015.08.003; European Medicines Agency, 2016, DRAFT GUID CLIN INV; [FDA Research CfDEa], 2013, GUID IND ALZH DIS DE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Galasko D, 2014, NEUROLOGY, V82, P1536, DOI 10.1212/WNL.0000000000000364; Galimberti D, 2016, EXPERT OPIN EMERG DR, V21, P5, DOI 10.1517/14728214.2016.1146678; Gauthier S, 2009, J NUTR HEALTH AGING, V13, P550, DOI 10.1007/s12603-009-0106-x; Gauthier S, 2016, ALZHEIMERS DEMENT, V12, P60, DOI 10.1016/j.jalz.2015.12.003; Gelinas I, 1999, AM J OCCUP THER, V53, P471, DOI 10.5014/ajot.53.5.471; Gold DA, 2012, J CLIN EXP NEUROPSYC, V34, P11, DOI 10.1080/13803395.2011.614598; Hancock GA, 2006, INT J GERIATR PSYCH, V21, P43, DOI 10.1002/gps.1421; Harrison JK, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0216-8; Howard R, 2011, INT J GERIATR PSYCH, V26, P812, DOI 10.1002/gps.2607; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; ICHOM, 2016, STAND SET DEM 2016; JPND, 2015, DEM OUTC MEAS CHART; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Lewis F., 2014, OFFICE HLTH EC CONSU; Lewis F., 2015, OFFICE HLTH EC CONSU; Li N, 2015, EVID-BASED COMPL ALT, V2015, P1; Long R., 2015, CHALLENGES FINDING T; Mak E, 2015, NEUROIMAGE-CLIN, V7, P456, DOI 10.1016/j.nicl.2015.01.017; Martyr A, 2017, INT J GERIATRIC PSYC; Matallana D, 2011, J GERIATR PSYCH NEUR, V24, P9, DOI 10.1177/0891988710373597; Mitchell A.J., 2013, COGNITIVE SCREENING, P15, DOI DOI 10.1007/978-1-4471-2452-8_2; Moniz-Cook E, 2008, AGING MENT HEALTH, V12, P14, DOI 10.1080/13607860801919850; National Institute for Health Research, 2016, ISRCTN93682878 NAT I; Newman JC, 2015, JAMA INTERN MED, V175, P1459, DOI 10.1001/jamainternmed.2015.2159; OECD, 2015, ENH TRANSL RES CLIN; Park So Young, 2015, [Dementia and Neurocognitive Disorders, Dementia and Neurocognitive Disorders(대한치매학회지)], V14, P12, DOI 10.12779/dnd.2015.14.1.12; PhRMA - Pharmaceutical Research and Manufacturers of America, 2012, RES ALZH MED SETB ST; Rockwood K, 2010, INT J GERIATR PSYCH, V25, P191, DOI 10.1002/gps.2319; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Rubinstein E., 2015, CALL ACTION GLOBAL R; Ryu SH, 2005, AM J GERIAT PSYCHIAT, V13, P976, DOI 10.1176/appi.ajgp.13.11.976; SALMON DP, 1990, NEUROLOGY, V40, P1225, DOI 10.1212/WNL.40.8.1225; Schrag A, 2012, J NEUROL NEUROSUR PS, V83, P171, DOI 10.1136/jnnp-2011-300881; Skinner J, 2012, BRAIN IMAGING BEHAV, V6, P489, DOI 10.1007/s11682-012-9166-3; Smith SC, 2005, HEALTH TECHNOL ASSES, V9, P1; Spalletta G, 2010, AM J GERIAT PSYCHIAT, V18, P1026, DOI 10.1097/JGP.0b013e3181d6b68d; Velayudhan L, 2014, INT PSYCHOGERIATR, V26, P1247, DOI 10.1017/S1041610214000416; Vellas B, 2011, LANCET NEUROL, V10, P297, DOI 10.1016/S1474-4422(08)70087-5; Vellas B, 2007, LANCET NEUROL, V6, P56, DOI 10.1016/S1474-4422(06)70677-9; Webster L, 2017, HLTH TECHNOLOGY ASSE, V21; Zhou B, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1124; Zoda TE., 2014, THERAPEUTICS J CLIN, V6, P44	56	33	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179521	10.1371/journal.pone.0179521	http://dx.doi.org/10.1371/journal.pone.0179521			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662127	Green Accepted, Green Published, gold			2022-12-27	WOS:000404608300028
J	Densten, IL; Borrowman, L				Densten, Iain L.; Borrowman, Luc			Does the implicit models of leadership influence the scanning of other-race faces in adults?	PLOS ONE			English	Article							EYE-TRACKING; INFORMATION; ATTRACTIVENESS; CATEGORIZATION; INTEGRATION; ACCURACY; EMOTION; PREDICT; MEMORY; VIDEO	The current study aims to identify the relationships between implicit leadership theoretical (ILT) prototypes/anti-prototype and five facial features (i.e., nasion, upper nose, lower nose, and upper lip) of a leader from a different race than respondents. A sample of 81 Asian respondents viewed a 30-second video of a Caucasian female who in a non-engaging manner talked about her career achievements. As participants watch the video, their eye movements were recorded via an eye tracking devise. While previous research has identified that ILT influences perceptional and attitudinal ratings of leaders, the current study extends these findings by confirming the impact of ILT on the gaze patterns of other race participants, who appear to adopt system one type thinking. This study advances our understanding in how cognitive categories or schemas influence the physicality of individuals (i.e., eye gaze or movements). Finally, this study confirms that individual ILT factors have a relationship with the eye movements of participants and suggests future research directions.	[Densten, Iain L.] Monash Univ Australia Alumni, Melbourne, Vic, Australia; [Borrowman, Luc] Monash Univ Malaysia, Sch Business, Dept Econ, Sunway, Malaysia; [Densten, Iain L.] 59 Golflinks Rd, Frankston, Vic, Australia	Monash University; Monash University; Monash University Sunway	Densten, IL (corresponding author), Monash Univ Australia Alumni, Melbourne, Vic, Australia.; Densten, IL (corresponding author), 59 Golflinks Rd, Frankston, Vic, Australia.	itangodeno@gmail.com	Densten, Iain L./AAE-7342-2021; Densten, Iain/AAF-3901-2021	Borrowman, Luc/0000-0002-1581-9962	Social & Economic Transformation in Asia (SETA)	Social & Economic Transformation in Asia (SETA)	Funded by Social & Economic Transformation in Asia (SETA).	Antonakis J. E, 2004, NATURE LEADERSHIP; Attard J, 2014, APPL COGNITIVE PSYCH, V28, P215, DOI 10.1002/acp.2986; Basil M, 2011, QUAL MARK RES, V14, P246, DOI 10.1108/13522751111137488; Baumeister RF, 2010, PSYCHOL REV, V117, P945, DOI 10.1037/a0019393; Boyce MA, 2008, LAW HUMAN BEHAV, V32, P439, DOI 10.1007/s10979-007-9125-5; Brown DJ, 2012, OXFORD HDB LEADERSHI; Cain J, 2013, CURR PHARM TEACH LEA, V5, P620, DOI 10.1016/j.cptl.2013.07.009; Campbell D, 1991, CAMPBELL LEADERSHIP; Caza A, 2015, LEADERSHIP QUART, V26, P518, DOI 10.1016/j.leaqua.2015.05.008; Chan E.K.H., 2014, VALIDITY VALIDATION; Cote S, 2011, PSYCHOL SCI, V22, P1073, DOI 10.1177/0956797611416251; Crehan ET, 2015, BEHAV RES METHODS, V47, P994, DOI 10.3758/s13428-014-0514-7; CRONSHAW SF, 1987, J APPL PSYCHOL, V72, P97, DOI 10.1037/0021-9010.72.1.97; Currie TE, 2009, EVOL HUM BEHAV, V30, P409, DOI 10.1016/j.evolhumbehav.2009.06.005; Dang JH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00933; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Duchowski A., 2007, EYE TRACKING METHODO; Duchowski A.T., 2003, EYE TRACKING METHODO; EDEN D, 1975, J APPL PSYCHOL, V60, P736, DOI 10.1037/0021-9010.60.6.736; Elfenbein HA, 2007, ACAD MANAG ANN, V1, P315, DOI 10.1080/078559812; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Epitropaki O, 2004, J APPL PSYCHOL, V89, P293, DOI 10.1037/0021-9010.89.2.293; Fernald RD, 1997, BRAIN BEHAV EVOLUT, V50, P253, DOI 10.1159/000113339; Fiedler S, 2013, ORGAN BEHAV HUM DEC, V120, P272, DOI 10.1016/j.obhdp.2012.07.002; FOSTER RA, 1994, APPL COGNITIVE PSYCH, V8, P107, DOI 10.1002/acp.2350080203; Foti RJ, 2007, J APPL PSYCHOL, V92, P347, DOI 10.1037/0021-9010.92.2.347; Fruhen LS, 2015, LEADERSHIP QUART, V26, P1005, DOI 10.1016/j.leaqua.2015.07.001; Fu G, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE; Furnham A, 2001, PERS INDIV DIFFER, V30, P491, DOI 10.1016/S0191-8869(00)00040-4; George JM, 2000, HUM RELAT, V53, P1027, DOI 10.1177/0018726700538001; GIOIA DA, 1985, EDUC PSYCHOL MEAS, V45, P217, DOI 10.1177/001316448504500204; Hansbrough TK, 2015, LEADERSHIP QUART, V26, P220, DOI 10.1016/j.leaqua.2014.11.006; Hareli S, 2010, COGNITION EMOTION, V24, P128, DOI 10.1080/02699930802613828; Hartmann M, 2016, PSYCHOL RES-PSYCH FO, V80, P325, DOI 10.1007/s00426-016-0759-0; Heck A, 2016, J EXP CHILD PSYCHOL, V147, P100, DOI 10.1016/j.jecp.2016.03.005; Helminen TM, 2016, PSYCHOL RES-PSYCH FO, V80, P159, DOI 10.1007/s00426-015-0649-x; House R. J., 1999, ADV GLOBAL LEADERSHI, P171; Hu C. S., 2015, COGNITION EMOTION, P1; Hu C, 2014, VISION RES, V102, P1, DOI 10.1016/j.visres.2014.05.010; Junker NM, 2014, LEADERSHIP QUART, V25, P1154, DOI 10.1016/j.leaqua.2014.09.002; Juslin P, 2007, PSYCHOL REV, V114, P678, DOI 10.1037/0033-295X.114.3.678; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; Keltner D, 1999, COGNITION EMOTION, V13, P505, DOI 10.1080/026999399379168; Kenney RA, 1996, PERS SOC PSYCHOL B, V22, P1128, DOI 10.1177/01461672962211004; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Ladkin D, 2014, MONOGR LEAD MANAGE, V6, P1, DOI 10.1108/S1479-357120140000006001; Little AC, 2012, Q J EXP PSYCHOL, V65, P2018, DOI 10.1080/17470218.2012.677048; Lord R.G., 1991, EXECUTIVE LEADERSHIP; LORD RG, 1985, HUM RELAT, V38, P47, DOI 10.1177/001872678503800103; LORD RG, 1984, ORGAN BEHAV HUM PERF, V34, P343, DOI 10.1016/0030-5073(84)90043-6; Lord RG, 1993, LEADERSHIP INFORM PR, Vxi; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Martell RF, 2005, J APPL PSYCHOL, V90, P956, DOI 10.1037/0021-9010.90.5.956; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Memon A, 2003, J APPL PSYCHOL, V88, P341, DOI 10.1037/0021-9010.88.2.341; Morewedge CK, 2010, TRENDS COGN SCI, V14, P435, DOI 10.1016/j.tics.2010.07.004; Nusseck M, 2008, J VISION, V8, DOI 10.1167/8.8.1; Offermann L. R., 1994, LEADERSHIP QUART, V5, P43, DOI DOI 10.1016/1048-9843(94)90005-1; Ohlsen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059471; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Perez WF, 2015, PSYCHOL REC, V65, P83, DOI 10.1007/s40732-014-0092-1; Pernice K, 2016, CONDUCT EYE TRACKING; PHILLIPS JS, 1984, ORGAN BEHAV HUM PERF, V33, P125, DOI 10.1016/0030-5073(84)90015-1; Podsakoff NP, 2013, J APPL PSYCHOL, V98, P99, DOI 10.1037/a0029570; Rayner K, 2015, CURR OPIN BEHAV SCI, V1, P107, DOI 10.1016/j.cobeha.2014.10.008; Rensink RA, 2003, ENCY COGNITIVE SCI, P509; Rosch E, 1978, COGNITION CATEGORIZA, P328; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; Rule NO, 2011, LEADERSHIP QUART, V22, P690, DOI 10.1016/j.leaqua.2011.05.009; RUSH MC, 1988, J EXP SOC PSYCHOL, V24, P88, DOI 10.1016/0022-1031(88)90045-5; Schall A., 2014, EYE TRACKING USER EX, P3; SCHEIN VE, 1973, J APPL PSYCHOL, V57, P95, DOI 10.1037/h0037128; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Schyns PG, CURRENT BIOL, V17, P1580; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shondrick SJ, 2010, LEADERSHIP QUART, V21, P959, DOI 10.1016/j.leaqua.2010.10.004; Smith ER, 2000, PERS SOC PSYCHOL REV, V4, P108, DOI 10.1207/S15327957PSPR0402_01; Smith JA, 1998, LEADERSHIP QUART, V9, P147, DOI 10.1016/S1048-9843(98)90002-9; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Tanaka JW, 2016, Q J EXP PSYCHOL, V69, P1876, DOI 10.1080/17470218.2016.1146780; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Van Kleef GA, 2011, EUR REV SOC PSYCHOL, V22, P114, DOI 10.1080/10463283.2011.627192; Weick K.E., 1995, SENSEMAKING ORG; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	88	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179058	10.1371/journal.pone.0179058	http://dx.doi.org/10.1371/journal.pone.0179058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686605	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100008
J	Lie, SA; Tveito, TH; Reme, SE; Eriksen, HR				Lie, Stein Atle; Tveito, Torill H.; Reme, Silje E.; Eriksen, Hege R.			IQ and mental health are vital predictors of work drop out and early mortality. Multi-state analyses of Norwegian male conscripts	PLOS ONE			English	Article							STAGE OCCUPATION PROBABILITIES; LONG-TERM SICKNESS; DISABILITY PENSION; PSEUDO-OBSERVATIONS; PROSPECTIVE COHORT; FOLLOW-UP; MODELS; ABSENCE; TRANSITIONS; DIAGNOSES	Background Disability benefits and sick leave benefits represents huge costs in western countries. The pathways and prognostic factors for receiving these benefits seen in recent years are complex and manifold. We postulate that mental health and IQ, both alone and concurrent, influence subsequent employment status, disability benefits and mortality. Methods A cohort of 918 888 Norwegian men was followed for 16 years from the age of 20 to 55. Risk for health benefits, emigration, and mortality were studied. Indicators of mental health and IQ at military enrolment were used as potential risk factors. Multi-state models were used to analyze transitions between employment, sick leave, time limited benefits, disability benefits, emigration, and mortality. Results During follow up, there were a total of 3 908 397 transitions between employment and different health benefits, plus 12 607 deaths. Men with low IQ (below 85), without any mental health problems at military enrolment, had an increased probability of receiving disability benefits before the age of 35 (HRR = 4.06, 95% CI: 3.88-4.26) compared to men with average IQ (85 to 115) and no mental health problems. For men with both low IQ and mental health problems, there was an excessive probability of receiving disability benefits before the age of 35 (HRR = 14.37, 95% CI: 13.59-15.19), as well as an increased probability for time limited benefits and death before the age of 35 compared to men with average IQ (85 to 115) and no mental health problems. Conclusion Low IQ and mental health problems are strong predictors of future disability benefits and early mortality for young men.	[Lie, Stein Atle; Tveito, Torill H.; Reme, Silje E.; Eriksen, Hege R.] Uni Res Hlth, Bergen, Norway; [Lie, Stein Atle] Univ Bergen, Dept Clin Dent, Bergen, Norway; [Tveito, Torill H.] Univ Coll Southeast Norway, Dept Hlth Social & Welf Studies, Horten, Norway; [Reme, Silje E.] Univ Oslo, Dept Psychol, Fac Social Sci, Oslo, Norway; [Eriksen, Hege R.] Western Norway Univ Appl Sci, Dept Sport & Phys Act, Bergen, Norway	University of Bergen; University College of Southeast Norway; University of Oslo; Western Norway University of Applied Sciences	Lie, SA (corresponding author), Uni Res Hlth, Bergen, Norway.; Lie, SA (corresponding author), Univ Bergen, Dept Clin Dent, Bergen, Norway.	stein.lie@uib.no	Reme, Silje E/K-5206-2018; Reme, Silje Endresen/AGT-7250-2022	Reme, Silje E/0000-0001-5870-4906; Reme, Silje Endresen/0000-0001-5870-4906	Research Council of Norway [1177315753906, 187885/H20]	Research Council of Norway(Research Council of Norway)	This work received support from The Research Council of Norway (http://www. forskningsradet.no/en/Home_page/ 1177315753906), GrantNo. 187885/H20, HegeR. Eriksen.	AALEN OO, 1978, SCAND J STAT, V5, P141; Andersen PK, 2008, LIFETIME DATA ANAL, V14, P405, DOI 10.1007/s10985-008-9097-x; Andersen PK, 2010, STAT METHODS MED RES, V19, P71, DOI 10.1177/0962280209105020; Andersen PK, 2003, BIOMETRIKA, V90, P15, DOI 10.1093/biomet/90.1.15; Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; [Anonymous], 2013, INSTRUCTION MILITARY; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Bratberg E, 2009, HEALTH PLACE, V15, P308, DOI 10.1016/j.healthplace.2008.06.004; Bratsberg B, 2013, LABOUR ECON, V24, P137, DOI 10.1016/j.labeco.2013.08.004; Brinch CN, 2012, P NATL ACAD SCI USA, V109, P425, DOI 10.1073/pnas.1106077109; Commenges D, 2002, STAT METHODS MED RES, V11, P167, DOI 10.1191/0962280202sm279ra; Datta S, 2002, BIOMETRICS, V58, P792, DOI 10.1111/j.0006-341X.2002.00792.x; De Ridder KAA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-941; De Ridder KAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074954; Evans-Lacko S, 2016, SOC PSYCH PSYCH EPID, V51, P1525, DOI 10.1007/s00127-016-1278-4; Fadum EA, 2017, J EPIDEMIOL COMMUN H, V71, P19, DOI 10.1136/jech-2016-207656; Gjesdal S, 2008, EUR J PUBLIC HEALTH, V18, P517, DOI 10.1093/eurpub/ckn010; Gjesdal S, 2009, SCAND J PUBLIC HEALT, V37, P387, DOI 10.1177/1403494809103994; Gonnot JP, 1995, EUR J POPUL, V11, P371, DOI 10.1007/BF01267726; Gran JM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2408-8; Gravseth HM, 2007, EUR J EPIDEMIOL, V22, P533, DOI 10.1007/s10654-007-9139-9; Gravseth HM, 2008, EUR J PUBLIC HEALTH, V18, P650, DOI 10.1093/eurpub/ckn055; Gunnes N, 2007, LIFETIME DATA ANAL, V13, P211, DOI 10.1007/s10985-007-9034-4; Henderson M, 2013, PSYCHOL MED, V43, P1755, DOI 10.1017/S0033291712002528; Henderson M, 2011, J ROY SOC MED, V104, P198, DOI 10.1258/jrsm.2011.100231; Henderson M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000777; Koslowski N, 2016, BRIT J PSYCHIAT, V209, P469, DOI 10.1192/bjp.bp.114.162313; Lie SA, 2008, SCAND J PUBLIC HEALT, V36, P279, DOI 10.1177/1403494807086979; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; OECD, 2013, MENT HLTH WORK NORW, DOI DOI 10.1787/9789264178984-EN; Oyeflaten I, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-748; Pape K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001942; Pedersen J, 2012, SCAND J WORK ENV HEA, V38, P516, DOI 10.5271/sjweh.3293; Reme SE, 2015, OCCUP ENVIRON MED, V72, P745, DOI 10.1136/oemed-2014-102700; Ritchie EC, 2007, MIL MED, V172, P31, DOI 10.7205/MILMED.172.1.31; Rueda S, 2012, AM J PUBLIC HEALTH, V102, P541, DOI 10.2105/AJPH.2011.300401; Samuelsson A, 2013, SCAND J WORK ENV HEA, V39, P351, DOI 10.5271/sjweh.3338; Sorberg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078268; Steele F, 2011, AUST NZ J STAT, V53, P1, DOI 10.1111/j.1467-842X.2011.00604.x; Stover M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-148; Sundet JM, 2004, INTELLIGENCE, V32, P349, DOI 10.1016/j.intell.2004.06.004; van der Noordt M, 2014, OCCUP ENVIRON MED, V71, P730, DOI 10.1136/oemed-2013-101891	42	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180737	10.1371/journal.pone.0180737	http://dx.doi.org/10.1371/journal.pone.0180737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683088	gold, Green Published, Green Submitted			2022-12-27	WOS:000405335200063
J	Stuhr, M; Reymond, CE; Rieder, V; Hallock, P; Rahnenfuhrer, J; Westphal, H; Kucera, M				Stuhr, Marleen; Reymond, Claire E.; Rieder, Vera; Hallock, Pamela; Rahnenfuehrer, Joerg; Westphal, Hildegard; Kucera, Michel			Reef calcifiers are adapted to episodic heat stress but vulnerable to sustained warming	PLOS ONE			English	Article							LARGE BENTHIC FORAMINIFERA; GREAT-BARRIER-REEF; MARGINOPORA-VERTEBRALIS; OCEAN ACIDIFICATION; FLORIDA-KEYS; CORAL-REEFS; TEMPERATURE; RESPONSES; GROWTH; ENVIRONMENTS	Shallow marine ecosystems naturally experience fluctuating physicochemical conditions across spatial and temporal scales. Widespread coral-bleaching events, induced by prolonged heat stress, highlight the importance of how the duration and frequency of thermal stress influence the adaptive physiology of photosymbiotic calcifiers. Large benthic foraminifera harboring algal endosymbionts are major tropical carbonate producers and bioindicators of ecosystem health. Like corals, they are sensitive to thermal stress and bleach at temperatures temporarily occurring in their natural habitat and projected to happen more frequently. However, their thermal tolerance has been studied so far only by chronic exposure, so how they respond under more realistic episodic heat-event scenarios remains unknown. Here, we determined the physiological responses of Amphistegina gibbosa, an abundant western Atlantic foraminifera, to four different treatments control, single, episodic, and chronic exposure to the same thermal stress (32 degrees C) in controlled laboratory cultures. Exposure to chronic thermal stress reduced motility and growth, while antioxidant capacity was elevated, and photosymbiont variables (coloration, oxygen-production rates, chlorophyll a concentration) indicated extensive bleaching. In contrast, single- and episodic-stress treatments were associated with higher motility and growth, while photosymbiont variables remained stable. The effects of single and episodic heat events were similar, except for the presumable occurrence of reproduction, which seemed to be suppressed by both episodic and chronic stress. The otherwise different responses between treatments with thermal fluctuations and chronic stress indicate adaptation to thermal peaks, but not to chronic exposure expected to ensue when baseline temperatures are elevated by climate change. This firstly implies that marine habitats with a history of fluctuating thermal stress potentially support resilient physiological mechanisms among photosymbiotic organisms. Secondly, there seem to be temporal constraints related to heat events among coral reef environments and reinforces the importance of temporal fluctuations in stress exposure in global-change studies and projections.	[Stuhr, Marleen; Reymond, Claire E.; Westphal, Hildegard] Leibniz Ctr Trop Marine Res ZMT, Dept Biogeochem & Geol, Bremen, Germany; [Rieder, Vera; Rahnenfuehrer, Joerg] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Hallock, Pamela] Univ S Florida, Coll Marine Sci, St Petersburg, FL USA; [Westphal, Hildegard] Univ Bremen, Dept Geosci, Bremen, Germany; [Kucera, Michel] Univ Bremen, MARUM, Ctr Marine Environm Sci, Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Dortmund University of Technology; State University System of Florida; University of South Florida; University of Bremen; University of Bremen	Stuhr, M (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Dept Biogeochem & Geol, Bremen, Germany.	marleen.stuhr@lebniz-zmt.de	Kucera, Michal/ABH-6065-2020; Stuhr, Marleen/T-9771-2019; Westphal, Hildegard/ACQ-0391-2022; Kucera, Michal/B-9277-2009; Kucera, Michal/AAE-8115-2020	Kucera, Michal/0000-0002-7817-9018; Kucera, Michal/0000-0002-7817-9018; Baumeister, Vera/0000-0002-8706-1492; Westphal, Hildegard/0000-0001-7324-6122; Hallock, Pamela/0000-0002-1813-0482; Rahnenfuhrer, Jorg/0000-0002-8947-440X	Leibniz Association [SAW-2014-ISAS-2]	Leibniz Association	This study was funded by the Leibniz Association (SAW-2014-ISAS-2, www.leibnizgemeinschaft.de) awarded to HW and JR. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LL, 2009, SCI TOTAL ENVIRON, V407, P2115, DOI 10.1016/j.scitotenv.2008.11.038; Anderson J, FLORIDA KEYS NATL MA; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernhard JM, 2000, MICROPALEONTOLOGY, V46, P38; Boyd PW, 2016, GLOBAL CHANGE BIOL, V22, P2633, DOI 10.1111/gcb.13287; Buerger P, 2015, J EXP MAR BIOL ECOL, V471, P232, DOI 10.1016/j.jembe.2015.06.014; Doo SS, 2012, ZOOL STUD, V51, P1298; Doo SS, 2012, J EXP MAR BIOL ECOL, V430, P63, DOI 10.1016/j.jembe.2012.06.025; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Faraway J.J., 2006, MIXED EFFECTS NONPAR, DOI 10.1201/b21296; Fujita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090304; Genolini C., 2016, LONGITUDINALDATA LON; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; HALLOCK P, 1986, J FORAMIN RES, V16, P224, DOI 10.2113/gsjfr.16.3.224; HALLOCK P, 1981, Journal of Foraminiferal Research, V11, P40; Hallock P, 2003, ENVIRON MONIT ASSESS, V81, P221, DOI 10.1023/A:1021337310386; HALLOCK P, 1995, J FORAMIN RES, V25, P280, DOI 10.2113/gsjfr.25.3.280; Hallock P., 1993, P 7 INT COR REEF S G, V1, P44; Harper D, 2001, PAST PALEONTOLOGICAL; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; JAAP WC, 1979, B MAR SCI, V29, P414; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Leichter JJ, 2006, J MAR RES, V64, P563, DOI 10.1357/002224006778715711; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Manzello DP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16762; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Prazeres M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45227; Prazeres M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21936; Putnam HM, 2011, J EXP MAR BIOL ECOL, V396, P216, DOI 10.1016/j.jembe.2010.10.026; Putnam HM, 2010, INVERTEBR BIOL, V129, P199, DOI 10.1111/j.1744-7410.2010.00199.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reymond CE, 2013, GLOBAL CHANGE BIOL, V19, P291, DOI 10.1111/gcb.12035; Reymond CE, 2011, MAR ECOL PROG SER, V435, P97, DOI 10.3354/meps09172; Rodolfo-Metalpa R, 2014, GLOBAL CHANGE BIOL, V20, P3036, DOI 10.1111/gcb.12571; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30930; Schmidt C, 2014, CORAL REEFS, V33, P805, DOI 10.1007/s00338-014-1151-4; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Schwartzwald D., 2012, COLOR SPACE CONVERTE; Sinutok S, 2011, LIMNOL OCEANOGR, V56, P1200, DOI 10.4319/lo.2011.56.4.1200; Soto I.M., 2011, Journal of Marine Biology, V2011, P1; Talge HK, 2003, J EUKARYOT MICROBIOL, V50, P324, DOI 10.1111/j.1550-7408.2003.tb00143.x; TERKUILE B, 1984, J FORAMIN RES, V14, P262, DOI 10.2113/gsjfr.14.4.262; Uthicke S, 2012, CORAL REEFS, V31, P401, DOI 10.1007/s00338-011-0851-2; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; Vega-Rodriguez M, 2015, MAR ECOL PROG SER, V528, P173, DOI 10.3354/meps11268; Waters H, 2017, J FORAMINIF IN PRESS, V47; Williams DE, 2004, MAR BIOL, V145, P641, DOI 10.1007/s00227-004-1351-5	53	22	23	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179753	10.1371/journal.pone.0179753	http://dx.doi.org/10.1371/journal.pone.0179753			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683118	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200014
J	Buhmann, C; Huckhagel, T; Engel, K; Gulberti, A; Hidding, U; Poetter-Nerger, M; Goerendt, I; Ludewig, P; Braass, H; Choe, CU; Krajewski, K; Oehlwein, C; Mittmann, K; Engel, AK; Gerloff, C; Westphal, M; Koppen, JA; Moll, CKE; Hamel, W				Buhmann, Carsten; Huckhagel, Torge; Engel, Katja; Gulberti, Alessandro; Hidding, Ute; Poetter-Nerger, Monika; Goerendt, Ines; Ludewig, Peter; Braass, Hanna; Choe, Chi-un; Krajewski, Kara; Oehlwein, Christian; Mittmann, Katrin; Engel, Andreas K.; Gerloff, Christian; Westphal, Manfred; Koeppen, Johannes A.; Moll, Christian K. E.; Hamel, Wolfgang			Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS STIMULATION; ADVANCED PARKINSONS-DISEASE; 5-YEAR FOLLOW-UP; QUALITY-OF-LIFE; ESSENTIAL TREMOR; THALAMIC-STIMULATION; COGNITIVE FUNCTION; BILATERAL STIMULATION; GENERALIZED DYSTONIA; URINARY-BLADDER	Background and objective The extent to which deep brain stimulation (DBS) can improve quality of life may be perceived as a permanent trade-off between neurological improvements and complications of therapy, comorbidities, and disease progression. Patients and methods We retrospectively investigated 123 consecutive and non-preselected patients. Indications for DBS surgery were Parkinson's disease (82), dystonia (18), tremor of different etiology (21), Huntington's disease (1) and Gilles de la Tourette syndrome (1). AEs were defined as any untoward clinical occurrence, sign or patient complaint or unintended disease if related or unrelated to the surgical procedures, implanted devices or ongoing DBS therapy. Results Over a mean/median follow-up period of 4.7 years (578 patient-years) 433 AEs were recorded in 106 of 123 patients (86.2%). There was no mortality or persistent morbidity from the surgical procedure. All serious adverse events (SAEs) that occurred within 4 weeks of surgery were reversible. Neurological AEs (193 in 85 patients) and psychiatric AEs (78 in 48 patients) were documented most frequently. AEs in 4 patients (suicide under GPI stimulation, weight gain >20 kg, impairment of gait and speech, cognitive decline >2 years following surgery) were severe or worse, at least possibly related to DBS and non reversible. In PD 23.1% of the STN-stimulated patients experienced non-reversible (or unknown reversibility) AEs that were at least possibly related to DBS in the form of impaired speech or gait, depression, weight gain, cognitive disturbances or urinary incontinence (severity was mild or moderate in 15 of 18 patients). Age and Hoehn&Yahr stage of STN-simulated PD patients, but not preoperative motor impairment or response to levodopa, showed a weak correlation (r = 0.24 and 0.22, respectively) with the number of AEs. Conclusions DBS-related AEs that were severe or worse and non-reversible were only observed in PD (4 of 82 patients; 4.9%), but not in other diseases. PD patients exhibited a significant risk for non-severe AEs most of which also represented preexisting and progressive axial and non-motor symptoms of PD. Mild gait and/or speech disturbances were rather frequent complaints under VIM stimulation. GPI stimulation for dystonia could be applied with negligible DBS-related side effects.	[Buhmann, Carsten; Hidding, Ute; Poetter-Nerger, Monika; Goerendt, Ines; Ludewig, Peter; Braass, Hanna; Choe, Chi-un; Gerloff, Christian] Univ Klinikum Hamburg Eppendorf, Klin Neurol, Hamburg, Germany; [Huckhagel, Torge; Engel, Katja; Krajewski, Kara; Westphal, Manfred; Koeppen, Johannes A.; Hamel, Wolfgang] Univ Klinikum Hamburg Eppendorf, Klin Neurochirurg, Hamburg, Germany; [Gulberti, Alessandro; Engel, Andreas K.; Moll, Christian K. E.] Univ Klinikum Hamburg Eppendorf, Inst Neurophysiol & Pathophysiol, Hamburg, Germany; [Oehlwein, Christian; Mittmann, Katrin] Praxis Neurol, Gera, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hamel, W (corresponding author), Univ Klinikum Hamburg Eppendorf, Klin Neurochirurg, Hamburg, Germany.	whamel@uke.de	Krajewski, Kara/ABH-2587-2020; Engel, Andreas K/C-7781-2012; Engel, Andreas K./AAH-6384-2019	Engel, Andreas K/0000-0003-4899-8466; Engel, Andreas K./0000-0003-4899-8466; Gerloff, Christian/0000-0002-6484-8882; Gulberti, Alessandro/0000-0003-0538-5109; Huckhagel, Torge/0000-0003-1183-2630				Alegret M, 2001, ARCH NEUROL-CHICAGO, V58, P1223, DOI 10.1001/archneur.58.8.1223; Blomstedt P, 2007, BRIT J NEUROSURG, V21, P504, DOI 10.1080/02688690701552278; Blomstedt P, 2006, STEREOT FUNCT NEUROS, V84, P72, DOI 10.1159/000094035; Castelli L, 2006, EUR NEUROL, V55, P136, DOI 10.1159/000093213; Combs HL, 2015, NEUROPSYCHOL REV, V25, P439, DOI 10.1007/s11065-015-9302-0; Contarino MF, 2007, J NEUROL NEUROSUR PS, V78, P248, DOI 10.1136/jnnp.2005.086660; Daniele A, 2003, J NEUROL NEUROSUR PS, V74, P175, DOI 10.1136/jnnp.74.2.175; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dujardin K, 2001, J NEUROL, V248, P603, DOI 10.1007/s004150170139; Faist M, 2001, BRAIN, V124, P1590, DOI 10.1093/brain/124.8.1590; Fasano A, 2010, BRAIN, V133, P2664, DOI 10.1093/brain/awq221; Favilla CG, 2012, BRAIN, V135, P1455, DOI 10.1093/brain/aws026; Ferraye MU, 2008, NEUROLOGY, V70, P1431, DOI 10.1212/01.wnl.0000310416.90757.85; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Frost E, 2010, INT J SPEECH-LANG PA, V12, P399, DOI 10.3109/17549507.2010.497560; Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803; Funkiewiez A, 2003, MOVEMENT DISORD, V18, P524, DOI 10.1002/mds.10441; Funkiewiez A, 2006, MOVEMENT DISORD, V21, P1656, DOI 10.1002/mds.21029; Gervais-Bernard H, 2009, J NEUROL, V256, P225, DOI 10.1007/s00415-009-0076-2; Gironell A, 2003, J NEUROL, V250, P917, DOI 10.1007/s00415-003-1109-x; Guehl D, 2006, EXP BRAIN RES, V170, P206, DOI 10.1007/s00221-005-0202-z; Hammer MJ, 2010, J NEUROL, V257, P1692, DOI 10.1007/s00415-010-5605-5; Hariz GM, 2002, J NEUROL NEUROSUR PS, V72, P47, DOI 10.1136/jnnp.72.1.47; Hariz MI, 2008, MOVEMENT DISORD, V23, P416, DOI 10.1002/mds.21888; Hariz MI, 1999, STEREOT FUNCT NEUROS, V72, P208, DOI 10.1159/000029728; Herzog J, 2008, BRAIN, V131, P132, DOI 10.1093/brain/awm254; Herzog J, 2006, BRAIN, V129, P3366, DOI 10.1093/brain/awl302; Kim HJ, 2014, J NEUROL, V261, P1090, DOI 10.1007/s00415-014-7321-z; Kim HJ, 2013, J NEUROL, V260, P2130, DOI 10.1007/s00415-013-6959-2; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Kronenbuerger M, 2009, CEREBELLUM, V8, P389, DOI 10.1007/s12311-009-0111-y; Krystkowiak P, 2003, ARCH NEUROL-CHICAGO, V60, P80, DOI 10.1001/archneur.60.1.80; Kumar R, 2003, NEUROLOGY, V61, P1601, DOI 10.1212/01.WNL.0000096012.07360.1C; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Louis ED, 2013, PARKINSONISM RELAT D, V19, P363, DOI 10.1016/j.parkreldis.2012.10.005; Louis ED, 2009, MOVEMENT DISORD, V24, P1606, DOI 10.1002/mds.22570; Maurer C, 2003, BRAIN, V126, P1146, DOI 10.1093/brain/awg100; McNeely ME, 2013, PARKINSONISM RELAT D, V19, P86, DOI 10.1016/j.parkreldis.2012.07.013; Merola A, 2014, J NEUROL, V261, P1745, DOI 10.1007/s00415-014-7414-8; Moll Christian K E, 2013, Acta Neurochir Suppl, V117, P19, DOI 10.1007/978-3-7091-1482-7_4; Mueller J, 2008, MOVEMENT DISORD, V23, P131, DOI 10.1002/mds.21783; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Papavassiliou E, 2004, NEUROSURGERY, V54, P1120, DOI 10.1227/01.NEU.0000119329.66931.9E; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Pilitsis JG, 2008, J NEUROSURG, V109, P640, DOI 10.3171/JNS/2008/109/10/0640; Pinto S, 2005, MOVEMENT DISORD, V20, P1507, DOI 10.1002/mds.20601; Putzke JD, 2006, J NEUROL NEUROSUR PS, V77, P1235, DOI 10.1136/jnnp.2006.086579; Rehncrona S, 2003, MOVEMENT DISORD, V18, P163, DOI 10.1002/mds.10309; Rousseaux M, 2004, J NEUROL, V251, P327, DOI 10.1007/s00415-004-0327-1; Saez-Zea C, 2012, EUR NEUROL, V68, P361, DOI 10.1159/000341380; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Schulz GM, 2012, J PARKINSON DIS, V2, P29, DOI 10.3233/JPD-2012-11049; Schupbach WMM, 2005, J NEUROL NEUROSUR PS, V76, P1640, DOI 10.1136/jnnp.2005.063206; Schuurman PR, 2008, MOVEMENT DISORD, V23, P1146, DOI 10.1002/mds.22059; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Shih LC, 2013, PARKINSONISM RELAT D, V19, P676, DOI 10.1016/j.parkreldis.2013.03.006; Skodda S, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00218; St George RJ, 2012, J NEUROSURG, V116, P1347, DOI 10.3171/2012.2.JNS11847; Stolze H, 2001, BRAIN, V124, P2278, DOI 10.1093/brain/124.11.2278; Stolze H, 2001, NEUROLOGY, V57, P144, DOI 10.1212/WNL.57.1.144; Sydow O, 2003, J NEUROL NEUROSUR PS, V74, P1387, DOI 10.1136/jnnp.74.10.1387; Timmermann L, 2015, LANCET NEUROL, V14, P693, DOI 10.1016/S1474-4422(15)00087-3; Tripoliti E, 2011, NEUROLOGY, V76, P80, DOI 10.1212/WNL.0b013e318203e7d0; Tripoliti E, 2014, MOVEMENT DISORD, V29, P532, DOI 10.1002/mds.25816; Tsuboi T, 2015, J NEUROL NEUROSUR PS, V86, P856, DOI 10.1136/jnnp-2014-308043; van Nuenen BFL, 2008, MOVEMENT DISORD, V23, P2404, DOI 10.1002/mds.21986; Vercruysse S, 2014, J NEUROL NEUROSUR PS, V85, P872, DOI 10.1136/jnnp-2013-306336; Vesper J, 2002, J NEUROL NEUROSUR PS, V73, P275, DOI 10.1136/jnnp.73.3.275; Vidailhet M, 2007, LANCET NEUROL, V6, P223, DOI 10.1016/S1474-4422(07)70035-2; Visser JE, 2008, J NEUROL, V255, P205, DOI 10.1007/s00415-008-0636-x; Volkmann J, 2014, LANCET NEUROL, V13, P875, DOI 10.1016/S1474-4422(14)70143-7; Volkmann J, 2012, LANCET NEUROL, V11, P1029, DOI 10.1016/S1474-4422(12)70257-0; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Weintraub D, 2013, J NEUROL NEUROSUR PS, V84, P1113, DOI 10.1136/jnnp-2012-304396; Wertheimer J, 2014, PARKINSONISM RELAT D, V20, P1065, DOI 10.1016/j.parkreldis.2014.06.010; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; Winge K, 2007, MOVEMENT DISORD, V22, P220, DOI 10.1002/mds.21253; Witt K, 2004, ARCH NEUROL-CHICAGO, V61, P697, DOI 10.1001/archneur.61.5.697; Witt K, 2006, J NEUROPSYCH CLIN N, V18, P397, DOI 10.1176/appi.neuropsych.18.3.397; Xie J, 2001, J NEUROL, V248, P1068, DOI 10.1007/s004150170027; Yaguez L, 2014, J CLIN NEUROSCI, V21, P445, DOI 10.1016/j.jocn.2013.06.005; York MK, 2008, J NEUROL NEUROSUR PS, V79, P789, DOI 10.1136/jnnp.2007.118786; Zhang K, 2010, J NEUROSURG, V112, P1271, DOI 10.3171/2009.10.JNS09371	87	68	68	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178984	10.1371/journal.pone.0178984	http://dx.doi.org/10.1371/journal.pone.0178984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678830	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200007
J	Wang, HL; Tang, XY; Su, YC; Chen, JB; Yan, JB				Wang, Hongling; Tang, Xiaoyang; Su, Yi-Cheng; Chen, Jiabei; Yan, Jianbo			Characterization of clinical Vibrio parahaemolyticus strains in Zhoushan, China, from 2013 to 2014	PLOS ONE			English	Article							RISK-ASSESSMENT; SEAFOOD; TEMPERATURE; VIRULENCE; PROVINCE; MODEL	Vibrio parahaemolyticus is recognized as major cause of foodborne illness of global public health concern. This study collected 107 strains of V. parahaemolyticus during active surveillance of diarrheal diseases in hospitals in Zhoushan during 2013 to 2014 and investigated their serotypes, virulence genes (tdh, trh, and orf8), antimicrobial resistance, and genotypes. The dominant serotypes of the 107 clinical strains were O3: K6, O4: K8, and O4: KUT with 87.9% and 3.7% of the strains carrying the virulence genes tdh and trh, respectively. Molecular typing by pulsed-field gel electrophoresis indicated divergence among the clinical strains. Most isolates were sensitive to the common antimicrobial agents used against the Vibrio species except ampicillin. We conclude that continuous surveillance of V. parahaemolyticus in diarrhea patients is a public health priority and is useful for conducting risk assessment of foodborne illnesses caused by V. parahaemolyticus.	[Wang, Hongling; Chen, Jiabei; Yan, Jianbo] Key Lab Hlth Risk Factors Seafood Zhejiang Prov, Zhoushan, Zhejiang, Peoples R China; [Wang, Hongling; Chen, Jiabei; Yan, Jianbo] Zhoushan Municipal Ctr Dis Control & Prevent, Zhoushan, Zhejiang, Peoples R China; [Tang, Xiaoyang] MasterKong Holding, Cent Res Inst, Food Safety Res Ctr, Shanghai, Peoples R China; [Su, Yi-Cheng] Oregon State Univ, Seafood Res & Educ Ctr, Astoria, OR USA	Oregon State University	Wang, HL (corresponding author), Key Lab Hlth Risk Factors Seafood Zhejiang Prov, Zhoushan, Zhejiang, Peoples R China.; Wang, HL (corresponding author), Zhoushan Municipal Ctr Dis Control & Prevent, Zhoushan, Zhejiang, Peoples R China.	whlwillia@163.com			Bureau of Science and Technology of Zhoushan [2014C31073]	Bureau of Science and Technology of Zhoushan	This research was supported by the grants from Bureau of Science and Technology of Zhoushan (Project NO.2014C31073).	Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Chao GX, 2009, FOODBORNE PATHOG DIS, V6, P1021, DOI 10.1089/fpd.2009.0295; Chen Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.003; Hernandez-Diaz LD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00221; Han HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130302; Iwahori J, 2010, RISK ANAL, V30, P1817, DOI 10.1111/j.1539-6924.2010.01444.x; Li BS, 2015, INT J FOOD MICROBIOL, V200, P13, DOI 10.1016/j.ijfoodmicro.2014.12.009; Liao YX, 2015, FOODBORNE PATHOG DIS, V12, P881, DOI 10.1089/fpd.2015.1988; Ludeke CHM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00564; Mahoney JC, 2010, APPL ENVIRON MICROB, V76, P7459, DOI 10.1128/AEM.01450-10; Pazhani GP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002815; Shinoda S, 2011, BIOCONTROL SCI, V16, P129, DOI 10.4265/bio.16.129; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Tsai SE, 2013, INT J FOOD MICROBIOL, V165, P18, DOI 10.1016/j.ijfoodmicro.2013.04.017; Vongxay K, 2008, FOODBORNE PATHOG DIS, V5, P127, DOI 10.1089/fpd.2007.0045; Wang RZ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00144; Wang XY, 2015, CHEMOSPHERE, V118, P163, DOI 10.1016/j.chemosphere.2014.07.057; Ward LN, 2006, APPL ENVIRON MICROB, V72, P2031, DOI 10.1128/AEM.72.3.2031-2042.2006; Wu YC, 2014, ACTA PSYCHOL, V153, P39, DOI 10.1016/j.actpsy.2014.09.002; Xie J, 2012, FOOD CONTROL, V23, P320, DOI 10.1016/j.foodcont.2011.07.019; Xue ChaoBo, 2008, Disease Surveillance, V23, P424; Yamamoto A, 2008, INT J FOOD MICROBIOL, V124, P70, DOI 10.1016/j.ijfoodmicro.2008.02.021; Yoon KS, 2008, FOOD MICROBIOL, V25, P635, DOI 10.1016/j.fm.2008.04.007; Zarei M, 2012, FOODBORNE PATHOG DIS, V9, P108, DOI 10.1089/fpd.2011.0989; Zhang HZ, 2013, FOODBORNE PATHOG DIS, V10, P796, DOI 10.1089/fpd.2012.1378	25	17	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180335	10.1371/journal.pone.0180335	http://dx.doi.org/10.1371/journal.pone.0180335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678810	gold, Green Submitted, Green Published			2022-12-27	WOS:000405272200055
J	Bighiu, MA; Gorokhova, E; Almroth, BC; Wiklund, AKE				Bighiu, Maria Alexandra; Gorokhova, Elena; Almroth, Bethanie Carney; Wiklund, Ann-Kristin Eriksson			Metal contamination in harbours impacts life-history traits and metallothionein levels in snails	PLOS ONE			English	Article							FRESH-WATER PULMONATE; ANTI-FOULING PAINTS; SPECTROPHOTOMETRIC METHOD; THEODOXUS-FLUVIATILIS; COPPER CONTAMINATION; AQUATIC ENVIRONMENT; ZINC CONCENTRATIONS; REPRODUCTIVE-CYCLE; BRACKISH-WATER; WEST-COAST	Harbours with limited water exchange are hotspots of contaminant accumulation. Antifouling paints (AF) contribute to this accumulation by leaching biocides that may affect non-target species. In several leisure boat harbours and reference areas in the Baltic Sea, chronic exposure effects were evaluated using caging experiments with the snail Theodoxus fluviatilis. We analysed variations in ecologically relevant endpoints (mortality, growth and reproduction) in concert with variation in metallothionein-like proteins (MTLP) levels. The latter is a biomarker of exposure to metals, such as copper (Cu) and zinc (Zn), which are used in AF paints as active ingredient and stabilizer, respectively. In addition, environmental samples (water, sediment) were analysed for metal (Cu and Zn) and nutrient (total phosphorous and nitrogen) concentrations. All life-history endpoints were negatively affected by the exposure, with higher mortality, reduced growth and lower fecundity in the harbours compared to the reference sites. Metal concentrations were the key explanatory variables for all observed adverse effects, suggesting that metal-driven toxicity, which is likely to stem from AF paints, is a source of anthropogenic stress for biota in the harbours.	[Bighiu, Maria Alexandra; Gorokhova, Elena; Wiklund, Ann-Kristin Eriksson] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Almroth, Bethanie Carney] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	Stockholm University; University of Gothenburg	Bighiu, MA (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	maria.bighiu@aces.su.se	Bighiu, Maria/ABA-9079-2020; Gorokhova, Elena/E-7105-2018; Almroth, Bethanie Carney/Q-6411-2019	Gorokhova, Elena/0000-0002-4192-6956; Almroth, Bethanie Carney/0000-0002-5037-4612; Bighiu, Maria/0000-0001-8478-0144	BONUS (CHANGE-project) - European Community's Seventh Framework Programme [2012-90]; BONUS (CHANGE-project) - Baltic Seanational funding institutions [2012-90]	BONUS (CHANGE-project) - European Community's Seventh Framework Programme; BONUS (CHANGE-project) - Baltic Seanational funding institutions	This study was funded by BONUS (CHANGE-project) financed jointly by the European Community's Seventh Framework Programme (grant agreement 2012-90) and Baltic Seanational funding institutions, www.bonusportal.org; AKEW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; Ancion PY, 2013, ENVIRON POLLUT, V173, P117, DOI 10.1016/j.envpol.2012.10.012; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Barranguet C, 2000, EUR J PHYCOL, V35, P397, DOI 10.1080/09670260010001736001; Berthelin C, 2000, COMP BIOCHEM PHYS B, V125, P359, DOI 10.1016/S0305-0491(99)00187-X; Besser JM, 2016, ARCH ENVIRON CON TOX, V70, P321, DOI 10.1007/s00244-015-0255-3; Biggs TW, 2012, MAR POLLUT BULL, V64, P627, DOI 10.1016/j.marpolbul.2011.12.006; Bighiu MA, 2016, ENV SCI POLLUT RES; Brix KV, 2011, COMP BIOCHEM PHYS C, V154, P261, DOI 10.1016/j.cbpc.2011.06.004; Connon RE, 2012, SENSORS-BASEL, V12, P12741, DOI 10.3390/s120912741; Cooper NL, 2009, ECOTOX ENVIRON SAFE, V72, P1523, DOI 10.1016/j.ecoenv.2009.03.002; Daka ER, 2006, WATER AIR SOIL POLL, V171, P19, DOI 10.1007/s11270-005-9009-6; DALLINGER R, 1993, EUR J BIOCHEM, V216, P739, DOI 10.1111/j.1432-1033.1993.tb18193.x; Das S, 2011, J HAZARD MATER, V185, P295, DOI 10.1016/j.jhazmat.2010.09.033; Dillon R. T., 2000, ECOLOGY FRESHWATER M, DOI 10.1017/CBO9780511542008; Ejhed H, 2011, FEASIBILITY STUDY NE; Eklund B., 2008, Open Environmental Sciences, V2, P124, DOI 10.2174/1876325100802010124; Eklund B., 2013, DISPOSAL PLASTIC END; Eklund B, 2016, ARCH ENVIRON CON TOX, V70, P583, DOI 10.1007/s00244-016-0262-z; Eklund B, 2014, ENVIRON MANAGE, V53, P930, DOI 10.1007/s00267-014-0249-3; Eklund B, 2010, J SOIL SEDIMENT, V10, P127, DOI 10.1007/s11368-009-0149-y; Ferrer LD, 2003, CHEM SPEC BIOAVAILAB, V15, P7, DOI 10.3184/095422903782775271; FLEMMING CA, 1989, WATER AIR SOIL POLL, V44, P143, DOI 10.1007/BF00228784; Costa LDF, 2013, ENVIRON MONIT ASSESS, V185, P6767, DOI 10.1007/s10661-013-3063-0; Galloway TS, 2004, ENVIRON SCI TECHNOL, V38, P1723, DOI 10.1021/es030570+; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Hagger JA, 2009, ENVIRON POLLUT, V157, P2003, DOI 10.1016/j.envpol.2009.02.038; Hamer B, 2008, AQUAT TOXICOL, V89, P137, DOI 10.1016/j.aquatox.2008.06.015; Helsinki Commission, 2012, BALT SEA ENV P; Holding KL, 2003, ENVIRON GEOCHEM HLTH, V25, P87, DOI 10.1023/A:1021205101133; Karlsson J, 2004, MAR POLLUT BULL, V49, P456, DOI 10.1016/j.marpolbul.2004.02.034; Karlsson J, 2010, ENVIRON POLLUT, V158, P681, DOI 10.1016/j.envpol.2009.10.024; Kirkegaard J, 2006, LIMNOLOGICA, V36, P26, DOI 10.1016/j.limno.2005.11.002; Konstantinou IK, 2004, ENVIRON INT, V30, P235, DOI 10.1016/S0160-4120(03)00176-4; Lawes JC, 2016, MAR POLLUT BULL, V102, P148, DOI 10.1016/j.marpolbul.2015.11.040; Legras S, 2000, J EXP MAR BIOL ECOL, V246, P259, DOI 10.1016/S0022-0981(99)00187-2; Leung KMY, 2001, MAR ENVIRON RES, V52, P173, DOI 10.1016/S0141-1136(00)00271-3; Machreki-Ajmi M, 2011, MAR BIOL RES, V7, P261, DOI 10.1080/17451000.2010.497187; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; MUNZINGER A, 1988, AQUAT TOXICOL, V12, P51, DOI 10.1016/0166-445X(88)90019-7; Neira C, 2014, MAR ECOL-EVOL PERSP, V35, P46, DOI 10.1111/maec.12054; Oaten JFP, 2015, SCI TOTAL ENVIRON, V518, P238, DOI 10.1016/j.scitotenv.2015.03.003; Obiakor MO, 2015, ECOTOX ENVIRON SAFE, V117, P149, DOI 10.1016/j.ecoenv.2015.03.035; Oehlmann J, 2007, ECOTOXICOLOGY, V16, P29, DOI 10.1007/s10646-006-0109-x; Palacios O, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-4; Perceval O, 2002, ENVIRON POLLUT, V118, P5, DOI 10.1016/S0269-7491(01)00282-2; Peters A, 2014, ENVIRON SCI POLLUT R, V21, P193, DOI 10.1007/s11356-013-1851-2; Real M, 2003, AQUAT TOXICOL, V63, P283, DOI 10.1016/S0166-445X(02)00187-X; Sapozhnikova Y, 2013, MAR POLLUT BULL, V69, P189, DOI 10.1016/j.marpolbul.2013.01.039; Schettino T., 2012, Open Environmental Sciences, V6, P20, DOI 10.2174/1876325101206010020; Schiedek D, 2006, MAR POLLUT BULL, V53, P387, DOI 10.1016/j.marpolbul.2005.11.013; Schiff K, 2007, MAR POLLUT BULL, V54, P322, DOI 10.1016/j.marpolbul.2006.10.013; Schmera D, 2015, CAN J ZOOL, V93, P403, DOI 10.1139/cjz-2014-0307; Serafim A, 2010, AQUAT TOXICOL, V99, P370, DOI 10.1016/j.aquatox.2010.05.016; Sim VXY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130537; Skoog G., 1978, ASPECTS BIOL ECOLOGY; Swedish Agency for Marine and Water Management, 2013, 201319 HVMFS; Swedish Chemicals Agency, 1993, 293 SWED CHEM AG; Swedish Environmental Protection Agency Swedish Chemicals Agency, 2008, FORSL TILL GRANSV SA; Turner A, 2010, MAR POLLUT BULL, V60, P159, DOI 10.1016/j.marpolbul.2009.12.004; Viarengo A, 1997, MAR ENVIRON RES, V44, P69, DOI 10.1016/S0141-1136(96)00103-1; Vijver MG, 2011, ENVIRON TOXICOL CHEM, V30, P1482, DOI 10.1002/etc.499; Wang WX, 2002, MAR ECOL PROG SER, V243, P295, DOI 10.3354/meps243295; Warnken J, 2004, MAR POLLUT BULL, V49, P833, DOI 10.1016/j.marpolbul.2004.06.012; Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1; Wiklund AKE, 2002, ENVIRON TOXICOL CHEM, V21, P1219, DOI 10.1002/etc.5620210615; Xie LT, 2011, AQUAT TOXICOL, V105, P199, DOI 10.1016/j.aquatox.2011.06.009; Zettler ML, 2004, J CONCHOL, V38, P305; Zorita I, 2005, BIOMARKERS, V10, P342, DOI 10.1080/13547500500264645	69	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180157	10.1371/journal.pone.0180157	http://dx.doi.org/10.1371/journal.pone.0180157			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671998	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500019
J	Kantor, L; Levitz, N				Kantor, Leslie; Levitz, Nicole			Parents' views on sex education in schools: How much do Democrats and Republicans agree?	PLOS ONE			English	Article							COMPREHENSIVE SEXUALITY EDUCATION; PUBLIC-OPINION; POLICY	More than 93 percent of parents place high importance on sex education in both middle and high school. Sex education in middle and high school is widely supported by parents regardless of their political affiliation. Using data from a large diverse sample of 1,633 parents of children aged 9 to 21 years, we examined whether views on sex education differed by parents' political affiliation. More than 89 percent of parents that identified as Republicans or Democrats support including a wide range of topics in sex education including puberty, healthy relationships, abstinence, sexually transmitted diseases (STDs) and birth control in high school. In middle school, 78 percent or more of both parents that identified as Republicans and Democrats support the inclusion of those topics. Controlling for key demographic factors, parents that identified as Democrats are more likely than those that identified as Republicans to support the inclusion of the topics of healthy relationships, birth control, STDs, and sexual orientation in both middle and high school. However, a strong majority of Republican parents want all these topics included in sex education. Sex education which includes a broad set of topics represents an area of strong agreement between parents of both political parties.	[Kantor, Leslie; Levitz, Nicole] Planned Parenthood Federat Amer, New York, NY 10038 USA		Kantor, L (corresponding author), Planned Parenthood Federat Amer, New York, NY 10038 USA.	leslie.kantor@ppfa.org	Levitz, Nicole/W-6545-2019	Levitz, Nicole/0000-0003-0984-0762; Kantor, Leslie/0000-0002-3550-612X				Alton FL, 2009, AM J SEX EDUC, V4, P116, DOI 10.1080/15546120903001381; Bleakley A, 2006, ARCH PEDIAT ADOL MED, V160, P1151, DOI 10.1001/archpedi.160.11.1151; Bleakley A, 2010, SEX RES SOC POLICY, V7, P50, DOI 10.1007/s13178-010-0008-z; Constantine NA, 2007, PERSPECT SEX REPRO H, V39, P167, DOI 10.1363/3916707; Demissie Z., 2015, SCH HLTH PROFILES 20; Eisenberg ME, 2008, J ADOLESCENT HEALTH, V42, P352, DOI 10.1016/j.jadohealth.2007.09.019; Heller HR, 2013, SEX ED, V13, P548; Herrman JW, 2013, AM J SEX EDUC, V8, P140, DOI 10.1080/15546128.2013.828342; Howard-Barr E, 2011, AM J SEX EDUC, V6, P176, DOI 10.1080/15546128.2011.571955; Howard-Barr EM, 2007, AM J SEX EDUC, V2, P27, DOI 10.1300/J455v02n03_03; Ito KE, 2006, J ADOLESCENT HEALTH, V39, P634, DOI 10.1016/j.jadohealth.2006.04.022; Landry DJ, 2007, PERSPECT SEX REPRO H, V35, P261; Lewis R. K., 2001, HEALTH PROMOTION PRA, V2, P155; Millner V, 2015, SEX RES SOC POLICY, V12, P101, DOI 10.1007/s13178-015-0180-2; National Public Radio (NPR) Kaiser Family Foundation and Kennedy School of Government, 2004, SEX ED AM GEN PUBL P	15	23	23	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180250	10.1371/journal.pone.0180250	http://dx.doi.org/10.1371/journal.pone.0180250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672027	gold, Green Submitted, Green Published			2022-12-27	WOS:000405268500034
J	Lajko, M; Cardona, HJ; Taylor, JM; Farrow, KN; Fawzi, AA				Lajko, Michelle; Cardona, Herminio J.; Taylor, Joann M.; Farrow, Kathryn N.; Fawzi, Amani A.			Photoreceptor oxidative stress in hyperoxiainduced proliferative retinopathy accelerates rd8 degeneration	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; MULLER GLIAL-CELLS; RETINITIS-PIGMENTOSA; NADPH OXIDASE; CRB1 GENE; RETINAL DYSTROPHIES; CRUMBS HOMOLOG-1; RHO GTPASES; MOUSE MODEL; MUTATION	To investigate the impact of photoreceptor oxidative stress on photoreceptor degeneration in mice carrying the rd8 mutation (C57BL/6N). We compared the hyperoxia-induced proliferative retinopathy (HIPR) model in two mouse strains (C57BL/6J and C57BL/6N). Pups were exposed to 75% oxygen, starting at birth and continuing for 14 days (P14). Mice were euthanized at P14, or allowed to recover in room air for one day (P15), seven days (P21), or 14 days (P28). We quantified retinal thickness and the length of residual photoreceptors not affected by rosette formation. In addition we explored differences in retinal immunostaining for NADPH oxidase 4 (NOX4), Rac1, vascular endothelium, and activated Muller cells. We analyzed photoreceptor oxidative stress using DCF staining in cross sections and quantified NOX4 protein levels using western blotting. C57BL/6N mice in HIPR showed increased oxidative stress, NOX4, and Rac1 in the photoreceptors at P14 and P15 compared to C57BL/6J. In addition, we observed significant progression of photoreceptor degeneration, with significantly accelerated rosette formation in C57BL/6N under HIPR, compared to their room air counterparts. Furthermore, C57BL/6N under HIPR had significantly thinner central retinas than C57BL/6J in HIPR. We did not find a difference in vascular disruption or Mu E ller cell activation comparing the two strains in hyperoxia. In HIPR, the C57BL/6N strain carrying the rd8 mutation showed significantly accelerated photoreceptor degeneration, mediated via exacerbated photoreceptor oxidative stress, which we believe relates to Rac1-NOX dysregulation in the setting of Crb1 loss-of-function.	[Lajko, Michelle; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Cardona, Herminio J.; Taylor, Joann M.; Farrow, Kathryn N.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558	North western University Mouse Histology and Phenotyping Laboratory; Cancer Center Support Grant [NCI CA060553]; NCI CCSG [P30 CA060553]; National Institutes of Health [R21HD077336]; Friends of Prentice Grants Initiative of the North western Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD077336] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109478] Funding Source: NIH RePORTER	North western University Mouse Histology and Phenotyping Laboratory; Cancer Center Support Grant; NCI CCSG; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends of Prentice Grants Initiative of the North western Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the North western University Mouse Histology and Phenotyping Laboratory and a Cancer Center Support Grant (NCI CA060553). Imaging work was performed at the North western University Center for Advanced Microscopy generously supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. Supported by grants from the National Institutes of Health (R21HD077336, A.A.F. and K.N.F.) and The Friends of Prentice Grants Initiative of the North western Memorial Foundation (K.N.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Alves CH, 2012, MOL SYNDROMOL; Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Belmonte MA, 2006, INVEST OPHTH VIS SCI, V47, P1193, DOI 10.1167/iovs.05-0446; Berkelhamer SK, 2013, FREE RADICAL BIO MED, V61, P51, DOI 10.1016/j.freeradbiomed.2013.03.003; Bernal S, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e89; Bhatt L, 2010, MOL VIS, V16, P283; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAITIN MH, 1994, EXP EYE RES, V58, P359, DOI 10.1006/exer.1994.1026; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2013, INVEST OPHTH VIS SCI, V54, P4974, DOI 10.1167/iovs.13-12289; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chartier FJM, 2012, J CELL BIOL, V198, P991, DOI 10.1083/jcb.201203083; Chartier FJM, 2011, J CELL SCI, V124, P3393, DOI 10.1242/jcs.092601; Chou JC, 2014, INVEST OPHTH VIS SCI, V55, P2516, DOI 10.1167/iovs.13-13676; Datta A, 2015, AM J PHYSIOL-LUNG C, V309, pL369, DOI 10.1152/ajplung.00176.2014; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Dworakowski R, 2008, PHARMACOL REP, V60, P21; Fawzi AA, 2014, INVEST OPHTH VIS SCI, V55, P1493, DOI 10.1167/iovs.13-13207; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gerber Sylvie, 2002, Ophthalmic Genet, V23, P225, DOI 10.1076/opge.23.4.225.13879; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Henderson RH, 2011, BRIT J OPHTHALMOL, V95, P811, DOI 10.1136/bjo.2010.186882; Heynen SR, 2011, MOL VIS, V17, P2934; Heynen SR, 2013, PROG RETIN EYE RES, V8; Ildefonso CJ, 2016, INVEST OPHTH VIS SCI, V57, P372, DOI 10.1167/iovs.15-17703; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jeanes A, 2009, J MOL HISTOL, V40, P395, DOI 10.1007/s10735-010-9253-y; Khaliq S, 2003, EXP EYE RES, V76, P343, DOI 10.1016/S0014-4835(02)00304-4; Korystov YN, 2007, RADIAT RES, V168, P226, DOI 10.1667/RR0925.1; Lajko M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166886; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lamont RE, 2016, EUR J HUM GENET, V24, P1436, DOI 10.1038/ejhg.2016.24; Laprise P, 2002, J BIOL CHEM, V277, P8226, DOI 10.1074/jbc.M110235200; Lee KJ, 2014, AM J RESP CELL MOL, V50, P369, DOI 10.1165/rcmb.2013-0118OC; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mehalow AK, 2003, HUM MOL GEN, V12; Mekada K, 2009, EXP ANIM, P58; Mekada K, 2009, EXP ANIM, V58; Roehlecke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071570; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Schnabolk G, 2014, EXP EYE RES, V129, P18, DOI 10.1016/j.exer.2014.10.005; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Slavotinek AM, 2016, MOL SYNDROMOL, V7, P274, DOI 10.1159/000448109; Soetikno BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep16752; Song HM, 2016, INVEST OPHTH VIS SCI, V57, P2864, DOI 10.1167/iovs.15-18974; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; Wang JF, 2016, INVEST OPHTH VIS SCI, V57, P3892, DOI 10.1167/iovs.16-19447; Wang J, 2015, FREE RADICAL BIO MED, V86, P25, DOI 10.1016/j.freeradbiomed.2015.04.009; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zhao M, 2015, J NEUROSCI, V35, P6093, DOI 10.1523/JNEUROSCI.3412-14.2015	61	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180384	10.1371/journal.pone.0180384	http://dx.doi.org/10.1371/journal.pone.0180384			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671996	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500048
J	Liguori, R; Incensi, A; de Pasqua, S; Mignani, R; Fileccia, E; Santostefano, M; Biagini, E; Rapezzi, C; Palmieri, S; Romani, I; Borsini, W; Burlina, A; Bombardi, R; Caprini, M; Avoni, P; Donadio, V				Liguori, Rocco; Incensi, Alex; de Pasqua, Silvia; Mignani, Renzo; Fileccia, Enrico; Santostefano, Marisa; Biagini, Elena; Rapezzi, Claudio; Palmieri, Silvia; Romani, Ilaria; Borsini, Walter; Burlina, Alessandro; Bombardi, Roberto; Caprini, Marco; Avoni, Patrizia; Donadio, Vincenzo			Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy	PLOS ONE			English	Article							GALACTOSIDASE-A-GENE; ALPHA-GALACTOSIDASE; REPLACEMENT THERAPY; INVOLVEMENT; NERVE	Background Fabry Disease (FD) is characterized by globotriaosylceramide-3 (Gb3) accumulation in several tissues and a small fibre neuropathy (SFN), however the underlying mechanisms are poorly known. This study aimed to: 1) ascertain the presence of Gb3 deposits in skin samples, by an immunofluorescence method collected from FD patients with classical GLA mutations or late-onset FD variants or GLA polymorphisms; 2) correlate skin GB3 deposits with skin innervation. Methods we studied 52 genetically-defined FD patients (32 with classical GLA mutations and 20 with late-onset variants or GLA polymorphisms), 15 patients with SFN associated with a specific cause and 22 healthy controls. Subjects underwent skin biopsy to evaluate Gb3 deposits and epi-dermal innervation. Results Skin Gb3 deposits were found in all FD patients with classical GLA mutations but never in FD patients with late-onset variants or GLA polymorphisms or in patients with SFN and healthy controls. Abnormal deposits were found inside different skin structures but never inside axons. FD patients with GB3 deposits showed lower skin innervation than FD patients with late-onset variants or polymorphisms. Conclusions 1) Skin Gb3 deposits are specific to FD patients with classical GLA mutations; 2) Gb3 deposits were associated with lower skin innervation but they were not found inside axons, suggesting an indirect damage on peripheral small fibre innervation.	[Liguori, Rocco; Incensi, Alex; Avoni, Patrizia; Donadio, Vincenzo] IRCCS Inst Neurol Sci, Bologna, Italy; [Liguori, Rocco; de Pasqua, Silvia; Fileccia, Enrico; Avoni, Patrizia] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Mignani, Renzo] Infermi Hosp, Dept Nephrol, Rimini, Italy; [Santostefano, Marisa] St Orsola Marcello Malpighi Hosp, Div Nephrol, Bologna, Italy; [Biagini, Elena; Rapezzi, Claudio; Palmieri, Silvia] St Orsola Marcello Malpighi Hosp, Dept Cardiol, Bologna, Italy; [Romani, Ilaria; Borsini, Walter] Univ Florence, Neurosci Sect, NEUROFARBA Dept, Florence, Italy; [Burlina, Alessandro; Bombardi, Roberto] S Bassiano Hosp, Dept Neurol, Bassano Del Grappa, VI, Italy; [Caprini, Marco] Univ Bologna, Lab Human & Gen Physiol, FaBiT, Bologna, Italy	IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; Hospital of Rimini; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Florence; ULSS 7 Pedemontana; Ospedale San Bassiano; University of Bologna	Liguori, R (corresponding author), IRCCS Inst Neurol Sci, Bologna, Italy.; Liguori, R (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.	rocco.liguori@unibo.it	Liguori, Rocco/AAB-7860-2020; Incensi, Alex/AAB-6092-2020; Donadio, Vincenzo/AAB-9165-2020; Avoni, Patrizia/AAC-1879-2020	Incensi, Alex/0000-0003-2163-5403; de Pasqua, Silvia/0000-0003-0457-9366; Liguori, Rocco/0000-0002-1815-1013; Romani, Ilaria/0000-0001-7966-3525	Ricerca Finalizzata Ministerodella Salute [RF-20102 313899]	Ricerca Finalizzata Ministerodella Salute(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work was supported by Ricerca Finalizzata Ministerodella Salute Grant RF-20102 313899 to R.L.,M.C. and V.D; Wethank Dr. Francesco Formaggio for technical assistance and Fondazione Del Montedi Bolognae Ravenna, Italy, for providing the F.F. Ph Dfellowship. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz D, 2010, CARBOHYD RES, V345, P1384, DOI 10.1016/j.carres.2010.02.006; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Chevrier M, 2010, AUTOPHAGY, V6, P589, DOI 10.4161/auto.6.5.11943; Desnick R., 2001, METABOLIC MOL BASES, P3733, DOI DOI 10.1036/OMMBID.181; Dobrovolny R, 2005, J MOL MED, V83, P647, DOI 10.1007/s00109-005-0656-2; Dutsch M, 2002, J CLIN NEUROPHYSIOL, V19, P575; El-Abassi R, 2014, J NEUROL SCI, V344, P5, DOI 10.1016/j.jns.2014.06.029; Elleder M, 2003, ACTA PAEDIATR, V92, P46, DOI 10.1080/08035320310000465; Froissart R, 2003, MOL GENET METAB, V80, P307, DOI 10.1016/S1096-7192(03)00136-7; GADOTH N, 1983, J MED GENET, V20, P309, DOI 10.1136/jmg.20.4.309; KAYE EM, 1988, ANN NEUROL, V23, P505, DOI 10.1002/ana.410230513; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; Lacomis D, 2005, MUSCLE NERVE, V31, P102, DOI 10.1002/mus.20130; Lakoma J, 2016, MOL PAIN, V12, DOI 10.1177/1744806916663729; Lakoma J, 2016, J CELL PHYSIOL, V231, P192, DOI 10.1002/jcp.25072; Lakoma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108641; Lenders M, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0441-z; Liguori R, 2010, MUSCLE NERVE, V41, P409, DOI 10.1002/mus.21606; Lukas J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003632; Mignani R, 2008, NEPHROL DIAL TRANSPL, V23, P1628, DOI 10.1093/ndt/gfm813; Navarro C, 2006, ACTA NEUROPATHOL, V111, P178, DOI 10.1007/s00401-005-0026-8; PELLISSIER JF, 1981, MUSCLE NERVE, V4, P381, DOI 10.1002/mus.880040506; Provitera V, 2016, EUR J NEUROL, V23, P333, DOI 10.1111/ene.12842; Rigoldi M, 2014, CLIN GENET, V86, P258, DOI 10.1111/cge.12261; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; SAKURABA H, 1990, AM J HUM GENET, V47, P784; Schiffmann R, 2002, ACTA PAEDIATR, V91, P48, DOI 10.1080/080352502762457923; Schiffmann R, 2006, ACTA NEUROL BELG, V106, P61; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Thurberg BL, 2004, J INVEST DERMATOL, V122, P900, DOI 10.1111/j.0022-202X.2004.22425.x; Toyooka K, 1997, J NEUROL, V244, P464, DOI 10.1007/s004150050125; Uceyler N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166484; Wijburg FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124987	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180581	10.1371/journal.pone.0180581	http://dx.doi.org/10.1371/journal.pone.0180581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672034	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500073
J	Zelik, KE; Franz, JR				Zelik, Karl E.; Franz, Jason R.			It's positive to be negative: Achilles tendon work loops during human locomotion	PLOS ONE			English	Article							MUSCLE-TENDON; IN-VIVO; GASTROCNEMIUS-MUSCLE; MECHANICAL-PROPERTIES; STRAIN PATTERNS; ANKLE; BEHAVIOR; WALKING; PERFORMANCE; DYNAMICS	Ultrasound imaging is increasingly used with motion and force data to quantify tendon dynamics during human movement. Frequently, tendon dynamics are estimated indirectly from muscle fascicle kinematics (by subtracting muscle from muscle-tendon unit length), but there is mounting evidence that this Indirect approach yields implausible tendon work loops. Since tendons are passive viscoelastic structures, when they undergo a loading-unloading cycle they must exhibit a negative work loop (i.e., perform net negative work). However, prior studies using this Indirect approach report large positive work loops, often estimating that tendons return 2-5 J of elastic energy for every 1 J of energy stored. More direct ultrasound estimates of tendon kinematics have emerged that quantify tendon elongations by tracking either the muscle-tendon junction or localized tendon tissue. However, it is unclear if these yield more plausible estimates of tendon dynamics. Our objective was to compute tendon work loops and hysteresis losses using these two Direct tendon kinematics estimates during human walking. We found that Direct estimates generally resulted in negative work loops, with average tendon hysteresis losses of 2-11% at 1.25 m/s and 33-49% at 0.75 m/s (N = 8), alluding to 0.51-0.98 J of tendon energy returned for every 1 J stored. We interpret this finding to suggest that Direct approaches provide more plausible estimates than the Indirect approach, and may be preferable for understanding tendon energy storage and return. However, the Direct approaches did exhibit speed-dependent trends that are not consistent with isolated, in vitro tendon hysteresis losses of about 5-10%. These trends suggest that Direct estimates also contain some level of error, albeit much smaller than Indirect estimates. Overall, this study serves to highlight the complexity and difficulty of estimating tendon dynamics non-invasively, and the care that must be taken to interpret biological function from current ultrasound-based estimates.	[Zelik, Karl E.] Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Phys Med & Rehabil, 221 Kirkland Hall, Nashville, TN 37235 USA; [Franz, Jason R.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Franz, Jason R.] North Carolina State Univ, Chapel Hill, NC 27599 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Zelik, KE (corresponding author), Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA.; Zelik, KE (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.; Zelik, KE (corresponding author), Vanderbilt Univ, Dept Phys Med & Rehabil, 221 Kirkland Hall, Nashville, TN 37235 USA.; Franz, JR (corresponding author), Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.; Franz, JR (corresponding author), North Carolina State Univ, Chapel Hill, NC 27599 USA.	karl.zelik@vanderbilt.edu; jrfranz@email.unc.edu		Zelik, Karl/0000-0002-5054-2479	National Institutes of Health [K12HD073945, F32AG044904, R01AG051748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD073945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG051748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by funding from the National Institutes of Health: K12HD073945 (awarded to KEZ), F32AG044904 and R01AG051748 (awarded to JRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alexander RM, 2002, COMP BIOCHEM PHYS A, V133, P1001; ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Arellano CJ, 2016, J BIOMECH, V49, P1812, DOI 10.1016/j.jbiomech.2016.04.022; Arndt A, 2012, KNEE SURG SPORT TR A, V20, P1868, DOI 10.1007/s00167-011-1801-9; Azizi E, 2009, J PHYSIOL-LONDON, V587, P4309, DOI 10.1113/jphysiol.2009.173690; Bennett MB, 1986, J ZOOL, V209, P548, DOI DOI 10.1111/J.1469-7998.1986.TB03609.X; Chernak LA, 2012, J BIOMECH, V45, P2618, DOI 10.1016/j.jbiomech.2012.08.001; Cronin NJ, 2013, GAIT POSTURE, V37, P305, DOI 10.1016/j.gaitpost.2012.07.024; Csapo R, 2013, J APPL PHYSIOL, V115, P468, DOI 10.1152/japplphysiol.00395.2013; DeVita P, 2007, J EXP BIOL, V210, P3361, DOI 10.1242/jeb.003970; Epstein M, 2006, J BIOMECH, V39, P2020, DOI 10.1016/j.jbiomech.2005.06.011; Farris DJ, 2016, COMPUT METH PROG BIO, V128, P111, DOI 10.1016/j.cmpb.2016.02.016; Farris DJ, 2016, J EXP BIOL, V219, P528, DOI 10.1242/jeb.126854; Farris DJ, 2013, J EXP BIOL, V216, P594, DOI 10.1242/jeb.077131; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; Finni T, 2016, SCAND J MED SCI SPOR, V26, P992, DOI 10.1111/sms.12731; Finni T, 2013, J APPL PHYSIOL, V114, P515, DOI 10.1152/japplphysiol.01005.2012; Franz JR, 2016, J BIOMECH, V49, P1403, DOI 10.1016/j.jbiomech.2016.04.032; Franz JR, 2015, J APPL PHYSIOL, V119, P242, DOI 10.1152/japplphysiol.00114.2015; Franz JR, 2015, GAIT POSTURE, V41, P192, DOI 10.1016/j.gaitpost.2014.10.001; Franz JR, 2012, GAIT POSTURE, V35, P143, DOI 10.1016/j.gaitpost.2011.08.025; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; Grieve D. W., 1978, INT SERIES BIOMECH A, V4, P405; Hall GW, 1999, J BIOMECH, V32, P203, DOI 10.1016/S0021-9290(98)00167-5; HAWKINS D, 1990, J BIOMECH, V23, P487, DOI 10.1016/0021-9290(90)90304-L; Henry HT, 2005, J EXP BIOL, V208, P3293, DOI 10.1242/jeb.01764; Honert EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163169; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; KER RF, 1981, J EXP BIOL, V93, P283; Konow N, 2012, P ROY SOC B-BIOL SCI, V279, P1108, DOI 10.1098/rspb.2011.1435; Korstanje JWH, 2010, J BIOMECH, V43, P1373, DOI 10.1016/j.jbiomech.2010.01.001; Kubo K, 2000, ACTA PHYSIOL SCAND, V170, P127, DOI 10.1046/j.1365-201x.2000.00768.x; Lichtwark GA, 2007, J BIOMECH, V40, P1768, DOI 10.1016/j.jbiomech.2006.07.025; Lichtwark GA, 2006, J EXP BIOL, V209, P4379, DOI 10.1242/jeb.02434; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; Maganaris CN, 2000, J BIOMECH, V33, P1723, DOI 10.1016/S0021-9290(00)00130-5; Mian OS, 2007, ACTA PHYSIOL, V189, P57, DOI 10.1111/j.1748-1716.2006.01634.x; Nigg BM, 2007, BIOMECHANICS MUSCULO, P162; Peltonen J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-212; Riemer R, 2008, GAIT POSTURE, V27, P578, DOI 10.1016/j.gaitpost.2007.07.012; Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588; Roberts TJ, 2010, J APPL PHYSIOL, V109, P396, DOI 10.1152/japplphysiol.01272.2009; Roberts TJ, 2003, J EXP BIOL, V206, P2567, DOI 10.1242/jeb.00452; Sakuma J, 2012, EUR J APPL PHYSIOL, V112, P887, DOI 10.1007/s00421-011-2032-y; Sawicki GS, 2009, EXERC SPORT SCI REV, V37, P130, DOI 10.1097/JES.0b013e31819c2df6; Seynnes OR, 2015, J APPL PHYSIOL, V118, P133, DOI 10.1152/japplphysiol.00849.2014; Slane LC, 2014, J BIOMECH, V47, P750, DOI 10.1016/j.jbiomech.2013.11.023; Sugisaki N, 2005, INT J SPORT HLTH SCI, V3, P100; Sugisaki N, 2010, J BIOMECH, V43, P2844, DOI 10.1016/j.jbiomech.2010.06.013; Zelik KE, 2015, J EXP BIOL, V218, P876, DOI 10.1242/jeb.115451; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; Zelik KE, 2014, J THEOR BIOL	52	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179976	10.1371/journal.pone.0179976	http://dx.doi.org/10.1371/journal.pone.0179976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671955	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500011
J	Ko, WK; Lee, SH; Kim, SJ; Jo, MJ; Kumar, H; Han, IB; Sohn, S				Ko, Wan-Kyu; Lee, Soo-Hong; Kim, Sung Jun; Jo, Min-Jae; Kumar, Hemant; Han, In-Bo; Sohn, Seil			Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages	PLOS ONE			English	Article							NF-KAPPA-B; CELL VIABILITY; NITRIC-OXIDE; PATHWAYS; KINASE	Purpose The aim of this study was to investigate the anti-inflammatory effects of Ursodeoxycholic acid (UDCA) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Methods We induced an inflammatory process in RAW 264.7 macrophages using LPS. The anti-inflammatory effects of UDCA on LPS-stimulated RAW 264.7 macrophages were analyzed using nitric oxide (NO). Pro-inflammatory and anti-inflammatory cytokines were analyzed by quantitative real time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA). The phosphorylations of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 in mitogen-activated protein kinase (MAPK) signaling pathways and nuclear factor kappa-light polypeptide gene enhancer in B-cells inhibitor, alpha (I kappa B alpha) signaling pathways were evaluated by western blot assays. Results UDCA decreased the LPS-stimulated release of the inflammatory mediator NO. UDCA also decreased the pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin 1-alpha (IL-1 alpha), interleukin 1-beta (IL-1 beta), and interleukin 6 (IL-6) in mRNA and protein levels. In addition, UDCA increased an anti-inflammatory cytokine interleukin 10 (IL-10) in the LPS-stimulated RAW 264.7 macrophages. UDCA inhibited the expression of inflammatory transcription factor nuclear factor kappa B (NF-kappa B) in LPS-stimulated RAW 264.7 macrophages. Furthermore, UDCA suppressed the phosphorylation of ERK, JNK, and p38 signals related to inflammatory pathways. In addition, the phosphorylation of I kappa B alpha, the inhibitor of NF-kappa B, also inhibited by UDCA. Conclusion UDCA inhibits the pro-inflammatory responses by LPS in RAW 264.7 macrophages. UDCA also suppresses the phosphorylation by LPS on ERK, JNK, and p38 in MAPKs and NF-kappa B pathway. These results suggest that UDCA can serve as a useful anti-inflammatory drug.	[Ko, Wan-Kyu; Kim, Sung Jun; Jo, Min-Jae; Kumar, Hemant; Han, In-Bo; Sohn, Seil] CHA Univ, Dept Neurosurg, CHA Bundang Med Ctr, Seongnam Si, Gyeonggi Do, South Korea; [Lee, Soo-Hong] CHA Univ, Dept Biomed Sci, Seongnam Si, Gyeonggi Do, South Korea	Pochon Cha University; Pochon Cha University	Han, IB; Sohn, S (corresponding author), CHA Univ, Dept Neurosurg, CHA Bundang Med Ctr, Seongnam Si, Gyeonggi Do, South Korea.	hanib@cha.ac.kr; sisohn@cha.ac.kr	Kumar, Hemant/G-4576-2018	Kumar, Hemant/0000-0002-6434-0245	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information & Communication Technology (ICT) and future Planning [NRF-2016M3A9E8941668]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information & Communication Technology (ICT) and future Planning	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) (http://www.nrf.re.kr/index) funded by the Ministry of Science, Information & Communication Technology (ICT) and future Planning (NRF-2016M3A9E8941668). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aupperle KR, 1999, J IMMUNOL, V163, P427; BACHRACH WH, 1982, DIGEST DIS SCI, V27, P737, DOI 10.1007/BF01393771; Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Cash JG, 2012, J BIOL CHEM, V287, P27876, DOI 10.1074/jbc.M112.377549; Chen HG, 2013, INT J SURG, V11, P1060, DOI 10.1016/j.ijsu.2013.10.007; Clarke CJP, 1998, EUR J IMMUNOL, V28, P1719, DOI 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gomez-Zorrilla S, 2016, MICROB DRUG RESIST; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Iwasawa A, 2013, REGUL TOXICOL PHARM, V66, P177, DOI 10.1016/j.yrtph.2013.03.014; Joo SS, 2003, ARCH PHARM RES, V26, P1067, DOI 10.1007/BF02994760; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kim HR, 2015, MOL IMMUNOL, V63, P355, DOI 10.1016/j.molimm.2014.09.003; Kullmann F, 1997, Z GASTROENTEROL, V35, P171; Lee CJ, 2010, SHOCK, V33, P93, DOI 10.1097/SHK.0b013e3181a6eaf5; LEUSCHNER U, 1989, GASTROENTEROLOGY, V97, P1268, DOI 10.1016/0016-5085(89)91698-3; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Ma CH, 2015, J ETHNOPHARMACOL, V168, P349, DOI 10.1016/j.jep.2015.03.068; Manzi S, 2000, ANN RHEUM DIS, V59, P321, DOI 10.1136/ard.59.5.321; Newton K., 2012, COLD SPRING HARB PER, V4; Parameswaran N., 2010, CRITICAL REV EUKARYO, V20; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; RYAN GB, 1977, AM J PATHOL, V86, P183; Salhanick MA, 2016, SHOCK, V46, P144, DOI 10.1097/SHK.0000000000000609; Shi KQ, 2012, MOL BIOL REP, V39, P9715, DOI 10.1007/s11033-012-1836-0; Sorensen NS, 2011, VET IMMUNOL IMMUNOP, V139, P296, DOI 10.1016/j.vetimm.2010.10.016; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Xu ZY, 2008, BIOCHEM ENG J, V41, P280, DOI 10.1016/j.bej.2008.05.019	32	57	60	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180673	10.1371/journal.pone.0180673	http://dx.doi.org/10.1371/journal.pone.0180673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665991	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700023
J	Yamamoto, K; Kawai-Toyooka, H; Hamaji, T; Tsuchikane, Y; Mori, T; Takahashi, F; Sekimoto, H; Ferris, PJ; Nozaki, H				Yamamoto, Kayoko; Kawai-Toyooka, Hiroko; Hamaji, Takashi; Tsuchikane, Yuki; Mori, Toshiyuki; Takahashi, Fumio; Sekimoto, Hiroyuki; Ferris, Patrick J.; Nozaki, Hisayoshi			Molecular evolutionary analysis of a gender-limited MID ortholog from the homothallic species Volvox africanus with male and monoecious spheroids	PLOS ONE			English	Article							MATING-TYPE LOCUS; PHYLOGENETIC ANALYSIS; CHLAMYDOMONAS; CHLOROPHYTA; VOLVOCALES	Volvox is a very interesting oogamous organism that exhibits various types of sexuality and/or sexual spheroids depending upon species or strains. However, molecular bases of such sexual reproduction characteristics have not been studied in this genus. In the model species V. carteri, an ortholog of the minus mating type-determining or minus dominance gene (MID) of isogamous Chlamydomonas reinhardtii is male-specific and determines the sperm formation. Male and female genders are genetically determined (heterothallism) in V. carteri, whereas in several other species of Volvox both male and female gametes (sperm and eggs) are formed within the same clonal culture (homothallism). To resolve the molecular basis of the evolution of Volvox species with monoecious spheroids, we here describe a MID ortholog in the homothallic species V. africanus that produces both monoecious and male spheroids within a single clonal culture. Comparison of synonymous and nonsynonymous nucleotide substitutions in MID genes between V. africanus and heterothallic volvocacean species suggests that the MID gene of V. africanus evolved under the same degree of functional constraint as those of the heterothallic species. Based on semi quantitative reverse transcription polymerase chain reaction analyses using the asexual, male and monoecious spheroids isolated from a sexually induced V. africanus culture, the MID mRNA level was significantly upregulated in the male spheroids, but suppressed in the monoecious spheroids. These results suggest that the monoecious spheroid-specific down regulation of gene expression of the MID homolog correlates with the formation of both eggs and sperm in the same spheroid in V. africanus.	[Yamamoto, Kayoko; Kawai-Toyooka, Hiroko; Hamaji, Takashi; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Tsuchikane, Yuki; Sekimoto, Hiroyuki] Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Bunkyo Ku, Tokyo, Japan; [Mori, Toshiyuki] Juntendo Univ, Sch Med, Dept Trop Med & Parasitol, Bunkyo Ku, Tokyo, Japan; [Takahashi, Fumio] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan; [Ferris, Patrick J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	University of Tokyo; Japan Womens University; Juntendo University; Ritsumeikan University; University of Arizona	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	nozaki@bs.s.u-tokyo.ac.jp	Mori, Toshiyuki/F-8488-2013	Sekimoto, Hiroyuki/0000-0002-7362-2324; Hamaji, Takashi/0000-0002-2801-2148; Nozaki, Hisayoshi/0000-0002-9308-4498; Tsuchikane, Yuki/0000-0002-2316-1574	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [15K14590, 16H02518]; National Aeronautics and Space Administration [NNX13AH41G]; National Science Foundation [MCB-1412395]; Grants-in-Aid for Scientific Research [15H05237] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TH and HN were supported by Grants-in-Aid for Scientific Research (grant numbers 16H06734, 15K14590 and 16H02518) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/). PJF was supported by the National Aeronautics and Space Administration (https://www.usa.gov/federal-agencies/national-aeronautics-and-space-administration; grant number NNX13AH41G) and the National Science Foundation (https://www.nsf.gov/;; grant number MCB-1412395). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Japanese Journal of Phycology, V57, P1; Coleman AW, 1999, P NATL ACAD SCI USA, V96, P13892, DOI 10.1073/pnas.96.24.13892; EBERSOLD WT, 1967, SCIENCE, V157, P447, DOI 10.1126/science.157.3787.447; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferris P, 2010, SCIENCE, V328, P351, DOI 10.1126/science.1186222; Ferris PJ, 1997, GENETICS, V146, P859; FERRIS PJ, 1994, CELL, V76, P1135, DOI 10.1016/0092-8674(94)90389-1; Geng S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001904; Hamaji T, 2008, GENETICS, V178, P283, DOI 10.1534/genetics.107.078618; Hamaji T, 2016, G3-GENES GENOM GENET, V6, P1179, DOI 10.1534/g3.115.026229; Hamaji T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064385; Hiraide R, 2013, MOL BIOL EVOL, V30, P1038, DOI 10.1093/molbev/mst018; Isaka N, 2012, J PHYCOL, V48, P759, DOI 10.1111/j.1529-8817.2012.01142.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KATO S, 1982, Japanese Journal of Phycology, V30, P63; Kianianmomeni A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1117; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; MILLER SM, 1993, PLANT CELL, V5, P1125, DOI 10.1105/tpc.5.9.1125; Nakada T, 2007, EUR J PHYCOL, V42, P177, DOI 10.1080/09670260601145816; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Nozaki H, 1997, J PHYCOL, V33, P864, DOI 10.1111/j.0022-3646.1997.00864.x; Nozaki H, 1995, J PHYCOL, V31, P970, DOI 10.1111/j.0022-3646.1995.00970.x; NOZAKI H, 1983, BOT MAG TOKYO, V96, P103, DOI 10.1007/BF02491095; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; Nozaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142632; Nozaki H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-37; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; Smith Gilbert M., 1944, TRANS AMER MICROSC SOC, V63, P265, DOI 10.2307/3223302; Starr RC, 1971, SEXUAL REPROD VOLVOX, P59; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180313	10.1371/journal.pone.0180313	http://dx.doi.org/10.1371/journal.pone.0180313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665990	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700083
J	Alvaro, L; Linhares, JMM; Moreira, H; Lillo, J; Nascimento, SMC				Alvaro, Leticia; Linhares, Joao M. M.; Moreira, Humberto; Lillo, Julio; Nascimento, Sergio M. C.			Robust colour constancy in red-green dichromats	PLOS ONE			English	Article							NATURAL SCENES; ILLUMINATION DISCRIMINATION; DEFICIENT OBSERVERS; DISCERNIBLE COLORS; BLINDNESS; DAYLIGHT; VISION; IMAGES; NUMBER	Colour discrimination has been widely studied in red-green (R-G) dichromats but the extent to which their colour constancy is affected remains unclear. This work estimated the extent of colour constancy for four normal trichromatic observers and seven R-G dichromats when viewing natural scenes under simulated daylight illuminants. Hyperspectral imaging data from natural scenes were used to generate the stimuli on a calibrated CRT display. In experiment 1, observers viewed a reference scene illuminated by daylight with a correlated colour temperature (CCT) of 6700K; observers then viewed sequentially two versions of the same scene, one illuminated by either a higher or lower CCT (condition 1, pure CCT change with constant luminance) or a higher or lower average luminance (condition 2, pure luminance change with a constant CCT). The observers' task was to identify the version of the scene that looked different from the reference scene. Thresholds for detecting a pure CCT change or a pure luminance change were estimated, and it was found that those for R-G dichromats were marginally higher than for normal trichromats regarding CCT. In experiment 2, observers viewed sequentially a reference scene and a comparison scene with a CCT change or a luminance change above threshold for each observer. The observers' task was to identify whether or not the change was an intensity change. No significant differences were found between the responses of normal trichromats and dichromats. These data suggest robust colour constancy mechanisms along daylight locus in R-G dichromacy.	[Alvaro, Leticia] Anglia Ruskin Univ, Dept Vis & Hearing Sci, Anglia Vis Res, Cambridge, England; [Alvaro, Leticia; Moreira, Humberto; Lillo, Julio] Univ Complutense Madrid, Fac Psicol, Pozuelo De Alarcon, Spain; [Linhares, Joao M. M.; Nascimento, Sergio M. C.] Univ Minho, Ctr Phys, Braga, Portugal	Anglia Ruskin University; Complutense University of Madrid; Universidade do Minho	Alvaro, L (corresponding author), Anglia Ruskin Univ, Dept Vis & Hearing Sci, Anglia Vis Res, Cambridge, England.; Alvaro, L (corresponding author), Univ Complutense Madrid, Fac Psicol, Pozuelo De Alarcon, Spain.	lalvaro@ucm.es	Linhares, João/M-7020-2013; Álvaro, Leticia/CAF-7974-2022; Álvaro, Leticia/S-3474-2019	Linhares, João/0000-0001-9197-5134; Álvaro, Leticia/0000-0003-2065-7491; Nascimento, Sergio/0000-0002-2503-9003	FEDER through the COMPETE Program; Portuguese Foundation for Science and Technology (FCT) [PTDC/MHC-PCN/4731/2012]; Ministerio de Cienciay Competitividad in the framework of the project [PSI2012-37778]; Beca Santander [JPI2014]; Anglia Ruskin Open Access Fund; Fundação para a Ciência e a Tecnologia [PTDC/MHC-PCN/4731/2012] Funding Source: FCT	FEDER through the COMPETE Program; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Ministerio de Cienciay Competitividad in the framework of the project; Beca Santander; Anglia Ruskin Open Access Fund; Fundação para a Ciência e a Tecnologia	This work was supported by FEDER through the COMPETE Program and by the Portuguese Foundation for Science and Technology (FCT) in the frame work of the project PTDC/MHC-PCN/4731/2012 and by Ministerio de Cienciay Competitividad in the framework of the project PSI2012-37778. LA was supported by Beca Santander JPI2014. The publication of this article was funded by the Anglia Ruskin Open Access Fund	Aldaba MA, 2006, VISUAL NEUROSCI, V23, P555, DOI 10.1017/S0952523806233467; [Anonymous], 1794, COMMUNICATION; Aston S, 2016, PERCEPTION, V45, P207; Baraas RC, 2004, VISUAL NEUROSCI, V21, P347, DOI 10.1017/S0952523804213451; Baraas RC, 2010, INVEST OPHTH VIS SCI, V51, P2286, DOI 10.1167/iovs.09-4576; Barbur J, 2009, DOTFAAAM0911 OFF AER, P20591; Bonnardel V, 2000, J OPT SOC AM A, V17, P677, DOI 10.1364/JOSAA.17.000677; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Farnsworth D., 1957, FARNSWORTH MUNSELL 1; Foster DH, 2006, J OPT SOC AM A, V23, P2359, DOI 10.1364/JOSAA.23.002359; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; HUNT DM, 1995, SCIENCE, V267, P984, DOI 10.1126/science.7863342; Ishihara M. D., 1996, ISHIHARAS TESTS COLO; JAMESON D, 1978, SENS PROCESS, V2, P146; JORDAN G, 1993, NATURE, V363, P546, DOI 10.1038/363546a0; JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031; Konstantakopoulou E, 2012, J VISION, V12, DOI 10.1167/12.2.11; Linhares JMM, 2008, VISUAL NEUROSCI, V25, P493, DOI 10.1017/S0952523808080620; Linhares JMM, 2016, J OPT SOC AM A, V33, pA178, DOI 10.1364/JOSAA.33.00A178; Liu HX, 2013, J OPT SOC AM A, V30, P616, DOI 10.1364/JOSAA.30.000616; Ma RQ, 2016, J OPT SOC AM A, V33, pA283, DOI 10.1364/JOSAA.33.00A283; Pearce B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087989; Perales E, 2010, J OPT SOC AM A, V27, P2106, DOI 10.1364/JOSAA.27.002106; Radonjic A, 2016, J VISION, V16, DOI 10.1167/16.11.2; Regan JD., 2000, CAMBRIDGE COLOUR TES; Ripamonti C, 2014, INVEST OPHTH VIS SCI, V55; Ruttiger L, 2001, COLOR RES APPL, V26, pS209, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL44>3.0.CO;2-D; Sharpe L.T., 1999, COLOR VISION GENES P, P3; Wachtler T, 2004, VISION RES, V44, P2843, DOI 10.1016/j.visres.2004.06.016; Weiss D, 2016, PERCEPTION, V45, P214; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; Zychaluk K, 2009, ATTEN PERCEPT PSYCHO, V71, P1414, DOI 10.3758/APP.71.6.1414	32	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180310	10.1371/journal.pone.0180310	http://dx.doi.org/10.1371/journal.pone.0180310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662218	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300140
J	Kanamori, H; Nakade, Y; Yamauchi, T; Sakamoto, K; Inoue, T; Yamamoto, T; Kobayashi, Y; Ishii, N; Ohashi, T; Ito, K; Sumida, Y; Nakao, H; Fukuzawa, Y; Yoneda, M				Kanamori, Hiroyuki; Nakade, Yukiomi; Yamauchi, Taeko; Sakamoto, Kazumasa; Inoue, Tadahisa; Yamamoto, Takaya; Kobayashi, Yuji; Ishii, Norimitsu; Ohashi, Tomohiko; Ito, Kiyoaki; Sumida, Yoshio; Nakao, Haruhisa; Fukuzawa, Yoshitaka; Yoneda, Masashi			Influence of nicotine on choline-deficient, L amino acid-defined diet-induced non-alcoholic steatohepatitis in rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HEPATIC STEATOSIS; INSULIN-RESISTANCE; BODY-WEIGHT; EXPRESSION; OBESITY; MICE; CONSUMPTION; PROTEIN-1; APOPTOSIS	Nicotine, a major compound in cigarette smoke, decreases food intake and body weight gain in mammals; however, the influence of nicotine on the progression of non-alcoholic steatohepatitis (NASH) remains controversial. This study aimed to investigate the effect of nicotine on NASH in rat models. Male Wistar rats were fed choline-deficient, L-amino acid defined (CDAA) diet and treated with nicotine or saline. Food intake, body weight gain, presence of hepatic steatosis, inflammation, and fibrosis were assessed 6 weeks after the rats were fed CDAA diet. Hepatic branch vagotomy was performed to elucidate the mechanism through which nicotine affected steatohepatitis. CDAA diet induced hepatic steatosis, inflammation, and fibrosis, as well as increased the expression of inflammation-related genes. Conversely, nicotine significantly attenuated food intake, body weight gain, and inhibited the CDAA-diet-induced hepatic steatosis, inflammation, and fibrosis, together with increased expression of inflammation-related genes. Hepatic branch vagotomy by itself decreased food intake, body weight gain, and attenuated the CDAA-diet-induced hepatic steatosis, but not inflammation. However, nicotine did not change the food intake, body weight gain, and CDAA diet-induced hepatic steatosis and inflammation in vagotomized rats. These results suggest that nicotine attenuates the CDAA-diet-induced hepatic steatosis and inflammation through the hepatic branch of the vagus nerve in rats.	[Kanamori, Hiroyuki; Nakade, Yukiomi; Yamauchi, Taeko; Sakamoto, Kazumasa; Inoue, Tadahisa; Yamamoto, Takaya; Kobayashi, Yuji; Ishii, Norimitsu; Ohashi, Tomohiko; Ito, Kiyoaki; Sumida, Yoshio; Nakao, Haruhisa; Fukuzawa, Yoshitaka; Yoneda, Masashi] Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan	Aichi Medical University	Nakade, Y (corresponding author), Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan.	ynakade@aichi-med-u.ac.jp	Inoue, Tadahisa/AFK-7576-2022; Sumida, Yoshio/AAL-6723-2020	Inoue, Tadahisa/0000-0003-0718-9099; 	Smoking Research Foundation (Japan); Program for the Strategic Research Foundation at Private Universities [S1101027]	Smoking Research Foundation (Japan); Program for the Strategic Research Foundation at Private Universities	This work was supported by the Smoking Research Foundation (Japan), and by the Program for the Strategic Research Foundation at Private Universities (S1101027) to MY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2001, AM J PHYSIOL-ENDOC M, V280, pE867, DOI 10.1152/ajpendo.2001.280.6.E867; BARTER PJ, 1973, METABOLISM, V22, P779, DOI 10.1016/0026-0495(73)90048-6; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Friedman TC, 2012, ENDOCRINOLOGY, V153, P5809, DOI 10.1210/en.2012-1750; GHOSHAL AK, 1983, AM J PATHOL, V113, P309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GRUNBERG NE, 1984, PSYCHOPHARMACOLOGY, V83, P93, DOI 10.1007/BF00427430; Hashimoto T, 2004, TOXICOL APPL PHARM, V196, P1, DOI 10.1016/j.taap.2003.09.004; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; LEVIN ED, 1987, PHYSIOL BEHAV, V39, P441, DOI 10.1016/0031-9384(87)90370-2; Liu RH, 2003, EUR J PHARMACOL, V458, P227, DOI 10.1016/S0014-2999(02)02726-7; Mangubat M, 2012, J ENDOCRINOL, V212, P317, DOI 10.1530/JOE-11-0350; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; Nakae D, 1999, PATHOL INT, V49, P1028, DOI 10.1046/j.1440-1827.1999.00990.x; Namikawa C, 2004, J HEPATOL, V40, P781, DOI 10.1016/j.jhep.2004.01.028; NIIJIMA A, 1983, AM J PHYSIOL, V244, pR611, DOI 10.1152/ajpregu.1983.244.5.R611; Niijima A, 2001, AUTON NEUROSCI-BASIC, V93, P48, DOI 10.1016/S1566-0702(01)00328-9; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; PULFORD KAF, 1990, INT IMMUNOL, V2, P973, DOI 10.1093/intimm/2.10.973; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Seoane-Collazo P, 2014, ENDOCRINOLOGY, V155, P1679, DOI 10.1210/en.2013-1839; Tamaki Y, 2013, J GASTROENTEROL, V48, P491, DOI 10.1007/s00535-012-0651-7; Uslusoy HS, 2009, WORLD J GASTROENTERO, V15, P1863, DOI 10.3748/wjg.15.1863; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wasada T, 2008, METABOLISM, V57, P980, DOI 10.1016/j.metabol.2008.02.015; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yoneda M, 2001, J GASTROENTEROL, V36, P361, DOI 10.1007/s005350170079; YUEN ST, 1995, PHARMACOL TOXICOL, V77, P225, DOI 10.1111/j.1600-0773.1995.tb01017.x	34	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180475	10.1371/journal.pone.0180475	http://dx.doi.org/10.1371/journal.pone.0180475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662136	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300160
J	Wasenius, NS; Grattan, KP; Harvey, ALJ; Barrowman, N; Goldfield, GS; Adamo, KB				Wasenius, Niko S.; Grattan, Kimberly P.; Harvey, Alysha L. J.; Barrowman, Nick; Goldfield, Gary S.; Adamo, Kristi B.			Maternal gestational weight gain and objectively measured physical activity among offspring	PLOS ONE			English	Article							BODY-MASS INDEX; SEDENTARY BEHAVIOR; BIRTH-WEIGHT; INSULIN-RESISTANCE; DIET QUALITY; PREGNANCY; OBESITY; CHILDREN; LEPTIN; LIFE	Objective Animal studies have suggested that maternal weight-related factors during pregnancy can program offspring physical activity in a sex-dependent manner. However, there is limited evidence in humans. The purpose of this study was to investigate the association between maternal gestational weight gain (GWG) and offspring total physical activity (TPA) level and to determine whether these associations are moderated by sex of offspring or maternal pre-pregnancy weight status. Method We studied 56 boys (mean age = 3.7 years, standard deviation (SD) 0.5) and 57 girls (mean age = 3.5 +/- 0.5 years) enrolled in licensed childcare centers. TPA was objectively measured using Actical (R) accelerometers. Information on pre-pregnancy body mass index (BMI), GWG, and other maternal factors were collected with a maternal health questionnaire. Associations between GWG, as a continuous variable or categorically (inadequate, adequate, and excessive), and offspring TPA were analysed using linear mixed models to take into account the intraclass correlation between the clusters (childcare centers). Models were adjusted for gestational age, accelerometer weartime, socioeconomic status, and pre-pregnancy BMI status. Results We found a significant sex interaction (P-value = 0.009). In boys, greater GWG was associated with decreased offspring TPA (beta = -3.2 counts.1000(-1)/d, 95% confidence intervals (CI) = -6.4-0.02, P-value = 0.049). In girls born to mothers categorized as overweight or obese, the association between the GWG and TPA followed an inverted U-shape curve (beta for GWG squared = -0.1 counts.1000(-1)/d, 95% CI = (-0.2 --0.04), P-value = 0.005). In contrast, a U-shaped curve was found in girls born to mothers classified as lean (pre-pregnancy BMI<25 kg/m(2)) (beta for GWG squared = 0.7 counts.1000(-1)/d, 95% CI = 0.2-1.2, P-value = 0.011). In boys, TPA in offspring was higher among women with inadequate GWG compared to adequate GWG (P-value = 0.0137), whereas no significant differences were found in girls (P-value = 0.107). Conclusion Maternal GWG can be an important biological marker of offspring TPA. These findings support the sex-dependent early developmental programming influence of GWG on TPA.	[Wasenius, Niko S.; Grattan, Kimberly P.; Harvey, Alysha L. J.; Adamo, Kristi B.] Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada; [Wasenius, Niko S.] Folkhalsan Res Ctr, Helsinki, Finland; [Barrowman, Nick] CHEO RI, Clin Res Unit, Ottawa, ON, Canada; [Goldfield, Gary S.; Adamo, Kristi B.] Hlth Act Living & Obes HALO Res Grp, Ottawa, ON, Canada	University of Ottawa; Folkhalsan Research Center; University of Ottawa; Children's Hospital of Eastern Ontario	Adamo, KB (corresponding author), Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada.; Adamo, KB (corresponding author), Hlth Act Living & Obes HALO Res Grp, Ottawa, ON, Canada.	kadamo@uottawa.ca	Wasenius, Niko/AAE-8927-2020; Barrowman, Nick/AAL-3166-2020	Wasenius, Niko/0000-0002-9007-6660; Barrowman, Nick/0000-0002-4704-9595; Adamo, Kristi/0000-0001-7925-1889; Goldfield, Gary/0000-0001-6216-7824	Canadian Institutes of Health Research [CIHR-MOP123326]; Yrjo Jahnsson Foundation; Institute of Human Development, Child and Youth Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Yrjo Jahnsson Foundation; Institute of Human Development, Child and Youth Health(Canadian Institutes of Health Research (CIHR))	This study was financially supported by the Canadian Institutes of Health Research (CIHR-MOP123326) (http://www.cihr-irsc.gc.ca/e/193. html). Dr. Wasenius was supported as a postdoctoral fellow by the Yrjo Jahnsson Foundation (http://www.yjs.fi/en/) and Dr.Adamo was supported by a CIHR New Investigator Award from the Institute of Human Development, Child and Youth Health (http://www.cihr-irsc.gc.ca/e/ 8688.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adamo KB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-305; AL Rayyan N, 2014, MOL CELL ENDOCRINOL, V384, P134, DOI 10.1016/j.mce.2014.01.017; Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Bacchi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166254; Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012; Baker MS, 2015, INT J OBESITY, V39, P98, DOI 10.1038/ijo.2013.146; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Biro F M, 1999, J Pediatr Adolesc Gynecol, V12, P31, DOI 10.1016/S1083-3188(00)86618-8; Breton C, 2013, J ENDOCRINOL, V216, pR19, DOI 10.1530/JOE-12-0157; Brett KE, 2016, J MATERN-FETAL NEO M, V29, P1399, DOI 10.3109/14767058.2015.1049522; Canadian Society for Exercise Physiology, 2013, CAN SOC EX PHYSL PHY; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Colley R., 2012, ACTICAL ACCELEROMETE; Colley R. C., 2011, HLTH REPORTS, V22, P15, DOI DOI 10.1016/j.yspm.2011.03.006; Colley RC, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-54; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; Diemert A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1012-y; Du M, 2010, BIOL REPROD, V82, P4, DOI 10.1095/biolreprod.109.077099; Eclarinal JD, 2016, FASEB J, V30, P2541, DOI 10.1096/fj.201500018R; Eriksson JG, 2014, ANN MED, V46, P434, DOI 10.3109/07853890.2014.919728; Ferraro ZM, 2012, J MATERN-FETAL NEO M, V25, P538, DOI 10.3109/14767058.2011.638953; Forno E, 2014, PEDIATRICS, V134, pE535, DOI 10.1542/peds.2014-0439; Garland T, 2017, PHYSIOL BIOCHEM ZOOL, V90, P1, DOI 10.1086/689775; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Gohlke BC, 2006, J PEDIATR ENDOCR MET, V19, P3; Goldfield GS, 2016, AM J PREV MED, V51, P225, DOI 10.1016/j.amepre.2016.03.024; Good DJ, 2015, EXERC SPORT SCI REV, V43, P231, DOI 10.1249/JES.0000000000000057; Guinhouya BC, 2011, INT J PEDIATR OBES, V6, P361, DOI 10.3109/17477166.2011.605896; Hrolfsdottir L, 2015, INT J OBESITY, V39, P671, DOI 10.1038/ijo.2014.179; Institute of Medicine, 2009, COMMITTEE REEXAMINE; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Johnson SA, 2017, J DEV ORIG HLTH DIS, V8, P75, DOI 10.1017/S2040174416000490; Kehoe SH, 2012, J DEV ORIG HLTH DIS, V3, P245, DOI 10.1017/S2040174412000189; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kuzik N, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0642-6; Lagiou P, 2004, EUR J CLIN NUTR, V58, P231, DOI 10.1038/sj.ejcn.1601771; Laraia BA, 2007, PUBLIC HEALTH NUTR, V10, P920, DOI 10.1017/S1368980007657991; Lesseur C, 2014, PSYCHONEUROENDOCRINO, V40, P1, DOI 10.1016/j.psyneuen.2013.10.012; Logan CA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41847; Mamun AA, 2014, OBES REV, V15, P338, DOI 10.1111/obr.12132; Mattocks C, 2008, BMJ-BRIT MED J, V336, P26, DOI 10.1136/bmj.39385.443565.BE; McClure CK, 2011, OBESITY, V19, P1047, DOI 10.1038/oby.2010.300; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Plagemann A, 2008, J MATERN-FETAL NEO M, V21, P143, DOI 10.1080/14767050801929869; Ridgway CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016125; Shin D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030162; Tikanmaki M, 2017, PEDIAT RES; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Tremblay Mark, 2007, Health Rep, V18 Suppl, P7; Tremblay MS, 2012, APPL PHYSIOL NUTR ME, V37, P357, DOI [10.1139/h2012-026, 10.1139/H2012-026, 10.1139/H2012-018, 10.1139/h2012-018]; Tsigga M, 2011, PUBLIC HEALTH NUTR, V14, P290, DOI 10.1017/S1368980010001989; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Wang H, 2015, J NEUROENDOCRINOL, V27, P600, DOI 10.1111/jne.12281; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	57	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180249	10.1371/journal.pone.0180249	http://dx.doi.org/10.1371/journal.pone.0180249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662129	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300131
J	Layous, K; Sweeny, K; Armenta, C; Na, S; Choi, I; Lyubomirsky, S				Layous, Kristin; Sweeny, Kate; Armenta, Christina; Na, Soojung; Choi, Incheol; Lyubomirsky, Sonja			The proximal experience of gratitude	PLOS ONE			English	Article							POSITIVE PSYCHOLOGY; SOCIAL SUPPORT; RELATIONSHIP MAINTENANCE; PURSUING HAPPINESS; COUNTING BLESSINGS; INTERVENTION; EMOTIONS; CULTURE; PEOPLE; APPRECIATION	Although a great deal of research has tested the longitudinal effects of regularly practicing gratitude, much less attention has been paid to the emotional landscape directly following engagement in gratitude exercises. In three studies, we explored the array of discrete emotions people experience after being prompted to express or recall gratitude. In Studies 1 and 2, two different gratitude exercises produced not only greater feelings of gratitude relative to two positive emotion control conditions (i.e., recalling relief), but also higher levels of other socially relevant states like elevation, connectedness, and indebtedness. In a third study, conducted in both the U.S. and S. Korea, we compared a gratitude exercise to another positive emotion elicitation (i.e., recalling a kind act) and to a neutral task, and again found that the gratitude exercise prompted greater gratitude, elevation, indebtedness, and guilt, but no more embarrassment or shame, than the two comparison conditions. Additionally, in all three studies, emodiversity and cluster analyses revealed that gratitude exercises led to the simultaneous experience of both pleasant and unpleasant socially-relevant states. In sum, although it may seem obvious that gratitude exercises would evoke grateful, positive states, a meta-analysis of our three studies revealed that gratitude exercises actually elicit a mixed emotional experience D one that simultaneously leads individuals to feel uplifted and indebted.	[Layous, Kristin] Calif State Univ Hayward, Dept Psychol, Hayward, CA 94542 USA; [Sweeny, Kate; Armenta, Christina; Lyubomirsky, Sonja] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Na, Soojung; Choi, Incheol] Seoul Natl Univ, Dept Psychol, Seoul, South Korea	California State University System; California State University East Bay; University of California System; University of California Riverside; Seoul National University (SNU)	Layous, K (corresponding author), Calif State Univ Hayward, Dept Psychol, Hayward, CA 94542 USA.	kristin.layous@csueastbay.edu		Layous, Kristin/0000-0003-0524-2802				Adler MG, 2005, J PERS, V73, P79, DOI 10.1111/j.1467-6494.2004.00305.x; Algoe SB, 2008, EMOTION, V8, P425, DOI 10.1037/1528-3542.8.3.425; Algoe SB, 2013, EMOTION, V13, P605, DOI 10.1037/a0032701; Algoe SB, 2010, PERS RELATIONSHIP, V17, P217, DOI 10.1111/j.1475-6811.2010.01273.x; Algoe SB, 2009, J POSIT PSYCHOL, V4, P105, DOI 10.1080/17439760802650519; Bartlett MY, 2012, COGNITION EMOTION, V26, P2, DOI 10.1080/02699931.2011.561297; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Bolger N, 2000, J PERS SOC PSYCHOL, V79, P953, DOI 10.1037//0022-3514.79.6.953; Champely S., 2020, PWR BASIC FUNCTIONS; CIALDINI RB, 1990, PSYCHOL BULL, V107, P210, DOI 10.1037/0033-2909.107.2.210; Davis DE, 2016, J COUNS PSYCHOL, V63, P20, DOI 10.1037/cou0000107; Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377; Emmons RA, 2000, J SOC CLIN PSYCHOL, V19, P56, DOI 10.1521/jscp.2000.19.1.56; Emmons RA., 2011, DESIGNING POSITIVE P, P248, DOI [10.1093/acprof:oso/9780195373585.003.0016, DOI 10.1093/ACPROF:OSO/9780195373585.003.0016]; Emmons RA, 2013, J CLIN PSYCHOL, V69, P846, DOI 10.1002/jclp.22020; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FISHER JD, 1982, PSYCHOL BULL, V91, P27, DOI 10.1037/0033-2909.91.1.27; Fredrickson BL, 2013, ADV EXP SOC PSYCHOL, V47, P1, DOI 10.1016/B978-0-12-407236-7.00001-2; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Froh JJ, 2008, J SCHOOL PSYCHOL, V46, P213, DOI 10.1016/j.jsp.2007.03.005; Froh JJ, 2014, SCHOOL PSYCHOL REV, V43, P132; Froh JJ, 2009, J POSIT PSYCHOL, V4, P408, DOI 10.1080/17439760902992464; Froh JJ, 2009, J ADOLESCENCE, V32, P633, DOI 10.1016/j.adolescence.2008.06.006; Furukawa E, 2012, SELF IDENTITY, V11, P90, DOI 10.1080/15298868.2010.512748; Goei R, 2005, COMMUN MONOGR, V72, P284, DOI 10.1080/03637750500206524; Gordon AM, 2012, J PERS SOC PSYCHOL, V103, P257, DOI 10.1037/a0028723; GREENBERG MS, 1971, SOCIOMETRY, V34, P290, DOI 10.2307/2786418; Grossman I, 2015, J PERS SOC PSYCHOL; Haidt J, 2003, FLOURISHING: POSITIVE PSYCHOLOGY AND THE LIFE WELL-LIVED, P275, DOI 10.1037/10594-012; Harbaugh CN, 2014, J POSIT PSYCHOL, V9, P535, DOI 10.1080/17439760.2014.927905; Hareli S, 2008, J THEOR SOC BEHAV, V38, P131, DOI 10.1111/j.1468-5914.2008.00363.x; Harpman E. J., 2004, PSYCHOL GRATITUDE, P19; Kaczmarek LD, 2015, PERS INDIV DIFFER, V75, P1, DOI 10.1016/j.paid.2014.11.004; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kerr SL, 2015, J HAPPINESS STUD, V16, P17, DOI 10.1007/s10902-013-9492-1; Kim HS, 2006, PERS SOC PSYCHOL B, V32, P1595, DOI 10.1177/0146167206291991; Kitayama S, 2000, COGNITION EMOTION, V14, P93, DOI 10.1080/026999300379003; Lambert NM, 2012, COGNITION EMOTION, V26, P615, DOI 10.1080/02699931.2011.595393; Lambert NM, 2011, EMOTION, V11, P52, DOI 10.1037/a0021557; Lambert NM, 2010, PSYCHOL SCI, V21, P574, DOI 10.1177/0956797610364003; Lambert NM, 2009, PERS SOC PSYCHOL B, V35, P1193, DOI 10.1177/0146167209338071; Layous K, 2014, J ABNORM PSYCHOL, V123, P3, DOI 10.1037/a0034709; Layous K, 2013, J CROSS CULT PSYCHOL, V44, P1294, DOI 10.1177/0022022113487591; Layous K, 2011, J ALTERN COMPLEM MED, V17, P675, DOI 10.1089/acm.2011.0139; Lench HC, 2011, PSYCHOL BULL, V137, P834, DOI 10.1037/a0024244; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Lyubomirsky S, 2011, EMOTION, V11, P391, DOI 10.1037/a0022575; Mathews MA, 2013, J RES PERS, V47, P191, DOI 10.1016/j.jrp.2013.01.001; Mathews MA, 2010, COGNITION EMOTION, V24, P710, DOI 10.1080/02699930802650796; McCullough ME, 2001, PSYCHOL BULL, V127, P249, DOI 10.1037//0033-2909.127.2.249; McCullough ME, 2002, J PERS SOC PSYCHOL, V82, P112, DOI 10.1037//0022-3514.82.1.112; Nolen-Hoeksema S, 2011, PERSPECT PSYCHOL SCI, V6, P589, DOI 10.1177/1745691611419672; Norcross J C, 1988, J Subst Abuse, V1, P127; Oishi S, 2007, PERSPECT PSYCHOL SCI, V2, P346, DOI 10.1111/j.1745-6916.2007.00048.x; Parks AC, 2012, EMOTION, V12, P1222, DOI 10.1037/a0028587; Quoidbach J, 2014, J EXP PSYCHOL GEN, V143, P2057, DOI 10.1037/a0038025; Rash JA, 2011, APPL PSYCHOL-HLTH WE, V3, P350, DOI 10.1111/j.1758-0854.2011.01058.x; Rosenthal R, 1991, METAANALYTIC PROCEDU; Rosenthal R., 2008, ESSENTIALS BEHAV RES; Rosenthal R., 2000, CONTRASTS EFFECT SIZ; Sauter D, 2010, CURR DIR PSYCHOL SCI, V19, P36, DOI 10.1177/0963721409359290; Schnall S, 2010, PSYCHOL SCI, V21, P315, DOI 10.1177/0956797609359882; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Sergeant S, 2011, J POSIT PSYCHOL, V6, P260, DOI 10.1080/17439760.2011.577089; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061; Sheldon K. M, 2006, J POSIT PSYCHOL, V1, P73, DOI DOI 10.1080/17439760500510676; Sheldon KM, 2012, MOTIV EMOTION, V36, P439, DOI 10.1007/s11031-012-9279-4; Shen H, 2011, J PERS SOC PSYCHOL, V100, P271, DOI 10.1037/a0021201; Sin NL, 2011, S APPL PSYC, P79; Sweeny K, 2012, PSYCHOL SCI, V23, P464, DOI 10.1177/0956797611434590; Taylor SE, 2004, J PERS SOC PSYCHOL, V87, P354, DOI 10.1037/0022-3514.87.3.354; Toepfer SM, 2009, J WRIT RES, V1, P181, DOI 10.17239/jowr-2009.01.03.1; Toepfer SM, 2012, J HAPPINESS STUD, V13, P187, DOI 10.1007/s10902-011-9257-7; Tsang JA, 2006, COGNITION EMOTION, V20, P138, DOI 10.1080/02699930500172341; Tsang JA, 2006, MOTIV EMOTION, V30, P199, DOI 10.1007/s11031-006-9031-z; Tsang Jo-Ann, 2007, J POSITIVE PSYCH, V2, P157, DOI DOI 10.1080/17439760701229019; Uchida Y, 2009, EMOTION, V9, P441, DOI 10.1037/a0015634; Watkins PC, 2006, COGNITION EMOTION, V20, P217, DOI 10.1080/02699930500172291; Watkins PC, 2003, SOC BEHAV PERSONAL, V31, P431, DOI 10.2224/sbp.2003.31.5.431; Watkins PC, 2015, J POSIT PSYCHOL, V10, P91, DOI 10.1080/17439760.2014.927909; Wing RR, 1999, J CONSULT CLIN PSYCH, V67, P132, DOI 10.1037/0022-006X.67.1.132; Wood AM, 2008, J RES PERS, V42, P854, DOI 10.1016/j.jrp.2007.11.003; Wood AM, 2008, PERS INDIV DIFFER, V44, P621, DOI 10.1016/j.paid.2007.09.028; Wood AM, 2010, CLIN PSYCHOL REV, V30, P890, DOI 10.1016/j.cpr.2010.03.005	86	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179123	10.1371/journal.pone.0179123	http://dx.doi.org/10.1371/journal.pone.0179123			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686593	Green Published, gold			2022-12-27	WOS:000405464100010
J	Belfry, KD; Trueman, C; Vyn, RJ; Loewen, SA; Van Eerd, LL				Belfry, Kimberly D.; Trueman, Cheryl; Vyn, Richard J.; Loewen, Steven A.; Van Eerd, Laura L.			Winter cover crops on processing tomato yield, quality, pest pressure, nitrogen availability, and profit margins	PLOS ONE			English	Article							SWEET CORN YIELD; SOIL; FERTILIZATION; TILLAGE; GROWTH; CARBON; ACCUMULATION; ATTRIBUTES; MANAGEMENT; DISEASE	Much of cover crop research to date focuses on key indicators of impact without considering the implications over multiple years, in the absence of a systems-based approach. To evaluate the effect of three years of autumn cover crops on subsequent processing tomato (Solanum lycopersicum L.) production in 2010 and 2011, a field split-split-plot factorial design trial with effects of cover crop type, urea ammonium nitrate fertilizer rate (0 or 140 kg N ha(-1) pre-plant broadcast incorporated) and tomato cultivar (early vs. late) was conducted. The main plot factor, cover crop, included a no cover crop control, oat (Avena sativa L.), winter cereal rye (hereafter referred to as rye) (Secale cereale L.), oilseed radish (OSR) (Raphanus sativus L. var. oleiferus Metzg Stokes), and mix of OSR and rye (OSR + rye) treatments. Cover crop biomass of 0.5 to 2.8 and 1.7 to 3.1 Mg ha-1 was attained in early Oct. and the following early May, respectively. In general, OSR increased soil mineral N during cover crop growth and into the succeeding summer tomato growing season, while the remaining cover crops did not differ from the no cover crop control. The lack of a cover crop by N rate interaction in soil and plant N analyses at harvest suggests that growers may not need to modify N fertilizer rates to tomatoes based on cover crop type. Processing tomato fruit quality at harvest (rots, insect or disease damage, Agtron colour, pH, or natural tomato soluble solids (NTSS)) was not affected by cover crop type. In both years, marketable yield in the no cover crop treatment was lower or not statistically different than all planted cover crops. Partial profit margins over both years were 1320 $ ha(-1) higher with OSR and $ 960 higher with oat compared to the no cover crop control. Thus, results from a systems-based approach suggest that the cover crops tested had no observed negative impact on processing tomato production and have the potential to increase marketable yield and profit margins.	[Belfry, Kimberly D.; Trueman, Cheryl; Loewen, Steven A.] Univ Guelph Ridgetown Campus, Ridgetown, ON, Canada; [Vyn, Richard J.] Univ Guelph Ridgetown Campus, Dept Food Agr & Resource Econ, Ridgetown, ON, Canada; [Van Eerd, Laura L.] Univ Guelph Ridgetown Campus, Sch Environm Sci, Ridgetown, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Van Eerd, LL (corresponding author), Univ Guelph Ridgetown Campus, Sch Environm Sci, Ridgetown, ON, Canada.	Ivaneerd@uoguelph.ca			Ontario Tomato Research Institute (OTRI); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) through the OMAFRA-University of Guelph; Conagra Foods Canada Inc	Ontario Tomato Research Institute (OTRI); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) through the OMAFRA-University of Guelph; Conagra Foods Canada Inc	The authors grate fully acknowledgethe contributions of J.Leboeuf, M.Zink, P.May, R.Wright, J.Newport, B.Eagen. LVE, CT and SAL received funding from Ontario Tomato Research Institute (OTRI). LVE received funding from Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) through the OMAFRA-University of Guelph Partnership. Conagra Foods Canada Inc.	[Anonymous], OPVG INF HDB, P84; Baysal F, 2009, ACTA HORTIC, V808, P117, DOI 10.17660/ActaHortic.2009.808.16; Bjorkman T, 2013, HORTTECHNOLOGY, V23, P575, DOI 10.21273/HORTTECH.23.5.575; Blanco-Canqui H, 2015, AGRON J, V107, P2449, DOI 10.2134/agronj15.0086; Bowley SR, 2008, HITCHHIKERS GUIDE ST, P97; BrandiDohrn FM, 1997, J ENVIRON QUAL, V26, P181, DOI 10.2134/jeq1997.00472425002600010026x; Carrera LM, 2007, APPL SOIL ECOL, V37, P247, DOI 10.1016/j.apsoil.2007.08.003; Creamer NG, 1996, J AM SOC HORTIC SCI, V121, P559, DOI 10.21273/JASHS.121.3.559; Dabney SM, 2001, COMMUN SOIL SCI PLAN, V32, P1221, DOI 10.1081/CSS-100104110; Ding GW, 2006, GEODERMA, V130, P229, DOI 10.1016/j.geoderma.2005.01.019; Feyereisen GW, 2006, AGRON J, V98, P1416, DOI 10.2134/agronj2005.0134; Galvao AG, 2013, HORTIC BRAS, V31, P68, DOI 10.1590/S0102-05362013000100011; Garcia E, 2006, J FOOD PROCESS PRES, V30, P20, DOI 10.1111/j.1745-4549.2005.00044.x; Gleason ML, 2014, COMPENDIUM TOMATO DI, P50; Gould W.A., 1992, TOMATO PRODUCTION PR, V3rd, P201; HARCOURT D. G., 1963, CANADIAN ENTOMOL, V95, P813; Hartz TK, 2005, HORTSCIENCE, V40, P2016, DOI 10.21273/HORTSCI.40.7.2016; Hendershot W. H., 1993, SOIL SAMPLING METHOD, P141; Hermawan B, 1997, SOIL TILL RES, V44, P109, DOI 10.1016/S0167-1987(97)00043-3; Hively WD, 2009, J SOIL WATER CONSERV, V64, P303, DOI 10.2489/jswc.64.5.303; Hu S, 1997, SOIL SCI SOC AM J, V61, P901, DOI 10.2136/sssaj1997.03615995006100030027x; Jones J.P., 2014, COMPENDIUM TOMATO DI, P23; Kaspar TC, 2012, AGR WATER MANAGE, V110, P25, DOI 10.1016/j.agwat.2012.03.010; Lenzi A, 2009, RENEW AGR FOOD SYST, V24, P92, DOI 10.1017/S1742170508002445; Loewen SA, 2007, ANN REPORT ONTARIO P; Lu YC, 2000, FOOD REV INT, V16, P121, DOI 10.1081/FRI-100100285; Maynard D, 1993, SOIL SAMPLING METHOD, P71; McKeown AW, 1998, CAN J PLANT SCI, V78, P341, DOI 10.4141/P97-090; MILLER MH, 1994, J ENVIRON QUAL, V23, P267, DOI 10.2134/jeq1994.00472425002300020007x; MILLER STEVEN P., 2014, COMPENDIUM TOMATO DI, P54; O'Reilly KA, 2012, CAN J SOIL SCI, V92, P353, DOI 10.4141/CJSS2011-065; O'Reilly KA, 2011, WEED TECHNOL, V25, P374, DOI 10.1614/WT-D-10-00051.1; OMAFRA, 2014, VEG CROP PROT GUID; OMAFRA, 2009, USITC PUBL, V363; Ouellette L, 2016, SOIL SCI SOC AM J, V80, P284, DOI 10.2136/sssaj2015.10.0371; PATRICK W. H. JR, 1957, Soil Science Society of America. Proceedings, V21, P366; Ranells NN, 1996, AGRON J, V88, P777, DOI 10.2134/agronj1996.00021962008800050015x; Rutherford P.M., 2008, SOIL SAMPLING METHOD, P239; Sainju UM, 2001, SCI HORTIC-AMSTERDAM, V91, P201, DOI 10.1016/S0304-4238(01)00264-3; Sainju UM, 2002, SOIL TILL RES, V63, P167, DOI 10.1016/S0167-1987(01)00244-6; Schomberg HH, 2006, BIOL FERT SOILS, V42, P299, DOI 10.1007/s00374-005-0027-8; Seliga JP, 1995, SCI HORTIC-AMSTERDAM, V64, P159, DOI 10.1016/0304-4238(95)00837-3; Snapp SS, 2005, AGRON J, V97, P322; Statistics Canada, 2012, FRUIT VEG PROD; Sterrett SB, 2005, HORTSCIENCE, V40, P602, DOI 10.21273/HORTSCI.40.3.602; Stevenson WR, 2014, COMPENDIUM TOMATO DI, P16; Stivers-Young L, 1998, HORTSCIENCE, V33, P60; Summers CF, 2014, APPL SOIL ECOL, V77, P51, DOI 10.1016/j.apsoil.2014.01.010; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; Tomatoes Mailvaganam S., 1979, HORTICULTURAL CROPS; USDA Natural Resources Conservation Service, 2011, CARB NITR RAT CROPP; Vyn TJ, 2000, AGRON J, V92, P915, DOI 10.2134/agronj2000.925915x; Vyn TJ, 1999, AGRON J, V91, P17, DOI 10.2134/agronj1999.00021962009100010004x; Wagger MG, 1998, J SOIL WATER CONSERV, V53, P214; Wang QR, 2005, HORTSCIENCE, V40, P2125, DOI 10.21273/HORTSCI.40.7.2125; Weinert TL, 2000, NITROGEN RECYCLING N, V94, P365; Yu L, 2015, CROP PROT, V75, P11, DOI 10.1016/j.cropro.2015.05.005	57	16	16	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180500	10.1371/journal.pone.0180500	http://dx.doi.org/10.1371/journal.pone.0180500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683080	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200041
J	Chang, YC; Ching, YH; Chiu, CC; Liu, JY; Hung, SW; Huang, WC; Huang, YT; Chuang, HL				Chang, Yi-Chih; Ching, Yung-Hao; Chiu, Chien-Chao; Liu, Ju-Yun; Hung, Shao-Wen; Huang, Wen-Ching; Huang, Yen-Te; Chuang, Hsiao-Li			TLR2 and interleukin-1 0 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; COMMENSAL; DISEASE; PATHOGENESIS; EXPRESSION; ATTENUATE; MUCOSA	Background and aims Bacteroides fragilis (BF) are Gram-negative anaerobe symbionts present in the colon. Recent studies have reported the beneficial role of BF in maintaining intestinal homeostasis, stimulating host immunologic development, and preventing infectious colitis caused by pathogenic bacteria. Our previous studies showed that monocolonization of germ-free mice with BFsignificantly reduced colon inflammations and damage. Methods In order to investigate the Toll-like receptor-2 (TLR2), TLR4, and interleukin 10 (IL-10) molecular signaling pathways involved in BF -mediated prevention of dextran sulfate sodium (DSS)-induced colitis. The wild -type (WT), TLR4, TLR2, and IL -10 knockout (-/-) germ -free mice grown were with or without BFcolonization for 28 days, and then administered 1% DSS in drinking water for 7 day to induce acute ulcerative colitis. Results We compared phenotypes such as weight loss, disease activity, intestinal histological scores, and immunohistochemistry for inflammatory cells. Unlike WT and TLR4(-/-) mice, the severity of DSS-colitis did not improve in TLR2(-/-) animals after BFcolonization. The BF enhanced anti-inflammatory cytokines IL -10 expression and inhibited pro -inflammatory related tumor necrosis factor (TNF-alpha) and IL-6 mRNA expression in both WT and TLR4(-/-) mice. In contrast, the failed to up-regulated IL -10 and down -regulated the TNF-a and IL-6 in BFcolonization TLR2-/- mice. In addition, we further perform IL -104- mice to clarify whether the BF through TLR2/IL -10 pathway to alleviate DSS-colitis. There were no significant differences in colitis severity and pro -inflammatory related genes expression in the IL -10-/mice with or without BFcolonization. Conclusions These results indicate the disease-preventing effects of BF in acute DSS-induced colitis may occur through the TLR2/IL-10 signal pathway.	[Chang, Yi-Chih] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Ching, Yung-Hao] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chiu, Chien-Chao; Hung, Shao-Wen] Agr Technol Res Inst, Div Anim Resources, Anim Technol Labs, Hsinchu, Taiwan; [Liu, Ju-Yun; Huang, Yen-Te; Chuang, Hsiao-Li] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan; [Huang, Wen-Ching] Natl Taipei Univ Nursing & Hlth Sci, Dept Exercise & Hlth Sci, Taipei, Taiwan	China Medical University Taiwan; Tzu Chi University; Agricultural Technology Research Institute; National Applied Research Laboratories - Taiwan; National Taipei University of Nursing & Health Science (NTUNHS)	Chuang, HL (corresponding author), Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan.	p650214@nlac.narl.org.tw		Chuang, Hsiao Li/0000-0002-3718-9076	Ministry of Science and Technology of Taiwan [NSC 101-2320-B-492-001-MY3]; National Laboratory Animal Center of Taiwan [104-1-3-1-2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Laboratory Animal Center of Taiwan	This study was supported by a Grant from Ministry of Science and Technology (NSC 101-2320-B-492-001-MY3) of Taiwan and 104-1-3-1-2 from National Laboratory Animal Center of Taiwan. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Baroja ML, 2007, CLIN EXP IMMUNOL, V149, P470, DOI 10.1111/j.1365-2249.2007.03434.x; Basso PJ, 2014, BRAZ J MED BIOL RES, V47, P727, DOI 10.1590/1414-431X20143932; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chiu CC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675786; Dong L, 2012, J GASTROEN HEPATOL, V27, P110, DOI 10.1111/j.1440-1746.2011.06839.x; Fan YJ, 2015, EXP THER MED, V9, P1455, DOI 10.3892/etm.2015.2258; Farrell RJ, 2002, GASTROENTEROL CLIN N, V31, P41, DOI 10.1016/S0889-8553(01)00004-8; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Hakansson A, 2015, CLIN EXP MED, V15, P107, DOI 10.1007/s10238-013-0270-5; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Komatsu M, 2001, CLIN CHEM, V47, P1297; Kumar NSN, 2008, J GASTROEN HEPATOL, V23, P1834, DOI 10.1111/j.1440-1746.2008.05723.x; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Luongo D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-298; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Osman N, 2008, DIGEST DIS SCI, V53, P2464, DOI 10.1007/s10620-007-0174-x; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sales-Campos H, 2015, BRAZ J MED BIOL RES, V48, P96, DOI [10.1590/1414-431X20143774, 10.1590/1414-431x20143774]; Shah R, 2016, GUT MICROBES, V23, P1; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Taghipour Niloofar, 2016, Gastroenterol Hepatol Bed Bench, V9, P45; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Toiyama Y, 2006, SURG TODAY, V36, P287, DOI 10.1007/s00595-005-3144-y; Whittem C.G., 2010, JOVE-J VIS EXP, V35, DOI [10.3791/1652, DOI 10.3791/1652]; Xu XR, 2014, WORLD J GASTROENTERO, V20, P3255, DOI 10.3748/wjg.v20.i12.3255	37	47	49	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180025	10.1371/journal.pone.0180025	http://dx.doi.org/10.1371/journal.pone.0180025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683149	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200017
J	Nacheva, E; Mokretar, K; Soenmez, A; Pittman, AM; Grace, C; Valli, R; Ejaz, A; Vattathil, S; Maserati, E; Houlden, H; Taanman, JW; Schapira, AH; Proukakis, C				Nacheva, Elizabeth; Mokretar, Katya; Soenmez, Aynur; Pittman, Alan M.; Grace, Colin; Valli, Roberto; Ejaz, Ayesha; Vattathil, Selina; Maserati, Emanuela; Houlden, Henry; Taanman, Jan-Willem; Schapira, Anthony H.; Proukakis, Christos			DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation	PLOS ONE			English	Article							HUMAN BRAIN; GENETIC-VARIATION; WAVES; CELL; MOSAICISM; DELETIONS; TISSUES	Potential bias introduced during DNA isolation is inadequately explored, although it could have significant impact on downstream analysis. To investigate this in human brain, we isolated DNA from cerebellum and frontal cortex using spin columns under different conditions, and salting-out. We first analysed DNA using array CGH, which revealed a striking wave pattern suggesting primarily GC-rich cerebellar losses, even against matched frontal cortex DNA, with a similar pattern on a SNP array. The aCGH changes varied with the isolation protocol. Droplet digital PCR of two genes also showed protocol-dependent losses. Whole genome sequencing showed GC-dependent variation in coverage with spin column isolation from cerebellum. We also extracted and sequenced DNA from substantia nigra using salting-out and phenol / chloroform. The mtDNA copy number, assessed by reads mapping to the mitochondrial genome, was higher in substantia nigra when using phenol /chloroform. We thus provide evidence for significant method-dependent bias in DNA isolation from human brain, as reported in rat tissues. This may contribute to array "waves", and could affect copy number determination, particularly if mosaicism is being sought, and sequencing coverage. Variations in isolation protocol may also affect apparent mtDNA abundance.	[Nacheva, Elizabeth; Mokretar, Katya; Grace, Colin] UCL, Acad Haematol, Royal Free Campus, London, England; [Mokretar, Katya; Soenmez, Aynur; Ejaz, Ayesha; Taanman, Jan-Willem; Schapira, Anthony H.; Proukakis, Christos] UCL, Inst Neurol, Clin Neurosci, London, England; [Pittman, Alan M.; Houlden, Henry] UCL, Inst Neurol, Mol Neurosci, London, England; [Valli, Roberto; Maserati, Emanuela] Univ Insubria, Dipartimento Med & Chirurg, Varese, Italy; [Vattathil, Selina] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of London; University College London; University of London; University College London; University of London; University College London; University of Insubria; University of Texas System; UTMD Anderson Cancer Center	Proukakis, C (corresponding author), UCL, Inst Neurol, Clin Neurosci, London, England.	c.proukakis@ucl.ac.uk	Pittman, Alan M/D-6231-2012; Schapira, Anthony H V/A-1245-2010; Taanman, Jan W/A-5379-2011; Houlden, Henry J/C-1532-2008; Pittman, Alan/AAP-2534-2020; proukakis, christos/ABE-3447-2020; Valli, Roberto/ABF-2985-2021	Pittman, Alan M/0000-0002-8112-2987; Schapira, Anthony H V/0000-0002-3018-3966; Taanman, Jan W/0000-0002-5476-9785; Houlden, Henry J/0000-0002-2866-7777; Pittman, Alan/0000-0002-8112-2987; proukakis, christos/0000-0001-6423-6539; VALLI, ROBERTO/0000-0002-3209-8917	Michael J Fox Foundation Rapid Response Innovation Award; Wellcome Trust [WT089698]; NIHR [RCF103/AS/2014, RCF73TS2045989]; Isaac Shapera Trust for medical research; Parkinson's UK in England [258197]; Parkinson's UK in Wales [258197]; Parkinson's UK in Scotland [SC037554]; MRC [G108/638, MR/J004758/1, G1001253, G0802760] Funding Source: UKRI; Medical Research Council [G108/638, MR/J004758/1, G0802760, G1001253] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish; Muscular Dystrophy UK [16GRO-PS36-0055] Funding Source: researchfish	Michael J Fox Foundation Rapid Response Innovation Award; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); Isaac Shapera Trust for medical research; Parkinson's UK in England; Parkinson's UK in Wales; Parkinson's UK in Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Muscular Dystrophy UK	This work was supported by a Michael J Fox Foundation Rapid Response Innovation Award https://www.rnichaelifokerg, the Wellcome Trust https://wellcomeac.uk /MRC https://www.mrc.ac.uk Joint Call in Neurodegeneration award (WT089698), NIHR http://wmnihrac.uk, Awards RCF103/AS/2014 and RCF73TS2045989, and the Isaac Shapera Trust for medical research. Tissue samples and associated anonymized data were supplied by the Parkinson's UK Tissue Bank, funded by Parkinson's UK, a charity registered in England and Wales (258197) and in Scotland (SC037554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghili L, 2014, CELL REP, V7, P1310, DOI 10.1016/j.celrep.2014.03.071; Aplenc R, 2002, LEUKEMIA, V16, P1865, DOI 10.1038/sj.leu.2402681; Atanesyan L, 2017, AM J CLIN PATHOL, V14; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; BENDICH A, 1958, J AM CHEM SOC, V80, P3949, DOI 10.1021/ja01548a038; Cai XY, 2014, CELL REP, V8, P1280, DOI 10.1016/j.celrep.2014.07.043; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Cozzi P, 2015, EVOL BIOINFORM, V11, P253, DOI 10.4137/EBO.S27693; D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005; Devall M., COMPARISON MITOCHOND; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Evrony GD, 2015, NEURON, V85, P49, DOI 10.1016/j.neuron.2014.12.028; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Huggett JF, 2014, CLIN CHEM; Jacobs K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5227; Kasak L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08342; Kluwe L, 2016, EUR J HUM GENET, V24, P1644, DOI 10.1038/ejhg.2016.56; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Leo A, 2012, J MOL DIAGN, V14, P550, DOI 10.1016/j.jmoldx.2012.06.002; Lindgren D, 2011, ADV CANCER RES, V112, P151, DOI 10.1016/B978-0-12-387688-1.00006-5; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Pyle A, 2015, NEUROBIOL AGING ELSE; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sakai M, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0144-5; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Speicher MR, 2010, VOGEL AND MOTULSKY'S HUMAN GENETICS, FOURTH EDITION, P1, DOI 10.1007/978-3-540-37654-5; Valli R, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-13; van de Wiel MA, 2009, BIOINFORMATICS, V25, P1099, DOI 10.1093/bioinformatics/btp132; van Heesch S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r33; Vattathil S, 2016, AM J HUM GENET, V98, P571, DOI 10.1016/j.ajhg.2016.02.003; Vattathil S, 2013, GENOME RES, V23, P152, DOI 10.1101/gr.141374.112; Ye F, 2014, MITOCHONDRION, V17, P157, DOI 10.1016/j.mito.2014.05.004	37	22	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180467	10.1371/journal.pone.0180467	http://dx.doi.org/10.1371/journal.pone.0180467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683077	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000405335200040
J	Boothroyd, LG; Cross, CP				Boothroyd, Lynda G.; Cross, Catharine P.			Father absence and gendered traits in sons and daughters	PLOS ONE			English	Article							SEX-ROLE DEVELOPMENT; AGGRESSION QUESTIONNAIRE; REPRODUCTIVE DEVELOPMENT; INHIBITORY CONTROL; CHILD-DEVELOPMENT; PARENTAL DIVORCE; ROLE ORIENTATION; ROLE INVENTORY; ADOLESCENTS; AGE	Research has previously found a number of apparently contradictory patterns in the relationship between 'father absence' (having a non-resident father during childhood) and the expression of gender roles, as well as other sexually dimorphic traits such as aggression. In the current study we measured a battery of sexually differentiated traits in relation to family background. 133 men and 558 women from the United States and Australia completed the Bem Sex Role Inventory, the Barrett Impulsivity Scale, the Fear Survey Schedule and the Buss & Perry Aggression Questionnaire. Principal components analysis found two main axes of variation in these traits. Firstly, a general 'reactivity' factor, on which aggression, impulsivity, and fear all loaded positively, was weakly associated with father absence in women. Secondly, 'masculinity' (consisting of high scores on masculine traits, low fear, and physical and verbal aggression) was not associated with father absence. Participants (except American males) reporting a poor childhood relationship with their parents also had high 'reactivity' but not higher 'masculinity'. We found some evidence of a link between father absence and earlier age of first coitus in American females (although not in Australia), but there was no link with age of menarche in either country. Overall, the current results suggest that previous findings linking gender development with father absence in girls may have arisen from a tendency towards greater externalising and reactive behaviour rather than a change in gender development per se.	[Boothroyd, Lynda G.] Univ Durham, Dept Psychol, Durham, England; [Cross, Catharine P.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	Durham University; University of St Andrews	Boothroyd, LG (corresponding author), Univ Durham, Dept Psychol, Durham, England.	l.g.boothroyd@dur.ac.uk	Boothroyd, Lynda/B-9168-2009; Cross, Catharine/G-1400-2015	Boothroyd, Lynda/0000-0001-6660-5828; Cross, Catharine/0000-0001-8110-8408	Economic and Social Research Council [PTA 026 -27-0475]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	LGB was supported during data collection and initial drafting of the manuscript by the Economic and Social Research Council (PTA 026 -27-0475).	AMATO PR, 1991, PSYCHOL BULL, V110, P26, DOI 10.1037/0033-2909.110.1.26; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Archer J, 2006, AGGRESSIVE BEHAV, V32, P464, DOI 10.1002/ab.20146; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Auster CJ, 2000, SEX ROLES, V43, P499, DOI 10.1023/A:1007119516728; Baillargeon RH, 2007, DEV PSYCHOL, V43, P13, DOI 10.1037/0012-1649.43.1.13; BARCLAY A, 1967, CHILD DEV, V38, P243, DOI 10.1111/j.1467-8624.1967.tb04344.x; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; Bereczkei T, 1996, HUM NATURE-INT BIOS, V7, P257, DOI 10.1007/BF02733397; Berenbaum SA, 1998, DEV NEUROPSYCHOL, V14, P175, DOI 10.1080/87565649809540708; Bettencourt BA, 1996, PSYCHOL BULL, V119, P422, DOI 10.1037/0033-2909.119.3.422; BILLER HB, 1969, CHILD DEV, V40, P539, DOI 10.2307/1127421; Boothroyd L.G., 2008, J EVOLUTIONARY PSYCH, V6, P187, DOI DOI 10.1556/JEP.6.2008.3.3; Boothroyd LG, 2013, AM J HUM BIOL, V25, P366, DOI 10.1002/ajhb.22378; Boothroyd LG, 2006, P ROY SOC B-BIOL SCI, V273, P2375, DOI 10.1098/rspb.2006.3579; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Campbell A, 1999, BEHAV BRAIN SCI, V22, P203, DOI 10.1017/S0140525X99001818; Campbell A, 2006, AGGRESS VIOLENT BEH, V11, P237, DOI 10.1016/j.avb.2005.09.002; Campbell A, 2016, PERS INDIV DIFFER, V97, P210, DOI 10.1016/j.paid.2016.03.049; Card NA, 2008, CHILD DEV, V79, P1185, DOI 10.1111/j.1467-8624.2008.01184.x; CHERLIN AJ, 1991, SCIENCE, V252, P1386, DOI 10.1126/science.2047851; Cortes CF, 1968, J SPEC ED; Cote S, 2002, J CHILD PSYCHOL PSYC, V43, P609, DOI 10.1111/1469-7610.00050; Cross CP, 2010, EVOL PSYCHOL-US, V8, P779, DOI 10.1177/147470491000800418; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Daly M., 1988, HOMICIDE; de Baca TC, 2016, ADAPT HUM BEHAV PHYS, V2, P93, DOI 10.1007/s40750-016-0042-z; DRAPER P, 1982, J ANTHROPOL RES, V38, P255, DOI 10.1086/jar.38.3.3629848; Driscoll H, 2006, BRIT J PSYCHOL, V97, P139, DOI 10.1348/000712605X63073; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellis BJ, 2012, DEV PSYCHOPATHOL, V24, P317, DOI 10.1017/S095457941100085X; Ember CR, 2001, ETHOS, V29, P296, DOI 10.1525/eth.2001.29.3.296; Enticott PG, 2006, PERS INDIV DIFFER, V41, P285, DOI 10.1016/j.paid.2006.01.011; FEATHER NT, 1978, AUST J PSYCHOL, V30, P241, DOI 10.1080/00049537808256377; FERGUSSON DM, 1994, J AM ACAD CHILD PSY, V33, P1122, DOI 10.1097/00004583-199410000-00008; Frankenhuis WE, 2012, DEV PSYCHOL, V48, P628, DOI 10.1037/a0025629; GILLY MC, 1988, J MARKETING, V52, P75, DOI 10.2307/1251266; Greenfeld DA, 2005, CURR OPIN OBSTET GYN, V17, P309, DOI 10.1097/01.gco.0000169109.92752.70; HETHERINGTON EM, 1972, DEV PSYCHOL, V7, P313, DOI 10.1037/h0033339; JACKSON LA, 1986, J SOC CLIN PSYCHOL, V4, P204, DOI 10.1521/jscp.1986.4.2.204; James J, 2012, DEV PSYCHOL, V48, P687, DOI 10.1037/a0026427; KASHIMA Y, 1995, J PERS SOC PSYCHOL, V69, P925, DOI 10.1037/0022-3514.69.5.925; KELLY JA, 1976, J CONSULT CLIN PSYCH, V44, P843, DOI 10.1037/0022-006X.44.5.843; Kim K, 1997, EVOL HUM BEHAV, V18, P109, DOI 10.1016/S1090-5138(96)00114-6; KING NJ, 1989, J CHILD PSYCHOL PSYC, V30, P775, DOI 10.1111/j.1469-7610.1989.tb00789.x; Mandara J, 2005, SEX ROLES, V53, P207, DOI 10.1007/s11199-005-5679-1; MARKS I, 1987, J CHILD PSYCHOL PSYC, V28, P667, DOI 10.1111/j.1469-7610.1987.tb01552.x; MILNE JM, 1995, J AM ACAD CHILD PSY, V34, P1202, DOI 10.1097/00004583-199509000-00018; MISCHEL W, 1958, J ABNORM SOC PSYCH, V56, P57, DOI 10.1037/h0041895; Oktem F, 1998, TURKISH J PEDIATR, V40, P159; ORLOFSKY JL, 1979, SEX ROLES, V5, P495, DOI 10.1007/BF00287324; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Rostad WL, 2014, J AM COLL HEALTH, V62, P213, DOI 10.1080/07448481.2014.887570; Russell A, 2003, INT J BEHAV DEV, V27, P74, DOI 10.1080/01650250244000038; Sear R, 2011, POPUL DEV REV, V37, P81, DOI 10.1111/j.1728-4457.2011.00379.x; SEXTON TL, 1985, J DIVORCE, V9, P17, DOI 10.1300/J279v09n01_02; Sheppard Paula, 2015, Evolution Medicine and Public Health, P332, DOI 10.1093/emph/eov028; Sheppard P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089539; Sheppard P, 2012, BIOL LETTERS, V8, P237, DOI 10.1098/rsbl.2011.0747; SIEGAL M, 1987, DEV REV, V7, P183, DOI 10.1016/0273-2297(87)90012-8; STEVENSON MR, 1988, CHILD DEV, V59, P793, DOI 10.2307/1130577; STEVENSON MR, 1991, SEX ROLES, V24, P239, DOI 10.1007/BF00288299; The United Nations Development Programme Human Development Reports, UN DEV PROGR HUMM DE; Tither JM, 2008, DEV PSYCHOL, V44, P1409, DOI 10.1037/a0013065; Twenge JM, 1997, SEX ROLES, V36, P305, DOI 10.1007/BF02766650; VESS JD, 1983, J DIVORCE, V7, P83, DOI 10.1300/J279v07n01_07; Waynforth D, 1998, EVOL HUM BEHAV, V19, P369, DOI 10.1016/S1090-5138(98)00031-2; Waynforth D., 2002, HDB FATHER INVOLVEME; WHITING BB, 1965, AM ANTHROPOL, V67, P123; WOLPE J, 1964, BEHAV RES THER, V2, P27, DOI 10.1016/0005-7967(64)90051-8; World Economic Forum, GLOB GEND GAP IND 20; Yang JA, 2000, ADOLESCENCE, V35, P731; YOUNG ER, 1977, SEX ROLES, V3, P217, DOI 10.1007/BF00287611	76	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179954	10.1371/journal.pone.0179954	http://dx.doi.org/10.1371/journal.pone.0179954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678822	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200032
J	Gu, RX; Wei, H; Wang, Y; Lin, D; Liu, BC; Zhou, CL; Liu, KQ; Gong, BF; Wei, SN; Zhang, GJ; Gong, XY; Liu, YT; Li, Y; Zhao, XL; Qiu, SW; Wang, HJ; Wang, M; Mi, YC; Wang, JX				Gu, Runxia; Wei, Hui; Wang, Ying; Lin, Dong; Liu, Bingcheng; Zhou, Chunlin; Liu, Kaiqi; Gong, Benfa; Wei, Shuning; Zhang, Guangji; Gong, Xiaoyuan; Liu, Yuntao; Li, Yan; Zhao, Xingli; Qiu, Shaowei; Wang, Huijun; Wang, Min; Mi, Yingchang; Wang, Jianxiang			The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; UMBILICAL-CORD BLOOD; PHASE-III; CD34(+); NICHES	Hematopoietic recovery is considered to be associated with the number of multipotent hematopoietic stem cells in the bone marrow, as observed in functional assays involving stem cell transplantation. However, there is little evidence related to hematopoietic recovery in non-transplantation settings, which is accomplished by endogenous hematopoietic cells. A recent study suggested that progenitors are the main contributors during this steady-state hematopoiesis, which differs from exogenous transplantation. We hypothesized that endogenous progenitor support post-chemotherapy hematopoietic recovery. To investigate the potential impact of these progenitor cell percentage on hematopoietic recovery, we retrospectively analyzed the percentage of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells (P cells) and hematopoietic recovery in 223 newly diagnosed acute myeloid leukemia patients during two courses of consolidation chemotherapy after complete remission. We found that a lower P cell percentage was significantly associated with prolonged neutropenia recovery time after the first and second courses of consolidation chemotherapy (p = 0.001; p = 0.045, respectively). We also observed similar results with regard to platelet recovery time after the first course of consolidation chemotherapy (p = 0.000). Univariate analysis showed that P cell percentage and consolidation chemotherapy regimens, and not gender, age, induction chemotherapy regimens, infection grade, WHO classification and NCCN risk category, were associated with neutrophil recovery after chemotherapy. Multivariate analysis demonstrated that P cell percentage is an independent factor affecting neutrophil recovery capacity for both the first and second courses (p = 0.008; p = 0.032, respectively). Our results indicate that CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells before each course of chemotherapy is independently associated with chemotherapy-related hematopoietic reconstitution capacity. These findings may help modify future chemotherapy regimens based on progenitor cell percentages.	[Gu, Runxia; Wei, Hui; Wang, Ying; Lin, Dong; Liu, Bingcheng; Zhou, Chunlin; Liu, Kaiqi; Gong, Benfa; Wei, Shuning; Zhang, Guangji; Gong, Xiaoyuan; Liu, Yuntao; Li, Yan; Zhao, Xingli; Qiu, Shaowei] Chinese Acad Med Sci, Hosp Blood Dis, Dept Leukemia, Inst Hematol, Tianjin, Peoples R China; [Wang, Huijun] Chinese Acad Med Sci, Dept Pathol & Lab Med, Inst Hematol, Hosp Blood Dis, Tianjin, Peoples R China; [Wang, Min; Mi, Yingchang; Wang, Jianxiang] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China; [Wang, Min; Mi, Yingchang; Wang, Jianxiang] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Wang, Min; Mi, Yingchang; Wang, Jianxiang] Peking Union Med Coll, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, JX (corresponding author), Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China.; Wang, JX (corresponding author), Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China.; Wang, JX (corresponding author), Peking Union Med Coll, Tianjin, Peoples R China.	wangjx@ihcams.ac.cn	刘, 云涛/GQQ-5223-2022; wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022		State Key Program of the National Natural Science of China [81430004]; Foundation for Innovative Research Groups of the Natural Science Foundation of China [81421002]; National Natural Science Foundation [81400136, 81570147]; National Science & Technology Pillar Program during the Twelfth Five year Plan Period [2014BAI09B12]	State Key Program of the National Natural Science of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program during the Twelfth Five year Plan Period	This study was supported, inpart, by the State Key Program of the National Natural Science of China (81430004), the Foundation for Innovative Research Groups of the Natural Science Foundation of China (81421002), the National Natural Science Foundation (81400136 and 81570147),and the National Science & Technology Pillar Program during the Twelfth Five year Plan Period (2014BAI09B12)	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Aksentijevich I, 2002, CANCER BIOTHER RADIO, V17, P399, DOI 10.1089/108497802760363196; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Ginestier C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1741; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Heil G, 1997, BLOOD, V90, P4710, DOI 10.1182/blood.V90.12.4710.4710_4710_4718; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Remberger M, 2015, BIOL BLOOD MARROW TR, V21, P889, DOI 10.1016/j.bbmt.2015.01.025; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; ROWE JM, 1995, BLOOD, V86, P457, DOI 10.1182/blood.V86.2.457.bloodjournal862457; Savarese TM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1674; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Terakura S, 2007, BIOL BLOOD MARROW TR, V13, P822, DOI 10.1016/j.bbmt.2007.03.006; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Zoller M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00235	20	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180624	10.1371/journal.pone.0180624	http://dx.doi.org/10.1371/journal.pone.0180624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678809	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200078
J	Schoemaker, MH; Kleemann, R; Morrison, MC; Verheij, J; Salic, K; van Tol, EAF; Kooistra, T; Wielinga, PY				Schoemaker, Marieke H.; Kleemann, Robert; Morrison, Martine C.; Verheij, Joanne; Salic, Kanita; van Tol, Eric A. F.; Kooistra, Teake; Wielinga, Peter Y.			A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; BODY-WEIGHT; DEVELOPMENTAL ORIGINS; INFANT FORMULAS; INFLAMMATION; ACIDS; SUPPLEMENTATION; STEATOHEPATITIS	Background Obesity frequently associates with the development of non-alcoholic fatty liver disease (NAFLD) and atherosclerosis. Chronic inflammation in white adipose tissue (WAT) seems to be an important driver of these manifestations. Objective This study investigated a combination of an extensively hydrolyzed casein (eHC), docosahexaenoic acid (DHA), arachidonic acid (ARA), and Lactobacillus Rhamnosus GG (LGG) (together referred to as nutritional ingredients, NI) on the development of obesity, metabolic risk factors, WAT inflammation, NAFLD and atherosclerosis in high-fat diet-fed LDLr-/-.Leiden mice, a model that mimics disease development in humans. Methods LDLr-/-.Leiden male mice (n = 15/group) received a high-fat diet (HFD, 45 Kcal%) for 21 weeks with or without the NI (23.7% eHC, 0.083% DHA, 0.166% ARA; all w/w and 1x10(9) CFU LGG gavage 3 times/week). HFD and HFD+NI diets were isocaloric. A low fat diet (LFD, 10 Kcal%) was used for reference. Body weight, food intake and metabolic risk factors were assessed over time. At week 21, tissues were analyzed for WAT inflammation (crown-like structures), NAFLD and atherosclerosis. Effects of the individual NI components were explored in a follow-up experiment (n = 7/group). Results When compared to HFD control, treatment with the NI strongly reduced body weight to levels of the LFD group, and significantly lowered (P<0.01) plasma insulin, cholesterol, triglycerides, leptin and serum amyloid A (P<0.01). NI also reduced WAT mass and inflammation. Strikingly, NI treatment significantly reduced macrovesicular steatosis, lobular inflammation and liver collagen (P<0.05), and attenuated atherosclerosis development (P<0.01). Of the individual components, the effects of eHC were most pronounced but could not explain the entire effects of the NI formulation. Conclusions A combination of eHC, ARA, DHA and LGG attenuates obesity and associated cardiometabolic diseases (NAFLD, atherosclerosis) in LDLr-/-.Leiden mice. The observed reduction of inflammation in adipose tissue and in the liver provides a rationale for these comprehensive health effects.	[Schoemaker, Marieke H.; van Tol, Eric A. F.] Global R&D, Mead Johnson Pediat Nutr Inst, Nijmegen, Netherlands; [Kleemann, Robert; Morrison, Martine C.; Salic, Kanita; Kooistra, Teake; Wielinga, Peter Y.] TNO, Netherlands Org Sci Res, Metab Hlth Res, Leiden, Netherlands; [Verheij, Joanne] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands	Netherlands Organization Applied Science Research; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Schoemaker, MH (corresponding author), Global R&D, Mead Johnson Pediat Nutr Inst, Nijmegen, Netherlands.	marieke.schoemaker@mjn.com	Morrison, Martine C./C-3168-2014	Morrison, Martine C./0000-0003-4996-943X; Verheij, Joanne/0000-0003-1283-630X	Mead Johnson Nutrition	Mead Johnson Nutrition	This study received unconditional funding support from Mead Johnson Nutrition. MH Schoemaker and EAF vanTolare employees of Mead Johnson Nutrition and contributed to the design of the study and manuscript preparation. Mead Johnson Nutrition employees were not involved in the execution of the study, the consequent data collection and analysis. No other authors declare a conflict of interest. The specific roles of these authors are articulated in the 'author contributions' section.	Arnoldussen IA, 2017, INT J OBES LOND; Astrup A, 2012, LANCET, V379, P1100, DOI 10.1016/S0140-6736(12)60456-5; Berni Canani R, 2015, ISME J; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brumbaugh DE, 2014, PEDIATR RES, V75, P140, DOI 10.1038/pr.2013.193; Calder PC, 2013, BRIT J NUTR, V109, pS1, DOI 10.1017/S0007114512005119; Canani RB, 2012, J ALLERGY CLIN IMMUN, V129, P580, DOI 10.1016/j.jaci.2011.10.004; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Clausen MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118895; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Drover J, 2009, CHILD DEV, V80, P1376, DOI 10.1111/j.1467-8624.2009.01339.x; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Fuijkschot WW, 2016, ATHEROSCLEROSIS, V255, P164, DOI 10.1016/j.atherosclerosis.2016.07.909; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Gray B, 2013, EUR J CLIN NUTR, V67, P1234, DOI 10.1038/ejcn.2013.197; Hojsak I, 2010, CLIN NUTR, V29, P312, DOI 10.1016/j.clnu.2009.09.008; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; Juarez-Hernandez E, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0191-8; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Krishack PA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001858; Lambers TT, 2015, FOOD SCI NUTR, V3, P81, DOI 10.1002/fsn3.196; Lapillonne A, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-168; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Lopez-Alarcon M, 2011, ARCH MED RES, V42, P502, DOI 10.1016/j.arcmed.2011.06.010; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luke A, 2013, INT J EPIDEMIOL, V42, P1831, DOI 10.1093/ije/dyt159; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Morrison MC, 2016, INT J OBESITY, V40, P1416, DOI 10.1038/ijo.2016.74; Morrison MC, 2015, J HEPATOL, V62, P1180, DOI 10.1016/j.jhep.2014.12.011; Mulder P., 2015, INT J OBES LOND; Mulder P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169740; Mulder P, 2016, SCI REP-UK, V6, DOI 10.1038/srep31542; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nobili V, 2013, J HEPATOL, V58, P1218, DOI 10.1016/j.jhep.2012.12.003; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Radonjic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056122; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; Romacho T, 2014, ACTA PHYSIOL, V210, P733, DOI 10.1111/apha.12246; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; von Berg A, 2008, J ALLERGY CLIN IMMUN, V121, P1442, DOI 10.1016/j.jaci.2008.04.021; Wielinga PY, 2012, MOL NUTR FOOD RES, V56, P1081, DOI 10.1002/mnfr.201100762; Yates T, 2012, BRIT J GEN PRACT, V62, P4, DOI 10.3399/bjgp12X616201; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	51	27	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180648	10.1371/journal.pone.0180648	http://dx.doi.org/10.1371/journal.pone.0180648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678821	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200083
J	Cortinez-O'Ryan, A; Albagli, A; Sadarangani, KP; Aguilar-Farias, N				Cortinez-O'Ryan, Andrea; Albagli, Andrea; Sadarangani, Kabir P.; Aguilar-Farias, Nicolas			Reclaiming streets for outdoor play: A process and impact evaluation of ''Juega en tu Barrio'' (Play in your Neighborhood), an intervention to increase physical activity and opportunities for play	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACTIVITY PROGRAM; CHILDRENS; HEALTH; TIME; AGE; ENVIRONMENT; CHILDHOOD; YOUTH; LIFE	Background New strategies are required to create supportive physical and social environments for children and promote active free-play. Juega en tu Barrio (JETB; Play in your Neighborhood) was designed and implemented to explore the effectiveness of closing a street in a low-tomiddle income neighborhood in order to increase children's outside play and physical activity. Methods A pretest-posttest design with control group was employed to investigate the intervention effects in a subsample of 100 children, 51 from the intervention neighborhood and 49 from the control neighborhood. The children wore pedometers for one week, and their parents completed questionnaires at two time points: before the intervention began and during the last two weeks of the intervention. JETB was conducted in the intervention neighborhood from 17: 30 to 20: 30, twice a week, from September to December 2014. Stewards ensured that the children were safe. Children and adults were assessed using systematic observation. Results The intervention and control neighborhoods included 177 and 116 children respectively. The average attendance per event was 60 children (SD = 22, reach 34%). In the intervention neighborhood, a significant increase between baseline and final assessment was observed in afterschool outdoor playtime (p = 0.02), steps during the 3-hour intervention (p = 0.004), and daily steps Monday to Sunday (p = 0.006). Meanwhile, no changes were observed in the control neighborhood for the same variables. The proportion of children who met recommended daily step counts increased from 27.5% to 53.0% in the intervention neighborhood (p = 0.007), while for control neighborhood no difference was observed (49.0% to 53.0% p = 0.804). Conclusions JETB showed high community engagement while offering opportunities for increased outdoor play in children. The intervention showed a significant effect on the number of children meeting the daily pedometer-derived physical activity recommendations.	[Cortinez-O'Ryan, Andrea; Aguilar-Farias, Nicolas] Univ La Frontera, Dept Phys Educ Sports & Recreat, Temuco, Chile; [Albagli, Andrea] Minist Hlth Santiago, Div Hlth Planning, Santiago, Chile; [Sadarangani, Kabir P.] Univ San Sebastian, Fac Hlth Sci, Sch Kinesiol, Santiago, Chile; [Sadarangani, Kabir P.] Autonomous Univ Madrid, Dept Phys Educ Sport & Human Movement, Madrid, Spain	Universidad de La Frontera; Universidad San Sebastian; Autonomous University of Madrid	Cortinez-O'Ryan, A (corresponding author), Univ La Frontera, Dept Phys Educ Sports & Recreat, Temuco, Chile.	andrea.cortinez@ufrontera.cl	Aguilar-Farias, Nicolas/AAF-5136-2019; Aguilar-Farias, Nicolas/V-2742-2018	Aguilar-Farias, Nicolas/0000-0002-6974-1312; Aguilar-Farias, Nicolas/0000-0002-6974-1312; Cortinez-O'Ryan, Andrea/0000-0001-6207-3377	National Fund for research and development in health, FONIS [EVS-13I0052]	National Fund for research and development in health, FONIS	This research was funded by the National Fund for research and development in health, FONIS, http://www.conicyt.cl/fonis/, Grantnumber: EVS-13I0052(AC).	Ajja R, 2014, PREV MED, V69, pS49, DOI 10.1016/j.ypmed.2014.09.010; Alexander SA, 2014, HEALTH PROMOT INT, V29, P155, DOI 10.1093/heapro/das042; Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6; [Anonymous], 2014, MED SCI SPORT EXER; Arundell L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140132; Ball K., 2007, CHILDRENS GEOGRAPHIE, V5, P409, DOI [10.1080/14733280701631874, DOI 10.1080/14733280701631874]; BARANOWSKI T, 1993, RES Q EXERCISE SPORT, V64, P127, DOI 10.1080/02701367.1993.10608789; Beaulac J, 2011, J YOUTH STUD, V14, P961, DOI 10.1080/13676261.2011.616488; Beets MW, 2012, AM J PREV MED, V42, P180, DOI 10.1016/j.amepre.2011.10.007; Brockman R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-461; Brussoni M, 2015, INT J ENV RES PUB HE, V12, P6423, DOI 10.3390/ijerph120606423; Burdette HL, 2005, ARCH PEDIAT ADOL MED, V159, P46, DOI 10.1001/archpedi.159.1.46; Burdette HL, 2004, ARCH PEDIAT ADOL MED, V158, P353, DOI 10.1001/archpedi.158.4.353; Burrows R, 2008, REV MED CHILE, V136, P53, DOI /S0034-98872008000100007; Cleland V, 2008, INT J OBESITY, V32, P1685, DOI 10.1038/ijo.2008.171; Coombes E, 2013, HEALTH PLACE, V20, P62, DOI 10.1016/j.healthplace.2012.11.008; Cooper AR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0274-5; Cooper AR, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-31; D'Haese S, 2015, INT J BEHAV NUTR PHY, V12, P171, DOI DOI 10.1186/S12966-015-0171-Y; Direccion Meteorologica de Chile, 2008, GUIA CLIM PRACT; Espinoza A., 2012, Californian Journal of Health Promotion, V10, P13; Fadel AC, 2015, RES Q EXERCISE SPORT, V86, pA13; Farley TA, 2007, AM J PUBLIC HEALTH, V97, P1625, DOI 10.2105/AJPH.2006.092692; Faulkner G., 2015, INT J PLAY, V4, P84, DOI [DOI 10.1080/21594937.2015.1017303, 10.1080/21594937.2015.1017303]; Fisher A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010110; Gomersall SR, 2013, SPORTS MED, V43, P135, DOI 10.1007/s40279-012-0008-7; Green J., 2018, QUALITATIVE METHODS, VFourth; Hewes J, 2014, CHILDREN-BASEL, V1, P280, DOI 10.3390/children1030280; Holt NL, 2015, CHILD GEOGR, V13, P73, DOI 10.1080/14733285.2013.828449; Hyndman BP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-164; Isenberg J. P., 2002, PLAY ESSENTIAL ALL C, V79, P33, DOI DOI 10.1080/00094056.2002.10522763; Jago R, 2009, J PUBLIC HEALTH-UK, V31, P472, DOI 10.1093/pubmed/fdp053; Jago R, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-4; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Karsten L, 2003, CHILDHOOD, V10, P457, DOI 10.1177/0907568203104005; Lawlor DA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-181; Martinez-Lopez EJ, 2012, J SPORT SCI MED, V11, P312; McKenzie Thomas L, 2006, J Phys Act Health, V3 Suppl 1, pS208, DOI 10.1123/jpah.3.s1.s208; Ngo CS, 2014, OPHTHAL PHYSL OPT, V34, P362, DOI 10.1111/opo.12112; Okely AD, 2012, SYSTEMATIC REV UPDAT, V1246, P1; Remmers T, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-76; Rowlands AV, 2005, RES Q EXERCISE SPORT, V76, P251; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sandseter EBH, 2011, EVOL PSYCHOL-US, V9, P257, DOI 10.1177/147470491100900212; Sarmiento O, 2010, J PHYS ACT HEALTH, V7, pS163, DOI 10.1123/jpah.7.s2.s163; Singer DG, 2009, AM J PLAY, V1, P283; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tremblay MS, 2016, J PHYS ACT HEALTH, V13, pS343, DOI 10.1123/jpah.2016-0594; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Tudor-Locke C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0172-x; Veitch J, 2006, HEALTH PLACE, V12, P383, DOI 10.1016/j.healthplace.2005.02.009; World Health Organization, 1986, OTT CHART GES; Zieff SG, 2016, CHILD YOUTH SERV REV, V70, P95, DOI 10.1016/j.childyouth.2016.09.014	53	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180172	10.1371/journal.pone.0180172	http://dx.doi.org/10.1371/journal.pone.0180172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28671984	gold, Green Published, Green Submitted			2022-12-27	WOS:000405268500021
J	Du, XK; Jiang, CL; Lv, Y; Dull, RO; Zhao, YY; Schwartz, DE; Hu, GC				Du, Xueke; Jiang, Chunling; Lv, Yang; Dull, Randal O.; Zhao, You-Yang; Schwartz, David E.; Hu, Guochang			Isoflurane promotes phagocytosis of apoptotic neutrophils through AMPK-mediated ADAM17/Mer signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ACUTE LUNG INJURY; ACUTE-INFLAMMATION; CELLS; MACROPHAGES; CLEARANCE; RESOLUTION; RECEPTOR; EFFEROCYTOSIS; TACE	A patient's recovery from lung inflammatory injury or development of multi-system organ failure is determined by the host's ability to resolve inflammation and repair tissue damage, both of which require the clearance of apoptotic neutrophils by macrophages (efferocytosis). Here, we investigated the effects of isoflurane on macrophage efferocytosis and resolution of lung inflammatory injury. Treatment of murine bone marrow-derived macrophages (BMDMs) or alveolar macrophages with isoflurane dramatically enhanced phagocytosis of apoptotic neutrophils. Isoflurane significantly increased the surface expression of the receptor tyrosine kinase Mer in macrophages, but markedly decreased the levels of a soluble form of Mer protein in the medium. Isoflurane treatment also caused a decrease in a disintegrin and metalloproteinase 17 (ADAM17) on the cell surface and a concomitant increase in its cytoplasmic fraction. These responses induced by isoflurane were completely reversed by a pharmacological inhibitor or genetic deletion of AMP-activated protein kinase (AMPK). In a mouse model of lipopolysaccharide-induced lung injury, isoflurane accelerated the recovery of lung inflammation and injury that was coupled with an increase in the number of alveolar macrophages containing apoptotic bodies. In alveolar macrophage-depleted mice, administration of isoflurane-pretreated BMDMs facilitated resolution of lung inflammation following lipopolysaccharide challenge. Thus, isoflurane promoted resolution of lipopolysaccharide-induced lung inflammatory injury via enhancement of macrophage efferocytosis. Increased macrophage efferocytosis following isoflurane treatment correlates with upregulation of Mer surface expression through AMPK-mediated blockade of ADAM17 trafficking to the cell membrane.	[Du, Xueke; Jiang, Chunling; Lv, Yang; Dull, Randal O.; Schwartz, David E.; Hu, Guochang] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA; [Du, Xueke] Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Guangxi, Peoples R China; [Zhao, You-Yang; Hu, Guochang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA; [Zhao, You-Yang] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA; [Hu, Guochang] Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Guangxi Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Xuzhou Medical University	Hu, GC (corresponding author), Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA.; Hu, GC (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA.; Hu, GC (corresponding author), Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.	gchu@uic.edu		Hu, Guochang/0000-0002-7054-7867; ZHAO, YOU-YANG/0000-0002-0041-0339	National Institutes of Health [HL104092]; Natural Science Foundation of China [81470259]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104092, R01HL125350, P01HL077806, R01HL123957, R01HL133951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health Grant HL104092 (to Guochang Hu), https://www.nih.gov/, and the Natural Science Foundation of China 81470259 (Guochang Hu),	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Aggarwal NR, 2014, J IMMUNOL, V192, P4453, DOI 10.4049/jimmunol.1400146; Akalu YT, 2017, IMMUNOL REV, V276, P165, DOI 10.1111/imr.12522; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Chiang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001879; Chung IS, 2013, ANESTH ANALG, V116, P327, DOI 10.1213/ANE.0b013e31827aec06; D'Alessio FR, 2012, J IMMUNOL, V189, P2234, DOI 10.4049/jimmunol.1102606; Driscoll WS, 2013, CIRC RES, V113, P52, DOI 10.1161/CIRCRESAHA.112.300683; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Flondor M, 2008, EUR SURG RES, V40, P1, DOI 10.1159/000107614; Goetzenich A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092827; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Hu GC, 2006, ANESTHESIOLOGY, V104, P777, DOI 10.1097/00000542-200604000-00023; Hu GC, 2008, AM J PHYSIOL-LUNG C, V294, pL178, DOI 10.1152/ajplung.00263.2007; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jiang CL, 2017, J IMMUNOL, V198, P1660, DOI 10.4049/jimmunol.1601495; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li QF, 2009, ANESTH ANALG, V109, P1591, DOI 10.1213/ANE.0b013e3181baf506; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Maiti G, 2012, P NATL ACAD SCI USA, V109, P16600, DOI 10.1073/pnas.1207789109; McCubbrey AL, 2013, CHEST, V143, P1750, DOI 10.1378/chest.12-2413; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Reutershan J, 2006, ANESTHESIOLOGY, V104, P511, DOI 10.1097/00000542-200603000-00019; Ross E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128013; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Sonner JM, 2000, ANESTH ANALG, V91, P720, DOI 10.1213/00000539-200009000-00042; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang YL, 2011, J IMMUNOL, V186, P3180, DOI 10.4049/jimmunol.1001252; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860; YAMAMOTO K, 1984, J EXP MED, V159, P405, DOI 10.1084/jem.159.2.405; Yang ZY, 2014, J IMMUNOL, V193, P1931, DOI 10.4049/jimmunol.1302863; Zaynagetdinov R, 2013, AM J RESP CELL MOL, V49, P180, DOI 10.1165/rcmb.2012-0366MA; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180213	10.1371/journal.pone.0180213	http://dx.doi.org/10.1371/journal.pone.0180213			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671983	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500029
J	Wagner, AP; Croudace, TJ; Bateman, N; Pennington, MW; Prince, E; Redley, M; White, SR; Ring, H				Wagner, Adam P.; Croudace, Tim J.; Bateman, Naomi; Pennington, Mark W.; Prince, Elizabeth; Redley, Marcus; White, Simon R.; Ring, Howard			Clinical services for adults with an intellectual disability and epilepsy: A comparison of management alternatives	PLOS ONE			English	Article							QUALITY-OF-LIFE; LEARNING-DISABILITY; PEOPLE; PREVALENCE; HEALTH; SCALE; CARER; PSYCHOPATHOLOGY; VALIDATION; SEVERITY	Background Intellectual disability (ID) is relatively common in people with epilepsy, with prevalence estimated to be around 25%. Surprisingly, given this relatively high frequency, along with higher rates of refractory epilepsy than in those without ID, little is known about outcomes of different management approaches/clinical services treating epilepsy in adults with ID D we investigate this area. Materials & methods We undertook a naturalistic observational cohort study measuring outcomes in n = 91 adults with ID over a 7-month period (recruited within the period March 2008 to April 2010). Participants were receiving treatment for refractory epilepsy (primarily) in one of two clinical service settings: community ID teams (CIDTs) or hospital Neurology services. Results The pattern of comorbidities appeared important in predicting clinical service, with Neurologists managing the epilepsy of relatively more of those with neurological comorbidities whilst CIDTs managed the epilepsy of relatively more of those with psychiatric comorbidities. Epilepsy- related outcomes, as measured by the Glasgow Epilepsy Outcome Scale 35 (GEOS35) and the Epilepsy and Learning Disabilities Quality of Life Scale (ELDQoL) did not differ significantly between Neurology services and CIDTs. Discussion In the context of this study, the absence of evidence for differences in epilepsy-related outcomes amongst adults with ID and refractory epilepsy between mainstream neurology and specialist ID clinical services is considered. Determining the selection of the service managing the epilepsy of adults with an ID on the basis of the skill sets also required to treat associated comorbidities may hence be a reasonable heuristic.	[Wagner, Adam P.; Ring, Howard] Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Cambridge, England; [Wagner, Adam P.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Wagner, Adam P.; Bateman, Naomi; Prince, Elizabeth; Redley, Marcus; Ring, Howard] Univ Cambridge, Dept Psychiat, Cambridge, England; [Croudace, Tim J.] Univ Dundee, Sch Nursing & Midwifery & Social Dimens, Hlth Inst, Dundee, Scotland; [Pennington, Mark W.] Kings Coll London, Kings Hlth Econ, London, England; [White, Simon R.] Univ Cambridge, Med Res Council Biostat Unit, Cambridge, England; [Ring, Howard] Cambridgeshire & Peterborough Natl Hlth Serv Fdn, Cambridge, England	University of East Anglia; University of Cambridge; University of Dundee; University of London; King's College London; MRC Biostatistics Unit; University of Cambridge	Ring, H (corresponding author), Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Cambridge, England.; Ring, H (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.; Ring, H (corresponding author), Cambridgeshire & Peterborough Natl Hlth Serv Fdn, Cambridge, England.	har28@cam.ac.uk	Croudace, Tim/ABC-9681-2021; Pennington, Mark/AAS-9946-2020; Wagner, Adam P/AAA-4346-2019	Pennington, Mark/0000-0002-1392-8700; Wagner, Adam P/0000-0002-9101-3477; Croudace, Tim/0000-0001-8346-7463; Redley, Marcus/0000-0001-8866-7990; White, Simon/0000-0001-8642-7037	National Institute for Health Research (NIHR) [PB-PG-07 06-10051]; NIHR CLAHRC for Cambrid geshire and Peterborough; NIHR Colaboration for Leadership in Appied Heailthe search and Care East of England at the Cambridge shire and Peterborough NHS Foundation Trust; Medical Research Council [U105292687]; Medical Research Council [MC_UU_00002/12, MC_U105292687] Funding Source: researchfish; National Institute for Health Research [PB-PG-0706-10051] Funding Source: researchfish; MRC [MC_U105292687, MC_UU_00002/12] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR CLAHRC for Cambrid geshire and Peterborough; NIHR Colaboration for Leadership in Appied Heailthe search and Care East of England at the Cambridge shire and Peterborough NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This paper presents independent research funded by the National Institute for Health Research (NIHR - www.nihr.ac.uk) under its Research for Patient Benefit (RfPB - https://www.nihr.ac.uk/funding-and-support/funding-forr esearch-studies/funding-programmes/researchfo r-patient-benefit/) Programme (Grant PB-PG-07 06-10051; PIDrHRing). During the time that this research was carried out, AP Wagner, TJ Cro udace, M Redley and H Ring also received support from the NIHR CLAHRC for Cambrid geshire and Peterborough (http://clahrccp.nihr.a c.uk/). In preparing this manuscript AP Wagner and H Ring received support from the NIHR Colaboration for Leadership in Appied Heailthe search and Care East of England at the Cambridge shire and Peterborough NHS Foundation Trust (http: //www.clahrc-eoe.nihr.ac.u k/). SR White was supported by the Medical Research Council (Unit Programme no.U105292687-http://www.mrc.ac.uk/)	Beavis J, 2009, SEIZURE-EUR J EPILEP, V18, P279, DOI 10.1016/j.seizure.2008.11.001; Buck D, 2007, EPILEPSY BEHAV, V10, P38, DOI 10.1016/j.yebeh.2006.10.010; Charlot L, 2011, J INTELL DISABIL RES, V55, P199, DOI 10.1111/j.1365-2788.2010.01294.x; Croudace TJ, 2003, AM J EPIDEMIOL, V157, P834, DOI 10.1093/aje/kwg049; Cuthill FM, 2003, BRIT J PSYCHIAT, V182, P347, DOI 10.1192/bjp.182.4.347; Espie CA, 2003, J NEUROL NEUROSUR PS, V74, P1485, DOI 10.1136/jnnp.74.11.1485; Espie CA, 2003, SEIZURE-EUR J EPILEP, V12, P195, DOI 10.1016/S1059-1311(02)00265-0; Espie CA, 2001, EPILEPSIA, V42, P1043, DOI 10.1046/j.1528-1157.2001.0420081043.x; Kerr M, 2009, J INTELL DISABIL RES, V53, P687, DOI 10.1111/j.1365-2788.2009.01182.x; Kerr MP, 2009, EPILEPSY BEHAV, V15, pS26, DOI 10.1016/j.yebeh.2009.03.020; Kerr MP, 2005, EPILEPSY BEHAV, V7, P472, DOI 10.1016/j.yebeh.2005.07.006; Lhatoo SD, 2001, EPILEPSIA, V42, P6, DOI 10.1046/j.1528-1157.2001.00502.x; Matthews T, 2008, J INTELL DISABIL RES, V52, P163, DOI 10.1111/j.1365-2788.2007.01025.x; McGrother CW, 2006, SEIZURE-EUR J EPILEP, V15, P376, DOI 10.1016/j.seizure.2006.04.002; McLachlan RS, 2003, EUR NEUROL, V50, P16, DOI 10.1159/000070853; Moran NF, 2004, SEIZURE-EUR J EPILEP, V13, P425, DOI 10.1016/j.seizure.2003.10.002; Nikolas H, 2007, EPILEPSY BEHAV, V10, P363, DOI 10.1016/j.yebeh.2007.01.005; Pennington M, 2012, SEIZURE-EUR J EPILEP, V21, P205, DOI 10.1016/j.seizure.2011.12.012; Perez CM, 2015, J INTELL DISABIL RES, V59, P638, DOI 10.1111/jir.12167; Prince L, 2010, INT C BEST PRACT INT; R Core Team, 2021, R LANGUAGE ENV STAT; Redley M, 2013, J INTELL DISABIL RES, V57, P531, DOI 10.1111/j.1365-2788.2012.01556.x; Ring H, 2009, SEIZURE-EUR J EPILEP, V18, P264, DOI 10.1016/j.seizure.2008.10.009; Robertson J, 2015, SEIZURE-EUR J EPILEP, V29, P46, DOI 10.1016/j.seizure.2015.03.016; Sillanpaa M, 2004, EPILEPSY BEHAV, V5, P937, DOI 10.1016/j.yebeh.2004.08.008; Smith KRM, 2010, RES DEV DISABIL, V31, P743, DOI 10.1016/j.ridd.2010.01.016	26	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180266	10.1371/journal.pone.0180266	http://dx.doi.org/10.1371/journal.pone.0180266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28671982	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000405268500036
J	Kaundun, SS; Hutchings, SJ; Dale, RP; Howell, A; Morris, JA; Kramer, VC; Shivrain, VK; Mcindoe, E				Kaundun, Shiv S.; Hutchings, Sarah-Jane; Dale, Richard P.; Howell, Anushka; Morris, James A.; Kramer, Vance C.; Shivrain, Vinod K.; Mcindoe, Eddie			Mechanism of resistance to mesotrione in an Amaranthus tuberculatus population from Nebraska, USA	PLOS ONE			English	Article							HPPD-INHIBITING HERBICIDES; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; GLYPHOSATE RESISTANCE; CRYSTAL-STRUCTURES; WATERHEMP; ATRAZINE; PLANTS; SELECTIVITY; RESPONSES; TRIAZINE	Amaranthus tuberculatus is a troublesome weed in corn and soybean production systems in Midwestern USA, due in part to its ability to evolve multiple resistance to key herbicides including 4-hydroxyphenylpyruvate dioxygenase (HPPD). Here we have investigated the mechanism of resistance to mesotrione, an important chemical for managing broadleaf weeds in corn, in a multiple herbicide resistant population (NEB) from Nebraska. NEB showed a 2.4-fold and 45-fold resistance increase to mesotrione compared to a standard sensitive population (SEN) in pre-emergence and post-emergence dose-response pot tests, respectively. Sequencing of the whole HPPD gene from 12 each of sensitive and resistant plants did not detect any target-site mutations that could be associated with post emergence resistance to mesotrione in NEB. Resistance was not due to HPPD gene duplication or over-expression before or after herbicide treatment, as revealed by qPCR. Additionally, no difference in mesotrione uptake was detected between NEB and SEN. In contrast, higher levels of mesotrione metabolism via 4-hydroxylation of the dione ring were observed in NEB compared to the sensitive population. Overall, the NEB population was characterised by lower levels of parent mesotrione exported to other parts of the plant, either as a consequence of metabolism in the treated leaves and/or impaired translocation of the herbicide. This study demonstrates another case of non-target-site based resistance to an important class of herbicides in an A. tuberculatus population. The knowledge generated here will help design strategies for managing multiple herbicide resistance in this problematic weed species.	[Kaundun, Shiv S.; Hutchings, Sarah-Jane; Dale, Richard P.; Howell, Anushka; Morris, James A.; Mcindoe, Eddie] Syngenta Ltd, Jealotts Hill Int Res Ctr, Bracknell, Berks, England; [Kramer, Vance C.] Syngenta, Res Triangle Pk, NC USA; [Shivrain, Vinod K.] Syngenta, Vero Beach Res Ctr, Vero Beach, FL USA	Syngenta; Syngenta; Syngenta	Kaundun, SS (corresponding author), Syngenta Ltd, Jealotts Hill Int Res Ctr, Bracknell, Berks, England.	deepak.kaundun@syngenta.com			Syngenta	Syngenta(Syngenta)	The study was commercially funded by Syngenta, which provided support in the form of salary for SSK, S-JH, RPD, AH, JAM, VCK, VKS, EM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abendroth JA, 2006, WEED TECHNOL, V20, P267, DOI 10.1614/WT-05-020R.1; Almsick A. van, 2009, Outlooks on Pest Management, V20, P27, DOI 10.1564/20feb09; [Anonymous], 2016, AGRISERVICE; Beaudegnies R, 2009, BIOORGAN MED CHEM, V17, P4134, DOI 10.1016/j.bmc.2009.03.015; Bell MS, 2013, WEED SCI, V61, P460, DOI 10.1614/WS-D-12-00166.1; Betha S, 2016, INCREASED HPPD GENE; Delye C, 2013, TRENDS GENET, V29, P649, DOI 10.1016/j.tig.2013.06.001; Duke SO, 2015, PEST MANAG SCI, V71, P652, DOI 10.1002/ps.3863; ELLIS MK, 1995, TOXICOL APPL PHARM, V133, P12, DOI 10.1006/taap.1995.1121; Evans C., 2016, THESIS; Falk J, 2010, J EXP BOT, V61, P1549, DOI 10.1093/jxb/erq030; Foes MJ, 1998, WEED SCI, V46, P514, DOI 10.1017/S0043174500091013; Fritze IM, 2004, PLANT PHYSIOL, V134, P1388, DOI 10.1104/pp.103.034082; Goggin DE, 2016, J EXP BOT, V67, P3223, DOI 10.1093/jxb/erw120; Goodwin B, 1972, BIOCH PHYSIOL CLINC, P1; Green JM, 2011, J AGR FOOD CHEM, V59, P5819, DOI 10.1021/jf101286h; Gressel J, 2009, PEST MANAG SCI, V65, P1164, DOI 10.1002/ps.1842; Grossmann K, 2007, PEST MANAG SCI, V63, P429, DOI 10.1002/ps.1341; Hamprecht G, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P197; Hausman NE, 2016, WEED TECHNOL, V30, P106, DOI 10.1614/WT-D-15-00098.1; Hausman NE, 2011, PEST MANAG SCI, V67, P258, DOI 10.1002/ps.2100; Hawkes T, 2010, US Patent Application, Patent No. [2010/01975032010, 01975032010]; Hawkes TR, 2014, PEST MANAG SCI, V70, P1316, DOI 10.1002/ps.3699; Heap I, 2016, INT SURVEY HERBICIDE; Hirai K, 2002, HERBICIDE CLASSES IN DEVELOPMENT, P179; Huffman J, 2015, WEED SCI, V63, P799, DOI 10.1614/WS-D-15-00055.1; Hugie JA, 2008, WEED SCI, V56, P265, DOI 10.1614/WS-07-128.1; JEFFORD CW, 1981, EXPERIENTIA, V37, P1134, DOI 10.1007/BF01989880; Jhala AJ, 2014, WEED TECHNOL, V28, P28, DOI 10.1614/WT-D-13-00090.1; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Ma R, 2016, AGRON J, V108, P1196, DOI 10.2134/agronj2015.0571; Ma R, 2013, PLANT PHYSIOL, V163, P363, DOI 10.1104/pp.113.223156; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Matringe M, 2005, PEST MANAG SCI, V61, P269, DOI 10.1002/ps.997; McMullan PM, 2011, WEED TECHNOL, V25, P514, DOI 10.1614/WT-D-10-00150.1; Michel A, 2012, JULIUS KUHN ARCH, V30, P103; Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Nandula VK, 2013, WEED SCI, V61, P374, DOI 10.1614/WS-D-12-00155.1; Pallett K. E., 1997, Pesticide Science, V50, P83, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;83::AID-PS554&gt;3.0.CO;2-S; Patzoldt WL, 2006, P NATL ACAD SCI USA, V103, P12329, DOI 10.1073/pnas.0603137103; Peterson D., 2012, CHARACTERIZATION HPP; Ruiz-Sola M, 2012, ARABIDOPSIS BOOK, P1; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Schultz JL, 2015, WEED SCI, V63, P336, DOI 10.1614/WS-D-14-00102.1; SECOR J, 1994, PLANT PHYSIOL, V106, P1429, DOI 10.1104/pp.106.4.1429; Siehl DL, 2014, PLANT PHYSIOL, V166, P1162, DOI 10.1104/pp.114.247205; STREIBIG JC, 1988, WEED RES, V28, P479, DOI 10.1111/j.1365-3180.1988.tb00831.x; Tan S, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P423, DOI 10.1079/9781780640853.0423; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993; Tranel PJ, 2011, J AGR FOOD CHEM, V59, P5808, DOI 10.1021/jf103797n; Viviani E, 1998, PESTIC BIOCHEM PHYS, V62, P125, DOI 10.1006/pest.1998.2375; Ward SM, 2013, WEED TECHNOL, V27, P12, DOI 10.1614/WT-D-12-00113.1; Williams MM, 2008, WEED SCI, V56, P364, DOI 10.1614/WS-07-149.1; Woodworth A.R., 1996, PLANT PHYSIOL, V111, P1353; Woodyard AJ, 2009, WEED SCI, V57, P369, DOI 10.1614/WS-08-175.1; Wuerffel RJ, 2015, WEED SCI, V63, P511, DOI 10.1614/WS-D-14-00108.1; Yang C, 2004, BIOCHEMISTRY-US, V43, P10414, DOI 10.1021/bi049323o; Yu Q, 2007, PLANTA, V225, P499, DOI 10.1007/s00425-006-0364-3	59	29	29	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180095	10.1371/journal.pone.0180095	http://dx.doi.org/10.1371/journal.pone.0180095			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662111	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608300103
J	Pillon, A; Gomes, B; Vandenberghe, I; Cartron, V; Cebe, P; Blanchet, JC; Sibaud, V; Guilbaud, N; Audoly, L; Lamant, L; Kruczynski, A				Pillon, Arnaud; Gomes, Bruno; Vandenberghe, Isabelle; Cartron, Valerie; Cebe, Patrick; Blanchet, Jean-Christophe; Sibaud, Vincent; Guilbaud, Nicolas; Audoly, Laurent; Lamant, Laurence; Kruczynski, Anna			Actinic keratosis modelling in mice: A translational study	PLOS ONE			English	Article							INGENOL MEBUTATE GEL; HAIRLESS MOUSE; KERATINOCYTE; APOPTOSIS; CANCER	Background Actinic keratoses (AK) are pre-malignant cutaneous lesions caused by prolonged exposure to ultraviolet radiation. As AKs lesions are generally accepted to be the initial lesions in a disease continuum that progresses to squamous cell carcinoma (SCC), AK lesions have to be treated. They are also the second most common reason for visits to the dermatologist. Several treatments are available but their efficacy still needs to be improved. The UV-B-induced KA lesion mouse model is used in preclinical studies to assess the efficacy of novel molecules, even though it is often more representative of advanced AK or SCC. Objectives Here we report on a translational study, comparing the various stages of AK development in humans and in the UV-B irradiated mouse model, as well as the optimization of photograph acquisition of AK lesions on mouse skin. Methods Human and mouse skin lesions were analysed by histology and immunohistochemistry. Mouse lesions were also assessed using a digital dermatoscope. Results An histological and phenotypic analysis, including p53, Ki67 and CD3 expression detection, performed on human and mouse AK lesions, shows that overall AK modelling in mice is relevant in the clinical situation. Some differences are observed, such as disorganization of keratinocytes of the basal layer and a number of atypical nuclei which are more numerous in human AK, whereas much more pronounced acanthosis is observed in skin lesion in mice. Thanks to this translational study, we are able to select appropriate experimental conditions for establishing either early or advanced stage AK or an SCC model. Furthermore, we optimized photograph acquisition of AK lesions on mouse skin by using a digital dermatoscope which is also used in clinics and allows reproducible photograph acquisition for further reliable assessment of mouse lesions. Use of this camera is illustrated through a pharmacological study assessing the activity of CARAC. Conclusion These data demonstrate that this mouse model of UV-B-induced skin lesions is predictive for the identification of novel therapeutic treatments for both early and advanced stages of the disease.	[Pillon, Arnaud; Gomes, Bruno; Vandenberghe, Isabelle; Cartron, Valerie; Cebe, Patrick; Blanchet, Jean-Christophe; Guilbaud, Nicolas; Audoly, Laurent; Kruczynski, Anna] Pierre Fabre Res Inst, Res & Dev Ctr, Toulouse, France; [Sibaud, Vincent] Univ Canc Inst Toulouse, Dept Dermatol, Toulouse, France; [Lamant, Laurence] Univ Canc Inst Toulouse, Dept Pathol, Toulouse, France		Kruczynski, A (corresponding author), Pierre Fabre Res Inst, Res & Dev Ctr, Toulouse, France.	anna.kruczynski@pierre-fabre.com			Pierre Fabre Research Institute	Pierre Fabre Research Institute	This work has been performed in Pierre Fabre Research Institute, and therefore has been funded by Pierre Fabre Research Institute.	Alam M., 2006, ADV STUD MED, V6, pS785; Benavides F, 2009, J DERMATOL SCI, V53, P10, DOI 10.1016/j.jdermsci.2008.08.012; Berman Brian, 2006, J Drugs Dermatol, V5, P167; Berman B, 2013, J AM ACAD DERMATOL, V68, pS10, DOI 10.1016/j.jaad.2012.09.053; Burns EM, 2013, CARCINOGENESIS, V34, P370, DOI 10.1093/carcin/bgs349; Cozzi SJ, 2013, ARCH DERMATOL RES, V305, P79, DOI 10.1007/s00403-012-1270-0; Delalleau A, 2011, IEEE T IMAGE PROCESS, V20, P2876, DOI 10.1109/TIP.2011.2142003; Figueras MTF, 2017, J EUR ACAD DERMATOL, V31, P5, DOI 10.1111/jdv.14151; George J, 2014, Visual observation device, especially for a dermatological application, Patent No. [WO/ 2015/ 075177. 2014, 2015075177]; Grin CM, 2002, DERMATOL CLIN, V20, P641, DOI 10.1016/S0733-8635(02)00035-9; Gupta AK, 2013, BRIT J DERMATOL, V169, P250, DOI 10.1111/bjd.12343; Handoko HY, 2015, CURR PROBL DERMATOL, V46, P42, DOI 10.1159/000366534; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Meyer N, 2014, J INVEST DERMATOL, V134, P203, DOI 10.1038/jid.2013.278; Nashan D, 2013, EUR J DERMATOL, V23, P14, DOI 10.1684/ejd.2013.1923; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P18, DOI 10.1111/j.1365-2133.2007.08267.x; Schaffer BS, 2010, MOL CANCER THER, V9, P2354, DOI 10.1158/1535-7163.MCT-10-0207; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2017, AM J PHYSIOL-ENDOC M, V301, pE484; Vander Haeghen Y, 2000, IEEE T MED IMAGING, V19, P722, DOI 10.1109/42.875195; Wu CH, 2011, J DERMATOL SCI, V63, P83, DOI 10.1016/j.jdermsci.2011.04.003; Yokogawa M, 2013, MOL CARCINOGEN, V52, P760, DOI 10.1002/mc.21901	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179991	10.1371/journal.pone.0179991	http://dx.doi.org/10.1371/journal.pone.0179991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662116	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300084
J	Hollmann, AK; Dammann, I; Wemheuer, WM; Wemheuer, WE; Chilla, A; Tipold, A; Schulz-Schaeffer, WJ; Beck, J; Schutz, E; Brenig, B				Hollmann, Anne K.; Dammann, Insa; Wemheuer, Wiebke M.; Wemheuer, Wilhelm E.; Chilla, Almuth; Tipold, Andrea; Schulz-Schaeffer, Walter J.; Beck, Julia; Schuetz, Ekkehard; Brenig, Bertram			Morgagnian cataract resulting from a naturally occurring nonsense mutation elucidates a role of CPAMD8 in mammalian lens development	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROTEOMIC ANALYSIS; AQUEOUS-HUMOR; CONGENITAL CATARACTS; HUMAN IRIS; GENOME; ASSOCIATION; EXPRESSION; HYBRIDIZATION; PREDICTION	To investigate the genetic basis of hereditary lens opacities we analyzed 31 cases of bilateral congenital cataract in Red Holstein Friesian cattle. A genome-wide association study revealed a significant association on bovine chromosome 7 at positions 6,166,179 and 12,429,691. Whole genome re-sequencing of one case and four relatives showed a nonsense mutation (g.5995966C>T) in the PZP-like, alpha-2-macroglobulin domain containing 8 (CPAMD8) gene leading to a premature stop codon (CPAMD8 p. Gln74*) associated with cataract development in cattle. With immunohistochemistry we confirmed a physiological expression of CPAMD8 in the ciliary body epithelium of the eye in unaffected cattle, while the protein was not detectable in the ciliary body of cattle with cataracts. RNA expression of CPAMD8 was detected in healthy adult, fetal and cataractous lenses.	[Hollmann, Anne K.; Wemheuer, Wilhelm E.; Chilla, Almuth; Schuetz, Ekkehard; Brenig, Bertram] Univ Goettingen, Inst Vet Med, Gottingen, Germany; [Dammann, Insa] Univ Med Ctr Goettingen, Dept Neuropathol, Prion & Dementia Res Unit, Gottingen, Germany; [Wemheuer, Wiebke M.; Schulz-Schaeffer, Walter J.] Univ Saarland, Inst Neuropathol, Homburg, Germany; [Tipold, Andrea] Univ Vet Med Hannover, Dept Small Anim Med & Surg, Hannover, Germany; [Beck, Julia] Chronix Biomed, Gottingen, Germany	University of Gottingen; University of Gottingen; Saarland University; University of Veterinary Medicine Hannover, Foundation	Brenig, B (corresponding author), Univ Goettingen, Inst Vet Med, Gottingen, Germany.	bbrenig@gwdg.de		Brenig, Bertram/0000-0002-7635-9656; Jurgens-Wemheuer, Wiebke/0000-0002-1234-3321	German Research Foundation; Open Access Publication Funds of the University of Goettingen	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the University of Goettingen	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the University of Goettingen. The German Research Foundation and the Open Access Publication Funds of the University of Goettingen only cover the publication costs and did not have any additional role in the study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; ASHTON N, 1977, VET REC, V100, P505, DOI 10.1136/vr.100.24.505; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; BISTNER SI, 1970, PATHOL VET, V7, P275, DOI 10.1177/030098587000700306; BRUBAKER RF, 1991, INVEST OPHTH VIS SCI, V32, P3145; CARTER A. H., 1960, PROC NEW ZEALAND SOC ANIMAL PROD, V20, P108; Cheong SS, 2016, AM J HUM GENET, V99, P1338, DOI 10.1016/j.ajhg.2016.09.022; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chowdhury UR, 2010, INVEST OPHTH VIS SCI, V51, P4921, DOI 10.1167/iovs.10-5531; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; COGAN DG, 1962, EXP EYE RES, V1, P291, DOI 10.1016/S0014-4835(62)80013-X; CROOKSTON KP, 1994, J BIOL CHEM, V269, P1533; De Iongh RU, 2001, EXP EYE RES, V72, P649, DOI 10.1006/exer.2001.1001; de Longh RU, 2001, DEVELOPMENT, V128, P3995; De Maria A, 2017, INVEST OPHTH VIS SCI, V58, P573, DOI 10.1167/iovs.16-20866; Detlefson JA, 1920, AM NAT, V54, P277, DOI 10.1086/279759; Duckman R. H., 2006, VISUAL DEV DIAGNOSIS, P124; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FREDDO TF, 1990, INVEST OPHTH VIS SCI, V31, P125; Garbe J., 2008, PEDIGRAPH SOFTWARE T; GELATT KN, 1971, J AM VET MED ASSOC, V159, P195; Goel R, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-9; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gregory PW, 1943, J HERED, V34, P125, DOI 10.1093/oxfordjournals.jhered.a105263; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hurley S, 2008, VET REC, V163, P579, DOI 10.1136/vr.163.19.579-b; Ji YH, 2015, CLIN BIOCHEM, V48, P1304, DOI 10.1016/j.clinbiochem.2015.08.006; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Krump L, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-2; Kurien BT, 2011, METHODS MOL BIOL, V717, P55, DOI 10.1007/978-1-61779-024-9_3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZF, 2004, GENOMICS, V83, P1083, DOI 10.1016/j.ygeno.2003.12.005; Lovicu FJ, 2002, BRIT J OPHTHALMOL, V86, P220, DOI 10.1136/bjo.86.2.220; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murgiano L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110628; Murthy KR, 2016, OMICS, V20, P510, DOI 10.1089/omi.2016.0100; Murthy KR, 2015, OMICS, V19, P283, DOI 10.1089/omi.2015.0029; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; POTTS JD, 1995, DEV DYNAM, V203, P317, DOI 10.1002/aja.1002030304; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SAUNDERS LZ, 1951, CORNELL VET, V41, P351; Schulz MW, 1996, INVEST OPHTH VIS SCI, V37, P1509; Schutz E, 1999, BIOTECHNIQUES, V27, P1218, DOI 10.2144/99276bc04; Skeie JM, 2014, JAMA OPHTHALMOL, V132, P1271, DOI 10.1001/jamaophthalmol.2014.2065; Sousounis K, 2014, REGENERATION, V1, P47, DOI 10.1002/reg2.25; To Chi-ho, 2002, Clin Exp Optom, V85, P335; von Ahsen N, 1999, CLIN CHEM, V45, P2094; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang PB, 2016, PROTEOMICS, V16, P1146, DOI 10.1002/pmic.201500188	56	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180665	10.1371/journal.pone.0180665	http://dx.doi.org/10.1371/journal.pone.0180665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683140	Green Published, gold			2022-12-27	WOS:000405335200058
J	Langford, ST; Wiggins, CS; Santos, R; Hauser, M; Becker, JM; Ruggles, AE				Langford, Seth T.; Wiggins, Cody S.; Santos, Roque; Hauser, Melinda; Becker, Jeffrey M.; Ruggles, Arthur E.			Three-dimensional spatiotemporal tracking of fluorine-18 radiolabeled yeast cells via positron emission particle tracking	PLOS ONE			English	Article							PROGENITOR CELLS; PET	A method for Positron Emission Particle Tracking (PEPT) based on optical feature point identification techniques is demonstrated for use in low activity tracking experiments. A population of yeast cells of approximately 125,000 members is activated to roughly 55 Bq/cell by F-18 uptake. An in vitro particle tracking experiment is performed with nearly 20 of these cells after decay to 32 Bq/cell. These cells are successfully identified and tracked simultaneously in this experiment. This work extends the applicability of PEPT as a cell tracking method by allowing a number of cells to be tracked together, and demonstrating tracking for very low activity tracers.	[Langford, Seth T.; Santos, Roque; Ruggles, Arthur E.] Univ Tennessee, Dept Nucl Engn, Knoxville, TN 37996 USA; [Wiggins, Cody S.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Santos, Roque] Escuela Politec Nacl, Dept Ciencias Nucl, Quito, Ecuador; [Hauser, Melinda; Becker, Jeffrey M.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Escuela Politecnica Nacional Ecuador; University of Tennessee System; University of Tennessee Knoxville	Wiggins, CS (corresponding author), Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA.	cwiggin2@vols.utk.edu		Wiggins, Cody/0000-0001-8767-8866	National Nuclear Security Administration under Stewardship Science Academic Alliances [DE-NA0001983]; National Institutes of Health [GM112496]; Nuclear Energy University Programs; Integrated University Programs fellowship	National Nuclear Security Administration under Stewardship Science Academic Alliances(National Nuclear Security Administration); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nuclear Energy University Programs; Integrated University Programs fellowship	This work was supported by the National Nuclear Security Administration (https://nnsa.energy.gov/)under the Stewardship Science Academic Alliances award DE-NA0001983, awarded to AER, and National Institutes of Health (https://www.nih.gov/) grant GM112496, awarded to JMB. This materialis based on work supported under a Nuclear Energy University Programs (https://neup.inl.gov/) Integrated University Programs fellowship awarded to CSW. The National Nuclear Security Administration assisted in the data collection and analysis in that they provided funding explicitly for the acquisition of the PET scanner used in this research	Adonai N, 2002, P NATL ACAD SCI USA, V99, P3030, DOI 10.1073/pnas.052709599; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Bao Q, 2009, J NUCL MED, V50, P401, DOI 10.2967/jnumed.108.056374; Bickell M, 2012, NUCL INSTRUM METH A, V682, P36, DOI 10.1016/j.nima.2012.04.037; Chang YF, 2015, EXP FLUIDS, V56, DOI 10.1007/s00348-014-1875-5; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Doherty P W, 1978, Clin Nucl Med, V3, P108; Game JC, 2005, GENETICS, V169, P51, DOI 10.1534/genetics.104.028613; Goertzen AL, 2006, P IEEE NUCL SCI S 20; Hamerly G, 2003, P NEUR INF PROC SYST, V16; Heyn C, 2006, MAGN RESON MED, V56, P1001, DOI 10.1002/mrm.21029; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Langford S, 2016, P INT C NUCL ENG 24, P24; Langford S, 2016, NUCL ENG DES, V302, P81, DOI 10.1016/j.nucengdes.2016.01.017; Lee KS, 2015, IEEE T MED IMAGING, V34, P994, DOI 10.1109/TMI.2014.2373351; Lee S, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00058; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Lu L, 2013, P IEEE NUCL SCI S ME; Ma B, 2005, NUCL MED BIOL, V32, P701, DOI 10.1016/j.nucmedbio.2005.04.018; MELDER RJ, 1994, J IMMUNOL METHODS, V175, P79, DOI 10.1016/0022-1759(94)90333-6; Morrison AJ, 2016, CHEM ENG SCI, V152, P186, DOI 10.1016/j.ces.2016.06.022; Ouyang Y, 2016, MOL IMAGING, V15, DOI 10.1177/1536012116646489; PARKER DJ, 1993, NUCL INSTRUM METH A, V326, P592, DOI 10.1016/0168-9002(93)90864-E; Patel N, 2017, EXP FLUIDS  IN PRESS; Perez-Mohedano R, 2015, CHEM ENG J, V259, P724, DOI 10.1016/j.cej.2014.08.033; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shaw RF, 1978, United States patent, Patent No. [US 4224303 A, 4224303]; Tong Shan, 2010, Imaging Med, V2, P529, DOI 10.2217/iim.10.49; Wiggins C, 2017, FEATURE POINT IDENTI, V843, P22; Wiggins C, 2016, NUCL INSTRUM METH A, V811, P18, DOI 10.1016/j.nima.2015.11.136; Yang Z, 2006, NUCL INSTRUM METH A, V564, P332, DOI 10.1016/j.nima.2006.04.054; Zhang Y, 2012, CELL TRANSPLANT, V21, P1821, DOI 10.3727/096368911X637416	33	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180503	10.1371/journal.pone.0180503	http://dx.doi.org/10.1371/journal.pone.0180503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683074	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200043
J	Tominami, K; Kanetaka, H; Sasaki, S; Mokudai, T; Kaneko, T; Niwano, Y				Tominami, Kanako; Kanetaka, Hiroyasu; Sasaki, Shota; Mokudai, Takayuki; Kaneko, Toshiro; Niwano, Yoshimi			Cold atmospheric plasma enhances osteoblast differentiation	PLOS ONE			English	Article							MC3T3-E1 CELLS; PROLIFERATION; RESPONSES; PRODUCTS; PATHWAY; ROS	This study was designed to assess the effects of cold atmospheric plasma on osteoblastic differentiation in pre-osteoblastic MC3T3-E1 cells. Plasma was irradiated directly to a culture medium containing plated cells for 5 s or 10 s. Alkaline phosphatase (ALP) activity assay and alizarin red staining were applied to assess osteoblastic differentiation. The plasma-generated radicals were detected directly using an electron spin resonance-spin trapping technique. Results show that plasma irradiation under specific conditions increased ALP activity and enhanced mineralization, and demonstrated that the yield of radicals was increased in an irradiation-time-dependent manner. Appropriate plasma irradiation stimulated the osteoblastic differentiation of the cells. This process offers the potential of promoting bone regeneration.	[Tominami, Kanako; Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi, Japan; [Kanetaka, Hiroyasu; Mokudai, Takayuki; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi, Japan; [Sasaki, Shota; Kaneko, Toshiro] Tohoku Univ, Dept Elect Engn, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Kanetaka, H (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi, Japan.; Kanetaka, H (corresponding author), Tohoku Univ, Grad Sch Dent, Sendai, Miyagi, Japan.	kanetaka@dent.tohoku.ac.jp	MOKUDAI, TAKAYUKI/AAK-1541-2020; Mokudai, Takayuki/M-1029-2018; Niwnao, Yoshimi/Z-3593-2019	MOKUDAI, TAKAYUKI/0000-0003-4628-6908; Mokudai, Takayuki/0000-0003-4628-6908; Sasaki, Shota/0000-0002-1478-7700; Tominami, Kanako/0000-0003-4342-6979; Kanetaka, Hiroyasu/0000-0001-7744-3879	JSPS KAKENHI [JP25293390, JP16H05520]; Grants-in-Aid for Scientific Research [16K13708] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers JP25293390, JP16H05520 (https://www.jsps.go.jp/english/index.html).The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript	Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; Chen LL, 2011, ARCH ORAL BIOL, V56, P1655, DOI 10.1016/j.archoralbio.2011.06.008; Fatokun AA, 2008, EUR J PHARMACOL, V587, P35, DOI 10.1016/j.ejphar.2008.03.024; He WW, 2014, J FOOD DRUG ANAL, V22, P49, DOI 10.1016/j.jfda.2014.01.004; Hirose Y, 1995, NIHON HOTETSU SHIKA, V39, P159; Houghton EA, 2009, J BIOL INORG CHEM, V14, P243, DOI 10.1007/s00775-008-0444-x; Ishaq M, 2014, MOL BIOL CELL, V25, P1523, DOI 10.1091/mbc.E13-10-0590; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Karkonen A, 2006, J EXP BOT, V57, P1633, DOI 10.1093/jxb/erj197; Kono R, 2011, BIOSCI BIOTECH BIOCH, V75, P1907, DOI 10.1271/bbb.110264; Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947; Mukohda M, 2010, J VET MED SCI, V72, P1547, DOI 10.1292/jvms.10-0232; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Saito K, 2009, FREE RADICAL RES, V43, P668, DOI 10.1080/10715760902988850; Sasaki S, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.026202; Takamatsu T, 2014, RSC ADV, V4, P39901, DOI 10.1039/c4ra05936k; Takenaka K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NE04; Toda M, 2014, BONE, V67, P237, DOI 10.1016/j.bone.2014.07.018; Tominami K, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.01AF03; Wu AS, 2013, J SURG RES, V179, pE1, DOI 10.1016/j.jss.2012.02.039; Yumoto H, 2015, CELL PHYSIOL BIOCHEM, V35, P601, DOI 10.1159/000369722; Zhou YH, 2012, ACTA BIOMATER, V8, P2307, DOI 10.1016/j.actbio.2012.03.012	25	23	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180507	10.1371/journal.pone.0180507	http://dx.doi.org/10.1371/journal.pone.0180507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683076	gold, Green Published, Green Submitted			2022-12-27	WOS:000405335200044
J	Kim, S; Choi, D; Lee, E; Rhee, W				Kim, Seungwook; Choi, Daeyoung; Lee, Eunjung; Rhee, Wonjong			Churn prediction of mobile and online casual games using play log data	PLOS ONE			English	Article							AREA	Internet-connected devices, especially mobile devices such as smartphones, have become widely accessible in the past decade. Interaction with such devices has evolved into frequent and short-duration usage, and this phenomenon has resulted in a pervasive popularity of casual games in the game sector. On the other hand, development of casual games has become easier than ever as a result of the advancement of development tools. With the resulting fierce competition, now both acquisition and retention of users are the prime concerns in the field. In this study, we focus on churn prediction of mobile and online casual games. While churn prediction and analysis can provide important insights and action cues on retention, its application using play log data has been primitive or very limited in the casual game area. Most of the existing methods cannot be applied to casual games because casual game players tend to churn very quickly and they do not pay periodic subscription fees. Therefore, we focus on the new players and formally define churn using observation period (OP) and churn prediction period (CP). Using the definition, we develop a standard churn analysis process for casual games. We cover essential topics such as preprocessing of raw data, feature engineering including feature analysis, churn prediction modeling using traditional machine learning algorithms (logistic regression, gradient boosting, and random forests) and two deep learning algorithms (CNN and LSTM), and sensitivity analysis for OP and CP. Play log data of three different casual games are considered by analyzing a total of 193,443 unique player records and 10,874,958 play log records. While the analysis results provide useful insights, the overall results indicate that a small number of well-chosen features used as performance metrics might be sufficient for making important action decisions and that OP and CP should be properly chosen depending on the analysis goal.	[Kim, Seungwook; Choi, Daeyoung; Lee, Eunjung; Rhee, Wonjong] Seoul Natl Univ, Dept Transdisciplinary Studies, Seoul, South Korea	Seoul National University (SNU)	Rhee, W (corresponding author), Seoul Natl Univ, Dept Transdisciplinary Studies, Seoul, South Korea.	wrhee@snu.a.c.kr		Lee, Eunjung/0000-0002-6476-9527; Rhee, Wonjong/0000-0002-2590-8774	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF2 016R1A2B1014734]; Seoul National University [490-20140016]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Seoul National University	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no. NRF2 016R1A2B1014734) and research grant for foreign professors through Seoul National University in 2014 (no. 490-20140016).	[Anonymous], 2016, ARXIV160405377; Association ES, 2010, ESS FACTS COMP VID G; Au WH, 2003, IEEE T EVOLUT COMPUT, V7, P532, DOI 10.1109/TEVC.2003.819264; BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burez J, 2009, EXPERT SYST APPL, V36, P4626, DOI 10.1016/j.eswa.2008.05.027; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chen T., 2015, XGBOOST EXTREME GRAD, V1, P1; Chen T.Q., 2016, PROC 22 ACM SIGKDD I, P785, DOI [10.1145/2939672.2939785, DOI 10.1145/2939672.2939785]; Coussement K, 2008, EXPERT SYST APPL, V34, P313, DOI 10.1016/j.eswa.2006.09.038; Coussement K, 2010, EXPERT SYST APPL, V37, P2132, DOI 10.1016/j.eswa.2009.07.029; Egenfeldt-Nielsen S., 2009, UNDERSTANDING VIDEO; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Ganesh J, 2000, J MARKETING, V64, P65, DOI 10.1509/jmkg.64.3.65.18028; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hadiji F, 2014, IEEE CONF COMPU INTE; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Juul J., 2010, CASUAL REVOLUTION RE; Kawale J, 2009, COMP SCI ENG 2009 CS; Koetsier J., 2014, MOBILE APP MONETIZAT; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kuittinen J, 2007, P 2007 C FUT PLAY; Kultima A, 2009, P 13 INT MINDTREK C; Kumar Dudyala Anil, 2008, International Journal of Data Analysis Techniques and Strategies, V1, P4, DOI 10.1504/IJDATS.2008.020020; Kwak H, 2015, P 33 ANN ACM C HUM F; Kwak H, 2014, INT C SOC INF; Kwon H, 2017, IEEE T INF FOREN SEC, V12, P544, DOI 10.1109/TIFS.2016.2623586; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee E, 2016, 23RD ANNUAL NETWORK AND DISTRIBUTED SYSTEM SECURITY SYMPOSIUM (NDSS 2016), DOI 10.14722/ndss.2016.23436; Morik K, 2004, EUR C PRINC DAT MIN; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Orji R, 2013, PERS UBIQUIT COMPUT, V17, P1211, DOI 10.1007/s00779-012-0590-6; Reichheld FF, 2000, HARVARD BUS REV, V78, P105; Runge J, 2014, IEEE CONF COMPU INTE; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Woo J, 2012, APPL MATH INFORM SCI, V6, P291; Xie YY, 2009, EXPERT SYST APPL, V36, P5445, DOI 10.1016/j.eswa.2008.06.121	42	22	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180735	10.1371/journal.pone.0180735	http://dx.doi.org/10.1371/journal.pone.0180735			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678880	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200088
J	Willems, MGM; Kemp, MW; Fast, LA; Wagemaker, NMM; Janssen, LEW; Newnham, JP; Payne, MS; Spiller, OB; Kallapur, SG; Jobe, AH; Delhaas, T; Kramer, BW; Wolfs, TGAM				Willems, Monique G. M.; Kemp, Matthew W.; Fast, Laura A.; Wagemaker, Nick M. M.; Janssen, Leon E. W.; Newnham, John P.; Payne, Matt S.; Spiller, Owen B.; Kallapur, Suhas G.; Jobe, Alan H.; Delhaas, Tammo; Kramer, Boris W.; Wolfs, Tim G. A. M.			Pulmonary vascular changes in extremely preterm sheep after intra-amniotic exposure to Ureaplasma parvum and lipopolysaccharide	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BRONCHOPULMONARY DYSPLASIA; TRAINED IMMUNITY; FETAL SHEEP; OVINE MODEL; LUNG; CHORIOAMNIONITIS; ENDOTOXIN; HYPERTENSION; INFLAMMATION	Background Chorioamnionitis can induce pulmonary inflammation and promote bronchopulmonary dysplasia development, distinguished by alveolar simplification and impaired vascular growth. Chorioamnionitis is more common during the extremely preterm canalicular lung stage (crucial for vascular development); and increases the risk for subsequent sepsis. We hypothesized that single/combined exposure to chronic and/or acute inflammation induces pulmonary inflammatory responses and vascular changes. Methods Ovine fetuses were intra-amniotically exposed to chronic Ureaplasma parvum (UP) at 24 days (d) before extreme preterm delivery at 94d (term 147d) and/or to lipopolysaccharide (LPS) 7 or 2d before delivery. Pulmonary inflammation, vascular remodeling and angiogenic factors were assessed. Results LPS exposure increased CD3-positive and myeloperoxidase-positive cells. Combined UP-LPS exposure increased pulmonary inflammation compared with 2d LPS or UP groups. The UP+2d LPS group had an increased adventitial fibrosis score when compared with UP-treated animals. A reduced wall-to-lumen ratio was found in the 7d LPS animals when compared to the 2d LPS-treated animals. Exposure to UP+2d LPS reduced VEGF and VEGFR2 levels compared with 2d LPS-treated animals. Angiopoietin-1 (Ang1) and tunica interna endothelial cell kinase 2 (Tie-2) levels were decreased after UP+7d LPS as well as after 7d LPS, but not with UP alone. Conclusion Chronic UP and subsequent LPS exposure increased pulmonary inflammation and decreased expression of angiogenic growth factors and receptors when compared to single	[Willems, Monique G. M.; Fast, Laura A.; Wagemaker, Nick M. M.; Janssen, Leon E. W.; Kramer, Boris W.; Wolfs, Tim G. A. M.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Willems, Monique G. M.; Delhaas, Tammo; Wolfs, Tim G. A. M.] Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands; [Willems, Monique G. M.; Kramer, Boris W.; Wolfs, Tim G. A. M.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Kemp, Matthew W.; Newnham, John P.; Payne, Matt S.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [Spiller, Owen B.] Cardiff Univ, Univ Wales Hosp, Sch Med, Cardiff, S Glam, Wales; [Kallapur, Suhas G.; Jobe, Alan H.] Cincinnati Childrens Hosp Med Ctr, Div Neonatol, Cincinnati, OH 45229 USA; [Delhaas, Tammo] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Kramer, Boris W.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Western Australia; Cardiff University; Cincinnati Children's Hospital Medical Center; Maastricht University; Maastricht University	Wolfs, TGAM (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands.; Wolfs, TGAM (corresponding author), Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands.; Wolfs, TGAM (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands.	tim.wolfs@maastrichtuniversity.nl	Spiller, Owen Brad/AAC-2474-2020; Kramer, Boris/AAO-3183-2021	Spiller, Owen Brad/0000-0002-9117-6911; Wolfs, Tim/0000-0003-4417-4144				Baker CD, 2014, PEDIAT ALLER IMM PUL, V27, P8, DOI 10.1089/ped.2013.0323; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; BUSH A, 1990, ARCH DIS CHILD, V65, P739, DOI 10.1136/adc.65.7.739; Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Collins JJP, 2010, AM J PHYSIOL-LUNG C, V299, pL852, DOI 10.1152/ajplung.00183.2010; Correa-Rocha R, 2012, PEDIATR RES, V71, P590, DOI 10.1038/pr.2012.6; Dempsey E, 2005, AM J PERINAT, V22, P155, DOI 10.1055/s-2005-865020; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Galinsky R, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/412831; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hagen ASE, 2005, PEDIATR RES, V58, P1228, DOI 10.1203/01.pdr.0000185266.23265.87; Jobe AH, 2012, CLIN PERINATOL, V39, P441, DOI 10.1016/j.clp.2012.06.010; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kallapur SG, 2004, AM J PHYSIOL-LUNG C, V287, pL1178, DOI 10.1152/ajplung.00049.2004; Kallapur SG, 2005, AM J PHYSIOL-LUNG C, V288, pL966, DOI 10.1152/ajplung.00389.2004; Kallapur SG, 2011, J IMMUNOL, V187, P2688, DOI 10.4049/jimmunol.1100779; Kemp MW, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.076; Kramer BW, 2011, NEONATOLOGY, V99, P320, DOI 10.1159/000326620; Lahra MM, 2004, AM J OBSTET GYNECOL, V190, P147, DOI 10.1016/j.ajog.2003.07.012; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Levy O, 2014, NEONATOLOGY, V105, P136, DOI 10.1159/000356035; Levy O, 2014, PEDIATR RES, V75, P184, DOI 10.1038/pr.2013.214; Lowe J, 2014, PEDIATR INFECT DIS J, V33, P697, DOI 10.1097/INF.0000000000000239; Melville JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00079; Moss TJM, 2002, AM J OBSTET GYNECOL, V187, P1059, DOI 10.1067/mob.2002.126296; Mulvany MJ, 1999, CARDIOVASC RES, V41, P9, DOI 10.1016/S0008-6363(98)00289-2; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Nikiforou M, 2015, INFLAMM BOWEL DIS, V21, P2026, DOI 10.1097/MIB.0000000000000455; Romero R, 2014, J MATERN-FETAL NEO M, V27, P1397, DOI 10.3109/14767058.2013.860963; Speer CP, 2006, J PERINATOL, V26, pS57, DOI 10.1038/sj.jp.7211476; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Sung TJ, 2011, PEDIATR INFECT DIS J, V30, P379, DOI 10.1097/INF.0b013e318202ac3a; Tang JR, 2010, AM J PHYSIOL-LUNG C, V299, pL735, DOI 10.1152/ajplung.00153.2010; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Van Rheen Z, 2011, AM J RESP CELL MOL, V44, P500, DOI 10.1165/rcmb.2010-0065OC; van Varik Bernard J., 2012, Frontiers in Genetics, V3, P290, DOI 10.3389/fgene.2012.00290; Willems MGM, 2016, AM J PHYSIOL-LUNG C, V310, pL1, DOI 10.1152/ajplung.00289.2015; Xiao L, 2014, INFECT IMMUN, V82, P1657, DOI 10.1128/IAI.01231-13	40	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180114	10.1371/journal.pone.0180114	http://dx.doi.org/10.1371/journal.pone.0180114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666032	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000404608700062
J	Ben Belgacem, Z; Carre, G; Charpentier, E; Le-Bras, F; Maho, T; Robert, E; Pouvesle, JM; Polidor, F; Gangloff, SC; Boudifa, M; Gelle, MP				Ben Belgacem, Zouhaier; Carre, Gaelle; Charpentier, Emilie; Le-Bras, Florian; Maho, Thomas; Robert, Eric; Pouvesle, Jean-Michel; Polidor, Franck; Gangloff, Sophie C.; Boudifa, Mohamed; Gelle, Marie-Paule			Innovative non-thermal plasma disinfection process inside sealed bags: Assessment of bactericidal and sporicidal effectiveness in regard to current sterilization norms	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE; BACILLUS-SUBTILIS; OXYGEN PLASMA; GAS PLASMA; INACTIVATION; SPORES; DISCHARGE; AIR; PARAMETERS; RADIATION	In this work, we developed a device capable to generate a non-thermal plasma discharge inside a sealed bag. The aim of this study was to assess the effectiveness of the oxygen, nitrogen and argon plasma sterilization on Pseudomonas aeruginosa, Staphylococcus aureus and Bacillus subtilis spores according to the NF EN 556 Norm. Moreover the bag integrity which is a critical key to maintain the sterile state of items after the end of the process was verified by Fourier Transform Infrared (FTIR) and X-ray Photoelectron Spectrometry (XPS) analyses. After plasma treatments, the bacterial counting showed a 6 log reduction of P. aeruginosa and S. aureus in 45 min and 120 min respectively whatever the gas used and a 4 log reduction of B. subtilis spores in 120 min with only oxygen plasma. These results were confirmed by Scanning Electron Microscopy (SEM) observations showing altered bacteria or spores and numerous debris. Taking into account the studied microorganisms, the oxygen plasma treatment showed the highest efficiency. FTIR and XPS analyses showed that this treatment induced no significant modification of the bags. To conclude this non-thermal plasma sterilization technique could be an opportunity to sterilize heat and chemical-sensitive medical devices and to preserve their sterile state after the end of the process.	[Ben Belgacem, Zouhaier; Carre, Gaelle; Charpentier, Emilie; Le-Bras, Florian; Gangloff, Sophie C.; Gelle, Marie-Paule] Univ Reims, SFR CAP Sante, Lab Biomat & Inflammat Site Osseux EA 4691, Reims, France; [Maho, Thomas; Boudifa, Mohamed] CRITT MDTS, Charleville Mezieres, France; [Maho, Thomas; Robert, Eric; Pouvesle, Jean-Michel] Grp Rech Energet Milieux Ionises UMR 7344, Orleans, France; [Polidor, Franck] Sominex, Bayeux, France	Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS)	Gelle, MP (corresponding author), Univ Reims, SFR CAP Sante, Lab Biomat & Inflammat Site Osseux EA 4691, Reims, France.	marie-paule.gelle@univ-reims.fr	robert, eric/E-7992-2019; POUVESLE, Jean-Michel/L-2087-2018	robert, eric/0000-0002-7894-7080; POUVESLE, Jean-Michel/0000-0002-3236-0102; Charpentier, Emilie/0000-0001-8470-4432; gangloff, sophie/0000-0003-2651-9372	national agency of Research of France Project TecSan PLAS'STER [ANR-12-TECS-0007]	national agency of Research of France Project TecSan PLAS'STER	This work was supported by funding by the national agency of Research of France Project TecSan PLAS'STER ANR-12-TECS-0007 (http://www.agence-nationale-recherche.fr/?Projet=ANR12-TECS-007) (GCECFLB); funding by the Champagne-Ardenne Region(https://www.crchampagne-ardenne.fr/Pages/Accueil.aspx) (ZBB); asso.fr/index.jsp?r=0) TM).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Franck Polidor is employed by Sominex. Sominex provided support in the form of salary for author FP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alkawareek MY, 2014, INT J ANTIMICROB AG, V43, P154, DOI 10.1016/j.ijantimicag.2013.08.022; Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; Ben Belgacem Z, 2016, IRBM, V37, P68, DOI 10.1016/j.irbm.2016.02.006; Bol'shakov AA, 2004, AIAA J, V42, P823, DOI 10.2514/1.9562; Boscariol MR, 2008, INT J PHARMACEUT, V353, P170, DOI [10.1016/j.ijphartn.2007.11.059, 10.1016/j.ijpharm.2007.11.059]; Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013; Connor M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41814; Cotter JJ, 2011, J HOSP INFECT, V78, P204, DOI 10.1016/j.jhin.2011.03.019; De Geyter N, 2012, ANNU REV BIOMED ENG, V14, P255, DOI 10.1146/annurev-bioeng-071811-150110; Deng XT, 2006, IEEE T PLASMA SCI, V34, P1310, DOI 10.1109/TPS.2006.877739; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; GALLY D, 1993, J GEN MICROBIOL, V139, P1907, DOI 10.1099/00221287-139-8-1907; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Guo J, 2017, J APPL MICROBIOL, V122, P87, DOI 10.1111/jam.13335; Hertwig C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00774; Holyoak GR, 1996, TOXICOLOGY, V108, P33, DOI 10.1016/S0300-483X(95)03268-K; Justan I, 2014, FOLIA MICROBIOL, V59, P315, DOI 10.1007/s12223-014-0301-y; Kawamura K, 2012, MICROBIOL IMMUNOL, V56, P431, DOI 10.1111/j.1348-0421.2012.00457.x; Keener KM, 2015, Patent, Patent No. [WO/2012/125435, 2012125435]; Klampfl TG, 2012, APPL ENVIRON MICROB, V78, P5077, DOI 10.1128/AEM.00583-12; Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Lerouge S, 2000, J BIOMED MATER RES, V51, P128, DOI 10.1002/(SICI)1097-4636(200007)51:1<128::AID-JBM17>3.3.CO;2-R; Lerouge S., 2001, PLASMAS POLYM, V6, P175, DOI DOI 10.1023/A:1013196629791; Levif P, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/40/405201; Marchal F, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/34/345202; Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9; Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349; Moisan M, 2013, EUR PHYS J-APPL PHYS, V63, DOI 10.1051/epjap/2013120510; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Patil S, 2014, J HOSP INFECT, V88, P162, DOI 10.1016/j.jhin.2014.08.009; Pavlovich MJ, 2013, PLASMA PROCESS POLYM, V10, P69, DOI 10.1002/ppap.201200073; Pignata C, 2017, J APPL MICROBIOL; Popot J.M., 2012, Device. Patent, Patent No. [WO2012/038669 A1, 2012038669, 2012/038669]; Raballand V, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/11/115207; Raguse M, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/28/285401; Reineke K, 2015, INNOV FOOD SCI EMERG, V30, P112, DOI 10.1016/j.ifset.2015.03.019; Rossi F, 2006, PLASMA PROCESS POLYM, V3, P431, DOI 10.1002/ppap.200600011; Roth S, 2010, J APPL MICROBIOL, V108, P521, DOI 10.1111/j.1365-2672.2009.04453.x; Sarrette JP, 2012, PLASMA PROCESS POLYM, V9, P576, DOI 10.1002/ppap.201100096; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Shintani H, 2016, BIOCONTROL SCI, V21, P1, DOI 10.4265/bio.21.1; Shintani H, 2010, EXP THER MED, V1, P731, DOI 10.3892/etm.2010.136; Silhavy T J, 2010, COLD SPRING HARB PER; Steelman VM, 1995, AORN J, V55, P778; Steelman VM, 1995, AORN J, V55, P773; Steelman VM, 1995, AORN J, V55, P782; Surdeau N, 2006, J HOSP INFECT, V62, P487, DOI 10.1016/j.jhin.2005.09.003; Sureshkumar A, 2010, INT J PHARMACEUT, V396, P17, DOI 10.1016/j.ijpharm.2010.05.045; Tanino M., 2007, INT J PLASMA ENV SCI, V1, P102; Tseng S, 2012, APPL MICROBIOL BIOT, V93, P2563, DOI 10.1007/s00253-011-3661-0; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Winter T, 2013, PROTEOMICS, V13, P2608, DOI 10.1002/pmic.201200343; Zhang YZ, 1996, BIOMATERIALS, V17, P2265, DOI 10.1016/0142-9612(96)00055-5	55	33	34	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180183	10.1371/journal.pone.0180183	http://dx.doi.org/10.1371/journal.pone.0180183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662202	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300119
J	Mata, GMSC; Ferreira, GM; Spira, B				Silva Campos Mata, Gardenia Marcia; Ferreira, Gerson Moura; Spira, Beny			RpoS role in virulence and fitness in enteropathogenic Escherichia coli	PLOS ONE			English	Article							BUNDLE-FORMING PILI; TRADE-OFF; TRANSCRIPTIONAL REGULATION; CONTROLS EXPRESSION; STRESS RESISTANCE; PROTEIN SECRETION; EPITHELIAL-CELLS; STRAIN VARIATION; GENE-EXPRESSION; III SECRETION	Enteropathogenic Escherichia coli (EPEC) is a diarrheagenic pathogen that afflicts infants in developing countries. The most important virulence trait of EPEC is its ability to intimately adhere to cells in the small intestine, and to elicit diarrhea. The alternative sigma factor RpoS is involved in the virulence of several bacterial species. RpoS coordinates the general stress response and accumulates in cells under stress or in the stationary phase. RpoS levels differ across E. coli strains. High-RpoS strains are highly resistant to environmental stresses, but usually display low nutritional competence, while low-RpoS strains show the opposite phenotype. Here we investigated whether RpoS plays a role in the virulence and fitness of two different EPEC strains, E2348/69 and LRT9. A rpoS null mutation had a small positive effect on LRT9 adherence to epithelial cells, but the expression of the EPEC adhesins BfpA and intimin was not significantly affected by the mutation. E2348/69 adherence was not significantly affected by the rpoS mutation. The intrinsic level of RpoS was higher in LRT9 than in E2348/69 while the latter adhered more strongly and expressed higher levels of the adhesin BfpA than the former. Knockout of rpoS strongly impaired resistance to oxidative, osmotic and acid stress in both E2348/69 and LRT9. However, strain E2348/69 was significantly more sensitive to oxidative stress than LRT9. Finally, competition assays showed that the rpoS mutant of LRT9 displayed higher fitness under continuous culture than its isogenic wild-type strain, while E2348/69 outcompeted its rpoS mutant. In conclusion, RpoS plays mostly a positive role in EPEC biology and at least in the case of strain E2348/69 it is not constrained by the trade-off between vegetative growth and stress resistance.	[Silva Campos Mata, Gardenia Marcia; Ferreira, Gerson Moura; Spira, Beny] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil; [Silva Campos Mata, Gardenia Marcia] Univ Fed Rio Janeiro, Macae, RJ, Brazil; [Ferreira, Gerson Moura] Inst Nacl Canc, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; National Cancer Institute (Inca)	Spira, B (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil.	benys@usp.br	Spira, Beny/D-6928-2012; Spira, Beny/AAR-2287-2020; Ferreira, Gerson Moura/B-4698-2017; Spira, Beny/GSD-2097-2022	Spira, Beny/0000-0001-5394-9074; Ferreira, Gerson Moura/0000-0002-3467-2580; Spira, Beny/0000-0001-5394-9074	Fundacao de Amparoa Pesquisa do Estado de SaoPaulo (FAPESP); FAPESP; Conselho Nacional de Desenvolvimento Cientfico e Tecnologico(CNPq)	Fundacao de Amparoa Pesquisa do Estado de SaoPaulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientfico e Tecnologico(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparoa Pesquisa do Estado de SaoPaulo (FAPESP).We are thankful to Diogo Oshiro for dedicated technical help. G.M.S.M and G.M.F.were supported by FAPESP scholarships. B.S. is a recipient of the Conselho Nacional de Desenvolvimento Cientfico e Tecnologico(CNPq) productivity scholarship.	Atlung T, 2002, MOL GENET GENOMICS, V266, P873, DOI 10.1007/s00438-001-0610-0; Battesti A, 2011, ANN REV MICROBIOL; Beltrametti F, 1999, J BACTERIOL, V181, P3409, DOI 10.1128/JB.181.11.3409-3418.1999; Bleibtreu A, 2014, J BACTERIOL, V196, P4276, DOI 10.1128/JB.01972-14; Bustamante VH, 1998, J BACTERIOL, V180, P3013, DOI 10.1128/JB.180.11.3013-3016.1998; Chiang SM, 2011, APPL ENVIRON MICROB, V77, P7915, DOI 10.1128/AEM.05274-11; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; Coldewey SM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-21; Conway T, 2015, GUT MICROBIOGY SPECT, V3; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dong T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-118; DONNENBERG MS, 1992, MOL MICROBIOL, V6, P3427, DOI 10.1111/j.1365-2958.1992.tb02210.x; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Ferenci T, 2016, TRENDS MICROBIOL, V24, P209, DOI 10.1016/j.tim.2015.11.009; Ferenci T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-62; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Ferrandiz MJ, 2005, INFECT IMMUN, V73, P1684, DOI 10.1128/IAI.73.3.1684-1694.2005; Ferreira GM, 2008, MICROBIOL-SGM, V154, P2025, DOI 10.1099/mic.0.2008/016634-0; Galbiati HF, 2014, ARCH MICROBIOL, V196, P589, DOI 10.1007/s00203-014-0994-y; GOBER JW, 1992, MOL BIOL CELL, V3, P913, DOI 10.1091/mbc.3.8.913; Handford CL, 2009, CAN J MICROBIOL, V55, P1229, DOI [10.1139/W09-079, 10.1139/w09-079]; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Herbelin CJ, 2000, J BACTERIOL, V182, P5381, DOI 10.1128/JB.182.19.5381-5390.2000; Hu J, 2015, CLIN MICROBIOL INFEC, V21, P729, DOI 10.1016/j.cmi.2015.01.015; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Iyoda S, 2005, J BACTERIOL, V187, P4086, DOI 10.1128/JB.187.12.4086-4094.2005; King T, 2006, GENETICS, V172, P2071, DOI 10.1534/genetics.105.053892; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; LEVINE MM, 1978, LANCET, V1, P1119; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Maharjan R, 2013, ECOL LETT, V16, P1267, DOI 10.1111/ele.12159; Martinez-Laguna Y, 1999, MOL MICROBIOL, V33, P153, DOI 10.1046/j.1365-2958.1999.01460.x; Mellies JL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-123; Miller J. H., 1992, LAB MANUAL HDB ESCHE; Neves HI, 2015, J BACTERIOL, V197, P1378, DOI 10.1128/JB.02566-14; Nisa S, 2013, J BACTERIOL, V195, P4476, DOI 10.1128/JB.00704-13; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Ochoa TJ, 2008, T ROY SOC TROP MED H, V102, P852, DOI 10.1016/j.trstmh.2008.03.017; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Porter ME, 2004, MOL MICROBIOL, V54, P1117, DOI 10.1111/j.1365-2958.2004.04333.x; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; Moreno ACR, 2010, DIAGN MICR INFEC DIS, V66, P50, DOI 10.1016/j.diagmicrobio.2008.03.017; Santos AS, 2015, CELL MICROBIOL, V17, P318, DOI 10.1111/cmi.12412; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Snyder E, 2012, G3-GENES GENOM GENET, V2, P1341, DOI 10.1534/g3.112.003855; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Spira B, 2011, BMC MICROBI IN PRESS; Spira B, 2008, MICROBIOL-SGM, V154, P2887, DOI 10.1099/mic.0.2008/018457-0; Spira B, 2008, ARCH MICROBIOL, V189, P43, DOI 10.1007/s00203-007-0291-0; Spira B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091703; Subbarayan PR, 2004, MOL GENET GENOMICS, V270, P533, DOI 10.1007/s00438-003-0944-x; Sutton A, 2000, J BACTERIOL, V182, P4375, DOI 10.1128/JB.182.16.4375-4379.2000; Taschner NP, 2004, MICROBIOL-SGM, V150, P2985, DOI 10.1099/mic.0.27124-0; Tomoyasu T, 2005, FEMS MICROBIOL LETT, V253, P59, DOI 10.1016/j.femsle.2005.09.020; Munevar NFV, 2017, MOL GENET GENOMICS, V292, P105, DOI 10.1007/s00438-016-1259-z; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	62	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180381	10.1371/journal.pone.0180381	http://dx.doi.org/10.1371/journal.pone.0180381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662183	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300147
J	Zhou, Z; Jordens, Z; Zhang, SG; Zhang, NX; Schmid, J				Zhou, Zhuo; Jordens, Zoe; Zhang, Shuguang; Zhang, Ningxin; Schmid, Jan			Highly mutable tandem DNA repeats generate a cell wall protein variant more frequent in disease-causing Candida albicans isolates than in commensal isolates	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC SIMILARITY; PURPOSE GENOTYPE; SEQUENCE; BACTERIAL; STRAINS; YEAST; IDENTIFICATION; COLONIZATION; MUTATIONS	During adaptation to host environments, many microorganisms alter their cell surface. One mechanism for doing so is variation in the number of amino acid repeats in cell surface proteins encoded by hypermutable DNA tandem repeats. In the yeast Candida albicans, an opportunistic human pathogen, the gene SSR1 encodes a GPI-anchored cell wall protein with a structural role. It contains two regions consisting of tandem repeats, almost exclusively encoding the amino acid pair Ser-Ala. As expected, the repeat regions make SSR1 highly mutable. New SSR1 alleles arose with a frequency of 1.11x10(-4) per cell division in serially propagated cells. We also observed a large number (25) of SSR1 alleles with different repeat lengths in a survey of 131 isolates from a global strain collection. C. albicans is diploid, and combinations of these allele generated 41 different SSR1 genotypes. In both repeat regions, nonsynonymous mutations were largely restricted to one particular repeat unit. Two very similar allele combinations were largely restricted to one clade, clade 1. Each combination was present in similar to 30% of 49 infection-causing clade 1 strains, but one was rare (2%), the other absent in 46 infection-causing strains representing the remainder of the species (P < 0.00018 and 0.00004; Fisher's exact test). These results indicate that both repeat regions are under selection and that amino acid repeat length polymorphisms generate Ssr1 protein variants most suitable for specific genetic backgrounds. One of these two allele combinations was 5.51 times more frequent, the other 1.75 times less frequent in 49 clade 1 strains that caused disease than in 36 commensal clade 1 strains (P = 0.0105; Chi(2) test). This indicates that insertion and deletion of repeats not only generates clade-optimized Ssr1p variants, but may also assist in short-term adaptation when C. albicans makes the transition from commensal to pathogen.	[Zhou, Zhuo; Jordens, Zoe; Zhang, Shuguang; Zhang, Ningxin; Schmid, Jan] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Zhang, Shuguang] Callaghan Innovat, Integrated Bioact Technol, Lower Hutt, New Zealand	Massey University; Callaghan Innovation	Schmid, J (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.	j.schmid@massey.ac.nz	Schmid, Jan/A-6863-2011	Schmid, Jan/0000-0001-8794-4175	Maurice and Phyllis Paykel Trust; Massey University Research Fund	Maurice and Phyllis Paykel Trust; Massey University Research Fund	This work was supported by: Maurice and Phyllis Paykel Trust (http://www.paykeltrust. co.nz), no grant numbers are allocated by this trust, JS; Massey University Research Fund, an internal fund to support research by Massey University (http://www.massey.ac.nz) staff 1000015870, JS. The funders had no role in study design, data collection and analysis, decisionto publish,or preparation of the manuscript.	Al-Aidan AW, 2007, YEAST, V24, P155, DOI 10.1002/yea.1462; Ausubel FM, 2014, CURRENT PROTOCOLS MO; Brillowska-Dabrowska A, 2010, SCAND J INFECT DIS, V42, P109, DOI 10.3109/00365540903348336; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Edelmann A, 2005, J CLIN MICROBIOL, V43, P6164, DOI 10.1128/JCM.43.12.6164-6166.2005; Garcera A, 2003, MICROBIOL-SGM, V149, P2137, DOI 10.1099/mic.0.26301-0; Gomez-Raja J, 2013, J MICROBIOL METH, V94, P47, DOI 10.1016/j.mimet.2013.04.007; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Jansen A, 2012, GENOME DYNAM, V7, P108, DOI 10.1159/000337121; Li F, 2008, MICROBIOL-SGM, V154, P1193, DOI 10.1099/mic.0.2007/013789-0; Lott TJ, 1999, MICROBIOL-UK, V145, P1137, DOI 10.1099/13500872-145-5-1137; Lott TJ, 2005, FUNGAL GENET BIOL, V42, P444, DOI 10.1016/j.fgb.2005.01.012; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Odds FC., 1988, CANDIDA CANDIDOSIS; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rauceo JM, 2006, EUKARYOT CELL, V5, P1664, DOI 10.1128/EC.00120-06; REAGAN DR, 1990, J CLIN MICROBIOL, V28, P2733, DOI 10.1128/JCM.28.12.2733-2738.1990; Sampaio P, 2009, ANTON LEEUW INT J G, V96, P395, DOI 10.1007/s10482-009-9352-5; SCHMID J, 1993, J CLIN MICROBIOL, V31, P39, DOI 10.1128/JCM.31.1.39-46.1993; Schmid J, 1999, MICROBIOL-UK, V145, P2405, DOI 10.1099/00221287-145-9-2405; Schmid J, 2012, MYCOSES, V55, P67; Schmid J, 2011, J CLIN MICROBIOL, V49, P3250, DOI 10.1128/JCM.00941-11; SCHMID J, 1990, J CLIN MICROBIOL, V28, P1236, DOI 10.1128/JCM.28.6.1236-1243.1990; SCHMID J, 1992, J CLIN MICROBIOL, V30, P935, DOI 10.1128/JCM.30.4.935-941.1992; SCHMID J, 1995, J CLIN MICROBIOL, V33, P1223, DOI 10.1128/JCM.33.5.1223-1230.1995; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Staab JF, 2004, J BIOL CHEM, V279, P40737, DOI 10.1074/jbc.M406005200; Sumita T, 2005, EUKARYOT CELL, V4, P1872, DOI 10.1128/EC.4.11.1872-1881.2005; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; Xu JP, 1999, J CLIN MICROBIOL, V37, P3835, DOI 10.1128/JCM.37.12.3835-3843.1999; Zhang NX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009614; Zhang NX, 2009, INFECT GENET EVOL, V9, P493, DOI 10.1016/j.meegid.2009.01.007; Zhang NX, 2003, GENOME RES, V13, P2005, DOI 10.1101/gr.1024903; Zhao XM, 2007, FUNGAL GENET BIOL, V44, P1298, DOI 10.1016/j.fgb.2007.05.004; Zhou K, 2014, FEMS MICROBIOL REV, V38, P119, DOI 10.1111/1574-6976.12036	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180246	10.1371/journal.pone.0180246	http://dx.doi.org/10.1371/journal.pone.0180246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662107	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300130
J	Della Mea, V; Baroni, GL; Pilutti, D; Di Loreto, C				Della Mea, Vincenzo; Baroni, Giulia L.; Pilutti, David; Di Loreto, Carla			SlideJ: An ImageJ plugin for automated processing of whole slide images	PLOS ONE			English	Article							PATHOLOGY; PLATFORM	The digital slide, or Whole Slide Image, is a digital image, acquired with specific scanners, that represents a complete tissue sample or cytological specimen at microscopic level. While Whole Slide image analysis is recognized among the most interesting opportunities, the typical size of such images-up to Gpixels- can be very demanding in terms of memory requirements. Thus, while algorithms and tools for processing and analysis of single microscopic field images are available, Whole Slide images size makes the direct use of such tools prohibitive or impossible. In this work a plugin for ImageJ, named SlideJ, is proposed with the objective to seamlessly extend the application of image analysis algorithms implemented in ImageJ for single microscopic field images to a whole digital slide analysis. The plugin has been complemented by examples of macro in the ImageJ scripting language to demonstrate its use in concrete situations.	[Della Mea, Vincenzo; Baroni, Giulia L.; Pilutti, David] Univ Udine, Dept Math Comp Sci & Phys, Udine, Italy; [Di Loreto, Carla] Univ Udine, Dept Med, Udine, Italy	University of Udine; University of Udine	Della Mea, V (corresponding author), Univ Udine, Dept Math Comp Sci & Phys, Udine, Italy.	vincenzo.dellamea@uniud.it	Mea, Vincenzo Della/A-7430-2008; Della Mea, Vincenzo/ABC-3477-2020	Mea, Vincenzo Della/0000-0002-0144-3802; Della Mea, Vincenzo/0000-0002-0144-3802	EU [612471]	EU(European Commission)	The work was partially supported and funded by the EU FP7 program, AIDPATH project, grant number 612471. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arena ET, 2016, WILEY INTERDISCIP RE; Bauer TW, 2014, ARCH PATHOL LAB MED, V138, P1459, DOI 10.5858/arpa.2013-0541-OA; Bray MA, 2015, CURR PROTOC MOL BIOL, V109, P14; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Goode Adam, 2013, J Pathol Inform, V4, P27, DOI 10.4103/2153-3539.119005; Haak D., 2014, BILDVERARBEITUNG MED, P415; Kothari S, 2013, J AM MED INFORM ASSN, V20, P1099, DOI 10.1136/amiajnl-2012-001540; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Fernandez-Carrobles MM, 2015, STUD HEALTH TECHNOL, V210, P756, DOI 10.3233/978-1-61499-512-8-756; Nelissen BGL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110289; Plancoulaine B, 2015, VIRCHOWS ARCH, V467, P711, DOI 10.1007/s00428-015-1865-x; Prasad K, 2012, J MED SYST, V36, P2621, DOI 10.1007/s10916-011-9737-7; Roux Ludovic, 2013, J Pathol Inform, V4, P8, DOI 10.4103/2153-3539.112693; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Taylor CR, 2011, APPL IMMUNOHISTO M M, V19, P1491, DOI 10.1097/PAI.0b013e318229ffd6; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615	20	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180540	10.1371/journal.pone.0180540	http://dx.doi.org/10.1371/journal.pone.0180540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683129	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200046
J	Ezura, K; Ji-Seong, K; Mori, K; Suzuki, Y; Kuhara, S; Ariizumi, T; Ezura, H				Ezura, Kentaro; Ji-Seong, Kim; Mori, Kazuki; Suzuki, Yutaka; Kuhara, Satoru; Ariizumi, Tohru; Ezura, Hiroshi			Genome-wide identification of pistil-specific genes expressed during fruit set initiation in tomato (Solanum lycopersicum)	PLOS ONE			English	Article							CELL-WALL INVERTASE; MADS-BOX GENE; MOSAIC VIRUS-35S PROMOTER; PEAR PYRUS-SEROTINA; PLANT DEVELOPMENT; TRANSCRIPTOME ANALYSIS; PECTIN METHYLESTERASE; ARABIDOPSIS-THALIANA; RECEPTOR KINASE; RNA-SEQ	Fruit set involves the developmental transition of an unfertilized quiescent ovary in the pistil into a fruit. While fruit set is known to involve the activation of signals (including various plant hormones) in the ovary, many biological aspects of this process remain elusive. To further expand our understanding of this process, we identified genes that are specifically expressed in tomato (Solanum lycopersicum L.) pistils during fruit set through comprehensive RNA-seq-based transcriptome analysis using 17 different tissues including pistils at six different developmental stages. First, we identified 532 candidate genes that are preferentially expressed in the pistil based on their tissue-specific expression profiles. Next, we compared our RNA-seq data with publically available transcriptome data, further refining the candidate genes that are specifically expressed within the pistil. As a result, 108 pistil-specific genes were identified, including several transcription factor genes that function in reproductive development. We also identified genes encoding hormone -like peptides with a secretion signal and cysteine-rich residues that are conserved among some Solanaceae species, suggesting that peptide hormones may function as signaling molecules during fruit set initiation. This study provides important information about pistil -specific genes, which may play specific roles in regulating pistil development in relation to fruit set.	[Ezura, Kentaro; Ariizumi, Tohru; Ezura, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ji-Seong, Kim; Ariizumi, Tohru; Ezura, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Mori, Kazuki; Kuhara, Satoru] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Chiba, Japan	University of Tsukuba; University of Tsukuba; Kyushu University; University of Tokyo	Ariizumi, T; Ezura, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Ariizumi, T; Ezura, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	arriizumi.toru.ge@u.tsukuba.ac.jp; ezura.hiroshi.fa@u.tsukuba.ac.jp	Ezura, Kentaro/AAK-4519-2020; Mori, Kazuki/M-2670-2018; Ezura, H/AAO-8184-2021	Mori, Kazuki/0000-0003-3238-2472; Ezura, Kentaro/0000-0002-2303-3396	Program to Disseminate Tenure Tracking System; JSPS Kakenhi [23780001, 221S0002]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan	Program to Disseminate Tenure Tracking System; JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan	This work was funded by Program to Disseminate Tenure Tracking System, http//www.jst.go_jp/tenure/, Receipt: TA; JSPS Kakenhi, https://www.jsps.go.jp/english/e-grants/, grant no. 23780001 and 221S0002 to TA; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan, http//www.affrc.maff.go.jp/index.htm, grant	Alvarez J, 1999, DEVELOPMENT, V126, P2377; Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; Appelhagen I, 2011, PLANT J, V67, P406, DOI 10.1111/j.1365-313X.2011.04603.x; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Ariizumi T, 2002, PLANT CELL REP, V21, P90, DOI 10.1007/s00299-002-0487-3; Ariizumi T, 2013, BREEDING SCI, V63, P3, DOI 10.1270/jsbbs.63.3; Azzi L, 2015, J EXP BOT, V66, P1075, DOI 10.1093/jxb/eru527; Balasubramanian S, 2000, DEVELOPMENT, V127, P4227; Belkhadir Y, 2015, NEW PHYTOL, V206, P522, DOI 10.1111/nph.13269; Bemer M, 2008, PLANT CELL, V20, P2088, DOI 10.1105/tpc.108.058958; Bemer M, 2010, PLANT PHYSIOL, V154, P287, DOI 10.1104/pp.110.160770; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Breiden M, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0280-3; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Colombo M, 2008, PLANT J, V54, P1037, DOI 10.1111/j.1365-313X.2008.03485.x; Costa LM, 2014, SCIENCE, V344, P168, DOI 10.1126/science.1243005; Daher FB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00523; Daminato M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0319-y; de Graaf BHJ, 2003, J EXP BOT, V54, P55, DOI 10.1093/jxb/54.380.55; de Martino G, 2006, PLANT CELL, V18, P1833, DOI 10.1105/tpc.106.042978; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; DEIKMAN J, 1992, PLANT PHYSIOL, V100, P2013, DOI 10.1104/pp.100.4.2013; Di C, 2014, PLANT J, V80, P848, DOI 10.1111/tpj.12679; Gomez MD, 2014, J EXP BOT, V65, P4515, DOI 10.1093/jxb/eru093; Dreni L, 2014, NEW PHYTOL, V201, P717, DOI 10.1111/nph.12555; Dutt M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.47; Eberle CA, 2013, PLANT J, V74, P805, DOI 10.1111/tpj.12163; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Ficker M, 1997, PLANT MOL BIOL, V35, P425, DOI 10.1023/A:1005898624425; FIEDLER U, 1993, PLANT MOL BIOL, V22, P669, DOI 10.1007/BF00047407; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Figueiredo DD, 2016, ELIFE, V5, DOI 10.7554/eLife.20542; Figueiredo DD, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.184, 10.1038/NPLANTS.2015.184]; Gaffe J, 1997, PLANT PHYSIOL, V114, P1547, DOI 10.1104/pp.114.4.1547; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; GOLDMAN MHD, 1992, PLANT CELL, V4, P1041, DOI 10.1105/tpc.4.9.1041; Golz JF, 1999, CURR BIOL, V9, pR861, DOI 10.1016/S0960-9822(00)80047-0; Gomez M, 2004, PLANTA, V219, P967, DOI 10.1007/s00425-004-1300-z; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Gupta V, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0046-9; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hazak O, 2016, J EXP BOT, V67, P4827, DOI 10.1093/jxb/erw247; Hiwasa-Tanase K, 2012, PLANT CELL REP, V31, P1415, DOI 10.1007/s00299-012-1257-5; Hong SB, 2000, PLANT CELL REP, V19, P680, DOI 10.1007/s002999900175; Hong YF, 2008, PLANT MOL BIOL, V67, P347, DOI 10.1007/s11103-008-9324-6; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Hu T, 2015, PLANT, V85, P16; Huang J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006147; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Ingrosso I, 2011, PLANT PHYSIOL BIOCH, V49, P1092, DOI 10.1016/j.plaphy.2011.07.012; Jeong HJ, 2014, GENE, V553, P17, DOI 10.1016/j.gene.2014.09.051; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jia GX, 2008, P NATL ACAD SCI USA, V105, P2220, DOI 10.1073/pnas.0708795105; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jin Y, 2009, PLANT CELL, V21, P2072, DOI 10.1105/tpc.108.063719; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Jones MO, 2008, FUNCT PLANT BIOL, V35, P1224, DOI 10.1071/FP08139; Ju CL, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.4, 10.1038/nplants.2014.4]; Kato H, 2010, PLANT MOL BIOL REP, V28, P381, DOI 10.1007/s11105-009-0162-8; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; KAUSS H, 1967, BIOCHEM BIOPH RES CO, V26, P234, DOI 10.1016/0006-291X(67)90240-9; Kesanakurti D, 2012, PHYSIOL PLANTARUM, V146, P136, DOI 10.1111/j.1399-3054.2012.01626.x; Kim G, 2014, SCIENCE, V345, P808, DOI 10.1126/science.1253122; Klap C, 2016, PLANT BIOTECHNOL J; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kuboyama T, 1998, SEX PLANT REPROD, V11, P251, DOI 10.1007/s004970050150; Lee J S, 2012, Cold Spring Harb Symp Quant Biol, V77, P83, DOI 10.1101/sqb.2012.77.014886; Li ZM, 2012, J EXP BOT, V63, P1155, DOI 10.1093/jxb/err329; Li ZJT, 2005, GENOME, V48, P312, DOI [10.1139/g04-110, 10.1139/G04-110]; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; LINERS F, 1992, PLANT PHYSIOL, V99, P1099, DOI 10.1104/pp.99.3.1099; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Martinelli F, 2009, J EXP BOT, V60, P3873, DOI 10.1093/jxb/erp227; Masiero S, 2011, PLANT CELL, V23, P865, DOI 10.1105/tpc.110.081737; Matsubayashi Y, 2011, PLANT CELL PHYSIOL, V52, P5, DOI 10.1093/pcp/pcq169; Mazzucato A, 2013, PLANT PHYSIOL BIOCH, V72, P125, DOI 10.1016/j.plaphy.2013.05.012; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Mezzetti B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-4; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; MIYOSHI H, 1995, SEX PLANT REPROD, V8, P205, DOI 10.1007/BF00228938; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Nibau C, 2011, J EXP BOT, V62, P949, DOI 10.1093/jxb/erq325; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Ocarez N, 2016, PLANT CELL REP, V35, P239, DOI 10.1007/s00299-015-1882-x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Palmer WM, 2015, MOL PLANT, V8, P315, DOI 10.1016/j.molp.2014.12.019; Pan LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01573; Pattison RJ, 2015, PLANT PHYSIOL, V168, P1684, DOI 10.1104/pp.15.00287; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pesaresi P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00124; Quinet M, 2014, J EXP BOT, V65, P2243, DOI 10.1093/jxb/eru089; Rhee SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2186-9; Ribone PA, 2015, J EXP BOT, V66, P5929, DOI 10.1093/jxb/erv302; Richardson LGL, 2013, J EXP BOT, V64, P5243, DOI 10.1093/jxb/ert246; Royo C, 2016, J EXP BOT, V67, P259, DOI 10.1093/jxb/erv452; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Ruiu F, 2015, PLANT MOL BIOL, V89, P263, DOI 10.1007/s11103-015-0367-1; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Sassa H, 1998, PLANTA, V205, P514, DOI 10.1007/s004250050350; Sassa H, 2002, PLANT MOL BIOL, V50, P371, DOI 10.1023/A:1019866029629; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Shen XY, 2014, PLANT MOL BIOL, V86, P303, DOI 10.1007/s11103-014-0230-9; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Sotelo-Silveira M, 2014, PLANTA, V239, P1147, DOI 10.1007/s00425-014-2057-7; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Tang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125355; Tavormina P, 2015, PLANT CELL, V27, P2095, DOI 10.1105/tpc.15.00440; Terao A, 2013, J PLANT RES, V126, P719, DOI 10.1007/s10265-013-0555-5; Tesfaye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058992; VANNIER MP, 1992, BIOCHEM J, V286, P863, DOI 10.1042/bj2860863; Vaughan SP, 2006, J EXP BOT, V57, P3901, DOI 10.1093/jxb/erl185; Villanneva JM, 1999, GENE DEV, V13, P3160, DOI 10.1101/gad.13.23.3160; Voss U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8641; Vriezen WH, 2008, NEW PHYTOL, V177, P60, DOI 10.1111/j.1469-8137.2007.02254.x; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Wei ZR, 2015, GENOME, V58, P121, DOI 10.1139/gen-2015-0035; Yamaguchi YL, 2016, J EXP BOT, V67, P4813, DOI 10.1093/jxb/erw208; Yang SL, 2003, PLANT CELL, V15, P2792, DOI 10.1105/tpc.016618; Yang XH, 2011, GENOME RES, V21, P634, DOI 10.1101/gr.109280.110; Ye J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130885; Yung MH, 1999, PLANT J, V17, P203, DOI 10.1046/j.1365-313X.1999.00359.x; Zhang SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23173; Zhu BZ, 2015, J EXP BOT, V66, P4483, DOI 10.1093/jxb/erv203	144	21	22	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180003	10.1371/journal.pone.0180003	http://dx.doi.org/10.1371/journal.pone.0180003			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683065	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200016
J	Li, TB; Lu, G; Chiang, EY; Chernov-Rogan, T; Grogan, JL; Chen, J				Li, Tianbo; Lu, Gang; Chiang, Eugene Y.; Chernov-Rogan, Tania; Grogan, Jane L.; Chen, Jun			High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE	PLOS ONE			English	Article							EXTREME PAIN DISORDER; PATCH-CLAMP; KV1.3; MODULATORS; MUTATIONS; NA(V)1.7; TARGET; DYE	Ion channels regulate a variety of physiological processes and represent an important class of drug target. Among the many methods of studying ion channel function, patch clamp electrophysiology is considered the gold standard by providing the ultimate precision and flexibility. However, its utility in ion channel drug discovery is impeded by low throughput. Additionally, characterization of endogenous ion channels in primary cells remains technical challenging. In recent years, many automated patch clamp (APC) platforms have been developed to overcome these challenges, albeit with varying throughput, data quality and success rate. In this study, we utilized SyncroPatch 768PE, one of the latest generation APC platforms which conducts parallel recording from two -384 modules with giga-seal data quality, to push these 2 boundaries. By optimizing various cell patching parameters and a two-step voltage protocol, we developed a high throughput APC assay for the voltage-gated sodium channel Nav1.7. By testing a group of Nav1.7 reference compounds' IC50, this assay was proved to be highly consistent with manual patch clamp (R > 0.9). In a pilot screening of 10,000 compounds, the success rate, defined by > 500 MCI seal resistance and >500 pA peak current, was 79%. The assay was robust with daily throughput - 6,000 data points and Z' factor 0.72. Using the same platform, we also successfully recorded endogenous voltage -gated potassium channel Kv1.3 in primary T cells. Together, our data suggest that SyncroPatch 768PE provides a powerful platform for ion channel research and drug discovery.	[Li, Tianbo; Lu, Gang; Chernov-Rogan, Tania; Chen, Jun] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Chiang, Eugene Y.; Grogan, Jane L.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Li, TB; Chen, J (corresponding author), Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA.	li.tianbo@gene.com; chen.jun@gene.com		Li, Tianbo/0000-0002-2386-910X	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	The studies in this manuscript were fully funded by Genentech, Inc. The funder, Genentech, Inc., approved the manuscript for public disclosure, and provided support in the form of salaries for authors [TL, GL, EC, TC, JG, JC], but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Benjamin ER, 2006, J BIOMOL SCREEN, V11, P29, DOI 10.1177/1087057105280918; Castle N, 2009, COMB CHEM HIGH T SCR, V12, P107, DOI 10.2174/138620709787047993; Cerne R, 2016, ASSAY DRUG DEV TECHN, V14, P75, DOI 10.1089/adt.2015.678; Cerne R, 2016, ASSAY DRUG DEV TECHN, V14, P84, DOI 10.1089/adt.2015.677; Chambers C, 2016, ASSAY DRUG DEV TECHN, V14, P93, DOI 10.1089/adt.2016.700; Chiang EY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14644; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Ehling P, 2016, J THEOR BIOL, V404, P236, DOI 10.1016/j.jtbi.2016.06.001; Estacion M, 2009, ANN NEUROL, V66, P862, DOI 10.1002/ana.21895; Felix JP, 2004, ASSAY DRUG DEV TECHN, V2, P260, DOI 10.1089/1540658041410696; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Hou P, 2014, PLOS ONE, V9; John Comley, 2014, DRUG DISCOV WORLD, P45; Li TB, 2012, J BIOL CHEM, V287, P40680, DOI 10.1074/jbc.M112.418400; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu JX, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-129; Mannikko R, 2015, BRIT J PHARMACOL, V172, P3112, DOI 10.1111/bph.13115; Milligan CJ, 2009, NAT PROTOC, V4, P244, DOI 10.1038/nprot.2008.230; Nicolaou SA, 2007, J IMMUNOL, V179, P346, DOI 10.4049/jimmunol.179.1.346; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Parihar AS, 2003, ASSAY DRUG DEV TECHN, V1, P647, DOI 10.1089/154065803770381002; Theile JW, 2011, J PHYSIOL-LONDON, V589, P597, DOI 10.1113/jphysiol.2010.200915; Vijayaragavan K, 2001, J NEUROSCI, V21, P7909, DOI 10.1523/JNEUROSCI.21-20-07909.2001; Wang DW, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00144; Wolff C, 2003, J BIOMOL SCREEN, V8, P533, DOI 10.1177/1087057103257806; Zakrzewska JM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-402; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	31	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180154	10.1371/journal.pone.0180154	http://dx.doi.org/10.1371/journal.pone.0180154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683073	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200018
J	Soares, MC; Cardoso, SC; Mazzei, R; Andre, GI; Morais, M; Gozdowska, M; Kalamarz-Kubiak, H; Kulczykowska, E				Soares, Marta C.; Cardoso, Sonia C.; Mazzei, Renata; Andre, Goncalo I.; Morais, Marta; Gozdowska, Magdalena; Kalamarz-Kubiak, Hanna; Kulczykowska, Ewa			Region specific changes in nonapeptide levels during client fish interactions with allopatric and sympatric cleaner fish	PLOS ONE			English	Article							ARGININE-VASOTOCIN; TELENCEPHALIC ABLATION; SOCIAL-BEHAVIOR; LABROIDES-DIMIDIATUS; AGGRESSIVE-BEHAVIOR; NEUROPEPTIDE REGULATION; PARTNER CONTROL; BRAIN LEVELS; REEF FISH; EVOLUTION	Social relationships are crucially dependent on individual ability to learn and remember ecologically relevant cues. However, the way animals recognize cues before engaging in any social interaction and how their response is regulated by brain neuromodulators remains unclear. We examined the putative involvement of arginine vasotocin (AVT) and isotocin (IT), acting at different brain regions, during fish decision-making in the context of cooperation, by trying to identify how fish distinguish and recognize the value of other social partners or species. We hypothesized that the behavioural responses of cleaner fish clients to different social contexts would be underlain by changes in brain AVT and IT levels. We have found that changes in AVT at the level of forebrain and optic tectum are linked with a response to allopatric cleaners (novel or unfamiliar stimuli) while those at cerebellum are associated with the willingness to be cleaned (in response to sympatric cleaners). On the other hand, higher brain IT levels that were solely found in the diencephalon, also in response to allopatric cleaners. Our results are the first to implicate these nonapeptides, AVT in particular, in the assessment of social cues which enable fish to engage in mutualistic activities.	[Soares, Marta C.; Cardoso, Sonia C.; Mazzei, Renata; Andre, Goncalo I.; Morais, Marta] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Campus Agr Vairao, Vairao, Portugal; [Mazzei, Renata] Univ Neuchatel, Inst Biol, Ecoethol, Rue Emilie Argand 11, Neuchatel, Switzerland; [Gozdowska, Magdalena; Kalamarz-Kubiak, Hanna; Kulczykowska, Ewa] Polish Acad Sci, Inst Oceanol, Genet & Marine Biotechnol Dept, Sopot, Poland	Universidade do Porto; University of Neuchatel; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Soares, MC (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Campus Agr Vairao, Vairao, Portugal.	marta.soares@cibio.up.pt	Kulczykowska, Ewa/X-2879-2019; Gozdowska, Magdalena/A-4169-2018; Kalamarz-Kubiak, Hanna/AAL-6172-2020; Soares, Marta C/J-4448-2013; Soares, Marta/GSM-7143-2022	Kulczykowska, Ewa/0000-0002-3979-9310; Gozdowska, Magdalena/0000-0002-7927-2230; Kalamarz-Kubiak, Hanna/0000-0002-1904-7146; Soares, Marta C/0000-0002-5213-2377; Soares, Marta/0000-0002-5213-2377; Andre, Goncalo/0000-0002-1513-4832; Cardoso, Sonia/0000-0002-5985-7792	Portuguese Foundation for Science and Technology-FCT [PTDC/MAR/105276/2008]; National Science Center [2012/05/B/NZ4/02410]; Institute of Oceanology of the Polish Academy of Sciences;  [SFRH/BPD/109433/2015]	Portuguese Foundation for Science and Technology-FCT(Portuguese Foundation for Science and Technology); National Science Center(National Science Centre, Poland); Institute of Oceanology of the Polish Academy of Sciences; 	This study was supported by the Portuguese Foundation for Science and Technology-FCT (grant PTDC/MAR/105276/2008 given to MCS). MSC is currently supported by SFRH/BPD/109433/2015. HPLC analyses of AVT and IT, and E2 analyses were partially financed by the National Science Center grant 2012/05/B/NZ4/02410 and by Institute of Oceanology of the Polish Academy of Sciences statutory research task IV.2.2 (giventoEK).	ACHER R, 1995, FRONT NEUROENDOCRIN, V16, P237, DOI 10.1006/frne.1995.1009; Almeida O, 2012, HORM BEHAV, V61, P212, DOI 10.1016/j.yhbeh.2011.12.008; [Anonymous], 2014, R LANG ENV STAT COMP; Backstrom T, 2009, PHYSIOL BEHAV, V96, P470, DOI 10.1016/j.physbeh.2008.11.013; Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Bshary R, 2001, P ROY SOC B-BIOL SCI, V268, P1495, DOI 10.1098/rspb.2001.1495; Bshary R., 2011, FISH COGNITION BEHAV, P277; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Bshary R, 2011, ETHOLOGY, V117, P271, DOI 10.1111/j.1439-0310.2011.01882.x; Bshary Redouan, 2008, P563; Cardoso SC, 2015, BEHAV ECOL SOCIOBIOL, V69, P1173, DOI 10.1007/s00265-015-1931-z; Cardoso SC, 2015, PHYSIOL BEHAV, V145, P1, DOI 10.1016/j.physbeh.2015.03.024; Cardoso SC, 2015, PHYSIOL BEHAV, V139, P314, DOI 10.1016/j.physbeh.2014.11.052; Carneiro LA, 2003, FISH PHYSIOL BIOCHEM, V28, P241, DOI 10.1023/B:FISH.0000030542.31395.8a; Cheney KL, 2008, BEHAV ECOL, V19, P583, DOI 10.1093/beheco/arn001; Cheney KL, 2012, BIOL LETTERS, V8, P10, DOI 10.1098/rsbl.2011.0687; Cheney KL, 2009, BEHAV ECOL, V20, P459, DOI 10.1093/beheco/arp017; Cheney KL, 2009, CURR BIOL, V19, P1283, DOI 10.1016/j.cub.2009.06.028; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Dugatkin L.A., 1997, COOPERATION ANIMALS; Feder HM., 1966, SYMBIOSIS, V1, P327; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Godwin J, 2012, HORM BEHAV, V61, P230, DOI 10.1016/j.yhbeh.2011.12.016; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; GORLICK DL, 1987, COPEIA, P41, DOI 10.2307/1446035; Gozdowska M, 2013, FISH PHYSIOL BIOCHEM, V39, P863, DOI 10.1007/s10695-012-9746-6; Groppe SE, 2013, BIOL PSYCHIAT, V74, P172, DOI 10.1016/j.biopsych.2012.12.023; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Herberstein ME, 2014, BEHAV ECOL, V25, P12, DOI 10.1093/beheco/art105; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Huffman LS, 2012, J CHEM NEUROANAT, V44, P86, DOI 10.1016/j.jchemneu.2012.05.002; Kline RJ, 2011, J CHEM NEUROANAT, V42, P72, DOI 10.1016/j.jchemneu.2011.06.005; Kulczykowska E, 2015, GEN COMP ENDOCR, V222, P99, DOI 10.1016/j.ygcen.2015.06.005; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lema SC, 2004, HORM BEHAV, V46, P628, DOI 10.1016/j.yhbeh.2004.07.003; Lema SC, 2012, GEN COMP ENDOCR, V179, P451, DOI 10.1016/j.ygcen.2012.10.001; Lettieri L, 2010, J EVOLUTION BIOL, V23, P2289, DOI 10.1111/j.1420-9101.2010.02098.x; LIMBAUGH C, 1961, SCI AM, V205, P42, DOI 10.1038/scientificamerican0861-42; Lopez JC, 2000, BEHAV BRAIN RES, V109, P91, DOI 10.1016/S0166-4328(99)00167-9; Lopez JC, 2000, BEHAV NEUROSCI, V114, P687, DOI 10.1037/0735-7044.114.4.687; Losey GC, 1999, BEHAV CONSERVATION L, P379; Loveland JL, 2017, BEHAV BRAIN RES, V317, P188, DOI 10.1016/j.bbr.2016.09.008; McNamara JM, 2010, PHILOS T R SOC B, V365, P2627, DOI 10.1098/rstb.2010.0159; Modi ME, 2012, HORM BEHAV, V61, P340, DOI 10.1016/j.yhbeh.2011.12.010; O'Connell LA, 2012, HORM BEHAV, V61, P725, DOI 10.1016/j.yhbeh.2012.03.009; Oldfield RG, 2011, PHYSIOL BEHAV, V102, P296, DOI 10.1016/j.physbeh.2010.11.022; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Rodriguez F, 2005, BRAIN RES BULL, V66, P365, DOI 10.1016/j.brainresbull.2004.11.026; Ros AFH, 2011, HORM BEHAV, V59, P151, DOI 10.1016/j.yhbeh.2010.11.006; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Saito D, 2004, NEUROSCIENCE, V124, P973, DOI 10.1016/j.neuroscience.2003.12.038; Salas C, 1996, BEHAV NEUROSCI, V110, P965, DOI 10.1037/0735-7044.110.5.965; Salas C, 1996, BEHAV BRAIN RES, V79, P193, DOI 10.1016/0166-4328(96)00014-9; Santangelo N, 2006, P ROY SOC B-BIOL SCI, V273, P3085, DOI 10.1098/rspb.2006.3683; Santangelo N, 2010, BRAIN BEHAV EVOLUT, V75, P282, DOI 10.1159/000316867; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Soares MC, 2008, ETHOLOGY, V114, P209, DOI 10.1111/j.1439-0310.2007.01471.x; Soares MC, 2008, ANIM BEHAV, V76, P123, DOI 10.1016/j.anbehav.2008.01.015; Soares MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039583; Soares MC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1547; Teles MC, 2016, HORM BEHAV, V84, P57, DOI 10.1016/j.yhbeh.2016.05.020; Yaeger C, 2014, NEUROSCIENCE, V267, P205, DOI 10.1016/j.neuroscience.2014.02.045	65	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180290	10.1371/journal.pone.0180290	http://dx.doi.org/10.1371/journal.pone.0180290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683143	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200022
J	Takahashi, H; Nishimura, R; Onda, Y; Ando, K; Tsujino, D; Utsunomiya, K				Takahashi, Hiroshi; Nishimura, Rimei; Onda, Yoshiko; Ando, Kiyotaka; Tsujino, Daisuke; Utsunomiya, Kazunori			Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study	PLOS ONE			English	Article							GLYCEMIC VARIABILITY; MONITORING-SYSTEM; JAPANESE PATIENTS; CROSS-OVER; MORTALITY; GLARGINE; FREQUENCY; MELLITUS; RISK	Objective To evaluate whether nocturnal asymptomatic hypoglycemia (NAH) can be predicted by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes (T1D) receiving insulin degludec. Methods Patients with T1D receiving insulin degludec underwent at-home CGM assessments. Indices for glycemic variability before and after breakfast included fasting glucose levels and the range of post-breakfast glucose elevation. For comparison, the patients were classified into those with NAH and those without. The optimal cut-off values for the relevant parameters were determined to predict NAH using ROC analysis. Results The study included a total of 31 patients (mean HbA1c values, 7.8 +/- 0.7%), and 16 patients (52%) had NAH. Those with NAH had significantly lower fasting glucose levels than did those without (82 +/- 48 mg/dL vs. 144 +/- 69 mg/dL; P = 0.009). The change from pre-to postbreakfast glucose levels was significantly greater among those with NAH (postprandial 1-h, P = 0.028; postprandial 2-h, P = 0.028). The cut-off values for prediction of NAH were as follows: fasting glucose level <84 mg/dL (sensitivity 0.80/specificity 0.75/AUC 0.80; P = 0.004), 1-h postprandial elevation >69 mg/dL (0.75/0.67/0.73; P = 0.033), and 2-h postprandial elevation > 99 mg/dL (0.69/0.67/0.71; P = 0.044). Conclusions The results suggest that fasting glucose level of <84 mg/dL had approximately 80% probability of predicting the occurrence of NAH in T1D receiving insulin degludec. It was also shown that the occurrence of hypoglycemia led to greater post-breakfast glucose fluctuations and steeper post-breakfast glucose gradients.	[Takahashi, Hiroshi; Nishimura, Rimei; Onda, Yoshiko; Ando, Kiyotaka; Tsujino, Daisuke; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Div Diabet Metab & Endocrinol, Dept Internal Med, Tokyo, Japan	Jikei University	Nishimura, R (corresponding author), Jikei Univ, Sch Med, Div Diabet Metab & Endocrinol, Dept Internal Med, Tokyo, Japan.	rimei@jikei.ac.jp			Boehringer Ingelheim; Takeda; Kowa; Kyowa Kirin; MSD; Onoand Tanabe-Mitsubishi	Boehringer Ingelheim(Boehringer Ingelheim); Takeda(Takeda Pharmaceutical Company Ltd); Kowa; Kyowa Kirin; MSD; Onoand Tanabe-Mitsubishi	Dr. Rimei Nishimura has participated in speaker's bureau/advisorypanels for Astellas, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, EliLilly, Johnson&JohnsonKssei, Kowa, Medtronic, NovoNordisk, Ono, Sanofi, Taisho, Takedaand Tanabe Mitsubishi, and served as a consultant for Abbott, Boehringer Ingelheim, EliLilly, and Taisho. Dr.Kiyotaka Ando has participate dinspeaker's bureau/advisory panels for Novo Nordiskand Sanofi. Dr.Daisuke Tsujino has participated in speaker's bureau/ advisory panels for Novo Nordisk, and has received research support from Boehringer Ingelheim, and Takeda. Dr. Kazunori Utsunomiya has received research support from Kowa, Kyowa Kirin, MSD, Onoand Tanabe-Mitsubishi, and has participate din speaker's bureau/advisory panels for Astellas, Astra Zeneca, Kowa, MSD, Novo Nordisk and Sanofi. All other authors declare to have no conflict ofinterest. However, these does not alter our adherence to PLOSONE policies on sharingdata and materials	Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; Banarer S, 2003, DIABETES, V52, P1195, DOI 10.2337/diabetes.52.5.1195; Birkeland KI, 2011, DIABETES CARE, V34, P661, DOI 10.2337/dc10-1925; Choudhary P, 2013, DIABETIC MED, V30, P914, DOI 10.1111/dme.12175; Chow E, 2014, DIABETES, V63, P1738, DOI 10.2337/db13-0468; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Diabet Control Complications Trial Res Grp, 1995, DIABETES CARE, V18, P1415; Diabetes C, 2016, DIABETES CARE, V39, P686, DOI DOI 10.2337/DC15-1990; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Gough SCL, 2013, DIABETES OBES METAB, V15, P301, DOI 10.1111/dom.12052; Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Heise T, 2012, DIABETES OBES METAB, V14, P859, DOI 10.1111/j.1463-1326.2012.01627.x; Heller S, 2012, LANCET, V379, P1489, DOI 10.1016/S0140-6736(12)60204-9; Hoi-Hansen T, 2005, DIABETOLOGIA, V48, P2437, DOI 10.1007/s00125-005-1946-5; Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303; Kaufman FR, 2002, J PEDIATR-US, V141, P625, DOI 10.1067/mpd.2002.129175; Khunti K, 2015, DIABETES CARE, V38, P316, DOI 10.2337/dc14-0920; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Lung TWC, 2014, DIABETES CARE, V37, P2974, DOI 10.2337/dc14-0405; Mauras N, 2007, PEDIATR DIABETES, V8, P199; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Mitsuishi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144041; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Onda Y, 2016, DIABETES RES CLIN PR, V120, P149, DOI 10.1016/j.diabres.2016.07.019; REICHARD P, 1991, J INTERN MED, V230, P101, DOI 10.1111/j.1365-2796.1991.tb00415.x; REICHARD P, 1994, DIABETES, V43, P313, DOI 10.2337/diabetes.43.2.313; Robinson RTCE, 2004, DIABETOLOGIA, V47, P312, DOI 10.1007/s00125-003-1292-4; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Suys B, 2006, DIABETES CARE, V29, P427, DOI 10.2337/diacare.29.02.06.dc05-1450; Takahashi H, 2017, EXPERT OPIN PHARMACO, V18, P335, DOI 10.1080/14656566.2017.1293652; TATTERSALL RB, 1991, DIABETIC MED, V8, P49, DOI 10.1111/j.1464-5491.1991.tb01516.x; Tsujimoto T, 2014, DIABETES CARE, V37, P217, DOI 10.2337/dc13-0701; Wentholt IME, 2007, DIABETIC MED, V24, P527, DOI 10.1111/j.1464-5491.2007.02107.x; Weston PJ, 1999, DIABETIC MED, V16, P626, DOI 10.1046/j.1464-5491.1999.00121.x; Wiltshire EJ, 2006, J PAEDIATR CHILD H, V42, P758, DOI 10.1111/j.1440-1754.2006.00973.x; Woodward A, 2009, QJM-INT J MED, V102, P603, DOI 10.1093/qjmed/hcp082; Zygalo KD, 2015, ACTA DIABETOL, V52, P231, DOI 10.1007/s00592-014-0604-0	39	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0177283	10.1371/journal.pone.0177283	http://dx.doi.org/10.1371/journal.pone.0177283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683068	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200001
J	Artioli, G; Angelini, I; Kaufmann, G; Canovaro, C; Dal Sasso, G; Villa, IM				Artioli, Gilberto; Angelini, Ivana; Kaufmann, Gunther; Canovaro, Caterina; Dal Sasso, Gregorio; Villa, Igor Maria			Long-distance connections in the Copper Age: New evidence from the Alpine Iceman's copper axe	PLOS ONE			English	Article							COLLECTOR ICP-MS; LEAD-ISOTOPE; METALLURGY; MINERALOGY; VALLEY; ORES; ALPS	25 years after the discovery in the Otztal Italian Alps, the 5,300-year-old mummy keeps providing key information on human biological and medical conditions, aspects of everyday life and societal organization in the Copper Age. The hand axe found with the body of the Alpine Iceman is one of the rare copper objects that is firmly dated to the early Copper Age because of the radiocarbon dating of the axe wooden shaft. Here we report the measurement of the lead isotope ratios of the copper blade. The results unambiguously indicate that the source of the metal is the ore-rich area of Southern Tuscany, despite ample evidence that Alpine copper ore sources were known and exploited at the time. The experimental results are discussed within the framework of all the available coeval archaeometallurgical data in Central-Southern Europe: they show that the Alps were a neat cultural barrier separating distinct metal circuits. The direct evidence of raw metal or object movement between Central Italy and the Alps is surprising and provides a new perspective on long-distance relocation of goods and relationships between the early Copper Age cultures in the area. The result is in line with the recent investigations re-evaluating the timing and extent of copper production in Central Italy in the 4 th millennium BC.	[Artioli, Gilberto; Canovaro, Caterina; Dal Sasso, Gregorio] Univ Padua, Dept Geosci, Padua, Italy; [Artioli, Gilberto; Angelini, Ivana; Canovaro, Caterina] Consorzio Interuniv Nazl Sci & Tecnol Mat, INSTM, Florence, Italy; [Angelini, Ivana] Univ Padua, Dept Cultural Heritage, Padua, Italy; [Kaufmann, Gunther] Sudtiroler Archaol Museum, Museo Archeol Alto Adige, Bolzano, Italy; [Villa, Igor Maria] Univ Milano Bicocca, Ctr Univ Dataz & Archeometria, Milan, Italy; [Villa, Igor Maria] Univ Bern, Inst Geol, Bern, Switzerland	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR); University of Padua; University of Milano-Bicocca; University of Bern	Artioli, G (corresponding author), Univ Padua, Dept Geosci, Padua, Italy.; Artioli, G (corresponding author), Consorzio Interuniv Nazl Sci & Tecnol Mat, INSTM, Florence, Italy.	gilberto.artioli@unipd.it	Canovaro, Caterina/AAL-8642-2020; Artioli, Gilberto/F-2149-2015; Dal Sasso, Gregorio/J-5074-2017; Angelini, Ivana/A-9839-2016	Canovaro, Caterina/0000-0003-3147-0219; Artioli, Gilberto/0000-0002-8693-7392; Dal Sasso, Gregorio/0000-0002-2176-5446; Villa, Igor M/0000-0002-8070-8142; Angelini, Ivana/0000-0002-7970-3416				Amov BG, 1994, PROBLEMS EARLIEST ME, P122; Angelini I, 2013, LETA RAME IA PIANURA, P101; Angelini I, 2014, MOVING METALS EUROPE; Angelini I, 2011, DEL VENETO, VXXVII, P107; [Anonymous], 3 BOLZ MUMM C; Artioli G, 2007, APPL PHYS A-MATER, V89, P899, DOI 10.1007/s00339-007-4215-2; Artioli G, 2016, J ARCHAEOL SCI, V75, P27, DOI 10.1016/j.jas.2016.09.005; Artioli G, 2015, J ARCHAEOL SCI, V63, P78, DOI 10.1016/j.jas.2015.08.013; Artioli G, 2003, MUMMIA DELLETA RAME, V3, P9; Artioli G., 2014, HIST METALL, V47, P51; Artioli G., 2016, METALLI METALLURGHI, P69; Artioli G., 2009, RIPOSTIGLIO MONTE CA, P167; Artioli G, 2011, EUR J MINERAL, V23, P849, DOI 10.1127/0935-1221/2011/0023-2119; Badocco D, 2014, SPECTROCHIM ACTA B, V96, P8, DOI 10.1016/j.sab.2014.03.013; Baron S, 2014, ARCHAEOMETRY, V56, P665, DOI 10.1111/arcm.12037; Baxter MJ, 1997, J ARCHAEOL SCI, V24, P347, DOI 10.1006/jasc.1996.0119; Begemann F., 2001, EUR J ARCHAEOL, V4, P43, DOI [10.1179/eja.2001.4.1.43, DOI 10.1179/EJA.2001.4.1.43]; Carancini GL, 1998, FERRANTE RITTATORE V, P29; Carancini GL, 1993, VULCANO MEZZANO INSE, P125; Coia V, 2016, SCI REP-UK, V6, DOI 10.1038/srep18932; De Angelis MC, 1995, RIVISTA SCIENZE PREI, V47, P397; de Marinis R. C., 2013, LETA RAME PIANURA PA, P301; De Marinis RC., 2006, RIV SCI PREISTORICHE, V56, P211; De Marinis RC, 1992, MANN EIS, V187, P389; Dickson JH, 2005, SCI AM, V15, P4; Dolfini A, 2013, EUR J ARCHAEOL, V16, P21, DOI 10.1179/1461957112Y.0000000023; Dolfini A, 2010, ANTIQUITY, V84, P707, DOI 10.1017/S0003598X00100183; Egg M, 2009, MONOGRAPHIEN ROMISCH, V77; Gale N, 2000, ANNUARY DEP ARCHAEOL, VIV-V, P102; Hoppner B, 2005, ARCHAEOMETRY, V47, P293, DOI 10.1111/j.1475-4754.2005.00203.x; KAUFMANN G., 2014, RIV SCI PREISTORICHE, VLXIV, P57; KIENLIN T. L., 2008, P PREHIST SOC, V74, P79, DOI DOI 10.1017/S0079497X00000153; Ling J, 2014, J ARCHAEOL SCI, V41, P106, DOI 10.1016/j.jas.2013.07.018; Miari M., 1993, RIV SCI PREISTORICHE, V45, P101; Muller W, 2003, SCIENCE, V302, P862, DOI 10.1126/science.1089837; Nimis P, 2012, EUR J MINERAL, V24, P23, DOI 10.1127/0935-1221/2012/0024-2163; O'Sullivan NJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31279; Pernicka E., 1997, EURASIA ANTIQUA, V3, P41; Pernicka E., 1993, PRAEHIST Z, V68, P1, DOI DOI 10.1515/PRHZ.1993.68.1.1; Pernicka E., 2013, ARCHAEOMETALLURGY GL, P239, DOI [DOI 10.1007/978-1-4614-9017-3_11, 10.1007/978-1-4614-9017-3_11]; Pernicka E, 2016, ARCHAEOL AUSTRIACA, P19, DOI 10.1553/archaeologia100s19; Perucchetti L, 2015, EUR J ARCHAEOL, V18, P599, DOI 10.1179/1461957115Y.0000000001; Putzer A, 2016, ANTIQUITY, V90, P319, DOI 10.15184/aqy.2015.185; Rehkamper M, 2000, J ANAL ATOM SPECTROM, V15, P1451, DOI 10.1039/b005262k; Robb J. E., 2009, SOCIAL BODIES, P100; Samadelli M, 2015, J CULT HERIT, V16, P753, DOI 10.1016/j.culher.2014.12.005; Sperl G., 1992, MANN EIS, V187, P454; Sperl G. O., 2005, MICROSC TODAY, V13, P8; Spindler K, 1993, SSDIE OTZTALER MUM V; Stos Z.A., 2009, MINE MICROSCOPE ADV, P163, DOI DOI 10.1016/J.JAS.2009.11.021; Stos-Gale ZA, 1998, ARCHAEOMETRY, V40, P217, DOI 10.1111/j.1475-4754.1998.tb00834.x; Stos-Gale ZA, 2009, ARCHAEOL ANTHROP SCI, V1, P195, DOI 10.1007/s12520-009-0011-6; Tapparo A, 2011, ANAL BIOANAL CHEM, V399, P2389, DOI 10.1007/s00216-010-4625-4; Villa I.M., 2016, ISOTOPIC LANDSCAPES, P141, DOI 10.1007/978-3-662-48339-8_8; Villa IM, 2009, ARCHAEOL ANTHROP SCI, V1, P149, DOI 10.1007/s12520-009-0012-5; White WM, 2000, CHEM GEOL, V167, P257, DOI 10.1016/S0009-2541(99)00182-5	56	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179263	10.1371/journal.pone.0179263	http://dx.doi.org/10.1371/journal.pone.0179263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA2LF	28678801	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200011
J	Mueller, S; Fiehler, K				Mueller, Stefanie; Fiehler, Katja			Gaze-centered coding of proprioceptive reach targets after effector movement: Testing the impact of online information, time of movement, and target distance	PLOS ONE			English	Article							WEIGHTED INTEGRATION; REFERENCE FRAMES; PERCEPTION; TACTILE; TRANSFORMATIONS; BODY	In previous research, we demonstrated that spatial coding of proprioceptive reach targets depends on the presence of an effector movement (Mueller & Fiehler, Neuropsychologia, 2014, 2016). In these studies, participants were asked to reach in darkness with their right hand to a proprioceptive target (tactile stimulation on the finger tip) while their gaze was varied. They either moved their left, stimulated hand towards a target location or kept it stationary at this location where they received a touch on the fingertip to which they reached with their right hand. When the stimulated hand was moved, reach errors varied as a function of gaze relative to target whereas reach errors were independent of gaze when the hand was kept stationary. The present study further examines whether (a) the availability of proprioceptive online information, i.e. reaching to an online versus a remembered target, (b) the time of the effector movement, i.e. before or after target presentation, or (c) the target distance from the body influences gaze-centered coding of proprioceptive reach targets. We found gaze-dependent reach errors in the conditions which included a movement of the stimulated hand irrespective of whether proprioceptive information was available online or remembered. This suggests that an effector movement leads to gaze-centered coding for both online and remembered proprioceptive reach targets. Moreover, moving the stimulated hand before or after target presentation did not affect gaze-dependent reach errors, thus, indicating a continuous spatial update of positional signals of the stimulated hand rather than the target location per se. However, reaching to a location close to the body rather than farther away (but still within reachable space) generally decreased the influence of a gaze-centered reference frame.	[Mueller, Stefanie; Fiehler, Katja] Justus Liebig Univ Giessen, Dept Expt Psychol, Giessen, Hesse, Germany	Justus Liebig University Giessen	Mueller, S (corresponding author), Justus Liebig Univ Giessen, Dept Expt Psychol, Giessen, Hesse, Germany.	stefanie.mueller@psychol.uni-giessen.de		Mueller, Stefanie/0000-0002-3611-6190	Deutsche Forschungsgemeinschaft [Fi1567/4-2, SFBTRR135]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de); grant numbers: Fi1567/4-2 (assigned to KF) and SFBTRR135 (project A4). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badde S, 2016, COGN NEUROPSYCHOL, V33, P26, DOI 10.1080/02643294.2016.1168791; Badde S, 2016, PSYCHON B REV, V23, P387, DOI 10.3758/s13423-015-0918-0; Badde S, 2015, NEUROPSYCHOLOGIA, V70, P367, DOI 10.1016/j.neuropsychologia.2014.10.001; Bernier PM, 2010, NEURON, V68, P776, DOI 10.1016/j.neuron.2010.11.002; Blangero A., 2005, ADV COGN PSYCHOL, V1, P9, DOI DOI 10.2478/V10053-008-0039-7; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Crawford JD, 2011, ANNU REV NEUROSCI, V34, P309, DOI 10.1146/annurev-neuro-061010-113749; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Fiehler K, 2011, VISION RES, V51, P890, DOI 10.1016/j.visres.2010.12.015; Goodale MA, 1998, NEUROSCI BIOBEHAV R, V22, P161, DOI 10.1016/S0149-7634(97)00007-9; Goodale M, 2008, COGN NEUROPSYCHOL, V25, P891, DOI 10.1080/02643290801961984; Henriques DYP, 2002, PROG BRAIN RES, V140, P329; Jones SAH, 2010, NEUROPSYCHOLOGIA, V48, P3782, DOI 10.1016/j.neuropsychologia.2010.10.001; Medendorp WP, 2011, PHILOS T R SOC B, V366, P476, DOI 10.1098/rstb.2010.0089; Mueller S, 2016, NEUROPSYCHOLOGIA, V87, P63, DOI 10.1016/j.neuropsychologia.2016.04.033; Mueller S, 2014, NEUROPSYCHOLOGIA, V62, P184, DOI 10.1016/j.neuropsychologia.2014.07.025; Mueller S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00066; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Pritchett LM, 2012, EXP BRAIN RES, V222, P437, DOI 10.1007/s00221-012-3231-4; Schutz I, 2015, EXP BRAIN RES, V233, P1225, DOI 10.1007/s00221-015-4197-9; Van Pelt S, 2007, J NEUROPHYSIOL, V97, P1209, DOI 10.1152/jn.00882.2006	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180782	10.1371/journal.pone.0180782	http://dx.doi.org/10.1371/journal.pone.0180782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678886	gold, Green Submitted, Green Published			2022-12-27	WOS:000405272200090
J	Nguyen, UC; Maffessanti, F; Mafi-Rad, M; Conte, G; Zeemering, S; Regoli, F; Caputo, ML; van Stipdonk, AMW; Bekkers, SCAM; Suerder, D; Moccetti, T; Krause, R; Prinzen', FW; Vernooy', K; Auricchio, A				Nguyen, Uyen Chau; Maffessanti, Francesco; Mafi-Rad, Masih; Conte, Giulio; Zeemering, Stef; Regoli, Francois; Caputo, Maria Luce; van Stipdonk, Antonius M. W.; Bekkers, Sebastiaan C. A. M.; Suerder, Daniel; Moccetti, Tiziano; Krause, Rolf; Prinzen', Frits W.; Vernooy', Kevin; Auricchio, Angelo			Evaluation of the use of unipolar voltage amplitudes for detection of myocardial scar assessed by cardiac magnetic resonance imaging in heart failure patients	PLOS ONE			English	Article							SINUS RHYTHM; NONISCHEMIC CARDIOMYOPATHY; VENTRICULAR TACHYCARDIAS; INTEGRATION; ELECTROGRAMS; INFARCTION; SUBSTRATE; ABLATION; THERAPY; MODEL	Background Validation of voltage-based scar delineation has been limited to small populations using mainly endocardial measurements. The aim of this study is to compare unipolar voltage amplitudes (UnipV) with scar on delayed enhancement cardiac magnetic resonance imaging (DE-CMR). Methods Heart failure patients who underwent DE-CMR and electro-anatomic mapping were included. Thirty-three endocardial mapped patients and 27 epicardial mapped patients were investigated. UnipV were computed peak-to-peak. Electrograms were matched with scar extent of the corresponding DE-CMR segment using a 16-segment/slice model. Non-scar was defined as 0% scar, while scar was defined as 1-100% scar extent. Results UnipVs were moderately lower in scar than in non-scar (endocardial 7.1 [4.6-10.6] vs. 10.3 [7.4-14.2] mV; epicardial 6.7 [3.6-10.5] vs. 7.8 [4.2-12.3] mV; both p< 0.001). The correlation between UnipV and scar extent was moderate for endocardial (R = -0.33, p< 0.001), and poor for epicardial measurements (R = -0.07, p< 0.001). Endocardial UnipV predicted segments with >25%, >50% and >75% scar extent with AUCs of 0.72, 0.73 and 0.76, respectively, while epicardial UnipV were poor scar predictors, independent of scar burden (AUC = 0.47-0.56). UnipV in non-scar varied widely between patients (p< 0.001) and were lower scar compared to non-scar in only 9/22 (41%) endocardial mapped patients and 4/19 (21%) epicardial mapped patients with scar. Conclusion UnipV are slightly lower in scar compared to non-scar. However, significant UnipV differences between and within patients and large overlap between non-scar and scar limits the reliability of accurate scar assessment, especially in epicardial measurements and in segments with less than 75% scar extent.	[Nguyen, Uyen Chau; Zeemering, Stef; Prinzen', Frits W.; Vernooy', Kevin] Maastricht Univ, Cardiovasc Res Inst, Dept Physiol, Maastricht, Netherlands; [Nguyen, Uyen Chau; Mafi-Rad, Masih; van Stipdonk, Antonius M. W.; Bekkers, Sebastiaan C. A. M.; Vernooy', Kevin] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands; [Nguyen, Uyen Chau; Maffessanti, Francesco; Krause, Rolf; Prinzen', Frits W.; Auricchio, Angelo] Univ Svizzera Italiana, Ctr Computat Med Cardiol, Inst Computat Sci, Lugano, Switzerland; [Conte, Giulio; Regoli, Francois; Caputo, Maria Luce; Suerder, Daniel; Moccetti, Tiziano; Auricchio, Angelo] Fdn Cardioctr Ticino, Dept Cardiol, Lugano, Switzerland	Maastricht University; Maastricht University; Universita della Svizzera Italiana	Nguyen, UC (corresponding author), Maastricht Univ, Cardiovasc Res Inst, Dept Physiol, Maastricht, Netherlands.; Nguyen, UC (corresponding author), Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands.; Nguyen, UC (corresponding author), Univ Svizzera Italiana, Ctr Computat Med Cardiol, Inst Computat Sci, Lugano, Switzerland.	chau27@gmail.com	Bekkers, Sebastiaan C.A.M./Y-1484-2019; Maffessanti, Francesco/ABH-6429-2020; Maffessanti, Francesco/CAF-3033-2022	Maffessanti, Francesco/0000-0001-7364-3734; Vernooy, Kevin/0000-0002-8818-5964; Conte, Giulio/0000-0003-2248-3456; Nguyen, Uyen Chau/0000-0002-4836-2946	Swiss National Science Foundation [32003B_165802]; Swiss Heart Foundation; Biologic Delivery Systems, Division of Biosense Webstera Johnson & Johnson Company; Fondazione Cardiocentro Ticino; Theo Rossidi Montelera Foundation; Mantegazza Foundation; FIDINAM; Maastricht University; Dutch Heart Foundation [2015T61]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; Biologic Delivery Systems, Division of Biosense Webstera Johnson & Johnson Company; Fondazione Cardiocentro Ticino; Theo Rossidi Montelera Foundation; Mantegazza Foundation; FIDINAM; Maastricht University; Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported by grants from the Swiss National Science Foundation under project 32003B_165802, from the Swiss Heart Foundation, and by are stricted grant of Biologic Delivery Systems, Division of Biosense Webstera Johnson & Johnson Company. The authors gratefully acknowledge financial support by Fondazione Cardiocentro Ticino, the Theo Rossidi Montelera Foundation, the Mantegazza Foundation, and FIDINAM to the Center of Computational Medicine in Cardiology. UCN received a Kootstra Talent Fellowship research grant from Maastricht University and was additionally funded by a research grant from the Dutch Heart Foundation (grant #2015T61).The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscrip.	Arenal A, 2014, HEART RHYTHM, V11, P1456, DOI 10.1016/j.hrthm.2014.04.022; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; CASSIDY DM, 1984, CIRCULATION, V70, P37, DOI 10.1161/01.CIR.70.1.37; Codreanu A, 2008, J AM COLL CARDIOL, V52, P839, DOI 10.1016/j.jacc.2008.05.038; Hutchinson MD, 2011, CIRC-ARRHYTHMIA ELEC, V4, P49, DOI 10.1161/CIRCEP.110.959957; Kroon W, 2015, HEART RHYTHM, V12, P1259, DOI 10.1016/j.hrthm.2015.03.006; Leyva F, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-29; Nguyen UC, 2016, HEART RHYTHM OFFICIA; Pavo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113245; Perin EC, 2002, CIRCULATION, V106, P957, DOI 10.1161/01.CIR.0000026394.01888.18; Piers SRD, 2013, EUR HEART J, V34, P586, DOI 10.1093/eurheartj/ehs382; Potse M, 2014, EUROPACE, V16, P56, DOI 10.1093/europace/euu257; Sasaki T, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1139, DOI 10.1161/CIRCEP.113.000159; Soejima K, 2001, CIRCULATION, V104, P664, DOI 10.1161/hc3101.093764; Tung R, 2016, CIRC ARRHYTHM ELECTR, V9; Tung R, 2016, HEART RHYTHM, V13, P1993, DOI 10.1016/j.hrthm.2016.07.003; Tung R, 2010, HEART RHYTHM, V7, P389, DOI 10.1016/j.hrthm.2009.11.023; Wijnmaalen AP, 2011, EUR HEART J, V32, P104, DOI 10.1093/eurheartj/ehq345; Wrobleski D, 2003, J CARDIOVASC ELECTR, V14, P524, DOI 10.1046/j.1540-8167.2003.02499.x	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180637	10.1371/journal.pone.0180637	http://dx.doi.org/10.1371/journal.pone.0180637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678875	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200081
J	Zhang, L; Liu, XR; Liu, JZ; Zhou, ZQ; Song, YX; Cao, BY; An, XP				Zhang, Lei; Liu, Xiaorui; Liu, Junze; Zhou, Zhanqin; Song, Yuxuan; Cao, Binyun; An, Xiaopeng			miR-182 aids in receptive endometrium development in dairy goats by down-regulating PTN expression	PLOS ONE			English	Article							GROWTH-FACTOR PLEIOTROPHIN; NF-KAPPA-B; MESSENGER-RNA; STROMAL CELLS; IN-VITRO; DIFFERENTIAL EXPRESSION; EMBRYO IMPLANTATION; HORMONAL-REGULATION; DIVERSE FUNCTIONS; MENSTRUAL-CYCLE	Increasing evidence has shown that miRNAs play important roles in endometrium development during the menstrual cycle in humans and many other animals. Our previous data indicated that miR-182 levels increase 15.55-fold and pleiotrophin (PTN) levels decrease 20.97-fold in the receptive endometrium (RE, D15) compared with the pre-receptive endometrium (PE, D5) in dairy goats. The present study shows that miR-182 is widely expressed in different tissues of dairy goats and that its expression levels are regulated by E2 and P4 in endometrial epithelium cells (EECs). We confirmed that PTN is a target of miR-182 and that miR-182 regulates the protein levels of AKT, Bcl-2, FAS, MAPK, Caspase-3 and SP1 in EECs. Furthermore, miR-182 up-regulates or maintains the expression levels of osteopontin (OPN), cyclooxygenase-2 (COX-2) and prolactin receptor (PRLR) in EECs, suggesting that miR-182 is an important regulatory factor in the construction of endometrial receptivity in dairy goats. In conclusion, miR-182 participates in the development of endometrial receptivity by down-regulating PTN and affecting the expression of select apoptosis-related genes and increasing or maintaining the expression levels of OPN, COX-2 and PRLR in the EECs of dairy goats.	[Zhang, Lei; Liu, Xiaorui; Liu, Junze; Zhou, Zhanqin; Song, Yuxuan; Cao, Binyun; An, Xiaopeng] Northwest Agr & Forestry Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Cao, BY; An, XP (corresponding author), Northwest Agr & Forestry Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	binyun_cao@163.com; 124495863@qq.com			Shaanxi science and technology innovation project plan;  [2013KTZBO2-02-01];  [2015KTCQ03-08]	Shaanxi science and technology innovation project plan; ; 	Shaanxi science and technology innovation project plan (2013KTZBO2-02-01), Shaanxi science and technology innovation project plan (2015KTCQ03-08). The funders had no role in study design, data collection and analysis, decision to publish ,orpreparation of the manuscript.	Alan E, 2016, MICROSC RES TECHNIQ, V79, P285, DOI 10.1002/jemt.22629; ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Altmae S, 2013, REPROD SCI, V20, P308, DOI 10.1177/1933719112453507; [Anonymous], 2015, SCI REPORTS, P5; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Antsiferova YS, 2016, WORLD J OBSTET GYNE, V5; Arai M, 2014, ANIM REPROD SCI, V151, P97, DOI 10.1016/j.anireprosci.2014.10.004; Arai M, 2013, ANIM REPROD SCI, V142, P1, DOI 10.1016/j.anireprosci.2013.08.003; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bany BM, 2001, ENDOCRINOLOGY, V142, P955, DOI 10.1210/en.142.2.955; Bauersachs S, 2013, J REPROD IMMUNOL, V97, P20, DOI 10.1016/j.jri.2012.11.002; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Brigstock DR, 1996, J ENDOCRINOL, V148, P103, DOI 10.1677/joe.0.1480103; Cai JL, 2016, TOXICOLOGY, V365, P25, DOI 10.1016/j.tox.2016.07.017; Cha J., 2013, MOL INTERPLAY SUCCES; CHAKRABORTY I, 1995, J ENDOCRINOL, V147, P339, DOI 10.1677/joe.0.1470339; Chen C, 2015, REPROD SCI, V120, P1297; Chen C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25302; Chen J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/985814; Chu PY, 2006, THERIOGENOLOGY, V66, P1545, DOI 10.1016/j.theriogenology.2006.01.018; Chung HW, 2002, MOL HUM REPROD, V8, P350, DOI 10.1093/molehr/8.4.350; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; da Costa RPR, 2007, REPROD FERT DEVELOP, V19, P925, DOI 10.1071/RD06159; Das SK, 1997, BIOL REPROD, V56, P1390, DOI 10.1095/biolreprod56.6.1390; Demir R, 2010, ACTA HISTOCHEM, V112, P203, DOI 10.1016/j.acthis.2009.04.004; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Dorjgochoo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060915; Du CL, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0182-1; Eissing T, 2007, BIOPHYS J, V92, P3332, DOI 10.1529/biophysj.106.100362; Evans PW, 1998, HUM REPROD, V13, P1057, DOI 10.1093/humrep/13.4.1057; Fluhr H, 2013, REPROD BIOL, V13, P113, DOI 10.1016/j.repbio.2013.03.001; Gartner MA, 2016, REPROD FERT DEVELOP, V28, P982, DOI 10.1071/RD14219; Galan A, 2000, BIOL REPROD, V63, P430, DOI 10.1093/biolreprod/63.2.430; Ganeff C, 2009, MOL HUM REPROD, V15, P27, DOI 10.1093/molehr/gan073; Gibson DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19970; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Greenbaum LE, 2004, CANCER BIOL THER, V3, P1200, DOI 10.4161/cbt.3.12.1392; Gu CO, 2011, CANCER SCI, V102, P557, DOI 10.1111/j.1349-7006.2010.01829.x; Gu DY, 2007, FEBS LETT, V581, P382, DOI 10.1016/j.febslet.2006.12.043; Gu Y, 2015, INT J CLIN EXP MED, V8, P3227; Gu YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150954; Harada T, 2004, HUM REPROD UPDATE, V10, P29, DOI 10.1093/humupd/dmh007; Henriques S, 2015, Reprod Fertil Dev, DOI 10.1071/RD14245; Horcajadas JA, 2004, ANN NY ACAD SCI, V1034, P166, DOI 10.1196/annals.1335.019; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Isayama K, 2015, AM J PHYSIOL-ENDOC M, V308, P2462, DOI DOI 10.1152/AJPEND0.00533.2014; Jabbour HN, 1998, J CLIN ENDOCR METAB, V83, P2545, DOI 10.1210/jc.83.7.2545; Jimenez PT, 2016, MOL ENDOCRINOL; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Johnson GA, 2003, BIOL REPROD, V68, P1951, DOI 10.1095/biolreprod.102.012948; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kanamori Y, 2001, CLIN CANCER RES, V7, P892; Kang YJ, 2015, J CELL SCI, V128, P804, DOI 10.1242/jcs.164004; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kennedy TG, 2007, REPRODUCTION, V134, P635, DOI 10.1530/REP-07-0328; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kouri FM, 2015, GENE DEV, V29, P732, DOI 10.1101/gad.257394.114; Krzymowska S, 2001, ACTA VET HUNG, P49; Kuo HP, 2015, J FUNCT FOODS, V17, P600, DOI 10.1016/j.jff.2015.06.006; Laaroubi Khalid, 1995, Progress in Growth Factor Research, V6, P25; Lei R, 2014, ONCOGENE, V33, P1287, DOI 10.1038/onc.2013.65; LESSEY BA, 1994, FERTIL STERIL, V62, P497; Li G, 2006, J BIOL CHEM, V281, P10663, DOI 10.1074/jbc.M512509200; LI R, 1991, CELL, V65, P493, DOI 10.1016/0092-8674(91)90467-D; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lin RK, 2014, BIOMED PHARMACOTHER, V68, P929, DOI 10.1016/j.biopha.2014.10.003; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Maruyama T, 2008, ENDOCR J, V55, P795, DOI 10.1507/endocrj.K08E-067; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Miravet-Valenciano JA, 2015, CURR OPIN OBSTET GYN, V27, P187, DOI 10.1097/GCO.0000000000000173; Muramatsu H, 2006, GENES CELLS, V11, P1405, DOI 10.1111/j.1365-2443.2006.01028.x; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Murphy CR, 2004, CELL RES, V14, P259, DOI 10.1038/sj.cr.7290227; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; NAWAZ S, 1987, AM J PATHOL, V127, P51; Nuchprayoon I, 1999, J BIOL CHEM, V274, P1085, DOI 10.1074/jbc.274.2.1085; Oner H, 2010, FOLIA HISTOCHEM CYTO, V48, P71, DOI 10.2478/v10042-008-0088-2; Otsuki Yoshinori, 2001, Medical Electron Microscopy, V34, P166, DOI 10.1007/s007950100011; Pampfer S, 1999, CELL DEATH DIFFER, V6, P533, DOI 10.1038/sj.cdd.4400516; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Pufe T, 2003, OSTEOARTHR CARTILAGE, V11, P260, DOI 10.1016/S1063-4584(02)00385-0; Qi XF, 2012, DOMEST ANIM ENDOCRIN, V42, P210, DOI 10.1016/j.domaniend.2011.12.004; Qi XF, 2012, REPROD BIOL, V12, P309, DOI 10.1016/j.repbio.2012.09.003; Qu Y, 2013, INT J CANCER, V133, P544, DOI 10.1002/ijc.28056; Schulte AM, 2000, ONCOGENE, V19, P3988, DOI 10.1038/sj.onc.1203742; SilosSantiago I, 1996, J NEUROBIOL, V31, P283, DOI 10.1002/(SICI)1097-4695(199611)31:3<283::AID-NEU2>3.0.CO;2-6; Song J, 2002, MOL HUM REPROD, V8, P447, DOI 10.1093/molehr/8.5.447; Song YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122202; Sookvanichsilp N, 2002, CONTRACEPTION, V65, P373, DOI 10.1016/S0010-7824(01)00322-5; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Souttou B, 2001, J CELL PHYSIOL, V187, P59, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F; Subramaniam KS, 2016, AM J CANCER RES, V6, P200; Sun X, 2014, MOL CELL BIOCHEM, V388, P11, DOI 10.1007/s11010-013-1895-0; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tamura I, 2014, ENDOCRINOLOGY, V155, P275, DOI 10.1210/en.2013-1569; Tao XJ, 1997, J CLIN ENDOCR METAB, V82, P2738, DOI 10.1210/jc.82.8.2738; Thie M, 2002, CELLS TISSUES ORGANS, V172, P237, DOI 10.1159/000066963; Tranguch S, 2014, INT J DEV BIOL, V58, P79, DOI 10.1387/ijdb.130332st; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; VACHEROT F, 1995, IN VITRO CELL DEV-AN, V31, P647; Van Cruchten S, 2003, THERIOGENOLOGY, V60, P1595, DOI 10.1016/S0093-691X(03)00178-X; Van SM, 2015, REPROD FERT DEVELOP; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Vilella F, 2013, J CLIN ENDOCR METAB, V98, P4123, DOI 10.1210/jc.2013-2205; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wallis CJD, 2015, J CANCER, V6, P1295, DOI 10.7150/jca.13176; Wei P, 2005, MOL REPROD DEV, V70, P478, DOI 10.1002/mrd.20215; Wei Q, 2015, THORAC CANCER, V6, P2, DOI 10.1111/1759-7714.12164; Wilkanowska A, 2014, FOLIA BIOL-KRAKOW, V62, P1, DOI 10.3409/fb62_1.1; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zeng J, 2013, EXP CLIN ENDOCR DIAB, V121, P425, DOI 10.1055/s-0033-1345169; Zhang DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123423; Zhang L. L., 2015, SCI REP, P5; Zhang S, 2013, MOL REPROD DEV, V80, P8, DOI 10.1002/mrd.22118; Zhang Y., 2013, J NANOMATER, V2013, P7, DOI DOI 10.1371/J0URNAL.P0NE.0069715; Zhao HH, 2014, J CELL MOL MED, V18, P283, DOI 10.1111/jcmm.12186; Zhu HQ, 2014, INT J CARDIOL, V176, P764, DOI 10.1016/j.ijcard.2014.07.095	130	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179783	10.1371/journal.pone.0179783	http://dx.doi.org/10.1371/journal.pone.0179783			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678802	gold, Green Submitted, Green Published			2022-12-27	WOS:000405272200027
J	Ge, F; Huang, X; Hu, HM; Zhang, YL; Li, ZL; Zou, CY; Peng, HW; Li, LJ; Gao, SB; Pan, GT; Shen, Y				Ge, Fei; Huang, Xing; Hu, Hongmei; Zhang, Yanling; Li, Zhaoling; Zou, Chaoying; Peng, Huanwei; Li, Lujiang; Gao, Shibin; Pan, Guangtang; Shen, Yaou			Endogenous small interfering RNAs associated with maize embryonic callus formation	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; MICRORNA REGULATION; DNA-METHYLATION; AUXIN; GENE; EMBRYOGENESIS; BIOGENESIS; STRESS; CELLS	The induction efficiency of maize embryonic callus is highly dependent on the genotype, and only a few lines possess a high capacity for callus formation. Although certain genes and pathways have been reported to contribute to the regulation of callus induction, to the best of our knowledge, the functions of the small interfering RNAs (siRNAs) involved in this process remain unknown. In this study, we identified 861 differentially expressed siRNAs and 576 target genes in the callus induction process. These target genes were classified into 3 clusters, and their functions involve controlling metalloexopeptidase activity, catalase activity, transcription regulation, and O-methyltransferase activity. In addition, certain genes related to auxin transport and stem cell or meristem development (e.g., PLT5-like, ARF15, SAUR-like, FAS1-like, Fea3, SCL5, and Zmwox2A) were regulated by the differentially expressed siRNAs. Moreover, zma-siR004119-2 directly cleaves the 5' UTR of Homeobox-transcription factor 25, which further leads to the down-regulation of its expression. Twelve 24-nt-siRNAs led to the hyper-methylation of GRMZM2G013465, which further decreases its expression. These results suggest that differentially expressed siRNAs regulate callus formation by controlling the expression of their target genes.	[Ge, Fei; Huang, Xing; Hu, Hongmei; Zhang, Yanling; Li, Zhaoling; Zou, Chaoying; Li, Lujiang; Gao, Shibin; Pan, Guangtang; Shen, Yaou] Sichuan Agr Univ, Key Lab Biol & Genet Improvement Maize Southwest, Maize Res Inst, Chengdu, Sichuan, Peoples R China; [Peng, Huanwei] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Shen, Y (corresponding author), Sichuan Agr Univ, Key Lab Biol & Genet Improvement Maize Southwest, Maize Res Inst, Chengdu, Sichuan, Peoples R China.	shenyaou@aliyun.com			National Natural Science Foundation of China [31271739, 31471512]; Yong Scientists Fund of Sichuan Province [2016JQ0008]; Project of Transgenic New Variety Cultivation [2016ZX080030 03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yong Scientists Fund of Sichuan Province; Project of Transgenic New Variety Cultivation	This study was supported by the National Natural Science Foundation of China (31271739 and 31471512, http://www.nsfc.gov.cn/), the Yong Scientists Fund of Sichuan Province (2016JQ0008, http://www.qnjj.sc.cn/) and the Project of Transgenic New Variety Cultivation (2016ZX080030 03,http://www.nmp.gov.cn/zxjs/200901/ t20090113_2113.htm). All of the funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barber WT, 2012, P NATL ACAD SCI USA, V109, P10444, DOI 10.1073/pnas.1202073109; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Gallavotti A, 2008, PLANT PHYSIOL, V147, P1913, DOI 10.1104/pp.108.121541; Ge F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01280-8; Il Je B, 2016, NAT GENET, V48, P785, DOI 10.1038/ng.3567; Izhaki A, 2007, PLANT CELL, V19, P495, DOI 10.1105/tpc.106.047472; Kasai M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-63; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Ledwon A, 2009, PLANT CELL REP, V28, P1677, DOI 10.1007/s00299-009-0767-2; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043451; Liu HJ, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1055-x; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Ma Li, 2007, Fen Zi Xi Bao Sheng Wu Xue Bao, V40, P164; Marsoni M, 2008, PLANT CELL REP, V27, P347, DOI 10.1007/s00299-007-0438-0; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Pasternak TP, 2002, PLANT PHYSIOL, V129, P1807, DOI 10.1104/pp.000810; Qi X, 2013, PLANT MOL BIOL, V83, P459, DOI 10.1007/s11103-013-0104-6; Shen Y, 2013, BIOCHEM BIOPH RES CO, V441, P425, DOI 10.1016/j.bbrc.2013.10.113; Shen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032237; Sun LF, 2013, PLANT CELL TISS ORG, V113, P103, DOI 10.1007/s11240-012-0255-1; Tan BC, 2013, PLANT MOL BIOL REP, V31, P1220, DOI 10.1007/s11105-013-0590-3; Varhanikova M, 2014, J PROTEOMICS, V104, P57, DOI 10.1016/j.jprot.2014.02.003; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Verdeil JL, 2007, TRENDS PLANT SCI, V12, P245, DOI 10.1016/j.tplants.2007.04.002; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Williams L, 2005, CURR OPIN PLANT BIOL, V8, P582, DOI 10.1016/j.pbi.2005.09.010; Wu XM, 2015, PLANT BIOTECHNOL J, V13, P383, DOI 10.1111/pbi.12317; Wu YJ, 2013, BIOORGAN MED CHEM, V21, P2217, DOI 10.1016/j.bmc.2013.02.010; Xu C, 2013, PROTEIN CELL, V4, P656, DOI 10.1007/s13238-013-3052-7; Yang X., 2012, P 20 ACM INT C MULT, P1057, DOI [10.1145/2393347.2396382, DOI 10.1145/2393347.2396382]; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Zhang TQ, 2017, PLANT CELL; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhong SH, 2013, P NATL ACAD SCI USA, V110, P9171, DOI 10.1073/pnas.1219655110	38	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180567	10.1371/journal.pone.0180567	http://dx.doi.org/10.1371/journal.pone.0180567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672003	gold, Green Published, Green Submitted			2022-12-27	WOS:000405268500068
J	Ghotbaddini, M; Cisse, K; Carey, A; Powell, JB				Ghotbaddini, Maryam; Cisse, Keyana; Carey, Alexis; Powell, Joann B.			Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling	PLOS ONE			English	Article							PROSTATE-CANCER PROGRESSION; TYROSINE PHOSPHORYLATION; GROWTH; ACTIVATION; CELLS; IDENTIFICATION	Altered c-Src activity has been strongly implicated in the development, growth, progression, and metastasis of human cancers including prostate cancer. Src is known to regulate several biological functions of tumor cells, including proliferation. There are several Src inhibitors under evaluation for clinical effectiveness but have shown little activity in monotherapy trials of solid tumors. Combination studies are being explored by in vitro analysis and in clinical trials. Here we investigate the effect of simultaneous inhibition of the aryl hydrocarbon receptor (AhR) and Src on androgen receptor (AR) signaling in prostate cancer cells. AhR has also been reported to interact with the Src signaling pathway during prostate development. c-Src protein kinase is associated with the AhR complex in the cytosol and upon ligand binding to AhR, c-Src is activated and released from the complex. AhR has also been shown to regulate AR signaling which remains functionally important in the development and progression of prostate cancer. We provide evidence that co-inhibition of AhR and Src abolish AR activity. Evaluation of total protein and cellular fractions revealed decreased pAR expression and AR nuclear localization. Assays utilizing an androgen responsive element (ARE) and qRT-PCR analysis of AR genes revealed decreased AR promoter activity and transcriptional activity in the presence of both AhR and Src inhibitors. Furthermore, coinhibition of AhR and Src reduced the growth of prostate cancer cells compared to individual treatments. Several studies have revealed that AhR and Src individually inhibit cellular proliferation. However, this study is the first to suggest simultaneous inhibition of AhR and Src to inhibit AR signaling and prostate cancer cell growth.	[Ghotbaddini, Maryam; Cisse, Keyana; Carey, Alexis; Powell, Joann B.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA	Clark Atlanta University	Powell, JB (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.	jpowell@cau.edu		Carey, Alexis/0000-0002-8555-8139; Powell, Joann/0000-0002-9864-6744	NIH-NIMHD [2G12MD007590-29]; National Institute on Minority Health and Health Disparities [G12MD007590] Funding Source: NIH RePORTER	NIH-NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH-NIMHD Grant: 2G12MD007590-29.	Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Tran C, 2013, BIOCHEM PHARMACOL, V85, P753, DOI 10.1016/j.bcp.2012.12.010; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Drake JM, 2012, P NATL ACAD SCI USA, V109, P1643, DOI 10.1073/pnas.1120985109; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; Frauenstein K, 2015, ARCH TOXICOL, V89, P1329, DOI 10.1007/s00204-014-1321-8; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Kraus S, 2006, CANCER RES, V66, P11047, DOI 10.1158/0008-5472.CAN-06-0596; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Mehta V, 2011, DIFFERENTIATION, V82, P211, DOI 10.1016/j.diff.2011.05.011; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Ojemuyiwa MA, 2014, EXPERT OPIN EMERG DR, V19, P459, DOI 10.1517/14728214.2014.969239; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Su B, 2013, CANCER MED-US, V2, P784, DOI 10.1002/cam4.144; Suzman DL, 2014, THER ADV MED ONCOL, V6, P167, DOI 10.1177/1758834014529176; Tatarov O, 2009, CLIN CANCER RES, V15, P3540, DOI 10.1158/1078-0432.CCR-08-1857; Vlaeminck-Guillem V, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00222; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Xie GF, 2012, AM J PHYSIOL-GASTR L, V302, pG1006, DOI 10.1152/ajpgi.00427.2011; Yang XH, 2008, J CELL BIOCHEM, V104, P402, DOI 10.1002/jcb.21630; Yu J, 2012, BIOCHEM BIOPH RES CO, V424, P538, DOI 10.1016/j.bbrc.2012.06.151	27	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179844	10.1371/journal.pone.0179844	http://dx.doi.org/10.1371/journal.pone.0179844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671964	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500006
J	Magennis, EP; Francini, N; Mastrotto, F; Catania, R; Redhead, M; Fernandez-Trillo, F; Bradshaw, D; Churchley, D; Winzer, K; Alexander, C; Mantovani, G				Magennis, Eugene P.; Francini, Nora; Mastrotto, Francesca; Catania, Rosa; Redhead, Martin; Fernandez-Trillo, Francisco; Bradshaw, David; Churchley, David; Winzer, Klaus; Alexander, Cameron; Mantovani, Giuseppe			Polymers for binding of the gram-positive oral pathogen Streptococcus mutans	PLOS ONE			English	Article							IN-VITRO CYTOTOXICITY; ANTIMICROBIAL POLYMERS; GENE DELIVERY; BACTERIA; SURFACES; GLYCOPOLYMERS; BIOFILM; COLOCALIZATION; AGGREGATION; ANTIBODIES	Streptococcus mutans is the most significant pathogenic bacterium implicated in the formation of dental caries and, both directly and indirectly, has been associated with severe conditions such as multiple sclerosis, cerebrovascular and peripheral artery disease. Polymers able to selectively bind S. mutans and/or inhibit its adhesion to oral tissue in a non-lethal manner would offer possibilities for addressing pathogenicity without selecting for populations resistant against bactericidal agents. In the present work two libraries of 2-(dimethylamino) ethyl methacrylate (pDMAEMA)-based polymers were synthesized with various proportions of either N, N, N-trimethylethanaminium cationic-or sulfobetaine zwitterionic groups. These copolymers where initially tested as potential macromolecular ligands for S. mutans NCTC 10449, whilst Escherichia coli MG1655 was used as Gram-negative control bacteria. pDMAEMA-derived materials with high proportions of zwitterionic repeating units were found to be selective for S. mutans, in both isolated and S. mutans-E. coli mixed bacterial cultures. Fully sulfobetainized pDMAEMA was subsequently found to bind/cluster preferentially Gram-positive S. mutans and S. aureus compared to Gram negative E. coli and V. harveyi. A key initial stage of S. mutans pathogenesis involves a lectin-mediated adhesion to the tooth surface, thus the range of potential macromolecular ligands was further expanded by investigating two glycopolymers bearing a-mannopyranoside and beta-galactopyranoside pendant units. Results with these polymers indicated that preferential binding to either S. mutans or E. coli can be obtained by modulating the glycosylation pattern of the chosen multivalent ligands without incurring unacceptable cytotoxicity in a model gastrointestinal cell line. Overall, our results allowed to identify a structure-property relationship for the potential antimicrobial polymers investigated, and suggest that preferential binding to Gram-positive S. mutans could be achieved by fine-tuning of the recognition elements in the polymer ligands.	[Magennis, Eugene P.; Mastrotto, Francesca; Catania, Rosa; Redhead, Martin; Alexander, Cameron; Mantovani, Giuseppe] Univ Nottingham, Sch Pharm, Nottingham, England; [Francini, Nora] Univ Nottingham, Sch Med, Nottingham, England; [Mastrotto, Francesca] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Fernandez-Trillo, Francisco] Univ Birmingham, Sch Chem, Haworth Bldg, Birmingham, W Midlands, England; [Bradshaw, David; Churchley, David] GlaxoSmithKline, St Georges Ave, Weybridge, Surrey, England; [Winzer, Klaus] Univ Nottingham, Sch Life Sci, BBSRC EPSRC Synthet Biol Res Ctr SBRC, Nottingham, England	University of Nottingham; University of Nottingham; University of Padua; University of Birmingham; GlaxoSmithKline; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Nottingham	Alexander, C; Mantovani, G (corresponding author), Univ Nottingham, Sch Pharm, Nottingham, England.	cameron.alexander@nottingham.ac.uk; giuseppe.mantovani@nottingham.ac.uk	Gao, Jing/M-8264-2018; Mastrotto, Francesca/AEU-4019-2022; Mantovani, Giuseppe/O-3430-2016; Fernandez-Trillo, Paco/D-7192-2013; Alexander, Cameron/N-7729-2014	Mantovani, Giuseppe/0000-0002-0837-0351; Fernandez-Trillo, Paco/0000-0002-6680-5683; Alexander, Cameron/0000-0001-8337-1875; Francini, Nora/0000-0001-7681-6442; Mastrotto, Francesca/0000-0002-2499-5490; Winzer, Klaus/0000-0002-3956-8096; Catania, Rosa/0000-0002-4717-808X	Biotechnology and Biological Sciences Research Council [BB/H53052X/1]; Engineering and Physical Sciences Research Council [EP/H005625/1, EP/G042462/1, EP/I01375X/1]; GSK Consumer Healthcare; EPSRC [EP/G042462/1, EP/H005625/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); GSK Consumer Healthcare; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council [grant number BB/H53052X/1] (UK, http://www.bbsrc.ac.uk) with GSK Consumer Healthcare, to EPM; and the Engineering and Physical Sciences Research Council [grant numbers EP/H005625/1, EP/G042462/1, EP/I01375X/1] (UK, http://www.epsrc.ac.uk) with the first grant to EPM, and the second and third grants to EP.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Aherne A, 1996, J AM CHEM SOC, V118, P8771, DOI 10.1021/ja960123c; Ahmed M, 2012, BIOCONJUGATE CHEM, V23, P1050, DOI 10.1021/bc3000723; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Alvarez-Paino M, 2015, BIOMACROMOLECULES, V16, P295, DOI 10.1021/bm5014876; Angelis ID, 2001, CURRENT PROTOCOLS TO; [Anonymous], 2010, NAT REV MICROBIOL, V8, P244, DOI 10.1038/nrmicro2345; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Baek MG, 2000, BIOCONJUGATE CHEM, V11, P777, DOI 10.1021/bc000026f; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Beyth N, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/246012; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Cao B, 2016, CHEM SCI, V7, P1976, DOI 10.1039/c5sc03887a; Chen J, 2014, CHEM COMMUN, V50, P14482, DOI 10.1039/c4cc03001j; Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041; Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058; CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U; De Geest BG, 2005, ADV MATER, V17, P2357, DOI 10.1002/adma.200401951; Deng ZC, 2009, J POLYM SCI POL CHEM, V47, P614, DOI 10.1002/pola.23187; DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832, DOI 10.1128/AEM.55.4.832-836.1989; Disney MD, 2004, J AM CHEM SOC, V126, P13343, DOI 10.1021/ja047936i; Du JZ, 2005, J AM CHEM SOC, V127, P17982, DOI 10.1021/ja056514l; Fine DH, 2001, J CLIN PERIODONTOL, V28, P697, DOI 10.1034/j.1600-051x.2001.028007697.x; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; GOLDBERG S, 1990, J BACTERIOL, V172, P5650, DOI 10.1128/jb.172.10.5650-5654.1990; Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7; Huang CJ, 2012, BIOMATERIALS, V33, P3626, DOI 10.1016/j.biomaterials.2012.01.059; Jain A, 2014, ADV HEALTHC MATER, V3, P1969, DOI 10.1002/adhm.201400418; JENKINS S, 1988, J CLIN PERIODONTOL, V15, P415, DOI 10.1111/j.1600-051X.1988.tb01595.x; Kamma JJ, 1999, J PERIODONTAL RES, V34, P25, DOI 10.1111/j.1600-0765.1999.tb02218.x; Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Krishnamurthy VM, 2006, BIOMATERIALS, V27, P3663, DOI 10.1016/j.biomaterials.2006.02.006; Kuroda K, 2013, WIRES NANOMED NANOBI, V5, P49, DOI 10.1002/wnan.1199; Ladmiral V, 2006, J AM CHEM SOC, V128, P4823, DOI 10.1021/ja058364k; LEVINE MJ, 1978, INFECT IMMUN, V19, P107, DOI 10.1128/IAI.19.1.107-115.1978; Lieberzeit PA, 2005, SENSORS-BASEL, V5, P509, DOI 10.3390/s5120509; LIGTENBERG AJM, 1990, ARCH ORAL BIOL, V35, pS141, DOI 10.1016/0003-9969(90)90145-Z; Little TJ, 2012, NAT MED, V18, P217, DOI 10.1038/nm.2572; Liu QS, 2016, LANGMUIR, V32, P7866, DOI 10.1021/acs.langmuir.6b01329; LOESCHE WJ, 1975, INFECT IMMUN, V11, P1252, DOI 10.1128/IAI.11.6.1252-1260.1975; Louzao I, 2015, EUR J PHARM BIOPHARM, V95, P47, DOI 10.1016/j.ejpb.2015.05.026; Lui LT, 2013, NAT CHEM, V5, P1058, DOI [10.1038/NCHEM.1793, 10.1038/nchem.1793]; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Lussi A, 2011, CLIN ORAL INVEST, P1; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Ma F, 2015, ANAL CHEM, V87, P1560, DOI 10.1021/ac502712q; Magennis EP, 2014, NAT MATER, V13, P748, DOI [10.1038/NMAT3949, 10.1038/nmat3949]; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marthaler TM, 2004, CARIES RES, V38, P173, DOI 10.1159/000077752; McCormack MG, 2015, AM J INFECT CONTROL, V43, P35, DOI 10.1016/j.ajic.2014.09.015; Metallo SJ, 2003, J AM CHEM SOC, V125, P4534, DOI 10.1021/ja030045a; Mi L, 2012, BIOMATERIALS, V33, P2001, DOI 10.1016/j.biomaterials.2011.11.071; Miura Y, 2016, CHEM REV, V116, P1673, DOI 10.1021/acs.chemrev.5b00247; Molander A, 1998, INT ENDOD J, V31, P1, DOI 10.1046/j.1365-2591.1998.t01-1-00111.x; Munoz-Bonilla A, 2015, MATERIALS, V8, P2276, DOI 10.3390/ma8052276; Munoz-Bonilla A, 2015, EUR POLYM J, V65, P46, DOI 10.1016/j.eurpolymj.2015.01.030; Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005; Nagata K, 1982, J DENTAL HLTH, V32, P386; Ohara-Nemoto Y, 2008, J MED MICROBIOL, V57, P95, DOI 10.1099/jmm.0.47561-0; Pasparakis G, 2008, ANGEW CHEM INT EDIT, V47, P4847, DOI 10.1002/anie.200801098; Pasparakis G, 2007, J AM CHEM SOC, V129, P11014, DOI 10.1021/ja074349z; Pennisi E, 2005, SCIENCE, V307, P1899, DOI 10.1126/science.307.5717.1899; Putnam D, 2001, P NATL ACAD SCI USA, V98, P1200, DOI 10.1073/pnas.031577698; Ravi P, 2005, J PHYS CHEM B, V109, P22791, DOI 10.1021/jp053088h; Rawlinson LAB, 2010, BIOMACROMOLECULES, V11, P443, DOI 10.1021/bm901166y; Salton M. R. J., 1996, MED MICROBIOLOGY; Schirhagl R, 2012, ANALYST, V137, P1495, DOI 10.1039/c2an15927a; Seemann R, 2001, CARIES RES, V35, P156, DOI 10.1159/000047448; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Sheiham A, 2006, BRIT DENT J, V201, P625, DOI 10.1038/sj.bdj.4814259; Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046; Smith AJ, 2003, BRIT DENT J, V195, P701, DOI 10.1038/sj.bdj.4810832; Soenen SJH, 2009, BIOMATERIALS, V30, P6803, DOI 10.1016/j.biomaterials.2009.08.050; Souto R, 2006, BRAZ J MICROBIOL, V37, P208, DOI 10.1590/S1517-83822006000300002; Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299; Timofeeva L, 2011, APPL MICROBIOL BIOT, V89, P475, DOI 10.1007/s00253-010-2920-9; Ting SRS, 2010, POLYM CHEM-UK, V1, P1392, DOI 10.1039/c0py00141d; Tu Q, 2013, COLLOID SURFACE B, V102, P361, DOI 10.1016/j.colsurfb.2012.08.033; van de Wetering P, 1998, J CONTROL RELEASE, V53, P145, DOI 10.1016/S0168-3659(97)00248-4; Wang YZ, 2014, ANAL CHEM, V86, P10164, DOI 10.1021/ac502583b; Xue X, 2011, ANGEW CHEM INT EDIT, V50, P9852, DOI 10.1002/anie.201103130; Yan XB, 2015, BIOMACROMOLECULES, V16, P1827, DOI 10.1021/acs.biomac.5b00413; Yilmaz Gokhan, 2014, Front Bioeng Biotechnol, V2, P39, DOI 10.3389/fbioe.2014.00039; You YZ, 2007, J CONTROL RELEASE, V122, P217, DOI 10.1016/j.jconrel.2007.04.020; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580; Zhang Q, 2013, ADV POLYM SCI, V262, P39, DOI 10.1007/12_2013_254; Zhao J, 2011, J MEMBRANE SCI, V369, P5, DOI 10.1016/j.memsci.2010.10.046	93	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180087	10.1371/journal.pone.0180087	http://dx.doi.org/10.1371/journal.pone.0180087			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672031	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000405268500014
J	Premaud, A; Filloux, M; Gatault, P; Thierry, A; Buchler, M; Munteanu, E; Marquet, P; Essig, M; Rousseau, A				Premaud, Aurelie; Filloux, Matthieu; Gatault, Philippe; Thierry, Antoine; Buchler, Matthias; Munteanu, Eliza; Marquet, Pierre; Essig, Marie; Rousseau, Annick			An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; SERUM CREATININE; ALLOGRAFT LOSS; FAILURE; REJECTION; OUTCOMES; FORESTS; SYSTEM; COHORT; TIME	Most predictive models and scores of graft survival in renal transplantation include factors known before transplant or at the end of the first year. They cannot be updated thereafter, even in patients developing donor-specific anti-HLA antibodies and acute rejection. We developed a conditional and adjustable score for prediction of graft failure (AdGFS) up to 10 years post-transplantation in 664 kidney transplant patients. AdGFS was externally validated and calibrated in 896 kidney transplant patients. The final model included five baseline factors (pretransplant non donor-specific anti-HLA antibodies, donor age, serum creatinine measured at 1 year, longitudinal serum creatinine clusters during the first year, proteinuria measured at 1 year), and two predictors updated over time (de novo donor-specific anti-HLA antibodies and first acute rejection). AdGFS was able to stratify patients into four riskgroups, at different post-transplantation times. It showed good discrimination (time-dependent ROC curve at ten years: 0.83 (CI95% 0.76-0.89).	[Premaud, Aurelie; Marquet, Pierre; Essig, Marie; Rousseau, Annick] INSERM, U850, Limoges, France; [Premaud, Aurelie; Marquet, Pierre; Essig, Marie; Rousseau, Annick] Univ Limoges, UMR S850, Limoges, France; [Filloux, Matthieu] CHU Limoges, Serv Immunol & Immunogenet, Limoges, France; [Filloux, Matthieu] CNRS, CRIBL, UMR 7276, Limoges, France; [Gatault, Philippe; Buchler, Matthias] CHU Tours, Serv Nephrol & Immunol Clin, Tours, France; [Thierry, Antoine] CHU Poitiers, Serv Nephrol Hemodialyse Transplantat Renal, Poitiers, France; [Munteanu, Eliza; Essig, Marie] CHU Limoges, Serv Nephrol, Dialyse Transplantat, Limoges, France; [Marquet, Pierre] CHU Limoges, Serv Pharmacol Toxicol & Pharmacovigilance, Limoges, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges; CHU Limoges; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Tours; CHU Poitiers; Universite de Poitiers; CHU Limoges; CHU Limoges	Premaud, A (corresponding author), INSERM, U850, Limoges, France.; Premaud, A (corresponding author), Univ Limoges, UMR S850, Limoges, France.	aurelie.premaud@unilim.fr	Essig, Marie/Q-5770-2016; Prémaud, Aurélie/A-2095-2017; MARQUET, Pierre/A-1727-2017; Essig, Marie/ABH-1342-2021	Essig, Marie/0000-0002-2030-5616; Prémaud, Aurélie/0000-0001-5004-5918; MARQUET, Pierre/0000-0001-7698-0760; Essig, Marie/0000-0002-2030-5616; Gatault, Philippe/0000-0003-1664-2879	Roche; Astellas; Sanofi	Roche(Roche Holding); Astellas(Astellas Pharmaceuticals); Sanofi(Sanofi-Aventis)	The Astre data base was funded by Roche, Astellas and Sanofi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aubert O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3557; Brown TS, 2012, AM J NEPHROL, V36, P561, DOI 10.1159/000345552; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Cooper JE, 2011, TRANSPLANTATION, V91, P1103, DOI 10.1097/TP.0b013e3182139da1; D'Agostino RB, 2004, HDB STAT, P1; Datema FR, 2012, HEAD NECK-J SCI SPEC, V34, P50, DOI 10.1002/hed.21698; Debout A, 2015, KIDNEY INT, V87, P343, DOI 10.1038/ki.2014.304; Dietrich S, 2016, INT J EPIDEMIOL, V45, P1406, DOI 10.1093/ije/dyw145; Everly MJ, 2013, TRANSPLANTATION, V95, P410, DOI 10.1097/TP.0b013e31827d62e3; First MR, 2003, NEPHROL DIAL TRANSPL, V18, P3, DOI 10.1093/ndt/gfg1027; Foucher Y, 2010, KIDNEY INT, V78, P1288, DOI 10.1038/ki.2010.232; Genolini C, 2011, COMPUT METH PROG BIO, V104, pE112, DOI 10.1016/j.cmpb.2011.05.008; Gonzales MM, 2016, J AM SOC NEPHROL JAS; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hourmant M, 2005, J AM SOC NEPHROL, V16, P2804, DOI 10.1681/ASN.2004121130; Hsich E, 2011, CIRC-CARDIOVASC QUAL, V4, P39, DOI 10.1161/CIRCOUTCOMES.110.939371; Irish WD, 2003, J AM SOC NEPHROL, V14, P2967, DOI 10.1097/01.ASN.0000093254.31868.85; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Ishwaran H, 2009, BIOSTATISTICS, V10, P603, DOI 10.1093/biostatistics/kxp016; Kaplan B, 2003, AM J TRANSPLANT, V3, P1560, DOI 10.1046/j.1600-6135.2003.00275.x; Kasiske BL, 2010, AM J KIDNEY DIS, V56, P947, DOI 10.1053/j.ajkd.2010.06.020; Kasiske BL, 2001, AM J KIDNEY DIS, V38, P1065, DOI 10.1053/ajkd.2001.28605; Lachmann N, 2009, TRANSPLANTATION, V87, P1505, DOI 10.1097/TP.0b013e3181a44206; Lefaucheur C, 2013, LANCET, V381, P313, DOI 10.1016/S0140-6736(12)61265-3; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Loupy A, 2014, J AM SOC NEPHROL, V25, P2267, DOI 10.1681/ASN.2013111149; Miao F, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/303250; Moore J, 2011, AM J KIDNEY DIS, V57, P744, DOI 10.1053/j.ajkd.2010.12.017; Naesens M, 2016, J AM SOC NEPHROL, V27, P281, DOI 10.1681/ASN.2015010062; Nyberg SL, 2003, AM J TRANSPLANT, V3, P715, DOI 10.1034/j.1600-6143.2003.00111.x; Sene M, 2014, STAT METHODS MED RES; Shabir S, 2014, AM J KIDNEY DIS, V63, P643, DOI 10.1053/j.ajkd.2013.10.059; Viglietti D, 2017, J AM SOC NEPHROL, V28, P702, DOI 10.1681/ASN.2016030368; Wiebe C, 2012, AM J TRANSPLANT, V12, P1157, DOI 10.1111/j.1600-6143.2012.04013.x	37	11	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180236	10.1371/journal.pone.0180236	http://dx.doi.org/10.1371/journal.pone.0180236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671951	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500031
J	Enomoto, Y; Nakamura, Y; Colby, TV; Johkoh, T; Sumikawa, H; Nishimoto, K; Yoshimura, K; Matsushima, S; Oyama, Y; Hozumi, H; Kono, M; Fujisawa, T; Enomoto, N; Inui, N; Iwashita, T; Suda, T				Enomoto, Yasunori; Nakamura, Yutaro; Colby, Thomas V.; Johkoh, Takeshi; Sumikawa, Hiromitsu; Nishimoto, Koji; Yoshimura, Katsuhiro; Matsushima, Sayomi; Oyama, Yoshiyuki; Hozumi, Hironao; Kono, Masato; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Inui, Naoki; Iwashita, Toshihide; Suda, Takafumi			Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; CLASSIFICATION CRITERIA; APICAL CAP; RHEUMATOID-ARTHRITIS; AMERICAN-COLLEGE; PNEUMONIA; DIAGNOSIS; SURVIVAL; ENTITY	Background Radiologic pleuroparenchymal fibroelastosis (PPFE)-like lesion including pulmonary apical cap can be occasionally observed in clinical settings. However, the significance of radiologic PPFE-like lesion is unclear in connective tissue disease (CTD)-related interstitial lung disease (ILD). Materials and methods A total of 113 patients with CTD-related ILD were enrolled and assessed for radiologic PPFE-like lesion, which was defined as bilateral, upper lobe, and subpleural dense consolidations with or without pleural thickening on chest high-resolution computed tomography. The clinical, radiologic, and pathologic characteristics were evaluated. Results Radiologic PPFE-like lesion was found in 21 patients (19%) and were relatively frequent in those with systemic sclerosis (6/14: 43%) and primary Sjogren's syndrome (4/14: 29%). Patients with PPFE-like lesion were significantly older, had lower body mass index, higher ratio of residual volume to total lung capacity, and higher complication rate of pneumothorax and/or pneumomediastinum than those without. Twelve of the 21 patients were diagnosed radiologically as usual interstitial pneumonia (UIP) or possible UIP pattern. Two of three patients who underwent surgical lung biopsy of the upper lobes showed UIP on histopathology. Another patient was confirmed to have upper lobe PPFE on autopsy. During the clinical course, progression of the radiologic PPFE-like lesions was observed in 13 of 21 patients. Six patients died (mortality rate: 29%) and their PPFE-like lesions were commonly progressive. In the total cohort, our multivariate analysis identified the presence of PPFE-like lesion as a significant risk factor for respiratory death (hazard ratio: 4.10, 95% confidence interval: 1.33-12.65, p = 0.01). Conclusion In patients with CTD-related ILD, radiologic PPFE-like lesion, which may present as not only PPFE but also apical cap and upper lobe subpleural fibrosis commonly due to UIP, was not uncommon and was associated with poor prognosis. Clinicians should be cautious with this radiologic finding, particularly when it is progressive.	[Enomoto, Yasunori; Nakamura, Yutaro; Nishimoto, Koji; Yoshimura, Katsuhiro; Matsushima, Sayomi; Oyama, Yoshiyuki; Hozumi, Hironao; Kono, Masato; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Inui, Naoki; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Shizuoka, Japan; [Enomoto, Yasunori; Matsushima, Sayomi; Iwashita, Toshihide] Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Shizuoka, Japan; [Colby, Thomas V.] Mayo Clin Arizona, Dept Lab Med & Pathol, Scottsdale, AZ USA; [Johkoh, Takeshi] Mutual Aid Assoc Publ Teachers, Kinki Cent Hosp, Dept Radiol, Itami, Hyogo, Japan; [Sumikawa, Hiromitsu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiol, Osaka, Japan; [Inui, Naoki] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Mayo Clinic; Mayo Clinic Phoenix; Osaka Medical Center for Cancer & Cardiovascular Diseases; Hamamatsu University School of Medicine	Enomoto, Y; Nakamura, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Shizuoka, Japan.; Enomoto, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Shizuoka, Japan.	enomotoy@hama-med.ac.jp; nakayuta@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264; Yoshimura, Katsuhiro/0000-0001-9522-3220				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Enomoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073774; EUWER RL, 1993, J INVEST DERMATOL, V100, pS124, DOI 10.1038/jid.1993.35; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Frankel SK, 2004, CHEST, V126, P2007, DOI 10.1378/chest.126.6.2007; Goldin JG, 2008, CHEST, V134, P358, DOI 10.1378/chest.07-2444; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Lagstein A, 2015, ARCH PATHOL LAB MED, V139, P1258, DOI 10.5858/arpa.2015-0224-RA; Leslie KO, 2011, PRACTICAL PULMONARY, P232; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; MCLOUD TC, 1981, AM J ROENTGENOL, V137, P299, DOI 10.2214/ajr.137.2.299; Mooney JJ, 2013, CHEST, V144, P586, DOI 10.1378/chest.12-2623; Nakatani T, 2015, EUR RESPIR J, V45, P1183, DOI 10.1183/09031936.00214714; Oda T, 2014, CHEST, V146, P1248, DOI 10.1378/chest.13-2866; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Reddy TL, 2012, EUR RESPIR J, V40, P377, DOI 10.1183/09031936.00165111; Ryerson CJ, 2014, CHEST, V145, P723, DOI 10.1378/chest.13-1474; Shea BS, 2015, NEW ENGL J MED, V372, P1749, DOI 10.1056/NEJMcpc1415200; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Suda T, 2009, RESP MED, V103, P846, DOI 10.1016/j.rmed.2008.12.019; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tsuchiya Y, 2011, EUR RESPIR J, V37, P1411, DOI 10.1183/09031936.00019210; Watanabe K, 2012, RESPIR INVESTIG, V50, P88, DOI 10.1016/j.resinv.2012.06.003; Yousem SA, 2001, AM J SURG PATHOL, V25, P679, DOI 10.1097/00000478-200105000-00018	28	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180283	10.1371/journal.pone.0180283	http://dx.doi.org/10.1371/journal.pone.0180283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666014	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608700081
J	Jernigan, NL; Naik, JS; Weise-Cross, L; Detweiler, ND; Herbert, LM; Yellowhair, TR; Resta, TC				Jernigan, Nikki L.; Naik, Jay S.; Weise-Cross, Laura; Detweiler, Neil D.; Herbert, Lindsay M.; Yellowhair, Tracylyn R.; Resta, Thomas C.			Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; INDUCED CA2+ SENSITIZATION; CHRONICALLY HYPOXIC RATS; FAWN-HOODED RATS; RHO-KINASE; CELL-PROLIFERATION; HYDROGEN-PEROXIDE; MOLECULAR CHAPERONE; NADPH OXIDASE; NITRIC-OXIDE	Pulmonary arterial hypertension is associated with a decreased antioxidant capacity. However, neither the contribution of reactive oxygen species to pulmonary vasoconstrictor sensitivity, nor the therapeutic efficacy of antioxidant strategies in this setting are known. We hypothesized that reactive oxygen species play a central role in mediating both vasoconstrictor and arterial remodeling components of severe pulmonary arterial hypertension. We examined the effect of the chemical antioxidant, TEMPOL, on right ventricular systolic pressure, vascular remodeling, and enhanced vasoconstrictor reactivity in both chronic hypoxia and hypoxia/SU5416 rat models of pulmonary hypertension. SU5416 is a vascular endothelial growth factor receptor antagonist and the combination of chronic hypoxia/SU5416 produces a model of severe pulmonary arterial hypertension with vascular plexiform lesions/fibrosis that is not present with chronic hypoxia alone. The major findings from this study are: 1) compared to hypoxia alone, hypoxia/SU5416 exposure caused more severe pulmonary hypertension, right ventricular hypertrophy, adventitial lesion formation, and greater vasoconstrictor sensitivity through a superoxide and Rho kinase-dependent Ca2+ sensitization mechanism. 2) Chronic hypoxia increased medial muscularization and superoxide levels, however there was no effect of SU5416 to augment these responses. 3) Treatment with TEMPOL decreased right ventricular systolic pressure in both hypoxia and hypoxia/SU5416 groups. 4) This effect of TEMPOL was associated with normalization of vasoconstrictor responses, but not arterial remodeling. Rather, medial hypertrophy and adventitial fibrotic lesion formation were more pronounced following chronic TEMPOL treatment in hypoxia/SU5416 rats. Our findings support a major role for reactive oxygen species in mediating enhanced vasoconstrictor reactivity and pulmonary hypertension in both chronic hypoxia and hypoxia/SU5416 rat models, despite a paradoxical effect of antioxidant therapy to exacerbate arterial remodeling in animals with severe pulmonary arterial hypertension in the hypoxia/SU5416 model.	[Jernigan, Nikki L.; Naik, Jay S.; Weise-Cross, Laura; Detweiler, Neil D.; Herbert, Lindsay M.; Yellowhair, Tracylyn R.; Resta, Thomas C.] Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Jernigan, NL (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp, Albuquerque, NM 87131 USA.	njernigan@salud.unm.edu	Naik, Jay/AHD-1227-2022; Jernigan, Nikki/AAE-7649-2020	Detweiler, Neil/0000-0003-4014-9988; Resta, Thomas/0000-0002-7219-6159; Jernigan, Nikki/0000-0001-6269-2274	National Heart, Lung, and Blood Institute [R01 HL111084, R01 HL132883, R01 HL088192, T32 HL007736]; American Heart Association [16GRNT27700010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111084, R01HL088192, R01HL132883, T32HL007736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021, R25GM060201] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Heart, Lung, and Blood Institute grants R01 HL111084 (to N.L. Jernigan), R01 HL132883, R01 HL088192, T32 HL007736 (to T.C. Resta), and American Heart Association grant 16GRNT27700010 (to T.C. Resta). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Adesina SE, 2015, FREE RADICAL BIO MED, V87, P36, DOI 10.1016/j.freeradbiomed.2015.05.042; Aggarwal S, 2013, COMPR PHYSIOL, V3, P1011, DOI 10.1002/cphy.c120024; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Brennan LA, 2003, CIRC RES, V92, P683, DOI 10.1161/01.RES.0000063424.28903.BB; Broughton BRS, 2008, AM J PHYSIOL-LUNG C, V294, pL797, DOI 10.1152/ajplung.00253.2007; Broughton BRS, 2010, AM J PHYSIOL-LUNG C, V298, pL232, DOI 10.1152/ajplung.00276.2009; BURKE TM, 1987, AM J PHYSIOL, V252, pH721, DOI 10.1152/ajpheart.1987.252.4.H721; Chaumais MC, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-65; Day Regina M., 2005, Dose-Response, V3, P425, DOI 10.2203/dose-response.003.03.010; Dennis KE, 2009, AM J PHYSIOL-LUNG C, V297, pL596, DOI 10.1152/ajplung.90568.2008; Elmedal B, 2004, BRIT J PHARMACOL, V141, P105, DOI 10.1038/sj.bjp.0705580; Fagan KA, 2004, AM J PHYSIOL-LUNG C, V287, pL656, DOI 10.1152/ajplung.00090.2003; Fike CD, 2008, AM J PHYSIOL-LUNG C, V295, pL881, DOI 10.1152/ajplung.00047.2008; Fike CD, 2013, ANTIOXID REDOX SIGN, V18, P1727, DOI 10.1089/ars.2012.4823; Fresquet F, 2006, BRIT J PHARMACOL, V148, P714, DOI 10.1038/sj.bjp.0706779; Frid MG, 1997, CIRC RES, V81, P940; Gharaee-Kermani M, AM J PATHOLOGY, V184, P732; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hartney T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027531; Hoshikawa Y, 2001, J APPL PHYSIOL, V90, P1299, DOI 10.1152/jappl.2001.90.4.1299; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Hu HL, 2010, AM J RESP CELL MOL, V42, P661, DOI 10.1165/rcmb.2009-0017OC; Hyvelin JM, 2005, CIRC RES, V97, P185, DOI 10.1161/01.RES.0000174287.17953.83; Ingold KU, 1997, J AM CHEM SOC, V119, P12364, DOI 10.1021/ja972886l; Jernigan NL, 2008, AM J PHYSIOL-LUNG C, V295, pL515, DOI 10.1152/ajplung.00355.2007; Jernigan NL, 2004, AM J PHYSIOL-LUNG C, V287, pL1220, DOI 10.1152/ajplung.00196.2004; Jernigan NL, 2004, AM J PHYSIOL-LUNG C, V286, pL947, DOI 10.1152/ajplung.00215.2003; Jones RD, 2000, PHARMACOL THERAPEUT, V88, P153, DOI 10.1016/S0163-7258(00)00089-9; Kamezaki F, 2008, AM J RESP CRIT CARE, V177, P219, DOI 10.1164/rccm.200702-264OC; Lachmanova V, 2005, LIFE SCI, V77, P175, DOI 10.1016/j.lfs.2004.11.027; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Masri FA, 2008, CTS-CLIN TRANSL SCI, V1, P99, DOI 10.1111/j.1752-8062.2008.00035.x; Mata M., 2012, OXID MED CELL LONGEV, V2012, DOI DOI 10.1155/2012/236572; Michelakis ED, 2002, CIRC RES, V90, P1307, DOI 10.1161/01.RES.0000024689.07590.C2; Nagaoka T, 2004, AM J PHYSIOL-LUNG C, V287, pL665, DOI 10.1152/ajplung.00050.2003; Nagata K, 1998, MATRIX BIOL, V16, P379, DOI 10.1016/S0945-053X(98)90011-7; Nitta CH, 2014, AM J PHYSIOL-HEART C, V306, pH41, DOI 10.1152/ajpheart.00269.2013; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; Nozik-Grayck E, 2007, ADV EXP MED BIOL, V618, P101; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Plomaritas DR, 2014, AM J PHYSIOL-LUNG C, V307, pL419, DOI 10.1152/ajplung.00095.2014; Porter KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098532; Pourmahram GE, 2008, FREE RADICAL BIO MED, V45, P1468, DOI 10.1016/j.freeradbiomed.2008.08.020; Ramiro-Diaz JM, 2013, AM J PHYSIOL-LUNG C, V304, pL613, DOI 10.1152/ajplung.00408.2012; Rehman J, 2010, ADV EXP MED BIOL, V661, P171, DOI 10.1007/978-1-60761-500-2_11; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Steinhorn RH, 2001, AM J RESP CRIT CARE, V164, P834, DOI 10.1164/ajrccm.164.5.2010104; Tabima DM, 2012, FREE RADICAL BIO MED, V52, P1970, DOI 10.1016/j.freeradbiomed.2012.02.041; Taguchi T, 2007, TRENDS MOL MED, V13, P45, DOI 10.1016/j.molmed.2006.12.001; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; TSIEN R, 1989, TRANSPORT MEMBRANE I; Vanderpool RR, 2011, J APPL PHYSIOL, V110, P188, DOI 10.1152/japplphysiol.00533.2010; Voelkel NF, 2013, ANTIOXID REDOX SIGN, V18, P1810, DOI 10.1089/ars.2012.4828; Wedgwood S, 2011, ANTIOXID REDOX SIGN, V15, P1497, DOI 10.1089/ars.2010.3630; Weigand L, 2006, AM J PHYSIOL-LUNG C, V290, pL284, DOI 10.1152/ajplung.00449.2004; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Wong CM, 2013, ANTIOXID REDOX SIGN, V18, P1789, DOI 10.1089/ars.2012.4568; Zhang JH, 1998, AM J RESP CELL MOL, V19, P324, DOI 10.1165/ajrcmb.19.2.3209	61	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180455	10.1371/journal.pone.0180455	http://dx.doi.org/10.1371/journal.pone.0180455			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666030	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700009
J	Jedrusik, P; Symonides, B; Wojciechowska, E; Gryglas, A; Gaciong, Z				Jedrusik, Piotr; Symonides, Bartosz; Wojciechowska, Ewa; Gryglas, Adam; Gaciong, Zbigniew			Diagnostic value of potassium level in a spot urine sample as an index of 24-hour urinary potassium excretion in unselected patients hospitalized in a hypertension unit	PLOS ONE			English	Article							DAILY SALT INTAKE; SODIUM-EXCRETION; PRIMARY ALDOSTERONISM; POPULATION; COLLECTIONS; VALIDATION; CREATININE	Background Primary hyperaldosteronism may be associated with elevated 24-hour urinary potassium excretion. We evaluated the diagnostic value of spot urine (SU) potassium as an index of 24-hour urinary potassium excretion. Methods We measured SU and 24-hour urinary collection potassium and creatinine in 382 patients. Correlations between SU and 24-hour collections were assessed for potassium levels and potassium/creatinine ratios. We used the PAHO formula to estimate 24-hour urinary potassium excretion based on SU potassium level. The agreement between estimated and measured 24-hour urinary potassium excretion was evaluated using the Bland-Altman method. To evaluate diagnostic performance of SU potassium, we calculated areas under the curve (AUC) for SU potassium/creatinine ratio and 24-hour urinary potassium excretion estimated using the PAHO formula. Results Strongest correlation between SU and 24-hour collection was found for potassium/creatinine ratio (r = 0.69, P<0.001). The PAHO formula underestimated 24-hour urinary potassium excretion by mean 8.3 +/- 18 mmol/d (95% limits of agreement-28 to +44 mmol/d). Diagnostic performance of SU potassium/creatinine ratio was borderline good only if 24-hour urinary potassium excretion was largely elevated (AUC 0.802 for 120 mmol K+/24 h) but poor with lower values (AUC 0.696 for 100 mmol K+/24 h, 0.636 for 80 mmol K+/24 h, 0.675 for 40 mmol K+/24 h). Diagnostic performance of 24-hour urinary potassium excretion estimated by the PAHO formula was excellent with values above 120 mmol/d and good with lower values (AUC 0.941 for 120 mmol K+/24 h, 0.819 for 100 mmol K+/24 h, 0.823 for 80 mmol K+/24 h, 0.836 for 40 mmol K+/24 h). Conclusions Spot urine potassium/creatinine ratio might be a marker of increased 24-hour urinary potassium excretion and a potentially useful screening test when reliable 24-hour urine collection is not available. The PAHO formula allowed estimation of the 24-hour urinary potassium excretion based on SU measurements with reasonable clinical accuracy.	[Jedrusik, Piotr; Symonides, Bartosz; Wojciechowska, Ewa; Gryglas, Adam; Gaciong, Zbigniew] Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland	Medical University of Warsaw	Jedrusik, P (corresponding author), Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland.	pjedrusik@wum.edu.pl	Symonides, Bartosz/N-1883-2018	Symonides, Bartosz/0000-0002-5933-609X; Jedrusik, Piotr/0000-0003-0037-6035				BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown IJ, 2013, AM J EPIDEMIOL, V177, P1180, DOI 10.1093/aje/kwt066; Chernecky CC, 2008, LAB TESTS DIAGNOSTIC, P399; Doenyas-Barak K, 2015, NEPHRON, V130, P35, DOI 10.1159/000430105; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Han WZ, 2015, AM J HYPERTENS, V28, P1368, DOI 10.1093/ajh/hpv037; Hong YH, 2010, UROLOGY, V75, P1294, DOI 10.1016/j.urology.2009.08.061; Huang L., 2014, J HYPERTENS S1, V32, P110; Ix JH, 2011, CLIN J AM SOC NEPHRO, V6, P184, DOI 10.2215/CJN.05030610; Ji C, 2014, NUTR METAB CARDIOVAS, V24, P140, DOI 10.1016/j.numecd.2013.06.011; Ji C, 2012, REV PANAM SALUD PUBL, V32, P307, DOI 10.1590/S1020-49892012001000010; KAMEL KS, 1990, AM J NEPHROL, V10, P89, DOI 10.1159/000168062; Kawamura M, 2006, HYPERTENS RES, V29, P397, DOI 10.1291/hypres.29.397; Kawamura M, 2012, HYPERTENS RES, V35, P611, DOI 10.1038/hr.2012.6; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Koo H, 2015, ANN LAB MED, V35, P238, DOI 10.3343/alm.2015.35.2.238; Lerchl K, 2015, HYPERTENSION, V66, P850, DOI 10.1161/HYPERTENSIONAHA.115.05851; Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x; Martin Helen, 2011, Clin Biochem Rev, V32, P97; McLean R, 2014, J HUM HYPERTENS, V28, P657, DOI 10.1038/jhh.2014.10; McLean RM, 2014, NUTRIENTS, V6, P4651, DOI 10.3390/nu6114651; Mizehoun-Adissoda C, 2016, J CLIN HYPERTENS, V18, P634, DOI 10.1111/jch.12722; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Organization WH, 2010, DIS PREV POP WID DIE; Palmer BF, 2015, CLIN J AM SOC NEPHRO, V10, P1050, DOI 10.2215/CJN.08580813; Rodby RA, 2016, AM J KIDNEY DIS, V68, P836, DOI 10.1053/j.ajkd.2016.06.025; Stern N., 2018, MANUAL ENDOCRINOLOGY, V5th, P202; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; van Huysduynen EJCH, 2014, PUBLIC HEALTH NUTR, V17, P2505, DOI 10.1017/S1368980014001177; Wang CY, 2013, J NUTR, V143, P1276, DOI 10.3945/jn.113.175927; Woywodt A, 2001, NEPHROL DIAL TRANSPL, V16, P1066, DOI 10.1093/ndt/16.5.1066	32	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180117	10.1371/journal.pone.0180117	http://dx.doi.org/10.1371/journal.pone.0180117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662194	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300105
J	Luo, CQ; Chen, XY; Jin, HC; Yao, K				Luo, Chenqi; Chen, Xinyi; Jin, Hongchuan; Yao, Ke			The association between gout and cataract risk: A meta-analysis	PLOS ONE			English	Article							SOCIOECONOMIC-FACTORS; ALLOPURINOL THERAPY; EXPOSURE	Purpose To evaluate the relationship between gout and age-related cataracts (ARCs). Methods A comprehensive literature search of the PubMed and Web of Science databases was conducted to identify papers on the association between gout and cataract risk that had been published between February 1991 and January 2017. Pooled relative risks (RRs) or odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were calculated. The random-effects model was used instead of the fixed-effects model when heterogeneity was identified, as indicated by a Cochran's Q statistic P-value <0.10 or I2 index score >50%. Results A total of 3 cross-sectional studies and 3 case-control studies were included in the meta-analysis. Gout was significantly associated with increased odds of ARCs (OR 1.53, 95% CI 1.27-1.84). In the subgroup analysis, gout exhibited positive associations with the odds of posterior subcapsular cataracts (PSCs, OR 1.69, 95% CI: 1.06-2.70) and cortical cataracts (CCs, OR 1.39, 95% CI: 1.06-1.81). However, no association was identified between gout and the odds of nuclear cataracts. Conclusions The current literature suggested that gout may be associated with increased odds of ARCs, especially PSCs and CCs. Further efforts should be made to confirm these findings and clarify the effect of gout and gout medications on the development of cataracts.	[Luo, Chenqi; Chen, Xinyi; Yao, Ke] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou, Zhejiang, Peoples R China; [Jin, Hongchuan] Zhejiang Univ, Sir Runrun Shaw Hosp, Dept Med Oncol, Key Lab Biotherapy Zhejiang,Med Sch, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yao, K (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou, Zhejiang, Peoples R China.; Jin, HC (corresponding author), Zhejiang Univ, Sir Runrun Shaw Hosp, Dept Med Oncol, Key Lab Biotherapy Zhejiang,Med Sch, Hangzhou, Zhejiang, Peoples R China.	jinhc@zju.edu.cn; xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Chen, Xinyi/0000-0002-1858-5671; Yao, Ke/0000-0002-6764-7365; Jin, Hongchuan/0000-0002-6697-3097	Zhejiang Key Laboratory Fund of China [2011E10006]; National Natural Science Foundation of China [81570822]	Zhejiang Key Laboratory Fund of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Zhejiang Key Laboratory Fund of China (Grant No. 2011E10006) and the National Natural Science Foundation of China (Grant No. 81570822).	Asbell PA, 2005, LANCET, V365, P599; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Dalbeth N, 2016, LANCET, V388, P2039, DOI 10.1016/S0140-6736(16)00346-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FRAUNFELDER FT, 1982, AM J OPHTHALMOL, V94, P137, DOI 10.1016/0002-9394(82)90067-8; Garbe E, 1998, ARCH OPHTHALMOL-CHIC, V116, P1652, DOI 10.1001/archopht.116.12.1652; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; LERMAN S, 1984, AM J OPHTHALMOL, V97, P205, DOI 10.1016/S0002-9394(14)76091-X; LERMAN S, 1982, AM J OPHTHALMOL, V94, P141, DOI 10.1016/0002-9394(82)90068-X; Leske MC, 1998, AM J EPIDEMIOL, V147, P36; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; LIU C S C, 1988, Eye (London), V2, P600; McCarty CA, 2000, INVEST OPHTH VIS SCI, V41, P3720; McCarty CA, 1999, AM J OPHTHALMOL, V128, P446, DOI 10.1016/S0002-9394(99)00218-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mukesh BN, 2006, ARCH OPHTHALMOL-CHIC, V124, P79, DOI 10.1001/archopht.124.1.79; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pogue J, 1998, LANCET, V351, P47, DOI 10.1016/S0140-6736(97)08461-4; Robman L, 2005, EYE, V19, P1074, DOI 10.1038/sj.eye.6701964; Tarwadi KV, 2011, NUTRITION, V27, P40, DOI 10.1016/j.nut.2009.11.015; TSUKIDATE K, 1993, AM J PATHOL, V143, P918; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Zubenko GS, 2007, J GERONTOL A-BIOL, V62, P500, DOI 10.1093/gerona/62.5.500	27	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180188	10.1371/journal.pone.0180188	http://dx.doi.org/10.1371/journal.pone.0180188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662131	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300122
J	Narayanaswamy, VP; Giatpaiboon, S; Baker, SM; Wiesmann, WP; LiPuma, JJ; Townsend, SM				Narayanaswamy, Vidya P.; Giatpaiboon, Scott; Baker, Shenda M.; Wiesmann, William P.; LiPuma, John J.; Townsend, Stacy M.			Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; ANTIBACTERIAL ACTION; CHITOSAN-ARGININE; INFECTIONS; EPIDEMIOLOGY; BACTERIA; SYNERGY; ISSUES	Burkholderia cepacia complex (Bcc) infection, associated with cystic fibrosis (CF) is intrinsically multidrug resistant to antibiotic treatment making eradication from the CF lung virtually impossible. Infection with Bcc leads to a rapid decline in lung function and is often a contraindication for lung transplant, significantly influencing morbidity and mortality associated with CF disease. Standard treatment frequently involves antibiotic combination therapy. However, no formal strategy has been adopted in clinical practice to guide successful eradication. A new class of direct-acting, large molecule polycationic glycopolymers, derivatives of a natural polysaccharide poly-N-acetyl-glucosamine (PAAG), are in development as an alternative to traditional antibiotic strategies. During treatment, PAAG rapidly targets the anionic structural composition of bacterial outer membranes. PAAG was observed to permeabilize bacterial membranes upon contact to facilitate potentiation of antibiotic activity. Three-dimensional checkerboard synergy analyses were used to test the susceptibility of eight Bcc strains (seven CF clinical isolates) to antibiotic combinations with PAAG or ceftazidime. Potentiation of tobramycin and meropenem activity was observed in combination with 8-128 mu g/mL PAAG. Treatment with PAAG reduced the minimum inhibitory concentration (MIC) of tobramycin and meropenem below their clinical sensitivity breakpoints (<= 4 mu g/mL), demonstrating the ability of PAAG to sensitize antibiotic resistant Bcc clinical isolates. Fractional inhibitory concentration (FIC) calculations showed PAAG was able to significantly potentiate antibacterial synergy with these antibiotics toward all Bcc species tested. These preliminary studies suggest PAAG facilitates a broad synergistic activity that may result in more positive therapeutic outcomes and supports further development of safe, polycationic glycopolymers for inhaled combination antibiotic therapy, particularly for CF-associated Bcc infections.	[Narayanaswamy, Vidya P.; Giatpaiboon, Scott; Baker, Shenda M.; Wiesmann, William P.; Townsend, Stacy M.] Synedgen Inc, Claremont, CA 91711 USA; [LiPuma, John J.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Townsend, SM (corresponding author), Synedgen Inc, Claremont, CA 91711 USA.	st@synedgen.com		Baker, Shenda/0000-0002-9985-473X; Narayanaswamy, Vidya/0000-0002-9165-5672	Synedgen Inc.	Synedgen Inc.	The funders, through Synedgen Inc., provides support in the form of salaries for authors SMT, VPN, SG, SMB and WPW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or Preparation of the manuscript. The specific roles of these authors are articulated in their 'author contributions' section.	Aaron SD, 2005, LANCET, V366, P463, DOI 10.1016/S0140-6736(05)67060-2; Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Abbott FK, 2016, INT J ANTIMICROB AG, V48, P521, DOI 10.1016/j.ijantimicag.2016.07.020; Baxter RM, 2013, J BIOMED MATER RES A, V101, P340, DOI 10.1002/jbm.a.34328; BERENBAUM MC, 1980, J INFECT DIS, V142, P476, DOI 10.1093/infdis/142.3.476; Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028; Burns JL, 1999, J INFECT DIS, V179, P1190, DOI 10.1086/314727; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Carla PC, 2011, FRONT CELL INFECT MI, V1, P12; Claudia S, 2015, PLOS ONE, V10; Clinical and Laboratory Standards Institute, 2014, M7A9 CLIN LAB STAND; Eliopoulos G.M., 1991, ANTIBIOTICS LAB MED, V3rd Edn, P432; Fischer TH, 2007, J BIOMED MATER RES A, V80A, P167, DOI 10.1002/jbm.a.30877; Garbers SM, 2011, WOUND RINSE REMOVES; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gilligan Peter H., 1995, P509; Harris A, 1999, CLIN INFECT DIS, V28, P1128, DOI 10.1086/514760; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Jones AM, 2001, EUR RESPIR J, V17, P295, DOI 10.1183/09031936.01.17202950; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Kwa AL, 2008, ANN ACAD MED SINGAP, V37, P870; Lahmer RA, 2012, FOOD CONTROL, V26, P206, DOI 10.1016/j.foodcont.2012.01.039; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; LiPuma JJ, 2009, ANTIMICROB AGENTS CH, V53, P249, DOI 10.1128/AAC.00691-08; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mahenthiralingam E, 2002, J MED MICROBIOL, V51, P533, DOI 10.1099/0022-1317-51-7-533; McCloskey M, 2001, IRISH J MED SCI, V170, P28, DOI 10.1007/BF03167716; McDowell A, 2004, J MED MICROBIOL, V53, P663, DOI 10.1099/jmm.0.45557-0; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260; Narayanaswamy V, 2016, POTENTIAL TREATMENTS; NIKAIDO H, 1990, ANTIMICROB AGENTS CH, V34, P337, DOI 10.1128/AAC.34.2.337; Noble L, 1999, INT J PHARM, V192, P173, DOI 10.1016/S0378-5173(99)00306-3; NORD NM, 1964, NEW ENGL J MED, V270, P1030, DOI 10.1056/NEJM196405142702002; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Rajyaguru JM, 1997, J ANTIMICROB CHEMOTH, V40, P345, DOI 10.1093/jac/40.3.345; Rhoades J, 2000, APPL ENVIRON MICROB, V66, P80, DOI 10.1128/AEM.66.1.80-86.2000; Roller S, 2000, J FOOD PROTECT, V63, P202, DOI 10.4315/0362-028X-63.2.202; Schneck E, 2010, P NATL ACAD SCI USA, V107, P9147, DOI 10.1073/pnas.0913737107; Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046; Sunagawa Makoto, 2000, Japanese Journal of Antibiotics, V53, P479; Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002; Zhanel GG, 2007, DRUGS, V67, P1027, DOI 10.2165/00003495-200767070-00006; Zhou JY, 2007, ANTIMICROB AGENTS CH, V51, P1085, DOI 10.1128/AAC.00954-06	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179776	10.1371/journal.pone.0179776	http://dx.doi.org/10.1371/journal.pone.0179776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662114	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608300047
J	Hammad, MM; Elshenawy, AK; El Singaby, MI				Hammad, Mohanad M.; Elshenawy, Ahmed K.; El Singaby, M. I.			Trajectory following and stabilization control of fully actuated AUV using inverse kinematics and self-tuning fuzzy PID	PLOS ONE			English	Article								In this work a design for self-tuning non-linear Fuzzy Proportional Integral Derivative (FPID) controller is presented to control position and speed of Multiple Input Multiple Output (MIMO) fully-actuated Autonomous Underwater Vehicles (AUV) to follow desired trajectories. Non-linearity that results from the hydrodynamics and the coupled AUV dynamics makes the design of a stable controller a very difficult task. In this study, the control scheme in a simulation environment is validated using dynamic and kinematic equations for the AUV model and hydrodynamic damping equations. An AUV configuration with eight thrusters and an inverse kinematic model from a previous work is utilized in the simulation. In the proposed controller, Mamdani fuzzy rules are used to tune the parameters of the PID. Nonlinear fuzzy Gaussian membership functions are selected to give better performance and response in the non-linear system. A control architecture with two feedback loops is designed such that the inner loop is for velocity control and outer loop is for position control. Several test scenarios are executed to validate the controller performance including different complex trajectories with and without injection of ocean current disturbances. A comparison between the proposed FPID controller and the conventional PID controller is studied and shows that the FPID controller has a faster response to the reference signal and more stable behavior in a disturbed non-linear environment.	[Hammad, Mohanad M.; Elshenawy, Ahmed K.; El Singaby, M. I.] Arab Acad Sci Technol & Maritime Transport, Elect & Control Engn, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport	Hammad, MM (corresponding author), Arab Acad Sci Technol & Maritime Transport, Elect & Control Engn, Alexandria, Egypt.	mohanad.magdy.hammad@gmail.com		Hammad, Mohanad/0000-0002-5796-7955				Aguilar LP, 2009, IFAC INT C MAN CONTR, P223; Amin R, 2010, INT C MECH EL ENG IC, V2, P117; Azrak RA, 2013, DISCRETE TIME AUV TR; Bellingham JG, 1996, P S AUT UND VEH TECH; Boiocchi R, 2016, WATER RES, V102, P346, DOI 10.1016/j.watres.2016.06.047; Busquets J, 2012, IEEE AUTO UNDER VEH; Chu Z, 2016, ADAPTIVE SLIDING MOD; Fernandes VH, 2015, AC UND GEOSC S RIO A; Fossen T., 2002, MARINE CONTROL SYSTE; Fossen T.I., 2012, IFAC P VOLUMES, V45, DOI [DOI 10.3182/20120919-3-IT-2046.00022, 10.3182/20120919-3-IT-2046.00022]; Fossen T.I., 1995, MATH MODEL SYST, V1, P17, DOI DOI 10.1080/; Godjevac J., 1993, COMP PID FUZZY CONTR, P361; Gonzalez J., 2015, IFAC - Papers Online, V48, P268, DOI 10.1016/j.ifacol.2015.06.044; Guo XX, 2016, IEEE ICARM 2016 - 2016 INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS AND MECHATRONICS (ICARM), P388, DOI 10.1109/ICARM.2016.7606951; Hammad MM, 2016, SAI INT SYST C SEP, P947; Hassanein O., 2011, 2011 5th International Conference on Automation, Robotics and Applications (ICARA 2011), P169, DOI 10.1109/ICARA.2011.6144876; Hu B, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (ICMA), P1528, DOI 10.1109/ICMA.2013.6618141; Khodayari MH, 2015, J MAR SCI TECH-JAPAN, V20, P559, DOI 10.1007/s00773-015-0312-7; Kim J, 2001, OCEANS 2001 MTS/IEEE: AN OCEAN ODYSSEY, VOLS 1-4, CONFERENCE PROCEEDINGS, P429, DOI 10.1109/OCEANS.2001.968763; Kim J, 2003, IEEE J OCEANIC ENG, P830; Kim MJ, 2015, INT C CONTR AUTOMAT, P744, DOI 10.1109/ICCAS.2015.7364719; Lee H, 2007, ANNU REV CONTROL, V31, P179, DOI 10.1016/j.arcontrol.2007.08.001; Li J, 2015, CHIN CONT DECIS CONF, P6118, DOI 10.1109/CCDC.2015.7161909; Lin WP, 2014, OCEANS; Martins R, 2011, REP10 AUV SHALLOW WA; Oktafianto Kresna, 2015, 2015 International Conference on Advanced Mechatronics, Intelligent Manufacture and Industrial Automation (ICAMIMIA). Proceedings, P162, DOI 10.1109/ICAMIMIA.2015.7508023; Painumgal UV, 2013, OCEANS-IEEE; Shenawy AKE, 2007, IEEE INT C OCT; Shine S, 2015, CHIN AUTOM CONGR, P411, DOI 10.1109/CAC.2015.7382535; Smith R.W., 1987, DEP DEFENSE WORLD GE; SNAM E, 1952, TECHNICAL RES B; Song YS, 2015, PROCEEDINGS 5TH IEEE INTERNATIONAL CONFERENCE ON CONTROL SYSTEM, COMPUTING AND ENGINEERING (ICCSCE 2015), P435, DOI 10.1109/ICCSCE.2015.7482225; Teo K, 2012, IEEE J OCEANIC ENG, V37, P143, DOI 10.1109/JOE.2011.2180058; Tipsuwan Y, 2015, 2015 7th International Conference on Information Technology and Electrical Engineering (ICITEE), P382, DOI 10.1109/ICITEED.2015.7408976; Upadhyay V, 2015, DESIGN MOTION CONTRO; Wang Y, 2016, FUZZY CONTROLLER USE; Wynn RB, 2014, MAR GEOL, V352, P451, DOI 10.1016/j.margeo.2014.03.012; Xia GQ, 2013, 2013 NINTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION (ICNC), P216, DOI 10.1109/ICNC.2013.6817973; Yan ZP, 2012, PROCEEDINGS OF THE 10TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA 2012), P3887, DOI 10.1109/WCICA.2012.6359121; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang GC, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, P2482, DOI 10.1109/ICMA.2016.7558956	41	19	20	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179611	10.1371/journal.pone.0179611	http://dx.doi.org/10.1371/journal.pone.0179611			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683071	gold, Green Submitted, Green Published			2022-12-27	WOS:000405335200009
J	Long, HM; Zhang, J; Tang, NY				Long, Haiming; Zhang, Ji; Tang, Nengyu			Does network topology influence systemic risk contribution? A perspective from the industry indices in Chinese stock market	PLOS ONE			English	Article							GLOBAL FINANCIAL CRISIS; HIERARCHICAL STRUCTURE; INTERBANK MARKET; EXPOSURES; EXCHANGE; DYNAMICS	This study considers the effect of an industry's network topology on its systemic risk contribution to the stock market using data from the CSI 300 two-tier industry indices from the Chinese stock market. We first measure industry's conditional-value-at-risk (CoVaR) and the systemic risk contribution(Delta CoVaR) using the fitted time-varying t-copula function. The network of the stock industry is established based on dynamic conditional correlations with the minimum spanning tree. Then, we investigate the connection characteristics and topology of the network. Finally, we utilize seemingly unrelated regression estimation (SUR) of panel data to analyze the relationship between network topology of the stock industry and the industry's systemic risk contribution. The results show that the systemic risk contribution of small-scale industries such as real estate, food and beverage, software services, and durable goods and clothing, is higher than that of large-scale industries, such as banking, insurance and energy. Industries with large betweenness centrality, closeness centrality, and clustering coefficient and small node occupancy layer are associated with greater systemic risk contribution. In addition, further analysis using a threshold model confirms that the results are robust.	[Long, Haiming; Zhang, Ji] Hunan Univ, Coll Finance & Stat, Changsha, Hunan, Peoples R China; [Tang, Nengyu] Rensselaer Polytech Inst, Lally Sch Management, New York, NY USA	Hunan University; Rensselaer Polytechnic Institute	Zhang, J (corresponding author), Hunan Univ, Coll Finance & Stat, Changsha, Hunan, Peoples R China.	574712096@qq.com			National Social Science Fund of China [12, ZD053]; HML	National Social Science Fund of China; HML	This work was supported by the National Social Science Fund of China(Grant No. 12&ZD053).The funding recipient was HML.	Acharya V. V., 2012, WORKING PAPERS, V29, P85; Adrian T, 2014, STAFF REPORTS, V106, P1705; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Bisias D, 2012, ANNU REV FINANC ECON, V4, P119; Boginski V, 2006, COMPUT OPER RES, V33, P3171, DOI 10.1016/j.cor.2005.01.027; Brida JG, 2010, EXPERT SYST APPL, V37, P3846, DOI 10.1016/j.eswa.2009.11.034; Brownlees CT, 2012, VOLATILITY CORRELATI, P16; Brunetti C., 2015, INTERCONNECTEDNESS I; Cajueiro DO, 2008, PHYSICA A, V387, P6825, DOI 10.1016/j.physa.2008.08.031; Cheng H, 2014, ANAL PANEL DATA; Engle R, 2002, J BUS ECON STAT, V20, P339, DOI 10.1198/073500102288618487; Fleming J, 1998, J FINANC ECON, V49, P111, DOI 10.1016/S0304-405X(98)00019-1; Furfine CH, 2003, J MONEY CREDIT BANK, V35, P111, DOI 10.1353/mcb.2003.0004; Hautsch N, 2015, REV FINANC, V19, P685, DOI 10.1093/rof/rfu010; Hawka B, 2012, PREPRINT; Huang WQ, 2016, PHYSICA A, V456, P183, DOI 10.1016/j.physa.2016.03.034; Huang X, 2009, J BANK FINANC, V33, P2036, DOI 10.1016/j.jbankfin.2009.05.017; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; Kantar E, 2012, PHYSICA A, V391, P2342, DOI 10.1016/j.physa.2011.12.014; Kantar E, 2011, PHYSICA A, V390, P3454, DOI 10.1016/j.physa.2011.05.004; Kaufman G, 2003, INDEP REV, V7, P371; Kazemilari M, 2015, PHYSICA A, V429, P62, DOI 10.1016/j.physa.2015.02.052; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kenett DY, 2015, MIND SOC, V14, P155; Kocheturov A, 2014, PHYSICA A, V413, P523, DOI 10.1016/j.physa.2014.06.077; Krause A, 2012, J ECON BEHAV ORGAN, V83, P583, DOI 10.1016/j.jebo.2012.05.015; Lopez-Espinosa G, 2012, J BANK FINANC, V36, P3150, DOI 10.1016/j.jbankfin.2012.04.020; Lubloy A., 2005, HUNG EC REV, V52, P377; Lyocsa S, 2012, PHYSICA A, V391, P4147, DOI 10.1016/j.physa.2012.03.038; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Namaki A, 2011, PHYSICA A, V390, P3835, DOI 10.1016/j.physa.2011.06.033; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Nobi A, 2014, PHYSICA A, V407, P135, DOI 10.1016/j.physa.2014.03.083; Qiao HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156784; Raddant M, 2016, INTERCONNECTEDNESS G, V16; Reboredo JC, 2015, J INT MONEY FINANC, V51, P214, DOI 10.1016/j.jimonfin.2014.12.002; Roncalli T., 2009, ECONOMICA; Sandoval L, 2015, J RISK FINANC MANAG, V8, P227, DOI 10.3390/jrfm8020227; Sheppard K, 2001, NBER WORKING PAPERS; Sienkiewicz A, 2013, ACTA PHYS POL A, V123, P615, DOI 10.12693/APhysPolA.123.615; Sirgel FA, 2011, PHYS REV E, V84; Soramaki K, 2007, PHYSICA A, V379, P317, DOI 10.1016/j.physa.2006.11.093; Tabak BM, 2010, PHYSICA A, V389, P3240, DOI 10.1016/j.physa.2010.04.002; Tarashev N., 2009, BIS Q REV; Tian Q, 2010, NEW J PHYS, V12, P39; Trancoso T, 2014, PHYSICA A, V395, P499, DOI 10.1016/j.physa.2013.10.031; Tse CK, 2010, J EMPIR FINANC, V17, P659, DOI 10.1016/j.jempfin.2010.04.008; Uechi L, 2015, PHYSICA A, V421, P488, DOI 10.1016/j.physa.2014.11.055; Upper C, 2004, EUR ECON REV, V48, P827, DOI 10.1016/j.euroecorev.2003.12.009; Wang GJ, 2015, PHYSICA A, V424, P176, DOI 10.1016/j.physa.2015.01.025; Wang GJ, 2012, PHYSICA A, V391, P4136, DOI 10.1016/j.physa.2012.03.036; Wang GJ, 2014, DISCRETE DYN NAT SOC, V17, P9; Wells S., 2002, FINANC STAB REV, V13, P175; Yang R, 2014, PHYSICA A, V411, P12, DOI 10.1016/j.physa.2014.05.072; Zheng Z, 2012, PHYS REV E, V87	56	10	11	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180382	10.1371/journal.pone.0180382	http://dx.doi.org/10.1371/journal.pone.0180382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683130	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200029
J	Turker, MS; Grygoryev, D; Lasarev, M; Ohlrichl, A; Rwatambuga, FA; Johnson, S; Dan, C; Eckelmann, B; Hryciw, G; Mao, JH; Snijders, AM; Gauny, S; Kronenberg, A				Turker, Mitchell S.; Grygoryev, Dmytro; Lasarev, Michael; Ohlrichl, Anna; Rwatambuga, Furaha A.; Johnson, Sorrel; Dan, Cristian; Eckelmann, Bradley; Hryciw, Gwen; Mao, Jian-Hua; Snijders, Antoine M.; Gauny, Stacey; Kronenberg, Amy			Simulated space radiation-induced mutants in the mouse kidney display widespread genomic change	PLOS ONE			English	Article							AUTOSOMAL MUTATIONS; IONIZING-RADIATION; SOLID TISSUES; MULTIPLE MUTATIONS; CELL-LINES; HEAVY-IONS; IN-VIVO; HETEROZYGOSITY; INSTABILITY; EXPOSURE	Exposure to a small number of high-energy heavy charged particles (HZE ions), as found in the deep space environment, could significantly affect astronaut health following prolonged periods of space travel if these ions induce mutations and related cancers. In this study, we used an in vivo mutagenesis assay to define the mutagenic effects of accelerated Fe-56 ions (1 GeV/amu, 151 keV/mu m) in the mouse kidney epithelium exposed to doses ranging from 0.25 to 2.0 Gy. These doses represent fluences ranging from 1 to 8 particle traversals per cell nucleus. The Aprt locus, located on chromosome 8, was used to select induced and spontaneous mutants. To fully define the mutagenic effects, we used multiple endpoints including mutant frequencies, mutation spectrum for chromosome 8, translocations involving chromosome 8, and mutations affecting non-selected chromosomes. The results demonstrate mutagenic effects that often affect multiple chromosomes for all Fe ion doses tested. For comparison with the most abundant sparsely ionizing particle found in space, we also examined the mutagenic effects of high-energy protons (1 GeV, 0.24 keV/mu m) at 0.5 and 1.0 Gy. Similar doses of protons were not as mutagenic as Fe ions for many assays, though genomic effects were detected in Aprt mutants at these doses. Considered as a whole, the data demonstrate that Fe ions are highly mutagenic at the low doses and fluences of relevance to human spaceflight, and that cells with considerable genomic mutations are readily induced by these exposures and persist in the kidney epithelium. The level of genomic change produced by low fluence exposure to heavy ions is reminiscent of the extensive rearrangements seen in tumor genomes suggesting a potential initiation step in radiation carcinogenesis.	[Turker, Mitchell S.; Grygoryev, Dmytro; Lasarev, Michael; Ohlrichl, Anna; Rwatambuga, Furaha A.; Johnson, Sorrel; Dan, Cristian; Eckelmann, Bradley; Hryciw, Gwen] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Turker, Mitchell S.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Mao, Jian-Hua; Snijders, Antoine M.; Gauny, Stacey; Kronenberg, Amy] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA USA; [Eckelmann, Bradley] Texas A&M Hlth Sci Ctr, Bryan, TX USA	Oregon Health & Science University; Oregon Health & Science University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Turker, MS (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA.; Turker, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.	turkerm@ohsu.edu	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Lasarev, Michael R/0000-0002-1896-2705; Turker, Mitchell/0000-0002-1438-7475	NASA [NNX1OAC12G, NNX14AC97G, NNJ12HB881, NNJ16HP23I]; Murdock Scholar Fellowships; Oregon Institute of Occupational Health Sciences; Ted. R. Lilley Cancer Cure fellowship	NASA(National Aeronautics & Space Administration (NASA)); Murdock Scholar Fellowships; Oregon Institute of Occupational Health Sciences; Ted. R. Lilley Cancer Cure fellowship	This work was supported by NASA grants NNX1OAC12G, NNX14AC97G, NNJ12HB881, and NNJ16HP23I, Murdock Scholar Fellowships to Gwen Hryciw and Sorrel Johnson, and an Oregon Institute of Occupational Health Sciences summer fellowship to Bradley Eckelmann, and the Ted. R. Lilley Cancer Cure fellowship for high school students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPEN EL, 1994, ADV SPACE RES, V14, P573, DOI 10.1016/0273-1177(94)90512-6; Chang PY, 2001, PHYS MEDICA, V17, P189; Chang PY, 2001, MUTAGENESIS, V16, P7, DOI 10.1093/mutage/16.1.7; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074988; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Curtis S B, 1989, Adv Space Res, V9, P293, DOI 10.1016/0273-1177(89)90452-3; CURTIS SB, 1992, ADV SPACE RES-SERIES, V12, P407, DOI 10.1016/0273-1177(92)90137-M; Dan C, 2011, GENE CHROMOSOME CANC, V50, P239, DOI 10.1002/gcc.20849; Durante M, 2005, ADV SPACE RES, V35, P180, DOI 10.1016/j.asr.2004.12.034; Durante M, 2002, RADIAT RES, V158, P581, DOI 10.1667/0033-7587(2002)158[0581:KOHLET]2.0.CO;2; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Gao RL, 2016, NAT GENET, V48, P1119, DOI 10.1038/ng.3641; Grygoryev D, 2016, MUTAT RES-FUND MOL M, V788, P32, DOI 10.1016/j.mrfmmm.2016.03.004; Grygoryev D, 2014, RADIAT RES, V181, P452, DOI 10.1667/RR13654.1; HORN PL, 1984, J CELL PHYSIOL, V121, P309, DOI 10.1002/jcp.1041210207; Hryciw G, 2015, RADIAT RES, V184, P367, DOI 10.1667/RR14130.1; Kagawa Y, 1999, MUTAGENESIS, V14, P199, DOI 10.1093/mutage/14.2.199; Kiefer J, 2002, J RADIAT RES, V43, pS21; Kraemer SM, 2000, RADIAT RES, V153, P743, DOI 10.1667/0033-7587(2000)153[0743:MTSOMI]2.0.CO;2; Kronenberg A, 2013, RADIAT RES, V179, P511, DOI 10.1667/RR3182.1; Kronenberg A, 2012, HEALTH PHYS, V103, P556, DOI 10.1097/HP.0b013e3182690caf; Kronenberg A, 2009, RADIAT RES, V172, P550, DOI 10.1667/RR1804.1; Little JB, 1997, RADIAT RES, V148, P299, DOI 10.2307/3579514; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Loeb LA, 1996, MUTAT RES-FUND MOL M, V350, P279, DOI 10.1016/0027-5107(95)00117-4; Maalouf M, 2011, J RADIAT RES, V52, P126, DOI 10.1269/jrr.10128; Masumura K, 2002, ENVIRON MOL MUTAGEN, V40, P207, DOI 10.1002/em.10108; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morgan WF, 2003, ONCOGENE, V22, P7094, DOI 10.1038/sj.onc.1206992; MuCullagh P, 1989, GENERALIZED LINEAR M; NELSON SL, 1995, RADIAT RES, V141, P2, DOI 10.2307/3579083; Padilla-Nash HM, 2012, GENE CHROMOSOME CANC, V51, P353, DOI 10.1002/gcc.21921; Plante I, RAD PROT DOSIMETRY, V143, P156; Ponomareva ON, 2002, CANCER RES, V62, P1518; Sasaki MS, 2009, INT J RADIAT BIOL, V85, P26, DOI 10.1080/09553000802641185; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Sudo H, 2008, RADIAT RES, V170, P23, DOI 10.1667/RR1317.1; Townshead LW, 2006, INFORM NEEDED MAKE R; Trani D, 2014, RADIAT RES, V181, P162, DOI 10.1667/RR13502.1; Tsuruoka C, 2016, RADIAT RES, V186, P407, DOI 10.1667/RR14499.1; Turker MS, 2007, AGING CELL, V6, P73, DOI 10.1111/j.1474-9726.2006.00264.x; Turker MS, 2013, RADIAT RES, V179, P521, DOI 10.1667/RR3174.1; Turker MS, 2009, RADIAT RES, V172, P558, DOI 10.1667/RR1805.1; Turker MS, 1997, MUTAT RES-FUND MOL M, V374, P201, DOI 10.1016/S0027-5107(96)00230-8; Turker MS, 2003, MUTAGENESIS, V18, P1, DOI 10.1093/mutage/18.1.1; Turker MS, 1999, CANCER RES, V59, P4781; Waldren C, 1998, ADV SPACE RES, V22, P579, DOI 10.1016/S0273-1177(98)00080-5; Wang X, 2015, RADIAT RES, V183, P233, DOI 10.1667/RR13884.1; Wiese C, 2001, CANCER RES, V61, P1129; Wilson C, 2005, HUM MOL GENET, V14, P1839, DOI 10.1093/hmg/ddi190; Yatagai Fumio, 2004, Biol Sci Space, V18, P224, DOI 10.2187/bss.18.224	52	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180412	10.1371/journal.pone.0180412	http://dx.doi.org/10.1371/journal.pone.0180412			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683078	Green Published, gold			2022-12-27	WOS:000405335200032
J	Versace, A; Sharma, V; Bertocci, MA; Bebko, G; Lyengar, S; Dwojak, A; Boner, L; Periman, SB; Schirda, C; Travis, M; Gill, MK; Diwadkar, VA; Sunshine, JL; Holland, SK; Kowatch, RA; Birmaher, B; Axelson, D; Frazier, TW; Arnold, LE; Fristad, MA; Youngstrom, EA; Horwitz, SM; Findling, RL; Phillips, ML				Versace, Amelia; Sharma, Vinod; Bertocci, Michele A.; Bebko, Genna; Lyengar, Satish; Dwojak, Amanda; Boner, Lisa; Periman, Susan B.; Schirda, Claudiu; Travis, Michael; Gill, Mary Kay; Diwadkar, Vaibhav A.; Sunshine, Jeffrey L.; Holland, Scott K.; Kowatch, Robert A.; Birmaher, Boris; Axelson, David; Frazier, Thomas W.; Arnold, L. Eugene; Fristad, Mary A.; Youngstrom, Eric A.; Horwitz, Sarah M.; Findling, Robert L.; Phillips, Mary L.			Using machine learning and surface reconstruction to accurately differentiate different trajectories of mood and energy dysregulation in youth	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MANIC SYMPTOMS; LONGITUDINAL ASSESSMENT; CORTICAL THICKNESS; EMOTION DYSREGULATION; BIPOLAR DISORDER; FAMILIAL RISK; CHILDREN; ADOLESCENTS; REGRESSION	Difficulty regulating positive mood and energy is a feature that cuts across different pediatric psychiatric disorders. Yet, little is known regarding the neural mechanisms underlying different developmental trajectories of positive mood and energy regulation in youth. Recent studies indicate that machine learning techniques can help elucidate the role of neuroimaging measures in classifying individual subjects by specific symptom trajectory. Cortical thickness measures were extracted in sixty-eight anatomical regions covering the entire brain in 115 participants from the Longitudinal Assessment of Manic Symptoms (LAMS) study and 31 healthy comparison youth (12.5 y/o;-Male/Female = 15/16; -IQ = 104;-Right/Left handedness = 24/5). Using a combination of trajectories analyses, surface reconstruction, and machine learning techniques, the present study aims to identify the extent to which measures of cortical thickness can accurately distinguish youth with higher (n = 18) from those with lower (n = 34) trajectories of manic -like behaviors in a large sample of LAMS youth (n = 115; 13.6 y/o; M/F = 68/47, IQ = 100.1, R/L = 108/7). Machine learning analyses revealed that widespread cortical thickening in portions of the left dorsolateral prefrontal cortex, right inferior and middle temporal gyrus, bilateral precuneus, and bilateral paracentral gyri and cortical thinning in portions of the right dorsolateral prefrontal cortex, left ventrolateral prefrontal cortex, and right parahippocampal gyrus accurately differentiate (Area Under Curve = 0.89;p = 0.03) youth with different (higher vs lower) trajectories of positive mood and energy dysregulation over a period up to 5years, as measured by the Parent General Behavior Inventory-10 Item Mania Scale. Our findings suggest that specific patterns of cortical thickness may reflect transdiagnostic neural mechanisms associated with different temporal trajectories of positive mood and energy dysregulation in youth. This approach has potential to identify patterns of neural markers of future clinical course.	[Versace, Amelia; Sharma, Vinod; Bertocci, Michele A.; Bebko, Genna; Dwojak, Amanda; Boner, Lisa; Periman, Susan B.; Schirda, Claudiu; Travis, Michael; Gill, Mary Kay; Birmaher, Boris; Phillips, Mary L.] Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA; [Lyengar, Satish] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA; [Diwadkar, Vaibhav A.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA; [Sunshine, Jeffrey L.] Case Western Reserve Univ, Case Med Ctr, Univ Hosp, Cleveland, OH 44106 USA; [Holland, Scott K.] Case Western Reserve Univ, Med Ctr, Univ Hosp, Dept Radiol, Cleveland, OH USA; [Kowatch, Robert A.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Axelson, David; Arnold, L. Eugene; Fristad, Mary A.] Ohio State Univ, Dept Psychiat, Columbus, OH 43210 USA; [Frazier, Thomas W.] Cleveland Clin, Pediat Inst, Cleveland, OH 44106 USA; [Youngstrom, Eric A.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Horwitz, Sarah M.] NYU, Dept Child & Adolescent Psychiat, Sch Med, New York, NY USA; [Findling, Robert L.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wayne State University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University Hospitals of Cleveland; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; University of North Carolina; University of North Carolina Chapel Hill; New York University; Johns Hopkins University	Versace, A (corresponding author), Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA.	versacea@upmc.edu	bertocci, michele/AAQ-2875-2021; Youngstrom, Eric A./ABE-3258-2020; Versace, Amelia/G-1772-2018; Fristad, Mary A/AAW-6472-2021	Youngstrom, Eric A./0000-0003-2251-6860; Versace, Amelia/0000-0001-9925-5203; Horwitz, Sarah/0000-0002-5262-1170; Schirda, Claudiu/0000-0002-5036-0640	National Institute of Mental Health [2R01 MH73953-06A1]; Pittsburgh Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073801, R01MH073967, R01MH073953, T32MH018951, R01MH073816] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pittsburgh Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Mental Health grant 2R01 MH73953-06A1 (BB and MLP, University of Pittsburgh) and by the Pittsburgh Foundation (MLP, University of Pittsburgh Emmerling Endowed Chair in Psychotic Disorders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreescu C, 2008, INT PSYCHOGERIATR, V20, P221, DOI 10.1017/S1041610207006667; Axelson D, 2003, J CHILD ADOL PSYCHOP, V13, P463, DOI 10.1089/104454603322724850; Bebko G, 2014, JAMA PSYCHIAT, V71, P71, DOI 10.1001/jamapsychiatry.2013.2870; Berkman ET, 2013, CURR DIR PSYCHOL SCI, V22, P45, DOI 10.1177/0963721412469394; Bertocci MA, 2013, BIOL PSYCHIAT, V73, p195S; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Birmaher B, 2009, AM J PSYCHIAT, V166, P795, DOI 10.1176/appi.ajp.2009.08101569; Bunford N, 2015, J ABNORM CHILD PSYCH, V43, P133, DOI 10.1007/s10802-014-9902-9; Carlson GA, 1998, J AFFECT DISORDERS, V51, P123, DOI 10.1016/S0165-0327(98)00211-0; Cavanagh M, 2014, J ATTEN DISORD, V13, P13; Cole P.M., 1994, MONOGRAPHS SOC RES C, V59, P73, DOI [10.2307/1166139, DOI 10.2307/1166139]; Copeland WE, 2013, AM J PSYCHIAT, V170, P173, DOI 10.1176/appi.ajp.2012.12010132; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Findling RL, 2013, BIPOLAR DISORD, V15, P669, DOI 10.1111/bdi.12100; Findling RL, 2010, J CLIN PSYCHIAT, V71, P1664, DOI 10.4088/JCP.09m05859yel; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Foland-Ross LC, 2015, J ABNORM PSYCHOL, V124, P476, DOI 10.1037/abn0000050; Frazier TW, 2011, J CLIN PSYCHIAT, V72, P846, DOI 10.4088/JCP.10m06081yel; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gogtay N, 2007, J CHILD PSYCHOL PSYC, V48, P852, DOI 10.1111/j.1469-7610.2007.01747.x; Group-based modeling of development, 2005, CHOIC CURR REV AC LI, V43, P375; Hastie T., 2009, ELEMENTS STAT LEARNI, Vxxii; Hazell PL, 2003, J AM ACAD CHILD PSY, V42, P552, DOI 10.1097/01.CHI.0000046830.95464.33; Heller AS, 2016, DEVELOPMENTAL SCI, V19, P3, DOI 10.1111/desc.12373; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Horwitz SM, 2010, J CLIN PSYCHIAT, V71, P1511, DOI 10.4088/JCP.09m05835yel; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Insel TR, 2014, JAMA PSYCHIAT, V71, P745, DOI 10.1001/jamapsychiatry.2014.426; Janssen J, 2014, SCHIZOPHR RES, V158, P91, DOI 10.1016/j.schres.2014.06.040; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Jones BL, 2013, SOCIOL METHOD RES, V42, P608, DOI 10.1177/0049124113503141; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kuo SY, 2011, PSYCHOL MED, V41, P1665, DOI 10.1017/S0033291710002473; Larson RW, 2002, CHILD DEV, V73, P1151, DOI 10.1111/1467-8624.00464; Leibenluft E, 2003, BIOL PSYCHIAT, V53, P1009, DOI 10.1016/S0006-3223(03)00069-6; McCarthy CS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00379; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Papmeyer M, 2015, BIOL PSYCHIAT, V78, P58, DOI 10.1016/j.biopsych.2014.10.018; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Rosen PJ, 2015, ADHD-ATTEND DEFICIT, V7, P281, DOI 10.1007/s12402-015-0175-0; Salters-Pedneault K, 2006, COGNITIVE THER RES, V30, P469, DOI 10.1007/s10608-006-9055-4; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wallace GL, 2014, J AM ACAD CHILD PSY, V53, P456, DOI 10.1016/j.jaac.2013.12.008; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Youngstrom E, 2005, BIPOLAR DISORD, V7, P507, DOI 10.1111/j.1399-5618.2005.00269.x; Youngstrom EA, 2008, J CLIN PSYCHIAT, V69, P831, DOI 10.4088/JCP.v69n0517; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	53	1	1	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180221	10.1371/journal.pone.0180221	http://dx.doi.org/10.1371/journal.pone.0180221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683115	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200019
J	Balseiro, A; Altuzarra, R; Vidal, E; Moll, X; Espada, Y; Sevilla, IA; Domingo, M; Garrido, JM; Juste, RA; Prieto, M; de Val, BP				Balseiro, Ana; Altuzarra, Raul; Vidal, Enric; Moll, Xavier; Espada, Yvonne; Sevilla, Iker A.; Domingo, Mariano; Garrido, Joseba M.; Juste, Ramon A.; Prieto, Miguel; Perez de Val, Bernat			Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; DEER ODOCOILEUS-VIRGINIANUS; ORAL VACCINATION; ANTIBODY-RESPONSES; BRUSHTAIL POSSUMS; CATTLE; BACILLUS; BADGERS; PROTECTION; PATHOLOGY	Background/Aims Animal tuberculosis (TB) is a complex animal health problem that causes disruption to trade and significant economic losses. TB involves a multi-host system where sheep, traditionally considered a rare host of this infection, have been recently included. The aims of this study were to develop an experimental TB infection model in sheep with a Mycobacterium caprae field strain isolated from a tuberculous diseased ewe, and to use this to evaluate the safety and efficacy of two vaccines against TB in sheep, the live-attenuated M. bovis BCG vaccine (Danish strain) and a heat-inactivated M. bovis (HIMB) vaccine. Methods Eighteen 2 month-old lambs were experimentally challenged with M. caprae by the endotracheal route (1.5 x 10(3) CFU). They were separated per treatment group into parenterally vaccinated with a live BCG Danish strain vaccine (n = 6), orally vaccinated with a suspension of HIMB (n = 6) and unvaccinated controls (n = 6). Clinical, immunological, pathological and bacteriological parameters of infection were measured. Results All lambs were successfully infected and developed gross TB lesions in the respiratory system. The BCG vaccine conferred considerable protection against experimental TB in lambs, as measured by a reduction of the gross lesion volumes and bacterial load. However, HIMB vaccinated animals did not show protection. Conclusions This study proposes a reliable new experimental model for a better understanding of tuberculosis in sheep. BCG vaccination offers an effective prospect for controlling the disease. Moreover alternative doses and/or routes of administration should be considered to evaluate the efficacy of the HIMB vaccine candidate.	[Balseiro, Ana; Juste, Ramon A.; Prieto, Miguel] SERIDA, Serv Reg Invest & Desarrollo Agroalimentario, Ctr Biotecnol Anim, Gijon, Asturias, Spain; [Altuzarra, Raul; Moll, Xavier; Espada, Yvonne] Univ Autonoma Barcelona, Dept Med & Cirugia Anim, Barcelona, Catalonia, Spain; [Vidal, Enric; Domingo, Mariano; Perez de Val, Bernat] UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autanoma Barcelona, Barcelona, Spain; [Sevilla, Iker A.; Garrido, Joseba M.] NEIKER Tecnalia, Inst Vasco Invest & Desarrollo Agr, Dept Sanidad Anim, Bizkaia, Pais Vasco, Spain; [Domingo, Mariano] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Catalonia, Spain	Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona	Balseiro, A (corresponding author), SERIDA, Serv Reg Invest & Desarrollo Agroalimentario, Ctr Biotecnol Anim, Gijon, Asturias, Spain.	abalseiro@serida.org	Balseiro, Ana/O-1794-2019; Juste, Ramon A./C-3570-2008; Moll, Xavier/H-3203-2018; DE VAL, BERNAT PÉREZ/G-6865-2012; Prieto Lage, Miguel Angel/G-4516-2011; Vidal, Enric/P-2901-2019; Vidal, Enric/I-1679-2014; Sevilla, Iker A/O-6060-2014; Domingo, Mariano/A-1015-2009	Balseiro, Ana/0000-0002-5121-7264; Juste, Ramon A./0000-0001-6037-5873; Moll, Xavier/0000-0002-2992-9361; DE VAL, BERNAT PÉREZ/0000-0003-3127-9182; Prieto Lage, Miguel Angel/0000-0002-3513-0054; Vidal, Enric/0000-0002-4965-3286; Vidal, Enric/0000-0002-4965-3286; Sevilla, Iker A/0000-0003-3968-3390; Domingo, Mariano/0000-0002-9623-4826; Joseba M., Garrido/0000-0002-7559-0653	Instituto Nacionalde Investigacio y Tecnologo Aa Agrariay Alimentaria (INIA) - FEDER [RTA2014-0002-C02-01]; CERCA Programme/Generalitat de Catalunya	Instituto Nacionalde Investigacio y Tecnologo Aa Agrariay Alimentaria (INIA) - FEDER; CERCA Programme/Generalitat de Catalunya	This work was funded by a grant from Instituto Nacionalde Investigacio y Tecnologo Aa Agrariay Alimentaria (INIA), reference number RTA2014-0002-C02-01 (FEDER co-funded). IRTA is supported by CERCA Programme/Generalitat de Catalunya.	Ballesteros C, 2009, VACCINE, V27, P6662, DOI 10.1016/j.vaccine.2009.08.095; Caswell J. L., 2007, PALMERIS PATHOL DOME, V2, P523; Chambers MA, 2014, VET REC, V175, P90, DOI 10.1136/vr.102581; Chambers MA, 2004, VACCINE, V22, P1063, DOI 10.1016/j.vaccine.2003.05.002; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; CORDES DO, 1981, NEW ZEAL VET J, V29, P60, DOI 10.1080/00480169.1981.34798; Corner LAL, 2007, RES VET SCI, V83, P53, DOI 10.1016/j.rvsc.2006.10.016; Corner LAL, 2002, RES VET SCI, V73, P145, DOI 10.1016/S0034-5288(02)00038-3; Cousins DV, 2001, REV SCI TECH OIE, V20, P71, DOI 10.20506/rst.20.1.1263; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gortazar C, 2011, VET MICROBIOL, V151, P170, DOI 10.1016/j.vetmic.2011.02.041; GRANGE JM, 1990, J APPL BACTERIOL, V68, P411, DOI 10.1111/j.1365-2672.1990.tb02892.x; Griffin J. F. T., 1999, Tubercle and Lung Disease, V79, P135, DOI 10.1054/tuld.1998.0202; Jones GJ, 2016, VET IMMUNOL IMMUNOP, V182, P85, DOI 10.1016/j.vetimm.2016.10.010; Lopez V, 2016, VET IMMUNOL IMMUNOP, V172, P21, DOI 10.1016/j.vetimm.2016.03.003; Lopez-Valencia G, 2010, RES VET SCI, V88, P44, DOI 10.1016/j.rvsc.2009.05.022; Lyashchenko K, 2004, INFECT IMMUN, V72, P2462, DOI 10.1128/IAI.72.5.2462-2467.2004; Murphy D, 2014, VET J, V200, P362, DOI 10.1016/j.tvjl.2014.02.031; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; Palmer MV, 2007, VACCINE, V25, P6589, DOI 10.1016/j.vaccine.2007.06.056; de Val BP, 2017, TRANSBOUND EMERG DIS, V64, P275, DOI 10.1111/tbed.12368; de Val BP, 2016, VACCINE, V34, P881, DOI 10.1016/j.vaccine.2016.01.004; de Val BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081317; de Val BP, 2011, CLIN VACCINE IMMUNOL, V18, P1872, DOI 10.1128/CVI.05323-11; Tompkins DM, 2009, P ROY SOC B-BIOL SCI, V276, P2987, DOI 10.1098/rspb.2009.0414; Vordermeier HM, 2016, ANNU REV ANIM BIOSCI, V4, P87, DOI 10.1146/annurev-animal-021815-111311; Vordermeier HM, 2014, RES VET SCI, V97, pS53, DOI 10.1016/j.rvsc.2014.04.015; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P648, DOI 10.1128/CVI.00061-06; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Wilton S, 1992, GENOME RES, V1, P269, DOI DOI 10.1101/GR.1.4.269	31	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180546	10.1371/journal.pone.0180546	http://dx.doi.org/10.1371/journal.pone.0180546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678885	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200072
J	Trudeau-Fisette, P; Tiede, M; Menard, L				Trudeau-Fisette, Pamela; Tiede, Mark; Menard, Lucie			Compensations to auditory feedback perturbations in congenitally blind and sighted speakers: Acoustic and articulatory data	PLOS ONE			English	Article							SENSORIMOTOR ADAPTATION; SPEECH ACQUISITION; NEURAL THEORY; MOTOR; PITCH; COORDINATION; SPECIFICITY; PERCEPTION; FREQUENCY; LANGUAGE	This study investigated the effects of visual deprivation on the relationship between speech perception and production by examining compensatory responses to real-time perturbations in auditory feedback. Specifically, acoustic and articulatory data were recorded while sighted and congenitally blind French speakers produced several repetitions of the vowel /phi/. At the acoustic level, blind speakers produced larger compensatory responses to altered vowels than their sighted peers. At the articulatory level, blind speakers also produced larger displacements of the upper lip, the tongue tip, and the tongue dorsum in compensatory responses. These findings suggest that blind speakers tolerate less discrepancy between actual and expected auditory feedback than sighted speakers. The study also suggests that sighted speakers have acquired more constrained somatosensory goals through the influence of visual cues perceived in face-to-face conversation, leading them to tolerate less discrepancy between expected and altered articulatory positions compared to blind speakers and thus resulting in smaller observed compensatory responses.	[Trudeau-Fisette, Pamela; Menard, Lucie] Univ Quebec Montreal, Lab Phonet, Ctr Res Brain Language & Mus, Montreal, PQ, Canada; [Tiede, Mark] Haskins Labs Inc, New Haven, CT USA	University of Quebec; University of Quebec Montreal; Yale University; Haskins Laboratories	Trudeau-Fisette, P (corresponding author), Univ Quebec Montreal, Lab Phonet, Ctr Res Brain Language & Mus, Montreal, PQ, Canada.	ptrudeaufisette@gmail.com			Social Sciences and Humanities Research Council of Canada (Canada Graduate Scholarships Master's Program) [766-20140 255]; Social Sciences and Humanities Research Council of Canada (Insight Grant) [4102 010-1785]; Natural Sciences and Engineering (LM) [RGPIN-2015-06544]	Social Sciences and Humanities Research Council of Canada (Canada Graduate Scholarships Master's Program); Social Sciences and Humanities Research Council of Canada (Insight Grant); Natural Sciences and Engineering (LM)	Funded by Grant number: 766-20140 255 - Social Sciences and Humanities Research Council of Canada (Canada Graduate Scholarships Master's Program) - http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx (PTF), Grant number: 4102 010-1785- Social Sciences and Humanities Research Council of Canada (Insight Grant) - http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx (LM), Grant number: RGPIN-2015-06544 - Natural Sciences and Engineering (LM). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	ABBS JH, 1984, J MOTOR BEHAV, V16, P195; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Dohen M, 2009, LANG SPEECH, V52, P177, DOI 10.1177/0023830909103166; ELMAN JL, 1981, J ACOUST SOC AM, V70, P45, DOI 10.1121/1.386580; Feng YQ, 2011, J NEUROPHYSIOL, V106, P667, DOI 10.1152/jn.00638.2010; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Gori M, 2010, CURR BIOL, V20, P223, DOI 10.1016/j.cub.2009.11.069; Gribble PL, 1998, J NEUROPHYSIOL, V79, P1409, DOI 10.1152/jn.1998.79.3.1409; Guenther F.H., 2004, SPEECH MOTOR CONTROL, P29; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Guenther FH, 2012, J NEUROLINGUIST, V25, P408, DOI 10.1016/j.jneuroling.2009.08.006; Hickok G, 2012, NAT REV NEUROSCI; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; HUGHES OM, 1976, PHONETICA, V33, P199; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Jones JA, 2005, CURR BIOL, V15, P1768, DOI 10.1016/j.cub.2005.08.063; Jones JA, 2003, J ACOUST SOC AM, V113, P532, DOI 10.1121/1.1529670; Katseff S, 2012, LANG SPEECH, V55, P295, DOI 10.1177/0023830911417802; Kawahara H, 1998, COMPUTATIONAL AUDITO, P335; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Kroos C, 2012, J PHONETICS, V40, P453, DOI 10.1016/j.wocn.2012.03.002; Lametti DR, 2012, J NEUROSCI, V32, P9351, DOI 10.1523/JNEUROSCI.0404-12.2012; Larson CR, 2008, EXP BRAIN RES, V187, P613, DOI 10.1007/s00221-008-1330-z; Leclerc A, 2007, ROLE VISION PRODUCTI; Liu H, 2012, PLOS ONE, V7; Liu HJ, 2011, CLIN NEUROPHYSIOL, V122, P951, DOI 10.1016/j.clinph.2010.08.010; MacDonald EN, 2011, J ACOUST SOC AM, V129, P955, DOI 10.1121/1.3531932; MacDonald EN, 2010, J ACOUST SOC AM, V127, P1059, DOI 10.1121/1.3278606; Maeda S., 1979, ACT 10 JOURN ET PAR, P152; Max L, 2003, P 15 INT C PHONETIC, P1053; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Menard L, 2013, P ANN C INT SPEECH C; Menard L, 2013, NEW PERSPECTIVES ORI; Menard L, FOLIA PHONI IN PRESS; Menard L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160088; Menard L, 2016, CLIN LINGUIST PHONET, V30, P227, DOI 10.3109/02699206.2015.1079247; Menard L, 2014, J SPEECH LANG HEAR R, V57, P793, DOI 10.1044/2014_JSLHR-S-12-0395; Menard L, 2009, J ACOUST SOC AM, V126, P1406, DOI 10.1121/1.3158930; Mitsuya T, 2013, J ACOUST SOC AM, V133, P2993, DOI 10.1121/1.4795786; Mitsuya T, 2011, J ACOUST SOC AM, V130, P2978, DOI 10.1121/1.3643826; Munhall KG, 2009, J ACOUST SOC AM, V125, P384, DOI 10.1121/1.3035829; Neufeld C, 2013, MULTIMODAL TARGETS S; Orfanidis S.J., 1988, OPTIMUM SIGNAL PROCE; Perkell JS, 2012, J NEUROLINGUIST, V25, P382, DOI 10.1016/j.jneuroling.2010.02.011; Purcell DW, 2006, J ACOUST SOC AM, V120, P966, DOI 10.1121/1.2217714; Purcell DW, 2006, J ACOUST SOC AM, V119, P2288, DOI 10.1121/1.2173514; Robert-Ribes J, 1998, J ACOUST SOC AM, V103, P3677, DOI 10.1121/1.423069; Rochet-Capellan A, 2012, J NEUROPHYSIOL, V107, P1711, DOI 10.1152/jn.00773.2011; Savariaux C, 2017, J SPEECH LANG HEAR R, V60, P322, DOI 10.1044/2016_JSLHR-S-15-0223; Shiller DM, 2009, J ACOUST SOC AM, V125, P1103, DOI 10.1121/1.3058638; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Tian X, 2015, J COGNITIVE NEUROSCI, V27, P352, DOI 10.1162/jocn_a_00692; Tian X, 2013, J COGNITIVE NEUROSCI, V25, P1020, DOI 10.1162/jocn_a_00381; Tian X, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00166; Tourville JA, 2011, LANG COGNITIVE PROC, V26, P952, DOI 10.1080/01690960903498424; Trudeau-Fisette P, 2013, P M AC; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; Villacorta VM, 2006, SENSORIMOTOR ADAPTAT	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180300	10.1371/journal.pone.0180300	http://dx.doi.org/10.1371/journal.pone.0180300			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678819	gold, Green Published, Green Submitted			2022-12-27	WOS:000405272200048
J	Unnanuntana, A; Jarusriwanna, A; Songcharoen, P				Unnanuntana, Aasis; Jarusriwanna, Atthakorn; Songcharoen, Panupan			Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax (R)) for osteoporosis treatment	PLOS ONE			English	Article							FEMORAL-NECK FRACTURES; QUALITY-OF-LIFE; POSTMENOPAUSAL OSTEOPOROSIS; VERTEBRAL FRACTURES; MEDICAL LITERATURE; USERS GUIDES; BONE-DENSITY; DOUBLE-BLIND; WOMEN; BISPHOSPHONATES	Introduction Although the same efficacy and tolerability are anticipated due to both drugs containing the same active ingredients, comparative studies between brand and generic alendronate are limited. Accordingly, the objective of this study was to compare efficacy and safety between brand alendronate and a recently introduced generic alendronate drug. Methods A total of 140 postmenopausal women or men aged older than 50 years who met the indications for osteoporosis treatment were randomized to receive either generic (Bonmax r) or brand alendronate (Fosamax r) 70 mg/week over a 12-month period during the May 2014 to June 2015 study period. Endpoints included bone mineral density (BMD) changes at the lumbar spine, total hip, and femoral neck; percentage of patients with predefined levels of change in total hip and lumbar spine BMD at 12 months; and, changes in biochemical bone markers at 3, 6, and 12 months. Tolerability was evaluated by patient self-reporting of adverse experiences. Results At 12 months post-treatment, BMD significantly increased at all sites in both groups. There were no differences in BMD percentage changes or the number of patients with stable or increased BMD after 1 year between groups. No significant differences in the amount of biochemical bone marker reduction or incidence of adverse events were observed between groups. Conclusions Generic and brand alendronate produced similar gains in BMD and reduction in bone turnover markers. Both medicadoitions were also equally well-tolerated. Based on these	[Unnanuntana, Aasis; Jarusriwanna, Atthakorn; Songcharoen, Panupan] Mahidol Univ, Siriraj Hosp, Dept Orthopaed Surg, Fac Med, Bangkok, Thailand	Mahidol University	Unnanuntana, A (corresponding author), Mahidol Univ, Siriraj Hosp, Dept Orthopaed Surg, Fac Med, Bangkok, Thailand.	uaasis@gmail.com	Jarusriwanna, Atthakorn/AAC-6568-2021	Jarusriwanna, Atthakorn/0000-0002-3919-8195	Medical Association of Thailand (Prasert Prasarttong-Osoth) Research Fund	Medical Association of Thailand (Prasert Prasarttong-Osoth) Research Fund	This study was partially supported by the Medical Association of Thailand (Prasert Prasarttong-Osoth) Research Fund. There was no additional external funding received for this study.	Baim S, 2005, J CLIN DENSITOM, V8, P371, DOI 10.1385/JCD:8:4:371; Biswas PN, 2003, OSTEOPOROSIS INT, V14, P507, DOI 10.1007/s00198-003-1399-y; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Bonnick SL, 2001, J CLIN DENSITOM, V4, P105, DOI 10.1385/JCD:4:2:105; Brown JP, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-550; Bucher HC, 1999, JAMA-J AM MED ASSOC, V282, P771, DOI 10.1001/jama.282.8.771; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; Dansereau RJ, 2009, CURR MED RES OPIN, V25, P449, DOI [10.1185/03007990802648903, 10.1185/03007990802648903 ]; Eisman JA, 2012, J BONE MINER RES, V27, P2039, DOI 10.1002/jbmr.1698; Greenspan SL, 2000, J CLIN ENDOCR METAB, V85, P3537, DOI 10.1210/jc.85.10.3537; Grima DT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-68; Hassler N, 2015, OSTEOPOROSIS INT, V26, P339, DOI 10.1007/s00198-014-2929-5; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Lai PSM, 2012, CURR MED RES OPIN, V28, P1347, DOI 10.1185/03007995.2012.708326; Lietzan EK, 2004, FOOD DRUG LAW J, V59, P287; McAlister FA, 1999, JAMA-J AM MED ASSOC, V282, P1371, DOI 10.1001/jama.282.14.1371; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Orwoll ES, 2010, J BONE MINER RES, V25, P2239, DOI 10.1002/jbmr.119; Paggiosi MA, 2014, OSTEOPOROSIS INT, V25, P2729, DOI 10.1007/s00198-014-2817-z; Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P703, DOI 10.1007/s00198-008-0743-7; Pongchaiyakul Chatlert, 2012, Journal of the Medical Association of Thailand, V95, P1528; Rosen CJ, 2005, J BONE MINER RES, V20, P141, DOI 10.1359/jbmr.2005.20.1.141; Sanderson J, 2016, BONE, V89, P52, DOI 10.1016/j.bone.2016.05.013; Savaridas T, 2013, BONE JOINT J, V95B, P1263, DOI 10.1302/0301-620X.95B9.31562; Strom O, 2012, OSTEOPOROSIS INT, V23, P2201, DOI 10.1007/s00198-011-1850-4; Tarride JE, 2012, OSTEOPOROSIS INT, V23, P2591, DOI 10.1007/s00198-012-1931-z; Tidermark J, 2003, QUAL LIFE RES, V12, P1069, DOI 10.1023/A:1026193812514; Tidermark J, 2002, QUAL LIFE RES, V11, P473, DOI 10.1023/A:1015632114068; van den Bergh JPW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078153; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Watts N, 1999, INT J CLIN PRACT, P51	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180325	10.1371/journal.pone.0180325	http://dx.doi.org/10.1371/journal.pone.0180325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678853	Green Submitted, gold, Green Published			2022-12-27	WOS:000405272200053
J	Clark, R; Locke, M; Hill, B; Wells, C; Bialocerkowski, A				Clark, Ramona; Locke, Melissa; Hill, Bridget; Wells, Cherie; Bialocerkowski, Andrea			Clinimetric properties of lower limb neurological impairment tests for children and young people with a neurological condition: A systematic review	PLOS ONE			English	Review							HAND-HELD DYNAMOMETRY; TEST-RETEST RELIABILITY; HEALTH-STATUS; CEREBRAL-PALSY; OUTCOME MEASURES; STRENGTH MEASUREMENT; LOWER-EXTREMITY; SEARCH STRATEGIES; VALIDITY; FRAMEWORK	Background Clinicians and researchers require sound neurological tests to measure changes in neurological impairments necessary for clinical decision-making. Little evidence-based guidance exists for selecting and interpreting an appropriate, paediatric-specific lower limb neurological test aimed at the impairment level. Objective To determine the clinimetric evidence underpinning neurological impairment tests currently used in paediatric rehabilitation to evaluate muscle strength, tactile sensitivity, and deep tendon reflexes of the lower limb in children and young people with a neurological condition. Methods Thirteen databases were systematically searched in two phases, from the date of database inception to 16 February 2017. Lower limb neurological impairment tests were first identified which evaluated muscle strength, tactile sensitivity or deep tendon reflexes in children or young people under 18 years of age with a neurological condition. Papers containing clinimetric evidence of these tests were then identified. The methodological quality of each paper was critically appraised using standardised tools and clinimetric evidence synthesised for each test. Results Thirteen papers were identified, which provided clinimetric evidence on six neurological tests. Muscle strength tests had the greatest volume of clinimetric evidence, however this evidence focused on reliability. Studies were variable in quality with inconsistent results. Clinimetric evidence for tactile sensitivity impairment tests was conflicting and difficult to extrapolate. No clinimetric evidence was found for impairment tests of deep tendon reflexes. Conclusions Limited high-quality clinimetric evidence exists for lower limb neurological impairment tests in children and young people with a neurological condition. Results of currently used neurological tests, therefore, should be interpreted with caution. Robust clinimetric evidence on these tests is required for clinicians and researchers to effectively select and evaluate rehabilitation interventions.	[Clark, Ramona; Hill, Bridget; Wells, Cherie; Bialocerkowski, Andrea] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Clark, Ramona; Hill, Bridget; Wells, Cherie; Bialocerkowski, Andrea] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia; [Locke, Melissa] Movement Solut, Coorparoo, Qld, Australia; [Hill, Bridget] Epworth Monash Rehabil Med Unit, Melbourne, Vic, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University; Monash University	Clark, R (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.; Clark, R (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia.	Ramona.Clark2@griffithuni.edu.au		Wells, Cherie/0000-0002-4424-1207; Hill, Bridget/0000-0002-8632-094X; Clark, Ramona/0000-0002-7906-7675				Ammann-Reiffer C, 2014, PHYS THER, V94, P1067, DOI 10.2522/ptj.20130299; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Auld ML, 2011, PHYS OCCUP THER PEDI, V31, P413, DOI 10.3109/01942638.2011.572150; Barrett E, 2014, MANUAL THER, V19, P10, DOI 10.1016/j.math.2013.09.003; Bellet RN, 2012, PHYSIOTHERAPY, V98, P277, DOI 10.1016/j.physio.2011.11.003; Benfer KA, 2012, DEV MED CHILD NEUROL, V54, P784, DOI 10.1111/j.1469-8749.2012.04302.x; Berry Emily T, 2004, Pediatr Phys Ther, V16, P191, DOI 10.1097/01.PEP.0000145932.21460.61; Bialocerkowski A, 2013, DEV MED CHILD NEUROL, V55, P1075, DOI 10.1111/dmcn.12194; Bialocerkowski AE, 2008, INT J THER REHABIL, V15, P422, DOI 10.12968/ijtr.2008.15.10.31210; Bohannon RW, 2005, CLIN REHABIL, V19, P662, DOI 10.1191/0269215505cr873oa; Boluyt N, 2008, ARCH PEDIAT ADOL MED, V162, P111, DOI 10.1001/archpediatrics.2007.40; Brink Y, 2012, J EVAL CLIN PRACT, V18, P1126, DOI 10.1111/j.1365-2753.2011.01707.x; Burns J, 2012, ANN NEUROL, V71, P642, DOI 10.1002/ana.23572; Clark R, 2015, DEV MED CHILD NEUROL, V57, P1011, DOI 10.1111/dmcn.12803; Crompton J, 2007, DEV MED CHILD NEUROL, V49, P106, DOI 10.1111/j.1469-8749.2007.00106.x; Damiano DL, 1998, ARCH PHYS MED REHAB, V79, P119, DOI 10.1016/S0003-9993(98)90287-8; de Vet HCW, 2003, J CLIN EPIDEMIOL, V56, P1137, DOI 10.1016/j.jclinepi.2003.08.012; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Dekkers KJFM, 2014, PHYS THER, V94, P609, DOI 10.2522/ptj.20130166; DIMDI, 2005, INT CLASS FUNCT DIS; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; EFFGEN SK, 1992, PHYS THER, V72, P458, DOI 10.1093/ptj/72.6.458; Escolar DM, 2001, MUSCLE NERVE, V24, P787, DOI 10.1002/mus.1070; Evans D, 2003, J CLIN NURS, V12, P77, DOI 10.1046/j.1365-2702.2003.00662.x; Fily A, 2003, ACTA PAEDIATR, V92, P1433, DOI 10.1080/08035250310006926; FLORENCE JM, 1992, PHYS THER, V72, P115, DOI 10.1093/ptj/72.2.115; Gerber CN, 2016, NEUROREHAB NEURAL RE, V30, P19, DOI 10.1177/1545968315583723; GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1341, DOI 10.1016/0895-4356(92)90194-R; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1353, DOI 10.1016/0895-4356(92)90196-T; Harris-Love MO, 2014, PHYS THER, V94, P543, DOI 10.2522/ptj.20130100; Hebert-Losier K, 2009, J SCI MED SPORT, V12, P594, DOI 10.1016/j.jsams.2008.12.628; Hill BE, 2011, ARCH PHYS MED REHAB, V92, P2082, DOI 10.1016/j.apmr.2011.07.188; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hobart JC, 1996, J NEUROL NEUROSUR PS, V60, P127, DOI 10.1136/jnnp.60.2.127; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Jerosch-Herold C., 2005, BRIT J OCCUP THER, V68, P347, DOI [10.1177/030802260506800803, DOI 10.1177/030802260506800803]; Kahn MG, 2014, PEDIATRICS, V133, P516, DOI 10.1542/peds.2013-1504; Kastner M, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e25; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; Kim WH, 2011, DEV MED CHILD NEUROL, V53, P68, DOI [10.1111/j.1469-8749.2010.03777.x, 10.1111/j.1469-8749.2011.04006.x]; LUNSFORD BR, 1995, PHYS THER, V75, P694, DOI 10.1093/ptj/75.8.694; Mahony K, 2009, PHYS OCCUP THER PEDI, V29, P44, DOI 10.1080/01942630802574858; Majnemer A, 2002, DEV MED CHILD NEUROL, V44, P773, DOI 10.1111/j.1469-8749.2002.tb00285.x; Majnemer A, 1998, DEV MED CHILD NEUROL, V40, P708; May S, 2010, PHYSIOTHERAPY, V96, P179, DOI 10.1016/j.physio.2009.12.002; Mokkink L B, 2006, BMC Med Res Methodol, V6, P2, DOI 10.1186/1471-2288-6-2; Mulcahey MJ, 2007, SPINAL CORD, V45, P452, DOI 10.1038/sj.sc.3101987; Mulder-Brouwer AN, 2016, PEDIATR PHYS THER, V28, P136, DOI 10.1097/PEP.0000000000000228; Oftedal S, 2012, INT J PEDIAT, V2012, P12; Pannucci CJ, 2010, PLAST RECONSTR SURG, V126, P619, DOI 10.1097/PRS.0b013e3181de24bc; Petty NJ., 2011, NEUROMUSCULOSKELETAL, V4th ed.; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; R. R. Bowker Company and Serials Solutions., 2001, ULR GLOB SER DIR; Rathinam C, 2014, GAIT POSTURE, V40, P279, DOI 10.1016/j.gaitpost.2014.04.187; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Schrama PPM, 2014, ARCH PHYS MED REHAB, V95, P2444, DOI 10.1016/j.apmr.2014.05.019; Smart A, 2006, INT J QUAL HEALTH C, V18, P377, DOI 10.1093/intqhc/mzl034; Spittle AJ, 2008, DEV MED CHILD NEUROL, V50, P254, DOI 10.1111/j.1469-8749.2008.02025.x; STUBERG WA, 1988, PHYS THER, V68, P977, DOI 10.1093/ptj/68.6.977; TAN J., 2016, PEDIAT INFECT DIS OP, P1, DOI 10.1109/BMSB.2016.7521901; Taylor NF, 2004, ARCH PHYS MED REHAB, V85, P77, DOI 10.1016/S0003-9993(03)00379-4; Terwee CB, 2016, QUAL LIFE RES, V25, P767, DOI 10.1007/s11136-015-1122-4; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tyson S, 2008, DISABIL REHABIL, V30, P142, DOI 10.1080/09638280701216847; van den Beld WA, 2006, J REHABIL MED, V38, P57, DOI 10.1080/16501970510044043; Van Vulpen LF, 2013, EUR J PHYS REHAB MED, V49, P803; Verschuren O, 2008, DISABIL REHABIL, V30, P1358, DOI 10.1080/09638280701639873; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WIKHOLM J B, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P191; Willemse L, 2013, PHYS THER, V93, P935, DOI 10.2522/ptj.20120079; Wright V, 2013, SEMIN PEDIATR NEUROL, V20, P84, DOI 10.1016/j.spen.2013.06.005; Yocum A, 2010, PHYS OCCUP THER PEDI, V30, P190, DOI 10.3109/01942631003761380	75	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180031	10.1371/journal.pone.0180031	http://dx.doi.org/10.1371/journal.pone.0180031			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28671957	gold, Green Published			2022-12-27	WOS:000405268500012
J	Mailleux, L; Jaspers, E; Ortibus, E; Simon-Martinez, C; Desloovere, K; Molenaers, G; Klingels, K; Feys, H				Mailleux, Lisa; Jaspers, Ellen; Ortibus, Els; Simon-Martinez, Cristina; Desloovere, Kaat; Molenaers, Guy; Klingels, Katrijn; Feys, Hilde			Clinical assessment and three-dimensional movement analysis: An integrated approach for upper limb evaluation in children with unilateral cerebral palsy	PLOS ONE			English	Article							IMPAIRED FOREARM ROTATION; UPPER EXTREMITY; MOTION ANALYSIS; SCALE; MOTOR; IMPAIRMENTS; RELIABILITY; PERFORMANCE; PATTERNS; VALIDITY	Introduction The clinical application of upper limb (UL) three-dimensional movement analysis (3DMA) in children with unilateral cerebral palsy (uCP) remains challenging, despite its benefits compared to conventional clinical scales. Moreover, knowledge on UL movement pathology and how this relates to clinical parameters remains scarce. Therefore, we investigated UL kinematics across different manual ability classification system (MACS) levels and explored the relation between clinical and kinematic parameters in children with uCP. Patients and methods Fifty children (MACS: I = 15, II = 26, III = 9) underwent an UL evaluation of sensorimotor impairments (grip force, muscle strength, muscle tone, two-point discrimination, stereognosis), bimanual performance (Assisting Hand Assessment, AHA), unimanual capacity (Melbourne Assessment 2, MA2) and UL-3DMA during hand-to-head, hand-to-mouth and reach-to-grasp tasks. Global parameters (Arm Profile Score (APS), duration, (timing of) maximum velocity, trajectory straightness) and joint specific parameters (angles at task endpoint, ROM and Arm Variable Scores (AVS)) were extracted. The APS and AVS refer respectively to the total amount of movement pathology and movement deviations of wrist, elbow, shoulder, scapula and trunk. Results Longer movement durations and increased APS were found with higher MACS-levels (p< 0.001). Increased APS was also associated with more severe sensorimotor impairments r = -0.30-(-0.73)) and with lower AHA and MA2-scores (r = -0.50-(-0.86)). For the joint specific parameters, stronger movement deviations distally were significantly associated with increased muscle weakness (r = -0.32-(-0.74)) and muscle tone (r = 0.33-(-0.61)); proximal movement deviations correlated only with muscle weakness (r = -0.35 - 0.59). Regression analysis exposed grip force as the most important predictor for the variability in APS (p< 0.002). Conclusion We found increased movement pathology with increasing MACS-levels and demonstrated the adverse impact of especially muscle weakness. The lower correlations suggest that 3DMA provides additional information regarding UL motor function, particularly for the proximal joints. Integrating both methods seems clinically meaningful to obtain a comprehensive representation of all aspects of a child's UL functioning.	[Mailleux, Lisa; Jaspers, Ellen; Simon-Martinez, Cristina; Desloovere, Kaat; Klingels, Katrijn; Feys, Hilde] Univ Leuven, Dept Rehabil Sci, KU Leuven, Leuven, Belgium; [Jaspers, Ellen] ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland; [Ortibus, Els; Molenaers, Guy] Univ Leuven, Dept Dev & Regenerat, KU Leuven, Leuven, Belgium; [Desloovere, Kaat] Univ Hosp Leuven, Clin Motion Anal Lab, Leuven, Belgium; [Molenaers, Guy] Univ Hosp Leuven, Dept Orthopaed Med, Leuven, Belgium; [Klingels, Katrijn] UHasselt Hasselt Univ, Rehabil Res Ctr REVAL, BIOMED, Diepenbeek, Belgium	KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Hasselt University	Mailleux, L (corresponding author), Univ Leuven, Dept Rehabil Sci, KU Leuven, Leuven, Belgium.	lisa.mailleux@kuleuven.be	Simon-Martinez, Cristina/P-2346-2018; Ortibus, Els/GYJ-3215-2022; Desloovere, Kaat/F-3240-2014; Mailleux, Lisa/J-6248-2019	Simon-Martinez, Cristina/0000-0001-6694-6358; Desloovere, Kaat/0000-0002-8507-5276; Mailleux, Lisa/0000-0002-9955-098X; Klingels, Katrijn/0000-0001-5853-9680	Fund Scientific Research Flanders [G087213N]; Special Research Fund, KU Leuven [OT/14/127]; Marie Curie Intra-European Fellowship for Career Development [623396]	Fund Scientific Research Flanders; Special Research Fund, KU Leuven; Marie Curie Intra-European Fellowship for Career Development	This study was supported by a grant from the Fund Scientific Research Flanders (grant G087213N, http://www.fwo.be/) and from the Special Research Fund, KU Leuven (grant OT/14/127). E. Jaspers received a Marie Curie Intra-European Fellowship for Career Development (FP7-PEOPLE-2013-IEF/Proposal No.623396, http://ec.europa.eu/research/mariecurieactions/about-mca/ actions/ief/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, APPL STAT BEHAV SCI; Bar-On L, 2013, GAIT POSTURE, V38, P141, DOI 10.1016/j.gaitpost.2012.11.003; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brochard S, 2012, CLIN BIOMECH, V27, P652, DOI 10.1016/j.clinbiomech.2012.04.001; Butler EE, 2012, J BIOMECH, V45, P945, DOI 10.1016/j.jbiomech.2012.01.018; Butler EE, 2010, GAIT POSTURE, V32, P301, DOI 10.1016/j.gaitpost.2010.05.013; Butler EE, 2010, GAIT POSTURE, V32, P72, DOI 10.1016/j.gaitpost.2010.03.011; Chruscikowski E, 2017, GAIT POSTURE, V52, P107, DOI 10.1016/j.gaitpost.2016.11.031; de Bruin M, 2013, J ELECTROMYOGR KINES, V23, P516, DOI 10.1016/j.jelekin.2012.10.013; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Fitoussi F, 2011, J CHILD ORTHOP, V5, P363, DOI 10.1007/s11832-011-0365-z; Fleuren JFM, 2010, J NEUROL NEUROSUR PS, V81, P46, DOI 10.1136/jnnp.2009.177071; Hoare BJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003469.pub4; HOLM S, 1979, SCAND J STAT, V6, P65; Jaspers E, 2011, RES DEV DISABIL, V32, P2283, DOI 10.1016/j.ridd.2011.07.038; Jaspers E, 2011, GAIT POSTURE, V34, P227, DOI 10.1016/j.gaitpost.2011.05.003; Jaspers E, 2011, GAIT POSTURE, V33, P568, DOI 10.1016/j.gaitpost.2011.01.011; Jaspers E, 2009, GAIT POSTURE, V30, P395, DOI 10.1016/j.gaitpost.2009.07.110; Klingels K, 2010, DISABIL REHABIL, V32, P409, DOI 10.3109/09638280903171469; Klingels K, 2012, EUR J PAEDIATR NEURO, V16, P475, DOI 10.1016/j.ejpn.2011.12.008; Klingels K, 2012, EUR J PAEDIATR NEURO, V16, P257, DOI 10.1016/j.ejpn.2011.08.001; Klotz MCM, 2014, RES DEV DISABIL, V35, P2950, DOI 10.1016/j.ridd.2014.07.021; Kreulen M, 2007, GAIT POSTURE, V25, P485, DOI 10.1016/j.gaitpost.2006.05.015; Kreulen M, 2006, DEV MED CHILD NEUROL, V48, P436, DOI 10.1017/S0012162206000958; Krumlinde-Sundholm L, 2007, DEV MED CHILD NEUROL, V49, P259, DOI 10.1111/j.1469-8749.2007.00259.x; Mackey AH, 2006, ARCH PHYS MED REHAB, V87, P207, DOI 10.1016/j.apmr.2005.10.023; Nieuwenhuys A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152697; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Perruchoud D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00458; Randall M, 2014, DEV MED CHILD NEUROL, V56, P665, DOI 10.1111/dmcn.12391; Sakzewski L, 2014, PEDIATRICS, V133, pE175, DOI 10.1542/peds.2013-0675; SCHENAU GJV, 1989, HUM MOVEMENT SCI, V8, P301; van Bolhuis BM, 1998, J PHYSIOL-LONDON, V508, P313, DOI 10.1111/j.1469-7793.1998.313br.x; Wagner LV, 2016, DEV MED CHILD NEUROL, V58, P612, DOI 10.1111/dmcn.12949; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	35	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180196	10.1371/journal.pone.0180196	http://dx.doi.org/10.1371/journal.pone.0180196			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671953	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500025
J	von Mollendorf, C; Tempia, S; von Gottberg, A; Meiring, S; Quan, V; Feldman, C; Cloete, J; Madhi, SA; O'Brien, KL; Klugman, KP; Whitney, CG; Cohen, C				von Mollendorf, Claire; Tempia, Stefano; von Gottberg, Anne; Meiring, Susan; Quan, Vanessa; Feldman, Charles; Cloete, Jeane; Madhi, Shabir A.; O'Brien, Katherine L.; Klugman, Keith P.; Whitney, Cynthia G.; Cohen, Cheryl			Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa	PLOS ONE			English	Article							EPIDEMIOLOGY; SURVEILLANCE; BACTEREMIA; INFECTION; PNEUMONIA; BURDEN; ADULTS; KENYA; AREA	Introduction Streptococcus pneumoniae is a leading cause of severe bacterial infections globally. A full understanding of the impact of pneumococcal conjugate vaccine (PCV) on pneumococcal disease burden, following its introduction in 2009 in South Africa, can support national policy on PCV use and assist with policy decisions elsewhere. Methods We developed a model to estimate the national burden of severe pneumococcal disease, i. e. disease requiring hospitalisation, pre-(2005-2008) and post-PCV introduction (2012-2013) in children aged 0-59 months in South Africa. We estimated case numbers for invasive pneumococcal disease using data from the national laboratory-based surveillance, adjusted for specimen-taking practices. We estimated non-bacteraemic pneumococcal pneumonia case numbers using vaccine probe study data. To estimate pneumococcal deaths, we applied observed case fatality ratios to estimated case numbers. Estimates were stratified by HIV status to account for the impact of PCV and HIV-related interventions. We assessed how different assumptions affected estimates using a sensitivity analysis. Bootstrapping created confidence intervals. Results In the pre-vaccine era, a total of approximately 107,600 (95% confidence interval [CI] 83,000-140,000) cases of severe hospitalised pneumococcal disease were estimated to have occurred annually. Following PCV introduction and the improvement in HIV interventions, 41,800 (95% CI 28,000-50,000) severe pneumococcal disease cases were estimated in 2012-2013, a rate reduction of 1,277 cases per 100,000 child-years. Approximately 5000 (95% CI 3000-6000) pneumococcal-related annual deaths were estimated in the prevaccine period and 1,900 (95% CI 1000-2500) in 2012-2013, a mortality rate difference of 61 per 100,000 child-years. Conclusions While a large number of hospitalisations and deaths due to pneumococcal disease still occur among children 0-59 months in South Africa, we found a large reduction in this estimate that is temporally associated with PCV introduction. In HIV-infected individuals the scale-up of other interventions, such as improvements in HIV care, may have also contributed to the declines in pneumococcal burden.	[von Mollendorf, Claire; von Gottberg, Anne; Madhi, Shabir A.; Cohen, Cheryl] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [von Mollendorf, Claire; Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Program, Pretoria, South Africa; [von Gottberg, Anne] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Meiring, Susan; Quan, Vanessa] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Feldman, Charles] Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Johannesburg, South Africa; [Feldman, Charles] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Cloete, Jeane] Univ Pretoria, Steve Biko Acad Hosp, Dept Paediat & Child Hlth, Pretoria, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD USA; [Klugman, Keith P.] Emory Univ, Hubert Sch Publ Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Bill & Melinda Gates Fdn, Seattle, WA USA	National Institute for Communicable Diseases (NICD); University of Witwatersrand; Centers for Disease Control & Prevention - USA; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Pretoria; University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University; Bill & Melinda Gates Foundation	von Mollendorf, C (corresponding author), Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa.; von Mollendorf, C (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.	clairevonmollendorf@yahoo.com.au	Meiring, Susan/M-1463-2019; Feldman, Charles/ABF-3315-2020	Meiring, Susan/0000-0003-4508-5469; Feldman, Charles/0000-0002-6881-8314; O'Brien, Katherine/0000-0002-0164-4030; von Gottberg, Anne/0000-0002-0243-7455; Cohen, Cheryl/0000-0003-0376-2302; Cloete, Jeane/0000-0001-6548-2475	National Institute for Communicable Diseases/National Health Laboratory Service (NICD/NHLS), South Africa; Centers for Disease Control and Prevention (CDC) Global AIDS Program (GAP) [U62/PSO022901]	National Institute for Communicable Diseases/National Health Laboratory Service (NICD/NHLS), South Africa; Centers for Disease Control and Prevention (CDC) Global AIDS Program (GAP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Development of this publication was partially funded by the National Institute for Communicable Diseases/National Health Laboratory Service (NICD/NHLS), South Africa and the Centers for Disease Control and Prevention (CDC) Global AIDS Program (GAP) Cooperative Agreement (U62/PSO022901). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or NICD/NHLS.	[Anonymous], 2008, HIB PNEUMOCOCCAL DEA; Ayieko P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067324; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cohen C, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3272; Collins S, 2016, 10 INT S PNEUM PNEUM; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Huang SS, 2011, VACCINE, V29, P3398, DOI 10.1016/j.vaccine.2011.02.088; Huebner RE, 1999, S AFR MED J, V89, P924; Izadnegahdar R, 2013, LANCET RESP MED, V1, P574, DOI 10.1016/S2213-2600(13)70075-4; Johnson LF, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30314; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Mackenzie GA, 2016, LANCET INFECT DIS, V16, P703, DOI 10.1016/S1473-3099(16)00054-2; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Madhi SA, 2015, THORAX, V70, P1149, DOI 10.1136/thoraxjnl-2014-206593; Meiring S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149104; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; Statistics South Africa, 2011, 030005 STAT S AFR; Statistics South Africa, 2013, MORT CAUS DEATH S AF; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; von Gottberg A, 2013, VACCINE, V31, P4200, DOI 10.1016/j.vaccine.2013.04.077; von Mollendorf C, 2015, CLIN INFECT DIS, V60, P1346, DOI 10.1093/cid/civ059; Wahl B, 2016, 10 INT S PNEUM PNEUM; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6	27	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179905	10.1371/journal.pone.0179905	http://dx.doi.org/10.1371/journal.pone.0179905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671978	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500008
J	Inskip, JA; Ravensbergen, HJC; Sahota, IS; Zawadzki, C; McPhail, LT; Borisoff, JF; Claydon, VE				Inskip, Jessica A.; Ravensbergen, Henrike (Rianne) J. C.; Sahota, Inderjeet S.; Zawadzki, Christine; McPhail, Lowell T.; Borisoff, Jaimie F.; Claydon, Victoria E.			Dynamic wheelchair seating positions impact cardiovascular function after spinal cord injury	PLOS ONE			English	Article							CEREBRAL-ARTERY DIAMETER; ORTHOSTATIC HYPOTENSION; AUTONOMIC CONTROL; PREVALENCE; PRESSURE; HUMANS; PEOPLE; HYPERCAPNIA; SPASTICITY; RESPONSES	Background Innovative wheelchairs allow individuals to change position easily for comfort and social situations. While these wheelchairs are beneficial in multiple ways, the effects of position changes on blood pressure might exacerbate hypotension and cerebral hypoperfusion, particularly in those with spinal cord injury (SCI) who can have injury to autonomic nerves that regulate cardiovascular control. Conversely, cardiovascular benefits may be obtained with lowered seating. Here we investigate the effect of moderate changes in wheelchair position on orthostatic cardiovascular and cerebrovascular reflex control. Methods Nineteen individuals with SCI and ten neurologically-intact controls were tested in supine and seated positions (neutral, lowered, and elevated) in the Elevation (TM) wheelchair. Participants with SCI were stratified into two groups by the severity of injury to cardiovascular autonomic pathways. Beat-to-beat blood pressure, heart rate and middle cerebral artery blood flow velocity (MCAv) were recorded non-invasively. Results Supine blood pressure and MCAv were reduced in individuals with lesions to autonomic pathways, and declined further with standard seating compared to those with preserved autonomic control. Movement to the elevated position triggered pronounced blood pressure and MCAv falls in those with autonomic lesions, with minimum values significantly reduced compared to the seated and lowered positions. The cumulative duration spent below supine blood pressure was greatest in this group. Lowered seating bolstered blood pressure in those with lesions to autonomic pathways. Conclusions Integrity of the autonomic nervous system is an important variable that affects cardiovascular responses to orthostatic stress and should be considered when individuals with SCI or autonomic dysfunction are selecting wheelchairs.	[Inskip, Jessica A.; Ravensbergen, Henrike (Rianne) J. C.; Sahota, Inderjeet S.; Zawadzki, Christine; Claydon, Victoria E.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Inskip, Jessica A.; Ravensbergen, Henrike (Rianne) J. C.; Sahota, Inderjeet S.; McPhail, Lowell T.; Borisoff, Jaimie F.; Claydon, Victoria E.] Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Borisoff, Jaimie F.] BCIT, Burnaby, BC, Canada	Simon Fraser University; University of British Columbia; British Columbia Institute of Technology	Claydon, VE (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.; Claydon, VE (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada.	victoria_claydon@sfu.ca		Claydon, Victoria/0000-0002-2720-8042	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada New Investigator Award	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada New Investigator Award	This work was supported in part by the Heart and Stroke Foundation of British Columbia and the Yukon (V.E.C). J.A.I. was supported by a doctoral research award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Evan Hutcheon, Jessica Camp, and Charlotte Mah for their assistance with testing and data processing. Research in our laboratory is supported in part by the Heart and Stroke Foundation of British Columbia and the Yukon (V.E.C). V.E.C. holds a Heart and Stroke Foundation of Canada New Investigator Award. J.A.I. was supported by a doctoral research award from the Canadian Institutes of Health Research. J.F.B. is the Canada Research Chair in Rehabilitation Engineering Design.	[Anonymous], 1996, CLIN AUTON RES, V6, P125; Anton HA, 2008, ARCH PHYS MED REHAB, V89, P538, DOI 10.1016/j.apmr.2007.11.009; Borisoff J, 2011, DEV ULTRALIGHT WHEEL; Chaudhuri K R, 1991, Clin Auton Res, V1, P37, DOI 10.1007/BF01826056; Chelvarajah R, 2009, NEUROREHABILITATION, V24, P237, DOI 10.3233/NRE-2009-0474; Chow JW, 2009, ARCH PHYS MED REHAB, V90, P271, DOI 10.1016/j.apmr.2008.07.019; Claydon VE, 2008, AM J PHYSIOL-HEART C, V294, pH668, DOI 10.1152/ajpheart.00869.2007; Claydon VE, 2006, J NEUROTRAUM, V23, P1713, DOI 10.1089/neu.2006.23.1713; Cobb John, 2014, Top Spinal Cord Inj Rehabil, V20, P277, DOI 10.1310/sci2004-277; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Cragg JJ, 2013, NEUROLOGY, V81, P723, DOI 10.1212/WNL.0b013e3182a1aa68; Crane BA, 2007, AM J PHYS MED REHAB, V86, P988, DOI [10.1097/PHM.0b013e3181583ed9, 10.1097/PHM.Ob013e3181583ed9]; Del-Ama AJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00298; Dhindsa MS, 2011, J SPINAL CORD MED, V34, P594, DOI 10.1179/2045772311Y.0000000040; Dudley-Javoroski S., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P227; Eser P, 2005, OSTEOPOROSIS INT, V16, P26, DOI 10.1007/s00198-004-1638-x; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Gibbons CH, 2006, NEUROLOGY, V67, P28, DOI 10.1212/01.wnl.0000223828.28215.0b; GOEMAERE S, 1994, OSTEOPOROSIS INT, V4, P138, DOI 10.1007/BF01623058; Goktepe AS, 2008, J SPINAL CORD MED, V31, P197, DOI 10.1080/10790268.2008.11760712; Harkema SJ, 2008, J NEUROTRAUM, V25, P1467, DOI 10.1089/neu.2008.0572; Harms MPM, 1999, CLIN SCI, V97, P291, DOI 10.1042/CS19990061; Hilz MJ, 2012, ACTA NEUROL SCAND, V126, P162, DOI 10.1111/j.1600-0404.2012.01670.x; HOBSON DA, 1992, J REHABIL RES DEV, V29, P21, DOI 10.1682/JRRD.1992.10.0021; Hopman MTE, 1998, SCAND J REHABIL MED, V30, P167; HUANG CT, 1983, ARCH PHYS MED REHAB, V64, P101; Illman A, 2000, SPINAL CORD, V38, P741, DOI 10.1038/sj.sc.3101089; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P1; Kilinc S, 1999, SPINAL CORD, V37, P332, DOI 10.1038/sj.sc.3100814; KUNKEL CF, 1993, ARCH PHYS MED REHAB, V74, P73; Lee AKY, 2010, SPINAL CORD, V48, P429, DOI 10.1038/sc.2009.145; MATHIAS CJ, 1975, CLIN SCI MOL MED, V49, P291, DOI 10.1042/cs0490291; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Minkel JL, 2000, PHYS THER, V80, P701, DOI 10.1093/ptj/80.7.701; Ng WF, 2012, QJM-INT J MED, V105, P1191, DOI 10.1093/qjmed/hcs172; Olive JL, 2003, MED SCI SPORT EXER, V35, P901, DOI 10.1249/01.MSS.0000069755.40046.96; Pang CCY, 2001, PHARMACOL THERAPEUT, V90, P179, DOI 10.1016/S0163-7258(01)00138-3; Ravensbergen HJC, 2012, CLIN AUTON RES, V22, P265, DOI 10.1007/s10286-012-0166-6; Ravensbergen HJC, 2014, NEUROREHAB NEURAL RE, V28, P219, DOI 10.1177/1545968313504542; Reenalda J, 2010, SPINAL CORD, V48, P336, DOI 10.1038/sc.2009.138; Sahota IS, 2012, J NEUROTRAUM, V29, P2446, DOI 10.1089/neu.2012.2379; Sankari A, 2014, J CLIN SLEEP MED, V10, P65, DOI 10.5664/jcsm.3362; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Sidorov E, 2008, SPINAL CORD, V46, P65, DOI 10.1038/sj.sc.3102064; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sprigle S, 2003, J SPINAL CORD MED, V26, P236, DOI 10.1080/10790268.2003.11753690; Stenberg G, 2014, DISABILITY REHABILIT, P1; Sutcliffe K, 2010, EUR J CLIN INVEST, V40, P18, DOI 10.1111/j.1365-2362.2009.02225.x; U.S. Food and Drug Administration, 2014, FDA ALL MARK 1 WEAR; VanLieshout JJ, 1997, PACE, V20, P753, DOI 10.1111/j.1540-8159.1997.tb03901.x; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Wadsworth BM, 2009, SPINAL CORD, V47, P274, DOI 10.1038/sc.2008.126; Wecht JM, 2013, J SPINAL CORD MED, V36, P454, DOI 10.1179/2045772313Y.0000000109; Wecht JM, 2013, J SPINAL CORD MED, V36, P74, DOI 10.1179/2045772312Y.0000000056; Wecht JM, 2012, CLIN AUTON RES, V22, P25, DOI 10.1007/s10286-011-0139-1; Wecht JM, 2004, J REHABIL RES DEV, V41, P89, DOI 10.1682/JRRD.2004.01.0089; West CR, 2012, RESP PHYSIOL NEUROBI, V180, P275, DOI 10.1016/j.resp.2011.12.003; World Medical Association, 2008, DECL HELS ETH PRINC	58	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180195	10.1371/journal.pone.0180195	http://dx.doi.org/10.1371/journal.pone.0180195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666000	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608700070
J	Lamperska, KM; Kolenda, T; Teresiak, A; Kowalik, A; Kruszyna-Mochalska, M; Jackowiak, W; Blizniak, R; Przybyla, W; Kapalczynska, M; Kozlowski, P				Lamperska, Katarzyna Monika; Kolenda, Tomasz; Teresiak, Anna; Kowalik, Anna; Kruszyna-Mochalska, Marta; Jackowiak, Weronika; Blizniak, Renata; Przybyla, Weronika; Kapalczynska, Marta; Kozlowski, Piotr			Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER-CELLS; BIOGENESIS; RADIOSENSITIVITY; PROGRESSION; MIRNA; HEAD	The implication of the let-7 family in cancer development is multifaceted. The family acts as tumor suppressor miRNA although overexpression of let-7 has also been described in many types of cancer, including head and neck squamous cell carcinoma (HNSCC). The aim of this study includes whether different expression levels of let-7d has an influence on chemo and radiosensitivity. FaDu cell line models with a gradually increased level of let-7d (models from A to E) were generated with the lentiviral system. Expression levels of pluripotency, chemo-radioresistance/apoptosis, and targets of mRNAs were analyzed by real-time reverse transcription-PCR (qRT-PCR). Radiosensitivity was analyzed using a clonogenic assay after irradiation. Response to cisplatin, 5-FU, doxorubicin, and paclitaxel was done with MTT assay. Statistically significant decrease of K-RAS (p = 0.0369) and CASPASE3 (p = 0.0342) were observed with the growing expression level of let-7d. Cisplatin, 5-FU and doxorubicin caused similar decreased of cell survival with the increase of let-7d level (p = 0.004, post-trend p = 0.046; p = 0.004, post trend p = 0.0005 and p<0.0001, post trend p = 0.0001, respectively). All models were resistant to paclitaxel, irrespective of let-7d expression levels. Only two of the generated models (A and C) were radiosensitive (p = 0.0002). Conclusion: the above results indicated that the level of let-7d expression is an important factor for cell response to irradiation and chemotherapeutics.	[Lamperska, Katarzyna Monika; Kolenda, Tomasz; Teresiak, Anna; Blizniak, Renata] Greater Poland Canc Ctr, Canc Genet Lab, Poznan, Poland; [Kolenda, Tomasz] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Kowalik, Anna; Kruszyna-Mochalska, Marta; Jackowiak, Weronika] Greater Poland Canc Ctr, Dept Med Phys, Poznan, Poland; [Przybyla, Weronika] Oslo Univ Hosp, Rikshosp, Div Pediat & Adolescent Med, Pediat Res, Oslo, Norway; [Kapalczynska, Marta] Charite Univ Med Berlin, Max Planck Inst Infect Biol, Dept Gastroenterol & Hepatol, Berlin, Germany; [Kozlowski, Piotr] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Wielkopolskie Centrum Onkologii; Medical University of Warsaw; Wielkopolskie Centrum Onkologii; University of Oslo; National Hospital Norway; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Lamperska, KM (corresponding author), Greater Poland Canc Ctr, Canc Genet Lab, Poznan, Poland.	kasialam@o2.pl	Kozlowski, Piotr/I-1860-2019; Kolenda, Tomasz/AAA-3321-2022	Kozlowski, Piotr/0000-0003-3770-7715; Teresiak, Anna/0000-0002-5327-6698; Kruszyna-Mochalska, Marta/0000-0003-2216-3129; Kolenda, Tomasz/0000-0001-5623-7398; Lamperska, Katarzyna/0000-0001-7583-207X	National Science Centre [2016/22/A/NZ2/00184, 2016/22A/NZ2/00184]; grant Greater Poland Cancer Center [12/2011(16/08/2011PGN/WCO/0003)]; Greater Cancer Center [12/2011(16/08/2011/PGN/WCO/0003)]	National Science Centre(National Science Centre, Poland); grant Greater Poland Cancer Center; Greater Cancer Center	Statistical analysis and manuscript preparing were supported by a grant from the National Science Centre 2016/22/A/NZ2/00184, and grant Greater Poland Cancer Center 12/2011(16/08/2011PGN/WCO/0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant: National Science Centre 2016/22A/NZ2/00184, Greater Cancer Center No 12/2011(16/08/2011/PGN/WCO/0003). The language correctness was checked by American Manuscript Editors.	Arora H, 2011, EXP MOL MED, V43, P298, DOI 10.3858/emm.2011.43.5.031; Barh D., 2008, CANC THERAPY, V6, P969; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang CJ, 2011, ONCOL REP, V26, P1003, DOI 10.3892/or.2011.1360; Chen DL, 2010, J CELL PHYSIOL, V225, P296, DOI 10.1002/jcp.22234; De Leeneer K, 2015, ADV EXP MED BIOL, V867, P263, DOI 10.1007/978-94-017-7215-0_16; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gowrishankar B, 2014, CANCER BIOL THER, V15, P329, DOI 10.4161/cbt.27314; Havens MA, 2012, NUCLEIC ACIDS RES, V40, P4626, DOI 10.1093/nar/gks026; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hertel J, 2012, RNA BIOL, V9, P231, DOI 10.4161/rna.18974; Huleihel L, 2014, AM J PHYSIOL-LUNG C, V306, pL534, DOI 10.1152/ajplung.00149.2013; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kinose Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249393; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kolenda T, 2014, WSPOLCZESNA ONKOL, V18, P293, DOI 10.5114/wo.2014.44467; Lamperska KM, 2016, CANCER BIOMARK, V16, P55, DOI 10.3233/CBM-150540; Liu N, 2015, ONCOTARGET, V6, P34649, DOI 10.18632/oncotarget.5299; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mu GY, 2010, HUM PATHOL, V41, P493, DOI 10.1016/j.humpath.2009.08.022; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Pan L, 2011, MOL CELL BIOCHEM, V355, P257, DOI 10.1007/s11010-011-0862-x; Park SJ, 2016, ONCOGENE, V35, P1292, DOI 10.1038/onc.2015.187; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Pasquinelli AE, 2013, BIOCHEM SOC T, V41, P821, DOI 10.1042/BST20130020; Patel K, 2014, CANCER LETT, V347, P54, DOI 10.1016/j.canlet.2014.01.020; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Tu HF, 2013, CURR OPIN OTOLARYNGO, V21, P104, DOI 10.1097/MOO.0b013e32835e1d6e; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wu LW, 2015, ELIFE, V4, DOI 10.7554/eLife.09431; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yu ML, 2011, CIRC J, V75, P703, DOI 10.1253/circj.CJ-10-0393; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhou C, 2012, INT C INTEL HUM MACH, P59, DOI 10.1109/IHMSC.2012.110	49	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180265	10.1371/journal.pone.0180265	http://dx.doi.org/10.1371/journal.pone.0180265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665983	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700079
J	Yen, CH; Wang, KT; Lee, PY; Liu, CC; Hsieh, YC; Kuo, JY; Bulwer, BE; Hung, CL; Chang, SC; Shih, SC; Hu, KC; Yeh, HI; Lam, CSP				Yen, Chih-Hsuan; Wang, Kuang-Te; Lee, Ping-Ying; Liu, Chuan-Chuan; Hsieh, Ya-Ching; Kuo, Jen-Yuan; Bulwer, Bernard E.; Hung, Chung-Lieh; Chang, Shun-Chuan; Shih, Shou-Chuan; Hu, Kuang-Chun; Yeh, Hung-I; Lam, Carolyn S. P.			Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians	PLOS ONE			English	Article							MUSCLE-FIBER TYPE; SKELETAL-MUSCLE; METABOLISM; OBESE; RISK; PHOSPHOKINASE; HYPERTENSION; POPULATION; ESTROGEN; RAT	Background Creatine kinase (CK) is a pivotal regulatory enzyme in energy metabolism linked to both blood pressure and cardio-metabolic components. However, data is lacking in a large population of asymptomatic Asians. Methods and results Cardio-metabolic assessment including anthropometric measures and non-alcoholic fatty liver disease (NAFLD) were evaluated by abdominal echo in 4,562 consecutive subjects who underwent an annual health survey. Serum CK levels were related to blood pressure components [systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP)], anthropometric measures, and excessive adiposity in liver as indicated by NAFLD. Circulating CK levels ranged from 4 to 1842 IU/L (mean [SE]: 108.7 [1.1] IU/L) in the study population which consisted of 2522 males (mean age: 48.7 +/- 11.2) and 2040 females (mean age: 49.4 +/- 11.5). In general, male subjects presented with higher circulating CK levels than females (mean +/- SE: 127.3 +/- 1.5 vs. 85.5 +/- 1.3 IU/L, respectively, p<.001). Gender-differences in circulating CK levels were also observed with increasing age, which showed a more pronounced positive relationship with age in female subjects (gender interaction: p<.05). Furthermore, an elevated circulating CK level was independently associated with higher blood pressure, waist circumference and fat mass (FM), greater body mass index (BMI), increased lower estimated glomerular filtration rate (eGFR) and presence of NAFLD in multivariate analysis (all p<.05), with CK elevation more pronounced with greater BMI and FM in males compared with females (sex interaction: p<.05). Conclusion In a large asymptomatic Asian population, circulating CK levels were increased with more advanced age, higher blood pressure, and greater body mass with gender differences. Our findings may be useful in interpreting elevated CK from subjects free of ongoing myocardial damage.	[Yen, Chih-Hsuan; Lee, Ping-Ying; Kuo, Jen-Yuan; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Yen, Chih-Hsuan; Lee, Ping-Ying; Kuo, Jen-Yuan; Hung, Chung-Lieh] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Yen, Chih-Hsuan; Lee, Ping-Ying; Kuo, Jen-Yuan; Hung, Chung-Lieh] Taipei Med Univ, Taipei, Taiwan; [Wang, Kuang-Te] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taitung Branch, Taipei, Taiwan; [Lee, Ping-Ying; Liu, Chuan-Chuan; Kuo, Jen-Yuan; Hung, Chung-Lieh; Chang, Shun-Chuan; Yeh, Hung-I] Mackay Med Coll, New Taipei, New Taipei Coun, Taiwan; [Liu, Chuan-Chuan] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Hlth Care Org Adm, Taipei, Taiwan; [Liu, Chuan-Chuan] Mackay Mem Hosp, Hlth Evaluat Ctr, Taipei, Taiwan; [Liu, Chuan-Chuan] Yuanpei Univ Sci & Technol, Dept Med Technol, Hsinchu, Taiwan; [Hsieh, Ya-Ching] Peking Univ, Hosp 1, Dept Anesthesiol, Beijing, Peoples R China; [Bulwer, Bernard E.] Brigham & Womens Hosp, Nonivas Cardiol, 75 Francis St, Boston, MA 02115 USA; [Bulwer, Bernard E.] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA; [Shih, Shou-Chuan; Hu, Kuang-Chun] MacKay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Lam, Carolyn S. P.] Natl Heart Ctr Singapore, Singapore, Singapore; [Lam, Carolyn S. P.] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Taipei Medical University; Mackay Memorial Hospital; Mackay Medical College; National Taiwan University; Mackay Memorial Hospital; Peking University; Harvard University; Brigham & Women's Hospital; Mackay Memorial Hospital; National Heart Centre Singapore; National University of Singapore	Hung, CL (corresponding author), Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Med Nursing & Management Coll, Taipei, Taiwan.; Hung, CL (corresponding author), Taipei Med Univ, Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Med Coll, New Taipei, New Taipei Coun, Taiwan.	jotaro3791@gmail.com	Lam, Carolyn SP/ABD-6810-2021; Hu, Kuang-Chun/L-9095-2019; Kuo, Jen-Yuan/AAX-5448-2021	Lam, Carolyn SP/0000-0003-1903-0018; Hsieh, Ya-Ching/0000-0001-9823-9957				Brewster LM, 2006, CIRCULATION, V114, P2034, DOI 10.1161/CIRCULATIONAHA.105.584490; Brewster LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032471; Brewster LM, 2000, J HYPERTENS, V18, P1537, DOI 10.1097/00004872-200018110-00002; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; CLARK JF, 1994, MOL CELL BIOCHEM, V133, P221, DOI 10.1007/BF01267956; CLARK JF, 1994, BIOCHEM J, V300, P211, DOI 10.1042/bj3000211; CLARKSON PM, 1982, INT J SPORTS MED, V3, P145, DOI 10.1055/s-2008-1026078; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; De Sousa E, 2000, CIRCULATION, V102, P1847; Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; GARCIA W, 1974, JAMA-J AM MED ASSOC, V228, P1395, DOI 10.1001/jama.228.11.1395; Gogia S, 2006, LIVER INT, V26, P899, DOI 10.1111/j.1478-3231.2006.01299.x; Grobe YG, 2010, ANN HEPATOL, V9, P402, DOI 10.1016/S1665-2681(19)31616-3; HADJIISKY P, 1991, CELL MOL BIOL, V37, P531; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Hittel DS, 2005, DIABETES, V54, P1283, DOI 10.2337/diabetes.54.5.1283; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Johnsen SH, 2011, J HYPERTENS, V29, P36, DOI 10.1097/HJH.0b013e32834068e0; KOTANI K, 1994, INT J OBESITY, V18, P207; LINDENA J, 1986, J CLIN CHEM CLIN BIO, V24, P61; Neal RC, 2009, AM J MED, V122, P73, DOI 10.1016/j.amjmed.2008.08.033; Omagari K, 2002, J GASTROEN HEPATOL, V17, P1098, DOI 10.1046/j.1440-1746.2002.02846.x; Pandke KE, 2008, AM J PHYSIOL-REG I, V295, pR806, DOI 10.1152/ajpregu.90540.2008; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Ramamani A, 1999, ACTA PHYSIOL SCAND, V166, P91; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Siegelman ES, 2001, SEMIN LIVER DIS, V21, P71, DOI 10.1055/s-2001-12930; Somjen D, 1998, HYPERTENSION, V32, P39, DOI 10.1161/01.HYP.32.1.39; Sun G, 2002, METABOLISM, V51, P451, DOI 10.1053/meta.2002.31324; Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001; WADE AJ, 1990, LANCET, V335, P805, DOI 10.1016/0140-6736(90)90933-V; Wallimann T, 1998, BIOFACTORS, V8, P229, DOI 10.1002/biof.5520080310; WONG ET, 1983, AM J CLIN PATHOL, V79, P582, DOI 10.1093/ajcp/79.5.582	37	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179898	10.1371/journal.pone.0179898	http://dx.doi.org/10.1371/journal.pone.0179898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665956	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700045
J	de Oliveira, HF; Bollela, VR; Anselmo-Lima, WT; Costa, CAPD; Nakanishi, M				de Oliveira, Henrique Fernandes; Bollela, Valdes Roberto; Anselmo-Lima, Wilma Terezinha; Pires de Oliveira Costa, Carlos Augusto; Nakanishi, Marcio			A feasible, low-cost, reproducible lamb's head model for endoscopic sinus surgery training	PLOS ONE			English	Article							CONSTRUCT-VALIDITY; ANIMAL-MODEL; OVINE MODEL; SIMULATOR; RESIDENTS	Objective To describe and standardize a reproducible, viable, low-cost lamb's head model for endoscopic sinus surgery training. Methods Otorhinolaryngology residents performed the following three endoscopic sinus surgeries using the lamb's head model: inferior turbinectomy, bullectomy, and maxillary antrostomy. Each student dissected 10 specimens before training these procedures on human patients, and the benefit of the animal model training was evaluated. Results Nineteen resident physicians of comparable academic level participated in training. All participants agreed that the lamb's head model dissections improved their skills in using surgical and videoendoscopic instruments, 90% agreed that the dissections improved their confidence with respect to training in human patients, and all stated they would recommend the same training to future residents. Discussion Lamb's heads have been used for training in endoscopic sinus surgery. However, no standardization of this training had been performed to ensure that it is a valuable tool for learning and skill-building. The standardized method described in this study increased resident physicians' skills and confidence before beginning their training on human patients. Moreover, our results demonstrate the feasibility of the model, considering its low cost and reproducibility.	[de Oliveira, Henrique Fernandes; Nakanishi, Marcio] Univ Brasilia UnB, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Brasilia, DF, Brazil; [Bollela, Valdes Roberto] Univ Sao Paulo, Ribeirao Preto Sch Med FMRP, Dept Infect & Trop Dis, Ribeirao Preto, Brazil; [Bollela, Valdes Roberto] Fdn Adv Med Educ & Res FAIMER, Philadelphia, PA USA; [Anselmo-Lima, Wilma Terezinha] Univ Sao Paulo, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, FMRP, Ribeirao Preto, Brazil; [Pires de Oliveira Costa, Carlos Augusto] Univ Brasilia, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Brasilia	de Oliveira, HF (corresponding author), Univ Brasilia UnB, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Brasilia, DF, Brazil.	hfdoliveira@yahoo.com.br		de Oliveira, Henrique/0000-0001-7889-6730				Arora H, 2005, ARCH OTOLARYNGOL, V131, P217, DOI 10.1001/archotol.131.3.217; Awad Z, 2012, OTOLARYNG HEAD NECK, V147, pP119; Awad Z, 2015, LARYNGOSCOPE, V125, P539, DOI 10.1002/lary.24927; Briner HR, 2007, RHINOLOGY, V45, P20; Delgado-Vargas B, 2016, EUR ARCH OTO-RHINO-L, V273, P2085, DOI 10.1007/s00405-015-3877-1; Fried MP, 2010, OTOLARYNG HEAD NECK, V142, P202, DOI 10.1016/j.otohns.2009.11.023; Gardiner Q, 1996, J LARYNGOL OTOL, V110, P425, DOI 10.1017/S0022215100133882; Hosemann W, 2013, GMS Curr Top Otorhinolaryngol Head Neck Surg, V12, pDoc06, DOI 10.3205/cto000098; KINSELLA JB, 1995, LARYNGOSCOPE, V105, P1029, DOI 10.1288/00005537-199510000-00003; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Mladina R, 2011, J LARYNGOL OTOL, V125, P696, DOI 10.1017/S0022215111000776; Mladina R., 2014, ENDOSCOPIC SURG ANAT; Mladina R, 2013, ORL J OTO-RHINO-LARY, V75, P32, DOI 10.1159/000347080; Mladina R, 2013, AM J RHINOL ALLERGY, V27, P251, DOI 10.2500/ajra.2013.27.3886; Nogueira JF, 2008, OTOLARYNG HEAD NECK, V139, P727, DOI 10.1016/j.otohns.2008.07.017; Touska P, 2013, LARYNGOSCOPE, V123, P1598, DOI 10.1002/lary.23974; World Health Organization, 2009, WHO PAT SAF CURR GUI; Zuckerman JD, 2009, AM J RHINOL ALLERGY, V23, P218, DOI 10.2500/ajra.2009.23.3297	18	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180273	10.1371/journal.pone.0180273	http://dx.doi.org/10.1371/journal.pone.0180273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662196	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300135
J	Ge, Y; Hu, KD; Wang, SS; Hu, LY; Chen, XY; Li, YH; Yang, Y; Yang, F; Zhang, H				Ge, Yun; Hu, Kang-Di; Wang, Sha-Sha; Hu, Lan-Ying; Chen, Xiao-Yan; Li, Yan-Hong; Yang, Ying; Yang, Feng; Zhang, Hua			Hydrogen sulfide alleviates postharvest ripening and senescence of banana by antagonizing the effect of ethylene	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; ABSCISIC-ACID; FRUIT; OXYGEN; BIOSYNTHESIS; ARABIDOPSIS; METABOLISM; PLANTS	Accumulating evidence shows that hydrogen sulfide (H2S) acts as a multifunctional signaling molecule in plants, whereas the interaction between H2S and ethylene is still unclear. In the present study we investigated the role of H2S in ethylene-promoted banana ripening and senescence by the application of ethylene released from 1.0 g-L-1 ethephon solution or H2S with 1 mM sodium hydrosulfide (NaHS) as the donor or in combination. Fumigation with ethylene was found to accelerate banana ripening and H2S treatment effectively alleviated ethylene-induced banana peel yellowing and fruit softening in parallel with decreased activity of polygalacturonase (PG). Ethylene+H2S treatment also delayed the decreases in chlorophyll and total phenolics, and increased the accumulation of flavonoid, whereas decreased the contents of carotenoid, soluble protein in banana peel and reducing sugar in pulp compared with ethylene treatment alone. Besides, ethylene+H2S treatment suppressed the accumulation of superoxide radicals (-O-2(-)), hydrogen peroxide (H2O2) and malondialdehyde (MDA) which accumulated highly in ethylene-treated banana peels. Furthermore H2S enhanced total antioxidant capacity in ethylene-treated banana peels with the 2,2'-azobis(3-ethylbenzthiazoline-6-sulfonic acid (ABTS) assay. The result of quantitative real-time PCR showed that the combined treatment of ethylene with H2S down-regulated the expression of ethylene synthesis genes MaACS1, MaACS2 and MaACO1 and pectate lyase MaPL compared with ethylene treatment, while the expression of ethylene receptor genes MaETR, MaERS1 and MaERS2 was enhanced in combination treatment compared with ethylene alone. In all, it can be concluded that H2S alleviates banana fruit ripening and senescence by antagonizing the effect of ethylene through reduction of oxidative stress and inhibition of ethylene signaling pathway.	[Ge, Yun; Hu, Kang-Di; Wang, Sha-Sha; Hu, Lan-Ying; Chen, Xiao-Yan; Li, Yan-Hong; Zhang, Hua] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Peoples R China; [Yang, Ying] Anhui Jianzhu Univ, Coll Environm & Energy Engn, Hefei, Peoples R China; [Yang, Feng] Xuzhou Inst Agr Sci Xuhuai Dist Jiangsu Prov, Xuzhou, Peoples R China	Hefei University of Technology; Anhui Jianzhu University; Jiangsu Academy of Agricultural Sciences	Zhang, H (corresponding author), Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Peoples R China.	hzhanglab@hfut.edu.cn	chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022		National Natural Science Foundation of China; Anhui Provincial Science and Technology Major Project; Anhui Provincial Education Department	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Science and Technology Major Project; Anhui Provincial Education Department	The funders, National Natural Science Foundation of China, Anhui Provincial Science and Technology Major Project, and Anhui Provincial Education Department, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2012, PLANT CELL, V24, P4621, DOI 10.1105/tpc.112.105403; Alvarez C, 2012, NEW PHYTOL, V193, P165, DOI 10.1111/j.1469-8137.2011.03889.x; Ammawath W, 2001, J SCI FOOD AGR, V81, P1166, DOI 10.1002/jsfa.922; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Cheng GP, 2008, FOOD CHEM, V109, P319, DOI 10.1016/j.foodchem.2007.12.041; DOMINGUEZ M, 1993, J HORTIC SCI BIOTECH, V68, P63, DOI 10.1080/00221589.1993.11516329; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Gao SP, 2013, HORTSCIENCE, V48, P1385, DOI 10.21273/HORTSCI.48.11.1385; Garcia I, 2010, PLANT CELL, V22, P3268, DOI 10.1105/tpc.110.076828; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Girennavar B, 2006, BIOORGAN MED CHEM, V14, P2606, DOI 10.1016/j.bmc.2005.11.039; Golding JB, 1998, POSTHARVEST BIOL TEC, V14, P87, DOI 10.1016/S0925-5214(98)00032-5; GRAY J, 1992, PLANT MOL BIOL, V19, P69, DOI 10.1007/BF00015607; Gupta SM, 2006, POSTHARVEST BIOL TEC, V42, P16, DOI 10.1016/j.postharvbio.2006.05.002; Harris DR, 2000, POSTHARVEST BIOL TEC, V20, P303, DOI 10.1016/S0925-5214(00)00150-2; Hu H., 2014, J FOOD SCI TECHNOL, V49, P399; Hu LY, 2012, J AGR FOOD CHEM, V60, P8684, DOI 10.1021/jf300728h; Jakubowicz M, 2010, J EXP BOT, V61, P3475, DOI 10.1093/jxb/erq177; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jin ZP, 2013, PLANT PHYSIOL BIOCH, V62, P41, DOI 10.1016/j.plaphy.2012.10.017; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Kabil O, 2014, ANNU REV NUTR, V34, P171, DOI 10.1146/annurev-nutr-071813-105654; Li ZR, 2015, HORTSCIENCE, V50, P416, DOI 10.21273/HORTSCI.50.3.416; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; Liu XJ, 1999, PLANT PHYSIOL, V121, P1257, DOI 10.1104/pp.121.4.1257; Lohani S, 2004, POSTHARVEST BIOL TEC, V31, P119, DOI 10.1016/j.postharvbio.2003.08.001; LopezGomez R, 1997, PLANT SCI, V123, P123, DOI 10.1016/S0168-9452(97)04578-0; Menniti AM, 2004, POSTHARVEST BIOL TEC, V31, P269, DOI 10.1016/j.postharvbio.2003.09.009; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mohapatra D, 2011, FOOD BIOPROCESS TECH, V4, P327, DOI 10.1007/s11947-010-0377-6; Nath A, 2011, FOOD CHEM, V127, P1510, DOI 10.1016/j.foodchem.2011.02.007; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; Pathak N, 1998, PHYTOCHEMISTRY, V48, P249, DOI 10.1016/S0031-9422(98)00005-3; PIRIE A, 1976, PLANT PHYSIOL, V58, P468, DOI 10.1104/pp.58.4.468; Prabha TN, 1998, PHYTOCHEMISTRY, V48, P915, DOI 10.1016/S0031-9422(97)00931-X; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; SEYMOUR GB, 1987, ANN APPL BIOL, V110, P153, DOI 10.1111/j.1744-7348.1987.tb03242.x; Tian SP, 2013, PLANT MOL BIOL, V82, P593, DOI 10.1007/s11103-013-0035-2; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Wang KL, 2012, PLANT CELL, V14, pS131; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x; Zhang H, 2010, ACTA PHYSIOL PLANT, V32, P849, DOI 10.1007/s11738-010-0469-y; Zhang H, 2009, PLANT GROWTH REGUL, V58, P243, DOI 10.1007/s10725-009-9372-1	46	61	64	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180113	10.1371/journal.pone.0180113	http://dx.doi.org/10.1371/journal.pone.0180113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662156	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300104
J	Kronborg, L; Bandholm, T; Palm, H; Kehlet, H; Kristensen, T				Kronborg, Lise; Bandholm, Thomas; Palm, Henrik; Kehlet, Henrik; Kristensen, Tange			Effectiveness of acute in-hospital physiotherapy with knee-extension strength training in reducing strength deficits in patients with a hip fracture: A randomised controlled trial	PLOS ONE			English	Article							INTERTESTER RELIABILITY; BASIC MOBILITY; OLDER-PEOPLE; SURGERY; PAIN; EXPERIENCES; MORTALITY; DISCHARGE; EXERCISE; EFFICACY	Question Is acute in-hospital physiotherapy with additional progressive knee-extension strength training (ST) of the fractured limb more effective in reducing knee-extension strength deficit at follow-up compared to physiotherapy without strength training in patients with a hip fracture? Design Assessor blinded, randomised controlled trial with intention-to-treat analysis. Participants 90 patients with a hip fracture admitted to an acute orthopaedic Hip Fracture Unit at a university hospital between October 2013 and May 2015. Intervention Daily physiotherapy with or without progressive knee-extension strength training (10RM), 3 x 10 repetitions, of the fractured limb using ankle weight cuffs conducted by ward physical therapists during hospital stay. Outcome measures Primary outcome was the change in maximal isometric knee-extension strength in the fractured limb in percentage of the non-fractured limb from inclusion to postoperative day 10 or discharge (follow-up). Secondary outcome was Timed Up and Go test measured early after surgery and at follow-up. Results In the intention-to-treat analysis of between-group differences, the primary outcome improved 8.1% (95% CI -2.3; 18.4) by additional strength training from baseline to follow-up. In the per-protocol analysis of non-missing data, significant between-group improvements by 10.5% (95% CI 0.3; 20.7) were found in favour of additional ST. No significant between-group differences were found in any secondary outcome. Conclusion Physiotherapy with addition of 5 sessions of ST yielded no additional improvements compared to physiotherapy without strength training in reducing the knee-extension strength deficit at follow-up in patients with a hip fracture. It is debatable whether larger improvements than the observed 8-10% can be expected given that only five exercise sessions, on average, were completed. In fragile patients with a hip fracture in the acute phase, where the ability to participate in functional exercise is compromised, we still consider early strength training a possibility to improve outcomes of clinical importance, given the results of the per-protocol analysis. The present data provides an important basis and call for future investigations including longer term interventions.	[Kronborg, Lise; Bandholm, Thomas; Kristensen, Tange] Copenhagen Univ Hosp, Dept Physio & Occupat Therapy, Phys Med & Rehabil Res Copenhagen PMR C, Hvidovre, Denmark; [Bandholm, Thomas] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Bandholm, Thomas; Palm, Henrik; Kristensen, Tange] Copenhagen Univ Hosp, Dept Orthopaed Surg, Hvidovre, Denmark; [Kehlet, Henrik] Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Kronborg, L (corresponding author), Copenhagen Univ Hosp, Dept Physio & Occupat Therapy, Phys Med & Rehabil Res Copenhagen PMR C, Hvidovre, Denmark.	lisekronborg@hotmail.com	Bandholm, Thomas/AAZ-8632-2020; Kristensen, Morten/L-3527-2019	Bandholm, Thomas/0000-0001-6884-1971; Kristensen, Morten/0000-0001-5868-4677; Kehlet, Henrik/0000-0002-2209-1711	IMK Foundation; Research Foundation of the Capital Region; Foundation of Hvidovre Hospital; UCSF Lundbeck Foundation [FP15/2013]	IMK Foundation; Research Foundation of the Capital Region; Foundation of Hvidovre Hospital; UCSF Lundbeck Foundation	The study was funded by grants from The IMK Foundation (LK), The Research Foundation of the Capital Region (MTK), https:// www.regionh.dk/til-fagfolk/forskning-ogi nnovation/Finansiering/Soeg-regionens-midler/ Sider/Forskningsprojekter.aspx. The Research Foundation of the Danish Physical Therapy Organisation (LK), https://fysio.dk/fafo/fonde/ danske-fysioterapeuters-fond-for-forskningu ddannelse-og-praksisudvikling/#.VsRHSfnhAsM. The Research Foundation of Hvidovre Hospital (LK), and The UCSF Lundbeck Foundation (LK), http://www.lundbeckfoundation.com/ grant number FP15/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza-Vega P, 2015, ARCH PHYS MED REHAB, V96, P1215, DOI 10.1016/j.apmr.2015.01.023; Ariza-Vega P, 2014, DISABIL REHABIL, V36, P685, DOI 10.3109/09638288.2013.813081; Beaupre LA, 2013, BEST PRACT RES CL RH, V27, P771, DOI 10.1016/j.berh.2014.01.001; Bech RD, 2015, PAIN RES TREAT, V2015, DOI 10.1155/2015/676212; Bloch ML, 2016, J GERIATR PHYS THER; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Christensen R, 2012, INT J SPORTS PHYS TH, V7, P504; Cummings SR, 2014, JAMA-J AM MED ASSOC, V311, P2061, DOI 10.1001/jama.2014.3033; Davenport SJ, 2014, PHYSIOTHER RES INT; de Camargo OP, 2011, SAO PAULO MED J, V129, P435, DOI [10.1590/S1516-31802011000600012, 10.1002/14651858.CD001704.pub4]; Diong J, 2015, BR J SPORTS MED; Egan M, 2008, CLIN REHABIL, V22, P272, DOI 10.1177/0269215507081573; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foss NB, 2009, BRIT J ANAESTH, V102, P111, DOI 10.1093/bja/aen345; Foss NB, 2005, ANESTHESIOLOGY, V102, P1197, DOI 10.1097/00000542-200506000-00020; Graham JE, 2010, PHYS THER, V90, P1591, DOI 10.2522/ptj.20100018; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Katoh M, 2014, J PHYS THER SCI, V26, P15, DOI 10.1589/jpts.26.15; Kehlet H, 2009, CURR OPIN CRIT CARE, V15, P355, DOI 10.1097/MCC.0b013e32832fbbe7; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; Kristensen MT, 2009, CLIN BIOMECH, V24, P218, DOI 10.1016/j.clinbiomech.2008.10.003; Kristensen MT, 2013, PM&R, V5, P135, DOI 10.1016/j.pmrj.2012.10.006; Kristensen MT, 2012, DAN MED J, V59; Kristensen MT, 2011, J AM GERIATR SOC, V59, P565, DOI 10.1111/j.1532-5415.2010.03293.x; Kristensen MT, 2009, CLIN REHABIL, V23, P1116, DOI 10.1177/0269215509342330; Kronborg L, 2016, J AGING PHYS ACTIV, P1; Kronborg L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093332; Manini TM, 2007, J AM GERIATR SOC, V55, P451, DOI 10.1111/j.1532-5415.2007.01087.x; Milte R, 2013, J REHABIL MED, V45, P81, DOI 10.2340/16501977-1054; Mitchell SL, 2001, CLIN REHABIL, V15, P282, DOI 10.1191/026921501676849095; Overgaard J, 2013, WORLD J ORTHOP, V4, P248, DOI 10.5312/wjo.v4.i4.248; Peterson MD, 2010, AGEING RES REV, V9, P226, DOI 10.1016/j.arr.2010.03.004; Rapp K, 2013, J BONE MINER RES, V28, P821, DOI 10.1002/jbmr.1809; Rosell PAE, 2003, INJURY, V34, P529, DOI 10.1016/S0020-1383(02)00414-X; Salkeld G, 2000, BMJ-BRIT MED J, V320, P341, DOI 10.1136/bmj.320.7231.341; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; Sherrington C, 2003, AUST J PHYSIOTHER, V49, P15, DOI 10.1016/S0004-9514(14)60184-7; Suetta C, 2004, J AM GERIATR SOC, V52, P2016, DOI 10.1111/j.1532-5415.2004.52557.x; Valenzuela T, 2012, J AM MED DIR ASSOC, V13, P418, DOI 10.1016/j.jamda.2011.11.001; Yau DT, 2012, CALCIF TISSUE INT; Ziden L, 2008, CLIN REHABIL, V22, P801, DOI 10.1177/0269215508090204; Ziden L, 2010, DISABIL REHABIL, V32, P103, DOI 10.3109/09638280903009263	44	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179867	10.1371/journal.pone.0179867	http://dx.doi.org/10.1371/journal.pone.0179867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662153	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300060
J	Schonfelder, ML; Bogner, FX				Schoenfelder, Mona Lisa; Bogner, Franz Xaver			Individual perception of bees: Between perceived danger and willingness to protect	PLOS ONE			English	Article							CHILDREN AGED 5-16; ATTITUDES; CONSERVATION; FEAR; ANIMALS; DISGUST; SCHOOLCHILDREN; EXPERIENCE; ORGANISMS; AGREEMENT	The current loss of biodiversity has found its way into the media. Especially the loss of bees as pollinators has recently received much attention aiming to increase public awareness about the consequence of pollinator loss and strategies for protection. However, pollinating insects like bees often prompt considerable anxiety. Negative emotions such as fear and disgust often lead to lack of support for conservation and appropriate initiatives for protection. Our study monitored perceptions of bees in the contexts of conservation and danger bees possibly represent by applying a semantic differential using contrasting adjectives under the heading "I think bees are... ". Additionally, open questions were applied to examine individual perceptions of danger and conservation of bees. Respondents were students from primary school, secondary school and university. We compared these novices (n = 499) to experts (beekeepers, n = 153). An exploratory factor analysis of the semantic differential responses yielded three major oblique factors: Interest, Danger and Conservation & Usefulness. The inter-correlations of these factors were significant. Although all subgroups showed an overall high willingness to protect bees, the perception of danger scored medium. The individual experience of bee stings was the most prevalent reason for expressing fear. Educational programs focusing on pollinator conservation may reduce the perceived danger through removing misinformation, and supporting interest in the species. Based on the overall positive attitude toward bees, we suggest introducing bees (e.g., Apis mellifera) as a flagship species for pollinator conservation.	[Schoenfelder, Mona Lisa; Bogner, Franz Xaver] Univ Bayreuth, Dept Biol Educ, Bayreuth, Germany	University of Bayreuth	Schonfelder, ML (corresponding author), Univ Bayreuth, Dept Biol Educ, Bayreuth, Germany.	mona.schoenfelder@uni-bayreuth.de			European Union LLP [527891]; University of Bayreuth; German Research Foundation (DFG)	European Union LLP; University of Bayreuth; German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support was granted by the Gree NET Project funded by European Union LLP Grant Agreement No. 527891 (http://greenet.ea.gr/) and the University of Bayreuth. Publishing fees were funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol DP, 2011, POLLINAT BIOL BIODIV, P1; [Anonymous], 1985, J ENVIRON EDUC, DOI DOI 10.1080/00958964.1985.9942709; Arrindell WA, 2000, BEHAV RES THER, V38, P509, DOI 10.1016/S0005-7967(99)00097-2; Ballouard JM, 2012, J HERPETOL, V46, P423, DOI 10.1670/11-118; Ballouard JM, 2013, ANTHROZOOS, V26, P93, DOI 10.2752/175303713X13534238631560; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bixler R. D., 1999, J ENV ED, V30, P4, DOI [10.1080/00958969909601871, DOI 10.1080/00958969909601871]; Bjerke T, 2004, ANTHROZOOS, V17, P109, DOI 10.2752/089279304786991783; Bjerke T, 1998, ANTHROZOOS, V11, P227, DOI 10.2752/089279398787000544; Bjerke T, 1998, ANTHROZOOS, V11, P79, DOI 10.2752/089279398787000742; Bogner F.X., 1996, ENVIRONMENTALIST, V16, P95, DOI [10.1007/BF01325101, DOI 10.1007/BF01325101]; Bogner F. X., 1998, J ENVIRON EDUC, V29, P17, DOI DOI 10.1080/00958969809599124; Breuer GB, 2015, INT J SCI EDUC, V37, P2664, DOI 10.1080/09500693.2015.1099171; Brewer C, 2006, CONSERV BIOL, V20, P689, DOI 10.1111/j.1523-1739.2006.00467.x; Byrne A, 2009, APIDOLOGIE, V40, P194, DOI 10.1051/apido/2009017; Calik M, 2005, J RES SCI TEACH, V42, P638, DOI 10.1002/tea.20076; Ceriaco LMP, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-26; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; Davey G.C., 1991, ANXIETY RES, V4, P299, DOI [https://doi.org/10.1080/08917779208248798, DOI 10.1080/08917779208248798, 10.1080/08917779208248798]; DAVEY GCL, 1994, BRIT J PSYCHOL, V85, P541, DOI 10.1111/j.2044-8295.1994.tb02540.x; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Drissner J, 2013, ISRN ED, V2013, P1; Eagly A. H., 1993, PSYCHOL ATTITUDES; Field A., 2013, DISCOVERING STAT USI; Flavell J. H., 1992, PIAGETS THEORY PROSP, V14, P107; Gerdes ABM, 2009, EVOL HUM BEHAV, V30, P66, DOI 10.1016/j.evolhumbehav.2008.08.005; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gupta R.K., 2014, BEEKEEPING POVERTY A, VVolume 1; Herzog H. A., 1988, ANTHROZOOS, V1, P214, DOI [DOI 10.2752/089279388787058317, 10.2752/089279388787058317]; HILL RJ, 1958, AM SOCIOL REV, V23, P227, DOI 10.2307/2089024; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; KELLERT SR, 1987, WILDLIFE SOC B, V15, P363; Killermann W, 1996, INT J SCI EDUC, V18, P333, DOI 10.1080/0950069960180306; Knight AJ, 2008, J ENVIRON PSYCHOL, V28, P94, DOI 10.1016/j.jenvp.2007.10.001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leach J, 1996, INT J SCI EDUC, V18, P19, DOI 10.1080/0950069960180102; Leach J, 1996, INT J SCI EDUC, V18, P129, DOI 10.1080/0950069960180201; Lieflander AK, 2013, ENVIRON EDUC RES, V19, P370, DOI 10.1080/13504622.2012.697545; Lieflander AK, 2014, J ENVIRON EDUC, V45, P105, DOI 10.1080/00958964.2013.875511; Lindemann-Matthies P, 2005, INT J SCI EDUC, V27, P655, DOI 10.1080/09500690500038116; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; Mayring P, 2010, HDB QUAL FORSCH PSYC, V1, P144; Mingo J, 2013, BEES MAKE BEST PETS; Mintzes JJ, 2005, ELSEVIER, P29; Munstedt K, 2013, ADV STUD MED SCI, V1, P125; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Prokop P, 2013, ANIM CONSERV, V16, P458, DOI 10.1111/acv.12014; Prokop P, 2007, J BIOL EDUC, V42, P36, DOI 10.1080/00219266.2007.9656105; Prokop P, 2010, ANN ZOOL FENN, V47, P417, DOI 10.5735/086.047.0606; Prokop P, 2010, ANTHROZOOS, V23, P21, DOI 10.2752/175303710X12627079939107; Prokop P, 2009, SOC ANIM, V17, P224, DOI 10.1163/156853009X445398; Prokop P, 2009, ANTHROZOOS, V22, P19, DOI 10.2752/175303708X390446; RACHMAN S, 1977, BEHAV RES THER, V15, P375, DOI 10.1016/0005-7967(77)90041-9; Randler, 2015, INT J ENV SCI ED, V10, P477, DOI [DOI 10.12973/IJESE.2015.255A, 10.12973/ijese.2015.255a]; Randler C, 2012, SOC ANIM, V20, P61, DOI 10.1163/156853012X614369; Schlegel J, 2015, ANTHROZOOS, V28, P229, DOI 10.2752/089279315X14219211661732; SELIGMAN ME, 1971, BEHAV THER, V2, P307, DOI 10.1016/S0005-7894(71)80064-3; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Tautz J., 2007, PHANOMEN HONIGBIENE; Tomazic I, 2011, SOC ANIM, V19, P225, DOI [10.1163/156853011X578901, 10.1163/156853011x578901]; Wilson C., 2005, J SOCIAL SCI, V1, P47, DOI [10.22004/ag.econ.51417, DOI 10.22004/AG.ECON.51417, DOI 10.3844/jssp.2005.47.51]	70	43	44	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180168	10.1371/journal.pone.0180168	http://dx.doi.org/10.1371/journal.pone.0180168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662124	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300118
J	Zhao, P; Hall, J; Durston, M; Voydanoff, A; VanSickle, E; Kelly, S; Nagulapally, AB; Bond, J; Sholler, GS				Zhao, Ping; Hall, Jacob; Durston, Mary; Voydanoff, Austin; VanSickle, Elizabeth; Kelly, Shannon; Nagulapally, Abhinav B.; Bond, Jeffery; Sholler, Giselle Saulnier			BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma	PLOS ONE			English	Article							CHILDHOOD MEDULLOBLASTOMA; PI3K INHIBITOR; BREAST-CANCER; PATHWAY; NVP-BKM120; BUPARLISIB; GLIOBLASTOMA; CELLS; METABOLISM; ACTIVATION	Medulloblastoma (MB) is the most common malignant brain tumor in children, accounting for nearly 20 percent of all childhood brain tumors. New treatment strategies are needed to improve patient survival outcomes and to reduce adverse effects of current therapy. The phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) intracellular signaling pathway plays a key role in cellular metabolism, proliferation, survival and angiogenesis, and is often constitutively activated in human cancers, providing unique opportunities for anticancer therapeutic intervention. The aim of this study was to evaluate the pre-clinical activity of BKM120, a selective pan-class I PI3K inhibitor, on MB cell lines and primary samples. IC50 values of BKM120 in the twelve MB cell lines tested ranged from 0.279 to 4.38 mu M as determined by cell viability assay. IncuCyte ZOOM Live-Cell Imaging system was used for kinetic monitoring of cytotoxicity of BKM120 and apoptosis in MB cells. BKM120 exhibited cytotoxicity in MB cells in a dose and time-dependent manner by inhibiting activation of downstream signaling molecules AKT and mTOR, and activating caspase-mediated apoptotic pathways. Furthermore, BKM120 decreased cellular glycolytic metabolic activity in MB cell lines in a dose-dependent manner demonstrated by ATP level per cell. In MB xenograft mouse study, DAOY cells were implanted in the flank of nude mice and treated with vehicle, BKM120 at 30 mg/kg and 60 mg/kg via oral gavage daily. BKM120 significantly suppressed tumor growth and prolonged mouse survival. These findings help to establish a basis for clinical trials of BKM120, which could be a novel therapy for the treatment of medulloblastoma patients.	[Zhao, Ping; Durston, Mary; VanSickle, Elizabeth; Kelly, Shannon; Nagulapally, Abhinav B.; Bond, Jeffery; Sholler, Giselle Saulnier] Helen DeVos Childrens Hosp, Pediat Oncol Translat Res Program, Grand Rapids, MI 49503 USA; [Hall, Jacob] Calvin Coll, Grand Rapids, MI USA; [Voydanoff, Austin; Sholler, Giselle Saulnier] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA	Calvin University; Michigan State University; Michigan State University College of Human Medicine	Sholler, GS (corresponding author), Helen DeVos Childrens Hosp, Pediat Oncol Translat Res Program, Grand Rapids, MI 49503 USA.; Sholler, GS (corresponding author), Michigan State Univ, Coll Human Med, Grand Rapids, MI USA.	Giselle.saulniersholler@helendevoschildrens.org			Swifity Foundation; Dick and Betsy DeVos Foundation, Meryl and Charles Witmer Foundation; Beat NB Foundation (GSS)	Swifity Foundation; Dick and Betsy DeVos Foundation, Meryl and Charles Witmer Foundation; Beat NB Foundation (GSS)	This work was supported by the Swifity Foundation, the Dick and Betsy DeVos Foundation, Meryl and Charles Witmer Foundation, and the Beat NB Foundation (GSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-88; Altomare DA, 2012, CURR MED CHEM, V19, P3748; Anderson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133610; Baryawno N, 2010, CANCER RES, V70, P266, DOI 10.1158/0008-5472.CAN-09-0578; Bashash D, 2016, INT J BIOCHEM CELL B, V79, P308, DOI 10.1016/j.biocel.2016.09.004; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Brown Kristin K, 2015, F1000Prime Rep, V7, P13, DOI 10.12703/P7-13; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Clarke JM, 2013, CURR TREAT OPTION ON, V14, P109, DOI 10.1007/s11864-012-0222-4; Delbaldo C, 2011, TARGET ONCOL, V6, P119, DOI 10.1007/s11523-011-0177-6; Dimitrova V, 2015, CURR MOL MED, V15, P82, DOI 10.2174/1566524015666150114115427; Hoang DH, 2014, J NEUROSURG-PEDIATR, V14, P136, DOI 10.3171/2014.5.PEDS13571; Dufour C, 2014, PEDIATR BLOOD CANCER, V61, P1398, DOI 10.1002/pbc.25009; Ellison DW, 2010, ACTA NEUROPATHOL, V120, P305, DOI 10.1007/s00401-010-0726-6; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Frasson C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/973912; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Geuna E, 2015, EXPERT OPIN INV DRUG, V24, P421, DOI 10.1517/13543784.2015.1008132; Gilbertson RJ, 2006, EUR J CANCER, V42, P646, DOI 10.1016/j.ejca.2005.11.023; Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007; Guerreiro AS, 2008, CLIN CANCER RES, V14, P6761, DOI 10.1158/1078-0432.CCR-08-0385; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Jane EP, 2014, J PHARMACOL EXP THER, V350, P22, DOI 10.1124/jpet.114.212910; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Liu WL, 2014, ONCOTARGET, V5, P3662, DOI 10.18632/oncotarget.1978; MacDonald TJ, 2014, NEURO-ONCOLOGY, V16, P9, DOI 10.1093/neuonc/not147; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Massacesi C, 2016, ONCOTARGETS THER, V9, P203, DOI 10.2147/OTT.S89967; Mayer IA, 2014, J CLIN ONCOL, V32, P1202, DOI 10.1200/JCO.2013.54.0518; McNeill RS, 2017, NEUROONCOLOGY; Milde T, 2012, J NEURO-ONCOL, V110, P335, DOI 10.1007/s11060-012-0978-1; Mohan AL, 2012, ANTICANCER RES, V32, P3141; Netland IA, 2016, J NEURO-ONCOL, V129, P57, DOI 10.1007/s11060-016-2158-1; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Othman RT, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-57; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Peiris-Pages M, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0712-6; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Singh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150836; Spiliopoulou P, 2014, WORLD J GASTROENTERO, V20, P10288, DOI 10.3748/wjg.v20.i30.10288; Vansteenkiste JF, 2015, J THORAC ONCOL, V10, P1319, DOI 10.1097/JTO.0000000000000607; Wachsberger PR, 2014, J CANCER RES CLIN, V140, P573, DOI 10.1007/s00432-014-1594-6; Wen PY, 2012, NEURO-ONCOLOGY, V14, P819, DOI 10.1093/neuonc/nos117; Wu Xiaochong, 2011, Chin J Cancer, V30, P442, DOI 10.5732/cjc.011.10040; Yogi Kedar, 2015, Oncoscience, V2, P334	49	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179948	10.1371/journal.pone.0179948	http://dx.doi.org/10.1371/journal.pone.0179948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662162	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300080
J	Denefrio, S; Simmons, A; Jha, A; Dennis-Tiwary, TA				Denefrio, Samantha; Simmons, Akeesha; Jha, Amishi; Dennis-Tiwary, Tracy A.			Emotional cue validity effects: The role of neurocognitive responses to emotion	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; VISUAL-ATTENTION; POSITIVE AFFECT; BRAIN POTENTIALS; NEUROPHYSIOLOGICAL MECHANISMS; INDIVIDUAL-DIFFERENCES; FOCUSED ATTENTION; ANXIETY; FACES; ERP	The beneficial effect of valid compared to invalid cues on attention performance is a basic attentional mechanism, but the impact of emotional content on cue validity is poorly understood. We tested whether the effect of cue validity on attention performance differed when cues were angry, happy, or neutral faces. Moreover, we used scalp-recorded event-related potentials (ERPs) reflecting the capture of early visual attention (P1, N170) to test whether effects were strengthened when neurocognitive responses to angry or happy cues were enhanced (larger P1 and N170 amplitudes). Twenty-five participants completed a modified flanker task using emotional face cues to measure the effects of emotion on conflict interference. Attention performance was enhanced following valid versus invalid cues, but effects did not differ by emotion cue type. However, for participants showing relatively larger N170 amplitudes to angry face cues, attention performance was specifically disrupted on those trials. Conversely, participants with relatively larger N170 amplitudes to happy face cues showed facilitated performance across all valid trials. These findings suggest that individual neurocognitive sensitivities to emotion predict the impact of emotional content on the basic attentional phenomenon of cue validity.	[Denefrio, Samantha; Dennis-Tiwary, Tracy A.] CUNY, Grad Ctr, New York, NY 10021 USA; [Simmons, Akeesha; Dennis-Tiwary, Tracy A.] CUNY, Hunter Coll, New York, NY 10021 USA; [Jha, Amishi] Univ Miami, Miami, FL USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); University of Miami	Dennis-Tiwary, TA (corresponding author), CUNY, Grad Ctr, New York, NY 10021 USA.; Dennis-Tiwary, TA (corresponding author), CUNY, Hunter Coll, New York, NY 10021 USA.	tracy.dennis@hunter.cuny.edu			National Institute of General Medical Sciences, National Institutes of Health [SC1MH104907]; National Center for Advancing Translational Sciences, National Institutes of Health [TR000457]; Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities, National Institutes of Health [MD007599]	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities, National Institutes of Health	This research was made possible by grant SC1MH104907 awarded to TDT from the National Institute of General Medical Sciences, grant TR000457 of the National Center for Advancing Translational Sciences, and by and a Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities (MD007599), all of the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIMHD or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir N, 2003, BEHAV RES THER, V41, P1325, DOI 10.1016/S0005-7967(03)00039-1; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; Basso M R, 1996, J Int Neuropsychol Soc, V2, P249; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Biss RK, 2010, MOTIV EMOTION, V34, P73, DOI 10.1007/s11031-010-9156-y; Blau Vera C, 2007, Behav Brain Funct, V3, P7; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Clore GL, 2009, EMOT REV, V1, P39, DOI 10.1177/1754073908097185; Davies PL, 2001, BIOL PSYCHOL, V56, P191, DOI 10.1016/S0301-0511(01)00080-1; Dennis TA, 2007, BIOL PSYCHOL, V76, P1, DOI 10.1016/j.biopsycho.2007.05.001; Dennis TA, 2007, INT J PSYCHOPHYSIOL, V65, P10, DOI 10.1016/j.ijpsycho.2007.02.006; Dennis TA, 2009, DEV NEUROPSYCHOL, V34, P85, DOI 10.1080/87565640802564887; Derryberry D., 1994, HEARTS EYE EMOTIONAL, P167, DOI [10.1016/B978-0-12-410560-7.50014-4, DOI 10.1016/B978-0-12-410560-7.50014-4]; Drollette ES, 2014, DEV COGN NEUROS-NETH, V7, P53, DOI 10.1016/j.dcn.2013.11.001; EASON RG, 1981, B PSYCHONOMIC SOC, V18, P203; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Eastwood JD, 2003, PERCEPT PSYCHOPHYS, V65, P352, DOI 10.3758/BF03194566; Eckstein MP, 2002, J VISION, V2, P25, DOI 10.1167/2.1.3; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2010, CEREB CORTEX, V20, P2442, DOI 10.1093/cercor/bhp312; Eimer M, 2008, J NEUROPSYCHOL, V2, P165, DOI 10.1348/174866407X245411; Estrada CA, 1997, ORGAN BEHAV HUM DEC, V72, P117, DOI 10.1006/obhd.1997.2734; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2011, BRAIN COGNITION, V70, P209; Fenske MJ, 2003, EMOTION, V3, P327, DOI 10.1037/1528-3542.3.4.327; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fredrickson BL, 1998, COGNITION EMOTION, V12, P191; Friedman RS, 2010, PSYCHOL BULL, V136, P875, DOI 10.1037/a0020495; Gable P.A., 2008, NETHERLANDS J PSYCHO, V64, P132, DOI [10.1007/BF03076416, DOI 10.1007/BF03076416]; Gable P, 2010, PSYCHOL SCI, V21, P211, DOI 10.1177/0956797609359622; Gable PA, 2008, PSYCHOL SCI, V19, P476, DOI 10.1111/j.1467-9280.2008.02112.x; Gable PA, 2011, BIOL PSYCHOL, V87, P303, DOI 10.1016/j.biopsycho.2011.02.007; Garland EL, 2010, CLIN PSYCHOL REV, V30, P849, DOI 10.1016/j.cpr.2010.03.002; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Harmon-Jones E, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00073; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Huntsinger JR, 2012, J EXP PSYCHOL GEN, V141, P595, DOI 10.1037/a0027709; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Kappenman ES, 2015, SOC COGN AFFECT NEUR, V10, P577, DOI 10.1093/scan/nsu098; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Luck SJ, 1995, BEHAV BRAIN RES, V71, P113, DOI 10.1016/0166-4328(95)00041-0; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Luck SJ, 1995, NEURAL SYSTEMS MEDIA; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; MANGUN GR, 1988, ELECTROEN CLIN NEURO, V70, P417, DOI 10.1016/0013-4694(88)90019-3; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; MANGUN GR, 1990, PERCEPT PSYCHOPHYS, V47, P532, DOI 10.3758/BF03203106; Mangun GR, 1990, NEUROBIOLOGY HIGHER; MANGUN GRR, 1987, HUM FACTORS, V29, P195, DOI 10.1177/001872088702900207; Mueller EM, 2009, PSYCHOL MED, V39, P1141, DOI 10.1017/S0033291708004820; O'Toole LJ, 2013, DEV NEUROPSYCHOL, V38, P352, DOI 10.1080/87565641.2013.802321; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Pollak SD, 2003, J ABNORM PSYCHOL, V112, P323, DOI 10.1037/0021-843X.112.3.323; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Schmitz TW, 2009, J NEUROSCI, V29, P7199, DOI 10.1523/JNEUROSCI.5387-08.2009; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; Talarico J, 2009, COGNITION EMOTION, V23, P380, DOI 10.1080/02699930801993999; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vanlessen N, 2013, COGN AFFECT BEHAV NE, V13, P60, DOI 10.3758/s13415-012-0130-x; Vossel S, 2006, NEUROIMAGE, V32, P1257, DOI 10.1016/j.neuroimage.2006.05.019; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Walentowska W, 2012, INT J PSYCHOPHYSIOL, V85, P27, DOI 10.1016/j.ijpsycho.2011.12.004; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; WRIGHT MJ, 1995, BIOL PSYCHOL, V41, P183, DOI 10.1016/0301-0511(95)05128-7; Wronka E, 2011, PSYCHOPHYSIOLOGY, V48, P1047, DOI 10.1111/j.1469-8986.2011.01180.x	77	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179714	10.1371/journal.pone.0179714	http://dx.doi.org/10.1371/journal.pone.0179714			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683069	Green Published, gold			2022-12-27	WOS:000405335200011
J	Crouzet, M; Claverol, S; Lomenech, AM; Le Senechal, C; Costaglioli, P; Barthe, C; Garbay, B; Bonneu, M; Vilain, S				Crouzet, Marc; Claverol, Stephane; Lomenech, Anne-Marie; Le Senechal, Caroline; Costaglioli, Patricia; Barthe, Christophe; Garbay, Bertrand; Bonneu, Marc; Vilain, Sebastien			Pseudomonas aeruginosa cells attached to a surface display a typical proteome early as 20 minutes of incubation	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; RNA-POLYMERASE; BACTERIAL SURVIVAL; TWITCHING MOTILITY; STRESS RESPONSES; DI-GMP; RESISTANCE; EXPRESSION	Biofilms are present in all environments and often result in negative effects due to properties of the biofilm lifestyle and especially antibiotics resistance. Biofilms are associated with chronic infections. Controlling bacterial attachment, the first step of biofilm formation, is crucial for fighting against biofilm and subsequently preventing the persistence of infection. Thus deciphering the underlying molecular mechanisms involved in attachment could allow discovering molecular targets from it would be possible to develop inhibitors against bacterial colonization and potentiate antibiotherapy. To identify the key components and pathways that aid the opportunistic pathogen Pseudomonas aeruginosa in attachment we performed for the first time a proteomic analysis as early as after 20 minutes of incubation using glass wool fibers as a surface. We compared the protein contents of the attached and unattached bacteria. Using mass spectrometry, 3043 proteins were identified. Our results showed that, as of 20 minutes of incubation, using stringent quantification criteria 616 proteins presented a modification of their abundance in the attached cells compared to their unattached counterparts. The attached cells presented an overall reduced gene expression and characteristics of slow-growing cells. The over-accumulation of outer membrane proteins, periplasmic folding proteins and O-antigen chain length regulators was also observed, indicating a profound modification of the cell envelope. Consistently the sigma factor AlgU required for cell envelope homeostasis was highly over-accumulated in attached cells. In addition our data suggested a role of alarmone (p) ppGpp and polyphosphate during the early attachment phase. Furthermore, almost 150 proteins of unknown function were differentially accumulated in the attached cells. Our proteomic analysis revealed the existence of distinctive biological features in attached cells as early as 20 minutes of incubation. Analysis of some mutants demonstrated the interest of this proteomic approach in identifying genes involved in the early phase of adhesion to a surface.	[Crouzet, Marc; Le Senechal, Caroline; Costaglioli, Patricia; Barthe, Christophe; Bonneu, Marc; Vilain, Sebastien] Univ Bordeaux, Inst Natl Polytech Bordeaux, CNRS, UMR 5248,Spectrometrie Masse Macromol Biol Chim B, Bordeaux, France; [Claverol, Stephane; Lomenech, Anne-Marie; Bonneu, Marc; Vilain, Sebastien] Univ Bordeaux, Ctr Genom Fonct Bordeaux, Plateforme Prote, Bordeaux, France; [Garbay, Bertrand] Univ Bordeaux, Inst Natl Polytech Bordeaux, CNRS, Lab Chim Polymeres Organ,UMR 5629, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Vilain, S (corresponding author), Univ Bordeaux, Inst Natl Polytech Bordeaux, CNRS, UMR 5248,Spectrometrie Masse Macromol Biol Chim B, Bordeaux, France.; Vilain, S (corresponding author), Univ Bordeaux, Ctr Genom Fonct Bordeaux, Plateforme Prote, Bordeaux, France.	sebastien.vilain@ipb.fr	Vilain, Sebastien/AAD-8031-2021; patricia, costaglioli/AAD-4560-2020	patricia, costaglioli/0000-0002-7953-427X; Vilain, Sebastien/0000-0003-0134-8511	University of Bordeaux, Bordeaux INP; CNRS	University of Bordeaux, Bordeaux INP; CNRS(Centre National de la Recherche Scientifique (CNRS))	The University of Bordeaux, Bordeaux INP and the CNRS financed this work through the recurrent funding of the research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bhavsar Rital B., 2010, Human Genomics, V4, P327; Bisicchia P, 2013, MBIO, V4, DOI 10.1128/mBio.00856-13; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; BUTLER K, 1970, J INFECT DIS, V122, pS1, DOI 10.1093/infdis/122.Supplement_1.S1; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Cohen D, 2015, P NATL ACAD SCI USA, V112, P11359, DOI 10.1073/pnas.1421450112; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Cooley RB, 2016, J BACTERIOL, V198, P66, DOI 10.1128/JB.00369-15; Creuzenet C, 2001, MOL MICROBIOL, V41, P1295, DOI 10.1046/j.1365-2958.2001.02589.x; Crouzet M, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0253-z; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; de la Fuente-Nunez C, 2015, CHEM BIOL, V22, P196, DOI 10.1016/j.chembiol.2015.01.002; de la Fuente-Nunez C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004152; de Paz LEC, 2012, APPL ENVIRON MICROB, V78, P1627, DOI 10.1128/AEM.07036-11; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Edrington TC, 2011, J BIOL CHEM, V286, P39211, DOI 10.1074/jbc.M111.280933; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fraley CD, 2007, P NATL ACAD SCI USA, V104, P3526, DOI 10.1073/pnas.0609733104; Francklyn CS, 2010, FEBS LETT, V584, P366, DOI 10.1016/j.febslet.2009.11.045; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Fuchs EL, 2010, J BACTERIOL, V192, P3553, DOI 10.1128/JB.00363-10; Gomes SL, 2009, ENCY MICROBIOLOGY, P464; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; Guvener ZT, 2006, MOL MICROBIOL, V61, P106, DOI 10.1111/j.1365-2958.2006.05218.x; He K, 2014, TRENDS MICROBIOL, V22, P389, DOI 10.1016/j.tim.2014.04.004; HEDSTROM RC, 1982, J BACTERIOL, V152, P255; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; HOOPER DC, 1987, AM J MED, V82, P12; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Huangyutitham V, 2013, MBIO, V4, DOI 10.1128/mBio.00242-13; Ivanov IE, 2011, J BACTERIOL, V193, P1259, DOI 10.1128/JB.01308-10; Jonas K, 2009, FUTURE MICROBIOL, V4, P341, DOI [10.2217/fmb.09.7, 10.2217/FMB.09.7]; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lamour V, 2008, J MOL BIOL, V383, P367, DOI 10.1016/j.jmb.2008.08.011; Leaper D, 2010, ANN ROY COLL SURG, V92, P453, DOI 10.1308/003588410X12699663905276; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Loots K, 2008, VACCINE, V26, P546, DOI 10.1016/j.vaccine.2007.11.030; Luo Y, 2015, MBIO, V6, DOI 10.1128/mBio.02456-14; Mace C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003897; Mignan SE, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-43; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Neznansky A, 2014, FASEB J, V28, P5223, DOI 10.1096/fj.14-258293; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Ohniwa RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019172; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Palmer SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080252; Park AJ, 2014, MOL CELL PROTEOMICS, V13, P1095, DOI 10.1074/mcp.M113.033985; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Poole K, 2012, J ANTIMICROB CHEMOTH, V67, P2069, DOI 10.1093/jac/dks196; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Reed D, 2009, OCHSNER J, V9, P27; Rutherford ST, 2012, COLD SPRING HARB PER, V2; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Shephard JJ, 2010, LANGMUIR, V26, P8659, DOI 10.1021/la1007878; Shrout JD, 2011, MRS BULL, V36, P367, DOI 10.1557/mrs.2011.67; Sobel ML, 2005, J BACTERIOL, V187, P1246, DOI 10.1128/JB.187.4.1246-1253.2005; SOMPOLINSKY D, 1972, J BACTERIOL, V110, P468, DOI 10.1128/JB.110.2.468-476.1972; Southey-Pillig CJ, 2005, J BACTERIOL, V187, P8114, DOI 10.1128/JB.187.23.8114-8126.2005; Sriramulu DD, 2005, PROTEOMICS, V5, P3712, DOI 10.1002/pmic.200401227; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2015, ANTIMICROB AGENTS CH, V59, P3838, DOI 10.1128/AAC.00433-15; Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taylor PK, 2014, J BIOTECHNOL, V191, P121, DOI 10.1016/j.jbiotec.2014.09.003; Toutain CM, 2007, RES MICROBIOL, V158, P471, DOI 10.1016/j.resmic.2007.04.001; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wehbi H, 2011, J BACTERIOL, V193, P540, DOI 10.1128/JB.01048-10; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wood LF, 2012, MBIO, V3, DOI 10.1128/mBio.00094-12; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yahr T, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00082; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07; Zhang ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041202; Zhang P, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0066-5; 2004, AM J INFECT CONTROL, V32, P470, DOI DOI 10.1016/J.AJIC.2004.10.001	100	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180341	10.1371/journal.pone.0180341	http://dx.doi.org/10.1371/journal.pone.0180341			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678862	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200056
J	Halpern, BS; Frazier, M; Afflerbach, J; O'Hara, C; Katona, S; Lowndes, JSS; Jiang, N; Pacheco, E; Scarborough, C; Polsenberg, J				Halpern, Benjamin S.; Frazier, Melanie; Afflerbach, Jamie; O'Hara, Casey; Katona, Steven; Lowndes, Julia S. Stewart; Jiang, Ning; Pacheco, Erich; Scarborough, Courtney; Polsenberg, Johanna			Drivers and implications of change in global ocean health over the past five years	PLOS ONE			English	Article							IMPACT	Growing international and national focus on quantitatively measuring and improving ocean health has increased the need for comprehensive, scientific, and repeated indicators to track progress towards achieving policy and societal goals. The Ocean Health Index (OHI) is one of the few indicators available for this purpose. Here we present results from five years of annual global assessment for 220 countries and territories, evaluating potential drivers and consequences of changes and presenting lessons learned about the challenges of using composite indicators to measure sustainability goals. Globally scores have shown little change, as would be expected. However, individual countries have seen notable increases or declines due in particular to improvements in the harvest and management of wild-caught fisheries, the creation of marine protected areas (MPAs), and decreases in natural product harvest. Rapid loss of sea ice and the consequent reduction of coastal protection from that sea ice was also responsible for declines in overall ocean health in many Arctic and sub-Arctic countries. The OHI performed reasonably well at predicting near-term future scores for many of the ten goals measured, but data gaps and limitations hindered these predictions for many other goals. Ultimately, all indicators face the substantial challenge of informing policy for progress toward broad goals and objectives with insufficient monitoring and assessment data. If countries and the global community hope to achieve and maintain healthy oceans, we will need to dedicate significant resources to measuring what we are trying to manage.	[Halpern, Benjamin S.; Frazier, Melanie; Afflerbach, Jamie; O'Hara, Casey; Lowndes, Julia S. Stewart; Jiang, Ning; Scarborough, Courtney] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Imperial Coll London, Silwood Pk Campus, Ascot, Berks, England; [Katona, Steven; Pacheco, Erich; Polsenberg, Johanna] Conservat Int, Arlington, VA USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Imperial College London; Conservation International	Halpern, BS (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.; Halpern, BS (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.; Halpern, BS (corresponding author), Imperial Coll London, Silwood Pk Campus, Ascot, Berks, England.	halpern@nceas.unsb.edu	Frazier, Melanie R/A-2367-2012; O'Hara, Casey/AGF-2964-2022	O'Hara, Casey/0000-0003-2968-7005; Lowndes, Julia/0000-0003-1682-3872; Scarborough, Courtney/0000-0001-7270-9228	Pacific Life Foundation	Pacific Life Foundation	Beau and Heather Wrigley generously provided the founding grant to the Ocean Health Index. The Pacific Life Foundation is the Founding Presenting Sponsor. Financial support has also been provided by Jayne and Hans Hufschmid and Dan Sten Olsson, CEO of Stena AB.	[Anonymous], 2021, LANG ENV STAT COMP; BirdLife International & NatureServe, 2015, BIRD SPEC DISTR MAPS; Branch TA, 2013, NATURE, V495, pE5, DOI 10.1038/nature11974; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Frazier M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160377; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117863; Halpern BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098995; Halpern BS, 2012, NATURE; Hovila J., 2013, OMI AURA SURFACE UVB, DOI 10.5067/Aura/OMI/DATA3009; IUCN, 2015, INT UN CONS NAT; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kaschner K., 2015, AQUAMAPS PREDICTED R; Kaufmann D, 2010, 1682130 SOC SCI RES; Lowndes JSS, 2015, PEERJ, V3, DOI 10.7717/peerj.1503; Martell S, 2013, FISH FISH, V14, P504, DOI 10.1111/j.1467-2979.2012.00485.x; Nardo M, 2005, 21682 EUR EN; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Northeast Regional Planning Body, 2016, NE OC PLAN; O'Hara CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175739; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Pinheiro J., 2019, NLME LINEAR NONLINEA; Republic of China, 2016, 13 5 YEAR PLAN EC SO; Republic of Ecuador, 2009, NAT PLAN GOOD LIV; Republic of South Africa, 2011, NAT STRAT SUST DEV A; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Stern S, 2016, SOCIAL PROGR INDEX M; United Nations Environment Program, 2010, C PART DEC X 2 STRAT; United Nations Statistical Commission, 2015, REP 46 SESS; Zuur Alain F., 2009, P1	32	25	25	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178267	10.1371/journal.pone.0178267	http://dx.doi.org/10.1371/journal.pone.0178267			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678881	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200003
J	Kataya, ARA; Creighton, MT; Napitupulu, TP; Saetre, C; Heidari, B; Ruoff, P; Lillo, C				Kataya, Amr R. A.; Creighton, Maria T.; Napitupulu, Toga P.; Saetre, Christine; Heidari, Behzad; Ruoff, Peter; Lillo, Cathrine			PLATINUM SENSITIVE 2 LIKE impacts growth, root morphology, seed set, and stress responses	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; DOUBLE-STRAND BREAKS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; HOMOLOGOUS RECOMBINATION; PROTEIN PHOSPHATASES; POSITIVE REGULATOR; CONSERVED PROTEIN; ABSCISIC-ACID; PP4	Eukaryotic protein phosphatase 4 (PP4) is a PP2A-type protein phosphatase that is part of a conserved complex with regulatory factors PSY2 and PP4R2. Various lines of Arabidopsis thaliana with mutated PP4 subunit genes were constructed to study the so far completely unknown functions of PP4 in plants. Mutants with knocked out putative functional homolog of the PSY2 LIKE (PSY2L) gene were dwarf and bushy, while plants with knocked out PP4R2 LIKE (PP4R2L) looked very similar to WT. The psy2l seedlings had short roots with disorganized morphology and impaired meristem. Seedling growth was sensitive to the genotoxin cisplatin. Global transcript analysis (RNA-seq) of seedlings and rosette leaves revealed several groups of genes, shared between both types of tissues, strongly influenced by knocked out PSY2L. Receptor kinases, CRINKLY3 and WAG1, important for growth and development, were down-regulated 3-7 times. EUKARYOTIC ELONGATION FACTOR5A1 was down-regulated 4-6 fold. Analysis of hormone sensitive genes indicated that abscisic acid levels were high, while auxin, cytokinin and gibberellic acid levels were low in psy2l. Expression of specific transcription factors involved in regulation of anthocyanin synthesis were strongly elevated, e. g. the master regulator PAP1, and intriguingly TT8, which is otherwise mainly expressed in seeds. The psy2l mutants accumulated anthocyanins under conditions where WT did not, pointing to PSY2L as a possible upstream negative regulator of PAP1 and TT8. Expression of the sugar-phosphate transporter GPT2, important for cellular sugar and phosphate homeostasis, was enhanced 7-8 times. Several DNA damage response genes, including the cell cycle inhibitor gene WEE1, were up-regulated in psy2l. The activation of DNA repair signaling genes, in combination with phenotypic traits showing aberrant root meristem and sensitivity to the genotoxic cisplatin, substantiate the involvement of Arabidopsis PSY2L in maintenance of genome integrity.	[Kataya, Amr R. A.; Creighton, Maria T.; Napitupulu, Toga P.; Saetre, Christine; Heidari, Behzad; Ruoff, Peter; Lillo, Cathrine] Univ Stavanger, Ctr Organelle Res, Fac Sci & Technol, Stavanger, Norway	Universitetet i Stavanger	Lillo, C (corresponding author), Univ Stavanger, Ctr Organelle Res, Fac Sci & Technol, Stavanger, Norway.	cathrine.lillo@uis.no	Ahootapeh, Behzad Heidari/R-3074-2018	Lillo, Cathrine/0000-0002-8470-8983; Kataya, Amr R.A./0000-0003-1349-0363	Norwegian Research Council [213853/F20]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by a grant from the Norwegian Research Council (grant no 213853/F20 to CL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Abe K, 2005, PLANT PHYSIOL, V139, P896, DOI 10.1104/pp.105.065243; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amiard S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00405; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; Demko V, 2016, PLANTA, V244, P275, DOI 10.1007/s00425-016-2526-2; Desvoyes B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00369; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dyson BC, 2015, PLANT CELL ENVIRON, V38, P1404, DOI 10.1111/pce.12495; Feyissa DN, 2009, PLANTA, V230, P747, DOI 10.1007/s00425-009-0978-3; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Furukawa T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00357; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Helps NR, 1998, J CELL SCI, V111, P1331; Hincha DK, 2012, BIOCHEM SOC T, V40, P1000, DOI 10.1042/BST20120109; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Huang JH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/623573; Kataya ARA, 2016, PLANTA, V243, P699, DOI 10.1007/s00425-015-2439-5; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Lee DH, 2012, EMBO J, V31, P2403, DOI 10.1038/emboj.2012.86; Lee SB, 2015, PLANT CELL REP, V34, P71, DOI 10.1007/s00299-014-1688-2; Lillo C, 2008, PLANT CELL ENVIRON, V31, P587, DOI 10.1111/j.1365-3040.2007.01748.x; Lillo C, 2014, PLANT CELL ENVIRON, V37, P2631, DOI 10.1111/pce.12364; Lipinszki Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6894; Liu Z, 2008, J EXP BOT, V59, P939, DOI 10.1093/jxb/ern017; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Ma CL, 2006, PLANT PHYSIOL, V141, P47, DOI 10.1104/pp.105.073841; Ma H, 2014, MOL CELL BIOL, V34, P452, DOI 10.1128/MCB.00279-13; Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008; Matre P, 2009, PLANTA, V230, P935, DOI 10.1007/s00425-009-0998-z; Mendoza MC, 2005, MOL CELL BIOL, V25, P7839, DOI 10.1128/MCB.25.17.7839-7853.2005; Moller SG, 2003, PLANT CELL, V15, P1111, DOI 10.1105/tpc.008649; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakada S, 2008, EMBO REP, V9, P1251, DOI 10.1038/embor.2008.204; Nikonorova N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00880; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Oler AJ, 2012, EMBO J, V31, P1440, DOI 10.1038/emboj.2011.501; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Otero S, 2016, PLANT CELL, V28, P1361, DOI 10.1105/tpc.15.01003; Re DA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-150; Ren H, 2015, MOL PLANT, V8, P1153, DOI 10.1016/j.molp.2015.05.003; SAMUEL MA, 2006, INT REV CYTOL, V253, P1, DOI DOI 10.1016/S0074-7696(06)53001-3; Santner AA, 2006, PLANT J, V45, P752, DOI 10.1111/j.1365-313X.2005.02641.x; Scheffzek K, 2012, FEBS LETT, V586, P2662, DOI 10.1016/j.febslet.2012.06.006; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Uhrig RG, 2013, TRENDS PLANT SCI, V18, P505, DOI 10.1016/j.tplants.2013.05.004; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Wang SC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-81; Waterworth WM, 2016, P NATL ACAD SCI USA, V113, P9647, DOI 10.1073/pnas.1608829113; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Xu WJ, 2015, TRENDS PLANT SCI, V20, P176, DOI 10.1016/j.tplants.2014.12.001; Yi D, 2014, PLANT CELL, V26, P296, DOI 10.1105/tpc.113.118943; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoon YS, 2010, P NATL ACAD SCI USA, V107, P17704, DOI 10.1073/pnas.1012665107; Yuan DK, 2014, DNA REPAIR, V21, P140, DOI 10.1016/j.dnarep.2014.04.006; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383	74	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180478	10.1371/journal.pone.0180478	http://dx.doi.org/10.1371/journal.pone.0180478			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678890	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200067
J	Neda, Z; Varga, L; Biro, TS				Neda, Zoltan; Varga, Levente; Biro, Tamas S.			Science and Facebook: The same popularity law!	PLOS ONE			English	Article							CITATION DISTRIBUTION; SCIENTIFIC PERFORMANCE; POWER LAWS; DISTRIBUTIONS; IMPACT; INDICATORS; REGRESSION; PHYSICS	The distribution of scientific citations for publications selected with different rules (author, topic, institution, country, journal, etc...) collapse on a single curve if one plots the citations relative to their mean value. We find that the distribution of "shares" for the Facebook posts rescale in the same manner to the very same curve with scientific citations. This finding suggests that citations are subjected to the same growth mechanism with Facebook popularity measures, being influenced by a statistically similar social environment and selection mechanism. In a simple master-equation approach the exponential growth of the number of publications and a preferential selection mechanism leads to a Tsallis-Pareto distribution offering an excellent description for the observed statistics. Based on our model and on the data derived from PubMed we predict that according to the present trend the average citations per scientific publications exponentially relaxes to about 4.	[Neda, Zoltan; Varga, Levente] Babes Bolyai Univ, Dept Phys, Cluj Napoca, Romania; [Biro, Tamas S.] HIRG, HAS Wigner Res Ctr Phys, Budapest, Hungary	Babes Bolyai University from Cluj; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics	Neda, Z (corresponding author), Babes Bolyai Univ, Dept Phys, Cluj Napoca, Romania.	zneda@phys.ubbcluj.ro	Néda, Zoltán/C-3754-2011; Varga, Levente/E-2434-2016	Varga, Levente/0000-0002-7770-6680; Neda, Zoltan/0000-0002-7319-5123	NKFIH/OTKA project [104260]; STAR-UBB fellowship	NKFIH/OTKA project(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); STAR-UBB fellowship	Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal, http://nkfih.gov.hu/, NKFIH/OTKA project Nr. 104260, funded the research of TSB. The authors also acknowledge Universitatea Babes-Bolyai, http://www.ubbcluj.ro/en/, STAR UBB fellowship for allowing the collaboration between ZN and TSB.	Azoulay P, 2012, NATURE, V484, P31, DOI 10.1038/484031a; Brzezinski M, 2015, SCIENTOMETRICS, V103, P213, DOI 10.1007/s11192-014-1524-z; Chatterjee A, 2016, PLOS ONE, V11; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corlan A.D., MEDLINE TREND AUTOMA; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; Gabaix X, 2009, ANNU REV ECON, V1, P255, DOI 10.1146/annurev.economics.050708.142940; GOLDSTONE JA, 1979, SOC STUD SCI, V9, P385, DOI 10.1177/030631277900900306; Golosovsky M, 2012, EUR PHYS J-SPEC TOP, V205, P303, DOI 10.1140/epjst/e2012-01576-4; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Hsu JW, 2011, COMPUT PHYS COMMUN, V182, P185, DOI 10.1016/j.cpc.2010.07.031; InCites, J CITATION REPORT; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Katchanov YL, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0821-1; Kathanov YL, 2015, SPRINGERPLUS, V4, P677; Kuhn T, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041036; Lehmann S, 2008, SCIENTOMETRICS, V76, P369, DOI 10.1007/s11192-007-1868-8; Lehmann S, 2006, NATURE, V444, P1003, DOI 10.1038/4441003a; Martin-Martin A, ARXIV201515010208; Medo M, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.032312; Newman MEJ, 2011, AM J PHYS, V79, P800, DOI 10.1119/1.3590372; Pareto, 1895, GIORNALE EC, V10, P59; Perc M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0378; Perc M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01720; Petersen AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00181; Petersen AM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036114; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046116; Sangwal K, 2013, J INFORMETR, V7, P36, DOI 10.1016/j.joi.2012.09.002; Sinatra R, 2016, SCIENCE, V354, DOI 10.1126/science.aaf5239; Sinatra R, 2015, NAT PHYS, V11, P791, DOI 10.1038/nphys3494; Sorzano COS, 2014, SCIENTOMETRICS, V101, P1731, DOI 10.1007/s11192-014-1368-6; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Thelwall M, 2016, J INFORMETR, V10, P454, DOI 10.1016/j.joi.2016.03.001; Thelwall M, 2016, J INFORMETR, V10, P336, DOI 10.1016/j.joi.2015.12.007; Thelwall M, 2014, J INFORMETR, V8, P963, DOI 10.1016/j.joi.2014.09.011; Thurner S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036111; Waltman L, 2015, J INFORMETR, V9, P872, DOI 10.1016/j.joi.2015.08.001; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Wang J, 2014, J INFORMETR, V8, P329, DOI 10.1016/j.joi.2014.01.006; Web of Science, WEB KNOWL TERMS USE; Zipf GK, 1949, CONT PHYS; Zuckerberg M., ONLINE SHARING IS GR	43	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179656	10.1371/journal.pone.0179656	http://dx.doi.org/10.1371/journal.pone.0179656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678796	gold, Green Submitted, Green Published			2022-12-27	WOS:000405272200019
J	Yang, L; Ge, M; Jin, D; He, DX; Fu, HZ; Wang, J; Cao, XC				Yang, Liang; Ge, Meng; Jin, Di; He, Dongxiao; Fu, Huazhu; Wang, Jing; Cao, Xiaochun			Exploring the roles of cannot-link constraint in community detection via Multi-variance Mixed Gaussian Generative Model	PLOS ONE			English	Article							COMPLEX NETWORKS	Due to the demand for performance improvement and the existence of prior information, semi-supervised community detection with pairwise constraints becomes a hot topic. Most existing methods have been successfully encoding the must-link constraints, but neglect the opposite ones, i.e., the cannot-link constraints, which can force the exclusion between nodes. In this paper, we are interested in understanding the role of cannot-link constraints and effectively encoding pairwise constraints. Towards these goals, we define an integral generative process jointly considering the network topology, must-link and cannot-link constraints. We propose to characterize this process as a Multi-variance Mixed Gaussian Generative (MMGG) Model to address diverse degrees of confidences that exist in network topology and pairwise constraints and formulate it as a weighted nonnegative matrix factorization problem. The experiments on artificial and real-world networks not only illustrate the superiority of our proposed MMGG, but also, most importantly, reveal the roles of pairwise constraints. That is, though the must-link is more important than cannot-link when either of them is available, both must-link and cannot-link are equally important when both of them are available. To the best of our knowledge, this is the first work on discovering and exploring the importance of cannot-link constraints in semi-supervised community detection.	[Yang, Liang] Tianjin Univ Commerce, Sch Informat Engn, Tianjin, Peoples R China; [Yang, Liang; Cao, Xiaochun] Chinese Acad Sci, Inst Informat Engn, State Key Lab Informat Secur, Beijing, Peoples R China; [Ge, Meng; Jin, Di] Tianjin Univ, Sch Comp Software, Tianjin, Peoples R China; [Jin, Di; He, Dongxiao] Tianjin Univ, Sch Comp Sci & Technol, Tianjin, Peoples R China; [Fu, Huazhu] ASTAR, Inst Infocomm Res, Singapore, Singapore; [Wang, Jing] Bournemouth Univ, Fac Sci & Technol, Bournemouth, Dorset, England	Tianjin University of Commerce; Chinese Academy of Sciences; Institute of Information Engineering, CAS; Tianjin University; Tianjin University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); Bournemouth University	Yang, L (corresponding author), Tianjin Univ Commerce, Sch Informat Engn, Tianjin, Peoples R China.; Yang, L (corresponding author), Chinese Acad Sci, Inst Informat Engn, State Key Lab Informat Secur, Beijing, Peoples R China.	yangliang@iie.ac.cn	Jin, Di/AAC-3716-2019; Fu, Huazhu/A-1411-2014	Fu, Huazhu/0000-0002-9702-5524; Yang, Liang/0000-0002-3358-4052	National Natural Science Foundation of China [61503281, 6102334, 61303110, 61422213]; National Basic Research Program of China [2013CB329305]; Open Funding Project of Tianjin Key Laboratory of Cognitive Computing and Application, Foundation for the Young Scholars by Tianjin University of Commerce [150113]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Open Funding Project of Tianjin Key Laboratory of Cognitive Computing and Application, Foundation for the Young Scholars by Tianjin University of Commerce; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Natural Science Foundation of China (No. 61503281, 6102334, 61303110, 61422213), National Basic Research Program of China (2013CB329305), Open Funding Project of Tianjin Key Laboratory of Cognitive Computing and Application, Foundation for the Young Scholars by Tianjin University of Commerce (150113)	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Allahverdyan AE, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/18002; Eaton E., 2012, P AAAI C ART INT, P900; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Li HJ, 2016, IEEE T KNOWL DATA EN, V28, P2349, DOI 10.1109/TKDE.2016.2563425; Li HJ, 2016, J INTELL FUZZY SYST, V31, P2887, DOI 10.3233/JIFS-169171; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Ma XK, 2010, PHYSICA A, V389, P187, DOI 10.1016/j.physa.2009.09.018; Malliaros FD, 2013, PHYS REP, V533, P95, DOI 10.1016/j.physrep.2013.08.002; Nadakuditi RR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.188701; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Traud AL, 2012, PHYSICA A, V391, P4165, DOI 10.1016/j.physa.2011.12.021; Xie JR, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501657; Yang L., 2016, P 25 INT JOINT C ART, P2252, DOI [10.55553060832.3060936////, DOI 10.5555/3060832.3060936]; Yang L, 2015, IEEE T CYBERNETICS, V45, P2585, DOI 10.1109/TCYB.2014.2377154; Yang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09039; Zhang Z-Y, SCI REP, P3; Zhang ZY, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/48005	23	7	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178029	10.1371/journal.pone.0178029	http://dx.doi.org/10.1371/journal.pone.0178029			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678864	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200002
J	Bennion, DM; Isenberg, JD; Harmel, AT; DeMars, K; Dang, AN; Jones, CH; Pignataro, ME; Graham, JT; Steckelings, UM; Alexander, JC; Febo, M; Krause, EG; de Kloet, AD; Candelario-Jalil, E; Sumners, C				Bennion, Douglas M.; Isenberg, Jacob D.; Harmel, Allison T.; DeMars, Kelly; Dang, Alex N.; Jones, Chad H.; Pignataro, Megan E.; Graham, Justin T.; Steckelings, U. Muscha; Alexander, Jon C.; Febo, Marcelo; Krause, Eric G.; de Kloet, Annette D.; Candelario-Jalil, Eduardo; Sumners, Colin			Post-stroke angiotensin II type 2 receptor activation provides long-term neuro-protection in aged rats	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ISCHEMIC-STROKE; CAUSES NEUROPROTECTION; COMPOUND 21; BRAIN; STIMULATION; CEREBROPROTECTION; SYSTEM; MODEL; MICE	Activation of the angiotensin II type 2 receptor (AT2R) by administration of Compound 21 (C21), a selective AT2R agonist, induces neuroprotection in models of ischemic stroke in young adult animals. The mechanisms of this neuroprotective action are varied, and may include direct and indirect effects of AT2R activation. Our objectives were to assess the long-term protective effects of post-stroke C21 treatments in a clinically-relevant model of stroke in aged rats and to characterize the cellular localization of AT2Rs in the mouse brain of transgenic reporter mice following stroke. Intraperitoneal injections of C21 (0.03mg/kg) after ischemic stroke induced by transient monofilament middle cerebral artery occlusion resulted in protective effects that were sustained for up to at least 3-weeks post-stroke. These included improved neurological function across multiple assessments and a significant reduction in infarct volume as assessed by magnetic resonance imaging. We also found AT2R expression to be on neurons, not astrocytes or microglia, in normal female and male mouse brains. Stroke did not induce altered cellular localization of AT2R when assessed at 7 and 14 days post-stroke. These findings demonstrate that the neuroprotection previously characterized only during earlier time points using stroke models in young animals is sustained long-term in aged rats, implying even greater clinical relevance for the study of AT2R agonists for the acute treatment of ischemic stroke in human disease. Further, it appears that this sustained neuroprotection is likely due to a mix of both direct and indirect effects stemming from selective activation of AT2Rs on neurons or other cells besides astrocytes and microglia.				csumners@ufl.edu	Candelario-Jalil, Eduardo/I-1139-2019; Febo, Marcelo/X-6769-2019	Candelario-Jalil, Eduardo/0000-0003-3631-1989; Febo, Marcelo/0000-0001-8981-4163; Steckelings, Ulrike Muscha/0000-0002-5430-4275; de Kloet, Annette/0000-0002-7213-6957; Krause, Eric/0000-0002-2718-3113; Sumners, Colin/0000-0002-9689-2255	American Heart Association [12PRE11940010]; National Heart Lung and Blood Institute [2T32HL083810-06A1]; McKnight Brain Institute at the University of Florida; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065849] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); McKnight Brain Institute at the University of Florida; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this study was provided by the American Heart Association (12PRE11940010, CS), National Heart Lung and Blood Institute (2T32HL083810-06A1, DMB), and the McKnight Brain Institute at the University of Florida (DMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alhusban A, 2015, J HYPERTENS, V33, P170, DOI 10.1097/HJH.0000000000000364; Bennion DM, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0512-2; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; de Kloet AD, 2014, BRAIN STRUCT FUNCT; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fouda AY, 2016, CLIN SCI, V130, P221, DOI 10.1042/CS20150350; Hawkins KE, 2013, J NEUROCHEM; Joseph JP, 2014, NEUROPHARMACOLOGY, V81, P134, DOI 10.1016/j.neuropharm.2014.01.044; Kagiyama T, 2003, REGUL PEPTIDES, V110, P241, DOI 10.1016/S0167-0115(02)00223-9; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lee Seyoung, 2012, Exp Transl Stroke Med, V4, P16, DOI 10.1186/2040-7378-4-16; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Makino I, 1996, NEUROPEPTIDES, V30, P596, DOI 10.1016/S0143-4179(96)90043-8; Mateos L, 2016, BIOCHIM BIOPHYS ACTA; McCarthy CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095762; McCarthy CA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0440-1; McCarthy CA, 2012, HYPERTENSION, V60, P1531, DOI 10.1161/HYPERTENSIONAHA.112.199646; McCarthy CA, 2009, STROKE, V40, P1482, DOI 10.1161/STROKEAHA.108.531509; Mecca AP, 2011, EXP PHYSIOL, V96, P1084, DOI 10.1113/expphysiol.2011.058578; Mecca AP, 2009, EXP PHYSIOL, V94, P937, DOI 10.1113/expphysiol.2009.047936; Min LJ, 2014, AM J HYPERTENS, V27, P1036, DOI 10.1093/ajh/hpu015; Miyamoto N, 2008, NEUROSCI RES, V61, P249, DOI 10.1016/j.neures.2008.03.003; Regenhardt RW, 2013, NEUROPHARMACOLOGY, V71, P154, DOI 10.1016/j.neuropharm.2013.03.025; Schwengel K, 2016, J MOL MED BERL; Villela D, 2015, CLIN SCI, V128, P227, DOI 10.1042/CS20130515	26	15	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180738	10.1371/journal.pone.0180738	http://dx.doi.org/10.1371/journal.pone.0180738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671997	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500084
J	Kozlowski, E; Wasserman, GA; Morgan, M; O'Carroll, D; Ramirez, NGP; Gummuluru, S; Rah, JY; Gower, AC; Ieong, M; Quinton, LJ; Mizgerd, JP; Jones, MR				Kozlowski, Elyse; Wasserman, Gregory A.; Morgan, Marcos; O'Carroll, Donal; Ramirez, Nora-Guadalupe P.; Gummuluru, Suryaram; Rah, Jasmine Y.; Gower, Adam C.; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.			The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses	PLOS ONE			English	Article							HISTONE MESSENGER-RNAS; ALVEOLAR MACROPHAGES; MICRORNA BIOGENESIS; CYTOPLASMIC RNA; GENE-EXPRESSION; EMERGING ROLES; PRE-MICRORNA; URIDYLATION; LIN28; TUT4	Alveolar macrophages orchestrate pulmonary innate immunity and are essential for early immune surveillance and clearance of microorganisms in the airways. Inflammatory signaling must be sufficiently robust to promote host defense but limited enough to prevent excessive tissue injury. Macrophages in the lungs utilize multiple transcriptional and post-transcriptional mechanisms of inflammatory gene expression to delicately balance the elaboration of immune mediators. RNA terminal uridyltransferases (TUTs), including the closely homologous family members Zcchc6 (TUT7) and Zcchc11 (TUT4), have been implicated in the post-transcriptional regulation of inflammation from studies conducted in vitro. In vivo, we observed that Zcchc6 is expressed in mouse and human primary macrophages. Zcchc6-deficient mice are viable and born in Mendelian ratios and do not exhibit an observable spontaneous phenotype under basal conditions. Following an intratracheal challenge with S. pneumoniae, Zcchc6 deficiency led to a modest but significant increase in the expression of select cytokines including IL-6, CXCL1, and CXCL5. These findings were recapitulated in vitro whereby Zcchc6-deficient macrophages exhibited similar increases in cytokine expression due to bacterial stimulation. Although loss of Zcchc6 also led to increased neutrophil emigration to the airways during pneumonia, these responses were not sufficient to impact host defense against infection.	[Kozlowski, Elyse; Wasserman, Gregory A.; Rah, Jasmine Y.; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Kozlowski, Elyse; Wasserman, Gregory A.; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wasserman, Gregory A.; Ramirez, Nora-Guadalupe P.; Gummuluru, Suryaram; Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Morgan, Marcos; O'Carroll, Donal] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [O'Carroll, Donal] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Gower, Adam C.] Boston Univ, Sch Med, Clin & Translat Sci Inst, Boston, MA 02118 USA; [Quinton, Lee J.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University; Boston University; European Molecular Biology Laboratory (EMBL); University of Edinburgh; Boston University; Boston University; Boston University	Jones, MR (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.; Jones, MR (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	mattj@bu.edu	Gummuluru, Rahm/AAV-5691-2020; Mizgerd, Joseph/GRY-6369-2022	Jones, Matthew/0000-0003-4647-2962; Morgan, Marcos/0000-0002-3549-0375; Quinton, Lee/0000-0003-1938-2507; Mizgerd, Joseph/0000-0002-4042-3169; O'Carroll, Donal/0000-0002-8626-2217; Wasserman, Gregory/0000-0002-0136-272X; Gower, Adam/0000-0002-6122-7511; Ramirez, Nora-Guadalupe/0000-0002-7992-1683; Gummuluru, Suryaram/0000-0002-8606-8481	National Institutes of Health [R01 HL-104053, R01 HL-0068153, R01 HL-079392, R00 HL-092956, R01 HL-111449, R01 AI-064099, T32 HL-007035, T32 AI-899673, F31 HL-127978]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007035, R01HL104053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064099, R01AI115053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120060] Funding Source: NIH RePORTER; Medical Research Council [MR/K017047/1] Funding Source: researchfish; MRC [MR/K017047/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by National Institutes of Health Grants R01 HL-104053 (to M. R.J.), R01 HL-0068153 (to J.P.M.), R01 HL-079392 (to J.P.M.), R00 HL-092956 (to L.J.Q.), R01 HL-111449 (to L.J.Q.), R01 AI-064099 (to S. G.), T32 HL-007035 (for E.K.), and T32 AI-899673 (for G.A.W.) and F31 HL-127978 (to G.A.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdein JD, 2013, CLIN EXP IMMUNOL, V174, P193, DOI 10.1111/cei.12170; Akiyama H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004751; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blahna MT, 2011, J BIOL CHEM, V286, P42381, DOI 10.1074/jbc.M111.259689; Brettschneider J, 2008, TECHNOMETRICS, V50, P241, DOI 10.1198/004017008000000334; Carpenter S, 2015, J INTERF CYTOK RES, V35, P79, DOI 10.1089/jir.2014.0120; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Hyatt LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109072; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jones MR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003105; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kamata H, 2016, AM J RESP CELL MOL, V55, P407, DOI 10.1165/rcmb.2015-0261OC; Kim B, 2015, EMBO J, V34, P1801, DOI 10.15252/embj.201590931; Kirby AC, 2006, J INFECT DIS, V193, P205, DOI 10.1086/498874; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Lee SR, 2013, TRENDS CELL BIOL, V23, P504, DOI 10.1016/j.tcb.2013.05.001; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; LeTonqueze O, 2012, RNA BIOL, V9, P871, DOI 10.4161/rna.20806; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Norbury CJ, 2013, NAT REV MOL CELL BIO, V14, P643, DOI 10.1038/nrm3645; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Quinton LJ, 2015, ANNU REV PHYSIOL, V77, P407, DOI 10.1146/annurev-physiol-021014-071937; Rehfeld F, 2015, CELL TISSUE RES, V359, P145, DOI 10.1007/s00441-014-1872-2; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Schmidt MJ, 2011, RNA, V17, P39, DOI 10.1261/rna.2252511; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Slevin MK, 2014, MOL CELL, V53, P1020, DOI 10.1016/j.molcel.2014.02.027; Thomas MP, 2013, IMMUNOL REV, V253, P237, DOI 10.1111/imr.12052; Thornton JE, 2014, NUCLEIC ACIDS RES, V42, P11777, DOI 10.1093/nar/gku805; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yeom KH, 2011, EMBO REP, V12, P690, DOI 10.1038/embor.2011.100; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179797	10.1371/journal.pone.0179797	http://dx.doi.org/10.1371/journal.pone.0179797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665939	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700040
J	Lehmann, S; Boe, T; Breivik, K				Lehmann, Stine; Boe, Tormod; Breivik, Kyrre			The internal structure of foster-parent completed SDQ for school-aged children	PLOS ONE			English	Article							DIFFICULTIES-QUESTIONNAIRE SDQ; CONFIRMATORY FACTOR-ANALYSIS; SELF-REPORT STRENGTHS; MENTAL-HEALTH; PSYCHIATRIC-DISORDER; COMMUNITY SAMPLE; VALIDITY; VERSION; CARE; PREVALENCE	Mental health problems are common in foster- children, and tools to measure the mental health of these children are needed. One candidate instrument is the Strengths and Difficulties Questionnaire (SDQ), a measure of child psychological adjustment that is increasingly being employed by Child Protection services. The aim of the current study was to examine the structural validity of the foster parent completed SDQ in a sample of 237 school aged foster children. Confirmatory factor analysis demonstrated an excellent fit of the foster parent completed SDQ data to a five- factor model (CFI = 0.96, RMSEA = 0.05, 90% CI [0.04, 0.06]), thus confirming the structural validity of the five- factor model for the parent- version of the SDQ in Norwegian foster children. Measurement invariance analyses indicated that boys had lower thresholds for fighting with or bullying other children than girls. Girls were on their side more likely to be rated as less popular than boys with a similar level of peer problems.	[Lehmann, Stine; Boe, Tormod; Breivik, Kyrre] Uni Res Hlth, Reg Ctr Child & Youth Mental Hlth & Child Welf, Bergen, Norway		Lehmann, S (corresponding author), Uni Res Hlth, Reg Ctr Child & Youth Mental Hlth & Child Welf, Bergen, Norway.	stine.lehmann@uni.no	Bøe, Tormod/GPF-4394-2022					Aguilar-Vafaie ME, 2011, CHILD YOUTH SERV REV, V33, P1, DOI 10.1016/j.childyouth.2010.08.005; Becker A, 2004, EUR CHILD ADOLES PSY, V13, P11, DOI 10.1007/s00787-004-2003-5; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; CALLAGHAN J, 2004, CLIN CHILD PSYCHOL P, V9, P130, DOI DOI 10.1177/1359104504039177; Dumenci L, 2008, PSYCHOL ASSESSMENT, V20, P55, DOI 10.1037/1040-3590.20.1.55; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Ford T, 2007, BRIT J PSYCHIAT, V190, P319, DOI 10.1192/bjp.bp.106.025023; Goodman A, 2012, BRIT J PSYCHIAT, V200, P426, DOI 10.1192/bjp.bp.111.104380; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 2004, EUR CHILD ADOLES PSY, V13, P25, DOI 10.1007/s00787-004-2005-3; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hill CR, 2007, SCHOOL PSYCHOL QUART, V22, P380, DOI 10.1037/1045-3830.22.3.380; Iversen AC., 2007, CHILD CARE PRACTICE, V13, P387, DOI [10.1080/13575270701488790, DOI 10.1080/13575270701488790]; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Janssens A, 2009, EUR CHILD ADOLES PSY, V18, P691, DOI 10.1007/s00787-009-0030-y; Klasen H, 2000, EUR CHILD ADOLES PSY, V9, P271, DOI 10.1007/s007870070030; Koskelainen M, 2000, EUR CHILD ADOLES PSY, V9, P277, DOI 10.1007/s007870070031; Lehmann S, 2015, J ABNORM CHILD PSYCH, P1; Lehmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102134; Lehmann S, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-39; Marquis RA, 2009, VULNERABLE CHILD YOU, V4, P114, DOI 10.1080/17450120902887392; Marzocchi GM, 2004, EUR CHILD ADOLES PSY, V13, P40, DOI 10.1007/s00787-004-2007-1; Mathai J, 2004, AUST NZ J PSYCHIAT, V38, P639, DOI 10.1111/j.1440-1614.2004.01428.x; Mathai J, 2003, AUSTRALAS PSYCHIATRY, V11, P334, DOI DOI 10.1046/J.1440-1665.2003.00544.X; MCDONALD RP, 1978, EDUC PSYCHOL MEAS, V38, P75, DOI 10.1177/001316447803800111; McMillen JC, 2005, J AM ACAD CHILD PSY, V44, P88, DOI 10.1097/01.chi.0000145806.24274.d2; Meade AW, 2008, J APPL PSYCHOL, V93, P568, DOI 10.1037/0021-9010.93.3.568; Minnis H, 2006, EUR CHILD ADOLES PSY, V15, P63, DOI 10.1007/s00787-006-0452-8; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; Muthen B., 2010, MPLUS USERS GUIDE; Muthen L. K, 2013, VERSION 7 1 MPLUS LA; Muthen LK, 2012, COMPREHENSIVE MODELL, V5; National Center for Health Statistics & Division of Health Interview Statistics, 2001, NAT HLTH INT SURV NH; Obel C, 2004, EUR CHILD ADOLES PSY, V13, P32, DOI 10.1007/s00787-004-2006-2; Palmieri PA, 2007, PSYCHOL ASSESSMENT, V19, P189, DOI 10.1037/1040-3590.19.2.189; Percy A, 2008, EUR J PSYCHOL ASSESS, V24, P43, DOI 10.1027/1015-5759.24.1.43; Richards L, 2006, ADOPT FOSTER, V30, P43, DOI 10.1177/030857590603000206; Ronning JA, 2004, EUR CHILD ADOLES PSY, V13, P73, DOI 10.1007/s00787-004-0356-4; Sanne B, 2009, PSYCHOL ASSESSMENT, V21, P352, DOI 10.1037/a0016317; Stone LL, 2013, EUR J PSYCHOL ASSESS, V29, P44, DOI 10.1027/1015-5759/a000119; Stringaris A, 2013, J ABNORMAL CHILD PSY, P1; Teggart T., 2005, CHILD CARE PRACTICE, V11, P39, DOI DOI 10.1080/1357527042000332781; Toplak ME, 2012, J CHILD PSYCHOL PSYC, V53, P292, DOI 10.1111/j.1469-7610.2011.02500.x; van de Looij-Jansen PM, 2011, BRIT J CLIN PSYCHOL, V50, P127, DOI 10.1348/014466510X498174; Van Leeuwen K, 2006, EUR J PSYCHOL ASSESS, V22, P189, DOI 10.1027/1015-5759.22.3.189; Van Roy B, 2008, J CHILD PSYCHOL PSYC, V49, P1304, DOI 10.1111/j.1469-7610.2008.01942.x; van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3; Woerner W, 2004, EUR CHILD ADOLES PSY, V13, P47, DOI 10.1007/s00787-004-2008-0; Yao SQ, 2009, J ADOLESCENT HEALTH, V45, P55, DOI 10.1016/j.jadohealth.2008.11.006; Yu C. Y, 2002, EVALUATION MODEL FIT	55	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0176625	10.1371/journal.pone.0176625	http://dx.doi.org/10.1371/journal.pone.0176625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665965	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608700025
J	Moradi, S; Sahebi, Z; Valojerdi, AE; Rohani, F; Ebrahimi, H				Moradi, Sedighe; Sahebi, Zeinab; Valojerdi, Ameneh Ebrahim; Rohani, Farzaneh; Ebrahimi, Hooman			ocr v56 The association between the number of office visits and the control of cardiovascular risk factors in Iranian patients with type2 diabetes	PLOS ONE			English	Article							GLYCEMIC CONTROL; ENCOUNTER FREQUENCY; BLOOD-PRESSURE; ADHERENCE; BARRIERS; MANAGEMENT; MELLITUS; QUALITY; GLUCOSE	Introduction Patients with diabetes type2 should receive regular medical care. We aimed at investigating the association between the number of office visits and improvement of their cardiovascular- risk factors. Methods Four hundred and ninety patients with type 2 diabetes mellitus who were followed in a tertiary center were enrolled in this longitudinal study. The minimum follow up period was 3 years. Patient data were extracted from manual or electronic records. Results Sixty-four percent of cases were females, the mean age was 61 +/- 12.45 years, and the mean disease duration was 6.5 +/- 7.9 years. The mean number of office visits was 2.69 +/- 0.91 per year. Comparing the means of each of the cardio-vascular risk factors showed a significant decrease in all cardiovascular risk factors, while there was a significant weight gain over the same period. The association between changes in these parameters and the number of patients' office visits per year were not statistically significant. In patients with disease duration less than 5 years, each additional office visits by one visit per year was associated with a decrease in serum total cholesterol by 6.94 mg/dl. The mean number of office visits per year in patients older than 60 years old was more than younger patient (p = 0.001). Conclusion The decrease in the mean values of the investigated parameters was statistically significant between the first year of follow up and the following years. Yet, these changes were not related to the mean number of patients' office visits per year, which may reflect the poor compliance of patients to treatment regardless of the number of their office visits.	[Moradi, Sedighe; Sahebi, Zeinab] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran; [Valojerdi, Ameneh Ebrahim] Iran Univ Med Sci, Inst Endocrinol & Metab, Div Biostat, Endocrine Res Ctr, Tehran, Iran; [Rohani, Farzaneh] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Res Ctr Growth & Dev Childhood & Adolescence, Tehran, Iran; [Ebrahimi, Hooman] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Tehran University of Medical Sciences	Moradi, S (corresponding author), Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran.	Moradi.s@iums.ac.ir	Moradi, Sedighe/AAE-8262-2020; Rohani, Farzaneh/O-9952-2018	Moradi, Sedighe/0000-0002-1840-6186; Rohani, Farzaneh/0000-0002-2277-4862; ebrahimi, hooman/0000-0001-5939-3185				Aikens JE, 2013, DIABETIC MED, V30, P338, DOI 10.1111/dme.12046; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2015, DIABETES CARE, V38, pS33, DOI 10.2337/dc15-S009; [Anonymous], 1997, AGE ADJUSTED PERCENT; Ashman JJ, NCHS DATA BRIEF, V2014, P1; Bhattacharyya OK, 2011, INT J CIRCUMPOL HEAL, V70, P552, DOI 10.3402/ijch.v70i5.17848; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Fenton JJ, 2006, ANN FAM MED, V4, P32, DOI 10.1370/afm.421; Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Huang ES, 2009, MULTIDISCIPLINARY AP; Kaufman FR, 1999, PEDIATRICS, V103, P948, DOI 10.1542/peds.103.5.948; Martin S, 2006, DIABETOLOGIA, V49, P271, DOI 10.1007/s00125-005-0083-5; Morrison F, 2011, ARCH INTERN MED, V171, P1542, DOI 10.1001/archinternmed.2011.400; Munshi MN, 2013, DIABETES CARE, V36, P543, DOI 10.2337/dc12-1303; National Diabetes Fact Sheet, 2011, NATL DIABETES FACT S; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Patel I, 2010, INT J DIABETES MELLI, V2, P122, DOI DOI 10.1016/J.IJDM.2010.05.003; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Ross SA, 2013, AM J MED, V126, pS38, DOI 10.1016/j.amjmed.2013.06.012; Takahashi PY, 2015, DIABET METAB SYND OB, V8, P1, DOI 10.2147/DMSO.S71726; Turchin A, 2010, HYPERTENSION, V56, P68, DOI 10.1161/HYPERTENSIONAHA.109.148791; Vijan S, 1997, J GEN INTERN MED, V12, P567, DOI 10.1046/j.1525-1497.1997.07111.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179190	10.1371/journal.pone.0179190	http://dx.doi.org/10.1371/journal.pone.0179190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666031	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700030
J	Anton-Sanchez, L; Larranaga, P; Benavides-Piccione, R; Fernaud-Espinosa, I; DeFelipe, J; Bielza, C				Anton-Sanchez, Laura; Larranaga, Pedro; Benavides-Piccione, Ruth; Fernaud-Espinosa, Isabel; DeFelipe, Javier; Bielza, Concha			Three-dimensional spatial modeling of spines along dendritic networks in human cortical pyramidal neurons	PLOS ONE			English	Article							POINT PATTERNS; INNERVATION	We modeled spine distribution along the dendritic networks of pyramidal neurons in both basal and apical dendrites. To do this, we applied network spatial analysis because spines can only lie on the dendritic shaft. We expanded the existing 2D computational techniques for spatial analysis along networks to perform a 3D network spatial analysis. We analyzed five detailed reconstructions of adult human pyramidal neurons of the temporal cortex with a total of more than 32,000 spines. We confirmed that there is a spatial variation in spine density that is dependent on the distance to the cell body in all dendrites. Considering the dendritic arborizations of each pyramidal cell as a group of instances of the same observation (the neuron), we used replicated point patterns together with network spatial analysis for the first time to search for significant differences in the spine distribution of basal dendrites between different cells and between all the basal and apical dendrites. To do this, we used a recent variant of Ripley's Kfunction defined to work along networks. The results showed that there were no significant differences in spine distribution along basal arbors of the same neuron and along basal arbors of different pyramidal neurons. This suggests that dendritic spine distribution in basal dendritic arbors adheres to common rules. However, we did find significant differences in spine distribution along basal versus apical networks. Therefore, not only do apical and basal dendritic arborizations have distinct morphologies but they also obey different rules of spine distribution. Specifically, the results suggested that spines are more clustered along apical than in basal dendrites. Collectively, the results further highlighted that synaptic input information processing is different between these two dendritic domains.	[Anton-Sanchez, Laura; Larranaga, Pedro; Bielza, Concha] Univ Politecn Madrid, Escuela Tecn Super Ingenieros Informat, Dept Inteligencia Artificial, Madrid, Spain; [Benavides-Piccione, Ruth; Fernaud-Espinosa, Isabel; DeFelipe, Javier] Univ Politecn Madrid, Lab Cajal Circuitos Cort, Ctr Tecnol Biomed, Madrid, Spain; [Benavides-Piccione, Ruth; Fernaud-Espinosa, Isabel; DeFelipe, Javier] CSIC, Inst Cajal, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Anton-Sanchez, L (corresponding author), Univ Politecn Madrid, Escuela Tecn Super Ingenieros Informat, Dept Inteligencia Artificial, Madrid, Spain.	l.anton-sanchez@upm.es	Fernaud-Espinosa, Isabel/H-1875-2015; Bielza, Concha/F-9277-2013; DEFELIPE, JAVIER/D-1195-2014; benavides-piccione, ruth/D-7889-2014; Larranaga, Pedro/F-9293-2013	Fernaud-Espinosa, Isabel/0000-0003-2391-0704; Bielza, Concha/0000-0001-7109-2668; DEFELIPE, JAVIER/0000-0001-5484-0660; benavides-piccione, ruth/0000-0003-3288-9820; Larranaga, Pedro/0000-0003-0652-9872; Anton-Sanchez, Laura/0000-0002-5556-1759	Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain [C080020-09, TIN2016-79684-P]; Regional Government of Madrid [S2013/ICE-2845-CASI-CAM-CM]; European Union [720270]; Spanish MINECO scholarship at the Residencia de Estudiantes	Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain(Spanish Government); Regional Government of Madrid; European Union(European Commission); Spanish MINECO scholarship at the Residencia de Estudiantes	This research has been partially supported by the Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain (C080020-09; the Spanish partner of the Blue Brain initiative from EPFL) and TIN2016-79684-P projects, by the Regional Government of Madrid through the S2013/ICE-2845-CASI-CAM-CM project, and by the European Union Horizon 2020 research and innovation programme under grant agreement No. 720270. LA-S acknowledges support from the Spanish MINECO scholarship at the Residencia de Estudiantes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang QW, 2012, SCAND J STAT, V39, P591, DOI 10.1111/j.1467-9469.2011.00752.x; Anton-Sanchez L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00085; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A., 2010, ANAL SPATIAL POINT P, P232; Baddeley A, 2015, SPATIAL POINT PATTER; Baddeley A.J., 1993, APPL STAT, V42, DOI [10.2307/2986181, DOI 10.2307/2986181]; Baddeley A, 2014, J R STAT SOC C-APPL, V63, P673, DOI 10.1111/rssc.12054; Baddeley AJ, 2000, STAT NEERL, V54, P329, DOI 10.1111/1467-9574.00144; Benavides-Piccione R, 2005, CEREB CORTEX, V15, P1584, DOI 10.1093/cercor/bhi036; Benavides-Piccione R, 2013, CEREB CORTEX, V23, P1798, DOI 10.1093/cercor/bhs154; BERMAN M, 1986, J R STAT SOC C-APPL, V35, P54; Blazquez-Llorca L, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00020; Burguet J, 2011, PATTERN RECOGN LETT, V32, P1894, DOI 10.1016/j.patrec.2011.07.008; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Diggle P., 2003, STAT ANAL SPATIAL PO; DIGGLE PJ, 1991, J AM STAT ASSOC, V86, P618, DOI 10.2307/2290390; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Elston GN, 2002, PROG BRAIN RES, V136, P109; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Garcia-Marin V, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.028.2009; Hahn U, 2012, J AM STAT ASSOC, V107, P754, DOI 10.1080/01621459.2012.688463; Illian J, 2008, STAT ANAL MODELLING; Jafari-Mamaghani M, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fninf.2010.00009; Jammalamadaka A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-287; McSwiggan G, 2016, SCANDINAVIAN J STAT; Myllymaki M, 2012, J MICROSC-OXFORD, V247, P228, DOI 10.1111/j.1365-2818.2012.03636.x; Okabe A, 2001, GEOGR ANAL, V33, P271, DOI 10.1111/j.1538-4632.2001.tb00448.x; Okabe A., 2009, INT J GEOGR INF SYST, V23, P1, DOI DOI 10.1080/13658810802475491; Okabe A., 2012, SPATIAL ANAL NETWORK; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Vaught J, 2012, BIOPRESERV BIOBANK, V10, P76, DOI [10.1089/bio.2012.1024, 10.1089/bio.2012.1025]; Wager CG, 2004, J R STAT SOC B, V66, P429, DOI 10.1046/j.1369-7412.2003.05285.x	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180400	10.1371/journal.pone.0180400	http://dx.doi.org/10.1371/journal.pone.0180400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662210	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300151
J	Bovo, S; Mazzoni, G; Ribani, A; Utzeri, VJ; Bertolini, F; Schiavo, G; Fontanesi, L				Bovo, Samuele; Mazzoni, Gianluca; Ribani, Anisa; Utzeri, Valerio Joe; Bertolini, Francesca; Schiavo, Giuseppina; Fontanesi, Luca			A viral metagenomic approach on a non-metagenomic experiment: Mining next generation sequencing datasets from pig DNA identified several porcine parvoviruses for a retrospective evaluation of viral infections	PLOS ONE			English	Article							COPY NUMBER; ASSOCIATION; GENOMES; QUALITY; PIPELINE; VIRUSES; SAMPLES; TRAITS; VIROME	Shot-gun next generation sequencing (NGS) on whole DNA extracted from specimens collected from mammals often produces reads that are not mapped (i.e. unmapped reads) on the host reference genome and that are usually discarded as by-products of the experiments. In this study, we mined Ion Torrent reads obtained by sequencing DNA isolated from archived blood samples collected from 100 performance tested Italian Large White pigs. Two reduced representation libraries were prepared from two DNA pools constructed each from 50 equimolar DNA samples. Bioinformatic analyses were carried out to mine unmapped reads on the reference pig genome that were obtained from the two NGS data sets. In silico analyses included read mapping and sequence assembly approaches for a viral metagenomic analysis using the NCBI Viral Genome Resource. Our approach identified sequences matching several viruses of the Pantoviridae family: porcine parvovirus 2 (PPV2), PPV4, PPV5 and PPV6 and porcine bocavirus 1-H18 isolate (PBoV1-H18). The presence of these viruses was confirmed by PCR and Sanger sequencing of individual DNA samples. PPV2, PPV4, PPV5, PPV6 and PBoV1-H18 were all identified in samples collected in 1998-2007,1998-2000,1997-2000,1998-2004 and 2003, respectively. For most of these viruses (PPV4, PPV5, PPV6 and PBoV1-H18) previous studies reported their first occurrence much later (from 5 to more than 10 years) than our identification period and in different geographic areas. Our study provided a retrospective evaluation of apparently asymptomatic parvovirus infected pigs providing information that could be important to define occurrence and prevalence of different parvoviruses in South Europe. This study demonstrated the potential of mining NGS datasets non-originally derived by metagenomics experiments for viral metagenomics analyses in a livestock species.	[Bovo, Samuele; Mazzoni, Gianluca; Ribani, Anisa; Utzeri, Valerio Joe; Bertolini, Francesca; Schiavo, Giuseppina; Fontanesi, Luca] Univ Bologna, Div Anim Sci, Dept Agr & Food Sci DISTAL, Bologna, Italy; [Bovo, Samuele] Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Biocomp Grp, Bologna, Italy; [Mazzoni, Gianluca] Univ Copenhagen, Dept Vet Clin & Anim Sci, Copenhagen, Denmark; [Bertolini, Francesca] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Bologna; University of Bologna; University of Copenhagen; Iowa State University	Fontanesi, L (corresponding author), Univ Bologna, Div Anim Sci, Dept Agr & Food Sci DISTAL, Bologna, Italy.	luca.fontanesi@unibo.it	Mazzoni, Gianluca/AAC-6041-2019; Bovo, Samuele/M-4179-2019; bertolini, francesca/AAX-3836-2021; Fontanesi, Luca/L-1770-2014	Mazzoni, Gianluca/0000-0003-2397-1064; Bovo, Samuele/0000-0002-5712-8211; Fontanesi, Luca/0000-0001-7050-3760; Bertolini, Francesca/0000-0003-4181-3895	Ministero delle Politiche Agricole, Alimentari e Forestall, grant INNOVAGEN; University of Bologna, grant RFO	Ministero delle Politiche Agricole, Alimentari e Forestall, grant INNOVAGEN; University of Bologna, grant RFO	Funders: 1) Ministero delle Politiche Agricole, Alimentari e Forestall, grant INNOVAGEN; 2) University of Bologna, grant RFO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Crcer DA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-989; Belak S, 2013, VET MICROBIOL, V165, P95, DOI 10.1016/j.vetmic.2013.01.022; Bexfield N, 2011, VET J, V190, P191, DOI 10.1016/j.tvjl.2010.10.014; Bibby K, 2013, TRENDS BIOTECHNOL, V31, P11, DOI 10.1016/j.tibtech.2013.01.016; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Bovo S, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/950737; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Cadar D, 2013, J GEN VIROL, V94, P2330, DOI 10.1099/vir.0.055129-0; Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; Daly GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129059; Fontanesi L, 2008, MEAT SCI, V80, P780, DOI 10.1016/j.meatsci.2008.03.022; Fontanesi L, 2010, J ANIM SCI, V88, P2235, DOI 10.2527/jas.2009-2560; Fontanesi L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-583; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gunn Lynda, 2015, Infection Ecology & Epidemiology, V5, P27270, DOI 10.3402/iee.v5.27270; Ho T, 2014, VIROLOGY, V471, P54, DOI 10.1016/j.virol.2014.09.019; Lee D, 2011, ANIM BIOTECHNOL, V22, P175, DOI 10.1080/10495398.2011.595294; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2015, J GEN VIROL, V96, P2721, DOI 10.1099/vir.0.000199; Mang R, 2001, J GEN VIROL, V82, P1829, DOI 10.1099/0022-1317-82-8-1829; Masembe C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-218; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Ndze VN, 2013, INFECT GENET EVOL, V17, P277, DOI 10.1016/j.meegid.2013.03.006; Ng TFF, 2015, J VIROL, V89, P5340, DOI 10.1128/JVI.00064-15; Ni JQ, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0203-2; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Opriessnig T, 2014, VET MICROBIOL, V173, P9, DOI 10.1016/j.vetmic.2014.06.024; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Sauvage V, 2016, TRANSFUS CLIN BIOL, V23, P28, DOI 10.1016/j.tracli.2015.12.002; Schirtzinger EE, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0401-6; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Shan TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017292; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smits SL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00714; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Streck AF, 2013, ARCH VIROL, V158, P1173, DOI 10.1007/s00705-013-1603-0; Vazquez-Castellanos JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-37; Warr A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00338; Wen LB, 2015, ARCH VIROL, V160, P371, DOI 10.1007/s00705-014-2242-9; Whitacre LK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2313-7; Xiao CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065312; Xiao CT, 2013, INFECT GENET EVOL, V16, P369, DOI 10.1016/j.meegid.2013.03.017	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179462	10.1371/journal.pone.0179462	http://dx.doi.org/10.1371/journal.pone.0179462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662150	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300025
J	Kropackova, L; Pechmanova, H; Vinkler, M; Svobodova, J; Velova, H; Tesicky, M; Martin, JF; Kreisinger, J				Kropackova, Lucie; Pechmanova, Hana; Vinkler, Michal; Svobodova, Jana; Velova, Hana; Tesicky, Martin; Martin, Jean-Francois; Kreisinger, Jakub			Variation between the oral and faecal microbiota in a free-living passerine bird, the great tit (Parus major)	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL COMMUNITIES; ELIZABETHKINGIA-MENINGOSEPTICA; INTESTINAL MICROBIOTA; WILD; ENERGY; HEALTH; TRACT; DIVERSITY; SEQUENCES	The gastrointestinal tract of vertebrates is inhabited by diverse bacterial communities that induce marked effects on the host physiology and health status. The composition of the gastrointestinal microbiota is characterized by pronounced taxonomic and functional variability among different regions of the vertebrate gastrointestinal tract. Despite the relatively solid knowledge on the among-region variations of the gastrointestinal microbiota in model mammalian species, there are only a few studies concerning among-region variations of the gastrointestinal microbiota in free-living non-mammalian vertebrate taxa. We used Illumina MiSeq sequencing of bacterial 16S rRNA amplicons to compare the diversity as well as taxonomic composition of bacterial communities in proximal vs. distal parts of the gastrointestinal tract (represented by oral swabs and faecal samples, respectively) in a wild passerine bird, the great tit (Parus major). The diversity of the oral microbiota was significantly higher compared to the faecal microbiota, whereas interindividual variation was higher in faecal than in oral samples. We also observed a pronounced difference in taxonomic content between the oral and faecal microbiota. Bacteria belonging to the phyla Proteobacteria, Firmicutes and Actinobacteria typically dominated in both oral and faecal samples. A high abundance of bacteria belonging to Tenericutes was observed only in faecal samples. Surprisingly, we found only a slight correlation between the faecal and oral microbiota at the within-individual level, suggesting that the microbial composition in these body sites is shaped by independent regulatory processes. Given the independence of these two communities at the individual level, we propose that simultaneous sampling of the faecal and oral microbiota will extend our understanding of host vs. microbiota interactions in wild populations.	[Kropackova, Lucie; Pechmanova, Hana; Vinkler, Michal; Velova, Hana; Tesicky, Martin; Kreisinger, Jakub] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Svobodova, Jana] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Martin, Jean-Francois] Montpellier SupAgro, UMR CBGP, Montferrier Sur Lez, France	Charles University Prague; Czech University of Life Sciences Prague; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Kropackova, L (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	lucie.kropackova@gmail.com	Martin, Jean-Francois/M-9426-2017; Těšický, Martin/AAX-5593-2021; Bainova, Hana/I-3888-2012; Vinkler, Michal/G-2072-2011; Martin, Jean-Francois/AAD-3883-2019; Schmiedová, Lucie/S-3351-2017; Svobodova, Jana/G-9692-2012; Tesicky, Martin/L-3370-2017; Kreisinger, Jakub/H-4020-2011	Martin, Jean-Francois/0000-0001-9176-4476; Těšický, Martin/0000-0001-8097-5331; Bainova, Hana/0000-0002-4578-633X; Vinkler, Michal/0000-0003-3572-9494; Martin, Jean-Francois/0000-0001-9176-4476; Schmiedová, Lucie/0000-0003-2180-5281; Svobodova, Jana/0000-0001-6161-4899; Tesicky, Martin/0000-0001-8097-5331; 	Czech Science foundation project [15-11782S]; Czech Science foundation [14-16596P]; Grant Agency of Charles University [281315]; SW project [260 434/2017]	Czech Science foundation project(Grant Agency of the Czech Republic); Czech Science foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University; SW project	Field works were funded by Czech Science foundation project 15-11782S (http://www.gacr.cz/). Wet-lab procedures and data analyses were funded by Czech Science foundation project 14-16596P, and by Grant Agency of Charles University (project 281315, http://www.cuni.cz/UK-33.html). LK, HP, HV and MT were supported by SW project no. 260 434/2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10189; [Anonymous], 2009, ORAL MICROBIOLOGY; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benskin CMH, 2015, ECOL EVOL, V5, P821, DOI 10.1002/ece3.1384; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bik EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10516; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Boutin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102649; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carson JK, 2009, FEMS MICROBIOL ECOL, V67, P381, DOI 10.1111/j.1574-6941.2008.00645.x; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; Colston TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128793; Costea PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057521; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cramp S., 1993, BIRDS W PALEARCTIC, V7; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Escallon C, 2017, FUNCT ECOL, V31, P192, DOI 10.1111/1365-2435.12696; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P431, DOI 10.1016/j.copbio.2011.11.017; Gonzalez-Braojos S, 2012, J ORNITHOL, V153, P181, DOI 10.1007/s10336-011-0725-y; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Han GG, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2604-8; Hildebrand F, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-30; Hird SM, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.01403, 10.3389/fmicb.2015.01403]; Hird SM, 2014, PEERJ, V2, DOI 10.7717/peerj.321; Jackson MK, 1996, AVIAN DIS, V40, P473, DOI 10.2307/1592248; Jean SS, 2014, J HOSP INFECT, V86, P244, DOI 10.1016/j.jhin.2014.01.009; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kienzle E, 2001, J ANIM PHYSIOL AN N, V85, P148, DOI 10.1046/j.1439-0396.2001.00311.x; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kohl KD, 2013, ENV MICROBIOL REP, V5, P899, DOI 10.1111/1758-2229.12092; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kreisinger J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00050; Kreisinger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137401; Kreisinger J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0295; Kreisinger J, 2014, MOL ECOL, V23, P5048, DOI 10.1111/mec.12909; Lear G, 2008, FEMS MICROBIOL ECOL, V65, P463, DOI 10.1111/j.1574-6941.2008.00548.x; Lee NK, 2015, LWT-FOOD SCI TECHNOL, V64, P1036, DOI 10.1016/j.lwt.2015.07.019; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Lewis WB, 2017, AUK, V134, P137, DOI 10.1642/AUK-16-120.1; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li H, 2016, FRONT MICROBIOL, P7; Li J, 2014, J APPL MICROBIOL, V117, P1750, DOI 10.1111/jam.12663; Li ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114513; Loch TP, 2015, J ADV RES, V6, P283, DOI 10.1016/j.jare.2014.10.009; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu L, 2001, AM J CLIN NUTR, V73, p1124S; Lucas FS, 2005, J AVIAN BIOL, V36, P510, DOI 10.1111/j.0908-8857.2005.03479.x; Luerce TD, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-33; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Matthews DM, 2013, BEHAV PROCESS, V96, P27, DOI 10.1016/j.beproc.2013.02.007; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McWhorter TJ, 2009, BIOL REV, V84, P533, DOI 10.1111/j.1469-185X.2009.00086.x; Meyer JM, 2002, APPL ENVIRON MICROB, V68, P2745, DOI 10.1128/AEM.68.6.2745-2753.2002; Mirn L., 2014, METAGENOMICS, V3, P1, DOI [10.4303/mg/235853, DOI 10.4303/MG/235853]; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nazef L, 2008, POULTRY SCI, V87, P329, DOI 10.3382/ps.2007-00282; Nelson KE, 2015, ILAR J, V56, P163, DOI 10.1093/ilar/ilv033; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Ouyang JQ, 2013, J EVOLUTION BIOL, V26, P1988, DOI 10.1111/jeb.12202; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pereira GH, 2013, BRAZ J INFECT DIS, V17, P606, DOI 10.1016/j.bjid.2013.02.011; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Core Team, 2021, R LANGUAGE ENV STAT; Rampelli S, 2013, J NUTR HEALTH AGING, V17, P166, DOI 10.1007/s12603-012-0372-x; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Robertson PAW, 2000, AQUACULTURE, V185, P235, DOI 10.1016/S0044-8486(99)00349-X; Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scupham AJ, 2008, MICROB ECOL, V56, P322, DOI 10.1007/s00248-007-9349-4; Seccareccia I, 2015, APPL ENVIRON MICROB, V81, P7098, DOI 10.1128/AEM.01781-15; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Sumithra TG, 2013, EUR J WILDLIFE RES, V59, P769, DOI 10.1007/s10344-013-0769-9; Suzuki TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163720; van Schijndel RJMS, 2006, CLIN NUTR, V25, P758, DOI 10.1016/j.clnu.2005.11.012; Voegeli B, 2012, J EVOLUTION BIOL, V25, P584, DOI 10.1111/j.1420-9101.2011.02445.x; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Waite DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035803; Walker SE, 2002, AVIAN DIS, V46, P1045, DOI 10.1637/0005-2086(2002)046[1045:COPAIA]2.0.CO;2; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7440; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinberger M, 2004, EPIDEMIOL INFECT, V132, P1023, DOI 10.1017/S0950268803001109; WELLS CL, 1988, REV INFECT DIS, V10, P958; Wichert B, 2007, J ANIM PHYSIOL AN N, V91, P278, DOI 10.1111/j.1439-0396.2007.00705.x; Wienemann T, 2011, SYST APPL MICROBIOL, V34, P542, DOI 10.1016/j.syapm.2011.06.003; Wilkinson N, 2016, APPL MICROBIOL BIOT, V100, P4201, DOI 10.1007/s00253-015-7280-z; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185	111	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179945	10.1371/journal.pone.0179945	http://dx.doi.org/10.1371/journal.pone.0179945			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662106	Green Published, gold			2022-12-27	WOS:000404608300078
J	Rasdal, V; Fudel, R; Kocbach, J; Moen, F; Ettema, G; Sandbakk, O				Rasdal, Vegard; Fudel, Ronny; Kocbach, Jan; Moen, Frode; Ettema, Gertjan; Sandbakk, Oyvind			Association between laboratory capacities and world-cup performance in Nordic combined	PLOS ONE			English	Article							CROSS-COUNTRY SKIERS; MAXIMAL OXYGEN-UPTAKE; TRAINING CHARACTERISTICS; JUMPERS; STRENGTH; GENDER; FORCES; SPEED	Background Nordic combined (NC) is an Olympic winter-sport performed as a ski jumping (SJ) event followed by a cross-country (XC) pursuit race employing the skating style. Purpose To elucidate the associations between sport-specific laboratory capacities and SJ, XC skiing, and overall NC performance in a world-cup NC event. Methods Twelve international world-cup NC athletes from 8 nations performed laboratory testing one day prior to participating in a world-cup NC event. Squat jumps and SJ imitations (IMIT) were performed on a three-dimensional force plate, whereas XC skiing-specific physiological characteristics were obtained from roller ski skating tests on a treadmill and an all-out double poling (DP) test. Finally, body composition was measured. Laboratory capacities were correlated against performance in SJ, 10-km XC skiing, and overall NC in the world-cup event. Multiple regression analysis was used to determine the best suited laboratory variables for predicting performance. Results Vertical IMIT velocity together with body-mass provided the best prediction for SJ performance (r(2) = 0.70, p<0.01), while body-mass-normalized VO2peak and DP power provided the best prediction for XC performance (r(2) = 0.68, p<0.05). Body-mass-normalized VO2peak was the only significant correlate with overall NC performance (r(2) = 0.43, p<0.05) in this competition. Conclusion Overall, the concurrent development of VO2peak, upper-body power, and SJ-specific vertical jump capacity while minimizing body-mass within the BMI limit set by FIS should be considered in the seasonal training of NC athletes.	[Rasdal, Vegard; Kocbach, Jan; Moen, Frode; Ettema, Gertjan; Sandbakk, Oyvind] Norwegian Univ Sci & Technol, Ctr Elite Sports Res, Dept Neuromed & Movement Sci, Factulty Med & Hlth Sci, Trondheim, Norway; [Fudel, Ronny] Univ Leipzig, Inst Movement & Training Sci Sports, Fac Sport Sci, Leipzig, Germany; [Moen, Frode] Norwegian Univ Sci & Technol, Dept Educ, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Leipzig University; Norwegian University of Science & Technology (NTNU)	Rasdal, V (corresponding author), Norwegian Univ Sci & Technol, Ctr Elite Sports Res, Dept Neuromed & Movement Sci, Factulty Med & Hlth Sci, Trondheim, Norway.	vegard.rasdal@ntnu.no	Ettema, Gertjan/C-2104-2018; Seys, Deborah/A-5177-2018; Sermeus, Walter/J-4290-2017	Sermeus, Walter/0000-0002-5915-1845; Kocbach, Jan/0000-0002-6360-6814	Centre for Elite Sports Research; Department of Neuroscience and MovementScience; Facultyof Medicine and Health; Norwegian University of Science and Technology; Norwegian Olympic Sports Center(Olympiatoppen)	Centre for Elite Sports Research; Department of Neuroscience and MovementScience; Facultyof Medicine and Health; Norwegian University of Science and Technology; Norwegian Olympic Sports Center(Olympiatoppen)	This research received funding from the Centre for Elite Sports Research, Department of Neuroscience and MovementScience, Facultyof Medicine and Health, Norwegian University of Science and Technology and the Norwegian Olympic Sports Center(Olympiatoppen). The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Andersson E, 2010, EUR J APPL PHYSIOL, V110, P585, DOI 10.1007/s00421-010-1535-2; Bilodeau B, 1996, MED SCI SPORT EXER, V28, P128, DOI 10.1097/00005768-199601000-00024; Bolger CM, 2015, INT J SPORT PHYSIOL, V10, P873, DOI 10.1123/ijspp.2014-0335; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Ettema G, 2016, J SPORT SCI, V34, P1081, DOI 10.1080/02640414.2015.1088660; Hegge AM, 2015, EUROPEAN J APPL PHYS; Hegge AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127509; Holmberg HC, 2007, SCAND J MED SCI SPOR, V17, P437, DOI 10.1111/j.1600-0838.2006.00592.x; Ingjer F, 1992, J SPORT SCI, V10, P49, DOI 10.1080/02640419208729906; Janura M, 2016, J STRENGTH COND RES, V30, P71, DOI 10.1519/JSC.0000000000001046; Janura M, 2015, J SPORT SCI, V33, P687, DOI 10.1080/02640414.2014.962570; Losnegard T, 2011, SCAND J MED SCI SPOR, V21, P389, DOI 10.1111/j.1600-0838.2009.01074.x; Millet GY, 1998, MED SCI SPORT EXER, V30, P1645, DOI 10.1097/00005768-199811000-00014; Muller W, 2009, SPORTS MED, V39, P85, DOI 10.2165/00007256-200939020-00001; Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Ronnestad BR, 2013, EUR J APPL PHYSIOL, V113, P1833, DOI 10.1007/s00421-013-2611-1; SALTIN B, 1967, J APPL PHYSIOL, V23, P353, DOI 10.1152/jappl.1967.23.3.353; Sandbakk O, 2014, SCAND J MED SCI SPOR, V24, P28, DOI 10.1111/j.1600-0838.2012.01482.x; Sandbakk O, 2011, SCAND J MED SCI SPOR, V21, pE9, DOI 10.1111/j.1600-0838.2010.01117.x; Sandbakk O, 2016, INT J SPORT PHYSIOL, V11, P899, DOI 10.1123/ijspp.2015-0285; Sandbakk O, 2014, INT J SPORT PHYSIOL, V9, P117, DOI [10.1123/ijspp.2013-0373, 10.1123/IJSPP.2013-0373]; Sandbakk O, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00293; Sandbakk O, 2011, EUR J APPL PHYSIOL, V111, P947, DOI 10.1007/s00421-010-1719-9; Sandbakk O, 2010, EUR J APPL PHYSIOL, V109, P473, DOI 10.1007/s00421-010-1372-3; Schmolzer B, 2002, J BIOMECH, V35, P1059, DOI 10.1016/S0021-9290(02)00066-0; Schwameder H, 2008, SPORT BIOMECH, V7, P114, DOI 10.1080/14763140701687560; Tonnessen E, 2016, INT J SPORT PHYSIOL, V11, P643, DOI 10.1123/ijspp.2015-0309; Tonnessen E, 2015, INT J SPORT PHYSIOL, V10, P835, DOI 10.1123/ijspp.2014-0431; Umberger BR, 2006, J BIOMECH, V39, P1472, DOI 10.1016/j.jbiomech.2005.03.025; Virmavirta M, 2009, J BIOMECH, V42, P1095, DOI 10.1016/j.jbiomech.2009.02.026; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d	32	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180388	10.1371/journal.pone.0180388	http://dx.doi.org/10.1371/journal.pone.0180388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662163	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300148
J	Song, YS; Joo, HW; Park, IH; Shen, GY; Lee, Y; Shin, JH; Kim, H; Kim, KS				Song, Yi-Sun; Joo, Hyun-Woo; Park, In-Hwa; Shen, Guang-Yin; Lee, Yonggu; Shin, Jeong Hun; Kim, Hyuck; Kim, Kyung-Soo			Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction	PLOS ONE			English	Article							ISCHEMIC-HEART; FUNCTIONAL IMPROVEMENT; MOUSE MODEL; TRANSPLANTATION; MICRORNAS; VEGF; CARDIOMYOCYTES; EXPRESSION; ANGIOGENESIS; MECHANISMS	Bone marrow-mesenchymal stem cell (BM-MSC) therapy improves the recovery of cardiac function after myocardial infarction (MI); however, the underlying molecular mechanisms are not completely understood. Recent studies have shown that microRNAs (miRNAs) modulate the pathophysiology of cardiovascular diseases. Here, we investigated the mechanisms underlying the effects of BM-MSC-derived paracrine factors and cardiac miRNAs on myocardial regeneration after MI. In our study, MI was induced by permanent ligation of the left anterior descending (LAD) coronary artery. BM-MSCs transplanted in infarcted rats significantly downregulated the expression of miRNA-23a and miRNA-92a and inhibited apoptosis in the myocardium. An in vitro experiment showed that supernatant from BM-MSCs cultured under hypoxia contained higher levels of vascular endothelial growth factor (VEGF) than that from BM-MSCs under normoxia. In addition, inhibition of miRNA-23a and miRNA-92a reduced cardiac apoptosis. Moreover, the VEGF-containing BM-MSC supernatant inhibited miRNA-23a and miRNA-92a expression and reduced apoptotic signaling in cardiomyocytes under hypoxia. These effects were inhibited when the supernatant was treated with neutralizing antibodies against VEGF. Our results indicate that the paracrine factor, VEGF, derived from transplanted BM-MSCs, regulated the expression of miRNAs such as miRNA-23a and miRNA-92a and exerted anti-apoptotic effects in cardiomyocytes after MI.	[Song, Yi-Sun; Joo, Hyun-Woo; Park, In-Hwa; Kim, Kyung-Soo] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea; [Shen, Guang-Yin; Kim, Kyung-Soo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Yonggu; Shin, Jeong Hun] Hanyang Univ, Guri Hosp, Dept Internal Med, Guri, South Korea; [Kim, Hyuck] Hanyang Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University	Kim, KS (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea.	kskim@hanyang.ac.kr	Lee, Yonggu/Q-3832-2018; Shin, Jeong Hun/O-1273-2019	Lee, Yonggu/0000-0002-3757-3692; Shin, Jeong Hun/0000-0002-6718-9763	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A02062008]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A02062008).	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Chou SH, 2014, CELL TRANSPLANT, V23, P513, DOI 10.3727/096368914X678436; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Fang CH, 2012, CELL TRANSPLANT, V21, P1687, DOI 10.3727/096368912X653039; Feygin J, 2007, AM J PHYSIOL-HEART C, V293, pH1772, DOI 10.1152/ajpheart.00242.2007; Frost RJA, 2010, J CARDIOVASC TRANSL, V3, P280, DOI 10.1007/s12265-010-9173-y; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; GOMEZ JP, 1994, PFLUG ARCH EUR J PHY, V428, P241, DOI 10.1007/BF00724503; Gulyaeva LF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0893-x; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hodgkinson CP, 2016, CIRC RES, V118, P95, DOI 10.1161/CIRCRESAHA.115.305373; Iekushi K, 2012, CIRCULATION, V125, P1765, DOI 10.1161/CIRCULATIONAHA.111.079699; Imanishi Y, 2008, J MOL CELL CARDIOL, V44, P662, DOI 10.1016/j.yjmcc.2007.11.001; Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017; Karantalis V, 2015, CIRC RES, V116, P1413, DOI 10.1161/CIRCRESAHA.116.303614; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kishore R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060161; Lee KM, 2012, BIOCHEM BIOPH RES CO, V428, P50, DOI 10.1016/j.bbrc.2012.09.145; Liu LF, 2014, APOPTOSIS, V19, P19, DOI 10.1007/s10495-013-0899-2; Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008; Marko SB, 2008, AM J PHYSIOL-HEART C, V294, pH2646, DOI 10.1152/ajpheart.00291.2008; Matsubayashi Keiji, 2003, Circulation, V108 Suppl 1, pII219, DOI 10.1161/01.cir.0000087450.34497.9a; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nguyen BK, 2010, J CARDIOVASC TRANSL, V3, P547, DOI 10.1007/s12265-010-9171-0; Papageorgiou N, 2012, CURR MED CHEM, V19, P2605, DOI 10.2174/092986712800493048; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; Port JD, 2011, PHYSIOL GENOMICS, V43, P1087, DOI 10.1152/physiolgenomics.00074.2011; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Romaine SPR, 2015, HEART, V101, P921, DOI 10.1136/heartjnl-2013-305402; Seideman J, 2002, J IMMUNOL METHODS, V267, P165, DOI 10.1016/S0022-1759(02)00168-0; Shi B, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-11; Shin JH, 2014, CARDIOVASC DRUG THER, V28, P211, DOI 10.1007/s10557-014-6519-8; Song YS, 2014, CELL TRANSPLANT; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Weir C, 2008, HEART LUNG CIRC, V17, P395, DOI 10.1016/j.hlc.2008.01.006; Zhang BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100298	55	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179972	10.1371/journal.pone.0179972	http://dx.doi.org/10.1371/journal.pone.0179972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662151	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300083
J	Mukherjee, S; Subramaniam, R; Chen, H; Smith, A; Keshava, S; Shams, H				Mukherjee, Sanjay; Subramaniam, Renuka; Chen, Han; Smith, Anthony; Keshava, Shiva; Shams, Homayoun			Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia	PLOS ONE			English	Article							APOPTOTIC CELL CLEARANCE; ACTIVATED RECEPTOR-GAMMA; MALIGNANT-MELANOMA; NUCLEAR RECEPTORS; VIRUS INFECTION; PPAR-GAMMA; IN-VITRO; GM-CSF; MACROPHAGES; LUNG	Efferocytosis by alveolar phagocytes (APs) is pivotal in maintenance of lung homeostasis. Increased efferocytosis by APs results in protection against lethal acute lung injury due to pulmonary infections whereas defective efferocytosis by APs results in chronic lung inflammation. In this report, we show that pulmonary delivery of Bacillus Calmette-Guerin (BCG) significantly enhances efferocytosis by APs. Increased efferocytosis by APs maintains lung homeostasis and protects mice against lethal influenza pneumonia. Intranasally treated wild type C57Bl/6 (WT) mice with BCG showed significant increase in APs efferocytosis in vivo compared to their PBS-treated counterparts. All BCG-treated WT mice survived lethal influenza A virus (IAV) infection whereas all PBS-treated mice succumbed. BCG-induced resistance was abrogated by depleting AP prior to IAV infection. BCG treatment increased uptake, and digestion/removal of apoptotic cells by APs. BCG significantly increased the expression of TIM4 on APs and increased expression of Rab5 and Rab7. We demonstrated that increased efferocytosis by APs through pulmonary delivery of BCG initiated rapid clearance of apoptotic cells from the alveolar space, maintained lung homeostasis, reduced inflammation and protected host against lethal IAV pneumonia.	[Mukherjee, Sanjay; Subramaniam, Renuka; Chen, Han; Smith, Anthony; Shams, Homayoun] Univ Texas Hlth Sci Ctr Tyler, CPIDC, Tyler, TX 75708 USA; [Keshava, Shiva] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX USA; [Subramaniam, Renuka] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Subramaniam, Renuka] Harvard Med Sch, Boston, MA USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shams, H (corresponding author), Univ Texas Hlth Sci Ctr Tyler, CPIDC, Tyler, TX 75708 USA.	homayoun.shams@uthct.edu	Mukherjee, Sanjay/R-9913-2019	Mukherjee, Sanjay/0000-0003-4853-2332				Gonzalez N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00211; Borges VM, 2009, AM J PHYSIOL-LUNG C, V297, pL586, DOI 10.1152/ajplung.90569.2008; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fujimori T, 2015, MUCOSAL IMMUNOL, V8, P1021, DOI 10.1038/mi.2014.129; Fujimoto I, 2000, J VIROL, V74, P3399, DOI 10.1128/JVI.74.7.3399-3403.2000; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; GONZALEZ N, 2009, IMMUNITY, V31, P245, DOI DOI 10.1016/J.IMMUNI.2009.06.018; Grabiec AM, 2016, SEMIN IMMUNOPATHOL, V38, P409, DOI 10.1007/s00281-016-0555-3; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Kirby AC, 2006, J INFECT DIS, V193, P205, DOI 10.1086/498874; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Lanz RB, 2006, NUCLEIC ACIDS RES, V34, pD221, DOI 10.1093/nar/gkj029; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lea S, 2014, EUR RESPIR J, V43, P409, DOI 10.1183/09031936.00187812; Leentjens J, 2015, J INFECT DIS, V212, P1930, DOI 10.1093/infdis/jiv332; Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74; Luca Simona, 2013, Maedica (Bucur), V8, P53; Martin CJ, 2014, CURR OPIN MICROBIOL, V17, P17, DOI 10.1016/j.mib.2013.10.007; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; MBAWUIKE IN, 1986, INFECT IMMUN, V51, P483, DOI 10.1128/IAI.51.2.483-489.1986; MORTON DL, 1974, ANN SURG, V180, P635, DOI 10.1097/00000658-197410000-00029; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; PATERSON AHG, 1984, CAN MED ASSOC J, V131, P744; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Serban KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176073; Setia MS, 2006, LANCET INFECT DIS, V6, P162, DOI 10.1016/S1473-3099(06)70412-1; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; SPENCER JC, 1977, J INFECT DIS, V136, P171, DOI 10.1093/infdis/136.2.171; Subramaniam R, 2016, MUCOSAL IMMUNOL, V9, P873, DOI 10.1038/mi.2015.120; Subramaniam R, 2013, J INFECT DIS; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	34	35	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180143	10.1371/journal.pone.0180143	http://dx.doi.org/10.1371/journal.pone.0180143			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686604	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100038
J	Kim, Y; Seok, JM; Park, J; Kim, KH; Min, JH; Cho, JW; Park, S; Kim, HJ; Kim, BJ; Youn, J				Kim, Younsoo; Seok, Jin Myoung; Park, Jongkyu; Kim, Kun-Hyun; Min, Ju-Hong; Cho, Jin Whan; Park, Suyeon; Kim, Hyun-jin; Kim, Byoung Joon; Youn, Jinyoung			The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; DISEASE; DIFFERENTIATION; QUANTIFICATION; DYSFUNCTION; DIAGNOSIS	Differentiation of multiple system atrophy with predominant parkinsonism (MSA-P) and Parkinson's disease (PD) is important, but an effective tool for differentiation has not been identified. We investigated the efficacy of the composite autonomic symptom scale 31 (COMPASS 31) questionnaire as a tool for evaluating autonomic function in parkinsonism patients. In this study, we enrolled drug-naive patients with MSA-P and PD, and administered the COMPASS-31 and an objective autonomic dysfunction test (AFT). Demographic and clinical data, including parkinsonism and autonomic dysfunction, were compared between the two groups. Additionally, we determined the optimal COMPASS 31 cut-off score to differentiate MSA-P from PD for use as a screening tool. In this study, 27 MSA-P patients and 41 PD patients were recruited. The total COMPASS 31 score was well correlated with the objective AFT results. When we compared the COMPASS 31 score between the two groups, MSA-P patients showed higher total scores and sub-scores in the orthostatic intolerance, gastrointestinal, and bladder domains compared with PD patients. Similarly, MSA-P patients had more abnormalities in expiration to inspiration ratio, Valsalva ratio and pressure recovery time than PD patients in objective AFT. With 13.25 as the cut-off score for diagnosis of MSA-P, the total COMPASS-31 score demonstrated high sensitivity (92.6%) and moderate specificity (51.2%) with an area under the curve of 0.765. Based on our results, the COMPASS 31 is an effective tool for evaluation of autonomic function in patients with parkinsonism. The COMPASS-31 could be used as a sensitive and convenient screening tool, especially for the differentiation between MSA-P and PD.	[Kim, Younsoo] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Seok, Jin Myoung] Soonchunhyang Univ, Cheonan Hosp, Coll Med, Dept Neurol, Cheonan, South Korea; [Park, Jongkyu] Soonchunhyang Univ, Dept Neurol, Gumi, South Korea; [Kim, Kun-Hyun; Min, Ju-Hong; Cho, Jin Whan; Kim, Hyun-jin; Kim, Byoung Joon; Youn, Jinyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Kun-Hyun; Min, Ju-Hong; Cho, Jin Whan; Kim, Byoung Joon; Youn, Jinyoung] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea; [Park, Suyeon] Soonchunhyang Univ, Seoul Hosp, Coll Med, Dept Biostat, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University; Soonchunhyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University	Kim, BJ; Youn, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.; Kim, BJ; Youn, J (corresponding author), Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea.	bjkim@skku.edu; genian@skku.edu	Youn, Jinyoung/ABD-4588-2020	Seok, Jin Myoung/0000-0002-1484-2968				Baschieri F, 2015, PARKINSONISM RELAT D, V21, P477, DOI 10.1016/j.parkreldis.2015.02.011; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chung EJ, 2009, MOVEMENT DISORD, V24, P1650, DOI 10.1002/mds.22649; Cortez MM, 2015, MULT SCLER RELAT DIS, V4, P258, DOI 10.1016/j.msard.2015.03.007; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Hoehn MM, 1967, NEUROLOGY, P50; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kang JH, 2016, ANN REHABIL MED-ARM, V40, P301, DOI 10.5535/arm.2016.40.2.301; Kim JS, 2016, J MOV DISORD, V9, P97, DOI 10.14802/jmd.16001; Kimpinski K, 2012, J NEUROL SCI, V317, P92, DOI 10.1016/j.jns.2012.02.023; Lipp A, 2009, ARCH NEUROL-CHICAGO, V66, P742, DOI 10.1001/archneurol.2009.71; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; Novak P, 2011, JOVE-J VIS EXP, DOI 10.3791/2502; Reimann M, 2010, J NEURAL TRANSM, V117, P69, DOI 10.1007/s00702-009-0313-y; Riley DE, 2003, J NEUROL NEUROSUR PS, V74, P56, DOI 10.1136/jnnp.74.1.56; Sletten DM, 2012, MAYO CLIN PROC, V87, P1196, DOI 10.1016/j.mayocp.2012.10.013; Treister R, 2015, EUR J NEUROL, V22, P1124, DOI 10.1111/ene.12717; Vogel ER, 2005, NEUROLOGY, V65, P1533, DOI 10.1212/01.wnl.0000184504.13173.ef; YOKOTA T, 1991, BRAIN, V114, P1381, DOI 10.1093/brain/114.3.1381	19	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180744	10.1371/journal.pone.0180744	http://dx.doi.org/10.1371/journal.pone.0180744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683089	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200064
J	Nieves-Moreno, M; Martinez-de-la-Casa, JM; Cifuentes-Canorea, P; Sastre-Ibanez, M; Santos-Bueso, E; Saenz-Frances, F; Morales-Fernandez, L; Garcia-Feijoo, J				Nieves-Moreno, Maria; Martinez-de-la-Casa, Jose M.; Cifuentes-Canorea, Pilar; Sastre-Ibanez, Marina; Santos-Bueso, Enrique; Saenz-Frances, Federico; Morales-Fernandez, Laura; Garcia-Feijoo, Julian			Normative database for separate inner retinal layers thickness using spectral domain optical coherence tomography in Caucasian population	PLOS ONE			English	Article							NERVE-FIBER LAYER; EARLY GLAUCOMA; EYES; ABILITY; OCT	Purpose Develop the first normative database of the thickness of every inner retinal layer in the macular area in a healthy, Caucasian population between 18 to 87 years old, using Spectralis Optical Coherence Tomography (OCT). Methods On this transversal, observational study, 300 patients between 18 to 87 years old and without an ophthalmological condition were recruited. Macular OCT scans were performed on all patients (Spectralis OCT, Heidelberg Engineering). An axial length measurement, and keratometry were performed using an optical biometer. The volume and thickness of the different macular sectors of the inner retinal layers (retinal nerve fiber layer (RNFL), ganglion cells layer (CGL) and inner plexiform layer (IPL)) were analyzed with the Spectralis OCT segmentation software. An eye was randomly selected for each patient. Results 297 patients (179 females and 118 males) were included in the study. The mean age was 56.07 years (range: 40.50-72). The multivariate analysis showed a positive correlation between the RNFL thickness and the axial length (p < 0.001). The mean central retinal thickness was 278.2 mu m (range: 266-291), the mean central RNFL thickness was 12.61 mu m (range: 11-14), the mean central CGL thickness was 17.63 mu m (range: 14-21) and the mean central IPL thickness was 22.02 mu m (range: 20-25). The multivariate analysis showed a negative correlation between age and CGL thickness and inner IPL thickness (p< 0.001). Conclusion This study provides a normative database of the volume of each of the inner retinal layers on a Caucasian population.	[Martinez-de-la-Casa, Jose M.] Hosp Clin San Carlos, Serv Oftalmol, Madrid, Spain; Univ Complutense Madrid, Fac Med, Dept Oftalmol, Madrid, Spain; Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain	Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos	Martinez-de-la-Casa, JM (corresponding author), Hosp Clin San Carlos, Serv Oftalmol, Madrid, Spain.	martinezcasa@ya.com	Ibáñez, Marina Sastre-/R-1346-2019; GARCIA FEIJOO, JULIAN/G-9762-2017; Saenz-Frances, Federico/A-3350-2012; Santos-Bueso, Enrique/G-9870-2017	GARCIA FEIJOO, JULIAN/0000-0002-7772-5718; Sastre Ibanez, Marina/0000-0003-0640-894X; Martinez-de-la-Casa, Jose Maria/0000-0001-9441-0542; Saenz-Frances, Federico/0000-0002-3196-1491; Nieves-Moreno, Maria/0000-0001-6972-0880; Santos-Bueso, Enrique/0000-0002-0097-1726				Akashi A, 2015, INVEST OPHTH VIS SCI, V56, P6573, DOI 10.1167/iovs.15-17635; Appukuttan B, 2014, INDIAN J OPHTHALMOL, V62, P316, DOI 10.4103/0301-4738.116466; Balendra SI, 2015, EYE, V29, P1260, DOI 10.1038/eye.2015.154; Cavallotti CAP., 2008, AGE RELATED CHANGES, DOI 10.1007/978-1-59745-507-7; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Chauhan DS, 1999, INVEST OPHTH VIS SCI, V40, P2332; Ctori I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129005; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Kanai Kaname, 2002, Nippon Ganka Gakkai Zasshi, V106, P162; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Knighton RW, 2012, INVEST OPHTH VIS SCI, V53, P3653, DOI 10.1167/iovs.12-9719; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Manassakorn A, 2008, JPN J OPHTHALMOL, V52, P450, DOI 10.1007/s10384-008-0538-6; Massin P, 2002, EUR J OPHTHALMOL, V12, P102, DOI 10.1177/112067210201200205; Mwanza JC, 2014, OPHTHALMOLOGY, V121, P849, DOI 10.1016/j.ophtha.2013.10.044; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Realini T, 2014, J GLAUCOMA; Shin HY, 2014, OPHTHALMOLOGY, V121, P93, DOI 10.1016/j.ophtha.2013.06.041; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004	23	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180450	10.1371/journal.pone.0180450	http://dx.doi.org/10.1371/journal.pone.0180450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678834	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000405272200064
J	Tao, S; Way, SF; Garland, J; Chrispin, J; Ciuffo, LA; Balouch, MA; Nazarian, S; Spragg, DD; Marine, JE; Berger, RD; Calkins, H; Ashikaga, H				Tao, Susumu; Way, Samuel F.; Garland, Joshua; Chrispin, Jonathan; Ciuffo, Luisa A.; Balouch, Muhammad A.; Nazarian, Saman; Spragg, David D.; Marine, Joseph E.; Berger, Ronald D.; Calkins, Hugh; Ashikaga, Hiroshi			Ablation as targeted perturbation to rewire communication network of persistent atrial fibrillation	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; CATHETER ABLATION; FOCAL IMPULSE; BRAIN ACTIVITY; ASSOCIATION; HEART; SYNCHRONIZATION; ENHANCEMENT; MECHANISMS; RESONANCE	Persistent atrial fibrillation (AF) can be viewed as disintegrated patterns of information transmission by action potential across the communication network consisting of nodes linked by functional connectivity. To test the hypothesis that ablation of persistent AF is associated with improvement in both local and global connectivity within the communication networks, we analyzed multi-electrode basket catheter electrograms of 22 consecutive patients (63.5 +/- 9.7 years, 78% male) during persistent AF before and after the focal impulse and rotor modulation-guided ablation. Eight patients (36%) developed recurrence within 6 months after ablation. We defined communication networks of AF by nodes (cardiac tissue adjacent to each electrode) and edges (mutual information between pairs of nodes). To evaluate patient-specific parameters of communication, thresholds of mutual information were applied to preserve 10% to 30% of the strongest edges. There was no significant difference in network parameters between both atria at baseline. Ablation effectively rewired the communication network of persistent AF to improve the overall connectivity. In addition, successful ablation improved local connectivity by increasing the average clustering coefficient, and also improved global connectivity by decreasing the characteristic path length. As a result, successful ablation improved the efficiency and robustness of the communication network by increasing the small-world index. These changes were not observed in patients with AF recurrence. Furthermore, a significant increase in the small-world index after ablation was associated with synchronization of the rhythm by acute AF termination. In conclusion, successful ablation rewires communication networks during persistent AF, making it more robust, efficient, and easier to synchronize. Quantitative analysis of communication networks provides not only a mechanistic insight that AF may be sustained by spatially localized sources and global connectivity, but also patient-specific metrics that could serve as a valid endpoint for therapeutic interventions.	[Tao, Susumu; Chrispin, Jonathan; Ciuffo, Luisa A.; Balouch, Muhammad A.; Spragg, David D.; Marine, Joseph E.; Berger, Ronald D.; Calkins, Hugh; Ashikaga, Hiroshi] Johns Hopkins Univ, Sch Med, Cardiac Arrhythmia Serv, Baltimore, MD 21218 USA; [Way, Samuel F.] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Garland, Joshua] Santa Fe Inst, Santa Fe, NM 87501 USA; [Nazarian, Saman] Univ Penn, Perelman Sch Med, Sect Cardiac Electrophysiol, Philadelphia, PA 19104 USA; [Berger, Ronald D.; Ashikaga, Hiroshi] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; University of Colorado System; University of Colorado Boulder; The Santa Fe Institute; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University	Ashikaga, H (corresponding author), Johns Hopkins Univ, Sch Med, Cardiac Arrhythmia Serv, Baltimore, MD 21218 USA.; Ashikaga, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	hashika1@jhmi.edu	Nazarian, Saman/ABC-8000-2020	Nazarian, Saman/0000-0002-8369-0259; Ashikaga, Hiroshi/0000-0003-3689-6892	W. W. Smith Charitable Trust; Johns Hopkins University Institute of Clinical and Translational Research; Edward St. John Foundation for AF Research; Roz and Marvin H Weiner and Family Foundation; Dr. Francis P. Chiaramonte Foundation; Marilyn and Christian Poindexter Arrhythmia Research Fund; Norbert and Louise Grunwald Cardiac Arrhythmia Research Fund	W. W. Smith Charitable Trust; Johns Hopkins University Institute of Clinical and Translational Research; Edward St. John Foundation for AF Research; Roz and Marvin H Weiner and Family Foundation; Dr. Francis P. Chiaramonte Foundation; Marilyn and Christian Poindexter Arrhythmia Research Fund; Norbert and Louise Grunwald Cardiac Arrhythmia Research Fund	This work was supported by grants from the W. W. Smith Charitable Trust (to Ashikaga), the Johns Hopkins University Institute of Clinical and Translational Research (to Ashikaga), the Edward St. John Foundation for AF Research (to Calkins), The Roz and Marvin H Weiner and Family Foundation (to Calkins), The Dr. Francis P. Chiaramonte Foundation (to Calkins), The Marilyn and Christian Poindexter Arrhythmia Research Fund (to Calkins), and The Norbert and Louise Grunwald Cardiac Arrhythmia Research Fund (to Calkins).	Allessie MA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P606, DOI 10.1161/CIRCEP.109.910125; Alonso S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166972; Alonso S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.158101; Ashikaga H, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1201; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Benharash P, 2015, CIRC-ARRHYTHMIA ELEC, V8, P554, DOI 10.1161/CIRCEP.115.002721; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Chen J, 2008, EUROPACE, V10, P263, DOI 10.1093/europace/eun029; Chrispin J, 2016, HEART RHYTHM, V13, P654, DOI 10.1016/j.hrthm.2015.11.011; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Damiano RJ, 2011, J THORAC CARDIOV SUR, V141, P113, DOI 10.1016/j.jtcvs.2010.08.067; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fassini G, 2005, J CARDIOVASC ELECTR, V16, P1150, DOI 10.1111/j.1540-8167.2005.50192.x; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Ganesan AN, 2013, CIRC-ARRHYTHMIA ELEC, V6, P48, DOI 10.1161/CIRCEP.112.976654; Garrey WE, 1914, AM J PHYSIOL, V33, P397, DOI 10.1152/ajplegacy.1914.33.3.397; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Leong-Sit P, 2013, J CARDIOVASC ELECTR, V24, P617, DOI 10.1111/jce.12088; Lever NA, 2007, EUROPACE, V9, P1054, DOI 10.1093/europace/eum194; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lizier JT, 2014, FRONT ROBOT AI, DOI 10.3389/frobt.2014.00011; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; McWilliam J A, 1887, J Physiol, V8, P296; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Mori T, 2002, INT J BIFURCAT CHAOS, V12, P2631, DOI 10.1142/S0218127402006151; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Patel MS, 2017, CIRCULATION, V135; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Sahadevan J, 2004, CIRCULATION, V110, P3293, DOI 10.1161/01.CIR.0000147781.02738.13; Sanders P, 2007, EUR HEART J, V28, P1862, DOI 10.1093/eurheartj/ehl548; Scherr D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P18, DOI 10.1161/CIRCEP.114.001943; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Skanes AC, 1998, CIRCULATION, V98, P1236, DOI 10.1161/01.CIR.98.12.1236; Sporns O., 2010, NETWORKS BRAIN; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tass PA, 2003, BIOL CYBERN, V89, P81, DOI [10.1007/s00422-003-0425-7, 10.1007/S00422-003-0425-7]; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Vigmond E, 2016, HEART RHYTHM, V13, P1536, DOI 10.1016/j.hrthm.2016.03.019; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Yu QB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025423; Zahid S, 2016, HEART RHYTHM, V13, P1687, DOI 10.1016/j.hrthm.2016.04.009; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	65	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179459	10.1371/journal.pone.0179459	http://dx.doi.org/10.1371/journal.pone.0179459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678805	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200016
J	Palma, RE; Gutierrez-Tapia, P; Gonzalez, JF; Boric-Bargetto, D; Torres-Perez, F				Eduardo Palma, R.; Gutierrez-Tapia, Pablo; Gonzalez, Juan F.; Boric-Bargetto, Dusan; Torres-Perez, Fernando			Mountaintops phylogeography: A case study using small mammals from the Andes and the coast of central Chile	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; SPECIES DISTRIBUTIONS; QUATERNARY GLACIATIONS; STATISTICAL-MODEL; LAKE DISTRICT; ISLA GRANDE; CLIMATE; RODENTIA; EVOLUTION; SEQUENCE	We evaluated if two sigmodontine rodent taxa (Abrothrix olivacea and Phyllotis darwini) from the Andes and Coastal mountaintops of central Chile, experienced distributional shifts due to altitudinal movements of habitat and climate change during and after the Last Glacial Maximum (LGM). We tested the hypothesis that during LGM populations of both species experienced altitudinal shifts from the Andes to the lowlands and the coastal Cordillera, and then range retractions during interglacial towards higher elevations in the Andes. These distributional shifts may have left remnants populations on the mountaintops. We evaluated the occurrence of intraspecific lineages for each species, to construct distribution models at LGM and at present, as extreme climatic conditions for each lineage. Differences in distribution between extreme climatic conditions were interpreted as post-glacial distributional shifts. Abrothrix olivacea displayed a lineage with shared sequences between both mountain systems, whereas a second lineage was restricted to the Andes. A similar scenario of panmictic unit in the past was recovered for A. olivacea in the Andes, along with an additional unit that included localities from the rest of its distribution. For P. darwini, both lineages recovered were distributed in coastal and Andean mountain ranges at present as well, and structuring analyses for this species recovered coastal and Andean localities as panmictic units in the past. Niche modeling depicted differential postglacial expansions in the recovered lineages. Results suggest that historical events such as LGM triggered the descending of populations to Andean refuge areas (one of the A. olivacea's lineages), to the lowlands, and to the coastal Cordillera. Backward movements of populations after glacial retreats may have left isolates on mountaintops of the coastal Cordillera, suggesting that current species distribution would be the outcome of climate change and habitat reconfiguration after LGM.	[Eduardo Palma, R.; Gonzalez, Juan F.] Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile; [Gutierrez-Tapia, Pablo] Univ Santiago Chile, Lab Ecol & Biodiversidad, Fac Quim & Biol, Santiago, Chile; [Boric-Bargetto, Dusan; Torres-Perez, Fernando] Pontificia Univ Catolica Valparaiso, Inst Biol, Valparaiso, Chile	Pontificia Universidad Catolica de Chile; Universidad de Santiago de Chile; Pontificia Universidad Catolica de Valparaiso	Palma, RE (corresponding author), Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile.	epalma@bio.puc.cl	Palma, Eduardo/N-1416-2014; Torres-Perez, Fernando/B-5002-2008	Torres-Perez, Fernando/0000-0001-8655-7288; Boric-Bargetto, Dusan/0000-0002-4568-8828	Fondo Nacional de Cienciay Tecnologo Aa (FONDECYT, Chile) [1100558, 1040929]; Grant USA [1555]	Fondo Nacional de Cienciay Tecnologo Aa (FONDECYT, Chile); Grant USA	This work was supported by Grants 1100558 and 1040929 from Fondo Nacional de Cienciay Tecnologo Aa (FONDECYT, Chile) funded to REP and FTP, respectively, url: http://www.conicyt.cl/fondecyt/; Grant USA 1555. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allnutt TR, 1999, MOL ECOL, V8, P975, DOI 10.1046/j.1365-294x.1999.00650.x; [Anonymous], CONVERGENCE MEDITERR; Bacigalupe LD, 2004, PHYSIOL BIOCHEM ZOOL, V77, P805, DOI 10.1086/422229; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Brown J. H., 1998, BIOGEOGRAPHY; BROWN JH, 1971, AM NAT, V105, P467, DOI 10.1086/282738; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bull-Herenu K, 2005, J BIOGEOGR, V32, P1129, DOI 10.1111/j.1365-2699.2004.01209.x; Cianferoni F, 2013, ZOOTAXA, V3619, P59, DOI 10.11646/zootaxa.3619.1.3; CLAPPERTON CM, 1990, QUATERNARY SCI REV, V9, P299, DOI 10.1016/0277-3791(90)90024-5; CLAPPERTON CM, 1993, PALAEOGEOGR PALAEOCL, V101, P189, DOI 10.1016/0031-0182(93)90012-8; CLAPPERTON CM, 1994, REV CHIL HIST NAT, V67, P369; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C, 1859, ORIGIN SPECIES MEANS; Denton GH, 1999, GEOGR ANN A, V81A, P167, DOI 10.1111/1468-0459.00057; Dress AWM, 2004, IEEE ACM T COMPUT BI, V1, P109, DOI 10.1109/TCBB.2004.27; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FUENTES ER, 1979, ARCH BIOL MED EXP, V12, P179; Garcia Berguecio N, 2006, ANALISIS FLORISTICO; GRAF K, 1994, REV CHIL HIST NAT, V67, P405; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; Gutierrez-Tapia P, 2016, DIVERS DISTRIB, V22, P638, DOI 10.1111/ddi.12433; HARRISON SP, 2000, PALEOCLIMATE MODELLI, P25; Hasumi H, 2004, 1 K 1; HEUSSER CJ, 1983, SCIENCE, V219, P1429, DOI 10.1126/science.219.4591.1429; HEUSSER CJ, 1990, PALAEOGEOGR PALAEOCL, V80, P107, DOI 10.1016/0031-0182(90)90124-P; Heusser CJ, 1999, GEOGR ANN A, V81A, P231, DOI 10.1111/1468-0459.00058; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holling J.T., 1981, LAST GREAT ICE SHEET, P179; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jezkova T, 2009, J MAMMAL, V90, P306, DOI 10.1644/08-MAMM-A-243.1; Kelt DA, 2010, J MAMMAL, V91, P1524, DOI 10.1644/10-MAMM-A-306.1; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Lamy F, 1999, QUATERNARY RES, V51, P83, DOI 10.1006/qres.1998.2010; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Matocq MD, 2007, MOL PHYLOGENET EVOL, V42, P637, DOI 10.1016/j.ympev.2006.08.011; MERCER JH, 1983, ANNU REV EARTH PL SC, V11, P99, DOI 10.1146/annurev.ea.11.050183.000531; MESERVE P L, 1987, Fieldiana Zoology, P413; MESERVE PL, 1981, J ANIM ECOL, V50, P745, DOI 10.2307/4134; MESERVE PL, 1978, J BIOGEOGR, V5, P135, DOI 10.2307/3038168; Mills JN, 1995, J MAMMAL, V76; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; PATTON JL, 1992, EVOLUTION, V46, P174, DOI 10.1111/j.1558-5646.1992.tb01992.x; Paula M, 2006, CONSERV GENET, V7, P591, DOI 10.1007/s10592-005-9069-6; Pearson RG, 2002, ECOL MODEL, V154, P289, DOI 10.1016/S0304-3800(02)00056-X; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Premoli AC, 2000, J BIOGEOGR, V27, P251, DOI 10.1046/j.1365-2699.2000.00402.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; RABASSA J, 1990, QUATERNARY SCI REV, V9, P153, DOI 10.1016/0277-3791(90)90016-4; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez-Serrano E, 2006, J MAMMAL, V87, P971, DOI 10.1644/05-MAMM-A-393R2.1; Romero F, 2003, B SOC ARGENT BOT, V38, P237; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simpson BB, 1983, REV CHIL HIST NAT, V56, P109; Spotorno AE, 2001, REV CHIL HIST NAT, V74, P151; Steppan SJ, 1998, J MAMMAL, V79, P573, DOI 10.2307/1382988; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Villagran C, 2001, REV CHIL HIST NAT, V74, P793; Villagran C, 2005, FITOGEOGRAFIA HIST C, P99; Villagran C., 2004, HIST NATURAL PARQUE, P3; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Walton A. I, 2008, MAMIFEROS CHILE	84	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180231	10.1371/journal.pone.0180231	http://dx.doi.org/10.1371/journal.pone.0180231			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672032	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500030
J	Ploug, T; Holm, S				Ploug, Thomas; Holm, Soren			Clinical genome sequencing and population preferences for information about 'incidental' findings D From medically actionable genes (MAGs) to patient actionable genes (PAGs)	PLOS ONE			English	Article							GENETICS PROFESSIONALS; CHAIR PERSPECTIVES; DISCLOSURE; RETURN; ATTITUDES; AUTONOMY; RESEARCHERS; SPECIALISTS; MEDICINE; ETHICS	Whole genome or exome sequencing is increasingly used in the clinical contexts, and ` incidental' findings are generated. There is need for an adequate policy for the reporting of these findings to individuals. Such a policy has been suggested by the American College of Medical Genetics and Genomics (ACMG). We argue that ACMG's policy is overly paternalistic, and that an adequate policy must take into account population preferences. We conducted a choice based conjoint survey of population preferences for reporting in a representative sample of the Danish population. In a 12 task survey respondents were asked about their preference for reporting in relation to three scenarios with seven different attributes. Of 1200 respondents 66.4% participated. We show that population preferences for reporting differs from ACMG's recommendations, and suggest a new policy based on both medically and patient actionable genes.	[Ploug, Thomas] Aalborg Univ, Ctr Appl Eth & Philosophy Sci, Dept Commun, Kbh Sv, Denmark; [Holm, Soren] Univ Manchester, Sch Law, Ctr Social Eth & Policy, Manchester, Lancs, England; [Holm, Soren] Univ Oslo, Ctr Med Eth, Fac Med, Oslo, Norway; [Holm, Soren] Aalborg Univ, Ctr Appl Eth, Aalborg, Denmark	Aalborg University; University of Manchester; University of Oslo; Aalborg University	Ploug, T (corresponding author), Aalborg Univ, Ctr Appl Eth & Philosophy Sci, Dept Commun, Kbh Sv, Denmark.	ploug@hum.aau.dk		Holm, Soren/0000-0002-7200-5607; Ploug, Thomas/0000-0002-3693-0547				American College of Medical Genetics and Genomics, 2013, GENET MED, V15; Bollinger JM, 2014, GENET MED, V16, P932, DOI 10.1038/gim.2014.50; Bollinger JM, 2013, GENET TEST MOL BIOMA, V17, P424, DOI 10.1089/gtmb.2012.0453; Brandt DS, 2013, J GENET COUNS, V22, P544, DOI 10.1007/s10897-013-9583-5; Cho MK, 2008, J LAW MED ETHICS, V36, P280, DOI 10.1111/j.1748-720X.2008.00270.x; Christenhusz GM, 2013, EUR J MED GENET, V56, P529, DOI 10.1016/j.ejmg.2013.08.006; Christenhusz GM, 2013, EUR J HUM GENET, V21, P248, DOI 10.1038/ejhg.2012.130; Chrzan K, 2000, RES PAPER SERIES OVE; Clift KE, 2015, APPL TRANSL GENOM, V4, P38, DOI 10.1016/j.atg.2015.02.005; Downing NR, 2013, PATIENT EDUC COUNS, V90, P133, DOI 10.1016/j.pec.2012.09.010; Driessnack M, 2013, J COMMUN GENET, V4, P435, DOI 10.1007/s12687-013-0145-1; Evans JP, 2013, GENET MED, V15, P852, DOI 10.1038/gim.2013.150; Green RC, 2013, JAMA-J AM MED ASSOC, V310, P365, DOI 10.1001/jama.2013.41703; Green RC, 2012, GENET MED, V14, P405, DOI 10.1038/gim.2012.21; Grove ME, 2014, J GENET COUNS, V23, P531, DOI 10.1007/s10897-013-9611-5; Haga SB, 2012, GENET TEST MOL BIOMA, V16, P193, DOI 10.1089/gtmb.2011.0118; Haga SB, 2012, GENET TEST MOL BIOMA, V16, P21, DOI 10.1089/gtmb.2011.0045; Haga SB, 2011, GENET MED, V13, P723, DOI 10.1097/GIM.0b013e31821afcc0; Hayeems RZ, 2011, EUR J HUM GENET, V19, P740, DOI 10.1038/ejhg.2011.34; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Lazaro-Munoz G, 2015, AM J BIOETHICS, V15, P3, DOI 10.1080/15265161.2015.1039721; Lemke AA, 2013, CLIN GENET, V84, P230, DOI 10.1111/cge.12060; Lohn Z, 2013, AM J MED GENET A, V161A, P542, DOI 10.1002/ajmg.a.35794; Matsui K, 2008, J EPIDEMIOL, V18, P217, DOI 10.2188/jea.JE2007425; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156; McGuire AL, 2013, JAMA-J AM MED ASSOC, V309, P1465, DOI 10.1001/jama.2013.1438; Meacham MC, 2010, J EMPIR RES HUM RES, V5, P31, DOI 10.1525/jer.2010.5.3.31; Middleton A, 2016, EUR J HUM GENET, V24, P21, DOI 10.1038/ejhg.2015.58; O'Daniel J, 2011, PUBLIC HEALTH GENOM, V14, P346, DOI 10.1159/000324933; Prucka SK, 2015, BIOETHICS, V29, P82, DOI 10.1111/bioe.12073; Regier DA, 2015, CAN MED ASSOC J, V187, pE190, DOI 10.1503/cmaj.140697; Ries NM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-4; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700; Sawtooth Software, 2007, TECHN PAP SER CBC LA; Sawtooth Software, 2013, TECHN PAP SER CBC SY; Sawtooth Software, 2009, TECHN PAP SER CBC HB; Simon CM, 2011, J EMPIR RES HUM RES, V6, P53, DOI 10.1525/jer.2011.6.4.53; Strong KA, 2014, CLIN GENET, V86, P461, DOI 10.1111/cge.12390; Tabor HK, 2007, GENET MED, V9, P626, DOI 10.1097/GIM.0b013e3181485688; Townsend A, 2012, AM J MED GENET A, V158A, P2519, DOI 10.1002/ajmg.a.35554; Ubel PA, 2003, QUAL LIFE RES, V12, P599, DOI 10.1023/A:1025119931010; Van Ness B, 2008, J LAW MED ETHICS, V36, P292, DOI 10.1111/j.1748-720X.2008.00272.x; Wachbroit R, 1998, KENNEDY INST ETHIC J, V8, P131, DOI 10.1353/ken.1998.0013; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Watson MS, 2015, GENET MED, V17, DOI [10.1038/gim.2015.94, 10.1038/gim.2014.151]; Williams JK, 2012, GENET TEST MOL BIOMA, V16, P508, DOI 10.1089/gtmb.2011.0248; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179935	10.1371/journal.pone.0179935	http://dx.doi.org/10.1371/journal.pone.0179935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671958	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500010
J	Rashid, A; Hasan, O; Siddique, U; Tahar, S				Rashid, Adnan; Hasan, Osman; Siddique, Umair; Tahar, Sofiene			Formal reasoning about systems biology using theorem proving	PLOS ONE			English	Article							MOLECULAR-BIOLOGY; CALCULUS; AXIOMATIZATION; FRAMEWORK; GENETICS; MODELS	System biology provides the basis to understand the behavioral properties of complex biological organisms at different levels of abstraction. Traditionally, analysing systems biology based models of various diseases have been carried out by paper-and-pencil based proofs and simulations. However, these methods cannot provide an accurate analysis, which is a serious drawback for the safety-critical domain of human medicine. In order to overcome these limitations, we propose a framework to formally analyze biological networks and pathways. In particular, we formalize the notion of reaction kinetics in higher-order logic and formally verify some of the commonly used reaction based models of biological networks using the HOL Light theorem prover. Furthermore, we have ported our earlier formalization of Zsyntax, i.e., a deductive language for reasoning about biological networks and pathways, from HOL4 to the HOL Light theorem prover to make it compatible with the above-mentioned formalization of reaction kinetics. To illustrate the usefulness of the proposed framework, we present the formal analysis of three case studies, i.e., the pathway leading to TP53 Phosphorylation, the pathway leading to the death of cancer stem cells and the tumor growth based on cancer stem cells, which is used for the prognosis and future drug designs to treat cancer patients.	[Rashid, Adnan; Hasan, Osman] Natl Univ Sci & Technol, Sch Elect Engn & Comp Sci, Islamabad, Pakistan; [Siddique, Umair; Tahar, Sofiene] Concordia Univ, Dept Elect & Comp Engn, Montreal, PQ, Canada	National University of Sciences & Technology - Pakistan; Concordia University - Canada	Rashid, A (corresponding author), Natl Univ Sci & Technol, Sch Elect Engn & Comp Sci, Islamabad, Pakistan.	adnan.rashid@seecs.edu.pk	Rashid, Adnan/ABA-8343-2021	Rashid, Adnan/0000-0002-9729-584X; Hasan, osman/0000-0003-2562-2669				Ahmad J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033532; Ahmad S, 2015, LECT NOTES COMPUT SC, V8941, P32, DOI [10.1007/978-3-319-15075-8_3, 10.1007/978-3-319-15075-8-3]; Ahmad S, 2014, 2014 IEEE 23RD INTERNATIONAL WETICE CONFERENCE (WETICE), P378, DOI 10.1109/WETICE.2014.22; Alon U., 2006, INTRO SYSTEMS BIOL D; Alur R., 1993, HS 1991 1992, V736, P209, DOI [10.1007, DOI 10.1007/3-540-57318-6]; Annapureddy Y, 2011, LECT NOTES COMPUT SC, V6605, P254, DOI 10.1007/978-3-642-19835-9_21; Avigad J, 2014, COMMUN ACM, V57, P66, DOI 10.1145/2591012; Azimi S, 2014, FUND INFORM, V131, P299, DOI 10.3233/FI-2014-1016; Baarir Soheib, 2009, Performance Evaluation Review, V36, P4, DOI 10.1145/1530873.1530876; Baier C, 2008, PRINCIPLES OF MODEL CHECKING, P1; Bartocci E, 2010, SCI ANN COMPUT SCI, V20, P1; Bernot G, 2007, ELECTRON NOTES THEOR, V180, P3, DOI 10.1016/j.entcs.2004.01.038; Boniolo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009511; Bortolussi L, 2008, CONSTRAINTS, V13, P66, DOI 10.1007/s10601-007-9034-8; Calder M., 2005, P COMP METH SYST BIO, P179; Camilleri A., 1986, HARDWARE VERIFICATIO; Chaouiya C, 2012, METHODS MOL BIOL, V804, P463, DOI 10.1007/978-1-61779-361-5_23; Ciocchetta F, 2009, THEOR COMPUT SCI, V410, P3065, DOI 10.1016/j.tcs.2009.02.037; Corblin F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-385; Cordero F, 2011, THEOR COMPUT SCI, V412, P6036, DOI 10.1016/j.tcs.2011.06.013; Danos V, 2004, THEOR COMPUT SCI, V325, P69, DOI 10.1016/j.tcs.2004.03.065; Danos V, 2007, LECT NOTES COMPUT SC, V4703, P17; Degasperi A, 2013, THEOR COMPUT SCI, V488, P15, DOI 10.1016/j.tcs.2013.03.018; Donze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024246; Donze A, 2010, LECT NOTES COMPUT SC, V6174, P167, DOI 10.1007/978-3-642-14295-6_17; Dubrova E, 2011, IEEE ACM T COMPUT BI, V8, P1393, DOI 10.1109/TCBB.2010.20; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Fages F, 2015, BIOCHAM 3 7 3 REFERE; Fages F, 2006, LECT NOTES COMPUT SC, V3901, P1, DOI 10.1007/11680093_1; Fokkink Wan J., 2000, TEXTS THEORETICAL CO; Fontana W, 2008, ACM SIGPLAN NOTICES, V43, P1, DOI 10.1145/1328897.1328439; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Hales T. C., 2005, MATH ALGORITHMS PROO, V5021, P1; Harrison J., 1996, FORMALIZED MATH, P36; Harrison J., 2009, HDB PRACTICAL LOGIC; Harrison J, 2013, J AUTOM REASONING, V50, P173, DOI 10.1007/s10817-012-9250-9; Heiner M., 2012, LNCS, P398, DOI [DOI 10.1007/978-3-642-31131-4_22, DOI 10.1007/978-3-642-31131-422]; Hirayama Kenji, 2002, Korean Journal of Parasitology, V40, P165, DOI 10.3347/kjp.2002.40.4.165; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Ingalls, 2013, MATH MODELING SYSTEM; John M, 2011, LECT NOTES COMPUT SC, V6602, P338, DOI 10.1007/978-3-642-19718-5_18; Koch I, 2005, BIOINFORMATICS, V21, P1219, DOI 10.1093/bioinformatics/bti145; Kong S., 2015, P TACAS 2015 21 INT, P200, DOI DOI 10.1007/978-3-662-46681-0; Korobov OV V., 2011, CHEM KINETICS MATHCA; Langmead C, 2009, P 8 INT C COMP SYST, P201; Molina-Pena R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026233; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Parvu O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154847; Pauleve L, 2011, ELECTRON NOTES THEOR, V272, P43, DOI 10.1016/j.entcs.2011.04.004; Paulson L. C., 1996, ML WORKING PROGRAMME; Pelanek R, 2009, LECT NOTES COMPUT SC, V5596, P37, DOI 10.1007/978-3-642-03240-0_7; Pilling M. J., 1996, REACTION KINETICS; POSPICHAL J, 1990, THEOR CHIM ACTA, V76, P423, DOI 10.1007/BF00528881; Priami C, 2001, INFORM PROCESS LETT, V80, P25, DOI 10.1016/S0020-0190(01)00214-9; Rashid A., 2017, FORMAL REASONING SYS; Rashid A, 2016, LECT NOTES COMPUT SC, V9807, P483, DOI 10.1007/978-3-319-43144-4_31; Regev A, 2004, NAT COMPUT SER, P219; RIZZOTTI M, 1986, J THEOR BIOL, V118, P61, DOI 10.1016/S0022-5193(86)80008-X; Schumann JM, 2001, AUTOMATED THEOREM PR; SIDDIQUE U., 2015, SCALABLE COMPUTING P, P16; Slind K, 2008, LECT NOTES COMPUT SC, V5170, P28, DOI 10.1007/978-3-540-71067-7_6; Tan BT, 2006, CANC STEM CELL HYPOT; Taqdees Syeda Hira, 2013, Logic for Programming, Artificial Intelligence and Reasoning. 19th International Conference, LPAR-19, Proceedings: LNCS 8312, P744, DOI 10.1007/978-3-642-45221-5_50; Thomas L.C., 1990, BIOL FEEDBACK; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; THOMAS R, 1979, LECT NOTES BIOMATHEM, V29; Wang E, 2010, CH CRC MATH COMP BIO, P1, DOI 10.1201/9781439811863-f; Woodger J.H., 1937, AXIOMATIC METHOD BIO; ZANARDO A, 1986, J THEOR BIOL, V118, P145, DOI 10.1016/S0022-5193(86)80130-8	70	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180179	10.1371/journal.pone.0180179	http://dx.doi.org/10.1371/journal.pone.0180179			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671950	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500022
J	Smidak, R; Kofeler, HC; Hoeger, H; Lubec, G				Smidak, Roman; Kofeler, Harald C.; Hoeger, Harald; Lubec, Gert			Comprehensive identification of age-related lipidome changes in rat amygdala during normal aging	PLOS ONE			English	Article							FEAR-POTENTIATED STARTLE; ALZHEIMERS-DISEASE; PHOSPHATIDIC-ACID; HUMAN BRAIN; MOUSE; INCREASES; RECEPTOR; CERAMIDE; KINASE; PROTEINS	Brain lipids are integral components of brain structure and function. However, only recent advancements of chromatographic techniques together with mass spectrometry allow comprehensive identification of lipid species in complex brain tissue. Lipid composition varies between the individual areas and the majority of previous reports was focusing on individual lipids rather than a lipidome. Herein, a mass spectrometry-based approach was used to evaluate age-related changes in the lipidome of the rat amygdala obtained from young (3 months) and old (20 months) males of the Sprague-Dawley rat strain. A total number of 70 lipid species with significantly changed levels between the two animal groups were identified spanning four main lipid classes, i.e. glycerolipids, glycerophospholipids, sphingolipids and sterol lipids. These included phospholipids with pleiotropic brain function, such as derivatives of phosphatidylcholine, phosphatidylserine, and phosphatidylethanolamine. The analysis also revealed significant level changes of phosphatidic acid, diacylglycerol, sphingomyelin and ceramide that directly represent lipid signaling and affect amygdala neuronal activity. The amygdala is a crucial brain region for cognitive functions and former studies on rats and humans showed that this region changes its activity during normal aging. As the information on amygdala lipidome is very limited the results obtained in the present study represent a significant novelty and may contribute to further studies on the role of lipid molecules in ageassociated changes of amygdala function.	[Smidak, Roman; Lubec, Gert] Univ Vienna, Dept Pharmaceut Chem, Fac Life Sci, Vienna, Austria; [Kofeler, Harald C.] Med Univ Graz, Ctr Med Res ZMF, Graz, Austria; [Hoeger, Harald] Med Univ Vienna, Div Lab Anim Sci & Genet, Core Unit Biomed Res, Himberg, Austria; [Lubec, Gert] Neuroprote Lab, Sci Pk,Ilkovicova 8, Bratislava, Slovakia	University of Vienna; Medical University of Graz; Medical University of Vienna	Lubec, G (corresponding author), Univ Vienna, Dept Pharmaceut Chem, Fac Life Sci, Vienna, Austria.; Lubec, G (corresponding author), Neuroprote Lab, Sci Pk,Ilkovicova 8, Bratislava, Slovakia.	lubec@gmx.at		Kofeler, Harald/0000-0002-2725-9616				Almaguer W, 2002, NEUROBIOL AGING, V23, P319, DOI 10.1016/S0197-4580(01)00278-0; Barrier L, 2010, INT J ALZHEIMERS DIS, V2011; BAUDRY M, 1991, BEHAV NEURAL BIOL, V55, P137, DOI 10.1016/0163-1047(91)80134-Z; Bozek K, 2015, NEURON, V85, P695, DOI 10.1016/j.neuron.2015.01.003; Brugger B, 2014, ANNU REV BIOCHEM, V83, P79, DOI 10.1146/annurev-biochem-060713-035324; Calderini G, 1985, Prog Clin Biol Res, V192, P383; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; CHAVKO M, 1993, MOL CHEM NEUROPATHOL, V18, P123, DOI 10.1007/BF03160026; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Costantini Claudio, 2005, Alzheimers Dement, V1, P43, DOI 10.1016/j.jalz.2005.06.004; Dawson G, 2015, BBA-MOL CELL BIOL L, V1851, P1026, DOI 10.1016/j.bbalip.2015.02.007; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; Favreliere S, 2000, NEUROBIOL AGING, V21, P653, DOI 10.1016/S0197-4580(00)00170-6; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Kim HY, 2014, PROG LIPID RES, V56, P1, DOI 10.1016/j.plipres.2014.06.002; Kim HY, 2000, J BIOL CHEM, V275, P35215, DOI 10.1074/jbc.M004446200; Krishnan B, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv139; Krishnan B, 2016, NEUROBIOL LEARN MEM, V128, P65, DOI 10.1016/j.nlm.2015.12.009; Krishnan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025639; Li G, 2014, NEUROSCI BULL, V30, P497, DOI 10.1007/s12264-013-1403-2; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2016, ANNU REV PSYCHOL, V67, P213, DOI 10.1146/annurev-psych-122414-033540; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Meyza KZ, 2011, BEHAV BRAIN RES, V225, P192, DOI 10.1016/j.bbr.2011.07.011; Muller CP, 2015, BBA-MOL CELL BIOL L, V1851, P1052, DOI 10.1016/j.bbalip.2014.12.014; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Naudi A, 2015, INT REV NEUROBIOL, V122, P133, DOI 10.1016/bs.irn.2015.05.008; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; Nothdurfter C, 2013, INT J NEUROPSYCHOPH, V16, P1361, DOI 10.1017/S146114571200140X; Oliveira TG, 2016, MOL PSYCHIATR, V21, P80, DOI 10.1038/mp.2015.14; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Oliveira TG, 2010, BBA-MOL CELL BIOL L, V1801, P799, DOI 10.1016/j.bbalip.2010.04.004; Oresic M, 2012, GENOME MED, V4, DOI 10.1186/gm300; PALESTINI P, 1990, J NEUROCHEM, V54, P230, DOI 10.1111/j.1471-4159.1990.tb13305.x; Paoletti L, 2011, IUBMB LIFE, V63, P714, DOI 10.1002/iub.521; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Prasain JK, 2015, METABOLITES, V5, P677, DOI 10.3390/metabo5040677; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Sacket SJ, 2009, ACTA PHARMACOL SIN, V30, P1454, DOI 10.1038/aps.2009.136; Salvador GA, 2005, J NEUROSCI RES, V81, P244, DOI 10.1002/jnr.20565; Shen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077047; Sjogren B, 2007, ACTA PHYSIOL, V190, P47, DOI 10.1111/j.1748-1716.2007.01687.x; Smiljanic K, 2013, LIPIDS, V48, P1069, DOI 10.1007/s11745-013-3836-9; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; Tajima Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-68; Triebl A, 2017, J CHROMATOGR B, V1053, P72, DOI 10.1016/j.jchromb.2017.03.027; Venkataraman K, 2000, TRENDS CELL BIOL, V10, P408, DOI 10.1016/S0962-8924(00)01830-4; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wood PL, 2014, SCHIZOPHR RES, V159, P365, DOI 10.1016/j.schres.2014.08.029; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	61	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180675	10.1371/journal.pone.0180675	http://dx.doi.org/10.1371/journal.pone.0180675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672041	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500078
J	Stromberg, ZR; Johnson, JR; Fairbrother, JM; Kilbourne, J; Van Goor, A; Curtiss, R; Mellata, M				Stromberg, Zachary R.; Johnson, James R.; Fairbrother, John M.; Kilbourne, Jacquelyn; Van Goor, Angelica; Curtiss, Roy, III; Mellata, Melha			Evaluation of Escherichia coli isolates from healthy chickens to determine their potential risk to poultry and human health	PLOS ONE			English	Article							VIRULENCE-ASSOCIATED GENES; RETAIL CHICKEN; EXTRAINTESTINAL INFECTIONS; ANTIMICROBIAL-RESISTANT; UROPATHOGENIC STRAINS; PREVALENCE; MENINGITIS; SEQUENCE; ANIMALS; EXPEC	Extraintestinal pathogenic Escherichia coli (ExPEC) strains are important pathogens that cause diverse diseases in humans and poultry. Some E. coli isolates from chicken feces contain ExPEC-associated virulence genes, so appear potentially pathogenic; they conceivably could be transmitted to humans through handling and/or consumption of contaminated meat. However, the actual extraintestinal virulence potential of chicken-source fecal E. coli is poorly understood. Here, we assessed whether fecal E. coli isolates from healthy production chickens could cause diseases in a chicken model of avian colibacillosis and three rodent models of ExPEC-associated human infections. From 304 E. coli isolates from chicken fecal samples, 175 E. coli isolates were screened by PCR for virulence genes associated with human-source ExPEC or avian pathogenic E. coli (APEC), an ExPEC subset that causes extraintestinal infections in poultry. Selected isolates genetically identified as ExPEC and non-ExPEC isolates were assessed in vitro for virulence-associated phenotypes, and in vivo for disease-causing ability in animal models of colibacillosis, sepsis, meningitis, and urinary tract infection. Among the study isolates, 13% (40/304) were identified as ExPEC; the majority of these were classified as APEC and uropathogenic E. coli, but none as neonatal meningitis E. coli. Multiple chicken-source fecal ExPEC isolates resembled avian and human clinical ExPEC isolates in causing one or more ExPEC-associated illnesses in experimental animal infection models. Additionally, some isolates that were classified as non-ExPEC were able to cause ExPEC-associated illnesses in animal models, and thus future studies are needed to elucidate their mechanisms of virulence. These findings show that E. coli isolates from chicken feces contain ExPEC-associated genes, exhibit ExPEC-associated in vitro phenotypes, and can cause ExPEC-associated infections in animal models, and thus may pose a health threat to poultry and consumers.	[Stromberg, Zachary R.; Van Goor, Angelica; Mellata, Melha] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; [Johnson, James R.] Vet Affairs Med Ctr, Minneapolis, MN USA; [Johnson, James R.] Univ Minnesota, Minneapolis, MN USA; [Fairbrother, John M.] Univ Montreal, Fac Vet Med, OIE Reference Lab Escherichia Coli, St Hyacinthe, PQ, Canada; [Kilbourne, Jacquelyn; Curtiss, Roy, III; Mellata, Melha] Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA; [Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Curtiss, Roy, III] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL USA	Iowa State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Universite de Montreal; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; State University System of Florida; University of Florida	Mellata, M (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.; Mellata, M (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.	mmellata@iastate.edu	Stromberg, Zachary R/H-8711-2018; Mellata, Melha/AAP-5491-2020; Stromberg, Zachary/ABF-4365-2021	Stromberg, Zachary R/0000-0002-1137-1128; Stromberg, Zachary/0000-0002-1137-1128; Mellata, Melha/0000-0002-4967-7173	U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI [20116 7005-30182]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01CX00019201]	U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI; Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs)	This research was supported by a grant from the U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI grant 20116 7005-30182 (M.M. and R.C.), and by Office of Research and Development, Medical Research Service, Department of Veterans Affairs grant # 1 I01CX00019201 (J.R.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, APPL ENVIRON MICROB, V75, P3522, DOI 10.1128/AEM.02685-08; Ballou AL, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00002; Belanger L, 2011, FEMS IMMUNOL MED MIC, V62, P1, DOI 10.1111/j.1574-695X.2011.00797.x; Berry RE, 2009, INFECT IMMUN, V77, P2762, DOI 10.1128/IAI.00323-09; BETTELHEIM K A, 1976, Infection, V4, P174, DOI 10.1007/BF01638945; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; DAVIES JK, 1975, J BACTERIOL, V123, P102, DOI 10.1128/JB.123.1.102-117.1975; Delicato ER, 2003, VET MICROBIOL, V94, P97, DOI 10.1016/S0378-1135(03)00076-2; Dezfulian H, 2003, J CLIN MICROBIOL, V41, P1375, DOI 10.1128/JCM.41.4.1375-1385.2003; Ewers C, 2005, AVIAN DIS, V49, P269, DOI 10.1637/7293-102604R; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Hall MR, 2014, SURG INFECT, V15, P1, DOI 10.1089/sur.2012.129; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Jakobsen L, 2012, EUR J CLIN MICROBIOL, V31, P1121, DOI 10.1007/s10096-011-1417-5; Jakobsen L, 2010, INT J FOOD MICROBIOL, V142, P264, DOI 10.1016/j.ijfoodmicro.2010.06.025; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; Johnson JR, 2005, FOODBORNE PATHOG DIS, V2, P38, DOI 10.1089/fpd.2005.2.38; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2005, J INFECT DIS, V191, P1040, DOI 10.1086/428451; Johnson JR, 2003, J INFECT DIS, V188, P759, DOI 10.1086/377455; Johnson JR, 2003, ANTIMICROB AGENTS CH, V47, P2161, DOI 10.1128/AAC.47.7.2161-2168.2003; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2012, J BACTERIOL, V194, P2846, DOI 10.1128/JB.06375-11; Johnson TJ, 2009, FOODBORNE PATHOG DIS, V6, P657, DOI 10.1089/fpd.2009.0266; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; LEE MD, 1991, AVIAN DIS, V35, P892, DOI 10.2307/1591625; Maluta RP, 2014, VET MICROBIOL, V169, P89, DOI 10.1016/j.vetmic.2013.12.013; Manges AR, 2012, CLIN INFECT DIS, V55, P712, DOI 10.1093/cid/cis502; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Mellata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004232; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mitchell NM, 2015, APPL ENVIRON MICROB, V81, P1177, DOI 10.1128/AEM.03524-14; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Ngeleka M, 2002, AVIAN DIS, V46, P143, DOI 10.1637/0005-2086(2002)046[0143:POAECA]2.0.CO;2; Obeng AS, 2012, VET MICROBIOL, V154, P305, DOI 10.1016/j.vetmic.2011.07.010; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Schouler C, 2012, J CLIN MICROBIOL, V50, P1673, DOI 10.1128/JCM.05057-11; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Singer RS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00028; Singer RS, 2000, VET MICROBIOL, V75, P59, DOI 10.1016/S0378-1135(00)00205-4; Tenke P, 2012, WORLD J UROL, V30, P51, DOI 10.1007/s00345-011-0689-9; Thai K.H., 2010, J VIS EXP; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Wu GH, 2012, VET MICROBIOL, V160, P197, DOI 10.1016/j.vetmic.2012.05.029; Yao YF, 2006, INFECT IMMUN, V74, P2196, DOI 10.1128/IAI.74.4.2196-2206.2006; Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001	56	70	74	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180599	10.1371/journal.pone.0180599	http://dx.doi.org/10.1371/journal.pone.0180599			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671990	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500075
J	Swigart, TM; Bonvecchio, A; Theodore, FL; Zamudio-Haas, S; Villanueva-Borbolla, MA; Thrasher, JF				Swigart, Tessa M.; Bonvecchio, Anabelle; Theodore, Florence L.; Zamudio-Haas, Sophia; Villanueva-Borbolla, Maria Angeles; Thrasher, James F.			Breastfeeding practices, beliefs, and social norms in low-resource communities in Mexico: Insights for how to improve future promotion strategies	PLOS ONE			English	Article							PERCEIVED INSUFFICIENT MILK; MATERNAL KNOWLEDGE; ATTITUDES; BEHAVIOR; HEALTH; INTENTIONS; TRANSITION; DURATION; INFANT; WOMEN	Introduction Breastfeeding is recommended exclusively for the first 6 months after birth, with continued breastfeeding for at least 2 years. Yet prevalence of these recommendations is low globally, although it is an effective and cost-effective way to prevent serious infections and chronic illness. Previous studies have reported that social support greatly influences breastfeeding, but there is little evidence on perceived social norms in Mexico and how they affect actual behavior. Objective Our objective was to investigate breastfeeding intention, practices, attitudes, and beliefs, particularly normative, among low-resource communities in central and southern Mexico. Methods We performed a secondary analysis using the theory of planned behavior with cross-sectional data, which included semi-structured individual interviews with fathers (n 10), 8 focus groups with mothers (n 50), and 8 focus groups with women community leaders (n 44) with a total of 104 participants. Our data also included a quantitative survey among pregnant women and mothers (n 321). Results Women reported supplementing breast milk with water and teas soon after birth, as well as introducing small bites of solid food a few months after birth. Social norms appeared to support breastfeeding, but not exclusive breastfeeding or breastfeeding for periods longer than about a year. This may be partially explained by: a) behavioral beliefs that for the first 6 months breast milk alone is insufficient for the baby, and that water in addition to breast milk is necessary to hydrate an infant and b) normative beliefs related to the appropriateness of breastfeeding in public and as the child gets older. Conclusions Future strategies should focus on positively influencing social norms to support recommended practices, and emphasize the specific reasons behind the recommendations. Future efforts should take a multi-pronged approach using a variety of influences, not only directed at healthcare providers but close family members, including fathers.	[Swigart, Tessa M.; Bonvecchio, Anabelle; Theodore, Florence L.; Villanueva-Borbolla, Maria Angeles; Thrasher, James F.] Natl Inst Publ Health, Nutr & Hlth Res Ctr, Cuernavaca, Morelos, Mexico; [Zamudio-Haas, Sophia] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Thrasher, James F.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC USA	Instituto Nacional de Salud Publica; University of California System; University of California San Francisco; University of South Carolina System; University of South Carolina Columbia	Bonvecchio, A (corresponding author), Natl Inst Publ Health, Nutr & Hlth Res Ctr, Cuernavaca, Morelos, Mexico.	bonvecchio@insp.mx		Theodore, Florence L./0000-0002-8111-0871	Mexican National Commission of Social Protection in Health; Mexican Ministry of Health; National Coordination of the Prospera Program; Mexican Ministry of Social Development; Bloomberg Philanthropies	Mexican National Commission of Social Protection in Health; Mexican Ministry of Health; National Coordination of the Prospera Program; Mexican Ministry of Social Development; Bloomberg Philanthropies	The Mexican National Commission of Social Protection in Health, the Mexican Ministry of Health, the National Coordination of the Prospera Program, and the Mexican Ministry of Social Development funded the study. This study was possible in part thanks to an unrestricted research grant from Bloomberg Philanthropies to the INSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahluwalia IB, 2005, PEDIATRICS, V116, P1408, DOI 10.1542/peds.2005-0013; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Colchero MA, 2015, AM J CLIN NUTR, V101, P579, DOI 10.3945/ajcn.114.092775; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; BAGOZZI RP, 1992, SOC PSYCHOL QUART, V55, P178, DOI 10.2307/2786945; Bar-Yam N B, 1997, J Hum Lact, V13, P45, DOI 10.1177/089033449701300116; Bonvecchio A., 2016, LACTANCIA MATERNA ME, P77; Bonvecchio A, 2007, J NUTR, V137, P440, DOI 10.1093/jn/137.2.440; Bryant CA, 1991, NAACOGS CLIN ISSU PE, V3, P723; Bueno-Gutierrez D, 2015, PUBLIC HEALTH NUTR, V18, P3371, DOI 10.1017/S1368980015000452; Bueno-Gutierrez D, 2015, BREASTFEED MED, V10, P124, DOI 10.1089/bfm.2014.0109; Dodgson JE, 2003, NURS RES, V52, P148, DOI 10.1097/00006199-200305000-00004; Duckett L, 1998, NURS RES, V47, P325, DOI 10.1097/00006199-199811000-00006; Dykes F, 1999, MIDWIFERY, V15, P232, DOI 10.1054/midw.1999.0185; Fairbank L., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/hta4250; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Foss KA, 2013, HEALTH COMMUN, V28, P329, DOI 10.1080/10410236.2012.685692; Goksen F, 2002, SOC SCI MED, V54, P1743, DOI 10.1016/S0277-9536(01)00145-9; de Cossio TG, 2013, J NUTR, V143, P664, DOI 10.3945/jn.112.163097; Guerrero ML, 1999, B WORLD HEALTH ORGAN, V77, P323; Guest G., 2011, APPL THEMAT ANAL; HARRISON GG, 1993, SOC SCI MED, V36, P1063, DOI 10.1016/0277-9536(93)90124-M; Ineichen B, 1997, J ADOLESCENCE, V20, P505, DOI 10.1006/jado.1997.0105; Kelishadi Roya, 2014, Adv Biomed Res, V3, P3, DOI 10.4103/2277-9175.124629; Khoury AJ, 2005, WOMEN HEALTH ISS, V15, P64, DOI 10.1016/j.whi.2004.09.003; Klement E, 2004, AM J CLIN NUTR, V80, P1342, DOI 10.1093/ajcn/80.5.1342; Kramer MS, 2004, ADV EXP MED BIOL, V554, P63; Ladomenou F, 2010, ARCH DIS CHILD, V95, P1004, DOI 10.1136/adc.2009.169912; Lapinski MK, 2005, COMMUN THEOR, V15, P127, DOI 10.1093/ct/15.2.127; Li Y, 1999, PEDIATR INT, V41, P648, DOI 10.1046/j.1442-200x.1999.01149.x; Mirkovic KR, 2014, J HUM LACT, V30, P416, DOI 10.1177/0890334414543522; Monterrosa EC, 2013, J NUTR, V143, P915, DOI 10.3945/jn.112.169235; Neufeld LM, 2008, EXTERN EVAL OPORTUNI, V107; O'Donoghue T., 2003, QUALITATIVE ED RES A; Oglethorpe J., 1995, J CONSUM POLICY, V18, P293; Otsuka K, 2008, JOGNN-J OBST GYN NEO, V37, P546, DOI 10.1111/j.1552-6909.2008.00277.x; Oweis A, 2009, INT J NURS PRACT, V15, P32, DOI 10.1111/j.1440-172X.2008.01720.x; PEREZESCAMILLA R, 1992, ECOL FOOD NUTR, V27, P91, DOI 10.1080/03670244.1992.9991231; Ping E., 2014, KEEPING ABREAST MULT, V1; Rivera JA, 2004, NUTR REV, V62, pS149, DOI 10.1111/j.1753-4887.2004.tb00086.x; Rivera JA, 2002, PUBLIC HEALTH NUTR, V5, P113, DOI 10.1079/PHN2001282; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Sacco LM, 2006, J HUM LACT, V22, P277, DOI 10.1177/0890334406287817; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wambach KA, 1997, RES NURS HEALTH, V20, P51, DOI 10.1002/(SICI)1098-240X(199702)20:1<51::AID-NUR6>3.0.CO;2-T; Weinreich NK., 1996, SOC MARK Q, V3, P53, DOI [10.1080/15245004.1996.9960961, DOI 10.1080/15245004.1996.9960961]; Williams Helen G, 2006, Breastfeed Rev, V14, P5; WRIGHT AL, 1988, PEDIATRICS, V82, P496; Xiang N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3883	53	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180185	10.1371/journal.pone.0180185	http://dx.doi.org/10.1371/journal.pone.0180185			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28671954	Green Published, gold			2022-12-27	WOS:000405268500024
J	Andreu-Cazenave, M; Subida, MD; Fernandez, M				Andreu-Cazenave, Miguel; Subida, Maria Dulce; Fernandez, Miriam			Exploitation rates of two benthic resources across management regimes in central Chile: Evidence of illegal fishing in artisanal fisheries operating in open access areas	PLOS ONE			English	Article							TERRITORIAL USER RIGHTS; SMALL-SCALE FISHERIES; MODEL STOCK SYNTHESIS; CATCH; COMANAGEMENT; CONSERVATION; RECRUITMENT; MORTALITY; WORLD; VARIABILITY	There is an urgent need to quantify the impacts of artisanal fisheries and define management practices that allow for the recovery and conservation of exploited stocks. The extent of illegal catch is particularly critical as a driver of overexploitation in artisanal fisheries. However, the lack of data at proper spatial scales limits the evaluation of illegal fishing and effectiveness of management practices. We used a catch curve analysis to estimate total instantaneous mortality as a proxy of fishing pressure in the artisanal benthic fishery in central Chile. We compared the patterns of total mortality in fishing grounds under the well-studied territorial use rights for fisheries system (TURF) immersed in a landscape of open access areas (OAA; no access restriction), and from these patterns determined the extent of illegal fishing in open access areas focusing on the two most frequently extracted resources: locos (Concholepas concholepas) and keyhole limpets (Fissurella spp.). The beauty of this seascape is the presence of the no-take (NT) area of Las Cruces as control (no fishing), allowing us to estimate natural mortality. Loco exploitation is banned in OAAs. However, loco mortality in OAAs was 92% higher than in the NT, and 42% higher than in TURFs. Keyhole limpet mortality was similar between TURFs and the NT, but doubled in OAAs. We also found strong differences in mortality among fishing grounds with the same level of protection (i.e. TURFs), and over time. Our results highlight (a) the high level of illegal fishing that may occur in artisanal fisheries under traditional management regimes, and (b) that TURFs can be effective to reduce fishing mortality. However, large variability among TURFs suggests the need for a deeper understanding of the drivers of success of TURFs.	[Andreu-Cazenave, Miguel; Subida, Maria Dulce; Fernandez, Miriam] Pontificia Univ Catolica Chile, Nucleo Milenio Ctr Conservac Marina CCM, Estn Costera Invest Marinas, Dept Ecol,Fac Ciencias Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Fernandez, M (corresponding author), Pontificia Univ Catolica Chile, Nucleo Milenio Ctr Conservac Marina CCM, Estn Costera Invest Marinas, Dept Ecol,Fac Ciencias Biol, Santiago, Chile.	mfernandez@bio.puc.cl		Subida, Maria Dulce/0000-0003-0205-8276	Fondo de Innovacion para la Competitividad, Ministerio de Economia y Fomento [CCM RC-130004]	Fondo de Innovacion para la Competitividad, Ministerio de Economia y Fomento	We thank FONDECYT 1130976 and 1171603 to MF, FONDECYT 11130580 to MDS and ICM project CCM RC-130004 (Fondo de Innovacion para la Competitividad, Ministerio de Economia y Fomento).	Aburto J, 2013, OCEAN COAST MANAGE, V71, P284, DOI 10.1016/j.ocecoaman.2012.09.015; ACUNA-S E, 1977, Revista de Biologia Marina, V16, P117; Afflerbach JC, 2014, GLOB ECOL CONSERV, V2, P97, DOI 10.1016/j.gecco.2014.08.001; Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Aiken CM, 2011, MAR ECOL PROG SER, V428, P77, DOI 10.3354/meps09079; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bandin RM, 2014, LAT AM J AQUAT RES, V42, P547, DOI 10.3856/vol42-issue3-fulltext-14; Berkes F., 2003, ENVIRONMENTS, V31, P5; Berkes F., 2001, MANAGING SMALL SCALE; Beverton RJH, 1957, QUANTITATIVE FISHERI; Bitecma, 1999, 731999 AMERB BIT; BRETOS M, 1980, BIOL BULL-US, V159, P606, DOI 10.2307/1540826; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Carruthers TR, 2014, FISH RES, V153, P48, DOI 10.1016/j.fishres.2013.12.014; Castilla J.C., 1986, Canadian Special Publication of Fisheries and Aquatic Sciences, V92, P133; Castilla J. C., 2012, CONTRIBUTIONS SCI, V8, P11; CASTILLA JC, 1985, OIKOS, V45, P391, DOI 10.2307/3565575; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Castilla Juan C., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P407; Cavole LM, 2015, FISH RES, V168, P1, DOI 10.1016/j.fishres.2015.03.012; Quynh NT, 2017, MAR POLICY, V75, P41, DOI 10.1016/j.marpol.2016.10.004; Cope JM, 2013, FISH RES, V142, P3, DOI 10.1016/j.fishres.2012.03.006; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Defeo O, 2005, REV FISH BIOL FISHER, V15, P265, DOI 10.1007/s11160-005-4865-0; Dowling NA, 2015, FISH RES, V171, P141, DOI 10.1016/j.fishres.2014.11.005; Dowling N. A., 2016, TOOLS STRATEGIES ASS; Dunn A, 2002, FISH RES, V59, P149, DOI 10.1016/S0165-7836(01)00407-6; FAO, 2010, STAT WORLD FISH AQ O, V2014, P2016; Fernandez M, 2005, CONSERV BIOL, V19, P1752, DOI 10.1111/j.1523-1739.2005.00277.x; Fernandez M., 2017, LAT AM J AQUAT RES; Free CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143960; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gallardo-Fernandez GL, 2011, INT J COMMONS, V5, P433; Gallucci V. F., 1995, STOCK ASSESSMENT QUA; Geaghan J.P., 1986, Canadian Special Publication of Fisheries and Aquatic Sciences, V92, P168; Gelcich S, 2008, ENVIRON CONSERV, V35, P36, DOI 10.1017/S0376892908004475; Gelcich S, 2008, ECOL APPL, V18, P273, DOI 10.1890/06-1896.1; Gelcich S, 2012, CONSERV BIOL, V26, P1005, DOI 10.1111/j.1523-1739.2012.01928.x; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Gelcich S, 2009, OCEAN COAST MANAGE, V52, P424, DOI 10.1016/j.ocecoaman.2009.07.005; Gonzalez J, 2006, B MAR SCI, V78, P499; Gordon HR, 2004, J SHELLFISH RES, V23, P935; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Hauck M, 2013, MARIT STUD, V12, DOI 10.1186/2212-9790-12-3; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Hilborn R, 2014, ICES J MAR SCI, V71, P1040, DOI 10.1093/icesjms/fsu034; Kay MC, 2012, ENVIRON CONSERV, V39, P215, DOI 10.1017/S0376892911000695; Martinez HDR, 2015, ANAL INTERACTIONS FI; McClanahan TR, 1999, CORAL REEFS, V18, P321, DOI 10.1007/s003380050205; Molina P, 2014, OCEAN COAST MANAGE, V93, P121, DOI 10.1016/j.ocecoaman.2014.03.005; Navarrete SA, 2002, LIMNOL OCEANOGR, V47, P791, DOI 10.4319/lo.2002.47.3.0791; Navarrete SA, 2008, ECOLOGY, V89, P1308, DOI 10.1890/07-0728.1; Navarrete SA, 2010, REV CHIL HIST NAT, V83, P143; Orensanz JM, 2005, B MAR SCI, V76, P527; Orensanz JM, 2012, 582 FAO FISH AQ; Panayotou T., 1982, 228 FAO FISH; Parma A.M., 2003, SUSTAINABILITY DATA, P8; Parma AM, 2010, SAMUDRA, V55, P42; Pauly D, 1997, AM FISH S S, V20, P40; Rabi Miguel, 1997, Scientia Marina, V61, P49; Raemaekers S, 2011, OCEAN COAST MANAGE, V54, P433, DOI 10.1016/j.ocecoaman.2011.02.001; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Rivera A, 2014, MAR POLICY, V50, P300, DOI 10.1016/j.marpol.2014.07.011; Rogers-Bennett L, 2016, ADV PURE MATH, V6, P321, DOI DOI 10.4236/APM.2016.65023; Salas S, 2007, FISH RES, V87, P5, DOI 10.1016/j.fishres.2007.06.015; Schumann S, 2007, MAR POLICY, V31, P101, DOI 10.1016/j.marpol.2006.05.008; SERNAPESCA, 2013, REG PESQ ART PESC EM; Smith MW, 2012, N AM J FISH MANAGE, V32, P956, DOI 10.1080/02755947.2012.711270; Song, 2011, MARITIME STUDIES, V10, P5; Stotz W, 2010, 200851 FIP, P51; Stotz W, 2008, 200654 FIP, P54; Stotz W, 2000, 9736 FIP; Subsecretaria de Pesca y Acuicultura, 2020, EST SIT PRINC PESQ C; Thorson JT, 2011, T AM FISH SOC, V140, P356, DOI 10.1080/00028487.2011.557016; Tognelli MF, 2009, BIOL CONSERV, V142, P3147, DOI 10.1016/j.biocon.2009.08.016; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Wetzel CR, 2011, MAR FRESHWATER RES, V62, P927, DOI 10.1071/MF11006; WOLFF M, 1989, STUD NEOTROP FAUNA E, V24, P87, DOI 10.1080/01650528909360779; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	79	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180012	10.1371/journal.pone.0180012	http://dx.doi.org/10.1371/journal.pone.0180012			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666013	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700053
J	Derebe, MM; Shiferaw, MB; Ayalew, MA				Derebe, Mulatu Melese; Shiferaw, Melashu Balew; Ayalew, Muluken Assefa			Low satisfaction of clients for the health service provision in West Amhara region, Ethiopia	PLOS ONE			English	Article								Introduction Client satisfaction is a key indicator to measure quality of healthcare and provides information on the level of success forproviders whether client expectations and values are met. Although there are some institutional based studies done in Ethiopia, still client satisfaction in our settings is not well addressed. Thus, this study was aimed to assess client satisfaction level and identify the underlying factors of poor health service provision in West Amhara, Ethiopia. Methods A cross-sectional study design was conducted from July to August, 2013. A structured questionnaire was used to collect data from 422 outpatient diagnosis (OPD) service users. The data were entered into EPI Info version 3.5.2 and analyzed usingSPSS version 16. Results Among the 422 study participants, 234 (55.5%) males, the mean (+/- SD) age was 37.3 (+/- 16.4) years. The overall satisfaction level of the study participants was 39.3%. Poor cleanliness of the facility, fewer service access provision, lack of prescribed drugs within the facility and longer waiting time to get the health care service wasreported by 73.2%, 67.8%, 65.6% and 59.2% of the clients respectively. Paying service users (AOR: 2.03, 95% CI: 1.22-3.39, P: 0.007), divorced clients (AOR: 4.26, 95% CI: 1.11-16.26, P: 0.034) and hospital users (AOR: 2.18, 95% CI: 1.29-3.69, P: 0.004) were more dissatisfied. Conclusions Client satisfaction was lowin the health provision in West Amhara region. Expansion of health facilities in remote areas, maintaining continuous availability of prescribed drugs, improving cleanliness of health facilities, and fast health service provision are recommended to satisfy clients in the setting.	[Derebe, Mulatu Melese; Shiferaw, Melashu Balew] Amhara Publ Hlth Inst, Bahir Dar, Ethiopia; [Ayalew, Muluken Assefa] Bahir Dar Hlth Sci Coll, Bahir Dar, Ethiopia		Derebe, MM (corresponding author), Amhara Publ Hlth Inst, Bahir Dar, Ethiopia.	mulatkonjo@yahoo.com	Shiferaw, Melashu/GPT-3320-2022	Shiferaw, Melashu Balew/0000-0002-5066-0758				Abebe Bekele, 2008, Ethiopian Journal of Health Development, V22, P42; Adane G., 2006, ASSESSMENT CLIENTS S; Al-Eisa IS, 2005, WORLD FAM MED, V3, P10; Al-Janabi S, 2016, EGYPTIAN INFORM J; Birhanu Z, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-78; Birna Abdosh, 2006, Ethiopian Journal of Health Development, V20, P199; Cui K, 2016, NEUROCOMPUTING; Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Fekadu A, 2011, ETHIOP J HLTH SCI, V21, P101; Health Resource & Services Administration, HLTH CTR PROGR REQ; Ige O. K., 2010, Journal of Rural and Tropical Public Health, V9, P19; Kebede S, 2010, INT J QUAL HEALTH C, V22, P39, DOI 10.1093/intqhc/mzp051; Kumari Ranjeeta, 2009, Indian J Community Med, V34, P35, DOI 10.4103/0970-0218.45372; Lemessa Oljira, 2001, Ethiopian Journal of Health Development, V15, P179; Lin C, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0446-0; Mequanint D, 2012, INT J RES COMMERCE M, V3, P10; Miles A., 2011, INT J PERSON CTR MED, V1, P207, DOI [https://doi.org/10.5750/ijpcm.v1i2.61, DOI 10.5750/IJPCM.V1I2.61]; Moghadam M. K., 2013, INT J SOFTWARE ENG I, V7, P23	18	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179909	10.1371/journal.pone.0179909	http://dx.doi.org/10.1371/journal.pone.0179909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665951	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700046
J	Cai, SS; Fischer, QS; He, Y; Zhang, L; Liu, HX; Daw, NW; Yang, YP				Cai, Shanshan; Fischer, Quentin S.; He, Yu; Zhang, Li; Liu, Hanxiao; Daw, Nigel W.; Yang, Yupeng			GABA(B) receptor-dependent bidirectional regulation of critical period ocular dominance plasticity in cats	PLOS ONE			English	Article							ADULT VISUAL-CORTEX; LONG-TERM POTENTIATION; DENDRITIC CA2+ SPIKES; PROTEIN-KINASE-A; MONOCULAR DEPRIVATION; RAT-BRAIN; INHIBITORY PLASTICITY; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; DIFFERENT LAYERS	Gama amino butyric acid (GABA) inhibition plays an important role in the onset and offset of the critical period for ocular dominance (OD) plasticity in the primary visual cortex. Previous studies have focused on the involvement of GABAA receptors, while the potential contribution of GABAB receptors to OD plasticity has been neglected. In this study, the GABAB receptor antagonist SCH50911 or agonist baclofen was infused into the primary visual cortex of cats concurrently with a period of monocular deprivation (MD). Using single-unit recordings we found that the OD shift induced by four days of MD during the critical period was impaired by infusion of the antagonist SCH50911, but enhanced by infusion of the agonist baclofen. In contrast, seven days of MD in adult cats did not induce any significant OD shift, even when combined with the infusion of SCH50911 or baclofen. Together, these findings indicate that an endogenous GABAB receptor-mediated inhibition contributes to juvenile, but not adult, OD plasticity.	[Cai, Shanshan; He, Yu; Zhang, Li; Liu, Hanxiao; Yang, Yupeng] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei, Peoples R China; [Fischer, Quentin S.; Daw, Nigel W.; Yang, Yupeng] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Fischer, Quentin S.] Virginia Tech, Caril Res Inst, Roanoke, VA USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Yale University; Virginia Polytechnic Institute & State University	Yang, YP (corresponding author), Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei, Peoples R China.; Yang, YP (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA.	yangyp@ustc.edu.cn	Liu, Han/GVT-8296-2022; Yang, Yupeng/G-5107-2018	Yang, Yupeng/0000-0002-9473-9994; Fischer, Quentin/0000-0002-7803-1179; Liu, Hanxiao/0000-0002-9460-4803	National Natural Science Foundation of China [31371112, 30870809]; National Institutes of Health, National Eye Institute [EY00053, EY11353]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Natural Science Foundation of China www.nsfc.gov.cn (31371112 and 30870809) to YY and National Institutes of Health, National Eye Institute of USA www.nei.nih.goV (EY00053 and EY11353) to NWD. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscrip	An X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093115; BEAR MF, 1990, J NEUROSCI, V10, P909; Beaver CJ, 2002, J NEUROPHYSIOL, V88, P1933, DOI 10.1152/jn.2002.88.4.1933; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Bowery NG, 1997, CNS DRUGS, V7, P167, DOI 10.2165/00023210-199707030-00001; Caddick SJ, 1996, MOL NEUROBIOL, V13, P23, DOI 10.1007/BF02740750; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Daw N, 2004, VISION RES, V44, P3377, DOI 10.1016/j.visres.2004.09.004; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; Dichter MA, 1997, EPILEPSIA, V38, pS2, DOI 10.1111/j.1528-1157.1997.tb05200.x; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Fritschy JM, 2004, J COMP NEUROL, V477, P235, DOI 10.1002/cne.20188; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Galuske RAW, 2000, EUR J NEUROSCI, V12, P3315, DOI 10.1046/j.1460-9568.2000.00213.x; Gonchar Y, 2001, J COMP NEUROL, V431, P182, DOI 10.1002/1096-9861(20010305)431:2<182::AID-CNE1064>3.0.CO;2-K; GU Q, 1994, P NATL ACAD SCI USA, V91, P8408, DOI 10.1073/pnas.91.18.8408; Gu Y., 2016, ELIFE, V5, P5; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Heimel JA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/391763; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Huang SY, 2010, J NEUROSCI, V30, P16636, DOI 10.1523/JNEUROSCI.4384-10.2010; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ivenshitz M, 2006, J NEUROSCI, V26, P1199, DOI 10.1523/JNEUROSCI.2964-05.2006; Jiang B, 2010, NEURON, V66, P248, DOI 10.1016/j.neuron.2010.03.021; JONES KR, 1984, J NEUROSCI, V4, P2543; Kamikubo Y, 2007, J PHYSIOL-LONDON, V585, P549, DOI 10.1113/jphysiol.2007.141010; KARBON EW, 1985, MOL PHARMACOL, V27, P53; KASAMATSU T, 1981, J NEUROPHYSIOL, V45, P254, DOI 10.1152/jn.1981.45.2.254; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Lefort S, 2013, P NATL ACAD SCI USA, V110, pE4540, DOI 10.1073/pnas.1319571110; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; Liu SL, 2003, CEREB CORTEX, V13, P864, DOI 10.1093/cercor/13.8.864; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Perez-Garci E, 2013, J PHYSIOL-LONDON, V591, P1599, DOI 10.1113/jphysiol.2012.245464; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Rao Y, 2004, EUR J NEUROSCI, V20, P837, DOI 10.1111/j.1460-9568.2004.03499.x; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SHAW C, 1987, DEV BRAIN RES, V37, P67, DOI 10.1016/0165-3806(87)90229-X; Shimegi S, 2003, J NEUROPHYSIOL, V90, P4027, DOI 10.1152/jn.00313.2003; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Tabata T, 2010, ADV PHARMACOL, V58, P149, DOI 10.1016/S1054-3589(10)58007-4; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; Uriguen L, 2011, J PSYCHOPHARMACOL, V25, P105, DOI 10.1177/0269881109358204; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Vorobyov V, 2013, J NEUROSCI, V33, P234, DOI 10.1523/JNEUROSCI.2283-12.2013; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; Wang L, 2014, J NEUROSCI, V34, P1083, DOI 10.1523/JNEUROSCI.4711-13.2014	67	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180162	10.1371/journal.pone.0180162	http://dx.doi.org/10.1371/journal.pone.0180162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662175	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300117
J	Hightow-Weidman, L; LeGrand, S; Choi, SK; Egger, J; Hurt, CB; Muessig, KE				Hightow-Weidman, Lisa; LeGrand, Sara; Choi, Seul Ki; Egger, Joseph; Hurt, Christopher B.; Muessig, Kathryn E.			Exploring the HIV continuum of care among young black MSM	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY USE; MARIJUANA USE; MEDICATION ADHERENCE; INFECTED PATIENTS; SUBSTANCE-ABUSE; UNITED-STATES; WHITE MEN; DRUG-USE; SEX; DISPARITIES	Background HIV disproportionately impacts young, black men who have sex with men (YBMSM) who experience disparities across the HIV care continuum. A more nuanced understanding of facilitators and barriers to engagement in care, missed visits, antiretroviral uptake, adherence and viral suppression could improve care and intervention design. Methods A randomized controlled trial of an online intervention, healthMpowerment, enrolled 465 YBMSM (18-30 years); 193 identified as HIV-positive. Bivariable and multivariable analyses of baseline data explored predictors of: engagement in care, missed visits, antiretroviral uptake, self-reported adherence, and viral suppression. Results Mean age was 24.9 years; most identified as gay (71.0%) and were receiving HIV care (89.1%). Among those in care, 52.1% reported no missed visits in the past 12 months, 41 (24.6%) reported one missed visit, and 39 (23.4%) reported two or more. Having insurance (prevalence odds ratio [POR] 4.5; 95% CI: 1.3, 15.8) and provider self-efficacy (POR 20.1; 95% CI: 6.1, 64.1) were associated with being in care. Those with a college degree (POR 9.1; 95% CI: 1.9, 45.2) and no recent marijuana (POR 2.6; 95% CI: 1.2, 5.6) or methamphetamine use (POR 5.4; 95% CI: 1.0, 28.5) were less likely to miss visits. Most (n = 153, 84.1%) had been prescribed antiretroviral therapy. A majority of participants (70.8%) reported >= 90% adherence; those with depressive symptoms had 4.7 times the odds of reporting adherence <90% (95% CI: 1.65, 13.37). Of participants who reported viral load testing in the past six months, 65% (n = 102) reported an undetectable viral load. Disclosure to sex partners was associated with viral suppression (POR 6.0; 95% CI: 1.6, 22.4). Conclusions Multi-level facilitators and barriers to engagement across the continuum of care were identified in this sample of YBMSM. Understanding the distinct needs of YBMSM at each stage of the continuum and addressing them through tailored approaches is critical for long term success in care.	[Hightow-Weidman, Lisa; Hurt, Christopher B.] Univ North Carolina Chapel Hill, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27599 USA; [LeGrand, Sara; Egger, Joseph] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Choi, Seul Ki; Muessig, Kathryn E.] Univ North Carolina Chapel Hill, Gillings Sch Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hightow-Weidman, L (corresponding author), Univ North Carolina Chapel Hill, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27599 USA.	lisa_hightow@med.unc.edu	LeGrand, Sara/AAB-2613-2021; Muessig, Kate/P-1242-2018	Choi, Seul Ki/0000-0003-0405-7787; Hightow-Weidman, Lisa/0000-0002-2421-923X	NIH [R01MH093275-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, UM1AI069423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NIH R01MH093275-01	Allshouse AA, 2015, JAIDS-J ACQ IMM DEF, V69, P187, DOI 10.1097/QAI.0000000000000562; [Anonymous], 2016, NSDUH SER H, V51; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Bouris A., 2013, J AIDS CLIN RES, V4; Buttram ME, 2015, J RACIAL ETHN HEALTH, V2, P1, DOI 10.1007/s40615-014-0042-2; Centers for Disease Control and Prevention, 2015, 2013 HIV SURV SUPPL, V20; Centers for Disease Control and Prevention (CDC), 2014, MMWR-MORBID MORTAL W, V63; Chibanda D, 2016, J AFFECT DISORDERS, V198, P50, DOI 10.1016/j.jad.2016.03.006; Conserve DF, 2015, AIDS BEHAV, V19, P1763, DOI 10.1007/s10461-015-1006-1; D'Souza G, 2012, JAIDS-J ACQ IMM DEF, V61, P618, DOI 10.1097/QAI.0b013e318273ab3a; Dyer TP, 2012, J URBAN HEALTH, V89, P697, DOI 10.1007/s11524-012-9674-x; Eaton LA, 2014, SEX HEALTH, V11, P244, DOI 10.1071/SH14022; Edwards M, 2014, J ASSOC NURSE AIDS C, V25, P243, DOI 10.1016/j.jana.2013.05.004; Giordano TP, 2004, HIV CLIN TRIALS, V5, P74, DOI 10.1310/JFXH-G3X2-EYM6-D6UG; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Harper GW, 2013, AIDS BEHAV, V17, P213, DOI 10.1007/s10461-011-0071-3; Hausmann LRM, 2011, MED CARE, V49, P626, DOI 10.1097/MLR.0b013e318215d93c; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Hightow-Weidman LB, 2015, HEALTH EDUC BEHAV, V42, P493, DOI 10.1177/1090198114562043; Hightow-Weidman LB, 2011, AIDS EDUC PREV, V23, P1, DOI 10.1521/aeap.2011.23.1.1; Hoots BE, 2017, J INFECT DIS; Howe CJ, 2010, AIDS RES HUM RETROV, V26, P875, DOI 10.1089/aid.2009.0282; Hussen SA, 2015, AIDS PATIENT CARE ST, V29, P77, DOI 10.1089/apc.2014.0117; Kahana SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151106; Kahana SY, 2015, JAIDS-J ACQ IMM DEF, V68, P169, DOI 10.1097/QAI.0000000000000408; Kalichman SC, 2016, AIDS PATIENT CARE ST, V30, P221, DOI 10.1089/apc.2015.0333; Kapogiannis B, 2015, 8 INT AIDS SOC C HIV; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Magnus M, 2010, JAIDS-J ACQ IMM DEF, V53, P529, DOI 10.1097/QAI.0b013e3181b56404; Maksut JL, 2016, J BEHAV MED, V39, P665, DOI 10.1007/s10865-016-9734-x; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Markin S, 2016, US UNINSURED RATE 11; Marks G, 2009, AIDS BEHAV, V13, P682, DOI 10.1007/s10461-008-9380-6; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; Maurer DM, 2012, AM FAM PHYSICIAN, V85, P139; Mayer KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087298; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mimiaga MJ, 2013, AM J PUBLIC HEALTH, V103, P1457, DOI 10.2105/AJPH.2012.301162; Morgan E, 2016, SUBST USE MISUSE, V51, P1751, DOI 10.1080/10826084.2016.1197265; Mugavero MJ, 2014, CLIN INFECT DIS, V59, P1471, DOI 10.1093/cid/ciu603; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P100, DOI 10.1097/QAI.0b013e31818d5c37; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; O'Neil Conar R, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P134, DOI 10.1177/1545109711423976; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; Pence BW, 2005, JAIDS-J ACQ IMM DEF, V40, P434, DOI 10.1097/01.qai.0000177512.30576.9c; Petroll AE, 2011, SEX TRANSM DIS, V38, P63, DOI 10.1097/OLQ.0b013e3181ebd50f; Quinn K, 2016, AIDS CARE, V28, P866, DOI 10.1080/09540121.2016.1153596; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramo DE, 2012, PSYCHOL ADDICT BEHAV, V26, P801, DOI 10.1037/a0026201; Ramo DE, 2011, HEALTH PSYCHOL, V30, P693, DOI 10.1037/a0023443; Rosenberg ES, 2014, LANCET HIV, V1, pE112, DOI 10.1016/S2352-3018(14)00011-3; Sam TS, 2015, AIDS BEHAV, V19, P2049, DOI 10.1007/s10461-015-1064-4; Samet JH, 2004, ALCOHOL CLIN EXP RES, V28, P572, DOI 10.1097/01.ALC.0000122103.74491.78; Schneider JA, 2017, AIDS, V31, P159, DOI 10.1097/QAD.0000000000001269; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Shively M., 2002, AIDS BEHAV, V6, P371, DOI DOI 10.1023/A:1021156914683; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Solowij N, 2012, PSYCHOPHARMACOLOGY, V219, P575, DOI 10.1007/s00213-011-2486-y; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Weber R, 2015, HIV MED, V16, P137, DOI 10.1111/hiv.12184; Whetten K, 2005, AIDS PATIENT CARE ST, V19, P89, DOI 10.1089/apc.2005.19.89	64	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179688	10.1371/journal.pone.0179688	http://dx.doi.org/10.1371/journal.pone.0179688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662170	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300041
J	Ishizaki, A; Tran, VT; Nguyen, CH; Tanimoto, T; Hoang, HTT; Pham, HV; Phan, CTT; Bi, XQ; Pham, TV; Ichimura, H				Ishizaki, Azumi; Vuong Thi Tran; Cuong Hung Nguyen; Tanimoto, Tomoaki; Huyen Thi Thanh Hoang; Hung Viet Pham; Chung Thi Thu Phan; Bi, Xiuqiong; Thuc Van Pham; Ichimura, Hiroshi			Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012	PLOS ONE			English	Article							DIRECT-ACTING ANTIVIRALS; NORTHERN VIETNAM; INJECT DRUGS; HAI PHONG; COINFECTION; INFECTION; PEOPLE; RISK; INDIVIDUALS; DISEASE	We previously reported a significant reduction in the prevalence of human immunodeficiency virus type 1 (HIV) from 2007 to 2012 in people who inject drugs (PWID; 35.9% to 18.5%, p < 0.001) and female sex workers (FSW; 23.1% to 9.8%, p < 0.05), but not in blood donors (BD) or pregnant women, in Haiphong, Vietnam. Our aim in the present study was to assess trends in the prevalence of infection with hepatitis B and C viruses (HBV and HCV, respectively). We also investigated the coinfection rates of HBV and HCV with HIV in the same groups. Between 2007 and 2012, HBV prevalence was significantly decreased in BD (18.1% vs. 9.0%, p = 0.007) and slightly decreased in FSW (11.0% vs. 3.9%, p = 0.21), but not in PWID (10.7% vs. 11.1%, p = 0.84). HCV prevalence was significantly decreased in PWID (62.1% in 2007 vs. 42.7% in 2008, p < 0.0001), but it had rebounded to 58.4% in 2012 (2008 vs. 2012, p < 0.0001). HCV prevalence also increased in FSW: 28.6% in 2007 and 2009 vs. 35.3% in 2012; however, this difference was not significant (2007 vs. 2012, p = 0.41). Rates of coinfection with HBV and HCV among HIV-infected PWID and FSW did not change significantly during the study period. Our findings suggest that the current harm reduction programs designed to prevent HIV transmission in PWID and FSW may be insufficient to prevent the transmission of hepatitis viruses, particularly HCV, in Haiphong, Vietnam. New approaches, such as the introduction of catch-up HBV vaccination to vulnerable adult populations and the introduction of HCV treatment as prevention, should be considered to reduce morbidity and mortality due to HIV and hepatitis virus coinfection in Vietnam.	[Ishizaki, Azumi; Tanimoto, Tomoaki; Hung Viet Pham; Chung Thi Thu Phan; Bi, Xiuqiong; Ichimura, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, Kanazawa, Ishikawa, Japan; [Vuong Thi Tran; Cuong Hung Nguyen; Huyen Thi Thanh Hoang; Thuc Van Pham] Hai Phong Univ Med & Pharm, Hai Phong, Vietnam	Kanazawa University; Hai Phong University Medicine & Pharmacy	Ichimura, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, Kanazawa, Ishikawa, Japan.	ichimura@med.kanazawa-u.ac.jp	ICHIMURA, Hiroshi/L-3605-2015	ICHIMURA, Hiroshi/0000-0003-4478-1964	Japan Society for the Promotion of Science KAKENHI [JP15H05289]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science KAKENHI Grant Number JP15H05289.	Ahmed T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1404-3; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; Bruggmann P, 2015, INT J DRUG POLICY, V26, pS22, DOI 10.1016/j.drugpo.2014.08.014; Huy BV, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/581021; Cuong HN, 2011, J MED VIROL, V83, P399, DOI 10.1002/jmv.21978; Degenhardt L, 2016, LANCET INFECT DIS, V16, P1385, DOI 10.1016/S1473-3099(16)30325-5; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039027; Durier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034548; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Pham HV, 2015, AIDS RES HUM RETROV, V31, P757, DOI [10.1089/AID.2015.0071, 10.1089/aid.2015.0071]; Ishizaki A, 2009, AIDS RES HUM RETROV, V25, P175, DOI 10.1089/aid.2008.0193; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Lima VD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143836; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; Martin NK, 2015, CURR OPIN HIV AIDS, V10, P374, DOI 10.1097/COH.0000000000000179; Ministry of Health Socialist Rebulic of Viet Nam, VIETN AIDS RESP REP; Nadol P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118304; Palmateer NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104515; Pollack TM, 2016, J VIRUS ERAD, V2, P102; Scott N, 2016, J GASTROEN HEPATOL, V31, P872, DOI 10.1111/jgh.13223; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Tanimoto T, 2010, J MED VIROL, V82, P1355, DOI 10.1002/jmv.21787; Taylor LE, 2013, CLIN INFECT DIS, V57, pS118, DOI 10.1093/cid/cit326; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Nguyen TH, 2014, VACCINE, V32, P217, DOI 10.1016/j.vaccine.2013.11.004; Treloar C, 2016, HARM REDUCT J, V13, DOI 10.1186/s12954-016-0107-0; van Santen DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163488; Tran VT, 2012, AIDS RES HUM RETROV, V28, P1349, DOI 10.1089/aid.2012.0006; WHO, 2016, MYANM NATL SIMPL TRE; Ye SD, 2014, CURR HIV-AIDS REP, V11, P128, DOI 10.1007/s11904-014-0206-z; Zhang FJ, 2014, LANCET INFECT DIS, V14, P1065, DOI 10.1016/S1473-3099(14)70946-6; Zhang L, 2015, EUR J GASTROEN HEPAT, V27, P550, DOI 10.1097/MEG.0000000000000321	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179616	10.1371/journal.pone.0179616	http://dx.doi.org/10.1371/journal.pone.0179616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662105	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300040
J	Lee, JH; Giger, U; Kim, HY				Lee, Jae Ho; Giger, Urs; Kim, Hee Young			Kai 1 and Kai 2: Characterization of these dog erythrocyte antigens by monoclonal antibodies	PLOS ONE			English	Article							TRANSFUSION COMPATIBILITY; BLOOD-GROUPS; GEL	Dog Erythrocyte Antigens (DEA) have thus far been found by sensitizing dogs with canine allogeneic blood and are clinically important regarding blood transfusion incompatibilities, but remain poorly defined. The goals of this study were to discover and characterize two DEAs, named as Kai 1 and Kai 2. The monoclonal antibodies were produced by mouse hybridoma techniques and examined by ELISA isotyping, immunoblotting, and affinity chromatography. Canine blood samples were typed and the development of alloantibodies was examined in transfused dogs. The monoclonal Kai 1 and Kai 2 antibodies were isotyped as IgM kappa and IgG3 lamda, respectively, and identified two different erythrocyte membrane proteins of 200 kDa and 80 kDa in molecular weights, respectively. Either Kai 1 or Kai 2 can be expressed but not both in an individual dog. There were no naturally occurring anti-Kai 1 or Kai 2 alloantibodies. In addition, Kai 1-and/or Kai 2- dogs developed Kai 1 and Kai 2 alloantibodies, respectively, when transfused with mismatched blood. This is the first discovery of canine blood types by screening monoclonal antibodies. Kai 1 and Kai 2 are novel blood types which can induce anti-Kai 1 or anti-Kai 2 alloantibodies when Kai 1-and/or Kai 2- dogs are transfused with Kai 1+ or Kai 2+ blood. These canine blood types may explain some of the blood incompatibilities and transfusion reactions observed in dogs in clinical practice.	[Lee, Jae Ho; Kim, Hee Young] Daegu Haany Univ, Coll Korean Med, Dept Physiol, KABB Bio Lab, Daegu, South Korea; [Giger, Urs] Univ Penn, Sch Vet Med, Med Genet Sect, Philadelphia, PA 19104 USA	Daegu Haany University; University of Pennsylvania	Kim, HY (corresponding author), Daegu Haany Univ, Coll Korean Med, Dept Physiol, KABB Bio Lab, Daegu, South Korea.	hykim@dhu.ac.kr		Kim, Hee Young/0000-0002-2495-9115	National Research Foundation of Korea [2014R1A2A1A11053104]; National Institutes of Health [OD 010939]	National Research Foundation of Korea(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Research Foundation of Korea (2014R1A2A1A11053104; vv-ww.nrf.rekr) and National Institutes of Health (OD 010939; https:// wmi.cdc.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno MM, 2014, J VET INTERN MED, V28, P592, DOI 10.1111/jvim.12321; ANDREWS GA, 1992, J AM VET MED ASSOC, V201, P1549; Blais MC, 2009, J VET INTERN MED, V23, P462, DOI 10.1111/j.1939-1676.2009.0286.x; CALLAN MB, 1995, J VET INTERN MED, V9, P277, DOI 10.1111/j.1939-1676.1995.tb01080.x; Canard B, 2013, J VET EMERG CRIT CAR, V23, pS12; Corato A, 1997, VET IMMUNOL IMMUNOP, V59, P213, DOI 10.1016/S0165-2427(97)00080-9; Ernst Manfred, 1999, Human Antibodies, V9, P165; Euler CC, 2016, J VET INTERN MED, V30, P1642, DOI 10.1111/jvim.14572; GIGER U, 1995, J AM VET MED ASSOC, V206, P1358; Goulet S, 2017, J VET INTERN MED, V31, P751, DOI 10.1111/jvim.14693; Goulet S, 2017, J VET INTERN MED; Goulet S, 2017, VET PATHOL; Green JL, 2000, COMP HAEMATOL INT, V10, P30, DOI 10.1007/s005800070024; HALE AS, 1995, VET CLIN N AM-SMALL, V25, P1323, DOI 10.1016/S0195-5616(95)50157-3; HARA Y, 1991, J VET MED SCI, V53, P1105, DOI 10.1292/jvms.53.1105; Kessler RJ, 2010, VET CLIN PATH, V39, P306, DOI 10.1111/j.1939-165X.2010.00249.x; Klaus T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30938; Luethy D, 2016, J VET INTERN MED, V30, P1864, DOI 10.1111/jvim.14604; Moller M, 2016, BLOOD ADV, V1, P240, DOI 10.1182/bloodadvances.2016001867; Ognean L, 2014, PAK VET J, V34, P96; Polak K, 2015, VET CLIN PATH, V44, P369, DOI 10.1111/vcp.12284; Power D A, 1990, Hum Antibodies Hybridomas, V1, P34; Quraishy N, 2016, ADV CLIN CHEM, V77, P221, DOI 10.1016/bs.acc.2016.06.006; Roux FA, 2007, XENOTRANSPLANTATION, V14, P208, DOI 10.1111/j.1399-3089.2007.00404.x; Safra N, 2014, VET CLIN PATH, V43, pE12; Wardrop KJ, 2007, J VET INTERN MED, V21, P205, DOI 10.1111/j.1939-1676.2007.tb02949.x	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179932	10.1371/journal.pone.0179932	http://dx.doi.org/10.1371/journal.pone.0179932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662180	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300073
J	Uematsu, H; Yamashita, K; Kunisawa, S; Otsubo, T; Imanaka, Y				Uematsu, Hironori; Yamashita, Kazuto; Kunisawa, Susumu; Otsubo, Tetsuya; Imanaka, Yuichi			Prediction of pneumonia hospitalization in adults using health checkup data	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; RISK-FACTORS; BENZODIAZEPINES; PERFORMANCE; FRAMEWORK; MORTALITY; EFFICACY	Objectives Community-acquired pneumonia is a common cause of hospitalization, and pneumococcal vaccinations are recommended for high-risk individuals. Although risk factors for pneumonia have been identified, there are currently no pneumonia hospitalization prediction models based on the risk profiles of healthy subjects. This study aimed to develop a predictive model for pneumonia hospitalization in adults to accurately identify high-risk individuals to facilitate the efficient prevention of pneumonia. Methods We conducted a retrospective database analysis using health checkup data and health insurance claims data for residents of Kyoto prefecture, Japan, between April 2010 and March 2015. We chose adults who had undergone health checkups in the first year of the study period, and tracked pneumonia hospitalizations over the next 5 years. Subjects were randomly divided into training and test sets. The outcome measure was pneumonia hospitalization, and candidate predictors were obtained from the health checkup data. The prediction model was developed and internally validated using a LASSO logistic regression analysis. Lastly, we compared the new model with comparative models. Results The study sample comprised 54,907 people who had undergone health checkups. Among these, 921 were hospitalized for pneumonia during the study period. The c-statistic for the prediction model in the test set was 0.71 (95% confidence interval: 0.69-0.73). In contrast, a comparative model with only age and comorbidities as predictors had a lower c-statistic of 0.55 (95% confidence interval: 0.54-0.56). Conclusions Our predictive model for pneumonia hospitalization performed better than comparative models, and may be useful for supporting the development of pneumonia prevention measures.	[Uematsu, Hironori; Yamashita, Kazuto; Kunisawa, Susumu; Otsubo, Tetsuya; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Kyoto, Japan	Kyoto University	Imanaka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Kyoto, Japan.	imanaka-y@umin.net	Otsubo, Tetsuya/HCH-1434-2022; KUNISAWA, Susumu/HCH-1094-2022		Ministry of Health, Labour and Welfare of Japan [H27-iryo-ippan-005, H27-shinkogyosei-shitei-005, H29-shinkogyosei-shitei-005]; Japan Society for the Promotion of Science [[A]16H02634]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Health Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan (H27-iryo-ippan-005, H27-shinkogyosei-shitei-005, H29-shinkogyosei-shitei-005; http://sci-hub.io/http://www.mhlw.go.jp), and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. ([A]16H02634; http://sci-hub.io/https://www.jsps.go.jp/j-grantsinaid) YI received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario CV, 2015, EUR J GASTROEN HEPAT, V27, P1259, DOI 10.1097/MEG.0000000000000444; Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Brown JS, 2012, CLIN MED, V12, P538, DOI 10.7861/clinmedicine.12-6-538; Chien YF, 2015, J CRIT CARE, V30, P506, DOI 10.1016/j.jcrc.2015.01.001; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; Diao WQ, 2016, VACCINE, V34, P1496, DOI 10.1016/j.vaccine.2016.02.023; Dublin S, 2011, J AM GERIATR SOC, V59, P1899, DOI 10.1111/j.1532-5415.2011.03586.x; Friedman J, GLMNET LASSO ELASTIC; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Ishida T., 2011, EFFICACY OF PNEUMOCO; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Miller ER, 2016, VACCINE, V34, P2841, DOI 10.1016/j.vaccine.2016.04.021; Ministry of Health, 2007, LAB WELF JAP STAND P; Ministry of Health, 2007, LAB WERLF JAP STAND; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; Orimo Hajime, 2006, Nihon Ronen Igakkai Zasshi, V43, P27; Remington LT, 2014, CURR OPIN PULM MED, V20, P215, DOI 10.1097/MCP.0000000000000052; Rossi RG, 2004, INT J TUBERC LUNG D, V8, P528; Schierenberg A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149895; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Taneja C, 2010, J HOSP MED, V5, P528, DOI 10.1002/jhm.704; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; Uematsu H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-203; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Whiteside J, 2006, CLIN INQUIRIES	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180159	10.1371/journal.pone.0180159	http://dx.doi.org/10.1371/journal.pone.0180159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662167	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300115
J	Leventer-Roberts, M; Hammerman, A; Brufman, I; Hoshen, M; Braun, M; Ashur, Y; Lieberman, N; Balicer, R				Leventer-Roberts, Maya; Hammerman, Ariel; Brufman, Ilan; Hoshen, Moshe; Braun, Marius; Ashur, Yaffa; Lieberman, Nicky; Balicer, Ran			Effectiveness of dasabuvir/ombitasvir/ paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study	PLOS ONE			English	Article							GENOTYPE 1; HCV; RIBAVIRIN; INFECTION; DASABUVIR; REGIMENS; ABT-450/R-OMBITASVIR; CIRRHOSIS; THERAPY; ISRAEL	Background Direct acting antivirals for hepatitis C virus have shown dramatic results in clinical trials. However, their effectiveness has yet to be demonstrated within observational cohorts which lack exclusion criteria found in randomized control trials. Aim To determine the effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir in achieving sustained virological response. Methods Retrospective observational cohort study of all Clalit Health Services members with hepatitis C virus genotype 1 who were dispensed dasabuvir/ombitasvir/paritaprevir/ritonavir from January 1, 2015 to- November 31, 2015. Results There were 564 participants during the study period. The average age was 61.9 years, 52.0% were male, and 61.5% were born Eastern/Central Europe or Central Asia. The prevalence of diabetes was 31.7% and 70.3% were overweight/obese. Cirrhosis was present in 41.0% of participants, of whom 52.8% had stage 4 fibrosis. Of the cohort, 416 ( 74.8%) had follow- up viral load testing at 10 or more weeks after the end of treatment. We report a sustained virological response of 98.8% among those tested. Conclusions Treatment with dasabuvir/ombitasvir/paritaprevir/ritonavir demonstrated a near universal effectiveness in achieving a sustained virological response among HCV patients in a large cohort.	[Leventer-Roberts, Maya; Brufman, Ilan; Hoshen, Moshe; Balicer, Ran] Clalit Res Inst, Tel Aviv, Israel; [Leventer-Roberts, Maya] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Hammerman, Ariel; Braun, Marius; Balicer, Ran] Clalit Hlth Serv, Chief Phys Off, Tel Aviv, Israel; [Braun, Marius] Beilinson Med Ctr, Liver Unit, Petah Tiqwa, Israel; [Braun, Marius] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Ashur, Yaffa] Clalit Hlth Serv, Hepatol, Tel Aviv, Israel; [Lieberman, Nicky] Clalit Hlth Serv, Community Med Div, Tel Aviv, Israel; [Balicer, Ran] Ben Gurion Univ Negev, Dept Epidemiol, Fac Hlth Sci, Beer Sheva, Israel	Icahn School of Medicine at Mount Sinai; Clalit Health Services; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Clalit Health Services; Clalit Health Services; Ben Gurion University	Leventer-Roberts, M (corresponding author), Clalit Res Inst, Tel Aviv, Israel.; Leventer-Roberts, M (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	mayale3@clalit.org.il	Hammerman, Ariel/AAG-4399-2020	Hammerman, Ariel/0000-0002-4396-5246	Abbvie; MSD; Jansen; Gilead; Novartis; Roche; BMS	Abbvie(AbbVie); MSD; Jansen; Gilead(Gilead Sciences); Novartis(Novartis); Roche(Roche Holding); BMS(Bristol-Myers Squibb)	Dr. Braun reports receiving consulting fees from Abbvie, MSD, and Jansen; educational travel grants from Gilead and Novartis; and personal fees from Roche and BMS. All other authors have no conflicts of interest to disclose. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; [Anonymous], 2014, J HOPK ACG SYST VERS; Ara A Kardashian, 2015, Gastroenterol Hepatol (N Y), V11, P458; Backus LI, 2016, ALIMENT PHARM THER, V44, P400, DOI 10.1111/apt.13696; Backus LI, 2015, ALIMENT PHARM THER, V42, P559, DOI 10.1111/apt.13300; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Fabrizi F, 2015, EXPERT REV CLIN PHAR, V8, P785, DOI 10.1586/17512433.2015.1086266; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gutierrez JA, 2015, J VIRAL HEPATITIS, V22, P861, DOI 10.1111/jvh.12422; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Ioannou GN, 2016, GASTROENTEROLOGY; Karpati T, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0032-y; Klibanov OM, 2015, ANN PHARMACOTHER, V49, P566, DOI 10.1177/1060028015570729; Kohli A, 2015, ANN INTERN MED, V163, P899, DOI 10.7326/M15-0642; Maruyama A, 2015, NEPHROL DIAL TRANSPL; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Saeed S, 2016, CLIN INFECT DIS, V62, P919, DOI 10.1093/cid/civ1222; Shmueli A, 2007, HEALTH ECON POLICY L, V2, P251, DOI 10.1017/S1744133107004100; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Suwanthawornkul T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145953; Walker DR, 2015, ADV THER, V32, P1117, DOI 10.1007/s12325-015-0258-5; Wilder JM, 2015, THER ADV CHRONIC DIS, V6, P314, DOI 10.1177/2040622315603642; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0176858	10.1371/journal.pone.0176858	http://dx.doi.org/10.1371/journal.pone.0176858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686590	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100003
J	Marild, K; Tapia, G; Haugen, M; Dahl, SR; Cohen, AS; Lundqvist, M; Lie, BA; Stene, LC; Stordal, K				Marild, Karl; Tapia, German; Haugen, Margareta; Dahl, Sandra R.; Cohen, Arieh S.; Lundqvist, Marika; Lie, Benedicte A.; Stene, Lars C.; Stordal, Ketil			Maternal and neonatal vitamin D status, genotype and childhood celiac disease	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; GENOME-WIDE ASSOCIATION; NORWEGIAN MOTHER; NATIONWIDE COHORT; PREGNANT-WOMEN; D DEFICIENCY; D LEVEL; RISK; BIRTH; MOBA	Background Low concentration of 25-hydroxyvitamin D during pregnancy may be associated with offspring autoimmune disorders. Little is known about environmental triggers except gluten for celiac disease, a common immune-mediated disorder where seasonality of birth has been reported as a risk factor. We therefore aimed to test whether low maternal and neonatal 25hydroxyvitamin D predicted higher risk of childhood celiac disease. Methods and Findings In this Norwegian nationwide pregnancy cohort (n = 113,053) and nested case-control study, we analyzed 25-hydroxyvitamin D in maternal blood from mid-pregnancy, postpartum and cord plasma of 416 children who developed celiac disease and 570 randomly selected controls. Mothers and children were genotyped for established celiac disease and vitamin D metabolism variants. We used mixed linear regression models and logistic regression to study associations. There was no significant difference in average 25-hydroxyvitamin D between cases and controls (63.1 and 62.1 nmol/l, respectively, p = 0.28), and no significant linear trend (adjusted odds ratio per 10 nM increase 1.05, 95% CI: 0.93 +/- 1.17). Results were similar when analyzing the mid-pregnancy, postpartum or cord plasma separately. Genetic variants for vitamin D deficiency were not associated with celiac disease (odds ratio per risk allele of the child, 1.00; 95% CI, 0.90 to 1.10, odds ratio per risk allele of the mother 0.94; 95% CI 0.85 to 1.04). Vitamin D intake in pregnancy or by the child in early life did not predict later celiac disease. Adjustment for established genetic risk markers for celiac disease gave similar results. Conclusions We found no support for the hypothesis that maternal or neonatal vitamin D status is related to the risk of childhood celiac disease.	[Marild, Karl; Tapia, German; Haugen, Margareta; Stene, Lars C.; Stordal, Ketil] Norwegian Inst Publ Hlth, Oslo, Norway; [Dahl, Sandra R.] Oslo Univ Hosp, Aker Hormone Lab, Oslo, Norway; [Cohen, Arieh S.; Lundqvist, Marika] Statens Serum Inst, Danish Ctr Newborn Screening, Copenhagen, Denmark; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Stordal, Ketil] Ostfold Hosp Trust, Dept Pediat, Gralum, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; Statens Serum Institut; University of Oslo; University of Oslo	Stordal, K (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.; Stordal, K (corresponding author), Ostfold Hosp Trust, Dept Pediat, Gralum, Norway.	ketil.stordal@fhi.no	Tapia, German/AAS-8467-2020	Tapia, German/0000-0002-1770-1183; Stordal, Ketil/0000-0001-7826-8646	Norwegian Ministry of Health and Care Services; Ministry of Education and Research, NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; Research Council of Norway; Oak Foundation, Geneva, Switzerland	Norwegian Ministry of Health and Care Services; Ministry of Education and Research, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Council of Norway(Research Council of Norway); Oak Foundation, Geneva, Switzerland	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no.1 UO1 NS 047537-01 and grant no.2 UO1 NS 047537-06A1). The sub-study was funded by a research grant from the Research Council of Norway. Dr Stordal was supported by an unrestricted grant from Oak Foundation, Geneva, Switzerland.	Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Aitken RJ, 2016, METHODS MOL BIOL, V1433, P13, DOI 10.1007/7651_2015_307; [Anonymous], [No title captured]; Aronsson CA, 2015, PEDIATRICS, V135, P239, DOI 10.1542/peds.2014-1787; BOUILLON R, 1981, J CLIN INVEST, V67, P589, DOI 10.1172/JCI110072; Brantsaeter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x; Brantsaeter AL, 2007, ANN NUTR METAB, V51, P146, DOI 10.1159/000103275; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Capriati T, 2015, EUR J PEDIATR, V174, P1657, DOI 10.1007/s00431-015-2589-2; Chen YH, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-9; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Haugen M, 2008, ANN NUTR METAB, V52, P272, DOI 10.1159/000146274; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holvik K, 2015, AM J CLIN NUTR, V102, P1289, DOI 10.3945/ajcn.115.110528; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Ivarsson A, 2003, J EPIDEMIOL COMMUN H, V57, P36, DOI 10.1136/jech.57.1.36; Lebwohl B, 2013, ARCH DIS CHILD, V98, P48, DOI 10.1136/archdischild-2012-302360; Lewy H, 2009, J PEDIATR GASTR NUTR, V48, P181, DOI 10.1097/MPG.0b013e3181709530; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Lohi S, 2007, ALIMENT PHARM THERAP, V26, P1217, DOI 10.1111/j.1365-2036.2007.03502.x; Magnus MC, 2013, PAEDIATR PERINAT EP, V27, P532, DOI 10.1111/ppe.12080; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; Marild K, 2015, ACTA PAEDIAT; Marild K, 2015, AM J GASTROENTEROL, V110, P1475, DOI 10.1038/ajg.2015.287; Meltzer HM, 2008, MATERN CHILD NUTR, V4, P14, DOI 10.1111/j.1740-8709.2007.00104.x; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Morales E, 2012, EPIDEMIOLOGY, V23, P64, DOI 10.1097/EDE.0b013e31823a44d3; Munger KL, 2016, JAMA NEUROL; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Namatovu F, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0613-y; Nissen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089907; Pettifor JM, 2005, ENDOCRIN METAB CLIN, V34, P537, DOI 10.1016/j.ecl.2005.04.002; Pourshahidi LK, 2015, P NUTR SOC, V74, P115, DOI 10.1017/S0029665114001578; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Saccone D, 2015, GENE, V561, P171, DOI 10.1016/j.gene.2015.02.024; Selvaraj P, 2009, J CLIN IMMUNOL, V29, P470, DOI 10.1007/s10875-009-9277-9; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Sorensen IM, 2012, DIABETES, V61, P175, DOI 10.2337/db11-0875; Tanpowpong P, 2013, J PEDIATR-US, V162, P501, DOI 10.1016/j.jpeds.2012.08.056; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086	47	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179080	10.1371/journal.pone.0179080	http://dx.doi.org/10.1371/journal.pone.0179080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686601	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000405464100009
J	Miazgowski, T; Kucharski, R; Soltysiak, M; Taszarek, A; Miazgowski, B; Widecka, K				Miazgowski, Tomasz; Kucharski, Robert; Soltysiak, Marta; Taszarek, Aleksandra; Miazgowski, Bartosz; Widecka, Krystyna			Visceral fat reference values derived from healthy European men and women aged 20-30 years using GE Healthcare dual-energy x-ray absorptiometry	PLOS ONE			English	Article							METABOLIC SYNDROME; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ASSOCIATIONS; OBESITY; MASS; ACCUMULATION; REDUCTION; DENSITY; LUNAR	Dual energy X-ray absorptiometry (DXA) is an established technique used in clinical and research settings to evaluate total and regional fat. Additionally, recently developed software allow to quantify visceral adipose tissue (VAT). Currently, there are no reference values available for GE Healthcare DXA systems for VAT. The aim of this study was to develop reference values for VAT in healthy European adults aged 20-30 years using a GE Healthcare Prodigy densitometer along with the dedicated CoreScan application. We also assessed the associations of VAT with traditional cardiometabolic risk factors. In 421 participants (207 men; 214 women), we performed DXA whole-body scans and calculated total body fat (BF) and VAT (in gender-specific percentiles). We also measured blood pressure and fasting glucose, insulin, and blood lipids. Males, in comparison with females, had 2-fold greater VAT both in units of mass (542 +/- 451 g; 95% CI: 479.6-605.1 g vs. 258 +/- 226 g; 95% CI: 226.9-288.6 g) and volume (570 +/- 468 cm(3); 95% CI: 505.1-635.2 cm 3 vs. 273 +/- 237 cm 3; 95% CI: 240.6-305.3 cm(3)). They also had significantly higher the VAT/BF ratio. VAT showed a stronger positive correlation than BF with blood pressure, triglycerides, LDL-cholesterol, glucose, insulin, and homeostasis model assessment-insulin resistance index and a stronger negative correlation with HDL-cholesterol. Among these variables, VAT had the highest area under the curve for triglycerides >= 150 mg/dL (0.727 in males and 0.712 in females). In conclusion, we provide reference values for VAT obtained from healthy adults using the GE Healthcare DXA. These values may be useful in the diagnosis of visceral obesity, for identifying subjects with high obesity-related risks, in epidemiological studies, as a target for therapies, and in physically trained individuals. In both genders, VAT was associated with traditional cardiometabolic risk factors, particularly hypertriglyceridemia.	[Miazgowski, Tomasz; Kucharski, Robert; Soltysiak, Marta; Taszarek, Aleksandra; Miazgowski, Bartosz; Widecka, Krystyna] Pomeranian Med Univ, Dept Hypertens & Internal Med, Szczecin, Poland; [Kucharski, Robert] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Liver & Internal Med Unit, Warsaw, Poland	Pomeranian Medical University; Medical University of Warsaw	Miazgowski, T (corresponding author), Pomeranian Med Univ, Dept Hypertens & Internal Med, Szczecin, Poland.	miazgowski@interia.pl	Miazgowski, Tomasz/H-9448-2014; Widecka, Krystyna/A-9510-2016	Miazgowski, Tomasz/0000-0002-4819-9376; Widecka, Krystyna/0000-0003-4574-927X	Polish Osteoporosis Foundation	Polish Osteoporosis Foundation	This study was financially supported by funding grant from the Polish Osteoporosis Foundation. The funders had no role in study design, data collection and analysis, decisionto publish, or preparation of the manuscrip	Arakaki Shingo, 2016, World J Gastrointest Pharmacol Ther, V7, P261, DOI 10.4292/wjgpt.v7.i2.261; Bazzocchi A, 2016, EUR J RADIOL, V85, P1481, DOI 10.1016/j.ejrad.2016.04.004; Bednarek-Tupikowska G, 2012, ENDOKRYNOL POL, V63, P447; Bi X, 2015, EUR J CLIN NUTR, V69, P329, DOI 10.1038/ejcn.2014.227; Bouchi R, 2017, ENDOCR J, V64, P269, DOI 10.1507/endocrj.EJ16-0449; Brede S, 2016, VISC MED, V32, P336, DOI 10.1159/000449028; Gillette-Guyonnet S, 2003, MECH AGEING DEV, V124, P317, DOI 10.1016/S0047-6374(02)00199-9; Guerrero-Romero F, 2016, ARCH MED RES, V47, P382, DOI 10.1016/j.arcmed.2016.08.012; Jung SH, 2016, YONSEI MED J, V57, P674, DOI 10.3349/ymj.2016.57.3.674; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Kawada T, 2013, INT J ENDOCRINOL MET, V11, DOI 10.5812/ijem.10418; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Keswell D, 2016, CARDIOVASC J AFR, V27, P177, DOI 10.5830/CVJA-2015-088; Kwon MS, 2016, IRAN J PUBLIC HEALTH, V45, P949; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922; Mellis MG, 2014, EUR J CLIN NUTR, V68, P1365, DOI 10.1038/ejcn.2014.213; Miazgowski T, 2014, ENDOCRINE, V47, P500, DOI 10.1007/s12020-014-0180-7; Moreno B, 2016, ENDOCRINE, V54, P681, DOI 10.1007/s12020-016-1050-2; Neeland IJ, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.28; Patel P, 2013, NUTRIENTS, V5, P2019, DOI 10.3390/nu5062019; Reinhardt M, 2017, OBESITY, V25, P332, DOI 10.1002/oby.21722; Shepherd JA, 2012, J BONE MINER RES, V27, P2208, DOI 10.1002/jbmr.1654; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Taverna MJ, 2011, EUR J ENDOCRINOL, V164, P559, DOI 10.1530/EJE-10-1039; Van Wijk DF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002823	26	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180614	10.1371/journal.pone.0180614	http://dx.doi.org/10.1371/journal.pone.0180614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683146	gold, Green Submitted, Green Published			2022-12-27	WOS:000405335200054
J	Tovar-Salazar, A; Weinberg, A				Tovar-Salazar, Adriana; Weinberg, Adriana			Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; PERSISTENT VIRUS; CUTTING EDGE; IN-VITRO; RISK; DISEASE; CD4(+); AIDS; CMV	Cytomegalovirus (CMV) infection is associated with immune-suppression in immune-compromised hosts and old adults. We previously showed that ex vivo CMV restimulation of peripheral blood mononuclear cells (PBMC) of CMV-seropositive volunteers expanded CD4+CD27-CD28-regulatory T cells (Tregs). Here we evaluate the phenotype and function of circulating CD4+CD27-CD28-T cells of CMV-seropositive adults. Compared with CMV-seronegative, CMV-seropositive adults had 10-fold higher CD4+CD27-CD28-% T cells in PBMC. Circulating CD4+CD27-CD28-T cells from both CMV-seropositive and seronegative donors expressed higher levels of TGF beta, granzyme B, CD39, CD147 and IL-35, and lower levels of CD127, compared with their parent circulating CD4+T cells. However, only CMV-seropositive circulating CD4+CD27-CD28-had increased FOXP3 expression. CD4+CD27-CD28-sorted from the PBMC of CMV-seropositive donors expanded ex vivo in the presence of rhIL2 and inhibited ex vivo proliferation of autologous PBMC restimulated with CMV, varicella-zoster virus or C. albicans antigens. CD4+CD27CD28- sorted from CMV-seronegative PBMC did not expand in the presence of rhIL2 and did not inhibit autologous PBMC proliferation. CD3+CD27-CD28-circulating T cells (>= 80% CD8+) from CMV-seropositive HIV-infected donors also inhibited ex vivo proliferation of autologous PBMC restimulated with CMV or HIV. These data indicate that CMVseropositive individuals have circulating Tregs that inhibit cell-mediated immune responses to CMV and other antigens and may be contribute to an immune-suppressive effect of CMV infection. Moreover, the phenotypic similarity between circulating CD4 +CD27-CD28-Tregs with differentiated effector T cells suggests that the two T-cell subsets might evolve in parallel or in sequence from the same progenitor cells in response to CMV stimulation during reactivations.	[Tovar-Salazar, Adriana; Weinberg, Adriana] Univ Colorado Denver, Anschutz Med Ctr, Sch Med, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Weinberg, A (corresponding author), Univ Colorado Denver, Anschutz Med Ctr, Sch Med, Aurora, CO 80045 USA.	adriana.weinberg@ucdenver.edu		Tovar Salazar, Adriana/0000-0002-5083-755X	National institute of Allergy and Infectious Diseases [R21AI073121]	National institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National institute of Allergy and Infectious Diseases Grant Number R21AI073121. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Derhovanessian E, 2014, J IMMUNOL, V193, P3624, DOI 10.4049/jimmunol.1303361; Derhovanessian E, 2013, VACCINE, V31, P685, DOI 10.1016/j.vaccine.2012.11.041; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; DuPage M, 2016, NAT REV IMMUNOL, V16, P149, DOI 10.1038/nri.2015.18; Duppach J, 2014, J VIROL, V88, P13892, DOI 10.1128/JVI.01941-14; Egli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043937; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Frasca D, 2015, VACCINE, V33, P1433, DOI 10.1016/j.vaccine.2015.01.071; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Holderried TAW, 2013, P NATL ACAD SCI USA, V110, P21089, DOI 10.1073/pnas.1320999110; Hu ZT, 2013, J IMMUNOL, V191, P312, DOI 10.4049/jimmunol.1201773; Jabs DA, 2005, OPHTHALMOLOGY, V112, P771, DOI 10.1016/j.ophtha.2004.10.049; Jahrsdorfer B, 2010, BLOOD, V115, P1156, DOI 10.1182/blood-2009-07-235382; Jesser RD, 2006, VIROLOGY, V352, P408, DOI 10.1016/j.virol.2006.04.035; Johnstone J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108481; Karlsson I, 2007, J VIROL, V81, P13444, DOI 10.1128/JVI.01466-07; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Molloy MJ, 2011, J IMMUNOL, V186, P6218, DOI 10.4049/jimmunol.1003812; Nigam P, 2010, J IMMUNOL, V184, P1690, DOI 10.4049/jimmunol.0902955; Pawelec G, 2011, VIRUS RES, V157, P175, DOI 10.1016/j.virusres.2010.09.010; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; RUBIN RH, 1989, JAMA-J AM MED ASSOC, V261, P3607; RUBIN RH, 1990, REV INFECT DIS, V12, pS754; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Slyker JA, 2009, AIDS, V23, P117, DOI 10.1097/QAD.0b013e32831c8abd; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Suzuki M, 2012, J IMMUNOL, V189, P2118, DOI 10.4049/jimmunol.1200122; Terrazzini N, 2014, J INFECT DIS, V209, P1382, DOI 10.1093/infdis/jit576; Tovar-Salazar A, 2010, VIROLOGY, V398, P158, DOI 10.1016/j.virol.2009.11.038; Turner JE, 2014, AGE, V36, P287, DOI 10.1007/s11357-013-9557-4; Verschoor CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104522; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; von Herrath MG, 2001, CURR DIRECT AUTOIMMU, V4, P91; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wang F, 2014, J VIROL, V88, P1011, DOI 10.1128/JVI.02586-13; Weinberg A, 2014, JAIDS-J ACQ IMM DEF, V66, P25, DOI 10.1097/QAI.0000000000000095; Wolf KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153705; Yu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028948; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180691	10.1371/journal.pone.0180691	http://dx.doi.org/10.1371/journal.pone.0180691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683106	gold, Green Published, Green Submitted			2022-12-27	WOS:000405335200060
J	Bashir, S; Teo, YY; Naeem, S; Ramesh, S; Ramesh, K				Bashir, Shahid; Teo, Yin Yin; Naeem, Sumaira; Ramesh, S.; Ramesh, K.			pH responsive N-succinyl chitosan/Poly (acrylamide-co-acrylic acid) hydrogels and in vitro release of 5-fluorouracil	PLOS ONE			English	Article							DRUG-DELIVERY; INTERPOLYMERIC PH; SENSITIVE HYDROGELS; SWELLING BEHAVIOR; SODIUM ALGINATE; SEMI-IPN; CHITIN; MICROSPHERES; DERIVATIVES; SYSTEM	There has been significant progress in the last few decades in addressing the biomedical applications of polymer hydrogels. Particularly, stimuli responsive hydrogels have been inspected as elegant drug delivery systems capable to deliver at the appropriate site of action within the specific time. The present work describes the synthesis of pH responsive semi-interpenetrating network (semi-IPN) hydrogels of N-succinyl-chitosan (NSC) via Schiff base mechanism using glutaraldehyde as a crosslinking agent and Poly (acrylamide-co-acrylic acid)(Poly (AAm-co-AA)) was embedded within the N-succinyl chitosan network. The physico-chemical interactions were characterized by Fourier transform infrared (FTIR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), and field emission scanning electron microscope (FESEM). The synthesized hydrogels constitute porous structure. The swelling ability was analyzed in physiological mediums of pH 7.4 and pH 1.2 at 37 degrees C. Swelling properties of formulations with various amounts of NSC/Poly (AAm-co-AA) and crosslinking agent at pH 7.4 and pH 1.2 were investigated. Hydrogels showed higher swelling ratios at pH 7.4 while lower at pH 1.2. Swelling kinetics and diffusion parameters were also determined. Drug loading, encapsulation efficiency, and in vitro release of 5-fluorouracil (5FU) from the synthesized hydrogels were observed. In vitro release profile revealed the significant influence of pH, amount of NSC, Poly (AAm-co-AA), and crosslinking agent on the release of 5-FU. Accordingly, rapid and large release of drug was observed at pH 7.4 than at pH 1.2. The maximum encapsulation efficiency and release of 5-FU from SP2 were found to be 72.45% and 85.99%, respectively. Kinetics of drug release suggested controlled release mechanism of 5-FU is according to trend of non-Fickian. From the above results, it can be concluded that the synthesized hydrogels have capability to adapt their potential exploitation as targeted oral drug delivery carriers.	[Bashir, Shahid; Teo, Yin Yin; Naeem, Sumaira] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia; [Ramesh, S.; Ramesh, K.] Univ Malaya, Dept Phys, Ctr Ion, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Bashir, S (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia.; Ramesh, S (corresponding author), Univ Malaya, Dept Phys, Ctr Ion, Fac Sci, Kuala Lumpur, Malaysia.	shahidbashirbaig@gmail.com; rameshtsubra@gmail.com	Ramesh, T.Subramaniam/C-2353-2009; Kasi, Ramesh/B-4765-2011; TEO, YIN YIN/B-9948-2010; Bashir, Shahid/AAH-1116-2019; Naeem, Dr. Sumaira/ACV-6371-2022	Ramesh, T.Subramaniam/0000-0002-5505-6429; Kasi, Ramesh/0000-0001-7843-5723; TEO, YIN YIN/0000-0002-2755-5589; Bashir, Shahid/0000-0001-6745-8874; 	Ministry of Education, Malaysia [H21001-F000046];  [RP025A-14 AFR];  [RP017C-14AFR]	Ministry of Education, Malaysia(Ministry of Education, Malaysia); ; 	This work was supported by the High Impact Research Grant (H21001-F000046) from the Ministry of Education, Malaysia, and University of Malaya Research Grants (RP025A-14 AFR and RP017C-14AFR).	Abdelaal MY, 2007, J APPL POLYM SCI, V103, P2864, DOI 10.1002/app.25154; Abreu Fernanda R. de, 2005, Polímeros, V15, P79, DOI 10.1590/S0104-14282005000200004; Alexander-Bryant AA, 2013, ADV CANCER RES, V118, P1, DOI 10.1016/B978-0-12-407173-5.00002-9; Babu VR, 2006, INT J PHARMACEUT, V325, P55, DOI 10.1016/j.ijpharm.2006.06.020; Bashir S, 2016, POLYMER, V92, P36, DOI 10.1016/j.polymer.2016.03.045; Bashir S, 2015, REV CHEM ENG, V31, P563, DOI 10.1515/revce-2015-0016; BRANNONPEPPAS L, 1990, BIOMATERIALS, V11, P635, DOI 10.1016/0142-9612(90)90021-H; Casettari L, 2012, PROG POLYM SCI, V37, P659, DOI 10.1016/j.progpolymsci.2011.10.001; Cheng R, 2013, BIOMATERIALS, V34, P3647, DOI 10.1016/j.biomaterials.2013.01.084; Costa ES, 2009, CARBOHYD POLYM, V76, P472, DOI 10.1016/j.carbpol.2008.11.015; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; Dash M, 2012, MATER CHEM PHYS, V135, P1070, DOI 10.1016/j.matchemphys.2012.06.019; El-Sherbiny IM, 2005, EUR POLYM J, V41, P2584, DOI 10.1016/j.eurpolymj.2005.05.035; Feng ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100732; Finetti F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168727; Fournier E, 2003, INT J PHARMACEUT, V268, P31, DOI 10.1016/j.ijpharm.2003.08.014; Ge HC, 2014, CARBOHYD POLYM, V113, P296, DOI 10.1016/j.carbpol.2014.06.078; Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9; Hashim AI, 2011, NMR BIOMED, V24, P582, DOI 10.1002/nbm.1644; Hawary DL, 2011, J RADIOANAL NUCL CH, V290, P557, DOI 10.1007/s10967-011-1310-9; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Hu XY, 2014, CARBOHYD POLYM, V105, P135, DOI 10.1016/j.carbpol.2014.01.051; Islam A, 2012, CARBOHYD POLYM, V88, P1055, DOI 10.1016/j.carbpol.2012.01.070; Jagadish RS, 2011, FOOD HYDROCOLLOID, V25, P1572, DOI 10.1016/j.foodhyd.2011.01.009; Kajjari PB, 2013, POLYM BULL, V70, P3387, DOI 10.1007/s00289-013-1029-6; Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5; Kulkarni RV, 2012, J COLLOID INTERF SCI, V367, P509, DOI 10.1016/j.jcis.2011.10.025; Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7; Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5; Lee WF, 2001, J APPL POLYM SCI, V82, P2487, DOI 10.1002/app.2099; Li P, 2007, MACROMOL MATER ENG, V292, P962, DOI 10.1002/mame.200700081; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu XH, 2013, ISRN MATH PHYS, V2013, P1, DOI DOI 10.1016/J.MICR0REL.2012.06.140; Malik NS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172727; Mall ID, 2006, COLLOID SURFACE A, V278, P175, DOI 10.1016/j.colsurfa.2005.12.017; Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405; Mirzaei BE, 2013, INT J POLYM MATER PO, V62, P605, DOI 10.1080/00914037.2013.769165; Mohan YM, 2005, J APPL POLYM SCI, V96, P1153, DOI 10.1002/app.21565; Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002; Mukhopadhyay P, 2014, CARBOHYD POLYM, V112, P627, DOI 10.1016/j.carbpol.2014.06.045; Mukhopadhyay P, 2013, J APPL POLYM SCI, V129, P835, DOI 10.1002/app.38814; Mura C, 2011, CARBOHYD POLYM, V85, P578, DOI 10.1016/j.carbpol.2011.03.017; Nadeem M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158084; Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030; Patil NS, 1996, BIOMATERIALS, V17, P2343, DOI 10.1016/S0142-9612(96)00089-0; PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y; Rama AR, 2015, INT J MOL SCI, V16, P12601, DOI 10.3390/ijms160612601; Ravichandran P, 1997, INT J PHARM, V154, P89, DOI 10.1016/S0378-5173(97)00131-2; Ray D, 2008, J BIOMAT SCI-POLYM E, V19, P1487, DOI 10.1163/156856208786140382; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4; Rizwan M, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9040137; ROORDA WE, 1986, PHARM WEEKBLAD, V8, P165, DOI 10.1007/BF01959775; Sagara A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164250; Samanta HS, 2014, CARBOHYD POLYM, V106, P109, DOI 10.1016/j.carbpol.2014.01.097; Samanta HS, 2014, CARBOHYD POLYM, V99, P666, DOI 10.1016/j.carbpol.2013.09.004; Sashiwa H, 2003, MACROMOL BIOSCI, V3, P231, DOI 10.1002/mabi.200390029; Sastre RL, 2007, INT J PHARMACEUT, V338, P180, DOI 10.1016/j.ijpharm.2007.02.001; Shantha KL, 2000, INT J PHARM, V207, P65, DOI 10.1016/S0378-5173(00)00533-0; Shim JW, 2003, J APPL POLYM SCI, V90, P3270, DOI 10.1002/app.12992; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455; Thurmer MB, 2014, MATER RES-IBERO-AM J, V17, P109, DOI 10.1590/1516-1439.223613; Wang Q, 2005, J APPL POLYM SCI, V96, P808, DOI 10.1002/app.21518; Yan C., 2006, J PHARM SOC JAPAN, V126, P789; Zeitoun AA, 2003, COMP SINGLE DOSE BIO; Zhang JT, 2010, ACTA BIOMATER, V6, P1297, DOI 10.1016/j.actbio.2009.11.005; Zhang XZ, 2002, INT J PHARMACEUT, V235, P43, DOI 10.1016/S0378-5173(01)00976-0; Zhou JQ, 2009, ENZYME MICROB TECH, V45, P299, DOI 10.1016/j.enzmictec.2009.07.007; Zhu AP, 2007, CARBOHYD POLYM, V69, P363, DOI 10.1016/j.carbpol.2006.11.023	70	51	51	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179250	10.1371/journal.pone.0179250	http://dx.doi.org/10.1371/journal.pone.0179250			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678803	gold, Green Published, Green Submitted			2022-12-27	WOS:000405272200010
J	Biadgo, B; Shiferaw, E; Woldu, B; Alene, KA; Melku, M				Biadgo, Belete; Shiferaw, Elias; Woldu, Berhanu; Alene, Kefyalew Addis; Melku, Mulugeta			Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; SYPHILIS INFECTIONS; SEROPREVALENCE; HIV; PREVALENCE; DISEASES; SEROEPIDEMIOLOGY; HBV	Background Transfusion-transmissible viral infections, such as hepatitis C virus (HCV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV), remain a major public health problem in developing countries. The prevalence of these viral infections among blood donors may reflect the burden of these diseases among populations. Therefore, the aim of this study was to assess the sero-prevalence of transfusion-transmissible viral infections among blood donors. Methods A retrospective study was conducted using data obtained from registration books of blood donors from the Ethiopian North Gondar District Blood Bank from 2010 to 2012. Descriptive statistics, such as percentages, medians and interquartile ranges were computed. A binary logistic regression model was fitted to identify factors associated with each viral infection. The odds ratio with a 99% confidence interval was calculated. A p-value < 0.01 was considered statistically significant. Result A total of 6,471 blood donors were included in the study. Of these, 5,311 (82.1%) were male, and 382 (5.9%) were voluntary blood donors. Overall, 424 (6.55%) of the blood donors were sero-reactive for at least one transfusion-transmissible viral infection. Of all study participants, 233 (3.6%) were sero-reactive for HBV, 145 (2.24%) were sero-reactive for HIV, and 51 (0.8%) were sero-reactive for HCV. Four (0.062%) of the study's participants were co-infected: 3 (75%) with HBV-HCV and 1 (25%) with HIV-HBV-HCV. Being a farmer, unemployed or employed donor was significantly associated with transfusion-transmissible viral infections compared to being a student donor. Conclusion The prevalence of transfusion-transmissible viral infections is substantial and has increased overtime. Hence, it demands more vigilance in routine screening of donated blood prior to transfusion. Further community-based studies to identify societal risk factors are necessary.	[Biadgo, Belete] Univ Gondar, Sch Biomed & Lab Sci, Dept Clin Chem, Coll Med & Hlth Sci, Gondar, Ethiopia; [Shiferaw, Elias; Woldu, Berhanu; Melku, Mulugeta] Univ Gondar, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Alene, Kefyalew Addis] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Melku, M (corresponding author), Univ Gondar, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Coll Med & Hlth Sci, Gondar, Ethiopia.	mulugeta.melku@gmail.com	Alene, Dr Kefyalew Addis/V-8240-2018	Alene, Dr Kefyalew Addis/0000-0002-1904-4682				Abdallah TM., 2012, J MED MED SCI, V3, P260; Abeje G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0756-8; Amiwero CE., 2013, IJMBR, V1, P1, DOI [10.33500/ijmbr.2013.1.001, DOI 10.33500/IJMBR.2013.1.001]; [Anonymous], FED DEM REP ETH NAT; Apata Ibironke W, 2014, MMWR Morb Mortal Wkly Rep, V63, P613; Awases M., 2004, WORLD HLTH ORGAN, V65, P38; Azene Dessie, 2007, Ethiopian Journal of Health Development, V21, P68; Bekele Abebe, 2014, Ethiop Med J, V52, P107; Belyhun Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2090-1; Birhaneselassie M, 2016, LAB MED, V47, P134, DOI 10.1093/labmed/lmw003; Bisetegen FS, CANADIAN J INFECT DI, V2016; Buseri FI, 2009, BLOOD TRANSFUS-ITALY, V7, P293, DOI 10.2450/2009.0071-08; CSA ICF, 2012, ETH DEM HLTH SURV 20; Diro Ermias, 2008, Ethiop Med J, V46, P7; Farshadpour F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157615; Federal Democratic Republic of Ethiopia MoH, 2005, NAT BLOOD TRANSF SER; Geberemicheal A, 2013, J ENV OCCUP SCI, V2, P9, DOI DOI 10.5455/JEOS.20130220105759; Gelaw B., 2007, ETHIOP J HEALTH DEV, V22, P3; Halile Meskal F, SURVEY HARMFUL TRADI; Jaddee A., 2014, MED J SRISAKET SURIN, V28, P197; KEFENE H, 1988, J MED VIROL, V24, P75, DOI 10.1002/jmv.1890240110; Khattab MA, 2010, AM J INFECT CONTROL, V38, P640, DOI 10.1016/j.ajic.2009.12.016; Liu CJ, 2006, J CLIN VIROL, V36, pS33, DOI 10.1016/S1386-6532(06)80007-7; Matee MIN, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-21; Mohammed Yusuf, 2016, BMC Res Notes, V9, P129, DOI 10.1186/s13104-016-1925-6; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Nada HA., 2013, J BLOOD DISORDERS TR, V5, P177, DOI DOI 10.4172/2155-9864.1000177; Nagalo MB, 2011, BLOOD TRANSFUS-ITALY, V9, P419, DOI 10.2450/2011.0112-10; Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007; Nwankwo E, 2012, TURK J MED SCI, V42, P337, DOI 10.3906/sag-1009-1176; Nwobegahay JM, 2016, MICROBIOL RES INT, V4, P6; Oner S, 2011, TURK J MED SCI, V41, P335, DOI 10.3906/sag-0906-64; Quadri S. A., 2013, Al Ameen Journal of Medical Sciences, V6, P180; Rerambiah LK, 2014, BLOOD TRANSFUS-ITALY, V12, P330, DOI 10.2450/2013.0144-13; Ryoo SM, 2012, J FORMOS MED ASSOC, V111, P113, DOI 10.1016/j.jfma.2011.05.005; Sermoneta-Gertel S, 2001, INFECT CONT HOSP EP, V22, P754, DOI 10.1086/501858; Sharew B., 2015, CURR RES MICROBIOL B, V3, P614; Song Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094528; Sube KL, 2011, S SUDAN MED J, V7, P76; Teklehaimanot HD, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2918-z; Tesfa Habtie, 2013, BMC Res Notes, V6, P164, DOI 10.1186/1756-0500-6-164; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Tserenpuntsag B, 2008, J INFECT DEV COUNTR, V2, P73, DOI 10.3855/jidc.326; Tserenpuntsag B, 2010, TRANSFUSION, V50, P92, DOI 10.1111/j.1537-2995.2009.02387.x; Tyagi S, 2013, J CLIN DIAGN RES, V7, P1930, DOI 10.7860/JCDR/2013/6002.3360; Walana W., 2014, British Microbiology Research Journal, V4, P1491, DOI 10.9734/BMRJ/2014/12160; WHO, GLOB DAT BLOOD SAF; WHO, BLOOD SAF ETH WHO RE; World Health Organization, GLOB POL REP PREV CO; World Health Organization, BLOOD DON SEL GUID A	51	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180416	10.1371/journal.pone.0180416	http://dx.doi.org/10.1371/journal.pone.0180416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678865	Green Submitted, gold, Green Published			2022-12-27	WOS:000405272200062
J	Holland, AE; Byrne, ME; Bryan, AL; DeVault, TL; Rhodes, OE; Beasley, JC				Holland, Amanda E.; Byrne, Michael E.; Bryan, A. Lawrence; DeVault, Travis L.; Rhodes, Olin E.; Beasley, James C.			Fine-scale assessment of home ranges and activity patterns for resident black vultures (Coragyps atratus) and turkey vultures (Cathartes aura)	PLOS ONE			English	Article							BROWNIAN BRIDGE MOVEMENT; DESPOTIC DISTRIBUTION; AIRCRAFT COLLISIONS; AVIAN SCAVENGERS; FLIGHT BEHAVIOR; BENEFITS; ECOLOGY; BIRDS; IDENTIFICATION; MIGRATION	Knowledge of black vulture (Coragyps atratus) and turkey vulture (Cathartes aura) spatial ecology is surprisingly limited despite their vital ecological roles. Fine-scale assessments of space use patterns and resource selection are particularly lacking, although development of tracking technologies has allowed data collection at finer temporal and spatial resolution. Objectives of this study were to conduct the first assessment of monthly home range and core area sizes of resident black and turkey vultures with consideration to sex, as well as elucidate differences in monthly, seasonal, and annual activity patterns based on fine-scale movement data analyses. We collected 2.8-million locations for 9 black and 9 turkey vultures from June 2013 -August 2015 using solar-powered GSM/GPS transmitters. We quantified home ranges and core areas using the dynamic Brownian bridge movement model and evaluated differences as a function of species, sex, and month. Mean monthly home ranges for turkey vultures were similar to 50% larger than those of black vultures, although mean core area sizes did not differ between species. Turkey vulture home ranges varied little across months, with exception to a notable reduction in space-use in May, which corresponds with timing of chick-rearing activities. Black vulture home ranges and core areas as well as turkey vulture core areas were larger in breeding season months (January-April). Comparison of space use between male and female vultures was only possible for black vultures, and space use was only slightly larger for females during breeding months (February-May). Analysis of activity patterns revealed turkey vultures spend more time in flight and switch motion states (between flight and stationary) more frequently than black vultures across temporal scales. This study reveals substantive variability in space use and activity rates between sympatric black and turkey vultures, providing insights into potential behavioral mechanisms contributing to niche differentiation between these species.	[Holland, Amanda E.; Beasley, James C.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Holland, Amanda E.; Byrne, Michael E.; Bryan, A. Lawrence; Rhodes, Olin E.; Beasley, James C.] Savannah River Ecol Lab, Aiken, SC 29808 USA; [DeVault, Travis L.] USDA APHIS WS Natl Wildlife Res Ctr, Sandusky, OH USA; [Rhodes, Olin E.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Savannah River Ecology Laboratory; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Holland, AE (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.; Holland, AE (corresponding author), Savannah River Ecol Lab, Aiken, SC 29808 USA.	aeholland@gmail.com		Holland, Amanda/0000-0001-5963-2692; DeVault, Travis/0000-0001-6413-1104	UnitedStates Department of Energy [DE-FC090 7SR22506]; United States Department of Agriculture's Animal and Plant Health Inspection Service/Wildlife Services and National Wild life Research Center [13-7439-0959-CA]; Georgia Museum of Natural History , Graduate Laerm Award	UnitedStates Department of Energy(United States Department of Energy (DOE)); United States Department of Agriculture's Animal and Plant Health Inspection Service/Wildlife Services and National Wild life Research Center; Georgia Museum of Natural History , Graduate Laerm Award	This work was funded by UnitedStates Department of Energy, Award No. DE-FC090 7SR22506; United States Department of Agriculture's Animal and Plant Health Inspection Service/Wildlife Services and National Wild life Research Center, Award No.13-7439-0959-CA; and Georgia Museum of Natural History, 2013 Graduate Laerm Award, http://museum.nhm.uga. edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Avery Michael L., 2004, Proceedings of the Vertebrate Pest Conference, V21, P116; Avery ML, 2011, J WILDLIFE MANAGE, V75, P1581, DOI 10.1002/jwmg.205; Beasley J.C., 2015, CARRION ECOLOGY EVOL, P107; Blackwell BF, 2006, J RAPTOR RES, V40, P76, DOI 10.3356/0892-1016(2006)40[76:CORHBJ]2.0.CO;2; Buckley NJ, 1998, WILSON BULL, V110, P122; Buckley NJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P267, DOI 10.1007/s002650050388; Buckley NJ, 1999, ACCOUNT 411 BIRDS N; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Byrne ME, 2017, CONDOR, V119, P389, DOI 10.1650/CONDOR-16-76.1; Coleman JS, 1998, J WILDLIFE MANAGE, V53, P782; Cortes-Avizanda A, 2016, FRONT ECOL ENVIRON, V14, P191, DOI 10.1002/fee.1257; DeVault T. L, 2016, WHY DO BIRDS MATTER; DeVault TL, 2005, J WILDLIFE MANAGE, V69, P601, DOI 10.2193/0022-541X(2005)069[0601:FBOBAT]2.0.CO;2; DeVault TL, 2004, CONDOR, V106, P706, DOI 10.1650/7461; DeVault TL, 2013, WILDL MANAGE CONSERV, P1; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; DeVault TL, 2016, J WILDLIFE MANAGE, V80, P746, DOI 10.1002/jwmg.1041; Deygout C, 2010, BEHAV ECOL, V21, P1131, DOI 10.1093/beheco/arq120; Dodge S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0195; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Ferguson-Lees J, 2012, RAPTORS WORLD; Fischer JW, 2013, CONDOR, V115, P298, DOI 10.1525/cond.2013.110168; Harel R, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0397; Houston CS, 2011, WILSON J ORNITHOL, V123, P472, DOI 10.1676/10-090.1; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; International Union for Conservation of Nature, 2016, IUCN RED LIST THREAT; Ito H, 2003, ZOOL SCI, V20, P339, DOI 10.2108/zsj.20.339; Jackson J.A., 1983, P245; Kelly NE, 2007, WILSON J ORNITHOL, V119, P267, DOI 10.1676/05-095.1; Kiff Lloyd F., 2000, P175; KIRK DA, 1995, BEHAV ECOL SOCIOBIOL, V36, P323, DOI 10.1007/BF00167793; Kirk DA, 1998, ACCOUNT 339 BIRDS N; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Kuznetsova A., 2016, J STAT SOFTW, V2, P33; Lopez-Lopez P, 2013, PLOS ONE, V8, P1; Mallon JM, 2016, AUK, V133, P79, DOI 10.1642/AUK-15-114.1; Mandel JT, 2008, P NATL ACAD SCI USA, V105, P19102, DOI 10.1073/pnas.0801789105; Margalida A, 2016, SCI REP-UK, V6, DOI 10.1038/srep35746; Margalida A, 2016, NATURE, V536, P274, DOI 10.1038/536274d; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; Martin James A., 2011, Human-Wildlife Interactions, V5, P198; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Microwave Telemetry, 2013, SOL GSM GPS TRANSM; Monsarrat S, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/J0URN; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Ogada DL, 2012, CONSERV BIOL, V26, P453, DOI 10.1111/j.1523-1739.2012.01827.x; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Platt SG, 2015, J RAPTOR RES, V49, P518, DOI 10.3356/rapt-49-04-518-520.1; Rivers JW, 2014, BIRD CONSERV INT, V24, P492, DOI 10.1017/S0959270913000592; Rolando A, 2002, REV ECOL-TERRE VIE, V57, P53; Sauer J. R., 2012, N AM BREEDING SURVEY; WALLACE MP, 1987, AUK, V104, P290, DOI 10.1093/auk/104.2.290; Walter WD, 2012, APPL GEOGR, V35, P53, DOI 10.1016/j.apgeog.2012.05.002; White David L., 2000, Studies in Avian Biology, V21, P8; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	56	34	35	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179819	10.1371/journal.pone.0179819	http://dx.doi.org/10.1371/journal.pone.0179819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678813	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200029
J	Kilicoglu, H; Rosemblat, G; Rindflesch, TC				Kilicoglu, Halil; Rosemblat, Graciela; Rindflesch, Thomas C.			Assigning factuality values to semantic relations extracted from biomedical research literature	PLOS ONE			English	Article							EVENT EXTRACTION; CORPUS; ANNOTATION; KNOWLEDGE; NEGATION	Biomedical knowledge claims are often expressed as hypotheses, speculations, or opinions, rather than explicit facts (propositions). Much biomedical text mining has focused on extracting propositions from biomedical literature. One such system is SemRep, which extracts propositional content in the form of subject-predicate-object triples called predications. In this study, we investigated the feasibility of assessing the factuality level of SemRep predications to provide more nuanced distinctions between predications for downstream applications. We annotated semantic predications extracted from 500 PubMed abstracts with seven factuality values (FACT, PROBABLE, POSSIBLE, DOUBTFUL, COUNTERFACT, UNCOMMITTED, and CONDITIONAL). We extended a rule-based, compositional approach that uses lexical and syntactic information to predict factuality levels. We compared this approach to a supervised machine learning method that uses a rich feature set based on the annotated corpus. Our results indicate that the compositional approach is more effective than the machine learning method in recognizing the factuality values of predications. The annotated corpus as well as the source code and binaries for factuality assignment are publicly available. We will also incorporate the results of the better performing compositional approach into SemMedDB, a PubMed-scale repository of semantic predications extracted using SemRep.	[Kilicoglu, Halil; Rosemblat, Graciela; Rindflesch, Thomas C.] US Natl Lib Med, Lister Hill Natl Ctr Biomed Commun, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Kilicoglu, H (corresponding author), US Natl Lib Med, Lister Hill Natl Ctr Biomed Commun, Bethesda, MD 20894 USA.	kilicogluh@mail.nih.gov			U.S. National Library of Medicine, National Institutes of Health; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	U.S. National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the intramural research program at the U.S. National Library of Medicine, National Institutes of Health.	[Anonymous], 2008, P 3 INT S SEM MIN BI; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Farkas R, 2010, P CONLL2010 SHAR TAS; GALE W, 1992, P 30 ANN M ASS COMP, P00249; Horn L. R., 1989, NATURAL HIST NEGATIO; Hyland K., 1998, HEDGING SCI RES ARTI; Jari Bjorne<spacing Tapio, 2011, P BIONLP SHAR TASK 2, P183; Kilicoglu H., 2015, EXPROM, V2015, P22; Kilicoglu H, 2012, EMBEDDING PREDICATIO; Kilicoglu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148538; Kilicoglu H, 2012, BIOINFORMATICS, V28, P3158, DOI 10.1093/bioinformatics/bts591; Kilicoglu H, 2011, COMPUT INTELL-US, V27, P583, DOI 10.1111/j.1467-8640.2011.00401.x; Kim JD, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S1; Kim JD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-10; Kim JH, 2009, ARTECH HSE METH BIOE, P1, DOI 10.1109/ICIMW.2009.5324773; Leaman R, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S3; Leaman R, 2013, BIOINFORMATICS, V29, P2909, DOI 10.1093/bioinformatics/btt474; Lee Kenton, 2015, P 2015 C EMP METH NA, P1643, DOI DOI 10.18653/V1/D15-1189; Light Marc, 2004, P HLT NAACL 2004 WOR, P17; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; MCCRAY AT, 1994, J AM MED INFORM ASSN, P235; Miwa M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-108; Miwa M, 2012, BIOINFORMATICS, V28, P1759, DOI 10.1093/bioinformatics/bts237; Morante R., 2010, P 14 C COMP NAT LANG, P40; Morante R, 2012, COMPUT LINGUIST, V38, P223, DOI 10.1162/COLI_a_00095; Oepen S, 2016, LREC 2016 - TENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P3991; Rebholz-Schuhmann D, 2012, NAT REV GENET, V13, P829, DOI 10.1038/nrg3337; Rindflesch TC, 2003, J BIOMED INFORM, V36, P462, DOI 10.1016/j.jbi.2003.11.003; Rindflesch TC, 2003, AMIA ANN S P AM MED, V2003, P554; Sandor A., 2012, P WORKSH DET STRUCT, P10; Sauri R, 2012, COMPUT LINGUIST, V38, P261, DOI 10.1162/COLI_a_00096; Smith L, 2004, BIOINFORMATICS, V20, P2320, DOI 10.1093/bioinformatics/bth227; Stenetorp Pontus, 2012, P DEM 13 C EUR CHAPT, P102; Szarvas G, 2012, COMPUT LINGUIST, V38, P335, DOI 10.1162/COLI_a_00098; Thompson P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-393; Vincze V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S9; Wei CH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/918710; Wilbur WJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-356; Xu Jun, 2016, DATABASE	43	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179926	10.1371/journal.pone.0179926	http://dx.doi.org/10.1371/journal.pone.0179926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678823	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200031
J	Scharf, M; Brendel, S; Melzer, K; Hentschke, C; May, M; Uder, M; Lell, MM				Scharf, Michael; Brendel, Stephanie; Melzer, Katja; Hentschke, Christian; May, Matthias; Uder, Michael; Lell, Michael M.			Image quality, diagnostic accuracy, and potential for radiation dose reduction in thoracoabdominal CT, using Sinogram Affirmed Iterative Reconstruction (SAFIRE) technique in a longitudinal study	PLOS ONE			English	Article							ABDOMINAL COMPUTED-TOMOGRAPHY; FILTERED BACK-PROJECTION; OPTIMIZATION; MODULATION; RESOLUTION; PHANTOM; NOISE	Objective To step-wise evaluate image quality of sinogram-affirmed iterative reconstruction (SAFIRE) in reduced-dose (RD) thoracoabdominal computed tomography (CT) compared to full-dose (FD) and RD filtered back projection (FBP) in a longitudinal study. Materials and methods 122 patients were included in this prospective study. 49 patients (14 men: mean age +/- SD, 56 +/- 0.4 years; 35 women: 58 +/- 1.3 years) completed FD, RD1 (80%-dose) and RD2 (60%dose) thoracoabdominal CT. Each CT dataset was reconstructed with FBP and SAFIRE. For quantitative image analysis image noise was measured in defined tissue regions. Qualitative image evaluation was performed according to the European Guidelines on Quality criteria for CT. Additionally artifacts, lesion conspicuity, and edge sharpness were assessed. Results Compared to FD-FBP noise in soft tissue increased by 12% in RD1-FBP and 27% in RD2FBP reconstructions, whereas SAFIRE lead to a decrease of 28% (RD1) and 17% (RD2), respectively (all p < 0.001). Visually sharp reproduction, lesion conspicuity, edge sharpness of pathologic findings, and overall image quality did not differ statistically significant between FD-FBP and RD-SAFIRE datasets. Image quality decreased in RD1-and RD2-FBP compared to FD-FBP, reaching statistically significance in RD2 datasets (p < 0.001). In RD1and RD2-FBP (p < 0.001) streak artifacts were noted. Conclusion Using SAFIRE the reference mAs in thoracoabdominal CT can be reduced by at least 30% in clinical routine without loss of image quality or diagnostic information.	[Scharf, Michael; Brendel, Stephanie; Melzer, Katja; May, Matthias; Uder, Michael; Lell, Michael M.] Friedrich Alexander Univ Erlangen Nuremberg, Dept Radiol, Erlangen, Germany; [Hentschke, Christian] Friedrich Alexander Univ Erlangen Nuremberg, Inst Sport Sci & Sport, Erlangen, Germany; [Brendel, Stephanie] Hosp Barmelweid, Dept Internal Med, Barmelweid, Switzerland; [Hentschke, Christian] Novartis Pharma AG, Nurnberg, Germany; [Lell, Michael M.] Paracelsus Med Univ, Dept Radiol & Nucl Med, Nurnberg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Novartis	Scharf, M (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Radiol, Erlangen, Germany.	michael.scharf@uk-erlangen.de	May, Matthias/AAZ-4877-2021	May, Matthias/0000-0002-2540-850X				American Association of Physicists in Medicine, 2008, MEAS REP MAN RAD CT; Baker ME, 2012, AM J ROENTGENOL, V199, P8, DOI 10.2214/AJR.11.7421; Bellini D, 2017, RADIOLOGY, V283, P526, DOI 10.1148/radiol.2016161233; Bittencourt MS, 2011, INT J CARDIOVAS IMAG, V27, P1081, DOI 10.1007/s10554-010-9756-3; BROOKS RA, 1975, RADIOLOGY, V117, P561, DOI 10.1148/117.3.561; Carmichael JHE, 1996, EUROPEAN GUIDELINES; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Dobeli KL, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120500; Eller A, 2012, INVEST RADIOL, V47, P559, DOI 10.1097/RLI.0b013e318260c5d6; Gandhi NS, 2016, RADIOLOGY, V280, P436, DOI 10.1148/radiol.2016151281; Greess H, 2000, EUR RADIOL, V10, P391, DOI 10.1007/s003300050062; Kalra MK, 2013, AM J ROENTGENOL, V201, pW235, DOI 10.2214/AJR.12.9569; Kalra MK, 2012, J COMPUT ASSIST TOMO, V36, P339, DOI 10.1097/RCT.0b013e31825586c0; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Khawaja RDA, 2015, PEDIATR RADIOL, V45, P1046, DOI 10.1007/s00247-014-3235-2; Lee CH, 2008, RADIOGRAPHICS, V28, P1451, DOI 10.1148/rg.285075075; Lell MM, 2015, INVEST RADIOL, V50, P629, DOI 10.1097/RLI.0000000000000172; May MS, 2011, INVEST RADIOL, V46, P465, DOI 10.1097/RLI.0b013e31821690a1; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Moscariello A, 2011, EUR RADIOL, V21, P2130, DOI 10.1007/s00330-011-2164-9; Mulkens TH, 2005, RADIOLOGY, V237, P213, DOI 10.1148/radiol.2363041220; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickhardt PJ, 2012, AM J ROENTGENOL, V199, P1266, DOI 10.2214/AJR.12.9382; Pontana F, 2015, EUR RADIOL, V25, P1182, DOI 10.1007/s00330-014-3393-5; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI 10.1097/RLI.ob013e3181dzfeec; Ridge CA, 2013, J COMPUT ASSIST TOMO, V37, P712, DOI 10.1097/RCT.0b013e31829727d2; Robertson DD, 1997, J COMPUT ASSIST TOMO, V21, P293, DOI 10.1097/00004728-199703000-00024; Singh S, 2012, J COMPUT ASSIST TOMO, V36, P347, DOI 10.1097/RCT.0b013e31824e639e; Smith-Bindman R, 2010, JAMA-J AM MED ASSOC, V307, P2400, DOI DOI 10.1001/JAMA.2012.5960; Solomon J, 2017, RADIOLOGY; Sunnegardh J, 2008, MED PHYS, V35, P4173, DOI 10.1118/1.2966353; Wang G, 2008, MED PHYS, V35, P1051, DOI 10.1118/1.2836950; Ziegler A, 2007, MED PHYS, V34, P585, DOI 10.1118/1.2409481	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180302	10.1371/journal.pone.0180302	http://dx.doi.org/10.1371/journal.pone.0180302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678818	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200050
J	Tijet, N; Faccone, D; Rapoport, M; Seah, C; Pasteran, F; Ceriana, P; Albornoz, E; Corso, A; Petroni, A; Melano, RG				Tijet, Nathalie; Faccone, Diego; Rapoport, Melina; Seah, Christine; Pasteran, Fernando; Ceriana, Paola; Albornoz, Ezequiel; Corso, Alejandra; Petroni, Alejandro; Melano, Roberto G.			Molecular characteristics of mcr-1-carrying plasmids and new mcr-1 variant recovered from polyclonal clinical Escherichia coli from Argentina and Canada	PLOS ONE			English	Article							RESISTANCE GENE MCR-1; ENTEROBACTERIACEAE; MECHANISMS; STRAIN	We have characterized nine mcr-1-harboring plasmids from clinical Escherichia coli isolates previously described in Argentina and Canada. Three of these plasmids carried a mcr-1-variant called here mcr-1.5. All these E. coli isolates were not clonally related and were recovered in different years and locations. However, their mcr-1-harboring plasmids showed high identity among them and to others characterized in other countries, which strongly suggests that this plasmid-type is playing an important role in spreading this mechanism of resistance to polymyxins.	[Tijet, Nathalie; Seah, Christine; Melano, Roberto G.] Publ Hlth Ontario Lab, Toronto, ON, Canada; [Faccone, Diego; Rapoport, Melina; Pasteran, Fernando; Ceriana, Paola; Albornoz, Ezequiel; Corso, Alejandra; Petroni, Alejandro] Inst Nacl Enfermedades Infecciosas INEI ANLIS Dr, Serv Antimicrobianos, Natl & Reg Reference Lab Antimicrobial Resistance, Buenos Aires, DF, Argentina; [Faccone, Diego] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Melano, Roberto G.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Toronto	Melano, RG (corresponding author), Publ Hlth Ontario Lab, Toronto, ON, Canada.; Melano, RG (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	roberto.melano@oahpp.ca		Petroni, Alejandro/0000-0003-1177-7037	internal budget, Public Health Ontario	internal budget, Public Health Ontario	The work was supported by internal budget, Public Health Ontario.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Baron S, 2016, INT J ANTIMICROB AG, V48, P583, DOI 10.1016/j.ijantimicag.2016.06.023; Catry B, 2015, INT J ANTIMICROB AG, V46, P297, DOI 10.1016/j.ijantimicag.2015.06.005; Clinical and Laboratory Standards Institute (CLSI), 2016, M100S262016 CLSI; Di Pilato V, 2016, ANTIMICROB AGENTS CH, V60, P5612, DOI 10.1128/AAC.01075-16; Dominguez JE, 2017, REV ARGENT MICROBIOL; Ellis C, 2013, DIAGN MICR INFEC DIS, V76, P399, DOI 10.1016/j.diagmicrobio.2013.04.017; Elnahriry SS, 2016, ANTIMICROB AGENTS CH, V60, P3249, DOI 10.1128/AAC.00269-16; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2016, BREAKP TABL INT MICS; Falgenhauer L, 2016, EMERG INFECT DIS, V22, P1689, DOI 10.3201/eid2209.160692; Gao RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005957; Hu ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep38793; Kieffer N, 2017, ANTIMICROB AGENTS CH; Li AQ, 2016, ANTIMICROB AGENTS CH, V60, P4351, DOI 10.1128/AAC.00550-16; Liakopoulos A, 2016, J ANTIMICROB CHEMOTH, V71, P2335, DOI 10.1093/jac/dkw262; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lu X, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.02632-16, 10.1128/AAC.02632-16]; Mulvey MR, 2016, LANCET INFECT DIS, V16, P289, DOI [10.1016/S1473-3099(16)00067-0, 10.1016/S1473-3099(15)00540-X]; Olaitan AO, 2016, INT J ANTIMICROB AG, V47, P1, DOI 10.1016/j.ijantimicag.2015.11.009; Payne M, 2016, EMERG INFECT DIS, V22, P1673, DOI 10.3201/eid2209.160177; Petrillo M, 2016, LANCET INFECT DIS, V16, P280, DOI 10.1016/S1473-3099(16)00005-0; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Poirel L, 2016, J ANTIMICROB CHEMOTH, V71, P2326, DOI 10.1093/jac/dkw074; Poirel L, 2016, ANTIMICROB AGENTS CH, V60, P4394, DOI 10.1128/AAC.00444-16; Rapoport M, 2016, ANTIMICROB AGENTS CH, V60, P4412, DOI 10.1128/AAC.00573-16; Rhouma M, 2016, INT J ANTIMICROB AG, V48, P119, DOI 10.1016/j.ijantimicag.2016.04.008; Rocha IV, 2017, INT J ANTIMICROB AG, V49, P655, DOI 10.1016/j.ijantimicag.2017.03.001; Schaufler K, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv155; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Sellera FP, 2017, J ANTIMICROB CHEMOTH, V72, P1255, DOI 10.1093/jac/dkw543; Snesrud E, 2016, ANTIMICROB AGENTS CH, V60, P6973, DOI 10.1128/AAC.01457-16; Sonnevend A, 2016, INT J INFECT DIS, V50, P85, DOI 10.1016/j.ijid.2016.07.007; Stojanoski V, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0303-0; Tijet N, 2016, J ANTIMICROB CHEMOTH, V71, P344, DOI 10.1093/jac/dkv356; Turrientes MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105395; Walkty Andrew, 2016, CMAJ Open, V4, pE641, DOI 10.9778/cmajo.20160080; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Xavier B. B., 2016, EURO SURVEILL, V21; Xavier BB, 2016, EUROSURVEILLANCE, V21, DOI [DOI 10.2807/1560-7917.ES.201621.2730280, 10.2807/1560-7917.ES.201621.2730280]; Yang YQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01204-16, 10.1128/AAC.01204-16]; Yu CY, 2017, J ANTIMICROB CHEMOTH, V72, P1253, DOI 10.1093/jac/dkw541; Yu H, 2016, ANTIMICROB AGENTS CH, V60, P5033, DOI 10.1128/AAC.00440-16; Zurfluh K., 2016, SDRP J FOOD SCI TECH, V1, DOI [10.15436/JFST.1.4.5, DOI 10.15436/JFST.1.4.5]; Zurfuh K, 2016, ANTIMICROB AGENTS CH, V60, P2594, DOI 10.1128/AAC.00066-16	44	44	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180347	10.1371/journal.pone.0180347	http://dx.doi.org/10.1371/journal.pone.0180347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678874	Green Published, gold			2022-12-27	WOS:000405272200058
J	Zehender, G; Veo, C; Ebranati, E; Carta, V; Rovida, F; Percivalle, E; Moreno, A; Lelli, D; Calzolari, M; Lavazza, A; Chiapponi, C; Baioni, L; Capelli, G; Ravagnan, S; Da Rold, G; Lavezze, E; Palu, G; Baldanti, F; Barzon, L; Galli, M				Zehender, Gianguglielmo; Veo, Carla; Ebranati, Erika; Carta, Valentina; Rovida, Francesca; Percivalle, Elena; Moreno, Ana; Lelli, Davide; Calzolari, Mattia; Lavazza, Antonio; Chiapponi, Chiara; Baioni, Laura; Capelli, Gioia; Ravagnan, Silvia; Da Rold, Graziana; Lavezze, Enrico; Palu, Giorgio; Baldanti, Fausto; Barzon, Luisa; Galli, Massimo			Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; RT-PCR; TRANSMISSION; ENCEPHALITIS; CIRCULATION; DYNAMICS; OUTBREAK; HUMANS; SPREAD; GREECE	West Nile virus lineage 2 (WNV-2) was mainly confined to sub-Saharan Africa until the early 2000s, when it was identified for the first time in Central Europe causing outbreaks of human and animal infection. The aim of this study was to reconstruct the origin and dispersion of WNV-2 in Central Europe and Italy on a phylodynamic and phylogeographical basis. To this aim, discrete and continuous space phylogeographical models were applied to a total of 33 newly characterised full-length viral genomes obtained from mosquitoes, birds and humans in Northern Italy in the years 2013-2015 aligned with 64 complete sequences isolated mainly in Europe. The European isolates segregated into two highly significant clades: a small one including three sequences and a large clade including the majority of isolates obtained in Central Europe since 2004. Discrete phylogeographical analysis showed that the most probable location of the root of the largest European clade was in Hungary a mean 12.78 years ago. The European clade bifurcated into two highly supported subclades: one including most of the Central/East European isolates and the other encompassing all of the isolates obtained in Greece. The continuous space phylogeographical analysis of the Italian clade showed that WNV-2 entered Italy in about 2008, probably by crossing the Adriatic sea and reaching a central area of the Po Valley. The epidemic then spread simultaneously eastward, to reach the region of the Po delta in 2013, and westward to the border area between Lombardy and Piedmont in 2014; later, the western strain changed direction southward, and reached the central area of the Po valley once again in 2015. Over a period of about seven years, the virus spread all over an area of northern Italy by following the Po river and its main tributaries.	[Zehender, Gianguglielmo; Veo, Carla; Ebranati, Erika; Carta, Valentina; Galli, Massimo] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Zehender, Gianguglielmo; Veo, Carla; Ebranati, Erika; Carta, Valentina; Galli, Massimo] Univ Milan, CRC Coordinated Res Ctr EpiSoMI, Milan, Italy; [Rovida, Francesca; Percivalle, Elena; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy; [Moreno, Ana; Lelli, Davide; Lavazza, Antonio] Expt Zooprophylact Inst Lombardy & Emilia Romagna, Brescia, Italy; [Calzolari, Mattia] Expt Zooprophylact Inst Lombardy & Emilia Romagna, Reggio Emilia, Italy; [Chiapponi, Chiara; Baioni, Laura] Expt Zooprophylact Inst Lombardy & Emilia Romagna, Parma, Italy; [Capelli, Gioia; Ravagnan, Silvia; Da Rold, Graziana] Expt Zooprophylact Inst Venice, Padua, Italy; [Lavezze, Enrico; Palu, Giorgio; Barzon, Luisa] Univ Padua, Dept Mol Med, Padua, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; IRCCS Fondazione San Matteo; IZS delle Venezie; University of Padua	Zehender, G (corresponding author), Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy.; Zehender, G (corresponding author), Univ Milan, CRC Coordinated Res Ctr EpiSoMI, Milan, Italy.	gianguglielmo.zehender@unimi.it	Lelli, Davide/AAB-6996-2019; Barzon, Luisa/K-7961-2016; Rovida, Francesca/K-7984-2016; Moreno, Ana/Q-2173-2019; Lelli, Davide DL/K-5178-2016; Baldanti, Fausto/J-4924-2018; Da Rold, Graziana/G-9255-2019; percivalle, elena/K-7994-2016; Calzolari, Mattia/AAB-9487-2019	Lelli, Davide/0000-0002-5775-6058; Barzon, Luisa/0000-0003-0720-8456; Rovida, Francesca/0000-0003-2345-2790; Moreno, Ana/0000-0002-8497-9708; Baldanti, Fausto/0000-0002-3358-8969; Da Rold, Graziana/0000-0002-4935-0349; percivalle, elena/0000-0002-3355-1410; Calzolari, Mattia/0000-0001-7489-2556; Lavezzo, Enrico/0000-0002-3902-8356; Carta, Valentina/0000-0003-1054-1348; Chiapponi, Chiara/0000-0001-8808-4680; Ravagnan, Silvia/0000-0002-7146-6452	"NANOMAX" Bandiera project - Italian Ministry for Education, University and Research [G42I12000180005]	"NANOMAX" Bandiera project - Italian Ministry for Education, University and Research	This work was partially financed by the "NANOMAX" Bandiera project (2013-2015) funded by Italian Ministry for Education, University and Research (grant number G42I12000180005).	Autorino GL, 2002, EMERG INFECT DIS, V8, P1372, DOI 10.3201/eid0812.020234; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bagnarelli P, 2011, EUROSURVEILLANCE, V16, P5; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Barzon L, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.018; Barzon L, 2013, EUROSURVEILLANCE, V18, P11, DOI 10.2807/1560-7917.ES2013.18.38.20591; Barzon L, 2013, INT J ENV RES PUB HE, V10, P4669, DOI 10.3390/ijerph10104669; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12; Del Amo J, 2013, J VIROL METHODS, V189, P321, DOI 10.1016/j.jviromet.2013.02.019; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hernandez-Triana LM, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00271; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kolodziejek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126381; Lemey P., 2009, PLOS CURR-TREE LIFE, V1, DOI [10.1371/currents.rrn1031, 10.1371/currents.RRN1031, DOI 10.1371/CURRENTS.RRN1031]; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Magurano F, 2012, CLIN MICROBIOL INFEC, V18, pE545, DOI 10.1111/1469-0691.12018; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Papa A, 2010, EUROSURVEILLANCE, V15; Papa A, 2010, VECTOR-BORNE ZOONOT, V10, P655, DOI 10.1089/vbz.2010.0042; Petric D, MOSQUITOES THEIR CON; Platonov AE, 2001, ANN NY ACAD SCI, V951, P102; Platonov AE, 2011, ZH MIKROBIOL EPIDEMI, V2, P29; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Ravagnan S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1031-y; Rizzo C, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.37.30340; Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135; Savini G, 2012, VET MICROBIOL, V158, P267, DOI 10.1016/j.vetmic.2012.02.018; Sirbu A., 2010, EUROSURVEILLANCE, V2011, P16; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tang YL, 2006, J CLIN VIROL, V36, P177, DOI 10.1016/j.jcv.2006.02.008; Troupin A, 2016, METHODS MOL BIOL, V1435, P15, DOI 10.1007/978-1-4939-3670-0_2; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Wodak E, 2011, VET MICROBIOL, V149, P358, DOI 10.1016/j.vetmic.2010.12.012; Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003; Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1	44	35	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179679	10.1371/journal.pone.0179679	http://dx.doi.org/10.1371/journal.pone.0179679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678837	Green Submitted, gold, Green Published			2022-12-27	WOS:000405272200022
J	Lumbala, C; Bessell, PR; Lutumba, P; Baloji, S; Bieler, S; Ndung'u, JM				Lumbala, Crispin; Bessell, Paul R.; Lutumba, Pascal; Baloji, Sylvain; Bieler, Sylvain; Ndung'u, Joseph M.			Performance of the SD BIOLINE (R) HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo	PLOS ONE			English	Article							SLEEPING SICKNESS; BRUCEI-GAMBIENSE; SERODIAGNOSIS; ELIMINATION; ACCURACY; OPTIONS; MAECT; GENE; DRUG	We carried out a study to compare the performance, in terms of sensitivity and specificity, of the new SD BIOLINE (R) HAT rapid diagnostic test (RDT) with the card agglutination test for trypanosomiasis (CATT) for diagnosis of human African trypanosomiasis (HAT) in the Democratic Republic of the Congo (DRC). Participants were enrolled actively by four mobile teams, and passively at four health facilities in three provinces. Consenting participants were tested concurrently with the RDT and CATT on whole blood. Those found positive by either test were tested with CATT on serial dilutions of plasma, and with a parasitological composite reference standard (CRS). Cases were only the individuals found positive by the CRS, while controls were negative by both CATT and RDT, as well as those that were positive by CATT or RDT, but were negative by the CRS, and had no history of HAT. Over five months, 131 cases and 13,527 controls were enrolled. The sensitivity of the RDT was 92.0% (95% confidence interval (CI) = 86.1-95.5), which was significantly higher than CATT (sensitivity 69.1%; 95% CI = 60.7-76.4). The sensitivity of CATT on plasma at a dilution of 1: 8 was 59.0% (95% CI = 50.2-67.2). The specificity of the RDT was 97.1% (95% CIs = 96.8-97.4) while that of CATT was 98.0% (95% CIs = 97.8, 98.2) and specificities of algorithms involving CATT at 1: 8 dilution were 99.6% (95% CI = 99.5-99.7). Reproducibility of results was excellent. We concluded that an algorithm in which the SD BIOLINE (R) HAT RDT is used for screening is optimal for case detection in both passive and active screening settings. However, the lower specificity of the RDT compared to that of CATT would result in a larger number of false positive individuals undergoing confirmatory testing.	[Lumbala, Crispin; Baloji, Sylvain] PNLTHA, Batiment PNMLS,1 Blvd Triomphal, Kinshasa, DEM REP CONGO; [Bessell, Paul R.] Epi Intervent Ltd, 32 Bell Pl, Edinburgh, Midlothian, Scotland; [Lutumba, Pascal] Univ Kinshasa, Fac Med, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Bieler, Sylvain; Ndung'u, Joseph M.] FIND, Campus Biotech,9 Chemin Mines, Geneva, Switzerland	Universite de Kinshasa; Institute Nacional de Recherche Biomedical; Foundation For Innovative New Diagnostics	Bessell, PR (corresponding author), Epi Intervent Ltd, 32 Bell Pl, Edinburgh, Midlothian, Scotland.	prbessell@gmail.com			FIND; Bill & Melinda Gates Foundation; Department for International Development (DFID) of the United Kingdom; Epi Interventions Ltd	FIND; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development (DFID) of the United Kingdom; Epi Interventions Ltd	This project was supported by FIND with funding from the Bill & Melinda Gates Foundation and the Department for International Development (DFID) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, o rpreparation of the manuscript. Epi Interventions Ltd. provided support in the form of salaries for author PRB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions'section	Archer E., 2016, RFPERMUTE ESTIMATE P; Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0; Bisser S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004608; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; Buscher P, 2014, LANCET GLOB HEALTH, V2, pE359, DOI 10.1016/S2214-109X(14)70203-7; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Checchi F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001233; DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2; Eperon G, 2014, EXPERT REV ANTI-INFE, V12, P1407, DOI 10.1586/14787210.2014.959496; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Grewal AS, 2016, CURR TOP MED CHEM, V16, P2245, DOI 10.2174/1568026616666160413125335; Harrell FE, 2014, CONTRIBUTIONS CHARLE; Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x; Holmes P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003244; Hutchinson OC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-234; Ilboudo H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004469; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI 10.1111/j.1365-3156.2006.01591.x; Lutumba P, 2005, EMERG INFECT DIS, V11, P1382; Mitashi P, 2015, TROP MED INT HEALTH, V20, P98, DOI 10.1111/tmi.12404; Mitashi P, 2015, MICROSC RES TECHNIQ, V03, P17, DOI [DOI 10.4236/MR.2015.32003, 10.4236/mr.2015.32003]; Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919; Mukadi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146450; Nakazawa M., 2014, FMSB FUNCTIONS MED S; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Steinmann P, 2015, TROP MED INT HEALTH, V20, P707, DOI 10.1111/tmi.12483; Sternberg JM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003373; Tarral A, 2014, CLIN PHARMACOKINET, V53, P565, DOI 10.1007/s40262-014-0136-3; Van Nieuwenhove L, 2013, TROP MED INT HEALTH, V18, P461, DOI 10.1111/tmi.12058; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; WHO, 2013, WHO TECH REP SER, V984, P1; WHO Expert Comm, 1998, WHO TECH REP SER, V881, P1	36	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180555	10.1371/journal.pone.0180555	http://dx.doi.org/10.1371/journal.pone.0180555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672036	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500066
J	Koide, M; Matsuo, A; Shimoo, S; Takamatsu, K; Kyodo, A; Tsuji, Y; Mera, K; Tsubakimoto, Y; Isodono, K; Sakatani, T; Inoue, K; Fujita, H				Koide, Masahiro; Matsuo, Akiko; Shimoo, Satoshi; Takamatsu, Kazuaki; Kyodo, Atsushi; Tsuji, Yumika; Mera, Kayoko; Tsubakimoto, Yoshinori; Isodono, Koji; Sakatani, Tomohiko; Inoue, Keiji; Fujita, Hiroshi			Cholesterol crystal depth in coronary atherosclerotic plaques: A novel index of plaque vulnerability using optical frequency domain imaging	PLOS ONE			English	Article							BIOLOGICAL-MEMBRANES; COHERENCE TOMOGRAPHY; ARTERY; RUPTURE	Background The involvement of cholesterol crystals (CCs) in plaque progression and destabilization of atherosclerotic plaques has been recently recognized. This study aimed to evaluate the association between the intraplaque localization of CCs and plaque vulnerability. Methods We investigated 55 acute coronary syndrome (ACS) and 80 stable angina pectoris (stable AP) lesions using optical frequency domain imaging (OFDI) prior to percutaneous coronary intervention. The distance between CCs and the luminal surface of coronary plaques was defined as CC depth. Results Although the incidence of CCs had similar frequencies in the ACS and stable AP groups (95% vs. 89%, p = 0.25), CC depth was significantly less in patients with ACS than in those with stable AP (median [25th to 75th percentile]: 68 mu m [58 to 92 mu m] vs. 152 mu m [115 to 218 mu m]; p < 0.001). The incidences of plaque rupture, thrombus, lipid-rich plaques, and thin-cap fibroatheroma were significantly greater in patients with ACS than in those with stable AP (62% vs. 18%, p < 0.001; 67% vs. 16%, p < 0.001; 84% vs. 57%, p < 0.01; and 56% vs. 19%, p < 0.001, respectively). Conclusion OFDI analysis revealed that CCs were found in the more superficial layers within the coronary atherosclerotic plaques in patients with ACS than in those with stable AP, suggesting that CC depth is associated with plaque vulnerability. CC depth, a novel OFDI-derived parameter, could be potentially used as an alternative means of evaluating plaque vulnerability in coronary arteries.	[Koide, Masahiro; Matsuo, Akiko; Shimoo, Satoshi; Takamatsu, Kazuaki; Kyodo, Atsushi; Tsuji, Yumika; Mera, Kayoko; Tsubakimoto, Yoshinori; Isodono, Koji; Sakatani, Tomohiko; Inoue, Keiji; Fujita, Hiroshi] Kyoto Daini Hosp, Japanese Red Cross Soc, Dept Cardiovasc Med, Kyoto, Japan		Koide, M (corresponding author), Kyoto Daini Hosp, Japanese Red Cross Soc, Dept Cardiovasc Med, Kyoto, Japan.	koide@koto.kpu-m.ac.jp	koide, masahiro/AAZ-3823-2021					Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Abela GS, 2006, SCANNING, V28, P1, DOI 10.1002/sca.4950280101; Abela GS, 2005, CLIN CARDIOL, V28, P413, DOI 10.1002/clc.4960280906; Cheng JM, 2014, EUR HEART J, V35, P639, DOI 10.1093/eurheartj/eht484; Dai JN, 2016, ATHEROSCLEROSIS, V247, P111, DOI 10.1016/j.atherosclerosis.2016.02.010; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7; Kataoka Y, 2015, J AM COLL CARDIOL, V65, P630, DOI 10.1016/j.jacc.2014.11.039; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nakamura S, 2014, CLIN RES CARDIOL, V103, P1015, DOI 10.1007/s00392-014-0748-5; Nishimura S, 2017, J CARDIOL, V69, P253, DOI 10.1016/j.jjcc.2016.04.003; Noguchi T, 2014, J AM COLL CARDIOL, V63, P989, DOI 10.1016/j.jacc.2013.11.034; Oemrawsingh RM, 2014, J AM COLL CARDIOL, V64, P2510, DOI 10.1016/j.jacc.2014.07.998; Sinclair H, 2015, JACC-CARDIOVASC IMAG, V8, P198, DOI 10.1016/j.jcmg.2014.12.005; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tanaka A, 2008, AM J CARDIOL, V102, P975, DOI 10.1016/j.amjcard.2008.05.062; Taruya A, 2015, J AM COLL CARDIOL, V65, P2469, DOI 10.1016/j.jacc.2015.04.020; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tearney GJ, 2008, JACC-CARDIOVASC IMAG, V1, P752, DOI 10.1016/j.jcmg.2008.06.007; Uemura S, 2012, EUR HEART J, V33, P78, DOI 10.1093/eurheartj/ehr284; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	25	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180303	10.1371/journal.pone.0180303	http://dx.doi.org/10.1371/journal.pone.0180303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665970	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700082
J	Shimada, T; Tanaka, K; Ishihama, A				Shimada, Tomohiro; Tanaka, Kan; Ishihama, Akira			The whole set of the constitutive promoters recognized by four minor sigma subunits of Escherichia coli RNA polymerase	PLOS ONE			English	Article							PROKARYOTIC GENOME REGULATION; STATIONARY-PHASE; GENE-EXPRESSION; CHROMATIN IMMUNOPRECIPITATION; TRANSCRIPTION ACTIVATION; SIGMA(S)-DEPENDENT GENES; INTRACELLULAR LEVELS; REGULATORY SYSTEM; FLAGELLAR; REGULON	The promoter selectivity of Escherichia coli RNA polymerase (RNAP) is determined by the sigma subunit. The model prokaryote Escherichia coli K-12 contains seven species of the sigma subunit, each recognizing a specific set of promoters. For identification of the | constitutive promoters that are recognized by each RNAP holoenzyme alone in the absence of other supporting factors, we have performed the genomic SELEX screening in vitro for their binding sites along the E. coli K-12 W3110 genome using each of the reconstituted RNAP holoenzymes and a collection of genome DNA segments of E. coli K-12. The whole set of constitutive promoters for each RNAP holoenzyme was then estimated based on the location of RNAP-binding sites. The first successful screening of the constitutive promoters was achieved for RpoD (sigma(70)), the principal sigma for transcription of growth-related genes. As an extension, we performed in this study the screening of constitutive promoters for four minor sigma subunits, stationary-phase specific RpoS (sigma(38)), heat-shock specific RpoH (sigma(32)), flagellar-chemotaxis specific RpoF (sigma(28)) and extra-cytoplasmic stress-response RpoE (sigma(24)). The total number of constitutive promoters were: 129179 for RpoS; 101142 for RpoH; 3441 for RpoF; and 77106 for RpoE. The list of constitutive promoters were compared with that of known promoters identified in vivo under various conditions and using varieties of E. coli strains, altogether allowing the estimation of | inducible promoters in the presence of additional supporting factors.	[Shimada, Tomohiro; Ishihama, Akira] Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo, Japan; [Shimada, Tomohiro; Tanaka, Kan] Tokyo Inst Technol, Inst Innovat Res, Lab Chem & Life Sci, Yokohama, Kanagawa, Japan; [Shimada, Tomohiro] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan	Hosei University; Tokyo Institute of Technology; Meiji University	Ishihama, A (corresponding author), Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo, Japan.	aishiham@hosei.ac.jp	Shimada, Tomohiro/E-7660-2014; Tanaka, Kan/E-3724-2015	Shimada, Tomohiro/0000-0002-8361-0730; Tanaka, Kan/0000-0001-7560-7884; Ishihama, Akira/0000-0002-6339-9042	National Institute of Genetics; MEXT [21241047, 18310133, 25430173, 24710214, 2082012 (S0801037)]; IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research [16K07195] Funding Source: KAKEN	National Institute of Genetics; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institute of Genetics to YY; MEXT Grants-in-Aid for Scientific Research (A) (21241047), (B) (18310133), and (C) (25430173) to Al; MEXT Grant-in-Aid for Young Scientists (B) (24710214) to TS; Research Fund from IFO (Institute for Fermentation, Osaka) to TS; funding from the MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices to Al and KT; and funding to Al and TS from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2082012 (S0801037) to Hosei University.	ARNOSTI DN, 1989, P NATL ACAD SCI USA, V86, P830, DOI 10.1073/pnas.86.3.830; Barembruch C, 2007, MOL MICROBIOL, V65, P76, DOI 10.1111/j.1365-2958.2007.05770.x; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; CHUANG SE, 1993, J BACTERIOL, V175, P5242, DOI 10.1128/JB.175.16.5242-5252.1993; Collet A, 2008, J PROTEOME RES, V7, P4659, DOI 10.1021/pr8001723; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fitzgerald DM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004649; FUJITA N, 1987, J BIOL CHEM, V262, P1855; Fujita N, 1996, METHOD ENZYMOL, V273, P121; Glover WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007316; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Hong SH, 2012, MICROB BIOTECHNOL, V5, P509, DOI 10.1111/j.1751-7915.2011.00327.x; Ide N, 1997, GENE, V199, P19, DOI 10.1016/S0378-1119(97)00233-3; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Ishihama A, 1997, CURR OPIN GENET DEV, V7, P582, DOI 10.1016/S0959-437X(97)80003-2; Ishihama A., 2016, STRESS ENV CONTROL G, P23; Ishihama A., 1999, NUCLEOID OVERVIEW EC; Ishihama A, 2016, NUCLEIC ACIDS RES, V44, P2058, DOI 10.1093/nar/gkw051; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Karp P, 2014, ECOSAL PLUS; KAWAKAMI K, 1979, MOL GEN GENET, V174, P107, DOI 10.1007/BF00268348; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Kundu TK, 1997, J BACTERIOL, V179, P4264, DOI 10.1128/jb.179.13.4264-4269.1997; KUTSUKAKE K, 1994, J BACTERIOL, V176, P3598, DOI 10.1128/JB.176.12.3598-3605.1994; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; LEMAUX PG, 1978, CELL, V13, P427, DOI 10.1016/0092-8674(78)90317-3; Liu XY, 1996, MOL MICROBIOL, V21, P613, DOI 10.1111/j.1365-2958.1996.tb02569.x; LOEWEN PC, 1994, ANNU REV MICROBIOL, V48, P53, DOI 10.1146/annurev.mi.48.100194.000413; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Maeda H, 2000, J BACTERIOL, V182, P1181, DOI 10.1128/JB.182.4.1181-1184.2000; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Nagamitsu H, 2013, J MOL MICROB BIOTECH, V23, P227, DOI 10.1159/000350370; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; OHNISHI K, 1990, MOL GEN GENET, V221, P139, DOI 10.1007/BF00261713; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Panyukov VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062601; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Peano C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10469; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; Rezuchova B, 2003, FEMS MICROBIOL LETT, V225, P1, DOI 10.1016/S0378-1097(03)00480-4; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Salgado H., 2006, NUCLEIC ACIDS RES, V32, pD303; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2004, J BACTERIOL, V186, P7112, DOI 10.1128/JB.186.21.7112-7122.2004; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shimada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090447; Shimada T, 2013, GENES CELLS, V18, P123, DOI 10.1111/gtc.12026; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; Singer BS, 1997, NUCLEIC ACIDS RES, V25, P781, DOI 10.1093/nar/25.4.781; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; WANG QP, 1989, J BACTERIOL, V171, P4248, DOI 10.1128/JB.171.8.4248-4253.1989; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; YAMAMORI T, 1978, J BACTERIOL, V134, P1133, DOI 10.1128/JB.134.3.1133-1140.1978; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200	80	28	29	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179181	10.1371/journal.pone.0179181	http://dx.doi.org/10.1371/journal.pone.0179181			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666008	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700029
J	Ezzat, H; Camarda, A; Cassotti, M; Agogue, M; Houde, O; Weil, B; Le Masson, P				Ezzat, Hicham; Camarda, Anaelle; Cassotti, Mathieu; Agogue, Marine; Houde, Olivier; Weil, Benoit; Le Masson, Pascal			How minimal executive feedback influences creative idea generation	PLOS ONE			English	Article							COGNITIVE INHIBITION; MATCHING BIAS; PERFORMANCE; CHILDREN; ADULTS; IMPACT; TASK; AGE	The fixation effect is known as one of the most dominant of the cognitive biases against creativity and limits individuals' creative capacities in contexts of idea generation. Numerous techniques and tools have been established to help overcome these cognitive biases in various disciplines ranging from neuroscience to design sciences. Several works in the developmental cognitive sciences have discussed the importance of inhibitory control and have argued that individuals must first inhibit the spontaneous ideas that come to their mind so that they can generate creative solutions to problems. In line with the above discussions, in the present study, we performed an experiment on one hundred undergraduates from the Faculty of Psychology at Paris Descartes University, in which we investigated a minimal executive feedback-based learning process that helps individuals inhibit intuitive paths to solutions and then gradually drive their ideation paths toward creativity. Our results provide new insights into novel forms of creative leadership for idea generation.	[Ezzat, Hicham; Weil, Benoit; Le Masson, Pascal] Mines ParisTech, Ctr Management Sci, Chair TMCI, Paris, France; [Camarda, Anaelle; Cassotti, Mathieu; Houde, Olivier] Paris Descartes Univ, Lab Psychol Child Dev & Educ, CNRS, Unit 8240, Paris, France; [Camarda, Anaelle; Cassotti, Mathieu; Houde, Olivier] Caen Univ, Paris, France; [Cassotti, Mathieu; Houde, Olivier] Inst Univ France, Paris, France; [Agogue, Marine] HEC Montreal, Montreal, PQ, Canada	UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France; Universite de Montreal; HEC Montreal	Ezzat, H (corresponding author), Mines ParisTech, Ctr Management Sci, Chair TMCI, Paris, France.	hicham.ezzat@mines-paristech.fr		Garbui, Maria Cristina/0000-0003-2100-9461	French National Research Agency [ANR-13-SOIN-0004-02]	French National Research Agency(French National Research Agency (ANR))	This work was supported by the French National Research Agency (project ANR-13-SOIN-0004-02 IDefixE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RE, 1952, J EXP PSYCHOL, V44, P288, DOI 10.1037/h0062487; Agogue M, 2015, PSYCHOL AESTHETICS C; Agogue M, 2014, J CREATIVE BEHAV, V48, P1, DOI 10.1002/jocb.37; Agogue M, 2014, THINK SKILLS CREAT, V11, P33, DOI 10.1016/j.tsc.2013.10.002; Agogue M, 2012, TECHNOL ANAL STRATEG, V24, P603, DOI 10.1080/09537325.2012.693672; [Anonymous], 2003, DS 31; Benedek M, 2012, PERS INDIV DIFFER, V53, P480, DOI 10.1016/j.paid.2012.04.014; Borst G, 2013, DEV PSYCHOL, V49, P1366, DOI 10.1037/a0029622; Camarda A, 2017, PSYCHOL AESTHETICS C; CARSON PP, 1993, J CREATIVE BEHAV, V27, P36, DOI 10.1002/j.2162-6057.1993.tb01385.x; Cassotti M, 2016, NEW DIR CHILD ADOLES, V151, P61, DOI 10.1002/cad.20153; Cassotti M, 2016, THINK SKILLS CREAT, V19, P146, DOI 10.1016/j.tsc.2015.10.008; Cassotti M, 2010, BRAIN COGNITION, V72, P378, DOI 10.1016/j.bandc.2009.11.004; Cheng LF, 2016, PSYCHOL AESTHET CREA, V10, P32, DOI 10.1037/aca0000036; De Stobbeleir KEM, 2011, ACAD MANAGE J, V54, P811, DOI 10.5465/AMJ.2011.64870144; De stobbeleir KE, 2008, ACAD MANAGE J, V54, P811; Duncker K, 1945, PSYCHOL MONOGR, V58, P1; Evans Jonathan, 2009, 2 MINDS DUAL PROCESS; Hatchuel A, 2002, P H SIM INT C DES SC; Hatchuel A, 2011, AI EDAM, V25, P77, DOI 10.1017/S089006041000048X; Houde A O, 1997, PROBLEM DEDUCTIVE CO; Houde O, 2000, J COGNITIVE NEUROSCI, V12, P721, DOI 10.1162/089892900562525; Houde O, 1996, CAH PSYCHOL COGN, V15, P409; Houde O, 1999, CAH PSYCHOL COGN, V18, P75; Houde O, 2003, NAT REV NEUROSCI, V4, P507, DOI 10.1038/nrn1117; Houde O, 2001, NEUROIMAGE, V14, P1486, DOI 10.1006/nimg.2001.0930; Houde O, 2007, THINK REASONING, V13, P81, DOI 10.1080/13546780500450599; Jansson D., 1991, DESIGN STUDIES, V12, P3, DOI DOI 10.1016/0142-694X(91)90003-F; Kahneman D., 2011, THINKING FAST SLOW; Maier NRF, 1931, PSYCHOL REV, V38, P332, DOI 10.1037/h0069991; Mumford MD, 2003, LEADERSHIP QUART, V14, P411, DOI 10.1016/S1048-9843(03)00045-6; RAMAPRASAD A, 1983, BEHAV SCI, V28, P4, DOI 10.1002/bs.3830280103; Reiter-Palmon R, 2004, LEADERSHIP QUART, V15, P55, DOI 10.1016/j.leaqua.2003.12.005; Zhou J, 1998, J APPL PSYCHOL, V83, P261, DOI 10.1037/0021-9010.83.2.261; Zhou J, 2003, J APPL PSYCHOL, V88, P413, DOI 10.1037/0021-9010.88.3.413; Zhou M-j, 2013, INF MAN INN MAN IND	36	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180458	10.1371/journal.pone.0180458	http://dx.doi.org/10.1371/journal.pone.0180458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662154	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300157
J	Kolt, GS; George, ES; Rebar, AL; Duncan, MJ; Vandelanotte, C; Caperchione, CM; Maeder, AJ; Tague, R; Savage, TN; Van Itallie, A; Mawella, NR; Hsu, WW; Mummery, WK; Rosenkranz, RR				Kolt, Gregory S.; George, Emma S.; Rebar, Amanda L.; Duncan, Mitch J.; Vandelanotte, Corneel; Caperchione, Cristina M.; Maeder, Anthony J.; Tague, Rhys; Savage, Trevor N.; Van Itallie, Anetta; Mawella, Nadeesha R.; Hsu, Wei-Wen; Mummery, W. Kerry; Rosenkranz, Richard R.			Associations between quality of life and duration and frequency of physical activity and sedentary behaviour: Baseline findings from the WALK 2.0 randomised controlled trial	PLOS ONE			English	Article							LEISURE-TIME; EXERCISE; POPULATION; DISEASE; BOUTS; TOO; PREDICTOR; SCIENCE; SF-36; RISK	While physical and mental health benefits of regular physical activity are well known, increasing evidence suggests that limiting sedentary behaviour is also important for health. Evidence shows associations of physical activity and sedentary behaviour with health related quality of life (HRQoL), however, these findings are based predominantly on duration measures of physical activity and sedentary behaviour (e.g., minutes/week), with less attention on frequency measures (e.g., number of bouts). We examined the association of HRQoL with physical activity and sedentary behaviour, using both continuous duration (average daily minutes) and frequency (average daily bouts>10 min) measures. Baseline data from the WALK 2.0 trial were analysed. WALK 2.0 is a randomised controlled trial investigating the effects of Web 2.0 applications on engagement, retention, and subsequent physical activity change. Daily physical activity and sedentary behaviour (duration = average minutes, frequency = average number of bouts >= 10 minutes) were measured (ActiGraph GT3X) across one week, and HRQoL was assessed with the 'general health' subscale of the RAND 36-Item Health Survey. Structural equation modelling was used to evaluate associations. Participants (N = 504) were 50.8 +/- 13.1 (mean SD) years old with a BMI of 29.3 +/- 6.0. The 465 participants with valid accelerometer data engaged in an average of 24.0 +/- 18.3 minutes and 0.64 +/- 0.74 bouts of moderate-vigorous physical activity per day, 535.2 +/- 83.8 minutes and 17.0 +/- 3.4 bouts of sedentary behaviour per day, and reported moderate-high general HRQoL (64.5 +/- 20.0). After adjusting for covariates, the duration measures of physical activity (path correlation = 0.294, p<0.05) and sedentary behaviour were related to general HRQoL (path coefficient = -0.217, p<0.05). The frequency measure of physical activity was also significant (path coefficient = -0.226, p<0.05) but the frequency of sedentary behaviour was not significantly associated with general HRQoL. Higher duration levels of physical activity in fewer bouts, and lower duration of sedentary behaviour are associated with better general HRQoL. Further prospective studies are required to investigate these associations in different population groups over time.	[Kolt, Gregory S.; George, Emma S.; Savage, Trevor N.] Western Sydney Univ, Sch Sci & Hlth, Sydney, NSW, Australia; [Rebar, Amanda L.; Vandelanotte, Corneel; Van Itallie, Anetta] Cent Queensland Univ, Sch Human Hlth & Social Sci, Rockhampton, Qld, Australia; [Duncan, Mitch J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Phys Act & Nutr, Fac Hlth & Med, Newcastle, NSW, Australia; [Caperchione, Cristina M.] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Maeder, Anthony J.] Flinders Univ S Australia, Sch Hlth Sci, Adelaide, SA, Australia; [Tague, Rhys] Western Sydney Univ, Sch Comp Engn & Math, Sydney, NSW, Australia; [Mawella, Nadeesha R.; Hsu, Wei-Wen] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA; [Mummery, W. Kerry] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada; [Rosenkranz, Richard R.] Kansas State Univ, Dept Food Nutr Dietet & Hlth, Manhattan, KS 66506 USA	Western Sydney University; Central Queensland University; University of Newcastle; University of British Columbia; Flinders University South Australia; Western Sydney University; Kansas State University; University of Alberta; Kansas State University	Kolt, GS (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Sydney, NSW, Australia.	g.kolt@westernsydney.edu.au	Rosenkranz, Richard/AAL-6154-2021; Duncan, Mitch/V-1708-2019; Savage, Trevor N/C-5709-2019; Vandelanotte, Corneel/ABF-5580-2020; George, Emma/AAU-4754-2021; Kolt, Gregory/W-1342-2019	Rosenkranz, Richard/0000-0002-8242-3546; Duncan, Mitch/0000-0002-9166-6195; Savage, Trevor N/0000-0001-6608-8664; George, Emma/0000-0001-9936-1911; Kolt, Gregory/0000-0002-9223-3324; Rebar, Amanda/0000-0003-3164-993X; Caperchione, Cristina M./0000-0003-2290-5946	National Health and Medical Research Council [589903]; Future Leader Fellowship from the National Heart Foundation of Australia; National Health Medical Research Council [GNT1105926]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Future Leader Fellowship from the National Heart Foundation of Australia(National Heart Foundation of Australia); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This trial was funded by the National Health and Medical Research Council (Project Grant number 589903). The funder did not have any role in the study other than to provide funding. MJD (ID 100029) and CV (ID 100427) are supported by a Future Leader Fellowship from the National Heart Foundation of Australia. ALR is supported by an Early Career Fellowship (GNT1105926) from the National Health Medical Research Council.	ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; [Anonymous], 2008, PHYS ACT GUID ADV CO; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV PHYS; Australian Bureau of Statistics, 1995, NAT HLTH SURV SF 36; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x; Barr-Anderson DJ, 2011, AM J PREV MED, V40, P76, DOI 10.1016/j.amepre.2010.09.033; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Bollen K.A., 1993, TESTING STRUCTURAL E, DOI DOI 10.1093/SF/73.3.1161; Bollen KA, 1989, STRUCTURAL EQUATIONS; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Caperchione CM, 2016, CONT CLIN TRIAL COMM, V2, P25, DOI 10.1016/j.conctc.2015.12.004; Caperchione CM, 2012, AM J MENS HEALTH, V6, P453, DOI 10.1177/1557988312444718; CELLA DF, 1994, J PAIN SYMPTOM MANAG, V9, P186, DOI 10.1016/0885-3924(94)90129-5; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Chyun DA, 2006, BIOL RES NURS, V7, P279, DOI 10.1177/1099800405285748; COURNEYA KS, 1994, BEHAV MED, V20, P84, DOI 10.1080/08964289.1994.9934621; Davies CA, 2012, PREV MED, V55, P46, DOI 10.1016/j.ypmed.2012.05.003; Department of Health, 2014, PHYS ACT SED BEH GUI; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; ELLEY CR, 2003, BMJ-BRIT MED J, V326, P793, DOI DOI 10.1136/BMJ.326.7393.793; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; George ES, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-20; George ES, 2014, AM J MENS HEALTH, V8, P148, DOI 10.1177/1557988313497217; Glazer NL, 2013, MED SCI SPORT EXER, V45, P109, DOI 10.1249/MSS.0b013e31826beae5; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Heesch KC, 2012, J EPIDEMIOL COMMUN H, V66, P670, DOI 10.1136/jech-2011-200850; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kendall AR, 2005, QUAL LIFE RES, V14, P361, DOI 10.1007/s11136-004-1468-5; Kolt GS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-436; Kolt GS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-404; Lee IM, 2000, CIRCULATION, V102, P981, DOI 10.1161/01.CIR.102.9.981; Loprinzi Paul D, 2016, Prev Med Rep, V3, P46, DOI 10.1016/j.pmedr.2015.12.005; Loprinzi Paul D, 2015, Prev Med Rep, V2, P959, DOI 10.1016/j.pmedr.2015.11.004; Loprinzi PD, 2015, PHYSIOL BEHAV, V141, P46, DOI 10.1016/j.physbeh.2015.01.002; Loprinzi PD, 2013, AM J HEALTH PROMOT, V27, P143, DOI 10.4278/ajhp.110916-QUAN-348; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MCCALLUM J, 1995, AUST J PUBLIC HEALTH, V19, P160; Mielenz T, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-66; Moriarty David G, 2003, Health Qual Life Outcomes, V1, P37, DOI 10.1186/1477-7525-1-37; Murphy MH, 2009, SPORTS MED, V39, P29, DOI 10.2165/00007256-200939010-00003; Owen N, 2009, BRIT J SPORT MED, V43, P81, DOI 10.1136/bjsm.2008.055269; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Rose SB, 2008, NZ MED J, V121, P1268; Rosenkranz RR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1071; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Stevenson C., 1996, AUSTR I HLTH WELFARE, P1; Vallance JK, 2014, CANCER-AM CANCER SOC, V120, P2919, DOI 10.1002/cncr.28779; Vuillemin A, 2005, PREV MED, V41, P562, DOI 10.1016/j.ypmed.2005.01.006; Wendel-Vos GCW, 2004, QUAL LIFE RES, V13, P667, DOI 10.1023/B:QURE.0000021313.51397.33; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2010, Global recommendations on physical activity for health	62	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180072	10.1371/journal.pone.0180072	http://dx.doi.org/10.1371/journal.pone.0180072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662137	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300097
J	Populo, H; Batista, R; Sampaio, C; Pardal, J; Lopes, JM; Soares, P				Populo, Helena; Batista, Rui; Sampaio, Cristina; Pardal, Joana; Lopes, Jose Manuel; Soares, Paula			SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; SUCCINATE-DEHYDROGENASE; UVEAL-MELANOMA; BRAF MUTATIONS; PATHWAY ACTIVATION; ENZYMATIC-ACTIVITY; NRAS MUTATIONS; MTOR PATHWAY; COMPLEX-II; TERT	Background SDHD promoter mutations were reported in 4-10% of cutaneous melanomas. The advanced clinico-pathological and patient survival association with SDHD mutation and/or expression in cutaneous melanoma remains controversial. Objectives To evaluate the presence of SDHD promoter mutations and SDHD protein expression in a melanoma series and its possible association with prognosis and survival of the patients. Methods We assessed SDHD promoter status in cutaneous melanomas (CM), ocular melanomas (OM) and melanoma cell lines, and the expression of SDHD protein by immunohistochemistry in CM and OM, and by western blot in melanoma cell lines. We explored the putative association between SDHD protein expression and clinico-pathological and prognostic parameters of melanoma. Results We detected 2% of SDHD promoter mutations in CM, but none in OM and cell lines. SDHD protein expression was present in all CM, in OM and in all CM and OM derived cell lines analysed. A significant association between lower SDHD mean protein expression and presence of ulceration and higher pT stage was found. Conclusions SDHD promoter mutation seems to be a rare event in CM but SDHD lower expression might associate with worst prognostic features in CM.	[Populo, Helena; Batista, Rui; Sampaio, Cristina; Lopes, Jose Manuel; Soares, Paula] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Populo, Helena; Batista, Rui; Sampaio, Cristina; Lopes, Jose Manuel; Soares, Paula] Univ Porto, Inst Res & Innovat Hlth, Oporto, Portugal; [Batista, Rui; Sampaio, Cristina] Univ Porto, Fac Med, Oporto, Portugal; [Pardal, Joana; Lopes, Jose Manuel] Hosp Sao Joao, Dept Pathol, Oporto, Portugal; [Lopes, Jose Manuel; Soares, Paula] Univ Porto, Fac Med, Dept Pathol & Oncol, Oporto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Sao Joao Hospital; Universidade do Porto	Populo, H (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.; Populo, H (corresponding author), Univ Porto, Inst Res & Innovat Hlth, Oporto, Portugal.	hpopulo@ipatimup.pt	Soares, Paula/B-6054-2008; Lopes, José Manuel Manuel/J-7428-2013; Pópulo, Helena I M/K-2964-2013; Batista, Rui/K-9177-2014	Soares, Paula/0000-0001-9607-6998; Lopes, José Manuel Manuel/0000-0001-8597-3474; Pópulo, Helena I M/0000-0002-6353-6879; Batista, Rui/0000-0002-6512-5328; Sampaio, Cristina/0000-0002-2974-210X	Portuguese Foundation for Science and Technology through Post-Docgrant to HP [SFRH/BPD/85249/2012]; FEDER-Fundo Europeude Desenvolvimen to Regional funds through the COMPETE2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT-Fundacao para a Ciencia e aTecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences [POCI-01-0145-FEDER-007274]; "Advancing cancer research: from basic knowledgment to application" [NORTE-01-0145F EDER-000029]; "Projetos Estruturados de IDI"; Norte2020-ProgramaOperacional Regional do Norte	Portuguese Foundation for Science and Technology through Post-Docgrant to HP; FEDER-Fundo Europeude Desenvolvimen to Regional funds through the COMPETE2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT-Fundacao para a Ciencia e aTecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences; "Advancing cancer research: from basic knowledgment to application"; "Projetos Estruturados de IDI"; Norte2020-ProgramaOperacional Regional do Norte	This study was supported by the Portuguese Foundation for Science and Technology through Post-Docgrant to HP(Ref.: SFRH/BPD/85249/2012). IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT. This work was financed by FEDER-Fundo Europeude Desenvolvimen to Regional funds through the COMPETE2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT-Fundacao para a Ciencia e aTecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences"(POCI-01-0145-FEDER-007274). Further funding was obtained from the project "Advancing cancer research: from basic knowledgment to application"; NORTE-01-0145F EDER-000029; "Projetos Estruturados de I&D&I", funded by Norte2020-ProgramaOperacional Regional do Norte.The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Barletta JA, 2012, ADV ANAT PATHOL, V19, P193, DOI 10.1097/PAP.0b013e31825c6bc6; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Chen PW, 1997, CLIN EXP METASTAS, V15, P509, DOI 10.1023/A:1018479011340; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Cruz F, 2003, CANCER RES, V63, P5761; Dekker PBD, 2003, J PATHOL, V201, P480, DOI 10.1002/path.1461; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Dono M, 2014, BRIT J CANCER, V110, P1058, DOI 10.1038/bjc.2013.804; El-Shabrawi Y, 1999, ACTA OPHTHALMOL SCAN, V77, P31, DOI 10.1034/j.1600-0420.1999.770107.x; Farber M, 1998, J AM ACAD DERMATOL, V38, P971, DOI 10.1016/S0190-9622(98)70162-8; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Gear J, 2004, INVEST OPHTH VIS SCI, V45, P2484, DOI 10.1167/iovs.04-0093; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Goldenberg-Cohen N, 2005, INVEST OPHTH VIS SCI, V46, P3027, DOI 10.1167/iovs.04-1449; Griewank KG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju246; Griewank KG, 2013, CLIN CANCER RES, V19, P3143, DOI 10.1158/1078-0432.CCR-13-0163; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang SB, 2013, CURR OPIN PLANT BIOL, V16, P344, DOI 10.1016/j.pbi.2013.02.007; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; KSANDER BR, 1991, INVEST OPHTH VIS SCI, V32, P3198; Lopez-Bergami P, 2008, PHOTOCHEM PHOTOBIOL, V84, P289, DOI 10.1111/j.1751-1097.2007.00254.x; Luyten GPM, 1996, INT J CANCER, V66, P380, DOI 10.1002/(SICI)1097-0215(19960503)66:3<380::AID-IJC19>3.0.CO;2-F; Mediouni A, 2014, EUR ANN OTORHINOLARY, V131, P159, DOI 10.1016/j.anorl.2013.05.003; Melanoma Bertolotto C., 2013, SCIENTIFICA, V2013, DOI DOI 10.1155/2013/635203; Pawlu C, 2005, FAM CANCER, V4, P49, DOI 10.1007/s10689-004-4227-4; Populo H, 2011, PIGM CELL MELANOMA R, V24, P254, DOI 10.1111/j.1755-148X.2010.00796.x; Populo H, 2014, J INVEST DERMATOL, V134, P2251, DOI 10.1038/jid.2014.163; Populo H, 2012, EXPERT OPIN THER TAR, V16, P689, DOI 10.1517/14728222.2012.691472; Populo H, 2011, BRIT J OPHTHALMOL, V95, P715, DOI 10.1136/bjo.2009.174417; Rimoldi D, 2003, CANCER RES, V63, P5712; Rustin P, 2002, EUR J HUM GENET, V10, P289, DOI 10.1038/sj.ejhg.5200793; Scholz SL, 2015, ONCOTARGET, V6, P25868, DOI 10.18632/oncotarget.4665; Seregard S, 1998, SURV OPHTHALMOL, V42, P321, DOI 10.1016/S0039-6257(97)00122-7; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh AD, 2004, SURV OPHTHALMOL, V49, P419, DOI 10.1016/j.survophthal.2004.04.009; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Spendlove HE, 2004, MELANOMA RES, V14, P449, DOI 10.1097/00008390-200412000-00003; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Xekouki P, 2012, J CLIN ENDOCR METAB, V97, pE357, DOI 10.1210/jc.2011-1179	48	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							E0180392	10.1371/journal.pone.0180392	http://dx.doi.org/10.1371/journal.pone.0180392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662141	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300150
J	Xiao, F; Zheng, R; Yang, D; Cao, KJ; Zhang, SJ; Wu, BR; Shao, YF; Zhou, B				Xiao, Feng; Zheng, Rui; Yang, Di; Cao, Kejiang; Zhang, Shijiang; Wu, Bingruo; Shao, Yongfeng; Zhou, Bin			Sex-dependent aortic valve pathology in patients with rheumatic heart disease	PLOS ONE			English	Article							NF-KAPPA-B; ATRIAL-FIBRILLATION; INTERSTITIAL-CELLS; GENDER-DIFFERENCES; ACTIVATION; PATHOGENESIS; STENOSIS; TISSUE; RISK; DIFFERENTIATION	Background Rheumatic heart disease is an autoimmune disease caused by group A streptococci infection and frequently affects the aortic valve. Sex differences are common in the disease progression, treatment, and outcome. However, little is known about the sex differences in the pathology of aortic valves in rheumatic heart disease. Design We studied the end-stage calcific aortic valves from male versus female patients to reveal the sex-dependent pathology differences and molecular changes associated with requiring valve replacement. Methods Aortic valves from 39 patients with rheumatic heart disease (19 males and 20 females) were collected at the time of aortic valve replacement for comparative pathology, immunohistochemistry, and gene expression analyses. Clinical characteristics were also analyzed and compared between the two groups. Results Aortic valves from female patients exhibited increased expression of collagens, infiltration of monocytes/macrophages and neovascularization. Aortic valves from female patients also had increased expression of inflammatory genes involved in the NFKB pathway (phosphorylated NFKB p65 subunit, IL8, and NOS3) and Th1 cytokine genes (IFNA and IL12B). The severe valve pathology in female patients was correlated with a higher serum level of antistreptolysin O antibodies. Conclusion Inflammation is more prominent in aortic valves of female patients with rheumatic heart disease. This sex difference may contribute to the severe valve pathology and worse outcome of female patients.	[Xiao, Feng; Yang, Di; Cao, Kejiang; Zhou, Bin] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Xiao, Feng; Wu, Bingruo; Zhou, Bin] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Genet, Dept Pediat, Bronx, NY 10467 USA; [Xiao, Feng; Wu, Bingruo; Zhou, Bin] Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10467 USA; [Zheng, Rui; Zhang, Shijiang; Shao, Yongfeng] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Nanjing Medical University	Zhou, B (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.; Zhou, B (corresponding author), Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Genet, Dept Pediat, Bronx, NY 10467 USA.; Zhou, B (corresponding author), Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10467 USA.; Shao, YF (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China.	yongfengshao30@hotmail.com; bin_zhou@yahoo.com		Zhou, Bin/0000-0003-0832-4002	The National Natural Science Foundation of China [81170212]; The National Heart, Lung, and Blood Institute [R01HL111770]; China Scholarship Council [201508320269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111770] Funding Source: NIH RePORTER	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study wassupported by The National Natural Science Foundation of China (81170212) and The National Heart, Lung, and Blood Institute (R01HL111770) and China Scholarship Council (201508320269).The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	AlFaleh HF, 2016, ANGIOLOGY, V67, P647, DOI 10.1177/0003319715607298; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bright PD, 2016, HEART, V102, P1527, DOI 10.1136/heartjnl-2015-309188; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Carapetis JR, 2008, CIRCULATION, V118, P2748, DOI 10.1161/CIRCULATIONAHA.108.774307; Cheng G, 2002, DEV DYNAM, V223, P119, DOI 10.1002/dvdy.1244; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Cunningham MW, 2012, CURR OPIN RHEUMATOL, V24, P408, DOI 10.1097/BOR.0b013e32835461d3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Duan XX, 2017, MOL IMMUNOL, V81, P160, DOI 10.1016/j.molimm.2016.12.005; Eveborn GW, 2015, HEART, V101, P1895, DOI 10.1136/heartjnl-2015-307807; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Guilherme Luiza, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S146239940501015X; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Lawrence JG, 2013, CIRCULATION, V128, P492, DOI 10.1161/CIRCULATIONAHA.113.001477; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Mathieu P, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/851945; McCormick Sally P A, 2004, Clin Biochem Rev, V25, P69; MERZ CNB, 2006, J AM COLL CARDIOL, V47, pS21, DOI [DOI 10.1016/J.JACC.2004.12.084, 10.1016/j.jacc.2004.12.084]; Mohler ER, 1997, ARTERIOSCL THROM VAS, V17, P547, DOI 10.1161/01.ATV.17.3.547; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Moreno PR, 1996, CIRCULATION, V94, P3090, DOI 10.1161/01.CIR.94.12.3090; Nadlonek N, 2013, ANN THORAC SURG, V96, P155, DOI 10.1016/j.athoracsur.2013.04.013; Novo G, 2011, CURR DRUG TARGETS, V12, P115, DOI 10.2174/138945011793591545; OBRIEN KD, 1995, CIRCULATION, V92, P2163, DOI 10.1161/01.CIR.92.8.2163; Ogah OS, 2015, CLIN RES CARDIOL, V104, P481, DOI 10.1007/s00392-015-0810-y; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Paar JA, 2010, AM J CARDIOL, V105, P1809, DOI 10.1016/j.amjcard.2010.01.364; Patel V, 2015, FASEB J, V29, P1859, DOI 10.1096/fj.14-257808; Procter NEK, 2016, J GERIATR CARDIOL, V13, P202, DOI 10.11909/j.issn.1671-5411.2016.03.005; Sorimachi K, 1999, CYTOKINE, V11, P571, DOI 10.1006/cyto.1998.0472; Tian L, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-64; Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; Wang Y, 2015, EUROPEAN HEART J; Xie ZJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002543; Yao GH, 2016, EUR HEART J-CARD IMG, V17, P512, DOI 10.1093/ehjci/jev330; Yu PJ, 2009, J THORAC CARDIOV SUR, V138, P196, DOI 10.1016/j.jtcvs.2008.10.045; Zeng QC, 2013, ARTERIOSCL THROM VAS, V33, P1580, DOI 10.1161/ATVBAHA.112.300912; Zhou JX, 2016, INT J CARDIOL, V221, P998, DOI 10.1016/j.ijcard.2016.07.036; Zhu QW, 2016, CLIN INTERV AGING, V11, P245, DOI 10.2147/CIA.S98151; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449	44	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180230	10.1371/journal.pone.0180230	http://dx.doi.org/10.1371/journal.pone.0180230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662157	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300129
J	Ebert, KD				Ebert, Kerry Danahy			Convergence between parent report and direct assessment of language and attention in culturally and linguistically diverse children	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; DEFICIT HYPERACTIVITY DISORDER; RATING-SCALE; DEFICIT/HYPERACTIVITY DISORDER; PSYCHOMETRIC PROPERTIES; VALIDITY; IMPAIRMENT; PREVALENCE; CONCURRENT; VARIABLES	Parent report is commonly used to assess language and attention in children for research and clinical purposes. It is therefore important to understand the convergent validity of parent-report tools in comparison to direct assessments of language and attention. In particular, cultural and linguistic background may influence this convergence. In this study a group of six-to eight-year old children (N = 110) completed direct assessments of language and attention and their parents reported on the same areas. Convergence between assessment types was explored using correlations. Possible influences of ethnicity (Hispanic or non-Hispanic) and of parent report language (English or Spanish) were explored using hierarchical linear regression. Correlations between parent report and direct child assessments were significant for both language and attention, suggesting convergence between assessment types. Ethnicity and parent report language did not moderate the relationships between direct child assessments and parent report tools for either attention or language.	[Ebert, Kerry Danahy] Rush Univ, Coll Hlth Sci, Dept Commun Disorders & Sci, Chicago, IL 60612 USA	Rush University	Ebert, KD (corresponding author), Rush Univ, Coll Hlth Sci, Dept Commun Disorders & Sci, Chicago, IL 60612 USA.	Kerry_ebert@rush.edu		Ebert, Kerry/0000-0002-7607-9742	National Instituteon Deafness and Other Communication Disorders [R03DC013760]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013760] Funding Source: NIH RePORTER	National Instituteon Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Instituteon Deafness and Other Communication Disorders R03DC013760 awarded to K.D.E. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Pediatrics & National Initiative for Children's Healthcare Quality, 2002, VAND ASS SCAL; American Academy of Pediatrics & University of North Carolina in Chapel Hill, 2005, VAND ASS SCAL SPAN A; American Psychiatric Association, 2013, DSM 5 DIAGN CLASS DI, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596.X00DIAGNOSTICCLASSIFICATION, DOI 10.1176/APPI.BOOKS.9780890425596.DSM05]; [Anonymous], 2013, TEST VAR ATT VERSION; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Bard DE, 2013, J DEV BEHAV PEDIATR, V34, P72, DOI 10.1097/DBP.0b013e31827a3a22; Bedore LM, 2011, INT J BILING EDUC BI, V14, P489, DOI 10.1080/13670050.2010.529102; Cohen J.E., 1988, STAT POWER ANAL BEHA; DALE PS, 1989, J CHILD LANG, V16, P239, DOI 10.1017/S0305000900010394; Dopfner M, 2006, EUR CHILD ADOLES PSY, V15, P46, DOI 10.1007/s00787-006-1007-8; Ebert KD, 2016, LANG TEACHING, V49, P301, DOI 10.1017/S0261444816000070; Ebert KD, 2014, LANG SPEECH HEAR SER, V45, P337, DOI 10.1044/2014_LSHSS-14-0034; Edwards MC, 2007, J ABNORM CHILD PSYCH, V35, P393, DOI 10.1007/s10802-007-9098-3; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Feldman HM, 2000, CHILD DEV, V71, P310, DOI 10.1111/1467-8624.00146; Forbes GB, 1998, J CLIN PSYCHOL, V54, P461, DOI 10.1002/(SICI)1097-4679(199806)54:4<461::AID-JCLP8>3.3.CO;2-S; Guiberson M, 2011, LANG SPEECH HEAR SER, V42, P536, DOI 10.1044/0161-1461(2011/10-0076); Gutierrez-Clellen VF, 2003, APPL PSYCHOLINGUIST, V24, P267, DOI 10.1017/S0142716403000158; Hillemeier MM, 2007, J DEV BEHAV PEDIATR, V28, P353, DOI 10.1097/DBP.0b013e31811ff8b8; International Alliance of Patients' Organizations (IAPO), 2007, REV DEF PRINC; Marchman VA, 2002, J SPEECH LANG HEAR R, V45, P983, DOI 10.1044/1092-4388(2002/080); Norbury CF, 2004, INT J LANG COMM DIS, V39, P345, DOI 10.1080/13682820410001654883; Paradis J., 2010, ALBERTA LANGUAGE ENV; Paradis J, 2010, J COMMUN DISORD, V43, P474, DOI 10.1016/j.jcomdis.2010.01.002; Paul R., 2012, LANGUAGE DISORDERS I; Perou R, 2013, MMWR SURVEILL SUM S2, V62, P1; Reilly S, 2014, INT J LANG COMM DIS, V49, P416, DOI 10.1111/1460-6984.12102; Restrepo MA, 1998, J SPEECH LANG HEAR R, V41, P1398, DOI 10.1044/jslhr.4106.1398; Sachse S, 2008, J DEV BEHAV PEDIATR, V29, P34, DOI 10.1097/DBP.0b013e318146902a; Semel E., 2003, CLIN EVALUATION LANG, V4th Edn; Szomlaiski N, 2009, ACTA PAEDIATR, V98, P397, DOI 10.1111/j.1651-2227.2008.01025.x; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Vaughn AJ, 2011, J ABNORM CHILD PSYCH, V39, P853, DOI 10.1007/s10802-011-9501-y; Wang LJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-65; White CDL, 2011, INT J LANG COMM DIS, V46, P613, DOI 10.1111/j.1460-6984.2011.00049.x; Wiig E.H., 2006, CELF PRESCHOOL 2 UK; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Williams CJ, 2012, INT J SPEECH-LANG PA, V14, P292, DOI 10.3109/17549507.2011.636071; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Wu YY, 2007, PSYCHIAT CLIN NEUROS, V61, P211, DOI 10.1111/j.1440-1819.2007.01658.x	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180598	10.1371/journal.pone.0180598	http://dx.doi.org/10.1371/journal.pone.0180598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683131	Green Submitted, Green Published, gold			2022-12-27	WOS:000405335200051
J	Elliott, P; G'Sell, M; Snyder, LM; Ross, SE; Ventura, V				Elliott, Peter; G'Sell, Max; Snyder, Lindsey M.; Ross, Sarah E.; Ventura, Valerie			Automated acoustic detection of mouse scratching	PLOS ONE			English	Article							EVALUATION SYSTEM; SPINAL-CORD; MICE; BEHAVIOR; ITCH; QUANTIFICATION; DERMATITIS	Itch is an aversive somatic sense that elicits the desire to scratch. In animal models of itch, scratching behavior is frequently used as a proxy for itch, and this behavior is typically assessed through visual quantification. However, manual scoring of videos has numerous limitations, underscoring the need for an automated approach. Here, we propose a novel automated method for acoustic detection of mouse scratching. Using this approach, we show that chloroquine-induced scratching behavior in C57BL/6 mice can be quantified with reasonable accuracy (85% sensitivity, 75% positive predictive value). This report is the first method to apply supervised learning techniques to automate acoustic scratch detection.	[Elliott, Peter; G'Sell, Max; Ventura, Valerie] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Snyder, Lindsey M.; Ross, Sarah E.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Snyder, Lindsey M.; Ross, Sarah E.] Univ Pittsburgh, Pittsburgh Ctr Pain Res, Pittsburgh, PA USA; [Ross, Sarah E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA; [Ross, Sarah E.; Ventura, Valerie] Ctr Neural Basis Cognit, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Elliott, P (corresponding author), Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA.	pwelliott@cmu.edu		Snyder, Lindsey/0000-0001-8831-0342	NIH [NS073548, NS092146, AR063772, AR064445, MH064537]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by NIH training grants NS073548 and NS092146 (LMS), NIH R01 grants AR063772 and AR064445 (SER), and NIH R01 grant MH064537 (VV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2010, ACTA DERM-VENEREOL, V90, P575, DOI 10.2340/00015555-0962; Brash HM, 2005, J NEUROSCI METH, V142, P107, DOI 10.1016/j.jneumeth.2004.08.001; Cuellar JM, 2003, NEUROSCI LETT, V339, P72, DOI 10.1016/S0304-3940(02)01458-1; Elliott GR, 2000, J PHARMACOL TOXICOL, V44, P453, DOI 10.1016/S1056-8719(01)00111-3; Ishii I, 2007, IEEE INT C AUT SCI E; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Marino M, 2012, J NEUROSCI METH, V211, P1, DOI 10.1016/j.jneumeth.2012.08.002; Nie Y, 2012, SICE J CONTROL MEASU, V4, P322; Noro Y, 2014, J DERMATOL, V41, P233, DOI 10.1111/1346-8138.12405; Orito K, 2004, BRIT J DERMATOL, V150, P33, DOI 10.1111/j.1365-2133.2004.05744.x; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Umeda K, 2006, LIFE SCI, V79, P2144, DOI 10.1016/j.lfs.2006.07.010; Weisshaar E, 2009, ACTA DERM-VENEREOL, V89, P339, DOI 10.2340/00015555-0662; Wiltschko AB, 2015, NEURON, V88, P1121, DOI 10.1016/j.neuron.2015.11.031; Yosipovitch G., 2008, ITCH BASIC MECH THER, P183	16	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179662	10.1371/journal.pone.0179662	http://dx.doi.org/10.1371/journal.pone.0179662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678797	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200020
J	Cubizolle, A; Guillou, L; Mollereau, B; Hamel, CP; Brabet, P				Cubizolle, Aurelie; Guillou, Laurent; Mollereau, Bertrand; Hamel, Christian P.; Brabet, Philippe			Fatty acid transport protein 1 regulates retinoid metabolism and photoreceptor development in mouse retina	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; PIGMENT EPITHELIUM; DOCOSAHEXAENOIC ACID; VISUAL CYCLE; LECITHINRETINOL ACYLTRANSFERASE; ROD PHOTORECEPTORS; RPE65; ISOMERASE; RHODOPSIN; DISEASE	In retinal pigment epithelium (RPE), RPE65 catalyzes the isomerization of all-trans-retinyl fatty acid esters to 11-cis-retinol in the visual cycle and controls the rhodopsin regeneration rate. However, the mechanisms by which these processes are regulated are still unclear. Fatty Acid Transport Protein 1 (FATP1) is involved in fatty acid uptake and lipid metabolism in a variety of cell types. FATP1 co-localizes with RPE65 in RPE and inhibits its isomerase activity in vitro. Here, we further investigated the role of FATP1 in the visual cycle using transgenic mice that overexpress human FATP1 specifically in the RPE (hFATP1TG mice). The mice displayed no delay in the kinetics of regeneration of the visual chromophore 11-cis-retinal after photobleaching and had no defects in light sensitivity. However, the total retinoid content was higher in the hFATP1TG mice than in wild type mice, and the transgenic mice also displayed an age-related accumulation (up to 40%) of all-trans-retinal and retinyl esters that was not observed in control mice. Consistent with these results, hFATP1TG mice were more susceptible to light-induced photoreceptor degeneration. hFATP1 overexpression also induced an similar to 3.5-fold increase in retinosome autofluorescence, as measured by two-photon microscopy. Interestingly, hFATP1TG retina contained similar to 25% more photoreceptor cells and similar to 35% longer outer segments than wild type mice, revealing a non-cell-autonomous effect of hFATP1 expressed in the RPE. These data are the first to show that FATP1-mediated fatty acid uptake in the RPE controls both retinoid metabolism in the outer retina and photoreceptor development.	[Cubizolle, Aurelie; Guillou, Laurent; Hamel, Christian P.; Brabet, Philippe] Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France; [Mollereau, Bertrand] Ecole Normale Super Lyon, Lab Biol & Modelisat Cellule, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Ecole Normale Superieure de Lyon (ENS de LYON)	Brabet, P (corresponding author), Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France.	philippe.brabet@inserm.fr	Brabet, Philippe/AAO-8522-2020; Mollereau, Bertrand/S-4447-2017	Brabet, Philippe/0000-0003-2739-1622; Mollereau, Bertrand/0000-0003-4710-8185	National Research Agency [ANR-12-BSV1-0019-02]; Labex EpiGenMed Programme for Future Investment [ANR-10-LABX-12-01]; Inserm	National Research Agency(French National Research Agency (ANR)); Labex EpiGenMed Programme for Future Investment; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by National Research Agency ANR-12-BSV1-0019-02 LipidinRetina and Labex EpiGenMed Programme for Future Investment ANR-10-LABX-12-01 (financial support to AC,BM and PB).r The authors were supported by National Research Agency ANR-12-BSV1-0019-02 LipidinRetina and Inserm. AC was supported byLabex EpiGenMed Programme for Future Investment ANR-10-LABX-12-01 for financial support. We are grateful to Marie Seveno, Nicolas Tricaud, RHEM platform, SEAT transgenesis service (CNRS D UPS44) and the animal facility of INM for technical assistance, and to Montpellier RIO Imaging for providing materials.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; BATES D, 1989, J NEUROL NEUROSUR PS, V52, P18, DOI 10.1136/jnnp.52.1.18; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; Chekroud K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050231; Cia D, 2016, J CELL MOL MED, V20, P1651, DOI 10.1111/jcmm.12857; Claybon A, 2011, JOVE-J VIS EXP, DOI 10.3791/2563; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Dourlen P, 2015, PROG LIPID RES, V60, P30, DOI 10.1016/j.plipres.2015.08.001; Dourlen P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002833; Eroglu A, 2016, J BIOL CHEM, V291, P4966, DOI 10.1074/jbc.M115.685651; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Ferguson LR, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-9; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Guesnet P, 2011, BIOCHIMIE, V93, P7, DOI 10.1016/j.biochi.2010.05.005; Guignard TJP, 2010, J BIOL CHEM, V285, P18759, DOI 10.1074/jbc.M109.064329; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Ivanovic I, 2011, INVEST OPHTH VIS SCI, V52, P6355, DOI 10.1167/iovs.10-7138; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kaylor JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125921; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Li SH, 2013, J NEUROSCI, V33, P3178, DOI 10.1523/JNEUROSCI.2428-12.2013; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Ochiai Y, 2017, J NEUROCHEM, V141, P400, DOI 10.1111/jnc.13943; Orban T, 2011, J BIOL CHEM, V286, P17248, DOI 10.1074/jbc.M110.195198; Palczewska G, 2014, NAT MED, V20, P785, DOI 10.1038/nm.3590; Parker RO, 2010, EXP EYE RES, V91, P788, DOI 10.1016/j.exer.2010.08.013; Pollock NL, 2014, BBA-BIOMEMBRANES, V1838, P134, DOI 10.1016/j.bbamem.2013.09.001; Qi RL, 2013, MOL BIOL REP, V40, P2907, DOI 10.1007/s11033-012-2306-4; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; Sears AE, 2016, BIOCHEMISTRY-US, V55, P3082, DOI 10.1021/acs.biochem.6b00319; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrrow JR, 2010, CURR MOL MED, V10, P802; SUZUKI T, 1986, VISION RES, V26, P425, DOI 10.1016/0042-6989(86)90185-9; Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1; Wright CB, 2015, PROG MOL BIOL TRANSL, V134, P433, DOI 10.1016/bs.pmbts.2015.06.009; Zhan TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045087	47	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180148	10.1371/journal.pone.0180148	http://dx.doi.org/10.1371/journal.pone.0180148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672005	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500018
J	Hackelberg, S; Tuck, SJ; He, L; Rastogi, A; White, C; Liu, LQ; Prieskorn, DM; Miller, RJ; Chan, C; Loomis, BR; Corey, JM; Miller, JM; Duncan, RK				Hackelberg, Sandra; Tuck, Samuel J.; He, Long; Rastogi, Arjun; White, Christina; Liu, Liqian; Prieskorn, Diane M.; Miller, Ryan J.; Chan, Che; Loomis, Benjamin R.; Corey, Joseph M.; Miller, Josef M.; Duncan, R. Keith			Nanofibrous scaffolds for the guidance of stem cell-derived neurons for auditory nerve regeneration	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; COCHLEAR IMPLANTATION; SCHWANN-CELLS; MOUSE MODEL; IN-VITRO; DIFFERENTIATION; TRANSPLANTATION; NEUROPATHY; OUABAIN; GROWTH	Impairment of spiral ganglion neurons (SGNs) of the auditory nerve is a major cause for hearing loss occurring independently or in addition to sensory hair cell damage. Unfortunately, mammalian SGNs lack the potential for autonomous regeneration. Stem cell based therapy is a promising approach for auditory nerve regeneration, but proper integration of exogenous cells into the auditory circuit remains a fundamental challenge. Here, we present novel nanofibrous scaffolds designed to guide the integration of human stem cell-derived neurons in the internal auditory meatus (IAM), the foramen allowing passage of the spiral ganglion to the auditory brainstem. Human embryonic stem cells (hESC) were differentiated into neural precursor cells (NPCs) and seeded onto aligned nanofiber mats. The NPCs terminally differentiated into glutamatergic neurons with high efficiency, and neurite projections aligned with nanofibers in vitro. Scaffolds were assembled by seeding GFP-labeled NPCs on nanofibers integrated in a polymer sheath. Biocompatibility and functionality of the NPC-seeded scaffolds were evaluated in vivo in deafened guinea pigs (Cavia porcellus). To this end, we established an ouabain-based deafening procedure that depleted an average 72% of SGNs from apex to base of the cochleae and caused profound hearing loss. Further, we developed a surgical procedure to implant seeded scaffolds directly into the guinea pig IAM. No evidence of an inflammatory response was observed, but post-surgery tissue repair appeared to be facilitated by infiltrating Schwann cells. While NPC survival was found to be poor, both subjects implanted with NPC-seeded and cell-free control scaffolds showed partial recovery of electrically-evoked auditory brainstem thresholds. Thus, while future studies	[Hackelberg, Sandra; He, Long; Liu, Liqian; Prieskorn, Diane M.; Miller, Ryan J.; Loomis, Benjamin R.; Miller, Josef M.; Duncan, R. Keith] Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, 1301 E Ann St, Ann Arbor, MI 48109 USA; [Tuck, Samuel J.; Rastogi, Arjun; White, Christina; Miller, Ryan J.; Chan, Che; Corey, Joseph M.] VAAAHC, GRECC, Ann Arbor, MI USA; [Tuck, Samuel J.; White, Christina; Miller, Ryan J.; Corey, Joseph M.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [He, Long] Jinan Univ, Dept Otorhinolaryngol, Guangzhou Peoples Hosp 1, Sch Med, Guangzhou, Guangdong, Peoples R China; [He, Long] Jinan Univ, Dept Otorhinolaryngol, Affiliated Hosp 1, Sch Med, Guangzhou, Guangdong, Peoples R China; [Chan, Che] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Corey, Joseph M.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Hackelberg, Sandra] Northwestern Univ, Ken & Ruth Davee Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan; Jinan University; Jinan University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Northwestern University; Feinberg School of Medicine	Duncan, RK (corresponding author), Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, 1301 E Ann St, Ann Arbor, MI 48109 USA.	rkduncan@umich.edu		Loomis, Benjamin/0000-0002-0212-6403	Department of Defense [W81XWH-12-10 492]; National Institutes of Health (NIH) [P30DC005188]	Department of Defense(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by agrant from the Department of Defense, W81XWH-12-10 492 to RKD, (http://cdmrp.army.mil) and National Institutes of Health (NIH) (P30DC005188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler RA, 2008, HEARING RES, V242, P110, DOI 10.1016/j.heares.2008.06.004; [Anonymous], 2018, WHO GLOB EST PREV HE; Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Bok J, 2011, P NATL ACAD SCI USA, V108, P161, DOI 10.1073/pnas.1010547108; Budenz CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08619; Callahan LAS, 2013, BIOMATERIALS, V34, P9089, DOI 10.1016/j.biomaterials.2013.08.028; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chen JC, 2013, HEARING RES, V297, P3, DOI 10.1016/j.heares.2012.11.018; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Chen W, 2009, STEM CELLS, V27, P1196, DOI 10.1002/stem.62; Cho YB, 2011, J KOREAN MED SCI, V26, P492, DOI 10.3346/jkms.2011.26.4.492; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; Dennis Daniel, 2016, Trends Dev Biol, V9, P77; Duthey B, 2013, PRIORITY MED EUROPE, P4; El-Akabawy G, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-97; Fu Y, 2012, NEUROTOX RES, V22, P158, DOI 10.1007/s12640-012-9320-0; Gerardo-Nava J, 2009, NANOMEDICINE-UK, V4, P11, DOI 10.2217/17435889.4.1.11; Gertz CC, 2010, DEV NEUROBIOL, V70, P589, DOI 10.1002/dneu.20792; Giger RJ, 2010, BIOL, P2; Glueckert R, 2008, J COMP NEUROL, V507, P1602, DOI 10.1002/cne.21619; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gunewardene N, 2014, BIORESEARCH OPEN ACC, V3, P162, DOI 10.1089/biores.2014.0019; Gunewardene N, 2012, STEM CELL REV REP, V8, P741, DOI 10.1007/s12015-011-9320-0; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; Hamada M, 1999, ACTA OTO-LARYNGOL, V119, P778; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Hynes RO, 2010, EXTRACELLULAR MATRIX, P1216; Jiao Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/356415; Joshi MK, 2015, ACS APPL MATER INTER, V7, P19672, DOI 10.1021/acsami.5b04682; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Krishnan M, 2005, FASEB J; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lang HN, 2008, JARO-J ASSOC RES OTO, V9, P225, DOI 10.1007/s10162-008-0119-x; Lawoko-Kerali G, 2004, MECH DEVELOP, V121, P287, DOI 10.1016/j.mod.2003.12.006; Li JP, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1028-0; Liang YJ, 2013, EXP NEUROL, V247, P73, DOI 10.1016/j.expneurol.2013.04.001; Liberman LD, 2015, JARO-J ASSOC RES OTO, V16, P205, DOI 10.1007/s10162-015-0510-3; Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021; Liu W, 2015, NEUROSCIENCE, V284, P470, DOI 10.1016/j.neuroscience.2014.09.059; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Maier EC, 2014, DEV BIOL, V389, P50, DOI 10.1016/j.ydbio.2014.01.023; Marques SR, 2012, IRAN J RADIOL, V9, P71, DOI 10.5812/iranjradiol.7849; Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616; Mcmurtrey RJ., 2014, PATTERNED FUNCTIONAL, V11, P1; Mitchell A, 1997, HEARING RES, V105, P30, DOI 10.1016/S0378-5955(96)00202-X; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Mohtaram NK, 2015, J MATER CHEM B, V3, P7974, DOI 10.1039/c5tb00871a; Moser T, 2016, NAT REV NEUROL, V12, P135, DOI 10.1038/nrneurol.2016.10; Nakamura M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014110; Nayagam BA, 2016, SPRINGER HANDB AUDIT, V52, P263, DOI 10.1007/978-1-4939-3031-9_9; Nayagam BA, 2011, HEARING RES, V278, P2, DOI 10.1016/j.heares.2011.04.003; Nishimura K, 2014, NEUROSCIENCE, V275, P125, DOI 10.1016/j.neuroscience.2014.05.067; Okano T, 2005, NEUROREPORT, V16, P1919, DOI 10.1097/01.wnr.0000187628.38010.5b; Pettingill LN, 2008, NEUROSCIENCE, V152, P821, DOI 10.1016/j.neuroscience.2007.11.057; Pfingst BE, HEAR RES; Pfingst BE, 2015, HEARING RES, V330, P98, DOI 10.1016/j.heares.2015.07.010; Prieskorn DM, 2000, HEARING RES, V140, P212, DOI 10.1016/S0378-5955(99)00193-8; Purcell EK, 2012, BIOMACROMOLECULES, V13, P3427, DOI 10.1021/bm301220k; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Rodriguez K, 2011, BIOMIMETIC CALCIUM P, P681; Sanchez-Rodriguez JE, 2015, J MOL BIOL, V427, P1335, DOI 10.1016/j.jmb.2015.01.011; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Schmiedt RA, 2002, JARO, V3, P223, DOI 10.1007/s1016200220017; Shahbazi E, 2011, TISSUE ENG PT A, V17, P3021, DOI [10.1089/ten.tea.2011.0121, 10.1089/ten.TEA.2011.0121]; Shi FX, 2007, EUR J NEUROSCI, V26, P3016, DOI 10.1111/j.1460-9568.2007.05909.x; Shibata SB, 2011, HEARING RES, V281, P56, DOI 10.1016/j.heares.2011.04.019; Swan EEL, 2008, ADV DRUG DELIVER REV, V60, P1583, DOI 10.1016/j.addr.2008.08.001; Triolo D, 2012, VIMENTIN REGULATES P, V1367, P1359; Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang JX, 2012, J BIOMED MATER RES A, V100A, P632, DOI 10.1002/jbm.a.33291; Whitfield TT, 2015, CURR OPIN GENET DEV, V32, P112, DOI 10.1016/j.gde.2015.02.006; Whitlon DS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15960; Wise AK, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065002; Wise AK, 2011, HEARING RES, V278, P69, DOI 10.1016/j.heares.2011.04.010; Xia HJ, 2014, BRAIN RES, V1565, P18, DOI 10.1016/j.brainres.2014.04.002; Yin Y, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-28; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7; Zanin MP, 2014, NEUROSCIENCE, V277, P690, DOI 10.1016/j.neuroscience.2014.07.044; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208; Zhou JH, 2013, NEURAL REGEN RES, V8, P1455, DOI 10.3969/j.issn.1673-5374.2013.16.002	88	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180427	10.1371/journal.pone.0180427	http://dx.doi.org/10.1371/journal.pone.0180427			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672008	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500053
J	Mattsson, A; Brunstrom, B				Mattsson, Anna; Brunstrom, Bjorn			Effects of selective and combined activation of estrogen receptor a and beta on reproductive organ development and sexual behaviour in Japanese quail (Coturnix japonica)	PLOS ONE			English	Article							CHICKEN EMBRYOS; VASOTOCIN SYSTEM; ALPHA ACTIVATION; OVO EXPOSURE; ER-ALPHA; DIFFERENTIATION; EXPRESSION; AROMATASE; AGONIST; DIETHYLSTILBESTROL	Excess estrogen exposure of avian embryos perturbs reproductive organ development in both sexes and demasculinizes the reproductive behaviors of adult males. We have previously shown that these characteristic effects on the reproductive organs also can be induced by exposure of Japanese quail (Coturnix japonica) embryos to selective agonists of estrogen receptor alpha (ER alpha). In contrast, the male copulatory behavior is only weakly affected by developmental exposure to an ERa agonist. To further elucidate the respective roles of ER alpha and ER beta in estrogen-induced disruption of sexual differentiation, we exposed Japanese quail embryos in ovo to the selective ER alpha agonist 16 alpha-lactone-estradiol (16 alpha LE2), the selective ER beta agonist WAY-200070, or both substances in combination. The ERa agonist feminized the testes in male embryos and reduced cloacal gland size in adult males. Furthermore, anomalous retention and malformations of the Mullerian ducts/oviducts were seen in embryos and juveniles of both sexes. The ER beta agonist did not induce any of these effects and did not influence the action of the ERa agonist. Male copulatory behavior was not affected by embryonic exposure to either the ER alpha-or the ER beta-selective agonist but was slightly suppressed by treatment with the two compounds combined. Our results suggest that the reproductive organs become sexually differentiated consequent to activation of ER alpha by endogenous estrogens; excessive activation of ER alpha, but not ER beta, during embryonic development may disrupt this process. Our results also suggest that the demasculinizing effect of estrogens on male copulatory behavior is only partly mediated by ER alpha and ER beta, and may rather involve other estrogen-responsive pathways.	[Mattsson, Anna; Brunstrom, Bjorn] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Mattsson, Anna; Brunstrom, Bjorn] Ctr Reprod Biol Uppsala CRU, Uppsala, Sweden	Uppsala University	Mattsson, A (corresponding author), Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden.; Mattsson, A (corresponding author), Ctr Reprod Biol Uppsala CRU, Uppsala, Sweden.	Anna.Mattsson@ebc.uu.se		Mattsson, Anna/0000-0002-5328-6255	Swedish Research Council Formas [2016-20128 99]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The project was funded by a grant from the Swedish Research Council Formas to BB (http://www.formas.se/en/; grant no. 2016-20128 99). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of themanuscript.	ADKINS E K, 1975, Journal of Comparative and Physiological Psychology, V89, P61, DOI 10.1037/h0076406; ADKINS EK, 1979, NEUROENDOCRINOLOGY, V29, P178, DOI 10.1159/000122920; Andrews JE, 1997, GEN COMP ENDOCR, V108, P182, DOI 10.1006/gcen.1997.6978; Axelsson J, 2007, DEV NEUROBIOL, V67, P1742, DOI 10.1002/dneu.20544; BALTHAZART J, 1992, HORM BEHAV, V26, P179, DOI 10.1016/0018-506X(92)90041-S; Berg C, 2004, REPRODUCTION, V128, P455, DOI 10.1530/rep.1.00211; Berg C, 1999, SCI TOTAL ENVIRON, V233, P57, DOI 10.1016/S0048-9697(99)00179-5; Berg C, 2001, ENVIRON TOXICOL CHEM, V20, P2836, DOI 10.1002/etc.5620201224; Blomqvist A, 2006, BIOL REPROD, V74, P481, DOI 10.1095/biolreprod.105.045104; Brennan PLR, 2014, NEUROSCI BIOBEHAV R, V46, P557, DOI 10.1016/j.neubiorev.2014.08.010; Brunstrom B, 2009, GEN COMP ENDOCR, V163, P97, DOI 10.1016/j.ygcen.2009.01.006; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Ellis HL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099747; Escande A, 2006, BIOCHEM PHARMACOL, V71, P1459, DOI 10.1016/j.bcp.2006.02.002; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; FRY DM, 1981, SCIENCE, V213, P922, DOI 10.1126/science.7256288; Greenwood AW, 1938, Q J EXP PHYSIOL CMS, V28, P61, DOI 10.1113/expphysiol.1938.sp000765; Halldin K, 2003, ARCH TOXICOL, V77, P116, DOI 10.1007/s00204-002-0417-8; Halldin K, 1999, ENVIRON HEALTH PERSP, V107, P861, DOI 10.2307/3454472; Hanafy Ahmed M., 2005, Journal of Poultry Science, V42, P238, DOI 10.2141/jpsa.42.238; Hanafy Ahmed M., 2004, Journal of Poultry Science, V41, P30, DOI 10.2141/jpsa.41.30; Hill RA, 2007, MOL CELL NEUROSCI, V36, P146, DOI 10.1016/j.mcn.2007.05.012; Hillisch A, 2004, MOL ENDOCRINOL, V18, P1599, DOI 10.1210/me.2004-0050; Hughes ZA, 2008, NEUROPHARMACOLOGY, V54, P1136, DOI 10.1016/j.neuropharm.2008.03.004; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Jia M, 2015, BEST PRACT RES CL EN, V29, P557, DOI 10.1016/j.beem.2015.04.008; Kohno S, 2015, ENDOCRINOLOGY, V156, P1887, DOI 10.1210/en.2014-1852; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lambeth LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068362; Leitman DC, 2010, CURR OPIN PHARMACOL, V10, P629, DOI 10.1016/j.coph.2010.09.009; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Mattsson A, 2008, GEN COMP ENDOCR, V159, P150, DOI 10.1016/j.ygcen.2008.08.012; Mattsson A, 2008, REPRODUCTION, V136, P175, DOI 10.1530/REP-08-0100; Mattsson A, 2011, GEN COMP ENDOCR, V172, P251, DOI 10.1016/j.ygcen.2011.03.010; Mattsson A, 2010, REPROD FERT DEVELOP, V22, P416, DOI 10.1071/RD08293; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Nakabayashi O, 1998, J MOL ENDOCRINOL, V20, P193, DOI 10.1677/jme.0.0200193; Panzica G, 2005, DOMEST ANIM ENDOCRIN, V29, P436, DOI 10.1016/j.domaniend.2005.02.010; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; RAHIL KS, 1972, GEN COMP ENDOCR, V18, P315, DOI 10.1016/0016-6480(72)90217-1; SCHEIB D, 1985, GEN COMP ENDOCR, V60, P266, DOI 10.1016/0016-6480(85)90323-5; SCHEIB D, 1983, DIFFERENTIATION, V23, pS87; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Vaillant S, 2003, MOL REPROD DEV, V65, P420, DOI 10.1002/mrd.10318; Willer BH, 1935, P NATL ACAD SCI USA, V21, P625, DOI 10.1073/pnas.21.11.625; WOLFF E, 1979, IN VITRO CELL DEV B, V15, P6	47	7	7	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180548	10.1371/journal.pone.0180548	http://dx.doi.org/10.1371/journal.pone.0180548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671963	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500063
J	Przybysz, R; Bunch, M				Przybysz, Raymond; Bunch, Martin			Exploring spatial patterns of sudden cardiac arrests in the city of Toronto using Poisson kriging and Hot Spot analyses	PLOS ONE			English	Article							RATES	Introduction Our study looked at out-of-hospital sudden cardiac arrest events in the City of Toronto. These are relatively rare events, yet present a serious global clinical and public health problem. We report on the application of spatial methods and tools that, although relatively well known to geographers and natural resource scientists, need to become better known and used more frequently by health care researchers. Materials and methods Our data came from the population-based Rescu Epistry cardiac arrest database. We limited it to the residents of the City of Toronto who experienced sudden arrest in 2010. The data was aggregated at the Dissemination Area level, and population rates were calculated. Poisson kriging was carried out on one year of data using three different spatial weights. Kriging estimates were then compared in Hot Spot analyses. Results Spatial analysis revealed that Poisson kriging can yield reliable rates using limited data of high quality. We observed the highest rates of sudden arrests in the north and central parts of Etobicoke, western parts of North York as well as the central and southwestern parts of Scarborough while the lowest rates were found in north and eastern parts of Scarborough, downtown Toronto, and East York as well as east central parts of North York. Influence of spatial neighbours on the results did not extend past two rings of adjacent units. Conclusions Poisson kriging has the potential to be applied to a wide range of healthcare research, particularly on rare events. This approach can be successfully combined with other spatial methods. More applied research, is needed to establish a wider acceptance for this method, especially among healthcare researchers and epidemiologists.				ray.prb@gmail.com	; Bunch, Martin/A-7025-2013	Przybysz, Raymond/0000-0001-9976-2408; Bunch, Martin/0000-0001-6940-372X				Allan KS, 2011, CIRCULATION, V124; [Anonymous], INT J MED MED SCI; Asmarian NS, 2013, ASIAN PAC J CANCER P, V14, P11, DOI 10.7314/APJCP.2013.14.1.11; Asmarian Naeimehossadat, 2016, Asian Pac J Cancer Prev, V17, P4587; Auchincloss AH, 2012, ANNU REV PUBL HEALTH, V33, P107, DOI 10.1146/annurev-publhealth-031811-124655; BioMedware, 2011, SPACESTAT SOFTW AN E; DMTI, 2010, GEOPINPOINT SUIT WIN; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; ESRI, 2010, DATA CLASSIFICATION; ESRI, 2012, HOT SPOT AN GET ORD; ESRI. ArcGIS Resources, 2012, ARCGIS RES ARCGIS HE; Geographic Research Inc, 2012, SIMPLYMAP; Goovaerts P, 2008, ENVIRON ECOL STAT, V15, P421, DOI 10.1007/s10651-007-0064-6; Goovaerts Pierre, 2005, Int J Health Geogr, V4, P31, DOI 10.1186/1476-072X-4-31; Goovaerts Pierre, 2006, Int J Health Geogr, V5, P7, DOI 10.1186/1476-072X-5-7; Goovaerts P, 2009, SPAT SPATIO-TEMPORAL, V1, P61, DOI 10.1016/j.sste.2009.07.001; Goovaerts P, 2010, GEOGR ANAL, V42, P32, DOI 10.1111/j.1538-4632.2009.00781.x; Goovaerts P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-6; Hampton KH, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-54; Heart and Stroke Foundation of Canada, 2015, CARD ARR 2015; Kyriakidis PC, 2004, GEOGR ANAL, V36, P259, DOI 10.1111/j.1538-4632.2004.tb01135.x; Monestiez P, 2005, QUANT GEO G, V14, P777; Morrison LJ, 2008, RESUSCITATION, V78, P161, DOI 10.1016/j.resuscitation.2008.02.020; Mozaffarian D., 2015, CIRCULATION; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Reinier K, 2011, CAN MED ASSOC J, V183, P1705, DOI 10.1503/cmaj.101512; Samal A, 2008, KRIGING PINCOCK PERS; Weisfeldt ML, 2011, NEW ENGL J MED, V364, P313, DOI 10.1056/NEJMoa1010663	29	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180721	10.1371/journal.pone.0180721	http://dx.doi.org/10.1371/journal.pone.0180721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672029	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500082
J	Tang, P; Zhang, Q; Yao, XH				Tang, Ping; Zhang, Qiong; Yao, Xiaohong			Comparative transcript profiling explores differentially expressed genes associated with sexual phenotype in kiwifruit	PLOS ONE			English	Article							CHROMOSOME EVOLUTION; ACTINIDIA-CHINENSIS; MALE-STERILITY; CUCUMBER; BIOSYNTHESIS; GENOME; MAIZE; FEMALENESS; GENETICS; FLOWERS	Background Kiwifruit is a perennial, deciduous and functionally dioecious plant. However, very little is known about the whole-genome molecular mechanisms contributing to distinct sexual phenotypes. To gain a global view of genes differentially expressed between male and female flowers, we analyzed genome-wide gene expression profiles in the flowers of male and female plants using high-throughput RNA sequencing. Results A total of 53.5 million reads were generated. Based on the alignments of unigenes to kiwifruit genome predicted genes, a total of 39,040 unique genes with a mean length of 970 bp were identified. There were 2,503 UniGenes differentially expressed between female and male flowers, with 1,793 up-regulated and 710 down-regulated in the female flowers. Moreover, the gene expression pattern of 17 out of 19 unigenes differentially expressed between male and female flowers revealed by RNA-Seq was confirmed by real-time quantitative PCR (qRT-PCR). Conclusions Here, we obtained a large number of EST sequences from female and male flowers of kiwifruit. This comparative transcriptome analysis provides an invaluable resource for gene expression, genomics, and functional genomic studies in A. chinensis and its related species. This study also represents a first step toward the investigation of genes involved in kiwifruit sex determination.	[Tang, Ping; Zhang, Qiong; Yao, Xiaohong] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Yao, XH (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Hubei, Peoples R China.	yaox@wbgcas.cn			Backbone Talent Program of Wuhan Botanical Garden; Chinese Academy of Sciences [Y655291A04]	Backbone Talent Program of Wuhan Botanical Garden; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Backbone Talent Program of Wuhan Botanical Garden, the Chinese Academy of Sciences (Y655291A04). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth C.C., 1999, SEX DETERMINATION PL, P173; Bagni N, 1999, FERTILIZATION HIGHER, P1; Belrose Inc., 2015, WORLD KIW REV 2015; Bergero R, 2011, CURR BIOL, V21, P1470, DOI 10.1016/j.cub.2011.07.032; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BRUNDELL D J, 1975, New Zealand Journal of Botany, V13, P485; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; Falasca G, 2010, BIOCHEMIST, V48, P565; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Ferguson A. R., 2007, Horticultural Reviews, V33, P1, DOI 10.1002/9780470168011.ch1; Fraser LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-102; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; HARBERD NP, 1989, GENETICS, V121, P827; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Harvey CF, 1997, ACTA HORTIC, P85, DOI 10.17660/ActaHortic.1997.444.10; Huang HW., 2014, GENUS ACTINIDIA WORL; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li JQ, 2007, FLORA CHINA, V12, P334, DOI DOI 10.3233/BME-141227; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; MARTINTANGUY J, 1996, FLOWER NEWSLETT, V21, P10; Messina R., 1993, Advances in Horticultural Science, V7, P77; Mibus H, 2004, THEOR APPL GENET, V109, P1669, DOI 10.1007/s00122-004-1793-7; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Papadopoulou E, 2005, HORTSCIENCE, V40, P1763, DOI 10.21273/HORTSCI.40.6.1763; Rhee SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2186-9; TAKAHASHI H, 1984, PHYTON-INT J EXP BOT, V44, P81; Tang W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00335; Tennessen JA, 2013, G3-GENES GENOM GENET, V3, P1341, DOI 10.1534/g3.113.006288; TESTOLIN R, 1995, SEX PLANT REPROD, V8, P129, DOI 10.1007/BF00242255; VANDERMEER IM, 1992, PLANT CELL, V4, P253, DOI 10.1105/tpc.4.3.253; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; WINKLER RG, 1995, PLANT CELL, V7, P1307, DOI 10.1105/tpc.7.8.1307; Zhang JS, 2014, CURR OPIN PLANT BIOL, V18, P110, DOI 10.1016/j.pbi.2014.02.012; Zhang Q, 2015, DNA RES, V22, P367, DOI 10.1093/dnares/dsv019	43	11	12	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180542	10.1371/journal.pone.0180542	http://dx.doi.org/10.1371/journal.pone.0180542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672040	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500062
J	Tulaimat, A; Trick, WE				Tulaimat, Aiman; Trick, William E.			DiapHRaGM: A mnemonic to describe the work of breathing in patients with respiratory failure	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MECHANICAL VENTILATION; MUSCLE-ACTIVITY; NONINVASIVE VENTILATION; RIB CAGE; DISTRESS; MORTALITY; ASTHMA; TRIAL; RELIABILITY	Background The assessment of the work of breathing in the definitions of respiratory failure is vague and variable. Objective Identify a parsimonious set of signs to describe the work of breathing in hypoxemic, acutely ill patients. Methods We examined consecutive medical ICU patients receiving oxygen with a mask, non-invasive ventilation, or T-piece. A physician inspected each patient for 10 seconds, rated the level of respiratory distress, and then examined the patient for vital signs and 17 other physical signs. We used the rating of distress as a surrogate for measuring the work of breathing, constructed three multivariate models to identify the one with the smallest number of signs and largest explained variance, and validated it with bootstrap analysis. Results We performed 402 observations on 240 patients. Respiratory distress was absent in 78, mild in 157, moderate in 107, and severe in 60. Respiratory rate, hypoxia, heart rate, and frequency of most signs increased as distress increased. Respiratory rate and hypoxia explained 43% of the variance in respiratory distress. Diaphoresis, gasping, and contraction of the sternomastoid explained an additional 28%. Heart rate, blood pressure, alertness, agitation, body posture, nasal flaring, audible breathing, cyanosis, tracheal tug, retractions, paradox, scalene or abdominal muscles contraction did not increase the explained variance in respiratory distress. Conclusion Most of the variance is respiratory distress can be explained by five signs summarized by the mnemonic DiapHRaGM (diaphoresis, hypoxia, respiratory rate, gasping, accessory muscle). This set of signs may allow for efficient, standardized assessments of the work of breathing of hypoxic patients.	[Tulaimat, Aiman] Cook Cty Hlth & Hosp Syst, Div Pulm Crit Care & Sleep Med, Chicago, IL 60612 USA; [Trick, William E.] Cook Cty Hlth & Hosp Syst, Collaborat Res Unit, Dept Med, Chicago, IL USA	John H Stroger Junior Hospital Cook County; John H Stroger Junior Hospital Cook County	Tulaimat, A (corresponding author), Cook Cty Hlth & Hosp Syst, Div Pulm Crit Care & Sleep Med, Chicago, IL 60612 USA.	atulaimat@cookcountyhhs.org		Tulaimat, Aiman/0000-0001-8085-9402; Trick, William/0000-0002-3243-5098	Department of Medicine at Cook County Health and Hospitals System	Department of Medicine at Cook County Health and Hospitals System	This study was funded by the Department of Medicine at Cook County Health and Hospitals System. The funds were used for salaries of research assistants.	Anderson CL, 1980, RESPIR CARE, V25, P937; [Anonymous], 2012, JAMA, P307; BRENNER BE, 1983, AM J MED, V74, P1005, DOI 10.1016/0002-9343(83)90802-1; BULLARD RW, 1964, J APPL PHYSIOL, V19, P137, DOI 10.1152/jappl.1964.19.1.137; Campbell ML, 2008, J PALLIAT MED, V11, P44, DOI 10.1089/jpm.2007.0090; Campbell ML, 2016, HEART LUNG J ACUTE C; CHADHA TS, 1987, CHEST, V92, P1037, DOI 10.1378/chest.92.6.1037; Churpek MM, 2016, CRIT CARE MED, V44, P368, DOI 10.1097/CCM.0000000000001571; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DETROYER A, 1994, AM J RESP CRIT CARE, V150, P41, DOI 10.1164/ajrccm.150.1.8025770; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Espana PP, 2006, AM J RESP CRIT CARE, V174, P1249, DOI 10.1164/rccm.200602-177OC; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; Estenne M, 1998, AM J RESP CRIT CARE, V158, P452, DOI 10.1164/ajrccm.158.2.9710116; Frat J-P, 2015, NEW ENGL J MED; Frazier SK, 2006, AM J CRIT CARE, V15, P580; Fuchs C., 2009, BUSINESS ADM REV, V69, P195, DOI DOI 10.2139/SSRN.2318105; GILSTON A, 1976, ANAESTHESIA, V31, P385, DOI 10.1111/j.1365-2044.1976.tb12332.x; GORINI M, 1988, EUR RESPIR J, V1, P691; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Jaber S, 2016, JAMA-J AM MED ASSOC, V315, P1345, DOI 10.1001/jama.2016.2706; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lemiale V, 2015, JAMA-J AM MED ASSOC, V314, P1711, DOI 10.1001/jama.2015.12402; McConville JF, 2012, NEW ENGL J MED, V367, P2233, DOI 10.1056/NEJMra1203367; MCFADDEN ER, 1973, NEW ENGL J MED, V288, P221, DOI 10.1056/NEJM197302012880501; MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103, DOI 10.1080/0022250X.1975.9989847; Mekjavic IB, 2006, J APPL PHYSIOL, V100, P2065, DOI 10.1152/japplphysiol.01118.2005; PARDEE NE, 1984, CHEST, V85, P203, DOI 10.1378/chest.85.2.203; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Parthasarathy S, 2007, J APPL PHYSIOL, V103, P140, DOI 10.1152/japplphysiol.00904.2006; Patrick W, 1996, AM J RESP CRIT CARE, V153, P1005, DOI 10.1164/ajrccm.153.3.8630538; Peche R, 1996, AM J RESP CRIT CARE, V153, P422, DOI 10.1164/ajrccm.153.1.8542153; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rice TW, 2007, CHEST, V132, P410, DOI 10.1378/chest.07-0617; Riegel B, 2010, AM HEART J, V159, P392, DOI 10.1016/j.ahj.2010.01.003; Stefan MS, 2016, J HOSP MED; Storli SL, 2015, AM J RESP CRIT CARE; TEUSCHER A, 1987, LANCET, V2, P382; Thille AW, 2016, AM J RESP CRIT CARE, V193, P1438, DOI 10.1164/rccm.201601-0187LE; Thys F, 2002, EUR RESPIR J, V20, P545, DOI 10.1183/09031936.02.00287402; Tobin MJ, 2012, COMPR PHYSIOL, V2, P2871, DOI 10.1002/cphy.c110030; TOBIN MJ, 1987, J APPL PHYSIOL, V63, P851, DOI 10.1152/jappl.1987.63.2.851; Tobin MJ., 2013, PRINCIPLES PRACTICE; Tulaimat A, 2016, J CRIT CARE, V34, P111, DOI 10.1016/j.jcrc.2016.04.013; Tulaimat A, 2014, RESP CARE, V59, P1338, DOI 10.4187/respcare.02650; Tulaimat A, 2012, RESP CARE, V57, P404, DOI 10.4187/respcare.01112; Williams AJ, 1998, BRIT MED J, V317, P1213, DOI 10.1136/bmj.317.7167.1213; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101	48	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179641	10.1371/journal.pone.0179641	http://dx.doi.org/10.1371/journal.pone.0179641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671972	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500003
J	Vidal-Bralo, L; Perez-Pampin, E; Regueiro, C; Montes, A; Varela, R; Boveda, MD; Gomez-Reino, JJ; Gonzalez, A				Vidal-Bralo, Laura; Perez-Pampin, Eva; Regueiro, Cristina; Montes, Ariana; Varela, Rosana; Dolores Boveda, Maria; Gomez-Reino, Juan J.; Gonzalez, Antonio			Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; AUTOIMMUNE-DISEASES; EXCESS MORTALITY; CARP ANTIBODIES; HEART-DISEASE; COHORTS; DEATH; RISK; SMOKING; PREDICT	Patients with rheumatoid arthritis (RA) have an increased mortality rate that is associated with the presence of RA-specific autoantibodies in many studies. However, the relative role of rheumatoid factor (RF), anti-CCP antibodies and the most recently established RA-auto-antibodies, directed against carbamylated proteins (anti-CarP antibodies), is unclear. Here, we have assessed the role of these three antibodies in 331 patients with established RA recruited from 2001 to 2009 and followed until November 2015. During this time, 124 patients died (37.5%). This death rate corresponds to a mortality rate 1.53 (95% CI 1.26 to 1.80) folds the observed in the reference population. We used for analysis of all-cause mortality the Cox proportional hazard regression model with adjustment for age, sex and smoking. It showed a trend for association with increased mortality of each of the three RA autoantibodies in antibody-specific analysis (hazards ratio (HR) from 1.37 to 1.79), but only the HR of the anti-CarP antibodies was significant (HR = 1.79, 95% CI 1.23 to 2.61, p = 0.002). In addition, the multivariate analysis that included all autoantibodies showed a marked decrease in the HR of RF and of anti-CCP antibodies, whereas the HR of anti-CarP remained significant. This increase was specific of respiratory system causes of death (HR = 3.19, 95% CI 1.52 to 6.69, p = 0.002). Therefore, our results suggest a specific relation of anti-CarP antibodies with the increased mortality in RA, and drive attention to their possible connection with respiratory diseases.	[Vidal-Bralo, Laura; Perez-Pampin, Eva; Regueiro, Cristina; Montes, Ariana; Varela, Rosana; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Lab Invest 10, Inst Invest Sanitaria, Santiago De Compostela, Spain; [Vidal-Bralo, Laura; Perez-Pampin, Eva; Regueiro, Cristina; Montes, Ariana; Varela, Rosana; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Rheumatol Unit, Inst Invest Sanitaria, Santiago De Compostela, Spain; [Dolores Boveda, Maria] Hosp Clin Univ Santiago, Unit Diag & Treatment Congenital Metab Dis, Inst Invest Sanitaria, Dept Pediat, Santiago De Compostela, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Gonzalez, A (corresponding author), Hosp Clin Univ Santiago, Lab Invest 10, Inst Invest Sanitaria, Santiago De Compostela, Spain.; Gonzalez, A (corresponding author), Hosp Clin Univ Santiago, Rheumatol Unit, Inst Invest Sanitaria, Santiago De Compostela, Spain.	agmartinezp@ser.es	Gonzalez, Antonio/C-4444-2008; Expósito, Cristina Regueiro/AAC-1405-2021; Gomez-Reino, Juan/ABI-2853-2020; Perez-Pampin, Eva/ABF-7200-2020	Gonzalez, Antonio/0000-0002-2624-0606; Regueiro, Cristina/0000-0002-8567-6784; Perez-Pampin, Eva/0000-0003-0319-4456; Gomez-Reino, Juan/0000-0001-5229-6294	Instituto de Salud Carlos III (Spain) [PI14/01651, PI12/01909, RD12/0009/0008]; European Regional Development Fund of the EU (FEDER)	Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); European Regional Development Fund of the EU (FEDER)	Funding was provided by the Instituto de Salud Carlos III (Spain) through grants PI14/01651 to AG, and PI12/01909 and RD12/0009/0008 to JJG-R. These grants are partially financed by the European Regional Development Fund of the EU (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajeganova S, 2016, ANN RHEUM DIS, V75, P1924, DOI 10.1136/annrheumdis-2015-208579; Aletaha D, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2014-000009; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berg AH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005218; Castelar-Pinheiro GD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00320; Catrina AI, 2014, NAT REV RHEUMATOL, V10, P645, DOI 10.1038/nrrheum.2014.115; Demoruelle MK, 2012, ARTHRITIS RHEUM-US, V64, P1756, DOI 10.1002/art.34344; Drechsler C, 2015, KIDNEY INT, V87, P1201, DOI 10.1038/ki.2014.429; England BR, 2016, ARTHRIT CARE RES, V68, P36, DOI 10.1002/acr.22642; Fisher BA, 2014, ANN RHEUM DIS, V73, P741, DOI 10.1136/annrheumdis-2012-202535; Furst DE, 2010, SEMIN ARTHRITIS RHEU, V39, P327, DOI 10.1016/j.semarthrit.2008.10.002; Gonzalez A, 2008, J RHEUMATOL, V35, P1009; Hecht C, 2015, ANN RHEUM DIS, V74, P2151, DOI 10.1136/annrheumdis-2014-205428; Humphreys JH, 2016, ANN RHEUM DIS, V75, P1139, DOI 10.1136/annrheumdis-2015-207326; Lopez-Longo FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P419, DOI 10.1002/art.24390; Jiang X, 2014, ANN RHEUM DIS, V73, P1761, DOI 10.1136/annrheumdis-2013-205109; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Kuller LH, 2014, ARTHRITIS RHEUMATOL, V66, P497, DOI 10.1002/art.38268; Liang KP, 2009, J RHEUMATOL, V36, P2462, DOI 10.3899/jrheum.090188; Listing J, 2015, ANN RHEUM DIS, V74, P415, DOI 10.1136/annrheumdis-2013-204021; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Mikuls TR, 2011, RHEUMATOLOGY, V50, P101, DOI 10.1093/rheumatology/keq232; Montes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161141; Montes A, 2015, ARTHRITIS RHEUMATOL, V67, P2861, DOI 10.1002/art.39302; Montes A, 2012, ARTHRITIS RHEUM-US, V64, P3102, DOI 10.1002/art.34569; Montes A, 2011, ARTHRITIS RHEUM-US, V63, P654, DOI 10.1002/art.30186; Myasoedova Elena, 2010, Curr Rheumatol Rep, V12, P379, DOI 10.1007/s11926-010-0117-y; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Radovits BJ, 2010, ARTHRIT CARE RES, V62, P362, DOI 10.1002/acr.20105; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Reynisdottir G, 2016, ANN RHEUM DIS, V75, P1722, DOI 10.1136/annrheumdis-2015-208216; Reynisdottir G, 2014, ARTHRITIS RHEUMATOL, V66, P31, DOI 10.1002/art.38201; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Shi J, 2013, ARTHRITIS RHEUM-US, V65, P911, DOI 10.1002/art.37830; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Sihvonen S, 2005, J RHEUMATOL, V32, P2089; Singh JA, 2015, LANCET, V386, P258, DOI 10.1016/S0140-6736(14)61704-9; Skopelja S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88912; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sokolove J, 2013, ARTHRITIS RHEUM-US, V65, P1719, DOI 10.1002/art.37961; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Sparks JA, 2016, ARTHRIT CARE RES, V68, P753, DOI 10.1002/acr.22752; Thomas SL, 2010, AM J PUBLIC HEALTH, V100, P2279, DOI 10.2105/AJPH.2009.180273; Tomasson G, 2010, ANN RHEUM DIS, V69, P1649, DOI 10.1136/ard.2009.110536; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463; Widdifield J, 2015, ARTHRIT CARE RES, V67, P1047, DOI 10.1002/acr.22553; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408	51	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180144	10.1371/journal.pone.0180144	http://dx.doi.org/10.1371/journal.pone.0180144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672020	gold, Green Submitted, Green Published			2022-12-27	WOS:000405268500017
J	Yvorel, V; Patoir, A; Casteillo, F; Tissot, C; Fournel, P; Stachowicz, ML; Karpathiou, G; Tiffet, O; Peoc'h, M; Forest, F				Yvorel, Violaine; Patoir, Arnaud; Casteillo, Francois; Tissot, Claire; Fournel, Pierre; Stachowicz, Marie-Laure; Karpathiou, Georgia; Tiffet, Olivier; Peoc'h, Michel; Forest, Fabien			PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis	PLOS ONE			English	Article							DEATH LIGAND-1 PD-L1; SHOW HIGH-LEVELS; CANCER	Lung sarcomatoid carcinoma of the lung is a rare tumor with a poor prognosis. More than 90% of them are pleomorphic, spindle cell and giant cell carcinoma (PSCGCC). This rare subtype of lung cancer is thought to be more resistant to chemotherapy, and a small subset of them seems to exhibit targetable mutations. Immunotherapy against PD1/PDL-1 is a new emerging treatment, and might be of interest in PSGSCC because they frequently express PD-L1. The aim of our work is to evaluate PD1 and PDL-1 expression in a surgical series of lung PSCGCC and their relationship with morphological and immunohistochemical parameters and prognosis. Thirty-six patients who underwent surgical resection of a PSGSCC were included. PD-L1 (E1L3N) expression on tumor cells and PD1 (NAT105) expression by tumor infiltrating lymphocytes (TILs) were performed by immunohistochemistry. Results were compared to immunohistochemistry tests of TTF1, Napsin A, p40 and to molecular study of EGFR, KRAS, BRAF and HER2. Seventy-five % of PSCGCC were considered as positive for PD-L1. PD-L1 expression in PSGSCC is associated with TTF-1 and/or Napsin A expression (47.2%, p = 0.039). Few p40 positive PSCGCC expressed PD-L1 (8.3%, p = 0.013). PD1 expression was not related to TTF-1 and/or Napsin A expression (p = 0.47), p40 expression (p = 0.68) or survival (p = 0.14). PD-L1 or PD1 expression were not related to the age, gender, pT, pN, stage, visceral pleura invasion, histopathological subtype, the presence of giant cell component, the predominance of sarcomatoid component, and the presence of EGFR or BRAF or HER2 or PIK3CA mutation (p> 0.05). PD-L1 expression was correlated with a worse overall survival in PSCGCC (p = 0.045). PD-L1 expression is frequent in PSCGCC and might be associated with the expression of adenocarcinoma markers (TTF-1, Napsin A) or the lack of expression of squamous cell carcinoma marker (p40).	[Yvorel, Violaine; Casteillo, Francois; Stachowicz, Marie-Laure; Karpathiou, Georgia; Peoc'h, Michel; Forest, Fabien] Univ Hosp St Etienne, North Hosp, Dept Pathol, St Etienne, France; [Patoir, Arnaud; Tiffet, Olivier] Univ Hosp St Etienne, North Hosp, Dept Thorac Surg, St Etienne, France; [Tissot, Claire] Univ Hosp St Etienne, North Hosp, Dept Pneumol, St Etienne, France; [Fournel, Pierre] Lucien Neuwirth Canc Inst, Dept Oncol, St Priest En Jarez, France	CHU de St Etienne; CHU de St Etienne; CHU de St Etienne; Institut de Cancerologie de la Loire	Forest, F (corresponding author), Univ Hosp St Etienne, North Hosp, Dept Pathol, St Etienne, France.	fabien.forest@chu-st-etienne.fr	Forest, Fabien/O-7054-2019; Karpathiou, Georgia/J-5312-2019	Forest, Fabien/0000-0001-7582-3923; Karpathiou, Georgia/0000-0003-0864-935X; Peoc'h, michel/0000-0001-5453-0021	Comite Loire de ia Ligue Contrele Cancer [AL-250/16]	Comite Loire de ia Ligue Contrele Cancer	This work was supported by the Comite Loire de ia Ligue Contrele Cancer (https://www.ligue-cancer.net/cd42/journal; Grant AL-250/16) to FF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Botti G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071046; Chang YL, 2016, EUR J CANCER, V60, P125, DOI 10.1016/j.ejca.2016.03.012; Forest F, 2016, HUM PATHOL, V49, P99, DOI 10.1016/j.humpath.2015.10.006; Gniadek TJ, 2017, MODERN PATHOL, V30, P530, DOI 10.1038/modpathol.2016.213; Gounant V, 2016, LUNG CANCER, V99, P162, DOI 10.1016/j.lungcan.2016.07.010; Guo Q, 2016, THORAC CANC; Hirsch F.R.M.A., 2016, J THORAC ONCOL; Huynh TG, 2016, J THORAC ONCOL, V11, P1869, DOI 10.1016/j.jtho.2016.08.134; Ilie M, 2016, ANN ONCOL, V27, P147, DOI 10.1093/annonc/mdv489; Kim MY, 2015, LUNG CANCER, V88, P24, DOI 10.1016/j.lungcan.2015.01.016; Kim SH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/904142; Pelosi G, 2016, EXPERT REV RESP MED, V10, P1105, DOI 10.1080/17476348.2017.1235975; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Schmidt LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136023; Schrock AB, 2016, J THORAC ONCOL, V11, P1493, DOI 10.1016/j.jtho.2016.06.004; Sun JM, 2016, J THORAC ONCOL, V11, P1003, DOI 10.1016/j.jtho.2016.04.007; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Velcheti V, 2013, J THORAC ONCOL, V8, P803, DOI 10.1097/JTO.0b013e318292be18; Vieira T, 2016, LUNG CANCER, V98, P51, DOI 10.1016/j.lungcan.2016.05.013	20	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180346	10.1371/journal.pone.0180346	http://dx.doi.org/10.1371/journal.pone.0180346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671973	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500044
J	Zhang, J; Jia, CR; Wu, Y; Xia, XF; Xi, BD; Wang, LJ; Zhai, YL				Zhang, Jun; Jia, Chunrong; Wu, Yi; Xia, Xunfeng; Xi, Beidou; Wang, Lijun; Zhai, Youlong			Life cycle energy efficiency and environmental impact assessment of bioethanol production from sweet potato based on different production modes	PLOS ONE			English	Article							FUEL ETHANOL; GHG EMISSIONS; CHINA; BALANCE; SYSTEM; PLANT	The bioethanol is playing an increasingly important role in renewable energy in China. Based on the theory of circular economy, integration of different resources by polygeneration is one of the solutions to improve energy efficiency and to reduce environmental impact. In this study, three modes of bioethanol production were selected to evaluate the life cycle energy efficiency and environmental impact of sweet potato-based bioethanol. The results showed that, the net energy ratio was greater than 1 and the value of net energy gain was positive in the three production modes, in which the maximum value appeared in the circular economy mode (CEM). The environment emission mainly occurred to bioethanol conversion unit in the conventional production mode (CPM) and the cogeneration mode (CGM), and eutrophication potential (EP) and global warming potential (GWP) were the most significant environmental impact category. While compared with CPM and CGM, the environmental impact of CEM significantly declined due to increasing recycling, and plant cultivation unit mainly contributed to EP and GWP. And the comprehensive evaluation score of environmental impact decreased by 73.46% and 23.36%. This study showed that CEM was effective in improving energy efficiency, especially in reducing the environmental impact, and it provides a new method for bioethanol production.	[Zhang, Jun; Jia, Chunrong; Zhai, Youlong] China West Normal Univ, Coll Land & Resources, Nanchong, Sichuan, Peoples R China; [Wu, Yi] Gui Zhou Acad Environm Sci & Designing, Guiyang, Guizhou, Peoples R China; [Xia, Xunfeng; Xi, Beidou; Wang, Lijun] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Xi, Beidou] Lanzhou Jiaotong Univ, Coll Environm & Municipal Engn, Lanzhou, Gansu, Peoples R China	China West Normal University; Chinese Research Academy of Environmental Sciences; Lanzhou Jiaotong University	Xia, XF (corresponding author), Chinese Res Inst Environm Sci, Beijing, Peoples R China.	Xiaxunfengg@sina.com			National Technology R D Program [2014BAL02B02]; National Water Pollution Control and Treatment Science and Technology Major Project [2015ZX07103-007]	National Technology R D Program; National Water Pollution Control and Treatment Science and Technology Major Project	This work was supported by National Technology R& D Program (2014BAL02B02); National Water Pollution Control and Treatment Science and Technology Major Project (2015ZX07103-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Chen S, 2012, RESOUR ENV, V22, P76; Dai D, 2006, ENERG CONVERS MANAGE, V47, P1686, DOI 10.1016/j.enconman.2005.10.019; Dong XB, 2008, ENERG POLICY, V36, P3882, DOI 10.1016/j.enpol.2008.04.027; Guo Z, 2011, DEV MODEL BASED INTR, P1553; Jury C, 2010, BIOMASS BIOENERG, V34, P54, DOI 10.1016/j.biombioe.2009.09.011; Laude A, 2011, INT J GREENH GAS CON, V5, P1220, DOI 10.1016/j.ijggc.2011.06.004; Leng R, 2008, J CLEAN PROD, V16, P374, DOI 10.1016/j.jclepro.2006.12.003; Li XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095455; Liu BB, 2013, ENERG POLICY, V56, P210, DOI 10.1016/j.enpol.2012.12.052; Luo L, 2009, RENEW SUST ENERG REV, V13, P1613, DOI 10.1016/j.rser.2008.09.024; Ma L, 2012, SCI TOTAL ENVIRON, V434, P51, DOI 10.1016/j.scitotenv.2012.03.028; Nguyen TLT, 2007, ENERG POLICY, V35, P4585, DOI 10.1016/j.enpol.2007.03.012; Papong S, 2010, BIORESOURCE TECHNOL, V101, pS112, DOI 10.1016/j.biortech.2009.09.006; Rasanen K, 2015, J CLEAN PROD, V89, P65, DOI 10.1016/j.jclepro.2014.11.008; Saga K, 2010, APPL ENERG, V87, P2164, DOI 10.1016/j.apenergy.2009.12.014; Sleeswijk AW, 2000, SCI TOTAL ENVIRON, V390, P227, DOI DOI 10.1016/J.SCIT0TENV.2007.09.040; Wang JY, 2011, ATMOS ENVIRON, V45, P6923, DOI 10.1016/j.atmosenv.2011.09.045; Wang MX, 2014, BIORESOURCE TECHNOL, V163, P74, DOI 10.1016/j.biortech.2014.04.014; Wang MX, 2013, BIORESOURCE TECHNOL, V133, P285, DOI 10.1016/j.biortech.2013.01.067; [王明新 WANG Mingxin], 2006, [农业环境科学学报, Journal of Agro-environment science], V25, P1127; Xia XunFeng, 2012, Research of Environmental Sciences, V25, P1187; [夏训峰 XIA Xunfeng], 2008, [环境科学与技术, Enuivonmental Science and Technology], V31, P154; Yang H, 2011, BIOMASS BIOENERG, V35, P581, DOI 10.1016/j.biombioe.2010.10.027; Zhang Jun, 2010, Research of Environmental Sciences, V23, P248; Zhang L, 2016, J CLEAN PROD, V113, P565, DOI 10.1016/j.jclepro.2015.11.053; Zhang YS, 2011, J ENVIRON MANAGE, V92, P480, DOI 10.1016/j.jenvman.2010.09.018; Zhou W, 2012, APPL ENERG, V95, P305, DOI 10.1016/j.apenergy.2012.02.014; 杨凌波, 2008, [给水排水, Water & Wastewater Engineering], V34, P42	28	5	5	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180685	10.1371/journal.pone.0180685	http://dx.doi.org/10.1371/journal.pone.0180685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672044	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500079
J	Mothes, H; Leukel, C; Seelig, H; Fuchs, R				Mothes, Hendrik; Leukel, Christian; Seelig, Harald; Fuchs, Reinhard			Do placebo expectations influence perceived exertion during physical exercise?	PLOS ONE			English	Article							COMPRESSION GARMENTS; PERFORMANCE; INTENSITY; MOOD; DISPLEASURE; EXPECTANCY; CONSUMERS; PLEASURE; RATINGS	This study investigates the role of placebo expectations in individuals' perception of exertion during acute physical exercise. Building upon findings from placebo and marketing research, we examined how perceived exertion is affected by expectations regarding a) the effects of exercise and b) the effects of the exercise product worn during the exercise. We also investigated whether these effects are moderated by physical self-concept. Seventy-eight participants conducted a moderate 30 min cycling exercise on an ergometer, with perceived exertion (RPE) measured every 5 minutes. Beforehand, each participant was randomly assigned to 1 of 4 conditions and watched a corresponding film clip presenting "scientific evidence" that the exercise would or would not result in health benefits and that the exercise product they were wearing (compression garment) would additionally enhance exercise benefits or would only be worn for control purposes. Participants' physical self-concept was assessed via questionnaire. Results partially demonstrated that participants with more positive expectations experienced reduced perceived exertion during the exercise. Furthermore, our results indicate a moderator effect of physical self-concept: Individuals with a high physical self-concept benefited (in terms of reduced perceived exertion levels) in particular from an induction of generally positive expectations. In contrast, individuals with a low physical self-concept benefited when positive expectations were related to the exercise product they were wearing. In sum, these results suggest that placebo expectations may be a further, previously neglected class of psychological factors that influence the perception of exertion.	[Mothes, Hendrik; Leukel, Christian; Fuchs, Reinhard] Univ Freiburg, Dept Sports Sci, Schwarzwaldstr 175, Freiburg, Germany; [Leukel, Christian] Univ Freiburg, Bernstein Ctr Freiburg, Hansastr 9a, Freiburg, Germany; [Seelig, Harald] Univ Basel, Dept Sport Exercise & Hlth, Birsstr 320 B, Basel, Switzerland	University of Freiburg; University of Freiburg; University of Basel	Mothes, H (corresponding author), Univ Freiburg, Dept Sports Sci, Schwarzwaldstr 175, Freiburg, Germany.	hendrik.mothes@sport.uni-freiburg.de	Seelig, Harald/AAH-6584-2020	Seelig, Harald/0000-0002-2178-4807; Mothes, Hendrik/0000-0003-1784-6398	Konrad Adenauer Foundation; German Research Foundation (DFG); University of Freiburg	Konrad Adenauer Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This research was supported by a grant to H. Mothes from the Konrad Adenauer Foundation (www.kas.de). The article processing charge was funded by the German Research Foundation (DFG) (www.dtg.de) and the University of Freiburg (www.uni-freiburg.de) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden DA, 2004, J SPORT EXERCISE PSY, V26, P215, DOI 10.1123/jsep.26.2.215; Beliard S, 2015, J SPORT SCI MED, V14, P75; BORG G, 1978, ERGONOMICS, V21, P215, DOI 10.1080/00140137808931715; Borg G., 1962, PHYS PERFORMANCE PER; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; Bryan AD, 2011, PSYCHOL SPORT EXERC, V12, P20, DOI 10.1016/j.psychsport.2010.05.002; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colloca L, 2004, LANCET NEUROL, V3, P679, DOI 10.1016/S1474-4422(04)00908-1; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; de la Fuente-Fernandez R, 2012, EUR J NEUROL, V19, P1305, DOI 10.1111/j.1468-1331.2012.03719.x; Deusinger IM, 1998, FRANKFURTER KORPERKO; DUNBAR CC, 1992, MED SCI SPORT EXER, V24, P94; Ekkekakis P, 2006, INT J OBESITY, V30, P652, DOI 10.1038/sj.ijo.0803052; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Garvey AM, 2016, J CONSUM RES, V42, P931, DOI 10.1093/jcr/ucv094; Geers AL, 2006, J BEHAV MED, V29, P171, DOI 10.1007/s10865-005-9040-5; Geers AL, 2011, J BEHAV MED, V34, P208, DOI 10.1007/s10865-010-9301-9; Haile L., 2015, PERCEIVED EXERTION L; HAWLEY JA, 1992, EUR J APPL PHYSIOL, V65, P79, DOI 10.1007/BF01466278; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hutchinson JC, 2015, ANN BEHAV MED, V49, P199, DOI 10.1007/s12160-014-9647-2; Jaksic N, 2013, PSYCHIAT DANUB, V25, P17; Kamata, 2012, MEASUREMENT SPORT EX, P265, DOI [10.5040/9781492596332.ch-024, DOI 10.5040/9781492596332.CH-024]; Killen LG, 2013, EUR J APPL PHYSIOL, V113, P721, DOI 10.1007/s00421-012-2480-z; Kirsch I., 1999, EXPECTANCIES SHAPE E; Lane AM, 2011, APPL PSYCHOPHYS BIOF, V36, P181, DOI 10.1007/s10484-011-9156-z; Lindheimer JB, 2017, PSYCHOSOM MED, V79, P243, DOI 10.1097/PSY.0000000000000381; LUNDH LG, 1987, SCAND J PSYCHOL, V28, P128, DOI 10.1111/j.1467-9450.1987.tb00747.x; MacRae BA, 2011, SPORTS MED, V41, P815, DOI 10.2165/11591420-000000000-00000; Mishra H, 2011, PSYCHOL SCI, V22, P733, DOI 10.1177/0956797611407208; MORGAN WP, 1994, MED SCI SPORT EXER, V26, P1071, DOI 10.1249/00005768-199409000-00001; MORGAN WP, 1973, INT J CLIN EXP HYP, V21, P86, DOI 10.1080/00207147308409309; Mothes H., 2016, J BEHAV MED; Noble B., 1996, PERCEIVED EXERTION; O'Halloran PD, 2002, PSYCHOL REP, V90, P834, DOI 10.2466/PR0.90.3.834-840; Oken BS, 2008, J CLIN EXP NEUROPSYC, V30, P7, DOI 10.1080/13803390701775428; Robertson R J, 1997, Exerc Sport Sci Rev, V25, P407; Shiv B, 2005, J MARKETING RES, V42, P383, DOI 10.1509/jmkr.2005.42.4.383; Sigall H, 1998, Pers Soc Psychol Rev, V2, P218, DOI 10.1207/s15327957pspr0203_5; Simonoff J.S., 2003, ANAL CATEGORICAL DAT; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Sudeck G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00900; Travlos AK, 1996, PERCEPT MOTOR SKILL, V82, P419, DOI 10.2466/pms.1996.82.2.419; Vickers AJ, 2005, PSYCHOSOM MED, V67, P652, DOI 10.1097/01.psy.0000172624.52957.a8; Wasserman K, 2012, PRINCIPLES EXERCISE, V5th; Weimer K, 2015, LANCET PSYCHIAT, V2, P246, DOI 10.1016/S2215-0366(14)00092-3; Yeung RR, 1996, J PSYCHOSOM RES, V40, P123, DOI 10.1016/0022-3999(95)00554-4	52	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180434	10.1371/journal.pone.0180434	http://dx.doi.org/10.1371/journal.pone.0180434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662168	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300155
J	Guerrero-Mendiola, C; Garcia-Trejo, JJ; Encalada, R; Saavedra, E; Ramirez-Silva, L				Guerrero-Mendiola, Carlos; Garcia-Trejo, Jose J.; Encalada, Rusely; Saavedra, Emma; Ramirez-Silva, Leticia			The contribution of two isozymes to the pyruvate kinase activity of Vibrio cholerae: One K (+)- dependent constitutively active and another K (+)- independent with essential allosteric activation	PLOS ONE			English	Article							ESCHERICHIA-COLI; MAGNETIC-RESONANCE; REGULATORY PROPERTIES; KINETIC-PROPERTIES; BINDING-SITE; ENZYME; FRUCTOSE-1,6-BISPHOSPHATE; PHOSPHOENOLPYRUVATE; MECHANISM; TRANSITIONS	In a previous phylogenetic study of the family of pyruvate kinase EC (2.7.1.40), a cluster with Glu117 and another with Lys117 were found (numbered according to the rabbit muscle enzyme). The sequences with Glu117 have been found to be K (+)-dependent, whereas those with Lys117 were K (+)-independent. Interestingly, only.-proteobacteria exhibit sequences in both branches of the tree. In this context, it was explored whether these phylogenetically distinct pyruvate kinases were both expressed and contribute to the pyruvate kinase activity in Vibrio cholerae. The main findings of this work showed that the isozyme with Glu117 is an active K (+)-dependent enzyme. At the same substrate concentration, its Vmax in the absence of fructose 1,6 bisphosphate was 80% of that with its effector. This result is in accordance with the non-essential activation described by allosteric ligands for most pyruvate kinases. In contrast, the pyruvate kinase with Lys117 was a K (+)-independent enzyme displaying an allosteric activation by ribose 5-phosphate. At the same substrate concentration, its activity without the effector was 0.5% of the one obtained in the presence of ribose 5-phosphate, indicating that this sugar monophosphate is a strong activator of this enzyme. This absolute allosteric dependence is a novel feature of pyruvate kinase activity. Interestingly, in the K (+) independent enzyme, Mn (2+) may "mimic" the allosteric effect of Rib 5-P. Despite their different allosteric behavior, both isozymes display a rapid equilibrium random order kinetic mechanism. The intracellular concentrations of fructose 1,6-bisphosphate and ribose 5phosphate in Vibrio cholerae have been experimentally verified to be sufficient to induce maximal activation of both enzymes. In addition, Western blot analysis indicated that both enzymes were co-expressed. Therefore, it is concluded that VcIPK and VcIIPK contribute to the activity of pyruvate kinase in this Y-proteobacterium.	[Guerrero-Mendiola, Carlos; Ramirez-Silva, Leticia] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Ciudad De Mexico, Mexico; [Garcia-Trejo, Jose J.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Ciudad De Mexico, Mexico; [Encalada, Rusely; Saavedra, Emma] Inst Nacl Cardiol, Dept Bioquim, Ignacio Chavez, Ciudad De Mexic, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ramirez-Silva, L (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Ciudad De Mexico, Mexico.	lramirez@bq.unam.mx	Saavedra, Emma/ABB-8989-2020	Saavedra, Emma/0000-0001-8661-9813; Ramirez-Silva, Leticia/0000-0002-0488-6385; GUERRERO MENDIOLA, CARLOS/0000-0002-9427-4090	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico [IN214415, IN221216]; Consejo Nacional de Ciencia y Tecnologia [CB-2011-01-167622]; Consejo Nacional de Ciencia y Tecnologia Ph. D. fellowship [335890]	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia Ph. D. fellowship	This work was supported by Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico, Grant IN214415 (to L. Ramirez-Silva), Grant IN221216 (to J.J. Garcia-Trejo); Consejo Nacional de Ciencia y Tecnologia Grant CB-2011-01-167622 (to J.J. Garcia-Trejo); and Consejo Nacional de Ciencia y Tecnologia Ph. D. fellowship, number 335890 (C. Guerrero-Mendiola). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AINSWORTH S, 1973, BIOCHEM J, V131, P223, DOI 10.1042/bj1310223; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BLAIR JB, 1984, ARCH BIOCHEM BIOPHYS, V232, P202, DOI 10.1016/0003-9861(84)90536-8; BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9; BUSTO F, 1988, BIOCHEM CELL BIOL, V66, P148, DOI 10.1139/o88-020; CARVAJAL N, 1985, COMP BIOCHEM PHYS B, V82, P63, DOI 10.1016/0305-0491(85)90128-2; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cholera Li J., 2015, RADIOLOGY INFECT DIS, V2, P75; Cleland W. W, 1970, ENZYMES, V2, P1; Collins RA, 1996, PROTEIN ENG, V9, P1203, DOI 10.1093/protein/9.12.1203; COLLINS RA, 1995, BIOCHEM J, V310, P117, DOI 10.1042/bj3100117; Dela Vega-Ruiz G, 2015, PLOS ONE, V10; Donovan KA, 2016, J BIOL CHEM, V291, P9244, DOI 10.1074/jbc.M115.676270; DOUGHERTY TM, 1985, BIOCHEMISTRY-US, V24, P5875, DOI 10.1021/bi00342a028; ERNEST I, 1994, MOL BIOCHEM PARASIT, V64, P43, DOI 10.1016/0166-6851(94)90133-3; Fenton AW, 2009, METHOD ENZYMOL, V466, P83, DOI 10.1016/S0076-6879(09)66005-5; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; GARCIAOLALLA C, 1987, BIOCHEM J, V241, P573, DOI 10.1042/bj2410573; Gohara DW, 2016, J BIOL CHEM, V291, P20840, DOI 10.1074/jbc.R116.737833; GUPTA RK, 1978, J BIOL CHEM, V253, P8878; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HELDAL M, 1985, APPL ENVIRON MICROB, V50, P1251, DOI 10.1128/AEM.50.5.1251-1257.1985; Hofmann J, 2013, PROTEIN EXPRES PURIF, V88, P243, DOI 10.1016/j.pep.2013.01.010; Hohle TH, 2012, MOL MICROBIOL, V84, P766, DOI 10.1111/j.1365-2958.2012.08057.x; Ishwar A, 2015, BIOCHEMISTRY-US, V54, P1516, DOI 10.1021/bi501426w; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; JETTEN MSM, 1994, APPL ENVIRON MICROB, V60, P2501, DOI 10.1128/AEM.60.7.2501-2507.1994; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KAPOOR R, 1981, BIOCHEM J, V193, P435, DOI 10.1042/bj1930435; KASAHARA M, 1978, J BIOL CHEM, V253, P4180; Knowles VL, 2001, J BIOL CHEM, V276, P20966, DOI 10.1074/jbc.M008878200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO CL, 1971, J BACTERIOL, V106, P37, DOI 10.1128/JB.106.1.37-44.1971; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mesecar AD, 1997, BIOCHEMISTRY-US, V36, P6803, DOI 10.1021/bi962870s; Mesecar AD, 1997, BIOCHEMISTRY-US, V36, P6792, DOI 10.1021/bi962869t; MILDVAN AS, 1965, J BIOL CHEM, V240, P238; MILDVAN AS, 1966, J BIOL CHEM, V241, P1178; Morgan HP, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140120; Morgan HP, 2010, J BIOL CHEM, V285, P12892, DOI 10.1074/jbc.M109.079905; MORIKAWA M, 1980, J BIOCHEM-TOKYO, V87, P441, DOI 10.1093/oxfordjournals.jbchem.a132764; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Naithani A, 2015, BIOPHYS J, V109, P1149, DOI 10.1016/j.bpj.2015.05.040; Oria-Hernandez J, 2005, J BIOL CHEM, V280, P37924, DOI 10.1074/jbc.M508490200; Oria-Hernandez J, 2006, J BIOL CHEM, V281, P30717, DOI 10.1074/jbc.M605310200; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Ramirez-Silva L, 2014, INT J MOL SCI, V15, P22214, DOI 10.3390/ijms151222214; RAMIREZSILVA L, 1993, BIOCHEMISTRY-US, V32, P5332, DOI 10.1021/bi00071a008; REED GH, 1974, BIOCHEMISTRY-US, V13, P3537, DOI 10.1021/bi00714a020; REUBEN J, 1971, J BIOL CHEM, V246, P6227; REYNARD AM, 1961, J BIOL CHEM, V236, P2277; Saavedra E, 2005, FEBS J, V272, P1767, DOI 10.1111/j.1742-4658.2005.04610.x; Saavedra E, 2007, FEBS J, V274, P4922, DOI 10.1111/j.1742-4658.2007.06012.x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schauer S, 2012, APPL ENVIRON MICROB, V78, P7369, DOI 10.1128/AEM.02190-12; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; SMART JB, 1979, ARCH MICROBIOL, V122, P281, DOI 10.1007/BF00411292; SOLVONUK PF, 1955, CAN J BIOCHEM PHYS, V33, P38; Steiner P, 1998, GENE, V220, P31, DOI 10.1016/S0378-1119(98)00418-1; Susan-Resiga D, 2004, BIOCHEMISTRY-US, V43, P15230, DOI 10.1021/bi049864d; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; VALENTINI G, 1979, ITAL J BIOCHEM, V28, P345; VALENTINI G, 1979, BIOCHIM BIOPHYS ACTA, V570, P248, DOI 10.1016/0005-2744(79)90145-1; VANSCHAFTINGEN E, 1985, EUR J BIOCHEM, V153, P403, DOI 10.1111/j.1432-1033.1985.tb09316.x; WAYGOOD EB, 1974, J BIOL CHEM, V249, P265; Waygood EB, 1975, CAN J BIOCHEM, V5, P44; YAMADA T, 1975, J BACTERIOL, V124, P562, DOI 10.1128/JB.124.1.562-563.1975; Zheng L, 2014, APPL MICROBIOL BIOT, V98, P1583, DOI 10.1007/s00253-013-4907-9	72	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0178673	10.1371/journal.pone.0178673	http://dx.doi.org/10.1371/journal.pone.0178673			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686591	Green Submitted, gold, Green Published			2022-12-27	WOS:000405464100006
J	Leng, T; Leng, G; MacGregor, DJ				Leng, Trystan; Leng, Gareth; MacGregor, Duncan J.			Spike patterning in oxytocin neurons: Capturing physiological behaviour with Hodgkin-Huxley and integrate-and-fire models	PLOS ONE			English	Article							RAT SUPRAOPTIC NUCLEUS; MAGNOCELLULAR NEUROSECRETORY-CELLS; IN-VITRO; VASOPRESSIN NEURONS; NEUROENDOCRINE CELLS; MEMBRANE-PROPERTIES; HYPOTHALAMUS; VIVO; CONDUCTANCE; MECHANISMS	Integrate-and-fire (IF) models can provide close matches to the discharge activity of neurons, but do they oversimplify the biophysical properties of the neurons? A single compartment Hodgkin-Huxley (HH) model of the oxytocin neuron has previously been developed, incorporating biophysical measurements of channel properties obtained in vitro. A simpler modified integrate-and-fire model has also been developed, which can match well the characteristic spike patterning of oxytocin neurons as observed in vivo. Here, we extended the HH model to incorporate synaptic input, to enable us to compare spike activity in the model with experimental data obtained in vivo. We refined the HH model parameters to closely match the data, and then matched the same experimental data with a modified IF model, using an evolutionary algorithm to optimise parameter matching. Finally we compared the properties of the modified HH model with those of the IF model to seek an explanation for differences between spike patterning in vitro and in vivo. We show that, with slight modifications, the original HH model, like the IF model, is able to closely match both the interspike interval (ISI) distributions of oxytocin neurons and the observed variability of spike firing rates in vivo and in vitro. This close match of both models to data depends on the presence of a slow activity-dependent hyperpolarisation (AHP); this is represented in both models and the parameters used in the HH model representation match well with optimal parameters of the IF model found by an evolutionary algorithm. The ability of both models to fit data closely also depends on a shorter hyperpolarising after potential (HAP); this is explicitly represented in the IF model, but in the HH model, it emerges from a combination of several components. The critical elements of this combination are identified.	[Leng, Trystan; Leng, Gareth; MacGregor, Duncan J.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	MacGregor, DJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	duncan.macgregor@ed.ac.uk	Leng, Gareth/C-6688-2011	Leng, Gareth/0000-0002-2388-8466; Leng, Trystan/0000-0001-8312-9405	EU [607310]	EU(European Commission)	This work was supported by EU Seventh Framework Programme 607310, https://ec.europa.eu/research/fp7/index_en.cfm, norole.	ANDREW RD, 1984, J PHYSIOL-LONDON, V353, P171, DOI 10.1113/jphysiol.1984.sp015330; Armstrong WE, 2010, J NEUROENDOCRINOL, V22, P330, DOI 10.1111/j.1365-2826.2010.01989.x; Armstrong WE, 1998, PROG BRAIN RES, V119, P101; ARMSTRONG WE, 1994, J PHYSIOL-LONDON, V475, P115, DOI 10.1113/jphysiol.1994.sp020053; BICKNELL RJ, 1988, J EXP BIOL, V139, P51; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; BOURQUE CW, 1987, NEUROSCI LETT, V82, P185, DOI 10.1016/0304-3940(87)90127-3; BOURQUE CW, 1988, J PHYSIOL-LONDON, V397, P331, DOI 10.1113/jphysiol.1988.sp017004; BOURQUE CW, 1991, BRAIN RES, V540, P349, DOI 10.1016/0006-8993(91)90535-4; Brette R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004114; Brown CH, 2013, J NEUROENDOCRINOL, V25, P678, DOI 10.1111/jne.12051; Brown CH, 2016, COMPR PHYSIOL, V6, P1701, DOI 10.1002/cphy.c150053; Clayton TF, 2010, J NEUROENDOCRINOL, V22, P1290, DOI 10.1111/j.1365-2826.2010.02080.x; COBBETT P, 1987, BRAIN RES, V409, P175, DOI 10.1016/0006-8993(87)90756-6; Destexhe A, 1997, NEURAL COMPUT, V9, P503, DOI 10.1162/neco.1997.9.3.503; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; DYBALL REJ, 1991, J NEUROENDOCRINOL, V3, P383, DOI 10.1111/j.1365-2826.1991.tb00291.x; GIES U, 1994, J NEUROSCI, V14, P2861; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jolivet R, 2004, J NEUROPHYSIOL, V92, P959, DOI 10.1152/jn.00190.2004; KIRKPATRICK K, 1995, J PHYSIOL-LONDON, V482, P373, DOI 10.1113/jphysiol.1995.sp020524; Kirkpatrick K, 1996, J PHYSIOL-LONDON, V494, P389, DOI 10.1113/jphysiol.1996.sp021500; Leng G, 2001, J NEUROSCI, V21, P6967, DOI 10.1523/JNEUROSCI.21-17-06967.2001; Leng G, 1999, PROG NEUROBIOL, V57, P625, DOI 10.1016/S0301-0082(98)00072-0; Li CY, 2007, J PHYSIOL-LONDON, V581, P221, DOI 10.1113/jphysiol.2006.123810; Li ZH, 1997, J PHYSIOL-LONDON, V505, P95, DOI 10.1111/j.1469-7793.1997.095bc.x; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; MacGregor DJ, 2009, J NEUROSCI METH, V176, P45, DOI 10.1016/j.jneumeth.2008.08.011; MacGregor DJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003187; MacGregor DJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002740; MEEKER RB, 1993, ANN NY ACAD SCI, V689, P636, DOI 10.1111/j.1749-6632.1993.tb55614.x; Pittman QJ, 1998, PROG BRAIN RES, V119, P311; Prager-Khoutorsky M, 2015, J NEUROENDOCRINOL, V27, P507, DOI 10.1111/jne.12270; RHODES CH, 1981, J COMP NEUROL, V198, P45, DOI 10.1002/cne.901980106; Roper P, 2004, J NEUROSCI, V24, P4818, DOI 10.1523/JNEUROSCI.4203-03.2004; Roper P, 2003, J COMPUT NEUROSCI, V15, P367, DOI 10.1023/A:1027424128972; Rossoni E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000123; Royo JM, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12358; Sabatier N, 2004, J PHYSIOL-LONDON, V558, P161, DOI 10.1113/jphysiol.2004.063982; Stern JE, 1997, J PHYSIOL-LONDON, V500, P497, DOI 10.1113/jphysiol.1997.sp022036; STERN JE, 1995, J PHYSIOL-LONDON, V488, P701, DOI 10.1113/jphysiol.1995.sp021001; Teruyama R, 2002, J NEUROENDOCRINOL, V14, P933, DOI 10.1046/j.1365-2826.2002.00844.x; Teruyama R, 2007, J NEUROPHYSIOL, V98, P2612, DOI 10.1152/jn.00599.2007	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180368	10.1371/journal.pone.0180368	http://dx.doi.org/10.1371/journal.pone.0180368			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683135	Green Submitted, gold, Green Published			2022-12-27	WOS:000405335200027
J	Lin, SP; Lin, WY; Chang, JT; Chu, CF				Lin, Shu-Ping; Lin, Wen-Ye; Chang, Jung-Tzu; Chu, Chun-Feng			Demonstration of disinfection procedure for the development of accurate blood glucose meters in accordance with ISO 15197:2013	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; MONITORING SYSTEMS; BORNE VIRUSES; PREVENTION; SURVIVAL; STORAGE	espite measures to reduce disease transmission, a risk can occur when blood glucose meters (BGMs) are used on multiple individuals or by caregivers assisting a patient. The laboratory and in-clinic performance of a BGM system before and after disinfection should be demonstrated to guarantee accurate readings and reliable control of blood glucose (BG) for patients. In this study, an effective disinfection procedure, conducting wiping 10 times to assure a one minute contact time of the disinfectant on contaminated surface, was first demonstrated using test samples of the meter housing materials, including acrylonitrile butadiene styrene (ABS), polymethyl methacrylate (PMMA), and polycarbonate (PC), in accordance with ISO 15197:2013. After bench studies comprising 10,000 disinfection cycles, the elemental compositions of the disinfected ABS, PMMA, and PC samples were almost the same as in the original samples, as indicated by electron spectroscopy for chemical analysis. Subsequently, the validated disinfection procedure was then directly applied to disinfect 5 commercial BGM systems composed of ABS, PMMA, or PC to observe the effect of the validated disinfection procedure on meter accuracy. The results of HBsAg values after treatment with HBV sera and disinfectant wipes for each material were less than the LoD of each material of 0.020 IU/mL. Before and after the multiple disinfection cycles, 900 of 900 samples (100%) were within the system accuracy requirements of ISO 15197: 2013. All of the systems showed high performance before and after the series of disinfection cycles and met the ISO 15197: 2013 requirements. In addition, our results demonstrated multiple cleaning and disinfection cycles that represented normal use over the lifetime of a meter of 3-5 years. Our validated cleaning and disinfection procedure can be directly applied to other registered disinfectants for cleaning commercial BGM products in the future.	[Lin, Shu-Ping] Natl Chung Hsing Univ, Grad Inst Biomed Engn, Taichung, Taiwan; [Lin, Shu-Ping] Natl Chung Hsing Univ, Res Ctr Sustainable Energy & Nanotechnol, Taichung, Taiwan; [Lin, Wen-Ye] Jen Ai Hosp, Taichung, Taiwan; [Chang, Jung-Tzu; Chu, Chun-Feng] Biotest Med Corp, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University	Lin, SP (corresponding author), Natl Chung Hsing Univ, Grad Inst Biomed Engn, Taichung, Taiwan.; Lin, SP (corresponding author), Natl Chung Hsing Univ, Res Ctr Sustainable Energy & Nanotechnol, Taichung, Taiwan.	splin@dragon.nchu.edu.tw	Lin, Shu-Ping/AFV-5955-2022	Lin, Shu-Ping/0000-0001-5169-0361	Ministry of Science and Technology of Taiwan [NSC 102-2221-E-005-005-MY3, MOST 105-2221-E-005-009-]; Biotest Medical Corp.Taichung City, Taiwan [105DA198.]; JTC; CFC	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Biotest Medical Corp.Taichung City, Taiwan; JTC; CFC	This work was supported by the Ministry of Science and Technology of Taiwan under grant numbers NSC 102-2221-E-005-005-MY3 and MOST 105-2221-E-005-009-. This work was supported in part by Biotest Medical Corp. (http://www.btm-medical.com/), Taichung City, Taiwan under grant number 105DA198. The Biotest Medical Corp. provided support in the form of salaries for JTC and CFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	Alvarez-Munoz MT, 2005, ARCH MED RES, V36, P382, DOI 10.1016/j.arcmed.2005.03.010; [Anonymous], 2014, SELF MON BLOOD GLUC; [Anonymous], 2014, BLOOD GLUC MON TEST; [Anonymous], 2015, 510 K PREM NOT; [Anonymous], 2013, VITR DIAGN TEST SYST; [Anonymous], 2012, EV DET CAP CLIN LAB; [Anonymous], 2003, VITR DIAGN TEST SYST; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bender TJ, 2010, PLOS ONE, V7; BOND WW, 1981, LANCET, V1, P550; Briggs D., 1992, HIGH RESOLUTION XPS; Counard CA, 2010, J AM GERIATR SOC, V58, P306, DOI 10.1111/j.1532-5415.2009.02669.x; Crist BV, 2000, HDB MONACHROMATIC XP; Czupryniak L, 2014, DIABETES TECHNOL THE, V16, P460, DOI 10.1089/dia.2013.0302; Deuffic-Burban S, 2011, J CLIN VIROL, V52, P4, DOI 10.1016/j.jcv.2011.05.016; Erbach Michael, 2016, J Diabetes Sci Technol, V10, P1161, DOI 10.1177/1932296816641433; Fischer R, 2015, EMERG INFECT DIS, V21, P1243, DOI 10.3201/eid2107.150253; Flore KMJ, 2009, PERITON DIALYSIS INT, V29, P377; Freckmann G, 2014, DIABETES TECHNOL THE, V16, P113, DOI 10.1089/dia.2013.0208; Freckmann G, 2010, DIABETES TECHNOL THE, V12, P221, DOI 10.1089/dia.2009.0128; Heinemann Lutz, 2012, J Diabetes Sci Technol, V6, P435; Klonoff David C, 2014, Diabetes Spectr, V27, P174, DOI 10.2337/diaspect.27.3.174; Klonoff David C, 2015, J Diabetes Sci Technol, V9, P895, DOI 10.1177/1932296815584797; Klonoff David C, 2015, J Diabetes Sci Technol, V9, P3, DOI 10.1177/1932296814563643; Klonoff David C, 2011, J Diabetes Sci Technol, V5, P1307; Kropff J, 2015, DIABETES OBES METAB, V17, P343, DOI 10.1111/dom.12378; Louie RF, 2015, GLOBAL POINT CARE ST; Mahoney John J, 2012, J Diabetes Sci Technol, V6, P81; Pfaender S, 2016, REV MED VIROL, V26, P330, DOI 10.1002/rmv.1890; Ramesh A., 2013, OVERVIEW PLASTIC MAT; Schaffzin JK, 2012, AM J INFECT CONTROL, V40, P726, DOI 10.1016/j.ajic.2011.11.002; Thompson Nicola D, 2009, J Diabetes Sci Technol, V3, P283; Thompson SC, 2003, AUST NZ J PUBL HEAL, V27, P602, DOI 10.1111/j.1467-842X.2003.tb00606.x; Vashist SK, 2011, ANAL CHIM ACTA, V703, P124, DOI 10.1016/j.aca.2011.07.024	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180617	10.1371/journal.pone.0180617	http://dx.doi.org/10.1371/journal.pone.0180617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683148	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200055
J	Mezzetti, F; Fay, JC; Giudici, P; De Vero, L				Mezzetti, Francesco; Fay, Justin C.; Giudici, Paolo; De Vero, Luciana			Genetic variation and expression changes associated with molybdate resistance from a glutathione producing wine strain of Saccharomyces cerevisiae	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; MOLECULAR CHARACTERIZATION; ADAPTIVE EVOLUTION; READ ALIGNMENT; AMINO-ACIDS; YEAST; SULFATE; PROTEIN; GENOME; BIOSYNTHESIS	Glutathione (GSH) production during wine fermentation is a desirable trait as it can limit must and wine oxidation and protect various aromatic compounds. UMCC 2581 is a Saccharomyces cerevisiae wine strain with enhanced GSH content at the end of wine fermentation. This strain was previously derived by selection for molybdate resistance following a sexual cycle of UMCC 855 using an evolution-based strategy. In this study, we examined genetic and gene expression changes associated with the derivation of UMCC 2581. For genetic analysis we sporulated the diploid UMCC 855 parental strain and found four phenotype classes of segregants related to molybdate resistance, demonstrating the presence of segregating variation from the parental strain. Using bulk segregant analysis we mapped molybdate traits to two loci. By sequencing both the parental and evolved strain genomes we identified candidate mutations within the two regions as well as an extra copy of chromosome 1 in UMCC 2581. Combining the mapped loci with gene expression profiles of the evolved and parental strains we identified a number of candidate genes with genetic and/or gene expression changes that could underlie molybdate resistance and increased GSH levels. Our results provide insight into the genetic basis of GSH production relevant to wine-making and highlight the value of enhancing wine strains using existing variation present in wine strains.	[Mezzetti, Francesco; Giudici, Paolo; De Vero, Luciana] Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy; [Fay, Justin C.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Fay, Justin C.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO USA	Universita di Modena e Reggio Emilia; Washington University (WUSTL); Washington University (WUSTL)	De Vero, L (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy.	luciana.devero@unimore.it	De Vero, Luciana/AAH-6705-2020	De Vero, Luciana/0000-0002-9887-9994; Fay, Justin/0000-0003-1893-877X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080669] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080669] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamis PDB, 2007, TOXICOL LETT, V173, P1, DOI 10.1016/j.toxlet.2007.06.002; Albers E, 2003, J BIOL CHEM, V278, P10264, DOI 10.1074/jbc.M211692200; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antonela G, 2015, SCI PAP-SER B-HORTIC, V59, P123; Ausubel FM, 2002, CURRENT PROTOCOLS MO, V5, P2; Avendano A, 1997, J BACTERIOL, V179, P5594, DOI 10.1128/jb.179.17.5594-5597.1997; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; BIDENNE C, 1992, CURR GENET, V22, P1, DOI 10.1007/BF00351734; Bleackley MR, 2011, METALLOMICS, V3, P195, DOI 10.1039/c0mt00035c; Bonciani T, 2016, EUR FOOD RES TECHNOL, V242, P899, DOI 10.1007/s00217-015-2596-6; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Cadiere A, 2011, METAB ENG, V13, P263, DOI 10.1016/j.ymben.2011.01.008; CHEREST H, 1993, J BACTERIOL, V175, P5366, DOI 10.1128/JB.175.17.5366-5374.1993; Cherest H, 1997, GENETICS, V145, P627; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chloupkova M, 2003, J MOL BIOL, V331, P155, DOI 10.1016/S0022-2836(03)00666-1; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; De Vero L, 2011, LETT APPL MICROBIOL, V53, P572, DOI 10.1111/j.1472-765X.2011.03140.x; De Vero L, 2017, AIMS MICROBIOL, V3, P155, DOI 10.3934/microbiol.2017.2.155; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dhaoui M, 2011, MOL BIOL CELL, V22, P2054, DOI 10.1091/mbc.E10-11-0906; Du J, 2015, GENE, V563, P155, DOI 10.1016/j.gene.2015.03.018; During-Olsen L, 1999, CURR GENET, V35, P609, DOI 10.1007/s002940050459; Ferreira ACS, 2002, J AGR FOOD CHEM, V50, P5919, DOI 10.1021/jf0115847; Filetici P, 1996, YEAST, V12, P1359, DOI 10.1002/(SICI)1097-0061(199610)12:13<1359::AID-YEA3>3.0.CO;2-5; GADD GM, 1989, SPEC PUBL SOC GEN MI, V26, P19; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gharieb MM, 1998, BIOMETALS, V11, P101, DOI 10.1023/A:1009221810760; Giudici P, 2005, APPL MICROBIOL BIOT, V66, P622, DOI 10.1007/s00253-004-1784-2; GIUDICI P, 1994, AM J ENOL VITICULT, V45, P107; Gobbi M, 2014, EUR FOOD RES TECHNOL, V239, P41, DOI 10.1007/s00217-014-2187-y; GRANDORI R, 1994, PROTEIN SCI, V3, P2185, DOI 10.1002/pro.5560031204; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Griffiths LM, 2009, MOL CELL BIOL, V29, P794, DOI 10.1128/MCB.01357-08; Higgins VJ, 2002, YEAST, V19, P203, DOI 10.1002/yea.811; Hinnebusch A. G., 1992, MOL CELLULAR BIOL YE, P319, DOI DOI 10.1016/J.ACA.2008.01.060; Izquierdo A, 2008, EUKARYOT CELL, V7, P1415, DOI 10.1128/EC.00133-08; JASPERS CJ, 1985, PHYTOCHEMISTRY, V24, P703; Jiang LH, 2014, FEMS YEAST RES, V14, P1263, DOI 10.1111/1567-1364.12220; Kim D, 2006, BIOCHEMISTRY-US, V45, P14772, DOI 10.1021/bi061429r; KOPP M, 1993, J BIOL CHEM, V268, P4766; Kritzinger EC, 2013, J AGR FOOD CHEM, V61, P269, DOI 10.1021/jf303665z; Kutyna DR, 2012, APPL MICROBIOL BIOT, V93, P1175, DOI 10.1007/s00253-011-3622-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li H, 2008, FOOD CHEM, V108, P1, DOI 10.1016/j.foodchem.2007.10.065; Li Y, 2004, APPL MICROBIOL BIOT, V66, P233, DOI 10.1007/s00253-004-1751-y; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; MASSELOT M, 1975, MOL GEN GENET, V139, P121, DOI 10.1007/BF00264692; McBryde C, 2006, AM J ENOL VITICULT, V57, P423; McNeil JB, 1997, GENE, V186, P13, DOI 10.1016/S0378-1119(96)00670-1; Meadows KL, 2003, NUCLEIC ACIDS RES, V31, P5560, DOI 10.1093/nar/gkg749; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Mesecke N, 2008, MOL BIOL CELL, V19, P2673, DOI 10.1091/mbc.E07-09-0896; Mezzetti F, 2014, FEMS YEAST RES, V14, P977, DOI 10.1111/1567-1364.12186; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Puigpinos J, 2015, MOL BIOL CELL, V26, P104, DOI 10.1091/mbc.E14-06-1137; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Rossignol T, 2003, YEAST, V20, P1369, DOI 10.1002/yea.1046; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; Sakurai H, 2000, J BIOL CHEM, V275, P37251, DOI 10.1074/jbc.M004364200; SMITH FW, 1995, MOL GEN GENET, V247, P709, DOI 10.1007/BF00290402; Stanley D, 2010, J IND MICROBIOL BIOT, V37, P139, DOI 10.1007/s10295-009-0655-3; Sumner ER, 2005, MICROBIOL-SGM, V151, P1939, DOI 10.1099/mic.0.27945-0; Tamas MJ, 2006, TOP CURR GENET, V14, P395; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Treu L, 2014, APPL MICROBIOL BIOT, V98, P4119, DOI 10.1007/s00253-014-5679-6; Ubiyvovk VM, 2006, CELL BIOL INT, V30, P665, DOI 10.1016/j.cellbi.2006.04.006; van Bakel H, 2005, PHYSIOL GENOMICS, V22, P356, DOI 10.1152/physiolgenomics.00055.2005; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957; Zahringer H, 1997, FEBS LETT, V412, P615, DOI 10.1016/S0014-5793(97)00868-5; Zechmann B, 2011, FEMS YEAST RES, V11, P631, DOI 10.1111/j.1567-1364.2011.00753.x; Zhou X, 2009, GENOMICS, V94, P294, DOI 10.1016/j.ygeno.2009.07.003	87	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180814	10.1371/journal.pone.0180814	http://dx.doi.org/10.1371/journal.pone.0180814			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683117	Green Submitted, Green Published, gold			2022-12-27	WOS:000405335200068
J	Righart, R; Schmidt, P; Dahnke, R; Biberacher, V; Beer, A; Buck, D; Hemmer, B; Kirschke, JS; Zimmer, C; Gaser, C; Muhlau, M				Righart, R.; Schmidt, P.; Dahnke, R.; Biberacher, V.; Beer, A.; Buck, D.; Hemmer, B.; Kirschke, J. S.; Zimmer, C.; Gaser, C.; Muehlau, M.			Volume versus surface-based cortical thickness measurements: A comparative study with healthy controls and multiple sclerosis patients	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; PERFORMANCE; DISEASE; ATROPHY	The cerebral cortex is a highly folded outer layer of grey matter tissue that plays a key role in cognitive functions. In part, alterations of the cortex during development and disease can be captured by measuring the cortical thickness across the whole brain. Available software tools differ with regard to labor intensity and computational demands. In this study, we compared the computational anatomy toolbox (CAT), a recently proposed volume-based tool, with the well-established surface-based tool FreeSurfer. We observed that overall thickness measures were highly inter-correlated, although thickness estimates were systematically lower in CAT than in FreeSurfer. Comparison of multiple sclerosis (MS) patients with agematched healthy control subjects showed highly comparable clusters of MS-related thinning for both methods. Likewise, both methods yielded comparable clusters of age-related cortical thinning, although correlations between age and average cortical thickness were stronger for FreeSurfer. Our data suggest that, for the analysis of cortical thickness, the volumebased CAT tool can be regarded a considerable alternative to the well-established surfacebased FreeSurfer tool.	[Righart, R.; Schmidt, P.; Biberacher, V.; Beer, A.; Buck, D.; Hemmer, B.; Muehlau, M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, Munich, Germany; [Righart, R.; Schmidt, P.; Biberacher, V.; Beer, A.; Muehlau, M.] Tech Univ Munich, Klinikum Rechts Isar, TUM Neuroimaging Ctr, Munich, Germany; [Schmidt, P.] Ludwig Maximilians Univ Munchen, Dept Stat, Munich, Germany; [Dahnke, R.; Gaser, C.] Jena Univ Hosp, Dept Psychiat, Jena, Germany; [Dahnke, R.; Gaser, C.] Jena Univ Hosp, Dept Neurol, Jena, Germany; [Hemmer, B.] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Kirschke, J. S.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Munich; Technical University of Munich	Righart, R (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, Munich, Germany.; Righart, R (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, TUM Neuroimaging Ctr, Munich, Germany.	righart@lrz.tu-muenchen.de	Hemmer, Bernhard/AAT-8388-2021; Gaser, Christian/F-5103-2010; Dahnke, Robert/ABC-4823-2020; Kirschke, Jan/E-2550-2012; Hemmer, Bernhard/GPX-8451-2022	Gaser, Christian/0000-0002-9940-099X; Kirschke, Jan/0000-0002-7557-0003; Hemmer, Bernhard/0000-0001-5985-6784; Dahnke, Robert/0000-0002-7478-7489; Pongratz, Viola/0000-0003-0981-1080; Schmidt, Paul/0000-0002-1676-1774	'Hertie Foundation' [P1140092]; 'German Competence Network Multiple Sclerosis' (German Ministry for Research and Education) [01GI1307B]; SFB [TR-128]	'Hertie Foundation'; 'German Competence Network Multiple Sclerosis' (German Ministry for Research and Education); SFB(Austrian Science Fund (FWF))	This work was funded by the 'Hertie Foundation' (Grant P1140092 'Myelin mapping in MS') and supported by the 'German Competence Network Multiple Sclerosis' (German Ministry for Research and Education Grant 01GI1307B). Bernhard Hemmer was also supported by SFB TR-128 Initiating/effect orver susregulatory mechanisms in Multiple Sclerosis progress towards tackling the disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Calabrese M, 2007, J NEUROL, V254, P1212, DOI 10.1007/s00415-006-0503-6; Charil A, 2007, NEUROIMAGE, V34, P509, DOI 10.1016/j.neuroimage.2006.10.006; Dahnke R, 2013, NEUROIMAGE, V65, P336, DOI 10.1016/j.neuroimage.2012.09.050; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Geisseler O, 2016, NEUROIMAGE-CLIN, V10, P89, DOI 10.1016/j.nicl.2015.11.008; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Magon S, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-106; McGugin RW, 2016, J COGNITIVE NEUROSCI, V28, P282, DOI 10.1162/jocn_a_00891; Narayana PA, 2013, NEUROIMAGE-CLIN, V2, P120, DOI 10.1016/j.nicl.2012.11.009; Ontaneda D, 2015, LANCET NEUROL, V14, P208, DOI 10.1016/S1474-4422(14)70264-9; Popescu V, 2016, HUM BRAIN MAPP, V37, P2223, DOI 10.1002/hbm.23168; RCore Team, 2016, R LANG ENV STAT COMP; Righart R, 2013, NEUROIMAGE-CLIN, V2, P854, DOI 10.1016/j.nicl.2013.06.006; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Sailer M, 2003, BRAIN, V126, P1734, DOI 10.1093/brain/awg175; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schmidt EL, 2016, NEUROPSYCHOLOGY, V30, P322, DOI 10.1037/neu0000242; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Yotter RA, 2011, J NEUROIMAGING, V21, pe134, DOI 10.1111/j.1552-6569.2010.00484.x	26	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179590	10.1371/journal.pone.0179590	http://dx.doi.org/10.1371/journal.pone.0179590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683072	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200007
J	Shahgholi, L; De Jesus, S; Wu, SS; Pei, QL; Hassan, A; Armstrong, MJ; Martinez-Ramirez, D; Schmidt, P; Okun, MS				Shahgholi, Leili; De Jesus, Sol; Wu, Samuel S.; Pei, Qinglin; Hassan, Anhar; Armstrong, Melissa J.; Martinez-Ramirez, Daniel; Schmidt, Peter; Okun, Michael S.			Hospitalization and rehospitalization in Parkinson disease patients: Data from the National Parkinson Foundation Centers of Excellence	PLOS ONE			English	Article							BURDEN; GO	Background Patients with Parkinson disease (PD) are at high risk of hospital encounters with increasing morbidity and mortality. This study aimed to determine the rate of hospital encounters in a cohort followed over 5 years and to identify associated factors. Methods We queried the data from the International Multicenter National Parkinson Foundation Quality Improvement study. Multivariate logistic regression with backward selection was performed to identify factors associated with hospitalencounter prior to baseline visit. Kaplan Meier estimates were obtained and Cox regression performed on time to hospital encounter after the baseline visit. Results Of the 7,507 PD patients (mean age 66.5 +/- 9.9 years and disease duration 8.9 +/- 6.4 years at baseline visit), 1919 (25.6%) had a history of a hospital encounter prior to their baseline visit. Significant factors associated with a history of a hospital encounter prior to baseline included race (white race: OR 0.49), utilization of physical therapy (OR 1.47), history of deep brain stimulation (OR 1.87), number of comorbidities (OR 1.30), caregiver strain (OR 1.17 per standard deviation), and the standardized Timed Up and Go Test (OR 1.21). Patients with a history of hospitalization prior to the baseline were more likely to have a rehospitalization (HR1.67, P<0.0001) compared to those without a prior hospitalization. In and number of medications. In patients with a history of hospitalization prior to the baseline visit, time to a second hospital encounter was significantly associated with caregiver strain and number of comorbidities. Conclusion Hospitalization and re-hospitalization were common in this cohort of people with PD. Our results suggest addressing caregiver burden, simplifying medications, and emphasizing primary and multidisciplinary care for comorbidities are potential avenues to explore for reducing hospitalization rates.	[Shahgholi, Leili; De Jesus, Sol; Armstrong, Melissa J.; Martinez-Ramirez, Daniel; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurol, Gainesville, FL 32611 USA; [Wu, Samuel S.; Pei, Qinglin] Univ Florida, Dept Biostat, Gainesville, FL USA; [Hassan, Anhar] Mayo Clin, Dept Neurol, Rochester, MN USA; [Schmidt, Peter] Natl Parkinsons Fdn, Miami, FL USA; [De Jesus, Sol] Penn State Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Okun, MS (corresponding author), Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurol, Gainesville, FL 32611 USA.	okun@neuralogy.ufl.edu	Ramirez, Daniel Martinez/O-6719-2018; Hassan, Anhar/J-6549-2019	Ramirez, Daniel Martinez/0000-0001-8003-0610; Hassan, Anhar/0000-0002-8351-2751; Armstrong, Melissa/0000-0002-2163-1907	The National Parkinson Foundation; NPF; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	The National Parkinson Foundation; NPF; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The National Parkinson Foundation provides a grant to each participating center in the NPF QII project. The grant covers coordinator expenses and data collection expenses. The NPF also provides a grant to Samuel Wu for data analysis at the University of Florida.	Ahlskog JE, 2014, MAYO CLIN PROC, V89, P997, DOI 10.1016/j.mayocp.2014.02.018; Aminoff MJ, 2011, PARKINSONISM RELAT D, V17, P139, DOI 10.1016/j.parkreldis.2010.11.009; Chou KL, 2011, PARKINSONISM RELAT D, V17, P440, DOI 10.1016/j.parkreldis.2011.03.002; E. S. The multidimensional caregiver strain index (MCSI), 1996, J CLIN GEROPSYCHOL, V2, P175; Gerlach OHH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-13; Gerlach OHH, 2011, MOVEMENT DISORD, V26, P197, DOI 10.1002/mds.23449; Guttman M, 2003, MOVEMENT DISORD, V18, P313, DOI 10.1002/mds.10333; Hassan A, 2013, PARKINSONISM RELAT D, V19, P949, DOI 10.1016/j.parkreldis.2013.06.006; Herman T, 2011, GERONTOLOGY, V57, P203, DOI 10.1159/000314963; JENKINSON C, 1995, AGE AGEING, V24, P505, DOI 10.1093/ageing/24.6.505; Low V, 2015, PARKINSONISM RELAT D, V21, P449, DOI 10.1016/j.parkreldis.2015.01.017; Martignoni E, 2004, NEUROL SCI, V25, P66, DOI 10.1007/s10072-004-0232-5; Morris S, 2001, PHYS THER, V81, P810, DOI 10.1093/ptj/81.2.810; Muzerengi S, 2016, PARKINSONISM RELAT D, V24, P3, DOI 10.1016/j.parkreldis.2016.01.011; Okun MS, 2010, PARKINSONISM RELAT D, V16, P517, DOI 10.1016/j.parkreldis.2010.06.005; Stegemoller EL, 2015, ARCH PHYS MED REHAB, V96, P1728, DOI 10.1016/j.apmr.2015.03.021; Woodford H, 2005, MOVEMENT DISORD, V20, P1104, DOI 10.1002/mds.20485	17	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180425	10.1371/journal.pone.0180425	http://dx.doi.org/10.1371/journal.pone.0180425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683150	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200035
J	Baek, SH; Lee, D; Kim, M; Lee, JH; Song, M				Baek, Seung Han; Lee, Dahee; Kim, Minjoo; Lee, Jong Ho; Song, Min			Enriching plausible new hypothesis generation in PubMed	PLOS ONE			English	Article							LITERATURE-BASED DISCOVERY; PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; FISH-OIL; CIGARETTE-SMOKING; OXIDATIVE STRESS; BLOOD-PRESSURE; KNOWLEDGE; LACTOSYLCERAMIDE; SUPPLEMENTATION	Background Most of earlier studies in the field of literature-based discovery have adopted Swanson's ABC model that links pieces of knowledge entailed in disjoint literatures. However, the issue concerning their practicability remains to be solved since most of them did not deal with the context surrounding the discovered associations and usually not accompanied with clinical confirmation. In this study, we aim to propose a method that expands and elaborates the existing hypothesis by advanced text mining techniques for capturing contexts. We extend ABC model to allow for multiple B terms with various biological types. Results We were able to concretize a specific, metabolite-related hypothesis with abundant contextual information by using the proposed method. Starting from explaining the relationship between lactosylceramide and arterial stiffness, the hypothesis was extended to suggest a potential pathway consisting of lactosylceramide, nitric oxide, malondialdehyde, and arterial stiffness. The experiment by domain experts showed that it is clinically valid. Conclusions The proposed method is designed to provide plausible candidates of the concretized hypothesis, which are based on extracted heterogeneous entities and detailed relation information, along with a reliable ranking criterion. Statistical tests collaboratively conducted with biomedical experts provide the validity and practical usefulness of the method unlike previous studies. Applying the proposed method to other cases, it would be helpful for biologists to support the existing hypothesis and easily expect the logical process within it.	[Baek, Seung Han] Yonsei Univ, Inst Convergence, Seoul, South Korea; [Lee, Dahee; Song, Min] Yonsei Univ, Dept Lib & Informat Sci, Seoul, South Korea; [Kim, Minjoo; Lee, Jong Ho] Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University	Song, M (corresponding author), Yonsei Univ, Dept Lib & Informat Sci, Seoul, South Korea.	min.song@yonsei.ac.kr		Baek, Seung Han/0000-0002-8722-0027; Song, Min/0000-0003-3255-1600	Bio-Synergy Research Project of Ministry of Science, ICT and Future Planning through National Research Foundation [NRF-2013M3A9C 4078138, NRF-2012M3A9C4048762]	Bio-Synergy Research Project of Ministry of Science, ICT and Future Planning through National Research Foundation	This work was supported by the Bio-Synergy Research Project (NRF-2013M3A9C 4078138, NRF-2012M3A9C4048762) of the Ministry of Science, ICT and Future Planning through the National Research Foundation. The authors who were funded are MS, JHL, and SHB.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayme Segolene, 2003, Soins, P46; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Bell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021474; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Cherney DZI, 2011, DIABETES CARE, V34, P1821, DOI 10.2337/dc11-0167; Chih-Ping Wei, 2014, Advances in Knowledge Discovery and Data Mining. 18th Pacific-Asia Conference, PAKDD 2014. Proceedings: LNCS 8444, P373, DOI 10.1007/978-3-319-06605-9_31; DIGIACOMO RA, 1989, AM J MED, V86, P158, DOI 10.1016/0002-9343(89)90261-1; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Hristovski D, 2008, INFORM SCI KNOWL MAN, V15, P133; Hristovski Dimitar, 2006, AMIA Annu Symp Proc, P349; Hristovski Dimitar, 2003, Stud Health Technol Inform, V95, P68; Hung CS, 2009, NUTR METAB CARDIOVAS, V19, P241, DOI 10.1016/j.numecd.2008.07.006; Jacobs DR, 1999, ARCH INTERN MED, V159, P733, DOI 10.1001/archinte.159.7.733; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; JONAS MA, 1992, CIRCULATION, V86, P1664, DOI 10.1161/01.CIR.86.5.1664; Jordan Rick, 2014, J Clin Bioinforma, V4, P13, DOI 10.1186/2043-9113-4-13; Jurgens D., 2010, P ACL 2010 SYST DEM, P30; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kim M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119519; Kim OY, 2013, CLIN EXP HYPERTENS, V35, P382, DOI 10.3109/10641963.2012.739232; Kwak JH, 2013, HYPERTENS RES, V36, P1060, DOI 10.1038/hr.2013.79; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Rajesh M, 2005, CIRC RES, V97, P796, DOI 10.1161/01.RES.0000185327.45463.A8; Rhee MY, 2007, AM J HYPERTENS, V20, P637, DOI 10.1016/j.amjhyper.2006.12.017; Rindflesch TC, 2003, J BIOMED INFORM, V36, P462, DOI 10.1016/j.jbi.2003.11.003; Rohde D.L., 2006, COMMUN ACM, V8, P627; Song M, 2015, J BIOMED INFORM, V57, P320, DOI 10.1016/j.jbi.2015.08.008; SPANJER HH, 1984, BIOCHIM BIOPHYS ACTA, V774, P49, DOI 10.1016/0005-2736(84)90273-6; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; SWANSON DR, 1988, PERSPECT BIOL MED, V31, P526; Tari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040946; Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037; Vos R, 2014, J AM MED INFORM ASSN, V21, P139, DOI 10.1136/amiajnl-2012-001448; Weeber M, 2001, J AM SOC INF SCI TEC, V52, P548, DOI 10.1002/asi.1104; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Yang ZH, 2006, CLIN MED RES, V4, P53, DOI 10.3121/cmr.4.1.53; YEN JY, 1971, MANAGE SCI, V17, P712, DOI 10.1287/mnsc.17.11.712; Yetisgen-Yildiz M, 2006, J BIOMED INFORM, V39, P600, DOI 10.1016/j.jbi.2005.11.010	46	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180539	10.1371/journal.pone.0180539	http://dx.doi.org/10.1371/journal.pone.0180539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678852	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200071
J	Duan, YL; Wu, FS; Wang, WF; He, DP; Gu, JD; Feng, HY; Chen, T; Liu, GX; An, LZ				Duan, Yulong; Wu, Fasi; Wang, Wanfu; He, Dongpeng; Gu, Ji-Dong; Feng, Huyuan; Chen, Tuo; Liu, Guangxiu; An, Lizhe			The microbial community characteristics of ancient painted sculptures in Maijishan Grottoes, China	PLOS ONE			English	Article							ALTAMIRA CAVE; WALL PAINTINGS; MOGAO GROTTOES; CULTURAL-HERITAGE; BACTERIAL COMMUNITIES; ROSY DISCOLORATION; AIRBORNE FUNGI; BAYON TEMPLE; ANGKOR THOM; SPAIN	In this study, a culture- independent Illumina MiSeq sequencing strategy was applied to investigate the microbial communities colonizing the ancient painted sculptures of the Maijishan Grottoes, a famous World Cultural Heritage site listed by UNESCO in China. Four mixed samples were collected from Cave 4-4 of the Maijishan Grottoes, the so- called Upper Seven Buddha Pavilion, which was built during the Northern Zhou Dynasty (557581AD). The 16/18S rRNA gene- based sequences revealed a rich bacterial diversity and a relatively low fungal abundance, including the bacterial groups Actinobacteria, Acidobacteria, Bacteroidetes, Cyanobacteria, Chloroflexi, Firmicutes, Proteobacteria and Verrucomicrobia and the fungal groups Ascomycota, Basidiomycota and Chytridiomycota. Among them, the bacteria genera of Pseudonocardia and Rubrobacter and unclassified fungi in the order of Capnodiales were dominant. The relative abundance of Pseudonocardia in the painted layer samples was higher than that in the dust sample, while Cyanobacteria dominated in the dust sample. Many of them have been discovered at other cultural heritage sites and associated with the biodeterioration of cultural relics. The presence and activity of these pioneering microorganisms may lead to an unexpected deterioration of the painted sculptures that are preserved in this heritage site. Thus, proper management strategies and potential risk monitoring should be used in the Maijishan Grottoes to improve the conservation of these precious painted sculptures.	[Duan, Yulong; Wang, Wanfu; Chen, Tuo; Liu, Guangxiu; An, Lizhe] Univ Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Key Lab Extreme Environm Microbial Resources & En, Lanzhou, Peoples R China; [Wu, Fasi; Wang, Wanfu; He, Dongpeng] Dunhuang Acad, Natl Res Ctr Conservat Ancient Wall Paintings & E, Dunhuang, Gansu, Peoples R China; [Wu, Fasi; Wang, Wanfu; Feng, Huyuan; An, Lizhe] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Peoples R China; [Gu, Ji-Dong] Univ Hong Kong, Sch Biol Sci, Lab Environm Microbiol & Toxicol, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University; University of Hong Kong	Wang, WF (corresponding author), Univ Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Key Lab Extreme Environm Microbial Resources & En, Lanzhou, Peoples R China.; Wang, WF (corresponding author), Dunhuang Acad, Natl Res Ctr Conservat Ancient Wall Paintings & E, Dunhuang, Gansu, Peoples R China.; Wang, WF; Feng, HY (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Peoples R China.	wwanfu@hotmail.com; fenghy@lzu.edu.cn	Yulong, Duan/AAC-7281-2022; Gu, Ji-Dong/AAF-2291-2019; Gu, Ji-Dong/AAO-7851-2020; Yang, Xiaoming/GRJ-9483-2022	Yulong, Duan/0000-0002-3759-6149; Yang, Xiaoming/0000-0002-1792-6921; Wu, Fasi/0000-0002-1175-8285	National Natural Science Foundation of China [31560160, 31500430, 31260136]; Gansu Province Science and Technology Plan [1604WKCA003]; Project of Gansu Cultural Relics Bureau [GWJ2014003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Province Science and Technology Plan; Project of Gansu Cultural Relics Bureau	Funded by National Natural Science Foundation of China (No. 31560160, 31500430, 31260136), Gansu Province Science and Technology Plan (No. 1604WKCA003), Project of Gansu Cultural Relics Bureau (No. GWJ2014003).	BASSI M, 1986, INT BIODETERIOR, V22, P201; Bastian F, 2010, MICROBIOL-SGM, V156, P644, DOI 10.1099/mic.0.036160-0; Bastian F, 2009, NATURWISSENSCHAFTEN, V96, P863, DOI 10.1007/s00114-009-0540-y; Capodicasa S, 2010, INT BIODETER BIODEGR, V64, P727, DOI 10.1016/j.ibiod.2010.08.006; Ciferri O, 1999, APPL ENVIRON MICROB, V65, P879; Cuezva S, 2012, FEMS MICROBIOL ECOL, V81, P281, DOI 10.1111/j.1574-6941.2012.01391.x; De Leo F, 2012, INT J SPELEOL, V41, P125, DOI 10.5038/1827-806X.41.2.1; Dennis KL, 2013, CANCER RES, V73, P5905, DOI 10.1158/0008-5472.CAN-13-1511; Ettenauer J, 2011, SCI TOTAL ENVIRON, V409, P5337, DOI 10.1016/j.scitotenv.2011.08.063; Feng Q., 1998, ACTA MICROBIOL SIN, V38, P131; Feng Q., 1998, ACTA MICROBIOL SIN, V38, P52; Fouhy F, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0738-z; Gu JD, 2003, INT BIODETER BIODEGR, V52, P69, DOI 10.1016/S0964-8305(02)00177-4; Gu JD, 2013, INT BIODETER BIODEGR, V85, P345, DOI 10.1016/j.ibiod.2013.08.018; Heyrman J, 1999, FEMS MICROBIOL LETT, V181, P55, DOI 10.1016/S0378-1097(99)00514-5; Imperi F, 2007, ENVIRON MICROBIOL, V9, P2894, DOI 10.1111/j.1462-2920.2007.01393.x; Jroundi F, 2010, MICROB ECOL, V60, P39, DOI 10.1007/s00248-010-9665-y; Jurado V, 2005, INT J SYST EVOL MICR, V55, P1897, DOI 10.1099/ijs.0.63637-0; Jurado V, 2005, INT J SYST EVOL MICR, V55, P153, DOI 10.1099/ijs.0.63199-0; Jurado V, 2008, INT J SYST EVOL MICR, V58, P2210, DOI 10.1099/ijs.0.65482-0; Jurado V, 2010, INT J SPELEOL, V39, P15, DOI 10.5038/1827-806X.39.1.2; Jurado V, 2009, NATURWISSENSCHAFTEN, V96, P1027, DOI 10.1007/s00114-009-0561-6; Konkol NR, 2012, J CULT HERIT, V13, P115, DOI 10.1016/j.culher.2010.05.002; Kusumi A, 2013, MICROBES ENVIRON, V28, P422, DOI 10.1264/jsme2.ME13033; Laiz L, 2009, NATURWISSENSCHAFTEN, V96, P71, DOI 10.1007/s00114-008-0452-2; Laiz L, 1999, J MICROBIOL METH, V36, P129, DOI 10.1016/S0167-7012(99)00018-4; Lan WS, 2010, MICROB ECOL, V60, P105, DOI 10.1007/s00248-010-9707-5; Lee NM, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P320, DOI 10.1079/9781845938147.0320; Ma YT, 2015, SCI REP-UK, V5, DOI 10.1038/srep07752; Mueller RC, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv153; Nugari MP, 2009, INT BIODETER BIODEGR, V63, P705, DOI 10.1016/j.ibiod.2009.03.013; Otlewska A, 2014, ACTA BIOCHIM POL, V61, P217; Pangallo D, 2012, WORLD J MICROB BIOT, V28, P2015, DOI 10.1007/s11274-012-1004-7; Pepe O, 2010, MICROBIOL RES, V165, P21, DOI 10.1016/j.micres.2008.03.005; Pinar G, 2010, MICROB ECOL, V60, P15, DOI 10.1007/s00248-010-9661-2; Porca E, 2012, FEMS MICROBIOL ECOL, V81, P255, DOI 10.1111/j.1574-6941.2012.01383.x; Portillo MC, 2008, J APPL MICROBIOL, V104, P681, DOI 10.1111/j.1365-2672.2007.03594.x; Principi P, 2011, MICROB ECOL, V61, P214, DOI 10.1007/s00248-010-9741-3; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sabev H, 2006, FUNGI BIOGEOCHEMICAL; Saiz-Jimenez C, 2012, WORLD J MICROB BIOT, V28, P2453, DOI 10.1007/s11274-012-1070-x; Saiz-Jimenez C, 2011, SCIENCE, V334, P42, DOI 10.1126/science.1206788; Sanchez-Moral S, 1999, SCI TOTAL ENVIRON, V243, P67, DOI 10.1016/S0048-9697(99)00348-4; Santos A, 2009, MICROB ECOL, V58, P692, DOI 10.1007/s00248-009-9564-2; Schabereiter-Gurtner C, 2001, ARCH MICROBIOL, V176, P347, DOI 10.1007/s002030100333; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V45, P77, DOI 10.1016/S0167-7012(01)00227-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; Stomeo F, 2008, INT BIODETER BIODEGR, V62, P483, DOI 10.1016/j.ibiod.2007.12.011; Vasanthakumar A, 2013, INT BIODETER BIODEGR, V79, P56, DOI 10.1016/j.ibiod.2013.01.014; Viles HA, 2012, GLOBAL CHANGE BIOL, V18, P2406, DOI 10.1111/j.1365-2486.2012.02713.x; Vivar I, 2013, INT BIODETER BIODEGR, V84, P372, DOI 10.1016/j.ibiod.2012.05.021; Wang WF, 2012, AEROBIOLOGIA, V28, P27, DOI 10.1007/s10453-011-9208-0; Wang WF, 2011, INT BIODETER BIODEGR, V65, P726, DOI 10.1016/j.ibiod.2011.04.006; Wang WF, 2010, INT BIODETER BIODEGR, V64, P461, DOI 10.1016/j.ibiod.2010.05.005; Wang WF, 2010, INT BIODETER BIODEGR, V64, P309, DOI 10.1016/j.ibiod.2010.03.004; Wu FS, 2011, DUNHUANG RES, V6, P51; Yan Fei, 2012, Weishengwu Xuebao, V52, P629; Zucconi L, 2012, INT BIODETER BIODEGR, V70, P40, DOI 10.1016/j.ibiod.2011.11.018	61	30	34	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179718	10.1371/journal.pone.0179718	http://dx.doi.org/10.1371/journal.pone.0179718			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA2LF	28678844	Green Submitted, gold, Green Published			2022-12-27	WOS:000405272200024
J	Hadar, A; Hadas, I; Lazarovits, A; Alyagon, U; Eliraz, D; Zangen, A				Hadar, Aviad; Hadas, Itay; Lazarovits, Avi; Alyagon, Uri; Eliraz, Daniel; Zangen, Abraham			Answering the missed call: Initial exploration of cognitive and electrophysiological changes associated with smartphone use and abuse	PLOS ONE			English	Article							MOBILE PHONE USE; DORSOLATERAL PREFRONTAL CORTEX; INTERVAL CORTICAL INHIBITION; HUMAN MOTOR CORTEX; PULSE TMS-EEG; INTERNET ADDICTION; SYMPTOMS; DISORDER; BEHAVIOR; GABA	Background Smartphone usage is now integral to human behavior. Recent studies associate extensive usage with a range of debilitating effects. We sought to determine whether excessive usage is accompanied by measurable neural, cognitive and behavioral changes. Method Subjects lacking previous experience with smartphones (n = 35) were compared to a matched group of heavy smartphone users (n = 16) on numerous behavioral and electrophysiological measures recorded using electroencephalogram (EEG) combined with transcranial magnetic stimulation (TMS) over the right prefrontal cortex (rPFC). In a second longitudinal intervention, a randomly selected sample of the original non-users received smartphones for 3 months while the others served as controls. All measurements were repeated following this intervention. Results Heavy users showed increased impulsivity, hyperactivity and negative social concern. We also found reduced early TMS evoked potentials in the rPFC of this group, which correlated with severity of self-reported inattention problems. Heavy users also obtained lower accuracy rates than nonusers in a numerical processing. Critically, the second part of the experiment revealed that both the numerical processing and social cognition domains are causally linked to smartphone usage. Conclusion Heavy usage was found to be associated with impaired attention, reduced numerical processing capacity, changes in social cognition, and reduced right prefrontal cortex (rPFC) excitability. Memory impairments were not detected. Novel usage over short period induced a significant reduction in numerical processing capacity and changes in social cognition.	[Hadar, Aviad; Zangen, Abraham] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Hadar, A; Zangen, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.	avhad@post.bgu.ac.il; azangen@bgu.ac.il	Hadas, Itay/J-5834-2019	Hadas, Itay/0000-0001-7518-1182; Zangen, Abraham/0000-0002-1488-5837; Hadar, Aviad/0000-0002-4994-9255; Lazarovits, Avi/0000-0001-5519-9174	Israeli Ministry of Science under the Prat and Eshkol scholarships	Israeli Ministry of Science under the Prat and Eshkol scholarships	The author received specific funding for this work from the Israeli Ministry of Science under the Prat and Eshkol scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboujaoude E, 2010, WORLD PSYCHIATRY, V9, P85; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashcraft M.H., 1995, MATH COGNITION, V1, P3; Augner C, 2012, INT J PUBLIC HEALTH, V57, P437, DOI 10.1007/s00038-011-0234-z; Bachner-Melman R, 2009, EUR J; Berger A, 2013, CHILD DEV, V84, P1616, DOI 10.1111/cdev.12072; Bianchi A, 2005, PSYCHOL PREDICTORS P, P39; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; Brand M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00375; Casarotto S, 2011, NEUROREPORT, V22, P592, DOI 10.1097/WNR.0b013e328349433a; Cash H, 2012, CURR PSYCHIATRY REV, V8, P292, DOI 10.2174/157340012803520513; Choi JS, 2014, PSYCHIAT RES, V215, P424, DOI 10.1016/j.psychres.2013.12.001; Choi SW, 2015, J BEHAV ADDICT, V4, P308, DOI 10.1556/2006.4.2015.043; Conners CK., 1999, J ATTEN DISORD, V3, P141, DOI [10.1177/108705479900300303, DOI 10.1177/108705479900300303, 10.1177/108705479900300304]; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Daskalakis ZJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2860, DOI 10.1038/npp.2008.22; Daskalakis ZJ, 2014, PLOS ONE, V9; DeStefano D, 2004, EUR J COGN PSYCHOL, V16, P353, DOI 10.1080/09541440244000328; Edden RAE, 2012, ARCH GEN PSYCHIAT, V69, P750, DOI 10.1001/archgenpsychiatry.2011.2280; Falbe J, 2015, PEDIATRICS, V135, pE367, DOI 10.1542/peds.2014-2306; Hadar AA, 2012, BRAIN STIMUL, V5, P652, DOI 10.1016/j.brs.2011.08.001; Hadas I, 2016, SCI REP-UK, V6, DOI 10.1038/srep21129; Hernandez-Pavon JC, 2012, J NEUROSCI METH, V209, P144, DOI 10.1016/j.jneumeth.2012.05.029; Huber R, 2013, CEREB CORTEX, V23, P1, DOI 10.1093/cercor/bhs014; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; Kim SM, 2012, J BEHAV ADDICT, V1, P41, DOI 10.1556/JBA.1.2012.2.1; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; Lee YK, 2014, COMPUT HUM BEHAV, V31, P373, DOI 10.1016/j.chb.2013.10.047; Lopez-Fernandez O, 2015, ADDICT BEHAV; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montag C, 2015, BEHAV SCI-BASEL, V5, P434, DOI 10.3390/bs5040434; Nasar JL, 2013, ACCIDENT ANAL PREV, V57, P91, DOI 10.1016/j.aap.2013.03.021; Noda Y, 2017, AGING-US, V9, P556, DOI 10.18632/aging.101178; Pawlikowski M, 2011, PSYCHIAT RES, V188, P428, DOI 10.1016/j.psychres.2011.05.017; Premoli I, 2014, NEUROIMAGE, V103, P152, DOI 10.1016/j.neuroimage.2014.09.028; Reed P, 2015, COMPUT HUM BEHAV, V49, P512, DOI 10.1016/j.chb.2015.03.064; Rogasch NC, 2015, CORTEX, V64, P68, DOI 10.1016/j.cortex.2014.10.003; Rogasch NC, 2013, J NEUROPHYSIOL, V109, P89, DOI 10.1152/jn.00762.2012; Rosen LD, 2013, COMPUT HUM BEHAV, V29, P1243, DOI 10.1016/j.chb.2012.11.012; Salehan M, 2013, COMPUT HUM BEHAV, V29, P2632, DOI 10.1016/j.chb.2013.07.003; Smith DC, 2013, J SAFETY RES, V47, P19, DOI 10.1016/j.jsr.2013.08.003; Spada MM, 2014, ADDICT BEHAV, V39, P3, DOI 10.1016/j.addbeh.2013.09.007; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Takao M, 2009, CYBERPSYCHOL BEHAV, V12, P501, DOI 10.1089/cpb.2009.0022; Thomee S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-66; Thompson LL, 2013, INJURY PREV, V19, P232, DOI 10.1136/injuryprev-2012-040601; Walsh SP, 2011, COMPUT HUM BEHAV, V27, P333, DOI 10.1016/j.chb.2010.08.011; Wang PW, 2014, COMPR PSYCHIAT, V55, P342, DOI 10.1016/j.comppsych.2013.09.006; Weinstein A, 2017, NEUROSCI BIOBEHAV R, V75, P314, DOI 10.1016/j.neubiorev.2017.01.040; Yoo HJ, 2004, PSYCHIAT CLIN NEUROS, V58, P487, DOI 10.1111/j.1440-1819.2004.01290.x; Zheng FZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1022	52	40	42	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180094	10.1371/journal.pone.0180094	http://dx.doi.org/10.1371/journal.pone.0180094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678870	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200038
J	Skar, MW; Haugland, GT; Powell, MD; Wergeland, HI; Samuelsen, OB				Skar, Malene W.; Haugland, Gyri T.; Powell, Mark D.; Wergeland, Heidrun I.; Samuelsen, Ole B.			Development of anaesthetic protocols for lumpfish (Cyclopterus lumpus L.): Effect of anaesthetic concentrations, sea water temperature and body weight	PLOS ONE			English	Article							DENTAL AFFERENT NEURONS; SALMON SALMO-SALAR; COD GADUS-MORHUA; ATLANTIC COD; TELEOST FISH; ONCORHYNCHUS-MYKISS; LOCAL-ANESTHETICS; TRICAINE MS-222; PLASMA-CORTISOL; XENOPUS OOCYTES	In recent years, use of lumpfish (Cyclopterus lumpus L.) as cleaner-fish to remove sea-lice have been chosen by many salmon farmers in Europe and Canada as an alternative to medical treatment, which has led to large scale production of lumpfish. At present, there is limited knowledge of how lumpfish respond upon anaesthesia, which anaesthetics and concentrations that are efficient and conditions for euthanasia. We have therefore tested and developed protocols for bath immersion for three commonly used anaesthetics metacaine (Finquel, buffered tricaine methanesulfonate, MS-222 and Tricaine Pharmaq), benzocaine (Benzoak vet) and isoeugenol (Aqui-S), determined concentration for normal and fast anaesthesia and evaluated safety margin for each condition. Also, a behavioral matrix has been developed. We have examined the effect of fish size (10-20 g, 200-400 g and 600-1300 g) and sea water temperature (6 degrees C and 12 degrees C). We found that 200 mg L-1 metacaine is an efficient dose for deep narcosis independently for fish size and temperature due to good safety margins with regards to both exposure times and doses. However, for many tasks lighter anaesthesia is sufficient, and then 100 mg L-1 metacaine can be used. Benzocaine is less efficient than metacaine, but can be used as anaesthetic of fish < 400 g. The optimal doses of benzocaine were 100-200 mg L-1 for small fish (10-20 g) and 200 mg L-1 for medium sized fish (200-400 g). For larger fish (> 600 g), benzocaine is not suitable. Isoeugenol cannot be recommended for full anesthesia of lumpfish. The conditions for lethal doses varied with chosen anaesthetic, fish size and temperature. For small fish (10-20 g), exposure to 1600 mgL(-1) of metacaine in 10 minutes it lethal. Guided protocols for non-lethal anaesthesia will contribute to ensure safe treatment of lumpfish according to an ethical standard for good fish welfare.	[Skar, Malene W.; Haugland, Gyri T.; Powell, Mark D.; Wergeland, Heidrun I.; Samuelsen, Ole B.] Univ Bergen, Dept Biol, Bergen, Norway; [Samuelsen, Ole B.] Inst Marine Res, Bergen, Norway	University of Bergen; Institute of Marine Research - Norway	Haugland, GT (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	Gyr.Haugland@uib.no		Haugland, Gyri/0000-0001-9494-9214	Research Council of Norway [244148 GTH]	Research Council of Norway(Research Council of Norway)	This work was supported by The Research Council of Norway (grant number 244148 GTH)	Ackerman P., 2005, CCAC GUIDELINES FISH; Aoshima H, 1999, BIOSCI BIOTECH BIOCH, V63, P743, DOI 10.1271/bbb.63.743; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bell G., CANADIAN TECHNICAL R, P16; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bowser P.R., 2001, RECENT ADV VET ANEST; Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Dunlop R, 2005, J PAIN, V6, P561, DOI 10.1016/j.jpain.2005.02.010; FRAZIER DT, 1975, EUR J PHARMACOL, V33, P313, DOI 10.1016/0014-2999(75)90175-2; GILDERHUS P A, 1987, North American Journal of Fisheries Management, V7, P288, DOI 10.1577/1548-8659(1987)7&lt;288:CEOACO&gt;2.0.CO;2; Hale ME, 2000, AM ZOOL, V40, P1040; Hara K, 2007, ANESTH ANALG, V104, P1434, DOI 10.1213/01.ane.0000261509.72234.a6; Hedrick MS, 2003, AM J PHYSIOL-REG I, V284, pR405, DOI 10.1152/ajpregu.00418.2002; HIKASA Y, 1986, JPN J VET SCI, V48, P341; Hoskonen P, 2004, J FISH BIOL, V64, P1136, DOI 10.1111/j.1095-8649.2004.00359.x; HOUSTON AH, 1976, COMP BIOCHEM PHYS C, V54, P1, DOI 10.1016/0306-4492(76)90016-2; Imsland AK, 2014, AQUACULTURE, V424, P18, DOI 10.1016/j.aquaculture.2013.12.033; Iversen MH, 2014, SEDASJON BERGGYLTE R, P42; Javahery S, 2012, FISH PHYSIOL BIOCHEM, V38, P1545, DOI 10.1007/s10695-012-9682-5; Kiessling A, 2009, AQUACULTURE, V286, P301, DOI 10.1016/j.aquaculture.2008.09.037; Kristan J, 2014, NEUROENDOCRINOL LETT, V35, P81; Lee MH, 2005, J DENT RES, V84, P848, DOI 10.1177/154405910508400913; MARKING LL, 1985, FISHERIES, V10, P2, DOI 10.1577/1548-8446(1985)010<0002:ABANIF>2.0.CO;2; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; NEUMCKE B, 1981, PFLUG ARCH EUR J PHY, V390, P230, DOI 10.1007/BF00658267; OLSEN YA, 1995, AQUACULTURE, V134, P155, DOI 10.1016/0044-8486(95)00008-P; Park CK, 2006, J DENT RES, V85, P900, DOI 10.1177/154405910608501005; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Powell AJ, 2017, ROUTL STUD RELIG, P1; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P1, DOI 10.1002/9781444302264; SAUNDERS RL, 1963, J FISH RES BOARD CAN, V20, P373, DOI 10.1139/f63-031; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Stehly GR, 1999, AQUAC RES, V30, P365, DOI 10.1046/j.1365-2109.1999.00339.x; SYLVESTER JR, 1982, PROG FISH CULT, V44, P138, DOI 10.1577/1548-8659(1982)44[138:IOTWHA]2.0.CO;2; Tsantilas H, 2006, AQUACULTURE, V253, P64, DOI 10.1016/j.aquaculture.2005.07.034; Ueta K, 2007, REGION ANESTH PAIN M, V32, P462, DOI 10.1016/j.rapm.2007.06.391; Wie MB, 1997, NEUROSCI LETT, V225, P93, DOI 10.1016/S0304-3940(97)00195-X; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zahl IH, 2011, AQUAC RES, V42, P1235, DOI 10.1111/j.1365-2109.2010.02711.x; Zahl IH, 2010, FISH PHYSIOL BIOCHEM, V36, P719, DOI 10.1007/s10695-009-9346-2; Zahl IH, 2009, AQUACULTURE, V295, P52, DOI 10.1016/j.aquaculture.2009.06.019	48	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179344	10.1371/journal.pone.0179344	http://dx.doi.org/10.1371/journal.pone.0179344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678815	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000405272200013
J	Alcantara, RS; Wall-Scheffler, CM				Alcantara, Ryan S.; Wall-Scheffler, Cara M.			Stroller running: Energetic and kinematic changes across pushing methods	PLOS ONE			English	Article							JOGGING STROLLER; WALKING; RESPONSES; EXERCISE; HUMANS; COST	Objective Running with a stroller provides an opportunity for parents to exercise near their child and counteract health declines experienced during early parenthood. Understanding biomechanical and physiological changes that occur when stroller running is needed to evaluate its health impact, yet the effects of stroller running have not been clearly presented. Here, three commonly used stroller pushing methods were investigated to detect potential changes in energetic cost and lower-limb kinematics. Methods Sixteen individuals (M/F: 10/6) ran at self-selected speeds for 800m under three stroller conditions (2-Hands, 1-Hand, and Push/Chase) and an independent running control. Results A significant decrease in speed (p = 0.001) and stride length (p<0.001) was observed between the control and stroller conditions, however no significant change in energetic cost (p = 0.080) or heart rate (p = 0.393) was observed. Additionally, pushing method had a significant effect on speed (p = 0.001) and stride length (p<0.001). Conclusions These findings suggest that pushing technique influences stroller running speed and kinematics. These findings suggest specific fitness effects may be achieved through the implementation of different pushing methods.	[Alcantara, Ryan S.; Wall-Scheffler, Cara M.] Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA; [Wall-Scheffler, Cara M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Alcantara, RS (corresponding author), Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA.	alcantarar@spu.edu		Alcantara, Ryan/0000-0002-8539-711X; Wall-Scheffler, Cara/0000-0002-0224-0476				Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Arellano CJ, 2014, J EXP BIOL, V217, P2456, DOI 10.1242/jeb.100420; Birken CS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1989-6; Brown GA, 2007, AFR J PHYS HLTH ED R, V14, P240; Garcin M, 1996, EUR J APPL PHYSIOL O, V72, P478, DOI 10.1007/BF00242278; Garfield CF, AM J MENS H IN PRESS; Greany JF, 2013, J WOMENS HLTH PHYS T, V37, P103; Gregory DA, 2012, INT J SPORTS MED, V33, P711, DOI 10.1055/s-0031-1299748; LONDEREE BR, 1995, MED SCI SPORT EXER, V27, P458; Meckes Nathanael, 2013, Int J Exerc Sci, V6, P11; O'Sullivan R, 2016, GAIT POSTURE, V43, P220, DOI 10.1016/j.gaitpost.2015.10.001; Ostbye T, 2009, AM J PREV MED, V37, P173, DOI 10.1016/j.amepre.2009.05.016; Pagliara R, 2014, J EXP BIOL, V217, P2939, DOI 10.1242/jeb.105270; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Perret C, 2006, INT J SPORTS MED, V27, P363, DOI 10.1055/s-2005-865666; Selinger JC, 2015, CURR BIOL, V25, P2452, DOI 10.1016/j.cub.2015.08.016; Smith JD, 2005, J SPORT MED PHYS FIT, V45, P270; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Wall-Scheffler CM, 2017, ANAT REC, V300, P764, DOI 10.1002/ar.23553; Wall-Scheffler CM, 2015, INTEGR COMP BIOL, V55, P1155, DOI 10.1093/icb/icv072; Wall-Scheffler CM, 2013, J HUM EVOL, V64, P448, DOI 10.1016/j.jhevol.2013.01.014; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180575	10.1371/journal.pone.0180575	http://dx.doi.org/10.1371/journal.pone.0180575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672004	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500070
J	Ogata, T; Nakamura, M; Sang, MJ; Yoda, H; Hiraoka, K; Yin, DJ; Sang, MX; Shimozato, O; Ozaki, T				Ogata, Takehiro; Nakamura, Mizuyo; Sang, Meijie; Yoda, Hiroyuki; Hiraoka, Kiriko; Yin, Danjing; Sang, Mexiang; Shimozato, Osamu; Ozaki, Toshinori			Depletion of runt- related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; P53-DEPENDENT APOPTOSIS; GEMCITABINE SENSITIVITY; EXPRESSION; PROTEIN; GAIN; GENE; RESISTANCE; INDUCTION	Suberoylanilide hydroxamic acid (SAHA) represents one of the new class of anti-cancer drugs. However, multiple lines of clinical evidence indicate that SAHA might be sometimes ineffective on certain solid tumors including pancreatic cancer. In this study, we have found for the first time that RUNX2/mutant p53/TAp63-regulatory axis has a pivotal role in the determination of SAHA sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells. According to our present results, MiaPaCa-2 cells responded poorly to SAHA. Forced depletion of mutant p53 stimulated SAHA-mediated cell death of MiaPaCa-2 cells, which was accomapanied by a further accumulation of.H2AX and cleaved PARP. Under these experimental conditions, pro-oncogenic RUNX2 was strongly down-regulated in mutant p53depleted MiaPaCa-2 cells. Surprisingly, RUNX2 silencing augmented SAHA-dependent cell death of MiaPaCa-2 cells and caused a significant reduction of mutant p53. Consistent with these observations, overexpression of RUNX2 in MiaPaCa-2 cells restored SAHA-mediated decrease in cell viability and increased the amount of mutant p53. Thus, it is suggestive that there exists a positive auto-regulatory loop between RUNX2 and mutant p53, which might amplify their pro-oncogenic signals. Intriguingly, knockdown of mutant p53 or RUNX2 potentiated SAHA-induced up-regulation of TAp63. Indeed, SAHA-stimulated cell death of MiaPaCa-2 cells was partially attenuated by p63 depletion. Collectively, our present observations strongly suggest that RUNX2/mutant p53/TAp63-regulatory axis is one of the key determinants of SAHA sensitivity of p53-mutated pancreatic cancer cells.	[Ogata, Takehiro; Nakamura, Mizuyo; Sang, Meijie; Shimozato, Osamu; Ozaki, Toshinori] Chiba Canc Ctr, Lab DNA Damage Signaling, Res Inst, Chiba, Japan; [Sang, Meijie] Univ Toyama, Grad Sch Med, Dept Regenerat Med, Toyama, Japan; [Yoda, Hiroyuki; Hiraoka, Kiriko] Chiba Canc Ctr, Canc Genet Lab, Res Inst, Chiba, Japan; [Yin, Danjing; Sang, Mexiang] Hebei Med Univ, Hosp 4, Res Ctr, Shijiazhuang, Hebei, Peoples R China	Chiba Cancer Center; University of Toyama; Chiba Cancer Center; Hebei Medical University	Ozaki, T (corresponding author), Chiba Canc Ctr, Lab DNA Damage Signaling, Res Inst, Chiba, Japan.	tozaki@chiba-cc.jp		Yoda, Hiroyuki/0000-0002-5528-8940	JSPS (MEXT) KAKENHI [23501278]; Grants-in-Aid for Scientific Research [15K08412] Funding Source: KAKEN	JSPS (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work received support from JSPS (MEXT) KAKENHI Grant Number 23501278.	Allocati N, 2012, EXP CELL RES, V318, P1285, DOI 10.1016/j.yexcr.2012.01.023; Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Barnes GL, 2003, CANCER RES, V63, P2631; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Boregowda RK, 2014, CANCER LETT, V348, P61, DOI 10.1016/j.canlet.2014.03.011; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Butler LM, 2006, INT J CANCER, V119, P944, DOI 10.1002/ijc.21939; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gokulnath M, 2015, TUMOR BIOL, V36, P1923, DOI 10.1007/s13277-014-2796-x; Grant S, 2007, NAT REV DRUG DISCOV, V6, P21, DOI 10.1038/nrd2227; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Guo ZJ, 2016, ONCOTARGET, V7, P20999, DOI 10.18632/oncotarget.8236; Haupt S, 2009, CANCER RES, V69, P4818, DOI 10.1158/0008-5472.CAN-08-4010; Ikawa S, 1999, CELL DEATH DIFFER, V6, P1154, DOI 10.1038/sj.cdd.4400631; Kaino M, 1997, J GASTROENTEROL, V32, P40, DOI 10.1007/BF01213295; Kayed H, 2007, BRIT J CANCER, V97, P1106, DOI 10.1038/sj.bjc.6603984; Knudsen ES, 2016, GASTROENTEROLOGY, V150, P48, DOI 10.1053/j.gastro.2015.08.056; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Koutsounas I, 2013, WORLD J GASTROENTERO, V19, P1173, DOI 10.3748/wjg.v19.i8.1173; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Le A, 2012, CLIN CANCER RES, V18, P4285, DOI 10.1158/1078-0432.CCR-12-0041; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Lee YJ, 2012, INT J MED SCI, V9, P881, DOI 10.7150/ijms.5011; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Li RZ, 1998, ONCOGENE, V16, P3269, DOI 10.1038/sj.onc.1201867; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Muller PA, 2009, NAT CELL BIOL, V15, P2; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nakamura M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.40; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ozaki T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.127; Ozaki T, 2016, ONCOTARGET; Ozaki T, 2015, FEBS J, V282, P114, DOI 10.1111/febs.13108; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Shim SH, 2010, TUMOR BIOL, V31, P659, DOI 10.1007/s13277-010-0083-z; Shin MH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005884; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soshnev AA, 2016, MOL CELL, V62, P681, DOI 10.1016/j.molcel.2016.05.004; Stojanovic N, 2016, ONCOGENE, V344; Suenaga Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003996; Sugimoto H, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.10; Wang Q, 2016, ONCOTARGET, V7, P10064, DOI 10.18632/oncotarget.7134; Wang ZT, 2016, CELL SIGNAL, V28, P506, DOI 10.1016/j.cellsig.2016.02.006; Wei SS, 2014, J BIOL CHEM, V289, P8947, DOI 10.1074/jbc.M113.503755; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zheng L, 2014, INT J CANCER, V135, P1721, DOI 10.1002/ijc.28810; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	54	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179884	10.1371/journal.pone.0179884	http://dx.doi.org/10.1371/journal.pone.0179884			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671946	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500007
J	Chang, WJ; Bennell, KL; Hodges, PW; Hinman, RS; Young, CL; Buscemi, V; Liston, MB; Schabrun, SM				Chang, Wei-Ju; Bennell, Kim L.; Hodges, Paul W.; Hinman, Rana S.; Young, Carolyn L.; Buscemi, Valentina; Liston, Matthew B.; Schabrun, Siobhan M.			Addition of transcranial direct current stimulation to quadriceps strengthening exercise in knee osteoarthritis: A pilot randomised controlled trial	PLOS ONE			English	Article							DC STIMULATION; PAIN; EXCITABILITY; BRAIN; HIP; CLASSIFICATION; RELIABILITY; PERFORMANCE; MODULATION; THRESHOLD	A randomised, assessor-and participant-blind, sham-controlled trial was conducted to assess the safety and feasibility of adding transcranial direct current stimulation (tDCS) to quadriceps strengthening exercise in knee osteoarthritis (OA), and provide data to inform a fully powered trial. Participants were randomised to receive active tDCS+exercise (AT+EX) or sham tDCS+exercise (ST+EX) twice weekly for 8 weeks whilst completing home exercises twice per week. Feasibility, safety, patient-perceived response, pain, function, pressure pain thresholds (PPTs) and conditioned pain modulation (CPM) were assessed before and after treatment. Fifty-seven people were screened for eligibility. Thirty (52%) entered randomisation and 25 (84%) completed the trial. One episode of headache in the AT+EX group was reported. Pain reduced in both groups following treatment (AT+EX: p<0.001, partial eta(2) = 0.55; ST+EX: p = 0.026, partial eta(2) = 0.18) but no between-group differences were observed (p = 0.18, partial eta(2) = 0.08). Function improved in the AT+EX (p = 0.01, partial eta(2) = 0.22), but not the ST+EX (p = 0.16, partial eta(2) = 0.08) group, between-group differences did not reach significance (p = 0.28, partial eta(2) = 0.052). AT+EX produced greater improvements in PPTs than ST+EX (p<0.05) (superolateral knee: partial eta(2) = 0.17; superior knee: partial eta(2) = 0.3; superomedial knee: partial eta(2) = 0.26). CPM only improved in the AT+EX group but no between-group difference was observed (p = 0.054, partial eta(2) = 0.158). This study provides the first feasibility and safety data for the addition of tDCS to quadriceps strengthening exercise in knee OA. Our data suggest AT+EX may improve pain, function and pain mechanisms beyond that of ST+EX, and provides support for progression to a fully powered randomised controlled trial.	[Chang, Wei-Ju; Young, Carolyn L.; Buscemi, Valentina; Liston, Matthew B.; Schabrun, Siobhan M.] Univ Sydney Western, Sch Sci & Hlth, Sydney, NSW, Australia; [Bennell, Kim L.; Hinman, Rana S.] Univ Melbourne, Sch Hlth Sci, Melbourne, Vic, Australia; [Hodges, Paul W.] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	University of Melbourne; University of Queensland	Schabrun, SM (corresponding author), Univ Sydney Western, Sch Sci & Hlth, Sydney, NSW, Australia.	s.schabrun@westernsydney.edu.au	Hodges, Paul W/B-6578-2008; Chang, Wei-Ju/ABC-1680-2021	Hodges, Paul W/0000-0002-1206-9107; Chang, Wei-Ju/0000-0003-0524-4883; Liston, Matthew/0000-0002-9694-6268; Schabrun, Siobhan/0000-0002-9083-3107	Arthritis Australia; National Health and Medical Research Council of Australia [1094434, 1002190, 1058440, 1059116, 1105040]; Australian Research Council [130100175]; Western Sydney University Postgraduate Research Award	Arthritis Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Western Sydney University Postgraduate Research Award	This trial was funded by Arthritis Australia (The Zimmer Australia Grant).W-JC(1094434), PWH (1002190), KLB (1058440), MBL (1059116) and SMS (1105040) receive salary support from the National Health and Medical Research Council of Australia, RSH from the Australian Research Council (FT#130100175) and VB from a Western Sydney University Postgraduate Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Arendt-Nielsen L, 2015, EUR J PAIN, V19, P1406, DOI 10.1002/ejp.651; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Bagce HF, 2013, J NEUROPHYSIOL, V109, P1097, DOI 10.1152/jn.00304.2012; Bellamy N, 1997, J RHEUMATOL, V24, P768; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bennell KL, 2013, CLIN J PAIN, V29, P26; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Carlesso LC, 2010, J ORTHOP SPORT PHYS, V40, P455, DOI 10.2519/jospt.2010.3229; Chang WJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008482; Fenton BW, 2009, BRAIN STIMUL, V2, P103, DOI 10.1016/j.brs.2008.09.009; Fingleton C, 2015, OSTEOARTHRITIS CARTI; Fransen M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub3; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Giacobbe V, 2013, NEUROREHABILITATION, V33, P49, DOI 10.3233/NRE-130927; Gierisch JM, 2014, ANN INTERN MED, V160, P836, DOI 10.7326/M14-0318; Hendy AM, 2013, MED SCI SPORT EXER, V45, P1721, DOI 10.1249/MSS.0b013e31828d2923; Hirano M, 2015, BRAIN STIMUL, V8, P1195, DOI 10.1016/j.brs.2015.07.025; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hoffman MD, 2004, ARCH PHYS MED REHAB, V85, P1183, DOI 10.1016/j.apmr.2003.09.010; Jensen JL, 2005, J APPL PHYSIOL, V99, P1558, DOI 10.1152/japplphysiol.01408.2004; Juhl C, 2014, ARTHRITIS RHEUMATOL, V66, P622, DOI 10.1002/art.38290; Koltyn KF, 1998, BRIT J SPORT MED, V32, P20, DOI 10.1136/bjsm.32.1.20; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Lange AK, 2008, ARTHRIT RHEUM-ARTHR, V59, P1488, DOI 10.1002/art.24118; Lattari E, 2016, J STRENGTH COND RES; Lee Soo-Jin, 2012, Evid Based Complement Alternat Med, V2012, P190370, DOI 10.1155/2012/190370; Lewis GN, 2012, PAIN RES MANAG, V17, P98, DOI 10.1155/2012/610561; Ljubisavljevic M, 2006, EXP BRAIN RES, V173, P215, DOI 10.1007/s00221-006-0538-z; Lluch E, 2014, EUR J PAIN; Marlow NM, 2013, PAIN PRACT, V13, P131, DOI 10.1111/j.1533-2500.2012.00562.x; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Mehta S, 2015, SPINAL CORD; Mendonca ME, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00068; Mendonca ME, 2011, J PAIN, V12, P610, DOI 10.1016/j.jpain.2010.12.015; Micalos PS, 2009, EUR J APPL PHYSIOL, V105, P55, DOI 10.1007/s00421-008-0872-x; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Moher D, 2012, INT J SURG, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moreton BJ, 2015, ARTHRIT CARE RES, V67, P519, DOI 10.1002/acr.22431; Nijs J, 2014, MAN THER; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; O'Connell NE, 2011, EUR J PHYS REHAB MED, V47, P309; O'Leary S, 2007, J PAIN, V8, P832, DOI 10.1016/j.jpain.2007.05.014; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Reis J, 2011, CURR OPIN NEUROL, V24, P590, DOI 10.1097/WCO.0b013e32834c3db0; Ribeiro DC, 2014, J ORTHOP SPORT PHYS, V44, P702, DOI 10.2519/jospt.2014.5009; Rizzo V, 2014, BRAIN STIMUL, V7, P113, DOI 10.1016/j.brs.2013.10.002; Schabrun S, 2012, MAN THERAP, V17; Schabrun SM, 2014, BRAIN STIMUL, V7, P451, DOI 10.1016/j.brs.2014.01.058; Schabrun SM, 2012, MANUAL THER, V17, P184, DOI 10.1016/j.math.2011.12.001; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; Uthman OA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5555; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Williams VJ, 2012, J ORTHOP SPORT PHYS, V42, P716, DOI 10.2519/jospt.2012.4038; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wylde V, 2011, OSTEOARTHR CARTILAGE, V19, P655, DOI 10.1016/j.joca.2011.02.009; Zaghi S, 2011, RESTOR NEUROL NEUROS, V29, P439, DOI 10.3233/RNN-2011-0615	62	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180328	10.1371/journal.pone.0180328	http://dx.doi.org/10.1371/journal.pone.0180328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665989	Green Published, gold			2022-12-27	WOS:000404608700086
J	Choi, HY; Kim, SH; Choi, AR; Kim, SG; Kim, H; Lee, JE; Kim, HJ; Park, HC				Choi, Hoon Young; Kim, Seok-hyung; Choi, Ah Ran; Kim, Seung Gyu; Kim, Hyunwook; Lee, Jung Eun; Kim, Hyung Jong; Park, Hyeong Cheon			Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population	PLOS ONE			English	Article							SERUM URIC-ACID; PULSE-WAVE VELOCITY; CARDIOVASCULAR-DISEASE; HORMONE REPLACEMENT; BLOOD-PRESSURE; FOLLOW-UP; ATHEROSCLEROSIS; ASSOCIATION; MORTALITY; IMPACT	Hyperuricemia is a risk factor for cardiovascular disease and is associated with increased arterial stiffness in high-risk populations. However, given the possible sex-related differences in the prevalence of hyperuricemia, the association between elevated serum uric acid (SUA) level and increased arterial stiffness has yielded conflicting results. We investigated the relationship between SUA and arterial stiffness in asymptomatic healthy subjects who underwent a health examination. Subjects who underwent a comprehensive health examination were enrolled. After exclusion of extensive confounding factors, 2,704 healthy subjects with coronary calcium score < 100 were evaluated in the final analysis. All subjects underwent brachial D ankle pulse wave velocity (baPWV) to detect arterial stiffness. The SUA was divided into quartiles for its association with arterial stiffness and was analyzed separately for men and women. The mean SUA level was significantly lower in women than in men. The baPWV was significantly elevated in subjects with the highest quartile of SUA in women, but not in men. After adjusting for age, smoking, systolic blood pressure, body mass index, estimated glomerular filtration rate, fasting plasma glucose, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, and coronary artery calcium score, the highest quartile of SUA in women was significantly associated with increased risk of high baPWV compared with the lowest quartile of SUA (OR = 1.7, p = 0.018), whereas in men, SUA level was not associated with high baPWV. Our study showed that elevated SUA is independently associated with increased baPWV in healthy Korean women, but not in men.	[Choi, Hoon Young; Kim, Seok-hyung; Choi, Ah Ran; Kim, Seung Gyu; Kim, Hyunwook; Park, Hyeong Cheon] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Choi, Hoon Young; Park, Hyeong Cheon] Yonsei Univ, Severance Inst Vasc & Metab Res, Coll Med, Seoul, South Korea; [Lee, Jung Eun] Yonsei Univ, Coll Med, Dept Internal Med, Yongin Severance Hosp, Seoul, South Korea; [Kim, Hyung Jong] CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Seongnam, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University	Park, HC (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.; Park, HC (corresponding author), Yonsei Univ, Severance Inst Vasc & Metab Res, Coll Med, Seoul, South Korea.; Kim, HJ (corresponding author), CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Seongnam, South Korea.	khj04@cha.ac.kr; AMP97@yuhs.ac		CHOI, HOON YOUNG/0000-0002-4245-0339; LEE, JUNG EUN/0000-0003-0917-2872; Park, Hyeong-Cheon/0000-0002-1550-0812; Kim, Hyunwook/0000-0002-4274-7562				Cipolli JAA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-52; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Andres M, 2016, ARTHRITIS RHEUMATOL, V68, P1531, DOI 10.1002/art.39581; Bae JS, 2013, ATHEROSCLEROSIS, V231, P145, DOI 10.1016/j.atherosclerosis.2013.08.017; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Barbieri L, 2015, ATHEROSCLEROSIS, V241, P241, DOI 10.1016/j.atherosclerosis.2015.03.030; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P724, DOI 10.2215/CJN.07700910; Chen X, 2010, AM J HYPERTENS, V23, P387, DOI 10.1038/ajh.2009.277; Choo J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-5; Cicero AFG, 2017, EUR J INTERN MED, V37, P38, DOI 10.1016/j.ejim.2016.07.026; Cicero AFG, 2016, INTERN EMERG MED, V11, P77, DOI 10.1007/s11739-015-1310-9; Cicero AFG, 2014, J HYPERTENS, V32, P57, DOI 10.1097/HJH.0b013e328365b916; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Davidson MB, 1999, J DIABETES COMPLICAT, V13, P52, DOI 10.1016/S1056-8727(98)00017-8; Erdogan D, 2005, INT J CLIN PRACT, V59, P1276, DOI 10.1111/j.1742-1241.2005.00621.x; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Fang JI, 2014, ATHEROSCLEROSIS, V236, P389, DOI 10.1016/j.atherosclerosis.2014.07.024; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Hayward CS, 2001, AM J HYPERTENS, V14, P699, DOI 10.1016/S0895-7061(01)01290-0; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Heo SH, 2010, J NEUROL SCI, V297, P6, DOI 10.1016/j.jns.2010.07.007; Hoieggen A, 2004, KIDNEY INT, V65, P1041, DOI 10.1111/j.1523-1755.2004.00484.x; Ishizaka N, 2007, ATHEROSCLEROSIS, V192, P131, DOI 10.1016/j.atherosclerosis.2006.04.016; Juraschek SP, 2014, ATHEROSCLEROSIS, V233, P623, DOI 10.1016/j.atherosclerosis.2014.01.026; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kawai T, 2015, HEART VESSELS, V30, P338, DOI 10.1007/s00380-014-0485-8; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Krishnan E, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3322; Lee SH, 2015, YONSEI MED J, V56, P1545, DOI 10.3349/ymj.2015.56.6.1545; LEVINE W, 1989, J CLIN EPIDEMIOL, V42, P257, DOI 10.1016/0895-4356(89)90061-9; Li X, 2015, RHEUMATOLOGY INT; Ljubojevic M, 2004, AM J PHYSIOL-RENAL, V287, pF124, DOI 10.1152/ajprenal.00029.2004; Madsen Troy E, 2005, Am J Nephrol, V25, P45, DOI 10.1159/000084085; Many A, 1996, AM J OBSTET GYNECOL, V174, P288, DOI 10.1016/S0002-9378(96)70410-6; Munakata M, 2003, AM J HYPERTENS, V16, P653, DOI 10.1016/S0895-7061(03)00918-X; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; Ohnishi H, 2003, DIABETES CARE, V26, P437, DOI 10.2337/diacare.26.2.437; Park JS, 2012, MATURITAS, V73, P344, DOI 10.1016/j.maturitas.2012.09.009; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; RAO GN, 1991, J BIOL CHEM, V266, P8604; Ruscica M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005764; Saijo Y, 2005, J HUM HYPERTENS, V19, P907, DOI 10.1038/sj.jhh.1001913; Schlotte V, 1998, FREE RADICAL BIO MED, V25, P839, DOI 10.1016/S0891-5849(98)00160-9; Shin JY, 2012, VASC MED, V17, P37, DOI 10.1177/1358863X11434197; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tamariz Leonardo, 2011, Congest Heart Fail, V17, P25, DOI 10.1111/j.1751-7133.2011.00200.x; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Viazzi Francesca, 2006, J Clin Hypertens (Greenwich), V8, P510, DOI 10.1111/j.1524-6175.2006.04755.x; Xiong Z, 2013, J NUTR HEALTH AGING, V17, P30, DOI 10.1007/s12603-012-0076-2; Xiong ZJ, 2012, J ATHEROSCLER THROMB, V19, P970, DOI 10.5551/jat.13326; Yamashina A, 2003, HYPERTENS RES, V26, P801, DOI 10.1291/hypres.26.801; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yousefzadeh G, 2013, ARYA ATHEROSCLER, V9, P332; Yu SS, 2015, GYNECOL ENDOCRINOL, V31, P736, DOI 10.3109/09513590.2015.1056730	57	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180406	10.1371/journal.pone.0180406	http://dx.doi.org/10.1371/journal.pone.0180406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666027	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608700006
J	Cordero, H; Ceballos-Francisco, D; Cuesta, A; Esteban, MA				Cordero, Hector; Ceballos-Francisco, Diana; Cuesta, Alberto; Angeles Esteban, Maria			Dorso-ventral skin characterization of the farmed fish gilthead seabream (Sparus aurata)	PLOS ONE			English	Article							LYMPHOCYSTIS DISEASE; MUCUS PROTEOME; SEA BREAM; TELEOST; PROFILE; REGENERATION; DORSAL; CELLS; MAP	The skin is the first barrier of defence in fish, protecting against any external stressor and preserving the integrity and homeostasis of the fish body. The aim of this study was to characterise gilthead seabream skin by isolating cells and studying the cell cycle by flow cytometry, to study the skin histology by scanning electron microscopy and the transcription level of some immune-relevant genes by RT-PCR. Furthermore, the results obtained from samples taken from the dorsal and the ventral part of the specimens are compared. No differences were observed in the cell cycle of cells isolated from the dorsal and ventral zones of the skin or in the gene expression of the genes studied in both epidermal zones. However, the epidermis thickness of the ventral skin was higher than that of the dorsal skin, as demonstrated by image analysis using light microscopy. Besides, scanning electron microscopy pointed to a greater cell size and area of microridges in the apical part of the dorsal epidermal cells compared with ventral skin epidermal cells. This study represents a step forward in our knowledge of the skin structure of an important farmed teleost, gilthead seabream, one of the most commonly farmed fish worldwide. Furthermore, for functional characterization, experimental wounds were carried out comparing the wound healing rate between the dorsal and ventral regions of skin over the time. The results showed higher ratio of wound healing in the ventral region, whose wounds were closed after 15 days, compared to dorsal region of skin. Taking into account all together, this study represents a step forward in our knowledge of the skin structure and skin regeneration of an important farmed teleost, gilthead seabream, one of the most commonly farmed fish worldwide.	[Cordero, Hector; Ceballos-Francisco, Diana; Cuesta, Alberto; Angeles Esteban, Maria] Univ Murcia, Dept Cell Biol & Histol, Fish Innate Immune Syst Grp, Fac Biol, Murcia, Spain	University of Murcia	Esteban, MA (corresponding author), Univ Murcia, Dept Cell Biol & Histol, Fish Innate Immune Syst Grp, Fac Biol, Murcia, Spain.	aesteban@um.es	Ceballos, Diana/AAT-4170-2021; Cuesta, Alberto/B-6372-2008; Esteban, MA/D-6709-2011	Ceballos, Diana/0000-0001-5205-5757; Cuesta, Alberto/0000-0002-0906-7995; Esteban, MA/0000-0002-6264-1458; Cordero, Hector/0000-0002-0420-0478	Spanish Ministry of Economy and Competitiveness (MINECO); MINECO; European Regional Development Funds (ERDF/FEDER) [AGL2014-51839-C5-1-R]; Fundacion Seneca de la Region de Murcia [19883/GERM/15]	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); MINECO(Spanish Government); European Regional Development Funds (ERDF/FEDER); Fundacion Seneca de la Region de Murcia(Fundacion Seneca)	Both F.P.I. grants for H.C. and D.C.F. are entirely funded by the Spanish Ministry of Economy and Competitiveness (MINECO). This research was funded by both MINECO (website: http://www.mineco.gob.es/portal/site/mineco/idi) and the European Regional Development Funds (ERDF/FEDER) (grant number AGL2014-51839-C5-1-R) as well as supported by the Fundacion Seneca de la Region de Murcia (grant number 19883/GERM/15, website: http://fseneca.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullock A.M., 1974, OCEANOGR MAR BIOL AN, V13, P383; BURTON D, 1989, J FISH BIOL, V35, P845, DOI 10.1111/j.1095-8649.1989.tb03036.x; Castillo-Briceno P, 2011, MOL IMMUNOL, V48, P826, DOI 10.1016/j.molimm.2010.12.004; Cerda-Reverter JM, 2005, ENDOCRINOLOGY, V146, P1597, DOI 10.1210/en.2004-1346; Cerezuela R, 2016, FISH SHELLFISH IMMUN, V49, P100, DOI 10.1016/j.fsi.2015.12.028; Corder H, 2016, FISH SHELLFISH IMMUN, V56, P188, DOI 10.1016/j.fsi.2016.07.018; Cordero H, 2016, J FISH DIS, V39, P1467, DOI 10.1111/jfd.12481; Cordero H, 2015, PROTEOMICS, V15, P4007, DOI 10.1002/pmic.201500120; Cordero H, 2016, J PROTEOMICS, V132, P41, DOI 10.1016/j.jprot.2015.11.017; Elliott Diane G., 2000, P271, DOI 10.1016/B978-012529650-2/50023-8; Esteban Angeles M, 2012, ISRN IMMUNOL, V2012, P853470, DOI [10.5402/2012/853470, DOI 10.5402/2012/853470]; FAO, 2014, STAT WORLD FISH AQ, P1; Ferrer C, 1999, HISTOL HISTOPATHOL, V14, P383, DOI 10.14670/HH-14.383; Guardiola FA, 2015, BIORHEOLOGY, V52, P247, DOI 10.3233/BIR-15052; Guardiola FA, 2014, FISH SHELLFISH IMMUN, V40, P24, DOI 10.1016/j.fsi.2014.06.018; Guardiola FA, 2014, FISH SHELLFISH IMMUN, V36, P545, DOI 10.1016/j.fsi.2014.01.001; HAWKES JW, 1974, CELL TISSUE RES, V149, P159, DOI 10.1007/BF00222271; Ibarz A, 2013, MAR BIOTECHNOL, V15, P629, DOI 10.1007/s10126-013-9513-4; IGER Y, 1990, J FISH BIOL, V36, P421, DOI 10.1111/j.1095-8649.1990.tb05622.x; Jurado J, 2015, J PROTEOMICS, V120, P21, DOI 10.1016/j.jprot.2015.02.019; Lazado CC, 2014, FISH SHELLFISH IMMUN, V36, P113, DOI 10.1016/j.fsi.2013.10.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado P, 2002, EUR J DERMATOL, V12, P449; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405; PICKERING AD, 1977, J FISH BIOL, V10, P561, DOI 10.1111/j.1095-8649.1977.tb04088.x; Rai AK, 2012, MICROSC RES TECHNIQ, V75, P890, DOI 10.1002/jemt.22009; Rajan B, 2011, FISH SHELLFISH IMMUN, V31, P224, DOI 10.1016/j.fsi.2011.05.006; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Sanahuja I, 2015, FISH SHELLFISH IMMUN, V46, P426, DOI 10.1016/j.fsi.2015.05.056; Sarasquete C, 1998, HISTOL HISTOPATHOL, V13, P37, DOI 10.14670/HH-13.37; Tapia-Paniagua ST, 2014, FISH SHELLFISH IMMUN, V41, P209, DOI 10.1016/j.fsi.2014.08.019; van der Marel M, 2010, J FISH DIS, V33, P431, DOI 10.1111/j.1365-2761.2010.01140.x; Vieira FA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-490; Whitear M., 1986, BIOL INTEGUMENT, P8, DOI DOI 10.1007/978-3-662-00989-5; WILKINS NP, 1979, J FISH BIOL, V15, P299, DOI 10.1111/j.1095-8649.1979.tb03609.x; Xu Z, 2013, P NATL ACAD SCI USA, V110, P13097, DOI 10.1073/pnas.1304319110; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	37	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180438	10.1371/journal.pone.0180438	http://dx.doi.org/10.1371/journal.pone.0180438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666033	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608700008
J	Jourdain, E; Vongraven, D; Bisther, A; Karoliussen, R				Jourdain, Eve; Vongraven, Dag; Bisther, Anna; Karoliussen, Richard			First longitudinal study of seal-feeding killer whales (Orcinus orca) in Norwegian coastal waters	PLOS ONE			English	Article							DIETARY SPECIALIZATION; SEASONAL MOVEMENTS; FORAGING BEHAVIOR; ASSOCIATION; TRANSIENT; PATTERNS; INDIVIDUALS; POPULATIONS; PREDATION; ECOTYPES	Killer whales (Orcinus orca) have been documented preying on either fish or marine mammals in several regions, suggesting that this odontocete species has the ability to specialize on different types of prey. Off Norway, killer whales have been shown to rely on the Atlantic herring (Clupea harengus) as a main prey resource. Infrequent observations have revealed seals as an additional component of their diet, yet the extent of predation on marine mammals has remained largely unknown. Here, we present the findings of 29 years of photographic and observational data on seal-feeding killer whale groups identified in Norwegian coastal waters. Four groups have been observed preying and feeding on seals over several years, taking both harbor (Phoca vitulina) and grey (Halichoerus grypus) seals. These stable groups are shown to adopt small group sizes, were typically observed in near-shore areas and were not encountered on herring wintering grounds. Behavioral and social traits adopted by these groups are similar to those of pinniped-feeding killer whales from other regions. The potential ecological reasons and the extent of such prey specializations are discussed.	[Jourdain, Eve; Karoliussen, Richard] Norwegian Orca Survey, Andenes, Norway; [Vongraven, Dag] Norwegian Polar Res Inst, Tromso, Norway; [Bisther, Anna] Reportageborsen, Gothenburg, Sweden	Norwegian Polar Institute	Jourdain, E (corresponding author), Norwegian Orca Survey, Andenes, Norway.	eve@norwegianorcasurvey.no		Jourdain, Eve/0000-0003-2619-7799; Vongraven, Dag/0000-0002-0505-7757	Marine Mammal Program of the National Research Council; Sea World and Busch Gardens Conservation fund; Spare-Bank 1 Nord-Norge; Sea Word and Parks Entertainment	Marine Mammal Program of the National Research Council; Sea World and Busch Gardens Conservation fund; Spare-Bank 1 Nord-Norge; Sea Word and Parks Entertainment	Fieldwork conducted from 1988 through 1993 was partly funded by the Marine Mammal Program of the National Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906) to DV and AB. From 2014 through 2016, fieldwork was financed by grants from Spare-Bank 1 Nord-Norge (https://www.sparebank1.no/bank/privat.html) to RK and EJ, Sea World and Busch Gardens Conservation fund (https://swbg-conservationfund.org) to RK and EJ, and Sea Word and Parks Entertainment (https://seaworldparks.com) to EJ and RK. One of the authors is also employed, at the time of writing, by a commercial company being Reportageborsen. The two commercial funding organizations only provided financial support to the study, and Reportageborsen only provides AB with support in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; BAIRD RW, 1992, OECOLOGIA, V89, P125, DOI 10.1007/BF00319024; BAIRD RW, 1995, CAN J ZOOL, V73, P1300, DOI 10.1139/z95-154; Baird RW, 1996, BEHAV ECOL, V7, P408, DOI 10.1093/beheco/7.4.408; Baird RW, 2000, CAN J ZOOL, V78, P2096, DOI 10.1139/cjz-78-12-2096; BarrettLennard LG, 1996, ANIM BEHAV, V51, P553, DOI 10.1006/anbe.1996.0059; Beck S, 2012, BEHAV ECOL, V23, P246, DOI 10.1093/beheco/arr151; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; Bigg M., 1982, REP INT WHALING COMM, V32, P655; Bigg M.A., 1990, Reports of the International Whaling Commission Special Issue, P383; Bisther A, 1995, STUDIES SOCIAL ECOLO, P169; Bisther A, 2001, 14 BIENN C BIOL MAR; BJORGE A, 1991, BIOL CONSERV, V58, P229, DOI 10.1016/0006-3207(91)90121-O; Cosentino AM, 2015, MARINE BIODIVERSITY, P8; Dahlheim ME, 2010, WILDLIFE BIOL, V16, P308, DOI 10.2981/09-075; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Deecke VB, 2011, AQUAT BIOL, V13, P79, DOI 10.3354/ab00353; ESRI, 2016, ARCGIS DESKT VERS 10; Esteban PR, 2008, ESTRUCTURA SOCIAL ME; Filatova OA, 2015, BIOL BULL+, V42, P674, DOI 10.1134/S1062359015070043; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford J. K., 2014, PRIMATES CETACEANS, P75, DOI DOI 10.1007/978-4-431-54523-1_4; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P650; Forney KA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P145; GINSBERG JR, 1992, ANIM BEHAV, V44, P377, DOI 10.1016/0003-3472(92)90042-8; GUINET C, 1992, CAN J ZOOL, V70, P1656, DOI 10.1139/z92-231; GUINET C, 1991, CAN J ZOOL, V69, P2712, DOI 10.1139/z91-383; HAUG T, 1994, BIOL CONSERV, V70, P59, DOI 10.1016/0006-3207(94)90299-2; HOELZEL AR, 1991, HEREDITY, V66, P191, DOI 10.1038/hdy.1991.24; Institute of Marine Research, 2016, FISKEN HAVET; Jourdain E, 2016, NORWEGIAN ORCA ID CA, DOI [10.6084/m9.figshare.4205226, DOI 10.6084/M9.FIGSHARE.4205226]; Krahn MM, 2008, MAR MAMMAL SCI, V24, P643, DOI 10.1111/j.1748-7692.2008.00213.x; Kuningas S, 2014, J MAR BIOL ASSOC UK, V94, P1277, DOI 10.1017/S0025315413000933; Marine Research Institute, 2016, CATCH KILL WHAL N AT; Morton A.B., 1990, Reports of the International Whaling Commission Special Issue, P245; Nichol LM, 1996, CAN J ZOOL, V74, P983, DOI 10.1139/z96-111; Nilssen Kjell Tormod, 2010, NAMMCO Scientific Publications, V8, P61; Nilssen Kjell Tormod, 2007, NAMMCO Scientific Publications, V6, P23; Ottensmeyer CA, 2003, CAN J ZOOL, V81, P1327, DOI 10.1139/Z03-127; Panzacchi M, 2008, CAN J ZOOL, V86, P116, DOI 10.1139/Z07-120; Piltz SH, 2014, SIAM J APPL DYN SYST, V13, P658, DOI 10.1137/130910920; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2012, MAR MAMMAL SCI, V28, P16, DOI 10.1111/j.1748-7692.2010.00453.x; R Core Team, 2021, R LANGUAGE ENV STAT; Randa LA, 2009, J MAMMAL, V90, P594, DOI 10.1644/08-MAMM-A-092R1.1; Reisinger RR, 2011, AFR J MAR SCI, V33, P99, DOI 10.2989/1814232X.2011.572356; Reisinger RR, 2017, BEHAV ECOL, V28, P750, DOI 10.1093/beheco/arx034; Riesch R, 2012, BIOL J LINN SOC, V106, P1, DOI 10.1111/j.1095-8312.2012.01872.x; Samarra FIP, 2015, AQUAT BIOL, V24, P75, DOI 10.3354/ab00637; Samarra FIP, 2015, MAR BIOL, V162, P809, DOI 10.1007/s00227-015-2626-8; Saulitis E, 2000, MAR MAMMAL SCI, V16, P94, DOI 10.1111/j.1748-7692.2000.tb00906.x; SIMILA T, 1993, CAN J ZOOL, V71, P1494, DOI 10.1139/z93-210; Simila T, 1996, CAN J FISH AQUAT SCI, V53, P769, DOI 10.1139/cjfas-53-4-769; Simon M, 2007, ACTA ETHOL, V10, P47, DOI 10.1007/s10211-007-0029-7; Tavares SB, 2017, BEHAV ECOL, V28, P500, DOI 10.1093/beheco/arw179; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Vongraven D, 1995, DEV MAR BIO, V4, P177; Vongraven D, 2014, J MAR BIOL ASSOC UK, V94, P1357, DOI 10.1017/S0025315413001707; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 2004, J ANIM ECOL, V73, P190, DOI 10.1111/j.1365-2656.2004.00798.x; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Whitehead Hal, 1999, Animal Behaviour Forum, V57, pF26, DOI 10.1006/anbe.1999.1099; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510	67	18	18	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180099	10.1371/journal.pone.0180099	http://dx.doi.org/10.1371/journal.pone.0180099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666015	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700061
J	Prestigiacomo, V; Weston, A; Messner, S; Lampart, F; Suter-Dick, L				Prestigiacomo, Vincenzo; Weston, Anna; Messner, Simon; Lampart, Franziska; Suter-Dick, Laura			Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis	PLOS ONE			English	Article							HEPATIC-FIBROSIS; HEPATOTOXICITY; PROLIFERATION; HEPATOCYTES; MECHANISMS; EXPRESSION; SPHEROIDS; REPAIR	Background & Aims Currently most liver fibrosis research is performed in vivo, since suitable alternative in vitro systems which are able to recapitulate the cellular events leading to liver fibrosis are lacking. Here we aimed at generating a system containing cells representing the three key players of liver fibrosis (hepatocyte, Kupffer cells and stellate cells) and assess their response to profibrotic compounds such as TGF-beta 1, methotrexate (MTX) and thioacetamide (TAA). Methods Human cell lines representing hepatocytes (HepaRG), Kupffer cell (THP-1 macrophages) and stellate cells (hTERT-HSC) were co-cultured using the InSphero hanging drop technology to generate scaffold-free 3D microtissues, that were treated with pro-fibrotic compounds (TGF-beta 1, MTX, TAA) for up to 14 days. The response of the microtissues was evaluated by determining the expression of cytokines (TNF-alpha, TGF-beta 1 and IL6), the deposition and secretion of ECM proteins and induction of gene expression of fibrosis biomarkers (e.g. alpha SMA). Induction of Nrf2 and Keap1, as key player of defence mechanism, was also evaluated. Results We could demonstrate that the multicellular 3D microtissue cultures could be maintained in a non-activated status, based on the low expression levels of activation markers. Macrophages were activated by stimulation with LPS and hTERT-HSC showed activation by TGF-beta 1. In addition, MTX and TAA elicited a fibrotic phenotype, as assessed by gene-expression and protein-deposition of ECM proteins such as collagens and fibronectin. An involvement of the antioxidant pathway upon stimulation with pro-fibrotic compounds was also observed. Conclusion Here, for the first time, we demonstrate the in vitro recapitulation of key molecular and cellular events leading to liver fibrosis: hepatocellular injury, antioxidant defence response, activation of Kupffer cells and activation of HSC leading to deposition of ECM.	[Prestigiacomo, Vincenzo; Weston, Anna; Lampart, Franziska; Suter-Dick, Laura] Univ Appl Sci Northwestern Switzerland, Sch Life Sci, Muttenz, Switzerland; [Prestigiacomo, Vincenzo] Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland; [Messner, Simon] InSphero AG, Schlieren, Canton Of Zuric, Switzerland	FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Basel; InSphero AG	Prestigiacomo, V (corresponding author), Univ Appl Sci Northwestern Switzerland, Sch Life Sci, Muttenz, Switzerland.; Prestigiacomo, V (corresponding author), Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland.	vincenzo.prestigiacomo@fhnw.ch	Sharma, Ashwani/AAK-3879-2020; Suter-Dick, Laura/A-9093-2019	Sharma, Ashwani/0000-0001-9835-1973; Suter-Dick, Laura/0000-0002-1449-3913; Lampart, Franziska/0000-0001-9040-0574; Weston, Anna/0000-0003-4339-3839	CTI (Commission for Technology and Innovation); SCANT (Swiss Center for Applied Human Toxicology); Swiss Commission for Innovation and Technology (CTI); Swiss Centre for Applied Human Toxicology (SCAHT)	CTI (Commission for Technology and Innovation); SCANT (Swiss Center for Applied Human Toxicology); Swiss Commission for Innovation and Technology (CTI); Swiss Centre for Applied Human Toxicology (SCAHT)	The work performed at FHNW was partly funded by the CTI (Commission for Technology and Innovation) and partly by SCANT (Swiss Center for Applied Human Toxicology), both Swiss federal organisations. The studies performed at InSphero AG were funded internally. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.; We would like to acknowledge the financial support of the Swiss Commission for Innovation and Technology (CTI), the Swiss Centre for Applied Human Toxicology (SCAHT) and the scientific support of Dr. Jens Kelm. We are very thankful to Dr. B. Schnabl for making the hTERT-HSC available for our research.	Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Arias M, 2002, CELL GROWTH DIFFER, V13, P265; Barker J, 2011, J EUR ACAD DERMATOL, V25, P758, DOI 10.1111/j.1468-3083.2010.03932.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Brophy CM, 2009, HEPATOLOGY, V49, P578, DOI 10.1002/hep.22674; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Ding ZB, 2013, J GASTROEN HEPATOL, V28, P188, DOI 10.1111/j.1440-1746.2012.07265.x; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gaca MDA, 2003, MATRIX BIOL, V22, P229, DOI 10.1016/S0945-053X(03)00017-9; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Horvat T, 2016, ARCH TOXICOL; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kasuya J, 2015, J TISSUE ENG REGEN M, V9, P247, DOI 10.1002/term.1630; Kikuchi S, 2005, J BIOL CHEM, V280, P15398, DOI 10.1074/jbc.M414048200; Kostadinova R, 2013, TOXICOL APPL PHARM, V268, P1, DOI 10.1016/j.taap.2013.01.012; Leite SB, 2016, BIOMATERIALS, V78, P1, DOI 10.1016/j.biomaterials.2015.11.026; Marques TG, 2012, ACTA CIR BRAS, V27, P589, DOI 10.1590/S0102-86502012000800013; Messner S, 2013, ARCH TOXICOL, V87, P209, DOI 10.1007/s00204-012-0968-2; Panesar N, 1999, J SURG RES, V85, P251, DOI 10.1006/jsre.1999.5648; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Preaux AM, 1999, HEPATOLOGY, V30, P944, DOI 10.1002/hep.510300432; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; Schnabl B, 2002, LAB INVEST, V82, P323, DOI 10.1038/labinvest.3780426; Takahashi Y., 2015, BIOSCI REP; Tostoes RM, 2012, HEPATOLOGY, V55, P1227, DOI 10.1002/hep.24760; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011; Yang JJ, 2014, CELL SIGNAL, V26, P2381, DOI 10.1016/j.cellsig.2014.07.016	34	61	65	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179995	10.1371/journal.pone.0179995	http://dx.doi.org/10.1371/journal.pone.0179995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665955	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700050
J	Boncler, M; Golanski, J; Lukasiak, M; Redzynia, M; Dastych, J; Watala, C				Boncler, Magdalena; Golanski, Jacek; Lukasiak, Magdalena; Redzynia, Malgorzata; Dastych, Jaroslaw; Watala, Cezary			A new approach for the assessment of the toxicity of polyphenol-rich compounds with the use of high content screening analysis	PLOS ONE			English	Article							LIVER-INJURY; CYTOTOXICITY; TOXICOLOGY; HEPATOTOXICITY; MECHANISMS; VIABILITY; HORMESIS; ASSAYS; CELLS	The toxicity of in vitro tested compounds is usually evaluated based on AC50 values calculated from dose-response curves. However, there is a large group of compounds for which a standard four -parametric sigmoid curve fitting may be inappropriate for estimating AC50. In the present study, 22 polyphenol-rich compounds were prioritized from the least to the most toxic based on the total area under and over the dose-response curves (AUOC) in relation to baselines. The studied compounds were ranked across three key cell indicators (mitochondria) membrane potential, cell membrane integrity and nuclear size) in a panel of five cell lines (HepG2, Caco-2, A549, HMEC-1, and 3T3), using a high-content screening (HCS) assay. Regarding AUOC score values, naringin (negative control) was the least toxic phenolic compound. Aronox, spent hop extract and kale leaf extract had very low cytotoxicity with regard to mitochondrial membrane potential and cell membrane integrity, as well as nuclear morphology (nuclear area). Kaempferol (positive control) exerted strong cytotoxic effects on the mitochondrial and nuclear compartments. Extracts from buckthorn bark, walnut husk and hollyhock flower were highly cytotoxic with regard to the mitochondrion and cell membrane, but not the nucleus. We propose an alternative algorithm for the screening of a large number of agents and for identifying those with adverse cellular effects at an early stage of drug discovery, using high content screening analysis. This approach should be recommended for series of compounds producing a non-sigmoidal cell response, and for agents with unknown toxicity or mechanisms of action.	[Boncler, Magdalena; Golanski, Jacek; Watala, Cezary] Med Univ Lodz, Dept Haemostasis & Haemostat Disorders, Lodz, Poland; [Lukasiak, Magdalena] Proteon Pharmaceut SA, Lodz, Poland; [Redzynia, Malgorzata] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Tech Biochem, Lodz, Poland; [Dastych, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lab Cellular Immunol, Lodz, Poland	Medical University Lodz; Lodz University of Technology; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Boncler, M (corresponding author), Med Univ Lodz, Dept Haemostasis & Haemostat Disorders, Lodz, Poland.	magdalena.boncler@umed.lodz.pl	BONCLER, MAGDALENA Agnieszka/S-9252-2016; Redzynia, Małgorzata/M-2775-2018; Watala, Cezary/ABF-4863-2020; Golanski, Jacek/S-9556-2016	BONCLER, MAGDALENA Agnieszka/0000-0002-4860-5338; Redzynia, Małgorzata/0000-0003-4625-9678; Watala, Cezary/0000-0002-5627-7872; Golanski, Jacek/0000-0003-4392-8274	grant "Production of polyphenol extracts of plant origin with antiplatelet and cardioprotective properties FLAWOPIRYNA" [UDA-POIG.01.03.01-10-129/08-00]; European Union from the European Regional Development Fund within the framework of the Innovative Economy Operational Programme	grant "Production of polyphenol extracts of plant origin with antiplatelet and cardioprotective properties FLAWOPIRYNA"; European Union from the European Regional Development Fund within the framework of the Innovative Economy Operational Programme	This work was supported by the grant "Production of polyphenol extracts of plant origin with antiplatelet and cardioprotective properties FLAWOPIRYNA" UDA-POIG.01.03.01-10-129/08-00, financed by The European Union from the European Regional Development Fund within the framework of the Innovative Economy Operational Programme. The part of the grant was used to pay for the contract with private company Proteon Pharmaceuticals. Proteon Pharmaceuticals and one of the co-authors (Magdalena Lukasiak) were responsible mainly for cell culture and for performing of HCS analysis. Raw data gathered by Proteon Pharmaceuticals were further analyzed by co-workers of the Medical University of Lodz.	Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Abraham VC, 2008, J BIOMOL SCREEN, V13, P527, DOI 10.1177/1087057108318428; Bacanli M, 2015, FOOD CHEM TOXICOL, V81, P160, DOI 10.1016/j.fct.2015.04.015; Bharti S, 2014, PLANTA MED, V80, P437, DOI 10.1055/s-0034-1368351; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boncler M, 2014, J PHARMACOL TOX MET, V69, P9, DOI 10.1016/j.vascn.2013.09.003; Bordonaba JG, 2008, J AGR FOOD CHEM, V56, P7422, DOI 10.1021/jf8009377; Bunel V, 2014, PLANTA MED, V80, P1210, DOI 10.1055/s-0033-1360273; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P249, DOI 10.1177/0960327109363973; Calabrese EJ, 1999, RISK ANAL, V19, P261, DOI 10.1111/j.1539-6924.1999.tb00404.x; Clarke R, 2015, Toxicol Lett, V233, P278, DOI 10.1016/j.toxlet.2015.01.011; Dhanya R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132429; Domingos MC, 2014, BASIC CLIN PHARMACOL, V115, P145, DOI 10.1111/bcpt.12219; Forbes AM, 2014, INT J ONCOL, V45, P831, DOI 10.3892/ijo.2014.2452; George S, 2010, ACS NANO, V4, P15, DOI 10.1021/nn901503q; Gorlach S, 2011, J AGR FOOD CHEM, V59, P6985, DOI 10.1021/jf200639e; Gustafsson F, 2014, TOXICOL SCI, V137, P189, DOI 10.1093/toxsci/kft223; Hayes DP, 2008, AM J CLIN NUTR, V88, p578S, DOI 10.1093/ajcn/88.2.578S; Jan E, 2008, ACS NANO, V2, P928, DOI 10.1021/nn7004393; Lattanzio V, 2012, REC ADV POLYPHEN RES, V3, P1; Li W, 2009, CHEM-BIOL INTERACT, V177, P121, DOI 10.1016/j.cbi.2008.10.048; Lieggi NT, 2010, TOXICOL IN VITRO, V24, P2063, DOI 10.1016/j.tiv.2010.07.014; Luo HT, 2008, NUTR CANCER, V60, P800, DOI 10.1080/01635580802100851; Martin HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088338; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; Middleton E, 2000, PHARMACOL REV, V52, P673; Morelli JK, 2006, CELL BIOL TOXICOL, V22, P15, DOI 10.1007/s10565-006-0176-z; Mundy WR, 2010, TOXICOLOGY, V270, P121, DOI 10.1016/j.tox.2010.02.004; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; O'Brien PJ, 2014, BASIC CLIN PHARMACOL, V115, P4, DOI 10.1111/bcpt.12227; Park BK, 2011, NAT REV DRUG DISCOV, V10, P292, DOI 10.1038/nrd3408; Persson M, 2013, J PHARMACOL TOX MET, V68, P302, DOI 10.1016/j.vascn.2013.08.001; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Rajendran P, 2014, EUR J MED CHEM, V86, P103, DOI 10.1016/j.ejmech.2014.08.011; Ramesh E, 2013, FOOD CHEM TOXICOL, V51, P97, DOI 10.1016/j.fct.2012.07.033; Rawlinson LAB, 2010, J CONTROL RELEASE, V146, P84, DOI 10.1016/j.jconrel.2010.05.002; Rouhollahi E, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0534-6; Tolosa L, 2016, TOXICOL SCI, V152, P214, DOI 10.1093/toxsci/kfw078; Vukovic LD, 2016, INT REV CEL MOL BIO, V322, P1, DOI 10.1016/bs.ircmb.2015.11.001; Walters AD, 2012, J CELL BIOCHEM, V113, P2813, DOI 10.1002/jcb.24178; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Xu JHJ, 2008, TOXICOL SCI, V105, P97, DOI 10.1093/toxsci/kfn109; Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005	45	24	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180022	10.1371/journal.pone.0180022	http://dx.doi.org/10.1371/journal.pone.0180022			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662177	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300088
J	Nunes, DCD; Bispo-Da-Silva, LB; Napolitano, DR; Costa, MS; Figueira, MMNR; Rodrigues, RS; Rodrigues, VD; Yoneyama, KAG				de Oliveira Nunes, Debora Cristina; Bispo-da-Silva, Luiz Borges; Napolitano, Danielle Reis; Costa, Monica Soares; Nunes Rocha Figueira, Marcia Moura; Rodrigues, Renata Santos; Rodrigues, Veridiana de Melo; Geraldo Yoneyama, Kelly Aparecida			In vitro additive interaction between ketoconazole and antimony against intramacrophage Leishmania (Leishmania) amazonensis amastigotes	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; SODIUM STIBOGLUCONATE; ORAL KETOCONAZOLE; PROLIFERATION; MILTEFOSINE; COMBINATION; ANTAGONISM; SIMULATION; DIAGNOSIS; EFFICACY	Leishmaniasis is a group of diseases caused by protozoa of Leishmania genus. The currently available treatments for this disease are expensive, present high toxicity and are associated to difficulties of healing and parasite resistance. Therefore, the development of strategies for leishmaniasis treatment is indispensable and includes reposition of existing drugs, as well as drug combination therapy. The aim of this study was to assess the nature of ketoconazole and antimony association on the cytotoxic effect against Leishmania (Leishmania) amazonensis amastigotes. The calculated mean sum of fractional 50% inhibitory concentration (x Sigma FIC50) was 2.54 and 1.43 for free and intracellular amastigotes, respectively, values that suggest an additive interaction between ketoconazole and antimony concerning to Leishmania toxicity only in the intramacrophage parasite form. Despite the clinical efficacy of ketoconazole-antimony combination has been shown in the literature, our study is the first to describe the nature of ketoconazole-antimony interaction against L. (L.) amazonensis amastigotes. Moreover, our results point out the need for future in vivo studies to confirm the nature of ketoconazole-antimony interaction and also to determine possible effective dosage regimens related to ketoconazole administration in association with the optimal lower dose of antimony.	[de Oliveira Nunes, Debora Cristina; Costa, Monica Soares; Nunes Rocha Figueira, Marcia Moura; Rodrigues, Renata Santos; Rodrigues, Veridiana de Melo; Geraldo Yoneyama, Kelly Aparecida] Univ Fed Uberlandia, Inst Genet & Bioquim, Uberlandia, MG, Brazil; [de Oliveira Nunes, Debora Cristina; Napolitano, Danielle Reis; Rodrigues, Renata Santos; Rodrigues, Veridiana de Melo] Inst Nacl Ciencia & Tecnol Nanobiofarmaceut N Bio, Belo Horizonte, MG, Brazil; [Bispo-da-Silva, Luiz Borges; Napolitano, Danielle Reis] Univ Fed Uberlandia, Inst Ciencias Biomed, Area Ciencias Fisiol, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Yoneyama, KAG (corresponding author), Univ Fed Uberlandia, Inst Genet & Bioquim, Uberlandia, MG, Brazil.	kelly.tudini@ufu.br	Veiga, Monica/AAU-6590-2021; Yoneyama, Kelly A. G./B-2690-2013; rodrigues, veridiana/A-3662-2013; Yoneyama, Kelly Aparecida Geraldo/GPP-0867-2022; Rodrigues, Renata Santos/AAD-3887-2021	rodrigues, veridiana/0000-0002-3386-9197; Yoneyama, Kelly Aparecida Geraldo/0000-0003-0329-5521; Nunes, Debora/0000-0001-5784-0519; Costa, Monica/0000-0001-5563-5116; Rodrigues, Renata Santos/0000-0002-3779-5236	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-02731-08]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [APQ-00376-10];  [479000/2013-1]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. Award Number: APQ-02731-08; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. Award Number: APQ-00376-10; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. Award Number: 479000/2013-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSALEH QA, 1995, INT J DERMATOL, V34, P495, DOI 10.1111/j.1365-4362.1995.tb00622.x; [Anonymous], 2014, ACTA TROP, V130, P112; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Boecken G, 2011, J DTSCH DERMATOL GES, V9, P1, DOI 10.1111/j.1610-0379.2011.07820.x; Callahan HL, 1997, ANTIMICROB AGENTS CH, V41, P818, DOI 10.1128/AAC.41.4.818; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; de Morais-Teixeira E, 2014, J ANTIMICROB CHEMOTH, V69, P150, DOI 10.1093/jac/dkt318; de Souza Wanderley, 2009, Interdiscip Perspect Infect Dis, V2009, P642502, DOI 10.1155/2009/642502; El-Sayed M, 2010, J EUR ACAD DERMATOL, V24, P335, DOI 10.1111/j.1468-3083.2009.03417.x; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Fontes CO, 2005, J MED MICROBIOL, V54, P1071, DOI 10.1099/jmm.0.46070-0; Goodwin LG, 1943, BIOCHEM J, V37, P198, DOI 10.1042/bj0370198; Gupta N, 2001, TRENDS PARASITOL, V17, P150, DOI 10.1016/S1471-4922(00)01811-0; Haldar Arun Kumar, 2011, Mol Biol Int, V2011, P571242, DOI 10.4061/2011/571242; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Hansen C, 2011, BIOL TRACE ELEM RES, V144, P234, DOI 10.1007/s12011-011-9079-9; JOLLIFFE DS, 1986, CLIN EXP DERMATOL, V11, P62, DOI 10.1111/j.1365-2230.1986.tb00425.x; Elmahallawy EK, 2014, J INFECT DEV COUNTR, V8, P961, DOI 10.3855/jidc.4310; Le Bras J, 2011, MANUAL CLIN MICROBIO, P2113; Lepesheva GI, 2011, CURR TOP MED CHEM, V11, P2060; Maes L, 2013, DRUG RESISTANCE LEIS, P407; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAVIN TR, 1992, J INFECT DIS, V165, P528, DOI 10.1093/infdis/165.3.528; Nunes DCO, 2013, PARASITOLOGY, V140, P844, DOI 10.1017/S0031182013000012; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pandharkar T, 2014, ANTIMICROB AGENTS CH, V58, P4682, DOI 10.1128/AAC.02405-14; SAENZ RE, 1990, AM J MED, V89, P147, DOI 10.1016/0002-9343(90)90292-L; Salmanpour R, 2001, J DERMATOL TREAT, V12, P159, DOI 10.1080/09546630152607899; Seifert K, 2011, J ANTIMICROB CHEMOTH, V66, P850, DOI 10.1093/jac/dkq542; Shakya N, 2011, ACTA TROP, V119, P188, DOI 10.1016/j.actatropica.2011.05.017; Te Dorsthorst DTA, 2002, ANTIMICROB AGENTS CH, V46, P702, DOI [10.1128/AAC.46.3.702-707.2002, 10.1128/AAC.46.3.702.2002]; Trinconi CT, 2014, ANTIMICROB AGENTS CH, V58, P2608, DOI 10.1128/AAC.01315-13; URCUYO FG, 1982, INT J DERMATOL, V21, P414, DOI 10.1111/j.1365-4362.1982.tb03163.x; Zhang G, 2009, HDB DRUG SCREENING, P142	36	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180530	10.1371/journal.pone.0180530	http://dx.doi.org/10.1371/journal.pone.0180530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662149	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300164
J	Haun, CT; Roberts, MD; Romero, MA; Osburn, SC; Mobley, CB; Anderson, RG; Goodlett, MD; Pascoe, DD; Martin, JS				Haun, Cody T.; Roberts, Michael D.; Romero, Matthew A.; Osburn, Shelby C.; Mobley, Christopher B.; Anderson, Richard G.; Goodlett, Michael D.; Pascoe, David D.; Martin, Jeffrey S.			Does external pneumatic compression treatment between bouts of overreaching resistance training sessions exert differential effects on molecular signaling and performance-related variables compared to passive recovery? An exploratory study	PLOS ONE			English	Article							UBIQUITIN PROTEASOME SYSTEM; MESSENGER-RNA EXPRESSION; SKELETAL-MUSCLE; DYNAMIC COMPRESSION; CREATINE-KINASE; PAIN THRESHOLD; EXERCISE; SINGLE; SYMPTOMS; PROTEIN	Purpose We sought to compare the effects of external pneumatic compression (EPC) and sham when used concurrently with resistance training on performance-related outcomes and molecular measures related to recovery. Methods Twenty (N = 20) resistance-trained male participants (aged 21.6 +/- 2.4 years) were randomized to balanced sham or EPC intervention groups. The protocol consisted of 3 consecutive days of heavy, voluminous back squat exercise followed by EPC/sham treatment (Days2-4) and 3 consecutive days of recovery (Days5-7) with EPC/sham only on Days5-6. On Day1 (PRE), and Days3-7, venipuncture, flexibility and pressure-to-pain threshold (PPT) measures were performed. Vastsus lateralis muscle tissue was biopsied at PRE, 1-h post-EPC/ sham treatment on Day2 (POST1) and 24-h post-EPC/sham treatment on Day? (POST2). Isokinetic peak torque was assessed at PRE and POST2. Results Peak isokinetic strength did not change from PRE to POST2 in either group. The PPT was significantly lower on Days3-6 with sham, indicating greater muscle soreness, though this was largely abolished in the EPC group. A significant decrease in flexibility with sham was observed on Day3 (+/- 16.2 +/- 4.6% knee joint angle; P<0.01) whereas there was no change with EPC (+2.8 3.8%; P>0.01). Vastus lateralis poly-ubiquitinated proteins significantly increased at the POST2 time point relative to PRE with sham (+66.6 +/- 24.6%; P<0.025) and were significantly greater (P<0.025) than those observed with EPC at the same time point (-18.6 8.5%). 4-hydroxynonenal values were significantly lower at POST2 relative to PRE with EPC (-16.2 +/- 5.6%; P<0.025) and were significantly lower (P<0.025) than those observed with sham at the same time point (+11.8 +/- 5.9%). Conclusion EPC mitigated a reduction in flexibility and PPT that occurred with sham. Moreover, EPC reduced select skeletal muscle oxidative stress and proteolysis markers during recovery from heavy resistance exercise.	[Haun, Cody T.; Roberts, Michael D.; Romero, Matthew A.; Osburn, Shelby C.; Mobley, Christopher B.; Anderson, Richard G.; Pascoe, David D.; Martin, Jeffrey S.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Roberts, Michael D.; Goodlett, Michael D.; Martin, Jeffrey S.] Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn Campus, Auburn, AL 36832 USA; [Goodlett, Michael D.] Auburn Univ, Athlet Dept, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Martin, JS (corresponding author), Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA.; Martin, JS (corresponding author), Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn Campus, Auburn, AL 36832 USA.	jmartin@auburn.vcom.edu	Mobley, Christopher/AAC-2123-2020	Mobley, C. Brooks/0000-0002-4045-9962				Attaix D, 1998, REPROD NUTR DEV, V38, P153, DOI 10.1051/rnd:19980202; Augustsson J, 2000, SCAND J MED SCI SPOR, V10, P164, DOI 10.1034/j.1600-0838.2000.010003164.x; Baird MF, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/960363; Baker S J, 1997, Eur J Pain, V1, P229, DOI 10.1016/S1090-3801(97)90108-7; BERRY MJ, 1990, CAN J SPORT SCI, V15, P244; Bilodeau PA, 2016, AM J PHYSIOL-CELL PH, V311, pC392, DOI 10.1152/ajpcell.00125.2016; Cochrane DJ, 2013, INT J SPORTS MED, V34, P969, DOI 10.1055/s-0033-1337944; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crane JD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002882; Duffield R, 2010, J SCI MED SPORT, V13, P136, DOI 10.1016/j.jsams.2008.10.006; Gill ND, 2006, BRIT J SPORT MED, V40, P260, DOI 10.1136/bjsm.2005.022483; Gulick Dawn T., 1996, Journal of Athletic Training, V31, P145; HAMILL J, 1991, INT J SPORT BIOMECH, V7, P125, DOI 10.1123/ijsb.7.2.125; Hilbert JE, 2003, BRIT J SPORT MED, V37, P72, DOI 10.1136/bjsm.37.1.72; JENSEN R, 1992, PAIN, V48, P197, DOI 10.1016/0304-3959(92)90059-K; Kephart WC, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0142-y; Kephart WC, 2015, EXP PHYSIOL, V100, P852, DOI 10.1113/EP085160; Koch AJ, 2014, J MUSCULOSKEL NEURON, V14, P68; KOSEK E, 1993, SCAND J REHABIL MED, V25, P117; Kraemer WJ, 2001, J ORTHOP SPORT PHYS, V31, P282, DOI 10.2519/jospt.2001.31.6.282; Krivickas LS, 1996, ARCH PHYS MED REHAB, V77, P1139, DOI 10.1016/S0003-9993(96)90137-9; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; MacDonald GZ, 2013, J STRENGTH COND RES, V27, P812, DOI 10.1519/JSC.0b013e31825c2bc1; Martin JS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13029; Martin JS, 2015, APPL PHYSIOL NUTR ME, V40, P1214, DOI 10.1139/apnm-2015-0247; Martin JS, 2015, EUR J APPL PHYSIOL, V115, P2019, DOI 10.1007/s00421-015-3187-8; Martin JS, 2015, J STRENGTH COND RES, V29, P2900, DOI 10.1519/JSC.0000000000000928; Martin JS, 2016, CLIN PHYSL FUNCT IMA; Mascher H, 2008, AM J PHYSIOL-ENDOC M, V294, pE43, DOI 10.1152/ajpendo.00504.2007; Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pillon NJ, 2012, ENDOCRINOLOGY, V153, P2099, DOI 10.1210/en.2011-1957; Proske U, 1999, J MUSCLE RES CELL M, V20, P433, DOI 10.1023/A:1005573625675; Raue U, 2007, J GERONTOL A-BIOL, V62, P1407, DOI 10.1093/gerona/62.12.1407; Sands WA, 2015, J STRENGTH COND RES, V29, P1263, DOI 10.1519/JSC.0000000000000412; Sands WA, 2014, J STRENGTH COND RES, V28, P1058, DOI 10.1519/JSC.0000000000000244; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siu PM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-58; THOMPSON HS, 1994, BIOCHEM BIOPH RES CO, V204, P1193, DOI 10.1006/bbrc.1994.2589; Van Thienen R, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.286; WORRELL T W, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P118; Yang YF, 2006, J APPL PHYSIOL, V101, P1442, DOI 10.1152/japplphysiol.00438.2006; Zarkovic Neven, 2003, Molecular Aspects of Medicine, V24, P281, DOI 10.1016/S0098-2997(03)00023-2	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180429	10.1371/journal.pone.0180429	http://dx.doi.org/10.1371/journal.pone.0180429			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662152	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300154
J	Kirchner, J; Sawicki, LM; Deusch, C; Gruneisen, J; Beiderwellen, K; Lauenstein, TC; Herrmann, K; Forsting, M; Heusch, P; Umutlu, L				Kirchner, Julian; Sawicki, Lino M.; Deusch, Cornelius; Grueneisen, Johannes; Beiderwellen, Karsten; Lauenstein, Thomas C.; Herrmann, Ken; Forsting, Michael; Heusch, Philipp; Umutlu, Lale			(18) F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine	PLOS ONE			English	Article							DUAL-MODALITY PET/CT; ONCOLOGIC PET/MRI; METASTASES; CT; ADENOMA; CANCER; TUMORS; BOPTA; MRI	Objectives To evaluate the added value of the application of the liver-specific contrast phase of Gadobenate dimeglumine (Gd-BOPTA) for detection and characterization of liver lesions in (18)FFDG PET/MRI. Methods 41 patients with histologically confirmed solid tumors and known / suspected liver metastases or not classifiable lesions in F-18-FDG PET/CT were included in this study. All patients underwent a subsequent Gd-BOPTA enhanced F-18-FDG PET/MRI examination. MRI without liver-specific contrast phase (MRI1), MRI with liver-specific contrast phase (MRI2), F-18-FDG PET/MRI without liver-specific contrast phase (PET/MRI1) and with liver-specific contrast phase (PET/MRI2) were separately evaluated for suspect lesions regarding lesion dignity, characterization, conspicuity and confidence. Results PET/MRI datasets enabled correct identification of 18/18 patients with malignant lesions; MRI datasets correctly identified 17/18 patients. On a lesion-based analysis PET/MRI2 provided highest accuracy for differentiation of lesions into malignant and benign lesions of 98% and 100%. Respective values were 95% and 100% for PET/MRI1, 93% and 96% for MRI2 and 91% and 93% for MRI1. Statistically significant higher diagnostic confidence was found for PET/MRI2 and MRI2 datasets compared to PET/MRI1 and MRI1, respectively (p < 0.001). Conclusion The application of the liver-specific contrast phase in F-18-FDG PET/MRI further increases the diagnostic accuracy and diagnostic confidence for correct assessment of benign and malignant liver lesions.	[Kirchner, Julian; Sawicki, Lino M.; Heusch, Philipp] Univ Dusseldorf, Med Fac, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Deusch, Cornelius; Grueneisen, Johannes; Beiderwellen, Karsten; Lauenstein, Thomas C.; Forsting, Michael; Umutlu, Lale] Univ Hosp Duisburg Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Duisburg, Germany; [Herrmann, Ken] Univ Duisburg Essen, Univ Hosp Essen, Dept Nucl Med, Essen, Germany	Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of Duisburg Essen	Kirchner, J (corresponding author), Univ Dusseldorf, Med Fac, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany.	Julian.Kirchner@med.uni-duesseldorf.de	Herrmann, Ken/GOH-1465-2022	Kirchner, Julian/0000-0001-8224-3433	Bracco, Milano, Italy	Bracco, Milano, Italy	This research was supported in part by a sponsored research agreement with Bracco, Milano, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Faruque, 2008, Prev Chronic Dis, V5, pA74; Antoch G, 2003, JAMA-J AM MED ASSOC, V290, P3199, DOI 10.1001/jama.290.24.3199; Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Beiderwellen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137285; Beiderwellen K, 2013, EUR J RADIOL, V82, pE669, DOI 10.1016/j.ejrad.2013.07.027; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Buchbender C, 2012, J NUCL MED, V53, P1244, DOI 10.2967/jnumed.112.109306; Buchbender C, 2012, J NUCL MED, V53, P928, DOI 10.2967/jnumed.112.105338; Caudana R, 1996, RADIOLOGY, V199, P513, DOI 10.1148/radiology.199.2.8668804; Dokmak S, 2009, GASTROENTEROLOGY, V137, P1698, DOI 10.1053/j.gastro.2009.07.061; Donati OF, 2010, J NUCL MED, V51, P692, DOI 10.2967/jnumed.109.068510; Drzezga A, 2012, J NUCL MED, V53, P845, DOI 10.2967/jnumed.111.098608; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Grazioli L, 2005, RADIOLOGY, V236, P166, DOI 10.1148/radiol.2361040338; Grazioli L, 2013, INT J HEPATOLOGY, V2013, P20; Grueneisen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157880; Grueneisen J, 2014, INVEST RADIOL, V49, P808, DOI 10.1097/RLI.0000000000000086; Heusch P, 2015, VISZERALMEDIZIN, V31, P387, DOI 10.1159/000441857; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Holzapfel K, 2012, ABDOM IMAGING, V37, P74, DOI 10.1007/s00261-011-9758-1; Imam K, 2000, Magn Reson Imaging Clin N Am, V8, P741; Kele PG, 2010, WORLD J GASTROENTERO, V16, P1567, DOI 10.3748/wjg.v16.i13.1567; Kirchin MA, 1998, INVEST RADIOL, V33, P798, DOI 10.1097/00004424-199811000-00003; Lee DH, 2016, RADIOLOGY, V280, P782, DOI 10.1148/radiol.2016151975; Lee KH, 2013, KOREAN J RADIOL, V14, P894, DOI 10.3348/kjr.2013.14.6.894; Namasivayam Saravanan, 2007, Cancer Imaging, V7, P2, DOI 10.1102/1470-7330.2007.0002; Neri E, 2016, EUR RADIOL, V26, P921, DOI 10.1007/s00330-015-3900-3; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Quick HH, 2014, J MAGN RESON IMAGING, V39, P243, DOI 10.1002/jmri.24523; Riemsma RP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009498.pub3; Sawicki LM, 2016, EUR J RADIOL, V85, P459, DOI 10.1016/j.ejrad.2015.12.010; Schwartz LH, 1999, RADIOLOGY, V210, P71, DOI 10.1148/radiology.210.1.r99ja0371; Silva AC, 2009, RADIOGRAPHICS, V29, P385, DOI 10.1148/rg.292085123; Spinazzi A, 1999, ACAD RADIOL, V6, P282, DOI 10.1016/S1076-6332(99)80451-6; Thomeer MG, 2016, THER ADV GASTROENTER, V9, P898, DOI 10.1177/1756283X16663882; van Aalten SM, 2012, BRIT J SURG, V99, P911, DOI 10.1002/bjs.8762; van Kessel CS, 2012, ANN SURG ONCOL, V19, P2805, DOI 10.1245/s10434-012-2300-z; Ward J, 2006, Cancer Imaging, V6, P33, DOI 10.1102/1470-7330.2006.0007; WEISS L, 1986, J PATHOL, V150, P195, DOI 10.1002/path.1711500308	39	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180349	10.1371/journal.pone.0180349	http://dx.doi.org/10.1371/journal.pone.0180349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683109	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200024
J	Broussard, S; Hickok, G; Saberi, K				Broussard, Sierra; Hickok, Gregory; Saberi, Kourosh			Robustness of speech intelligibility at moderate levels of spectral degradation	PLOS ONE			English	Article							HUMAN LISTENING TESTS; AUDITORY-PERCEPTION; CORTICAL OSCILLATIONS; TEMPORAL ENVELOPE; PHASE SPECTRUM; FINE-STRUCTURE; CUES; DISCRIMINATION; COMPREHENSION; RECOGNITION	The current study investigated how amplitude and phase information differentially contribute to speech intelligibility. Listeners performed a word-identification task after hearing spectrally degraded sentences. Each stimulus was degraded by first dividing it into segments, then the amplitude and phase components of each segment were decorrelated independently to various degrees relative to those of the original segment. Segments were then concatenated into their original sequence to present to the listener. We used three segment lengths: 30 ms (phoneme length), 250 ms (syllable length), and full sentence (non-segmented). We found that for intermediate spectral correlation values, segment length is generally inconsequential to intelligibility. Overall, intelligibility was more adversely affected by phase-spectrum decorrelation than by amplitude-spectrum decorrelation. If the phase information was left intact, decorrelating the amplitude spectrum to intermediate values had no effect on intelligibility. If the amplitude information was left intact, decorrelating the phase spectrum to intermediate values significantly degraded intelligibility. Some exceptions to this rule are described. These results delineate the range of amplitude- and phase-spectrum correlations necessary for speech processing and its dependency on the temporal window of analysis (phoneme or syllable length). Results further point to the robustness of speech information in environments that acoustically degrade cues to intelligibility (e.g., reverberant or noisy environments).	[Broussard, Sierra; Hickok, Gregory; Saberi, Kourosh] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Broussard, S (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA.	sbroussa@uci.edu	Saberi, Kourosh/GXG-0944-2022		National Institutes of Health [R01 DC009659]; National Institute on Deafness and Other Disorders [T32DC010775]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Disorders	This work was supported by National Institutes of Health (nih.gov) grant R01 DC009659 (KS) and National Institute on Deafness and Other Disorders (nidcd.nih.gov) training-grant fellowship T32DC010775 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsteris LD, 2006, SPEECH COMMUN, V48, P727, DOI 10.1016/j.specom.2005.10.005; Baltzell LS, 2016, BRAIN RES, V1644, P203, DOI 10.1016/j.brainres.2016.05.029; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; DORMAN MF, 1980, J PHONETICS, V8, P397, DOI 10.1016/S0095-4470(19)31496-2; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; Fisher N., 1995, STAT ANAL CIRCULAR D; Fry DB, 1968, MANUAL PHONETICS, P365; Gilbert G, 2006, J ACOUST SOC AM, V119, P2438, DOI 10.1121/1.2173522; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Greenberg S, 1998, ICSLP; HARRIS KS, 1958, LANG SPEECH, V1, P1; HAZAN V, 1991, PERCEPT PSYCHOPHYS, V49, P187, DOI 10.3758/BF03205038; Howard MF, 2010, J NEUROPHYSIOL, V104, P2500, DOI 10.1152/jn.00251.2010; Lehiste I., 1970, SUPRASEGMENTALS; Liu L, 1997, SPEECH COMMUN, V22, P403, DOI 10.1016/S0167-6393(97)00054-X; Luo H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00170; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; Paliwal KK, 2005, SPEECH COMMUN, V45, P153, DOI 10.1016/j.specom.2004.08.001; Peelle JE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00320; REPP BH, 1978, J EXP PSYCHOL HUMAN, V4, P621, DOI 10.1037/0096-1523.4.4.621; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shi GJ, 2006, IEEE T AUDIO SPEECH, V14, P1867, DOI 10.1109/TSA.2005.858512; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; SOLI SD, 1983, J ACOUST SOC AM, V73, P2150, DOI 10.1121/1.389539; SUMMERFIELD Q, 1981, PHONETICA, V38, P181, DOI 10.1159/000260022; TRAUNMULLER H, 1987, SPEECH COMMUN, V6, P143, DOI 10.1016/0167-6393(87)90037-9; Zeng FG, 2004, J ACOUST SOC AM, V116, P1351, DOI 10.1121/1.1777938	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180734	10.1371/journal.pone.0180734	http://dx.doi.org/10.1371/journal.pone.0180734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678831	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200087
J	Navarro, BV; Elbl, P; de Souza, AP; Jardim, V; de Oliveira, LF; Macedo, AF; dos Santos, ALW; Buckeridge, MS; Floh, EIS				Navarro, Bruno V.; Elbl, Paula; de Souza, Amanda P.; Jardim, Vinicius; de Oliveira, Leandro F.; Macedo, Amanda F.; dos Santos, Andre L. W.; Buckeridge, Marcos S.; Floh, Eny I. S.			Carbohydrate-mediated responses during zygotic and early somatic embryogenesis in the endangered conifer, Araucaria angustifolia	PLOS ONE			English	Article							NORWAY SPRUCE; SEED DEVELOPMENT; BRAZILIAN PINE; ABSCISIC-ACID; EMBRYO DEVELOPMENT; PROTEOMIC ANALYSIS; GENE-EXPRESSION; PLANT-GROWTH; TREHALOSE-6-PHOSPHATE; METABOLISM	Three zygotic developmental stages and two somatic Araucaria angustifolia cell lines with contrasting embryogenic potential were analyzed to identify the carbohydrate-mediated responses associated with embryo formation. Using a comparison between zygotic and somatic embryogenesis systems, the non-structural carbohydrate content, cell wall sugar composition and expression of genes involved in sugar sensing were analyzed, and a network analysis was used to identify coordinated features during embryogenesis. We observed that carbohydrate-mediated responses occur mainly during the early stages of zygotic embryo formation, and that during seed development there are coordinated changes that affect the development of the different structures (embryo and megagametophyte). Furthermore, sucrose and starch accumulation were associated with the responsiveness of the cell lines. This study sheds light on how carbohydrate metabolism is influenced during zygotic and somatic embryogenesis in the endangered conifer species, A. angustifolia.	[Navarro, Bruno V.; Elbl, Paula; de Oliveira, Leandro F.; Macedo, Amanda F.; dos Santos, Andre L. W.; Floh, Eny I. S.] Univ Sao Paulo, Inst Biosci, Dept Bot, Lab Plant Cell Biol, Sao Paulo, SP, Brazil; [de Souza, Amanda P.; Jardim, Vinicius] Univ Sao Paulo, Inst Biosci, Dept Bot, Lab Plant Physiol Ecol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Floh, EIS (corresponding author), Univ Sao Paulo, Inst Biosci, Dept Bot, Lab Plant Cell Biol, Sao Paulo, SP, Brazil.	enyfloh@usp.br	de Oliveira, Leandro Francisco/ACG-6315-2022; de Oliveira, Leandro Francisco/I-4521-2012; Buckeridge, Marcos Silveira/E-7773-2012; Macedo, Amanda Ferreira F/L-2166-2014; Navarro, Bruno/N-3800-2014; Iochevet Segal Floh, Eny/D-9526-2012	de Oliveira, Leandro Francisco/0000-0002-5318-2771; de Oliveira, Leandro Francisco/0000-0002-5318-2771; Buckeridge, Marcos Silveira/0000-0002-5455-8136; Navarro, Bruno/0000-0001-9289-4328; De Souza, Amanda/0000-0002-7237-6483; Iochevet Segal Floh, Eny/0000-0001-6529-2065	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	BN, AS, LO, VJ and AWS were recipients of fellowships from the Fundagao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapespbr/), Sao Paulo, Brazil. PE was funded by a fellowship from Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (http://wwwcapesgov.br/). This research was carried out with financial support from Fundagao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral LIV, 2008, HOEHNEA, V34, P425; Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; [Anonymous], 2015, PHYTOZOME 11 PLANT G; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Blochl A, 2005, PLANT SCI, V168, P1075, DOI 10.1016/j.plantsci.2004.12.004; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Businge E, 2014, TREE PHYSIOL, V34, P657, DOI 10.1093/treephys/tpu053; Businge E, 2012, TREE PHYSIOL, V32, P232, DOI 10.1093/treephys/tpr142; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldana C, 2013, PLANT J, V73, P897, DOI 10.1111/tpj.12080; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Oliveira LF, 2017, TREE PHYSIOL, V37, P116, DOI 10.1093/treephys/tpw107; de Souza AP, 2013, BIOENERG RES, V6, P564, DOI 10.1007/s12155-012-9268-1; de Souza AP, 2013, AGR FOREST METEOROL, V171, P82, DOI 10.1016/j.agrformet.2012.11.006; Delatte TL, 2011, PLANT PHYSIOL, V157, P160, DOI 10.1104/pp.111.180422; Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dobrenel T, 2016, ANNU REV PLANT BIOL, V67, P261, DOI 10.1146/annurev-arplant-043014-114648; Dobrenel T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00093; dos Santos ALW, 2008, BIOL PLANTARUM, V52, P195, DOI 10.1007/s10535-008-0044-1; Eastmond PJ, 2002, PLANT J, V29, P225, DOI 10.1046/j.1365-313x.2002.01220.x; Elbl P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136714; Elbl P, 2015, PLANT CELL TISS ORG, V120, P903, DOI 10.1007/s11240-014-0523-3; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Figueroa CM, 2016, PLANT PHYSIOL, V172, P7, DOI 10.1104/pp.16.00417; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Gaj MD, 2011, METHODS MOL BIOL, V710, P257, DOI 10.1007/978-1-61737-988-8_18; Gosslova M, 2001, IN VITRO CELL DEV-PL, V37, P24, DOI 10.1007/s11627-001-0005-2; Grigova M, 2007, TREE PHYSIOL, V27, P1533, DOI 10.1093/treephys/27.11.1533; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; Harada JJ, 2010, PLANT EMBRYOGENESIS; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hincha DK, 2003, BBA-BIOMEMBRANES, V1612, P172, DOI 10.1016/S0005-2736(03)00116-0; Hudec L, 2016, TREE PHYSIOL, V36, P548, DOI 10.1093/treephys/tpw016; Husson F, 2007, FACTOMINER PACKAGE 2; Iraqi D, 2001, J EXP BOT, V52, P2301, DOI 10.1093/jexbot/52.365.2301; Jo L, 2014, TREE PHYSIOL, V34, P94, DOI 10.1093/treephys/tpt102; Kim YW, 2014, PLANT BIOTECHNOL REP, V8, P259, DOI 10.1007/s11816-014-0319-2; Klimaszewska K, 2004, PHYSIOL PLANTARUM, V121, P682, DOI 10.1111/j.1399-3054.2004.00370.x; Konradova H, 2002, J PLANT PHYSIOL, V159, P387, DOI 10.1078/0176-1617-00624; Kube M, 2014, IN VITRO CELL DEV-PL, V50, P45, DOI 10.1007/s11627-013-9589-6; Lastdrager J, 2014, J EXP BOT, V65, P799, DOI 10.1093/jxb/ert474; Leljak-Levanic D, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1875-y; Lelu-Walter MA, 2006, PLANT CELL REP, V25, P767, DOI 10.1007/s00299-006-0115-8; Lelu-Walter MA, 2013, TREE GENET GENOMES, V9, P883, DOI 10.1007/s11295-013-0620-1; Li L, 2016, CURR OPIN PLANT BIOL, V33, P116, DOI 10.1016/j.pbi.2016.06.018; Lipavska H, 2000, IN VITRO CELL DEV-PL, V36, P260, DOI 10.1007/s11627-000-0048-9; Lipavska H, 2004, IN VITRO CELL DEV-PL, V40, P23, DOI 10.1079/IVP2003482; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maegawa K, 2015, MOL GENET GENOMICS, V290, P2019, DOI 10.1007/s00438-015-1056-0; Merkle SA, 2000, CURR OPIN BIOTECH, V11, P298, DOI 10.1016/S0958-1669(00)00099-9; Morel A, 2014, PLANTA, V240, P1075, DOI 10.1007/s00425-014-2125-z; Nishizawa A, 2008, PLANT PHYSIOL, V147, p[1251, 108]; Park YS, 2006, PLANT CELL TISS ORG, V86, P87, DOI 10.1007/s11240-006-9101-7; Pullman GS, 2008, TREE PHYSIOL, V28, P985, DOI 10.1093/treephys/28.7.985; Pullman GS, 2003, PLANT CELL REP, V22, P85, DOI 10.1007/s00299-003-0673-y; R Development Core Team, 2015, LANG ENV STAT COMP R; Radchuk R, 2006, PLANT PHYSIOL, V140, P263, DOI 10.1104/pp.105.071167; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlogl PS, 2012, PLANT CELL TISS ORG, V108, P173, DOI 10.1007/s11240-011-0023-7; Silveira V, 2008, BIOL PLANTARUM, V52, P101, DOI 10.1007/s10535-008-0018-3; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Steiner N, 2008, FUNCT PLANT SCI BIOT, V2, P20; Su YH, 2009, PLANT J, V59, P448, DOI 10.1111/j.1365-313X.2009.03880.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; ten Hove CA, 2015, DEVELOPMENT, V142, P420, DOI 10.1242/dev.111500; Tereso S, 2007, TREE PHYSIOL, V27, P661, DOI 10.1093/treephys/27.5.661; Tome F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00353; van Hengel AJ, 2002, PHYSIOL PLANTARUM, V114, P637, DOI 10.1034/j.1399-3054.2002.1140418.x; Vandesteene L, 2012, PLANT PHYSIOL, V160, P884, DOI 10.1104/pp.112.201400; Vieira LD, 2012, PLANT SCI, V195, P80, DOI 10.1016/j.plantsci.2012.06.011; von Arnold S, 2002, PLANT CELL TISS ORG, V69, P233, DOI 10.1023/A:1015673200621; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; dos Santos ALW, 2016, J PROTEOMICS, V130, P180, DOI 10.1016/j.jprot.2015.09.027; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Xiong Y, 2014, PLANT PHYSIOL, V164, P499, DOI 10.1104/pp.113.229948; Yang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042438; Zhang Y, 2013, MOL PLANT, V6, P1731, DOI 10.1093/mp/sst094	87	18	18	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180051	10.1371/journal.pone.0180051	http://dx.doi.org/10.1371/journal.pone.0180051			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678868	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200036
J	Grimm, I; Garben, N; Dreier, J; Knabbe, C; Vollmer, T				Grimm, Imke; Garben, Nina; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja			Transcriptome analysis of Streptococcus gallolyticus subsp gallolyticus in interaction with THP-1 macrophage-like cells	PLOS ONE			English	Article							BOVIS; ASSOCIATION; SUSCEPTIBILITY; PHAGOCYTOSIS; PNEUMONIAE; MECHANISMS; BACTERIA; ABILITY; GENOME; ACID	Background Streptococcus gallolyticus subsp. gallolyticus (S. gallolyticus) is a pathogen of infective endocarditis. It was observed previously that this bacterium survives longer in macrophages than other species and the phagocytic uptake by and survival in THP-1 macrophages is strain-dependent. Methods The phagocytosis assay was performed with THP-1 macrophages. S. gallolyticus specific whole genome microarrays were used for transcriptome analysis. Results Better survival in macrophages was observed for UCN34, BAA-2069 and ATCC43143 than for DSM16831 and LMG17956. S. gallolyticus strains show high resistance to tested bactericidal agents (acid, lysozyme and hydrogen peroxide). S. gallolyticus stimulates significant lower cytokine gene expression and causes less lysis of macrophages compared to the control strain Staphylococcus aureus. S. gallolyticus reacts to oxidative burst with a higher gene expression of NADH oxidase initially at the early phase. Expression of genes involved in Dalanylation of teichoic acid, carbohydrate metabolism and transport systems were upregulated thereafter. Conclusion S. gallolyticus is very resistant to bactericidal agents normally causing degradation of bacteria in phagolysosomes. Additionally, the D-alanylation of teichoic acid is an important factor for survival.	[Grimm, Imke; Garben, Nina; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja] Ruhr Univ Bochum, Univ Klinikum, Inst Lab & Transfus Med Herz & Diabet Zentrum Nor, Bad Oeynhausen, Germany	Ruhr University Bochum	Vollmer, T (corresponding author), Ruhr Univ Bochum, Univ Klinikum, Inst Lab & Transfus Med Herz & Diabet Zentrum Nor, Bad Oeynhausen, Germany.	tvollmer@hdz-nrw.de	Vollmer, Tanja/F-1149-2013	Vollmer, Tanja/0000-0001-7032-5423				Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Abeni Chiara, 2013, J Med Case Rep, V7, P185, DOI 10.1186/1752-1947-7-185; Aderem A, 2003, J INFECT DIS, V187, pS340, DOI 10.1086/374747; Baker JL, 2014, J BACTERIOL, V196, P2166, DOI 10.1128/JB.01542-14; Benoit M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008939; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; DARJEE R, 1993, J CLIN PATHOL, V46, P1116, DOI 10.1136/jcp.46.12.1116; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; DEHERDT P, 1995, VET MICROBIOL, V45, P157, DOI 10.1016/0378-1135(95)00035-9; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dupre-Crochet S, 2013, J LEUKOCYTE BIOL, V94, P657, DOI 10.1189/jlb.1012544; El Aamri F, 2015, MICROBES INFECT, V17, P258, DOI 10.1016/j.micinf.2014.06.006; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Hinse D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-400; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Kaneko M, 2016, YONSEI MED J, V57, P283, DOI 10.3349/ymj.2016.57.2.283; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Kurtovic A, 2003, J CLIN MICROBIOL, V41, P3951, DOI 10.1128/JCM.41.8.3951-3954.2003; Lazarovitch T, 2013, INFECTION, V41, P329, DOI 10.1007/s15010-012-0314-x; Lin IH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020519; Masoudian M, 2015, IRAN J VET RES, V16, P368; Mouithys-Mickalad A, 2004, BIOCHEM BIOPH RES CO, V325, P1122, DOI 10.1016/j.bbrc.2004.10.155; Nusse O, 2011, THESCIENTIFICWORLDJO, V11, P2364, DOI 10.1100/2011/741046; Olmos C, 2016, AM HEART J, V171, P7, DOI 10.1016/j.ahj.2015.10.012; Poyart C, 2003, MOL MICROBIOL, V49, P1615, DOI 10.1046/j.1365-2958.2003.03655.x; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Romero-Hernandez B, 2015, ANTIMICROB AGENTS CH, V59, P2006, DOI 10.1128/AAC.04083-14; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Smith LM, 2013, BIOCHEM SOC T, V41, P475, DOI 10.1042/BST20130014; Song XM, 2009, GENOMICS, V93, P72, DOI 10.1016/j.ygeno.2008.09.008; Srisuwan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110321; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vollmer T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-78; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180044	10.1371/journal.pone.0180044	http://dx.doi.org/10.1371/journal.pone.0180044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672015	gold, Green Published, Green Submitted			2022-12-27	WOS:000405268500013
J	Lucas, JMEX; Crollius, HR				Lucas, Joseph M. E. X.; Crollius, Hugues Roest			High precision detection of conserved segments from synteny blocks	PLOS ONE			English	Article							GENOME REARRANGEMENTS; ADHORE	A conserved segment, i.e. a segment of chromosome unbroken during evolution, is an important operational concept in comparative genomics. Until now, algorithms that are designed to identify conserved segments often return synteny blocks that overlap, synteny blocks that include micro-rearrangements or synteny blocks erroneously short. Here we present definitions of conserved segments and synteny blocks independent of any heuristic method and we describe four new post-processing strategies to refine synteny blocks into accurate conserved segments. The first strategy identifies micro-rearrangements, the second strategy identifies mono-genic conserved segments, the third returns non-overlapping segments and the fourth repairs incorrect ruptures of synteny. All these refinements are implemented in a new version of PhylDiag that has been benchmarked against i-ADHoRe 3.0 and Cyntenator, based on a realistic simulated evolution and true simulated conserved segments.	[Lucas, Joseph M. E. X.; Crollius, Hugues Roest] Univ Paris, Ecole Normale Super, Dept Biol, IBENS,CNRS,Inserm,PSL Res, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Lucas, JMEX; Crollius, HR (corresponding author), Univ Paris, Ecole Normale Super, Dept Biol, IBENS,CNRS,Inserm,PSL Res, Paris, France.	jlucas@ens.fr; hrc@ens.fr		ROEST CROLLIUS, Hugues/0000-0002-8209-173X	Centre National de la Recherche Scientifique (CNRS); program "Investissements d'Avenir" launched by the French Government; Agence Nationale de la Recherche (ANR) [ANR-10-BINF-01-03]; Memo Life project [ANR1 0-LABX-54 MEMO LIFE]; Paris Science set Lettres (PSL) Research University [ANR-11-IDEX-0001-02]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); program "Investissements d'Avenir" launched by the French Government(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Memo Life project; Paris Science set Lettres (PSL) Research University	The work of JMEXL and HRC has been funded by Centre National de la Recherche Scientifique (CNRS), the program "Investissements d'Avenir" launched by the French Government, the Agence Nationale de la Recherche (ANR) [Grant: Ancestrome Project ANR-10-BINF-01-03] and received support from the Memo Life project [ANR1 0-LABX-54 MEMO LIFE]. The work of HRC has also been funded by Paris Science set Lettres (PSL) Research University [ANR-11-IDEX-0001-02 PSL* Research University]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafna V, 1996, DISCRETE APPL MATH, V71, P41, DOI 10.1016/S0166-218X(96)00063-7; Chaisson MJ, 2006, P NATL ACAD SCI USA, V103, P19824, DOI 10.1073/pnas.0603984103; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Ghiurcuta CG, 2014, BIOINFORMATICS, V30, P9, DOI 10.1093/bioinformatics/btu259; Kehr B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-99; Lefebvre JF, 2003, BIOINFORMATICS, V19, pi190, DOI 10.1093/bioinformatics/btg1025; Lemaitre C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-286; Lucas JM, 2016, ETUDE EVOLUTION ORDR; Lucas JM, 2014, BMC BIOINFORMATICS, V15, P1; Ma J, 2008, P NATL ACAD SCI USA, V105, P14254, DOI 10.1073/pnas.0805217105; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Noutahi E., 2015, EFFICIENT GENE TREE; Pan D, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/545269; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Paten B, 2011, J COMPUT BIOL, V18, P469, DOI 10.1089/cmb.2010.0252; Peng Q, 2006, PLOS COMPUT BIOL, V2, P100, DOI 10.1371/journal.pcbi.0020014; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; Pham SK, 2010, BIOINFORMATICS, V26, P2509, DOI 10.1093/bioinformatics/btq465; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Rodelsperger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008861; Sankoff D, 2006, PLOS COMPUT BIOL, V2, P320, DOI 10.1371/journal.pcbi.0020035; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Vandepoele K, 2002, GENOME RES, V12, P1792, DOI 10.1101/gr.400202	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180198	10.1371/journal.pone.0180198	http://dx.doi.org/10.1371/journal.pone.0180198			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671949	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500026
J	MacGlashan, D				MacGlashan, Donald, Jr.			FceRI density and spontaneous secretion from human basophils	PLOS ONE			English	Article							BIVALENT PENICILLOYL HAPTENS; IGE-MEDIATED STIMULATION; CELL-SURFACE ANTIBODY; FC-EPSILON-RI; HISTAMINE-RELEASE; LEUKEMIA-CELLS; MEMBRANE TARGETS; IMMUNOGLOBULIN-E; MAST-CELLS; RECEPTOR	Mast cells and basophils depend on aggregation of the high-affinity IgE receptor, FceRI, to initiate secretion. A variety of studies have shown that FceRI densities vary 100 fold among subjects' basophils and it has been speculated that high densities might be responsible for unusual behaviors of the cells, notably sensitivity to certain monomeric IgE antibodies or spontaneous release. These studies experimentally examined the density dependence of spontaneous release and signaling element expression in subjects' basophils with FceRI densities ranging from approximately 6000 to 600,000 per cell. Through the use of numerical simulation, this study examined the expectations for spontaneous receptor aggregation and aggregate persistence at densities of FceRI ranging from 5000 to 500,000. Experimentally, FceRI density was not associated with greater spontaneous histamine release even when secretion was enhanced by the inclusion of deuterium oxide in the buffers. There was also no association of 15 activating or de-activating signaling elements with FceRI density. The numerical simulations demonstrated that at densities of approximate to 500,000 receptors, 13% of receptors were involved in transient aggregates at any given moment but that these aggregates rarely persisted for greater than 10 milliseconds. In contrast, a weak linear antigen aggregator, with ligand affinities known to induce secretion, would generate aggregates persisting for an average of approximate to 60 milliseconds. These results suggest that although a high density of FceRI likely produces a large number of transient aggregates, these aggregates do not persist long enough to induce signaling that results in secretion and do not induce the cells to alter their expression of several signaling elements known to be important in regulating secretion from human basophils. The results set some boundaries on the aggregation requirements for inducing histamine release from human basophils.	[MacGlashan, Donald, Jr.] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	MacGlashan, D (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA.	dmacglas@jhmi.edu			National Institutes of Health [AI20253, AI100952]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health, grants AI20253 and AI100952 supported all aspects of this study but had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; BALAKRISHNAN K, 1982, J BIOL CHEM, V257, P6427; COOPER AD, 1981, J BIOL CHEM, V256, P9379; DEMBO M, 1978, J IMMUNOL, V121, P354; DEMBO M, 1979, J IMMUNOL, V122, P518; DEMBO M, 1978, J IMMUNOL, V121, P345; GILBERT HS, 1975, BLOOD, V46, P279; GILLESPIE E, 1972, J CLIN INVEST, V51, P2941, DOI 10.1172/JCI107118; Hlavacek WS, 2001, P NATL ACAD SCI US; Ishmael S, 2009, J LEUKOCYTE BIOL, V86, P313, DOI 10.1189/jlb.1208724; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; KANE P, 1990, IMMUNOL INVEST, V19, P1, DOI 10.3109/08820139009042022; Kashiwakura JI, 2012, ALLERGY ASTHMA IMMUN, V4, P332, DOI 10.4168/aair.2012.4.6.332; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Lavens-Phillips SE, 2000, AM J RESP CELL MOL, V23, P566, DOI 10.1165/ajrcmb.23.4.4123; Liu ZJ, 2001, P NATL ACAD SCI USA, V98, P7289, DOI 10.1073/pnas.121171998; MacGlashan D, 2001, J LEUKOCYTE BIOL, V70, P207; MacGlashan D, 2001, J LEUKOCYTE BIOL, V69, P224; MacGlashan DW, 2007, J LEUKOCYTE BIOL, V82, P1003, DOI 10.1189/jlb.0207103; MacGlashan DW, 2007, J ALLERGY CLIN IMMUN, V119, P626, DOI 10.1016/j.jaci.2006.09.040; MacGlashan DW, 2013, J ALLERGY CLIN IMMUN, V132, P906, DOI 10.1016/j.jaci.2013.04.056; MacGlashan DW, 2012, J ALLERGY CLIN IMMUN, V130, P1130, DOI 10.1016/j.jaci.2012.05.038; MACGLASHAN DW, 1983, J IMMUNOL, V130, P4; MACGLASHAN DW, 1985, J IMMUNOL, V135, P4129; MACGLASHAN DW, 1986, J IMMUNOL, V136, P2231; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Mao SY, 1997, J BIOL CHEM, V272, P14067, DOI 10.1074/jbc.272.22.14067; Schweitzer-Stenner R, 2005, J IMMUNOL, V174, P4461, DOI 10.4049/jimmunol.174.8.4461; Sil D, 2007, ACS CHEM BIOL, V2, P674, DOI 10.1021/cb7001472; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; TUNG R, 1982, J IMMUNOL, V128, P2067; WEIS RM, 1982, J BIOL CHEM, V257, P6440; Wofsy C, 1997, J IMMUNOL, V159, P5984; Xie LP, 2008, J ALLERGY CLIN IMMUN, V121, P1027, DOI 10.1016/j.jaci.2007.12.1157; Zaidi AK, 2010, J ALLERGY CLIN IMMUN, V125, P902, DOI 10.1016/j.jaci.2009.12.996	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179734	10.1371/journal.pone.0179734	http://dx.doi.org/10.1371/journal.pone.0179734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671980	gold, Green Submitted, Green Published			2022-12-27	WOS:000405268500005
J	Song, RJ; Lin, HP; Chen, Y; Zhang, XY; Feng, WY				Song, Rongjing; Lin, Hepu; Chen, Yue; Zhang, Xiuying; Feng, Wanyu			Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis	PLOS ONE			English	Article							ANTITHYROID DRUG-USE; GRAVES-DISEASE; BIRTH-DEFECTS; HYPERTHYROIDISM; THYROTOXICOSIS; OUTCOMES; WOMEN; PREVALENCE	Objective The aim of this study was to determine the effect of exposure to different antithyroid drugs during pregnancy on the incidence of neonatal congenital malformations. Methods A meta-analysis was performed to compare the incidence of neonatal congenital malformations after exposure to different antithyroid drugs during pregnancy. Twelve studies that met the inclusion criteria were included in this meta-analysis. PubMed, Embase, and CENTRAL databases were searched from inception until January 2017. Study designs included case- control studies, prospective cohort studies, and retrospective cohort studies. Results Twelve studies involving 8028 participants with exposure to different antithyroid drugs during pregnancy were included in this study; however, only 10 studies involving 5059 participants involved exposure to different antithyroid drugs exactly during pregnancy. Our results indicated that exposure to methimazole (MMI)/carbimazole (CMZ) only during pregnancy significantly increased the risk of neonatal congenital malformations compared to no antithyroid drug exposure (OR 1.88; 95% CI 1.33 to 2.65; P = 0.0004). No differences were observed between propylthiouracil (PTU) exposure and no antithyroid drug exposure only during pregnancy (OR 0.81; 95% CI 0.58 to 1.15; P = 0.24). Exposure to MMI/CMZ only during pregnancy significantly increased the risk of neonatal congenital malformations compared to that associated with exposure to PTU (OR 1.90; 95% CI 1.30 to 2.78; P = 0.001). Conclusion For pregnant women with hyperthyroidism, exposure to MMI/CMZ significantly increased the incidence of neonatal congenital malformations compared to exposure to PTU and no antithyroid drug exposure; however, no differences were observed between PTU exposure and no antithyroid drug exposure.	[Song, Rongjing; Chen, Yue; Feng, Wanyu] Peking Univ, Dept Pharm, Peoples Hosp, Beijing, Peoples R China; [Lin, Hepu] PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing, Peoples R China; [Zhang, Xiuying] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China	Peking University; Peking University	Feng, WY (corresponding author), Peking Univ, Dept Pharm, Peoples Hosp, Beijing, Peoples R China.; Zhang, XY (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China.	zhangxiuying717@163.com; renminyaojike12@sina.com		Feng, Wanyu/0000-0002-6171-7342				Andersen SL, 2013, J CLIN ENDOCR METAB, V98, P4373, DOI 10.1210/jc.2013-2831; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Chen CH, 2011, BJOG-INT J OBSTET GY, V118, P1365, DOI 10.1111/j.1471-0528.2011.03019.x; Clementi M, 2010, J CLIN ENDOCR METAB, V95, pE337, DOI 10.1210/jc.2010-0652; Cooper DS, 2013, LANCET DIABETES ENDO, V1, P238, DOI 10.1016/S2213-8587(13)70086-X; Di Gianantonio E, 2001, TERATOLOGY, V64, P262, DOI 10.1002/tera.1072; Gianetti E, 2015, J ENDOCRINOL INVEST, V38, P977, DOI 10.1007/s40618-015-0281-z; Hawken C, 2016, ANN ENDOCRINOL PARIS; Korelitz JJ, 2013, THYROID, V23, P758, DOI 10.1089/thy.2012.0488; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Laurberg P, 2016, EUR J ENDOCRINOL, V175, pR219, DOI 10.1530/EJE-16-0410; Laurberg P, 2015, THYROID, V25, P1185, DOI 10.1089/thy.2015.0182; Li HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126610; Li X, 2015, CLINICS, V70, P453, DOI 10.6061/clinics/2015(06)12; Lian Xiao-lan, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P511; Lo JC, 2015, THYROID, V25, P698, DOI 10.1089/thy.2014.0434; Mannisto T, 2013, J CLIN ENDOCR METAB, V98, P2725, DOI 10.1210/jc.2012-4233; MILHAM S, 1972, TERATOLOGY, V5, P125, DOI 10.1002/tera.1420050117; MOMOTANI N, 1984, CLIN ENDOCRINOL, V20, P695, DOI 10.1111/j.1365-2265.1984.tb00119.x; Moore K L, 2013, DEV HUMAN CLIN ORIEN, P471; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Prunty JJ, 2016, PHARMACOTHERAPY, V36, P64, DOI 10.1002/phar.1676; Rivkees SA, 2013, J CLIN ENDOCR METAB, V98, P4332, DOI 10.1210/jc.2013-3549; Rivkees SA, 2011, HORM RES PAEDIAT, V76, P91, DOI 10.1159/000329186; Rosenfeld H, 2009, BRIT J CLIN PHARMACO, V68, P609, DOI 10.1111/j.1365-2125.2009.03495.x; Taylor PN, 2012, EUR THYROID J, V1, P176, DOI 10.1159/000342920; WING DA, 1994, AM J OBSTET GYNECOL, V170, P90; Yoshihara A, 2012, J CLIN ENDOCR METAB, V97, P2396, DOI 10.1210/jc.2011-2860	30	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180108	10.1371/journal.pone.0180108	http://dx.doi.org/10.1371/journal.pone.0180108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671971	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500016
J	Tan, TL; Goh, YY				Tan, Toh Leong; Goh, Yew Yip			The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults-A systematic review	PLOS ONE			English	Review							C-REACTIVE PROTEIN; INFLAMMATORY RESPONSE; SERUM PHOSPHOLIPASE; GENE-EXPRESSION; SYNOVIAL-FLUID; ORGAN FAILURE; A(2); ATHEROSCLEROSIS; IDENTIFICATION; PROCALCITONIN	Introduction This paper investigates the role of Group II Secretory Phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults. Sepsis and bacterial infection are common problems encountered by patients in the hospital and often carry adverse outcomes if not managed early. Methods Two independent reviewers conducted a comprehensive search using Ovid MEDLINE published from years 1993 to 2016 and SCOPUS published from year 1985 to 2017 to screen for relevant studies. The main inclusion criteria included adult subjects, patients with suspected or confirmed signs of infection and relevant outcomes which looked into the role of sPLA2-IIA in detecting the presence of sepsis and bacterial infection in the subjects. Results and discussion Four studies met the inclusion criteria. SPLA2-IIA was found to be effective in detecting the presence of sepsis and bacterial infection in adults. The levels of serum sPLA2-IIA also correlated well with the presence of sepsis and bacterial infection. Conclusion This systematic review highlights the role of sPLA2-IIA as a reliable tool to diagnose sepsis and bacterial infection in adult patients. Nonetheless, further studies should be done in the future to provide more compelling evidence on its application in the clinical setting.	[Tan, Toh Leong; Goh, Yew Yip] Univ Kebangsaan Malaysia, Fac Med, Dept Emergency Med, Kuala Lumpur, Malaysia; [Tan, Toh Leong; Goh, Yew Yip] Univ Kebangsaan Malaysia, Med Ctr, Dept Emergency Med, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Tan, TL (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Emergency Med, Kuala Lumpur, Malaysia.; Tan, TL (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Dept Emergency Med, Kuala Lumpur, Malaysia.	sebastianttl@yahoo.co.uk	TAN, TOH LEONG/N-1653-2015	TAN, TOH LEONG/0000-0002-6771-0141	 [FRGS/1/2014/SKK01/UKM/03/3];  [FF-2015-322];  [FF2017-049]	; ; 	The research was funded by FRGS/1/2014/SKK01/UKM/03/3, FF-2015-322 and FF2017-049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bauer M, 2010, INT J MED MICROBIOL, V300, P411, DOI 10.1016/j.ijmm.2010.04.006; BAUR M, 1989, KLIN WOCHENSCHR, V67, P196, DOI 10.1007/BF01711353; Bidgood MJ, 2000, J IMMUNOL, V165, P2790, DOI 10.4049/jimmunol.165.5.2790; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; Brunkhorst FM, 2000, INTENS CARE MED, V26, pS148, DOI 10.1007/BF02900728; Caporarello N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159874; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; CIRINO G, 1994, J RHEUMATOL, V21, P824; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CROWL RM, 1991, J BIOL CHEM, V266, P2647; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Fillipo N, 2014, INTERN EMERG MED, P749; GREEN JA, 1991, INFLAMMATION, V15, P355, DOI 10.1007/BF00917352; HARA S, 1989, J BIOCHEM-TOKYO, V105, P395, DOI 10.1093/oxfordjournals.jbchem.a122675; HOFFMANN GE, 1989, KLIN WOCHENSCHR, V67, P144, DOI 10.1007/BF01711341; HOFFMANN GE, 1989, CLIN CHIM ACTA, V183, P59, DOI 10.1016/0009-8981(89)90272-6; Hollie NI, 2014, ATHEROSCLEROSIS, V234, P377, DOI 10.1016/j.atherosclerosis.2014.03.027; Huang Q, 2015, INT J MOL MED, V35, P587, DOI 10.3892/ijmm.2014.2047; Jaross W, 2002, EUR J CLIN INVEST, V32, P383, DOI 10.1046/j.1365-2362.2002.01000.x; Kirschnek S, 2006, INFECT IMMUN, V74, P850, DOI 10.1128/IAI.74.2.850-860.2006; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; LILJA I, 1995, GUT, V37, P380, DOI 10.1136/gut.37.3.380; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; MINAMI T, 1994, GUT, V35, P1593, DOI 10.1136/gut.35.11.1593; Morgenthaler NG, 2015, INT J MICROBIOLOGY, V2015; Motta C, 2014, INFECT IMMUN, V82, P851, DOI 10.1128/IAI.00843-13; Nahecr RA, 2016, J BIOL CHEM, V291, P3076, DOI 10.1074/jbc.M115.677799; Nakae H, 1996, RES COMMUN MOL PATH, V92, P131; NEVALAINEN TJ, 1992, CLIN CHEM, V38, P1824; NEVALAINEN TJ, 1993, CLIN CHEM, V39, P2453; Niessen HWM, 2003, CARDIOVASC RES, V60, P68, DOI 10.1016/S0008-6363(03)00324-9; Nyman KM, 1996, J SURG RES, V60, P7, DOI 10.1006/jsre.1996.0003; Povoa P, 1998, INTENS CARE MED, V24, P1052, DOI 10.1007/s001340050715; PRUZANSKI W, 1991, IMMUNOL TODAY, V12, P143, DOI 10.1016/0167-5699(91)90077-7; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Rintala EM, 2001, SCAND J CLIN LAB INV, V61, P523; RINTALA EM, 1993, CLIN INFECT DIS, V17, P864, DOI 10.1093/clinids/17.5.864; Salmeri M, 2012, NEUROSCI LETT, V511, P33, DOI 10.1016/j.neulet.2012.01.031; Sankar V, 2013, J ANESTH, V27, P269, DOI 10.1007/s00540-012-1502-7; STEFANSKI E, 1986, J BIOCHEM-TOKYO, V100, P1297, DOI 10.1093/oxfordjournals.jbchem.a121836; Styles LA, 1996, BLOOD, V87, P2573, DOI 10.1182/blood.V87.6.2573.bloodjournal8762573; Sumi-Akamaru H, 2015, NEUROPATHOLOGY, V35, P289, DOI 10.1111/neup.12202; Takada Y, 2016, SECRETED PHOSPHOLIPA; Tan TL, 2014, MED HEALTH-KUALA LUM, V9, P124; Toh Leong Tan NSA, 2016, PLOS ONE; VADAS P, 1984, J LAB CLIN MED, V104, P873; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WOLF RA, 1985, J BIOL CHEM, V260, P7295; Yui DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143518	53	27	27	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180554	10.1371/journal.pone.0180554	http://dx.doi.org/10.1371/journal.pone.0180554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671974	Green Submitted, gold, Green Published			2022-12-27	WOS:000405268500065
J	Houston, DMJ; Bugert, JJ; Denyer, SP; Heard, CM				Houston, David M. J.; Bugert, Joachim J.; Denyer, Stephen P.; Heard, Charles M.			Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV	PLOS ONE			English	Article							ACID; ELLAGITANNINS; REPLICATION; HUSK	Background There is a clinical need for new therapeutic products against Herpes simplex virus (HSV). The pomegranate, fruit of the tree Punica granatum L, has since ancient times been linked to activity against infection. This work probed the activity of pomegranate rind extract (PRE) and co-administered zinc (II) ions. Materials and methods PRE was used in conjunction with zinc (II) salts to challenge HSV-1 and aciclovir-resistant HSV in terms of virucidal plaque assay reduction and antiviral activities in epithelial Vero host cells. Cytotoxicity was determined by the MTS assay using a commercial kit. Results Zinc sulphate, zinc citrate, zinc stearate and zinc gluconate demonstrated similar potentiated virucidal activity with PRE against HSV-1 by up to 4-fold. A generally parabolic relationship was observed when HSV-1 was challenged with PRE and varying concentrations of ZnSO4, with a maximum potentiation factor of 5.5. Punicalagin had 8-fold greater virucidal activity than an equivalent mass of PRE. However, antiviral data showed that punicalagin had significantly lower antiviral activity compared to the activity of PRE (EC50 = 0.56 mu g mL(-1)) a value comparable to aciclovir (EC50 = 0.18 mu g mL(-1)); however, PRE also demonstrated potency against aciclovir-resistant HSV (EC50 = 0.02 mu mL(-1)), whereas aciclovir showed no activity. Antiviral action of PRE was not influenced by ZnSO4. No cytotoxicity was detected with any test solution. Conclusions The potentiated virucidal activity of PRE by coadministered zinc (II) has potential as a multiaction novel topical therapeutic agent against HSV infections, such as coldsores.	[Houston, David M. J.; Denyer, Stephen P.; Heard, Charles M.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, S Glam, Wales; [Houston, David M. J.; Bugert, Joachim J.] Cardiff Univ, Sch Med, Dept Microbiol & Infect Dis, Cardiff, S Glam, Wales; [Bugert, Joachim J.] Inst Mikrobiol Bundeswehr, Neuherbergstr 11, Munich, Germany; [Denyer, Stephen P.] Univ Brighton, Mithras House,Lewes Rd, Brighton, E Sussex, England	Cardiff University; Cardiff University; University of Brighton	Heard, CM (corresponding author), Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, S Glam, Wales.	heard@cardiff.ac.uk	Bugert, Joachim/AAK-6459-2021; Heard, Charles/O-3362-2014; Bugert, Joachim Jakob/D-1705-2012	Heard, Charles/0000-0001-9703-9777; Bugert, Joachim Jakob/0000-0002-0556-3211	Welsh Assembly Government [RESSA07-03-013]	Welsh Assembly Government	This work was funded by the Welsh Assembly Government RESSA07-03-013.	Aranha-Creado H, 1999, PDA J PHARM SCI TECH, V53, P75; Arens M, 2000, J CLIN MICROBIOL, V38, P1758, DOI 10.1128/JCM.38.5.1758-1762.2000; Braga LKA, 2011, AFR J PHARM PHARMACO, V5, P2145, DOI 10.5897/AJPP11.414; Cam M, 2009, FOOD CHEM, V112, P721, DOI 10.1016/j.foodchem.2008.06.009; Colombo E, 2013, EVIDENCE BASED COMPL; Corao GMD, 2001, THESIS; Ekambaram SP, 2016, PHYTOTHER RES, V30, P1035, DOI 10.1002/ptr.5616; Golstein J, 1996, J ENDOCRINOL INVEST, V19, P119, DOI 10.1007/BF03349847; Greenwood N.N., 1997, CHEM ELEMENTS; Hobden JA, 2011, INVEST OPHTH VIS SCI, V52, P830, DOI 10.1167/iovs.10-5671; Houston DMJ, 2017, EUR J PHARM BIOPHARM, V112, P30, DOI 10.1016/j.ejpb.2016.11.014; Houston DMJ, 2017, EUR J PHARM SCI, V96, P99, DOI 10.1016/j.ejps.2016.08.013; Houston DM, 2011, THESIS; Hulisz Darrell, 2004, J Am Pharm Assoc (2003), V44, P594, DOI 10.1331/1544-3191.44.5.594.Hulisz; Kenney J, 2013, ANTIMICROB AGENTS CH, V57, P4001, DOI 10.1128/AAC.00796-13; KUMEL G, 1990, J GEN VIROL, V71, P2989, DOI 10.1099/0022-1317-71-12-2989; Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187; Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10; Lopes GKB, 1999, BBA-GEN SUBJECTS, V1472, P142, DOI 10.1016/S0304-4165(99)00117-8; Lu JJ, 2007, J CHROMATOGR B, V857, P175, DOI 10.1016/j.jchromb.2007.06.038; Mahajan B B, 2013, Indian J Sex Transm Dis AIDS, V34, P32, DOI 10.4103/0253-7184.112867; Murthy KNC, 2002, J AGR FOOD CHEM, V50, P4791, DOI 10.1021/jf0255735; Nagai T, 1993, ANTIVIR RES, V21, P289; Negi P.S., 2003, FOOD MICROBIOL SAF, V68, P1136; Neurath AR, 2005, ANN NY ACAD SCI, V1056, P311, DOI 10.1196/annals.1352.015; Patel C, 2008, FOOD CHEM TOXICOL, V46, P2728, DOI 10.1016/j.fct.2008.04.035; Pieren M, 2012, CURR OPIN PHARMACOL, V12, P551, DOI 10.1016/j.coph.2012.07.005; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Qiu M, 2013, ANTIVIR RES, V100, P44, DOI 10.1016/j.antiviral.2013.07.001; Sanchez-Lamar A, 2008, J ETHNOPHARMACOL, V115, P416, DOI 10.1016/j.jep.2007.10.011; Sarisky RT, 2001, CLIN INFECT DIS, V33, P2034, DOI 10.1086/338046; Seeram N, 2005, SEP PURIF TECHNOL, V41, P49, DOI 10.1016/j.seppur.2004.04.003; Seeram NP, 2005, J NUTR BIOCHEM, V16, P360, DOI 10.1016/j.jnutbio.2005.01.006; Seeram NP, 2006, POMEGRANATES ANCIENT, P193; Stewart GSAB, 1998, J APPL MICROBIOL, V84, P777, DOI 10.1046/j.1365-2672.1998.00408.x; Vilhelmova-Ilieva N, 2014, ANTIVIR RES, V110, P104, DOI 10.1016/j.antiviral.2014.07.017; Wei ZY, 2012, VET MICROBIOL, V160, P468, DOI 10.1016/j.vetmic.2012.06.019	37	32	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179291	10.1371/journal.pone.0179291	http://dx.doi.org/10.1371/journal.pone.0179291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665969	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000404608700032
J	Jiang, XN; Yu, BH; Wang, WG; Zhou, XY; Li, XQ				Jiang, Xiang-Nan; Yu, Bao-Hua; Wang, Wei-Ge; Zhou, Xiao-Yan; Li, Xiao-Qiu			Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature	PLOS ONE			English	Article							ALK FUSION; COMPLEX KARYOTYPE; NPM-ALK; REARRANGEMENTS; STAT3; IDENTIFICATION; TRANSLOCATION; SEC31A-ALK; SQSTM1-ALK; INHIBITOR	We retrospectively analysed 17 cases of anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK+, LBCL) according to the morphological, immunohistochemical, molecular and clinical features, using which we intend to elucidate the clinicopathological characteristics of this rare entity. In this study, all cases de facto share common features that defined them as a single entity, and various characteristics may expand the spectrum. Among 15 cases, 60% followed an aggressive clinical course with advanced stage and high IPI scores; the median survival of these patients was only 8 months. An analysis showed that both the IPI score and the Ann Arbor stage were significant prognostic factors. Most patients received a chemotherapy regimen including CHOP, CHOEP, EPOCH, and CVAD, and some also underwent localized radiotherapy. However, ALK+, LBCL cases display a dismal clinical outcome and can only be cured with conventional chemotherapy protocols at the stage of localized disease. Novel front-line intensive chemotherapy regimens should therefore be evaluated in this group of patients.	[Jiang, Xiang-Nan; Yu, Bao-Hua; Wang, Wei-Ge; Zhou, Xiao-Yan; Li, Xiao-Qiu] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China; [Jiang, Xiang-Nan; Yu, Bao-Hua; Wang, Wei-Ge; Zhou, Xiao-Yan; Li, Xiao-Qiu] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University; Fudan University	Li, XQ (corresponding author), Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China.; Li, XQ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	leexiaoqiu@hotmail.com			Guide Project of Science and Technology Commission of Shanghai Municipality [134119a5000]	Guide Project of Science and Technology Commission of Shanghai Municipality	This study was supported by a grant from the Guide Project of Science and Technology Commission of Shanghai Municipality (No. 134119a5000). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2003, AM J SURG PATHOL, V27, P1473, DOI 10.1097/00000478-200311000-00012; [Anonymous], 2013, VYSIS ALK BREAK APAR; Bedwell C, 2011, HAEMATOL-HEMATOL J, V96, P343, DOI 10.3324/haematol.2010.031484; Beltran B, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-11; Cerchietti L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018436; Chen YP, 2013, EUR J HAEMATOL, V90, P261, DOI 10.1111/ejh.12031; Cheng MG, 2012, MOL CANCER THER, V11, P670, DOI 10.1158/1535-7163.MCT-11-0776; d'Amore ESG, 2013, AM J SURG PATHOL, V37, P780, DOI 10.1097/PAS.0b013e318287791f; De Paepe P, 2003, BLOOD, V102, P2638, DOI 10.1182/blood-2003-04-1050; Delsol G, 1997, BLOOD, V89, P1483, DOI 10.1182/blood.V89.5.1483.1483_1483_1490; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gascoyne RD, 2003, BLOOD, V102, P2568, DOI 10.1182/blood-2003-03-0786; Laurent C, 2009, J CLIN ONCOL, V27, P4211, DOI 10.1200/JCO.2008.21.5020; Lee HW, 2008, HEMATOL ONCOL, V26, P108, DOI 10.1002/hon.841; Li K, 2011, INT J CLIN EXP PATHO, V4, P190; Momose S, 2009, HUM PATHOL, V40, P75, DOI 10.1016/j.humpath.2008.06.009; Morgan Elizabeth A, 2012, Adv Hematol, V2012, P529572, DOI 10.1155/2012/529572; Onciu M, 2003, BLOOD, V102, P2642, DOI 10.1182/blood-2003-04-1095; Pan ZG, 2017, AM J SURG PATHOL, V41, P25, DOI 10.1097/PAS.0000000000000753; Rudzki Zbigniew, 2005, Polish Journal of Pathology, V56, P37; Shi M, 2011, HUM PATHOL, V42, P1562, DOI 10.1016/j.humpath.2011.01.012; Stachurski D, 2007, HUM PATHOL, V38, P940, DOI 10.1016/j.humpath.2006.12.019; Swerdlow SH, 2008, WHO CLASSIFICATION T; Takeuchi K, 2011, HAEMATOL-HEMATOL J, V96, P464, DOI 10.3324/haematol.2010.033514; Valera A, 2013, MODERN PATHOL, V26, P1329, DOI 10.1038/modpathol.2013.73; Van Roosbroeck K, 2010, HAEMATOL-HEMATOL J, V95, P509, DOI 10.3324/haematol.2009.014761; Wang Wei-ya, 2006, Zhonghua Bing Li Xue Za Zhi, V35, P529; Wass M, 2014, EUR J HAEMATOL, V92, P268, DOI 10.1111/ejh.12240; Yu Hong, 2011, Chinese Journal of Pathology, V40, P561, DOI 10.3760/cma.j.issn.0529-5807.2011.08.016	29	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0178416	10.1371/journal.pone.0178416	http://dx.doi.org/10.1371/journal.pone.0178416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665943	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700001
J	Kumar, R; de Mooij, T; Peterson, TE; Kaptzan, T; Johnson, AJ; Daniels, DJ; Parney, IF				Kumar, Ravi; de Mooij, Tristan; Peterson, Timothy E.; Kaptzan, Tatiana; Johnson, Aaron J.; Daniels, David J.; Parney, Ian F.			Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; BROCCOLI SPROUT BEVERAGES; ISOTHIOCYANATE SULFORAPHANE; MACROPHAGE INFILTRATION; IMMUNE SUPPRESSION; PERIPHERAL-BLOOD; CLINICAL-TRIAL; CANCER; GLIOBLASTOMA; EXPRESSION	Glioblastoma is the most common primary tumor of the brain and has few long-term survivors. The local and systemic immunosuppressive environment created by glioblastoma allows it to evade immunosurveillance. Myeloid-derived suppressor cells (MDSCs) are a critical component of this immunosuppression. Understanding mechanisms of MDSC formation and function are key to developing effective immunotherapies. In this study, we developed a novel model to reliably generate human MDSCs from healthy-donor CD14(+) monocytes by culture in human glioma-conditioned media. Monocytic MDSC frequency was assessed by flow cytometry and confocal microscopy. The resulting MDSCs robustly inhibited T cell proliferation. A cytokine array identified multiple components of the GCM potentially contributing to MDSC generation, including Monocyte Chemoattractive Protein-1, interleukin-6, interleukin-8, and Macrophage Migration Inhibitory Factor (MIF). Of these, Macrophage Migration Inhibitory Factor is a particularly attractive therapeutic target as sulforaphane, a naturally occurring MIF inhibitor derived from broccoli sprouts, has excellent oral bioavailability. Sulforaphane inhibits the transformation of normal monocytes to MDSCs by glioma-conditioned media in vitro at pharmacologically relevant concentrations that are non-toxic to normal leukocytes. This is associated with a corresponding increase in mature dendritic cells. Interestingly, sulforaphane treatment had similar pro-inflammatory effects on normal monocytes in fresh media but specifically increased immature dendritic cells. Thus, we have used a simple in vitro model system to identify a novel contributor to glioblastoma immunosuppression for which a natural inhibitor exists that increases mature dendritic cell development at the expense of myeloidderived suppressor cells when normal monocytes are exposed to glioma conditioned media.	[Kumar, Ravi; de Mooij, Tristan; Peterson, Timothy E.; Kaptzan, Tatiana; Daniels, David J.; Parney, Ian F.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Johnson, Aaron J.; Parney, Ian F.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Parney, IF (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.; Parney, IF (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	parney.ian@mayo.edu		Parney, Ian/0000-0002-9702-8047	Brains Together For a Cure [BTFC-0004]; National Institutes of Health Training Grant [T32NS07494]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007494] Funding Source: NIH RePORTER	Brains Together For a Cure; National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by Brains Together For a Cure (BTFC-0004; http://www.brainstogetherforacure.org). Dr. Kumar received support via the National Institutes of Health Training Grant T32NS07494 (https://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Brian J, 2013, Cancers (Basel), V5, P1379, DOI 10.3390/cancers5041379; Atai NA, 2011, IMMUNOLOGY, V132, P39, DOI 10.1111/j.1365-2567.2010.03335.x; Baron N, 2011, J NEUROSCI RES, V89, P711, DOI 10.1002/jnr.22595; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Bronte V, 2009, EUR J IMMUNOL, V39, P2670, DOI 10.1002/eji.200939892; Chae M, 2014, NEUROONCOL; Chen MF, 2014, ONCOTARGET, V5, P8716, DOI 10.18632/oncotarget.2368; Clarke JD, 2011, PHARM RES-DORDR, V28, P3171, DOI 10.1007/s11095-011-0500-z; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Egner PA, 2011, CANCER PREV RES, V4, P384, DOI 10.1158/1940-6207.CAPR-10-0296; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Geisel J, 2014, J IMMUNOL, V192, P3530, DOI 10.4049/jimmunol.1300556; Guedez L, 2012, J IMMUNOTHER, V35, P502, DOI 10.1097/CJI.0b013e3182619c8e; Gustafson MP, 2010, NEURO-ONCOLOGY, V12, P631, DOI 10.1093/neuonc/noq001; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanlon N, 2008, BRIT J NUTR, V99, P559, DOI 10.1017/S0007114507824093; Healy ZR, 2011, CANCER EPIDEM BIOMAR, V20, P1516, DOI 10.1158/1055-9965.EPI-11-0279; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hu R, 2004, J PHARMACOL EXP THER, V310, P263, DOI 10.1124/jpet.103.064261; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huang MC, 2010, FASEB J, V24, P2558, DOI 10.1096/fj.09-153148; Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413; Jacobs JFM, 2010, J NEUROIMMUNOL, V225, P195, DOI 10.1016/j.jneuroim.2010.05.020; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kallifatidis G, 2011, MOL THER, V19, P188, DOI 10.1038/mt.2010.216; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Kensler TW, 2012, CARCINOGENESIS, V33, P101, DOI 10.1093/carcin/bgr229; Kensler TW, 2005, CANCER EPIDEM BIOMAR, V14, P2605, DOI 10.1158/1055-9965.EPI-05-0368; Kim EK, 2014, CANCER RES, V74, P6705, DOI 10.1158/0008-5472.CAN-14-1482; Kim HJ, 2008, J ALLERGY CLIN IMMUN, V121, P1255, DOI 10.1016/j.jaci.2008.01.016; Kumar V, 2014, IMMUNOLOGY, V143, P512, DOI 10.1111/imm.12380; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li CH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086022, 10.1371/journal.pone.0090520]; Mittelbronn M, 2011, ACTA NEUROPATHOL, V122, P353, DOI 10.1007/s00401-011-0858-3; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Munaut C, 2002, NEUROPATH APPL NEURO, V28, P452, DOI 10.1046/j.1365-2990.2002.00416.x; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Otvos B, 2016, STEM CELLS, V34, P2026, DOI 10.1002/stem.2393; Parney IF, 2012, ADV EXP MED BIOL, V746, P42, DOI 10.1007/978-1-4614-3146-6_4; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; Parney IF, 2000, NEUROSURGERY, V46, P778, DOI 10.1097/00006123-200004000-00002; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Qu XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121574; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Rodrigues JC, 2010, NEURO-ONCOLOGY, V12, P351, DOI 10.1093/neuonc/nop023; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rupreht RR, 2000, PFLUG ARCH EUR J PHY, V440, pR78, DOI 10.1007/s004240000013; Shapiro TA, 2006, NUTR CANCER, V55, P53, DOI 10.1207/s15327914nc5501_7; Shiina A, 2015, CLIN PSYCHOPHARM NEU, V13, P62, DOI 10.9758/cpn.2015.13.1.62; Sielska M, 2013, J PATHOL, V230, P310, DOI 10.1002/path.4192; Simpson KD, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23337; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Singh K, 2014, P NATL ACAD SCI USA, V111, P15550, DOI 10.1073/pnas.1416940111; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trikha P, 2014, BBA-REV CANCER, V1846, P55, DOI 10.1016/j.bbcan.2014.04.003; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Waigel S, 2016, GENOM DATA, V7, P240, DOI 10.1016/j.gdata.2015.12.025; Waziri A, 2010, NEUROSURG CLIN N AM, V21, P31, DOI 10.1016/j.nec.2009.08.005; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Wu CT, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-159; Wu CT, 2012, J MOL MED, V90, P1343, DOI 10.1007/s00109-012-0916-x; Wu LY, 2011, AM J PATHOL, V179, P2131, DOI 10.1016/j.ajpath.2011.06.028; Xu L, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/796856; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Zhang H, 2016, ONCOGENE; Zhang YS, 2002, BIOCHEM J, V364, P301, DOI 10.1042/bj3640301; Zhou W, 2015, NATURE CELL BIOL	76	38	40	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179012	10.1371/journal.pone.0179012	http://dx.doi.org/10.1371/journal.pone.0179012			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666020	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700028
J	Madani, A; Garakani, K; Mofrad, MRK				Madani, Ali; Garakani, Kiavash; Mofrad, Mohammad R. K.			Molecular mechanics of Staphylococcus aureus adhesin, CNA, and the inhibition of bacterial adhesion by stretching collagen	PLOS ONE			English	Article							BINDING PROTEIN; EXPERIMENTAL ENDOCARDITIS; ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-MUTANS; VIRULENCE FACTOR; HUG MODEL; DYNAMICS; MSCRAMM; LIGAND; DOMAIN	Bacterial adhesion to collagen, the most abundant protein in humans, is a critical step in the initiation and persistence of numerous bacterial infections. In this study, we explore the collagen binding mechanism of the multi-modular cell wall anchored collagen adhesin (CNA) in Staphylococcus aureus and examine how applied mechanical forces can modulate adhesion ability. The common structural-functional elements and domain organization of CNA are present across over 50 genera of bacteria. Through the use of molecular dynamics models and normal mode analysis, we shed light on the CNA's structural and conformational dynamics and its interactions with collagen that lead to collagen binding. Our results suggest that the linker region, CNA(165-173), acts as a hinge exhibiting bending, extensional, and torsional modes of structural flexibility and its residues are key in the interaction of the CNA-collagen complex. Steered molecular dynamics simulations were conducted with umbrella sampling. During the course of these simulations, the ` locking' latch from the CNA N2 domain was dissociated from its groove in the CNA N1 domain, implying the importance of the latch for effective ligand binding. Finally, we observed that the binding efficiency of the CNA N1-N2 domains to collagen decreases greatly with increasing tensile force application to the collagen peptides. Thus, CNA and similar adhesins might preferentially bind to sites in which collagen fibers are cleaved, such as in wounded, injured, or inflamed tissues, or in which the collagenous tissue is less mature. As alternative techniques for control of bacterial infection are in-demand due to the rise of bacterial antibiotic resistance, results from our computational studies with respect to the mechanoregulation of the collagen binding site may inspire new therapeutics and engineering solutions by mechanically preventing colonization and/or further pathogenesis.	[Madani, Ali; Garakani, Kiavash; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA; [Madani, Ali; Garakani, Kiavash; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; [Mofrad, Mohammad R. K.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA.; Mofrad, MRK (corresponding author), Univ Calif Berkeley, Dept Mech Engn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.; Mofrad, MRK (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859; Garakani, Kiavash/0000-0002-2896-3234	National Science Foundation [CMMI 1538707]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant CMMI 1538707 to M.R. K.M.	Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Anderson D., 2005, THESIS U CAMBRIDGE; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Consortium TU, 2017, UN U PROT KNOWL, V45, P158; Devi AS, 2012, BBA-GEN SUBJECTS, V1820, P819, DOI 10.1016/j.bbagen.2012.04.006; Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fratzl P, 2008, SPRINGER SCI BUSINES; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRIPENBERGLERCHE C, 1995, INFECT IMMUN, V63, P3222, DOI 10.1128/IAI.63.8.3222-3226.1995; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Herman-Bausier P, MECH STRENGTH INHIBI; Hienz SA, 1996, J INFECT DIS, V174, P83, DOI 10.1093/infdis/174.1.83; Hollup SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-52; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kang MS, 2013, J BIOL CHEM, V288, P20520, DOI 10.1074/jbc.M113.454462; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kumar V, 2014, ROBBINS COTRAN PATHO; Lannergard J, 2003, FEMS MICROBIOL LETT, V222, P69, DOI 10.1016/S0378-1097(03)00222-2; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Lu MY, 2005, BIOPHYS J, V89, P2395, DOI 10.1529/biophysj.105.065904; Nakano K, 2010, ARCH ORAL BIOL, V55, P34, DOI 10.1016/j.archoralbio.2009.11.008; Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; Nallapareddy SR, 2008, INFECT IMMUN, V76, P4120, DOI 10.1128/IAI.00376-08; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021; PATTI JM, 1994, INFECT IMMUN, V62, P152, DOI 10.1128/IAI.62.1.152-161.1994; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rich RL, 1999, J BIOL CHEM, V274, P26939, DOI 10.1074/jbc.274.38.26939; Ross CL, 2012, J BIOL CHEM, V287, P34856, DOI 10.1074/jbc.M112.371054; Shimoji Y, 2003, J BACTERIOL, V185, P2739, DOI 10.1128/JB.185.9.2739-2748.2003; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Sun YL, 2002, BIOCHEM BIOPH RES CO, V295, P382, DOI 10.1016/S0006-291X(02)00685-X; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Visai L, 2000, J BIOL CHEM, V275, P39837, DOI 10.1074/jbc.M005297200; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Zheng WJ, 2005, J MOL BIOL, V346, P745, DOI 10.1016/j.jmb.2004.12.020; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	46	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179601	10.1371/journal.pone.0179601	http://dx.doi.org/10.1371/journal.pone.0179601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665944	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608700037
J	Timmis, MA; Bijl, H; Turner, K; Basevitch, I; Taylor, MJD; van Paridon, KN				Timmis, Matthew A.; Bijl, Herre; Turner, Kieran; Basevitch, Itay; Taylor, Matthew J. D.; van Paridon, Kjell N.			The impact of mobile phone use on where we look and how we walk when negotiating floor based obstacles	PLOS ONE			English	Article							PERIPHERAL-VISION; CELL PHONE; LIMB DOMINANCE; ATTENTION; GAIT; INJURIES; SYMMETRY; TALKING	Pedestrians regularly engage with their mobile phone whilst walking. The current study investigated how mobile phone use affects where people look (visual search behaviour) and how they negotiate a floor based hazard placed along the walking path. Whilst wearing a mobile eye tracker and motion analysis sensors, participants walked up to and negotiated a surface height change whilst writing a text, reading a text, talking on the phone, or without a phone. Differences in gait and visual search behaviour were found when using a mobile phone compared to when not using a phone. Using a phone resulted in looking less frequently and for less time at the surface height change, which led to adaptations in gait by negotiating it in a manner consistent with adopting an increasingly cautious stepping strategy. When using a mobile phone, writing a text whilst walking resulted in the greatest adaptions in gait and visual search behaviour compared to reading a text and talking on a mobile phone. Findings indicate that mobile phone users were able to adapt their visual search behaviour and gait to incorporate mobile phone use in a safe manner when negotiating floor based obstacles.	[Timmis, Matthew A.; Bijl, Herre; Turner, Kieran; Basevitch, Itay; van Paridon, Kjell N.] Anglia Ruskin Univ, Dept Sport & Exercise Sci, Cambridge Ctr Sport & Exercise Sci, Cambridge, England; [Taylor, Matthew J. D.] Univ Essex, Sch Biol Sci, Ctr Sports & Exercise Sci, Colchester, Essex, England	Anglia Ruskin University; University of Essex	Timmis, MA (corresponding author), Anglia Ruskin Univ, Dept Sport & Exercise Sci, Cambridge Ctr Sport & Exercise Sci, Cambridge, England.	Matthew.Timmis@anglia.ac.uk	Basevitch, Itay/AFR-2861-2022; Basevitch, Itay/V-2211-2019	Basevitch, Itay/0000-0001-7505-4597				Ahlstrom C, 2016, TRANSPORT RES F-TRAF, V41, P204, DOI 10.1016/j.trf.2015.01.010; [Anonymous], 2012, BEST WORST MOBILE CO; [Anonymous], [No title captured], DOI DOI 10.1016/S0166-4115(01)80008-X; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bardy BG, 1999, PERCEPT PSYCHOPHYS, V61, P1356, DOI 10.3758/BF03206186; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Chou LS, 1998, J BIOMECH, V31, P685, DOI 10.1016/S0021-9290(98)00081-5; CTIA- The Wireless Association, 2011, CTIA ADV; Da Rocha ES, 2013, HUMAN MOVEMENT, V14, P138; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; GHSA. Everyone Walks, 2015, UND ADDR PED SAF; HE PY, 1992, VISION RES, V32, P2151, DOI 10.1016/0042-6989(92)90076-U; HILZ R, 1974, VISION RES, V14, P1333, DOI 10.1016/0042-6989(74)90006-6; Hyman IE, 2010, APPL COGNITIVE PSYCH, V24, P597, DOI 10.1002/acp.1638; Kao PC, 2015, GAIT POSTURE, V41, P947, DOI 10.1016/j.gaitpost.2015.03.347; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Lamble D, 1999, ERGONOMICS, V42, P807, DOI 10.1080/001401399185306; Lopresti-Goodman SM, 2012, APPL COGNITIVE PSYCH, V26, P644, DOI 10.1002/acp.2846; MANDELBAUM J, 1947, AM J OPHTHALMOL, V30, P581, DOI 10.1016/0002-9394(47)92311-8; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; Murray M P, 1966, Am J Phys Med, V45, P8; Nagano H, 2011, CLIN BIOMECH, V26, P962, DOI 10.1016/j.clinbiomech.2011.05.013; Nasar J, 2008, ACCIDENT ANAL PREV, V40, P69, DOI 10.1016/j.aap.2007.04.005; Nasar JL, 2013, ACCIDENT ANAL PREV, V57, P91, DOI 10.1016/j.aap.2013.03.021; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Oulasvirta Antti, 2005, P SIGCHI C HUM FACT, P919, DOI [DOI 10.1145/1054972.1055101, 10.1145/1054972.1055101]; Patla AE, 1997, GAIT POSTURE, V5, P54, DOI 10.1016/S0966-6362(96)01109-5; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; PATLA AE, 1993, GAIT POSTURE, V1, P45, DOI 10.1016/0966-6362(93)90042-Y; Perry MC, 2007, EUR J APPL PHYSIOL, V100, P553, DOI 10.1007/s00421-006-0247-0; Pew Research Center, 2008, PEW INT AM LIF PROJ; Plummer P, 2015, GAIT POSTURE, V41, P46, DOI 10.1016/j.gaitpost.2014.08.007; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rainie, 2012, CELL PHONE ACTIVITIE; Rhea C K., 2011, GAIT POSTURE, V34, P439; Richtel M, 2010, NY TIMES, P17; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Schabrun SM, 2014, PLOS ONE, V22; SCHLINGENSIEPEN KH, 1986, VISION RES, V26, P1111, DOI 10.1016/0042-6989(86)90045-3; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; SIMONEAU GG, 1991, J GERONTOL, V46, pM188, DOI 10.1093/geronj/46.6.M188; Sky UK, 2015, GO SLOW SMARTPH WALK; Smith DC, 2013, J SAFETY RES, V47, P19, DOI 10.1016/j.jsr.2013.08.003; Stavrinos D, 2011, J SAFETY RES, V42, P101, DOI 10.1016/j.jsr.2011.01.004; Summala H, 1996, HUM FACTORS, V38, P442, DOI 10.1518/001872096778701944; The Radicati Group, 2013, EMA STAT REP 2013 20; Thornton B, 2014, SOC PSYCHOL-GERMANY, V45, P479, DOI 10.1027/1864-9335/a000216; Timmis MA, 2016, GAIT POSTURE, V44, P55, DOI 10.1016/j.gaitpost.2015.11.008; Tornros JEB, 2005, ACCIDENT ANAL PREV, V37, P902, DOI 10.1016/j.aap.2005.04.007; Vansteenkiste P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102792; WILLIAMS AM, 1994, RES Q EXERCISE SPORT, V65, P127, DOI 10.1080/02701367.1994.10607607; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wright RD, 1998, VISUAL ATTENTION, P132; Wrightson JG, 2016, MOTOR CONTROL, V20, P109, DOI 10.1123/mc.2014-0060; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	56	30	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179802	10.1371/journal.pone.0179802	http://dx.doi.org/10.1371/journal.pone.0179802			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665942	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000404608700041
J	Zhang, XW; Wu, SL; Naccarato, T; Prakash-Damani, M; Chou, Y; Chu, CQ; Zhu, Y				Zhang, Xiaowei; Wu, Shili; Naccarato, Ty; Prakash-Damani, Manan; Chou, Yuan; Chu, Cong-Qiu; Zhu, Yong			Regeneration of hyaline-like cartilage in situ with SOX9 stimulation of bone marrow-derived mesenchymal stem cells	PLOS ONE			English	Article							REPAIR-SOCIETY ICRS; TISSUE-ENGINEERING STRATEGIES; ARTICULAR-CARTILAGE; MICROFRACTURE TECHNIQUE; FUNCTIONAL PROTEINS; KNEE ARTHROSCOPIES; COLLAGEN GENE; VIVO; CHONDROGENESIS; DIFFERENTIATION	Microfracture, a common procedure for treatment of cartilage injury, induces fibrocartilage repair by recruiting bone marrow derived mesenchymal stem cells (MSC) to the site of cartilage injury. However, fibrocartilage is inferior biomechanically to hyaline cartilage. SRY-type high-mobility group box-9 (SOX9) is a master regulator of chondrogenesis by promoting proliferation and differentiation of MSC into chondrocytes. In this study we aimed to test the therapeutic potential of cell penetrating recombinant SOX9 protein in regeneration of hyaline cartilage in situ at the site of cartilage injury. We generated a recombinant SOX9 protein which was fused with super positively charged green fluorescence protein (GFP) (scSOX9) to facilitate cell penetration. scSOX9 was able to induce chondrogenesis of bone marrow derived MSC in vitro. In a rabbit cartilage injury model, scSOX9 in combination with microfracture significantly improved quality of repaired cartilage as shown by macroscopic appearance. Histological analysis revealed that the reparative tissue induced by microfracture with scSOX9 had features of hyaline cartilage; and collagen type II to type I ratio was similar to that in normal cartilage. This short term in vivo study demonstrated that when administered at the site of microfracture, scSOX9 was able to induce reparative tissue with features of hyaline cartilage.	[Zhang, Xiaowei; Chou, Yuan; Chu, Cong-Qiu] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA; [Zhang, Xiaowei; Chou, Yuan; Chu, Cong-Qiu] VA Portland Hlth Care Syst, Rheumatol Sect, Portland, OR 97239 USA; [Wu, Shili; Naccarato, Ty; Prakash-Damani, Manan; Zhu, Yong] VivoScript Inc, Costa Mesa, CA 92626 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Chu, CQ (corresponding author), Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA.; Chu, CQ (corresponding author), VA Portland Hlth Care Syst, Rheumatol Sect, Portland, OR 97239 USA.; Zhu, Y (corresponding author), VivoScript Inc, Costa Mesa, CA 92626 USA.	chuc@ohsu.edu; zhu@vivoscript.com		Zhu, Yong/0000-0002-7468-8798	VivoScript, Inc.; VA Merit Review [IBX002858]; Veterans Affairs [I01BX002858] Funding Source: NIH RePORTER	VivoScript, Inc.; VA Merit Review(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from VivoScript, Inc and VA Merit Review (IBX002858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors SW, TN, MPD and YZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.; This was supported by a grant from VivoScript, Inc (to CQC) and VA Merit Review (IBX002858, to CQC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors SW, TN, MPD and YZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section. The authors would like to thank Dr. Brian Johnstone for providing human bone marrow mesenchymal stem cells and Ms. Lijuan Liu for technical assistance in histology.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cao L, 2011, BIOMATERIALS, V32, P3910, DOI 10.1016/j.biomaterials.2011.02.014; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153; Cucchiarini M, 2014, GENE THER, V21, P811, DOI 10.1038/gt.2014.58; Cucchiarini M, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0449-0; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elnager Abuzar, 2014, Adv Hematol, V2014, P814684, DOI 10.1155/2014/814684; Vallone VBF, 2013, DIFFERENTIATION, V85, P1, DOI 10.1016/j.diff.2012.08.004; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; Hoemann C, 2011, CARTILAGE, V2, P153, DOI 10.1177/1947603510397535; Illien-Junger S, 2016, J ORTHOP RES, V34, P876, DOI 10.1002/jor.23088; Jiang YZ, 2010, TISSUE ENG PT A, V16, P1621, DOI [10.1089/ten.tea.2009.0681, 10.1089/ten.TEA.2009.0681]; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Li L, 2017, FASEB J, V31, P1067, DOI 10.1096/fj.201600918R; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Madry H, 2014, Eur Cell Mater, V27, P17; Madry H, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0450-7; Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007; Matsui H, 2003, CURR PROTEIN PEPT SC, V4, P151, DOI 10.2174/1389203033487270; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Richter W, 2009, J INTERN MED, V266, P390, DOI 10.1111/j.1365-2796.2009.02153.x; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Solchaga LA, 2011, METHODS MOL BIOL, V698, P253, DOI 10.1007/978-1-60761-999-4_20; Strauss E, 2009, AM J SPORT MED, V37, P720, DOI 10.1177/0363546508328415; Tsuchiya H, 2003, BIOCHEM BIOPH RES CO, V301, P338, DOI 10.1016/S0006-291X(02)03026-7; Van den Borne MPJ, 2007, OSTEOARTHR CARTILAGE, V15, P1397, DOI 10.1016/j.joca.2007.05.005; Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yang HS, 2011, TISSUE ENG PT A, V17, P1809, DOI 10.1089/ten.tea.2010.0540; Yokota M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-49; Yomogida K, 2013, BIOCHEM BIOPH RES CO, V434, P263, DOI 10.1016/j.bbrc.2013.02.114; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	43	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180138	10.1371/journal.pone.0180138	http://dx.doi.org/10.1371/journal.pone.0180138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666028	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700063
J	Alexeev, EE; He, X; Slupsky, CM; Lonnerdal, B				Alexeev, Erica E.; He, Xuan; Slupsky, Carolyn M.; Lonnerdal, Bo			Effects of iron supplementation on growth, gut microbiota, metabolomics and cognitive development of rat pups	PLOS ONE			English	Article							BREAST-FED INFANTS; CATCH-UP GROWTH; NITRIC-OXIDE; AFRICAN CHILDREN; RANDOMIZED TRIAL; YOUNG-CHILDREN; ADULT MICE; DEFICIENCY; REPLETE; TAURINE	Background Iron deficiency is common during infancy and therefore iron supplementation is recommended. Recent reports suggest that iron supplementation in already iron replete infants may adversely affect growth, cognitive development, and morbidity. Methods Normal and growth restricted rat pups were given iron daily (30 or 150 mu g/d) from birth to postnatal day (PD) 20, and followed to PD56. At PD20, hematology, tissue iron, and the hepatic metabolome were measured. The plasma metabolome and colonic microbial ecology were assessed at PD20 and PD56. T-maze (PD35) and passive avoidance (PD40) tests were used to evaluate cognitive development. Results Iron supplementation increased iron status in a dose-dependent manner in both groups, but no significant effect of iron on growth was observed. Passive avoidance was significantly lower only in normal rats given high iron compared with controls. In plasma and liver of normal and growth-restricted rats, excess iron increased 3-hydroxybutyrate and decreased several amino acids, urea and myo-inositol. While a profound difference in gut microbiota of normal and growth-restricted rats was observed, with iron supplementation differences in the abundance of strict anaerobes were observed. Conclusion Excess iron adversely affects cognitive development, which may be a consequence of altered metabolism and/or shifts in gut microbiota.	[Alexeev, Erica E.; He, Xuan; Slupsky, Carolyn M.; Lonnerdal, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [He, Xuan; Slupsky, Carolyn M.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Lonnerdal, B (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	bllonnerdal@ucdavis.edu			USDA National Institution of Food and Agricultural Hatch Project [1005945]; Mead Johnson Nutrition	USDA National Institution of Food and Agricultural Hatch Project; Mead Johnson Nutrition	This study was funded by Mead Johnson Nutrition to BL.Additionally, CS acknowledges support of USDA National Institution of Food and Agricultural Hatch Project 1005945. The funders had no role in study design, data collections and analysis, decision to Publish, or Preparation of the manuscript.	Albrecht J, 2005, NEUROCHEM RES, V30, P1615, DOI 10.1007/s11064-005-8986-6; Alexeev Erica E., 2015, BMC Physiology, V15, P3, DOI 10.1186/s12899-015-0017-5; Arboleya S, 2012, GUT MICROBES, V3, P583, DOI 10.4161/gmic.21942; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brodziak A, 2014, MED SCI MONITOR, V20, P2733, DOI 10.12659/MSM.891056; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Capozzi L, 2011, HEMATOLOGY, V16, P261, DOI 10.1179/102453311X13085644679980; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dewey KG, 2002, J NUTR, V132, P3249, DOI 10.1093/jn/132.11.3249; Domellof M, 2004, AM J CLIN NUTR, V79, P111; Domellof M, 2002, AM J CLIN NUTR, V76, P198, DOI 10.1093/ajcn/76.1.198; Dostal A, 2014, BRIT J NUTR, V112, P547, DOI 10.1017/S0007114514001160; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fredriksson A, 1999, TOXICOL APPL PHARM, V159, P25, DOI 10.1006/taap.1999.8711; Fredriksson A, 2000, DEV BRAIN RES, V119, P65, DOI 10.1016/S0165-3806(99)00160-1; Galleano Monica, 2004, Molecular Aspects of Medicine, V25, P141, DOI 10.1016/j.mam.2004.02.015; Garcia-Calatayud S, 2005, PEDIATR RES, V57, P719, DOI 10.1203/01.PDR.0000156506.03057.AD; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; He X, 2013, J AGR FOOD CHEM, V61, P9559, DOI 10.1021/jf4029046; Hida AI, 2003, FREE RADICAL BIO MED, V34, P1426, DOI 10.1016/S0891-5849(03)00143-6; IDJRADINATA P, 1994, LANCET, V343, P1252, DOI 10.1016/S0140-6736(94)92151-2; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; JARVIK ME, 1967, PSYCHOL REP, V21, P221, DOI 10.2466/pr0.1967.21.1.221; Jou MY, 2013, PEDIATR RES, V73, P596, DOI 10.1038/pr.2013.27; Kaur D, 2007, NEUROBIOL AGING, V28, P907, DOI 10.1016/j.neurobiolaging.2006.04.003; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Leong I, 2003, AM J CLIN NUTR, V78, P1203, DOI 10.1093/ajcn/78.6.1203; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; Lind T, 2008, ACTA PAEDIATR, V97, P770, DOI 10.1111/j.1651-2227.2008.00773.x; Lonnerdal B, 2015, J PEDIATR-US, V167, pS8, DOI 10.1016/j.jpeds.2015.07.014; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Lozoff B, 2012, ARCH PEDIAT ADOL MED, V166, P208, DOI 10.1001/archpediatrics.2011.197; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Majumdar I, 2003, J TROP PEDIATRICS, V49, P84, DOI 10.1093/tropej/49.2.84; Miller JL, 2013, COLD SPRING HARB PER, V3; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702; Paul V, 2011, INDIAN J MED RES, V133, P471; Puiman P, 2008, CURR OPIN CLIN NUTR, V11, P601, DOI 10.1097/MCO.0b013e32830b5b15; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Unger EL, 2012, J NUTR, V142, P2040, DOI 10.3945/jn.112.162198; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; WADE JV, 1988, J NEUROCHEM, V51, P740, DOI 10.1111/j.1471-4159.1988.tb01807.x; Zhang ZY, 2014, MOL MED REP, V10, P2255, DOI 10.3892/mmr.2014.2544; Ziegler EE, 2009, AM J CLIN NUTR, V90, P76, DOI 10.3945/ajcn.2008.27350; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	51	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179713	10.1371/journal.pone.0179713	http://dx.doi.org/10.1371/journal.pone.0179713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662197	Green Published, gold			2022-12-27	WOS:000404608300044
J	Pickering, K; Monahan, M; Guariglia, A; Roberts, TE				Pickering, Karen; Monahan, Mark; Guariglia, Alessandra; Roberts, Tracy E.			Time to tighten the belts? Exploring the relationship between savings and obesity	PLOS ONE			English	Article							BODY-MASS INDEX; PREFERENCE; OVERWEIGHT; WOMEN; RISK; DECISIONS; HEALTH; MEN; AGE	Background Literature suggests that the higher the rate of time preference people have, the less likely they are to save for the future. Likewise, it has been hypothesised that rising rates of being overweight/obesity are associated with an increase in peoples' marginal rate of time preference. Aim To investigate the relationship between being overweight/obese and the rate of time preference in an older English population, using savings as a proxy for time preference. Methods Three different econometric methods Random-effects Probit Estimation, Fixed-effects Estimation, and Generalised Method of Moments Estimation were used to explore the link between being overweight/obese and rate of time preference in the English Longitudinal Study of Ageing dataset. Six waves of panel data spanning eleven years provided the data to test whether savings variables are related to being overweight/obese. Results The decision to save was shown to hold a statistically significant negative relationship with body mass index but only in the Generalised Method of Moments model. Placing savings in safe, low risk investments was significantly related to a lower probability of being obese but only in the random-effects Probit model. The proportion that people saved relative to their income was not found to be significantly associated with the probability of being overweight/obese in any of the models. Conclusion There is an unclear relationship between saving behaviour and being overweight/obese in an older English population. A financial variable such as savings is a potentially appropriate but imperfect proxy for the rate of time preference of the population. Further research is required to clarify the relationship in order to help develop strategies for obesity prevention. The inconsistency in the results between methods highlights the importance of using a wide range of alternative techniques before implementing important policy decisions.	[Pickering, Karen; Monahan, Mark; Roberts, Tracy E.] Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England; [Guariglia, Alessandra] Univ Birmingham, Dept Econ, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Roberts, TE (corresponding author), Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England.	t.e.roberts@bham.ac.uk	Monahan, Mark/AAO-3992-2021; Roberts, Tracy/AAO-4610-2021	Monahan, Mark/0000-0002-1175-9421; Roberts, Tracy/0000-0002-0624-0537; Pickering, Karen/0000-0001-8982-5540; Guariglia, Alessandra/0000-0001-5417-2615	National Institute for Health Research [EoH-2014-03-01-101] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], [No title captured]; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Averett SL, 2014, ECON HUM BIOL, V15, P201, DOI 10.1016/j.ehb.2013.12.004; Banks J, 2010, ECON J, V120, pF381, DOI 10.1111/j.1468-0297.2010.02395.x; Baum CL, 2009, J HEALTH ECON, V28, P635, DOI 10.1016/j.jhealeco.2009.01.004; Borghans L, 2006, ECON HUM BIOL, V4, P39, DOI 10.1016/j.ehb.2005.10.001; Brown H, 2016, SOC SCI MED, V158, P75, DOI 10.1016/j.socscimed.2016.04.016; Butland BJ, 2007, FORESIGHT TACKLING O; Cawley J, 2015, J HEALTH ECON, V43, P244, DOI 10.1016/j.jhealeco.2015.03.001; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; Courtemanche C, 2014, EC J; Crossley T. F., 2010, WEALTH SAVING UK FAM; Duvigneaud N, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-23; Fonda SJ, 2004, RES AGING, V26, P153, DOI 10.1177/0164027503258739; Gujarati D. N., 2009, BASIC ECONOMETRICS; Gujarati D. N., 2005, BASIC ECONOMETRICS, Vfifth; Hsiao Cheng., 2003, ANAL PANEL DATA, VSecond; Ikeda S, 2010, J HEALTH ECON, V29, P268, DOI 10.1016/j.jhealeco.2010.01.002; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Keese M, 2014, REV INCOME WEALTH, V60, P525, DOI 10.1111/roiw.12002; Khwaja A, 2007, J HEALTH ECON, V26, P927, DOI 10.1016/j.jhealeco.2007.02.004; Komlos J, 2004, OBESITY RATE TIME PR; Lifestyles Statistics Team HaSCIC, 2016, STAT OB PHYS ACT DIE; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; Moody A., 2013, HLTH SURV ENGL, V1; Observatory NO, 2010, EC BURD OB; PAXSON CH, 1992, AM ECON REV, V82, P15; Pouliou T, 2010, HEALTH PLACE, V16, P389, DOI 10.1016/j.healthplace.2009.11.011; Regidor E, 2004, EUR J CLIN NUTR, V58, P488, DOI 10.1038/sj.ejcn.1601835; Research NS, 2015, US GUID NURS DAT; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Seeyave DM, 2009, ARCH PEDIAT ADOL MED, V163, P303, DOI 10.1001/archpediatrics.2009.12; Smith PK, 2005, ECON HUM BIOL, V3, P259, DOI 10.1016/j.ehb.2005.05.001; Sutter M, 2010, WORKING PAPERS EC ST; Sutter M, 2013, AM ECON REV, V103, P510, DOI 10.1257/aer.103.1.510; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Who.int. WHO, WHO OB OV 2015; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang L, 2007, J BIOSOC SCI, V40	39	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179921	10.1371/journal.pone.0179921	http://dx.doi.org/10.1371/journal.pone.0179921			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662132	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300072
J	Wang, J; Hu, WJ; Li, LZ; Huang, XP; Liu, YG; Wang, D; Teng, LR				Wang, Juan; Hu, Wenji; Li, Lanzhou; Huang, Xinping; Liu, Yange; Wang, Di; Teng, Lirong			Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes	PLOS ONE			English	Article							NF-KAPPA-B; OPHIOPOGON-JAPONICUS; SUBMERGED CULTURE; PROTECTS MICE; RENAL INJURY; DRY-MATTER; NEPHROPATHY; INFLAMMATION; EXPRESSION; EXTRACT	This study evaluated the effects of Inonotus obliquus polysaccharides (IOs) on diabetes and other underlying mechanisms related to inflammatory factors and oxidative stress in a mouse model of streptozotocin (STZ)-induced diabetes. Four weeks administration of metformin (120 mg/kg) and IO1-4 (50%-80% alcohol precipitation), or IO5 (total 80% alcohol precipitation) at doses of 50 mg/kg reverses the abnormal changes of bodyweights and fasting blood glucose levels of diabetic mice. IOs significantly increased the insulin and pyruvate kinase levels in serum, and improved the synthesis of glycogen, especially for IO5. IOs restored the disturbed serum levels of superoxide dismutase, catalase, glutathione peroxidase, and malondialdehyde. The down-regulation of interleukin-2 receptor, matrix metalloproteinase-9, and the enhancement of interleukin-2 in serum of diabetic mice were significantly attenuated by IOs. Histologic and morphology examinations showed that IOs repaired the damage on kidney tissues, inhibited inflammatory infiltrate and extracellular matrix deposit injuries in diabetic mice. Compared with untreated diabetic mice, IOs decreased the expression of phosphor-NF-.B in the kidneys. These results show that IOs treatment attenuated diabetic and renal injure in STZ-induced diabetic mice, possibly through the modulation of oxidative stress and inflammatory factors. These results provide valuable evidences to support the use of I. obliquus as a hypoglycemic functional food and/or medicine.	[Wang, Juan; Hu, Wenji; Li, Lanzhou; Huang, Xinping; Liu, Yange; Wang, Di; Teng, Lirong] Jilin Univ, Sch Life Sci, Changchun, Jilin, Peoples R China; [Wang, Di; Teng, Lirong] Jilin Univ, Zhuhai Coll, Zhuhai, Guangdong, Peoples R China	Jilin University; Jilin University	Wang, D; Teng, LR (corresponding author), Jilin Univ, Sch Life Sci, Changchun, Jilin, Peoples R China.; Wang, D; Teng, LR (corresponding author), Jilin Univ, Zhuhai Coll, Zhuhai, Guangdong, Peoples R China.	jluwangdi@outlook.com; tenglr@jlu.edu.cn			Science and Technology Key Project in Jilin Province of China [20140311072YY, 20150203002NY, 20160204029YY]	Science and Technology Key Project in Jilin Province of China	The manuscript has been supported by the funding of Science and Technology Key Project in Jilin Province of China (Grant No. 20140311072YY, 20150203002NY and 20160204029YY).The funder had no role in study design, data collection andanalysis,decision to publish, or preparation of the manuscript.	Adler SG, 2000, KIDNEY INT, V57, P2084, DOI 10.1046/j.1523-1755.2000.00058.x; Anand P, 2010, CHEM-BIOL INTERACT, V186, P72, DOI 10.1016/j.cbi.2010.03.044; Bertelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111285; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Ceriello A, 2013, DIABETES CARE, V36, P4104, DOI 10.2337/dc13-0750; Chen XM, 2013, CARBOHYD POLYM, V94, P378, DOI 10.1016/j.carbpol.2013.01.037; Chen XM, 2011, CARBOHYD POLYM, V83, P749, DOI 10.1016/j.carbpol.2010.08.050; Chou YJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091535; Cui HL, 2011, J SCI FOOD AGR, V91, P2180, DOI 10.1002/jsfa.4436; Cui Y, 2005, J ETHNOPHARMACOL, V96, P79, DOI 10.1016/j.jep.2004.08.037; Dong Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/160980; Du LN, 2016, MOL MED REP, V13, P1701, DOI 10.3892/mmr.2015.4736; Dun CP, 2016, NEUROPSYCH DIS TREAT, V12, P1617, DOI 10.2147/NDT.S106123; Goyal SN, 2016, CHEM-BIOL INTERACT, V244, P49, DOI 10.1016/j.cbi.2015.11.032; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Habibi F, 2016, ADV PHARM BULL, V6, P99, DOI 10.15171/apb.2016.015; Harlev E, 2013, PLANTA MED, V79, P425, DOI 10.1055/s-0032-1328331; Jellestad L, 2014, EUR J PHARMACOL, V724, P175, DOI 10.1016/j.ejphar.2013.12.029; Jiang S, 2013, INT J BIOL MACROMOL, V55, P118, DOI 10.1016/j.ijbiomac.2012.12.035; Jothivel N, 2007, J HEALTH SCI, V53, P655, DOI 10.1248/jhs.53.655; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kim MJ, 2006, LIFE SCI, V79, P2288, DOI 10.1016/j.lfs.2006.07.027; KOHLER SM, 1994, ACTA DIABETOL, V31, P119, DOI 10.1007/BF00570363; Lelongt B, 2001, J EXP MED, V193, P793, DOI 10.1084/jem.193.7.793; Li X, 2015, CELL PHYSIOL BIOCHEM, V37, P2125, DOI 10.1159/000438570; Liu YT, 2013, FOOD CHEM TOXICOL, V62, P285, DOI 10.1016/j.fct.2013.08.082; Ma CH, 2015, J ETHNOPHARMACOL, V172, P108, DOI 10.1016/j.jep.2015.06.015; Ma L, 2015, NUTR RES, V35, P431, DOI 10.1016/j.nutres.2015.04.011; McLennan SV, 2002, DIABETOLOGIA, V45, P268, DOI 10.1007/s00125-001-0730-4; Melin J, 2002, KIDNEY INT, V61, P1383, DOI 10.1046/j.1523-1755.2002.00284.x; Nabben M, 2016, CARDIOVASC DRUG THER, V30, P233, DOI 10.1007/s10557-016-6669-y; Pan D, 2014, FOOD CHEM TOXICOL, V63, P111, DOI 10.1016/j.fct.2013.10.046; Patel S, 2009, PHARMACOL REP, V61, P595, DOI 10.1016/S1734-1140(09)70111-2; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Sainaghi PP, 2007, EXP CLIN ENDOCR DIAB, V115, P112, DOI 10.1055/s-2007-949151; Saksida T, 2013, J NEUROIMMUNOL, V262, P72, DOI 10.1016/j.jneuroim.2013.07.001; Seto S, 2012, BIOORGAN MED CHEM, V20, P1188, DOI 10.1016/j.bmc.2011.12.046; Sim YC, 2016, MOL MED REP, V14, P4263, DOI 10.3892/mmr.2016.5763; Singh J, 2013, FOOD CHEM TOXICOL, V62, P722, DOI 10.1016/j.fct.2013.09.035; Song JJ, 2016, FOOD FUNCT, V7, P2006, DOI [10.1039/C5FO01017A, 10.1039/c5fo01017a]; Sun JE, 2008, J ETHNOPHARMACOL, V118, P7, DOI 10.1016/j.jep.2008.02.030; Wang J, 2014, MAR DRUGS, V12, P3292, DOI 10.3390/md12063292; Wang J, 2013, CARBOHYD POLYM, V95, P143, DOI 10.1016/j.carbpol.2013.02.076; Wang J, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4368380; Wang L, 2013, INT J BIOL MACROMOL, V61, P317, DOI 10.1016/j.ijbiomac.2013.07.028; Wang Y, 2015, INT J MOL SCI, V16, P22473, DOI 10.3390/ijms160922473; Wei JT, 2014, INT J BIOL MACROMOL, V64, P1, DOI 10.1016/j.ijbiomac.2013.11.013; Xu HY, 2010, NAT PROD RES, V24, P542, DOI 10.1080/14786410902751009; Xu W, 2015, INT J BIOL MACROMOL, V72, P575, DOI 10.1016/j.ijbiomac.2014.09.011; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Zhang J., 2016, INT J MOL SCI, V17, pE1810, DOI 10.3390/ijms17111810; Zhao LY, 2011, PHYTOMEDICINE, V18, P661, DOI 10.1016/j.phymed.2011.01.001; Zhong YQW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098850; Zhu ZY, 2016, INT J BIOL MACROMOL, V82, P959, DOI 10.1016/j.ijbiomac.2015.10.075	55	35	40	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180476	10.1371/journal.pone.0180476	http://dx.doi.org/10.1371/journal.pone.0180476			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662169	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300161
J	Charych, D; Khalili, S; Dixit, V; Kirk, P; Chang, T; Langowski, J; Rubas, W; Doberstein, SK; Eldon, M; Hoch, U; Zalevsky, J				Charych, Deborah; Khalili, Samira; Dixit, Vidula; Kirk, Peter; Chang, Thomas; Langowski, John; Rubas, Werner; Doberstein, Stephen K.; Eldon, Michael; Hoch, Ute; Zalevsky, Jonathan			Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; REGULATORY T-CELLS; HIGH-DOSE INTERLEUKIN-2; LONG-TERM SAFETY; MODULATION THERAPIES; ALPHA-RECEPTOR; LIGAND-BINDING; IL-2; COMPLEXES; CYTOKINE	Cytokines are potent immune modulating agents but are not ideal medicines in their natural form due to their short half-life and pleiotropic systemic effects. NKTR-214 is a clinical-stage biologic that comprises interleukin-2 (IL2) protein bound by multiple releasable polyethylene glycol (PEG) chains. In this highly PEG-bound form, the IL2 is inactive; therefore, NKTR214 is a biologic prodrug. When administered in vivo, the PEG chains slowly release, creating a cascade of increasingly active IL2 protein conjugates bound by fewer PEG chains. The 1-PEG-IL2 and 2-PEG-IL2 species derived from NKTR-214 are the most active conjugatedIL2 species. Free-IL2 protein is undetectable in vivo as it is eliminated faster than formed. The PEG chains on NKTR-214 are located at the region of IL2 that contacts the alpha (a) subunit of the heterotrimeric IL2 receptor complex, IL2Rapy, reducing its ability to bind and activate the heterotrimer. The IL2Rapy complex is constitutively expressed on regulatory T cells (Tregs). Therefore, without the use of mutations, PEGylation reduces the affinity for IL2Rapy to a greater extent than for IL293y, the receptor complex predominant on CD8 T cells. NKTR-214 treatment in vivo favors activation of CD8 T cells over Tregs in the tumor microenvironment to provide anti-tumor efficacy in multiple syngeneic models. Mechanistic modeling based on in vitro and in vivo kinetic data provides insight into the mechanism of NKTR-214 pharmacology. The model reveals that conjugated-IL2 protein derived from NKTR-214 occupy IL-293y to a greater extent compared to free-IL2 protein. The model accurately describes the sustained in vivo signaling observed after a single dose of NKTR214 and explains how the properties of NKTR-214 impart a unique kinetically-controlled immunological mechanism of action.	[Charych, Deborah; Khalili, Samira; Dixit, Vidula; Kirk, Peter; Chang, Thomas; Langowski, John; Rubas, Werner; Doberstein, Stephen K.; Eldon, Michael; Hoch, Ute; Zalevsky, Jonathan] Nektar Therapeut, San Francisco, CA 94158 USA	Nektar Therapeutics	Charych, D (corresponding author), Nektar Therapeut, San Francisco, CA 94158 USA.	DCharych@nektar.com			Nektar Therapeutics, San Francisco, California, United States of America	Nektar Therapeutics, San Francisco, California, United States of America	The study was funded by Nektar Therapeutics, San Francisco, California, United States of America. All authors are salaried employees of Nektar Therapeutics. DC, SK and JZ were involved in the study design, data collection and analysis. DC and JZ were involved in the decision to publish. DC, SK and UH were involved with the writing and preparation of the manuscript. Nektar Therapeutics provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexandrescu DT, 2005, J IMMUNOTHER, V28, P144, DOI 10.1097/01.cji.0000154250.82007.4a; Assal A, 2015, IMMUNOTHERAPY-UK, V7, P1169, DOI 10.2217/imt.15.78; Bos GW, 2004, EUR J PHARM SCI, V21, P561, DOI 10.1016/j.ejps.2003.12.007; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Charych DH, 2016, CLIN CANCER RES, V22, P680, DOI 10.1158/1078-0432.CCR-15-1631; Craiu A, 2001, AIDS RES HUM RETROV, V17, P873, DOI 10.1089/088922201750290005; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Garcia-Martinez K, 2012, INT IMMUNOL, V24, P427, DOI 10.1093/intimm/dxr120; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Konigsberg PJ, 1998, BBA-BIOMEMBRANES, V1370, P243, DOI 10.1016/S0005-2736(97)00269-1; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Le Mercier I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00418; Leon K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00439; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Lipiainen T, 2015, J PHARM SCI-US, V104, P307, DOI 10.1002/jps.24243; Luheshi NM, 2016, ONCOTARGET, V7, P18508, DOI 10.18632/oncotarget.7610; McDermott DF, 2016, J CLIN ONCOL, V34, P833, DOI 10.1200/JCO.2015.63.7421; McDermott DF, 2015, J CLIN ONCOL, V33, P2013, DOI 10.1200/JCO.2014.58.1041; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Myszka DG, 1996, PROTEIN SCI, V5, P2468, DOI 10.1002/pro.5560051209; Payne R, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-13; Penichet Manuel L., 1997, Human Antibodies, V8, P106; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Samlowski WE, 2006, J IMMUNOTHER, V29, P524, DOI 10.1097/01.cji.0000211306.05869.25; Schein CH, 2002, CURR PHARM DESIGN, V8, P2113, DOI 10.2174/1381612023393161; Shanafelt AB, 2000, NAT BIOTECHNOL, V18, P1197, DOI 10.1038/81199; Sim GC, 2014, IL 2 CYTOKINE FAMILY; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Sznol M, 2015, NEW ENGL J MED, V372, P374, DOI 10.1056/NEJMe1413488; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WU ZN, 1995, J BIOL CHEM, V270, P16045, DOI 10.1074/jbc.270.27.16045; Zhang L, 2015, MOL CANC THERAPEUTIC; Zhang L, 2015, MOL CANC THERAPEU S2, V14, pA6	38	92	102	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179431	10.1371/journal.pone.0179431	http://dx.doi.org/10.1371/journal.pone.0179431			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678791	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200014
J	Jennings, S; Chenevert, M; Liu, LQ; Mottamal, M; Wojcik, EJ; Huckaba, TM				Jennings, Scott; Chenevert, Madeline; Liu, Liqiong; Mottamal, Madhusoodanan; Wojcik, Edward J.; Huckaba, Thomas M.			Characterization of kinesin switch I mutations that cause hereditary spastic paraplegia	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT; KIF5A MUTATIONS; MOTOR DOMAIN; SPG10; PARAPARESIS; PROTEINS; TUBULIN; ATPASE; NEUROPATHOLOGY; MECHANISM	Kif5A is a neuronally-enriched isoform of the Kinesin-1 family of cellular transport motors. 23 separate mutations in the motor domain of Kif5A have been identified in patients with the complicated form of hereditary spastic paraplegia (HSP). We performed in vitro assays on dimeric recombinant Kif5A with HSP-causing mutations in the Switch I domain, which participates in the coordination and hydrolysis of ATP by kinesin. We observed a variety of significantly reduced catalytic and mechanical activities as a result of each mutation, with the shared phenotype from each that motility was significantly reduced. Substitution of Mn (2+) for Mg (2+) in our reaction buffers provides a dose-dependent rescue in both the catalytic and ensemble mechanical properties of the S203C mutant. This work provides mechanistic insight into the cause of HSP in patients with these mutations and points to future experiments to further dissect the root cause of this disease.	[Jennings, Scott; Chenevert, Madeline; Huckaba, Thomas M.] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA; [Liu, Liqiong; Wojcik, Edward J.] LSU Sch Med, Dept Biochem & Mol Biol, New Orleans, LA USA; [Liu, Liqiong; Wojcik, Edward J.] Hlth Sci Ctr, New Orleans, LA USA; [Mottamal, Madhusoodanan] Xavier Univ Louisiana, RCMI Mol Modeling Core, New Orleans, LA USA	Xavier University of Louisiana; Louisiana State University System; Louisiana State University; Xavier University of Louisiana	Huckaba, TM (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA.	thuckaba@xula.edu		Huckaba, Thomas/0000-0002-6711-9175; Wojcik, Edward/0000-0002-3023-0312	Louisiana Cancer Research Consortium; NIH-RCMI from the National Institutes on Minority Health and Health Disparities [2G12MD007595-06]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103424]; National Institute of General Medical Sciences of the National Institutes of Health [5UL1GM118967, R01GM066328]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [UL1GM118967, P20GM103424] Funding Source: NIH RePORTER	Louisiana Cancer Research Consortium; NIH-RCMI from the National Institutes on Minority Health and Health Disparities; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Louisiana Cancer Research Consortium and the NIH-RCMI grant 2G12MD007595-06 from the National Institutes on Minority Health and Health Disparities to TMH, an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health grant P20GM103424 to TMH, a National Institute of General Medical Sciences of the National Institutes of Health grant 5UL1GM118967 to TMH, and a National Institute of General Medical Sciences of the National Institutes of Health grant R01GM066328 to EJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHAN WMH, 1974, J NEUROL NEUROSUR PS, V37, P8, DOI 10.1136/jnnp.37.1.8; Blair MA, 2006, NEUROGENETICS, V7, P47, DOI 10.1007/s10048-005-0027-8; BRUYN RPM, 1992, CLIN NEUROL NEUROSUR, V94, pS16; Cao LY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42558; Cao LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6364; Carosi L, 2015, J NEUROL NEUROSUR PS, V86, P702, DOI 10.1136/jnnp-2014-308625; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Crimella C, 2012, CLIN GENET, V82, P157, DOI 10.1111/j.1399-0004.2011.01717.x; Djagaeva I, 2012, GENETICS, V192, P173, DOI 10.1534/genetics.112.140798; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Frederiksen JK, 2009, METHODS, V49, P148, DOI 10.1016/j.ymeth.2009.07.005; Fuger P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003066; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Goizet C, 2009, HUM MUTAT, V30, pE376, DOI 10.1002/humu.20920; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Huckaba TM, 2011, J BIOL CHEM, V286, P7457, DOI 10.1074/jbc.M110.167023; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Klebe S, 2015, REV NEUROL-FRANCE, V171, P505, DOI 10.1016/j.neurol.2015.02.017; Kull FJ, 2002, J CELL SCI, V115, P15; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Liu YT, 2014, NEUROLOGY, V83, P612, DOI 10.1212/WNL.0000000000000691; Lo Giudice M, 2006, ARCH NEUROL-CHICAGO, V63, P284, DOI 10.1001/archneur.63.2.284; Lopez E, 2015, J NEUROL SCI, V358, P422, DOI 10.1016/j.jns.2015.08.1529; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13233, DOI 10.1021/bi00040a039; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; Muglia M, 2014, J NEUROL SCI, V343, P218, DOI 10.1016/j.jns.2014.05.063; Musumeci O, 2011, NEUROL SCI, V32, P665, DOI 10.1007/s10072-010-0445-8; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Rinaldi Fabrizio, 2015, J Clin Neuromuscul Dis, V16, P153, DOI 10.1097/CND.0000000000000063; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; SADHU A, 1992, J BIOL CHEM, V267, P11352; Schule R, 2008, J NEUROL NEUROSUR PS, V79, P584, DOI 10.1136/jnnp.2007.137596; Tessa A, 2008, J NEUROL, V255, P1090, DOI 10.1007/s00415-008-0840-8; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	43	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180353	10.1371/journal.pone.0180353	http://dx.doi.org/10.1371/journal.pone.0180353			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678816	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200059
J	Rissin, DM; Lopez-Longarela, B; Pernagallo, S; Ilyine, H; Vliegenthart, ADB; Dear, JW; Diaz-Mochon, JJ; Duffy, DC				Rissin, David M.; Lopez-Longarela, Barbara; Pernagallo, Salvatore; Ilyine, Hugh; Vliegenthart, A. D. Bastiaan; Dear, James W.; Diaz-Mochon, Juan J.; Duffy, David C.			Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury	PLOS ONE			English	Article							NUCLEIC-ACIDS; BIOMARKERS; CHEMISTRY; PLATFORM; PCR; DNA	We have developed a single probe method for detecting microRNA from human serum using single molecule arrays, with sequence specificity down to a single base, and without the use of amplification by polymerases. An abasic peptide nucleic acid (PNA) probe D containing a reactive amine instead of a nucleotide at a specific position in the sequence D for detecting a microRNA was conjugated to superparamagnetic beads. These beads were incubated with a sample containing microRNA, a biotinylated reactive nucleobase D containing an aldehyde group D that was complementary to the missing base in the probe sequence, and a reducing agent. When a target molecule with an exact match in sequence hybridized to the capture probe, the reactive nucleobase was covalently attached to the backbone of the probe by a dynamic covalent chemical reaction. Single molecules of the biotin-labeled probe were then labeled with streptavidin-beta-galactosidase (S beta G), the beads were resuspended in a fluorogenic enzyme substrate, loaded into an array of femtoliter wells, and sealed with oil. The array was imaged fluorescently to determine which beads were associated with single enzymes, and the average number of enzymes per bead was determined. The assay had a limit of detection of 500 fM, approximately 500 times more sensitive than a corresponding analog bead-based assay, with target specificity down to a single base mis-match. This assay was used to measure microRNA-122 (miR-122) D an established biomarker of liver toxicity D extracted from the serum of patients who had acute liver injury due to acetaminophen, and control healthy patients. All patients with liver injury had higher levels of miR-122 in their serum compared to controls, and the concentrations measured correlated well with those determined using RT-qPCR. This approach allows rapid quantification of circulating microRNA with single-based specificity and a limit of quantification suitable for clinical use.	[Rissin, David M.; Duffy, David C.] Quanterix Corp, Lexington, MA 02421 USA; [Lopez-Longarela, Barbara; Pernagallo, Salvatore; Ilyine, Hugh; Diaz-Mochon, Juan J.] DestiNA Genom Ltd, Edinburgh, Midlothian, Scotland; [Lopez-Longarela, Barbara; Pernagallo, Salvatore; Ilyine, Hugh; Diaz-Mochon, Juan J.] DestiNA Genom SL Parque Tecnol Ciencias Salud PTS, Ave Innovac 1,Edificio BIC, Granada, Spain; [Vliegenthart, A. D. Bastiaan; Dear, James W.] Univ Edinburgh, BHF Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Diaz-Mochon, Juan J.] Univ Granada, Pfizer, Junta Andalucia Ctr Genom & Oncol Res GENYO, Parque Tecnol Ciencias Salud PTS, Ave Ilustrac 114, Granada, Spain	University of Edinburgh; Pfizer; University of Granada	Duffy, DC (corresponding author), Quanterix Corp, Lexington, MA 02421 USA.; Diaz-Mochon, JJ (corresponding author), DestiNA Genom Ltd, Edinburgh, Midlothian, Scotland.; Diaz-Mochon, JJ (corresponding author), DestiNA Genom SL Parque Tecnol Ciencias Salud PTS, Ave Innovac 1,Edificio BIC, Granada, Spain.; Diaz-Mochon, JJ (corresponding author), Univ Granada, Pfizer, Junta Andalucia Ctr Genom & Oncol Res GENYO, Parque Tecnol Ciencias Salud PTS, Ave Ilustrac 114, Granada, Spain.	juan@destinagenomics.com; dduffy@quanterix.com	Pernagallo, Salvatore/K-3003-2017; Diaz-Mochon, Juan/A-4297-2009; Pernagallo, Salvatore/P-3224-2019; Diaz-Mochon, Juan/Q-1065-2019	Pernagallo, Salvatore/0000-0002-0259-9008; Diaz-Mochon, Juan/0000-0002-3599-1954; Pernagallo, Salvatore/0000-0002-0259-9008; Diaz-Mochon, Juan/0000-0002-3599-1954	Medical Research Council [MC_PC_12014] Funding Source: Medline; National Centre for the Replacement, Refinement and Reduction of Animals in Research [NC/K001485/1] Funding Source: Medline; National Centre for the Replacement [NC/K001485/1] Funding Source: researchfish; MRC [MC_PC_12014] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Bowler FR, 2010, ANGEW CHEM INT EDIT, V49, P1809, DOI 10.1002/anie.200905699; Dear JW, 2014, EXPERT REV CLIN PHAR, V7, P181, DOI 10.1586/17512433.2014.880650; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Heemstra JM, 2009, J AM CHEM SOC, V131, P11347, DOI 10.1021/ja904712t; Kan CW, 2012, LAB CHIP, V12, P977, DOI 10.1039/c2lc20744c; Khodakov D, 2016, ADV DRUG DELIVER REV, V105, P3, DOI 10.1016/j.addr.2016.04.005; Krauskopf J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177928; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Pernagallo S, 2012, SENSORS-BASEL, V12, P8100, DOI 10.3390/s120608100; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rissin DM, 2013, LAB CHIP, V13, P2902, DOI 10.1039/c3lc50416f; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Smith SJ, 2017, J AM CHEM SOC, V139, P1020, DOI 10.1021/jacs.6b10850; Song LA, 2013, ANAL CHEM, V85, P1932, DOI 10.1021/ac303426b; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Venkateswaran S, 2016, TALANTA, V161, P489, DOI 10.1016/j.talanta.2016.08.072; Vliegenthart ADB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15501; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Wu HX, 2014, J AM CHEM SOC, V136, P17942, DOI 10.1021/ja510839r; Zhang L, 2010, PROSTATE, V70, P297, DOI 10.1002/pros.21064	22	38	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179669	10.1371/journal.pone.0179669	http://dx.doi.org/10.1371/journal.pone.0179669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678845	gold, Green Published, Green Submitted			2022-12-27	WOS:000405272200021
J	Seiler, A; Knee, A; Shaaban, R; Bryson, C; Paadam, J; Harvey, R; Igarashi, S; LaChance, C; Benjamin, E; Legu, T				Seiler, Adrianne; Knee, Alexander; Shaaban, Reham; Bryson, Christine; Paadam, Jasmine; Harvey, Rohini; Igarashi, Satoko; LaChance, Christopher; Benjamin, Evan; Legu, Tara			Physician communication coaching effects on patient experience	PLOS ONE			English	Article							DELIBERATE PRACTICE; HOSPITALIZED-PATIENTS; PATIENTS PERCEPTION; MEDICAL-EDUCATION; SKILLS; CARE; SATISFACTION; QUALITY; FEEDBACK; IMPACT	Background Excellent communication is a necessary component of high-quality health care. We aimed to determine whether a training module could improve patients' perceptions of physician communication behaviors, as measured by change over time in domains of patient experience scores related to physician communication. Study design We designed a comprehensive physician-training module focused on improving specific ''etiquette-based'' physician communication skills through standardized simulations and physician coaching with structured feedback. We employed a quasi-experimental pre-post design, with an intervention group consisting of internal medicine hospitalists and residents and a control group consisting of surgeons. The outcome was percent | always scores for questions related to patients' perceptions of physician communication using the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey and a Non-HCAHPS Physician-Specific Patient Experience Survey (NHPPES) administered to patients cared for by hospitalists. Results A total of 128 physicians participated in the simulation. Responses from 5020 patients were analyzed using HCAHPS survey data and 1990 patients using NHPPES survey data. The intercept shift, or the degree of change from pre-intervention percent ''always'' responses, for the HCAHPS questions of doctors ''treating patients with courtesy'' ''explaining things in a way patients could understand,'' and ''overall teamwork'' showed no significant differences between surgical control and hospitalist intervention patients. Adjusted NHPPES percent excellent survey results increased significantly post-intervention for the questions of specified individual doctors ''keeping patient informed'' (adjusted intercept shift 9.9% P = 0.019), ''overall teamwork'' (adjusted intercept shift 11%, P = 0.037), and ''using words the patient could understand'' (adjusted intercept shift 14.8%, p = 0.001). Conclusion A simulation based physician communication coaching method focused on specific ''etiquette-based'' communication behaviors through a deliberate practice framework was not associated with significantly improved HCAHPS physician communication patient experience scores. Further research could reveal ways that this model affects patients' perceptions of physician communication relating to specific physicians or behaviors.	[Seiler, Adrianne; Shaaban, Reham; Bryson, Christine; Paadam, Jasmine; Harvey, Rohini; Igarashi, Satoko; LaChance, Christopher; Benjamin, Evan; Legu, Tara] Baystate Med Ctr, Dept Med, Springfield, MA 01199 USA; [Seiler, Adrianne; Knee, Alexander; Shaaban, Reham; Bryson, Christine; Paadam, Jasmine; Harvey, Rohini; Igarashi, Satoko; LaChance, Christopher; Benjamin, Evan; Legu, Tara] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Seiler, Adrianne] Baycare Hlth Partners Pioneer Valley ACO, Springfield, MA USA; [Knee, Alexander] Baystate Med Ctr, Res Off, Springfield, MA USA; [Benjamin, Evan; Legu, Tara] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA USA; [Benjamin, Evan] Baystate Med Ctr, Dept Healthcare Qual, Springfield, MA USA; [Legu, Tara] Baystate Hlth Univ Massachusetts, Sch Med, Springfield, MA USA	Baystate Medical Center; Tufts University; Baystate Medical Center; Baystate Medical Center; Baystate Medical Center	Seiler, A (corresponding author), Baystate Med Ctr, Dept Med, Springfield, MA 01199 USA.; Seiler, A (corresponding author), Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA.; Seiler, A (corresponding author), Baycare Hlth Partners Pioneer Valley ACO, Springfield, MA USA.	Adrianne.seiler@bhs.org		Knee, Alexander/0000-0001-5656-6095	National Heart, Lung and Blood Institute of the National Institutes of Health [K01HL114745]; Institute for Health care Improvement; IPRO; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL114745] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institute for Health care Improvement; IPRO; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Lagu is supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under Award Number K01HL114745, personal fees from the Institute for Health care Improvement, personal fees from IPRO, outside of the submitted work.	Arora V, 2009, ARCH INTERN MED, V169, P199, DOI 10.1001/archinternmed.2008.565; Aspegren K, 1999, MED TEACH, V21, P563, DOI 10.1080/01421599978979; Back AL, 2007, ARCH INTERN MED, V167, P453, DOI 10.1001/archinte.167.5.453; Back AL, 2009, J CLIN ONCOL, V27, P1137, DOI 10.1200/JCO.2008.20.2408; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Banka G, 2015, J HOSP MED, V10, P497, DOI 10.1002/jhm.2373; Boehm Frank H, 2008, Acad Med, V83, P534, DOI 10.1097/ACM.0b013e3181722d7c; Brown JB, 1999, ANN INTERN MED, V131, P822, DOI 10.7326/0003-4819-131-11-199912070-00004; Curtis JR, 2013, JAMA-J AM MED ASSOC, V310, P2271, DOI 10.1001/jama.2013.282081; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Duvivier RJ, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-101; Dwamena F, 2012, INTERVENTIONS PROVID; Fallowfield L, 1998, J CLIN ONCOL, V16, P1961, DOI 10.1200/JCO.1998.16.5.1961; Gelfman LP, 2014, J PAIN SYMPTOM MANAG, V48, P738, DOI 10.1016/j.jpainsymman.2013.12.231; Goldstein E, 2005, HEALTH SERV RES, V40, P1977, DOI 10.1111/j.1475-6773.2005.00477.x; Gysels M, 2005, SUPPORT CARE CANCER, V13, P356, DOI 10.1007/s00520-004-0732-0; Handel DA, 2010, ACAD EMERG MED, V17, P495, DOI 10.1111/j.1553-2712.2010.00721.x; Hawkins RE, 2010, ACAD MED, V85, P1453, DOI 10.1097/ACM.0b013e3181eac3e6; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Isaac T, 2010, HEALTH SERV RES, V45, P1024, DOI 10.1111/j.1475-6773.2010.01122.x; Jackson CA, 2010, AM J GASTROENTEROL, V105, P525, DOI 10.1038/ajg.2009.685; Jackson VA, 2011, J PALLIAT MED, V14, P775, DOI 10.1089/jpm.2010.0493; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Lindenauer PK, 2014, JAMA INTERN MED, V174, P1904, DOI 10.1001/jamainternmed.2014.5161; MAGUIRE P, 1986, BRIT MED J, V292, P1573, DOI 10.1136/bmj.292.6535.1573; McGaghie WC, 2011, ACAD MED, V86, P706, DOI 10.1097/ACM.0b013e318217e119; Moore PM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003751.pub3; O'Leary KJ, 2015, J HOSP MED, V10, P555, DOI 10.1002/jhm.2403; O'Leary KJ, 2013, J HOSP MED, V8, P315, DOI 10.1002/jhm.2041; O'Leary KJ, 2010, MAYO CLIN PROC, V85, P47, DOI 10.4065/mcp.2009.0232; Okuda Y, 2009, MT SINAI J MED, V76, P330, DOI 10.1002/msj.20127; Raper SE, J SURG ED, V72, pe202; Scott Jason, 2012, Radiol Manage, V34, P29; Sequist TD, 2012, INT J QUAL HEALTH C, V24, P206, DOI 10.1093/intqhc/mzs018; Sequist TD, 2008, J GEN INTERN MED, V23, P1784, DOI 10.1007/s11606-008-0760-4; Smith S, 2007, EVAL HEALTH PROF, V30, P3, DOI 10.1177/0163278706297333; Studer Group, ACKN INTR DUR EXPL T; Tackett S, 2013, J GEN INTERN MED, V28, P908, DOI 10.1007/s11606-012-2328-6; Teutsch C, 2003, MED CLIN N AM, V87, P1115, DOI 10.1016/S0025-7125(03)00066-X; Torok H, 2014, J HOSP MED, V9, P553, DOI 10.1002/jhm.2220; Turner JS, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0671-8; Wild DMG, 2011, JT COMM J QUAL PATIE, V37, P461, DOI 10.1016/S1553-7250(11)37059-6; Yoder E., 2007, RADIOL MANAGE, V29; Zabar S, 2010, PATIENT EDUC COUNS, V80, P248, DOI 10.1016/j.pec.2009.11.015	44	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180294	10.1371/journal.pone.0180294	http://dx.doi.org/10.1371/journal.pone.0180294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678872	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200047
J	Wubull, A; Li, YH; Xue, F; Yao, XM; Upur, H; Wushouer, Q				Wubull, Atikaimu; Li, Yuehua; Xue, Feng; Yao, Xuemei; Upur, Halmurat; Wushouer, Qimanguli			Seasonality of active tuberculosis notification from 2005 to 2014 in Xinjiang, China	PLOS ONE			English	Article							VITAMIN-D; PULMONARY TUBERCULOSIS; EPIDEMIOLOGY	Objectives Xinjiang is one of the highest TB- burdened provinces of China. A time- series analysis was conducted to evaluate the trend, seasonality of active TB in Xinjiang, and explore the underlying mechanism of TB seasonality by comparing the seasonal variations of different subgroups. Methods Monthly active TB cases from 2005 to 2014 in Xinjiang were analyzed by the X- 12- ARIMA seasonal adjustment program. Seasonal amplitude (SA) was calculated and compared within the subgroups. Results A total of 277,300 confirmed active TB cases were notified from 2005 to 2014 in Xinjiang, China, with a monthly average of 2311 +/- 577. The seasonality of active TB notification was peaked in March and troughed in October, with a decreasing SA trend. The annual 77.31% SA indicated an annual mean of additional TB cases diagnosed in March as compared to October. The 0-14-year-old group had significantly higher SA than 15-44-year-old group (P<0.05). Students had the highest SA, followed by herder and migrant workers (P<0.05). The pleural TB cases had significantly higher SA than the pulmonary cases (P<0.05). Significant associations were not observed between SA and sex, ethnic group, regions, the result of sputum smear microcopy, and treatment history (P>0.05). Conclusion TB notification in Xinjiang shows an apparent seasonal variation with a peak in March and trough in October. For the underlying mechanism of TB seasonality, our results hypothesize that winter indoor crowding increases the risk of TB transmission, and seasonality was mainly influenced by the recent exogenous infection rather than the endogenous reactivation.	[Wubull, Atikaimu; Yao, Xuemei] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China; [Li, Yuehua; Xue, Feng] Xinjiang Uygur Autonomous Reg Ctr Dis Control & P, Ctr TB Control & Prevent, Urumqi, Xinjiang, Peoples R China; [Upur, Halmurat] Xinjiang Med Univ, Dept Tradit Uygur Med, Urumqi, Xinjiang, Peoples R China; [Wushouer, Qimanguli] Xinjiang Med Univ, Teaching Hosp 1, Dept Resp Med, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Upur, H (corresponding author), Xinjiang Med Univ, Dept Tradit Uygur Med, Urumqi, Xinjiang, Peoples R China.; Wushouer, Q (corresponding author), Xinjiang Med Univ, Teaching Hosp 1, Dept Resp Med, Urumqi, Xinjiang, Peoples R China.	halmurat@263.net; 1634035430@qq.com	LI, Yue/GRS-8071-2022		Natural Science Fund of Xinjiang Uyghur Autonomous Region [2016D01C189]	Natural Science Fund of Xinjiang Uyghur Autonomous Region	This study was funded by the Natural Science Fund of Xinjiang Uyghur Autonomous Region (grant number: 2016D01C189). AW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-3; Altes HK, 2012, INT J TUBERC LUNG D, V16, P639, DOI 10.5588/ijtld.11.0680; Bai Li-qiong, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P617; Bras AL, 2014, INT J TUBERC LUNG D, V18, P1202, DOI 10.5588/ijtld.14.0158; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Findley D F, 2000, ANN STAT 10, VX; Findley DF, 1998, J BUS ECON STAT, V16, P127, DOI 10.2307/1392565; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; MAES M, 1994, EXPERIENTIA, V50, P821, DOI 10.1007/BF01956463; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P278; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Nagayama N, 2006, INT J TUBERC LUNG D, V10, P1117; Naranbat N, 2009, EUR RESPIR J, V34, P921, DOI 10.1183/09031936.00035309; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Varun Kumar, 2014, TUBERCULOSIS RES TRE, V10; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121; Wubuli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144010; Xin-Xu Li, 2013, PLOS ONE, V8; Yang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108369; Zhang Z B, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P1183, DOI 10.3760/cma.j.issn.0254-6450.2016.08.025	29	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180226	10.1371/journal.pone.0180226	http://dx.doi.org/10.1371/journal.pone.0180226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678873	gold, Green Submitted, Green Published			2022-12-27	WOS:000405272200040
J	Yang, SH; Lee, JC; Guo, JC; Kuo, SH; Tien, YW; Kuo, TC; Cheng, AL; Yeh, KH				Yang, Shih-Hung; Lee, Jen-Chieh; Guo, Jhe-Cyuan; Kuo, Sung-Hsin; Tien, Yu-Wen; Kuo, Ting-Chun; Cheng, Ann-Lii; Yeh, Kun-Huei			Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy	PLOS ONE			English	Article							ONCOPROTEIN MDM2; MUTANT P53; PHASE-III; MUTATIONS; TUMOR; RAS; P16(INK4A); ACTIVATION; CARCINOMA; CELLS	This study evaluated the prognostic roles of murine double minute 2 (MDM2) and p53 in pancreatic cancer patients treated with gemcitabine-based chemotherapy. A total of 137 advanced or recurrent adenocarcinoma patients who were treated with gemcitabine-based palliative chemotherapy were reviewed, selected from 957 patients with pancreatic malignancy between 2008 and 2013 at our hospital. Immunohistochemical staining for MDM2 and p53 with formalin-fixed, paraffin-embedded tumor tissues was independently reviewed. Nuclear or cytoplasmic expression of MDM2 and p53 was found in tumor cells of 30 (21.9%) and 71 (51.8%) patients, respectively. Patients with MDM2 expression had shorter median overall survival (OS) (3.7 vs 5.8 mo; P = .048) and median progression-free survival (PFS) (1.5 vs 2.5 mo; P < .001); by contrast, p53 expression was not correlated with OS or PFS. In the multivariate analysis, MDM2 expression (hazard ratio = 1.731; P = .025) was an independent and unfavorable prognostic factor of OS. Additionally, MDM2 expression was significantly associated with progressive disease (PD) and death (P = .015) following first-line gemcitabine-based therapy. In advanced pancreatic cancer patients, MDM2 expression is associated with shorter OS and PFS after gemcitabine-based chemotherapy.	[Yang, Shih-Hung; Guo, Jhe-Cyuan; Kuo, Sung-Hsin; Cheng, Ann-Lii; Yeh, Kun-Huei] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Yang, Shih-Hung; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Yang, Shih-Hung; Guo, Jhe-Cyuan; Yeh, Kun-Huei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lee, Jen-Chieh] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Kuo, Sung-Hsin; Cheng, Ann-Lii; Yeh, Kun-Huei] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Tien, Yu-Wen; Kuo, Ting-Chun] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Kuo, Ting-Chun] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Yeh, KH (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan.; Yeh, KH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Yeh, KH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan.	khyeh@ntu.edu.tw	Lee, Jen-Chieh/AAG-3533-2019; Yeh, Kun-Huei/HGD-3316-2022	Lee, Jen-Chieh/0000-0001-7739-5934; KUO, TING-CHUN/0000-0003-1960-1423; Kuo, Sung-Hsin/0000-0003-0054-887X; Guo, Jhe-Cyuan/0000-0002-6689-9640; TIEN, YU-WEN/0000-0002-9126-2705; YEH, Kun-Huei/0000-0002-7306-174X; Cheng, Ann-Lii/0000-0002-9152-6512	Ministry of Health and Welfare [MOHW103T D-B-111-04, MOHW104-TD-B-111-04]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by MOHW103T D-B-111-04 and MOHW104-TD-B-111-04, Ministry of Health and Welfare (http://www.mohw. gov.tw/EN/Ministry/).	Achanta G, 2001, CANCER RES, V61, P8723; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cascallo M, 2005, ONCOLOGY-BASEL, V68, P179, DOI 10.1159/000086772; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Dong M, 2005, WORLD J GASTROENTERO, V11, P2162, DOI 10.3748/wjg.v11.i14.2162; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P89, DOI 10.1016/j.bbamcr.2014.10.003; Galmarini CM, 2002, INT J CANCER, V97, P439, DOI 10.1002/ijc.1628; Gerdes B, 2002, ANN SURG, V235, P51, DOI 10.1097/00000658-200201000-00007; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Gu LB, 2016, CANCER CELL, V30, P623, DOI 10.1016/j.ccell.2016.08.015; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Hermanova M, 2009, PANCREAS, V38, P565, DOI 10.1097/MPA.0b013e31819fef8b; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUANG P, 1991, CANCER RES, V51, P6110; Kimura H, 2013, INT J CLIN EXP PATHO, V6, P1306; Lee JC, 2011, AM J SURG PATHOL, V35, P1177, DOI 10.1097/PAS.0b013e318219cd0b; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; NAKAMORI S, 1995, JPN J CANCER RES, V86, P174, DOI 10.1111/j.1349-7006.1995.tb03036.x; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Poplin E, 2009, J CLIN ONCOL, V27, P3778, DOI 10.1200/JCO.2008.20.9007; REDSTON MS, 1994, CANCER RES, V54, P3025; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Ruggeri BA, 1997, CANCER, V79, P700, DOI 10.1002/(SICI)1097-0142(19970215)79:4<700::AID-CNCR7>3.0.CO;2-H; Shi WD, 2014, MOL CELL BIOCHEM, V387, P1, DOI 10.1007/s11010-011-1208-4; Sui X, 2009, ONCOGENE, V28, P709, DOI 10.1038/onc.2008.423; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang W, 2014, GASTROENTEROLOGY, V147, P893, DOI 10.1053/j.gastro.2014.07.001; Wei CH, 2013, PANCREAS, V42, P1303, DOI 10.1097/MPA.0b013e3182a23ae4; Weyrer K, 1996, LAB INVEST, V74, P279; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yang SH, 2016, J GASTROEN HEPATOL, V31, P2004, DOI 10.1111/jgh.13395; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang Zhenrong, 2004, J CFHI TECHNOLOGY, V1, P1, DOI DOI 10.1074/JBC	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180628	10.1371/journal.pone.0180628	http://dx.doi.org/10.1371/journal.pone.0180628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678832	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200080
J	Rudaz, M; Ledermann, T; Margraf, J; Becker, ES; Craske, MG				Rudaz, Myriam; Ledermann, Thomas; Margraf, Juergen; Becker, Eni S.; Craske, Michelle G.			The moderating role of avoidance behavior on anxiety over time: Is there a difference between social anxiety disorder and specific phobia?	PLOS ONE			English	Article							AGE-OF-ONSET; SAFETY BEHAVIORS; PSYCHOLOGICAL TREATMENTS; LIFETIME PREVALENCE; MENTAL-DISORDERS; ADOLESCENTS; FEARS; SYMPTOMS; THERAPY; ADULTS	Theories of anxiety disorders and phobias have ascribed a critical role to avoidance behavior in explaining the persistence of fear and anxiety, but knowledge about the role of avoidance behavior in the maintenance of anxiety in social anxiety disorder relative to specific phobia is lacking. This study examined the extent to which avoidance behavior moderates the relationship between general anxiety at baseline and 18 months later in women with a diagnosed social anxiety disorder (n = 91) and women with a diagnosed specific phobia (n = 130) at baseline. Circumscribed avoidance of social and specific situations were clinicianrated using the Anxiety Disorders Interview Schedule-Lifetime (ADIS-IV-L), and general anxiety was measured using the Beck Anxiety Inventory (BAI). Moderated regression analyses revealed that (a) general anxiety at baseline predicted general anxiety at follow-up in both women with a specific phobia and women with a social anxiety disorder and (b) avoidance behavior moderated this relationship in women with a specific phobia but not in women with a social anxiety disorder. Specifically, high avoidance behavior was found to amplify the effect between general anxiety at baseline and follow-up in specific phobia. Reasons for the absence of a similar moderating effect of avoidance behavior within social anxiety disorder are discussed.	[Rudaz, Myriam; Ledermann, Thomas] Utah State Univ, Dept Psychol, Logan, UT 84322 USA; [Margraf, Juergen] Ruhr Univ Bochum, Dept Psychol, Bochum, Germany; [Becker, Eni S.] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [Craske, Michelle G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA	Utah System of Higher Education; Utah State University; Ruhr University Bochum; Radboud University Nijmegen; University of California System; University of California Los Angeles	Rudaz, M (corresponding author), Utah State Univ, Dept Psychol, Logan, UT 84322 USA.	myriam.rudaz@usu.edu	Becker, Eni S/A-2668-2010; Margraf, Jürgen/A-6873-2008	Becker, Eni S/0000-0003-3524-426X; Margraf, Jürgen/0000-0001-5207-7016	German Ministry of Science, Research and Education [DLR01EG9410]; National Centre of Competence in Research sesam, Swiss National Science Foundation [51A240-104890]; Swiss National Science Foundation [PBBS1-120509, PBFR1-120897]	German Ministry of Science, Research and Education; National Centre of Competence in Research sesam, Swiss National Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the German Ministry of Science, Research and Education grant no. DLR01EG9410 and by the National Centre of Competence in Research sesam, Swiss National Science Foundation grant no.51A240-104890. The research of the first and second authors was supported by grants from the Swiss National Science Foundation, no.PBBS1-120509 and PBFR1-120897.	Abramowitz J. S., 2011, EXPOSURE THERAPY ANX; Aiken L. S., 1991, MULTIPLE REGRESSION; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2013, DIAGNOSTIC STAT MANU, V5; Barlow D. H., 2004, ANXIETY ITS DISORDER; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Becker ES., 2000, INCIDENCE PREVALENCE; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Beesdo-Baum K, 2012, ACTA PSYCHIAT SCAND, V126, P411, DOI 10.1111/j.1600-0447.2012.01886.x; Beesdo-Baum K, 2012, CHILD ADOL PSYCH CL, V21, P457, DOI 10.1016/j.chc.2012.05.001; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Bogels SM, 2004, CLIN PSYCHOL REV, V24, P827, DOI 10.1016/j.cpr.2004.06.005; Choy Y, 2007, CLIN PSYCHOL REV, V27, P266, DOI 10.1016/j.cpr.2006.10.002; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Clark D. M., 1988, PANIC PSYCHOL PERSPE, P71; Clark DM, 2002, BIOL PSYCHIAT, V51, P92, DOI 10.1016/S0006-3223(01)01296-3; CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2; Clark LA, 2006, BRIT J PSYCHIAT, V189, P481, DOI 10.1192/bjp.bp.106.03825; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craske M.G., 2007, FEAR LEARNING BASIC, P217, DOI [10.1037/11474-011, DOI 10.1037/11474-011, 10.1037/11474-000, DOI 10.1037/11474-000]; Craske M. G, 2003, ORIGINS PHOBIAS ANXI, P71, DOI [DOI 10.1016/B978-008044032-3/50005-8, 10.1016/B978-008044032-3/50005-8]; Craske MG, 2009, DEPRESS ANXIETY, V26, P1066, DOI 10.1002/da.20633; DAVEY GCL, 1992, ADV BEHAV RES THER, V14, P29, DOI 10.1016/0146-6402(92)90010-L; De Castella K, 2015, COGN BEHAV THERAPY, V44, P128, DOI 10.1080/16506073.2014.974665; Di Nardo P. A., 1995, ANXIETY DISORDERS IN; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fedoroff IC, 2001, J CLIN PSYCHOPHARM, V21, P311, DOI 10.1097/00004714-200106000-00011; Fehm L, 2005, EUR NEUROPSYCHOPHARM, V15, P453, DOI 10.1016/j.euroneuro.2005.04.002; FESKE U, 1995, BEHAV THER, V26, P695, DOI 10.1016/S0005-7894(05)80040-1; Field A. P., 2001, ANXIETY DISORDERS CH, P187; Gloster AT, 2008, BEHAV RES THER, V46, P642, DOI 10.1016/j.brat.2008.02.010; Gould RA, 1997, CLIN PSYCHOL-SCI PR, V4, P291, DOI 10.1111/j.1468-2850.1997.tb00123.x; Heimberg RG, 2014, SOCIAL ANXIETY: CLINICAL, DEVELOPMENTAL, AND SOCIAL PERSPECTIVES, 3RD EDITION, P705, DOI 10.1016/B978-0-12-394427-6.00024-8; Hendriks SM, 2013, ACTA PSYCHIAT SCAND, V128, P212, DOI 10.1111/acps.12024; Hirsch CR, 2004, CLIN PSYCHOL REV, V24, P799, DOI 10.1016/j.cpr.2004.07.005; Hudson JL, 2015, J AM ACAD CHILD PSY, V54, P454, DOI 10.1016/j.jaac.2015.03.018; In-Albon T, 2008, Z KL PSYCH PSYCHOTH, V37, P33, DOI 10.1026/1616-3443.37.1.33; Jacobi F, 2014, INT J METH PSYCH RES, V23, P304, DOI 10.1002/mpr.1439; Johnson P. O., 1936, STAT RES MEMOIRS; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kim EJ, 2005, J ANXIETY DISORD, V19, P69, DOI 10.1016/j.janxdis.2003.11.002; LeBeau RT, 2010, DEPRESS ANXIETY, V27, P148, DOI 10.1002/da.20655; Margraf J., 2007, PSYCHIATRY, V6, P136, DOI [10.1016/j.mppsy.2007.01.007, DOI 10.1016/J.MPPSY.2007.01.007]; Margraf J., 2007, BAI BECK ANGST INVEN; Margraf J, 1991, VERHALTENSTHERAPIE, V1, P110; Margraf J, 1996, F DIPS DIAGNOSTISCH; Marks M, 1999, J ANXIETY DISORD, V13, P463, DOI 10.1016/S0887-6185(99)00015-8; Mayo-Wilson E, 2014, LANCET PSYCHIAT, V1, P368, DOI 10.1016/S2215-0366(14)70329-3; Morgan H, 1999, AUST NZ J PSYCHIAT, V33, P503, DOI 10.1046/j.1440-1614.1999.00599.x; MOWRER OH, 1960, AM PSYCHOL, V15, P301, DOI 10.1037/h0045069; Mowrer OH, 1939, PSYCHOL REV, V46, P553, DOI 10.1037/h0054288; Norton PJ, 2007, J NERV MENT DIS, V195, P521, DOI 10.1097/01.nmd.0000253843.70149.9a; Ollendick TH, 2010, BEHAV RES THER, V48, P827, DOI 10.1016/j.brat.2010.05.024; Powers MB, 2008, INT J COGN THER, V1, P94, DOI 10.1680/ijct.2008.1.2.94; RACHMAN S, 1986, BEHAV RES THER, V24, P387, DOI 10.1016/0005-7967(86)90003-3; RACHMAN S, 1994, BEHAV RES THER, V32, P683, DOI 10.1016/0005-7967(94)90025-6; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Rudaz M, 2016, PSYCHOLOGY, V7, P1810; Rudaz M, 2010, DEPRESS ANXIETY, V27, P404, DOI 10.1002/da.20645; Ruhmland M, 2001, VERHALTENSTHERAPIE, V11, P41, DOI 10.1159/000050323; Ruscio AM, 2008, PSYCHOL MED, V38, P15, DOI 10.1017/S0033291707001699; SALKOVSKIS PM, 1991, BEHAV PSYCHOTHER, V19, P6, DOI 10.1017/S0141347300011472; Schneider S, 1992, DIAGNOSTICA, V38, P209; Suppiger A, 2009, BEHAV THER, V40, P272, DOI 10.1016/j.beth.2008.07.002; Suppiger A, 2008, VERHALTENSTHERAPIE, V18, P237, DOI 10.1159/000169699; Taylor CT, 2016, J BEHAV THER EXP PSY, V50, P68, DOI 10.1016/j.jbtep.2015.05.008; Taylor S, 1996, J BEHAV THER EXP PSY, V27, P1, DOI 10.1016/0005-7916(95)00058-5; Trumpf J, 2010, SOC PSYCH PSYCH EPID, V45, P853, DOI 10.1007/s00127-009-0133-2; Vanden Bogaerde A, 2011, J ANXIETY DISORD, V25, P422, DOI 10.1016/j.janxdis.2010.11.005; WELLS A, 1995, BEHAV THER, V26, P153, DOI 10.1016/S0005-7894(05)80088-7; Wittchen HU, 1999, PSYCHOL MED, V29, P309, DOI 10.1017/S0033291798008174; Wittchen HU, 2000, COMPR PSYCHIAT, V41, P122, DOI 10.1016/S0010-440X(00)80018-8; Wolitzky-Taylor KB, 2008, CLIN PSYCHOL REV, V28, P1021, DOI 10.1016/j.cpr.2008.02.007; Zlomke K, 2008, BEHAV THER, V39, P207, DOI 10.1016/j.beth.2007.07.003	76	16	17	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180298	10.1371/journal.pone.0180298	http://dx.doi.org/10.1371/journal.pone.0180298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28671977	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500042
J	Bartelt, A; Jeschke, A; Muller, B; Gaziano, I; Morales, M; Yorgan, T; Heckt, T; Heine, M; Gagel, RF; Emeson, RB; Amling, M; Niemeier, A; Heeren, J; Schinke, T; Keller, J				Bartelt, Alexander; Jeschke, Anke; Mueller, Brigitte; Gaziano, Isabella; Morales, Michelle; Yorgan, Timur; Heckt, Timo; Heine, Markus; Gagel, Robert F.; Emeson, Ronald B.; Amling, Michael; Niemeier, Andreas; Heeren, Joerg; Schinke, Thorsten; Keller, Johannes			Differential effects of Calca-derived peptides in male mice with diet-induced obesity	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; CONTROLS BONE-FORMATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CALCITONIN; PROCALCITONIN; ADRENOMEDULLIN; INFLAMMATION; METABOLISM; EXPRESSION	Key metabolic hormones, such as insulin, leptin, and adiponectin, have been studied extensively in obesity, however the pathophysiologic relevance of the calcitonin family of peptides remains unclear. This family includes calcitonin (CT), its precursor procalcitonin (PCT), and alpha calcitonin-gene related peptide (aCGRP), which are all encoded by the gene Calca. Here, we studied the role of Calca-derived peptides in diet-induced obesity (DIO) by challenging Calcr(-/-) (encoding the calcitonin receptor, CTR), Calca(-/-), and aCGRP(-/-) mice and their respective littermates with high-fat diet (HFD) feeding for 16 weeks. HFD-induced pathologies were assessed by glucose tolerance, plasma cytokine and lipid markers, expression studies and histology. We found that DIO in mice lacking the CTR resulted in impaired glucose tolerance, features of enhanced nonalcoholic steatohepatitis (NASH) and adipose tissue inflammation compared to wildtype littermates. Furthermore, CTR-deficient mice were characterized by dyslipidemia and elevated HDL levels. In contrast, mice lacking Calca were protected from DIO, NASH and adipose tissue inflammation, and displayed improved glucose tolerance. Mice exclusively lacking aCGRP displayed a significantly less improved DIO phenotype compared to Calca-deficient mice. In summary, we demonstrate that the CT/CTR axis is involved in regulating plasma cholesterol levels while Calca, presumably through PCT, seems to have a detrimental effect in the context of metabolic disease. Our study provides the first comparative analyses of the roles of Calca-derived peptides and the CTR in metabolic disease.	[Bartelt, Alexander; Mueller, Brigitte; Gaziano, Isabella; Heine, Markus; Niemeier, Andreas; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Bartelt, Alexander; Mueller, Brigitte; Gaziano, Isabella; Niemeier, Andreas] Univ Med Ctr Hamburg Eppendorf, Dept Orthoped, Hamburg, Germany; [Jeschke, Anke; Yorgan, Timur; Heckt, Timo; Amling, Michael; Schinke, Thorsten; Keller, Johannes] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Morales, Michelle] Scripps Mercy Hosp, Dept Internal Med, San Diego, CA USA; [Gagel, Robert F.] Univ Texas MD Anderson Canc Ctr, Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; [Emeson, Ronald B.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	Keller, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany.	johannes.keller@charite.de	Bartelt, Alexander/ABC-2525-2020	Gaziano, Isabella/0000-0002-9513-5156; Keller, Johannes/0000-0002-8925-7288	Deutsche Forschungsgemeinschaft [Ni 637/2-3, SFB841, AM103/15-1]; Bundesministerium fur Bildung and Forschung (Project ANCYLOSS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung and Forschung (Project ANCYLOSS)(Federal Ministry of Education & Research (BMBF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Deutsche Forschungsgemeinschaft to AN (Ni 637/2-3), JH (SFB841) and AM (AM103/15-1,) and Bundesministerium fur Bildung and Forschung (Project ANCYLOSS) to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2010, J CLIN ENDOCR METAB, V95, pE26, DOI 10.1210/jc.2010-0305; Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Bartelt A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15010; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartelt A, 2010, BONE, V47, P736, DOI 10.1016/j.bone.2010.07.002; Becker KL, 2010, BRIT J PHARMACOL, V159, P253, DOI 10.1111/j.1476-5381.2009.00433.x; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Dacquin R, 2004, J CELL BIOL, V164, P509, DOI 10.1083/jcb.200312135; Dahaba AA, 2009, MINERVA ANESTESIOL, V75, P447; Davey RA, 2008, J BONE MINER RES, V23, P1182, DOI 10.1359/JBMR.080310; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; Feigh M, 2013, MENOPAUSE; Feigh M, 2014, EUR J PHARMACOL, V737, P91, DOI 10.1016/j.ejphar.2014.05.016; Gebre-Medhin S, 1998, MOL BRAIN RES, V63, P180, DOI 10.1016/S0169-328X(98)00269-1; Gebre-Medhin S, 1998, BIOCHEM BIOPH RES CO, V250, P271, DOI 10.1006/bbrc.1998.9308; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gydesen S, 2017, BR J PHARM; Hay DL, 2015, PHARMACOL REV, V67, P564, DOI 10.1124/pr.115.010629; Hoff AO, 2002, J CLIN INVEST, V110, P1849, DOI 10.1172/JCI200214218; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Huebner AK, 2008, ARCH BIOCHEM BIOPHYS, V473, P210, DOI 10.1016/j.abb.2008.02.013; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Linscheid P, 2005, ENDOCRINOLOGY, V146, P2699, DOI 10.1210/en.2004-1424; Linscheid P, 2003, ENDOCRINOLOGY, V144, P5578, DOI 10.1210/en.2003-0854; Liu T, 2017, ENDOCRINOLOGY; Luna-Luna M, 2015, ARCH MED RES; Matwiyoff GN, 2012, INFLAMM RES, V61, P401, DOI 10.1007/s00011-012-0439-5; Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1002/oby.20135, 10.1038/oby.20135]; Nilsson C, 2016, EUR J PHARMACOL, V773, P24, DOI 10.1016/j.ejphar.2016.01.003; NISHIZAWA Y, 1988, J CLIN INVEST, V82, P1165, DOI 10.1172/JCI113713; Popeijus HE, 2008, INT J OBESITY, V32, P1076, DOI 10.1038/ijo.2008.55; Radimerski TM, 2011, INNATE IMMUN-LONDON, V17, P403, DOI 10.1177/1753425910377100; Recober A, 2010, DRUG NEWS PERSPECT, V23, P112, DOI 10.1358/dnp.2010.23.2.1475909; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Schinke T, 2004, J BONE MINER RES, V19, P2049, DOI 10.1359/JBMR.040915; Sexton PM, 2008, CRIT CARE MED, V36, P1637, DOI 10.1097/CCM.0b013e318170a554; Timper K, 2011, J CLIN ENDOCR METAB, V96, pE297, DOI 10.1210/jc.2010-1324; Walker CS, 2013, BRIT J PHARMACOL, V170, P1293, DOI 10.1111/bph.12129; Walker CS, 2010, ENDOCRINOLOGY, V151, P4257, DOI 10.1210/en.2010-0284; ZELISSEN PMJ, 1991, PEPTIDES, V12, P861, DOI 10.1016/0196-9781(91)90147-H; Zhang H, 2016, INT J OBESITY, V40, P852, DOI 10.1038/ijo.2016.2; Zhang SY, 2016, DIABETES, V65, P2342, DOI 10.2337/db15-1626	47	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180547	10.1371/journal.pone.0180547	http://dx.doi.org/10.1371/journal.pone.0180547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666011	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608700016
J	Groeneveld, KM; Koenderman, L; Warren, BL; Jol, S; Leenen, LPH; Hietbrink, F				Groeneveld, Kathelijne M.; Koenderman, Leo; Warren, Brian L.; Jol, Saskia; Leenen, Luke P. H.; Hietbrink, Falco			Early decreased neutrophil responsiveness is related to late onset sepsis in multitrauma patients: An international cohort study	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; MIGRATORY ACTIVITY; IMMUNE-RESPONSE; MAJOR TRAUMA; EXPRESSION; PATHOPHYSIOLOGY; DEFINITIONS; MECHANISMS; SEVERITY; KINETICS	Background Severe trauma can lead to the development of infectious complications after several days, such as sepsis. Early identification of patients at risk will aid anticipating these complications. The aim of this study was to test the relation between the acute (<24 hours) inflammatory response after injury measured by neutrophil responsiveness and the late (>5 days) development of septic complications and validate this in different trauma populations. Methods and findings Two prospective, observational, cohort series in the Netherlands and South Africa, consisting of severely injured trauma patients. Neutrophil responsiveness by fMLF-induced active Fc(Upsilon)RII was measured in whole blood flowcytometry, as read out for the systemic immune response within hours after trauma. Sepsis was scored daily. Ten of the 36 included Dutch patients developed septic shock. In patients with septic shock, neutrophils showed a lower expression of fMLF-induced active Fc(Upsilon)RII immediately after trauma when compared to patients without septic shock (P = 0.001). In South Africa 11 of 73 included patients developed septic shock. Again neutrophils showed lower expression of fMLF induced active Fc(Upsilon)RII (P = 0.001). In the combined cohort, all patients who developed septic shock demonstrated a decreased neutrophil responsiveness. Conclusions Low responsiveness of neutrophils for the innate stimulus fMLF immediately after trauma preceded the development of septic shock during admission by almost a week and did not depend on a geographical/racial background, hospital protocols and health care facilities. Decreased neutrophil responsiveness appears to be a prerequisite for septic shock after trauma. This might enable anticipation of this severe complication in trauma patients.	[Groeneveld, Kathelijne M.; Jol, Saskia; Leenen, Luke P. H.; Hietbrink, Falco] UMC Utrecht, Dept Surg, Utrecht, Netherlands; [Koenderman, Leo] UMC Utrecht, Dept Resp Med, Utrecht, Netherlands; [Koenderman, Leo] UMC Utrecht, Lab Translat Immunolgy, Utrecht, Netherlands; [Warren, Brian L.] Stellenbosch Univ, Tygerberg Hosp, Div Surg, Cape Town, South Africa	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Stellenbosch University; Tygerberg Hospital	Hietbrink, F (corresponding author), UMC Utrecht, Dept Surg, Utrecht, Netherlands.	F.Hietbrink@umcutrecht.nl						BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; Botha AJ, 1997, INTENS CARE MED, V23, P504, DOI 10.1007/s001340050365; Butcher SK, 2001, J LEUKOCYTE BIOL, V70, P881; Ciesla DJ, 2005, ARCH SURG-CHICAGO, V140, P432, DOI 10.1001/archsurg.140.5.432; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; DEHAAS M, 1994, J IMMUNOL, V152, P900; FONTES B, 1995, J SURG RES, V58, P599, DOI 10.1006/jsre.1995.1094; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Harwood PJ, 2006, J TRAUMA, V60, P334, DOI 10.1097/01.ta.0000197148.86271.13; Hietbrink F, 2006, SHOCK, V26, P558, DOI 10.1097/01.shk.0000233196.40989.78; Hietbrink F, 2013, SHOCK, V40, P21, DOI 10.1097/SHK.0b013e318295a40a; Hietbrink F, 2009, INJURY, V40, P851, DOI 10.1016/j.injury.2008.11.002; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Leliefeld PHC, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1250-4; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Oudijk EJD, 2006, RESP MED, V100, P1791, DOI 10.1016/j.rmed.2006.01.022; Pallister I, 2006, J TRAUMA, V60, P844, DOI 10.1097/01.ta.0000215583.08765.ce; Pallister I, 2002, CRIT CARE MED, V30, P1717, DOI 10.1097/00003246-200208000-00007; Pillay J, 2007, INJURY, V38, P1365, DOI 10.1016/j.injury.2007.09.016; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Wang X, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0972-z	31	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180145	10.1371/journal.pone.0180145	http://dx.doi.org/10.1371/journal.pone.0180145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665985	Green Published, gold			2022-12-27	WOS:000404608700065
J	Gentillon, C; Connell, AJ; Kirk, RW; Butchbach, MER				Gentillon, Cinsley; Connell, Andrew J.; Kirk, Ryan W.; Butchbach, Matthew E. R.			The effects of C5-substituted 2,4-diaminoquinazolines on selected transcript expression in spinal muscular atrophy cells	PLOS ONE			English	Article							RETINAL GANGLION-CELL; MOTOR-NEURON 2; MOUSE MODEL; SPLICING MODIFIERS; SINGLE NUCLEOTIDE; PROTECTIVE ACTION; DECAPPING ENZYME; SMN EXPRESSION; PCR DATA; SURVIVAL	C5-substituted 2,4-diaminoquinazolines (2,4-DAQs) ameliorate disease severity in SMA mice. It is uncertain, however, that these compounds increase SMN protein levels in vivo even though they were identified as activators of the SMN2 promoter. These compounds also regulate the expression of other transcripts in neuroblastoma cells. In this study, we investigate the mechanism by which the 2,4-DAQs regulate the expression of SMN2 as well as other targets. D156844, D158872, D157161 and D157495 (RG3039) increased SMN2 promoter-driven reporter gene activity by at least 3-fold in NSC-34 cells. These compounds, however, did not significantly increase SMN2 mRNA levels in type II SMA fibroblasts nor in NSC-34 cells, although there was a trend for these compounds increasing SMN protein in SMA fibroblasts. The number of SMN-containing gems was increased in SMA fibroblasts in response to 2,4-DAQ treatment in a dose-dependent manner. ATOH7 mRNA levels were significantly lower in type II SMA fibroblasts. 2,4-DAQs significantly increased ATOH7, DRNT1 and DRTN2 transcript levels in type II SMA fibroblasts and restored ATOH7 levels to those observed in healthy fibroblasts. These compounds also increase Atoh7 mRNA expression in NSC-34 cells. In conclusion, 2,4-DAQs regulate SMN2 by increasing protein levels and gem localization. They also increase ATOH7, DRNT1 and DRNT2 transcript levels. This study reveals that the protective effects of 2,4-DAQs in SMA may be independent of SMN2 gene regulation. These compounds could be used in concert with a proven SMN2 inducer to develop a multi-faceted approach to treating SMA.	[Gentillon, Cinsley; Connell, Andrew J.; Kirk, Ryan W.; Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Ctr Appl Clin Genom, Nemours Biomed Res, Wilmington, DE USA; [Gentillon, Cinsley; Butchbach, Matthew E. R.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Ctr Pediat Res, Nemours Biomed Res, Wilmington, DE USA; [Butchbach, Matthew E. R.] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA	Nemours Alfred I. duPont Hospital for Children; University of Delaware; Nemours Alfred I. duPont Hospital for Children; Jefferson University	Butchbach, MER (corresponding author), Nemours Alfred I duPont Hosp Children, Ctr Appl Clin Genom, Nemours Biomed Res, Wilmington, DE USA.; Butchbach, MER (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE USA.; Butchbach, MER (corresponding author), Nemours Alfred I duPont Hosp Children, Ctr Pediat Res, Nemours Biomed Res, Wilmington, DE USA.; Butchbach, MER (corresponding author), Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA.	butchbach@nemoursresearch.org		Butchbach, Matthew/0000-0003-2912-6400	Nemours Foundation (MERB); Cure SMA (MERB); National Institutes of Health [P30GM114736]; University of Delaware	Nemours Foundation (MERB); Cure SMA (MERB); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Delaware	This work was supported in part by the Nemours Foundation (MERB), Cure SMA (MERB) and National Institutes of Health [grant number P30GM114736; MERB]. CG was supported by the University of Delaware.The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Brown NL, 2002, MAMM GENOME, V13, P95, DOI 10.1007/s00335-001-2101-3; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Butchbach MER, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00007; Butchbach MER, 2014, EXP NEUROL, V256, P1, DOI 10.1016/j.expneurol.2014.03.005; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen JH, 2012, INVEST OPHTH VIS SCI, V53, P779, DOI 10.1167/iovs.11-8277; Cherry JJ, 2014, ASSAY DRUG DEV TECHN, V12, P315, DOI 10.1089/adt.2014.587; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Cusco I, 2002, BJOG-INT J OBSTET GY, V109, P1244, DOI 10.1016/S1470-0328(02)02983-X; DURHAM HD, 1993, NEUROTOXICOLOGY, V14, P387; Echaniz-Laguna A, 1999, AM J HUM GENET, V64, P1365, DOI 10.1086/302372; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Ghiasvand NM, 2011, NAT NEUROSCI, V14, P578, DOI 10.1038/nn.2798; Gogliotti RG, 2013, HUM MOL GENET, V22, P4084, DOI 10.1093/hmg/ddt258; Hache M, 2016, J CHILD NEUROL, V31, P899, DOI 10.1177/0883073815627882; Harris ALW, 2015, NEUROMUSCULAR DISORD, V25, P699, DOI 10.1016/j.nmd.2015.05.008; Heier CR, 2007, J CHILD NEUROL, V22, P1013, DOI 10.1177/0883073807305669; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Husseiny MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094591; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lim SH, 2014, OPHTHALMIC GENET, V35, P1, DOI 10.3109/13816810.2012.752017; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Liu H, 2011, DEV NEUROBIOL, V71, P153, DOI 10.1002/dneu.20840; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Liu W, 2001, P NATL ACAD SCI USA, V98, P1649, DOI 10.1073/pnas.98.4.1649; Liu YT, 2014, INVEST OPHTH VIS SCI, V55, P8251, DOI 10.1167/iovs.14-15712; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Mack SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115473; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Milac AL, 2014, BBA-GENE REGUL MECH, V1839, P452, DOI 10.1016/j.bbagrm.2014.04.007; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 1999, BBA-GENE STRUCT EXPR, V1445, P330, DOI 10.1016/S0167-4781(99)00060-3; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasov L, 2012, HUM MOL GENET, V21, P3681, DOI 10.1093/hmg/dds197; Prasov L, 2012, DEV BIOL, V368, P214, DOI 10.1016/j.ydbio.2012.05.005; Prasov L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012315; Ratni H, 2016, J MED CHEM, V59, P6086, DOI 10.1021/acs.jmedchem.6b00459; Saul SM, 2008, MOL CELL NEUROSCI, V37, P153, DOI 10.1016/j.mcn.2007.09.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCUDIERO DA, 1986, MUTAT RES, V159, P125, DOI 10.1016/0027-5107(86)90121-1; Shen V, 2008, RNA, V14, P1132, DOI 10.1261/rna.1008208; Singh J, 2008, ACS CHEM BIOL, V3, P711, DOI 10.1021/cb800120t; Singh RN, 2017, BBA-GENE REGUL MECH, V1860, P299, DOI 10.1016/j.bbagrm.2016.12.008; Stabley DL, 2017, NEUROMUSCULAR DISORD, V27, P439, DOI 10.1016/j.nmd.2017.02.002; Stabley DL, 2015, MOL GENET GENOM MED, V3, P248, DOI 10.1002/mgg3.141; Thurmond J, 2008, J MED CHEM, V51, P449, DOI 10.1021/jm061475p; Tisdale S, 2015, J NEUROSCI, V35, P8691, DOI 10.1523/JNEUROSCI.0417-15.2015; van Dijk E, 2003, P NATL ACAD SCI USA, V100, P12081, DOI 10.1073/pnas.1635192100; Van Meerbeke JP, 2013, HUM MOL GENET, V22, P4074, DOI 10.1093/hmg/ddt257; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venturini C, 2014, BRIT J OPHTHALMOL, V98, P562, DOI 10.1136/bjophthalmol-2013-304080; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Woll MG, 2016, J MED CHEM, V59, P6070, DOI 10.1021/acs.jmedchem.6b00460; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhou M, 2015, RNA, V21, P1306, DOI 10.1261/rna.051573.115	72	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180657	10.1371/journal.pone.0180657	http://dx.doi.org/10.1371/journal.pone.0180657			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662219	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300172
J	Klimza, H; Jackowska, J; Tokarski, M; Piersiala, K; Wierzbicka, M				Klimza, H.; Jackowska, J.; Tokarski, M.; Piersiala, K.; Wierzbicka, M.			Narrow-band imaging (NBI) for improving the assessment of vocal fold leukoplakia and overcoming the umbrella effect	PLOS ONE			English	Article							LESIONS; CLASSIFICATION; CANCER	Background It is crucial to find a balance between functional and oncological outcome when choosing an adequate method for the management of vocal fold leukoplakia. Therefore, a detailed examination is a milestone in the decision-making process. Aim To examine whether narrow-band imaging (NBI) can be helpful in vocal fold assessment in the case of leukoplakia and how to overcome the "umbrella effect"- understood as the submucosal vascular pattern hidden under the plaque. Material and methods Prospective cohort of 41 consecutive patients. Inclusion criteria: vocal fold leukoplakia, no previous procedures (surgery, radiotherapy), and preoperative endoscopy with an optical filter for NBI. Two groups: "suspicious" and "normal", according to the submucosal microvascular pattern of peripheral regions of the mucosa surrounding the plaque, were distinguished. Patients were qualified for a full-thickness or partial-thickness biopsy, respectively. Criteria defining suspected characters were well-demarcated brownish areas with scattered brown spots corresponding to type IV, Va, Vb, and Vc NI classifications. Results In 22/41 (53.7%) patients with "suspected" microvascular pattern, full-thickness biopsy was performed. Moderate and severe dysplasia was revealed in 15 type IV and 7 type Va NI patients. In 19/41 (46.3%) patients with proper NBI vessel pattern treated by partial-thickness biopsy, hyperkeratosis was diagnosed. There was a strong correlation between the NBI pattern and final histology: Chi2 (2) = 41.0 (p = 0.0000).	[Klimza, H.; Jackowska, J.; Tokarski, M.; Wierzbicka, M.] Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Poznan, Poland; [Piersiala, K.] Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Student Res Grp, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Klimza, H (corresponding author), Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Poznan, Poland.	hnogala@wp.pl	Piersiala, Krzysztof/AAC-5351-2021	Wierzbicka, Malgorzata/0000-0003-0006-6352; Jackowska, Joanna/0000-0002-5189-5823; Piersiala, Krzysztof/0000-0003-3844-5999				Ahn A, 2016, LARYNGOSCOPE, V126, P923, DOI 10.1002/lary.25609; Barnes L., 2005, WHO CLASSIFICATION T; Bartlett RS, 2012, LARYNGOSCOPE, V122, P336, DOI 10.1002/lary.22417; Burkhardt A, 1997, ACTA OTO-LARYNGOL, P12; Fang TJ, 2016, HEAD NECK-J SCI SPEC, V38, pE1998, DOI 10.1002/hed.24368; Gale N., 2005, WHO CLASSIFICATION T, P143; Gale N, 2014, HISTOPATHOLOGY, V65, P456, DOI 10.1111/his.12427; Gale N, 2014, HEAD NECK PATHOL, V8, P16, DOI 10.1007/s12105-014-0530-z; Kambic V, 1997, ACTA OTO-LARYNGOL, P7; Kono T, 2017, LARYNGOSCOPE, V127, P679, DOI 10.1002/lary.26210; Ma LJ, 2013, CHINESE MED J-PEKING, V126, P3523, DOI 10.3760/cma.j.issn.0366-6999.20131206; Ni XG, 2011, J LARYNGOL OTOL, V125, P288, DOI 10.1017/S0022215110002033; Peretti G, 2006, OTOLARYNG CLIN N AM, V39, P173, DOI 10.1016/j.otc.2005.10.003; Piazza C, 2010, ORAL ONCOL, V46, P307, DOI 10.1016/j.oraloncology.2010.01.020; Qi XM, 2014, INT J CLIN EXP MED, V7, P3305; Stanikova L, 2017, EUR ARCH OTO-RHINO-L, V274, P355, DOI 10.1007/s00405-016-4244-6; van Hulst AM, 2015, HEAD NECK-J SCI SPEC, V38, P24185; Watanabe A, 2009, EUR ARCH OTO-RHINO-L, V266, P1017, DOI 10.1007/s00405-008-0835-1	18	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180590	10.1371/journal.pone.0180590	http://dx.doi.org/10.1371/journal.pone.0180590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662209	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300169
J	Vongpunsawad, S; Intharasongkroh, D; Thongmee, T; Poovorawan, Y				Vongpunsawad, Sompong; Intharasongkroh, Duangnapa; Thongmee, Thanunrat; Poovorawan, Yong			Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SOUTHERN THAILAND; INFECTION; DISEASE; SINGAPORE; CHILDREN; ADULTS; SEROEPIDEMIOLOGY; TRANSMISSION; PATHOGENESIS	The abundance of Aedes mosquito species enabled widespread transmission of mosquito-borne chikungunya virus (CHIKV) and dengue virus (DENV) in Southeast Asia. Periodic seroprevalence surveys are therefore necessary to assess the viral burden in the population and the effectiveness of public health interventions. Since the current seroprevalence for CHIKV and DENV in Thailand are unknown, we evaluated evidence of past infection among Thais. Eight-hundred and thirty-five serum samples obtained from individuals living in central and southern Thailand were assessed for anti-CHIKV and anti-DENV IgG antibodies using commercial enzyme-linked immunosorbent assays. Overall, 26.8% (224/835) of individuals were seropositive for CHIKV, the majority of whom were also DENV-seropositive (91.1%, 204/224). Approximately half of all adults in their fifth decade of life had attained CHIKV seropositivity. Children under 15 years of age in southern Thailand were significantly more likely to be CHIKV-seropositive compared to those residing in central Thailand. In contrast, 79.2% (661/835) of Thais were DENV-seropositive, 30.9% (204/661) of whom also had antibodies to CHIKV. CHIKV/DENV dual seropositivity among Thais was 24.4% (204/835). The age-standardized seroprevalence for DENV was three times that of CHIKV (80.5% vs. 27.2%). Relatively high CHIKV seroprevalence among adults living in central Thailand revealed an under-recognized CHIKV burden in the region, while the low-to-moderate transmission intensity of DENV (seroprevalence <50% at 9 years) is expected to reduce the impact of DENV vaccination in Thailand. This most recent seroprevalence data provide serological baselines for two of the most common mosquito-borne viruses in this region.	[Vongpunsawad, Sompong; Intharasongkroh, Duangnapa; Thongmee, Thanunrat; Poovorawan, Yong] Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; vongpunsawad, sompong/0000-0001-7520-8728	The National Research Council of Thailand; National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project [CU56HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; The Out standing Professor of Thailand Research Fund [DPG5480002]; The National Research University Project, Office of Higher Education Commission [NRU59-002-HR]; Chulalongkorn University Fund	The National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); The Out standing Professor of Thailand Research Fund; The National Research University Project, Office of Higher Education Commission; Chulalongkorn University Fund(Chulalongkorn University)	This work was supported by The National Research Council of Thailand, The Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093),The Out standing Professor of Thailand Research Fund (DPG5480002), and The National Research University Project, Office of Higher Education Commission (NRU59-002-HR). This research was also supported by the 100th Anniversary Chulalongkorn University Fund for adoctoral scholarship to Duangnapa Intharasongkroh. The funders had n orole in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2015, EPIDEMIOL INFECT, V143, P1585, DOI 10.1017/S0950268814002507; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; Azami NAM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-67; BURKE DS, 1985, T ROY SOC TROP MED H, V79, P419, DOI 10.1016/0035-9203(85)90398-0; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005; Ditsuwan T, 2011, ANN EPIDEMIOL, V21, P253, DOI 10.1016/j.annepidem.2010.12.002; Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181; HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997; Halstead SB, 1988, SCIENCE, P239; Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879; HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102; Hoke CH, 2012, VACCINE, V30, P6713, DOI 10.1016/j.vaccine.2012.08.025; JOHNSON D E, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P184; Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065; Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d; Lertanekawattana Sujet, 2013, Southeast Asian J Trop Med Public Health, V44, P780; Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241; Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671; Muhammad Azami Nor Azila, 2011, BMC Res Notes, V4, P216, DOI 10.1186/1756-0500-4-216; NELSON ER, 1960, J PEDIATR-US, V56, P101, DOI 10.1016/S0022-3476(60)80294-6; Nkoghe D, 2012, INFECT DIS REP, V4, P11, DOI 10.4081/idr.2012.e5; Pongsiri P, 2010, TROP BIOMED, V27, P167; Pongsiri P, 2012, J HEALTH POPUL NUTR, V30, P366; Posuwan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150499; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Suwannakarn K, 2011, ASIAN PAC J TROP MED, V4, P535, DOI 10.1016/S1995-7645(11)60141-7; Thaikruea Lakkana, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P359; Thavara U, 2009, SE ASIAN J TROP MED, V40, P951; Theamboonlers A, 2009, JPN J INFECT DIS, V62, P303; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]; Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667	39	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180560	10.1371/journal.pone.0180560	http://dx.doi.org/10.1371/journal.pone.0180560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662144	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300165
J	Bogdanowicz, W; Rutkowski, R; Gabrielyan, BK; Ryspaev, A; Asatryan, AN; Mkrtchyan, JA; Bujalska, BM				Bogdanowicz, Wieslaw; Rutkowski, Robert; Gabrielyan, Bardukh K.; Ryspaev, Akylbek; Asatryan, Anzhela N.; Mkrtchyan, Jon A.; Bujalska, Barbara M.			Fish introductions in the former Soviet Union: The Sevan trout (Salmo ischchan)-80 years later	PLOS ONE			English	Article							SALMON SALMO-SALAR; GENETIC DIVERSITY; POPULATION-STRUCTURE; MICROSATELLITE LOCI; CONSERVATION GENETICS; DNA POLYMORPHISM; BROWN TROUT; MITOCHONDRIAL-DNA; RE-IMPLEMENTATION; RAPID EVOLUTION	The Soviet Union played the leading role in fish introductions in Eurasia. However, only 3% of all introductions prior to 1978 gave a commercial benefit. One of the noteworthy examples appears to be the Sevan trout (Salmo ischchan Kessler, 1877) - an endemic salmonid of Lake Sevan in Armenia. This species has been introduced to Kirghizstan, Kazakhstan, and Uzbekistan, however, only the Kirghiz population has persisted in relatively high numbers. In this paper we provide the first extensive molecular study of S. ischchan using samples from the native population from Lake Sevan and three hatcheries in Armenia, as well as from the population introduced to Lake Issyk Kul in Kirghizstan. The Kirghiz population has been isolated since the introductions took place in 1930 and 1936. Our results, based on 11 nuclear microsatellites and a 905 bp fragment of the mitochondrial control region suggest that hatcheries have maintained genetic variability by way of ongoing translocations of individuals from Lake Sevan. Simultaneously, significant Garza-Williamson M-values suggest that bottlenecks could have reduced the genetic variability of the wild populations in the past. This hypothesis is supported by historical data, indicating highly manipulated waterlevel regulations and poaching as two main factors that dramatically impact fish abundance in the lake. On the other hand, a similar situation has been observed in Kirghizstan, but this population likely rebounded from small population size faster than the other populations examined. The Kirghiz population is significantly genetically differentiated from the other groups and have morphological features and biological attributes not observed in the source population. Genetic data imply that the effective population size in the native population is lower than that found in the introduced population, suggesting that some active protection of the Lake Sevan population may be needed urgently.	[Bogdanowicz, Wieslaw; Rutkowski, Robert; Bujalska, Barbara M.] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Gabrielyan, Bardukh K.] Natl Acad Sci Armenia, Sci Ctr Zool & Hydroecol, Yerevan, Armenia; [Ryspaev, Akylbek] Kirghizstan Natl Acad Sci, Inst Biol & Pedol, Bishkek, Kyrgyzstan; [Asatryan, Anzhela N.; Mkrtchyan, Jon A.] Sevani Ishkhan CJSC, Yerevan, Armenia	Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; National Academy of Sciences of Armenia	Bogdanowicz, W (corresponding author), Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland.	wieslawb@miiz.waw.pl		Rutkowski, Robert/0000-0003-0265-7455; Bogdanowicz, Wieslaw/0000-0003-1196-2494	Ministry of Nature Protection in Armenia; National Science Centre in Poland [N N303 566339]	Ministry of Nature Protection in Armenia; National Science Centre in Poland(National Science Centre, Poland)	Fish sampling in Lake Sevan was granted by the Ministry of Nature Protection in Armenia. Fish from the lake were killed and used for other ichthyologic analyses, but fish from the farms, for which no permission was needed, were released back to the pools. No permission was required to capture Sevan trout in Kirghizstan. The idea of this project emerged during scientific trips of the first author to Armenia and Nagorno Karabakh funded by the National Science Centre in Poland (grant N N303 566339 on the Caucasian refugium). We thank Ron Van Den Bussche (Oklahoma State University, Stillwater, USA) and three anonymous reviewers for critical comments on the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Alamanov A, 2011, AMBIO, V40, P479, DOI 10.1007/s13280-011-0140-x; [Anonymous], 2000, ALIENS INVASIVE SPEC, DOI DOI 10.1614/WT-04-126.1; Avise JC, 2010, CONSERV GENET, V11, P665, DOI 10.1007/s10592-009-0006-y; Ayres RM, 2012, MAR FRESHWATER RES, V63, P1206, DOI 10.1071/MF11279; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERNATCHEZ L, 1995, MOL ECOL, V4, P285, DOI 10.1111/j.1365-294X.1995.tb00222.x; Bernatchez L, 2001, EVOLUTION, V55, P351, DOI 10.1111/j.0014-3820.2001.tb01300.x; Bohling J, 2016, AQUACULTURE, V462, P1, DOI 10.1016/j.aquaculture.2016.04.013; Burmakin E.V., 1963, IZV GOS NAUCHNO ISSL, V53, P1; Caballero P, 2013, REV GENETIC ECOLOGIC, P9; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Cornuet JM, 1996, GENETICS, V144, P2001; Cortey M, 2002, J FISH BIOL, V60, P1058, DOI 10.1111/j.1095-8649.2002.tb02429.x; Dadikyan MG, 1986, FISHES ARMENIA; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dorofeeva EA, 1988, VOP IKHTIOL, V38, P437; Dorofeyeva EA, 2008, P ZOOL I RAS, V312, P114; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans B, 2004, AQUACULTURE, V233, P109, DOI 10.1016/j.aquaculture.2003.09.037; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO Fisheries and Aquaculture Department, 2016, INTR SPEC FACT SHEET; Fortunatov MA, 1927, T SEVAN LAKE STATION, V1; Franklin JR, 1980, CONSERVATION BIOL EV, P135; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gabrielyan BK, 2010, NATL ACAD SCI; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gemayel R, 2012, GENES-BASEL, V3, P461, DOI 10.3390/genes3030461; Goudet J., 2001, FSTAT V2 9 3 PROGRAM; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Heath DD, 2003, SCIENCE, V299, P1738, DOI 10.1126/science.1079707; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; Hoicik J., 1991, CAN J FISH AQUAT SCI, V48, P13; Huff DD, 2011, MOL ECOL, V20, P4246, DOI 10.1111/j.1365-294X.2011.05271.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Khurshut EE, 2006, RYBY UZBEKISTANA; Kohn MH, 2006, TRENDS ECOL EVOL, V21, P629, DOI 10.1016/j.tree.2006.08.001; Koljonen ML, 2002, AQUACULTURE, V212, P69, DOI 10.1016/S0044-8486(01)00808-0; Konurbayev AO, 1981, P 17 SCI C BALKH; Lambert DM, 2005, CONSERV GENET, V6, P1, DOI 10.1007/s10592-004-7857-z; Lavrovsky VV, 1968, 2547 FAO UNDPTA; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lifshits SM, 1979, OBZOR INFORMAT SII N, V1979, P1; Lind D, 2005, ARMENIA ENVIRONS, V29, P29; Linlokken AN, 2014, FISHERIES MANAG ECOL, V21, P515, DOI 10.1111/fme.12101; Luzhin BP., 1956, ISSYK KUL TROUT GEGA; Lynch M., 1997, NMFSNWFSC30 NOAA, P59; McClelland EK, 2007, CONSERV GENET, V8, P397, DOI 10.1007/s10592-006-9178-x; Mila B, 2000, P ROY SOC LOND B BIO, V267, P1033; Mitrofanov VP, 1999, 385 FAO FISH, P149; Mitrofanov VP, 1992, FISHES KAZAKHSTAN; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; NEI M, 1978, GENETICS, V89, P583; Nikolic N, 2009, J FISH BIOL, V74, P458, DOI 10.1111/j.1095-8649.2008.02094.x; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; Osinov A, 1996, J ICHTHYOLOGY, V36, P762; Park SDE, 2001, THESIS; PEAKALL R, 2006, GENALEX V6 GENETIC A; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petr Tomislav, 1998, Lakes Reservoirs Research and Management, V3, P143, DOI 10.1046/j.1440-1770.1998.00069.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell KM, 2012, BIOL INVASIONS, V14, P2057, DOI 10.1007/s10530-012-0213-1; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Rambaut A, 2007, VERSION 1 4 HIGHER; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reisenbichler RR, 2004, ONCORHYNCHUS MYKISS, P371; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Savvaitova KA, 1999, 385 FAO FISH, P168; Skaala O, 2004, AQUACULTURE, V240, P131, DOI 10.1016/j.aquaculture.2004.07.009; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TAJIMA F, 1989, GENETICS, V123, P585; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Welcomme LR, 1988, 294 FAO, P1; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1969, THEORY GENE FREQUENC, V2	94	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180605	10.1371/journal.pone.0180605	http://dx.doi.org/10.1371/journal.pone.0180605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683097	gold, Green Published, Green Submitted			2022-12-27	WOS:000405335200052
J	Huerta, JM; Chirlaque, MD; Molina, AJ; Amiano, P; Martin, V; Fernandez-Villa, T; Perez-Gomez, B; Moreno, V; Burgui, R; Gomez-Acebo, I; Ramos-Lora, M; Fernandez-Tardon, G; Peiro, R; Olmedo-Requena, R; Pollan, M; Kogevinas, M; Castano-Vinyals, G; Aragones, N; Navarro				Huerta, Jose M.; Dolores Chirlaque, Maria; Molina, Antonio J.; Amiano, Pilar; Martin, Vicente; Fernandez-Villa, Tania; Perez-Gomez, Beatriz; Moreno, Victor; Burgui, Rosana; Gomez-Acebo, Ines; Ramos-Lora, Manuel; Fernandez-Tardon, Guillermo; Peiro, Rosana; Olmedo-Requena, Rocio; Pollan, Marina; Kogevinas, Manolis; Castano-Vinyals, Gemma; Aragones, Nuria; Navarro			Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control study	PLOS ONE			English	Article							CANCER; MORTALITY; EPIDEMIOLOGY; ASSOCIATION; HOUSEHOLD	Background Evidence for a protective role of physical activity against development of stomach cancer is yet inconclusive. We studied the association of domain-specific physical activity and the risk of gastric adenocarcinoma (GAC), by site and histology, in the MCC-Spain case-control study. Methods 428 histologically confirmed GAC cases (67% men) including the gastro-esophageal region and 3225 controls were included. Cases were recruited in hospitals from 10 different Spanish regions, whereas population controls were randomly selected within the respective hospitals' catchment areas. A physical activity (PA) questionnaire was used to gather information on household and recreational activities, allowing estimation of PA volume (in metabolic equivalents (MET)-min/week). Participants also reported the intensity of working PA and daily sitting time. Questionnaire data on diet, lifestyles and clinical variables including Helicobacter pylori serology were available. Adjusted odds ratios (OR) of GAC were estimated for domains of physical activity, stratifying by sex, site (cardia vs. non-cardia), and Lauren classification (intestinal vs. diffuse). Results Household physical activity (HPA) showed a strong inverse association with GAC, observed for both cardia and non-cardia tumours. Risk of overall gastric cancer was 50% lower risk among participants in the highest HPA category (OR = 0.50, 95`)Cl: 0.38, 0.66). Recreational physical activity (RPA) was also associated with lower overall GAC risk (OR = 0.68, 95% CI: 0.52, 0.88), particularly at moderate levels of intensity such as walking (OR = 0.61, 95% CI: 0.46, 0.79). The protective effect of RPA was strongest for non-cardia tumours. Sedentary time was not related to GAC risk (p-trend = 0.392), but the potential protective effect of RPA was restricted to non -sedentary participants. Conclusions Both household and recreational physical activities were independently related to lower GAC risk in the MCC-Spain study.	[Huerta, Jose M.; Dolores Chirlaque, Maria; Navarro] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Huerta, Jose M.; Dolores Chirlaque, Maria; Molina, Antonio J.; Amiano, Pilar; Martin, Vicente; Perez-Gomez, Beatriz; Moreno, Victor; Burgui, Rosana; Gomez-Acebo, Ines; Fernandez-Tardon, Guillermo; Peiro, Rosana; Olmedo-Requena, Rocio; Pollan, Marina; Kogevinas, Manolis; Castano-Vinyals, Gemma; Aragones, Nuria; Navarro] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Dolores Chirlaque, Maria; Navarro] Univ Murcia, Dept Hlth & Social Sci, Murcia, Spain; [Molina, Antonio J.; Martin, Vicente; Fernandez-Villa, Tania] Univ Leon, Res Grp Gene Environm Interact & Hlth, Leon, Spain; [Amiano, Pilar] Govt Basque Country, Publ Hlth Div Gipuzkoa, BioDonostia Res Inst, San Sebastian, Spain; [Perez-Gomez, Beatriz; Pollan, Marina; Aragones, Nuria] Inst Salud Carlos III, Canc Epidemiol Unit, Madrid, Spain; [Perez-Gomez, Beatriz; Pollan, Marina; Aragones, Nuria] IIS Puerta Hierro, Oncol & Hematol Area, Canc Epidemiol Res Grp, Madrid, Spain; [Moreno, Victor] Catalan Inst Oncol IDIBELL, Canc Prevent & Control Program, Lhospitalet De Llobregat, Spain; [Moreno, Victor] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona, Spain; [Burgui, Rosana] IdiSNA Navarra Inst Hlth Res, Navarra Publ Hlth Inst, Pamplona, Spain; [Gomez-Acebo, Ines] Univ Cantabria IDIVAL, Santander, Spain; [Ramos-Lora, Manuel] Hosp Juan Ramon Jimenez, Dept Gastroenterol, Huelva, Spain; [Ramos-Lora, Manuel] Univ Huelva, Ctr Invest Salud & Medio Ambiente CYSMA, Huelva, Spain; [Fernandez-Tardon, Guillermo] Univ Oviedo IUOPA, Oviedo, Spain; [Peiro, Rosana] Fdn FISABIO Salud Publ, Area Canc & Salud PUbl, Valencia, Spain; [Olmedo-Requena, Rocio] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain; [Olmedo-Requena, Rocio] Univ Granada, Inst Invest Biosanitaria Ibs, Complejo Hosp Univ Granada, Granada, Spain; [Kogevinas, Manolis; Castano-Vinyals, Gemma] Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain; [Kogevinas, Manolis; Castano-Vinyals, Gemma] IMIM Hosp Mar Med Res Inst, Barcelona, Spain; [Kogevinas, Manolis; Castano-Vinyals, Gemma] Univ Pompeu Fabra, Barcelona, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Murcia; Universidad de Leon; Basque Government; Instituto de Salud Carlos III; Hospital Puerta de Hierro-Majadahonda; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Public Health Institute of Navarra; Universidad de Cantabria; Hospital Juan Ramon Jimenez; Universidad de Huelva; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; ISGlobal; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University	Huerta, JM (corresponding author), IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain.; Huerta, JM (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	jmhuerta.carm@gmail.com	Pollan, Marina/M-3259-2014; Fernández-Villa, Tania/R-6534-2017; Aragones, Nuria/O-5962-2015; Martin, Vicente/ABF-2276-2021; Gomez-Acebo, Ines/C-9122-2018; Castaño-Vinyals, Gemma/H-7021-2017; Castaño-Vinyals, Gemma/N-3885-2019; Martin, Vicente/GRE-8306-2022; Kogevinas, Manolis/C-3918-2017; Huerta, José María/N-8654-2015; Perez-Gomez, Beatriz/C-4715-2012; Olmedo-Requena, Rocío/H-3845-2017; DE LA TORRE, ANTONIO JOSÉ MOLINA/T-8682-2019; Martin, Vicente/A-1597-2008; Fernandez-Tardon, Guillermo/AAC-1832-2022; Moreno, Victor/A-1697-2010	Pollan, Marina/0000-0002-4328-1565; Aragones, Nuria/0000-0003-0983-2156; Gomez-Acebo, Ines/0000-0001-8793-8314; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Martin, Vicente/0000-0003-0552-2804; Kogevinas, Manolis/0000-0002-9605-0461; Huerta, José María/0000-0002-9637-3869; Perez-Gomez, Beatriz/0000-0002-4299-8214; Olmedo-Requena, Rocío/0000-0003-0054-6700; DE LA TORRE, ANTONIO JOSÉ MOLINA/0000-0002-5948-6397; Martin, Vicente/0000-0003-0552-2804; Fernandez-Tardon, Guillermo/0000-0002-7680-158X; Moreno, Victor/0000-0002-2818-5487; Peiro Perez, Rosana/0000-0003-1525-4030	Accion Transversal del Cancer; Instituto de Salud Carlos III-FEDER [PI08/1770, PI08/1359, PI09/00773, PI09/01286, PI09/01903, PI09/02078, PI09/01662, PI11/01403, PI11/01889, PI12/00265]; Fundacion Marques de Valdecilla [API 10/09]; Junta de Castilla y Leon [LE22A10-2]; Consejeria de Salud of the Junta de Andalucia [2009-S0143]; Conselleria de Sanitat of the Generalitat Valenciana [AP_061/10]; Recercaixa [2010ACUP 00310]; Regional Government of the Basque Country; Consejeria de Sanidad de la Region de Murcia; European Commission [FOOD-CT-2006-036224-HIWATE]; Spanish Association Against Cancer (AECC) Scientific Foundation; Catalan Government DURSI grant [2014SGR647]; Fundacion Caja de Ahorros de Asturias; University of Oviedo	Accion Transversal del Cancer(Instituto de Salud Carlos III); Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Marques de Valdecilla(Instituto de Salud Carlos III); Junta de Castilla y Leon(Junta de Castilla y Leon); Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); Conselleria de Sanitat of the Generalitat Valenciana; Recercaixa(La Caixa Foundation); Regional Government of the Basque Country; Consejeria de Sanidad de la Region de Murcia; European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Association Against Cancer (AECC) Scientific Foundation; Catalan Government DURSI grant; Fundacion Caja de Ahorros de Asturias(Principality of Asturias); University of Oviedo	The study was partially funded by the 'Action Transversal del Cancer', approved by the Spanish Ministry Council on 11 October 2007, by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/1359, PI09/00773, PI09/01286, PI09/01903, PI09/02078, PI09/01662, PI11/01403, PI11/01889, PI12/00265), the Fundacion Marques de Valdecilla (API 10/09), the Junta de Castilla y Leon (LE22A10-2), the Consejeria de Salud of the Junta de Andalucia (2009-S0143), the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10), the Recercaixa (2010ACUP 00310), the Regional Government of the Basque Country, the Consejeria de Sanidad de la Region de Murcia, the European Commission grants FOOD-CT-2006-036224-HIWATE, the Spanish Association Against Cancer (AECC) Scientific Foundation, the Catalan Government DURSI grant 2014SGR647, the Fundacion Caja de Ahorros de Asturias and by the University of Oviedo.	Abioye AI, 2015, BRIT J SPORT MED, V49, P224, DOI 10.1136/bjsports-2013-092778; Ainsworth BE, COMPENDIUM PHYS ACTI; Ang TL, 2014, SINGAP MED J, V55, P621, DOI 10.11622/smedj.2014174; [Anonymous], CANC INCIDENCE 5 CON; Arnold M, 2015, EUR J CANCER, V51, P1164, DOI 10.1016/j.ejca.2013.09.002; Ayan C, 2013, EUR REV AGING PHYS A, V10, P7, DOI 10.1007/s11556-012-0113-5; Behrens G, 2014, EUR J EPIDEMIOL, V29, P151, DOI 10.1007/s10654-014-9895-2; Castano-Vinyals G, 2015, GAC SANIT, V29, P308, DOI 10.1016/j.gaceta.2014.12.003; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088082; Cook MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084805; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; de Batlle J, 2016, EUR J NUTR; Fernandez deLarrea N, 2017, FRONT MICROBIOL; Hu B, 2012, J GASTROINTEST ONCOL, V3, P251, DOI 10.3978/j.issn.2078-6891.2012.021; Keum N, 2016, JAMA ONCOL, V2, P1146, DOI 10.1001/jamaoncol.2016.0740; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leitzmann M, 2015, CANC EPIDEMIOL S1, V39; Leitzmann M, 2015, CANCER EPIDEMIOL, V39, pS46, DOI 10.1016/j.canep.2015.03.009; Huerta JM, 2016, PREV MED, V85, P106, DOI 10.1016/j.ypmed.2016.02.009; Huerta JM, 2010, CANCER CAUSE CONTROL, V21, P657, DOI 10.1007/s10552-009-9493-x; Martinez-Gomez D, 2014, PREV MED, V61, P14, DOI 10.1016/j.ypmed.2014.01.006; Moore SC, 2016, JAMA INTERN MED, V175, P959; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Shi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14901; Singh S, 2014, CANCER PREV RES, V7, P12, DOI 10.1158/1940-6207.CAPR-13-0282; Wen XY, 2010, ASIAN PAC J CANCER P, V11, P1473; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; WHO-IARC, 2012, GLOBOCAN 2012 EST IN; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	30	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179731	10.1371/journal.pone.0179731	http://dx.doi.org/10.1371/journal.pone.0179731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683070	gold, Green Published, Green Submitted			2022-12-27	WOS:000405335200012
J	van Exel, E; Koopman, JJE; van Bodegom, D; Meij, JJ; de Knijff, P; Ziem, JB; Finch, CE; Westendorp, RGJ				van Exel, Eric; Koopman, Jacob J. E.; van Bodegom, David; Meij, Johannes J.; de Knijff, Peter; Ziem, Juventus B.; Finch, Caleb E.; Westendorp, Rudi G. J.			Effect of APOE epsilon 4 allele on survival and fertility in an adverse environment	PLOS ONE			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMER-DISEASE; TRADE-OFF; GENE; ATHEROSCLEROSIS; POPULATIONS; INFECTION; EVOLUTION	The apolipoprotein-epsilon 4 allele (APOE-epsilon 4) is strongly associated with detrimental outcomes in affluent populations including atherosclerotic disease, Alzheimer's disease, and reduced lifespan. Despite these detrimental outcomes, population frequencies of APOE-epsilon 4 are high. We hypothesize that the high frequency of APOE-epsilon 4 was maintained because of beneficial effects during evolution when infectious pathogens were more prevalent and a major cause of mortality. We examined a rural Ghanaian population with a high pathogen exposure for selective advantages of APOE-epsilon 4, to survival and or fertility.	[van Exel, Eric] VU Univ Med Center GGZinGeest, Dept Psychiat, Amsterdam, Netherlands; [van Exel, Eric] EMGO Inst Hlth & Care Res & Neurosci, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Koopman, Jacob J. E.; van Bodegom, David; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [van Bodegom, David; Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Meij, Johannes J.] Univ Melbourne, Melbourne Acad Ctr Hlth, Melbourne, Australia; [de Knijff, Peter] Leiden Univ, Dept Human Genet, Leiden, Netherlands; [Ziem, Juventus B.] Univ Dev Studies, Sch Med & Hlth Sci, Dept Clin Lab Sci, Tamale, Ghana; [Finch, Caleb E.] Univ Southern Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Finch, Caleb E.] Univ Southern Calif, Dept Biol Sci, Dornsife Coll, Los Angeles, CA USA; [Westendorp, Rudi G. J.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Westendorp, Rudi G. J.] Univ Copenhagen, Ctr Hlth Ageing, Copenhagen, Denmark	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Melbourne; Leiden University; Leiden University - Excl LUMC; University for Development Studies; University of Southern California; University of Southern California; University of Copenhagen; University of Copenhagen	van Exel, E (corresponding author), VU Univ Med Center GGZinGeest, Dept Psychiat, Amsterdam, Netherlands.; van Exel, E (corresponding author), EMGO Inst Hlth & Care Res & Neurosci, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	e.vanexel@ggzingeest.nl	de Knijff, Peter/Y-2519-2018; Meij, Johannes/ABB-6973-2021; Finch, Caleb/AAA-7250-2022	de Knijff, Peter/0000-0002-0899-771X; van Bodegom, David/0000-0002-5691-8342; van Exel, Eric/0000-0002-5737-9600	Netherlands Foundation for the Advancements of Tropical Research [WOTRO93-467]; Netherlands Organization for Scientific Research [NWO 051-14-050]; European Union-funded Network of Excellence Life Span [FP6036894]; Board of Leiden University Medical Center, Stichting Dioraphte; EMGO Institute, VU University Medical Center; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER	Netherlands Foundation for the Advancements of Tropical Research; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union-funded Network of Excellence Life Span; Board of Leiden University Medical Center, Stichting Dioraphte; EMGO Institute, VU University Medical Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Netherlands Foundation for the Advancements of Tropical Research (WOTRO93-467), the Netherlands Organization for Scientific Research (NWO 051-14-050), the European Union-funded Network of Excellence Life Span (FP6036894),a grant of the Board of Leiden University Medical Center, Stichting Dioraphte and a grant of the EMGO Institute, VU University Medical Center.	Asienska G, 2015, P BIOL SCI, V282; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boef AGC, 2013, IMMUNOBIOLOGY, V218, P706, DOI 10.1016/j.imbio.2012.08.273; Corbo RM, 2004, MOL HUM REPROD, V10, P617, DOI 10.1093/molehr/gah082; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Engelaer FM, 2014, T ROY SOC TROP MED H, V108, P372, DOI 10.1093/trstmh/tru053; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Franceschini Nora, 2011, Circ Cardiovasc Genet, V4, P661, DOI 10.1161/CIRCGENETICS.111.960096; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Ghana Health Service, 2012, ANN REP E REG; Ghana Health Service, 2003, ANN REPORT; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Humphries SE, 2004, LANCET NEUROL, V3, P227, DOI 10.1016/S1474-4422(04)00708-2; Koopman JJE, 2016, AGING-US, V8, P1364, DOI 10.18632/aging.100986; Koopman JJE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046855; Kulminski AM, 2011, AGING CELL, V10, P533, DOI 10.1111/j.1474-9726.2011.00689.x; Kuningas M, 2009, PLOS ONE, V11; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Martin GM, 1999, NEUROBIOL AGING, V20, P441, DOI 10.1016/S0197-4580(99)00078-0; Mastana SS, 1998, ANN HUM BIOL, V25, P137, DOI 10.1080/03014469800005512; May L, 2010, BIOL REPROD, V82, P299, DOI 10.1095/biolreprod.109.079111; May Linda, 2009, Immun Ageing, V6, P7, DOI 10.1186/1742-4933-6-7; Meij JJ, 2009, J EVOLUTION BIOL, V22, P1014, DOI 10.1111/j.1420-9101.2009.01713.x; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Sijbrands EJG, 2001, BMJ-BRIT MED J, V322, P1019, DOI 10.1136/bmj.322.7293.1019; Singh PP, 2006, ANN HUM BIOL, V33, P279, DOI 10.1080/03014460600594513; van Bodegom D, 2009, T ROY SOC TROP MED H, V103, P795, DOI 10.1016/j.trstmh.2008.12.003; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074	31	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179497	10.1371/journal.pone.0179497	http://dx.doi.org/10.1371/journal.pone.0179497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683096	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200005
J	Zhang, YH; Li, C; Zhang, JX; Wang, JJ; Yang, JW; Lv, YX; Yang, NA; Liu, JP; Wang, XB; Palfalvi, G; Wang, GD; Zheng, LL				Zhang, Yonghong; Li, Chen; Zhang, Jingxuan; Wang, Jiajing; Yang, Jingwei; Lv, Yanxia; Yang, Nian; Liu, Jianping; Wang, Xuanbin; Palfalvi, Gergo; Wang, Guodong; Zheng, Lanlan			Dissection of HY5/HYH expression in Arabidopsis reveals a root-autonomous HY5-mediated photomorphogenic pathway	PLOS ONE			English	Article							FACTOR ELONGATED HYPOCOTYL5; SIGNALING PATHWAYS; PLANT PHOTOMORPHOGENESIS; LIGHT CONTROL; HY5; TRANSCRIPTION; COP1; THALIANA; SHOOT; PHYTOCHROME	ELONGATED HYPOCOTYL 5 (HY5), a member of the bZIP gene family, is a positive regulator of the light signaling pathway in Arabidopsis thaliana. Whereas the hy5 mutant exhibits an elongated hypocotyl when grown in the light, the hy5 homolog (hyh) mutant does not. Although the functions of HY5 and HYH in light-mediated seedling development have been revealed, the tissue-specific expression patterns of HY5 and HYH and their interconnected regulation are largely unknown. Here, we report that HY5 regulates HYH expression in roots and contributes to root growth under different light conditions. We generated HY5 and HYH transcriptional and translational fusion reporter lines to investigate their expression patterns. HY5 was constitutively expressed in all root tissues, while HYH was predominantly expressed in root xylem cells. Root growth after a dark-to-light transition was perturbed in the hy5 and hy5hyh mutant lines, but not in the hyh mutant line, indicating that HY5 plays a major role in light-regulated root growth. Light-induced HY5/HYH expression occurred autonomously in roots. HYH expression in roots was decreased in the hy5 mutant, suggesting that HY5 regulates HYH expression. Collectively, these results indicate that an organ-specific HY5-mediated pathway controls root photomorphogenic development independently of light signaling in the shoot.	[Zhang, Yonghong; Li, Chen; Zhang, Jingxuan; Lv, Yanxia; Yang, Nian; Zheng, Lanlan] Hubei Univ Med, Sch Basic Med, Lab Med Plant, Shiyan, Peoples R China; [Li, Chen; Yang, Nian; Wang, Xuanbin] Hubei Univ Med, Lab Chinese Herbal Pharmacol, Hubei Key Lab Wudang Local Chinese Med Res, Oncol Ctr,Renmin Hosp, Shiyan, Peoples R China; [Wang, Jiajing; Yang, Jingwei; Wang, Guodong] Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Dev Endangered Chinese Cru, Key Lab,Minist Educ Med Plant Resource & Nat Phar, Xian, Peoples R China; [Liu, Jianping] Chinese Acad Agr Sci, Tobacco Res Inst, Qingdao, Shandong, Peoples R China; [Palfalvi, Gergo] Univ Pecs, Inst Biol, Fac Sci, Pecs, Hungary	Hubei University of Medicine; Hubei University of Medicine; Shaanxi Normal University; Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS; University of Pecs	Zheng, LL (corresponding author), Hubei Univ Med, Sch Basic Med, Lab Med Plant, Shiyan, Peoples R China.; Wang, GD (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Dev Endangered Chinese Cru, Key Lab,Minist Educ Med Plant Resource & Nat Phar, Xian, Peoples R China.	guodong_wang@snnu.edu.en; zhenglanlan0622@163.com	Wang, Xuanbin/AHE-9819-2022	Wang, Xuanbin/0000-0003-0769-2874; Palfalvi, Gergo/0000-0002-4526-8954	Initial Project for Post-Graduates of Hubei University of Medicine [2016QDJZR14, 2016QDJZR11]; Foundation of Hu'Bei Health and Family planning Commission [WJ2017F068]; Fundamental Research Funds for the Central Universities [GK201702016]	Initial Project for Post-Graduates of Hubei University of Medicine; Foundation of Hu'Bei Health and Family planning Commission; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially funded by the Initial Project for Post-Graduates of Hubei University of Medicine to Y.Z. (2016QDJZR14), L.Z. (2016QDJZR11), and C.L., the Foundation of Hu'Bei Health and Family planning Commission (WJ2017F068) to Y.Z. and the Fundamental Research Funds for the Central Universities (GK201702016) to G.W.	Abbas N, 2014, PLANT CELL, V26, P1036, DOI 10.1105/tpc.113.122515; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Arsovski AA, 2012, ARABIDOPSIS BOOK, pe0147; Binkert M, 2014, PLANT CELL, V26, P4200, DOI 10.1105/tpc.114.130716; Briggs WR, 2012, MOL PLANT, V5, P531, DOI 10.1093/mp/sss059; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Burbach C, 2012, PLANT SIGNAL BEHAV, V7, P874, DOI 10.4161/psb.21012; Charron JBF, 2009, PLANT CELL, V21, P3732, DOI 10.1105/tpc.109.066845; Chen XB, 2016, CURR BIOL, V26, P640, DOI 10.1016/j.cub.2015.12.066; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; Delker C, 2014, CELL REP, V9, P1983, DOI 10.1016/j.celrep.2014.11.043; Dyachok J, 2011, PLANT CELL, V23, P3610, DOI 10.1105/tpc.111.088823; Galen C, 2007, PLANT SIGNAL BEHAV, V2, P106, DOI 10.4161/psb.2.2.3638; Gangappa Sreeramaiah N, 2016, MOL PLANT, V9, P1353; Halliday KJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001586; He ZM, 2016, J EXP BOT, V67, P775, DOI 10.1093/jxb/erv495; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Huang X, 2012, PLANT CELL, V24, P4590, DOI 10.1105/tpc.112.103994; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Jonassen EM, 2009, J PLANT PHYSIOL, V166, P2071, DOI 10.1016/j.jplph.2009.05.010; Kang B, 2008, PLANTA, V227, P1091, DOI 10.1007/s00425-007-0683-z; Kiss John Z, 2003, Gravit Space Biol Bull, V16, P55; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Lee Hyo-Jun, 2016, Commun Integr Biol, V9, pe1261769, DOI 10.1080/19420889.2016.1261769; Lee HJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6530; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Li C, 2017, GENE, V619, P44, DOI 10.1016/j.gene.2017.04.001; Li JG, 2012, PROTEIN CELL, V3, P106, DOI 10.1007/s13238-012-2016-7; Li JG, 2010, PLANT CELL, V22, P3634, DOI 10.1105/tpc.110.075788; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Ruppel NJ, 2001, PLANTA, V212, P424, DOI 10.1007/s004250000410; Salisbury FJ, 2007, PLANT J, V50, P429, DOI 10.1111/j.1365-313X.2007.03059.x; Sassi M, 2012, DEVELOPMENT, V139, P3402, DOI 10.1242/dev.078212; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; Singh A, 2012, J BIOL CHEM, V287, P25995, DOI 10.1074/jbc.M111.333906; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Xu WF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01273; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yokawa K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00718; Yokawa K, 2013, TRENDS PLANT SCI, V18, P117, DOI 10.1016/j.tplants.2013.01.002; Yokawa K, 2011, PLANT SIGNAL BEHAV, V6, P1460, DOI 10.4161/psb.6.10.18165; Zhang HY, 2011, PLANT J, V65, P346, DOI 10.1111/j.1365-313X.2010.04426.x	46	21	21	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180449	10.1371/journal.pone.0180449	http://dx.doi.org/10.1371/journal.pone.0180449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683099	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200038
J	Ludke, A; Akolkar, G; Ayyappan, P; Sharma, AK; Singal, PK				Ludke, Ana; Akolkar, Gauri; Ayyappan, Prathapan; Sharma, Anita K.; Singal, Pawan K.			Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C	PLOS ONE			English	Article							CARDIAC MYOCYTE APOPTOSIS; ADRIAMYCIN CARDIOMYOPATHY; INDUCED CARDIOTOXICITY; MITOCHONDRIAL; PATHWAYS; INVOLVEMENT; DYSFUNCTION; TOXICITY; SURVIVAL; KINASES	We previously reported that Vitamin C (Vit C) protects against doxorubicin (Dox)-induced cardiotoxicity by reducing oxidative stress, p38 mitogen-activated kinase (MAPK) and p53 activation and rescuing cell death in isolated adult cardiomyocytes. The pattern of activation and the role of oxidative stress as well as down-stream mechanisms for such protection remain elusive. Therefore the present study aims to analyze time-dependant generation of reactive oxygen species (ROS) and the activation of stress induced signalling pathways in cardiomyocytes treated with Dox and Vit C. The data provides further understanding of heart pathophysiology in response to Dox at the cellular level, and may help to optimize the timing of various therapeutic approaches. Cardiomyocytes isolated from adult SpragueDawley rats were exposed to Dox (10 mu M), Vit C (25 mu M), and Dox + Vit C for different time intervals up to 24 h. p38-JNK (SB203580) and p53 (pifithrin-alpha inhibitors were used to determine the role of each respective signalling protein. Dox administration to cardiomyocytes increased the levels of ROS in a time-dependent manner that followed the activation of stress-induced proteins p53, p38 and JNK MAPKs, culminating in an increase in autophagy and apoptosis markers. Dox-induced increase in ROS was alleviated by Vit C adjuvant treatment at all time-points and this was also correlated with blunting of the activation of the studied signaling pathways leading to the prevention of apoptosis and preservation of cell viability. Protective effect of Vit C against the activation of stress induced proteins, autophagy and apoptosis was mainly attributed to its antioxidant properties even though blockage of p38, JNK and p53 by pharmacological inhibitors also suppressed Dox-induced apoptosis. ROS is defined as a key inducer of cardiomyocyte damage under Dox exposure; Vit C could effectively counteract all Dox-induced changes in cardiomyocytes and may potentially be used as an antioxidant adjuvant therapy to protect against Dox-induced cardiomyopathy.	[Ludke, Ana; Akolkar, Gauri; Ayyappan, Prathapan; Sharma, Anita K.; Singal, Pawan K.] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med,Dept Physiol & Pathophysiol, Inst Cardiovasc Sci,St Boniface Hosp,Albrechtsen, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba	Singal, PK (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med,Dept Physiol & Pathophysiol, Inst Cardiovasc Sci,St Boniface Hosp,Albrechtsen, Winnipeg, MB, Canada.	psingal@sbrc.ca		Ayappan, Prathapan/0000-0002-5508-2360	Heart and Stroke Foundation Canada; Research Manitoba; Bank of Montreal; Canadian Circulatory and Respiratory Institute; St. Boniface Hospital and Research Foundation	Heart and Stroke Foundation Canada(Heart & Stroke Foundation of Canada); Research Manitoba; Bank of Montreal; Canadian Circulatory and Respiratory Institute; St. Boniface Hospital and Research Foundation	This work was supported by a fellowship from Heart and Stroke Foundation Canada, Research Manitoba, a studentship from Bank of Montreal, and the Canadian Circulatory and Respiratory Institute. Dr. Singal is the holder of Naranjan Dhalla Chair in Cardiovascular Researched supported by the St. Boniface Hospital and Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659; Dhingra S, 2007, AM J PHYSIOL-HEART C, V293, pH3524, DOI 10.1152/ajpheart.00919.2007; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FUJITA K, 1982, CANCER RES, V42, P309; Goncalves TL, 2005, CLIN BIOCHEM, V38, P1071, DOI 10.1016/j.clinbiochem.2005.09.008; GREENE RF, 1983, CANCER RES, V43, P3417; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Lou H, 2005, AM J PHYSIOL-HEART C, V288, pH1925, DOI 10.1152/ajpheart.01054.2004; Lou Huiquan, 2006, Pathophysiology, V13, P103, DOI 10.1016/j.pathophys.2006.02.004; Ludke A, 2012, MOL CELL BIOCHEM, V360, P215, DOI 10.1007/s11010-011-1059-z; Ludke AR, 2012, AM J PHYSIOL-CELL PH, V303, pC645, DOI 10.1152/ajpcell.00186.2012; Ludke ARL, 2009, CAN J PHYSIOL PHARM, V87, P756, DOI 10.1139/Y09-059; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nithipongvanitch R, 2007, ANTIOXID REDOX SIGN, V9, P1001, DOI 10.1089/ars.2007.1632; Ruan Y, 2015, CELL PHYSIOL BIOCHEM, V35, P1116, DOI 10.1159/000373937; SAIJO N, 1973, IMMUNOLOGY, V24, P683; Salvatorelli E, 2013, J PHARMACOL EXP THER, V344, P467, DOI 10.1124/jpet.112.200568; Santos RVT, 2007, CLIN EXP PHARMACOL P, V34, P1294, DOI 10.1111/j.1440-1681.2007.04717.x; SAUBERLICH HE, 1994, ANNU REV NUTR, V14, P371, DOI 10.1146/annurev.nu.14.070194.002103; SHIMPO K, 1991, AM J CLIN NUTR, V54, pS1298, DOI 10.1093/ajcn/54.6.1298s; Singal PK, 1997, FASEB J, V11, P931, DOI 10.1096/fasebj.11.12.9337145; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; SIVESKIILISKOVIC N, 1995, CIRCULATION, V91, P10, DOI 10.1161/01.CIR.91.1.10; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005; Wallace KB, 2007, CARDIOVASC TOXICOL, V7, P101, DOI 10.1007/s12012-007-0008-2; Wold LE, 2005, CANCER DETECT PREV, V29, P294, DOI 10.1016/j.cdp.2004.07.008; Yamamoto Y, 2008, CARDIOVASC RES, V79, P89, DOI 10.1093/cvr/cvn076; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Yeh PY, 2001, BIOCHEM BIOPH RES CO, V284, P880, DOI 10.1006/bbrc.2001.5043; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zhou SY, 2001, CANCER RES, V61, P771	41	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179452	10.1371/journal.pone.0179452	http://dx.doi.org/10.1371/journal.pone.0179452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678856	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200015
J	Bughani, U; Saha, A; Kuriakose, A; Nair, R; Sadashivarao, RB; Venkataraman, R; Patel, S; Deshchougule, AT; Kumar, SS; Montero, E; Pai, HV; Palanivelu, DV; Melarkode, R; Nair, P				Bughani, Usha; Saha, Arindam; Kuriakose, Anshu; Nair, Reshmi; Sadashivarao, Ravindra B.; Venkataraman, Rasika; Patel, Swati; Deshchougule, Anuja Tushar; Kumar, Satish S.; Montero, Enrique; Pai, Harish V.; Palanivelu, Dinesh V.; Melarkode, Ramakrishnan; Nair, Pradip			T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab	PLOS ONE			English	Article							CHEMOKINE RECEPTOR EXPRESSION; ROR-GAMMA-T; MULTIPLE-SCLEROSIS; TH17 CELLS; AUTOIMMUNE-DISEASES; MONOCLONAL-ANTIBODY; SURFACE-RECEPTOR; PLAQUE PSORIASIS; RESPONSES; ALCAM	CD6 is associated with T-cell modulation and is implicated in several autoimmune diseases. We previously demonstrated that Itolizumab, a CD6 domain 1 (CD6D1) specific humanized monoclonal antibody, inhibited the proliferation and cytokine production by T lymphocytes stimulated with anti-CD3 antibody or when co-stimulated with ALCAM. Aberrant IL-17 producing CD4(+) helper T-cells (Th17) have been identified as pivotal for the pathogenesis of certain inflammatory autoimmune disorders, including psoriasis. Itolizumab has demonstrated efficacy in human diseases known to have an IL-17 driven pathogenesis. Here, in in vitro experiments we show that by day 3 of human PBMC activation using anti-CD3 and anti-CD28 co-stimulation in a Th17 polarizing milieu, 15-35% of CD4(+) T-cells overexpress CD6 and there is an establishment of differentiated Th17 cells. Addition of Itolizumab reduces the activation and differentiation of T cells to Th17 cells and decreases production of IL-17. These effects are associated with the reduction of key transcription factors pSTAT3 and ROR gamma T. Further, transcription analysis studies in these conditions indicate that Itolizumab suppressed T cell activation by primarily reducing cell cycle, DNA transcription and translation associated genes. To understand the mechanism of this inhibition, we evaluated the effect of this anti-human CD6D1 mAb on ALCAM-CD6 as well as TCR-mediated T cell activation. We show that Itolizumab but not its F(ab') 2 fragment directly inhibits CD6 receptor hyper-phosphorylation and leads to subsequent decrease in associated ZAP70 kinase and docking protein SLP76. Since Itolizumab binds to CD6 expressed only on human and chimpanzee, we developed an antibody binding specifically to mouse CD6D1. This antibody successfully ameliorated the incidence of experimental autoimmune encephalitis in the mice model. These results position CD6 as a key molecule in sustaining the activation and differentiation of T cells and an important target for modulating autoimmune diseases.	[Bughani, Usha; Saha, Arindam; Kuriakose, Anshu; Nair, Reshmi; Sadashivarao, Ravindra B.; Venkataraman, Rasika; Patel, Swati; Deshchougule, Anuja Tushar; Kumar, Satish S.; Montero, Enrique; Pai, Harish V.; Palanivelu, Dinesh V.; Melarkode, Ramakrishnan; Nair, Pradip] Biocon Res Ltd, Res & Dev, Bangalore, Karnataka, India	Biocon Limited	Nair, P (corresponding author), Biocon Res Ltd, Res & Dev, Bangalore, Karnataka, India.	pradip.nair@biocon.com	Patel, Swati/AAT-8352-2020; Capital Partners, L.P., Willow Creek/E-7792-2018	Patel, Swati/0000-0003-2543-0448; Montero, Enrique/0000-0002-7127-6675; Capital Partners, L.P., Willow Creek/0000-0001-9902-2688	Biocon Research Limited	Biocon Research Limited	Please note that the study is funded by Biocon Research Limited. The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	AbuHilal M, 2016, J CUTAN MED SURG, V20, P509, DOI 10.1177/1203475416651605; Aira LE, 2014, MABS-AUSTIN, V6, P782, DOI 10.4161/mabs.28376; Alonso R, 2008, HYBRIDOMA, V27, P291, DOI 10.1089/hyb.2008.0007; Alonso R, 2010, J AUTOIMMUN, V35, P336, DOI 10.1016/j.jaut.2010.07.005; Alonso-Ramirez R, 2010, ARTHRITIS, DOI 10.1155/2010/130646; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Beck A, 2011, MABS, V3, P111; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; BOTT CM, 1994, J IMMUNOL, V153, P1; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Brown MH, 2016, CURR DRUG TARGETS, V17, P619, DOI 10.2174/1389450116666150825120536; Brown MH, 2015, CURRENT DRUG TARGETS, V16, P1; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Canavan TN, 2016, AM J CLIN DERMATOL, V17, P33, DOI 10.1007/s40257-015-0162-4; Carmo AM, 2016, CURR DRUG TARGETS, V17, P618, DOI 10.2174/138945011706160324153314; Castro MAA, 2007, J IMMUNOL, V178, P4351, DOI 10.4049/jimmunol.178.7.4351; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chappell PE, 2015, STRUCTURE, V23, P1426, DOI 10.1016/j.str.2015.05.019; Chen W, 2016, INT J CLIN EXP PATHO, V9, P7428; Chen Y, 2015, IMMUNOTHERAPY-UK, V7, P1023, DOI 10.2217/imt.15.50; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Chopra A, 2016, CLIN RHEUMATOL, V35, P1059, DOI 10.1007/s10067-015-2988-9; da Gloria VG, 2014, J IMMUNOL, V193, P391, DOI 10.4049/jimmunol.1400038; de Wit J, 2011, BLOOD, V118, P6107, DOI 10.1182/blood-2011-05-352682; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Gardner D, 2014, AM J TRANSPLANT, V14, P1985, DOI 10.1111/ajt.12834; Garnock-Jones KP, 2015, AM J CLIN DERMATOL, V16, P323, DOI 10.1007/s40257-015-0143-7; Gimferrer I, 2005, J IMMUNOL, V175, P1406, DOI 10.4049/jimmunol.175.3.1406; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Hernandez P, 2016, CURR DRUG TARGETS, V17, P666, DOI 10.2174/1389450117666160201114308; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Ibanez A, 2006, J IMMUNOL, V177, P1152, DOI 10.4049/jimmunol.177.2.1152; Jurewicz A, 2014, J NEUROIMMUNOL, V276, P187, DOI 10.1016/j.jneuroim.2014.08.620; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; Krintel SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038539; Krupashankar DS, 2014, J AM ACAD DERMATOL, V71, P484, DOI 10.1016/j.jaad.2014.01.897; Lecuyer MA, 2017, P NATL ACAD SCI USA, V114, pE524, DOI 10.1073/pnas.1614336114; Levesque MC, 1998, ARTHRITIS RHEUM, V41, P2221, DOI 10.1002/1529-0131(199812)41:12<2221::AID-ART18>3.0.CO;2-I; Li Y, 2017, P NATL ACAD SCI USA, V114, P2687, DOI 10.1073/pnas.1615253114; Li Y, 2010, PROCEEDINGS OF 2010 ASIA-PACIFIC YOUTH CONFERENCE ON COMMUNICATION, VOLS 1 AND 2, P10, DOI 10.1371/journal.pbio.1000533; Liao F, 1999, J IMMUNOL, V162, P186; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Nair P, 2010, CLIN EXP IMMUNOL, V162, P116, DOI 10.1111/j.1365-2249.2010.04235.x; Oliveira MI, 2012, EUR J IMMUNOL, V42, P195, DOI 10.1002/eji.201040528; Orta-Mascaro M, 2016, J EXP MED, V213, P1387, DOI 10.1084/jem.20151785; Pena-Rossi C, 1999, J IMMUNOL, V163, P6494; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Pinto M, 2013, BIODRUGS, V27, P191, DOI 10.1007/s40259-013-0027-4; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Ramos-Casals M, 2001, RHEUMATOLOGY, V40, P1056, DOI 10.1093/rheumatology/40.9.1056; Rodriguez Pedro C, 2012, Results Immunol, V2, P204, DOI 10.1016/j.rinim.2012.11.001; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Saha A, 2014, MOL CELL, V55, P264, DOI 10.1016/j.molcel.2014.05.028; Saifullah MK, 2004, J IMMUNOL, V173, P6125, DOI 10.4049/jimmunol.173.10.6125; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Santos RF, 2016, CURR DRUG TARGETS, V17, P630, DOI 10.2174/1389450116666150531152439; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sarukhan A, 2016, CURR DRUG TARGETS, V17, P640, DOI 10.2174/1389450116666150316224308; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Singer NG, 1996, IMMUNOLOGY, V88, P537; Singer NG, 2002, INT IMMUNOL, V14, P585, DOI 10.1093/intimm/dxf025; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Swaminathan B, 2010, J NEUROIMMUNOL, V223, P100, DOI 10.1016/j.jneuroim.2010.03.020; TARAKHOVSKY A, 1994, EUR J IMMUNOL, V24, P1678, DOI 10.1002/eji.1830240733; Tibaldi E, 2011, LEUKEMIA, V25, P1768, DOI 10.1038/leu.2011.152; Wagner M, 2014, J NEUROIMMUNOL, V276, P98, DOI 10.1016/j.jneuroim.2014.08.621; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang WG, 2000, SEMIN IMMUNOL, V12, P35, DOI 10.1006/smim.2000.0205; Zhu ED, 2014, J IMMUNOL, V192, P5599, DOI 10.4049/jimmunol.1303488; Zimmerman AW, 2006, BLOOD, V107, P3212, DOI 10.1182/blood-2005-09-3881	78	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180088	10.1371/journal.pone.0180088	http://dx.doi.org/10.1371/journal.pone.0180088			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672038	gold, Green Submitted, Green Published			2022-12-27	WOS:000405268500015
J	Hammerschmidt-Kamper, C; Biljes, D; Merches, K; Steiner, I; Daldrup, T; Bol-Schoenmakers, M; Pieters, RHH; Esser, C				Hammerschmidt-Kamper, Christiane; Biljes, Daniel; Merches, Katja; Steiner, Irina; Daldrup, Thomas; Bol-Schoenmakers, Marianne; Pieters, Raymond H. H.; Esser, Charlotte			Indole-3-carbinol, a plant nutrient and AhR-Ligand precursor, supports oral tolerance against OVA and improves peanut allergy symptoms in mice	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SITE-DIRECTED MUTAGENESIS; RETINOIC-ACID; DENDRITIC CELLS; SMALL-INTESTINE; VITAMIN-A; II COLLAGEN; IN-VITRO	In general, dietary antigens are tolerated by the gut associated immune system. Impairment of this so-called oral tolerance is a serious health risk. We have previously shown that activation of the ligand-dependent transcription factor aryl hydrocarbon receptor (AhR) by the environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) affects both oral tolerance and food allergy. In this study, we determine whether a common plant-derived, dietary AhR-ligand modulates oral tolerance as well. We therefore fed mice with indole-3-carbinole (I3C), an AhR ligand that is abundant in cruciferous plants. We show that several I3C metabolites were detectable in the serum after feeding, including the high-affinity ligand 3,3 A -diindolylmethane (DIM). I3C feeding robustly induced the AhR-target gene CYP4501A1 in the intestine; I3C feeding also induced the aldh1 gene, whose product catalyzes the formation of retinoic acid (RA), an inducer of regulatory T cells. We then measured parameters indicating oral tolerance and severity of peanut-induced food allergy. In contrast to the tolerance breaking effect of TCDD, feeding mice with chow containing 2 g/kg I3C lowered the serum anti-ovalbumin IgG1 response in an experimental oral tolerance protocol. Moreover, I3C feeding attenuated symptoms of peanut allergy. In conclusion, the dietary compound I3C can positively influence a vital immune function of the gut.	[Hammerschmidt-Kamper, Christiane; Biljes, Daniel; Merches, Katja; Esser, Charlotte] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Steiner, Irina; Daldrup, Thomas] Univ Hosp Dusseldorf, Inst Legal Med, Dept Forens Toxicol, Dusseldorf, Germany; [Bol-Schoenmakers, Marianne; Pieters, Raymond H. H.] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Utrecht University	Esser, C (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	chesser@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft [ES103/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, ES103/6-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2012, TRENDS IMMUNOL, V33, P42, DOI 10.1016/j.it.2011.10.001; Baba N, 2012, HUM IMMUNOL, V73, P795, DOI 10.1016/j.humimm.2012.05.002; Bhat PV, 1998, FEBS LETT, V426, P260, DOI 10.1016/S0014-5793(98)00355-X; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bol-Schoenmakers M, 2011, ALLERGY, V66, P331, DOI 10.1111/j.1398-9995.2010.02479.x; Bunaciu RP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-39; Bunaciu RP, 2011, CANCER RES, V71, P2371, DOI 10.1158/0008-5472.CAN-10-2299; Chmill S, 2010, TOXICOL SCI, V118, P98, DOI 10.1093/toxsci/kfq232; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Duarte JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079819; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Fraccalvieri D, 2013, BIOCHEMISTRY-US, V52, P714, DOI 10.1021/bi301457f; Frericks M, 2008, BBA-GENE REGUL MECH, V1779, P830, DOI 10.1016/j.bbagrm.2008.08.007; FRIEDMAN A, 1994, CHEM IMMUNOL, V58, P259; FRIEDMAN A, 1994, P NATL ACAD SCI USA, V91, P6688, DOI 10.1073/pnas.91.14.6688; Goodyear AW, 2014, J IMMUNOL METHODS, V405, P97, DOI 10.1016/j.jim.2014.01.014; Hanieh H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/520763; Huber A, 2015, MOL IMMUNOL, V63, P215, DOI 10.1016/j.molimm.2014.07.009; HUSBY S, 1994, J IMMUNOL, V152, P4663; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Ito SJ, 2007, J CLIN INVEST, V117, P1940, DOI 10.1172/JCI31647; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jeong KT, 2012, INT IMMUNOPHARMACOL, V13, P377, DOI 10.1016/j.intimp.2012.04.014; Julliard W, 2017, ANN SURG, V265, P1183, DOI 10.1097/SLA.0000000000001830; Kapp K, 2010, EUR J IMMUNOL, V40, P3128, DOI 10.1002/eji.201040701; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lampen A, 2000, J PHARMACOL EXP THER, V295, P979; Latte KP, 2011, FOOD CHEM TOXICOL, V49, P3287, DOI 10.1016/j.fct.2011.08.019; Li Y, 2011, CELL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minich DA, 2007, NUTR REV, V65, P259, DOI 10.1111/j.1753-4887.2007.tb00303.x; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Park JH, 2015, IMMUNE NETW, V15, P278, DOI 10.4110/in.2015.15.6.278; Park KS, 2009, MOD RHEUMATOL, V19, P581, DOI 10.1007/s10165-009-0210-0; Pot C, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13592; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rezende MM, 2011, CLIN EXP ALLERGY, V41, P1324, DOI 10.1111/j.1365-2222.2010.03662.x; Rouse M, 2014, J PHARMACOL EXP THER, V350, P341, DOI 10.1124/jpet.114.214742; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Schulz VJ, 2011, TOXICOL SCI, V123, P491, DOI 10.1093/toxsci/kfr175; Siewert C, 2008, J IMMUNOL, V180, P146, DOI 10.4049/jimmunol.180.1.146; Singh NP, 2016, J IMMUNOL, V196, P1108, DOI 10.4049/jimmunol.1501727; Soshilov AA, 2014, MOL CELL BIOL, V34, P1707, DOI 10.1128/MCB.01183-13; Staack R, 1998, TOXICOL APPL PHARM, V149, P17, DOI 10.1006/taap.1997.8340; Stanford EA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0240-y; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Thurau SR, 2002, PROG RETIN EYE RES, V21, P577, DOI 10.1016/S1350-9462(02)00039-3; van den Elsen LWJ, 2014, J NUTR, V144, P1970, DOI 10.3945/jn.114.198515; van Wijk F, 2005, J IMMUNOL, V174, P174, DOI 10.4049/jimmunol.174.1.174; Verhoeven DTH, 1997, CHEM-BIOL INTERACT, V103, P79, DOI 10.1016/S0009-2797(96)03745-3; von Boehmer H, 2007, J EXP MED, V204, P1737, DOI 10.1084/jem.20071251; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109	66	21	22	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180321	10.1371/journal.pone.0180321	http://dx.doi.org/10.1371/journal.pone.0180321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666018	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700085
J	del Pino, LM; Arana, A; Alfonso, L; Mendizabal, JA; Soret, B				Martinez del Pino, Lara; Arana, Ana; Alfonso, Leopoldo; Antonio Mendizabal, Jose; Soret, Beatriz			Adiposity and adipogenic gene expression in four different muscles in beef cattle	PLOS ONE			English	Article							ACID-BINDING PROTEIN; INTRAMUSCULAR FAT DEPOSITION; MEAT-PRODUCING ANIMALS; SKELETAL-MUSCLE; ADIPOCYTE DIFFERENTIATION; RELATIVE QUANTIFICATION; FIBER CHARACTERISTICS; LONGISSIMUS MUSCLE; SIZE DISTRIBUTION; HOLSTEIN BULLS	Anatomical site and divergent functionalities of muscles can be related to differences in IMF content, metabolism and adipogenic gene expression. Then, potential differences in different muscles in beef cattle were studied. As a second objective, the main sources of experimental variability associated to RT-qPCR results were analyzed following a nested design in order to implement appropriate experimental designs minimizing gene expression variability. To perform the study Longissimus thoracis (LT), Semitendinosus (SM), Masseter (MS), Sternomandibularis (ST) and subcutaneous adipose tissue (SAT) samples of Pirenaica young bulls (n = 4) were collected for IMF, collagen and protein quantification, analysis of adipocyte size distribution and gene expression (PPARG, CEBPA, FAPB4 and WNT10B). A greater IMF content was observed in MS and SM muscles, which had a bimodal adipocyte size distribution while it was unimodal in the muscles LT and ST. This suggest that the different IMF accretion in the muscles studied might be related to different rates of hyperplasia and hypertrophy and that IMF might develop later in LT and ST muscles. The former differences were not mirrored by the expression of the genes analyzed, which might be related to the different contribution of mature and non-mature adipocytes to the total gene expression. When comparing IMF and SAT gene expression, late and early developing tissues respectively, expression of PPARG, CEBPA and FABP4 was higher in the SAT, in agreement with bigger cell size and numbers. The variability study indicates that the analytical factors that add higher variability to the gene expression are the sampling and RT and therefore, it would be appropriate to include those replicates in the design of future experiments. Based on the results, the use of MS and SM muscles could allow less expensive experimental designs and bigger sample size that could permit the detection of lower relevant differences in gene expression.	[Martinez del Pino, Lara; Arana, Ana; Alfonso, Leopoldo; Antonio Mendizabal, Jose; Soret, Beatriz] Univ Publ Navarra, Dept Prod Agr, Escuela Super Ingenieros Agronomos, Pamplona, Spain	Universidad Publica de Navarra	Soret, B (corresponding author), Univ Publ Navarra, Dept Prod Agr, Escuela Super Ingenieros Agronomos, Pamplona, Spain.	soret@unavarra.es	Alfonso, Leopoldo/AAG-3790-2021; Alfonso, Leopoldo/G-2998-2015; Mendizabal, José Antonio/F-9844-2014; Soret, Beatriz/L-5776-2014	Alfonso, Leopoldo/0000-0002-5662-9997; Alfonso, Leopoldo/0000-0002-5662-9997; Mendizabal, José Antonio/0000-0003-1316-4293; Soret, Beatriz/0000-0001-9214-8595				Alberti P, 2013, MEAT SCI, V94, P208, DOI 10.1016/j.meatsci.2013.01.015; Albrecht E., 2017, J ANIM SCI, V95; Alfonso L, 2016, ITEA-INF TEC ECON AG, V112, P147; Alzon M, 2007, ANIMAL, V1, P261, DOI 10.1017/S1751731107392744; Barendse W, 2009, ANIM GENET, V40, P770, DOI 10.1111/j.1365-2052.2009.01913.x; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Bonnet M, 2010, ANIMAL, V4, P1093, DOI 10.1017/S1751731110000601; CIANZIO DS, 1982, J ANIM SCI, V55, P305, DOI 10.2527/jas1982.552305x; Costa P, 2008, MEAT SCI, V78, P502, DOI 10.1016/j.meatsci.2007.07.020; Cruz GD, 2014, J ANIM SCI, V92, P4761, DOI 10.2527/jas.2014-8180; Dai FW, 2009, S AFR J ANIM SCI, V39, P267; DEVINE CE, 1984, MEAT SCI, V10, P35, DOI 10.1016/0309-1740(84)90030-5; Du M, 2013, J ANIM SCI, V91, P1419, DOI 10.2527/jas.2012-5670; Duarte MS, 2013, J ANIM SCI, V91, P2938, DOI 10.2527/jas.2012-5892; Eguinoa P, 2003, J ANIM SCI, V81, P432; Freeman JB, 2013, BEHAV RES METHODS, V45, P83, DOI 10.3758/s13428-012-0225-x; Gerbens F, 1998, MAMM GENOME, V9, P1022, DOI 10.1007/s003359900918; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Harper GS, 2004, AUST J EXP AGR, V44, P653, DOI 10.1071/EA02114; Hartigan J. A., 1985, ANN STAT, P70; Hauser N, 1997, REPROD NUTR DEV, V37, P617, DOI 10.1051/rnd:19970601; Hocquette J, 2003, EAAP PUBLIC, P513; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hocquette JF, 2000, PROD ANIM, V13, P185; HOOD RL, 1973, J LIPID RES, V14, P605; Hwang YH, 2010, MEAT SCI, V86, P456, DOI 10.1016/j.meatsci.2010.05.034; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jeremiah LE, 2003, MEAT SCI, V65, P1013, DOI 10.1016/S0309-1740(02)00309-1; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Le Roy P., 2003, INRA PROD ANIM, V16, P159; Lee HJ, 2000, ASIAN AUSTRAL J ANIM, V13, P155, DOI 10.5713/ajas.2000.155; Listrat Anne, 2016, ScientificWorldJournal, V2016, P3182746, DOI 10.1155/2016/3182746; Luo HF, 2009, LIPIDS, V44, P999, DOI 10.1007/s11745-009-3346-y; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Martins TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139943; MATARESE V, 1988, J BIOL CHEM, V263, P14544; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Michal JJ, 2006, ANIM GENET, V37, P400, DOI 10.1111/j.1365-2052.2006.01464.x; Moreno-Sanchez N, 2010, FUNCT INTEGR GENOMIC, V10, P609, DOI 10.1007/s10142-010-0175-2; Oddy VH, 2001, AUST J EXP AGR, V41, P921, DOI 10.1071/EA00029; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard B, 1996, BASIC APPL MYOL, V6; Pickworth CL, 2011, J ANIM SCI, V89, P355, DOI 10.2527/jas.2010-3229; ROBELIN J, 1993, REPROD NUTR DEV, V33, P25, DOI 10.1051/rnd:19930103; Roberts SL, 2015, J ANIM SCI, V93, P4302, DOI 10.2527/jas.2015-8886; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sainz R. D., 2000, Modelling nutrient utilization in farm animals, P175, DOI 10.1079/9780851994499.0175; Schoonmaker JP, 2004, J ANIM SCI, V82, P137; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Smith SB, 1998, COMP BIOCHEM PHYS B, V120, P165, DOI 10.1016/S0305-0491(98)10005-6; Smith SB, 2009, ASIAN AUSTRAL J ANIM, V22, P1225, DOI 10.5713/ajas.2009.r.10; Soret B, 2016, ANIMAL, V10, P2018, DOI 10.1017/S175173111600118X; Soula HA, 2013, J THEOR BIOL, V332, P89, DOI 10.1016/j.jtbi.2013.04.025; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Thaller G, 2003, ANIM GENET, V34, P354, DOI 10.1046/j.1365-2052.2003.01011.x; Tichopad A, 2009, CLIN CHEM, V55, P1816, DOI 10.1373/clinchem.2009.126201; Torrescano G, 2003, MEAT SCI, V64, P85, DOI 10.1016/S0309-1740(02)00165-1; TOTLAND GK, 1991, ANAT EMBRYOL, V184, P441, DOI 10.1007/BF01236050; Tume RK, 2010, MEAT SCI, V84, P66, DOI 10.1016/j.meatsci.2009.08.013; Urrutia O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156765; Vernon R. G., 1986, Control and manipulation of animal growth. Proceedings of the 43rd Nottingham Easter School in Agricultural Science., P67; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8	68	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179604	10.1371/journal.pone.0179604	http://dx.doi.org/10.1371/journal.pone.0179604			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665940	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700038
J	Smith, EG; Hume, BCC; Delaney, P; Wiedenmann, J; Burt, JA				Smith, Edward G.; Hume, Benjamin C. C.; Delaney, Patrice; Wiedenmann, Jorg; Burt, John A.			Genetic structure of coral-Symbiodinium symbioses on the world's warmest reefs	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENUS POCILLOPORA; LOCAL ADAPTATION; PERSIAN-GULF; DIVERSITY; ITS2; TOOL; SEA; DIVERSIFICATION; SPECIFICITY	Corals in the Arabian/Persian Gulf (PAG) survive extreme sea temperatures (summer mean: >34 degrees C), and it is unclear whether these corals have genetically adapted or physiologically acclimated to these conditions. In order to elucidate the processes involved in the thermal tolerance of PAG corals, it is essential to understand the connectivity between reefs within and outside of the PAG. To this end, this study set out to investigate the genetic structure of the coral, Platygyra daedalea, and its symbiotic algae in the PAG and neighbouring Gulf of Oman. Using nuclear markers (the ITS region and an intron of the Pax-C gene), this study demonstrates genetic divergence of P. daedalea on reefs within the thermally extreme PAG compared with those in the neighbouring Gulf of Oman. Isolation by distance of P. daedalea was supported by the ITS dataset but not the Pax-C intron. In addition, the symbiont community within the PAG was dominated by C3 symbionts, while the purportedly thermotolerant clade D was extremely rare and was common only at sites outside of the PAG. Analysis of the psbA(ncr) indicates that the C3 variant hosted by P. daedalea in the PAG belongs to the newly described species, Symbiodinium thermophilum. The structuring of the coral and symbiont populations suggests that both partners of the symbiosis may contribute to the high bleaching thresholds of PAG corals. While limited gene flow has likely played a role in local adaptation within the PAG, it also indicates limited potential for natural export of thermal tolerance traits to reefs elsewhere in the Indian Ocean threatened by climate change.	[Smith, Edward G.; Delaney, Patrice; Burt, John A.] New York Univ Abu Dhabi, Marine Biol Lab, CGSB, Abu Dhabi, U Arab Emirates; [Hume, Benjamin C. C.; Wiedenmann, Jorg] Univ Southampton, Natl Oceanog Ctr, Coral Reef Lab, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Smith, EG (corresponding author), New York Univ Abu Dhabi, Marine Biol Lab, CGSB, Abu Dhabi, U Arab Emirates.	edsmith@nyu.edu		Hume, Benjamin/0000-0001-7753-3903; Smith, Emily/0000-0001-5715-9459; Sinha, Bireshwar/0000-0002-7408-7474; Burt, John/0000-0001-6087-6424	New York University Abu Dhabi's Research Enhancement Fund; Natural Environment Research Council [NE/I01683X/1]; European Research Council under the European Union's Seventh Framework Programme (FP) / European Research Council [311179]; NERC [NE/I01683X/1] Funding Source: UKRI	New York University Abu Dhabi's Research Enhancement Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council under the European Union's Seventh Framework Programme (FP) / European Research Council; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by New York University Abu Dhabi's Research Enhancement Fund (ES and JB) and by Natural Environment Research Council (NE/I01683X/1 to JW), European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / European Research Council Grant Agreement n. 311179 to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosairi Y, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006769; Arif C, 2014, MOL ECOL, V23, P4418, DOI 10.1111/mec.12869; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Bauman AG, 2013, MAR POLLUT BULL, V72, P302, DOI 10.1016/j.marpolbul.2012.10.013; Burt J, 2011, MAR ENVIRON RES, V72, P225, DOI 10.1016/j.marenvres.2011.08.005; Coles SL, 2013, MAR POLLUT BULL, V72, P323, DOI 10.1016/j.marpolbul.2012.09.006; D'Angelo C, 2015, ISME J, V9, P2551, DOI 10.1038/ismej.2015.80; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; DOYLE JJ, 1995, SYST BOT, V20, P574, DOI 10.2307/2419811; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Flot Jean-Francois, 2013, BMC Research Notes, V6, P144, DOI 10.1186/1756-0500-6-144; Flot Jean-Francois, 2011, BMC Ecology, V11, P22, DOI 10.1186/1472-6785-11-22; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-372; Goodbody-Gringley G, 2012, MAR ECOL-EVOL PERSP, V33, P32, DOI 10.1111/j.1439-0485.2011.00452.x; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Hartle-Mougiou K, 2012, J MAR BIOL ASSOC UK, V92, P687, DOI 10.1017/S0025315411001159; Hume B, 2013, MAR POLLUT BULL, V72, P313, DOI 10.1016/j.marpolbul.2012.11.032; Hume BCC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08562; Hume BCC, 2016, P NATL ACAD SCI USA, V113, P4416, DOI 10.1073/pnas.1601910113; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Kenkel CD, 2013, MOL ECOL, V22, P4322, DOI 10.1111/mec.12390; Keshavmurthy S, 2012, MOL ECOL, V21, P4393, DOI 10.1111/j.1365-294X.2012.05704.x; Kleypas JA, 1999, AM ZOOL, V39, P146; LaJeunesse TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029013; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Lambeck K, 1996, EARTH PLANET SC LETT, V142, P43, DOI 10.1016/0012-821X(96)00069-6; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Mostafavi PG, 2007, MAR BIOL, V153, P25, DOI 10.1007/s00227-007-0796-8; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; REYNOLDS RM, 1993, MAR POLLUT BULL, V27, P35; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Schwartz SA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-123; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Shuail D, 2016, MAR POLLUT BULL, V105, P654, DOI 10.1016/j.marpolbul.2016.03.001; Smith EG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01569-8; Smith EG, 2017, ISME J, V11, P1500, DOI 10.1038/ismej.2016.206; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Takabayashi M, 2003, CORAL REEFS, V22, P17, DOI 10.1007/s00338-002-0272-3; Thornhill DJ, 2014, EVOLUTION, V68, P352, DOI 10.1111/evo.12270; Yao F, 2010, J GEOPHYS RES, V115, pC11	45	49	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180169	10.1371/journal.pone.0180169	http://dx.doi.org/10.1371/journal.pone.0180169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666005	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000404608700067
J	Lindner, C; Nagy, G; Arhuis, WAR; Retelsdorf, J				Lindner, Christoph; Nagy, Gabriel; Arhuis, Wolfgang Andreas Ramos; Retelsdorf, Jan			A new perspective on the interplay between self-control and cognitive performance: Modeling progressive depletion patterns	PLOS ONE			English	Article							EGO-DEPLETION; MATHEMATICS ACHIEVEMENT; EXECUTIVE FUNCTIONS; LIMITED RESOURCES; CONTROL STRENGTH; ATTENTION; TASK; METAANALYSIS; DISCIPLINE; CAPACITY	Exerting self-control in a first task weakens self-control performance in a subsequent unrelated task (ego depletion). In self-control research new strategies are required to investigate the ego-depletion effect, which has recently been shown to be more fragile than previously assumed. Moreover, the relation between ego depletion and trait self-control is still unclear, as various studies have reported heterogeneous findings concerning the interplay of both variables. We addressed these lacunas by drawing on a sample of N = 120 students, who participated in two test sessions. In the first test session, we assessed trait self-control and several control variables. The second test session followed an experimental design and tested the effects of ego depletion on invested effort and cognitive performance trajectories in an ecologically valid computer-based assessment setting (i.e., a 30-minute mathematical problem-solving and reasoning test). Trait self-control was then used as a moderator of the ego-depletion effect. Combining an established ego-depletion paradigm (i.e., the sequential-task paradigm) with multilevel modeling of time-on-task and performance changes, our results indicate (1) that trait self-control predicted the motivation to solve cognitive tasks, (2) that ego depletion led to a progressive performance decrease, and (3) that the negative effect of ego depletion on performance was stronger for students with high trait self-control. Additional analyses revealed that our results could not be alternatively explained by fatigue effects. All effects were robust even after controlling for the students' cognitive abilities, which are known to be closely related to mathematical performance. Our results provide evidence that the self-control invested in order to keep performance at a consistently high level wanes over time. By modeling progressive ego-depletion effects while considering trait self-control, we provide an alternative approach that may help future researchers to investigate the underlying mechanisms of self-control.	[Lindner, Christoph; Nagy, Gabriel; Arhuis, Wolfgang Andreas Ramos; Retelsdorf, Jan] Univ Kiel, Leibniz Inst Sci & Math Educ, Kiel, Germany	Leibniz Institut fur die Padagogik der Naturwissenschaften und Mathematik an der Universitat Kiel (IPN); University of Kiel	Lindner, C (corresponding author), Univ Kiel, Leibniz Inst Sci & Math Educ, Kiel, Germany.	clindner@ipn.uni-kiel.de	Retelsdorf, Jan/B-3492-2013; Lindner, Christoph/K-6145-2015	Retelsdorf, Jan/0000-0002-9892-9613; Lindner, Christoph/0000-0001-5688-3146				Apache Friends, 2013, XAMPP; Baumeister RF, 2016, ADV EXP SOC PSYCHOL, V54, P67, DOI 10.1016/bs.aesp.2016.04.001; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 1994, LOSING CONTROL WHY P, DOI 10.5860/choice.32-6508; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Baumeister RF, 2016, PERSPECT PSYCHOL SCI, V11, P574, DOI 10.1177/1745691616652878; Bertrams A, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyci.2016.00485, 10.3389/fpsyg.2016.00485]; Bertrams A, 2015, PERS SOC PSYCHOL B, V41, P311, DOI 10.1177/0146167214564968; Bertrams A, 2013, EMOTION, V13, P668, DOI 10.1037/a0031921; Bertrams A, 2009, DIAGNOSTICA, V55, P2, DOI 10.1026/0012-1924.55.1.2; Blazquez D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00197; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Bull R, 2014, CHILD DEV PERSPECT, V8, P36, DOI 10.1111/cdep.12059; Dahm T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026351; De Rammelaere S, 1999, PSYCHOL RES-PSYCH FO, V62, P72, DOI 10.1007/s004260050041; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; Drummond A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00273; Duckworth AL, 2006, J EDUC PSYCHOL, V98, P198, DOI 10.1037/0022-0663.98.1.198; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Duckworth AL, 2015, SOC PERSONAL PSYCHOL, V9, P359, DOI 10.1111/spc3.12178; Dummel S, 2016, J COGN PSYCHOL, V28, P374, DOI 10.1080/20445911.2015.1135929; Englert C., 2017, ED PSYCHOL, V3410, P1; Englert C., 2015, FRONT PSYCHOL, V6, P1; Englert C, 2015, PSYCHOL SPORT EXERC, V18, P26, DOI 10.1016/j.psychsport.2014.12.001; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Floyd RG, 2003, PSYCHOL SCHOOLS, V40, P155, DOI 10.1002/pits.10083; Gendolla GHE, 2010, REV GEN PSYCHOL, V14, P212, DOI 10.1037/a0019742; Gillebaart M, 2015, SOC PERSONAL PSYCHOL, V9, P88, DOI 10.1111/spc3.12160; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hartenstein S., 2012, FLEXSURVEY FLEXIBLE; Hartig J., 2012, PSYCHOL TEST ASSESSM, V54, P418; Heller K. A, 2000, KOGNITIVER FA E HIGK; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Hohensinn C., 2008, PSYCHOL SCI Q, V50, P391; Imhoff R, 2014, EUR J PERSONALITY, V28, P413, DOI 10.1002/per.1899; Inzlicht M, 2015, SOC PERSONAL PSYCHOL, V9, P511, DOI 10.1111/spc3.12200; Inzlicht M, 2014, TRENDS COGN SCI, V18, P127, DOI 10.1016/j.tics.2013.12.009; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Katzenbach M., 2009, BILDUNGSSTANDARDS KO; Kotsopoulos D, 2012, J MATH BEHAV, V31, P196, DOI 10.1016/j.jmathb.2011.12.005; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; Lindner C, 2015, PERS INDIV DIFFER, V86, P465, DOI 10.1016/j.paid.2015.07.006; Lurquin JH, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00568; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Meyers JL, 2009, APPL MEAS EDUC, V22, P38, DOI 10.1080/08957340802558342; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muraven M, 2005, PSYCHOL ADDICT BEHAV, V19, P140, DOI 10.1037/0893-164X.19.2.140; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Muraven M, 2003, PERS SOC PSYCHOL B, V29, P894, DOI 10.1177/0146167203029007008; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Neubrand M., 2002, GERMAN SCALE HDB PIS; Oaten M, 2006, BASIC APPL SOC PSYCH, V28, P1, DOI 10.1207/s15324834basp2801_1; Oaten M, 2005, J SOC CLIN PSYCHOL, V24, P254, DOI 10.1521/jscp.24.2.254.62276; Price DA, 2015, EDUC PSYCHOL-UK, V35, P328, DOI 10.1080/01443410.2013.860219; Price DA, 2010, EDUC PSYCHOL-UK, V30, P269, DOI 10.1080/01443410903563330; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Reinhard MA, 2013, BRIT J SOC PSYCHOL, V52, P618, DOI 10.1111/j.2044-8309.2012.02113.x; Ren XZ, 2012, LEARN INDIVID DIFFER, V22, P1, DOI 10.1016/j.lindif.2011.09.009; Schmeichel BJ, 2003, J PERS SOC PSYCHOL, V85, P33, DOI 10.1037/0022-3514.85.1.33; Schmeichel BJ, 2007, J PERS, V75, P743, DOI 10.1111/j.1467-6494.2007.00455.x; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Schwanzer AD, 2005, DIAGNOSTICA, V51, P183, DOI 10.1026/0012-1924.51.4.183; Steyer, 1997, MEHRDIMENSIONALE BEF; Stillman TF, 2009, J SOC CLIN PSYCHOL, V28, P498, DOI 10.1521/jscp.2009.28.4.498; Wan EW, 2008, PERS SOC PSYCHOL B, V34, P32, DOI 10.1177/0146167207306756; Wiesner CD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170245	70	23	23	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180149	10.1371/journal.pone.0180149	http://dx.doi.org/10.1371/journal.pone.0180149			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662176	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300112
J	Huang, WS; Yang, M; Wang, CN; Song, YL				Huang, Wushuang; Yang, Mei; Wang, Changning; Song, Yaling			Evolutionary analysis of FAM83H in vertebrates!	PLOS ONE			English	Article							AMELOGENESIS IMPERFECTA; KERATIN CYTOSKELETON; MUTATION; ENAMEL; ORGANIZATION; CANDIDATE; DELETION; TEETH	Amelogenesis imperfecta is a group of disorders causing abnormalities in enamel formation in various phenotypes. Many mutations in the FAM83H gene have been identified to result in autosomal dominant hypocalcified amelogenesis imperfecta in different populations. However, the structure and function of FAM83H and its pathological mechanism have yet to be further explored. Evolutionary analysis is an alternative for revealing residues or motifs that are important for protein function. In the present study, we chose 50 vertebrate species in public databases representative of approximately 230 million years of evolution, including 1 amphibian, 2 fishes, 7 sauropsidas and 40 mammals, and we performed evolutionary analysis on the FAM83H protein. By sequence alignment, conserved residues and motifs were indicated, and the loss of important residues and motifs of five special species (Malayan pangolin, platypus, minke whale, nine-banded armadillo and aardvark) was discovered. A phylogenetic time tree showed the FAM83H divergent process. Positive selection sites in the Cterminus suggested that the C-terminus of FAM83H played certain adaptive roles during evolution. The results confirmed some important motifs reported in previous findings and identified some new highly conserved residues and motifs that need further investigation. The results suggest that the C-terminus of FAM83H contain key conserved regions critical to enamel formation and calcification.	[Song, Yaling] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Minist Educ, Wuhan, Peoples R China; Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China	Wuhan University; Wuhan University	Song, YL (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Minist Educ, Wuhan, Peoples R China.	sningya@whu.edu.cn		Song, Yaling/0000-0003-0747-7381	National Natural Science Foundation of China [81670976]; Bureau of Science and Technology of Wuhan [[2014]160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Wuhan	The study was supported by grants from the National Natural Science Foundation of China No.81670976,and from the Bureau of Science and Technology of Wuhan ([2014]160). The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript	Crawford PJM, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-17; Davit-Beal T, 2009, J ANAT, V214, P477, DOI 10.1111/j.1469-7580.2009.01060.x; Delgado S, 2007, J DENT RES, V86, P326, DOI 10.1177/154405910708600405; Delsuc F, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0431-0; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Ding Y, 2009, J DENT RES, V88, P991, DOI 10.1177/0022034509349454; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Foley NM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0140; Forman OP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002462; Gasse B, 2012, J DENT RES, V91, P1085, DOI 10.1177/0022034512460551; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Horovitz I, 2005, ACTA PALAEONTOL POL, V50, P545; Kawasaki K, 2014, BIOL CHEM, V395, P1003, DOI 10.1515/hsz-2014-0122; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Kueon YS, 2013, ARCH ORAL BIOL, V58, P1148, DOI 10.1016/j.archoralbio.2013.03.001; Kuga T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26557; Kuga T, 2013, J CELL SCI, V126, P4721, DOI 10.1242/jcs.129684; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; Lee MJ, 2009, ARCH ORAL BIOL, V54, P846, DOI 10.1016/j.archoralbio.2009.05.009; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Parry DA, 2012, AM J HUM GENET, V91, P565, DOI 10.1016/j.ajhg.2012.07.020; Poulter JA, 2014, HUM MOL GENET, V23, P5317, DOI 10.1093/hmg/ddu247; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Song YL, 2012, CELLS TISSUES ORGANS, V196, P271, DOI 10.1159/000334210; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Urzua B, 2015, ARCH ORAL BIOL, V60, P1356, DOI 10.1016/j.archoralbio.2015.06.016; Wang SK, 2016, MOL GENET GENOM MED, V4, P46, DOI 10.1002/mgg3.178; Wright JT, 2009, J DENT RES, V88, P356, DOI 10.1177/0022034509333822; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180360	10.1371/journal.pone.0180360	http://dx.doi.org/10.1371/journal.pone.0180360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683132	gold, Green Published, Green Submitted			2022-12-27	WOS:000405335200026
J	Hauge, H; Vendramin, N; Taksdal, T; Olsen, AB; Wessel, O; Mikkelsen, SS; Alencar, ALF; Olesen, NJ; Dahle, MK				Hauge, Helena; Vendramin, Niccolo; Taksdal, Torunn; Olsen, Anne Berit; Wessel, Oystein; Mikkelsen, Susie Sommer; Alencar, Anna Luiza Farias; Olesen, Niels Jorgen; Dahle, Maria Krudtaa			Infection experiments with novel Piscine orthoreovirus from rainbow trout (Oncorhynchus mykiss) in salmonids	PLOS ONE			English	Article							SKELETAL-MUSCLE INFLAMMATION; JUNCTIONAL ADHESION MOLECULE; PANCREATIC-NECROSIS-VIRUS; ATLANTIC SALMON; REOVIRUS PRV; SALAR L.; DISEASE; HEART; ERYTHROCYTES; TRANSCRIPTION	A new disease in farmed rainbow trout (Onchorhyncus mykiss) was described in Norway in 2013. The disease mainly affected the heart and resembled heart and skeletal muscle inflammation (HSMI) in Atlantic salmon (Salmo salar L.). HSMI is associated with Piscine orthoreovirus (PRV), and a search for a similar virus in the diseased rainbow trout led to detection of a sequence with 85% similarity to PRV. This finding called for a targeted effort to assess the risk the new PRV-variant pose on farmed rainbow trout and Atlantic salmon by studying infection and disease pathogenesis, aiming to provide more diagnostic knowledge. Based on the genetic relationship to PRV, the novel virus is referred to as PRV-Oncorhynchus mykiss (PRV-Om) in contrast to PRV-Salmo salar (PRV-Ss). In experimental trials, intraperitoneally injected PRV-Om was shown to replicate in blood in both salmonid species, but more effectively in rainbow trout. In rainbow trout, the virus levels peaked in blood and heart of cohabitants 6 weeks post challenge, along with increased expression of antiviral genes (Mx and viperin) in the spleen, with 80-100% of the cohabitants infected. Heart inflammation was diagnosed in all cohabitants examined 8 weeks post challenge. In contrast, less than 50% of the Atlantic salmon cohabitants were infected between 8 and 16 weeks post challenge and the antiviral response in these fish was very low. From 12 weeks post challenge and onwards, mild focal myocarditis was demonstrated in a few virus-positive salmon. In conclusion, PRV-Om infects both salmonid species, but faster transmission, more notable antiviral response and more prominent heart pathology were observed in rainbow trout.	[Hauge, Helena; Taksdal, Torunn; Olsen, Anne Berit; Dahle, Maria Krudtaa] Norwegian Vet Inst, Oslo, Norway; [Hauge, Helena; Taksdal, Torunn; Olsen, Anne Berit; Dahle, Maria Krudtaa] Norwegian Vet Inst, Bergen, Norway; [Vendramin, Niccolo; Mikkelsen, Susie Sommer; Alencar, Anna Luiza Farias; Olesen, Niels Jorgen] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark; [Wessel, Oystein] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway	Norwegian Veterinary Institute; Norwegian Veterinary Institute; Technical University of Denmark; Norwegian University of Life Sciences	Dahle, MK (corresponding author), Norwegian Vet Inst, Oslo, Norway.; Dahle, MK (corresponding author), Norwegian Vet Inst, Bergen, Norway.	maria.dahle@vetinst.no	Alencar, Anna/M-1681-2016; Farias Alencar, Anna Luiza/GYU-1369-2022; Olesen, Niels Jørgen/AAJ-8851-2021; Dahle, Maria K/AAK-5130-2021	Alencar, Anna/0000-0002-4864-9111; Farias Alencar, Anna Luiza/0000-0002-4864-9111; Olesen, Niels Jørgen/0000-0002-0152-4135; Dahle, Maria K/0000-0003-0380-084X; Vendramin, Niccolo/0000-0002-9217-7887	Norwegian Veterinary Institute (NVI); EU Reference Laboratory for Fish Diseases; DTU National Veterinary Institute; FAPESP (Sao Paulo Research Foundation) Research internship abroad [2015/04027-6]; Norwegian Research Council [237315/E40]	Norwegian Veterinary Institute (NVI); EU Reference Laboratory for Fish Diseases; DTU National Veterinary Institute; FAPESP (Sao Paulo Research Foundation) Research internship abroad(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	The pilot study (trial1), the Atlantic salmon main study (trial3), and his to pathological analyses for both species were funded by the Norwegian Veterinary Institute (NVI). The rainbow trout study (trial2) was funded by the EU Reference Laboratory for Fish Diseases, DTU National Veterinary Institute and FAPESP (Sao Paulo Research Foundation) Research internship abroad (2015/04027-6). Experiments perform e dat the Norwegian University of Life Sciences were funded by the Norwegian Research Council grant # 237315/E40. Many thanks to Renate Johansen and Monika Hjortaas (NVI) for fruitful initial discussions on the pilot study design, and to Even Thoen (NVI) for practical assistance setting up the pilot study. The Atlantic salmon trial at VESO Vikan was managed by Anne Ramstad and crew. We greatly appreciate the help from several NVI and DTU Vet technicians. In particular; Elisabeth Dahl Nybo (NVI) for sample handling in the Atlantic salmon main study and RNA preparation for immune analysis, R and i Faller (NVI) for RT-qPCR analysis of immune genes, Linh Tran (NVI) for immuno his to chemistry, Didde Hedegaard Sorensen and Troels Secher Rundqvist (DTU Vet) for nucleic acid purification and RT-qPCR and Kari Karbech Mouritsen (DTU Vet) for sample handling and preparation.	[Anonymous], 2015, EUROPEAN AQUACULTURE; Ballesteros NA, 2015, VET IMMUNOL IMMUNOP, V165, P127, DOI 10.1016/j.vetimm.2015.04.001; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Campbell JA, 2005, J VIROL, V79, P7967, DOI 10.1128/JVI.79.13.7967-7978.2005; Dahle MK, 2015, FISH SHELLFISH IMMUN, V45, P780, DOI 10.1016/j.fsi.2015.05.049; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garver KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146229; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; Grove S, 2013, FISH SHELLFISH IMMUN, V34, P789, DOI 10.1016/j.fsi.2012.12.014; Guglielmi KM, 2007, J BIOL CHEM, V282, P17930, DOI 10.1074/jbc.M702180200; Haatveit HM, 2016, VET RES, V47, DOI 10.1186/s13567-015-0302-0; Hauge H, 2016, VET RES, V47, DOI 10.1186/s13567-016-0343-z; Hodneland K, 2006, J VIROL METHODS, V131, P184, DOI 10.1016/j.jviromet.2005.08.012; Jansen MD, 2016, J FISH DIS, V18, P109; Jensen BB, 2015, DIS AQUAT ORGAN, V114, P177, DOI 10.3354/dao02867; Johansen LH, 2016, MOL IMMUNOL, V73, P138, DOI 10.1016/j.molimm.2016.04.007; Johansen LH, 2015, FISH SHELLFISH IMMUN, V46, P612, DOI 10.1016/j.fsi.2015.07.023; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Kongtorp RT, 2009, J FISH DIS, V32, P253, DOI 10.1111/j.1365-2761.2008.00983.x; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; Lovoll M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-8; Lovoll M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-309; Lund M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0389-y; Madren JA, 2012, J VIROL, V86, P3466, DOI 10.1128/JVI.06659-11; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070075; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Mikalsen AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037269; Nomikou K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005056; Olsen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131638; Orpetveit I, 2010, J VET DIAGN INVEST, V22, P886, DOI 10.1177/104063871002200606; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Polinski MP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3196-y; RHIM JS, 1962, VIROLOGY, V17, P342, DOI 10.1016/0042-6822(62)90125-3; Sibley SD, 2016, J GEN VIROL, V97, P2482, DOI 10.1099/jgv.0.000568; Takano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165424; Toffolo V, 2007, MOL PHYLOGENET EVOL, V43, P298, DOI 10.1016/j.ympev.2006.08.003; Verrier ER, 2011, DEV COMP IMMUNOL, V35, P1204, DOI 10.1016/j.dci.2011.03.012; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wessel O, 2015, VET RES, V46, DOI 10.1186/s13567-015-0154-7	42	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180293	10.1371/journal.pone.0180293	http://dx.doi.org/10.1371/journal.pone.0180293			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678799	Green Published, Green Accepted, gold			2022-12-27	WOS:000405272200046
J	Moulton, ST; Turkay, S; Kosslyn, SM				Moulton, Samuel T.; Turkay, Selen; Kosslyn, Stephen M.			Does a presentation's medium affect its message? PowerPoint, Prezi, and oral presentations	PLOS ONE			English	Article							STUDENTS SELF-EFFICACY; PRESENTATION SOFTWARE; MULTIMEDIA; IMPACT; CLASSROOM; COMPUTER; OBJECT; INSTRUCTION; TECHNOLOGY; ANIMATION	Despite the prevalence of PowerPoint in professional and educational presentations, surprisingly little is known about how effective such presentations are. All else being equal, are PowerPoint presentations better than purely oral presentations or those that use alternative software tools? To address this question we recreated a real-world business scenario in which individuals presented to a corporate board. Participants (playing the role of the presenter) were randomly assigned to create PowerPoint, Prezi, or oral presentations, and then actually delivered the presentation live to other participants (playing the role of corporate executives). Across two experiments and on a variety of dimensions, participants evaluated PowerPoint presentations comparably to oral presentations, but evaluated Prezi presentations more favorably than both PowerPoint and oral presentations. There was some evidence that participants who viewed different types of presentations came to different conclusions about the business scenario, but no evidence that they remembered or comprehended the scenario differently. We conclude that the observed effects of presentation format are not merely the result of novelty, bias, experimenter-, or software-specific characteristics, but instead reveal a communication preference for using the panning-andzooming animations that characterize Prezi presentations.	[Moulton, Samuel T.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Moulton, Samuel T.; Turkay, Selen] Harvard Univ, Harvard Initiat Learning & Teaching, Cambridge, MA 02138 USA; [Kosslyn, Stephen M.] Keck Grad Inst, Minerva Sch, San Francisco, CA USA	Harvard University; Harvard University; Claremont Colleges; Keck Graduate Institute	Moulton, ST (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.; Moulton, ST (corresponding author), Harvard Univ, Harvard Initiat Learning & Teaching, Cambridge, MA 02138 USA.	samuel_moulton@harvard.edu	Turkay, Selen/K-6199-2017	Turkay, Selen/0000-0001-8684-2070	Prezi	Prezi	This research was supported by a grant from Prezi (http://www.prezi.com) to SMK. In the sponsored research agreement (which we are happy to provide) and in our conversations with Prezi leadership, they agreed to let us conduct the study as we wished and publish it no matter what the results revealed. Aside from funding the research, the only role that any employees of Prezi played was (as documented in the manuscript) 1) to provide us with a distribution list of Boston-area Prezi customers (8 of whom participated in the first experiment) and 2) as experts in Prezi, review the background questionnaire to ensure that we were accurately describing Prezi's purported benefits and features (just as PowerPoint and oral presentation experts did the same). No employees at Prezi had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors have any professional or financial connection to Prezi or personal relationships with any Prezi employees. We do not plan to conduct any follow-up research on this topic or obtain future funding from Prezi. As evident in the manuscript, we took special care not to allow bias or demand characteristics to influence this research.	Adams C, 2006, J CURRICULUM STUD, V38, P389, DOI 10.1080/00220270600579141; Adams S., 2016, PREZIS PETER ARVAI P; Amare N., 2006, J TECHNICAL WRITING, V36, P297, DOI DOI 10.2190/03GX-F1HW-VW5M-7DAR; [Anonymous], INT J INSTR TECHNOL; Apperson JM, 2008, COMPUT EDUC, V50, P148, DOI 10.1016/j.compedu.2006.04.003; Astleitner H., 2002, J INSTRUCTIONAL PSYC, V29, P53; Ballentine B, 2012, PROFESSIONAL COMMUNI, P1; Bartlett RM, 2003, TEACH PSYCHOL, V30, P335, DOI 10.1207/S15328023TOP3004_07; Bartsch RA, 2003, COMPUT EDUC, V41, P77, DOI 10.1016/S0360-1315(03)00027-7; Bean J., 2012, PROF COMM C IPCC ORL, P1; Bederson BB, 2011, BEHAV INFORM TECHNOL, V30, P853, DOI 10.1080/0144929X.2011.586724; Beets S. D., 2001, J ED BUSINESS, V76, P231; Blokzijl W., 2004, Business Communication Quarterly, V67, P70, DOI 10.1177/1080569903262046; Brock S, 2013, J INF TECHNOL EDUC-R, V12, P95; Burke LA, 2008, BUS COMMUN Q; Casteleyn J, 2015, RES LEARN TECHNOL, V23, DOI 10.3402/rlt.v23.25161; Casteleyn J, 2013, TECHNOL PEDAGOG EDUC, V22, P283, DOI 10.1080/1475939X.2013.784621; CHAIKEN S, 1989, P212; Chou PN, 2015, COMPUT EDUC, V91, P73, DOI 10.1016/j.compedu.2015.10.020; Clark C, 2008, VENTUR CAP, V10, P257, DOI 10.1080/13691060802151945; CLARK RE, 1983, REV EDUC RES, V53, P445, DOI 10.2307/1170217; CLARK RE, 1994, ETR&D-EDUC TECH RES, V42, P21, DOI 10.1007/BF02299088; Conboy C, 2012, INNOV PRACT, V7, P31; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Coyle JR, 2001, J ADVERTISING, V30, P65, DOI 10.1080/00913367.2001.10673646; Daniels L., 1999, Journal of Computing in Higher Education, V10, P42, DOI 10.1007/BF02948722; DeBord KA, 2004, TEACH PSYCHOL, V31, P65, DOI 10.1207/s15328023top3101_13; Duffy RM, 2014, ACAD PSYCHIATR, P1; El Khoury RM, 2012, INT J BUS SOC SCI, V3; Erwin TD, 1999, TEACH PSYCHOL, V26, P58, DOI 10.1207/s15328023top2601_18; Frey BA, 2002, LEARNERS PERCEPTIONS; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Good L., 2002, Information Visualization, V1, P35, DOI 10.1057/palgrave/ivs/9500004; Guadagno RE, 2011, P 6 INT C PERS TECHN, P2; Gunelius S, 2011, STAND OUT COMPETITOR; Harknett RJ, 1997, PS, V30, P496, DOI 10.2307/420130; Harris D, 2011, J HOSP LEIS SPORT TO, V10, P72, DOI 10.3794/johlste.101.339; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Hegarty M, 2011, TOP COGN SCI, V3, P446, DOI 10.1111/j.1756-8765.2011.01150.x; HUNT RR, 1995, PSYCHON B REV, V2, P105, DOI 10.3758/BF03214414; Jensen R., 1992, J ACCOUNTING ED, V10, P39; Kahneman D., 2011, THINKING FAST SLOW; Kjeldsen JE, 2013, ARGUMENTATION, V27, P425, DOI 10.1007/s10503-013-9296-9; Knoblauch H, 2013, COMMUN THEORY   0801, P23; Kosslyn SM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00230; Kozhevnikov M, 2005, MEM COGNITION, V33, P710, DOI 10.3758/BF03195337; Lai Y-L, 2007, PACIS 2007 P, V6; Lang A, 2002, COMMUN RES, V29, P215, DOI 10.1177/0093650202029003001; Levasseur D. G., 2006, REV COMMUNICATION, V6, P101, DOI [10.1080/15358590600763383., DOI 10.1080/15358590600763383]; Li HR, 1999, JOURNALISM MASS COMM, V76, P341, DOI 10.1177/107769909907600211; Lowry RB, 1999, J TERT ED GROUP R SO; Luria A. R., 1968, MIND MNEMONIST LITTL; Mantei E. J., 2000, J COLL SCI TEACH, V29, P301; Mason GS, 2013, IEEE T EDUC, V56, P430, DOI 10.1109/TE.2013.2249066; Mayer RE, 2002, PSYCHOL LEARN MOTIV, V41, P85, DOI 10.1016/S0079-7421(02)80005-6; McCloud Scott, 2000, REINVENTING COMICS; McLuhan M., 1964, UNDERSTANDING MEDIA, P1; McNeill T, 2009, E LEARNING DIGITAL C; Meo SA, 2013, JCPSP-J COLL PHYSICI, V23, P47, DOI 01.2013/JCPSP.4750; Moreno R, 1999, J EDUC PSYCHOL, V91, P358, DOI 10.1037/0022-0663.91.2.358; Nesbit JC, 2006, REV EDUC RES, V76, P413, DOI 10.3102/00346543076003413; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Nouri H., 2005, GLOBAL PERSPECTIVES, V2, P53; Nowaczyk R, 1998, INT J INSTRUCTIONAL, V25, P367; PAIVIO A, 1973, COGNITIVE PSYCHOL, V5, P176, DOI 10.1016/0010-0285(73)90032-7; Park J, 2013, APPL COGNITIVE PSYCH, V27, P235, DOI 10.1002/acp.2900; Parker I, NEW YORKER; Perron BE, 2011, RES SOCIAL WORK PRAC, V21, P376, DOI 10.1177/1049731510390700; Perry T, 1998, BRIT J EDUC TECHNOL, V29, P375, DOI 10.1111/1467-8535.00083; Petty R. E., 1986, COMMUN PERSUATION, P1; Petty RE, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P41; Pippert TD, 1999, TEACH SOCIOL, V27, P92, DOI 10.2307/1318697; Ponce HR, 2014, COMPUT HUM BEHAV, V30, P121, DOI 10.1016/j.chb.2013.07.054; Rankin EL, 2001, ATLANTIC ECON J, V29, P113, DOI DOI 10.1007/BF02299936; Ricer RE, 2005, TEACH LEARN MED, V17, P107, DOI 10.1207/s15328015tlm1702_3; RIEBER LP, 1991, J EDUC PSYCHOL, V83, P318, DOI 10.1037/0022-0663.83.3.318; Rockinson-Szapkiw AJ, 2011, TRADING LINEAR PRESE; Roehling PV, 2011, TECHNOL PEDAGOG EDUC, V20, P113, DOI 10.1080/1475939X.2011.554018; Rudow SR, 2015, CONT ISSUES ED RES O, V8; Salomon Gavriel, 2012, INTERACTION MEDIA CO; Savoy A, 2009, COMPUT EDUC, V52, P858, DOI 10.1016/j.compedu.2008.12.005; Settle Q, 2011, NACTA J, V55, P105; Shanmugasundaram M., 2008, P WORK ADV VIS INT A, P396, DOI DOI 10.1145/1385569.1385642; Simons RF, 1999, PSYCHOPHYSIOLOGY, V36, P619, DOI 10.1017/S0048577299980976; Sirikasem P, PSYCHOL RES, V53, P113; Smith SM, 2000, TEACH PSYCHOL, V27, P220, DOI 10.1207/S15328023TOP2703_10; Stokes D. E., 1997, PASTEURS QUADRANT BA; Strasser N., 2014, J COLL TEACHING LEAR, V11, P95, DOI DOI 10.19030/TLC.V11I2.8547; Sugahara S, 2006, ACCOUNT EDUC, V15, P391, DOI 10.1080/09639280601011099; Sundar S.S., 2005, J INTERACTIVE ADVERT, V5, P5, DOI [https://doi.org/10.1080/15252019.2005.10722097, DOI 10.1080/15252019.2005.10722097, 10.1080/15252019.2005.10722097]; Susskind JE, 2005, COMPUT EDUC, V45, P203, DOI 10.1016/j.compedu.2004.07.005; Susskind JE, 2008, COMPUT EDUC, V50, P1228, DOI 10.1016/j.compedu.2006.12.001; Szabo A, 2000, COMPUT EDUC, V35, P175, DOI 10.1016/S0360-1315(00)00030-0; Tang TLP, 2009, COMPUT EDUC, V53, P1241, DOI 10.1016/j.compedu.2009.06.007; Thielsch MT, 2012, TECH COMMUN-STC, V59, P112; Tufte ER, 2013, COGNITIVE STYLE POWE; Turkay S, 2016, P 7 INT C LEARN INT, P283; TURKLE S, 2004, CHRONICLE HIGHER ED, V0050; Tversky B, 2002, INT J HUM-COMPUT ST, V57, P247, DOI 10.1006/ijhc.1017; Virtanen Pasi, 2013, Campus-Wide Information Systems, V30, P201, DOI 10.1108/10650741311330384; von Restorff H, 1933, PSYCHOL FORSCH, V18, P299, DOI 10.1007/BF02409636; Weinraub HJ, 1998, FINANCIAL PRACTICE E, V8, P88; Wilmoth J, 1998, TEACH SOCIOL, V26, P166, DOI 10.2307/1318830; Wilson ML, 2008, P 8 ACM IEEE CS JOIN, P52; Worthington DL, 2015, COMPUT EDUC, V85, P14, DOI 10.1016/j.compedu.2015.02.002; Zongker D. E., 2003, ACM SIGGRAPH/Eurographics Symposium on Computer Animation, P298	106	19	19	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178774	10.1371/journal.pone.0178774	http://dx.doi.org/10.1371/journal.pone.0178774			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678855	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200006
J	Wu, QX; Luo, XY; Chen, SB; Qi, C; Long, J; Xiong, YF; Liao, YH; Liu, TQ				Wu, Qiuxia; Luo, Xiaoyang; Chen, Shubao; Qi, Chang; Long, Jiang; Xiong, Yifan; Liao, Yanhui; Liu, Tieqiao			Mental health literacy survey of non-mental health professionals in six general hospitals in Hunan Province of China	PLOS ONE			English	Article							PUBLIC BELIEFS; DISORDERS; BURDEN; INTERVENTIONS; PSYCHIATRISTS; HELPFULNESS; PREVALENCE; DISABILITY	Background Mental illness has brought great economic burden related to misdiagnosis by non-mental health professionals in general hospitals. The aim of this study was to explore non-mental health professionals' conceptions related to the identification of mental illness and perceived treatments, first aid and prognosis. Methods In 2014-2015, we presented 1123 non-mental health professionals from six general hospitals in Hunan Province with one of three vignettes describing a person with schizophrenia, depression, or generalized anxiety disorder. Identification rates, beliefs about various interventions, best methods, and the prognosis with or without treatment were measured. Results Less than 60% of the non-mental health professionals could identify the mental disorders correctly. Psychiatrists and psychologists were considered to be the people who would be most helpful in all vignettes. Over 70% of participants identified the correct medication for each vignette. Participants gave higher ratings to lifestyle interventions than to psychological and medical interventions, especially in the depression and generalized anxiety disorder vignettes. For the question about how the person could best be helped, about half of the participants rated listening or talking with the person more highly than accompanying the person to professional help or encouraging the person to visit a psychiatrist or psychologist. Participants believed that, with professional help, the people in the vignettes would fully recover but that problems would probably reoccur and that, without professional help, the people described would get worse. Conclusions The beliefs that non-mental health professionals hold about mental disorders are inadequate to provide appropriate help. There is an urgent need for mental health education campaigns to improve non-mental health professionals' mental health knowledge in mainland China in order to provide better support for mental health service users.	[Wu, Qiuxia; Chen, Shubao; Qi, Chang; Long, Jiang; Xiong, Yifan; Liao, Yanhui; Liu, Tieqiao] Cent South Univ, Xiangya Hosp 2, Mental Hlth Inst,China Natl Clin Res Ctr Mental H, Natl Technol Inst Psychiat,Key Lab Psychiat & Men, Changsha, Hunan, Peoples R China; [Luo, Xiaoyang] First Psychiat Hosp Hengyang City, Female Psychiat Ward, Hengyang, Hunan, Peoples R China; [Long, Jiang] Catholic Univ Louvain, Lab Expt Psychopathol, Psychol Sci Res Inst, Louvain, Belgium	Central South University; Universite Catholique Louvain	Liu, TQ (corresponding author), Cent South Univ, Xiangya Hosp 2, Mental Hlth Inst,China Natl Clin Res Ctr Mental H, Natl Technol Inst Psychiat,Key Lab Psychiat & Men, Changsha, Hunan, Peoples R China.	liutieqiaochina@163.com	Xiong, Yifan/GSD-4318-2022; Long, Jiang/ADG-1028-2022; liu, tieqiao/GSE-2327-2022	Long, Jiang/0000-0001-6571-0589; 	National Natural Science Foundation of China [81371465]; Provincial Natural Science Foundation of Hunan [2015JJ2180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Hunan(Natural Science Foundation of Hunan Province)	This research was jointly funded by the National Natural Science Foundation of China (grant no. 81371465) and the Provincial Natural Science Foundation of Hunan (grant no. 2015JJ2180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Furnham Adrian, 2014, Int J Adolesc Med Health, V26, P283, DOI 10.1515/ijamh-2013-0301; Jorm AF, 1997, MED J AUSTRALIA, V166, P182, DOI 10.5694/j.1326-5377.1997.tb140071.x; Jorm AF, 1997, BRIT J PSYCHIAT, V171, P233, DOI 10.1192/bjp.171.3.233; Jorm AF, 1997, AUST NZ J PSYCHIAT, V31, P844, DOI 10.3109/00048679709065510; Jorm AF, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-12; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Li L, 2014, CHINA JOUNAL HLTH PS, V22, P1021; Liu W, 2011, INT NURS REV, V58, P361, DOI 10.1111/j.1466-7657.2011.00883.x; Morgan AJ, 2014, AUST NZ J PSYCHIAT, V48, P442, DOI 10.1177/0004867413512686; O'Reilly CL, 2010, AUST NZ J PSYCHIAT, V44, P1089, DOI 10.3109/00048674.2010.512864; Peng Y, 2011, SHANGHAI ARCH PSYCHI, V23, P353; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Reavley NJ, 2011, AUST NZ J PSYCHIAT, V45, P890, DOI 10.3109/00048674.2011.614215; Tartakovsky M, 2016, MEDIA MENTAL ILLNESS; Thompson A, 2004, SOC PSYCH PSYCH EPID, V39, P810, DOI 10.1007/s00127-004-0816-7; Vermani Monica, 2011, Prim Care Companion CNS Disord, V13, DOI 10.4088/PCC.10m01013; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wang Jingyi, 2013, Shanghai Arch Psychiatry, V25, P224, DOI 10.3969/j.issn.1002-0829.2013.04.004; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Xiong Wei, 2016, Shanghai Arch Psychiatry, V28, P4, DOI 10.11919/j.issn.1002-0829.216012; Xu JF, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0839-0	22	24	27	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180327	10.1371/journal.pone.0180327	http://dx.doi.org/10.1371/journal.pone.0180327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678848	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200054
J	Frizelle, P; Harte, J; O'Sullivan, K; Fletcher, P; Gibbon, F				Frizelle, Pauline; Harte, Jennifer; O'Sullivan, Kathleen; Fletcher, Paul; Gibbon, Fiona			The relationship between information carrying words, memory and language skills in school age children with specific language impairment	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PHONOLOGICAL WORKING-MEMORY; SENTENCE COMPREHENSION; NONWORD-REPETITION; VOCABULARY DEVELOPMENT; IMMEDIATE RECALL; YOUNG-CHILDREN; SPAN; MARKERS; SPEED	The receptive language measure information-carrying word (ICW) level, is used extensively by speech and language therapists in the UK and Ireland. Despite this it has never been validated via its relationship to any other relevant measures. This study aims to validate the ICW measure by investigating the relationship between the receptive ICW score of children with specific language impairment (SLI) and their performance on standardized memory and language assessments. Twenty-seven children with SLI, aged between 5; 07 and 8; 11, completed a sentence comprehension task in which the instructions gradually increased in number of ICWs. The children also completed subtests from The Working Memory Test Battery for children and The Clinical Evaluation of Language Fundamentals-4. Results showed that there was a significant positive relationship between both language and memory measures and children's ICW score. While both receptive and expressive language were significant in their contribution to children's ICW score, the contribution of memory was solely determined by children's working memory ability. ICW score is in fact a valid measure of the language ability of children with SLI. However therapists should also be cognisant of its strong association with working memory when using this construct in assessment or intervention methods.	[Frizelle, Pauline] Univ Oxford, Dept Expt Psychol, Oxford, England; [Frizelle, Pauline; Harte, Jennifer; Fletcher, Paul; Gibbon, Fiona] Univ Coll Cork, Dept Speech & Hearing Sci, Brookfield Complex, Cork, Ireland; [O'Sullivan, Kathleen] Univ Coll Cork, Sch Math Sci, Cork, Ireland	University of Oxford; University College Cork; University College Cork	Frizelle, P (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.; Frizelle, P (corresponding author), Univ Coll Cork, Dept Speech & Hearing Sci, Brookfield Complex, Cork, Ireland.	p.frizelle@ucc.ie	Gibbon, Fiona E/J-8255-2013		Health Research Award from the Irish Health Research Board [HRA_POR/2012/ 68]	Health Research Award from the Irish Health Research Board	This work was supported by a Health Research Award, research grant HRA_POR/2012/ 68 from the Irish Health Research Board. The grant was awarded to Professor Fiona Gibbon. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway TP, 2005, EUR J COGN PSYCHOL, V17, P207, DOI 10.1080/09541440440000005; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bamford J, 2007, HEALTH TECHNOL ASSES, V11, P1; Bayliss DM, 2005, MEMORY, V13, P414, DOI 10.1080/09658210344000332; Bishop DMV, 1989, TEST RECEPTION GRAMM; Bishop DV, PEERJ PREPRINTS, V4; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; BROWN GDA, 1995, J MEM LANG, V34, P594, DOI 10.1006/jmla.1995.1027; CASE R, 1982, J EXP CHILD PSYCHOL, V33, P386, DOI 10.1016/0022-0965(82)90054-6; Coady J, 2010, INT J LANG COMM DIS, V45, P494, DOI 10.3109/13682820903222783; Conti-Ramsden G, 2003, J SPEECH LANG HEAR R, V46, P1029, DOI 10.1044/1092-4388(2003/082); Conti-Ramsden G, 2001, J CHILD PSYCHOL PSYC, V42, P741, DOI 10.1111/1469-7610.00770; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Davis J., 1971, ELEMENTARY SURVEY AN; Donlan C, 1998, INT J LANG COMM DIS, V33, P149, DOI 10.1080/136828298247802; Dunn L.M., 1982, BRIT PICTURE VOCABUL; Durkin K, 2007, CHILD DEV, V78, P1441, DOI 10.1111/j.1467-8624.2007.01076.x; Eisenberg SL, 2001, AM J SPEECH-LANG PAT, V10, P323, DOI 10.1044/1058-0360(2001/028); Epstein B, 2013, INT J LANG COMM DIS, V48, P351, DOI 10.1111/1460-6984.12009; Frizelle P, 2017, J CHILD LANG, P1; Frizelle P, 2015, AM J SPEECH LANG PAT; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; Gray S, 2006, J SPEECH LANG HEAR R, V49, P955, DOI 10.1044/1092-4388(2006/069); Hanten G, 2000, J MEM LANG, V43, P335, DOI 10.1006/jmla.2000.2731; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Jones G, 2016, COGNITION, V153, P79, DOI 10.1016/j.cognition.2016.04.017; Jones G, 2015, COGNITION, V144, P1, DOI 10.1016/j.cognition.2015.07.009; Klem M, 2015, DEVELOPMENTAL SCI, V18, P146, DOI 10.1111/desc.12202; Knowles W., 1982, DERBYSHIRE LANGUAGE; Leonard LB, 2007, J SPEECH LANG HEAR R, V50, P408, DOI 10.1044/1092-4388(2007/029); Leonard LB, 2013, J SPEECH LANG HEAR R, V56, P577, DOI 10.1044/1092-4388(2012/11-0254); MCCARTHY RA, 1987, BRAIN, V110, P1545, DOI 10.1093/brain/110.6.1545; McGhee R. L., 2007, TOKEN TEST CHILDREN; Melby-Lervag M, 2012, PSYCHOL SCI, V23, P1092, DOI 10.1177/0956797612443833; Montgomery J, 2004, INT J LANG COMM DIS, V39, P115, DOI 10.1080/13682820310001616985; Montgomery JW, 2007, J SPEECH LANG HEAR R, V50, P778, DOI 10.1044/1092-4388(2007/054); Montgomery JW, 2016, J SPEECH LANG HEAR R, V59, P1491, DOI 10.1044/2016_JSLHR-L-15-0325; Montgomery JW, 2009, APPL PSYCHOLINGUIST, V30, P485, DOI 10.1017/S0142716409090249; Montgomery JW, 2009, J SPEECH LANG HEAR R, V52, P269, DOI 10.1044/1092-4388(2008/07-0116); Montgomery JW, 2000, APPL PSYCHOLINGUIST, V21, P117, DOI 10.1017/S0142716400001065; Montgomery JW, 2000, J SPEECH LANG HEAR R, V43, P293, DOI 10.1044/jslhr.4302.293; MONTGOMERY JW, 1995, J SPEECH HEAR RES, V38, P187, DOI 10.1044/jshr.3801.187; Morgan L, 2013, BULLETIN, V738, P16; Norbury CF, 2002, APPL PSYCHOLINGUIST, V23, P247, DOI 10.1017/S0142716402002059; Pickering S., 2001, WORKING MEMORY TEST; POTTER MC, 1990, J MEM LANG, V29, P633, DOI 10.1016/0749-596X(90)90042-X; Potter MC, 1998, J MEM LANG, V38, P265, DOI 10.1006/jmla.1997.2546; Raven J.C., 2008, RAVENS ED CPM CVS; Riches NG, 2012, INT J LANG COMM DIS, V47, P499, DOI 10.1111/j.1460-6984.2012.00158.x; Robertson EK, 2010, APPL PSYCHOLINGUIST, V31, P141, DOI 10.1017/S0142716409990208; Rummer R, 2001, J MEM LANG, V45, P451, DOI 10.1006/jmla.2000.2788; SCHWEICKERT R, 1993, MEM COGNITION, V21, P168, DOI 10.3758/BF03202729; Semel E., 2006, CLIN EVALUATION LANG, V4th UK ed.; Semel EM, 1987, CLIN EVALUATION LANG	58	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180496	10.1371/journal.pone.0180496	http://dx.doi.org/10.1371/journal.pone.0180496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672043	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500059
J	Ma, FQ; Ren, MY; Wang, LH; Wang, Q; Guo, JL				Ma, Fangqin; Ren, Meiyu; Wang, Lihua; Wang, Qi; Guo, Jingli			Visual outcomes of dense pediatric cataract surgery in eastern China	PLOS ONE			English	Article							INTRAOCULAR-LENS IMPLANTATION; CONGENITAL CATARACT; DEVELOPMENTAL CATARACTS; POSTERIOR CHAMBER; CHILDREN; COMPLICATIONS; GLAUCOMA; EXTRACTION; CHILDHOOD; AGE	Purpose To evaluate the visual outcomes of dense pediatric cataract surgery in eastern China. Methods Medical records of children who underwent surgery for dense unilateral or bilateral pediatric cataract in Shandong Provincial Hospital between January 2007 and December 2012 were collected. Patients who cooperated with optical correction and aggressive patching of the sound eye and who had a minimum postoperative follow-up of more than 2 years were included. Risk factors for poor visual outcomes were analyzed. Results Of the 105 eligible patients (181 eyes), 76 had bilateral cataract, and 29 unilateral. With a mean follow up of 46.77 mo (range 24.0-96.0 mo), the final best corrected visual acuity (BCVA) of 158 eyes were recorded, and 4.43% (7/158) achieved 0.1 logarithm of the minimum angle of resolution (logMAR) or better; 15.19% (24/ 158) obtained a BCVA between 0.1 logMAR and 0.3 logMAR; 18.99%, (30/158) between 0.3 logMAR and 0.5 logMAR; 46.84% (74/158), between 0.5 logMAR and 1 logMAR; 14.55%, worse than 1 logMAR. The mean BCVA of the patients who underwent lensectomy before 3 months of age was significantly better than that of patients who underwent lensectomy between 3 and 12 months (p = 0.001). In the same lensectomy age groups, the final BCVA of the children in the bilateral and unilateral groups did not differ significantly (P>0.05). Lensectomy after 3 months of age, postoperative complications, strabismus and nystagmus were shown to be risk factors for poor visual outcomes. Conclusions Lensectomy before 3 months of age, IOL implantation, proper managing of postoperative complications, early optical correction and aggressive postoperative patching of the sound eye would increase the final BCVA for patients with dense pediatric cataract.	[Ma, Fangqin; Ren, Meiyu; Wang, Lihua; Wang, Qi; Guo, Jingli] Shandong Univ, Shandong Prov Hosp, Dept Ophthalmol, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wang, LH (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Ophthalmol, Jinan, Peoples R China.	wang_glasses@163.com						Allen RJ, 2010, EYE, V24, P1263, DOI 10.1038/eye.2009.295; Asrani S, 2000, J AAPOS, V4, P33, DOI 10.1016/S1091-8531(00)90009-0; Birch EE, 1996, INVEST OPHTH VIS SCI, V37, P1532; Birch EE, 2012, J AAPOS, V16, P156, DOI 10.1016/j.jaapos.2011.11.007; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Garza-Reyes M, 2000, ARCH MED RES, V31, P500, DOI 10.1016/S0188-4409(00)00101-6; HING S, 1990, BRIT J OPHTHALMOL, V74, P73, DOI 10.1136/bjo.74.2.73; Hosal BM, 2000, OPHTHALMOLOGY, V107, P1647, DOI 10.1016/S0161-6420(00)00226-8; Kang Kui Dong, 2006, Korean J Ophthalmol, V20, P41; Khanna RC, 2013, INDIAN J OPHTHALMOL, V61, P65, DOI 10.4103/0301-4738.107194; Kim Kuk Hyoe, 2008, Korean J Ophthalmol, V22, P87, DOI 10.3341/kjo.2008.22.2.87; KnightNanan D, 1996, J CATARACT REFR SURG, V22, P730, DOI 10.1016/S0886-3350(96)80312-9; Lambert SR, 2013, AM J OPHTHALMOL, V156, P355, DOI 10.1016/j.ajo.2013.03.013; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; Lambert SR, 2001, J AAPOS, V5, P70, DOI 10.1067/mpa.2001.111015; Lu Y, 2010, GRAEF ARCH CLIN EXP, V248, P681, DOI 10.1007/s00417-010-1310-4; Magli A, 2008, EUR J OPHTHALMOL, V18, P903, DOI 10.1177/112067210801800608; MILLS MD, 1994, J PEDIATR OPHTHALMOL, V31, P355; O'Keefe M, 2001, J CATARACT REFR SURG, V27, P2006, DOI 10.1016/S0886-3350(01)00973-7; Sjostrand J, 2011, ACTA OPHTHALMOL, V89, P30, DOI 10.1111/j.1755-3768.2009.01618.x; Solebo AL, 2015, BRIT J OPHTHALMOL, V99, P1471, DOI 10.1136/bjophthalmol-2014-306394; Thakur J, 2004, J CATARACT REFR SURG, V30, P1629, DOI 10.1016/j.jcrs.2003.12.047; Thylefors B, 1998, Community Eye Health, V11, P1; Vasavada AR, 2006, CURR OPIN OPHTHALMOL, V17, P54; Weisberg OL, 2005, OPHTHALMOLOGY, V112, P1625, DOI 10.1016/j.ophtha.2005.06.002; Yang ML, 2006, GRAEF ARCH CLIN EXP, V244, P1485, DOI 10.1007/s00417-006-0308-4; You CY, 2011, OPHTHALMOLOGY, V118, P17, DOI 10.1016/j.ophtha.2010.04.014; Zhan H, 2012, J AAPOS, V16, P65, DOI 10.1016/j.jaapos.2011.09.012	28	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180166	10.1371/journal.pone.0180166	http://dx.doi.org/10.1371/journal.pone.0180166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671961	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500020
J	Samiullah, S; Roberts, J; Wu, SB				Samiullah, Sami; Roberts, Juliet; Wu, Shu-Biao			Reference gene selection for the shell gland of laying hens in response to time-points of eggshell formation and nicarbazin	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; HOUSEKEEPING GENES; RELATIVE QUANTIFICATION; MICROARRAY ANALYSIS; PCR ANALYSIS; EXPRESSION; NORMALIZATION; CHICKENS; PROTOPORPHYRIN; PROTEINS	Ten reference genes were investigated for normalization of gene expression data in the shell gland of laying hens. Analyses performed with geNorm revealed that hypoxanthine phosphoribosyltransferase 1 (HPRT1) and hydroxymethylbilane synthase (HMBS) were the two most stable reference genes in response to post-oviposition time alone (POT) or with nicarbazin treatment (POT+N) of laying hens. NormFinder analyses showed that the two most stable reference genes in response to POT and POT+N were 18S ribosomal RNA (18S rRNA), ribosomal protein L4 (RPL4) and HMBS, RPL4, respectively. BestKeeper analyses showed that 18S rRNA, RPL4 and HPRT1, HMBS were the two most stable reference genes for POT, and POT+N, respectively. Of the ten reference genes, all except B2M showed geNorm M <0.5, suggesting that they were stably expressed in the shell gland tissue. Consensus from these three programs suggested HPRT1 and HMBS could be used as the two most stable reference genes in the present study. Expression analyses of four candidate target genes with the two most and the two least stable genes showed that a combination of stable reference genes leads to more discriminable quantification of expression levels of target genes, while the least stable genes failed to do so. Therefore, HMBS and HPRT1 are recommended as the two most stable reference genes for the normalization of gene expression data at different stages of eggshell formation in brown-egg laying hens. Available statistical programs for reference gene ranking should include more robust analysis capability to analyse the gene expression data generated from factorial design experiments.	[Samiullah, Sami; Roberts, Juliet; Wu, Shu-Biao] Univ New England, Sch Environm & Rural Sci, Anim Sci, Armidale, NSW, Australia	University of New England	Wu, SB (corresponding author), Univ New England, Sch Environm & Rural Sci, Anim Sci, Armidale, NSW, Australia.	shubiao.wu@une.edu.au	Wu, Shu-Biao/R-5951-2019; KHAN, SAMIULLAH/O-3257-2015	Wu, Shu-Biao/0000-0002-1790-6015; KHAN, SAMIULLAH/0000-0002-0292-2979	Australian Egg Corporation Limited (AECL) [AECL1UN121]	Australian Egg Corporation Limited (AECL)(Australian Eggs)	This study was financially supported by Australian Egg Corporation Limited (AECL) under grant number AECL1UN121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2010, EFSA J, V8, P1551; [Anonymous], 2006, BIORAD APPL USER GUI; ARIAS JL, 1993, INT REV CYTOL, V145, P217, DOI 10.1016/S0074-7696(08)60428-3; Beekman L, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-5; Bilandzic N, 2013, FOOD ADDIT CONTAM B, V6, P90, DOI 10.1080/19393210.2012.727474; Cinar Mehmet Ulas, 2013, BMC Res Notes, V6, P56, DOI 10.1186/1756-0500-6-56; Cinar Mehmet Ulas, 2012, BMC Res Notes, V5, P107, DOI 10.1186/1756-0500-5-107; Dalgaard TS, 2015, VET IMMUNOL IMMUNOP, V164, P79, DOI 10.1016/j.vetimm.2015.01.003; Day AL, 1998, ARCH BIOCHEM BIOPHYS, V359, P160, DOI 10.1006/abbi.1998.0910; Dorne JLCM, 2013, TOXICOL APPL PHARM, V270, P196, DOI 10.1016/j.taap.2010.12.014; Dunn IC, 2009, GEN COMP ENDOCR, V163, P225, DOI 10.1016/j.ygcen.2009.03.006; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; HARBIN BM, 1985, BIOCHEMISTRY-US, V24, P366, DOI 10.1021/bi00323a019; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HUGHES BL, 1991, POULTRY SCI, V70, P476, DOI 10.3382/ps.0700476; Ji H, 2013, ASIAN AUSTRAL J ANIM, V26, P423, DOI 10.5713/ajas.2012.12417; Johnson AL, 2015, REPROD FEMALE; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Kuchipudi SV, 2014, VET RES, V45, DOI 10.1186/s13567-014-0118-3; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; LEESON S, 1989, CAN J ANIM SCI, V69, P757, DOI 10.4141/cjas89-088; Li GQ, 2013, POULTRY SCI, V92, P3120, DOI 10.3382/ps.2013-03484; Liu ZG, 2013, ASIAN AUSTRAL J ANIM, V26, P609, DOI 10.5713/ajas.2012.12398; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; MELEK O, 1973, BRIT POULTRY SCI, V14, P493, DOI 10.1080/00071667308416056; Nascimento CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127935; NYS Y, 1986, BRIT POULTRY SCI, V27, P253, DOI 10.1080/00071668608416878; Pereira-Fantini PM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26476; Petriccione M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16961; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radonic A, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-7; Samiullah S, 2013, POULTRY SCI, V92, P2783, DOI 10.3382/ps.2013-03051; Shivhare R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23036; Song G, 2011, BIOL REPROD, V85, P306, DOI 10.1095/biolreprod.110.089227; Svingen T, 2015, PEERJ, V3, DOI 10.7717/peerj.855; Takahashi S, 1998, BLOOD, V92, P3436, DOI 10.1182/blood.V92.9.3436.421k13_3436_3444; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Uddin Muhammad Jasim, 2011, BMC Res Notes, V4, P441, DOI 10.1186/1756-0500-4-441; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wellman-Labadie O, 2007, WORLD POULTRY SCI J, V63, P421, DOI 10.1017/S0043933907001559; Wu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19748; Yang Falong, 2013, BMC Res Notes, V6, P402, DOI 10.1186/1756-0500-6-402; Yin RF, 2011, BIOCHEM BIOPH RES CO, V413, P537, DOI 10.1016/j.bbrc.2011.08.131	47	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180432	10.1371/journal.pone.0180432	http://dx.doi.org/10.1371/journal.pone.0180432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671969	gold, Green Published, Green Submitted			2022-12-27	WOS:000405268500054
J	Zhang, ST; Chen, C; Xie, TN; Ye, SD				Zhang, Shutao; Chen, Chun; Xie, Tingna; Ye, Sudan			Identification and validation of reference genes for qRT-PCR studies of the obligate aphid pathogenic fungus Pandora neoaphidis during different developmental stages	PLOS ONE			English	Article							TIME RT-PCR; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; NORMALIZATION; SELECTION; QPCR	The selection of stable reference genes is a critical step for the accurate quantification of gene expression. To identify and validate the reference genes in Pandora neoaphidis-an obligate aphid pathogenic fungus D the expression of 13classical candidate reference genes were evaluated by quantitative real-time reverse transcriptase polymerase chain reaction(qPCR) at four developmental stages (conidia, conidia with germ tubes, short hyphae and elongated hyphae). Four statistical algorithms, including geNorm, NormFinder, BestKeeper and Delta Ct method were used to rank putative reference genes according to their expression stability and indicate the best reference gene or combination of reference genes for accurate normalization. The analysis of comprehensive ranking revealed that ACT1and 18Swas the most stably expressed genes throughout the developmental stages. To further validate the suitability of the reference genes identified in this study, the expression of cell division control protein 25 (CDC25) and Chitinase 1(CHI1) genes were used to further confirm the validated candidate reference genes. Our study presented the first systematic study of reference gene(s) selection for P. neoaphidis study and provided guidelines to obtain more accurate qPCR results for future developmental efforts.	[Zhang, Shutao; Chen, Chun; Xie, Tingna] China Jiliang Univ, Zhejiang Prov Key Lab Biometrol & Inspect Quarant, Hangzhou, Zhejiang, Peoples R China; [Ye, Sudan] Zhejiang Econ & Trade Polytech, Hangzhou, Zhejiang, Peoples R China	China Jiliang University	Chen, C (corresponding author), China Jiliang Univ, Zhejiang Prov Key Lab Biometrol & Inspect Quarant, Hangzhou, Zhejiang, Peoples R China.	aspring@cjlu.edu.cn	Chen, Chun/ABG-4161-2021	Chen, Chun/0000-0002-3053-1019; Ye, Sudan/0000-0002-0587-1812	Natural Science Foundation of China [31461143030]; Science and Technology Planning Project of Zhejiang Province [2013C37087]; Zhejiang Natural Science Foundation [LR12C03001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Zhejiang Province; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This study was funded by the Natural Science Foundation of China (31461143030), the Science and Technology Planning Project of Zhejiang Province (2013C37087) and the Zhejiang Natural Science Foundation (LR12C03001).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38; BEAUVAIS A, 1988, J INVERTEBR PATHOL, V51, P175, DOI 10.1016/0022-2011(88)90079-1; Botstein D., 1997, MOL CELLULAR BIOL YE, P1; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chen C, 2006, ENVIRON MICROBIOL, V8, P69, DOI 10.1111/j.1462-2920.2005.00869.x; Chen C, 2016, BRAZ J MICROBIOL, V47, P259, DOI 10.1016/j.bjm.2015.11.031; Chen C, 2014, BIOL CONTROL, V69, P52, DOI 10.1016/j.biocontrol.2013.10.016; de Almeida MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-73; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Fang WG, 2006, MYCOL RES, V110, P1165, DOI 10.1016/j.mycres.2006.04.014; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Grell MN, 2011, FUNGAL GENET BIOL, V48, P343, DOI 10.1016/j.fgb.2010.12.003; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; HUMBER RA, 1989, MYCOTAXON, V34, P441; Jensen AB, 2008, AGR FOREST ENTOMOL, V10, P279, DOI 10.1111/j.1461-9563.2008.00383.x; Jin K, 2010, APPL ENVIRON MICROB, V76, P254, DOI 10.1128/AEM.00882-09; Kianianmomeni A, 2013, MOL BIOL REP, V40, P6691, DOI 10.1007/s11033-013-2784-z; Lian TT, 2014, FEMS MICROBIOL LETT, V356, P97, DOI 10.1111/1574-6968.12492; Licht HHD, 2016, ADV GENET, V94, P41, DOI 10.1016/bs.adgen.2016.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llanos A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1224-y; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Morgan D, 2007, CELL CYCLE PRINCIPLE, P96; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; PAPIEROK B, 1989, ANN ENTOMOL FENN, V55, P63; Pell J. K., 2001, Fungi as biocontrol agents: progress, problems and potential, P71, DOI 10.1079/9780851993560.0071; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-648; Rocha-Martins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043028; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; TANG QY, 2002, DPS DATA PROCESSING, P648; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieira A, 2011, FUNGAL BIOL-UK, V115, P891, DOI 10.1016/j.funbio.2011.07.002; WILDING N, 1980, T BRIT MYCOL SOC, V75, P297, DOI 10.1016/S0007-1536(80)80092-1; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yin RF, 2011, BIOCHEM BIOPH RES CO, V413, P537, DOI 10.1016/j.bbrc.2011.08.131	41	1	2	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179930	10.1371/journal.pone.0179930	http://dx.doi.org/10.1371/journal.pone.0179930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672012	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500009
J	Dutta, P; Li, WX				Dutta, Pranabananda; Li, Willis X.			The SERTAD protein Taranis plays a role in Polycomb-mediated gene repression	PLOS ONE			English	Article							GROUP RESPONSE ELEMENTS; TRITHORAX GROUP GENES; DROSOPHILA-MELANOGASTER; BITHORAX COMPLEX; ENGRAILED EXPRESSION; MOLECULAR-GENETICS; EMBRYONIC PATTERN; BINDING-PROTEIN; IMAGINAL-DISCS; CELL IDENTITY	The Polycomb group (PcG) proteins have been implicated in epigenetic transcriptional repression in development, stem cell maintenance and in cancer. The chromodomain protein Polycomb (Pc) is a key member of the PcG. Pc binds to the histone mark, trimethylated histone 3 lysine 27 (H3K27me3), to initiate transcriptional repression. How PcG proteins are recruited to target loci is not fully understood. Here we show that the Drosophila SERTA domain protein Taranis (Tara) is involved in transcriptional regulation of Pc target genes. Embryos lacking Tara exhibit a partial homeotic transformation of cuticular the segments, a phenotype associated with the loss of Pc function. Moreover, Drosophila embryos homozygous for a tara hypomorphic allele also misexpress engrailed, a Pc-regulated gene, and this phenotype is associated with the loss of Pc binding to the cis response element in the engrailed enhancer. In relation to that, Pc recruitment is reduced on the salivary gland polytene chromosomes and specifically at the engrailed locus. These results suggest that Tara might be required for positioning Pc to a subset of its target genes.	[Dutta, Pranabananda; Li, Willis X.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Dutta, Pranabananda; Li, Willis X.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Dutta, Pranabananda] Charles R Drew Univ Med & Sci, Div Canc Res & Training, 1621 E 120th St, Los Angeles, CA 90059 USA	University of California System; University of California San Diego; University of Rochester; Charles R. Drew University of Medicine & Science	Dutta, P (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Dutta, P (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.; Dutta, P (corresponding author), Charles R Drew Univ Med & Sci, Div Canc Res & Training, 1621 E 120th St, Los Angeles, CA 90059 USA.	pranabandutta@cdrewu.edu	Li, Willis/ABC-5695-2020; Li, Willis X/AAL-7212-2020	Li, Willis/0000-0001-9041-7341; Li, Willis X/0000-0001-9041-7341	NIH [5R01CA131326-04]; University of California San Diego Cancer Research Coordinating Committee; National Institutes of Health; University of California Cancer Research Coordinating Committee; NATIONAL CANCER INSTITUTE [R03CA212727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Cancer Research Coordinating Committee; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by previous NIH 5R01CA131326-04 and by University of California San Diego Cancer Research Coordinating Committee.; We Thank Dr. G. Cavalli (CNRS, France) for kindly providing Fab-X flies, Dr. Judith Kassis (NIH, USA) for the P(EN1) plasmid, Dr. Dirk Bohmann (Rochester, NY) for Sgs3-Gal4 flies and various other fly strains and reagents, Dr. Henri-Marc Bourbon (Toulouse Cedex, France) for providing the pUbi-TaraB plasmid. We thank the Drosophila Stock Center (Bloomington, IN) and the Vienna Drosophila Resource Center (Vienna, Austria) for various strains, the Developmental Studies Hybridoma Bank for various antibodies. The work is supported, in part, by grants from the National Institutes of Health and the University of California Cancer Research Coordinating Committee.	Bajusz I, 2001, GENETICS, V159, P1135; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Calgaro S, 2002, GENETICS, V160, P547; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CASTELLIGAIR JE, 1990, GENETICS, V126, P177; Chanas G, 2004, DEV BIOL, V272, P522, DOI 10.1016/j.ydbio.2004.05.020; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; DeVido SK, 2008, DEVELOPMENT, V135, P669, DOI 10.1242/dev.014779; DINARDO S, 1985, CELL, V43, P59, DOI 10.1016/0092-8674(85)90012-1; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Gildea JJ, 2000, GENETICS, V156, P645; GONZALEZGAITAN MA, 1990, GENETICS, V126, P139; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Hagstrom K, 1997, GENETICS, V146, P1365; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; KARCH F, 1990, GENE DEV, V4, P1573, DOI 10.1101/gad.4.9.1573; KARR TL, 1989, DEVELOPMENT, V105, P605; KASSIS JA, 1994, GENETICS, V136, P1025; Kurzhals RL, 2008, DEV BIOL, V313, P293, DOI 10.1016/j.ydbio.2007.10.025; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; LEWIS EB, 1955, AM NAT, V89, P73, DOI 10.1086/281867; Lim SJ, 2014, RNA BIOL, V11, P1171, DOI 10.4161/rna.34381; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Maeda RK, 2009, CURR TOP DEV BIOL, V88, P1, DOI 10.1016/S0070-2153(09)88001-0; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; MOAZED D, 1992, DEVELOPMENT, V116, P805; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Orsi GA, 2014, GENOME RES, V24, P809, DOI 10.1101/gr.163642.113; Paumard-Rigal S, 1998, DEV GENES EVOL, V208, P440, DOI 10.1007/s004270050201; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuster KJ, 2015, DEV CELL, V34, P119, DOI 10.1016/j.devcel.2015.04.017; SERRANO N, 1995, DEVELOPMENT, V121, P1691; SIMON J, 1992, DEVELOPMENT, V114, P493; SOTO MC, 1995, GENETICS, V140, P231; Stepanik VA, 2012, DEV BIOL, V364, P249, DOI 10.1016/j.ydbio.2011.12.007; Takashi S, 1985, DEV BIOL, V110, P53; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104	51	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e018002	10.1371/journal.pone.0180026	http://dx.doi.org/10.1371/journal.pone.0180026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665982	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700056
J	Li, SS; Jin, XQ; Wu, H; Wang, Y; Li, XQ; Guo, YX; Liang, SY				Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan			HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6	PLOS ONE			English	Article							TRANS-RETINOIC ACID; SELF-RENEWAL; CYCLE ARREST; RESISTANCE; GENE; IDENTIFICATION; PROLIFERATION; MECHANISMS	All-trans retinoic acid (ATRA) induces complete remission in almost all patients with acute promyelocytic leukemia (APL) via its ability to induce the in vivo differentiation of APL blasts. However, prolonged ATRA treatment can result in drug resistance. In previous studies, we generated a multi-drug-resistant HL60/ATRA cell line and found it to contain a new drug resistance-related gene segment, HA117. In this study, we demonstrate that ATRA induces multi-drug-resistant subpopulations of HL60 cells with a putative stem-like signature by up-regulating the expression of the new gene segment HA117. Western blot analysis and quantitative real-time PCR demonstrated that HA117 causes alternative splicing of regulator of G-protein signaling 6 (RGS6) and down-regulation of the expression of the GGL domain of RGS6, which plays an important role in DNA methyltransferase 1 (DNMT1) degradation. Moreover, DNMT1 expression was increased in multi-drug resistance HL60/ATRA cells. Knockdown of HA117 restored expression of the GGL domain and blocked DNMT1 expression. Moreover, resistant cells displayed a putative stem-like signature with increased expression of cancer steam cell markers CD133 and CD123. The stem cell marker, Nanog, was significantly up-regulated. In conclusion, our study shows that HA117 potentially promotes the stem-like signature of the HL60/ATRA cell line by inhibiting by the ubiquitination and degradation of DNMT1 and by down-regulating the expression of the GGL domain of RGS6. These results throw light on the cellular events associated with the ATRA-induced multi-drug resistance phenotype in acute leukemia.	[Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan] Chongqing Med Univ, Dept Gastrointestinal Surg & Neonatal Surg, Key Lab Child Dev & Disorders, Childrens Hosp,Minist Educ, Chongqing, Peoples R China; [Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan] Chongqing Med Univ, China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China; [Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan] Chongqing Med Univ, Chongqing Key Lab Pediat, Chongqing, Peoples R China; [Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan] Chongqing Med Univ, Dept Pediat, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Jin, XQ (corresponding author), Chongqing Med Univ, Dept Gastrointestinal Surg & Neonatal Surg, Key Lab Child Dev & Disorders, Childrens Hosp,Minist Educ, Chongqing, Peoples R China.; Jin, XQ (corresponding author), Chongqing Med Univ, China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China.; Jin, XQ (corresponding author), Chongqing Med Univ, Chongqing Key Lab Pediat, Chongqing, Peoples R China.; Jin, XQ (corresponding author), Chongqing Med Univ, Dept Pediat, Chongqing, Peoples R China.	etzhl@163.com		Li, Shuangshuang/0000-0002-5885-3706	National Natural Science Foundation of China [NSFC 81370474]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	JXQ received The National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (NSFC 81370474) for this work. This found had roles in study design, reagent and matieral providing, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2000, ANNU REV BIOCHEM, V69, P33; [Anonymous], 2000, MED PEDIATR ONCOL, V35, P6; [Anonymous], 2014, J PEDIATRIC HEMATOLO, V36, P6; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Cao J, 2013, LEUKEMIA RES, V37, P1170, DOI 10.1016/j.leukres.2013.04.021; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; DELVA L, 1993, BLOOD, V82, P2175; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Dohlma HG, 1997, J BIOL CHEM, V272, P4; Fung TK, 2013, ONCOTARGET, V4, P1128, DOI 10.18632/oncotarget.1244; Gallagher RE, 2002, LEUKEMIA, V16, P1940, DOI 10.1038/sj.leu.2402719; Guo YX, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-63; Han JH, 2012, CANCER LETT, V321, P80, DOI 10.1016/j.canlet.2012.02.021; Harding PL, MOL THERAPY, V15, P157; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Hossain MM, 2012, NEUROCHEM INT, V61, P1102, DOI 10.1016/j.neuint.2012.08.002; Huang JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-839; Li JW, 2015, BRIEF BIOINFORM, V16, P806, DOI 10.1093/bib/bbu048; Liu CC, 2015, INT J CANCER, V136, P547, DOI 10.1002/ijc.29033; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Martelli AM, 2003, LEUKEMIA, V17, P1794, DOI 10.1038/sj.leu.2403044; Pan XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105381; Pathania R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7910; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Shi J, 2008, CANCER LETT, V270, P19, DOI 10.1016/j.canlet.2008.04.048; Siddikuzzaman, 2011, IMMUNOPHARM IMMUNOT, V33, P241, DOI 10.3109/08923973.2010.521507; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Tomita A, 2013, INT J HEMATOL, V97, P717, DOI 10.1007/s12185-013-1354-4; Trowbridge JJ, 2012, GENE DEV, V26, P344, DOI 10.1101/gad.184341.111; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhang W, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/417432; Zheng GH, 2009, LEUKEMIA RES, V33, P1120, DOI 10.1016/j.leukres.2008.11.018	36	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180142	10.1371/journal.pone.0180142	http://dx.doi.org/10.1371/journal.pone.0180142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665981	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608700064
J	Chiu, WT; Hong, CT; Chi, NF; Hu, CJ; Hu, HH; Chan, L				Chiu, Wei Ting; Hong, Chien Tai; Chi, Nai Fang; Hu, Chaur Jong; Hu, Han Hwa; Chan, Lung			The risk of intravenous thrombolysis-induced intracranial hemorrhage in Taiwanese patients with unruptured intracranial aneurysm	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; CONTROLLED-TRIAL; EARLY MANAGEMENT; ECASS II; THERAPY; RUPTURE; TRANSFORMATION; ASSOCIATION; PREVALENCE	Background The presence of an intracranial aneurysm is contraindicated to recombinant tissue plasminogen activator (r-tPA) treatment for acute ischemic stroke. However, it is difficult to exclude asymptomatic intracranial aneurysms by using conventional, noncontrast head computed tomography (CT), which is the only neuroimaging suggested before r-tPA. Recent case reports and series have shown that administering r-tPA to patients with a pre-existing aneurysm does not increase the bleeding risk. However, Asians are known to have a relatively higher bleeding risk, and little evidence is available regarding the risk of using r-tPA on Asian patients with intracranial aneurysms. Methods Medical records from the Shuang Ho hospital stroke registration between July 2010 and December 2014 were retrospectively reviewed, and 144 patients received r-tPA. Unruptured intracranial aneurysms were detected using CT, or magnetic resonance or conventional angiography after r-tPA. The primary and secondary outcomes were the difference in overall intracranial hemorrhage (ICH) and symptomatic ICH after r-tPA. The differences were analyzed using Fisher's exact or Mann Whitney U tests, and p < 0.05 was defined as the statistical significance. Results A total of 144 patients were reviewed, and incidental unruptured intracranial aneurysms were found in 11 of them (7.6%). No significant difference was observed in baseline demographic data between the aneurysm and nonaneurysm groups. Among patients with an unruptured aneurysm, two had giant aneurysms (7.7 and 7.4 mm, respectively). The bleeding risk was not significant different between aneurysm group (2 out of 11, 18%) with nonaneurysm group (7 out of 133, 5.3%) (p = 0.14). None of the patients with an unruptured aneurysm had symptomatic ICH, whereas one patient without an aneurysm exhibited symptomatic ICH. Conclusions The presence of an unruptured intracranial aneurysm did not significantly increase the risk of overall and symptomatic ICH in Taiwanese patients after they received r-tPA.	[Chiu, Wei Ting; Hong, Chien Tai; Chi, Nai Fang; Hu, Chaur Jong; Hu, Han Hwa; Chan, Lung] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Chiu, Wei Ting; Hong, Chien Tai; Chi, Nai Fang; Hu, Chaur Jong; Hu, Han Hwa; Chan, Lung] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Chiu, Wei Ting; Hong, Chien Tai; Chi, Nai Fang; Hu, Chaur Jong; Hu, Han Hwa; Chan, Lung] Taipei Med Univ, Shuang Ho Hosp, Stroke Ctr, New Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Chan, L (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan.; Chan, L (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan.; Chan, L (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Stroke Ctr, New Taipei, Taiwan.	cjustinmd@gmail.com	Chan, Lung/AAI-6349-2020; Chan, Lung/AAM-3231-2021; Chi, Nai-Fang/G-3561-2016; Chi, Nai-Fang/E-2851-2017	Chan, Lung/0000-0001-5795-4460; Chi, Nai-Fang/0000-0002-2204-4923; Chi, Nai-Fang/0000-0002-2204-4923				Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; Almeida A, 2014, CASE REPORTS NEUROLO, V2014; Chao AC, 2010, STROKE, V41, P885, DOI 10.1161/STROKEAHA.109.575605; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; Derex L, 2008, J NEUROL NEUROSUR PS, V79, P1093, DOI 10.1136/jnnp.2007.133371; Dharmasaroja PA, 2013, J STROKE CEREBROVASC, V22, P227, DOI 10.1016/j.jstrokecerebrovasdis.2011.08.001; Ding JY, 2016, AM J EMERG MED, V34, P636, DOI 10.1016/j.ajem.2015.12.025; Edwards NJ, 2012, STROKE, V43, P412, DOI 10.1161/STROKEAHA.111.634147; Ganesalingam J, 2013, JRSM CARDIOVASC DIS, V2, DOI 10.1177/2048004013478808; Garibaldi AA, 2006, J ENDOVASC THER, V13, P111, DOI 10.1583/05-1551.1; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Haji F, 2014, CAN J NEUROL SCI, V41, P95, DOI 10.1017/S0317167100016358; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kim JE, 2012, J BREAST CANCER, V15, P197, DOI 10.4048/jbc.2012.15.2.197; Lansberg MG, 2007, CEREBROVASC DIS, V24, P1, DOI 10.1159/000103110; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Mehta RH, 2014, STROKE, V45, P2263, DOI 10.1161/STROKEAHA.114.005019; Mowla A, 2015, INT J STROKE, V10, P113, DOI 10.1111/ijs.12616; Rammos SK, 2012, NEUROSURGERY, V70, pE1603, DOI 10.1227/NEU.0b013e31822e1097; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Saver JL, 2007, STROKE, V38, P2279, DOI 10.1161/STROKEAHA.107.487009; Sheth KN, 2012, NEUROCRIT CARE, V17, P199, DOI 10.1007/s12028-012-9734-9; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wang Hsin-Fan, 2013, Acta Neurol Taiwan, V22, P43; Xu M, 2014, CNS NEUROSCI THER, V20, P473, DOI 10.1111/cns.12254; Yoneda Y, 2009, CASE REP NEUROL, V1, P20, DOI 10.1159/000224714; Zaldivar-Jolissaint JF, 2015, J STROKE CEREBROVASC, V24, pE63, DOI 10.1016/j.jstrokecerebrovasdis.2014.10.004	28	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180021	10.1371/journal.pone.0180021	http://dx.doi.org/10.1371/journal.pone.0180021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662192	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300087
J	Jiang, HC; Su, M; Kui, LY; Huang, HL; Qiu, LJ; Li, L; Ma, J; Du, TY; Fan, M; Sun, QM; Liu, XM				Jiang, Hongchao; Su, Min; Kui, Liyue; Huang, Hailin; Qiu, Lijuan; Li, Li; Ma, Jing; Du, Tingyi; Fan, Mao; Sun, Qiangming; Liu, Xiaomei			Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012-2015	PLOS ONE			English	Article							CONJUGATE VACCINE; EPIDEMIOLOGY; CHILDHOOD; SURVEILLANCE; TURKEY; PCR	Acute bacterial meningitis is still considered one of the most dangerous infectious diseases in children. To investigate the prevalence and antibiotic resistance profiles of cerebrospinal fluid (CSF) pathogens in children with acute bacterial meningitis in Southwest China, CSF samples from 179 meningitis patients ( 3 days to 12 years old) with positive culture results were collected from 2012 to 2015. Isolated pathogens were identified using the Vitek-32 system. Gram stain results were used to guide subcultures and susceptibility testing. The antimicrobial susceptibility of isolates was determined using the disc diffusion method. Of the isolates, 50.8% were Gram-positive bacteria, and 49.2% were Gram-negative bacteria. The most prevalent pathogens were E. coli (28.5%), Streptococcus pneumoniae (17.8%), Staphylococcus epidermidis (10.0%), Haemophilus influenzae type b (9.5%), and group B streptococcus (7.2%). In young infants aged <= 3 months, E. coli was the organism most frequently isolated from CSF (39/76; 51.3%), followed by group B streptococcus (13/76; 17.1%) and Streptococcus pneumoniae (8/76; 10.5%). However, in young infants aged >3 months, the most frequently isolated organism was Streptococcus pneumoniae (24/103; 23.3%), followed by Staphylococcus epidermidis (18/103; 17.5%) and Haemophilus influenzae type b (16/103; 15.5%). Antimicrobial susceptibility tests indicated that for E. coli isolates, the susceptibility rates to aminoglycosides ranged from 56.8% to 100.0%, among them, amikacin was identified as the most effective against E. coli. As for cephalosporins, the susceptibility rates ranged from 29.4% to 78.4%, and cefoxitin was identified as the most effective cephalosporin. In addition, the susceptibility rates of piperacillin/tazobactam and imipenem against E. coli were 86.3% and 100%. Meanwhile, the susceptibility rates of Streptococcus pneumoniae isolates to penicillin G, erythromycin, chloramphenicol, ceftriaxone and tetracycline were 68.8%, 0.0%, 87.5%, 81.3% and 0.0%, respectively. Gentamycin, ofloxacin, linezolid and vancomycin were identified as the most effective antibiotics for Streptococcus pneumoniae, each with susceptibility rates of 100%. It was notable that other emerging pathogens, such as Listeria monocytogenes and group D streptococcus, cannot be underestimated in meningitis.	[Jiang, Hongchao; Su, Min; Kui, Liyue; Huang, Hailin; Qiu, Lijuan; Li, Li; Ma, Jing; Du, Tingyi; Fan, Mao; Liu, Xiaomei] Kunming Med Univ, Affiliated Childrens Hosp, Kunming, Peoples R China; [Jiang, Hongchao; Qiu, Lijuan; Sun, Qiangming] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Jiang, Hongchao; Qiu, Lijuan; Sun, Qiangming] Peking Union Med Coll, Kunming, Peoples R China; [Sun, Qiangming] Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China	Kunming Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases	Liu, XM (corresponding author), Kunming Med Univ, Affiliated Childrens Hosp, Kunming, Peoples R China.; Sun, QM (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China.; Sun, QM (corresponding author), Peking Union Med Coll, Kunming, Peoples R China.; Sun, QM (corresponding author), Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China.	msun08@yahoo.com; liuxiaomei2@yahoo.com	Sun, Qiangming/GYE-2002-2022		National Natural Science Foundation of China [81171946]; Foundation of the CAMS Initiative for Innovative Medicine (CAMS-I2M) [2016-I2M-1-19]; Natural Science Foundation of Yunnan Province [2012FB188, 2016FA029]; Yunnan Science and Technology Department and Kunming Medical University [2014FZ058]; Training Project for the Medical Science and Technology Experts in Kunming City [2016-SW-51]; Foundation of the Yunnan Medical Science and Technology [2016NS124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of the CAMS Initiative for Innovative Medicine (CAMS-I2M); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Yunnan Science and Technology Department and Kunming Medical University; Training Project for the Medical Science and Technology Experts in Kunming City; Foundation of the Yunnan Medical Science and Technology	Our research was supported by the National Natural Science Foundation of China (grant no. 81171946), the Foundation of the CAMS Initiative for Innovative Medicine (CAMS-I2M) (grant no. 2016-I2M-1-19), the Natural ScienceFoundation of Yunnan Province (grant no. 2012FB188 and 2016FA029), the Joint Fund of the Yunnan Science and Technology Department and Kunming Medical University (grant no.2014FZ058), the Training Project for the Medical Science and Technology Experts in Kunming City (grant no. 2016-SW-51), and Foundation of the Yunnan Medical Science and Technology (grant no. 2016NS124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdinia B, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.17616; Al Jarousha AM, 2014, IRAN J PUBLIC HEALTH, V43, P1176; Ba O, 2010, AM J TROP MED HYG, V83, P1330, DOI 10.4269/ajtmh.2010.10-0346; Briand C, 2016, OUTCOMES BACTERIAL M; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Castelblanco RL, 2014, LANCET INFECT DIS, V14, P813, DOI 10.1016/S1473-3099(14)70805-9; de Souza SF, 2012, REV SOC BRAS MED TRO, V45, P323, DOI 10.1590/S0037-86822012000300009; Elenga N, 2015, MED MALADIES INFECT, V45, P441, DOI 10.1016/j.medmal.2015.10.003; Furyk JS, 2011, TROP MED INT HEALTH, V16, P672, DOI 10.1111/j.1365-3156.2011.02750.x; Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7; Gervaix A, 2012, PEDIATR INFECT DIS J, V31, P1084, DOI 10.1097/INF.0b013e318260552d; Gounder PP, 2015, J INFECTION, V71, P179, DOI 10.1016/j.jinf.2015.04.001; Gonzalez-Granado LI, 2010, LANCET INFECT DIS, V10, P596, DOI 10.1016/S1473-3099(10)70184-5; Iregbu Kenneth C, 2015, Niger Med J, V56, P297, DOI 10.4103/0300-1652.169749; Juganariu G, 2012, MED-SURG J, V116, P722; Karou SD, 2012, ASIAN PAC J TROP MED, V5, P848, DOI 10.1016/S1995-7645(12)60158-8; Kilic A, 2006, J CLIN MICROBIOL, V44, P222, DOI 10.1128/JCM.44.1.222-224.2006; Kuti BP, 2015, J NEUROSCI RURAL PRA, V6, P549, DOI 10.4103/0976-3147.165424; Levy C, 2011, PEDIATR INFECT DIS J, V30, P168, DOI 10.1097/INF.0b013e3181f4cf69; Madhi SA, 2015, J PEDIAT-BRAZIL, V91, P108, DOI 10.1016/j.jped.2014.11.001; McCormick DW, 2013, PEDIATR INFECT DIS J, V32, pE54, DOI 10.1097/INF.0b013e31826faf5a; Mebonia N, GEORGIAN MED NEWS, V2010, P44; Molyneux EM, 2015, CURR OPIN INFECT DIS, V28, P215, DOI 10.1097/QCO.0000000000000162; Namani S, 2012, J CHILD NEUROL, V27, P46, DOI 10.1177/0883073811413280; Nickerson JW, 2013, MMWR MORBIDITY MORTA, V64; Nwadioha S I, 2013, Niger Postgrad Med J, V20, P9; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; Papavasileiou K, 2011, MOL DIAGN THER, V15, P109, DOI 10.2165/11587690-000000000-00000; Pelkonen T, 2008, SCAND J INFECT DIS, V40, P859, DOI 10.1080/00365540802262091; Piet JR, 2014, J INFECT DIS, V209, P1781, DOI 10.1093/infdis/jit818; Porobic-Jahic Humera, 2013, Med Arch, V67, P13, DOI 10.5455/medarh.2013.67.13-16; Sadarangani M, 2011, ADV EXP MED BIOL, V719, P185, DOI 10.1007/978-1-4614-0204-6_16; Shrestha RG, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0416-6; Snaebjarnardottir K, 2013, SCAND J INFECT DIS, V45, P819, DOI 10.3109/00365548.2013.817680; Toprak D, 2014, PEDIATR INFECT DIS J, V33, P1087, DOI 10.1097/INF.0000000000000378	35	21	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e180161	10.1371/journal.pone.0180161	http://dx.doi.org/10.1371/journal.pone.0180161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662145	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300116
J	Marquez-Lona, EM; Torres-Machorro, AL; Gonzales, FR; Pillus, L; Patrick, GN				Marquez-Lona, Esther Magdalena; Torres-Machorro, Ana Lilia; Gonzales, Frankie R.; Pillus, Lorraine; Patrick, Gentry N.			Phosphorylation of the 19S regulatory particle ATPase subunit, Rpt6, modifies susceptibility to proteotoxic stress and protein aggregation	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; SACCHAROMYCES-CEREVISIAE; 26S PROTEASOME; YEAST; DISEASE; PROTEOLYSIS; MUTANTS; MODEL; INHIBITION; GENES	The ubiquitin proteasome system (UPS) is a highly conserved and tightly regulated biochemical pathway that degrades the majority of proteins in eukaryotic cells. Importantly, the UPS is responsible for counteracting altered protein homeostasis induced by a variety of proteotoxic stresses. We previously reported that Rpt6, the ATPase subunit of the 19S regulatory particle (RP) of the 26S proteasome, is phosphorylated in mammalian neurons at serine 120 in response to neuronal activity. Furthermore, we found that Rpt6 S120 phosphorylation, which regulates the activity and distribution of proteasomes in neurons, is relevant for proteasome-dependent synaptic remodeling and function. To better understand the role of proteasome phosphorylation, we have constructed models of altered Rpt6 phosphorylation in S. cerevisiae by introducing chromosomal point mutations that prevent or mimic phosphorylation at the conserved serine (S119). We find that mutants which prevent Rpt6 phosphorylation at this site (rpt6-S119A), had increased susceptibility to proteotoxic stress, displayed abnormal morphology and had reduced proteasome activity. Since impaired proteasome function has been linked to the aggregation of toxic proteins including the Huntington's disease (HD) related huntingtin (Htt) protein with expanded polyglutamine repeats, we evaluated the extent of Htt aggregation in our phospho-dead (rpt6-S119A) and phospho-mimetic (rpt6-S119D) mutants. We showed Htt103Q aggregate size to be significantly larger in rpt6-S119A mutants compared to wild-type or rpt6-S119D strains. Furthermore, we observed that phosphorylation of endogenous Rpt6 at S119 is increased in response to various stress conditions. Together, these data suggest that Rpt6 phosphorylation at S119 may play an important function in proteasome-dependent relief of proteotoxic stress that can be critical in protein aggregation pathologies.	[Marquez-Lona, Esther Magdalena; Gonzales, Frankie R.; Patrick, Gentry N.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Torres-Machorro, Ana Lilia; Pillus, Lorraine] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA; [Torres-Machorro, Ana Lilia; Pillus, Lorraine] Univ Calif San Diego, Moores Canc Ctr, Div Biol Sci, La Jolla, CA 92093 USA; [Marquez-Lona, Esther Magdalena] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Torres-Machorro, Ana Lilia] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, CONACYT, Mexico City, DF, Mexico	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Tennessee System; University of Tennessee Health Science Center	Patrick, GN (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	gpatrick@ucsd.edu	Torres-Machorro, Ana Lilia/GPX-8416-2022; Torres-Machorro, Ana Lilia/ABC-4610-2021	Torres-Machorro, Ana Lilia/0000-0003-3100-6897	National Institutes of Health [NS060847, GM090177]; Center for Systems Biology [P50-GM085764]; University of California Institute for Mexico; United States (UCMEXUS); National Council of Science and Technology of Mexico (CONACYT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Systems Biology; University of California Institute for Mexico; United States (UCMEXUS); National Council of Science and Technology of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NS060847 to GNP and GM090177 to LP) and the Center for Systems Biology (grant P50-GM085764 to GNP). We thank Chalongrat Noree for technical advice on microscopy. ALTM was supported by the University of California Institute for Mexico and the United States (UCMEXUS) and the National Council of Science and Technology of Mexico (CONACYT).	Adams J, 1999, CANCER RES, V59, P2615; Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; BOND JF, 1986, CELL, V44, P461, DOI 10.1016/0092-8674(86)90467-8; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Braun RJ, 2015, FRONT MOL NEUROSCI, V8, DOI [10.3389/fnmol.7015.00008, 10.3389/fnmol.2015.00008]; Chang CS, 2012, G3-GENES GENOM GENET, V2, P1223, DOI 10.1534/g3.112.003558; Chang CS, 2009, GENETICS, V183, P149, DOI 10.1534/genetics.109.103846; Chen QH, 2005, BIOGERONTOLOGY, V6, P1, DOI 10.1007/s10522-004-7379-6; Chouduri Aktar Uzzaman, 2008, BMC Biochemistry, V9, P20, DOI 10.1186/1471-2091-9-20; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Ciechanover A, 2009, BIOCHEM BIOPH RES CO, V387, P1, DOI 10.1016/j.bbrc.2009.06.065; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Dantuma NP, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00070, 10.3389/fnmol.2014.00070]; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Ehlinger A, 2013, STRUCTURE, V21, P753, DOI 10.1016/j.str.2013.02.021; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; ETLINGER JD, 1993, ENZYME PROTEIN, V47, P325, DOI 10.1159/000468690; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hieter P, 2014, GENETICS, V198, P443, DOI 10.1534/genetics.114.170217; Jana NR, 2012, NEUROCHEM INT, V60, P443, DOI 10.1016/j.neuint.2012.02.009; Jentsch S, 1992, Trends Cell Biol, V2, P98, DOI 10.1016/0962-8924(92)90013-D; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kikuchi J, 2010, PROTEOMICS, V10, P2769, DOI 10.1002/pmic.200900283; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kumeda SI, 1999, ANTICANCER RES, V19, P3961; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lin JT, 2013, MOL CELL BIOL, V33, P1073, DOI 10.1128/MCB.01434-12; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Machiels BM, 1997, CYTOMETRY, V28, P243; Mason RP, 2011, PRION, V5, P269, DOI [10.4161/pri.5.4.18005, 10.4161/pri.18005]; MATTHEWS W, 1989, P NATL ACAD SCI USA, V86, P2597, DOI 10.1073/pnas.86.8.2597; Mayer RJ, 2003, DRUG NEWS PERSPECT, V16, P103, DOI 10.1358/dnp.2003.16.2.829327; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Mitchell L, 2013, P NATL ACAD SCI USA, V110, pE1641, DOI 10.1073/pnas.1218515110; Moloney TC, 2014, CNS NEUROSCI THER, V20, P50, DOI 10.1111/cns.12200; Nijholt DAT, 2011, CURR MED CHEM, V18, P2459; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; Park S, 2013, NATURE, V497, P512, DOI 10.1038/nature12123; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Pereira C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/941232; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Rivett AJ, 2001, BIOCHIMIE, V83, P363; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; SAUER B, 1994, BIOTECHNIQUES, V16, P1086; SCHWARTZ AL, 1992, AM J RESP CELL MOL, V7, P463, DOI 10.1165/ajrcmb/7.5.463; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Sokolova V, 2015, SCI REP-UK, V5, DOI 10.1038/srep14909; Stolzing A, 2001, CLIN EXP DERMATOL, V26, P566, DOI 10.1046/j.1365-2230.2001.00867.x; Tanaka K, 2014, BBA-MOL CELL RES, V1843, P197, DOI 10.1016/j.bbamcr.2013.03.012; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wirz KTS, 2014, J ALZHEIMERS DIS, V38, P719, DOI 10.3233/JAD-130920; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; XU QL, 1995, MOL CELL BIOL, V15, P6025; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	89	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179893	10.1371/journal.pone.0179893	http://dx.doi.org/10.1371/journal.pone.0179893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662109	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300065
J	Sobalska-Kwapis, M; Suchanecka, A; Slomka, M; Siewierska-Gorska, A; Kepka, E; Strapagiel, D				Sobalska-Kwapis, Marta; Suchanecka, Aleksandra; Slomka, Marcin; Siewierska-Gorska, Anna; Kepka, Ewa; Strapagiel, Dominik			Genetic association of FTO/IRX region with obesity and overweight in the Polish population	PLOS ONE			English	Article							FTO RS9939609 POLYMORPHISM; BODY-MASS INDEX; FAT MASS; CHILDHOOD OBESITY; ENERGY-INTAKE; LIFE-COURSE; VARIANT; LOCI; METAANALYSIS; BMI	Background/Objectives Genome-wide association studies (GWAS) have identified many loci associated with body mass index (BMI) in many different populations. Variants in the FTO locus are reported to be one of the strongest genetic predictors of obesity. Recent publications pointed also to a topologically associated domain (TAD) which is identified as a novel region affecting BMI. The TAD area encompasses the IRXB cluster (IRX3, IRX5, IRX6), FTO and RPGRIP1L genes. Subjects/Methods In this study, we investigated the relationship between variation of the FTO and IRX genes and obesity in Poles. We presented a case-control association analysis (normal versus overweight and/or obesity group) of Polish adult individuals (N = 5418). We determined whether or not the chromosomal region 16: 53 500 000-55 500 000 contains polymorphic variants which are correlated with BMI in Polish population, including sex and age stratified analysis. Results The obtained results showed that the problem of weight-height abnormalities differently affects populations of Polish women and men (chi(2) = 187.1; p<0.0001). From 353 SNPs enrolled to this study, 86 were statistically significant (highest chi(2) = 15.72; p = 7.35E-05 observed for rs1558902). Linkage disequilibrium (LD) analysis revealed 61 blocks in the tested region of chromosome 16, with 24 SNPs located within the same block (block 8) of approximately 40 kb, in almost complete LD (vertical bar D'vertical bar>0.98, r(2)>0.80). We confirmed presence of the genetic susceptibility loci located in intron 1 of the FTO gene, which were correlated with BMI in our study group. For the first time, our analyses revealed strong association of FTO intronic variants (block 8) with overweight in group of men only. We have also identified association of the IRX region with overweight and/or obesity in Polish individuals. Conclusion Our study demonstrated how tested SNPs make differential contributions to obesity and overweight risk. We revealed sex dependent differences in the distribution of tested loci which are associated with BMI in the population of Poles.	[Sobalska-Kwapis, Marta; Slomka, Marcin; Strapagiel, Dominik] Univ Lodz, Dept Mol Biophys, Biobank Lab, Lodz, Poland; [Sobalska-Kwapis, Marta; Suchanecka, Aleksandra; Slomka, Marcin; Strapagiel, Dominik] BBMRI Pl Consortium, Lodz, Poland; [Siewierska-Gorska, Anna; Kepka, Ewa] Univ Lodz, Dept Mol Biophys, Lodz, Poland	University of Lodz; University of Lodz	Strapagiel, D (corresponding author), Univ Lodz, Dept Mol Biophys, Biobank Lab, Lodz, Poland.; Strapagiel, D (corresponding author), BBMRI Pl Consortium, Lodz, Poland.	dominik.strapagiel@biol.uni.lodz.pl	Suchanecka, Aleksandra/R-1892-2019; Strapagiel, Dominik/AAD-4351-2020; Suchanecka, Aleksandra/Q-2963-2017	Suchanecka, Aleksandra/0000-0002-7137-1429; Strapagiel, Dominik/0000-0001-9752-4270; Suchanecka, Aleksandra/0000-0002-7137-1429; Sobalska-Kwapis, Marta/0000-0003-1982-2621; Slomka, Marcin/0000-0002-7906-5549	POIG TESTOPLEK from the European Regional Development Fund [01.01.02-10-005/08]; Polish Ministry of Science and Higher Education [DIR/WK/2017/01]	POIG TESTOPLEK from the European Regional Development Fund; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish POIG grant 01.01.02-10-005/08 TESTOPLEK from the European Regional Development Fund and through the Polish Ministry of Science and Higher Education Grant DIR/WK/2017/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Field SF, 2007, DIABETOLOGIA, V50, P2218, DOI 10.1007/s00125-007-0767-0; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Graff M, 2013, HUM MOL GENET, V22, P3597, DOI 10.1093/hmg/ddt205; Graff M, 2013, DIABETES, V62, P1763, DOI 10.2337/db12-0863; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Huh I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138700; Hunt LE, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0250-3; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Jess T, 2008, INT J OBESITY, V32, P1388, DOI 10.1038/ijo.2008.110; Kilpelaeinen TO, 2011, AM J CLIN NUTR, V93, P851, DOI 10.3945/ajcn.110.000828; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; Lally P, 2008, INT J OBESITY, V32, P700, DOI 10.1038/sj.ijo.0803771; Landgraf K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161739; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Luczynski W, 2012, J PHYSIOL PHARMACOL, V63, P241; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Magi R, 2010, GENET EPIDEMIOL, V34, P846, DOI 10.1002/gepi.20540; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Park SL, 2013, AM J EPIDEMIOL, V178, P780, DOI 10.1093/aje/kwt028; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rosset I, 2016, ANTHROPOL REV, V79, P17, DOI DOI 10.1515/anre-2016-0002; Saldana-Alvarez Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145984; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Singh RK, C R BIOL, V340, P87; Sitek A, 2014, ANTHROPOL REV, V77, P33, DOI DOI 10.2478/anre-2014-0003; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Strapagiel D., 2015, INVENTORS METHOD DET; Strapagiel D., 2016, POLAND OPEN J BIORES, V3, pe6, DOI DOI 10.5334/OJB.22; Sung YJ, 2016, INT J OBESITY, V40, P662, DOI 10.1038/ijo.2015.217; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wisniewski AB, 2009, GENDER MED, V6, P76, DOI 10.1016/j.genm.2008.12.001; Wrzosek M, 2016, INDIAN J MED RES, V143, P281, DOI 10.4103/0971-5916.182617; Zhang MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097545	57	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180295	10.1371/journal.pone.0180295	http://dx.doi.org/10.1371/journal.pone.0180295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662178	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300138
J	Soder, J; Hagman, R; Dicksved, J; Lindase, S; Malmlof, K; Agback, P; Moazzami, A; Hoglund, K; Wernersson, S				Soder, Josefin; Hagman, Ragnvi; Dicksved, Johan; Lindase, Sanna; Malmlof, Kjell; Agback, Peter; Moazzami, Ali; Hoglund, Katja; Wernersson, Sara			The urine metabolome differs between lean and overweight Labrador Retriever dogs during a feed-challenge	PLOS ONE			English	Article							PLASMA LEPTIN CONCENTRATION; BODY CONDITION SCORE; OBESITY-PRONE; HEALTHY DOGS; POMC GENE; TAURINE; WEIGHT; CREATININE; RESTRICTION; VALIDATION	Obesity in dogs is an increasing problem and better knowledge of the metabolism of overweight dogs is needed. Identification of molecular changes related to overweight may lead to new methods to improve obesity prevention and treatment. The aim of the study was firstly to investigate whether Nuclear Magnetic Resonance (NMR) based metabolomics could be used to differentiate postprandial from fasting urine in dogs, and secondly to investigate whether metabolite profiles differ between lean and overweight dogs in fasting and postprandial urine, respectively. Twenty-eight healthy intact male Labrador Retrievers were included, 12 of which were classified as lean (body condition score (BCS) 4-5 on a 9-point scale) and 16 as overweight (BCS 6-8). After overnight fasting, a voided morning urine sample was collected. Dogs were then fed a high-fat mixed meal and postprandial urine was collected after 3 hours. Metabolic profiles were generated using NMR and 45 metabolites identified from the spectral data were evaluated using multivariate data analysis. The results revealed that fasting and postprandial urine differed in relative metabolite concentration (partial least-squares discriminant analysis (PLS-DA) 1 comp: (RY)-Y-2 = 0.4, Q(2)Y = 0.32; cross validated ANOVA: P=0.00006). Univariate analyses of discriminant metabolites showed that taurine and citrate concentrations were elevated in postprandial urine, while allantoin concentration had decreased. Interestingly, lean and overweight dogs differed in terms of relative metabolite concentrations in postprandial urine (PLS-DA 1 comp: (RY)-Y-2 = 0.5, Q(2)Y = 0.36, cross-validated ANOVA: P=0.005) but not in fasting urine. Overweight dogs had lower postprandial taurine and a trend of higher allantoin concentrations compared with lean dogs. These findings demonstrate that metabolomics can differentiate 3-hour postprandial urine from fasting urine in dogs, and that postprandial urine metabolites may be more useful than fasting metabolites for identification of metabolic alterations linked to overweight. The lowered urinary taurine concentration in overweight dogs could indicate alterations in lipid metabolism and merits further investigation.	[Soder, Josefin; Malmlof, Kjell; Hoglund, Katja; Wernersson, Sara] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Hagman, Ragnvi; Lindase, Sanna] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Dicksved, Johan] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden; [Agback, Peter; Moazzami, Ali] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Soder, J (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	josefin.soder@slu.se	Wernersson, Sara/N-8830-2019	Wernersson, Sara/0000-0003-3067-7875; Dicksved, Johan/0000-0002-7515-4480	Future Animal Health and Welfare Platform, Swedish University of Agricultural Sciences; Thure F. and Karin Forsberg Foundation, Sweden; Michael Forsgren Foundation, Sweden; Swedish Research Council Formas [222-20141341]	Future Animal Health and Welfare Platform, Swedish University of Agricultural Sciences; Thure F. and Karin Forsberg Foundation, Sweden; Michael Forsgren Foundation, Sweden; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The study was financially supported by the Future Animal Health and Welfare Platform, Swedish University of Agricultural Sciences, the Thure F. and Karin Forsberg Foundation, Sweden, the Michael Forsgren Foundation, Sweden and The Swedish Research Council Formas 222-20141341. Assoc. Prof. Sara Wernersson, DVM Josefin Soder and Assoc. Prof. Ali Moazzami received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker N, 2012, TIERAERZTL PRAX K H, V40, P391; Beckmann M, 2010, BRIT J NUTR, V103, P1127, DOI 10.1017/S000711450999300X; Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Braun JP, 2003, VET CLIN PATH, V32, P162, DOI 10.1111/j.1939-165X.2003.tb00332.x; Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Fave G, 2011, METABOLOMICS, V7, P469, DOI 10.1007/s11306-011-0289-0; German AJ, 2012, VET J, V192, P428, DOI 10.1016/j.tvjl.2011.09.015; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Gray K, 2016, J ANIM PHYSIOL AN N, V100, P532, DOI 10.1111/jpn.12378; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; HAYES KC, 1981, ANNU REV NUTR, V1, P401, DOI 10.1146/annurev.nu.01.070181.002153; Hoglund K, 2012, J VET INTERN MED, V26, P1300, DOI 10.1111/j.1939-1676.2012.00999.x; Honda A, 2009, J LIPID RES, V50, P2124, DOI 10.1194/jlr.D800054-JLR200; Ishioka K, 2007, RES VET SCI, V82, P11, DOI 10.1016/j.rvsc.2006.06.002; KIENZLE E, 1991, J NUTR, V121, pS39, DOI 10.1093/jn/121.suppl_11.S39; Kim SH, 2009, ANAL BIOANAL CHEM, V395, P1117, DOI 10.1007/s00216-009-3054-8; Ko KS, 2007, J NUTR, V137, P1171, DOI 10.1093/jn/137.5.1171; Kook PH, 2007, J VET INTERN MED, V21, P388, DOI 10.1892/0891-6640(2007)21[388:UCAMTC]2.0.CO;2; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Laflamme D, 1997, CANINE PRACT, V22, P10; Lawler DF, 2008, BRIT J NUTR, V99, P793, DOI 10.1017/S0007114507871686; Lee MY, 2003, ADV EXP MED BIOL, V526, P285; Li HK, 2008, J PROTEOME RES, V7, P4775, DOI 10.1021/pr800352k; Mankowska M, 2017, RES VET SCI, V112, P116, DOI 10.1016/j.rvsc.2017.02.014; Murakami S, 2015, MOL NUTR FOOD RES, V59, P1353, DOI 10.1002/mnfr.201500067; Nakaya Y, 2000, AM J CLIN NUTR, V71, P54; Pellis L, 2012, METABOLOMICS, V8, P347, DOI 10.1007/s11306-011-0320-5; Raffan E, 2016, CELL METAB, V23, P893, DOI 10.1016/j.cmet.2016.04.012; Sagawa MM, 2002, AM J VET RES, V63, P7, DOI 10.2460/AJVR.2002.63.7; Sanderson SL, 2006, VET CLIN N AM-SMALL, V36, P1325, DOI 10.1016/j.cvsm.2006.08.010; Saude EJ, 2007, METABOLOMICS, V3, P439, DOI 10.1007/s11306-007-0091-1; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Shestopalov AV, 2006, BIOL BULL+, V33, P437, DOI 10.1134/S1062359006050037; Soder J, 2016, J VET INTERN MED, V30, P574, DOI 10.1111/jvim.13830; Tsuboyama-Kasaoka N, 2006, ENDOCRINOLOGY, V147, P3276, DOI 10.1210/en.2005-1007; Tung YCL, 2014, CELL METAB, V20, P710, DOI 10.1016/j.cmet.2014.09.010; Tvarijonaviciute A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-147; Verkest KR, 2012, DOMEST ANIM ENDOCRIN, V42, P103, DOI 10.1016/j.domaniend.2011.10.002; Viant MR, 2007, METABOLOMICS, V3, P453, DOI 10.1007/s11306-007-0092-0; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Wang YL, 2007, J PROTEOME RES, V6, P1846, DOI 10.1021/pr060685n; Witzel AL, 2014, JAVMA-J AM VET MED A, V244, P1279, DOI 10.2460/javma.244.11.1279; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xie B, 2012, BIOMED RES INT, V2012; Xie BG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/805683; Xu J, 2013, IEEE VEHICLE POWER, P1; Zhang A, 2013, OBES REV, V14, P344, DOI 10.1111/obr.12011; Zhang M, 2004, AMINO ACIDS, V26, P267, DOI 10.1007/s00726-003-0059-z	53	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180086	10.1371/journal.pone.0180086	http://dx.doi.org/10.1371/journal.pone.0180086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662207	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300102
J	Zhang, LR; Xie, FX; Wang, XG; Peng, DZ; Bi, CR; Jiang, LB; Zhao, DM; Tian, XX; Qi, DB				Zhang, Liran; Xie, Fengxiang; Wang, Xinguo; Peng, Dezhi; Bi, Chunrui; Jiang, Lingbo; Zhao, Dongman; Tian, Xinxin; Qi, Debo			Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China	PLOS ONE			English	Article							LIQUID-BASED CYTOLOGY; POOLED ANALYSIS; INTRAEPITHELIAL NEOPLASIA; PAPANICOLAOU TESTS; FOLLOW-UP; CANCER; HPV; WOMEN; DNA; RECRUITMENT	Background Currently, available data regarding previous cervical cytology and high-risk human papillomavirus (hrHPV) test results to detect invasive cervical cancer are limited and controversial in China. Therefore, this retrospective study in a population of Chinese women with invasive cervical carcinoma aimed to gain further insight into the roles of cytology and hrHPV testing in cervical cancer screening. Methods A total of 1214 cases with a histological diagnosis of invasive cervical cancer were retrieved from the Pathology Database of Jinan KingMed Diagnostics (JKD) over a 5-year period. Previous cytology and hrHPV test results of 469 patients carried out within the year before cancer diagnosis were documented. Results A higher percentage of patients who had undergone prior screening had micro-invasive cervical carcinoma than patients who had no prior screening (25.4% vs. 12.1%, P < 0.001). Of the 469 patients with available prior screening results, 170 had cytology alone, 161 had hrHPV testing alone, and 138 had both cytology and hrHPV testing. There was a significantly lower percentage of hrHPV-positive cases with adenocarcinoma than with squamous cell carcinoma (77.8% vs. 96.4%, P = 0.001). The hrHPV test showed a significantly higher sensitivity than cytology alone (94.4% vs. 85.3%, P = 0.006). The overall sensitivity of the combination of cytology and hrHPV testing (98.6%) was much higher than that of cytology alone (P < 0.001) but only marginally higher than that of hrHPV testing alone (P = 0.058). Conclusions The results revealed that prior cervical screening can detect a significantly larger number of micro-invasive cervical cancers. The hrHPV test can provide a more sensitive and efficient strategy than cytology alone. As the addition of cytology to hrHPV testing can only marginally increase the efficiency of the hrHPV test, hrHPV testing should be used as the primary screening approach, especially in the low-resource settings of China.	[Zhang, Liran; Xie, Fengxiang; Wang, Xinguo; Zhao, Dongman; Qi, Debo] Jinan KingMed Diagnost, Dept Pathol, Jinan, Shandong, Peoples R China; [Peng, Dezhi; Bi, Chunrui; Jiang, Lingbo; Tian, Xinxin] Jinan KingMed Diagnost, Dept Lab Med, Jinan, Shandong, Peoples R China		Qi, DB (corresponding author), Jinan KingMed Diagnost, Dept Pathol, Jinan, Shandong, Peoples R China.	bobo8369@163.com						Blatt AJ, 2015, CANCER CYTOPATHOL, V123, P282, DOI 10.1002/cncy.21544; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Di Jiangli, 2015, Asian Pac J Cancer Prev, V16, P7401; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Li YX, 2015, PLOS ONE, V10; Li ZB, 2012, ARCH PATHOL LAB MED, V136, P1533, DOI 10.5858/arpa.2011-0609-OA; Maucort-Boulch D, 2008, CANCER EPIDEM BIOMAR, V17, P717, DOI 10.1158/1055-9965.EPI-07-2691; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Mezei AK, 2017, INT J CANC; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Pan QJ, 2014, GYNECOL ONCOL, V133, P172, DOI 10.1016/j.ygyno.2014.03.008; Pan QJ, 2013, CANCER CYTOPATHOL, V121, P473, DOI 10.1002/cncy.21297; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Tao X, 2015, CANCER CYTOPATHOL, V123, P421, DOI 10.1002/cncy.21545; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Xu He, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P399; Zeng ZY, 2016, J CANCER, V7, P1037, DOI 10.7150/jca.14971; Zeng ZY, 2016, AM J CLIN PATHOL, V145, P622, DOI [10.1093/ajcp/aqw010, 10.1093/AJCP/AQW010]; Zhao CQ, 2015, ARCH PATHOL LAB MED, V139, P184, DOI 10.5858/arpa.2014-0028-OA; Zhao FH, 2010, LANCET ONCOL, V11, P1160, DOI 10.1016/S1470-2045(10)70256-4; Zheng Baowen, 2015, J Am Soc Cytopathol, V4, P84, DOI 10.1016/j.jasc.2014.10.005; Zheng BW, 2015, CANCER CYTOPATHOL, V123, P428, DOI 10.1002/cncy.21557; Zheng BW, 2015, ARCH PATHOL LAB MED, V139, P373, DOI 10.5858/arpa.2014-0070-OA	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180618	10.1371/journal.pone.0180618	http://dx.doi.org/10.1371/journal.pone.0180618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662160	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300171
J	Milyayskyl, M; Kruglanski, AW; Chernikova, M; Schori-Eyal, N				Milyayskyl, Maxim; Kruglanski, Arie W.; Chernikova, Marina; Schori-Eyal, Noa			Evidence for arrogance: On the relative importance of expertise, outcome, and manner	PLOS ONE			English	Article							SOCIAL COGNITION; DECISION-MAKING; SELF; ADVICE; KNOWLEDGE; CONTEMPT; JUDGMENT; AGENCY; CONSEQUENCES; UNIVERSALITY	Arrogant behavior is as old as human nature. Nonetheless, the factors that cause people to be perceived as arrogant have received very little research attention. In this paper, we focused on a typical manifestation of arrogance: dismissive behavior. In particular, we explored the conditions under which a person who dismissed advice would be perceived as arrogant. We examined two factors: the advisee's competence, and the manner in which he or she dismissed the advice. The effect of the advisee's competence was tested by manipulating two competence cues: relative expertise, and the outcome of the advice dismissal (i.e., whether the advisee was right or wrong). In six studies (N = 1304), participants made arrogance judgments about protagonists who dismissed the advice of another person while the advisees' relative expertise (compared to the advisor), their eventual correctness, and the manner of their dismissal were manipulated in between-participant designs. Across various types of decisions and advisee-advisor relationships, the results show that less expert, less correct, and ruder advisees are perceived as more arrogant. We also find that outcome trumps expertise, and manner trumps both expertise and outcomes. In two additional studies (N = 101), we examined people's nave theories about the relative importance of the aforementioned arrogance cues. These studies showed that people overestimate the role of expertise information as compared to the role of interpersonal manner and outcomes. Thus, our results suggest that people may commit arrogant faux pas because they erroneously expect that their expertise will justify their dismissive behavior.	[Milyayskyl, Maxim; Kruglanski, Arie W.; Chernikova, Marina] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Schori-Eyal, Noa] Interdisciplinary Ctr, Dept Psychol, Herzliyya, Israel	University System of Maryland; University of Maryland College Park; Reichman University	Milyayskyl, M (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	mmilyaysky@gmail.com			John Templeton Foundation [I H 117]	John Templeton Foundation	This project was funded by John Templeton Foundation grant number I H 117.	Abele AE, 2007, J PERS SOC PSYCHOL, V93, P751, DOI 10.1037/0022-3514.93.5.751; Abele AE, 2014, ADV EXP SOC PSYCHOL, V50, P195, DOI 10.1016/B978-0-12-800284-1.00004-7; Anderson C, 2012, J PERS SOC PSYCHOL, V103, P718, DOI 10.1037/a0029395; [Anonymous], 1990, PSYCHOL INQ; BARON J, 1988, J PERS SOC PSYCHOL, V54, P569, DOI 10.1037/0022-3514.54.4.569; Bell M., 2013, HARD FEELINGS MORAL; BIRNBAUM MH, 1976, MEM COGNITION, V4, P330, DOI 10.3758/BF03213185; Bonaccio S, 2006, ORGAN BEHAV HUM DEC, V101, P127, DOI 10.1016/j.obhdp.2006.07.001; Brown RV, 1974, DECISION ANAL MANAGE; BUCZEK TA, 1981, J COUNS PSYCHOL, V28, P13; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Campbell WK, 2007, FRONT SOC PSYCHOL, P115; CARLSTON DE, 1983, J PERS SOC PSYCHOL, V44, P515, DOI 10.1037/0022-3514.44.3.515; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Deelstra JT, 2003, J APPL PSYCHOL, V88, P324, DOI 10.1037/0021-9010.88.2.324; Dietze P, 2016, PSYCHOL SCI; Drass K., 1986, SOC PSYCHOL Q; EKMAN P, 1988, MOTIV EMOTION, V12, P303, DOI 10.1007/BF00993116; Ellyson S, 1980, SOC PSYCHOL Q; Exline JJ, 2004, J PERS SOC PSYCHOL, V87, P894, DOI 10.1037/0022-3514.87.6.894; Fast NJ, 2011, J EXP SOC PSYCHOL; Feng B, 2006, SOUTH COMMUN J, V71, P67, DOI 10.1080/10417940500503548; FISCHHOFF B, 1975, J EXP PSYCHOL HUMAN, V1, P288, DOI 10.1037/0096-1523.1.3.288; Fiske S., 1980, J PERS SOC PSYCHOL; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; FOLGER R, 1977, J PERS SOC PSYCHOL, V35, P108, DOI 10.1037/0022-3514.35.2.108; Gilovich T., 2002, PSYCHOL INTUITIVE JU; Gino F, 2009, HARM FOUL OUTCOME BI; Gregg AP, 2014, J PSYCHOL THEOL, V42, P7, DOI 10.1177/009164711404200102; gyal-mtshan T, 1975, MIND BUDDHIST PSYCHO; Hall EV, 2012, J EXP SOC PSYCHOL, V48, P899, DOI 10.1016/j.jesp.2012.02.004; Hamilton D, 1971, PERSONAL SOC PSYCHOL; Hareli S, 2000, MOTIV EMOTION, V24, P215, DOI 10.1023/A:1005666212320; Harvey N, 1997, ORGAN BEHAV HUM DEC, V70, P117, DOI 10.1006/obhd.1997.2697; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; ICKES W, 1986, J PERS SOC PSYCHOL, V51, P66, DOI 10.1037/0022-3514.51.1.66; Johnson RE, 2010, HUM PERFORM, V23, P403, DOI 10.1080/08959285.2010.515279; 'Ju Mi-phamrgya-mtsho 'Jam-mgon, 1997, GATEWAY KNOWLEDGE TR; Jungermann H, 2005, ROUTINES OF DECISION MAKING, P157; Kahneman D, 1972, CONCEPT PROBABILITY, P25, DOI DOI 10.1007/978-94-010-2288-0_3; Kogut T, 2005, J BEHAV DECIS MAK; Kowalski RM, 2003, J SOC PERS RELAT, V20, P471, DOI 10.1177/02654075030204003; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P221, DOI 10.1037/0022-3514.77.2.221; Kruglanski AW, 2010, SOC PERSONAL PSYCHOL, V4, P939, DOI 10.1111/j.1751-9004.2010.00308.x; Kruglanski AW, 2009, EUR REV SOC PSYCHOL, V20, P146, DOI 10.1080/10463280902860037; Kruglanski AW, 2005, ADV EXP SOC PSYCHOL, V37, P345, DOI 10.1016/S0065-2601(05)37006-7; Kruglanski AW, 1996, PSYCHOL REV, V103, P263, DOI 10.1037/0033-295X.103.2.263; Kruglanski AW, 2002, ADV EXP SOC PSYCHOL, V34, P331, DOI 10.1016/S0065-2601(02)80008-9; MATSUMOTO D, 1992, MOTIV EMOTION, V16, P363, DOI 10.1007/BF00992972; Milkman KL, 2015, J APPL PSYCHOL, V100, P1678, DOI 10.1037/apl0000022; Mill JohnStuart., 1957, UTILITARIANISM; Minson JA, 2011, PERS SOC PSYCHOL B, V37, P1325, DOI 10.1177/0146167211410436; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Muller-Trede J, 2016, MANAGE SCI; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; ROSS M, 1992, J SOC PERS RELAT, V9, P585, DOI 10.1177/0265407592094007; Sah S, 2013, ORGAN BEHAV HUM DEC, V121, P246, DOI 10.1016/j.obhdp.2013.02.001; Samuelson PL, SCI INTELLECTUAL HUM; Scheffler S., 1988, CONSEQUENTIALISM ITS; SCHLENKER BR, 1982, J EXP SOC PSYCHOL, V18, P89, DOI 10.1016/0022-1031(82)90083-X; SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131; Sniezek JA, 2001, ORGAN BEHAV HUM DEC, V84, P288, DOI 10.1006/obhd.2000.2926; Soll JB, 2011, INT J FORECASTING, V27, P81, DOI 10.1016/j.ijforecast.2010.05.003; Soll JB, 2009, J EXP PSYCHOL LEARN, V35, P780, DOI 10.1037/a0015145; Solomon RC, 1976, PASSIONS EMOTIONS ME; Tesser A., 1988, ADV EXP SOC PSYCHOL, V21, P181, DOI 10.1016/S0065-2601(08)60227-0; Tracy JL, 2007, CURR DIR PSYCHOL SCI, V16, P147, DOI 10.1111/j.1467-8721.2007.00493.x; Tracy JL, 2007, J PERS SOC PSYCHOL, V92, P506, DOI 10.1037/0022-3514.92.3.506; Tracy JL, 2012, COGNITION EMOTION, V26, P14, DOI 10.1080/02699931.2011.561298; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; Underwood MK, 2004, FEM PSYCHOL, V14, P371, DOI 10.1177/0959-353504044637; van den Bos K, 1998, J PERS SOC PSYCHOL, V75, P1449, DOI 10.1037/0022-3514.75.6.1449; VLEK C, 1984, ACTA PSYCHOL, V56, P5, DOI 10.1016/0001-6918(84)90004-0; WOJCISZKE B, 2005, EUROPEAN REV SOCIAL, V0016; Wojciszke B, 2008, EUR J SOC PSYCHOL, V38, P1139, DOI 10.1002/ejsp.549; Yaniv I, 2000, ORGAN BEHAV HUM DEC, V83, P260, DOI 10.1006/obhd.2000.2909; Yaniv I, 2004, CURR DIR PSYCHOL SCI, V13, P75, DOI 10.1111/j.0963-7214.2004.00278.x; Yaniv I, 2007, ORGAN BEHAV HUM DEC, V103, P104, DOI 10.1016/j.obhdp.2006.05.006; Yaniv I, 2011, ORGAN BEHAV HUM DEC, V115, P111, DOI 10.1016/j.obhdp.2010.11.006; Yee J., 2006, SOC PSYCHOL EDUC, V9, P119	80	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180420	10.1371/journal.pone.0180420	http://dx.doi.org/10.1371/journal.pone.0180420			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683114	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200034
J	Rasmussen, D; Voelker, A; Eliasmith, C				Rasmussen, Daniel; Voelker, Aaron; Eliasmith, Chris			A neural model of hierarchical reinforcement learning	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; BASAL GANGLIA; COMPUTATIONAL MODEL; PREFRONTAL CORTEX; SELECTION; TIME	We develop a novel, biologically detailed neural model of reinforcement learning (RL) processes in the brain. This model incorporates a broad range of biological features that pose challenges to neural RL, such as temporally extended action sequences, continuous environments involving unknown time delays, and noisy/imprecise computations. Most significantly, we expand the model into the realm of hierarchical reinforcement learning (HRL), which divides the RL process into a hierarchy of actions at different levels of abstraction. Here we implement all the major components of HRL in a neural model that captures a variety of known anatomical and physiological properties of the brain. We demonstrate the performance of the model in a range of different environments, in order to emphasize the aim of understanding the brain's general reinforcement learning ability. These results show that the model compares well to previous modelling work and demonstrates improved performance as a result of its hierarchical ability. We also show that the model's behaviour is consistent with available data on human hierarchical RL, and generate several novel predictions.	[Rasmussen, Daniel; Eliasmith, Chris] Appl Brain Res Inc, Waterloo, ON, Canada; [Voelker, Aaron; Eliasmith, Chris] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON, Canada	University of Waterloo	Rasmussen, D (corresponding author), Appl Brain Res Inc, Waterloo, ON, Canada.	daniel.rasmussen@appliedbrainresearch.com			Canada Foundation for Innovation; Ontario Innovation Trust; Canada Research Chairs, National Science and Engineering Research Council of Canada Discovery [261453]; Office of Naval Research [N000141310419]; Air Force Office of Scientific Research [FA8655-13-1-3084]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust; Canada Research Chairs, National Science and Engineering Research Council of Canada Discovery; Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by Canada Foundation for Innovation and Ontario Innovation Trust infrastructure funding and grants from Canada Research Chairs, National Science and Engineering Research Council of Canada Discovery grant 261453,Office of Naval Research grant N000141310419, and Air Force Office of Scientific Research grant FA8655-13-1-3084.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DR, CE are employees of Applied Brain Research, Inc.The funder provided support in the form of salaries for DR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2004, ACM INT C P SERIES, DOI DOI 10.1145/1015330.1015353; [Anonymous], 2003, NEURAL ENG COMPUTATI; [Anonymous], 2001, P 18 INT C MACHINE L; [Anonymous], 2012, OXFORD HDB COMPOSITI; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Baras D, 2007, NEURAL COMPUT, V19, P2245, DOI 10.1162/neco.2007.19.8.2245; Barto AG, 2003, DISCRETE EVENT DYN S, P1; Barton-Gooden A, 2015, CLIN NURS RES, V24, P73, DOI 10.1177/1054773813493112; Bekolay T, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00048; Botvinick M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0480; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Botvinick MM, 2004, PSYCHOL REV; Braver TS, 1999, PROGR BRAIN RES, V121; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Collins AGE, 2013, PSYCHOL REV, V120, P190, DOI 10.1037/a0030852; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Dayan P., 1992, ADV NEURAL INF PROCE, V5, P271; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Dietterich TG, 2000, J ARTIF INTELL RES, V13, P227, DOI 10.1613/jair.639; Diuk C, 2012, COMPUTATION IN PRESS; Diuk C, 2013, J NEUROSCI, V33, P5797, DOI 10.1523/JNEUROSCI.5445-12.2013; Eliasmith C, 2005, NEURAL COMPUT, V17, P1276, DOI 10.1162/0899766053630332; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Frank MJ, 2012, CEREB CORTEX, V22, P509, DOI 10.1093/cercor/bhr114; Fremaux N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003024; Friedrich J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002092; Gershman SJ, 2015, SCIENCE, V349, P273, DOI 10.1126/science.aac6076; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; Haruno M, 2006, NEURAL NETWORKS, V19, P1242, DOI 10.1016/j.neunet.2006.06.007; Hengst B, 2012, ADAPT LEARN OPTIM, V12, P293; Holroyd CB, 2015, PSYCHOL REV, V122, P54, DOI 10.1037/a0038339; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Howard R. A., 1971, DYNAMIC PROBABILISTI; Howard R. A., 1960, DYNAMIC PROGRAMMING; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Jong NK, 2008, 7 INT C AUT AG MULT; Klein U., 2004, P 21 INT C MACH LEAR, P71, DOI DOI 10.1145/1015330.1015355; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Lawson CL, 1974, SOLVING LEAST SQUARE; MacNeil D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022885; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Menache I, 2002, LECT NOTES ARTIF INT, V2430, P295; Neymotin SA, 2013, NEURAL COMPUT, V25, P3263, DOI 10.1162/NECO_a_00521; Niv Y., 2009, J MATH PSYCHOL, P1; O'Reilly RC, 2007, BEHAV NEUROSCI, V121, P31, DOI 10.1037/0735-7044.121.1.31; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Parr R, 1998, ADV NEURAL INFORM PR; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; Rasmussen D., 2013, P 35 ANN C COGN SCI, P3257; Rasmussen D, 2014, THESIS; Rasmussen D, 2014, INTELLIGENCE, V42, P53, DOI 10.1016/j.intell.2013.10.003; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Ribas-Fernandes JJF, 2011, NEURON, V71, P370, DOI 10.1016/j.neuron.2011.05.042; Rougier NP, 2002, COGNITIVE SCI, V26, P503, DOI 10.1207/s15516709cog2604_4; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; SINGH SP, 1994, PROCEEDINGS OF THE TWELFTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P700; Solway A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003779; Stewart T. C., 2010, P 10 INT C COGN MOD, P235; Stewart TC, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00002; Stewart Terrence C, 2009, Front Neuroinform, V3, P7, DOI 10.3389/neuro.11.007.2009; Strosslin T, 2003, INT C ART NEUR NETW; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1999, ARTIF INTELL, V112, P181, DOI 10.1016/S0004-3702(99)00052-1; Taylor ME, 2009, J MACH LEARN RES, V10, P1633; Todd MT, 2008, ADV NEURAL INFORM PR; Uithol S, 2012, J COGNITIVE NEUROSCI, V24, P1077, DOI 10.1162/jocn_a_00204; Urbanczik R, 2009, NAT NEUROSCI, V12, P250, DOI 10.1038/nn.2264; Vasilaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000586; Wilson RC, 2014, NEURON, V81, P267, DOI 10.1016/j.neuron.2013.11.005	73	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e080234	10.1371/journal.pone.0180234	http://dx.doi.org/10.1371/journal.pone.0180234			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683111	Green Submitted, gold, Green Published			2022-12-27	WOS:000405335200021
J	Amorim, T; Metsios, GS; Wyonm, M; Neville, AM; Flouris, AD; Maia, J; Teixeira, E; Machado, JC; Marques, F; Koutedakis, Y				Amorim, Tania; Metsios, George S.; Wyonm, Matthew; Neville, Alan M.; Flouris, Andreas D.; Maia, Jose; Teixeira, Eduardo; Machado, Jose Carlos; Marques, Franklim; Koutedakis, Yiannis			Bone mass of female dance students prior to professional dance training: A cross-sectional study	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; MINERAL DENSITY; WEIGHT-BEARING; BALLET DANCERS; ATHLETE TRIAD; FEMORAL-NECK; EXERCISE; PUBERTY; GIRLS; ACQUISITION	Background Professional dancers are at risk of developing low bone mineral density (BMD). However, whether low BMD phenotypes already exist in pre-vocational dance students is relatively unknown. Aim To cross-sectionally assess bone mass parameters in female dance students selected for professional dance training (first year vocational dance students) in relation to aged- and sex-matched controls. Methods 34 female selected for professional dance training (10.9yrs +/- 0.7) and 30 controls (11.1yrs +/- 0.5) were examined. Anthropometry, pubertal development (Tanner) and dietary data (3day food diary) were recorded. BMD and bone mineral content (BMC) at forearm, femur neck (FN) and lumbar spine (LS) were assessed using Dual-Energy X-Ray Absorptiometry. Volumetric densities were estimated by calculating bone mineral apparent density (BMAD). Results Dancers were mainly at Tanner pubertal stage I (vs. stage IV in controls, p<0.001), and demonstrated significantly lower body weight (p<0.001) and height (p<0.01) than controls. Calorie intake was not different between groups, but calcium intake was significantly greater in dancers (p<0.05). Dancers revealed a significantly lower BMC and BMD values at all anatomical sites (p<0.001), and significantly lower BMAD values at the LS and FN (p<0.001). When adjusted for covariates (body weight, height, pubertal development and calcium intake), dance students continued to display a significantly lower BMD and BMAD at the FN (p<0.05; p<0.001) at the forearm (p<0.01). Conclusion Before undergoing professional dance training, first year vocational dance students demonstrated inferior bone mass compared to controls. Longitudinal models are required to assess how bone health-status changes with time throughout professional training.	[Amorim, Tania; Maia, Jose] Univ Porto, Fac Sports, Ctr Res Educ Innovat & Intervent Sport, Oporto, Portugal; [Amorim, Tania; Metsios, George S.; Wyonm, Matthew; Neville, Alan M.; Koutedakis, Yiannis] Univ Wolverhampton, Fac Educ Hlth & Wellbeing, Walsall, W Midlands, England; [Metsios, George S.; Flouris, Andreas D.; Koutedakis, Yiannis] Univ Thessaly, Sch Exercise Sci, Trikala, Greece; [Wyonm, Matthew] Natl Inst Dance Med & Sci, London, England; [Flouris, Andreas D.] Univ Thessaly, Dept Exercise Sci, FAME Lab, Trikala, Greece; [Teixeira, Eduardo] Univ Porto, Fac Sports, Res Ctr Phys Act Hlth & Leisure, Oporto, Portugal; [Machado, Jose Carlos] Univ Porto, Inst Mol Pathol & Immunol, Oporto, Portugal; [Marques, Franklim] Univ Porto, Fac Pharm, Oporto, Portugal; [Koutedakis, Yiannis] Inst Res & Technol Thessaly, CERTH, Trikala, Greece	Universidade do Porto; University of Wolverhampton; University of Thessaly; University of Thessaly; Universidade do Porto; Universidade do Porto; Universidade do Porto	Amorim, T (corresponding author), Univ Porto, Fac Sports, Ctr Res Educ Innovat & Intervent Sport, Oporto, Portugal.; Amorim, T (corresponding author), Univ Wolverhampton, Fac Educ Hlth & Wellbeing, Walsall, W Midlands, England.	tania_amorim@hotmail.com	Teixeira, Eduardo/AAD-6456-2021; Machado, Jose Carlos/C-5907-2009; Nevill, Alan/Q-1010-2019; Flouris, Andreas/GXG-4893-2022; Marques, Franklim/K-5879-2013	Machado, Jose Carlos/0000-0003-4741-8415; Nevill, Alan/0000-0003-0506-3652; Koutedakis, Yiannis/0000-0002-7065-9447; Teixeira, Eduardo/0000-0002-1696-2111; Marques, Franklim/0000-0001-9362-1217	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/88585/2012]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	Author Ta Ania Amorim has received a PhD grant from the Portuguese Foundation for Science and Technology (FCT); (SFRH/BD/88585/2012).	Abraham S, 1996, PSYCHOPATHOLOGY, V29, P218, DOI 10.1159/000284996; Amorim T, 2015, SPORTS MED, V45, P257, DOI 10.1007/s40279-014-0268-5; [Anonymous], 2007, MED SCI SPORT EXER, V39, P1867, DOI 10.1249/mss.0b013e318149f111; Armann S, 1990, KINESIOL MED DANCE, V13, P1; Baxter-Jones ADG, 2010, BONE, V46, P208, DOI 10.1016/j.bone.2009.10.017; Bennell K, 2000, PEDIATR EXERC SCI, V12, P371, DOI 10.1123/pes.12.4.371; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bradney M, 1998, J BONE MINER RES, V13, P1814, DOI 10.1359/jbmr.1998.13.12.1814; Burckhardt Peter, 2011, J Dance Med Sci, V15, P51; Calbet JAL, 1998, CALCIFIED TISSUE INT, V62, P491, DOI 10.1007/s002239900467; Chevalley T, 2009, J CLIN ENDOCR METAB, V94, P3424, DOI 10.1210/jc.2009-0241; CRAWFORD PB, 1994, J AM DIET ASSOC, V94, P626, DOI 10.1016/0002-8223(94)90158-9; Darelid A, 2012, J BONE MINER RES, V27, P2198, DOI 10.1002/jbmr.1675; Faulkner KG, 1996, OSTEOPOROSIS INT, V6, P432, DOI 10.1007/BF01629574; Foldes A, 1996, ORTHOPEDICS CLIN SCI, V18, P296; FREDERICK L, 1992, J AM DIET ASSOC, V92, P299; Gomez-Bruton A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070119; Guadalupe-Grau A, 2009, SPORTS MED, V39, P439, DOI 10.2165/00007256-200939060-00002; HAGIWARA S, 1994, J BONE MINER RES, V9, P1425; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Ishikawa S, 2013, SPORTS MED, V43, P875, DOI 10.1007/s40279-013-0060-y; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332, DOI 10.1210/jcem-73-6-1332; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Koutedakis Y, 2004, J STRENGTH COND RES, V18, P714; Koutedakis Y, 2004, SPORTS MED, V34, P651, DOI 10.2165/00007256-200434100-00003; Koutedakis Y., 1997, J DANCE MED SCI, V1, P12; Koutedakis Y, 2007, J STRENGTH COND RES, V21, P808; KROGER H, 1993, BONE MINER, V23, P171, DOI 10.1016/S0169-6009(08)80094-3; Lu Y, 2001, OSTEOPOROSIS INT, V12, P438, DOI 10.1007/s001980170087; Ma NS, 2012, J PEDIATR-US, V161, P983, DOI 10.1016/j.jpeds.2012.07.057; Matthews BL, 2006, OSTEOPOROSIS INT, V17, P1043, DOI 10.1007/s00198-006-0093-2; McKay HA, 2000, J BONE MINER RES, V15, P1181, DOI 10.1359/jbmr.2000.15.6.1181; Morris FL, 1997, J BONE MINER RES, V12, P1453, DOI 10.1359/jbmr.1997.12.9.1453; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; Mughal MZ, 2011, CURR OPIN ENDOCRINOL, V18, P28, DOI 10.1097/MED.0b013e3283416441; Nurmi-Lawton JA, 2004, J BONE MINER RES, V19, P314, DOI 10.1359/JBMR.0301222; Pearson D, 2006, J CLIN DENSITOM, V9, P287, DOI 10.1016/j.jocd.2006.02.006; POCOCK NA, 1992, J BONE MINER RES, V7, P1081; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Shepherd JA, 2002, J BONE MINER RES, V17, P734, DOI 10.1359/jbmr.2002.17.4.734; Torstveit MK, 2005, MED SCI SPORT EXER, V37, P184, DOI 10.1249/01.MSS.0000152677.60545.3A; Valentino R, 2001, J CLIN ENDOCR METAB, V86, P4674, DOI 10.1210/jc.86.10.4674; Vicente-Rodriguez G, 2004, BONE, V35, P1208, DOI 10.1016/j.bone.2004.06.012; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; WARREN MP, 1991, J CLIN ENDOCR METAB, V72, P847, DOI 10.1210/jcem-72-4-847; Warren MP, 1998, J AM MED WOMEN ASSOC, V54, P115; Yannakoulia M, 2004, INT J SPORT NUTR EXE, V14, P285, DOI 10.1123/ijsnem.14.3.285; YOUNG N, 1994, J CLIN ENDOCR METAB, V78, P449, DOI 10.1210/jc.78.2.449	49	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180639	10.1371/journal.pone.0180639	http://dx.doi.org/10.1371/journal.pone.0180639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678833	Green Submitted, gold, Green Published			2022-12-27	WOS:000405272200082
J	Beau, A; Rivollat, M; Reveillas, H; Pemonge, MH; Mendisco, F; Thomas, Y; Lefranc, P; Deguilloux, MF				Beau, Alice; Rivollat, Maite; Reveillas, Helene; Pemonge, Marie-Helene; Mendisco, Fanny; Thomas, Yohann; Lefranc, Philippe; Deguilloux, Marie-France			Multi-scale ancient DNA analyses confirm the western origin of Michelsberg farmers and document probable practices of human sacrifice	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HUNTER-GATHERERS; GENOMES	In Europe, the Middle Neolithic is characterized by an important diversification of cultures. In northeastern France, the appearance of the Michelsberg culture has been correlated with major cultural changes and interpreted as the result of the settlement of new groups originating from the Paris Basin. This cultural transition has been accompanied by the expansion of particular funerary practices involving inhumations within circular pits and individuals in "non-conventional" positions (deposited in the pits without any particular treatment). If the status of such individuals has been highly debated, the sacrifice hypothesis has been retained for the site of Gougenheim (Alsace). At the regional level, the analysis of the Gougenheim mitochondrial gene pool (SNPs and HVR-I sequence analyses) permitted us to highlight a major genetic break associated with the emergence of the Michelsberg in the region. This genetic discontinuity appeared to be linked to new affinities with farmers from the Paris Basin, correlated to a noticeable hunter-gatherer legacy. All of the evidence gathered supports (i) the occidental origin of the Michelsberg groups and (ii) the potential implication of this migration in the progression of the hunter-gatherer legacy from the Paris Basin to Alsace / Western Germany at the beginning of the Late Neolithic. At the local level, we noted some differences in the maternal gene pool of individuals in "conventional" vs. "non-conventional" positions. The relative genetic isolation of these sub-groups nicely echoes both their social distinction and the hypothesis of sacrifices retained for the site. Our investigation demonstrates that a multi-scale aDNA study of ancient communities offers a unique opportunity to disentangle the complex relationships between cultural and biological evolution.	[Beau, Alice; Rivollat, Maite; Reveillas, Helene; Pemonge, Marie-Helene; Mendisco, Fanny; Deguilloux, Marie-France] Univ Bordeaux, CNRS, Anthropol UMR 5199, Prehist Actuel,Culture,Environm,CS, Allee Geoffroy St Hilaire, Pessac, France; [Rivollat, Maite] Ctr Archeol Prevent Bordeaux Metropole, Direct Batiments & Moyens, Esplanade Charles de Gaulle, Bordeaux, France; [Reveillas, Helene; Thomas, Yohann; Lefranc, Philippe] Ctr Archeol Strasbourg, Inst Natl Rech Archeol Prevent, 10 Rue Altkirch, Strasbourg, France; [Lefranc, Philippe] Univ Strasbourg, Archeol & Hist Ancienne Mediterranee Europe UMR 7, Maison Interuniv Sci Homme Alsace, CS, 5 Allee Gen Rouvillois, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rivollat, M (corresponding author), Univ Bordeaux, CNRS, Anthropol UMR 5199, Prehist Actuel,Culture,Environm,CS, Allee Geoffroy St Hilaire, Pessac, France.; Lefranc, P (corresponding author), Ctr Archeol Strasbourg, Inst Natl Rech Archeol Prevent, 10 Rue Altkirch, Strasbourg, France.; Lefranc, P (corresponding author), Univ Strasbourg, Archeol & Hist Ancienne Mediterranee Europe UMR 7, Maison Interuniv Sci Homme Alsace, CS, 5 Allee Gen Rouvillois, Strasbourg, France.	rivollat.maite@gmail.com; philippe.lefranc@inrap.fr		Rivollat, Maite/0000-0002-4011-2862	Research National Agency [ANR-10-LABX-52]; Minist Sredel 'Enseignement Supe Arieuret dela Recherche; Conseil Regionald 'Aquitainen E [20030304002FA, 20040305003FA]; European Union, FEDER [2003227]; Investissements davenir, Convention attributive daide [NEANR-10-EQPX-16-01]	Research National Agency; Minist Sredel 'Enseignement Supe Arieuret dela Recherche; Conseil Regionald 'Aquitainen E; European Union, FEDER; Investissements davenir, Convention attributive daide(French National Research Agency (ANR))	This research was funded through a ministerial grant from the Research National Agency as a program of prospects investments ANR-10-LABX-52 (http://www.agence-nationaler echerche.fr/). The study was also financially supported through a PhD research grant from the Minist Sredel 'Enseignement Supe Arieuret dela Recherche for MR (http://www.enseignementsupr echerche.gouv.fr/). Part of the presented experiments (SNP sanalyses) were performed at the Genomic and Sequencing Facility of Bordeaux, grants from the Conseil Regionald 'Aquitainen E 20030304002FA and 20040305003FA, https:// www.nouvelle-aquitaine.fr/, and from the European Union, FEDER no 2003227 and from Investissements davenir, Convention attributive daide NEANR-10-EQPX-16-01, http://www.agencen ationale-recherche.fr/. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Beeching A, 1991, ID CHASS ACT C INT N; Boulestin B, 2008, BULL SOC PREHIST FR, V105, P103, DOI 10.3406/bspf.2008.13707; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2015, J HUM EVOL, V79, P73, DOI 10.1016/j.jhevol.2014.06.017; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Denaire A, 2016, J ARCHAEOLOGICAL MET; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004401; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Garanger J., 1972, ARCHEOLOGIE MISE PLA, V1; Goude G, 2015, INT J OSTEOARCHAEOL, V25, P988, DOI 10.1002/oa.2399; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Jeunesse C., 1982, REV ARCHEOLOGIQUE PI, V4, P49; Jeunesse C., 2006, MORTS ANORMAUX SEPUT, P28; Jeunesse C., 1998, MICHELSBERGER KULTUR, V43, P29; Jeunesse C, 2004, CAHIERS ASS PROMOTIO, V18, P1; Keller M, 2015, AM J PHYS ANTHROPOL, V157, P458, DOI 10.1002/ajpa.22738; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Le Bolloch MA, 1989, CERAMIQUE MICHELSBER; Lee E, 2014, ARCHAEOL ANTHROP SCI, V6, P199, DOI 10.1007/s12520-013-0173-0; Lefranc P, 2014, NEOLITHIC BODIES NEO; Lefranc P, 2015, DEATH ARCHAEOLOGY TR, P131; Lefranc P., 2009, FOUILLES DECOUVERTES, P25; Lichardus J., 1986, NEOL FRANC, P243; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Mendisco F, 2011, ELECTROPHORESIS, V32, P386, DOI 10.1002/elps.201000483; Nickel C., 1998, BERICHT ROMISCH GERM; Olalde I., 2015, MOL BIOL EVOL, DOI DOI 10.1093/MOLBEV/MSV181; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Omrak A, 2016, CURR BIOL, V26, P270, DOI 10.1016/j.cub.2015.12.019; Price TD, 2000, EUROPES 1 FARMERS; Rivollat M, 2016, EUROPEAN J HUMAN GEN; Rivollat M, 2016, AM J PHYS ANTHROPOL, V161, P522, DOI 10.1002/ajpa.23055; Rivollat M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125521; SCHWEITZER J., 1987, CAHIERS ASS PROMOTIO, V3, P50; SCOLLAR I, 1959, P PREHIST SOC, V25, P52, DOI 10.1017/S0079497X00016509; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Szecsenyi-Nagy A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0339; Testart A., 2004, SERVITUDE VOLONTAIRE; Thomas L-V, 1980, CADAVRE BIOL EDITONS; Thomas Y, 2016, GOUGENHEIM GINGSHEIM; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Whittle A., 1996, EUROPE NEOLITHIC CRE	51	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179742	10.1371/journal.pone.0179742	http://dx.doi.org/10.1371/journal.pone.0179742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA2LF	28678860	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200026
J	Bhak, Y; Jeon, Y; Jeon, S; Chung, O; Jho, S; Jun, J; Kim, HM; Cho, Y; Yoon, C; Lee, S; Kang, JH; Lim, JD; An, J; Cho, YS; Ryu, DY; Bhak, J				Bhak, Youngjune; Jeon, Yeonsu; Jeon, Sungwon; Chung, Oksung; Jho, Sungwoong; Jun, JeHoon; Kim, Hak-Min; Cho, Yongsoo; Yoon, Changhan; Lee, Seungwoo; Kang, Jung-Hoon; Lim, Jong-Deock; An, Junghwa; Cho, Yun Sung; Ryu, Doug-Young; Bhak, Jong			Myotis rufoniger genome sequence and analyses: M-rufoniger's genomic feature and the decreasing effective population size of Myotis bats	PLOS ONE			English	Article							OCULOCUTANEOUS ALBINISM; CHIROPTERA; ALIGNMENT; GENE; DNA; VESPERTILIONIDAE; IDENTIFICATION; SPERMATOZOA; GENERATION; MUTATIONS	Myotis rufoniger is a vesper bat in the genus Myotis. Here we report the whole genome sequence and analyses of the M. rufoniger. We generated 124 Gb of short-read DNA sequences with an estimated genome size of 1.88 Gb at a sequencing depth of 66x fold. The sequences were aligned to M. brandtii bat reference genome at a mapping rate of 96.50% covering 95.71% coding sequence region at 10x coverage. The divergence time of Myotis bat family is estimated to be 11.5 million years, and the divergence time between M. rufoniger and its closest species M. davidii is estimated to be 10.4 million years. We found 1,239 function-altering M. rufoniger specific amino acid sequences from 929 genes compared to other Myotis bat and mammalian genomes. The functional enrichment test of the 929 genes detected amino acid changes in melanin associated DCT, SLC45A2, TYRP1, and OCA2 genes possibly responsible for the M. rufoniger's red fur color and a general coloration in Myotis. N6AMT1 gene, associated with arsenic resistance, showed a high degree of function alteration in M. rufoniger. We further confirmed that the M. rufoniger also has batspecific sequences within FSHB, GHR, IGF1R, TP53, MDM2, SLC45A2, RGS7BP, RHO, OPN1SW, and CNGB3 genes that have already been published to be related to bat's reproduction, lifespan, flight, low vision, and echolocation. Additionally, our demographic history analysis found that the effective population size of Myotis clade has been consistently decreasing since similar to 30k years ago. M. rufoniger's effective population size was the lowest in Myotis bats, confirming its relatively low genetic diversity.	[Bhak, Youngjune; Jeon, Yeonsu; Jeon, Sungwon; Kim, Hak-Min; Cho, Yongsoo; Yoon, Changhan; Cho, Yun Sung; Bhak, Jong] Ulsan Natl Inst Sci & Technol, Genom Inst, Ulsan, South Korea; [Bhak, Youngjune; Jeon, Yeonsu; Jeon, Sungwon; Kim, Hak-Min; Cho, Yongsoo; Cho, Yun Sung; Bhak, Jong] Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Sch Life Sci, Ulsan, South Korea; [Chung, Oksung; Jho, Sungwoong; Jun, JeHoon; Cho, Yun Sung; Bhak, Jong] Genome Res Fdn, Personal Genom Inst, Cheongju, South Korea; [Yoon, Changhan] Ulsan Natl Inst Sci & Technol, Dept Biomed Sci, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Lee, Seungwoo; Ryu, Doug-Young] Seoul Natl Univ, PLUS Program Creat Vet Sci Res BK21, Res Inst Vet Sci, Seoul, South Korea; [Lee, Seungwoo; Ryu, Doug-Young] Seoul Natl Univ, Coll Vet Med, Seoul, South Korea; [Kang, Jung-Hoon; Lim, Jong-Deock] Cultural Heritage Adm, Natl Res Inst Cultural Heritage, Daejeon, South Korea; [An, Junghwa] Natl Inst Biol Resources, Anim Resources Div, Incheon, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Seoul National University (SNU); Seoul National University (SNU); National Institute of Biological Resources	Cho, YS; Bhak, J (corresponding author), Ulsan Natl Inst Sci & Technol, Genom Inst, Ulsan, South Korea.; Cho, YS; Bhak, J (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Sch Life Sci, Ulsan, South Korea.; Cho, YS; Bhak, J (corresponding author), Genome Res Fdn, Personal Genom Inst, Cheongju, South Korea.; Ryu, DY (corresponding author), Seoul Natl Univ, PLUS Program Creat Vet Sci Res BK21, Res Inst Vet Sci, Seoul, South Korea.; Ryu, DY (corresponding author), Seoul Natl Univ, Coll Vet Med, Seoul, South Korea.	joys0406@gmail.com; dyryu@snu.ac.kr; jongbhak@genomics.org		Bhak, Youngjune/0000-0002-9273-6984; Jeon, Sungwon/0000-0002-2729-9087; Cho, Yun Sung/0000-0003-4490-8769	'the bioinformatics marker discovery analysis system using genomic big data' Research Fund of Ulsan National Institute of Science & Technology (UNIST) [1.150014.01]; 'Software Convergence Technology Development Program' through the Ministry of Science, ICT and Future Planning [S0503-171 007]; PGI of Genome Research Foundation; National Institute of Biological Resources - Ministry of Environment, Republic of Korea [NIBR201603103]; Ulsancity's Genome Korea Project	'the bioinformatics marker discovery analysis system using genomic big data' Research Fund of Ulsan National Institute of Science & Technology (UNIST); 'Software Convergence Technology Development Program' through the Ministry of Science, ICT and Future Planning; PGI of Genome Research Foundation; National Institute of Biological Resources - Ministry of Environment, Republic of Korea; Ulsancity's Genome Korea Project	This work was supported by 'the bioinformatics marker discovery analysis system using genomic big data' Research Fund (1.150014.01) of Ulsan National Institute of Science & Technology (UNIST). It was also supported by 'Software Convergence Technology Development Program' through the Ministry of Science, ICT and Future Planning (S0503-171 007), PGI of Genome Research Foundation internal research fund, a grant (NIBR201603103) from the National Institute of Biological Resources funded by the Ministry of Environment, Republic of Korea, and Ulsancity's Genome Korea Project. Geromics Inc. provided support in the form of salaries for OC, JHJ, and JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Boissy RE, 1996, AM J HUM GENET, V58, P1145; Cho YS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3433; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Chung O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0780-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hartman CG, 1933, Q REV BIOL, V8, P185, DOI 10.1086/394433; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iannelli M, 2011, COMMUNICATION   0618; Kim S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1071-4; Kim YM, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2011.624598; KITCHENER DJ, 1975, AUST J ZOOL, V23, P29, DOI 10.1071/ZO9750029; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Monge G, 2014, SCI REPORTS, V5, P14252; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; RACEY PA, 1979, J REPROD FERTIL, V56, P391; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P771, DOI 10.1289/ehp.1002733; Ruedi M, 2015, ZOOTAXA, V3920, P301, DOI 10.11646/zootaxa.3920.2.6; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith JDL, 2009, BIOL LETTERS, V5, P347, DOI 10.1098/rsbl.2009.0016; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sturm RA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-248; Tacutu R, 2012, NUCLEIC ACIDS RES; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Tomes RF, 1858, P ZOOLOGICAL SOC LON; Xu X, 2013, CURR BIOL, V23, P1031, DOI 10.1016/j.cub.2013.04.054; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Yu HeeJeong, 2016, Korean Journal of Veterinary Research, V56, P51, DOI 10.14405/kjvr.2016.56.1.51; Zhang G, 2012, SCIENCE	45	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180418	10.1371/journal.pone.0180418	http://dx.doi.org/10.1371/journal.pone.0180418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678835	gold, Green Published, Green Submitted			2022-12-27	WOS:000405272200063
J	Eschalier, B; Descamps, S; Pereira, B; Vaillant-Roussel, H; Girard, G; Boisgard, S; Coudeyre, E				Eschalier, Benedicte; Descamps, Stephane; Pereira, Bruno; Vaillant-Roussel, Helene; Girard, Guillaume; Boisgard, Stephane; Coudeyre, Emmanuel			Randomized blinded trial of standardized written patient information before total knee arthroplasty	PLOS ONE			English	Article							QUALITY-OF-LIFE; EDUCATIONAL BOOKLET; HIP; REHABILITATION; OSTEOARTHRITIS; PROGRAM; REPLACEMENT; ELABORATION; VALIDATION; OUTCOMES	Background The effect of patient education before total knee arthroplasty (TKA) is controversial. No consensus exists about the optimal content of educational interventions. In a previous study, we developed and validated an educational booklet on the peri-TKA management of knee osteoarthritis. Purposes Our primary purpose was to evaluate the impact of the educational booklet on knowledge among patients awaiting TKA. Patients and methods This randomized controlled single-blind trial evaluated standard information by the surgeon with or without delivery of the educational booklet 4-6 weeks before primary noncomplex TKA in patients aged 55-75 years with incapacitating knee osteoarthritis. Patients were enrolled at a French surgical center between June 2011 and January 2012. A patient knowledge score was determined at baseline, on the day before TKA, and 3-6 weeks after TKA, using a self-administered questionnaire developed for our previous study. The assessor was blinded to group assignment. Results Of 44 eligible patients, 42 were randomized, 22 to the intervention and 20 to the control group, all of whom were included in the analysis. The groups were comparable at baseline. The intervention was associated with significantly better patient knowledge scores. Conclusions An educational booklet improves knowledge among patients awaiting TKA. A study assessing the impact of the booklet combined with a exercise program would be helpful.	[Eschalier, Benedicte; Vaillant-Roussel, Helene] Univ Clermont Auvergne Clermont, Fac Med, Dept Med Gen, Clermont Ferrand, France; [Descamps, Stephane; Girard, Guillaume; Boisgard, Stephane] Univ Clermont Auvergne, CHU Clermont Ferrand, Serv Chirurg Orthoped & Traumatol, C BIOSENSS, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Direct Rech Clin Innovat, Clermont Ferrand, France; [Coudeyre, Emmanuel] Univ Clermont Auvergne, CHU Clermont Ferrand, INRA, Serv Med Phys & Readaptat, Clermont Ferrand, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; CHU Clermont Ferrand; INRAE; Universite Clermont Auvergne (UCA)	Coudeyre, E (corresponding author), Univ Clermont Auvergne, CHU Clermont Ferrand, INRA, Serv Med Phys & Readaptat, Clermont Ferrand, France.	ecoudeyre@chu-clermontferrand.fr		coudeyre, emmanuel/0000-0001-5753-2890; descamps, stephane/0000-0002-9065-7385				Beaupre LA, 2004, J RHEUMATOL, V31, P1166; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Benhamou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053886; Beswick AD, 2012, BMJ OPEN, V22, P2; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Coudeyre E, 2002, JOINT BONE SPINE, V69, P597, DOI 10.1016/S1297-319X(02)00457-8; Coudeyre E., 2010, Annals of Physical and Rehabilitation Medicine, V53, P434, DOI 10.1016/j.rehab.2010.07.002; Coudeyre E., 2009, Annals of Physical and Rehabilitation Medicine, V52, P694, DOI 10.1016/j.rehab.2009.09.003; Coudeyre E., 2007, Annales de Readaptation et de Medecine Physique, V50, P327, DOI 10.1016/j.annrmp.2007.04.002; Coudeyre E., 2007, Annales de Readaptation et de Medecine Physique, V50, P189, DOI 10.1016/j.annrmp.2007.02.002; Coudeyre E., 2007, Annales de Readaptation et de Medecine Physique, V50, P179, DOI 10.1016/j.annrmp.2007.02.001; Eschalier B, 2013, ORTHOP TRAUMATOL-SUR, V99, P313, DOI 10.1016/j.otsr.2013.01.007; Faucher M, 2004, JOINT BONE SPINE, V71, P121, DOI 10.1016/S1297-319X(03)00112-X; Fortin PR, 1999, ARTHRITIS RHEUM, V42, pS99; Heuts PHTG, 2004, PAIN, V110, P228, DOI 10.1016/j.pain.2004.03.035; Huang SW, 2012, ORTHOP TRAUMATOL-SUR, V98, P259, DOI 10.1016/j.otsr.2011.12.004; JACKSON C, 1995, BRIT DENT J, V179, P163, DOI 10.1038/sj.bdj.4808865; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Luo YY, 2012, J CLIN NURS; Mancuso CA, 2008, CLIN ORTHOP RELAT R, V466, P424, DOI 10.1007/s11999-007-0052-z; McClune T, 2003, EMERG MED J, V20, P514, DOI 10.1136/emj.20.6.514; Nunez M, 2006, OSTEOARTHR CARTILAGE, V14, P279, DOI 10.1016/j.joca.2005.10.002; Oldmeadow LB, 2003, J ARTHROPLASTY, V18, P775, DOI 10.1016/S0883-5403(03)00151-7; Semanik PA, 2012, PM&R, V4, pS37, DOI 10.1016/j.pmrj.2012.02.015; Spencer C, 2005, PEDIATR ANESTH, V15, P547, DOI 10.1111/j.1460-9592.2005.01500.x; Suri P, 2012, PM&R, V4, pS10, DOI 10.1016/j.pmrj.2012.01.007; Viton JM, 1999, SCAND J REHABIL MED, V31, P43; Wallis JA, 2011, OSTEOARTHR CARTILAGE, V19, P1381, DOI 10.1016/j.joca.2011.09.001	28	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178358	10.1371/journal.pone.0178358	http://dx.doi.org/10.1371/journal.pone.0178358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678854	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200004
J	Wotodjo, AN; Doucoure, S; Gaudart, J; Diagne, N; Sarr, FD; Faye, N; Tall, A; Raoult, D; Sokhna, C				Wotodjo, Amele Nyedzie; Doucoure, Souleymane; Gaudart, Jean; Diagne, Nafissatou; Sarr, Fatoumata Diene; Faye, Ngor; Tall, Adama; Raoult, Didier; Sokhna, Cheikh			Malaria in Dielmo, a Senegal village: Is its elimination possible after seven years of implementation of long-lasting insecticide-treated nets?	PLOS ONE			English	Article							BED NETS; PYRETHROID RESISTANCE; ARTEMETHER-LUMEFANTRINE; ARTEMISININ RESISTANCE; FALCIPARUM-MALARIA; HOLOENDEMIC AREA; VECTOR CONTROL; TRANSMISSION; EFFICACY; IMPACT	Background The malaria burden has decreased significantly in recent years in Africa through the widespread use of artemisinin-based combination therapy (ACT) and long-lasting insectici-detreated nets (LLINs). However, the occurrence of malaria resurgences, the loss of immunity of exposed populations constitute among other factors, serious concerns about the future of malaria elimination efforts. This study investigated the evolution of malaria morbidity in Dielmo (Senegal) before and after the implementation of LLINs. Methods A longitudinal study was carried out in Dielmo over eight years, from July 2007 to July 2015. In July 2008, LLINs were offered to all villagers, and in July 2011 and August 2014 the LLINs were renewed. A survey on LLINs use was done each quarter of the year. Thick smears stained with Giemsa, a rapid diagnostic test (RDT) and quantitative polymerase chain reaction (PCR) methods were performed for all cases of fever to assess malaria clinical attacks. Malaria cases were treated with ACT since June 2006. Results Malaria morbidity has decreased significantly since the implementation of LLINs in Dielmo, together with ACT. However, malaria resurgences have occurred twice during the seven years of LLINs use. These resurgences occurred the first time during the third year after the introduction of LLINs (aIRR (adjusted incidence-rate ratio) [95% CI] = 5.90 [3.53; 9.88] p< 0.001) and a second time during the third year after the renewal of LLINs (aIRR [95% CI] = 5.60 [3.34; 9.39] p<0.001). Sixty-nine percent (69%) of the nets tested for their long-lasting insecticidal activity remained effective after 3 years of use. Conclusion Good management of malaria cases by the use of ACT as first-line treatment against malaria in addition to the use of LLINshas significantly reduced malaria in Dielmo and allowed to reach the phase of pre-elimination of the disease. However, the occurrence of malaria resurgences raised serious concerns about malaria elimination, which would require additional tools in this village.	[Wotodjo, Amele Nyedzie; Doucoure, Souleymane; Diagne, Nafissatou; Sokhna, Cheikh] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, INSERMU1095, IRD198,UM63,CNRS7278, Campus UCAD IRD, Dakar, Senegal; [Wotodjo, Amele Nyedzie; Faye, Ngor] Univ Cheikh Anta Diop Dakar, Fac Sci & Tech, Lab Parasitol, Dakar, Senegal; [Gaudart, Jean] Aix Marseille Univ, IER, INSERM, SESSTIM UMR912, Marseille, France; [Sarr, Fatoumata Diene; Tall, Adama] Inst Pasteur, Unite Epiderniol Malad Infect, Dakar, Senegal; [Raoult, Didier] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, Inst Hosp Univ Mediterranee Infect, IRD198,UM63,CNRS7278,INSERMU1095, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; University Cheikh Anta Diop Dakar; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Sokhna, C (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, INSERMU1095, IRD198,UM63,CNRS7278, Campus UCAD IRD, Dakar, Senegal.	cheikh.sokhna@ird.fr	wotodjo, Amélé Nyedzie/AAK-5188-2020; gaudart, jean/D-9071-2013; RAOULT, Didier/A-8434-2008	wotodjo, Amélé Nyedzie/0000-0001-6940-7325; gaudart, jean/0000-0001-9006-5729; RAOULT, Didier/0000-0002-0633-5974	Institut de Recherche pour le Developpement; Pasteur Institute of Dakar	Institut de Recherche pour le Developpement; Pasteur Institute of Dakar	Funded by Institut de Recherche pour le Developpement and the Pasteur Institute of Dakar.	[Anonymous], MALARIA J; [Anonymous], 2019, GUID LAB FIELD TEST; [Anonymous], 2005, GUIDELINES LAB FIELD; [Anonymous], 2008, GLOB MAL ACT PLAN MA; [Anonymous], PLOS ONE; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Barnes KI, 2005, ACTA TROP, V94, P230, DOI 10.1016/j.actatropica.2005.04.014; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Berthelemy JC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-200; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; CHOI HW, 1995, AM J TROP MED HYG, V52, P377, DOI 10.4269/ajtmh.1995.52.377; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Drakeley C, 2014, LANCET INFECT DIS, V14, P445, DOI 10.1016/S1473-3099(14)70742-X; Egrot M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-247; Faye B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-80; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Greenwood B, 2014, LANCET, V383, P1703, DOI 10.1016/S0140-6736(14)60044-1; Greenwood Brian, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS2, DOI 10.1016/j.trstmh.2008.10.027; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Honjo K, 2013, PARASITOLOGY, V140, P580, DOI 10.1017/S0031182012002077; Kariuki SK, 2003, AM J TROP MED HYG, V68, P108, DOI 10.4269/ajtmh.2003.68.108; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-264; Makanga M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-291; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Ndour C T, 2006, Bull Soc Pathol Exot, V99, P290; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Nuwaha F, 2001, AM J TROP MED HYG, V65, P877, DOI 10.4269/ajtmh.2001.65.877; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; Trape JF, 2012, J INFECT DIS, V205, P672, DOI 10.1093/infdis/jir805; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2008, GLOB MAL CONTR EL RE; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Wotodjo AN, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0871-9; Wotodjo AN, 2015, AM J TROP MED HYG, V92, P565, DOI 10.4269/ajtmh.14-0485; Zwang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006358	54	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179528	10.1371/journal.pone.0179528	http://dx.doi.org/10.1371/journal.pone.0179528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678846	gold, Green Published, Green Submitted			2022-12-27	WOS:000405272200017
J	Ho, SY; Liu, PH; Hsu, CY; Hsia, CY; Lee, YH; Lee, RC; Huang, YH; Lee, FY; Hou, MC; Tsai, YJ; Huo, TI				Ho, Shu-Yein; Liu, Po-Hong; Hsu, Chia-Yang; Hsia, Cheng-Yuan; Lee, Yun-Hsuan; Lee, Rheun-Chuan; Huang, Yi-Hsiang; Lee, Fa-Yauh; Hou, Ming-Chih; Tsai, Ya-Ju; Huo, Teh-Ia			Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization	PLOS ONE			English	Article							HEPATITIS-B; RENAL-FAILURE; CIRRHOSIS; SCORE; FIBROSIS; DISEASE; RISK; DETERMINANTS; VALIDATION; PREDICTION	Background Various noninvasive liver reserve markers were proposed to indicate the severity of liver damage. However, the role and feasibility of these markers to predict the prognosis of patients with hepatocellular carcinoma (HCC) are unknown. We aimed to identify the prognostic role of the 8 currently used hepatic reserve markers in patients with HCC undergoing transarterial chemoembolization (TACE). Methods Between 2002 and 2013, a total of 881 patients with HCC undergoing TACE were prospectively identified and retrospectively analyzed. The baseline characteristics, tumor status and noninvasive markers were collected. Homogeneity and corrected Akaike information criteria (AICc) were compared between these markers. The Cox proportional hazards model was used to identify independent predictors of survival. Results Significant differences in survival distribution were found for albumin-bilirubin (ALBI) grade, Child-Turcotte-Pugh (CTP) class, Lok index, fibrosis index based on 4 factors (FIB-4), Go E teborg University cirrhosis index (GUCI), cirrhosis discriminant index (CDI) and model for endstage liver disease (MELD) score (all p values <0.05). Among these markers, the ALBI grade showed the highest homogeneity and lowest AICc value, indicating a better prognostic performance. Cox multivariate analysis confirmed that ALBI grade 2, ascites, serum alkaline phosphatase and alpha-fetoprotein level, tumor diameter, vascular invasion and performance status were significant independent prognostic predictors. The distribution of the ALBI score well correlated with baseline CTP and MLED scores. Conclusions Our data suggest that among the currently used liver reserve markers, ALBI grade may serve as an objective and feasible surrogate to predict the prognosis of HCC patients undergoing TACE.	[Ho, Shu-Yein; Liu, Po-Hong; Lee, Yun-Hsuan; Huang, Yi-Hsiang; Lee, Fa-Yauh; Hou, Ming-Chih; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Ho, Shu-Yein; Liu, Po-Hong; Hsu, Chia-Yang; Hsia, Cheng-Yuan; Lee, Yun-Hsuan; Lee, Rheun-Chuan; Huang, Yi-Hsiang; Lee, Fa-Yauh; Hou, Ming-Chih; Huo, Teh-Ia] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Liu, Po-Hong] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Hsu, Chia-Yang] Univ Nevada, Sch Med, Dept Internal Med, Reno, NV 89557 USA; [Hsia, Cheng-Yuan] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Lee, Rheun-Chuan] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Huang, Yi-Hsiang] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Tsai, Ya-Ju] Renown Reg Med Ctr, Reno, NV USA; [Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Harvard University; Harvard T.H. Chan School of Public Health; Nevada System of Higher Education (NSHE); University of Nevada Reno; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huo, TI (corresponding author), Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.; Huo, TI (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.; Huo, TI (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei, Taiwan.	tihuo@vghtpe.gov.tw	Liu, Po-Hong/HGB-9015-2022; Liu, Po-Hong/G-8459-2015	Liu, Po-Hong/0000-0001-6205-3704; Huang, Yi-Hsiang/0000-0001-5241-5425	Center of Excellence for Cancer Research at Taipei Veterans General Hospital Taiwan [MOHW104-TDUB -211-124-001]; Taipei Veterans Genera lHospital Taiwan [V105C-009, V105A-011, VN1061 1]	Center of Excellence for Cancer Research at Taipei Veterans General Hospital Taiwan; Taipei Veterans Genera lHospital Taiwan(Taipei Veterans General Hospital)	This study was supported by grants from the Center of Excellence for Cancer Research at Taipei Veterans General Hospital (MOHW104-TDUB -211-124-001), Taiwan, from Taipei Veterans Genera lHospital (V105C-009,V105A-011,VN1061 1), Taiwan.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chan AWH, 2016, J GASTROEN HEPATOL, V31, P1300, DOI 10.1111/jgh.13291; Choi WM, 2015, LIVER INT, V35, P1992, DOI 10.1111/liv.12776; Durand F, 2008, SEMIN LIVER DIS, V28, P110, DOI 10.1055/s-2008-1040325; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Hiraoka A, 2016, J GASTROEN HEPATOL, V31, P1031, DOI 10.1111/jgh.13250; Hsu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118825; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; Hsu CY, 2010, LIVER INT, V30, P77, DOI 10.1111/j.1478-3231.2009.02128.x; Huang YH, 2005, ALIMENT PHARM THER, V21, P687, DOI 10.1111/j.1365-2036.2005.02404.x; Huo TI, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-146; Huo TI, 2006, J CLIN GASTROENTEROL, V40, P543, DOI 10.1097/00004836-200607000-00014; Huo TI, 2004, ALIMENT PHARM THER, V19, P999, DOI 10.1111/j.1365-2036.2004.01936.x; Ibrahim JG, 2012, J CLIN ONCOL, V30, P3297, DOI 10.1200/JCO.2011.38.7589; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kao WY, 2011, WORLD J SURG, V35, P858, DOI 10.1007/s00268-010-0928-z; Lee IC, 2012, HEPATOL INT, V6, P753, DOI 10.1007/s12072-011-9322-7; Lee MH, 2013, HEPATOLOGY, V58, P546, DOI 10.1002/hep.26385; Lee YH, 2014, J CLIN GASTROENTEROL, V48, P734, DOI 10.1097/MCG.0b013e3182a8a254; Liu P. H., 2016, J GASTROENTEROL HEPA; Liu PH, 2016, EUR J CANCER, V63, P25, DOI 10.1016/j.ejca.2016.04.023; Liu PH, 2016, J HEPATOL, V64, P601, DOI 10.1016/j.jhep.2015.10.029; Liu PH, 2015, J SURG ONCOL, V111, P404, DOI 10.1002/jso.23854; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petrick JL, 2016, J CLIN ONCOL, V34, P1787, DOI 10.1200/JCO.2015.64.7412; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Su YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174333; Tournoux-Facon C, 2011, J HEPATOL, V54, P108, DOI 10.1016/j.jhep.2010.06.015; Udell JA, 2012, JAMA-J AM MED ASSOC, V307, P832, DOI 10.1001/jama.2012.186; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Waked I, 2017, BRIT J CANCER, V116, P448, DOI 10.1038/bjc.2016.423	39	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180408	10.1371/journal.pone.0180408	http://dx.doi.org/10.1371/journal.pone.0180408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672011	gold, Green Submitted, Green Published			2022-12-27	WOS:000405268500051
J	Perez-Basterrechea, M; Esteban, MM; Alvarez-Viejo, M; Fontanil, T; Cal, S; Pitiot, MS; Otero, J; Obaya, AJ				Perez-Basterrechea, Marcos; Martinez Esteban, Manuel; Alvarez-Viejo, Maria; Fontanil, Tania; Cal, Santiago; Sanchez Pitiot, Marta; Otero, Jesus; Jesus Obaya, Alvaro			Fibroblasts accelerate islet revascularization and improve long-term graft survival in a mouse model of subcutaneous islet transplantation	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL REGENERATION; PANCREATIC-ISLETS; ENGRAFTMENT; INTERLEUKIN-6; ANGIOGENESIS; ACTIVATION; SITE; RATS	Pancreatic islet transplantation has been considered for many years a promising therapy for beta-cell replacement in patients with type-1 diabetes despite that long-term clinical results are not as satisfactory. This fact points to the necessity of designing strategies to improve and accelerate islets engraftment, paying special attention to events assuring their revascularization. Fibroblasts constitute a cell population that collaborates on tissue homeostasis, keeping the equilibrium between production and degradation of structural components as well as maintaining the required amount of survival factors. Our group has developed a model for subcutaneous islet transplantation using a plasma-based scaffold containing fibroblasts as accessory cells that allowed achieving glycemic control in diabetic mice. Transplanted tissue engraftment is critical during the first days after transplantation, thus we have gone in depth into the graft-supporting role of fibroblasts during the first ten days after islet transplantation. All mice transplanted with islets embedded in the plasma-based scaffold reversed hyperglycemia, although long-term glycemic control was maintained only in the group transplanted with the fibroblasts-containing scaffold. By gene expression analysis and histology examination during the first days we could conclude that these differences might be explained by overexpression of genes involved in vessel development as well as in beta-cell regeneration that were detected when fibroblasts were present in the graft. Furthermore, fibroblasts presence correlated with a faster graft re-vascularization, a higher insulinpositive area and a lower cell death. Therefore, this work underlines the importance of fibroblasts as accessory cells in islet transplantation, and suggests its possible use in other graft supporting strategies.	[Perez-Basterrechea, Marcos; Alvarez-Viejo, Maria; Otero, Jesus] Hosp Univ Cent Asturias, Unidad Trasplantes Terapia Celular & Med Regenera, Oviedo, Spain; [Martinez Esteban, Manuel; Jesus Obaya, Alvaro] Univ Oviedo, Dept Biol Func, Oviedo, Spain; [Fontanil, Tania; Cal, Santiago] Univ Oviedo, Dept Bioquim & Biol Mol, Oviedo, Spain; [Sanchez Pitiot, Marta] Inst Univ Oncol Principado Asturias, Unidad Histopatol Mol Modelos Anim Canc, Oviedo, Spain	Central University Hospital Asturias; University of Oviedo; University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Perez-Basterrechea, M (corresponding author), Hosp Univ Cent Asturias, Unidad Trasplantes Terapia Celular & Med Regenera, Oviedo, Spain.	mpbasterrechea@gmail.com	Obaya, Alvaro J./AAQ-6115-2021; López, tania Fontanil/AAM-6512-2020; Basterrechea, Marcos Perez/L-9052-2014	Obaya, Alvaro J./0000-0002-4163-2173; Basterrechea, Marcos Perez/0000-0002-8242-5365; Fontanil, Tania/0000-0003-2261-7661	European Union FEDER Funds; Plande Ciencia, Tecnologia e Innovacion del Principado de Asturias; Fundacion para el Fomento en Asturias de la Investigacion Cientofica Aplicada y la Tecnologia (FICYT)	European Union FEDER Funds(European Commission); Plande Ciencia, Tecnologia e Innovacion del Principado de Asturias; Fundacion para el Fomento en Asturias de la Investigacion Cientofica Aplicada y la Tecnologia (FICYT)	This work was supported by a grant (Grant number: GRUPIN14-069) from the European Union FEDER Funds, Plande Ciencia, Tecnologia e Innovacion del Principado de Asturias, Fundacion para el Fomento en Asturias de la Investigacion Cientofica Aplicada y la Tecnologia (FICYT, http://www.ficyt.es/) to JO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2001, P NATL ACAD SCI USA, V98, P48, DOI 10.1073/pnas.240458597; Baeza N, 1996, DIABETES METAB, V22, P229; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Bhang SH, 2013, BIOMATERIALS, V34, P7247, DOI 10.1016/j.biomaterials.2013.06.018; Bharat A, 2005, TRANSPLANTATION, V79, P1627, DOI 10.1097/01.TP.0000159145.86990.44; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Brady AC, 2013, TISSUE ENG PT A, V19, P2544, DOI [10.1089/ten.tea.2012.0686, 10.1089/ten.TEA.2012.0686]; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Calderari S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090045; D'Addio F, 2014, DIABETES, V63, P3041, DOI 10.2337/db14-0295; Delgado E, 2015, EBIOMEDICINE, V2, P2024, DOI 10.1016/j.ebiom.2015.11.003; Dirice E, 2014, DIABETES, V63, P188, DOI 10.2337/db13-0204; Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Gu Y, 2001, CELL TRANSPLANT, V10, P453; Juang JH, 1996, TRANSPLANTATION, V61, P1557, DOI 10.1097/00007890-199606150-00001; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Krause MD, 2012, J ENDOCRINOL, V214, P301, DOI 10.1530/JOE-12-0223; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Luo C, 2013, MOL CELL ENDOCRINOL, V365, P187, DOI 10.1016/j.mce.2012.10.018; Maffi P, 2015, PHARMACOL RES, V98, P86, DOI 10.1016/j.phrs.2015.04.010; Matsushima H, 2016, CELL TRANSPLANT, V25, P1525, DOI 10.3727/096368916X690854; Najjar M, 2015, BIOTECHNOL BIOENG, V112, P1916, DOI 10.1002/bit.25589; Ngernyuang N, 2014, INT J BIOCHEM CELL B, V51, P45, DOI 10.1016/j.biocel.2014.03.021; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Park KS, 2009, TRANSPL P, V41, P3813, DOI 10.1016/j.transproceed.2009.06.193; Pepper AR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/352315; Perez-Basterrechea M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073526; Perez-Basterrechea M, 2009, TISSUE ENG PT A, V15, P569, DOI 10.1089/ten.tea.2008.0088; Prokop A, 2001, Diabetes Technol Ther, V3, P245, DOI 10.1089/152091501300209624; PURVES RD, 1992, J PHARMACOKINET BIOP, V20, P501, DOI 10.1007/BF01061468; Rodemann HP, 2011, TUMOR MICROENVIRON, V4, P23, DOI 10.1007/978-94-007-0659-0_2; Sakata N, 2014, DIABETES-METAB RES, V30, P1, DOI 10.1002/dmrr.2463; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Singh B, 2011, J INTERF CYTOK RES, V31, P711, DOI 10.1089/jir.2011.0025; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Staels W, 2016, DIABETES OBES METAB, V18, P115, DOI 10.1111/dom.12556; Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P957, DOI 10.1163/156856299X00559; Tezza S, 2015, PHARMACOL RES, V98, P69, DOI 10.1016/j.phrs.2014.06.016; Timper K, 2016, GASTROENTEROLOGY, V151, P165, DOI 10.1053/j.gastro.2016.03.003; UNNO M, 1992, ADV EXP MED BIOL, V321, P61; VANDERVLIET JA, 1988, TRANSPLANTATION, V45, P493; Vantyghem MC, 2014, DIABETES METAB, V40, P108, DOI 10.1016/j.diabet.2013.10.003; Velmurugan K, 2012, J NEUROCHEM, V123, P919, DOI 10.1111/jnc.12036; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Wang WJ, 2002, TRANSPLANTATION, V73, P122, DOI 10.1097/00007890-200201150-00023; WATANABE T, 1994, P NATL ACAD SCI USA, V91, P3589, DOI 10.1073/pnas.91.9.3589; Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x; Xia F, 2016, J LEUKOCYTE BIOL, V99, P1131, DOI 10.1189/jlb.3A0815-371RRR	52	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180695	10.1371/journal.pone.0180695	http://dx.doi.org/10.1371/journal.pone.0180695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672010	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500080
J	van Dijk, EHC; Tsonaka, R; Klar-Mohamad, N; Wouters, D; de Vries, APJ; de Jong, EK; van Kooten, C; Boon, CJF				van Dijk, Elon H. C.; Tsonaka, Roula; Klar-Mohamad, Ngaisah; Wouters, Diana; de Vries, Aiko P. J.; de Jong, Eiko K.; van Kooten, Cees; Boon, Camiel J. F.			Systemic complement activation in central serous chorioretinopathy	PLOS ONE			English	Article							MACULAR DEGENERATION; FACTOR-H; LUPUS-ERYTHEMATOSUS; RISK; POLYMORPHISM; VARIANTS; GENE; PATHOPHYSIOLOGY; CORTICOSTEROIDS; PERSPECTIVE	Purpose A clear link between several variants in genes involved in the complement system and chronic central serous chorioretinopathy (CSC) has been described. In age-related macular degeneration, a disease that shows clinical features that overlap with CSC, both genetic risk factors and systemic activation of the complement system have previously been found. In this case-control study, we assessed whether there is evidence of either systemic activation or inhibition of the complement system in patients with chronic CSC. Methods A prospective case-control study of 76 typical chronic CSC patients and 29 controls without ophthalmological history was conducted. Complement activity assays (classical, alternative, and mannose-binding lectin pathway), complement factors 3, 4, 4A, 4B, B, D, H, I, and P, activation products C3d, C5a, and sC5b-C9, and the C3d/C3 ratio were analysed in either serum or plasma. A correction for possible effects of gender, age, body mass index, and smoking status was performed. Results In this study, none of the tested variables, including regulation and activation products, proved to be significantly different between the groups. Moreover, no associations with either CSC disease activity or possible CSC related steroid use were observed. Conclusion Despite the available literature regarding a possible relationship between chronic CSC and variants in genes involved in the complement system, we did not find evidence of an association of chronic CSC with either systemic complement activation or inhibition.	[van Dijk, Elon H. C.; Boon, Camiel J. F.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [Tsonaka, Roula] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Klar-Mohamad, Ngaisah; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Wouters, Diana] Acad Med Ctr, Dept Immunopathol, Sanquin Res, Amsterdam, Netherlands; [Wouters, Diana] Acad Med Ctr, Landsteiner Lab, Amsterdam, Netherlands; [de Vries, Aiko P. J.] Leiden Univ, Med Ctr, Dept Med, Div Nephrol & Transplantat, Leiden, Netherlands; [de Jong, Eiko K.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Boon, Camiel J. F.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Boon, CJF (corresponding author), Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands.; Boon, CJF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands.	c.j.f.boon@lumc.nl	de Jong, Eiko/P-3407-2015; Boon, CJF/P-7534-2014; de Vries, Aiko/J-5397-2015	de Jong, Eiko/0000-0001-6520-0407; Boon, CJF/0000-0002-6737-7932; van Dijk, Elon/0000-0002-6351-7942; de Vries, Aiko/0000-0002-9284-3595	Macula Fonds; Retina Netherlands; Blinden Penning; Landelijke Stichting voor Blindenen Slechtzienden; UitZicht; Rotterdamse Stichting Blindenbelangen; Haagse Stichting Blindenhulp; ZonMw VENI; GiselaThie rFellowship of Leiden University (CJFB)	Macula Fonds; Retina Netherlands; Blinden Penning; Landelijke Stichting voor Blindenen Slechtzienden; UitZicht; Rotterdamse Stichting Blindenbelangen; Haagse Stichting Blindenhulp; ZonMw VENI; GiselaThie rFellowship of Leiden University (CJFB)	This research was supported by the following foundations: Macula Fonds, Retina Netherlands, Blinden Penning, and Landelijke Stichting voor Blindenen Slechtzienden, which contributed through UitZicht, as well as Rotterdamse Stichting Blindenbelangen, Haagse Stichting Blindenhulp, ZonMw VENI Grant, and the GiselaThie rFellowship of Leiden University (CJFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Awan MA, 2008, CLIN EXP OPTOM, V91, P476, DOI 10.1111/j.1444-0938.2008.00268.x; Bauer ME, 2005, STRESS, V8, P69, DOI 10.1080/10253890500100240; Boon CJF, 2009, MOL IMMUNOL, V46, P1573, DOI 10.1016/j.molimm.2009.02.013; BOUZAS EA, 1993, ARCH OPHTHALMOL-CHIC, V111, P1229, DOI 10.1001/archopht.1993.01090090081024; Breukink MB, 2017, CLIN OPHTHALMOL, V11, P39, DOI 10.2147/OPTH.S115685; Breukink MB, 2015, INVEST OPHTH VIS SCI, V56, P5608, DOI 10.1167/iovs.15-17343; Carvalho-Recchia CA, 2002, OPHTHALMOLOGY, V109, P1834, DOI 10.1016/S0161-6420(02)01117-X; Daruich A, 2015, PROG RETIN EYE RES, V48, P82, DOI 10.1016/j.preteyeres.2015.05.003; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Jong EK, 2015, OPHTHALMOLOGY, V122, P562, DOI 10.1016/j.ophtha.2014.09.026; Francis PJ, 2009, J MED GENET, V46, P300, DOI 10.1136/jmg.2008.062737; Gemenetzi M, 2010, EYE, V24, P1743, DOI 10.1038/eye.2010.130; Haimovici R, 2004, OPHTHALMOLOGY, V111, P244, DOI 10.1016/j.ophtha.2003.09.024; Jonas JB, 2005, BRIT J OPHTHALMOL, V89, P386, DOI 10.1136/bjo.2004.054247; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Liew G, 2013, CLIN EXP OPHTHALMOL, V41, P201, DOI 10.1111/j.1442-9071.2012.02848.x; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Miki A, 2014, OPHTHALMOLOGY, V121, P1067, DOI 10.1016/j.ophtha.2013.11.020; Moschos MM, 2016, RETINA-J RET VIT DIS, V36, P402, DOI 10.1097/IAE.0000000000000693; Nicholson B, 2013, SURV OPHTHALMOL, V58, P103, DOI 10.1016/j.survophthal.2012.07.004; Oosterhuis JA, 1996, GRAEF ARCH CLIN EXP, V234, P337, DOI 10.1007/BF00220710; ROTHER E, 1993, CLIN RHEUMATOL, V12, P31, DOI 10.1007/BF02231555; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Schubert C, 2014, HUM MUTAT, V35, P859, DOI 10.1002/humu.22551; Shimura M, 2003, JPN J OPHTHALMOL, V47, P312, DOI 10.1016/S0021-5155(03)00012-1; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Wang M, 2008, ACTA OPHTHALMOL, V86, P126, DOI 10.1111/j.1600-0420.2007.00889.x; Warrow DJ, 2013, RETINA-J RET VIT DIS, V33, P1659, DOI 10.1097/IAE.0b013e3182953df4; Weenink AC, 2001, OPHTHALMOLOGICA, V215, P183, DOI 10.1159/000050855; Wouters D, 2009, MOL IMMUNOL, V46, P592, DOI 10.1016/j.molimm.2008.07.028; Yannuzzi LA, 2000, OPHTHALMOLOGY, V107, P767, DOI 10.1016/S0161-6420(99)00173-6; Yannuzzi LA, 2010, AM J OPHTHALMOL, V149, P361, DOI 10.1016/j.ajo.2009.11.017	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180312	10.1371/journal.pone.0180312	http://dx.doi.org/10.1371/journal.pone.0180312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671968	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500043
J	Xiao, H; Bid, HK; Chen, X; Wu, XJ; Wei, J; Bian, Y; Zhao, CG; Li, HM; Li, CL; Lin, J				Xiao, Hui; Bid, Hemant Kumar; Chen, Xiang; Wu, Xiaojuan; Wei, Jia; Bian, Yang; Zhao, Chengguang; Li, Huameng; Li, Chenglong; Lin, Jiayuh			Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy	PLOS ONE			English	Article							ESTROGEN-RECEPTOR MODULATOR; ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODY; ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER CELLS; SILTUXIMAB CNTO 328; STAT3 ACTIVATION; SMALL-MOLECULE; POSTMENOPAUSAL OSTEOPOROSIS; CONJUGATED ESTROGENS; CONTROLLED-TRIAL	Interleukins-6 (IL-6)/GP130 signaling pathway represents a promising target for cancer therapy due to its critical role in survival and progression of multiple types of cancer. We have identified Bazedoxifene, a Food and Drug Administration (FDA)-approved drug used for the prevention of postmenopausal osteoporosis, with novel function as inhibitor of IL-6/GP130 interaction. In this study, we investigate the effect of Bazedoxifene in rhabdomyosarcoma and evaluate whether inhibiting IL-6/GP130 signaling is an effective therapeutic strategy for rhabdomyosarcoma. The inhibitory effect of Bazedoxifene was assessed in rhabdomyosarcoma cell lines in vitro and RH30 xenograft model was used to further examine the suppressive efficacy of Bazedoxifene on tumor growth in vivo. Rhabdomyosarcoma cells showed their sensitivity to GP130 inhibition using gene knockdown or neutralized antibody, suggesting IL-6/GP130 as therapeutic target in rhabdomyosarcoma cells. Bazedoxifene decreased the signal transducer and activator of transcription3 (STAT3) phosphorylation, blocked STAT3 DNA binding, and down-regulated the expression of STAT3 downstream genes. Bazedoxifene also induced cell apoptosis, reduced cell viability, and inhibited colony formation in rhabdomyosarcoma cells. The inhibition of colony formation, STAT3 phosphorylation, or cell viability following Bazedoxifene treatment was partially reversed by addition of excess IL-6 or overexpression of constitutive STAT3, respectively, supporting Bazedoxifene acted through IL-6/GP130 signaling. In addition, Bazedoxifene repressed cell invasion and angiogenesis in vitro. Furthermore, oral administration of Bazedoxifene significantly suppressed tumor growth and expression of STAT3 phosphorylation in nude mice bearing established human rhabdomyosarcoma xenograft. Taken together, these findings validate IL-6/GP130 signaling as therapeutic target in rhabdomyosarcoma and provide first evidence that Bazedoxifene may serve as a novel promising drug targeting IL-6/GP130 for treatment of rhabdomyosarcoma.	[Xiao, Hui; Bian, Yang] Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH USA; [Bid, Hemant Kumar] Univ Michigan, Life Sci Inst, Resonant Therapeut Inc, Ann Arbor, MI 48109 USA; [Chen, Xiang; Wei, Jia; Lin, Jiayuh] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wu, Xiaojuan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Pediat Surg, Wuhan, Peoples R China; [Zhao, Chengguang] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou, Zhejiang, Peoples R China; [Li, Huameng] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Li, Chenglong] Univ Florida, Coll Pharm, Gainesville, FL USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore; Huazhong University of Science & Technology; Wenzhou Medical University; University System of Ohio; Ohio State University; State University System of Florida; University of Florida	Lin, J (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	JLin@som.umaryland.edu	zhao, chengguang/F-9548-2013		NIH [R21 CA191751-01]; NATIONAL CANCER INSTITUTE [R21CA191751] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the NIH R21 CA191751-01 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andrews B, 2002, J UROLOGY, V167, P1475, DOI 10.1016/S0022-5347(05)65348-7; [Anonymous], J NATL TAIPEI COLL B, DOI DOI 10.1007/S11010-012-1443-3; Archer DF, 2009, MENOPAUSE, V16, P1109, DOI 10.1097/gme.0b013e3181a818db; Arndt CAS, 2012, MAYO CLIN PROC, V87, P475, DOI 10.1016/j.mayocp.2012.01.015; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cen L, 2007, BRIT J CANCER, V97, P785, DOI 10.1038/sj.bjc.6603952; Chen CL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-111; Chen MF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-26; Chines AA, 2009, DRUG TODAY, V45, P507, DOI 10.1358/dot.2009.45.7.1395293; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Egas-Bejar D, 2014, ADOLESC HEALTH MED T, V5, P115, DOI 10.2147/AHMT.S44582; Fizazi K, 2012, EUR J CANCER, V48, P85, DOI 10.1016/j.ejca.2011.10.014; Greenberg JA, 2008, CANCER RES, V68, P3476, DOI 10.1158/0008-5472.CAN-07-3046; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; He L, 2013, GENET MOL RES, V12, P1012, DOI 10.4238/2013.April.2.17; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kharode Y, 2008, ENDOCRINOLOGY, V149, P6084, DOI 10.1210/en.2008-0817; KISHIMOTO T, 1994, STEM CELLS, V12, P37; Kitamura Y, 1997, SURG TODAY, V27, P534, DOI 10.1007/BF02385807; Komm BS, 2005, ENDOCRINOLOGY, V146, P3999, DOI 10.1210/en.2005-0030; Lavie O, 2008, INT J GYNECOL CANCER, V18, P352, DOI 10.1111/j.1525-1438.2007.01025.x; Lewiecki EM, 2007, EXPERT OPIN INV DRUG, V16, P1663, DOI 10.1517/13543784.16.10.1663; Lewis-Wambi JS, 2011, MOL PHARMACOL, V80, P610, DOI 10.1124/mol.111.072249; Li RH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/743716; Liu AG, 2011, CANCER SCI, V102, P1381, DOI 10.1111/j.1349-7006.2011.01932.x; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Palacios S, 2015, MENOPAUSE, V22, P806, DOI [10.1097/gme.0000000000000419, 10.1097/GME.0000000000000419]; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Pu YS, 2004, PROSTATE, V60, P120, DOI 10.1002/pros.20057; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Rieck G C, 2005, J Obstet Gynaecol, V25, P39, DOI 10.1080/01443610400024740; Rossi JF, 2010, BRIT J CANCER, V103, P1154, DOI 10.1038/sj.bjc.6605872; Saleh AZM, 2005, BIOCHEMISTRY-US, V44, P10822, DOI 10.1021/bi050439+; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Siegel DA, 2014, PEDIATRICS, V134, pE945, DOI 10.1542/peds.2013-3926; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; Song Y, 2013, ENDOCRINOLOGY, V154, P656, DOI 10.1210/en.2012-2038; Tomita Y, 2006, CLIN CANCER RES, V12, P3070, DOI 10.1158/1078-0432.CCR-05-1732; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Voorhees PM, 2013, BRIT J HAEMATOL, V161, P357, DOI 10.1111/bjh.12266; Wei CC, 2011, INT J ONCOL, V38, P279, DOI 10.3892/ijo_00000848; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xu SL, 2013, EXPERT OPIN THER TAR, V17, P1303, DOI 10.1517/14728222.2013.830105; Xu SL, 2013, MOL CANCER THER, V12, P937, DOI 10.1158/1535-7163.MCT-12-1082; Yan S, 2013, ONCOTARGET, V4, P433, DOI 10.18632/oncotarget.930; Zhang YF, 2014, APPL THERM ENG, V65, P1, DOI 10.1016/j.applthermaleng.2013.12.069	61	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180297	10.1371/journal.pone.0180297	http://dx.doi.org/10.1371/journal.pone.0180297			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672024	gold, Green Submitted, Green Published			2022-12-27	WOS:000405268500041
J	Bjorge, JD; Pang, A; Fujita, DJ				Bjorge, Jeffrey D.; Pang, Andy; Fujita, Donald J.			Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release	PLOS ONE			English	Article							PENETRATING PEPTIDES; TUMOR-CELLS; NANOPARTICLES; BARRIERS; SYSTEMS; GROWTH; OLIGOARGININE; ARGININE; RECEPTOR; CPPS	RNA interference has been used to dissect the importance of individual gene products in various human disease processes, including cancer. Small-interfering RNA, or siRNA, is one of the tools utilized in this regard, but specially-designed delivery agents are required to allow the siRNA to gain optimal access to the cell interior. Our laboratory has utilized two different siRNA-binding delivery peptides containing a polyarginine core, and modified by myristoylation and targeting motifs (iRGD or Lyp-1). A third peptide was designed to assist with endosomal release. Various ratios of the peptides and siRNA were combined and assayed for the ability to form stable complexes, and optimized ratios were determined. The complexes were found to form particles, with the majority having a diameter of 100-300 nm, as visualized by electron microscopy. These siRNA complexes have enhanced protection from nucleases present in serum, as compared to "naked" unprotected siRNA. The particles were internalized by the cells and could be detected in the cell cytoplasm by confocal fluorescence microscopy. In functional assays, peptide/siRNA complexes were shown to cause the knock down of corresponding targeted proteins. The peptide with the LyP-1 targeting motif was more effective at knockdown in MDA-MB-231 breast cancer cells than the peptide with the iRGD motif. Inclusion of the endosomal release peptide in the complexes greatly enhanced the peptide/siRNA effects. Peptide/siRNA complexes simultaneously targeting Stat3 and c-Myc caused a marked reduction in anchorage-independent growth, a property correlated with tumorigenicity. This study demonstrates the ability of a peptide-based siRNA-delivery system to deliver siRNA into breast cancer cells and cause both protein knockdown and suppression of the malignant phenotype. Such peptide complexes are likely to become highly useful siRNA-delivery vehicles for the characterization, and potentially for the treatment, of human cancer.	[Bjorge, Jeffrey D.; Pang, Andy; Fujita, Donald J.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Bjorge, Jeffrey D.; Pang, Andy; Fujita, Donald J.] Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Bjorge, JD; Fujita, DJ (corresponding author), Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.; Bjorge, JD; Fujita, DJ (corresponding author), Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Calgary, AB, Canada.	jbjorge@ucalgary.ca; dfujita@ucalgary.ca			Canada Research Society (Montreal); Alberta Innovates Health Solutions (AHS)	Canada Research Society (Montreal); Alberta Innovates Health Solutions (AHS)	This work was supported by the Canada Research Society (Montreal) to DJF, (http://www.crs-src.ca) and the Alberta Innovates Health Solutions (AHS) to DJF, (http://www.aihealthsolutons.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bjorge JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019309; Cantini L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073348; Chu DF, 2015, NANOMED-NANOTECHNOL, V11, P435, DOI 10.1016/j.nano.2014.08.007; Cuellar TL, 2015, NUCLEIC ACIDS RES, V43, P1189, DOI 10.1093/nar/gku1362; Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/NNANO.2014.84, 10.1038/nnano.2014.84]; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Esposito Carla Lucia, 2014, J RNAi Gene Silencing, V10, P500; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; Ku SH, 2014, ADV HEALTHC MATER, V3, P1182, DOI 10.1002/adhm.201300607; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Lee JM, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/782041, 10.1155/2013/758731]; Li YH, 2015, INT J PHARMACEUT, V495, P527, DOI 10.1016/j.ijpharm.2015.09.006; Lorenzer C, 2015, J CONTROL RELEASE, V203, P1, DOI 10.1016/j.jconrel.2015.02.003; Ly P, 2012, CELL RES, V22, P1605, DOI 10.1038/cr.2012.140; Mansoori B, 2014, ADV PHARM BULL, V4, P313, DOI 10.5681/apb.2014.046; Margus H, 2012, MOL THER, V20, P525, DOI 10.1038/mt.2011.284; Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; MONTESANO R, 1977, J NATL CANCER I, V59, P1651, DOI 10.1093/jnci/59.6.1651; Nakase I, 2013, MOL BIOSYST, V9, P855, DOI 10.1039/c2mb25467k; Oliveira S, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/63675; PLANK C, 1994, J BIOL CHEM, V269, P12918; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Wan C, 2014, DRUG DELIV TRANSL RE, V4, P74, DOI 10.1007/s13346-013-0161-z; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Wang YH, 2007, J BIOCHEM BIOPH METH, V70, P579, DOI 10.1016/j.jbbm.2007.01.010; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu SY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008362; Xu CF, 2015, ASIAN J PHARM SCI, V10, P1, DOI 10.1016/j.ajps.2014.08.011; Yan RY, 2014, BIOCHEM J, V461, P1, DOI 10.1042/BJ20140173; Zaro JL, 2015, FRONT CHEM SCI ENG, V9, P407, DOI 10.1007/s11705-015-1538-y; Zhou JH, 2013, PHARMACEUTICALS, V6, P85, DOI 10.3390/ph6010085	42	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180578	10.1371/journal.pone.0180578	http://dx.doi.org/10.1371/journal.pone.0180578			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666009	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608700019
J	Elschner, C; Korn, P; Hauptstock, M; Schulz, MC; Range, U; Junger, D; Scheler, U				Elschner, Cindy; Korn, Paula; Hauptstock, Maria; Schulz, Matthias C.; Range, Ursula; Juenger, Diana; Scheler, Ulrich			Assessing agreement between preclinical magnetic resonance imaging and histology: An evaluation of their image qualities and quantitative results	PLOS ONE			English	Article							ENGINEERED BONE-GRAFTS; CORTICAL BONE; ANIMAL-MODELS; CLEFT; MRI; OSTEOPLASTY; CONCORDANCE; TISSUES; CELLS	One consequence of demographic change is the increasing demand for biocompatible materials for use in implants and prostheses. This is accompanied by a growing number of experimental animals because the interactions between new biomaterials and its host tissue have to be investigated. To evaluate novel materials and engineered tissues the use of nondestructive imaging modalities have been identified as a strategic priority. This provides the opportunity for studying interactions repeatedly with individual animals, along with the advantages of reduced biological variability and decreased number of laboratory animals. However, histological techniques are still the golden standard in preclinical biomaterial research. The present article demonstrates a detailed method comparison between histology and magnetic resonance imaging. This includes the presentation of their image qualities as well as the detailed statistical analysis for assessing agreement between quantitative measures. Exemplarily, the bony ingrowth of tissue engineered bone substitutes for treatment of a cleft-like maxillary bone defect has been evaluated. By using a graphical concordance analysis the mean difference between MRI results and histomorphometrical measures has been examined. The analysis revealed a slightly but significant bias in the case of the bone volume. (bias(Histo-MRI:Bone volume =) 2.40%; p < 0.005) and a clearly significant deviation for the remaining defect width. (bias(Histo-MRI:Defect width) = -6.73%; p << 0: 005). But the study although showed a considerable effect of the analyzed section position to the quantitative result. It could be proven, that the bias of the data sets was less originated due to the imaging modalities, but mainly on the evaluation of different slice positions. The article demonstrated that method comparisons not always need the use of an independent animal study, additionally.	[Elschner, Cindy; Scheler, Ulrich] Leibniz Inst Polymer Res Dresden, Dresden, Germany; [Korn, Paula; Hauptstock, Maria; Schulz, Matthias C.; Juenger, Diana] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Oral & Maxillofacial Surg, Dresden, Germany; [Range, Ursula] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Informat & Biometry, Dresden, Germany	Leibniz Institut fur Polymerforschung Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Elschner, C (corresponding author), Leibniz Inst Polymer Res Dresden, Dresden, Germany.	elschner@ipfdd.de	Scheler, Ulrich/A-7522-2012	Scheler, Ulrich/0000-0002-4714-316X; Elschner, Cindy/0000-0002-2108-7040	European Social Fund [100107173]; "MeDDrive Project Start" of the Faculty of Medicine "Carl Gustav Carus", Technische Universitat Dresden [60.307]; European Social Fund; MeDDrive grant	European Social Fund(European Social Fund (ESF)); "MeDDrive Project Start" of the Faculty of Medicine "Carl Gustav Carus", Technische Universitat Dresden; European Social Fund(European Social Fund (ESF)); MeDDrive grant	The study was supported by research grants of the European Social Fund (grant number: 100107173) and the "MeDDrive Project Start" of the Faculty of Medicine "Carl Gustav Carus", Technische Universitat Dresden (grant number: 60.307); European Social Fund: http://www.strukturfonds.sachsen.de/index.html; MeDDrive grant: https://tu-dresden.de/med/mf/forschung/foerderung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033; Bargmann W, 1958, PATHOLOGIE LABORATOR; Behe M, 2007, ROFO-FORTSCHR RONTG, V179, P796, DOI 10.1055/s-2007-963263; Bernhardt R, 2012, EUR CELLS MAT; Bittermann GKP, 2016, CLIN ORAL INVEST, V20, P207, DOI 10.1007/s00784-015-1589-y; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brito Luciano Abreu, 2012, Plast Surg Int, V2012, P782821, DOI 10.1155/2012/782821; Brouwer KM, 2015, WOUND REPAIR REGEN, V23, P302, DOI 10.1111/wrr.12283; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Cunha L, 2014, MOL DIAGN THER, V18, P153, DOI 10.1007/s40291-013-0062-3; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Ferrare N, 2013, SURG RADIOL ANAT, V35, P495, DOI 10.1007/s00276-013-1080-x; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gold GE, 2004, AM J ROENTGENOL, V183, P343, DOI 10.2214/ajr.183.2.1830343; GRUBER HE, 1992, BIOTECH HISTOCHEM, V67, P30, DOI 10.3109/10520299209110002; Guhad F, 2005, CONTEMP TOP LAB ANIM, V44, P58; Janssen NG, 2014, CLIN ORAL INVEST, V18, P219, DOI 10.1007/s00784-013-0947-x; Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kirschner S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165994; Koba W, 2011, SEMIN NUCL MED, V41, P151, DOI 10.1053/j.semnuclmed.2010.12.003; Koch R, 2007, KLIN MONATSBL AUGENH, V224, P52, DOI 10.1055/s-2006-927278; Korn P, 2015, BIOMATERIALS, V53, P634, DOI 10.1016/j.biomaterials.2015.02.114; Korn P, 2014, J CRANIO MAXILL SURG, V42, P1277, DOI 10.1016/j.jcms.2014.03.010; Korn P, 2017, CLIN ORAL INVESTIG; Kwiecien R, 2011, DTSCH ARZTEBL INT, V108, P515, DOI 10.3238/arztebl.2011.0515; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Particelli F, 2012, J MICROSC-OXFORD, V245, P302, DOI 10.1111/j.1365-2818.2011.03573.x; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Pradel W, 2012, ANN ANAT, V194, P545, DOI 10.1016/j.aanat.2012.06.002; RAHN BA, 1971, STAIN TECHNOL, V46, P125, DOI 10.3109/10520297109067836; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Stadlinger B, 2012, J CLIN PERIODONTOL, V39, P28, DOI 10.1111/j.1600-051X.2011.01835.x; Tanaka SA, 2012, PLAST RECONSTR SURG, V129, p511E, DOI 10.1097/PRS.0b013e3182402dd1; Wehrli FW, 2007, J MAGN RESON IMAGING, V25, P390, DOI 10.1002/jmri.20807; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908; Zuk PA, 2008, PEDIATR RES, V63, P478, DOI 10.1203/PDR.0b013e31816bdf36	40	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179249	10.1371/journal.pone.0179249	http://dx.doi.org/10.1371/journal.pone.0179249			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666026	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608700031
J	Li, X; Baker, J; Cracknell, T; Haynes, AR; Blanco, G				Li, Xiang; Baker, Jane; Cracknell, Tobias; Haynes, Andrew R.; Blanco, Gonzalo			IGFN1_v1 is required for myoblast fusion and differentiation	PLOS ONE			English	Article							KY; PROTEIN; DROSOPHILA; MUTATION; MOUSE; RAC1; GENE; DEFICIENCY; EXPRESSION; MUSCLES	Igfn1 is a complex locus that codes for multiple splicing variants of Immunoglobulin-and Fibronectin-like domain containing proteins predominantly expressed in skeletal muscle. To reveal possible roles for Igfn1, we applied non-selective knock-down by shRNAs as well as specific targeting of Igfn1 exon 13 by CRISPR/Cas9 mutagenesis in C2C12 cells. Decreased expression of Igfn1 variants via shRNAs against the common 3'-UTR region caused a total blunting of myoblast fusion, but did not prevent expression of differentiation markers. Targeting of N-terminal domains by elimination of exon 13 via CRISPR/Cas9 mediated homologous recombination, also resulted in fusion defects as well as large multinucleated cells. Expression of IGFN1_v1 partially rescued fusion and myotube morphology in the Igfn1 exon 13 knock-out cell line, indicating a role for this variant in myoblast fusion and differentiation. However, in vivo overexpression of IGFN1_v1 or the Igfn1 Exon 13 CRISPR/Cas9 targeting vector did not result in significant size changes in transfected fibres.	[Li, Xiang; Cracknell, Tobias; Blanco, Gonzalo] Univ York, Dept Biol, York, N Yorkshire, England; [Baker, Jane; Haynes, Andrew R.] MRC Harwell Inst, Mammalian Genet Unit, Harwell, Berks, England	University of York - UK; MRC Harwell	Blanco, G (corresponding author), Univ York, Dept Biol, York, N Yorkshire, England.	gonzalo.blanco@york.ac.uk	Blanco, Gonzalo/D-8735-2014	Blanco, Gonzalo/0000-0003-3827-3111	Medical Research Council [MC_U142684168]; Biotechnology and Biological Sciences Research Council [BB/M011151/1]; BBSRC [1642919] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1642919] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Support was provided by the Medical Research Council (MC_U142684168 to Andy Haynes) and Biotechnology and Biological Sciences Research Council (BB/M011151/1 to Tobias Cracknell).	Baker J, 2010, EXP CELL RES, V316, P1856, DOI 10.1016/j.yexcr.2010.02.027; Beatham J, 2004, HUM MOL GENET, V13, P2863, DOI 10.1093/hmg/ddh308; Blanco G, 2001, HUM MOL GENET, V10, P9, DOI 10.1093/hmg/10.1.9; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Fernandes JJ, 2005, DEV BIOL, V285, P11, DOI 10.1016/j.ydbio.2005.05.040; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hedberg-Oldfors C, 2016, EUR J HUM GENET, V24, P1771, DOI 10.1038/ejhg.2016.98; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mansilla F, 2008, J CELL BIOCHEM, V105, P847, DOI 10.1002/jcb.21880; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Otey CA, 2009, CELL MOTIL CYTOSKEL, V66, P618, DOI 10.1002/cm.20385; Pinotsis N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001261; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Straussberg R, 2016, ACTA NEUROPATHOL, V132, P475, DOI 10.1007/s00401-016-1602-9; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106	20	95	97	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180217	10.1371/journal.pone.0180217	http://dx.doi.org/10.1371/journal.pone.0180217			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665998	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000404608700074
J	Tamura, M; Sugiura, S; Takagi, T; Satoh, T; Sumaru, K; Kanamori, T; Okada, T; Matsui, H				Tamura, Masato; Sugiura, Shinji; Takagi, Toshiyuki; Satoh, Taku; Sumaru, Kimio; Kanamori, Toshiyuki; Okada, Tomoko; Matsui, Hirofumi			Morphology-based optical separation of subpopulations from a heterogeneous murine breast cancer cell line	PLOS ONE			English	Article							INTRA-TUMOR HETEROGENEITY; CULTURE; TECHNOLOGY; HYDROGELS; MATRIGEL; GROWTH; MODELS; 3D	Understanding tumor heterogeneity is an urgent and unmet need in cancer research. In this study, we used a morphology-based optical cell separation process to classify a heterogeneous cancer cell population into characteristic subpopulations. To classify the cell subpopulations, we assessed their morphology in hydrogel, a three-dimensional culture environment that induces morphological changes according to the characteristics of the cells (i.e., growth, migration, and invasion). We encapsulated the murine breast cancer cell line 4T1E, as a heterogeneous population that includes highly metastatic cells, in click-crosslinkable and photodegradable gelatin hydrogels, which we developed previously. We observed morphological changes within 3 days of encapsulating the cells in the hydrogel. We separated the 4T1E cell population into colony-and granular-type cells by optical separation, in which local UVinduced degradation of the photodegradable hydrogel around the target cells enabled us to collect those cells. The obtained colony-and granular-type cells were evaluated in vitro by using a spheroid assay and in vivo by means of a tumor growth and metastasis assay. The spheroid assay showed that the colony-type cells formed compact spheroids in 2 days, whereas the granular-type cells did not form spheroids. The tumor growth assay in mice revealed that the granular-type cells exhibited lower tumor growth and a different metastasis behavior compared with the colony-type cells. These results suggest that morphology-based optical cell separation is a useful technique to classify a heterogeneous cancer cell population according to its cellular characteristics.	[Tamura, Masato; Sugiura, Shinji; Takagi, Toshiyuki; Satoh, Taku; Sumaru, Kimio; Kanamori, Toshiyuki] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan; [Tamura, Masato] Japan Soc Promot Sci, Tokyo, Japan; [Okada, Tomoko] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Matsui, Hirofumi] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Tamura, Masato] Osaka Univ, Res Ctr Nucl Phys, Ibaraki, Osaka, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Society for the Promotion of Science; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Osaka University	Sugiura, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan.	shinji.sugiura@aist.go.jp	Okada, Tomoko/L-7055-2018; Sumaru, Kimio/M-1022-2018; Kanamori, Toshiyuki/M-1009-2018; Sugiura, Shinji/J-2565-2018; Takagi, Toshiyuki/L-9665-2018	Okada, Tomoko/0000-0003-3723-1147; Sumaru, Kimio/0000-0002-2583-0647; Kanamori, Toshiyuki/0000-0002-4856-0037; Sugiura, Shinji/0000-0002-1070-2482; Takagi, Toshiyuki/0000-0002-3854-8456	Japan Society for the Promotion of Science, KAKENHI [14J07186]; Japan Agency for Medical Research and Development [16hm0102044h0001]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by Japan Society for the Promotion of Science, KAKENHI (No. 14J07186) (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT 14J07186) to Masato Tamura; and Japan Agency for Medical Research and Development, No. 16hm0102044h0001 (http://www.amed.go.jp/news/release_20160711.html to Shinji Sugiura.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fitzgerald KA, 2015, J CONTROL RELEASE, V215, P39, DOI 10.1016/j.jconrel.2015.07.020; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kronig M, 2015, ONCOTARGET, V6, P1302; Lamb R, 2015, ONCOTARGET, P6; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sasaki H, 2016, J BIOSCI BIOENG, V121, P117, DOI 10.1016/j.jbiosc.2015.05.011; Sumaru K, 2014, METHOD CELL BIOL, V120, P185, DOI 10.1016/B978-0-12-417136-7.00012-4; Sun XX, 2015, ACTA PHARMACOL SIN, V36, P1219, DOI 10.1038/aps.2015.92; Takahashi M, 2008, CLIN EXP METASTAS, V25, P517, DOI 10.1007/s10585-008-9163-5; Takahashi M, 2009, CLIN EXP METASTAS, V26, P817, DOI 10.1007/s10585-009-9281-8; Tamura M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15060; Tamura M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04793; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yanagawa F, 2016, REGEN THER, V3, P45, DOI 10.1016/j.reth.2016.02.007	25	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179372	10.1371/journal.pone.0179372	http://dx.doi.org/10.1371/journal.pone.0179372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665963	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608700033
J	Masugi, Y; Obata, H; Inoue, D; Kawashima, N; Nakazawa, K				Masugi, Yohei; Obata, Hiroki; Inoue, Daisuke; Kawashima, Noritaka; Nakazawa, Kimitaka			Neural effects of muscle stretching on the spinal reflexes in multiple lower-limb muscles	PLOS ONE			English	Article							H-REFLEX; GROUP-I; SOLEUS MUSCLE; CROSSED INHIBITION; CORD-INJURY; AFFERENTS; HUMANS; EXCITABILITY; STIMULATION; MODULATION	While previous studies have shown that muscle stretching suppresses monosynaptic spinal reflex excitability in stretched muscles, its effects on non-stretched muscles is still largely unknown. The purpose of this study was to examine the effects of muscle stretching on monosynaptic spinal reflex in non-stretched muscles. Ten healthy male subjects participated in this study. Muscle stretching of the right triceps surae muscle was performed using a motor torque device for 1 minute. Three different dorsiflexion torques (at approximately 5, 10, and 15 Nm) were applied during muscle stretching. Spinal reflexes evoked by transcutaneous spinal cord stimulation were recorded in both the lower-limb muscles before, during, and at 0 and 5 min following muscle stretching. The amplitudes of the spinal reflexes in both the stretched and non-stretched muscles in the right (ipsilateral) leg were smaller during stretching compared to before, and at 0 and 5 min after stretching. Furthermore, the degree of reduction in the amplitude of the spinal reflexes in the right (ipsilateral) leg muscles increased significantly as the dorsiflexion torque (i.e., stretching of the right triceps surae muscles) increased. In contrast, reduction in the amplitude of the spinal reflexes with increasing dorsiflexion torque was not seen in the left (contralateral) leg muscles. Our results clearly indicate that muscle stretching has inhibitory effects on monosynaptic spinal reflexes, not only in stretched muscles, but also in non-stretched muscles of the ipsilateral leg.	[Masugi, Yohei; Obata, Hiroki; Inoue, Daisuke; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Masugi, Yohei; Kawashima, Noritaka] Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan; [Masugi, Yohei] Tokyo Int Univ, Inst Sports Med & Sci, Kawagoe, Saitama, Japan; [Obata, Hiroki] Kyushu Inst Technol, Inst Liberal Arts, Dept Humanities & Social Sci, Tobata Ku, Sensui Cho, Kitakyushu, Fukuoka, Japan	University of Tokyo; Kyushu Institute of Technology	Masugi, Y (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.; Masugi, Y (corresponding author), Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan.; Masugi, Y (corresponding author), Tokyo Int Univ, Inst Sports Med & Sci, Kawagoe, Saitama, Japan.	ymasugi@tiu.ac.jp		Masugi, Yohei/0000-0001-8156-8586	Japan Society for the Promotion [26242056]; JSPS [26350564, 16H07456]; Tokyo International University, CREST from the Japan Science and Technology Agency	Japan Society for the Promotion(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo International University, CREST from the Japan Science and Technology Agency	This work was supported by a Grant-in-Aid for Scientific Research (A) (#26242056) to Kimitaka Nakazawa from the Japan Society for the Promotion of Science (https://kaken.nii.ac.jp/en/), A Grant-in-Aid for Scientific Research (C) (#26350564) to Hiroki Obata from the JSPS, A Grant-in-Aid for Research Activity Start-up (#16H07456) to Yohei Masugi from the JSPS, A research grant to Yohei Masugi from Tokyo International University, CREST from the Japan Science and Technology Agency (http://www.jst. go.jp/kisoken/crest/en/about/index.html) to Kimitaka Nakazawa. The funders had no role in study design, data collection anda nalysis, decision to publish, or preparation of the manuscript.	AGGELOPOULOS NC, 1995, NEUROSCI LETT, V185, P60, DOI 10.1016/0304-3940(94)11225-8; Behm DG, 2013, J ELECTROMYOGR KINES, V23, P1215, DOI 10.1016/j.jelekin.2013.05.002; Behm DG, 2016, EUR J APPL PHYSIOL, V116, P241, DOI 10.1007/s00421-015-3270-1; Chaouachi A, 2017, CLIN PHYSIOL FUNCT I, V37, P23, DOI 10.1111/cpf.12263; Cheng JG, 1998, BRAIN RES, V779, P280, DOI 10.1016/S0006-8993(97)01168-2; COLLINS DF, 1993, BRAIN RES, V603, P96, DOI 10.1016/0006-8993(93)91303-A; CONDON SM, 1987, PHYS THER, V67, P24, DOI 10.1093/ptj/67.1.24; Courtine GG, 2007, J PHYSIOL-LONDON, V582, P1125, DOI 10.1113/jphysiol.2007.128447; CRONE C, 1987, J PHYSIOL-LONDON, V389, P163, DOI 10.1113/jphysiol.1987.sp016652; Danner SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147479; DELWAIDE PJ, 1991, J PHYSIOL-LONDON, V439, P161, DOI 10.1113/jphysiol.1991.sp018662; DEVANAND.MS, 1965, ACTA PHYSIOL SCAND, V63, P46, DOI 10.1111/j.1748-1716.1965.tb04040.x; Dy CJ, 2010, J NEUROPHYSIOL, V103, P2808, DOI 10.1152/jn.00316.2009; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; ETNYRE BR, 1986, ELECTROEN CLIN NEURO, V63, P174, DOI 10.1016/0013-4694(86)90010-6; Funase K, 2003, ADV EXERC SPORTS PHY, V9, P119; Gervasio S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168557; GUISSARD N, 1988, EUR J APPL PHYSIOL O, V58, P47; Guissard N, 2004, MUSCLE NERVE, V29, P248, DOI 10.1002/mus.10549; HARRISON PJ, 1984, J PHYSIOL-LONDON, V356, P263, DOI 10.1113/jphysiol.1984.sp015463; Hultborn H, 1996, EXP BRAIN RES, V108, P450; Jankowska E, 2009, J PHYSIOL-LONDON, V587, P401, DOI 10.1113/jphysiol.2008.159236; Knikou M, 2002, CLIN NEUROPHYSIOL, V113, P1698, DOI 10.1016/S1388-2457(02)00285-7; Knikou M, 2002, EXP BRAIN RES, V143, P149, DOI 10.1007/s00221-001-0978-4; Marque P, 2001, J PHYSIOL-LONDON, V536, P313, DOI 10.1111/j.1469-7793.2001.t01-1-00313.x; Masugi Y, 2016, NEUROSCI LETT, V627, P100, DOI 10.1016/j.neulet.2016.05.047; MEUNIER S, 1993, EXP BRAIN RES, V96, P534; Mezzarane RA, 2012, J NEUROPHYSIOL, V108, P1176, DOI 10.1152/jn.00831.2011; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Nakazawa K, 2006, ARCH PHYS MED REHAB, V87, P71, DOI 10.1016/j.apmr.2005.08.122; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; ROBINSON KL, 1982, J NEUROL NEUROSUR PS, V45, P699, DOI 10.1136/jnnp.45.8.699; Roy FD, 2012, EXP BRAIN RES, V223, P281, DOI 10.1007/s00221-012-3258-6; Stubbs PW, 2011, MUSCLE NERVE, V43, P845, DOI 10.1002/mus.21964; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	36	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180275	10.1371/journal.pone.0180275	http://dx.doi.org/10.1371/journal.pone.0180275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662201	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300137
J	Nagata, Y; Wu, VCC; Otsuji, Y; Takeuchi, M				Nagata, Yasufumi; Wu, Victor Chien-Chia; Otsuji, Yutaka; Takeuchi, Masaaki			Normal range of myocardial layer-specific strain using two-dimensional speckle tracking echocardiography	PLOS ONE			English	Article							LEFT-VENTRICULAR STRAIN; CARDIAC MAGNETIC-RESONANCE; SEVERE AORTIC-STENOSIS; EJECTION FRACTION; LONGITUDINAL STRAIN; CHRONIC PRESSURE; HEART-FAILURE; DEFORMATION; DYSFUNCTION; FIBROSIS	Background Newer 2D strain software has a potential to assess layer-specific strain. However, normal reference values for layer-specific strain have not been established. We aimed to establish the normal ranges of layer-specific longitudinal and circumferential strain ( endocardial global longitudinal strain (GLS), transmural GLS, epicardial GLS, endocardial global circumferential strain (GCS), transmural GCS, and epicardial GCS). Methods and results We retrospectively analyzed longitudinal and circumferential strain parameters in 235 healthy subjects, with use of layer-specific 2D speckle tracking software (GE). The endocardial strain/epicardial strain (Endo/Epi) ratio was also measured to assess the strain gradient across the myocardium. The endocardial, transmural, and epicardial GLS values and the Endo/Epi ratio in the normal subjects were -23.1 +/- 2.3, -20.0 +/- 2.0, -17.6 +/- 1.9, and 1.31 +/- 0.07, respectively. The corresponding values of GCS were -28.5 +/- 3.0, -20.8 +/- 2.3, -15.3 +/- 2.0, and 1.88 +/- 0.17, respectively. The layer-specific global strain parameters exhibited no age dependency but did exhibit gender dependency except for endocardial GCS. A subgroup analysis revealed that basal and middle levels of endocardial LS was decreased in the middle and elderly aged group. However, apical endocardial LS was preserved even in the elderly subjects. Conclusions We proposed normal reference values for layer-specific strain based on both age and gender. This detailed strain analysis provides layer-oriented information with the potential to characterize abnormal findings in various cardiovascular diseases.	[Nagata, Yasufumi; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan; [Wu, Victor Chien-Chia] Chang Gung Univ, Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Taipei, Taiwan; [Takeuchi, Masaaki] Univ Occupat & Environm Hlth, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; Chang Gung Memorial Hospital; Chang Gung University; University of Occupational & Environmental Health - Japan	Nagata, Y (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan.	nyasufumi1979@yahoo.co.jp	Wu, Victor Chien-Chia/ABB-6872-2021; Wu, Victor Chien-Chia/GXF-4623-2022	Wu, Victor Chien-Chia/0000-0002-9918-4369; Wu, Victor Chien-Chia/0000-0002-9918-4369; Nagata, Yasufumi/0000-0001-5481-7524				Abbate A, 2015, INT J CARDIOL, V179, P430, DOI 10.1016/j.ijcard.2014.11.106; Altiok E, 2012, J AM SOC ECHOCARDIOG, V25, P1179, DOI 10.1016/j.echo.2012.07.019; Andre F, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0123-3; Augustine D, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-8; Becker M, 2009, EUR HEART J, V30, P1467, DOI 10.1093/eurheartj/ehp112; Bogaert J, 2001, AM J PHYSIOL-HEART C, V280, pH610; BUCHI M, 1990, BASIC RES CARDIOL, V85, P367; Cheng S, 2013, CIRC-CARDIOVASC IMAG, V6, P692, DOI 10.1161/CIRCIMAGING.112.000627; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Hamada S, 2016, J AM SOC ECHOCARDIOG, V29, P412, DOI 10.1016/j.echo.2016.02.001; Haruki N, 2010, EUR J ECHOCARDIOGR, V11, P352, DOI 10.1093/ejechocard/jep215; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hoffmann R, 2014, AM J CARDIOL, V114, P1083, DOI 10.1016/j.amjcard.2014.07.018; Ishizu T, 2014, HYPERTENSION, V63, P500, DOI 10.1161/HYPERTENSIONAHA.113.02149; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee HF, 2013, J CARDIOL, V62, P301, DOI 10.1016/j.jjcc.2013.05.001; Leitman M, 2010, J AM SOC ECHOCARDIOG, V23, P64, DOI 10.1016/j.echo.2009.10.004; Mizuguchi Y, 2008, J AM SOC ECHOCARDIOG, V21, P1138, DOI 10.1016/j.echo.2008.07.016; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Ng ACT, 2009, AM J CARDIOL, V104, P1398, DOI 10.1016/j.amjcard.2009.06.063; Ozawa K, 2015, INT J CARDIOL, V184, P237, DOI 10.1016/j.ijcard.2015.01.070; PALMON LC, 1994, CIRCULATION, V89, P122, DOI 10.1161/01.CIR.89.1.122; PATH G, 1990, CIRC RES, V67, P660, DOI 10.1161/01.RES.67.3.660; Sarvari SI, 2013, JACC-CARDIOVASC IMAG, V6, P535, DOI 10.1016/j.jcmg.2013.01.009; Sengupta PP, 2007, J AM SOC ECHOCARDIOG, V20, P539, DOI 10.1016/j.echo.2006.10.013; Sengupta Shantanu P, 2013, Indian Heart J, V65, P48, DOI 10.1016/j.ihj.2012.12.009; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; VINTENJOHANSEN J, 1980, CIRC RES, V46, P139, DOI 10.1161/01.RES.46.1.139; Voigt JU, 2015, EUR HEART J-CARD IMG, V16, P1, DOI 10.1093/ehjci/jeu184; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Yan GH, 2012, HEART RHYTHM, V9, P928, DOI 10.1016/j.hrthm.2012.01.007; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Yukihiro K, 2000, J CARDIOL, V35, P205; Zhang L, 2016, ACTA BIOMATER, V42, P90, DOI 10.1016/j.actbio.2016.06.031	39	52	58	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180584	10.1371/journal.pone.0180584	http://dx.doi.org/10.1371/journal.pone.0180584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662186	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300168
J	Rodriguez-Salvador, M; Rio-Belver, RM; Garechana-Anacabe, G				Rodriguez-Salvador, Marisela; Maria Rio-Belver, Rosa; Garechana-Anacabe, Gaizka			Scientometric and patentometric analyses to determine the knowledge landscape in innovative technologies: The case of 3D bioprinting	PLOS ONE			English	Article							INTELLIGENCE PROCESSES; SCIENCE; ORGANS; TRENDS	This research proposes an innovative data model to determine the landscape of emerging technologies. It is based on a competitive technology intelligence methodology that incorporates the assessment of scientific publications and patent analysis production, and is further supported by experts' feedback. It enables the definition of the growth rate of scientific and technological output in terms of the top countries, institutions and journals producing knowledge within the field as well as the identification of main areas of research and development by analyzing the International Patent Classification codes including keyword clusterization and co-occurrence of patent assignees and patent codes. This model was applied to the evolving domain of 3D bioprinting. Scientific documents from the Scopus and Web of Science data-bases, along with patents from 27 authorities and 140 countries, were retrieved. In total, 4782 scientific publications and 706 patents were identified from 2000 to mid-2016. The number of scientific documents published and patents in the last five years showed an annual average growth of 20% and 40%, respectively. Results indicate that the most prolific nations and institutions publishing on 3D bioprinting are the USA and China, including the Massachusetts Institute of Technology (USA), Nanyang Technological University (Singapore) and Tsinghua University (China), respectively. Biomaterials and Biofabrication are the predominant journals. The most prolific patenting countries are China and the USA; while Organovo Holdings Inc. (USA) and Tsinghua University (China) are the institutions leading. International Patent Classification codes reveal that most 3D bioprinting inventions intended for medical purposes apply porous or cellular materials or biologically active materials. Knowledge clusters and expert drivers indicate that there is a research focus on tissue engineering including the fabrication of organs, bioinks and new 3D bioprinting systems. Our model offers a guide to researchers to understand the knowledge production of pioneering technologies, in this case 3D bioprinting.	[Rodriguez-Salvador, Marisela] Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey, Nuevo Leon, Mexico; [Maria Rio-Belver, Rosa] Univ Basque Country UPV EHU, Foresight Technol & Management FTM Grp, Ind Org & Management Engn Dept, Univ Coll Engn Vitoria Gasteiz, Basque Country, Spain; [Garechana-Anacabe, Gaizka] Univ Basque Country UPV EHU, Foresight Technol & Management FTM Grp, Ind Org & Management Engn Dept, Escuela Univ Estudios Empresariales Bilbao, Basque Country, Spain	Tecnologico de Monterrey; University of Basque Country; University of Basque Country	Rodriguez-Salvador, M (corresponding author), Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey, Nuevo Leon, Mexico.	marisrod@itesm.mx	Rio-Belver, Rosa M/C-9742-2009; Garechana, Gaizka/ABG-9948-2020; Rodriguez-Salvador, Marisela/AAT-9250-2020	Rio-Belver, Rosa M/0000-0002-4244-9098; Garechana, Gaizka/0000-0002-1913-3239; Rodriguez Salvador, Marisela/0000-0002-5206-3447	Tecnologico de Monterrey through the Escuela de Ingenieria y Ciencias; National Council for Science and Technology (CONACYT), Mexico [261683]	Tecnologico de Monterrey through the Escuela de Ingenieria y Ciencias; National Council for Science and Technology (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by Tecnologico de Monterrey through the Escuela de Ingenieria y Ciencias and also supported by a grant from the National Council for Science and Technology (CONACYT), Mexico (Grant number:261683).The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ORG DON TRANSPL ACT; Banks J, 2013, IEEE PULSE, V4, P22, DOI 10.1109/MPUL.2013.2279617; Basiliere P, 2014, G00263487 GARTN; Basiliere P, 2014, G00262529 GARTN; Birchall MA, 2014, LANCET, V384, P288, DOI [10.1016/S0140-6736(14)60533-X, 10.1016/S0140-6736(14)60533-x]; Bloomberg, HEALTHC EQ SUPPL CO; Boland T., 2006, US Pat, Patent No. [US 7051654B2, 7051654]; Burnham Judy F, 2006, Biomed Digit Libr, V3, P1; Burton B., 2015, G00289755 GARTN; Campbell T., 2011, COULD 3D PRINTING CH; Cao C, 2006, PHYS TODAY, V59, P38, DOI 10.1063/1.2435680; Cerneels J., 2015, F2792 ASTM TEMPUS KU, P19; Chang PL, 2010, SCIENTOMETRICS, V82, P5, DOI 10.1007/s11192-009-0033-y; de Kemp V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118653; Doyle K, 2014, GENET ENG BIOTECHNOL, V34, P34, DOI DOI 10.1089/GEN.34.10.02; EPSRC Center for Innovative Manufacturing in Additive Manufacturing, 2015, ANN REP 2014 2015; European Patent Office, PAT FAM; Garechana G, 2017, SCIENTOMETRICS; Grezes V, 2015, J INTELL STUD BUS, V5, P40, DOI 10.37380/jisib.v5i1.111; Gridlogics, INT PROP SOFTW SOL; Gridlogics, 2012, US MAN US GUID PAT I; Groll J, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/1/013001; Integra LifeSciences Corporation, INT CO PROF; Kostoff RN, 2001, IEEE T ENG MANAGE, V48, P132, DOI 10.1109/17.922473; Kostoff RN, 2007, SCIENTOMETRICS, V70, P565, DOI 10.1007/s11192-007-0303-5; Lichtenthaler E, 2004, R&D MANAGE, V34, P121, DOI 10.1111/j.1467-9310.2004.00328.x; Lichtenthaler E, 2003, R&D MANAGE, V33, P361, DOI 10.1111/1467-9310.00304; Lv PH, 2011, SCIENTOMETRICS, V88, P399, DOI 10.1007/s11192-011-0386-x; Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007; Michael S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057741; Mironov V, 2006, TISSUE ENG, V12, P631, DOI 10.1089/ten.2006.12.631; Murphy SV, NATURE BIOTECHNOLOGY, V32, P773; OECD. OECD Science, 2014, TECHN IND OUTL 2014; OECD. Science and Research Today: Highlights of the OECD Science, 2015, TECHN IND SCOR; Organovo, CO FACT SHEET; Organovo, 3D HUM LIV TISS TEST; Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912; Porter A., 2005, COMPETITIVE INTELLIG, P30; Reuters T., WEB SCI WORLDS MOST; Salvador MR, 2012, J INTELL STUD BUS, V2, P51, DOI 10.37380/jisib.v2i1.31; Shaffer V, 2016, G00303428 GARTN; Sheehan Timothy, 2011, Recent Patents on Biomedical Engineering, V4, P26, DOI 10.2174/1874764711104010026; Sneddon M., INTELLECTUAL PROPERT; Thomson Reuters, J CITATION REPORTS; Trappey AJC, 2017, TECHNOL ANAL STRATEG, V29, P339, DOI 10.1080/09537325.2016.1211267; Tsinghua University, TSINGH STAT; Tsinghua University, TSINGH GEN INF; UNESCO Institute for Statistics, SCI TECHN INN; Ventola C Lee, 2014, P T, V39, P704; Wake Forest Institute for Regenerative Medicine, US INK JET TECHN PRI; World Intellectual Property Organization, INT PAT CLASS IPC; Xi'an Jiaotong University, HISTORY; Yoo SS, 2015, EXPERT OPIN THER PAT, V25, P507, DOI 10.1517/13543776.2015.1019466; Zhou X, 2014, BIOL MED, V10, pe889	54	42	44	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180375	10.1371/journal.pone.0180375	http://dx.doi.org/10.1371/journal.pone.0180375			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662187	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300146
J	Steele, CC; Pirkle, JRA; Kirkpatrick, K				Steele, Catherine C.; Pirkle, Jesseca R. A.; Kirkpatrick, Kimberly			Diet-induced impulsivity: Effects of a high-fat and a high-sugar diet on impulsive choice in rats	PLOS ONE			English	Article							INDUCED OBESITY; INDIVIDUAL-DIFFERENCES; PATHOLOGICAL GAMBLERS; MECHANISMS; ADDICTION; BEHAVIOR; WEIGHT	Impulsive choice is a common charactertistic among individuals with gambling problems, obesity, and substance abuse issues. Impulsive choice has been classified as a trans-disease process, and understanding the etiology of trait impulsivity could help to understand how diseases and disorders related to impulsive choice are manifested. The Western diet is a possible catalyst of impulsive choice as individuals who are obese and who eat diets high in fat and sugar are typically more impulsive. However, such correlational evidence is unable to discern the direction and causal nature of the relationship. The present study sought to determine how diet may directly contribute to impulsive choice. After 8 weeks of dietary exposure (high-fat, high-sugar, chow), the rats were tested on an impulsive choice task, which presented choices between a smaller-sooner reward (SS) and a larger-later reward (LL). Then, the rats were transferred to a chow diet and retested on the impulsive choice task. The high-sugar and high-fat groups made significantly more impulsive choices than the chow group. Both groups became more self-controlled when they were off the diet, but there were some residual effects of the diet on choice behavior. These results suggest that diet, specifically one high in processed fat or sugar, induces impulsive choice. This diet-induced impulsivity could be a precursor to other disorders that are characterized by impulsivity, such as diet-induced obesity, and could offer potential understanding of the trans-disease nature of impulsive choice.	[Steele, Catherine C.; Pirkle, Jesseca R. A.; Kirkpatrick, Kimberly] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA	Kansas State University	Steele, CC (corresponding author), Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA.	cchill1@ksu.edu		Steele, Catherine/0000-0002-1898-3338	National Institutes of Health [MH085739]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by R01 grant MH085739 from the National Institutes of Health awarded to Kimberly Kirkpatrick and Kansas State University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrit.	Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Baguley T, 2009, BRIT J PSYCHOL, V100, P603, DOI 10.1348/000712608X377117; Baumann AA, 2012, BEHAV PROCESS, V90, P408, DOI 10.1016/j.beproc.2012.04.005; Bickel WK, 2014, APPETITE, V75, P82, DOI 10.1016/j.appet.2013.12.018; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Daugherty JR, 2010, PERS INDIV DIFFER, V48, P202, DOI 10.1016/j.paid.2009.10.007; Dixon MR, 2006, J APPL BEHAV ANAL, V39, P413, DOI 10.1901/jaba.2006.173-05; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Fields SA, 2013, APPETITE, V70, P60, DOI 10.1016/j.appet.2013.06.089; Jarmolowicz DP, 2014, APPETITE, V78, P63, DOI 10.1016/j.appet.2014.02.013; Jurdak N, 2008, NUTR NEUROSCI, V11, P48, DOI 10.1179/147683008X301333; Jurdak N, 2009, PHYSIOL BEHAV, V96, P1, DOI 10.1016/j.physbeh.2008.07.023; Kirkpatrick K, 2014, BEHAV BRAIN RES, V269, P115, DOI 10.1016/j.bbr.2014.04.024; Kirkpatrick K, 2013, BEHAV NEUROSCI, V127, P712, DOI 10.1037/a0034124; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; Lumley J, 2016, PERS INDIV DIFFER, V97, P178, DOI 10.1016/j.paid.2016.03.055; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216; Marshall AT, 2014, J EXP ANAL BEHAV, V102, P86, DOI 10.1002/jeab.88; McClure J, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00003; Narayanaswami V, 2013, INT J OBESITY, V37, P1095, DOI 10.1038/ijo.2012.178; Nederkoorn C, 2006, APPETITE, V47, P253, DOI 10.1016/j.appet.2006.05.008; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Novelli ELB, 2007, LAB ANIM-UK, V41, P111, DOI 10.1258/002367707779399518; Odum AL, 2011, J EXP ANAL BEHAV, V96, P427, DOI 10.1901/jeab.2011.96-423; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Rasmussen EB, 2010, BEHAV PROCESS, V83, P23, DOI 10.1016/j.beproc.2009.09.001; Reynolds B, 2006, BEHAV PHARMACOL, V17, P651, DOI 10.1097/FBP.0b013e3280115f99; SCHEMMEL R, 1970, J NUTR, V100, P1041; Smith AP, 2015, BEHAV PROCESS, V112, P29, DOI 10.1016/j.beproc.2014.10.010; STEPHENS DW, 1981, ANIM BEHAV, V29, P628, DOI 10.1016/S0003-3472(81)80128-5; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; TATHAM TA, 1989, BEHAV RES METH INSTR, V21, P294, DOI 10.3758/BF03205598; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Wileyto EP, 2004, BEHAV RES METH INS C, V36, P41, DOI 10.3758/BF03195548	37	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e180510	10.1371/journal.pone.0180510	http://dx.doi.org/10.1371/journal.pone.0180510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662133	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300162
J	Duthie, E; Verissimo, D; Keane, A; Knight, AT				Duthie, Elizabeth; Verissimo, Diogo; Keane, Aidan; Knight, Andrew T.			The effectiveness of celebrities in conservation marketing	PLOS ONE			English	Article							MATCH-UP HYPOTHESIS; CLIMATE-CHANGE; COMMUNICATION; FLAGSHIPS; ADVOCACY; IMAGERY; MEMORY; BRAND	Celebrities are frequently used in conservation marketing as a tool to raise awareness, generate funding and effect behaviour change. The importance of evaluating effectiveness is widely recognised in both marketing and conservation but, to date, little research into the effectiveness of celebrity endorsement as a tool for conservation marketing has been published. Using a combination of interviews and an online choice survey instrument, we investigated the extent to which a sample of UK-based conservation organisations, and other charities, evaluate their own usage of celebrity endorsement, and then carried out an experimental evaluation of a hypothetical marketing campaign. This experiment compared participants' willingness-to-engage (WTE) with, and recall of, a conservation message presented in versions of an advert featuring one of three prominent UK celebrities (David Beckham, Chris Packham or HRH Prince William) or a non-celebrity control treatment (featuring Crawford Allan, a director of TRAFFIC USA). We find that the organisations we interviewed did not routinely evaluate their marketing campaigns featuring celebrities. Furthermore, our experiment provides evidence that celebrity endorsement can produce both positive and negative effects. Participants were more willing to engage when presented with an advert featuring one of the three celebrities than the non-celebrity control, and WTE varied according to the characteristics of the celebrity and the respondent. However, celebrities were less effective at generating campaign message recall than non-celebrities. These findings suggest that celebrity endorsement should be used carefully. Further work is required to fully understand the role celebrity endorsers can play in conservation but, drawing on best practice from the field of marketing, this study introduces an approach to evaluation which could be applied more widely to improve the effectiveness of conservation marketing.	[Duthie, Elizabeth; Knight, Andrew T.] Imperial Coll, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England; [Verissimo, Diogo] Georgia State Univ, Andrew Young Sch Policy Studies, Dept Econ, Atlanta, GA 30303 USA; [Keane, Aidan] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Knight, Andrew T.] Univ Queensland, Ctr Excellence Environm Decis, St Lucia, Qld, Australia; [Knight, Andrew T.] Nelson Mandela Metropolitan Univ, Dept Bot, Port Elizabeth, South Africa; [Knight, Andrew T.] Silwood Grp, Silwood Pk Campus, Ascot, Berks, England	Imperial College London; University System of Georgia; Georgia State University; University of Edinburgh; University of Queensland; Nelson Mandela University	Duthie, E (corresponding author), Imperial Coll, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England.	lizzie_duthie@mac.com	Knight, Andrew Thomas/C-8394-2009; Keane, Aidan/Q-5153-2019	Knight, Andrew Thomas/0000-0002-6563-0500; Keane, Aidan/0000-0002-9704-5576; Verissimo, Diogo/0000-0002-3519-6782; Duthie, Elizabeth/0000-0002-4454-1058	David H. Smith Conservation Research Fellowship	David H. Smith Conservation Research Fellowship	DV is funded by a David H. Smith Conservation Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2013, CELEBR STUD, V4, P339, DOI 10.1080/19392397.2013.831617; Anderson A, 2011, WIRES CLIM CHANGE, V2, P535, DOI 10.1002/wcc.119; Andreasen A., 2003, STRATEGIC MARKETING; Atkin C., 1983, J ADVERTISING RES; BAKER MJ, 1977, J MARKETING RES, V14, P538, DOI 10.2307/3151194; Balmford A, 2006, CONSERV BIOL, V20, P692, DOI 10.1111/j.1523-1739.2006.00434.x; Barkham Patrick, 2014, GUARDIAN; Boykoff MT, 2009, GEOFORUM, V40, P395, DOI 10.1016/j.geoforum.2008.04.006; Brian D., 2002, HDB MARKETING, P39; Brockington D, 2009, CELEBRITY ENV DISTRI; Brockington D, 2014, INT J CULTURAL STUD; Charities Aid Foundation, UK GIV 2014 SUMM FIN; CHILDERS TL, 1984, J CONSUM RES, V11, P643, DOI 10.1086/209001; Conservation International, 2015 ANN REP, P32; Cramphorn S, 2004, J ADVERTISING RES, V44, P170, DOI 10.1017/S0021849904040115; Croft R., 1996, P MARK ED GROUP C; Erdogan B. Z., 1999, J MARKETING MANAGEME, V15, P291, DOI DOI 10.1362/026725799784870379; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Forkan J., 1980, ADVERTISING AGE, V51, P42; Gelman A., 2021, BAYESIAN DATA ANAL; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; HILBORN R, 1993, ECOL APPL, V3, P550, DOI 10.2307/1942075; Hovland C.I., 1953, COMMUN PERSUATION; Hovland CI, 1951, PUBLIC OPIN QUART, V15, P635, DOI 10.1086/266350; Hudson Institute Centre For Global Prosperity, 2013 IND GLOB PHIL R; Jain SC, 1985, MARKETING PLANNING S; KAMEN JM, 1975, J ADVERTISING RES, V15, P17; KAMINS MA, 1990, J ADVERTISING, V19, P4, DOI 10.1080/00913367.1990.10673175; Kotler P., 2014, PRINCIPLES MARKETING, V15; Leas EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159885; LUTZ KA, 1977, J APPL PSYCHOL, V62, P493, DOI 10.1037/0021-9010.62.4.493; McCole P., 2004, MARK INTELL PLAN, V22, P531, DOI DOI 10.1108/02634500410551914; MEHTA A, 1994, J ADVERTISING RES, V34, P62; Moeller Susan, 1999, COMPASSION FATIGUE M; Moore K, 2008, BUS HIST, V50, P419, DOI 10.1080/00076790802106299; Moriarty S., 2014, ADVERTISING PRINCIPL; Mowen JC, 1981, NA ADV CONSUMER RES, V08; Nikkhah R., 2017, BLOODSPORTS ROYAL FA; Ohanian R, 1991, J ADVERTISING RES; OMalley L., 2000, EUR J MARKETING, V34, P797, DOI DOI 10.1108/03090560010331225; PAIVIO A, 1969, PSYCHOL REV, V76, P241, DOI 10.1037/h0027272; PETTY RE, 1983, J CONSUM RES, V10, P135, DOI 10.1086/208954; Pornpitakpan C., 2004, J INT CONSUM MARK, V16, P55; Pringle H., 2004, CELEBRITY SELLS; R Core Team, 2013, R LANG ENV STAT COMP; Radio Times, 2009, RADIO TIMES; SILK AJ, 1978, J MARKETING RES, V15, P171, DOI 10.2307/3151248; Solomon M., 2012, CONSUMER BEHAV; Stan Development Team, 2015, RSTAN R INT STAN; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Su YS, 2011, J STAT SOFTW, V45, P1; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Thrall AT, 2008, INT J PRESS/POLIT, V13, P362, DOI 10.1177/1940161208319098; Till BD, 2000, J ADVERTISING, V29, P1; Verissimo D, 2016, ORYX, V50, P14; Verissimo D, 2014, CONSERV LETT, V7, P263, DOI 10.1111/conl.12070; Verissimo D, 2011, CONSERV LETT, V4, P1, DOI 10.1111/j.1755-263X.2010.00151.x; World Wildlife Fund, 2015 ANN REP, P26	59	27	27	8	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180027	10.1371/journal.pone.0180027	http://dx.doi.org/10.1371/journal.pone.0180027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686595	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100031
J	Han, ZL; Chen, Z; Lan, RF; Di, WC; Li, XH; Yu, HS; Ji, WQ; Zhang, XL; Xu, BA; Xu, W				Han, Zhonglin; Chen, Zheng; Lan, Rongfang; Di, Wencheng; Li, Xiaohong; Yu, Hongsong; Ji, Wenqing; Zhang, Xinlin; Xu, Biao; Xu, Wei			Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy	PLOS ONE			English	Article							LONG-TERM SURVIVAL; GENDER-RELATED DIFFERENCES; VENTRICULAR LEAD POSITION; DOPPLER CROSS-CORRELATION; ATRIAL-FIBRILLATION; DEFIBRILLATOR IMPLANTATION; CARDIOVERTER-DEFIBRILLATOR; MECHANICAL DYSSYNCHRONY; CONDUCTION DELAY; ADVERSE EVENTS	Background Recent studies have reported prognosis differences between male and female heart failure patients following cardiac resynchronization therapy (CRT). However, the potential clinical factors that underpin these differences remain to be elucidated. Methods A meta-analysis was performed to investigate the factors that characterize sex-specific differences following CRT. This analysis involved searching the Medline (Pubmed source) and Embase databases in the period from January 1980 to September 2016. Results Fifty-eight studies involving 33445 patients (23.08% of whom were women) were analyzed as part of this study. Only patients receiving CRT with follow-up greater than six months were included in our analysis. Compared with males, females exhibited a reduction of 33% (hazard ratio, 0.67; 95% confidence interval, 0.62-0.73; P < 0.0001) and 42% (hazard ratio, 0.58; 95% confidence interval, 0.46-0.74; P = 0.003) in all-cause mortality and heart failure hospitalization or heart failure, respectively. Following a stratified analysis of all-cause mortality, we observed that ischemic causes (p = 0.03) were likely to account for most of the sex-specific differences in relation to CRT. Conclusion These data suggest that women have a reduced risk of all-cause mortality and heart failure hospitalization or heart failure following CRT. Based on the results from the stratified analysis, we observed more optimal outcomes for females with ischemic heart disease. Thus, ischemia are likely to play a role in sex-related differences associated with CRT in heart failure patients. Further studies are required to determine other indications and the potential mechanisms that might be associated with sex-specific CRT outcomes.	[Han, Zhonglin; Chen, Zheng; Lan, Rongfang; Di, Wencheng; Li, Xiaohong; Yu, Hongsong; Ji, Wenqing; Zhang, Xinlin; Xu, Biao; Xu, Wei] Nanjing Univ, Sch Med, Affiliated Nanjing Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Xu, W (corresponding author), Nanjing Univ, Sch Med, Affiliated Nanjing Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	xuwei2003@medmail.com.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022		National Natural Science Foundation of China [81600267]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No.81600267) to Zhonglin Han. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Alaeddini J, 2008, PACE, V31, P468, DOI 10.1111/j.1540-8159.2008.01016.x; Arshad A, 2011, J AM COLL CARDIOL, V57, P814, DOI 10.1016/j.jacc.2010.06.061; Auricchio A, 2007, AM J CARDIOL, V99, P232, DOI 10.1016/j.amjcard.2006.07.087; Bai R, 2008, J CARDIOVASC ELECTR, V19, P1259, DOI 10.1111/j.1540-8167.2008.01234.x; Bogale N, 2012, EUR J HEART FAIL, V14, P61, DOI 10.1093/eurjhf/hfr158; Cheng YJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P807, DOI 10.1161/CIRCEP.113.001786; Cipriani M, 2016, EUR J HEART FAIL, V18, P1060, DOI 10.1002/ejhf.569; Cipriani M, 2016, J CARDIOVASC MED, V17, P291, DOI 10.2459/JCM.0000000000000187; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047; Delgado V, 2011, CIRCULATION, V123, P70, DOI 10.1161/CIRCULATIONAHA.110.945345; Di Biase L, 2008, EUR HEART J, V29, P2497, DOI 10.1093/eurheartj/ehn221; Eitel C, 2012, EUROPACE, V14, P358, DOI 10.1093/europace/eur298; El-Saed Aiman, 2009, Clin Cardiol, V32, pE33, DOI 10.1002/clc.20490; Fantoni C, 2008, EUR J HEART FAIL, V10, P298, DOI 10.1016/j.ejheart.2008.01.006; Ferreira AM, 2008, EUROPACE, V10, P809, DOI 10.1093/europace/eun135; Foley PWX, 2011, EUR J HEART FAIL, V13, P43, DOI 10.1093/eurjhf/hfq182; Frigerio M, 2014, INT J CARDIOL, V172, P64, DOI 10.1016/j.ijcard.2013.12.005; Gasparini M, 2015, EUR J HEART FAIL, V17, P717, DOI 10.1002/ejhf.269; Gasparini M, 2014, AM HEART J, V167, P203, DOI 10.1016/j.ahj.2013.10.017; Gold MR, 2015, HEART RHYTHM, V12, P524, DOI 10.1016/j.hrthm.2014.11.014; Herz ND, 2015, J WOMENS HEALTH, V24, P261, DOI 10.1089/jwh.2014.4980; Hoke U, 2014, CIRC-CARDIOVASC QUAL, V7, P437, DOI 10.1161/CIRCOUTCOMES.113.000821; Iler MA, 2008, AM J CARDIOL, V101, P359, DOI 10.1016/j.amjcard.2007.08.043; Jacobsson J, 2016, AM J CARDIOL, V118, P389, DOI 10.1016/j.amjcard.2016.05.017; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kappert K, 2012, CIRCULATION, V126, P934, DOI 10.1161/CIRCULATIONAHA.111.086660; Khatib M, 2014, EUR J HEART FAIL, V16, P802, DOI 10.1002/ejhf.102; Kotecha D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1855; Kreuz J, 2012, EUROPACE, V14, P1596, DOI 10.1093/europace/eus152; Kronborg MB, 2008, EUR J HEART FAIL, V10, P796, DOI 10.1016/j.ejheart.2008.06.013; Leyva F, 2011, PACE, V34, P82, DOI 10.1111/j.1540-8159.2010.02909.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lilli A, 2007, PACE, V30, P1349, DOI 10.1111/j.1540-8159.2007.00870.x; Lin G, 2011, EUR HEART J, V32, P184, DOI 10.1093/eurheartj/ehq403; Looi KL, 2014, HEART, V100, P794, DOI 10.1136/heartjnl-2014-305537; Lumens J, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003744; Miller AL, 2011, PACE, V34, P490, DOI 10.1111/j.1540-8159.2010.03014.x; Mitoff PR, 2011, HEART, V97, P382, DOI 10.1136/hrt.2010.199760; Mooyaart EAQ, 2011, AM J CARDIOL, V108, P63, DOI 10.1016/j.amjcard.2011.02.345; Morani G, 2013, EUROPACE, V15, P1273, DOI 10.1093/europace/eut032; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Munir MB, 2016, J CARDIOVASC ELECTR, V27, P730, DOI 10.1111/jce.12951; Nagy VK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143907; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; Perini AP, 2014, EUROPACE, V16, P71, DOI 10.1093/europace/eut190; Pfau G, 2010, J CARDIOTHOR VASC AN, V24, P30, DOI 10.1053/j.jvca.2009.07.009; Poli D, 2015, INT J WOMENS HEALTH, V7, P605, DOI 10.2147/IJWH.S45925; Prochnau D, 2011, CAN J CARDIOL, V27, P363, DOI 10.1016/j.cjca.2010.12.066; Reitan C, 2014, EUROPACE, V16, P1603, DOI 10.1093/europace/euu058; Rickard J, 2015, AM J CARDIOL, V115, P82, DOI 10.1016/j.amjcard.2014.09.052; Rickard J, 2011, AM HEART J, V162, P646, DOI 10.1016/j.ahj.2011.07.008; Risum N, 2013, EUR HEART J, V34, P48, DOI 10.1093/eurheartj/ehs035; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Roubicek T, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1113, DOI 10.1161/CIRCEP.115.003004; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Saxon LA, 2006, CIRCULATION, V114, P2766, DOI 10.1161/CIRCULATIONAHA.106.642892; Schuchert A, 2013, CLIN CARDIOL, V36, P683, DOI 10.1002/clc.22203; Shalaby A, 2008, AM J CARDIOL, V101, P238, DOI 10.1016/j.amjcard.2007.07.064; Sharma AK, 2015, AM J CARDIOL, V115, P1249, DOI 10.1016/j.amjcard.2015.01.559; Shekelle PG, 2003, J AM COLL CARDIOL, V41, P1529, DOI 10.1016/S0735-1097(03)00262-6; Shen XD, 2011, INT J CARDIOL, V152, P13, DOI 10.1016/j.ijcard.2010.06.016; Smit MD, 2011, EUR J HEART FAIL, V13, P543, DOI 10.1093/eurjhf/hfr006; Stabile G, 2015, HEART RHYTHM, V12, P2221, DOI 10.1016/j.hrthm.2015.05.020; Stabile G, 2009, PACE, V32, pS141, DOI 10.1111/j.1540-8159.2008.02271.x; Sutton MGS, 2006, CIRCULATION, V113, P266, DOI 10.1161/CIRCULATIONAHA.104.520817; Taneja T, 2001, PACE, V24, P16, DOI 10.1046/j.1460-9592.2001.00016.x; Tayal B, 2015, J AM SOC ECHOCARDIOG, V28, P1474, DOI 10.1016/j.echo.2015.07.021; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Van Bommel RJ, 2011, J AM COLL CARDIOL, V57, P549, DOI 10.1016/j.jacc.2010.06.060; Wilcox JE, 2014, CIRC-HEART FAIL, V7, P146, DOI 10.1161/CIRCHEARTFAILURE.113.000789; Xu YZ, 2012, J CARDIOVASC ELECTR, V23, P172, DOI 10.1111/j.1540-8167.2011.02168.x; Yanagisawa S, 2015, J INTERV CARD ELECTR, V43, P269, DOI 10.1007/s10840-015-0015-3; Yancy CW, 2009, AM HEART J, V157, P754, DOI 10.1016/j.ahj.2008.12.016; Yu CM, 2005, CIRCULATION, V112, P1580, DOI 10.1161/CIRCULATIONAHA.105.538272; Zabarovskaja S, 2012, EUROPACE, V14, P1148, DOI 10.1093/europace/eus039; Zardkoohi O, 2007, PACE, V30, P1344, DOI 10.1111/j.1540-8159.2007.00869.x; Zhang Q, 2009, CLIN SCI, V117, P397, DOI 10.1042/CS20080580; Zusterzeel R, 2016, J CARDIOVASC TRANSL, V9, P12, DOI 10.1007/s12265-015-9663-z; Zusterzeel R, 2014, JAMA INTERN MED, V174, P1340, DOI 10.1001/jamainternmed.2014.2717	81	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180513	10.1371/journal.pone.0180513	http://dx.doi.org/10.1371/journal.pone.0180513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683134	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200045
J	Matsunaga, M; Ishii, K; Ohtsubo, Y; Noguchi, Y; Ochi, M; Yamasue, H				Matsunaga, Masahiro; Ishii, Keiko; Ohtsubo, Yohsuke; Noguchi, Yasuki; Ochi, Misaki; Yamasue, Hidenori			Association between salivary serotonin and the social sharing of happiness	PLOS ONE			English	Article							EMOTIONAL CONTAGION; EMPATHY; STRESS; SYSTEM; REWARD; MALTREATMENT; HEALTH; ADULTS; STATES; AGE	Although human saliva contains the monoamine serotonin, which plays a key role in the modulation of emotional states, the association between salivary serotonin and empathic ability remains unclear. In order to elucidate the associations between salivary serotonin levels, trait empathy, and the sharing effect of emotions (i.e., sharing emotional experiences with others), we performed a vignette-based study. Participants were asked to evaluate their happiness when they experience several hypothetical life events, whereby we manipulated the valence of the imagined event (positive, neutral, or negative), as well as the presence of a friend (absent, positive, or negative). Results indicated that the presence of a happy friend significantly enhanced participants' happiness. Correlation analysis demonstrated that salivary serotonin levels were negatively correlated with happiness when both the self and friend conditions were positive. Correlation analysis also indicated a negative relationship between salivary serotonin levels and trait empathy (particularly in perspective taking), which was measured by the Interpersonal Reactivity Index. Furthermore, an exploratory multiple regression analysis suggested that mothers' attention during childhood predicted salivary serotonin levels. Our findings indicate that empathic abilities and the social sharing of happiness decreases as a function of salivary serotonin levels.	[Matsunaga, Masahiro] Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Nagakute, Aichi, Japan; [Ishii, Keiko; Ohtsubo, Yohsuke; Noguchi, Yasuki; Ochi, Misaki] Kobe Univ, Fac Letters, Grad Sch Humanities, Dept Psychol, Kobe, Hyogo, Japan; [Yamasue, Hidenori] Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka, Japan	Aichi Medical University; Kobe University; Hamamatsu University School of Medicine	Matsunaga, M (corresponding author), Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Nagakute, Aichi, Japan.	matsunag@aichi-med-u.ac.jp	Ishii, Keiko/H-5607-2019		JSPS Topic-Setting Program; Kobe University	JSPS Topic-Setting Program; Kobe University	This work was supported by a JSPS Topic-Setting Program to Advance Cutting-Edge Humanities and Social Sciences Research (Responding-to-Real-Society) (to KI). This work was also supported by Kobe University (Young Scholar Award) (to YO). The funders had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aketa H., 1999, PSYCHOL REP SOPHIA U, V2, P19; Beadle JN, 2012, INT PSYCHOGERIATR, V24, P822, DOI 10.1017/S1041610211002547; Berglund KJ, 2013, ALCOHOL CLIN EXP RES, V37, P757, DOI 10.1111/acer.12023; Bravo JA, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00024; Choi Damee., 2016, PSYCHOLOGY, V7, P1240, DOI [10.4236/psych.2016.79126, DOI 10.4236/PSYCH.2016.79126]; Chopik WJ, 2017, J CROSS CULT PSYCHOL, V48, P23, DOI 10.1177/0022022116673910; DOHERTY RW, 1995, PSYCHOL WOMEN QUART, V19, P355, DOI 10.1111/j.1471-6402.1995.tb00080.x; Dolder PC, 2016, NEUROPSYCHOPHARMACOL, V41, P2638, DOI 10.1038/npp.2016.82; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferreira JN, 2013, ORGANOGENESIS, V9, P199, DOI 10.4161/org.25224; Germine L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129612; Groschl M, 2008, CLIN CHEM, V54, P1759, DOI 10.1373/clinchem.2008.108910; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Himichi Toshiyuki, 2017, Shinrigaku Kenkyu, V88, P61; Ito Y, 2013, INT J TRYPTOPHAN RES, P75, DOI 10.4137/IJTR.S11760; Izawa S, 2013, BIOL PSYCHOL, V94, P249, DOI 10.1016/j.biopsycho.2013.06.006; Izawa S, 2012, PSYCHONEUROENDOCRINO, V37, P852, DOI 10.1016/j.psyneuen.2011.10.001; Kawamichi H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00164; Kawamichi H, 2013, SOC NEUROSCI-UK, V8, P90, DOI 10.1080/17470919.2012.744349; Kimura M., 2007, JPN J INTERPERS SOC, V7, P31, DOI DOI 10.18910/6043; Kranz GS, 2010, NEUROSCIENCE, V166, P1023, DOI 10.1016/j.neuroscience.2010.01.036; Lamm C, 2008, BRAIN RES, V1227, P153, DOI 10.1016/j.brainres.2008.06.066; Lin HC, 2012, INFANT BEHAV DEV, V35, P887, DOI 10.1016/j.infbeh.2012.08.001; Mascaro JS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00109; Matsunaga M, 2016, NEUROIMAGE, V134, P132, DOI 10.1016/j.neuroimage.2016.04.020; Morelli SA, 2015, SOC PERSONAL PSYCHOL, V9, P57, DOI 10.1111/spc3.12157; Morelli SA, 2014, SOC COGN AFFECT NEUR, V9, P39, DOI 10.1093/scan/nss088; Preller KH, 2016, P NATL ACAD SCI USA, V113, P5119, DOI 10.1073/pnas.1524187113; Price J, 2009, BRIT J PSYCHIAT, V195, P211, DOI 10.1192/bjp.bp.108.051110; Ren TH, 2007, AM J PHYSIOL-GASTR L, V292, pG849, DOI 10.1152/ajpgi.00400.2006; RIME B, 1991, COGNITION EMOTION, V5, P435, DOI 10.1080/02699939108411052; Roy A, 2002, PSYCHIAT RES, V112, P69, DOI 10.1016/S0165-1781(02)00176-2; Stafford M, 2016, J POSIT PSYCHOL, V11, P326, DOI 10.1080/17439760.2015.1081971; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Taillieu TL, 2016, CHILD ABUSE NEGLECT, V59, P1, DOI 10.1016/j.chiabu.2016.07.005; Tan ZL, 2007, NEUROENDOCRINOL LETT, V28, P395; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; Ul-Haq Z, 2014, PSYCHOL MED, V44, P2231, DOI 10.1017/S0033291713002833; Vuoskoski JK, 2012, PSYCHOL AESTHET CREA, V6, P204, DOI 10.1037/a0026937; Wagner U, 2015, SOC COGN AFFECT NEUR, V10, P801, DOI 10.1093/scan/nsu121	42	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180391	10.1371/journal.pone.0180391	http://dx.doi.org/10.1371/journal.pone.0180391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683075	gold, Green Submitted, Green Published			2022-12-27	WOS:000405335200031
J	Schulte, MJ; Solocinski, J; Wang, M; Kovacs, M; Kilgore, R; Osgood, Q; Underwood, L; Flickinger, MC; Chakraborty, N				Schulte, Mark J.; Solocinski, Jason; Wang, Mian; Kovacs, Michelle; Kilgore, Ryan; Osgood, Quinn; Underwood, Lukas; Flickinger, Michael C.; Chakraborty, Nilay			A technique for lyopreservation of Clostridium ljungdahlii in a biocomposite matrix for CO absorption	PLOS ONE			English	Article							MAMMALIAN-CELLS; PRESERVATION; TREHALOSE; BACTERIA; CRYOPRESERVATION; CARBOXIDIVORANS; MICROORGANISMS; ANHYDROBIOSIS; VITRIFICATION; CYANOBACTERIA	A system capable of biocatalytic conversion of distributed sources of single carbon gases such as carbon monoxide into hydrocarbons can be highly beneficial for developing commercially viable biotechnology applications in alternative energy. Several anaerobic bacterial strains can be used for such conversion. The anaerobic carbon monoxide-fixing bacteria Clostridium ljungdahlii OTA1 is a model CO assimilating microorganism that currently requires cryogenic temperature for storage of the viable strains. If these organisms can be stabilized and concentrated in thin films in advanced porous materials, it will enable development of high gas fraction, biocomposite absorbers with elevated carbon monoxide (CO) mass transfer rate, that require minimal power input and liquid, and demonstrate elevated substrate consumption rate compared to conventional suspended cell bioreactors. We report development of a technique for dry-stabilization of C.ljungdahlii OTA1 on a paper biocomposite. Bacterial samples coated onto paper were desiccated in the presence of trehalose using convective drying and stored at 4 degrees C. Optimal dryness was similar to 1g H2O per gram of dry weight (gDW). CO uptake directly following biocomposite rehydration steadily increases over time indicating immediate cellular metabolic recovery. A high-resolution Raman microspectroscopic hyperspectral imaging technique was employed to spatially quantify the residual moisture content. We have demonstrated for the first time that convectively dried and stored C. ljungdahlii strains were stabilized in a desiccated state for over 38 days without a loss in CO absorbing reactivity. The Raman hyperspectral imaging technique described here is a non-invasive characterization tool to support development of dry-stabilization techniques for microorganisms on inexpensive porous support materials. The present study successfully extends and implements the principles of dry-stabilization for preservation of strictly anaerobic bacteria as an alternative to lyophilization or spray drying that could enable centralized biocomposite biocatalyst fabrication and decentralized bioprocessing of CO to liquid fuels or chemicals.	[Schulte, Mark J.; Kovacs, Michelle; Kilgore, Ryan; Flickinger, Michael C.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Solocinski, Jason; Wang, Mian; Osgood, Quinn; Underwood, Lukas; Chakraborty, Nilay] Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA; [Flickinger, Michael C.] North Carolina State Univ, Biomfg Training & Educ Ctr, Raleigh, NC 27695 USA; [Wang, Mian] Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA	University of North Carolina; North Carolina State University; University of Michigan System; University of Michigan; University of North Carolina; North Carolina State University; University of Minnesota System; University of Minnesota Twin Cities	Flickinger, MC (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.; Chakraborty, N (corresponding author), Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA.; Flickinger, MC (corresponding author), North Carolina State Univ, Biomfg Training & Educ Ctr, Raleigh, NC 27695 USA.	mcflicki@ncsu.edu; nilay@umich.edu	Chakraborty, Nilay/AAK-4812-2020	Chakraborty, Nilay/0000-0001-8138-3506; Flickinger, Michael/0000-0002-6814-0427	National Institutes of Health Molecular Biotechnology Training Program [T32 GM008776-11]; Department of Energy Office of Energy Efficiency and Renewable Energy (EERE) [DE-EE0006877]; Golden LEAF Biotechnology Training and Education Center (BTEC) at NCSU; NSF [SusChEM 1510072, CHE 1609440]; University of Michigan [U038726, U046888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008776] Funding Source: NIH RePORTER	National Institutes of Health Molecular Biotechnology Training Program; Department of Energy Office of Energy Efficiency and Renewable Energy (EERE); Golden LEAF Biotechnology Training and Education Center (BTEC) at NCSU; NSF(National Science Foundation (NSF)); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (www.nih.gov) Molecular Biotechnology Training Program (T32 GM008776-11), the Department of Energy (www. energy.gov), Office of Energy Efficiency and Renewable Energy (EERE) under Award Number DE-EE0006877, and the Golden LEAF Biotechnology Training and Education Center (BTEC) at NCSU (https://www.btec.ncsu.edu). Authors would also like to acknowledge the NSF (www.nsf.gov) grant numbers SusChEM 1510072 and CHE 1609440. Authors would also like to acknowledge University of Michigan (www.umich.edu) Grant Numbers U038726 and U046888. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 2002, CELL PRESERV TECHNOL, V1, P129; [Anonymous], 1998, PROPERTIES WATER FOO; Ben M, 2016, J CHEM TECHNOL BIOT, V91, P2817, DOI 10.1002/jctb.4891; Bernal OI, 2014, BIOTECHNOL BIOENG, V111, P1993, DOI 10.1002/bit.25280; BERNY JF, 1991, MYCOLOGIA, V83, P805, DOI 10.2307/3760439; Bjerketorp J, 2006, CURR OPIN BIOTECH, V17, P43, DOI 10.1016/j.copbio.2005.12.005; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CARPENTER JF, 1991, DEV BIOL STAND, V74, P225; Champagne CP, 1996, FOOD RES INT, V29, P555, DOI 10.1016/0963-9969(95)00050-X; Chen Z, 2001, ANN CLIN LAB SCI, V31, P391; Cheng ZW, 2016, BIORESOURCE TECHNOL, V218, P751, DOI 10.1016/j.biortech.2016.07.001; Crowe J.H., 1992, MEMBRANE INTEGRITY A, P87; Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; De Giulio B, 2005, WORLD J MICROB BIOT, V21, P739, DOI [10.1007/sl1274-004-4735-2, 10.1007/s11274-004-4735-2]; ELLIOTT GD, 2008, CELL PRESERV TECHNOL, V6, P253; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Fahy G, 2015, CRYOBIOLOGY, V71, P169; Fernandez-Naveira A, 2017, J CHEM TECHNOLOGY BI; Fernandez-Naveira A, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2188-z; Fernandez-Naveira A, 2016, APPL MICROBIOL BIOT, V100, P3361, DOI 10.1007/s00253-015-7238-1; Hernandez A, 2009, J APPL MICROBIOL, V107, P436, DOI 10.1111/j.1365-2672.2009.04216.x; Iravani S, 2015, J FOOD SCI TECH MYS, V52, P4679, DOI 10.1007/s13197-014-1516-2; Leang C, 2013, APPL ENVIRON MICROB, V79, P1102, DOI 10.1128/AEM.02891-12; LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592, DOI 10.1128/AEM.61.10.3592-3597.1995; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Nystul TG, 2003, SCIENCE, V302, P1038, DOI 10.1126/science.1089705; Oliver AE, 1998, SEED SCI RES, V8, P211, DOI 10.1017/S0960258500004128; Pegg DE, 2015, METHODS MOL BIOL, V1257, P3, DOI 10.1007/978-1-4939-2193-5_1; Peighambardoust SH, 2011, TRENDS FOOD SCI TECH, V22, P215, DOI 10.1016/j.tifs.2011.01.009; Potts M, 1999, EUR J PHYCOL, V34, P319, DOI 10.1017/S0967026299002267; Roser B., 1991, Trends in Food Science & Technology, V2, P166, DOI 10.1016/0924-2244(91)90671-5; Schoebitz M, 2013, AGRON SUSTAIN DEV, V33, P751, DOI 10.1007/s13593-013-0142-0; Schuck P, 2013, INT DAIRY J, V31, P12, DOI 10.1016/j.idairyj.2012.01.006; Schulte MJ, 2016, BIOTECHNOL BIOENG, V113, P1913, DOI 10.1002/bit.25966; SHIER WT, 1988, CRYOBIOLOGY, V25, P110, DOI 10.1016/0011-2240(88)90004-1; Slininger PJ, 2010, BIOCONTROL SCI TECHN, V20, P227, DOI 10.1080/09583150903469525; Solocinski J., 2017, CRYOBIOLOGY	38	1	1	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180806	10.1371/journal.pone.0180806	http://dx.doi.org/10.1371/journal.pone.0180806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678828	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200091
J	Sorensen, L; Sorhus, E; Nordtug, T; Incardone, JP; Linbo, TL; Giovanetti, L; Karlsen, O; Meier, S				Sorensen, Lisbet; Sorhus, Elin; Nordtug, Trond; Incardone, John P.; Linbo, Tiffany L.; Giovanetti, Laura; Karlsen, Orjan; Meier, Sonnich			Oil droplet fouling and differential toxicokinetics of polycyclic aromatic hydrocarbons in embryos of Atlantic haddock and cod	PLOS ONE			English	Article							WEATHERED CRUDE-OIL; FISH EMBRYOS; DISPERSED OIL; MELANOGRAMMUS-AEGLEFINUS; ACUTE TOXICITY; PAHS; MORTALITY; RECEPTOR; BIOACCUMULATION; SENSITIVITY	The impact of crude oil pollution on early life stages (ELS) of fish, including larvae and embryos, has received considerable attention in recent years. Of the organic components present in crude oil, polycyclic aromatic hydrocarbons (PAHs) are considered the main class of compounds responsible for toxic effects in marine organisms. Although evidence suggests that they are more toxic, alkylated PAHs remain much less studied than their unsubstituted congeners. Recently, it was established that embryos of Atlantic haddock (Melanogrammus aeglefinus) are particularly sensitive to dispersed crude oil, and it was hypothesized that this was caused by direct interaction with crude oil droplets, which adhered to the chorion of exposed embryos. Such a phenomenon would increase the potential for uptake of less water-soluble compounds, including alkylated PAHs. In the current study, we compared the uptake of parent and alkylated PAHs in Atlantic cod (Gadus morhua) and haddock embryos exposed to dispersed crude oil at a range of environmentally relevant concentrations (10 - 600 mu g oil/ liter seawater). Although the species are biologically very similar, the cod chorion does not become fouled with oil droplets, even when the two species are exposed to dispersions of crude oil droplets under similar conditions. A close correlation between the degree of fouling and toxicological response (heart defects, craniofacial malformation) was observed. Oil droplet fouling in haddock led to both quantitative and qualitative differences in PAH uptake. Finally, kinetic data on a large suite of PAHs showed differential elimination, suggesting differential metabolism of unsubstituted versus alkylated compounds.	[Sorensen, Lisbet; Sorhus, Elin; Karlsen, Orjan; Meier, Sonnich] Inst Marine Res, Bergen, Norway; [Sorensen, Lisbet] Univ Bergen, Dept Chem, Bergen, Norway; [Nordtug, Trond] SINTEF Ocean, Environm Technol, Trondheim, Norway; [Incardone, John P.; Linbo, Tiffany L.] NOAA, Northwest Fisheries Sci Ctr, Seattle, WA USA; [Giovanetti, Laura] Univ Siena, Dept Environm Sci, Siena, Italy	Institute of Marine Research - Norway; University of Bergen; SINTEF; National Oceanic Atmospheric Admin (NOAA) - USA; University of Siena	Sorensen, L (corresponding author), Inst Marine Res, Bergen, Norway.; Sorensen, L (corresponding author), Univ Bergen, Dept Chem, Bergen, Norway.	lisbet.soerensen@imr.no	Karlsen, Ørjan/K-6137-2012; Nordtug, Trond/GZG-7597-2022	Karlsen, Ørjan/0000-0001-5801-4200; Nordtug, Trond/0000-0002-0269-2974; Sorensen, Lisbet/0000-0003-0455-3545; Sorhus, Elin/0000-0003-3542-4201	Norwegian Research Council [234367]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was financed by the Norwegian Research Council (Grant Nr. 234367, my./forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron MG, 2004, MAR ENVIRON RES, V58, P95, DOI 10.1016/j.marenvres.2004.03.001; Barron MG, 2004, TOXICOL SCI, V78, P60, DOI 10.1093/toxsci/kfh051; Bence AE, 1996, ORG GEOCHEM, V24, P7, DOI 10.1016/0146-6380(96)00010-1; Boehm PD., 2010, ENV FORENSICS CONTAM, P313; Bogerd J, 2001, BIOL REPROD, V64, P1633, DOI 10.1095/biolreprod64.6.1633; Brandvik PJ, 2013, MAR POLLUT BULL, V73, P319, DOI 10.1016/j.marpolbul.2013.05.020; Brette F, 2014, SCIENCE, V343, P772, DOI 10.1126/science.1242747; Brinkworth LC, 2003, J TOXICOL ENV HEAL A, V66, P627, DOI 10.1080/15287390309353771; Carls MG, 2008, AQUAT TOXICOL, V88, P121, DOI 10.1016/j.aquatox.2008.03.014; Carls MG, 2009, HUM ECOL RISK ASSESS, V15, P1084, DOI 10.1080/10807030903304708; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Caroll J., 2011, INTEGRATED MODELING; Devillers J, 1996, CHEMOSPHERE, V33, P1047, DOI 10.1016/0045-6535(96)00246-9; El-Amrani S, 2013, TALANTA, V104, P67, DOI 10.1016/j.talanta.2012.11.025; FRIDGEIRSSON E, 1978, Rit Fiskideildar, V5, P1; Gonzalez-Doncel M, 2008, AQUAT TOXICOL, V87, P280, DOI 10.1016/j.aquatox.2008.02.013; Goodale BC, 2013, TOXICOL APPL PHARM, V272, P656, DOI 10.1016/j.taap.2013.04.024; Hall TE, 2004, J MORPHOL, V259, P255, DOI 10.1002/jmor.10222; Hansen BH, 2012, ECOTOX ENVIRON SAFE, V86, P38, DOI 10.1016/j.ecoenv.2012.09.009; Heintz RA, 1999, ENVIRON TOXICOL CHEM, V18, P494, DOI 10.1002/etc.5620180318; HISLOP JRG, 1987, J FISH BIOL, V31, P1, DOI 10.1111/j.1095-8649.1987.tb05209.x; Hjermann DO, 2007, MAR ECOL PROG SER, V339, P283, DOI 10.3354/meps339283; Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018; Incardona JP, 2016, AQUAT TOXICOL, V177, P515, DOI 10.1016/j.aquatox.2016.06.016; Incardona JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep13499; Incardona JP, 2012, P NATL ACAD SCI USA, V109, pE51, DOI 10.1073/pnas.1108884109; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Jonsson G, 2004, ENVIRON TOXICOL CHEM, V23, P1538, DOI 10.1897/03-173; Jung JH, 2015, ENVIRON SCI TECHNOL, V49, P13639, DOI 10.1021/acs.est.5b03729; Kang HJ, 2016, J HAZARD MATER, V312, P200, DOI 10.1016/j.jhazmat.2016.03.051; Kuhnert A, 2013, ENVIRON TOXICOL CHEM, V32, P1819, DOI 10.1002/etc.2239; LAURENCE GC, 1976, J CONSEIL, V36, P220; Li M, 1998, MAR POLLUT BULL, V36, P961, DOI 10.1016/S0025-326X(98)00096-4; LONNING S, 1988, SARSIA, V73, P49, DOI 10.1080/00364827.1988.10420671; Malmquist LMV, 2015, ENVIRON SCI TECHNOL, V49, P5713, DOI 10.1021/acs.est.5b01453; Malmquist LMV, 2013, ENVIRON SCI TECHNOL, V47, P5383, DOI 10.1021/es400809p; Mathew R, 2008, ENVIRON TOXICOL CHEM, V27, P1515, DOI 10.1897/07-355.1; Meador JP, 1995, REV ENVIRON CONTA<D>, V143, P79; Morrison C, 1999, CAN J ZOOL, V77, P890, DOI 10.1139/cjz-77-6-890; Nordtug T, 2015, PLOS ONE, V10; Nordtug T, 2011, SCI TOTAL ENVIRON, V412, P148, DOI 10.1016/j.scitotenv.2011.10.021; Nordtug T, 2011, MAR POLLUT BULL, V62, P2106, DOI 10.1016/j.marpolbul.2011.07.015; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Olsen GH, 2013, MAR ENVIRON RES, V90, P9, DOI 10.1016/j.marenvres.2013.05.007; Olsvik PA, 2011, COMP BIOCHEM PHYS C, V154, P333, DOI 10.1016/j.cbpc.2011.07.002; Petersen GI, 1998, ENVIRON TOXICOL CHEM, V17, P1385, DOI 10.1002/etc.5620170724; R Core Team, 2018, R LANG ENV STAT COMP; Rasband W., 1997, IMAGEJ BETHESDA; Sorensen L, 2016, RAPID COMMUN MASS SP, V30, P2052, DOI 10.1002/rcm.7688; Sorensen L, 2016, ANAL BIOANAL CHEM, V408, P1023, DOI 10.1007/s00216-015-9225-x; Sorhus E, 2017, ELIFE, V6, DOI 10.7554/eLife.20707; Sorhus E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31058; STIVER W, 1984, ENVIRON SCI TECHNOL, V18, P834, DOI 10.1021/es00129a006; Turcotte D, 2008, TOXICITY METABOLISM; Turcotte D, 2011, CHEMOSPHERE, V85, P1585, DOI 10.1016/j.chemosphere.2011.08.005; Turcotte D, 2011, ENVIRON TOXICOL CHEM, V30, P487, DOI 10.1002/etc.404; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Varanasi U., 1989, METABOLISM POLYCYCLI, P93; Vikebo FB, 2014, ICES J MAR SCI, V71, P970, DOI 10.1093/icesjms/fst131; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; Wu DM, 2012, ENVIRON TOXICOL CHEM, V31, P754, DOI 10.1002/etc.1739	61	40	42	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180048	10.1371/journal.pone.0180048	http://dx.doi.org/10.1371/journal.pone.0180048			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678887	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200035
J	Zhang, ZY; Chang, YY; Zhang, JM; Lu, YX; Zheng, L; Hu, YH; Zhang, F; Li, XM; Zhang, WJ; Li, XN				Zhang, Zheying; Chang, Yaya; Zhang, Jianming; Lu, Yanxia; Zheng, Lin; Hu, Yuhan; Zhang, Fan; Li, Xiaomin; Zhang, Wenjuan; Li, Xuenong			HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/beta-catenin pathway	PLOS ONE			English	Article							GASTRIC-CANCER; CELL; METASTASIS; EXPRESSION; PROGRESSION; CARCINOMA; PROTEINS; LIVER	Colorectal cancer (CRC) is the third leading cause of cancer-related deaths and a major health problem. High mobility group box 3 (HMGB3), a member of the high-mobility group box (HMGB) family, was reported to be over-expressed in gastric carcinoma and bladder cancer. However, the function of HMGB3 in CRC remains unclear. Here, we found that HMGB3 was up-regulated in CRC at both mRNA and protein levels. qRT-PCR results showed that high expression of HMGB3 had positive correlation with serosal invasion, lymph metastasis, and tumor-node-metastasis (TNM) stage in CRC patient. Functional experiments showed that HMGB3 can promote CRC cells proliferation and migration in vitro. Moreover, we found HMGB3 can active WNT/beta-catenin pathway to increase the expression level of c-Myc and MMP7. These results may be the reason for HMGB3 oncogene role in CRC. In summary, our data indicated that HMGB3 may serve as an oncoprotein and could be used as a potential prognostic marker in CRC.	[Zhang, Zheying; Chang, Yaya; Zhang, Jianming; Lu, Yanxia; Zheng, Lin; Hu, Yuhan; Zhang, Fan; Li, Xiaomin; Zhang, Wenjuan; Li, Xuenong] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhang, Zheying] Xinxiang Med Univ, Dept Pathol, Xinxiang, Henan, Peoples R China; [Chang, Yaya] Capital Med Univ, ShijingShan Teaching Hosp, Beijing, Peoples R China; [Zhang, Jianming] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Xinxiang Medical University; Capital Medical University; Southern Medical University - China	Li, XN (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	nfydlxn@126.com	Hu, Yuhan/F-1634-2016	Li, Xuenong/0000-0003-1535-0735	National Natural Science Foundation of China [81672429, 81502479]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/, No. 81672429 to XNL and No. 81502479 to YXL). XNL designed the experiments and YXL prepared the manuscript.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chen XD, 2014, TUMOR BIOL, V35, P11081, DOI 10.1007/s13277-014-2405-z; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Elgamal OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076402; Emmons KM, 2007, CANCER EPIDEM BIOMAR, V16, P2186, DOI 10.1158/1055-9965.EPI-07-0211; Gao J, 2015, INT J CLIN EXP PATHO, V8, P345; Gong Y, 2013, GENET MOL RES, V12, P6032, DOI 10.4238/2013.December.2.1; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Petit A, 2010, LEUKEMIA, V24, P654, DOI 10.1038/leu.2009.241; Shin YJ, 2013, CANCER BIOL THER, V14, P213, DOI 10.4161/cbt.23292; Smolarczyk R, 2012, POSTEP HIG MED DOSW, V66, P913, DOI 10.5604/17322693.1021108; Song N, 2013, TUMOR BIOL, V34, P2599, DOI 10.1007/s13277-013-0807-y; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Wang XB, 2015, INT J MOL SCI, V16, P22527, DOI 10.3390/ijms160922527; Yuan L, 2015, CANCER LETT, V359, P136, DOI 10.1016/j.canlet.2015.01.003; Zhang ZY, 2016, CANCER LETT, V376, P62, DOI 10.1016/j.canlet.2016.03.022; Zhou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063142	23	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179741	10.1371/journal.pone.0179741	http://dx.doi.org/10.1371/journal.pone.0179741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678825	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200025
J	Lee, KH; Lee, SR; Cho, H; Woo, JS; Kang, JH; Jeong, YM; Cheng, XW; Kim, WS; Kim, W				Lee, Kyung Hye; Lee, So-Ra; Cho, Haneul; Woo, Jong Shin; Kang, Jung Hee; Jeong, Yun-Mi; Cheng, Xian Wu; Kim, Woo-Shik; Kim, Weon			Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts	PLOS ONE			English	Article							GUANYLATE-CYCLASE STIMULATORS; INDEPENDENT STIMULATION; CARDIOVASCULAR-DISEASE; POTASSIUM CHANNELS; OBESE MICE; PROTECTION; EXPRESSION; MITOCHONDRIA; RELAXATION; STRESS	\ Soluble guanylate cyclase (sGC) has been suggested as a therapeutic target for cardiac ischemia-reperfusion (IR) injury. Until now, the molecular mechanism of BAY 60-2770, a sGC activator, in cardiac IR injury has not been assessed. To identify the cardioprotective effects of BAY 60-2770 in IR-injured rat hearts, IR injury was established by occlusion of LAD for 40 min and reperfusion for 7 days, and the effects of BAY 60-2770 on myocardial protection were assessed by echocardiography and TTC staining. 5 nM and 5 mu M of BAY 60-2770 were perfused into isolated rat hearts in a Langendorff system. After 10-or 30-min reperfusion with BAY 60-2770, cGMP and cAMP concentrations and PKG activation status were examined. Hearts were also perfused with 1 mu M KT5823 or 100 mu M 5-HD in conjunction with 5 nM Bay 60-2770 to evaluate the protective role of PKG. Mitochondrial oxidative stress was investigated under hypoxia-reoxygenation in H9c2 cells. In IR-injured rat hearts, BAY 60-2770 oral administration reduced infarct size by TTC staining and improved left ventricular function by echocardiography. Tissue samples from BAY 60-2770-perfused hearts had approximately two-fold higher cGMP levels. BAY 60-2770 increased PKG activity in the myocardium, and the reduced infarct area by BAY 60-2770 was abrogated by KT5823 in isolated myocardium. In H9c2 cardiac myoblasts, hypoxia-reoxygenation-mediated mitochondrial ROS generation was diminished with BAY 60-2770 treatment, but was recovered by pretreatment with KT-5823. BAY 60-2770 demonstrated a protective effect against cardiac IR injury via mitoKATP opening and decreased mitoROS by PKG activation. BAY 60-2770 has a protective effect against cardiac IR injury via mitoKATP opening and decreased mitoROS by PKG activation. These results demonstrated that BAY 60-2770 may be used as a therapeutic agent for cardiac IR injury.	[Lee, Kyung Hye; Lee, So-Ra; Cho, Haneul; Woo, Jong Shin; Kang, Jung Hee; Jeong, Yun-Mi; Cheng, Xian Wu; Kim, Woo-Shik; Kim, Weon] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Cardiovasc Internal Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital	Kim, W (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Cardiovasc Internal Med, Seoul, South Korea.	mylovekw@hanmail.net			Kyung Hee University [KHU-20131361]	Kyung Hee University	This work was supported by a postdoctoral fellowship grant from Kyung Hee University in 2013 (KHU-20131361).	Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101; Akao M, 2002, J AM COLL CARDIOL, V40, P803, DOI 10.1016/S0735-1097(02)02007-7; Alexandre EC, 2014, J PHARMACOL EXP THER, V349, P2, DOI 10.1124/jpet.113.211029; Behrends S, 2002, J HISTOCHEM CYTOCHEM, V50, P1325, DOI 10.1177/002215540205001005; Bice JS, 2014, CARDIOVASC RES, V101, P220, DOI 10.1093/cvr/cvt257; Boerrigter G, 2007, CARDIOVASC DRUG REV, V25, P30, DOI 10.1111/j.1527-3466.2007.00003.x; Brahmajothi MV, 2007, CHANNELS, V1, P353, DOI 10.4161/chan.5189; Costell MH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00128; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Dudek M, 2014, PHARMACOL REP, V66, P499, DOI 10.1016/j.pharep.2013.11.001; Facundo HTF, 2006, BBA-MOL BASIS DIS, V1762, P202, DOI 10.1016/j.bbadis.2005.06.003; Follmann M, 2013, ANGEW CHEM INT EDIT, V52, P9442, DOI 10.1002/anie.201302588; Forini F, 2015, INT J MOL SCI, V16, P6312, DOI 10.3390/ijms16036312; Frank A, 2012, SEMIN CARDIOTHORAC V, V16, P123, DOI 10.1177/1089253211436350; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao JJ, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-19; Ghosh A, 2016, P NATL ACAD SCI USA, V113, pE2355, DOI 10.1073/pnas.1524398113; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Jabs A, 2015, VASC PHARMACOL, V71, P181, DOI 10.1016/j.vph.2015.03.007; Kisinska A, 2003, GEN PHYSIOL BIOPHYS, V22, P383; Leiria LO, 2014, J UROLOGY, V191, P539, DOI 10.1016/j.juro.2013.09.020; Malinska D, 2010, FEBS LETT, V584, P2043, DOI 10.1016/j.febslet.2010.01.013; Mendes-Silverio CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047223; Moon JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150745; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Ozcan C, 2002, AM J PHYSIOL-HEART C, V282, pH531, DOI 10.1152/ajpheart.00552.2001; Pain T, 2000, CIRC RES, V87, P460; Queliconi BB, 2011, BBA-MOL CELL RES, V1813, P1309, DOI 10.1016/j.bbamcr.2010.11.005; Salloum FN, 2012, AM J PHYSIOL-HEART C, V302, pH1347, DOI 10.1152/ajpheart.00544.2011; Samavati L, 2002, AM J PHYSIOL-CELL PH, V283, pC273, DOI 10.1152/ajpcell.00514.2001; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; Tawa M, 2015, J CARDIOVASC PHARM, V65, P160, DOI 10.1097/FJC.0000000000000173; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y	34	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180207	10.1371/journal.pone.0180207	http://dx.doi.org/10.1371/journal.pone.0180207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671970	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500028
J	Chang, YW; Chou, YC; Yeh, CC; Hu, CJ; Hung, CJ; Lin, CS; Chen, TL; Liao, CC				Chang, Yi-Wen; Chou, Yi-Chun; Yeh, Chun-Chieh; Hu, Chaur-Jong; Hung, Chih-Jen; Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang			Outcomes after major surgery in patients with myasthenia gravis: A nationwide matched cohort study	PLOS ONE			English	Article							POPULATION-BASED COHORT; NEUROMUSCULAR-TRANSMISSION; NONCARDIAC SURGERY; ADVERSE OUTCOMES; THYMECTOMY; CRISIS; COMORBIDITY; DISORDERS; MORTALITY; TOXICITY	Objective To validate the comprehensive features of adverse outcomes after surgery for patients with myasthenia gravis. Methods Using reimbursement claims from Taiwan's National Health Insurance Research Database, we analyzed 2290 patients who received major surgery between 2004 and 2010 and were diagnosed with myasthenia gravis preoperatively. Surgical patients without myasthenia gravis (n = 22,900) were randomly selected by matching procedure with propensity score for comparison. The adjusted odds ratios and 95% confidence intervals of postoperative adverse events associated with preoperative myasthenia gravis were calculated under the multiple logistic regressions. Results Compared with surgical patients without myasthenia gravis, surgical patients with myasthenia gravis had higher risks of postoperative pneumonia (OR = 2.09; 95% CI: 1.65-2.65), septicemia (OR = 1.31; 95% CI: 1.05-1.64), postoperative bleeding (OR = 1.71; 95% CI: 1.07-2.72), and overall complications (OR = 1.70; 95% CI: 1.44-2.00). The ORs of postoperative adverse events for patients with myasthenia gravis who had symptomatic therapy, chronic immunotherapy, and short-term immunotherapy were 1.76 (95% CI 1.50-2.08), 1.70 (95% CI 1.36-2.11), and 4.36 (95% CI 2.11-9.04), respectively. Conclusions Patients with myasthenia gravis had increased risks of postoperative adverse events, particularly those experiencing emergency care, hospitalization, and thymectomy for care of myasthenia gravis. Our findings suggest the urgency of revising protocols for perioperative care for these populations.	[Chang, Yi-Wen] Taichung Vet Gen Hosp, Chia Yi Branch, Dept Anesthesiol, Chiayi, Taiwan; [Chang, Yi-Wen; Hung, Chih-Jen] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Chou, Yi-Chun] China Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Hlth Policy Res Ctr, Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Dept Anesthesiol, Coll Med, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Liao, Chien-Chang] Taipei Med Univ, Shuan Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; China Medical University Taiwan; Taipei Medical University; Shuang Ho Hospital	Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ Hosp, Hlth Policy Res Ctr, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ, Sch Med, Dept Anesthesiol, Coll Med, Taipei, Taiwan.; Liao, CC (corresponding author), China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ, Shuan Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan.	ccliao@tmu.edu.tw	Yeh, Chun Chieh/I-4893-2019; Yeh, Chun Chieh/Y-3304-2019	Yeh, Chun Chieh/0000-0001-6753-7564; 	Shuang Ho Hospital; Taipei Medical University [104TMU-SHH-23]; Taiwan's Ministry of Science and Technology [MOST105-2629-B-038-001, MOST105-2314-B-038-025, MOST104-2314-B-038-027-MY2, NSC102-2314-B-038-021-MY3]; Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDUB-212-113004]	Shuang Ho Hospital; Taipei Medical University; Taiwan's Ministry of Science and Technology; Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This research was supported in part by Shuang Ho Hospital, Taipei Medical University (104TMU-SHH-23), Taiwan's Ministry of Science and Technology (MOST105-2629-B-038-001; MOST105-2314-B-038-025; MOST104-2314-B-038-027-MY2; NSC102-2314-B-038-021-MY3), and Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDUB-212-113004).	Alshaikh JT, 2016, MUSCLE NERVE, V53, P370, DOI 10.1002/mus.24904; Alshekhlee A, 2009, NEUROLOGY, V72, P1548, DOI 10.1212/WNL.0b013e3181a41211; Andersen JB, 2014, EUR J NEUROL, V21, P948, DOI 10.1111/ene.12439; Ando T, 2015, EUR J CARDIO-THORAC, V48, P705, DOI 10.1093/ejcts/ezu530; BUZELLO W, 1986, ANESTHESIOLOGY, V64, P507, DOI 10.1097/00000542-198604000-00017; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; Cheng C, 2013, ANN THORAC SURG, V95, P1035, DOI 10.1016/j.athoracsur.2012.11.074; Chou CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127731; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Fang F, 2015, J INTERN MED, V277, P594, DOI 10.1111/joim.12310; FRAISER LH, 1991, DRUGS, V42, P781, DOI 10.2165/00003495-199142050-00005; Gilhus NE, 2015, EUR J NEUROL, V22, P17, DOI 10.1111/ene.12599; Gilhus NE, 2015, LANCET NEUROL, V14, P1023, DOI 10.1016/S1474-4422(15)00145-3; Guptill JT, 2012, MUSCLE NERVE, V45, P363, DOI 10.1002/mus.22327; Hansen JS, 2016, MUSCLE NERVE, V53, P73, DOI 10.1002/mus.24697; Harvey AM, 1942, J CLIN INVEST, V21, P579, DOI 10.1172/JCI101336; De Lapiscina EHM, 2012, MUSCLE NERVE, V46, P174, DOI 10.1002/mus.23296; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Ke CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133064; Keijzers M, 2015, EUR J CARDIO-THORAC, V48, P40, DOI 10.1093/ejcts/ezu352; Kulaksizoglu IB, 2007, CNS DRUGS, V21, P473, DOI 10.2165/00023210-200721060-00004; Leuzzi G, 2014, EUR J CARDIO-THORAC, V45, pE76, DOI 10.1093/ejcts/ezt641; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Marulli G, 2013, J THORAC CARDIOV SUR, V145, P730, DOI 10.1016/j.jtcvs.2012.12.031; Marx A, 2013, AUTOIMMUN REV, V12, P875, DOI 10.1016/j.autrev.2013.03.007; Pakzad Z, 2011, NEUROLOGY, V76, P1526, DOI 10.1212/WNL.0b013e318217e735; Plante J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5389; Ramagopalan SV, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-1; Ramos-Fransi A, 2015, EUR J NEUROL, V22, P1056, DOI 10.1111/ene.12703; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Seneviratne J, 2008, ARCH NEUROL-CHICAGO, V65, P929, DOI 10.1001/archneur.65.7.929; Skeie GO, 2010, EUR J NEUROL, V17, P893, DOI 10.1111/j.1468-1331.2010.03019.x; Spillane J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8497; Termsarasab P, 2012, J NEUROIMMUNOL, V249, P83, DOI 10.1016/j.jneuroim.2012.04.016; Tomulescu V, 2011, ANN SURG, V254, P761, DOI 10.1097/SLA.0b013e31823686f6; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180433	10.1371/journal.pone.0180433	http://dx.doi.org/10.1371/journal.pone.0180433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666024	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700007
J	Esposito, MR; Guillari, A; Angelillo, IF				Esposito, Maria Rosaria; Guillari, Assunta; Angelillo, Italo Francesco			Knowledge, attitudes, and practice on the prevention of central line-associated bloodstream infections among nurses in oncological care: A cross-sectional study in an area of southern Italy	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; EVIDENCE-BASED GUIDELINES; DISEASES WORKING PARTY; RISK-FACTORS; MANAGEMENT; CANCER; HOSPITALS; SOCIETY; PATIENT; IMPACT	The objectives of the cross-sectional study were to delineate the knowledge, attitudes, and behavior among nurses regarding the prevention of central line-associated bloodstream infections (CLABSIs) and to identify their predisposing factors. A questionnaire was self-administered from September to November 2011 to nurses in oncology and outpatient chemotherapy units in 16 teaching and non-teaching public and private hospitals in the Campania region (Italy). The questionnaire gathered information on demographic and occupational characteristics; knowledge about evidence-based practices for the prevention of CLABSIs; attitudes towards guidelines, the risk of transmitting infections, and hand-washing when using central venous catheter (CVC); practices about catheter site care; and sources of information. The vast majority of the 335 nurses answered questions correctly about the main recommendations to prevent CLABSIs (use sterile gauze or sterile transparent semi-permeable dressing to cover the catheter site, disinfect the needleless connectors before administer medication or fluid, disinfect with hydrogen peroxide the catheter insertion site, and use routinely anticoagulants solutions). Nurses aged 36 to 50 years were less likely to know these main recommendations to prevent CLABSIs, whereas this knowledge was higher in those who have received information about the prevention of these infections from courses. Nurses with lower education and those who do not know two of the main recommendations on the site's care to prevent the CLABSIs, were more likely to perceive the risk of transmitting an infection. Higher education, attitude toward the utility allow to dry antiseptic, and the need of washing hands before wearing gloves for access to port infusion were predictors of performing skin antiseptic and aseptic technique for dressing the catheter insertion site. Educational interventions should be implemented to address the gaps regarding knowledge and practice regarding the prevention of CLABSIs and to ensure that nurses use evidence-based prevention interventions.	[Esposito, Maria Rosaria] Fdn G Pascale, Ist Nazl Tumori, Naples, Italy; [Guillari, Assunta; Angelillo, Italo Francesco] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy	IRCCS Fondazione Pascale; Universita della Campania Vanvitelli	Angelillo, IF (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy.	italof.angelillo@unicampania.it	Angelillo, Italo Francesco/AAK-1301-2021; GUILLARI, ASSUNTA/AAT-2669-2020	Angelillo, Italo Francesco/0000-0003-1213-6602; esposito, maria rosaria/0000-0002-8578-1250; GUILLARI, ASSUNTA/0000-0001-8423-8195				AHRQ Projects to Prevent Healthcare-Associated Infections, 2014, FISC YEAR 2011; Al-Sayaghi KM, 2011, SAUDI MED J, V32, P275; Alkubati SA, 2015, AM J INFECT CONTROL, V43, P26, DOI 10.1016/j.ajic.2014.09.021; Apostolopoulou E, 2013, AM J CRIT CARE, V22, pE12, DOI 10.4037/ajcc2013324; Bianco A, 2013, AM J INFECT CONTROL, V41, P107, DOI 10.1016/j.ajic.2012.02.038; Boersma RS, 2010, EUR J ONCOL NURS, V14, P200, DOI 10.1016/j.ejon.2009.12.005; Centers for Disease Control and Prevention, 2013, NAT STAT HEALTHC ASS; Chopra V, 2013, MAKING HLTH CARE SAF; Dedunska K, 2015, AM J INFECT CONTROL, V43, P1368, DOI 10.1016/j.ajic.2015.07.022; Flodgren G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006559.pub2; Furuya EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015452; Guembe M, 2012, EUR J CLIN MICROBIOL, V31, P2799, DOI 10.1007/s10096-012-1630-x; Hentrich M, 2014, ANN ONCOL, V25, P936, DOI 10.1093/annonc/mdt545; Ider BE, 2012, INT J INFECT DIS, V16, pE551, DOI 10.1016/j.ijid.2012.03.006; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; Koutzavekiaris I, 2011, AM J INFECT CONTROL, V39, P542, DOI 10.1016/j.ajic.2010.11.003; Krein SL, 2015, BMJ QUAL SAF, V24, P385, DOI 10.1136/bmjqs-2014-003870; Labeau SO, 2009, CRIT CARE MED, V37, P320, DOI 10.1097/CCM.0b013e3181926489; Ling ML, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0116-5; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Moureau NL, 2015, NURS RES PRACT, V2015, DOI 10.1155/2015/796762; Nelson RE, 2015, INFECT CONT HOSP EP, V36, P534, DOI 10.1017/ice.2015.22; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Raad I, 2014, CLIN INFECT DIS, V59, pS340, DOI 10.1093/cid/ciu670; Rickard CM, 2004, J ADV NURS, V48, P247, DOI 10.1111/j.1365-2648.2004.03193.x; Schiffer CA, 2013, J CLIN ONCOL, V31, P1357, DOI 10.1200/JCO.2012.45.5733; Sessa A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-148; Shapey IM, 2009, J HOSP INFECT, V71, P117, DOI 10.1016/j.jhin.2008.09.016; Snarski E, 2015, TRANSPL INFECT DIS, V17, P558, DOI 10.1111/tid.12399; The Joint Commission, 2012, PREV CENTR LIN ASS B; Tomlinson D, 2011, CLIN INFECT DIS, V53, P697, DOI 10.1093/cid/cir523; Ullman Amanda J, 2014, Br J Nurs, V23, pS14; Vaz LE, 2015, INFECT CONT HOSP EP, V36, P649, DOI 10.1017/ice.2015.38; Wang TY, 2015, J FORMOS MED ASSOC, V114, P1055, DOI 10.1016/j.jfma.2015.06.013; Yacobovich J, 2015, PEDIATR BLOOD CANCER, V62, P471, DOI 10.1002/pbc.25281; Zingg W, 2011, J HOSP INFECT, V77, P304, DOI 10.1016/j.jhin.2010.11.011	36	18	18	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180473	10.1371/journal.pone.0180473	http://dx.doi.org/10.1371/journal.pone.0180473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665993	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700010
J	Ji, WJ; Zhao, M; Wang, M; Yan, WH; Liu, Y; Ren, ST; Lu, J; Wang, B; Chen, LN				Ji, Wenjun; Zhao, Mei; Wang, Meng; Yan, Wenhui; Liu, Yuan; Ren, Shuting; Lu, Jun; Wang, Bing; Chen, Lina			Effects of canagliflozin on weight loss in highfat diet-induced obese mice	PLOS ONE			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE-2 DGAT2; TYPE-2 DIABETES-MELLITUS; PPAR-ALPHA; EXPRESSION; SAFETY	Canagliflozin, an inhibitor of sodium glucose co-transporter (SGLT) 2, has been shown to reduce body weight during the treatment of type 2 diabetes mellitus (T2DM). In this study, we sought to determine the role of canagliflozin in body weight loss and liver injury in obesity. C57BL/6J mice were fed a high-fat diet to simulate diet-induced obesity (DIO). Canagliflozin (15 and 60 mg/kg) was administered to DIO mice for 4 weeks. Orlistat (10 mg/kg) was used as a positive control. The body weight, liver weight, liver morphology, total cholesterol (TC) and triglyceride (TG) levels were examined. Signaling molecules, including diacylgycero1 acyltransferase-2 (DGAT2), peroxisome proliferation receptor alpha-1 (PPAR alpha 1), PPAR gamma 1, PPAR gamma 2 mRNA levels and the protein expression of SGLT2 were evaluated. Canagliflozin reduced body weight, especially the high-dose canagliflozin, and resulted in increased body weight loss compared with orlistat. Moreover, canagliflozin reduced the liver weight and the ratio of liver weight to body weight, lowered the serum levels of TC and TG, and ameliorated liver steatosis. During the canagliflozin treatment, SGLT2, DGAT2, PPAR gamma 1 and PPAR gamma 2 were inhibited, and PPARa1 was elevated in the liver tissues. This finding may explain why body weight was reduced and secondary liver injury was ameliorated in response to canagliflozin. Together, the results suggest that canagliflozin may be a potential anti-obesity strategy.	[Ji, Wenjun; Zhao, Mei; Wang, Meng; Yan, Wenhui; Liu, Yuan; Chen, Lina] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pharmacol, Xian, Shaanxi, Peoples R China; [Ji, Wenjun] Taizhou Peoples Hosp, Dept Pharm, Taizhou, Jiangsu, Peoples R China; [Zhao, Mei] 302 Mil Hosp China, Dept Pharm, Beijing, Peoples R China; [Wang, Meng] Shijiazhuang Matern Hosp, Dept Pharm, Shijiazhuang, Hebei, Peoples R China; [Ren, Shuting; Wang, Bing; Chen, Lina] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China; [Ren, Shuting; Wang, Bing] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Xian, Shaanxi, Peoples R China; [Lu, Jun] Xi An Jiao Tong Univ, Hlth Sci Ctr, Affiliated Hosp 1, Clin Res Ctr, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Fifth Medical Center of Chinese PLA General Hospital; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Chen, LN (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pharmacol, Xian, Shaanxi, Peoples R China.; Chen, LN (corresponding author), Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China.	chenlin@mail.xjtu.edu.cn			National Natural Science Foundation of China [81471031, 30901808]; e Technology and Innovation Project of Shaanxi Province [2011KTCL03-20]; Key Novel Drug Discovery of Major National Science and Technology Projects [2013ZX09509106]; Natural Science Foundation of Shaanxi Province [2015JM8415]; Fundamental Research Funds for the Central Universities [xjj2014143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); e Technology and Innovation Project of Shaanxi Province; Key Novel Drug Discovery of Major National Science and Technology Projects; Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The present study was supported by grants from the National Natural Science Foundation of China (no. 81471031, 30901808), the Technology and Innovation Project of Shaanxi Province (no. 2011KTCL03-20), the Key Novel Drug Discovery of Major National Science and Technology Projects (no. 2013ZX09509106), the Natural Science Foundation of Shaanxi Province (no. 2015JM8415) and the Fundamental Research Funds for the Central Universities (no. xjj2014143).	Blasio A, 2014, BEHAV PHARMACOL, V25, P609, DOI 10.1097/FBP.0000000000000059; Boyle LD, 2014, EXPERT OPIN DRUG SAF, V13, P1535, DOI 10.1517/14740338.2014.959488; Gao BZ, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/501272; Ginsberg Henry N, 2009, J Cardiometab Syndr, V4, P113, DOI 10.1111/j.1559-4572.2008.00044.x; Gu M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/342561; Haque M, 2002, BEST PRACT RES CL GA, V16, P709, DOI 10.1053/bega.2002.0325; Honda Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146337; Jin YZ, 2014, J BIOL CHEM, V289, P28237, DOI 10.1074/jbc.M114.571190; Kim Hyoung-Jun, 2014, J Exerc Nutrition Biochem, V18, P249, DOI 10.5717/jenb.2014.18.3.249; Komiya C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151511; Krentz AJ, 2016, DIABETES OBES METAB, V18, P558, DOI 10.1111/dom.12657; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030555; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Palacios-Martinez D, 2013, INT J ENDOCRINOL MET, V11, DOI 10.5812/ijem.6721; Qin YW, 2010, ACTA PHARMACOL SIN, V31, P1350, DOI 10.1038/aps.2010.109; Ross PK, 2009, TOXICOL APPL PHARM, V235, P199, DOI 10.1016/j.taap.2008.12.011; Takahashi N, 2011, MOL NUTR FOOD RES, V55, P1791, DOI 10.1002/mnfr.201100401; Triplitt C, 2015, CLIN MED INSIGHTS-EN, V8, P73, DOI [10.4137/CMED.S31526, 10.4137/CMEDED.S31526]; WHO, 2014, OB OV; Wilding JPH, 2013, INT J CLIN PRACT, V67, P1267, DOI 10.1111/ijcp.12322; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; You DY, 2015, J ENDOCRINOL INVEST, V38, P901, DOI 10.1007/s40618-015-0272-0	25	42	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179960	10.1371/journal.pone.0179960	http://dx.doi.org/10.1371/journal.pone.0179960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665967	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608700047
J	Fomina, T; Weichwald, S; Synofzik, M; Just, J; Schols, L; Scholkopf, B; Grosse-Wentrup, M				Fomina, Tatiana; Weichwald, Sebastian; Synofzik, Matthis; Just, Jenifer; Schoels, Ludger; Schoelkopf, Bernhard; Grosse-Wentrup, Moritz			Absence of EEG correlates of self-referential processing depth in ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DEFAULT MODE NETWORK; SLEEP DISORDERS; CONSCIOUSNESS; DEGENERATION; IMPAIRMENT; PREVALENCE; DEFICITS; SCALE; ONSET	Self-referential processing is a key cognitive process, associated with the serotonergic system and the default mode network (DMN). Decreased levels of serotonin and reduced activations of the DMN observed in amyotrophic lateral sclerosis (ALS) suggest that self-referential processing might be altered in patients with ALS. Here, we investigate the effects of ALS on the electroencephalography correlates of self-referential thinking. We find that electroencephalography (EEG) correlates of self-referential thinking are present in healthy individuals, but not in those with ALS. In particular, thinking about themselves or others significantly modulates the bandpower in the medial prefrontal cortex in healthy individuals, but not in ALS patients. This finding supports the view of ALS as a complex multisystem disorder which, as shown here, includes dysfunctional processing of the medial prefrontal cortex. It points towards possible alterations of self-consciousness in ALS patients, which might have important consequences for patients' self-conceptions, personal relations, and decision-making.	[Fomina, Tatiana; Weichwald, Sebastian; Schoelkopf, Bernhard; Grosse-Wentrup, Moritz] Max Planck Inst Intelligent Syst, Dept Empir Inference, Tubingen, Germany; [Fomina, Tatiana] Univ Tubingen, Int Max Planck Res Sch Cognit & Syst Neurosci, Tubingen, Germany; [Synofzik, Matthis; Just, Jenifer; Schoels, Ludger] Univ Tubingen, Dept Neurol, Tubingen, Germany; [Synofzik, Matthis; Just, Jenifer; Schoels, Ludger] German Ctr Neu rodegenerat Dis DZNE, Tubingen, Germany; [Synofzik, Matthis; Just, Jenifer; Schoels, Ludger] Hertie Inst Clin Brain Res, Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Fomina, T (corresponding author), Max Planck Inst Intelligent Syst, Dept Empir Inference, Tubingen, Germany.; Fomina, T (corresponding author), Univ Tubingen, Int Max Planck Res Sch Cognit & Syst Neurosci, Tubingen, Germany.	tfomina@tuebingen.mpg.de	Schölkopf, Bernhard/A-7570-2013; Schöls, Ludger/ABB-2482-2021	Schölkopf, Bernhard/0000-0002-8177-0925; Schöls, Ludger/0000-0001-7774-5025; Synofzik, Matthis/0000-0002-2280-7273; Weichwald, Sebastian/0000-0003-0169-7244				Abrahams S, 2005, J NEUROL, V252, P321, DOI 10.1007/s00415-005-0646-x; Abrahams S, 1996, BRAIN, V119, P2105, DOI 10.1093/brain/119.6.2105; Ahmed RM, 2016, SLEEP MED REV, V26, P33, DOI 10.1016/j.smrv.2015.05.007; Arnulf I, 2000, AM J RESP CRIT CARE, V161, P849, DOI 10.1164/ajrccm.161.3.9805008; Averill AJ, 2007, AMYOTROPH LATERAL SC, V8, P243, DOI 10.1080/17482960701374643; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Birbaumer N, 2012, PSYCHOL RES-PSYCH FO, V76, P183, DOI 10.1007/s00426-012-0412-5; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Dentel C, 2013, BRAIN, V136, P483, DOI 10.1093/brain/aws274; Dupuis L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013346; Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; Esslen M, 2008, NEUROIMAGE, V42, P437, DOI 10.1016/j.neuroimage.2008.01.060; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Grosse-Wentrup M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046001; Grosskreutz J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-17; Hagemann D, 2001, CLIN NEUROPHYSIOL, V112, P215, DOI 10.1016/S1388-2457(00)00541-1; Hahn A, 2012, P NATL ACAD SCI USA, V109, P2619, DOI 10.1073/pnas.1117104109; Harvey PO, 2011, SCHIZOPHR RES, V127, P171, DOI 10.1016/j.schres.2010.11.011; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Heilman KM, 1998, PHILOS T R SOC B, V353, P1903, DOI 10.1098/rstb.1998.0342; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knyazev GG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00264; Lehrer Douglas S, 2014, Innov Clin Neurosci, V11, P10; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; LUDOLPH AC, 1992, ACTA NEUROL SCAND, V85, P81, DOI 10.1111/j.1600-0404.1992.tb04003.x; Mantovan MC, 2003, EUR J NEUROL, V10, P221, DOI 10.1046/j.1468-1331.2003.00607.x; Marchetti M, 2015, CLIN NEUROPHYSIOL, V126, P1255, DOI 10.1016/j.clinph.2014.09.017; Massman PJ, 1996, J NEUROL NEUROSUR PS, V61, P450, DOI 10.1136/jnnp.61.5.450; McCullagh S, 1999, J NEUROL SCI, V169, P43, DOI 10.1016/S0022-510X(99)00214-2; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Mosher J C, 2005, 5 INT S NON FUNCT SO; Mu Y, 2010, NEUROIMAGE, V53, P757, DOI 10.1016/j.neuroimage.2010.07.008; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nihei K, 1993, ACTA NEUROPATHOL, V86, P55; Pinkhardt EH, 2008, J NEUROL, V255, P532, DOI 10.1007/s00415-008-0734-9; Portas CM, 2000, SEROTONIN SLEEP WAKE; Portet F, 2001, RES GROUP MOTOR NEUR, V2, P23; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rosen HJ, 2011, NEUROCASE, V17, P231, DOI 10.1080/13554794.2010.522588; Salmon E, 2005, 2 ASPECTS IMPAIRED C; Sandyk R, 2006, INT J NEUROSCI, V116, P775, DOI 10.1080/00207450600754087; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Schmidt R, 2014, HUM BRAIN MAPP, V35, P4386, DOI 10.1002/hbm.22481; SCHONBACH P, 1972, EUR J SOC PSYCHOL, V2, P327, DOI 10.1002/ejsp.2420020309; Schreiber H, 2005, J NEUROL, V252, P772, DOI 10.1007/s00415-005-0739-6; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Soekadar SR, 2013, J CLIN SLEEP MED, V9, P951, DOI 10.5664/jcsm.3002; Starkstein SE, 2014, ANOSOGNOSIA ALZHEIME; Strong MJ, 2003, ANN NEUROLOGY, V54; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; WOHLFART G, 1957, NEUROLOGY, V7, P124, DOI 10.1212/WNL.7.2.124; Zimmerman EK, 2007, COGN BEHAV NEUROL, V20, P79, DOI 10.1097/WNN.0b013e31804c700b	63	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180136	10.1371/journal.pone.0180136	http://dx.doi.org/10.1371/journal.pone.0180136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662161	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300111
J	Zhou, XF; Xing, XJ; Hou, JL; Liu, JH				Zhou, Xuefeng; Xing, Xuejiao; Hou, Jingli; Liu, Jianhua			Quantitative proteomics analysis of proteins involved in alkane uptake comparing the profiling of Pseudomonas aeruginosa SJTD-1 in response to n-octadecane and n-hexadecane	PLOS ONE			English	Article							LABEL-FREE; MICROBIAL-DEGRADATION; MICROORGANISMS; ACCUMULATION; BACTERIUM; MOTILITY; COMPLEX	While many data are available on genes encoding proteins for degradation of hydrocarbons in bacteria, the impact of alkane on transporter protein expression is unclear. Pseudomonas aeruginosa SJTD-1 is a strain that can consume medium-and long-chain n-alkanes. In order to study the proteins involved in n-octadecane uptake, we use iTRAQ and label free comparative proteomics analysis to identify the proteins of alkane uptake in response to n-octadecane (C18) comparing with n-hexadecane (C16) in P. aeruginosa SJTD-1. A total of 1102 and 1249 proteins were identified by iTRAQ-based and label free quantitative methodologies, respectively. By application of 1.5 (iTRAQ) or 2-fold (label free) for upregulated and 0.65 (iTRAQ) or 0.5-fold (label free) for downregulated cutoff values, 91 and 99 proteins were found to be differentially expressed comparing SJTD-1 cultivated on C18 with C16 respectively. There are six proteins with the common differential expression by iTRAQ and label free-based methods. Results of bioinformational analysis suggested the involvement of bacterial chemotaxis in responds to C18. Additionally, quantitative reverse transcriptase PCR (qRT-PCR) results confirmed C18-induced change in levels of FleQ, FliC, NirS, FadL and FadD proteins and the role of the proteins in n-octadecane uptake was further discussed in P. aeruginosa. In conclusion, results of the present study provided information about possible target-related proteins of bacterial chemotaxis, swimming performance, alkane transport to stimulus of n-ctadecane rather than n-hexadecane in P. aeruginosa SJTD-1.	[Zhou, Xuefeng; Liu, Jianhua] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Xing, Xuejiao] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Hou, Jingli] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hou, JL (corresponding author), Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai, Peoples R China.	hopie00@sjtu.edu.cn			National Natural Science Foundation of China [31200062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Grant No. 31200062).The sponsor was Jingli Hou. The URL of the funders's website is http://www.nsfc.gov.cn/.	BLACK PN, BIOCH BIOPHYS ACTA, V1046, P97; Borrero-de Acuna JM, 2015, J BACTERIOL, V197, P3066, DOI 10.1128/JB.00415-15; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Call TP, 2016, J BIOL ENG, V10, DOI 10.1186/s13036-016-0026-3; Chang SJ, 2009, MOL BIOL REP, V36, P2165, DOI 10.1007/s11033-008-9430-1; Coon MJ, 2005, BIOCHEM BIOPH RES CO, V338, P378, DOI 10.1016/j.bbrc.2005.08.169; Das Nilanjana, 2011, Biotechnol Res Int, V2011, P941810, DOI 10.4061/2011/941810; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Golyshin PN, 2003, J BIOTECHNOL, V106, P215, DOI 10.1016/j.jbiotec.2003.07.013; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hemamalini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103788; Hua F, 2015, ENVIRON SCI POLLUT R, V22, P6660, DOI 10.1007/s11356-014-3853-0; Julsing MK, 2012, APPL ENVIRON MICROB, V78, P5724, DOI 10.1128/AEM.00949-12; Kim IS, 2002, BIOTECHNOL BIOENG, V80, P650, DOI 10.1002/bit.10421; Klein B, 2008, RES MICROBIOL, V159, P137, DOI 10.1016/j.resmic.2007.11.013; Latosinska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137048; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Li Z, 2012, J PROTEOME RES, V11, P1582, DOI 10.1021/pr200748h; Liu H., 2015, NANOMATER, V2015, P1, DOI [DOI 10.1155/2015/685323, DOI 10.1111/IEP.12131)]; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105506; Luo R, 2014, J PROTEOME RES, V13, P1270, DOI 10.1021/pr400852d; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Mulder H, 1998, APPL MICROBIOL BIOT, V50, P277, DOI 10.1007/s002530051290; Nogales J, 2015, APPL ENVIRON MICROB, V81, P7533, DOI 10.1128/AEM.01798-15; Rahman KSM, 2002, BIORESOURCE TECHNOL, V85, P257, DOI 10.1016/S0960-8524(02)00119-0; Rojo F., 2010, HDB HYDROCARBON LIPI, P781, DOI DOI 10.1007/978-3-540-77587-4_59; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; Segura A, 2012, CURR OPIN BIOTECH, V23, P415, DOI 10.1016/j.copbio.2011.11.015; THOMAS JM, 1986, APPL ENVIRON MICROB, V52, P290, DOI 10.1128/AEM.52.2.290-296.1986; Trinh Hung V, 2013, Int J Proteomics, V2013, P581862, DOI 10.1155/2013/581862; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; Varjani SJ, 2017, BIORESOURCE TECHNOL, V223, P277, DOI 10.1016/j.biortech.2016.10.037; Vaysse PJ, 2009, RES MICROBIOL, V160, P829, DOI 10.1016/j.resmic.2009.09.010; Wang HX, 2012, J PROTEOME RES, V11, P487, DOI 10.1021/pr2008225; Wentzel A, 2007, APPL MICROBIOL BIOT, V76, P1209, DOI 10.1007/s00253-007-1119-1; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yakimov MM, 2004, INT J SYST EVOL MICR, V54, P141, DOI 10.1099/ijs.0.02424-0; YOSHIDA F, 1971, BIOTECHNOL BIOENG, V13, P691, DOI 10.1002/bit.260130509	40	5	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179842	10.1371/journal.pone.0179842	http://dx.doi.org/10.1371/journal.pone.0179842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662172	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300057
J	Shukla, A; Bhattacharyya, A; Kuppusamy, L; Srivas, M; Thattai, M				Shukla, Ankit; Bhattacharyya, Arnab; Kuppusamy, Lakshmanan; Srivas, Mandayam; Thattai, Mukund			Discovering vesicle traffic network constraints by model checking	PLOS ONE			English	Article							MEMBRANE; PROTEINS; SNARES	A eukaryotic cell contains multiple membrane-bound compartments. Transport vesicles move cargo between these compartments, just as trucks move cargo between warehouses. These processes are regulated by specific molecular interactions, as summarized in the Rothman-Schekman-Sudhof model of vesicle traffic. The whole structure can be represented as a transport graph: each organelle is a node, and each vesicle route is a directed edge. What constraints must such a graph satisfy, if it is to represent a biologically realizable vesicle traffic network? Graph connectedness is an informative feature: 2-connectedness is necessary and sufficient for mass balance, but stronger conditions are required to ensure correct molecular specificity. Here we use Boolean satisfiability (SAT) and model checking as a framework to discover and verify graph constraints. The poor scalability of SAT model checkers often prevents their broad application. By exploiting the special structure of the problem, we scale our model checker to vesicle traffic systems with reasonably large numbers of molecules and compartments. This allows us to test a range of hypotheses about graph connectivity, which can later be proved in full generality by other methods.	[Shukla, Ankit; Kuppusamy, Lakshmanan] Vellore Inst Technol, Sch Comp Sci & Engn, Vellore, Tamil Nadu, India; [Bhattacharyya, Arnab] Indian Inst Sci, Dept Comp Sci & Automat, Bengaluru, India; [Srivas, Mandayam] Chennai Math Inst, Madras, Tamil Nadu, India; [Thattai, Mukund] Tata Inst Fundamental Res, Simons Ctr Study Living Machines, Natl Ctr Biol Sci, Bengaluru, India	Vellore Institute of Technology; Indian Institute of Science (IISC) - Bangalore; Chennai Mathematical Institute; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Thattai, M (corresponding author), Tata Inst Fundamental Res, Simons Ctr Study Living Machines, Natl Ctr Biol Sci, Bengaluru, India.	thattai@ncbs.res.in	Kuppusamy, Lakshmanan/U-8264-2019	Kuppusamy, Lakshmanan/0000-0003-2358-905X	Wellcome Trust-DBT India Alliance Intermediate Fellowship [500103/Z/09/Z]	Wellcome Trust-DBT India Alliance Intermediate Fellowship(Wellcome Trust DBT India Alliance)	MT was supported in part by a Wellcome Trust-DBT India Alliance Intermediate Fellowship (500103/Z/09/Z).	Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1; Bondy J.A., 1976, GRAPH THEORY APPL, V290; Cimatti A., 2002, Computer Aided Verification. 14th International Conference, CAV 2002. Proceedings (Lecture Notes in Computer Science Vol.2404), P359; Clarke E, 2004, LECT NOTES COMPUT SC, V2988, P168, DOI 10.1007/978-3-540-24730-2_15; Clarke E, 2003, CMUCS03126 CARN MELL; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Moura L, 2007, LECT NOTES ARTIF INT, V4603, P183; Een N, 2004, LECT NOTES COMPUT SC, V2919, P502, DOI 10.1007/978-3-540-24605-3_37; Giacobbe Mirco, 2015, Tools and Algorithms for the Construction and Analysis of Systems. 21st International Conference, TACAS 2015, held as part of the European Joint Conferences on Theory and Practice of Software, ETAPS 2015. Proceedings: LNCS 9035, P469, DOI 10.1007/978-3-662-46681-0_47; Giunchiglia E, 2016, QUANTIFIED BOOLEAN F; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Kroening D., 2016, DECISION PROCEDURES; Mangla K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008906; Mani S, 2016, MOL BIOCHEM PARASIT, V209, P58, DOI 10.1016/j.molbiopara.2016.03.006; Mani S, 2016, ELIFE, V5, DOI 10.7554/eLife.16231; Munro S, 2004, NAT CELL BIOL, V6, P469, DOI 10.1038/ncb0604-469; OEIS Foundation Inc, 2016, ON LINE ENCY INTEGER; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; SAT-Race, 2015, 18 INT C THEOR APPL; Soos M., 2016, ADV SAT SOLVER; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Zuliani P, 2015, INT J SOFTW TOOLS TE, V17, P527, DOI 10.1007/s10009-014-0343-0	28	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180692	10.1371/journal.pone.0180692	http://dx.doi.org/10.1371/journal.pone.0180692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683137	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000405335200061
J	Wen, F; Wu, XZ; Li, TJ; Jia, ML; Liu, XS; Li, P; Zhou, XJ; Ji, XX; Yue, XM				Wen, Feng; Wu, Xiaozhu; Li, Tongjian; Jia, Mingliang; Liu, Xinshen; Li, Peng; Zhou, Xiaojian; Ji, Xinxin; Yue, Xiaomin			Genome-wide survey of heat shock factors and heat shock protein 70s and their regulatory network under abiotic stresses in Brachypodium distachyon	PLOS ONE			English	Article							FACTOR GENE FAMILY; TRANSCRIPTION FACTOR; MOLECULAR CHAPERONES; EXPRESSION PROFILE; BINDING-FACTORS; CELL-DEATH; ARABIDOPSIS; THERMOTOLERANCE; DROUGHT; HSFA1	The heat shock protein 70s (Hsp70s) and heat shock factors (Hsfs) play key roles in protecting plant cells or tissues from various abiotic stresses. Brachypodium distachyon, recently developed an excellent model organism for functional genomics research, is related to the major cereal grain species. Although B. distachyon genome has been fully sequenced, the information of Hsf and Hsp70 genes and especially the regulatory network between Hsfs and Hsp70s remains incomplete. Here, a total of 24 BdHsfs and 29 BdHsp70s were identified in the genome by bioinformatics analysis and the regulatory network between Hsfs and Hsp70s were performed in this study. Based on highly conserved domain and motif analysis, BdHsfs were grouped into three classes, and BdHsp70s divided into six groups, respectively. Most of Hsf proteins contain five conserved domains: DBD, HR-A/B region, NLS and NES motifs and AHA domain, while Hsp70 proteins have three conserved domains: Nterminal nucleotide binding domain, peptide binding domain and a variable C-terminal lid region. Expression data revealed a large number of BdHsfs and BdHsp70s were induced by HS challenge, and a previous heat acclimation could induce the acquired thermotolerance to help seedling suffer the severe HS challenge, suggesting that the BdHsfs and BdHsp70s played a role in alleviating the damage by HS. The comparison revealed that, most BdHsfs and BdHsp70s genes responded to multiple abiotic stresses in an overlapping relationship, while some of them were stress specific response genes. Moreover, co-expression relationships and predicted protein-protein interaction network implied that class A and B Hsfs played as activator and repressors, respectively, suggesting that BdHsp70s might be regulated by both the activation and the repression mechanisms under stress condition. Our genomics analysis of BdHsfs and BdHsp70s provides important evolutionary and functional characterization for further investigation of the accurate regulatory mechanisms among Hsfs and Hsp70s in herbaceous plants.	[Wen, Feng; Wu, Xiaozhu; Li, Tongjian; Jia, Mingliang; Liu, Xinshen; Zhou, Xiaojian; Ji, Xinxin; Yue, Xiaomin] Jiujiang Univ, Sch Pharm & Life Sci, Jiujiang, Peoples R China; [Li, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai Chenshan Bot Garden, Shanghai, Peoples R China	Jiujiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wen, F (corresponding author), Jiujiang Univ, Sch Pharm & Life Sci, Jiujiang, Peoples R China.	wenfeng332@126.com	Liu, Xinsheng/AAW-2881-2021	Liu, Xinsheng/0000-0001-7609-796X	National Natural Science Foundation of China [31560075, 31460046]; Natural Science Foundation of Jiangxi Province [20151BAB214003, 20161BAB214149]; Foundation of Chinese medicine research of health and family planning commission of Jiangxi province [2015A075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Foundation of Chinese medicine research of health and family planning commission of Jiangxi province	This work was supported by National Natural Science Foundation of China [31560075,31460046] (http://www.nsfc.gov.cn/). The funder played roles in study design,data collection and analysis, decision to publish, and preparation of the manuscript. It was also supported by Natural Science Foundation of Jiangxi Province [20151BAB214003, 20161BAB214149] (http://www.jxstc.gov.cn/). The funder played roles in study design, data collection and analysis. This work was also supported by Foundation of Chinese medicine research of health and family planning commission of Jiangxi province [2015A075] (http://www.jxwst.gov.cn/). The funder played roles in data collection and analysis.	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; ALVIM FC, 2001, PLANT PHYSL, V126; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Bechtold U, 2013, J EXP BOT, V64, P3467, DOI 10.1093/jxb/ert185; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Chan-Schaminet KY, 2009, J BIOL CHEM, V284, P20848, DOI 10.1074/jbc.M109.007336; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Czarnecka-Verner E, 2004, PLANT MOL BIOL, V56, P57, DOI 10.1007/s11103-004-2307-3; Czarnecka-Verner E, 2000, PLANT MOL BIOL, V43, P459, DOI 10.1023/A:1006448607740; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Doring P, 2000, PLANT CELL, V12, P265, DOI 10.1105/tpc.12.2.265; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Evgen'ev MB, 2004, CHROMOSOMA, V113, P223, DOI 10.1007/s00412-004-0312-6; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Finka A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00029; Guo JK, 2008, J GENET GENOMICS, V35, P105, DOI 10.1016/S1673-8527(08)60016-8; Guo LH, 2008, PLANT CELL PHYSIOL, V49, P1306, DOI 10.1093/pcp/pcn105; Guo M, 2016, FRONT PLANT SCI, P7; Guo M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0512-7; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Ikeda M, 2011, PLANT PHYSIOL, V157, P1243, DOI 10.1104/pp.111.179036; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ito M, 2014, J PLANT PHYSIOL, V171, P173, DOI 10.1016/j.jplph.2013.10.012; Jiang SS, 2014, MOL PLANT PATHOL, V15, P907, DOI 10.1111/mpp.12153; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jung KH, 2013, FUNCT INTEGR GENOMIC, V13, P391, DOI 10.1007/s10142-013-0331-6; Kim BH, 2002, J EXP BOT, V53, P371, DOI 10.1093/jexbot/53.367.371; Kim NH, 2015, PLANT PHYSIOL, V167, P307, DOI 10.1104/pp.114.253898; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Latijnhouwers M, 2010, PLANTA, V232, P567, DOI 10.1007/s00425-010-1192-z; Lee JH, 1996, MOL GEN GENET, V252, P11, DOI 10.1007/BF02173200; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li QB, 1999, PLANT MOL BIOL, V39, P21, DOI 10.1023/A:1006100532501; Liu HC, 2011, PLANT CELL ENVIRON, V34, P738, DOI 10.1111/j.1365-3040.2011.02278.x; Liu JY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-281; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Maruyama D, 2010, P NATL ACAD SCI USA, V107, P1684, DOI 10.1073/pnas.0905795107; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Ohta T, 2008, ENCY LIFE SCI; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; Perez DE, 2009, PLANT PHYSIOL, V151, P241, DOI 10.1104/pp.109.142125; Priest HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087499; Qi YC, 2011, FEBS LETT, V585, P231, DOI 10.1016/j.febslet.2010.11.051; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Ryu JY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-15; Scharf KD, 1998, MOL CELL BIOL, V18, P2240, DOI 10.1128/MCB.18.4.2240; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schneider M, 2004, PLANT PHYSIOL BIOCH, V42, P1013, DOI 10.1016/j.plaphy.2004.10.009; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Skinner MK, 2014, BMC GENOMICS, P15; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Storozhenko S, 1998, PLANT PHYSIOL, V118, P1005, DOI 10.1104/pp.118.3.1005; Su PH, 2008, PLANT PHYSIOL, V146, P1231, DOI 10.1104/pp.107.114496; Sun JT, 2015, PLANT CELL REP, V34, P23, DOI 10.1007/s00299-014-1684-6; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Swindell WR, 2007, BMC GENOMICS, V8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wen F, 2014, DNA RES, V21, P327, DOI 10.1093/dnares/dst060; Yang KZ, 2009, PLANT J, V57, P870, DOI 10.1111/j.1365-313X.2008.03732.x; Yu A., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/510319; Zhang J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-532; Zhang LR, 2009, J EXP BOT, V60, P2073, DOI 10.1093/jxb/erp078; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	82	18	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180352	10.1371/journal.pone.0180352	http://dx.doi.org/10.1371/journal.pone.0180352			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683139	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200025
J	Suzuki, S; Arai, K; Munehara, H				Suzuki, Shota; Arai, Katsutoshi; Munehara, Hiroyuki			Karyological evidence of hybridogenesis in Greenlings (Teleostei: Hexagrammidae)	PLOS ONE			English	Article							GENOME EXCLUSION; DNA-CONTENT; FISH; GENUS; HYBRIDIZATION; POECILIOPSIS; REPRODUCTION; CHROMOSOMES; EVOLUTION; STRAINS	Two types of natural hybrids were discovered in populations of three Hexagrammos species (Teleostei: Hexagrammidae) distributed off the southern coast of Hokkaido in the North Pacific Ocean. Both hybrids reproduce by hybridogenesis, in which the maternal haploid genome is transmitted to offspring without recombination and the paternal haploid genome is eliminated during gametogenesis. While natural hybrids are unisexual and reproduce hemiclonally by backcrossing with the paternal species (BC-P), artificial F-1-hybrids between the pure species produce recombinant gametes. Thus, despite having the same genome composition, the natural hybrids and the F-1-hybrids are not genetically identical. Here, to clarify the differences between both hybrids, we examined the karyotypes of the three Hexagrammos species, their natural hybrids, the artificial F-1-hybrids, and several backcrosses. Artificial F-1-hybrids have karyotypes and chromosome numbers that are intermediate between those of the parental species. Conversely, the natural hybrids differed from F-1-hybrids by having several large metacentric chromosomes and microchromosomes. Since the entire maternal haploid genome is inherited by the natural hybrids, maternal backcrosses (BC-M) between natural hybrids and males of the maternal species (H. octogrammus; Hoc) have a hemiclonal Hoc genome with large chromosomes from the mother and a normal Hoc genome from the father. However, the large chromosomes disappear in offspring of BC-M, probably due to fissuring during gametogenesis. Similarly, microsatellite DNA analysis revealed that chromosomes of BC-M undergo recombination. These findings suggest that genetic factors associated with hemiclonal reproduction may be located on the large metacentric chromosomes of natural hybrids.	[Suzuki, Shota; Munehara, Hiroyuki] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Suzuki, Shota; Munehara, Hiroyuki] Hokkaido Univ, Usujiri Fisheries Stn, Field Sci Ctr Northern Biosphere, Hakodate, Hokkaido, Japan; [Arai, Katsutoshi] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Suzuki, S (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.; Suzuki, S (corresponding author), Hokkaido Univ, Usujiri Fisheries Stn, Field Sci Ctr Northern Biosphere, Hakodate, Hokkaido, Japan.	ainame0501@gmail.com	Munehara, Hiroyuki/A-3445-2012		Japan Society forthe Promotion of Science [KAKENHI23380107, 26292098, 15H02457]	Japan Society forthe Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for scientific research from the Japan Society forthe Promotion of Science (KAKENHI23380107 and 26292098 to HM, and 15H02457 toKA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Balanov AA, 2001, J ICHTHYOL+, V41, P766; Burt A, 2006, GENES CONFLICT BIOL; Carmona JA, 1997, GENETICS, V146, P983; CIMINO MC, 1974, CHROMOSOMA, V47, P297, DOI 10.1007/BF00328863; CIMINO MC, 1972, EVOLUTION, V26, P294, DOI 10.1111/j.1558-5646.1972.tb00195.x; CIMINO MC, 1970, COPEIA, P760; Coyne J.A., 2004, SPECIATION; Crow KD, 2007, BIOL J LINN SOC, V91, P135, DOI 10.1111/j.1095-8312.2007.00786.x; Crow KD, 2010, MOL ECOL, V19, P2089, DOI 10.1111/j.1365-294X.2010.04611.x; Crow KD, 2004, MOL PHYLOGENET EVOL, V32, P986, DOI 10.1016/j.ympev.2004.03.012; Dawley Robert M., 1989, New York State Museum Bulletin, V466, P1; Dmitry L. Lajus, 2007, FISH CYTOGENETICS, P261; Kimura MR, 2007, AQUAT BIOL, V1, P187, DOI 10.3354/ab00019; Kimura-Kawaguchi MR, 2014, J FISH BIOL, V85, P189, DOI 10.1111/jfb.12414; Lamatsch DK, 2002, J FISH BIOL, V60, P1417, DOI [10.1111/j.1095-8649.2002.tb02436.x, 10.1006/jfbi.2002.1939]; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Makino S., 1937, Zoological Magazine Tokyo, V49, P75; MATSUMIYA T, 1980, JPN J ICHTHYOL, V27, P273; MILLER RR, 1959, SCIENCE, V130, P1656, DOI 10.1126/science.130.3389.1656-a; Moritz C. C., 1989, EVOLUTION ECOLOGY UN, P87; Munehara H, 2016, ECOL EVOL, V6, P7126, DOI 10.1002/ece3.2446; Nakabo T., 2013, FISHES JAPAN PICTORI; Nanda I, 2007, GENETICS, V177, P917, DOI 10.1534/genetics.107.076893; Nishikawa S, 1982, CHROMOSOME INFORM SE, V33, P17; Ogielska M., 2009, REPROD AMPHIBIANS, P343; Ogielska M., 1994, ZOOL POLONIAE, V39, P461; Ojima Y., 1983, FISH CYTOGENETICS; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Rutenberg E, 1970, SURVEY FISH FAMILY H, V59, P1; Schartl A, 1997, CANCER RES, V57, P2993; Schmidt DJ, 2011, MOL ECOL, V20, P3367, DOI 10.1111/j.1365-294X.2011.05206.x; SCHULTZ RJ, 1961, EVOLUTION, V15, P302, DOI 10.2307/2406230; SCHULTZ RJ, 1973, SCIENCE, V179, P180, DOI 10.1126/science.179.4069.180; SCHULTZ RJ, 1969, AM NAT, V103, P605, DOI 10.1086/282629; Shinohara Gento, 1994, Memoirs of the Faculty of Fisheries Hokkaido University, V41, P1; Stock M, 2010, MOL ECOL, V19, P5204, DOI 10.1111/j.1365-294X.2010.04869.x; TINTI F, 1992, MOL REPROD DEV, V33, P235, DOI 10.1002/mrd.1080330302; TUNNER HG, 1991, NATURWISSENSCHAFTEN, V78, P32, DOI 10.1007/BF01134041; VINOGRADOV AE, 1990, GENOME, V33, P619, DOI 10.1139/g90-092; Vrijenhoek RC, 1998, BIOSCIENCE, V48, P617, DOI 10.2307/1313421; Vrijenhoek Robert C., 1989, New York State Museum Bulletin, V466, P19; Vrijenhoek RC, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P99, DOI 10.1007/978-90-481-2770-2_6	44	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180626	10.1371/journal.pone.0180626	http://dx.doi.org/10.1371/journal.pone.0180626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678883	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200079
J	Adler, C; Steinbrecher, A; Jaeschke, L; Mahler, A; Boschmann, M; Jeran, S; Pischon, T				Adler, Carolin; Steinbrecher, Astrid; Jaeschke, Lina; Maehler, Anja; Boschmann, Michael; Jeran, Stephanie; Pischon, Tobias			Validity and reliability of total body volume and relative body fat mass from a 3-dimensional photonic body surface scanner	PLOS ONE			English	Article							AIR-DISPLACEMENT PLETHYSMOGRAPHY; TEST-RETEST RELIABILITY; MAGNETIC-FIELDS; VALIDATION; OVERWEIGHT; AGREEMENT; ACCURACY	Objective Three-dimensional photonic body surface scanners (3DPS) feature a tool to estimate total body volume (BV) from 3D images of the human body, from which the relative body fat mass (% BF) can be calculated. However, information on validity and reliability of these measurements for application in epidemiological studies is limited. Methods Validity was assessed among 32 participants (men, 50%) aged 20-58 years. BV and % BF were assessed using a 3DPS (VitusSmart XXL) and air displacement plethysmography (ADP) with a BOD POD (R) device using equations by Siri and Brozek. Three scans were obtained per participant (standard, relaxed, exhaled scan). Validity was evaluated based on the agreement of 3DPS with ADP using Bland Altman plots, correlation analysis and Wilcoxon signed ranks test for paired samples. Reliability was investigated in a separate sample of 18 participants (men, 67%) aged 25-66 years using intraclass correlation coefficients (ICC) based on two repeated 3DPS measurements four weeks apart. Results Mean BV and % BF were higher using 3DPS compared to ADP, (3DPS-ADP BV difference 1.1 +/- 0.9 L, p< 0.01; % BF difference 7.0 +/- 5.6, p< 0.01), yet the disagreement was not associated with gender, age or body mass index (BMI). Reliability was excellent for 3DPS BV (ICC, 0.998) and good for 3DPS % BF (ICC, 0.982). Results were similar for the standard scan and the relaxed scan but somewhat weaker for the exhaled scan. Conclusions Although BV and % BF are higher than ADP measurements, our data indicate good validity and reliability for an application of 3DPS in epidemiological studies.	[Adler, Carolin; Steinbrecher, Astrid; Jaeschke, Lina; Jeran, Stephanie; Pischon, Tobias] Max Delbruck Ctr Mol Med, Mol Epidemiol Res Grp, Berlin, Germany; [Maehler, Anja; Boschmann, Michael] Expt & Clin Res Ctr, Berlin, Germany; [Pischon, Tobias] Charite, Berlin, Germany; [Pischon, Tobias] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research	Pischon, T (corresponding author), Max Delbruck Ctr Mol Med, Mol Epidemiol Res Grp, Berlin, Germany.; Pischon, T (corresponding author), Charite, Berlin, Germany.; Pischon, T (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	tobias.pischon@mdc-berlin.de	Pischon, Tobias/HGE-8577-2022	Pischon, Tobias/0000-0003-1568-767X; Jaeschke, Lina/0000-0002-5661-228X; Mahler, Anja/0000-0002-3904-5789	Federal Ministry for Economic Affairs and Energy [KF2135010BZ4]	Federal Ministry for Economic Affairs and Energy	This work was supported by Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag (KF2135010BZ4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2010, 159E ISOTC; [Anonymous], 1997, MONICA MANUAL 3; Bailey BW, 2001, MED SCI SPORT EXER, V33, pS174, DOI 10.1097/00005768-200105001-00988; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; CRAPO RO, 1982, B EUR PHYSIOPATH RES, V18, P419; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Fosbol MO, 2015, CLIN PHYSIOL FUNCT I, V35, P81, DOI 10.1111/cpf.12152; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Ginde SR, 2005, OBES RES, V13, P1232, DOI 10.1038/oby.2005.146; Guerra RS, 2010, J NUTR HEALTH AGING, V14, P744, DOI 10.1007/s12603-010-0112-z; Heinrich A, 2011, J MAGN RESON IMAGING, V34, P758, DOI 10.1002/jmri.22720; Jaeschke L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119430; MCCRORY MA, 1995, MED SCI SPORT EXER, V27, P1686; Ng B. K., 2016, EUR J CLIN NUTR; Noreen EE, 2006, MED SCI SPORT EXER, V38, P1505, DOI 10.1249/01.mss.0000228950.60097.01; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pepper MR, 2011, J TEST EVAL, V39, P82, DOI 10.1520/JTE102871; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Seidl A, 2008, SIZEGERMANY D NEUE D, P391; Siri W.E., 1956, BODY COMPOSITION FLU; Streiner DL, 2006, J CLIN EPIDEMIOL, V59, P327, DOI 10.1016/j.jclinepi.2005.09.005; Tucker LA, 2014, PERCEPT MOTOR SKILL, V118, P563, DOI 10.2466/03.PMS.118k15w5; van Nierop LE, 2015, MAGN RESON MED, V74, P840, DOI 10.1002/mrm.25443; Walter-Kroker A, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-35; Wang J, 2006, AM J CLIN NUTR, V83, P809; Wells JCK, 2000, ANN NY ACAD SCI, V904, P247; Wingfield HL, 2014, CLIN PHYSIOL FUNCT I, V34, P72, DOI 10.1111/cpf.12067; Withers RT, 1999, AM J HUM BIOL, V11, P175, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;175::AID-AJHB5&gt;3.0.CO;2-C	39	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180201	10.1371/journal.pone.0180201	http://dx.doi.org/10.1371/journal.pone.0180201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672039	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000405268500027
J	Li, B; Guo, WR; Zhang, F; Liu, MY; Wang, S; Liu, ZH; Xiang, SL; Zeng, YL				Li, Bo; Guo, Wanrong; Zhang, Fan; Liu, Meiyan; Wang, Shang; Liu, Zhonghua; Xiang, Shuanglin; Zeng, Youlin			Synthesis and evaluation of L-arabinose-based cationic glycolipids as effective vectors for pDNA and siRNA in vitro	PLOS ONE			English	Article							MEDIATED DNA-TRANSFECTION; GENE DELIVERY; VIRAL VECTORS; LIPIDS; EFFICIENCY; THERAPY; VIVO; CELLS; MECHANISMS; COMPLEXES	Glycolipids might become a new type of promising non-viral gene delivery systems because of their low cytotoxicity, structural diversity, controllable aqua-and lipo-solubility, appropriate density and distribution of positive charges, high transfer efficiency and potential targeting function. In this study, four kinds of L-arabinose-based cationic glycolipids (Ara-DiC12MA, Ara-DiC14MA, Ara-DiC16MA and Ara-DiC18MA) containing quaternary ammonium as hydrophilic headgroup and two alkane chains as hydrophobic domain were synthesized and characterized. They were observed to have strong affinities for plasmid DNA (pDNA) and siRNA, the pDNA can be completely condensed at N/P ratio less than 2, and the siRNA can be completely retarded at N/P ratio less than 3. The dynamic light scattering (DLS) experiment and atomic force microscopy (AFM) experiment demonstrated that cationic lipids and their lipoplexes possessed suitable particle sizes with near-spherical shape and proper.-potentials for cell transfection. The Ara-DiC16MA liposome was found to have good transfection efficacy in HEK293, PC-3 and Mat cells compared with other three kinds of liposomes, and also maintain low cytotoxicity and better uptake capability in vitro. Furthermore, the gene silencing assay showed that Ara-DiC14MA and Ara-DiC16MA liposomes have demonstrated effective delivery and higher gene knockdown activity (>80%) in the above mentioned cells than Lipofectamine 2000. These results indicated Ara-DiC16MA can be developed for efficient and low toxic gene delivery.	[Li, Bo; Guo, Wanrong; Zhang, Fan; Liu, Meiyan; Zeng, Youlin] Hunan Normal Univ, Coll Chem & Chem Engn, Natl & Local Joint Engn Lab New Petrochem Mat & F, Changsha, Hunan, Peoples R China; [Wang, Shang; Xiang, Shuanglin] Hunan Normal Univ, Coll Life Sci, State Educ Minist China, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha, Hunan, Peoples R China	Hunan Normal University; Hunan Normal University; Hunan Normal University	Zeng, YL (corresponding author), Hunan Normal Univ, Coll Chem & Chem Engn, Natl & Local Joint Engn Lab New Petrochem Mat & F, Changsha, Hunan, Peoples R China.	youlinzengcn@gmail.com	Zeng, Youlin/HCI-6949-2022	zeng, youlin/0000-0002-1110-4759	Nation Nature Sciences Foundation of China [21272064]; Science & Technology Department of Changsha City [K1205221-31]	Nation Nature Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Department of Changsha City	Tis research was financially supported by the Nation Nature Sciences Foundation of China (Gene ral Program: 21272064) and Science & Technology Department of Changsha City (K1205221-31)	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762; Bae YU, 2012, MOL PHARMACEUT, V9, P3579, DOI 10.1021/mp300458h; Bovolenta C, 2013, CURR PHARM BIOTECHNO, V14, P488, DOI 10.2174/138920101405131111104009; Byk G, 1998, J MED CHEM, V41, P224, DOI 10.1021/jm9704964; CAPLEN NJ, 1995, GENE THER, V2, P603; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Chan CL, 2012, BIOMATERIALS, V33, P4928, DOI 10.1016/j.biomaterials.2012.03.038; Crooke ST, 2000, ONCOGENE, V19, P6651, DOI 10.1038/sj.onc.1204093; Duan Y, 2009, EXPERT OPIN DRUG DEL, V6, P1351, DOI 10.1517/17425240903287153; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Gopal V, 2006, BIOCONJUGATE CHEM, V17, P1530, DOI 10.1021/bc0601020; Gopal V, 2011, BIOCONJUGATE CHEM, V22, P2244, DOI 10.1021/bc2002874; Gu L, 2014, J CONTROL RELEASE, V184, P28, DOI 10.1016/j.jconrel.2014.04.005; Guillot-Nieckowski M, 2007, NEW J CHEM, V31, P1111, DOI 10.1039/b614877h; Guo QF, 2011, INT J NANOMED, V6, P1641, DOI 10.2147/IJN.S21141; Guo QF, 2009, INT J PHARMACEUT, V379, P82, DOI 10.1016/j.ijpharm.2009.06.010; He CX, 2016, ORG BIOMOL CHEM, V14, P1611, DOI 10.1039/c5ob02107c; Herrera-Carrillo E, 2015, EXPERT OPIN THER TAR, V19, P245, DOI 10.1517/14728222.2014.980236; Jiang TY, 2012, BIOMATERIALS, V33, P9246, DOI 10.1016/j.biomaterials.2012.09.027; JOLLY D, 1994, CANCER GENE THER, V1, P51; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kedika B, 2012, MOL PHARMACEUT, V9, P1146, DOI 10.1021/mp200435y; Kim HS, 2004, BIOCONJUGATE CHEM, V15, P1095, DOI 10.1021/bc049934t; Koynova R, 2009, MOL PHARMACEUT, V6, P951, DOI 10.1021/mp8002573; Lee SJ, 2016, ADV DRUG DELIVER REV, V104, P2, DOI 10.1016/j.addr.2016.05.010; LEVENTIS R, 1990, BIOCHIM BIOPHYS ACTA, V1023, P124, DOI 10.1016/0005-2736(90)90017-I; Liu JL, 2011, EUR J MED CHEM, V46, P4133, DOI 10.1016/j.ejmech.2011.06.015; Medina-Kauwe LK, 2006, GENE THER GENE THERA, V12, P1734; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller AD, 1998, ANGEW CHEM INT EDIT, V37, P1769; Mrsny RJ, 1999, J DRUG TARGET, V7, P1; Mun JY, 2016, BIOMATERIALS, V101, P310, DOI 10.1016/j.biomaterials.2016.05.057; Ojeda E, 2015, ORG BIOMOL CHEM, V13, P1068, DOI 10.1039/c4ob02087a; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Pathak Atul, 2009, Biotechnology Journal, V4, P1559, DOI 10.1002/biot.200900161; Peel AL, 2000, J NEUROSCI METH, V98, P95, DOI 10.1016/S0165-0270(00)00183-7; Qiao WH, 2014, J SURFACTANTS DETERG, V17, P261, DOI 10.1007/s11743-013-1474-0; Rajesh M, 2007, J AM CHEM SOC, V129, P11408, DOI 10.1021/ja0704683; Raper SE, 2002, HUM GENE THER, V13, P163, DOI 10.1089/10430340152712719; Raviv L, 2015, MOL PHARMACEUT, V12, P453, DOI 10.1021/mp5005492; Risbo J., 2010, APPL ENVIRON MICROB, V76, P7925; Santos JL, 2011, CURRENT GENE THERAPY, V11, P35; Sapru MK, 2002, J NEUROSCI METH, V114, P99, DOI 10.1016/S0165-0270(01)00518-0; Sheng RL, 2014, COLLOID SURFACE B, V116, P32, DOI 10.1016/j.colsurfb.2013.12.039; Shi QS, 2014, J BIOMED NANOTECHNOL, V10, P436, DOI 10.1166/jbn.2014.1728; Shi S, 2014, BIOMATERIALS, V35, P4536, DOI 10.1016/j.biomaterials.2014.02.010; Sobajima S, 2004, GENE THER, V11, P390, DOI 10.1038/sj.gt.3302200; Teo PY, 2016, ADV DRUG DELIVER REV, V98, P41, DOI 10.1016/j.addr.2015.10.014; Terada T, 2006, J CONTROL RELEASE, V111, P333, DOI 10.1016/j.jconrel.2005.12.023; Thapa B, 2015, BIOMACROMOLECULES, V16, P3008, DOI 10.1021/acs.biomac.5b00906; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Vora L, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2781-8; Wang F, 2014, ACTA MATER, V80, P77, DOI 10.1016/j.actamat.2014.07.048; Wang N, 2014, EUR J PHARM BIOPHARM, V88, P194, DOI 10.1016/j.ejpb.2014.04.007; Xia YQ, 2016, BIOMATERIALS, V79, P56, DOI 10.1016/j.biomaterials.2015.11.056; YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568; Zhang M, 2003, BIOCONJUGATE CHEM, V14, P709, DOI 10.1021/bc034038n; Zhi DF, 2013, BIOCONJUGATE CHEM, V24, P487, DOI 10.1021/bc300381s; Zhi DF, 2010, BIOCONJUGATE CHEM, V21, P563, DOI 10.1021/bc900393r	62	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180276	10.1371/journal.pone.0180276	http://dx.doi.org/10.1371/journal.pone.0180276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672000	Green Submitted, gold, Green Published			2022-12-27	WOS:000405268500037
J	Plass-Christl, A; Haller, AC; Otto, C; Barkmann, C; Wiegand-Grefe, S; Holling, H; Schulte-Markwort, M; Ravens-Sieberer, U; Klasen, F				Plass-Christl, Angela; Haller, Anne-Catherine; Otto, Christiane; Barkmann, Claus; Wiegand-Grefe, Silke; Hoelling, Heike; Schulte-Markwort, Michael; Ravens-Sieberer, Ulrike; Klasen, Fionna			Parents with mental health problems and their children in a German population based sample: Results of the BELLA study	PLOS ONE			English	Article							STRESSFUL LIFE EVENTS; ILL PARENTS; DIFFICULTIES QUESTIONNAIRE; CHILDHOOD ADVERSITIES; PSYCHIATRIC-DISORDERS; AFFECTIVELY ILL; ADOLESCENTS; PREVALENCE; PSYCHOPATHOLOGY; METAANALYSIS	Background Mental health problems (MHP) of parents are associated with an increased risk of psychological and developmental difficulties in their children. This study aims at analyzing population-based data of parents with MHP and their children and the effects of associated risk factors in order to further targeted preventive and therapeutic interventions. Methods The BELLA study is the mental health module of the German National Health Interview and Examination Survey among Children and Adolescents. MHP in parents and in their children as well as associated risk factors were examined in a sample of N = 1158 parents with children aged 11 to 17 years. Results Parental MHP were identified in 18.6% of the sample. Risk factors associated with parental MHP were low SES, parental unemployment, stressful life events, parental daily strain, parental chronic disease, and child MHP. A rate of 19.1% of the children of parents with MHP reported MHP themselves, the corresponding rate among children of parents without MHP was 7.7%. In multiple regression analyses the risk for children of parents with MHP to report MHP themselves was almost two times higher than the risk of children of parents without MHP. Other significant associations with child MHP included gender, the parents' age, and stressful life events. Conclusions Parental MHP constitute a significant risk for the mental health of their children. Targeted screening methods and preventive interventions are needed.	[Plass-Christl, Angela; Haller, Anne-Catherine; Otto, Christiane; Barkmann, Claus; Wiegand-Grefe, Silke; Schulte-Markwort, Michael; Ravens-Sieberer, Ulrike; Klasen, Fionna] Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat Psychotherapy &, Hamburg, Germany; [Hoelling, Heike] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Robert Koch Institute	Ravens-Sieberer, U (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat Psychotherapy &, Hamburg, Germany.	ravens-sieberer@uke.de	Plass-Christl, Angela/AAP-8517-2021	Plass-Christl, Angela/0000-0002-9105-5204				Angelini V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167703; Barkmann C, 2012, J EPIDEMIOL COMMUN H, V66, P194, DOI 10.1136/jech.2009.102467; Beardslee WR, 2011, J AM ACAD CHILD PSY, V50, P1098, DOI 10.1016/j.jaac.2011.07.020; Beardslee WR, 2003, PEDIATRICS, V112, pE119, DOI 10.1542/peds.112.2.e119; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005; Brent DA, 2015, JAMA PSYCHIAT, V30, P1; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Franke G.H., 2002, SCL 90 R SYMPTOM CHE; Frasquilho D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2720-y; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman SH, 2007, ANNU REV CLIN PSYCHO, V3, P107, DOI 10.1146/annurev.clinpsy.3.022806.091401; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Herpertz-Dahlmann B, 2008, EUR CHILD ADOLES PSY, V17, P82, DOI 10.1007/s00787-008-1009-9; Holling H, 2014, BUNDESGESUNDHEITSBLA, V57, P807, DOI 10.1007/s00103-014-1979-3; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Ihle W, 2002, PSYCHOL RUNDSCH, V53, P159, DOI 10.1026//0033-3042.53.4.159; Jacobi F, 2015, INT J METH PSYCH RES, V24, P305, DOI 10.1002/mpr.1479; Jacobi F, 2014, INT J METH PSYCH RES, V23, P304, DOI 10.1002/mpr.1439; Johnson S, 2014, DEV MED CHILD NEUROL, V56, P453, DOI 10.1111/dmcn.12360; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9; Karow A, 2013, FORTSCHR NEUROL PSYC, V81, P628, DOI 10.1055/s-0033-1355840; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160; Klaghofer R, 2001, Z KLIN PSYCHOL PSYCH, V49, P115; Kuhn C, 2016, CHILD PSYCHIAT HUM D; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Lapalme M, 1997, CAN J PSYCHIAT, V42, P623, DOI 10.1177/070674379704200609; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mattejat F, 2008, DTSCH ARZTEBL INT, V105, P413, DOI [10.3238/arztebl.2008.0413, 10.3238/arztebl.2008.413]; McLaughlin KA, 2012, ARCH GEN PSYCHIAT, V69, P1151, DOI 10.1001/archgenpsychiatry.2011.2277; McLaughlin KA, 2012, BRIT J PSYCHIAT, V200, P290, DOI 10.1192/bjp.bp.111.101253; McLaughlin KA, 2009, J ADOLESCENT HEALTH, V44, P153, DOI 10.1016/j.jadohealth.2008.06.019; Meltzer H., 2000, MENTAL HLTH CHILDREN; Middeldorp CM, 2016, EUR CHILD ADOLES PSY, V25, P919, DOI 10.1007/s00787-015-0813-2; Najman JM, 2000, J AM ACAD CHILD PSY, V39, P592, DOI 10.1097/00004583-200005000-00013; PELLEGRINI DS, 1990, J DEV BEHAV PEDIATR, V11, P201; Petermann F, 2005, KINDH ENTWICKL, V14, P48, DOI 10.1026/0942-5403.14.1.48; Plass A, 2016, KINDH ENTWICKL, V25, P41, DOI 10.1026/0942-5403/a000187; Prinz U, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-104; Ravens-Sieberer U, 2015, EUR CHILD ADOLES PSY, V24, P651, DOI 10.1007/s00787-014-0638-4; Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P10, DOI 10.1007/s00787-008-1002-3; Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P22, DOI 10.1007/s00787-008-1003-2; Scheithauer H., 1999, KINDH ENTWICKL, V8, P3, DOI 10.1026//0942-5403.8.1.3; Siegenthaler E, 2012, J AM ACAD CHILD PSY, V51, P8, DOI 10.1016/j.jaac.2011.10.018; Statistisches Bundesamt WBfS, 2016, DAT REP 2016 KAP 2 F; TARULLO LB, 1995, J CLIN CHILD PSYCHOL, V24, P173, DOI 10.1207/s15374424jccp2402_5; van der Pol LD, 2016, J CHILD FAM STUD, V25, P3367, DOI 10.1007/s10826-016-0490-x; Wiegand-Grefe S, 2016, KINDH ENTWICKL, V25, P77, DOI 10.1026/0942-5403/a000192; Wiegand-Grefe S, 2016, KINDH ENTWICKL, V25, P63, DOI 10.1026/0942-5403/a000190; Wiegand-Grefe S, 2009, KINDH ENTWICKL, V18, P111, DOI 10.1026/0942-5403.18.2.111; Wille N, 2008, EUR CHILD ADOLES PSY, V17, P133, DOI 10.1007/s00787-008-1015-y; Winkler J., 1999, GESUNDHEITSWESEN, V61, pS178; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Zechmeister I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-20	56	33	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180410	10.1371/journal.pone.0180410	http://dx.doi.org/10.1371/journal.pone.0180410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28671981	Green Published, gold			2022-12-27	WOS:000405268500052
J	Schregel, J; Kopatz, A; Eiken, HG; Swenson, JE; Hagen, SB				Schregel, Julia; Kopatz, Alexander; Eiken, Hans Geir; Swenson, Jon E.; Hagen, Snorre B.			Sex-specific genetic analysis indicates low correlation between demographic and genetic connectivity in the Scandinavian brown bear (Ursus arctos)	PLOS ONE			English	Article							DEPENDENT NATAL DISPERSAL; POPULATION-STRUCTURE; MICROSATELLITE ANALYSIS; SPATIAL AUTOCORRELATION; RARE ALLELES; DIFFERENTIATION; DIVERSITY; G(ST); FLOW; INFERENCE	The degree of gene flow within and among populations, i.e. genetic population connectivity, may closely track demographic population connectivity. Alternatively, the rate of gene flow may change relative to the rate of dispersal. In this study, we explored the relationship between genetic and demographic population connectivity using the Scandinavian brown bear as model species, due to its pronounced male dispersal and female philopatry. Thus, we expected that females would shape genetic structure locally, whereas males would act as genetic mediators among regions. To test this, we used eight validated microsatellite markers on 1531 individuals sampled noninvasively during country-wide genetic population monitoring in Sweden and Norway from 2006 to 2013. First, we determined sex-specific genetic structure and substructure across the study area. Second, we compared genetic differentiation, migration/gene flow patterns, and spatial autocorrelation results between the sexes both within and among genetic clusters and geographic regions. Our results indicated that demographic connectivity was not a reliable indicator of genetic connectivity. Among regions, we found no consistent difference in long-term gene flow and estimated current migration rates between males and females. Within regions/genetic clusters, only females consistently displayed significant positive spatial autocorrelation, indicating male-biased small-scale dispersal. In one cluster, however, males showed a dispersal pattern similar to females. The Scandinavian brown bear population has experienced substantial recovery over the last decades; however, our results did not show any changes in its large-scale population structure compared to previous studies, suggesting that an increase in population size and dispersal of individuals does not necessary lead to increased genetic connectivity. Thus, we conclude that both genetic and demographic connectivity should be estimated, so as not to make false assumptions about the reality of wildlife populations.				julia.schregel@nibio.no; snorre.hagen@nibio.no	Swenson, Jon/AAE-2890-2019; Hagen, Snorre/O-5220-2015; Kopatz, Alexander/AAC-3967-2022; Kopatz, Alexander/A-3174-2012	Hagen, Snorre/0000-0001-8289-7752; Kopatz, Alexander/0000-0002-9139-1179; Kopatz, Alexander/0000-0002-9139-1179; Eiken, Hans Geir/0000-0002-5368-3648				Aarnes SG, 2016, DNA AN; Andreassen R, 2012, FORENSIC SCI INT-GEN, V6, P798, DOI 10.1016/j.fsigen.2012.03.002; Andren H, 2006, ANN REV ECOLOGY EVOL, V131, P23; Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; [Anonymous], 2011, CONSERV LETT; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Belkhir K, 1996, MOL ECOLOGY RESOURCE; Braaker S, 2017, LANDSCAPE URBAN PLAN, V160, P107, DOI 10.1016/j.landurbplan.2016.12.011; Castric V, 2003, GENETICS, V163, P983; Debeffe L, 2012, J ANIM ECOL, V81, DOI 10.1111/j.1365-2656.2012.02014.x; DeGiorgio M, 2011, GENETICS, V189, P579, DOI 10.1534/genetics.111.129296; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Fischer ML, 2017, DIVERS DISTRIB, V23, P409, DOI 10.1111/ddi.12538; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gangaas KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068849; Gilroy JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038091; Gonzalez EG, 2016, PEERJ, P4; Gonzalez EG, 2016, PEERJ, V4, DOI 10.7717/peerj.1928; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Greminger MP, 2010, MOL ECOL RESOUR, V10, P409, DOI 10.1111/j.1755-0998.2009.02798.x; Hagen SB, 2015, CANADIAN J ZOOLOGY R, V282; Hagen SB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0092; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Hovestadt T, 2014, AM NAT, V184, P38, DOI 10.1086/676524; Inoue K, 2017, GLOBAL CHANGE BIOL, V23, P94, DOI 10.1111/gcb.13369; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Kentie R, 2014, J AVIAN BIOL, V45, P396, DOI 10.1111/jav.00273; Kojola I, 2004, SUURPETOJEN LUKUMAAR, P1; Kopatz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097558; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Logan ML, 2016, EVOLUTION, V70, P2395, DOI 10.1111/evo.13031; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Ma L, 2015, CURR ZOOL, V61, P886, DOI 10.1093/czoolo/61.5.886; Manel S, 2004, MOL ECOL, V13, P1327, DOI 10.1111/j.1365-294X.2004.02074.x; McLellan BN, 2001, CAN J ZOOL, V79, P838, DOI 10.1139/cjz-79-5-838; Meirmans PG, 2014, MOL ECOL RESOUR, V14, P726, DOI 10.1111/1755-0998.12216; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; PAETKAU D, 1995, MOL ECOL, V4, P133; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pelletier A, 2012, CAN J ZOOL, V90, P999, DOI 10.1139/Z2012-068; Pelletier A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172319; Persson J, 2009, BIOL CONSERV, V142, P325, DOI 10.1016/j.biocon.2008.10.028; Pritchard JK, 2000, GENETICS, V155, P945; Rauset GR, 2016, CONSERV LETT, V9, P334, DOI 10.1111/conl.12226; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2008, EVOLUTION, V62, P2250, DOI 10.1111/j.1558-5646.2008.00453.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Schregel J, 2015, MOL ECOL, V24, P6041, DOI 10.1111/mec.13448; Schregel J, 2012, MOL ECOL, V21, P3474, DOI 10.1111/j.1365-294X.2012.05631.x; Schulte U, 2013, BIOL INVASIONS, V15, P2639, DOI 10.1007/s10530-013-0480-5; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Verity R, 2014, MOL ECOL, V23, P4216, DOI 10.1111/mec.12856; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Wang J, 2015, MOL ECOL, V24, P3546, DOI 10.1111/mec.13204; Wang J, 2012, GENET RES, V94, P275, DOI 10.1017/S0016672312000481; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wilson GA, 2003, GENETICS, V163, P1177; Yamamichi M, 2012, HEREDITY, V108, P362, DOI 10.1038/hdy.2011.83; Zedrosser A, 2007, ANIM BEHAV, V74, P369, DOI 10.1016/j.anbehav.2006.09.015	85	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180701	10.1371/journal.pone.0180701	http://dx.doi.org/10.1371/journal.pone.0180701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672045	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000405268500081
J	Yu, L; Lutz, MW; Wilson, RS; Burns, DK; Roses, AD; Saunders, AM; Yang, JY; Gaiteri, C; De Jager, PL; Barnes, LL; Bennett, DA				Yu, Lei; Lutz, Michael W.; Wilson, Robert S.; Burns, Daniel K.; Roses, Allen D.; Saunders, Ann M.; Yang, Jingyun; Gaiteri, Chris; De Jager, Philip L.; Barnes, Lisa L.; Bennett, David A.			APOE epsilon 4-TOMM40'523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; GENETIC-VARIATION; ASSOCIATION; PROMOTER; REPEAT; DEMENTIA; TOMM40; APOE-EPSILON-4; EXPRESSION; COMMUNITY	Patterns of linkage between the epsilon 4 allele of Apolipoprotein E (APOE) and '523 poly-T alleles in the adjacent gene, TOMM40, differ between Caucasian and African Americans. The extent to which this difference affects the risk of Alzheimer's disease (AD) is unclear. We compared the APOE epsilon 4-TOMM40 '523 haplotypes between older Caucasian and African Americans, and examined their relationship with AD dementia. Data came from three community based cohort studies of diverse participants. APOE genotypes were determined by polymorphisms of rs429358 and rs7412. TOMM40 '523 genotypes were defined by the poly-T repeat length of rs10524523 (short ['523-S]: poly-T <= 19, long ['523-L]: 20 <= poly-T <= 29, and very long ['523-VL]: poly-T >= 30). Cox proportional hazards models examined the effect of haplotype variation on the risk of incident AD dementia. A total of 1,848 Caucasian and 540 African American individuals were included in the study. In Caucasians, nearly none (0.8%) of the non-epsilon 4 carriers and almost all (94.2%) of the epsilon 4 carriers had '523-L. The classification was highly concordant. Each epsilon 4 allele doubled the risk for AD dementia and the dose effect was evident. Almost identical effect size and effect pattern were observed for TOMM40 '523-L. In African Americans, nearly none (1.1%) of the non-epsilon 4 carriers had '523-L, but only 47.8% of the epsilon 4 carriers had '523-L. The concordance was weaker compared with Caucasians. The effect patterns on incident AD dementia differed distinctively between epsilon 4 and '523-L carriers. Further, both genotypic and allelic data support that among African Americans the epsilon 4-'523-L haplotype had stronger effect on risk of AD dementia than other epsilon 4-'523 haplotypes.	[Yu, Lei; Wilson, Robert S.; Yang, Jingyun; Gaiteri, Chris; Barnes, Lisa L.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Yu, Lei; Wilson, Robert S.; Yang, Jingyun; Gaiteri, Chris; Barnes, Lisa L.; Bennett, David A.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Lutz, Michael W.; Roses, Allen D.] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [Burns, Daniel K.; Roses, Allen D.; Saunders, Ann M.] Zinfandel Pharmaceut Inc, Res Triangle Pk, NC USA; [De Jager, Philip L.] Columbia Univ, Dept Neurol, Med Ctr, Ctr Translat & Computat Neuroimmunol, New York, NY USA; [De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	Rush University; Rush University; Duke University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bennett, DA (corresponding author), Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA.; Bennett, DA (corresponding author), Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA.	David_A_Bennett@rush.edu	Yang, Jingyun/D-5361-2009; Yu, Lei/AAT-3685-2020	Yang, Jingyun/0000-0002-3495-3710; 	National Instituteon Aging [R01AG17917, P30AG10161, RF1AG15819, RF1AG22018]; Illinois Department of Public Health; Zinfandel Pharmaceuticals,Inc.; NATIONAL INSTITUTE ON AGING [P30AG010161, RF1AG022018, RF1AG015819, R01AG017917] Funding Source: NIH RePORTER	National Instituteon Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; Zinfandel Pharmaceuticals,Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was funded by the National Instituteon Aging R01AG17917, P30AG10161, RF1AG15819, RF1AG22018, and the Illinois Department of Public Health. The study was partially supported by an unrestricted educational grant from Zinfandel Pharmaceuticals,Inc. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DKB is an employee of Zinfandel Pharmaceuticals,Inc. ADR was the CEO of Zinfandel Pharmaceuticals,Inc. AMS is the CEO of Zinfandel Pharmaceuticals,Inc. The specific roles of these authors are articulated in the'author contributions' section.	Akai J, 1999, GENE, V239, P65, DOI 10.1016/S0378-1119(99)00380-7; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Barnes LL, 2013, NEUROEPIDEMIOLOGY, V40, P211, DOI 10.1159/000342778; Barnes LL, 2012, CURR ALZHEIMER RES, V9, P734, DOI 10.2174/156720512801322627; Bekris LM, 2012, J HUM GENET, V57, P18, DOI 10.1038/jhg.2011.123; Bennett DA, 2005, J NEUROL NEUROSUR PS, V76, P1194, DOI 10.1136/jnnp.2004.054445; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chiba-Falek O, 2017, EXPERT REV PRECISION, P1; Chu SH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.016; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crenshaw DG, 2013, CLIN PHARMACOL THER, V93, P177, DOI 10.1038/clpt.2012.222; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Evans DA, 1997, JAMA-J AM MED ASSOC, V277, P822, DOI 10.1001/jama.277.10.822; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Graff-Radford NR, 2002, ARCH NEUROL-CHICAGO, V59, P594, DOI 10.1001/archneur.59.4.594; Gureje O, 2006, ANN NEUROL, V59, P182, DOI 10.1002/ana.20694; Hefferon TW, 2004, P NATL ACAD SCI USA, V101, P3504, DOI 10.1073/pnas.0400182101; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Jun G, 2012, ARCH NEUROL-CHICAGO, V69, P1270, DOI 10.1001/archneurol.2012.2052; Kline A, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt135; Linnertz C, 2014, ALZHEIMERS DEMENT, V10, P541, DOI 10.1016/j.jalz.2013.08.280; Linnertz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030994; Logue MW, 2011, ARCH NEUROL-CHICAGO, V68, P1569, DOI 10.1001/archneurol.2011.646; Lutz MW, 2010, ALZHEIMERS DEMENT, V6, P125, DOI 10.1016/j.jalz.2010.01.011; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mortimer JA, 2009, ALZ DIS ASSOC DIS, V23, P152, DOI 10.1097/WAD.0b013e318190a855; Murrell JR, 2006, ARCH NEUROL-CHICAGO, V63, P431, DOI 10.1001/archneur.63.3.431; Okladnova O, 1998, BIOCHEM BIOPH RES CO, V248, P402, DOI 10.1006/bbrc.1998.8972; Payton A, 2015, NEUROBIOLOGY AGING; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Peters DG, 1999, STROKE, V30, P2612, DOI 10.1161/01.STR.30.12.2612; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Roses AD, 2014, ALZHEIMERS DEMENT, V10, P592, DOI 10.1016/j.jalz.2014.06.009; Roses AD, 2013, ALZHEIMERS DEMENT, V9, P132, DOI 10.1016/j.jalz.2012.10.009; Searle S, 1999, J MED GENET, V36, P295; Shimajiri S, 1999, FEBS LETT, V455, P70, DOI 10.1016/S0014-5793(99)00863-7; Slooter AJC, 2004, NEUROLOGY, V62, P1196, DOI 10.1212/01.WNL.0000118302.66674.E1; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tycko B, 2004, ARCH NEUROL-CHICAGO, V61, P1434, DOI 10.1001/archneur.61.9.1434; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Willems T, 2014, GENOME RES, V24, P1894, DOI 10.1101/gr.177774.114; Yu L, 2017, NEUROLOGY, V88, P661, DOI 10.1212/WNL.0000000000003614	51	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e180356	10.1371/journal.pone.0180356	http://dx.doi.org/10.1371/journal.pone.0180356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672022	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500045
J	Qian, ZM; Chen, YQ				Qian, Zhi-Ming; Chen, Yan Qiu			Feature point based 3D tracking of multiple fish from multi-view images	PLOS ONE			English	Article							ZEBRAFISH; KINEMATICS; BEHAVIOR	A feature point based method is proposed for tracking multiple fish in 3D space. First, a simplified representation of the object is realized through construction of two feature point models based on its appearance characteristics. After feature points are classified into occluded and non-occluded types, matching and association are performed, respectively. Finally, the object's motion trajectory in 3D space is obtained through integrating multi-view tracking results. Experimental results show that the proposed method can simultaneously track 3D motion trajectories for up to 10 fish accurately and robustly.	[Qian, Zhi-Ming; Chen, Yan Qiu] Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Sch Comp Sci, Shanghai, Peoples R China; [Qian, Zhi-Ming] Chuxiong Normal Univ, Chuxiong, Peoples R China	Fudan University; Chuxiong Normal University	Chen, YQ (corresponding author), Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Sch Comp Sci, Shanghai, Peoples R China.	chenyq@fudan.edu.cn			National Natural Science Foundation of China [61175036, 61363023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research work presented in this paper is supported by National Natural Science Foundation of China (Grant No. 61175036 to YQC and No. 61363023 to ZMQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Butail S, 2012, J R SOC INTERFACE, V9, P77, DOI 10.1098/rsif.2011.0113; Chuang MC, 2015, IEEE T CIRC SYST VID, V25, P167, DOI 10.1109/TCSVT.2014.2357093; Delcourt J, 2013, FISH FISH, V14, P186, DOI 10.1111/j.1467-2979.2012.00462.x; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Ebert D., 2002, P S DATA VISUALISATI, P251; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Maaswinkel H, 2013, JOVE-J VIS EXP, DOI 10.3791/50681; Mao JF, 2016, NEUROCOMPUTING, V214, P61, DOI 10.1016/j.neucom.2016.05.067; Martineau PR, 2013, METHODS, V62, P292, DOI 10.1016/j.ymeth.2013.05.002; Mendelson L, 2015, EXP FLUIDS, V56, DOI 10.1007/s00348-015-2003-x; Nimkerdphol K, 2008, J BIOSCI BIOENG, V105, P486, DOI 10.1263/jbb.105.486; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Qian ZM, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1138-y; Stewart AM, 2015, J NEUROSCI METH, V255, P66, DOI 10.1016/j.jneumeth.2015.07.023; Voesenek CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146682; Wang SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154714; Wu B, 2007, INT J COMPUT VISION, V75, P247, DOI 10.1007/s11263-006-0027-7; Wu GH, 2010, J BIONIC ENG, V7, P49, DOI 10.1016/S1672-6529(09)60190-6; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718; Zhiping X, 2017, SCI REPORTS, P7; Zhu LQ, 2007, PHYSIOL BEHAV, V91, P106, DOI 10.1016/j.physbeh.2007.01.023	23	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180254	10.1371/journal.pone.0180254	http://dx.doi.org/10.1371/journal.pone.0180254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665966	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608700078
J	Hari, P; Aakala, T; Hilasvuori, E; Hakkinen, R; Korhola, A; Korpela, M; Linkosalo, T; Makinen, H; Nikinmaa, E; Nojd, P; Seppa, H; Sulkava, M; Terhivuo, J; Tuomenvirta, H; Weckstrom, J; Hollmen, J				Hari, Pertti; Aakala, Tuomas; Hilasvuori, Emmi; Hakkinen, Risto; Korhola, Atte; Korpela, Mikko; Linkosalo, Tapio; Makinen, Harri; Nikinmaa, Eero; Nojd, Pekka; Seppa, Heikki; Sulkava, Mika; Terhivuo, Juhani; Tuomenvirta, Heikki; Weckstrom, Jan; Hollmen, Jaakko			Reliability of temperature signal in various climate indicators from northern Europe	PLOS ONE			English	Article							STABLE CARBON ISOTOPES; RING-WIDTH; SUMMER SUNSHINE; TREE-RINGS; ICE-COVER; LAKE; RECONSTRUCTION; DROUGHT; RECORDS; DENSITY	We collected relevant observational and measured annual-resolution time series dealing with climate in northern Europe, focusing in Finland. We analysed these series for the reliability of their temperature signal at annual and seasonal resolutions. Importantly, we analysed all of the indicators within the same statistical framework, which allows for their meaningful comparison. In this framework, we employed a cross-validation procedure designed to reduce the adverse effects of estimation bias that may inflate the reliability of various temperature indicators, especially when several indicators are used in a multiple regression model. In our data sets, timing of phenological observations and ice break-up were connected with spring, tree ring characteristics (width, density, carbon isotopic composition) with summer and ice formation with autumn temperatures. Baltic Sea ice extent and the duration of ice cover in different watercourses were good indicators of winter temperatures. Using combinations of various temperature indicator series resulted in reliable temperature signals for each of the four seasons, as well as a reliable annual temperature signal. The results hence demonstrated that we can obtain reliable temperature information over different seasons, using a careful selection of indicators, combining the results with regression analysis, and by determining the reliability of the obtained indicator.	[Hari, Pertti; Aakala, Tuomas; Nikinmaa, Eero] Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Hilasvuori, Emmi] Univ Helsinki, Finnish Museum Nat Hist, Lab Chronol, Helsinki, Finland; [Hakkinen, Risto; Linkosalo, Tapio] Nat Resources Inst Finland Luke, Helsinki, Finland; [Korhola, Atte; Weckstrom, Jan] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Korpela, Mikko; Hollmen, Jaakko] Aalto Univ, Dept Informat & Comp Sci, Espoo, Finland; [Korpela, Mikko; Seppa, Heikki] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Makinen, Harri; Nojd, Pekka] Nat Resources Inst Finland Luke, Helsinki, Finland; [Sulkava, Mika] Nat Resources Inst Finland Luke, Stat Serv, Helsinki, Finland; [Terhivuo, Juhani] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Tuomenvirta, Heikki] Finnish Meteorol Inst, Helsinki, Finland	University of Helsinki; University of Helsinki; Natural Resources Institute Finland (Luke); University of Helsinki; Aalto University; University of Helsinki; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); University of Helsinki; Finnish Meteorological Institute	Aakala, T (corresponding author), Univ Helsinki, Dept Forest Sci, Helsinki, Finland.	tuomas.aakala@helsinki.fi	Mäkinen, Harri/C-9817-2015; Aakala, Tuomas/AAA-2574-2020; Weckstrom, Jan/N-7665-2013	Mäkinen, Harri/0000-0002-1820-6264; Aakala, Tuomas/0000-0003-0160-6410; Korhola, Atte A./0000-0003-2577-6502; Weckstrom, Jan/0000-0001-5604-617X; Seppa, Heikki/0000-0003-2494-7955	Academy of Finland [276255, 257641, 265504]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (www.aka.fi; proj. no 276255 for TA, and 257641 and 265504 for HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, GEOPHYSICA; [Anonymous], 2011, SWIPA SNOW WATER ICE; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Battarbee RW, 2005, FRESHWATER BIOL, V50, P1772, DOI 10.1111/j.1365-2427.2005.01427.x; Bergmeir C, 2012, INFORM SCIENCES, V191, P192, DOI 10.1016/j.ins.2011.12.028; Bjorklund JA, 2014, CLIM PAST, V10, P877, DOI 10.5194/cp-10-877-2014; Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Christiansen B, 2017, REV GEOPHYS, V55, P40, DOI 10.1002/2016RG000521; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Cook E.R., 1990, METHODS DENDROCHRONO, P97, DOI [10.2307/1551446, DOI 10.1007/978-94-015-7879-0_3, 10.1007/978-94-015-7879-0_3]; Cook ER, 2004, QUATERNARY SCI REV, V23, P2063, DOI 10.1016/j.quascirev.2004.08.013; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; DARRIGO RD, 1992, CAN J FOREST RES, V22, P1290, DOI 10.1139/x92-171; De Jong R, 2011, J QUATERNARY SCI, V26, P268, DOI 10.1002/jqs.1451; Douglas Marianne S.V., 1999, P227; Drew DM, 2013, TREE PHYSIOL, V33, P37, DOI 10.1093/treephys/tps111; Duda R.O., 2000, PATTERN CLASSIFICATI; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Esper J, 2014, J QUATERNARY SCI, V29, P487, DOI 10.1002/jqs.2726; Fang X, 1998, COLD REG SCI TECHNOL, V27, P119, DOI 10.1016/S0165-232X(97)00027-X; Gagen M, 2011, DEV PALEOENVIRON RES, V11, P147, DOI 10.1007/978-1-4020-5725-0_6; Gauthier S, 2014, ENVIRON REV, V22, P256, DOI 10.1139/er-2013-0064; Gebre S, 2014, CRYOSPHERE, V8, P1589, DOI 10.5194/tc-8-1589-2014; Grudd H, 2002, HOLOCENE, V12, P657, DOI 10.1191/0959683602hl578rp; Gurskaya M, 2012, DENDROCHRONOLOGIA, V30, P302, DOI 10.1016/j.dendro.2012.04.002; Hafner P, 2014, CLIM DYNAM, V43, P971, DOI 10.1007/s00382-013-1864-z; Hafner P, 2011, TREES-STRUCT FUNCT, V25, P1141, DOI 10.1007/s00468-011-0589-z; HAKKINEN R, 1995, TREE PHYSL, V15; HANNINEN H, 1990, Acta Forestalia Fennica, V213, P1; Haykins S., 1999, NEURAL NETWORKS COMP; Hegerl GC, 2007, J CLIMATE, V20, P650, DOI 10.1175/JCLI4011.1; Helama S, 2017, HOLOCENE, V27, P172, DOI 10.1177/0959683616652709; Helama S, 2009, J QUATERNARY SCI, V24, P450, DOI 10.1002/jqs.1291; Helama S, 2009, GEOLOGY, V37, P175, DOI 10.1130/G25329A.1; Hilasvuori E, 2009, J QUATERNARY SCI, V24, P469, DOI 10.1002/jqs.1260; Holopainen J, 2013, INT J BIOMETEOROL, V57, P423, DOI 10.1007/s00484-012-0568-0; Holtta T, 2010, TREE PHYSIOL, V30, P1235, DOI 10.1093/treephys/tpq068; Hommel R, 2016, PLANT BIOLOGY, V18, P785, DOI 10.1111/plb.12461; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jensen AM, 2015, ANN BOT-LONDON, V116, P821, DOI 10.1093/aob/mcv115; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Jylha K, 2008, CLIMATIC CHANGE, V86, P441, DOI 10.1007/s10584-007-9310-z; Klein T, 2015, NEW PHYTOL, V205, P147, DOI 10.1111/nph.12993; Kuusisto E, 2001, INT VER THEOR ANGEW, V27, P2761; LANDSBERG JJ, 1974, ANN BOT-LONDON, V38, P1013, DOI 10.1093/oxfordjournals.aob.a084891; Latifovic R, 2007, REMOTE SENS ENVIRON, V106, P492, DOI 10.1016/j.rse.2006.09.015; Leijonhufvud L, 2008, HOLOCENE, V18, P333, DOI 10.1177/0959683607086770; Leijonhufvud L, 2010, CLIMATIC CHANGE, V101, P109, DOI 10.1007/s10584-009-9650-y; Leuenberger M, 2007, TERR ECOL SER, V1, P211; Li B, 2010, J AM STAT ASSOC, V105, P883, DOI 10.1198/jasa.2010.ap09379; Linkosalo T, 2008, TREE PHYSIOL, V28, P1873, DOI 10.1093/treephys/28.12.1873; Loader NJ, 2013, QUATERNARY SCI REV, V62, P97, DOI 10.1016/j.quascirev.2012.11.014; Loader NJ, 1997, CHEM GEOL, V136, P313, DOI 10.1016/S0009-2541(96)00133-7; Luomaranta A, 2014, TELLUS A, V66, DOI 10.3402/tellusa.v66.22617; McCarroll D, 2013, HOLOCENE; Mccarroll D, 2011, J QUATERNARY SCI, V26, P7, DOI 10.1002/jqs.1408; Melvin TM, 2008, DENDROCHRONOLOGIA, V26, P71, DOI 10.1016/j.dendro.2007.12.001; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Olano JM, 2013, NEW PHYTOL, V198, P486, DOI 10.1111/nph.12113; National Research Council, 2007, SURF TEMP REC LAST 2; Oiva Database, 2008, OIVA ENV GEOGR INF S; Omstedt A, 2001, J GEOPHYS RES-OCEANS, V106, P4493, DOI 10.1029/1999JC000173; PALECKI MA, 1986, J CLIM APPL METEOROL, V25, P893, DOI 10.1175/1520-0450(1986)025<0893:FUABUO>2.0.CO;2; Pla-Rabes S, 2011, J PALEOLIMNOL, V46, P139, DOI 10.1007/s10933-011-9529-6; Prowse T, 2011, AMBIO, V40, P53, DOI 10.1007/s13280-011-0216-7; Prowse T, 2011, AMBIO, V40, P46, DOI 10.1007/s13280-011-0214-9; ROBERTSON DM, 1992, CLIMATIC CHANGE, V21, P407, DOI 10.1007/BF00141379; Robertson I, 1997, GEOPHYS RES LETT, V24, P1487, DOI 10.1029/97GL01293; Sarvas R., 1974, COMMUNICATIONES I FO, V84, P1; Sarvas R., 1972, COMMUN I FOREST FENN, V76, P1; Schneider L, 2014, OIKOS, V123, P559, DOI 10.1111/j.1600-0706.2013.00836.x; Seina A, 1996, MERI, V27, P79; Stove B, 2012, J CLIMATE, V25, P7173, DOI 10.1175/JCLI-D-11-00632.1; Sulkava M, 2006, ECOL MODEL, V191, P118, DOI 10.1016/j.ecolmodel.2005.08.016; Theodoridis S., 2008, PATTERN RECOGN, V4th ed.; Thompson R, 2005, ARCT ANTARC ALP RES, V37; Tingley MP, 2013, NATURE, V496, P201, DOI 10.1038/nature11969; Tinz B, 1996, GEOPHYSICA, V32, P319; Tomkins JD, 2009, J PALEOLIMNOL, V41, P225, DOI 10.1007/s10933-008-9255-x; Tuovinen Mervi, 2005, Dendrochronologia, V22, P83, DOI 10.1016/j.dendro.2005.02.001; Vaganov E.A., 2006, ECOL STU AN, V183, DOI 10.1007/3-540-31298-6_6; Vihma T, 2009, PROG OCEANOGR, V80, P129, DOI 10.1016/j.pocean.2009.02.002; Walsh J., 2005, ARCTIC CLIMATE IMPAC, P183; Weckstrom J, 2014, GEOPHYS RES LETT, V41, P2026, DOI 10.1002/2014GL059474; Wilson R, 2016, QUATERNARY SCI REV, V134, P1, DOI 10.1016/j.quascirev.2015.12.005; Wynne RH, 1998, PHOTOGRAMM ENG REM S, V64, P607	89	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180042	10.1371/journal.pone.0180042	http://dx.doi.org/10.1371/journal.pone.0180042			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662166	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300092
J	Arca-Diaz, G; Re, TJ; Drottar, M; Fortuno, CR; De Macedo-Rodrigues, K; Im, K; Figueras-Aloy, J; Grant, PE				Arca-Diaz, Gemma; Re, Thomas J.; Drottar, Marie; Fortuno, Carmen Rosa; De Macedo-Rodrigues, Katyucia; Im, Kiho; Figueras-Aloy, Josep; Grant, Patricia Ellen			Can cerebellar and brainstem apparent diffusion coefficient (ADC) values predict neuromotor outcome in term neonates with hypoxic-ischemic encephalopathy (HIE) treated with hypothermia?	PLOS ONE			English	Article							WHOLE-BODY HYPOTHERMIA; PERINATAL ASPHYXIA; RANDOMIZED-TRIAL; BASAL GANGLIA; INJURY; MRI; ANISOTROPY; CHILDREN; NEWBORNS; INFANTS	Background and purpose To determine the apparent diffusion coefficient (ADC) in specific infratentorial brain structures during the first week of life and its relation with neuromotor outcome for Hypoxic-ischemic encephalopathy (HIE) in term neonates with and without whole-body hypothermia (TH). Materials and methods We retrospectively evaluated 45 MRI studies performed in the first week of life of term neonates born between 2010 and 2013 at Boston Children's Hospital. Selected cases were classified into three groups: 1) HIE neonates who underwent TH, 2) HIE normothermics (TN), and 3) controls. The neuromotor outcome was categorized as normal, abnormal and death. The ADC(mean) was calculated for six infratentorial brain regions. Results A total of 45 infants were included: 28 HIE TH treated, 8 HIE TN, and 9 controls. The mean gestational age was 39 weeks; 57.8% were male; 11.1% were non-survivors. The median age at MRI was 3 days (interquartile range, 1-4 days). A statistically significant relationship was shown between motor outcome or death and the ADCmean in the vermis (P = 0.002), cerebellar left hemisphere (P = 0.002), midbrain (P = 0.009), pons (P = 0.014) and medulla (P = 0.005). In patients treated with TH, the ADC (mean) remained significantly lower than that in the controls only in the hemispheres (P = 0.01). In comparison with abnormal motor outcome, ADC(mean) was lowest in the left hemisphere (P = 0.003), vermis (P = 0.003), pons (P = 0.0036) and medulla (P = 0.008) in case of death. Conclusion ADCmean values during the first week of life in the left hemisphere, vermis, pons and medulla are related to motor outcome or death in infants with HIE either with or without hypothermic therapy. Therefore, this objective tool can be assessed prospectively to determine if it can be used to establish prognosis in the first week of life, particularly in severe cases of HIE.	[Arca-Diaz, Gemma; Figueras-Aloy, Josep] Univ Barcelona, IDIBAPS, Hosp St Joan de Deu, Serv Neonatol,Agrupacio Sanitaria Hosp Clin, Barcelona, Spain; [Re, Thomas J.; Drottar, Marie; De Macedo-Rodrigues, Katyucia; Im, Kiho; Grant, Patricia Ellen] Childrens Hosp Boston, Fetal Neonatal Neuroimaging & Dev Sci Ctr, Boston, MA USA; [Fortuno, Carmen Rosa] Boston Childrens Hosp, Fetal Neonatal Neurol Program, Dept Neurol, Boston, MA USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Arca-Diaz, G (corresponding author), Univ Barcelona, IDIBAPS, Hosp St Joan de Deu, Serv Neonatol,Agrupacio Sanitaria Hosp Clin, Barcelona, Spain.	garca@clinic.ub.es	de Macedo Rodrigues, Katyucia/W-6049-2019; Grant, Peter/HIR-3733-2022	de Macedo Rodrigues, Katyucia/0000-0002-3649-102X; Arca, Gemma/0000-0003-3647-0656; Grant, Patricia/0000-0003-1005-4013; Figueras-Aloy, Josep/0000-0003-1261-8193	Spanish Society of Neonatology; Hospital Clinic of the University of Barcelona; Ralph Schlaeger Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER	Spanish Society of Neonatology; Hospital Clinic of the University of Barcelona; Ralph Schlaeger Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication was made possible by a grant from the Spanish Society of Neonatology (S.E.N.), the support of the Hospital Clinic of the University of Barcelona, and the Ralph Schlaeger Foundation (for support of T.J.Re.).	Alderliesten T, 2011, RADIOLOGY, V261, P235, DOI 10.1148/radiol.11110213; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bednarek N, 2012, NEUROLOGY, V78, P1420, DOI 10.1212/WNL.0b013e318253d589; Cheong JLY, 2012, ARCH PEDIAT ADOL MED, V166, P634, DOI 10.1001/archpediatrics.2012.284; Coats JS, 2009, PEDIATR NEUROL, V41, P263, DOI 10.1016/j.pediatrneurol.2009.04.013; Connolly DJA, 2007, AM J NEURORADIOL, V28, P16; Garcia-Alix A, 2009, AN PEDIATR, V71, P319, DOI 10.1016/j.anpedi.2009.07.021; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Grant PE, 2006, RADIOL CLIN N AM, V44, P63, DOI 10.1016/j.rcl.2005.08.001; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Johnson AJ, 1999, AM J ROENTGENOL, V172, P219, DOI 10.2214/ajr.172.1.9888771; Karaarslan E, 2008, EUR J RADIOL, V65, P402, DOI 10.1016/j.ejrad.2007.04.023; Le Strange E, 2004, AM J NEURORADIOL, V25, P463; LEVENE MI, 1986, LANCET, V1, P67, DOI 10.1016/S0140-6736(86)90718-X; Liauw L, 2009, AM J NEURORADIOL, V30, P264, DOI 10.3174/ajnr.A1318; Lovblad KO, 2003, NEURORADIOLOGY, V45, P400, DOI 10.1007/s00234-003-1009-x; Martinez-Biarge M, 2011, NEUROLOGY, V76, P2055, DOI 10.1212/WNL.0b013e31821f442d; Martinez-Biarge M, 2010, EARLY HUM DEV, V86, P675, DOI 10.1016/j.earlhumdev.2010.08.013; Massaro AN, 2010, J PERINATOL, V30, P596, DOI 10.1038/jp.2010.7; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Nishida M, 2006, NEUROIMAGE, V32, P1041, DOI 10.1016/j.neuroimage.2006.05.020; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pelzer EA, 2013, EUR J NEUROSCI, V38, P3106, DOI 10.1111/ejn.12314; Rutherford M, 2004, PEDIATRICS, V114, P1004, DOI 10.1542/peds.2004-0222; Rutherford M, 2010, EARLY HUM DEV, V86, P351, DOI 10.1016/j.earlhumdev.2010.05.014; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Sener RN, 2001, COMPUT MED IMAG GRAP, V25, P299, DOI 10.1016/S0895-6111(00)00083-5; Shah PS, 2010, SEMIN FETAL NEONAT M, V15, P238, DOI 10.1016/j.siny.2010.02.003; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Soul JS, 2001, PEDIATRICS, V108, P1211, DOI 10.1542/peds.108.5.1211; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tanner SF, 2000, AM J ROENTGENOL, V174, P1643, DOI 10.2214/ajr.174.6.1741643; Twomey E, 2010, PEDIATR RADIOL, V40, P1526, DOI 10.1007/s00247-010-1692-9; van Laerhoven H, 2013, PEDIATRICS, V131, P88, DOI 10.1542/peds.2012-1297; VANNUCCI RC, 1990, PEDIATRICS, V85, P961; Vermeulen RJ, 2008, RADIOLOGY, V249, P631, DOI 10.1148/radiol.2492071581; Ward P, 2006, PEDIATRICS, V117, pE619, DOI 10.1542/peds.2005-0545; Wolf RL, 2001, RADIOLOGY, V218, P825, DOI 10.1148/radiology.218.3.r01fe47825; Zwiener U, 2003, INTENS CARE MED, V29, P2277, DOI 10.1007/s00134-003-2007-5	41	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0178510	10.1371/journal.pone.0178510	http://dx.doi.org/10.1371/journal.pone.0178510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686592	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100005
J	Moyes, AJ; Lamb, RM; Ella-Tongwiis, P; Pushkaran, A; Ahmed, I; Shergill, I; Hughes, SF				Moyes, Alyson Jayne; Lamb, Rebecca May; Ella-Tongwiis, Peter; Pushkaran, Anish; Ahmed, Issam; Shergill, Iqbal; Hughes, Stephen Fon			A pilot study evaluating changes to haematological and biochemical tests after Flexible Ureterorenoscopy for the treatment of kidney stones	PLOS ONE			English	Article							COAGULATION	Background Currently there is limited research documenting the changes in blood parameters, following Flexible Ureterorenoscopy. This study aims to determine whether there are any changes in haematology and biochemistry parameters, following Flexible Ureterorenoscopy for the treatment of kidney stones. Methods 40 consecutive patients aged between 27-87 years (median 49 years) undergoing Flexible Ureterorenoscopy for the treatment of kidney stones were recruited (26 male, 14 female). Blood samples were collected from each patient at four time points: baseline (pre-operatively) followed by 30 minutes, 120 minutes and 240 minutes post-operatively. On these samples, routine haematological and biochemistry tests were carried out. In addition to the assessment of clinical parameters prospectively from the medical notes. Results There was a significant decrease observed following Flexible Ureterorenoscopy in the following parameters: lymphocytes (p = 0.007), eosinophils (p = 0.001), basophils (p = 0.001), haemoglobin (p = 0.002), red blood cells (p = 0.001), platelet count (p = 0.001), fibrinogen concentration (p = 0.001), von Willebrand factor (p = 0.046), C reactive protein (p = 0.01), total protein (p = 0.001), albumin (p = 0.001), globulin (p = 0.001) and alkaline phosphatase (p = 0.001). In addition, there was a significant increase observed in the following parameters: white blood cells (p = 0.001), neutrophils (p = 0.001), activated partial thromboplastin time (p = 0.001), total bilirubin (p = 0.012), creatinine (p = 0.008), sodium (p = 0.002) and potassium (p = 0.001). Limiting factors for this study were the sample size, and restriction on the recruitment time points. Conclusions Significant changes were noted to occur in haematology and biochemistry parameters following Flexible Ureterorenoscopy. Some of the data presented in this study may represent the 'normal' post-operative response following FURS, as no major complications occurred, in the majority of our patients. This data on the 'normal response' will need to be validated but may ultimately aid clinicians in distinguishing patients at risk of complications, if reproduced in larger multi-centre studies.	[Moyes, Alyson Jayne; Lamb, Rebecca May; Ella-Tongwiis, Peter; Hughes, Stephen Fon] Univ Chester, Dept Biol Sci, Chester, Cheshire, England; [Moyes, Alyson Jayne; Lamb, Rebecca May; Ella-Tongwiis, Peter; Pushkaran, Anish; Ahmed, Issam; Shergill, Iqbal; Hughes, Stephen Fon] Wrexham Maelor Hosp, NW2URC, BCUHB, Wrexham, Wales; [Moyes, Alyson Jayne; Lamb, Rebecca May; Ella-Tongwiis, Peter; Pushkaran, Anish; Ahmed, Issam; Shergill, Iqbal; Hughes, Stephen Fon] BCUHB Wrexham Maelor Hosp, Dept Urol, Wrexham, Wales; [Moyes, Alyson Jayne] Bangor Univ, Dept Med Sci, Bangor, Gwynedd, Wales	University of Chester; Bangor University	Hughes, SF (corresponding author), Univ Chester, Dept Biol Sci, Chester, Cheshire, England.; Hughes, SF (corresponding author), Wrexham Maelor Hosp, NW2URC, BCUHB, Wrexham, Wales.; Hughes, SF (corresponding author), BCUHB Wrexham Maelor Hosp, Dept Urol, Wrexham, Wales.	Stephen.hughes@wales.nhs.uk		Moyes, Alyson/0000-0002-5408-7039	Women Graduates, Foundation; University of Chester, Knowledge Transfer Award; Cadwaladr University Health Board; Women Graduates, Foundation; University of Chester, Knowledge Transfer Award; Cadwaladr University Health Board	Women Graduates, Foundation; University of Chester, Knowledge Transfer Award; Cadwaladr University Health Board; Women Graduates, Foundation; University of Chester, Knowledge Transfer Award; Cadwaladr University Health Board	Funds for Women Graduates, Foundation award.http://www.ffwg.org.uk/our-grants.html. Institute of Biomedical Science, Research Award. https://www.ibms.org/learning/prizes-and-awards/. University of Chester, Knowledge Transfer Award. https://www.chester.ac.uk/business-supports ervices/rkt-office. Betsi Cadwaladr University Health Board. All of the named funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghamir SMK, 2008, J ENDOUROL, V22, P2495, DOI 10.1089/end.2008.0319; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Cornu JN, 2016, EUR UROL FOCUS, V2, P49, DOI 10.1016/j.euf.2016.03.014; Global Burden of Disease Study 2013 Collaborators, 2015, COCHRANE DB SYST REV, V386, P743; Handa RK, 2010, BJU INT, V103, P1270; Heers H, 2016, BJU INT, V118, P785, DOI 10.1111/bju.13520; Hirakata H, 1991, ANESTHESIOLOGY, V91, P1361; Hughes SF, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-40; Hughes SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125840; Iba T, 2016, BLOOD REV, V30, P149, DOI 10.1016/j.blre.2015.10.002; Khafagy HF, 2010, HEMATOLOGY, V15, P360, DOI 10.1179/102453310X12647083620886; Lakomkin N, 2016, INJURY, V47, P1217, DOI 10.1016/j.injury.2016.03.004; Lingeman JE, 2006, SURG MANAGEMENT URIN; McAteer JA, 2008, SEMIN NEPHROL, V28, P200, DOI 10.1016/j.semnephrol.2008.01.003; Miller NL, 2007, BMJ-BRIT MED J, V334, P468, DOI 10.1136/bmj.39113.480185.80; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Portis AJ, 2001, AM FAM PHYSICIAN, V63, P1329; Romero V, 2010, REV UROL, V12, P86; Arellano-Buendia AS, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4693801; Samhan Y, 2016, EGYPT J ANAESTH, V32, P45, DOI 10.1016/j.egja.2015.09.014; Skolarikos A, 2015, J UROLOGY, V194, P137, DOI 10.1016/j.juro.2015.01.112; Ternstrom L, 2010, THROMB RES, V126, pE128, DOI 10.1016/j.thromres.2010.05.028; Tseng TY, 2015, BMJ CLINICAL EVIDENC, V6, P89; Turk C, 2014, GUIDELINES UROLITHIA, P7; Ucar HI, 2007, HEART SURG FORUM, V10, pE392, DOI 10.1532/HSF98.20071065; Uguz S, 2016, RENAL FAILURE, V38, P974, DOI 10.3109/0886022X.2016.1172941; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wood Kyle, 2011, Rev Urol, V13, P73	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179599	10.1371/journal.pone.0179599	http://dx.doi.org/10.1371/journal.pone.0179599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683066	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200008
J	Ramilo, DW; Nunes, T; Madeira, S; Boinas, F; da Fonseca, IP				Ramilo, David W.; Nunes, Telmo; Madeira, Sara; Boinas, Fernando; da Fonseca, Isabel Pereira			Geographical distribution of Culicoides (DIPTERA: CERATOPOGONIDAE) in mainland Portugal: Presence/absence modelling of vector and potential vector species	PLOS ONE			English	Article							BLUETONGUE VIRUS; BITING MIDGES; SCHMALLENBERG VIRUS; OBSOLETUS COMPLEX; IMICOLA; ABUNDANCE; EUROPE; SITES; ASSOCIATION; HABITATS	Vector-borne diseases are not only accounted responsible for their burden on human health-care systems, but also known to cause economic constraints to livestock and animal production. Animals are affected directly by the transmitted pathogens and indirectly when animal movement is restricted. Distribution of such diseases depends on climatic and social factors, namely, environmental changes, globalization, trade and unplanned urbanization. Culicoides biting midges are responsible for the transmission of several pathogenic agents with relevant economic impact. Due to a fragmentary knowledge of their ecology, occurrence is difficult to predict consequently, limiting the control of these arthropod vectors. In order to understand the distribution of Culicoides species, in mainland Portugal, data collected during the National Entomologic Surveillance Program for Bluetongue disease (2005 - 2013), were used for statistical evaluation. Logistic regression analysis was preformed and prediction maps (per season) were obtained for vector and potentially vector species. The variables used at the present study were selected from WorldClim (two climatic variables) and CORINE databases (twenty-two land cover variables). This work points to an opposite distribution of C. imicola and species from the Obsoletus group within mainland Portugal. Such findings are evidenced in autumn, with the former appearing in Central and Southern regions. Although appearing northwards, on summer and autumn, C. newsteadi reveals a similar distribution to C. imicola. The species C. punctatus appears in all Portuguese territory throughout the year. Contrary, C. pulicaris is poorly caught in all areas of mainland Portugal, being paradoxical present near coastal areas and higher altitude regions.	[Ramilo, David W.; Nunes, Telmo; Madeira, Sara; Boinas, Fernando; da Fonseca, Isabel Pereira] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, Lisbon, Portugal	Universidade de Lisboa	da Fonseca, IP (corresponding author), Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, Lisbon, Portugal.	ifonseca@fmv.ulisboa.pt	Pereira da Fonseca, I/AAR-2441-2021; Boinas, Fernando/AAD-9779-2022; da Fonseca, Isabel Pereira/AAY-1828-2021	Pereira da Fonseca, I/0000-0002-6632-1224; Boinas, Fernando/0000-0001-6259-4404; Madeira, Sara/0000-0001-5804-9745; Ramilo, David/0000-0003-4096-2581; Nunes, Telmo/0000-0003-4388-5366	National Entomologic Surveillance Program of Culicoides biting midges, vectors of Bluetonguevirus, in National Territory; Direcao Geralde Veterinaria/Faculdade de Medicina Veterinaria, Universidade Tecnica de Lisboa; Centre for Interdisciplinary Research in Animal Health (CIISA); Faculty of Veterinary Medicine, University of Lisbon - FCT [UID/CVT/00276/ 2013]; FCT [SFRH/BD/77268/2011]	National Entomologic Surveillance Program of Culicoides biting midges, vectors of Bluetonguevirus, in National Territory; Direcao Geralde Veterinaria/Faculdade de Medicina Veterinaria, Universidade Tecnica de Lisboa; Centre for Interdisciplinary Research in Animal Health (CIISA); Faculty of Veterinary Medicine, University of Lisbon - FCT; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	National Entomologic Surveillance Program of Culicoides biting midges, vectors of Bluetonguevirus, in National Territory, funded by Direcao Geralde Veterinaria/Faculdade de Medicina Veterinaria, Universidade Tecnica de Lisboa. Centre for Interdisciplinary Research in Animal Health (CIISA), Faculty of Veterinary Medicine, University of Lisbon, through the Projects UID/CVT/00276/ 2013 (funded by FCT). FCT Grant SFRH/BD/77268/2011.	[Anonymous], 2009, ENTOMOL FENNICA, V20, P228; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Boavida J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36460; Boorman J., 1989, Fauna of Saudi Arabia, V10, P160; BRAVERMAN Y, 1977, RHOD J AGR RES, V15, P101; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; Caracappa S, 2003, VET REC, V153, P71, DOI 10.1136/vr.153.3.71; Carpenter S, 2008, MED VET ENTOMOL, V22, P175, DOI 10.1111/j.1365-2915.2008.00743.x; Chalghaf B, 2016, AM J TROP MED HYG, V94, P844, DOI 10.4269/ajtmh.15-0345; Conraths FJ, 2013, NEW ZEAL VET J, V61, P63, DOI 10.1080/00480169.2012.738403; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Dzhafarov SM, 1976, CAIRO FRANKLIN BOOK; Europaea Fauna, 2015, CUL PUL DISTR; European Food Safety Authority, 2007, EFSA J, V479, P1; Falconi C, 2011, VET MICROBIOL, V151, P209, DOI 10.1016/j.vetmic.2011.02.011; Fish D, 1996, ADV ASTRONAUT SCI, V91, P1057; Foxi C, 2010, MED VET ENTOMOL, V24, P199, DOI 10.1111/j.1365-2915.2010.00861.x; Goffredo M, 2015, VET ITAL, V51, P131, DOI 10.12834/VetIt.771.3854.1; Gonzalez de Heredia M.G., 2011, GENERO CULICOIDES PA; Gonzalez M, 2013, VET PARASITOL, V191, P81, DOI 10.1016/j.vetpar.2012.08.025; Guichard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112491; Ippoliti C, 2013, GEOSPATIAL HEALTH, V8, P267, DOI 10.4081/gh.2013.72; KETTLE DS, 1952, B ENTOMOL RES, V43, P421, DOI 10.1017/S000748530002945X; KONURBAYEV E O, 1965, ENTOMOL REV (ENGL TRANSL ENTOMOL OBOZR), V44, P75; Lemon SM, 2008, VECTOR BORNE DISEASE; Maclachlan NJ, 2013, ANTIVIR RES, V99, P79, DOI 10.1016/j.antiviral.2013.04.021; Meiswinkel R., 2004, Infectious diseases of livestock, Volume One, P93; Meiswinkel R, 2014, VET PARASITOL, V207, P324; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Meneguzzi VC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164580; Miranda MA, 2003, MED VET ENTOMOL, V17, P52, DOI 10.1046/j.1365-2915.2003.00405.x; Nevill E.M, 1967, THESIS; Nevill H, 2007, ONDERSTEPOORT J VET, V74, P97; Ninio C, 2011, PARASITOL RES, V108, P657, DOI 10.1007/s00436-010-2110-9; Osburn B., 2008, VECTORBORNE DIS UNDE, P190; Pena I., 2003, THESIS; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Ramilo DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034896; Ribeiro R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124019; Romon P, 2012, VET PARASITOL, V186, P415, DOI 10.1016/j.vetpar.2011.11.023; Santiago-Alarcon D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031098; Savini G, 2005, VET REC, V157, P133, DOI 10.1136/vr.157.5.133; Schultz J., 2005, ECOZONES WORLD ECOLO, V2; Scolamacchia F, 2014, MED VET ENTOMOL, V28, P143, DOI 10.1111/mve.12028; Slama D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120528; Steinke S, 2015, VET PARASITOL, V209, P146, DOI 10.1016/j.vetpar.2015.01.027; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Talavera S, 2015, PLOS ONE, V10, DOI [10.1371/journ, 10.1371/journal.pone.0141667]; Vanbinst T, 2009, TRANSBOUND EMERG DIS, V56, P170, DOI 10.1111/j.1865-1682.2009.01077.x; Verhoef FA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-384; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Zimmer JY, 2014, VET PARASITOL, V205, P676, DOI 10.1016/j.vetpar.2014.08.029; Zimmer JY, 2013, ANN SOC ENTOMOL FR, V49, P335, DOI 10.1080/00379271.2013.854100	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180606	10.1371/journal.pone.0180606	http://dx.doi.org/10.1371/journal.pone.0180606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683145	Green Submitted, gold, Green Published			2022-12-27	WOS:000405335200053
J	Aziz, O; Klenk, J; Schwickert, L; Chiari, L; Becker, C; Park, EJ; Mori, G; Robinovitch, SN				Aziz, Omar; Klenk, Jochen; Schwickert, Lars; Chiari, Lorenzo; Becker, Clemens; Park, Edward J.; Mori, Greg; Robinovitch, Stephen N.			Validation of accuracy of SVM-based fall detection system using real-world fall and non-fall datasets	PLOS ONE			English	Article							EMERGENCY RESPONSE SYSTEMS; ALGORITHMS; INABILITY; PEOPLE	Falls are a major cause of injuries and deaths in older adults. Even when no injury occurs, about half of all older adults who fall are unable to get up without assistance. The extended period of lying on the floor often leads to medical complications, including muscle damage, dehydration, anxiety and fear of falling. Wearable sensor systems incorporating accelerometers and/or gyroscopes are designed to prevent long lies by automatically detecting and alerting care providers to the occurrence of a fall. Research groups have reported up to 100% accuracy in detecting falls in experimental settings. However, there is a lack of studies examining accuracy in the real-world setting. In this study, we examined the accuracy of a fall detection system based on real-world fall and non-fall data sets. Five young adults and 19 older adults went about their daily activities while wearing tri-axial accelerometers. Older adults experienced 10 unanticipated falls during the data collection. Approximately 400 hours of activities of daily living were recorded. We employed a machine learning algorithm, Support Vector Machine (SVM) classifier, to identify falls and non-fall events. We found that our system was able to detect 8 out of the 10 falls in older adults using signals from a single accelerometer (waist or sternum). Furthermore, our system did not report any false alarm during approximately 28.5 hours of recorded data from young adults. However, with older adults, the false positive rate among individuals ranged from 0 to 0.3 false alarms per hour. While our system showed higher fall detection and substantially lower false positive rate than the existing fall detection systems, there is a need for continuous efforts to collect realworld data within the target population to perform fall validation studies for fall detection systems on bigger real-world fall and non-fall datasets.	[Aziz, Omar; Robinovitch, Stephen N.] Simon Fraser Univ, Injury Prevent & Mobil Lab, Burnaby, BC, Canada; [Aziz, Omar; Robinovitch, Stephen N.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada; [Aziz, Omar; Park, Edward J.] Simon Fraser Univ, Sch Mechatron Syst Engn, Surrey, BC, Canada; [Klenk, Jochen; Schwickert, Lars; Becker, Clemens] Robert Bosch Krankenhaus, Dept Clin Gerontol, Stuttgart, Germany; [Klenk, Jochen] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Chiari, Lorenzo] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Bologna, Italy; [Mori, Greg] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada; [Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada	Simon Fraser University; Simon Fraser University; Simon Fraser University; Bosch; Robert Bosch Krankenhaus; Ulm University; University of Bologna; Simon Fraser University; Simon Fraser University	Aziz, O (corresponding author), Simon Fraser Univ, Injury Prevent & Mobil Lab, Burnaby, BC, Canada.; Aziz, O (corresponding author), Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada.; Aziz, O (corresponding author), Simon Fraser Univ, Sch Mechatron Syst Engn, Surrey, BC, Canada.	oaziz@sfu.ca	Klenk, Jochen/C-2164-2012; Klenk, Jochen/R-3614-2019; Chiari, Lorenzo/N-7622-2015; Becker, Clemens/ABI-5405-2020; PAN, ZEQIANG/X-6341-2018	Klenk, Jochen/0000-0002-5987-447X; Chiari, Lorenzo/0000-0002-2318-4370; Robinovitch, Stephen/0000-0003-3881-6227	Mitacs; Canadian Institutes of Health Research [AMG-100487, TIR-103945]; Canada Research Chairs program	Mitacs; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by Mitacs and team grants from the Canadian Institutes of Health Research (funding reference numbers: AMG-100487 and TIR-103945). SNR was also supported by the Canada Research Chairs program. The funding agencies had no direct role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Aziz O, 2017, MED BIOL ENG COMPUT, V55, P45, DOI 10.1007/s11517-016-1504-y; Bailly S, 2014, MATURITAS, V79, P334, DOI 10.1016/j.maturitas.2014.07.017; Bourke AK, 2010, J BIOMECH, V43, P3051, DOI 10.1016/j.jbiomech.2010.07.005; Bourke AK, 2008, IEEE ENG MED BIO, P2844, DOI 10.1109/IEMBS.2008.4649795; Boyle J, 2008, IEEE ENG MED BIO, P1274, DOI 10.1109/IEMBS.2008.4649396; Chen J, 2005, P ANN INT IEEE EMBS, P3551, DOI 10.1109/IEMBS.2005.1617246; Chih-Chung C, ACM T INTELL SYST TE, V2, P1; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Diaz A, 2004, P ANN INT IEEE EMBS, V26, P2180; Fleming J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2227; Heinbuchner B, 2010, Z GERONTOL GERIATR, V43, P219, DOI 10.1007/s00391-010-0127-4; Kangas M, 2007, P ANN INT IEEE EMBS, P1367, DOI 10.1109/IEMBS.2007.4352552; Kangas M, 2008, GAIT POSTURE, V28, P285, DOI 10.1016/j.gaitpost.2008.01.003; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; Lee Y, 2007, P ANN INT IEEE EMBS, P2315, DOI 10.1109/IEMBS.2007.4352789; LEVINE DA, 1995, MT SINAI J MED, V62, P293; Lipsitz LA, 2016, J AM GERIATR SOC, V64, P365, DOI 10.1111/jgs.13708; Liu SH, 2012, SENSORS-BASEL, V12, P12301, DOI 10.3390/s120912301; MALLINSON WJW, 1985, AGE AGEING, V14, P174, DOI 10.1093/ageing/14.3.174; Mann WC, 2005, ASSIST TECHNOL, V17, P82, DOI 10.1080/10400435.2005.10132098; Quagliarella L, 2008, GAIT POSTURE, V28, P699, DOI 10.1016/j.gaitpost.2008.04.011; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; ROUSH RE, 1995, SOUTHERN MED J, V88, P917, DOI 10.1097/00007611-199509000-00006; Tan MP, 2015, GERIATRICS GERONTOLO; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65	26	44	47	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180318	10.1371/journal.pone.0180318	http://dx.doi.org/10.1371/journal.pone.0180318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678808	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200051
J	Kaniak-Golik, A; Kuberska, R; Dzierzbicki, P; Sledziewska-Gojska, E				Kaniak-Golik, Aneta; Kuberska, Renata; Dzierzbicki, Piotr; Sledziewska-Gojska, Ewa			Activation of Dun1 in response to nuclear DNA instability accounts for the increase in mitochondrial point mutations in Rad27/FEN1 deficient S. cerevisiae	PLOS ONE			English	Article							DAMAGE-INDUCIBLE GENE; BASE EXCISION-REPAIR; OKAZAKI FRAGMENT MATURATION; LARGE RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; MISMATCH REPAIR; RIBONUCLEOTIDE REDUCTASE; YEAST MITOCHONDRIA; IMAGE-ANALYSIS; RESISTANCE MUTATIONS	Rad27/FEN1 nuclease that plays important roles in the maintenance of DNA stability in the nucleus has recently been shown to reside in mitochondria. Accordingly, it has been established that Rad27 deficiency causes increased mutagenesis, but decreased microsatellite instability and homologous recombination in mitochondria. Our current analysis of mutations leading to erythromycin resistance indicates that only some of them arise in mitochondrial DNA and that the GC! AT transition is a hallmark of the mitochondrial mutagenesis in rad27 null background. We also show that the mitochondrial mutator phenotype resulting from Rad27 deficiency entirely depends on the DNA damage checkpoint kinase Dun1. DUN1 inactivation suppresses the mitochondrial mutator phenotype caused by Rad27 deficiency and this suppression is eliminated at least in part by subsequent deletion of SML1 encoding a repressor of ribonucleotide reductase. We conclude that Rad27 deficiency causes a mitochondrial mutator phenotype via activation of DNA damage checkpoint kinase Dun1 and that a Dun1-mediated increase of dNTP pools contributes to this phenomenon. These results point to the nuclear DNA instability as the source of mitochondrial mutagenesis. Consistently, we show that mitochondrial mutations occurring more frequently in yeast devoid of Rrm3, a DNA helicase involved in rDNA replication, are also dependent on Dun1. In addition, we have established that overproduction of Exo1, which suppresses DNA damage sensitivity and replication stress in nuclei of Rad27 deficient cells, but does not enter mitochondria, suppresses the mitochondrial mutagenesis. Exo1 overproduction restores also a great part of allelic recombination and microsatellite instability in mitochondria of Rad27 deficient cells. In contrast, the overproduction of Exo1 does not influence mitochondrial direct-repeat mediated deletions in rad27 null background, pointing to this homologous recombination pathway as the direct target of Rad27 activity in mitochondria.	[Kaniak-Golik, Aneta; Kuberska, Renata; Dzierzbicki, Piotr; Sledziewska-Gojska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Kaniak-Golik, A; Sledziewska-Gojska, E (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	aneta.kaniak@gmail.com; esg@ibb.waw.pl	Kaniak-Golik, Aneta/CAF-8607-2022; Sledziewska-Gojska, Ewa/C-7831-2013	Sledziewska-Gojska, Ewa/0000-0001-8409-0864; Kaniak-Golik, Aneta/0000-0003-4027-6282	National Science Center in Poland [2012/07/B/NZ3/02914]	National Science Center in Poland(National Science Centre, Poland)	This work was supported by the grant 2012/07/B/NZ3/02914 from the National Science Center (https//www.ncn.gov.pl/) in Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002; Amberg DC., 2005, METHODS YEAST GENETI; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023; Becker JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005659; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; Boldogh IR, 2007, METHOD CELL BIOL, V80, P45, DOI 10.1016/S0091-679X(06)80002-6; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Dmowski M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006572; Dzierzbicki P, 2012, MUTAT RES-FUND MOL M, V740, P21, DOI 10.1016/j.mrfmmm.2012.12.004; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Fikus MU, 2000, GENETICS, V154, P73; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; GASSER SM, 1982, J BIOL CHEM, V257, P3034; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Halas A, 2016, MUTAT RES-FUND MOL M, V791, P10, DOI 10.1016/j.mrfmmm.2016.08.001; Hendry JA, 2015, G3-GENES GENOM GENET, V5, P997, DOI 10.1534/g3.115.016576; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Johnson RE, 1998, CURR GENET, V34, P21, DOI 10.1007/s002940050362; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Johnston M, 2002, METHOD ENZYMOL, V350, P290, DOI 10.1016/S0076-6879(02)50970-8; Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005; Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008; Kaniak A, 2009, DNA REPAIR, V8, P318, DOI 10.1016/j.dnarep.2008.11.004; Karanja KK, 2009, GENETICS, V183, P63, DOI 10.1534/genetics.109.103937; Karniely S, 2006, EXP CELL RES, V312, P3835, DOI 10.1016/j.yexcr.2006.08.021; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; Koprowski P, 2003, MOL GENET GENOMICS, V269, P632, DOI 10.1007/s00438-003-0873-8; Koprowski P, 2002, MOL GENET GENOMICS, V266, P988, DOI 10.1007/s00438-001-0621-x; Kreutzer DA, 1998, P NATL ACAD SCI USA, P95; Krol K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120702; LANCASHIRE WE, 1979, MOL GEN GENET, V170, P333, DOI 10.1007/BF00267067; Lewis LK, 2002, GENETICS, V160, P49; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McIntyre J, 2007, CURR GENET, V52, P221, DOI 10.1007/s00294-007-0156-8; Mieczkowski PA, 1997, MOL GEN GENET, V253, P655, DOI 10.1007/s004380050369; Mookerjee SA, 2005, CURR GENET, V47, P84, DOI 10.1007/s00294-004-0537-1; Moreau S, 2001, GENETICS, V159, P1423; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; O'Rourke TW, 2005, GENE, V354, P86, DOI 10.1016/j.gene.2005.03.031; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petrova VY, 2004, BIOCHEM J, V380, P393, DOI 10.1042/BJ20040042; Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Richard GF, 1999, MOL GEN GENETICS MGG, V261, P725; Sakamoto AN, 2007, DNA REPAIR, V6, P1829, DOI 10.1016/j.dnarep.2007.07.002; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; SCHIESTL RH, 1989, NATURE, V337, P285, DOI 10.1038/337285a0; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Sia EA, 2000, P NATL ACAD SCI USA, V97, P250, DOI 10.1073/pnas.97.1.250; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; SLEDZIEWSKA E, 1980, MUTAT RES, V70, P11, DOI 10.1016/0027-5107(80)90053-6; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313; SOR F, 1982, NUCLEIC ACIDS RES, V10, P6571, DOI 10.1093/nar/10.21.6571; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Stein A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005664; Strand Micheline K, 2002, Methods Mol Biol, V197, P151, DOI 10.1385/1-59259-284-8:151; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003; Styles C, 2002, METHOD ENZYMOL, V350, P42, DOI 10.1016/S0076-6879(02)50955-1; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; Sun X.-y., 2003, CHINA TEXTILE LEADER, V2, P40; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Szczepanowska K, 2015, BBA-BIOENERGETICS, V1847, P1362, DOI 10.1016/j.bbabio.2015.05.016; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Tang HMV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000697; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran PT, 2007, DNA REPAIR, V6, P1572, DOI 10.1016/j.dnarep.2007.05.004; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Williams EH, 2007, GENETICS, V175, P1117, DOI 10.1534/genetics.106.064576; Wu XH, 1999, NUCLEIC ACIDS RES, V27, P956, DOI 10.1093/nar/27.4.956; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; Yonekura SI, 2009, J RADIAT RES, V50, P19, DOI 10.1269/jrr.08080; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	105	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180153	10.1371/journal.pone.0180153	http://dx.doi.org/10.1371/journal.pone.0180153			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678842	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200039
J	Dornhof, R; Maschowski, C; Osipova, A; Giere, R; Seidl, M; Merfort, I; Humar, M				Dornhof, Regina; Maschowski, Christoph; Osipova, Anastasiya; Giere, Reto; Seidl, Maximilian; Merfort, Irmgard; Humar, Matjaz			Stress fibers, autophagy and necrosis by persistent exposure to PM2.5 from biomass combustion	PLOS ONE			English	Article							HOUSEHOLD AIR-POLLUTION; LUNG EPITHELIAL-CELLS; ELONGATION FACTOR-II; HEAT-SHOCK PROTEINS; P38 MAP KINASE; PARTICULATE MATTER; ACTIN DYNAMICS; WOOD SMOKE; MECHANISMS; PHOSPHORYLATION	Fine particulate matter (PM2.5) can adversely affect human health. Emissions from residential energy sources have the largest impact on premature mortality globally, but their pathological and molecular implications on cellular physiology are still elusive. In the present study potential molecular consequences were investigated during long-term exposure of human bronchial epithelial BEAS-2B cells to PM2.5, collected from a biomass power plant. Initially, we observed that PM2.5 did not affect cellular survival or proliferation. However, it triggered an activation of the stress response p38 MAPK which, along with RhoA GTPase and HSP27, mediated morphological changes in BEAS-2B cells, including actin cytoskeletal rearrangements and paracellular gap formation. The p38 inhibitor SB203580 prevented phosphorylation of HSP27 and ameliorated morphological changes. During an intermediate phase of long-term exposure, PM2.5 triggered proliferative regression and activation of an adaptive stress response necessary to maintain energy homeostasis, including AMPK, repression of translational elongation, and autophagy. Finally, accumulation of intracellular PM2.5 promoted lysosomal destabilization and cell death, which was dependent on lysosomal hydrolases and p38 MAPK, but not on the inflammasome and pyroptosis. TEM images revealed formation of protrusions and cellular internalization of PM2.5, induction of autophagosomes, amphisomes, autophagosome-lysosomal fusion, multiple compartmental fusion, lysosomal burst, swollen mitochondria and finally necrosis. In consequence, persistent exposure to PM2.5 may impair epithelial barriers and reduce regenerative capacity. Hence, our results contribute to a better understanding of PM-associated lung and systemic diseases on the basis of molecular events.	[Dornhof, Regina; Osipova, Anastasiya; Merfort, Irmgard; Humar, Matjaz] Albert Ludwigs Univ Freiburg, Inst Pharmaceut Sci Pharmaceut Biol & Biotechnol, Freiburg, Germany; [Maschowski, Christoph] Albert Ludwigs Univ Freiburg, Inst Earth & Environm Sci, Freiburg, Germany; [Giere, Reto] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Giere, Reto] Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Seidl, Maximilian] Albert Ludwigs Univ Freiburg, Inst Surg Pathol, Fac Med, Freiburg, Germany; [Seidl, Maximilian] Albert Ludwigs Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency CCI, Freiburg, Germany; [Merfort, Irmgard] Albert Ludwigs Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Pennsylvania; University of Pennsylvania; University of Freiburg; University of Freiburg; University of Freiburg	Merfort, I; Humar, M (corresponding author), Albert Ludwigs Univ Freiburg, Inst Pharmaceut Sci Pharmaceut Biol & Biotechnol, Freiburg, Germany.; Merfort, I (corresponding author), Albert Ludwigs Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany.	irmgard.merfort@pharmazie.uni-freiburg.de; matjaz.humar@pharmazie.uni-freiburg.de	Seidl, Maxmilian/ABF-3322-2021	Seidl, Maxmilian/0000-0002-5559-4980; Giere, Reto/0000-0001-8507-1956; Maschowski, Christoph/0000-0003-4211-3700	EU; Interreg IV Program ''Oberrhein'' [C35 BIOCOMBUST]; National Institute of Environmental Health Sciences [P30-ES13508]; German Research Foundation (DFG); University of Freiburg; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	EU(European Commission); Interreg IV Program ''Oberrhein''; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The presented work is part of aninter disciplinary EU-funded research project (seehttp : //www.biocombust.eu), supported in part by the Interreg IV Program ''Oberrhein'' (project C35 BIOCOMBUST).This work was also supported in part by the National Institute of Environmental Health Sciences (P30-ES13508). Thearticle processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; [Anonymous], 2016, HOUS AIR POLL HLTH I; Boutilier RG, 2000, COMP BIOCHEM PHYS A, V126, P481, DOI 10.1016/S1095-6433(00)00234-8; Cao DS, 2010, AM J RESP CELL MOL, V42, P88, DOI 10.1165/rcmb.2008-0455OC; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Carroll B, 2017, BIOCHEM J, V474, P1453, DOI 10.1042/BCJ20160780; D'Anna C, 2015, LIFE SCI, V126, P10, DOI 10.1016/j.lfs.2015.01.017; Deng XB, 2014, APOPTOSIS, V19, P1099, DOI 10.1007/s10495-014-0980-5; Desai S, 2013, CELL SIGNAL, V25, P1780, DOI 10.1016/j.cellsig.2013.05.025; Dilger M, 2016, ARCH TOXICOL, V90, P3029, DOI 10.1007/s00204-016-1659-1; Duan JC, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0050-8; Duch A, 2012, FEBS LETT, V586, P2925, DOI 10.1016/j.febslet.2012.07.034; Ebeling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086147; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Guay J, 1997, J CELL SCI, V110, P357; Guicciardi ME, 2013, CELL CYCLE, V12, P1995, DOI 10.4161/cc.25317; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Herd HL, 2011, J CONTROL RELEASE, V153, P40, DOI 10.1016/j.jconrel.2011.02.017; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kim HP, 2008, AUTOPHAGY, V4, P887, DOI 10.4161/auto.6767; Kim KH, 2011, J HAZARD MATER, V192, P425, DOI 10.1016/j.jhazmat.2011.05.087; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Landry J, 1995, BIOCHEM CELL BIOL, V73, P703, DOI 10.1139/o95-078; Lehane C, 2013, J PHARMACOL EXP THER, V347, P781, DOI 10.1124/jpet.113.205989; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Mizumura K, 2012, CHEST, V142, P1289, DOI 10.1378/chest.12-0809; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Muala A, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0111-7; Ovrevik J, 2015, BIOMOLECULES, V5, P1399, DOI 10.3390/biom5031399; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Schweitzer KS, 2011, AM J PHYSIOL-LUNG C, V301, pL836, DOI 10.1152/ajplung.00385.2010; Schwer CI, 2013, INT J BIOCHEM CELL B, V45, P201, DOI 10.1016/j.biocel.2012.09.020; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stern ST, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-20; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tao ZM, 2009, CHEM RES TOXICOL, V22, P1869, DOI 10.1021/tx900276u; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Veljkovic E, 2011, TOXICOL IN VITRO, V25, P446, DOI 10.1016/j.tiv.2010.11.011; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Yao XF, 2014, FOOD CHEM TOXICOL, V67, P96, DOI 10.1016/j.fct.2014.02.017	55	22	24	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180291	10.1371/journal.pone.0180291	http://dx.doi.org/10.1371/journal.pone.0180291			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671960	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500039
J	Lahey, KA; Ronaghan, NJ; Shang, J; Dion, SP; Desilets, A; Leduc, R; MacNaughton, WK				Lahey, Kelcie A.; Ronaghan, Natalie J.; Shang, Judie; Dion, Sebastien P.; Desilets, Antoine; Leduc, Richard; MacNaughton, Wallace K.			Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; KINASE C-ZETA; TIGHT JUNCTIONS; FACTOR-ALPHA; CELLS; PHOSPHORYLATION; ACTIVATION; OCCLUDIN; PROTEIN; MATRIPTASE	Changes in barrier function of the gastrointestinal tract are thought to contribute to the inflammatory bowel diseases Crohn's disease and ulcerative colitis. Previous work in our lab demonstrated that apical exposure of intestinal epithelial cell lines to serine proteases results in an increase in transepithelial electrical resistance (TER). However, the underlying mechanisms governing this response are unclear. We aimed to determine the requirement for proteolytic activity, epidermal growth factor receptor (EGFR) activation, and downstream intracellular signaling in initiating and maintaining enhanced barrier function following protease treatment using a canine intestinal epithelial cell line (SCBN). We also examined the role of phosphorylation of myosin regulatory light chain on the serine protease-induced increase in TER through. It was found that proteolytic activity of the serine proteases trypsin and matriptase is required to initiate and maintain the protease-mediated increase in TER. We also show that MMP-independent EGFR activation is essential to the sustained phase of the protease response, and that Src kinases may mediate EGFR transactivation. PI3-K and ERK1/2 signaling were important in reaching a maximal increase in TER following protease stimulation; however, their upstream activators are yet to be determined. CK2 inhibition prevented the increase in TER induced by serine proteases. The bradykinin B(2) receptor was not involved in the change in TER in response to serine proteases, and no change in phosphorylation of MLC was observed after trypsin or matriptase treatment. Taken together, our data show a requirement for ongoing proteolytic activity, EGFR transactivation, as well as downstream PI3-K, ERK1/2, and CK2 signaling in protease-mediated barrier enhancement of intestinal epithelial cells. The pathways mediating enhanced barrier function by proteases may be novel therapeutic targets for intestinal disorders characterized by disrupted epithelial barrier function.	[Lahey, Kelcie A.; Ronaghan, Natalie J.; Shang, Judie; MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Dion, Sebastien P.; Desilets, Antoine; Leduc, Richard] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ, Canada	University of Calgary; University of Sherbrooke	MacNaughton, WK (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.	wmacnaug@ucalgary.ca		Leduc, Richard/0000-0001-6854-8003; MacNaughton, Wallace/0000-0002-7050-666X; Desilets, Antoine/0000-0001-5081-5564	Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council (Canada); Natural Sciences	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences	This work was supported by a grant to WKM from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca). NJR was the recipient of a studentship from the Natural Sciences and Engineering Research Council (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chen M, 2008, BBA-MOL CELL RES, V1783, P896, DOI 10.1016/j.bbamcr.2007.10.019; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Dey M, 2010, J PHARMACOL EXP THER, V334, P775, DOI 10.1124/jpet.110.168054; Dorfel MJ, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-40; Dorfel MJ, 2012, ANN NY ACAD SCI, V1257, P38, DOI 10.1111/j.1749-6632.2012.06536.x; Dorfel MJ, 2009, ANN NY ACAD SCI, V1165, P69, DOI 10.1111/j.1749-6632.2009.04043.x; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Fletcher SJ, 2014, BIOCHEM SOC T, V42, P195, DOI 10.1042/BST20130162; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Ganz ML, 2016, INFLAMM BOWEL DIS, V22, P1032, DOI 10.1097/MIB.0000000000000742; Garcia-Hernandez V, 2014, J CELL PHYSL; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Hecquet C, 2000, MOL PHARMACOL, V58, P828, DOI 10.1124/mol.58.4.828; Jain S, 2011, BIOCHEM J, V437, P289, DOI 10.1042/BJ20110587; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; LEE DC, 1985, NATURE, V313, P489, DOI 10.1038/313489a0; Li N, 2009, J NUTR, V139, P710, DOI 10.3945/jn.108.101485; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Liu PCC, 2006, CANCER BIOL THER, V5, P657, DOI 10.4161/cbt.5.6.2708; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; Marcon R, 2013, BRIT J PHARMACOL, V168, P389, DOI 10.1111/j.1476-5381.2012.02136.x; Myhre GM, 2004, AM J PHYSIOL-GASTR L, P1213; Netzel-Arnett S, 2012, INFLAMM BOWEL DIS, V18, P1303, DOI 10.1002/ibd.21930; Nusrat A, 2000, J CELL SCI, V113, P1771; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Ronaghan NJ, 2016, AM J PHYSIOL-GASTR L, V311, pG466, DOI 10.1152/ajpgi.00441.2015; Samak G, 2011, AM J PHYSIOL-GASTR L, V301, pG50, DOI 10.1152/ajpgi.00494.2010; Samak G, 2015, BIOCHEM J, V465, P503, DOI 10.1042/BJ20140450; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Singh AB, 2004, J BIOL CHEM, V279, P3543, DOI 10.1074/jbc.M308682200; Smales C, 2003, FEBS LETT, V545, P161, DOI 10.1016/S0014-5793(03)00525-8; Smyth D, 2012, CELL MICROBIOL; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Swystun V, 2005, AM J PHYSIOL-LUNG C, V288, pL820, DOI 10.1152/ajplung.00396.2004; Swystun VA, 2009, AM J PHYSIOL-GASTR L, V297, pG60, DOI 10.1152/ajpgi.00096.2009; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wang LH, 2014, J BIOL CHEM, V289, P20234, DOI 10.1074/jbc.M114.553800; Yan F, 2013, J BIOL CHEM, V288, P30742, DOI 10.1074/jbc.M113.492397; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zha JM, 2016, GENE, V588, P1, DOI 10.1016/j.gene.2016.04.048	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180259	10.1371/journal.pone.0180259	http://dx.doi.org/10.1371/journal.pone.0180259			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671992	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500035
J	Rovetto, F; Carlier, A; Van den Abeele, AM; Illeghems, K; Van Nieuwerburgh, F; Cocolin, L; Houf, K				Rovetto, Francesca; Carlier, Aurelien; Van den Abeele, Anne-Marie; Illeghems, Koen; Van Nieuwerburgh, Filip; Cocolin, Luca; Houf, Kurt			Characterization of the emerging zoonotic pathogen Arcobacter thereius by whole genome sequencing and comparative genomics	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI; SP NOV.; HEPTOSYLTRANSFERASE-I; GENE; IDENTIFICATION; PROTEIN; OPERON; TOOL; POLYSACCHARIDE; MECHANISMS	Four Arcobacter species have been associated with human disease, and based on current knowledge, these Gram negative bacteria are considered as potential food and waterborne zoonotic pathogens. At present, only the genome of the species Arcobacter butzleri has been analysed, and still little is known about their physiology and genetics. The species Arcobacter thereius has first been isolated from tissue of aborted piglets, duck and pig faeces, and recently from stool of human patients with enteritis. In the present study, the complete genome and analysis of the A. thereius type strain LMG24486(T), as well as the comparative genome analysis with 8 other A. thereius strains are presented. Genome analysis revealed metabolic pathways for the utilization of amino acids, which represent the main source of energy, together with the presence of genes encoding for respiration-associated and chemotaxis proteins. Comparative genome analysis with the A. butzleri type strain RM4018 revealed a large correlation, though also unique features. Furthermore, in silico DDH and ANI based analysis of the nine A. thereius strains disclosed clustering into two closely related genotypes. No discriminatory differences in genome content nor phenotypic behaviour were detected, though recently the species Arcobacter porcinus was proposed to encompass part of the formerly identified Arcobacter thereius strains. The report of the presence of virulence associated genes in A. thereius, the presence of antibiotic resistance genes, verified by in vitro susceptibility testing, as well as other pathogenic related relevant features, support the classification of A. thereius as an emerging pathogen.	[Rovetto, Francesca; Illeghems, Koen; Houf, Kurt] Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Salisburylaan 133, Merelbeke, Belgium; [Rovetto, Francesca; Cocolin, Luca] Univ Torino, Dept Forestry Agr & Food Sci, Largo Braccini 2, Grugliasco, Italy; [Carlier, Aurelien] Univ Ghent, Fac Sci, Microbiol Lab, KL Ledeganckstr 35, Ghent, Belgium; [Van den Abeele, Anne-Marie] St Lucas Hosp, Microbiol Lab, Groenebriel 1, Ghent, Belgium; [Van Nieuwerburgh, Filip] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, Harelbekestr 72, Ghent, Belgium	Ghent University; University of Turin; Ghent University; Ghent University; Ghent University	Houf, K (corresponding author), Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Salisburylaan 133, Merelbeke, Belgium.	Kurt.houf@UGent.be	Houf, Kurt/AAC-4027-2019; Cocolin, Luca/H-5091-2012; Carlier, Aurelien/M-9671-2016; Van Nieuwerburgh, Filip/H-9697-2015	Houf, Kurt/0000-0002-0909-7756; Cocolin, Luca/0000-0003-4799-7074; Carlier, Aurelien/0000-0001-7565-1586; Van Nieuwerburgh, Filip/0000-0001-8815-5485	joint PhD grant of Ghent University; Ghent University research Council [BOF2013-01SF1613]	joint PhD grant of Ghent University; Ghent University research Council(Ghent University)	FR is funded by a joint PhD grant of Ghent University, in collaboration with the University of Torino. Grant is provided by the Ghent University research Council with reference: BOF2013-01SF1613. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbaqi K, 2007, FEMS IMMUNOL MED MIC, V49, P337, DOI 10.1111/j.1574-695X.2006.00208.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berg JM, 2002, CITRIC ACID CYCLE IS; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bruen T., 2005, PHIPACK PHI TEST OTH; Bunkova L, 2010, FOOD CHEM, V121, P203, DOI 10.1016/j.foodchem.2009.12.012; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carattoli A, 2002, FEMS MICROBIOL LETT, V214, P87, DOI 10.1111/j.1574-6968.2002.tb11329.x; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Centres for Disease Control and Prevention (CDCP), 2012, NAT ANT RES MON SYST, V104, P75, DOI [10.1093/infdis/jis901, DOI 10.1093/INFDIS/JIS901]; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Smet S, 2011, APPL ENVIRON MICROB, V77, P1732, DOI 10.1128/AEM.02409-10; Dhillon BK, 2013, NUCLEIC ACIDS RES, V41, pW129, DOI 10.1093/nar/gkt394; DIORIO C, 1995, J BACTERIOL, V177, P2050, DOI 10.1128/jb.177.8.2050-2056.1995; Douidah L, 2014, FOODBORNE PATHOG DIS, V11, P272, DOI 10.1089/fpd.2013.1661; Douidah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085487; Douidah L, 2012, J CLIN MICROBIOL, V50, P735, DOI 10.1128/JCM.05872-11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; Figueras M. J., 2017, New Microbes and New Infections, V15, P104, DOI 10.1016/j.nmni.2016.11.014; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Guccione E, 2008, MOL MICROBIOL, V69, P77, DOI 10.1111/j.1365-2958.2008.06263.x; Guo BQ, 2008, J BACTERIOL, V190, P1879, DOI 10.1128/JB.01796-07; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Ho HTK, 2006, VET MICROBIOL, V115, P1, DOI 10.1016/j.vetmic.2006.03.004; Houf K, 2009, INT J SYST EVOL MICR, V59, P2599, DOI 10.1099/ijs.0.006650-0; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iovine NM, 2013, VIRULENCE, V4, P230, DOI 10.4161/viru.23753; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Kehrenberg C, 2005, ANTIMICROB AGENTS CH, V49, P3046, DOI 10.1128/AAC.49.7.3046-3049.2005; Kelly DJ, 2001, J APPL MICROBIOL, V90, p16S, DOI 10.1046/j.1365-2672.2001.01350.x; Klena JD, 1998, GENE, V222, P177, DOI 10.1016/S0378-1119(98)00501-0; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Levican A, 2015, SYST APPL MICROBIOL, V38, P30, DOI 10.1016/j.syapm.2014.10.011; Levican A, 2013, APPL ENVIRON MICROB, V79, P4951, DOI 10.1128/AEM.01073-13; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Liu F, 2006, J BIOL CHEM, V281, P20902, DOI 10.1074/jbc.M602972200; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Meier-Kolthoff Jan P, 2013, BMC BIOINFORMATICS, V14; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; Miller WG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-196; Miller WG, 2011, GENOMES OF FOODBORNE AND WATERBORNE PATHOGENS, P49; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oldfield NJ, 2002, J BACTERIOL, V184, P2100, DOI 10.1128/JB.184.8.2100-2107.2002; On SLW, 2003, J APPL MICROBIOL, V95, P1096, DOI 10.1046/j.1365-2672.2003.02100.x; On SLW, 2002, VET MICROBIOL, V85, P159, DOI 10.1016/S0378-1135(01)00503-X; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Ren GWN, 2011, FOODBORNE PATHOG DIS, V8, P375, DOI 10.1089/fpd.2010.0676; Richter M, 2015, BIOINFORMATICS, V32; Roberts MC, 1996, FEMS MICROBIOL REV, V19, P1, DOI 10.1111/j.1574-6976.1996.tb00251.x; SCHWAN ET, 1995, MOL MICROBIOL, V15, P267, DOI 10.1111/j.1365-2958.1995.tb02241.x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SIRISENA DM, 1992, J BIOL CHEM, V267, P18874; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stolz JF, 1999, FEMS MICROBIOL REV, V23, P615, DOI 10.1016/S0168-6445(99)00024-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van den Abeele AM, 2016, J ANTIMICROB CHEMOTH, V71, P1241, DOI 10.1093/jac/dkv483; Van den Abeele AM, 2014, EMERG INFECT DIS, V20, P1731, DOI 10.3201/eid2010.140433; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; VANDAMME P, 1991, INT J SYST BACTERIOL, V41, P88, DOI 10.1099/00207713-41-1-88; Vandamme P., 1987, J CLIN MICROBIOL, V25, P2398; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Whiteduck-Leveillee K, 2016, SYST APPL MICROBIOL, V39, P93, DOI 10.1016/j.syapm.2015.12.002; Whiteduck-Leveillee K, 2015, INT J SYST EVOL MICR, V65, P2709, DOI 10.1099/ijs.0.000318; Wybo I, 2004, J CLIN MICROBIOL, V42, P1851, DOI 10.1128/JCM.42.4.1851-1852.2004; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Zhang J, 2016, INT J SYST EVOL MICR, V66, P56, DOI [10.1099/ijsem.0.000669, 10.1099/ijsem.0.000751]; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	92	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180493	10.1371/journal.pone.0180493	http://dx.doi.org/10.1371/journal.pone.0180493			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671965	Green Published, gold			2022-12-27	WOS:000405268500058
J	Bratton, E; Vannappagari, V; Kobayashi, MG				Bratton, Emily; Vannappagari, Vani; Kobayashi, Monica G.			Prevalence of and risk for gastrointestinal bleeding and peptic ulcerative disorders in a cohort of HIV patients from a US healthcare claims database	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HELICOBACTER-PYLORI INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; CD4 COUNTS; AIDS; DISEASE; ENDOSCOPY; ERA; HEMORRHAGE; GASTRITIS	The primary study objectives were to estimate the frequencies and rates of gastrointestinal bleeding and peptic ulcerative disorder in HIV-positive patients compared with age- and sex-matched HIV-negative subjects. Data from a US insurance claims database was used for this analysis. Among 89,207 patients with HIV, 9.0% had a GI bleed, 1.0% had an upper gastrointestinal bleed, 5.6% had a lower gastrointestinal bleed, 1.9% had a peptic ulcerative disorder diagnosis, and 0.6% had both gastrointestinal/peptic ulcerative disorder. Among 267,615 HIV-negative subjects, the respective frequencies were 6.9%, 0.6%, 4.3%, 1.4%, and 0.4% (p < 0.0001 for each diagnosis subcategory). After combining effect measure modifiers into comedication and comorbidity strata, gastrointestinal bleeding hazard ratios (HRs) were higher for HIV-positive patients without comedication/comorbidity, and those with comedication alone (HR, 2.73; 95% confidence interval [CI], 2.62-2.84; HR, 1.59; 95% CI, 1.47-1.71). The rate of peptic ulcerative disorder among those without a history of ulcers and no comorbidity/comedication was also elevated (HR, 2.72; 95% CI, 2.48-2.99). Hazard ratios of gastrointestinal bleeding, and peptic ulcerative disorder without a history of ulcers were lower among patients infected with HIV with comedication/comorbidity (HR, 0.64; 95% CI, 0.56-0.73; HR, 0.46; 95% CI, 0.33-0.65). Rates of gastrointestinal bleeding plus peptic ulcerative disorder followed a similar pattern. In summary, the rates of gastrointestinal/peptic ulcerative disorder events comparing HIV-infected subjects to non-HIV-infected subjects were differential based on comorbidity and comedication status.	[Bratton, Emily] QuintilesIMS, Real World Evidence Solut, Durham, NC USA; [Vannappagari, Vani] ViiV Healthcare Ltd, Epidemiol & Real World Evidence, Res Triangle Pk, NC 27709 USA; [Vannappagari, Vani] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Kobayashi, Monica G.] PAREXEL Int, PAREXEL Access Consulting, Durham, NC USA	IQVIA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Parexel International	Vannappagari, V (corresponding author), ViiV Healthcare Ltd, Epidemiol & Real World Evidence, Res Triangle Pk, NC 27709 USA.; Vannappagari, V (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA.	vani.x.vannappagari@viivhealthcare.com						Balderas V, 2006, NAT CLIN PRACT GASTR, V3, P349, DOI 10.1038/ncpgasthep0497; Bashir RM, 1996, J CLIN GASTROENTEROL, V23, P292, DOI 10.1097/00004836-199612000-00011; Bhaijee F, 2011, PATHOLOG RES INT, V2011, DOI DOI 10.4061/2011/247923; Bini EJ, 1999, AM J GASTROENTEROL, V94, P358, DOI 10.1111/j.1572-0241.1999.858_a.x; BLECKER U, 1993, AM J GASTROENTEROL, V88, P1294; Cacciarelli AG, 1996, AM J GASTROENTEROL, V91, P1783; Chalasani N, 1999, AIDS PATIENT CARE ST, V13, P343, DOI 10.1089/apc.1999.13.343; Charpignon C, 2013, ALIMENT PHARM THER, V38, P946, DOI 10.1111/apt.12465; Chiu HM, 2004, J GASTROEN HEPATOL, V19, P423, DOI 10.1111/j.1440-1746.2003.03278.x; Chong VH, 2005, J GASTROEN HEPATOL, V20, P722, DOI 10.1111/j.1440-1746.2005.03793.x; Chubineh S, 2008, INT J STD AIDS, V19, P723, DOI 10.1258/ijsa.2008.008244; EDWARDS PD, 1991, AM J GASTROENTEROL, V86, P1761; Hill A, 2009, AIDS REV, V11, P30; Karus D, 2005, J PAIN SYMPTOM MANAG, V30, P408, DOI 10.1016/j.jpainsymman.2005.04.011; Kelly P, 2014, JAIDS-J ACQ IMM DEF, V67, pS79, DOI 10.1097/QAI.0000000000000260; Monkemuller KE, 2000, AM J GASTROENTEROL, V95, P457, DOI 10.1111/j.1572-0241.2000.01768.x; Najm WI, 2011, PRIMARY CARE, V38, P383, DOI 10.1016/j.pop.2011.05.001; Nevin DT, 2014, HELICOBACTER, V19, P323, DOI 10.1111/hel.12131; Nielsen H, 1995, APMIS, V103, P689, DOI 10.1111/j.1699-0463.1995.tb01424.x; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Olmos M, 2004, DIGEST DIS SCI, V49, P1836, DOI 10.1007/s10620-004-9580-5; PARENTE F, 1991, GUT, V32, P987, DOI 10.1136/gut.32.9.987; Szajerka T, 2012, INT J STD AIDS, V23, pE33, DOI 10.1258/ijsa.2009.009074; Vannappagari V, 2010, 18 INT AIDS C JUL 18; Wallace M R, 2000, Curr Gastroenterol Rep, V2, P283, DOI 10.1007/s11894-000-0020-1; Werneck-Silva AL, 2007, J GASTROEN HEPATOL, V22, P1712, DOI 10.1111/j.1440-1746.2007.04897.x; Wilcox CM, 2008, GUT, V57, P861, DOI 10.1136/gut.2006.103432; Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005	28	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180612	10.1371/journal.pone.0180612	http://dx.doi.org/10.1371/journal.pone.0180612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666006	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608700020
J	Punsawad, C; Viriyavejakul, P				Punsawad, Chuchard; Viriyavejakul, Parnpen			Reduction in serum sphingosine 1-phosphate concentration in malaria	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SPHINGOSINE-1-PHOSPHATE; S1P; PATHOGENESIS; PROTECTION; RELEASE	Sphingosine 1-phosphate (S1P) is a lipid mediator formed by the metabolism of sphingomyelin which is involved in the endothelial permeability and inflammation. Although the plasma S1P concentration is reportedly decreased in patients with cerebral malaria, the role of S1P in malaria is still unclear. The purpose of this study was to examine the impact of malaria on circulating S1P concentration and its relationship with clinical data in malaria patients. Serum S1P levels were measured in 29 patients with P. vivax, 30 patients with uncomplicated P. falciparum, and 13 patients with complicated P. falciparum malaria on admission and on day 7, compared with healthy subjects (n = 18) as control group. The lowest level of serum S1P concentration was found in the complicated P. falciparum malaria group, compared with P. vivax, uncomplicated P. falciparum patients and healthy controls (all p < 0.001). In addition, serum S1P level was positively correlated with platelet count, hemoglobin and hematocrit levels in malaria patients. In conclusions, low levels of S1P are associated with the severity of malaria, and are correlated with thrombocytopenia and anemia. These findings highlight a role of S1P in the severity of malaria and support the use of S1P and its analogue as a novel adjuvant therapy for malaria complications.	[Punsawad, Chuchard] Walailak Univ, Sch Med, Nakhon Si Thammarat, Thailand; [Punsawad, Chuchard] Walailak Univ, Trop Dis & Parasit Infect Dis Res Grp, Nakhon Si Thammarat, Thailand; [Viriyavejakul, Parnpen] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand	Walailak University; Walailak University; Mahidol University	Viriyavejakul, P (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand.	parnpen.vir@mahidol.ac.th	Punsawad, C/AAI-9258-2020	Viriyavejakul, Parnpen/0000-0001-5157-1143	Faculty of Tropical Medicine, Mahidol University, Thailand [07/2557]	Faculty of Tropical Medicine, Mahidol University, Thailand	PV received a grant from the Faculty of Tropical Medicine, Mahidol University, Thailand (Fiscal year 2014, Contract no. 07/2557). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo I, 2002, CLIN DIAGN LAB IMMUN, V9, P1145, DOI 10.1128/CDLI.9.6.1145-1152.2002; Autino B, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.061; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Carr JM, 2013, REV MED VIROL, V23, P73, DOI 10.1002/rmv.1718; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; de Alencar AC, 2014, ARQ BRAS CARDIOL, V103, P165, DOI 10.5935/abc.20140088; Finney CAM, 2011, MOL MED, V17, P717, DOI 10.2119/molmed.2010.00214; Ghosh K, 2007, PARASITOL RES, V101, P1463, DOI 10.1007/s00436-007-0742-1; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; Gomes L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113394; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Haldar Kasturi, 2009, Hematology Am Soc Hematol Educ Program, P87, DOI 10.1182/asheducation-2009.1.87; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hla T, 2012, J EXP MED, V209, P2137, DOI 10.1084/jem.20122284; HO M, 1995, J INFECT DIS, V172, P838, DOI 10.1093/infdis/172.3.838; Ikeda H, 2010, CLIN CHIM ACTA, V411, P765, DOI 10.1016/j.cca.2010.02.063; Kotepui M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121057; Kotepui M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-218; Kowalski GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072449; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Ono Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-20; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Schaphorst KL, 2003, AM J PHYSIOL-LUNG C, V285, pL258, DOI 10.1152/ajplung.00311.2002; Sharma L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00378; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tokumura A, 2009, INT J MED SCI, V6, P168; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; Watson L, 2012, J CLIN IMMUNOL, V32, P1019, DOI 10.1007/s10875-012-9710-3; WHO, 2015, WORLD MAL REP 2015; Winkler MS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1089-0; Xiong YQ, 2014, CURR TOP MICROBIOL, V378, P85, DOI 10.1007/978-3-319-05879-5_4; Yu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021230; Zhang L, 2012, J EXP MED, V209, P2165, DOI 10.1084/jem.20121090	36	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180631	10.1371/journal.pone.0180631	http://dx.doi.org/10.1371/journal.pone.0180631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666023	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700021
J	Wandera, B; Tumwesigye, NM; Nankabirwa, JI; Kambugu, AD; Mafigiri, DK; Kapiga, S; Sethi, AK				Wandera, Bonnie; Tumwesigye, Nazarius M.; Nankabirwa, Joaniter I.; Kambugu, Andrew D.; Mafigiri, David K.; Kapiga, Saidi; Sethi, Ajay K.			Hazardous alcohol consumption is not associated with CD4+T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study	PLOS ONE			English	Article							HIV DISEASE PROGRESSION; ANTIRETROVIRAL ADHERENCE; USE DISORDERS; INFECTION; IMMUNODEFICIENCY; METAANALYSIS; INDIVIDUALS; THERAPY; HEALTH; IMPACT	Introduction There is limited data on the effects of alcohol on immunological response among persons living with HIV (PLHIV) in sub-Saharan Africa. We assessed the relationship between hazardous alcohol use and CD4+ T-cell count, among PLHIV in Uganda. Methods PLHIV aged >= 18 years were enrolled in a cohort study at the Infectious diseases clinic Kampala, Uganda. Alcohol consumption was assessed at enrolment (baseline) and 6 monthly thereafter using the alcohol use disorders identification test (AUDIT). The CD4+ T-cell counts, assessed at baseline and over the next 12 months were compared between alcohol use strata, using linear mixed effects regression. Using longitudinal mediation analysis methods, we estimated the effect of alcohol induced ART non-adherence on CD4+ T-cell count. Results Of the 1566 participants enrolled, 863(44.1%) were non-alcohol users (AUDIT score = 0), 433(27.7%) were non-hazardous (AUDIT score 1 - 7) alcohol users while 270 (17.2%) were hazardous (AUDIT score >= 8) alcohol users. The overall median (IQR) baseline CD4+ T-cell count was 356 (243 - 516) cells/mu l. There were no differences in the median baseline CD4+ T-cell count between hazardous and nonhazardous alcohol users compared to non-alcohol users in both the non-ART (p = 0.43) and ART group (p = 0.77). The mean CD4+ T-cell count over 12 months was not different between hazardous alcohol users and non-alcohol users (non-ART group p = 0.88 and ART group p = 0.62), nor between non-hazardous alcohol users and non-alcohol users (and non-ART group p = 0.66 and ART group p = 0.20). Alcohol use was not associated with a significant natural direct effect on CD4(+) T-cell count (1.37 95% CI [-1.78, 4.52] cells/mu l, p = 0.39) but had a statistically significant natural indirect effect on reduction of CD4(+) T-cell count (-0.91 cells/mu l [-1.36, -0.45], p < 0.001) mediated through ART non-adherence. Conclusion Hazardous alcohol use among PLHIV was not directly associated with lower CD4+ T-cell count but had a significant natural indirect effect on CD4+ T-cell count mediated through ART non-adherence. Among PLHIV with lower than expected CD4+ T-cell count, alcohol consumption should be excluded as an underlying factor for non-adherence to ART and any interventions targeting alcohol use should tackle possible ART non-adherence.	[Wandera, Bonnie; Tumwesigye, Nazarius M.] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Wandera, Bonnie; Kambugu, Andrew D.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Nankabirwa, Joaniter I.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Mafigiri, David K.] Makerere Univ, Coll Humanities & Social Sci, Dept Social Work & Social Adm, Kampala, Uganda; [Kapiga, Saidi] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Sethi, Ajay K.] Univ Wisconsin Madison, Dept Populat Hlth Sci, Madison, WI USA	Makerere University; Makerere University; Makerere University; Makerere University; University of London; London School of Hygiene & Tropical Medicine; University of Wisconsin System; University of Wisconsin Madison	Wandera, B (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.; Wandera, B (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	bonniewandera@gmail.com		Mafigiri, David/0000-0002-2699-4248; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780; Kapiga, Saidi/0000-0003-1753-4060	Wellcome Trust Training of Health Researchers into Vocational Excellence in East Africa (THRIVE) consortium [087540]; Infectious Diseases Institute, Makerere College of Health Sciences	Wellcome Trust Training of Health Researchers into Vocational Excellence in East Africa (THRIVE) consortium; Infectious Diseases Institute, Makerere College of Health Sciences	This study was supported by the Wellcome Trust through Training of Health Researchers into Vocational Excellence in East Africa (THRIVE) consortium grant no. 087540. Additional funding was obtained from the Infectious Diseases Institute, Makerere College of Health Sciences.	Asiimwe SB, 2015, ALCOHOL CLIN EXP RES, V39, P1518, DOI 10.1111/acer.12781; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Bryan J, 2004, BIOSTATISTICS, V5, P361, DOI 10.1093/biostatistics/kxg041; Carney MA, 1998, J STUD ALCOHOL, V59, P447, DOI 10.15288/jsa.1998.59.447; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Chandiwana S. K., 1999, Central African Journal of Medicine, V45, P303; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Conen A, 2013, JAIDS-J ACQ IMM DEF, V64, P472, DOI 10.1097/QAI.0b013e3182a61ea9; Conen A, 2009, ANTIVIR THER, V14, P349; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1046/j.1360-0443.1995.901013496.x; Cook JA, 2008, AIDS, V22, P1355, DOI 10.1097/QAD.0b013e32830507f2; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Finucane Mariel M, 2007, Epidemiol Perspect Innov, V4, P8, DOI 10.1186/1742-5573-4-8; Ghebremichael M, 2009, AIDS CARE, V21, P834, DOI 10.1080/09540120802537864; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gordon LL, 2015, AIDS PATIENT CARE ST, V29, P384, DOI 10.1089/apc.2014.0165; Hahn JA, CURR HIV AIDS REP, V7, P226; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Hahn Judith A, 2010, Curr HIV/AIDS Rep, V7, P226, DOI 10.1007/s11904-010-0060-6; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Kader R, 2014, AIDS BEHAV, V18, P525, DOI 10.1007/s10461-013-0587-9; Kahler C. W., 2016, AIDS BEHAV; KASLOW RA, 1989, JAMA-J AM MED ASSOC, V261, P3424, DOI 10.1001/jama.261.23.3424; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kowalski S, 2012, JAIDS-J ACQ IMM DEF, V61, P455, DOI 10.1097/QAI.0b013e3182712d39; Marcondes MCG, 2008, ALCOHOL CLIN EXP RES, V32, P1583, DOI 10.1111/j.1530-0277.2008.00730.x; Miguez-Burbano MJ, 2009, ALCOHOL ALCOHOLISM, V44, P366, DOI 10.1093/alcalc/agp024; Pellowski JA, 2016, AIDS CARE, P1; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Sankar A, 2007, AIDS BEHAV, V11, P195, DOI 10.1007/s10461-006-9144-0; Scott-Sheldon LAJ, 2013, CURR HIV-AIDS REP, V10, P314, DOI 10.1007/s11904-013-0177-5; Szabo G, 2015, ALCOHOL RES-CURR REV, V37, P159; Vagenas P, 2015, CURR HIV-AIDS REP, V12, P421, DOI 10.1007/s11904-015-0285-5; Wandera B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126236; World Health Organization, 2001, ALCOHOL USE DISORDER	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180015	10.1371/journal.pone.0180015	http://dx.doi.org/10.1371/journal.pone.0180015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665974	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000404608700054
J	Cao, LZ; Lafyatis, R; Burkly, LC				Cao, Lizhi; Lafyatis, Robert; Burkly, Linda C.			Increased dermal collagen bundle alignment in systemic sclerosis is associated with a cell migration signature and role of Arhgdib in directed fibroblast migration on aligned ECMs	PLOS ONE			English	Article							ANIMAL-MODEL; SKIN; SCLERODERMA; DISEASE; BLEOMYCIN; SCORE; HETEROGENEITY; ARCHITECTURE; MORPHOMETRY; THICKNESS	Systemic sclerosis (SSc) is a devastating disease affecting the skin and internal organs. Dermal fibrosis manifests early and Modified Rodnan Skin Scores (MRSS) correlate with disease progression. Transcriptomics of SSc skin biopsies suggest the role of the in vivo microenvironment in maintaining the pathological myofibroblasts. Therefore, defining the structural changes in dermal collagen in SSc patients could inform our understanding of fibrosis pathogenesis. Here, we report a method for quantitative whole-slide image analysis of dermal collagen from SSc patients, and our findings of more aligned dermal collagen bundles in diffuse cutaneous SSc (dcSSc) patients. Using the bleomycin-induced mouse model of SSc, we identified a distinct high dermal collagen bundle alignment gene signature, characterized by a concerted upregulation in cell migration, adhesion, and guidance pathways, and downregulation of spindle, replication, and cytokinesis pathways. Furthermore, increased bundle alignment induced a cell migration gene signature in fibroblasts in vitro, and these cells demonstrated increased directed migration on aligned ECM fibers that is dependent on expression of Arhgdib (Rho GDP-dissociation inhibitor 2). Our results indicate that increased cell migration is a cellular response to the increased collagen bundle alignment featured in fibrotic skin. Moreover, many of the cell migration genes identified in our study are shared with human SSc skin and may be new targets for therapeutic intervention.	[Cao, Lizhi; Burkly, Linda C.] Biogen, Dept Neuroimmunol, Cambridge, MA 02142 USA; [Lafyatis, Robert] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Biogen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cao, LZ (corresponding author), Biogen, Dept Neuroimmunol, Cambridge, MA 02142 USA.	lizhicao1986@gmail.com						Agarwal NK, 2013, ONCOGENE, V32, P2521, DOI 10.1038/onc.2012.287; Assassi S, 2015, ARTHRITIS RHEUMATOL, V67, P3016, DOI 10.1002/art.39289; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; de Vries HJC, 2000, LAB INVEST, V80, P1281, DOI 10.1038/labinvest.3780136; Drifka CR, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0128-1; Furst DE, 1998, J RHEUMATOL, V25, P84; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; Gnavi S, 2016, J TISSUE ENG REGENER; Greenblatt MB, 2012, AM J PATHOL, V180, P1080, DOI 10.1016/j.ajpath.2011.11.024; Hall MS, 2016, P NATL ACAD SCI; Katsumoto TR, 2011, ANNU REV PATHOL-MECH, V6, P509, DOI 10.1146/annurev-pathol-011110-130312; Kimmel JN, 2016, NEUROGASTROENT MOTIL, V28, P1157, DOI 10.1111/nmo.12813; Kissin EY, 2006, ARTHRITIS RHEUM-US, V54, P3655, DOI 10.1002/art.22186; Li XR, 2016, SMALL, V12, P5009, DOI 10.1002/smll.201601285; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Niu HY, 2015, TUMOR BIOL, V36, P409, DOI 10.1007/s13277-014-2671-9; Okutucu S, 2016, CARDIOL J, V23, P242, DOI 10.5603/CJ.a2016.0021; Osman OS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-260; Pendergrass SA, 2012, J INVEST DERMATOL, V132, P1363, DOI 10.1038/jid.2011.472; Sargent JL, 2011, EXPERT REV CLIN IMMU, V7, P463, DOI [10.1586/ECI.11.41, 10.1586/eci.11.41]; Schulz JN, 2015, J INVEST DERMATOL, V135, P1435, DOI 10.1038/jid.2015.24; Scleroderma Fett N., 2013, CLIN DERMATOL, V31, P432; Sharma Ved P, 2012, Intravital, V1, P77; van Zuijlen PPM, 2002, J PATHOL, V198, P284, DOI 10.1002/path.1219; Verhaegen PDHM, 2012, J MICROSC-OXFORD, V245, P82, DOI 10.1111/j.1365-2818.2011.03547.x; Verhaegen PDHM, 2009, WOUND REPAIR REGEN, V17, P649, DOI 10.1111/j.1524-475X.2009.00533.x; Wei J, 2011, AUTOIMMUN REV, V10, P267, DOI 10.1016/j.autrev.2010.09.015; Yamamoto T, 2004, ARCH DERMATOL RES, V295, P453, DOI 10.1007/s00403-003-0439-y; Yamamoto T, 2001, J INVEST DERMATOL, V117, P999, DOI 10.1046/j.0022-202x.2001.01509.x; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P535, DOI 10.1007/s004030000183; Yi B, 2014, INT J MOL MED, V34, P205, DOI 10.3892/ijmm.2014.1765	31	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180751	10.1371/journal.pone.0180751	http://dx.doi.org/10.1371/journal.pone.0180751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662216	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300175
J	Chin, MC; Sivasampu, S; Khoo, EM				Chin, May Chien; Sivasampu, Sheamini; Khoo, Ee Ming			Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia	PLOS ONE			English	Article							INHALED CORTICOSTEROIDS; QUESTIONNAIRE SURVEY; ASIA-PACIFIC; SALBUTAMOL; MANAGEMENT; CHILDREN; COUNTRIES; DOCTORS; ADULTS; CARE	Objective Use of oral short-acting beta 2-agonist (SABA) persists in non-resource poor countries despite concerns for its lower efficacy and safety. Utilisation and reasons for such use is needed to support the effort to discourage the use of oral SABA in asthma. This study examined the frequency of oral short-acting Beta 2-agonist (SABA) usage in the management of asthma in primary care and determined correlates of its usage. Methods Data used were from the 2014 National Medical Care Survey in Malaysia, a nationally representative survey of primary care encounters (weighted n = 325818). Using methods of analysis of data for complex surveys, we determined the frequency of asthma diagnosis in primary care and the rate of asthma medication prescription, which includes oral SABA. Multivariate logistic regression models were built to assess associations with the prescription of oral SABA. Results A weighted estimate of 9241 encounters presented to primary care with asthma in 2014. The mean age of the patients was 39.1 years. The rate of oral SABA, oral steroids, inhaled SABA and inhaled corticosteroids prescriptions were 33, 33, 50 and 23 per 100 asthma encounters, respectively. It was most commonly used in patients with the age ranged between 20 to less than 40 years. Logistic regression models showed that there was a higher odds of oral SABA usage in the presence of respiratory infection, prescription of oral corticosteroids and in the private sector. Conclusion Oral SABA use in asthma is found to be common in a non-resource poor setting and its use could be attributed to a preference for oral medicines along undesirable clinical practices within a fragmented health system.	[Chin, May Chien; Sivasampu, Sheamini] Natl Clin Res Ctr, Healthcare Stat Unit, Kuala Lumpur, Malaysia; [Khoo, Ee Ming] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia	Universiti Malaya	Chin, MC (corresponding author), Natl Clin Res Ctr, Healthcare Stat Unit, Kuala Lumpur, Malaysia.	chinmc@crc.gov.my	KHOO, EE MING/B-8785-2010	KHOO, EE MING/0000-0003-3191-1264; Sivasampu, Sheamini/0000-0003-2314-6048	Ministry of Health, Malaysia [NMRR-09-842-4718]	Ministry of Health, Malaysia	This study was supported by a grant from the Ministry of Health, Malaysia (grant number: NMRR-09-842-4718). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medicine of Malaysia Malaysian Thoracic Society Lung Foundation of Malaysia, 2014, CLIN PRACT GUID MAN; Ait-Khaled N, 2006, INT J TUBERC LUNG D, V10, P104; Ait-Khaled N, 2000, INT J TUBERC LUNG D, V4, P268; [Anonymous], 2017, GLOB STRAT ASTHM MAN; [Anonymous], 2016, SIGN 153 BRIT GUID M; Babar Z, 2005, SURVEY MED PRICES AV; Babar ZUD, 2013, PHARMACOECONOMICS, V31, P1063, DOI 10.1007/s40273-013-0095-9; BARTFIELD JM, 1995, AM J EMERG MED, V13, P375, DOI 10.1016/0735-6757(95)90224-4; Bernama, 2016, NEW STRAITS TIM 0723; Bonner S, 2006, J ASTHMA, V43, P31, DOI 10.1080/02770900500446989; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Craig S, 2016, AUST FAM PHYSICIAN, V45, P245; Gilks WR, 1996, MARKOV CHAIN MONTE C; Global_Asthma_Network, GLOB ASTHM REP 2014; Hajjaj FM, 2010, J ROY SOC MED, V103, P178, DOI 10.1258/jrsm.2010.100104; Hosmer DW, 2005, APPL LOGISTIC REGRES, P91, DOI 10.1002/0471722146.ch4; Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; JUNIPER EF, 1990, AM REV RESPIR DIS, V142, P832, DOI 10.1164/ajrccm/142.4.832; Ko Fanny W. S., 2010, Hong Kong Medical Journal, V16, P86; Laforest L, 2005, FUND CLIN PHARMACOL, V19, P107, DOI 10.1111/j.1472-8206.2004.00302.x; Lahariya C., 2013, INTRO HEALTHCARE LOW, V2013; Loh LC, 2005, ASIAN PAC J ALLERGY, V23, P7; LOURIDAS G, 1983, RESPIRATION, V44, P439, DOI 10.1159/000194582; National Asthma Council Australia, 2014, AUSTR ASTHM HDB VERS; Pharmaceutical Services Divisions. National Essential Medicine List (NEML), 2016, NAT ESS MED LIST NEM; Ranganathan SS, 2011, 18 EXP COMM M SEL US; Reiter J. P., 2006, SURV METHODOL, V32, P143; Reschovsky JD, 2015, J GEN INTERN MED, V30, P555, DOI 10.1007/s11606-015-3366-7; Safurah J, 2012, HLTH SYSTEMS TRANSIT, V2, P10; SCALABRIN DMF, 1993, J ASTHMA, V30, P51, DOI 10.3109/02770909309066380; Singapore Ministry of Health, 2008, CLIN PRACT GUID MAN; Sivasampu S., 2016, NATL MED CARE STAT N; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Sy D. Q., 2007, SMJ Singapore Medical Journal, V48, P294; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tan NC, 2009, SINGAP MED J, V50, P312; United Nations, 2022, SUSTAIN DEV, DOI DOI 10.1002/SD.2445; Van Sickle D, 2006, INT J TUBERC LUNG D, V10, P1386; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Watson JP, 1997, THORAX, V52, P605, DOI 10.1136/thx.52.7.605; *WHO, 1998, GUID ATC CLASS DDD A; Wong GWK, 2013, ALLERGY, V68, P524, DOI 10.1111/all.12117; World Health Organization, 2011, SEL US ESS MED; Yuksel N, 2000, PHARMACOTHERAPY, V20, P387, DOI 10.1592/phco.20.5.387.35050; Zainudin BMZ, 2005, RESPIROLOGY, V10, P579, DOI 10.1111/j.1440-1843.2005.00753.x	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180443	10.1371/journal.pone.0180443	http://dx.doi.org/10.1371/journal.pone.0180443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662193	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300156
J	Freitas, TT; Martinez-Rodriguez, A; Calleja-Gonzalez, J; Alcaraz, PE				Freitas, Tomas T.; Martinez-Rodriguez, Alejandro; Calleja-Gonzalez, Julio; Alcaraz, Pedro E.			Short-term adaptations following Complex Training in team-sports: A meta-analysis	PLOS ONE			English	Article							POSTACTIVATION POTENTIATION; VERTICAL JUMP; SPRINTING PERFORMANCE; LIGHT RESISTANCES; MAXIMAL POWER; STRENGTH; HEAVY; ELITE; LOAD; FOOTBALL	Objective The purpose of this meta-analysis was to study the short-term adaptations on sprint and vertical jump (VJ) performance following Complex Training (CT) in team-sports. CT is a resistance training method aimed at developing both strength and power, which has a direct effect on sprint and VJ. It consists on alternating heavy resistance training exercises with plyometric/power ones, set for set, on the same workout. Methods A search of electronic databases up to July 2016 (PubMed-MEDLINE, SPORTDiscus, Web of Knowledge) was conducted. Inclusion criteria: 1) at least one CT intervention group; 2) training protocols >= 4-wks; 3) sample of team-sport players; 4) sprint or VJ as an outcome variable. Effect sizes (ES) of each intervention were calculated and subgroup analyses were performed. Results A total of 9 studies (13 CT groups) met the inclusion criteria. Medium effect sizes (ES) (ES = 0.73) were obtained for pre-post improvements in sprint, and small (ES = 0.41) in VJ, following CT. Experimental-groups presented better post-intervention sprint (ES = 1.01) and VJ (ES = 0.63) performance than control-groups. Sprint large ESs were exhibited in younger athletes (<20 years old; ES = 1.13); longer CT interventions (>= 6 weeks; ES = 0.95); conditioning activities with intensities <= 85% 1RM (ES = 0.96) and protocols with frequencies of <3 sessions/week (ES = 0.84). Medium ESs were obtained in Division I players (ES = 0.76); training programs >12 total sessions (ES = 0.74). VJ Large ESs in programs with >12 total sessions (ES = 0.81). Medium ESs obtained for under-Division I individuals (ES = 0.56); protocols with intracomplex rest intervals >= 2 min (ES = 0.55); conditioning activities with intensities <= 85% 1RM (ES = 0.64); basketball/volleyball players (ES = 0.55). Small ESs were found for younger athletes (ES = 0.42); interventions >= 6 weeks (ES = 0.45). Conclusions CT interventions have positive medium effects on sprint performance and small effects on VJ in team-sport athletes. This training method is a suitable option to include in the season planning.	[Freitas, Tomas T.; Alcaraz, Pedro E.] Catholic Univ Murcia, UCAM Res Ctr High Performance Sport, Murcia, Spain; [Martinez-Rodriguez, Alejandro] Univ Alicante, Dept Analyt Chem Nutr & Food Sci, Alicante, Spain; [Calleja-Gonzalez, Julio] Univ Basque Country, Lab Sport Performance Anal, Vitoria, Spain; [Alcaraz, Pedro E.] Catholic Univ Murcia, Fac Sport Sci, UCAM, Murcia, Spain	Universidad Catolica de Murcia; Universitat d'Alacant; University of Basque Country; Universidad Catolica de Murcia	Alcaraz, PE (corresponding author), Catholic Univ Murcia, UCAM Res Ctr High Performance Sport, Murcia, Spain.; Alcaraz, PE (corresponding author), Catholic Univ Murcia, Fac Sport Sci, UCAM, Murcia, Spain.	palcaraz@ucam.edu	Martínez-Rodríguez, Alejandro/AAK-5669-2020; Alcaraz, Pedro E./E-4910-2010; Calleja-Gonzalez, Julio/AAX-3058-2021; Freitas, Tomas/O-4899-2016	Martínez-Rodríguez, Alejandro/0000-0002-7499-1471; Alcaraz, Pedro E./0000-0002-9792-6656; del Pino Ortega, Daniel/0000-0001-5051-9482; Freitas, Tomas/0000-0001-8571-3189				Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; Argus CK, 2012, INT J SPORT PHYSIOL, V7, P68, DOI 10.1123/ijspp.7.1.68; Baker D, 2003, J STRENGTH COND RES, V17, P493, DOI 10.1519/00124278-200308000-00011; Baker D., 1996, J STRENGTH COND RES, V10, P131, DOI 10.1519/00124278-199605000-00015; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; Ben Abdelkrim N, 2007, BRIT J SPORT MED, V41, P69, DOI 10.1136/bjsm.2006.032318; Benoist G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155556; Bolger R, 2015, J STRENGTH COND RES, V29, P1146, DOI 10.1519/JSC.0000000000000720; Brito J, 2014, J HUM KINET, V40, P121, DOI 10.2478/hukin-2014-0014; Carter J, 2014, STRENGTH COND J, V36, P11, DOI 10.1519/SSC.0000000000000036; Cavaco B, 2014, J HUM KINET, V43, P105, DOI 10.2478/hukin-2014-0095; Chiu LZF, 2003, J STRENGTH COND RES, V17, P671, DOI 10.1519/1533-4287(2003)017<0671:PPRIAA>2.0.CO;2; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Cometti G, 2001, INT J SPORTS MED, V22, P45, DOI 10.1055/s-2001-11331; Comyns TM, 2007, SPORT BIOMECH, V6, P59, DOI 10.1080/14763140601058540; Comyns TM, 2010, J STRENGTH COND RES, V24, P610, DOI 10.1519/JSC.0b013e3181c7c3fc; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deschenes MR, 2002, AM J PHYS MED REHAB, V81, pS3, DOI 10.1097/01.PHM.0000029722.06777.E9; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Docherty D, 2004, STRENGTH COND J, V26, P52, DOI 10.1519/00126548-200412000-00011; Docherty D, 2007, INT J SPORT PHYSIOL, V2, P439, DOI 10.1123/ijspp.2.4.439; Dodd DJ, 2007, J STRENGTH COND RES, V21, P1177, DOI 10.1519/00124278-200711000-00033; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Duthie GM, 2002, J STRENGTH COND RES, V16, P530, DOI 10.1519/00124278-200211000-00007; Ebben William P, 2002, J Sports Sci Med, V1, P42; Ebben WP, 1998, STRENGTH COND, V20, P18, DOI 10.1519/1073-6840(1998)020<0018:AROCWT>2.3.CO;2; Fatouros IG, 2000, J STRENGTH COND RES, V14, P470; Faude O, 2013, J SPORT SCI, V31, P1460, DOI 10.1080/02640414.2013.796065; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Garcia-Pinillos F, 2014, J STRENGTH COND RES, V28, P2452, DOI 10.1519/JSC.0000000000000452; Granacher U, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00164; Haff GG, 2015, STRENGTH COND J, V37, P2, DOI 10.1519/SSC.0000000000000153; Hamada T, 2000, J APPL PHYSIOL, V88, P2131, DOI 10.1152/jappl.2000.88.6.2131; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Izquierdo M, 2002, EUR J APPL PHYSIOL, V87, P264, DOI 10.1007/s00421-002-0628-y; Jensen RL, 2003, J STRENGTH COND RES, V17, P345, DOI 10.1519/00124278-200305000-00022; Kukric A., 2012, FIZICKA KULTURA, V66, P25; Lim JJH, 2016, STRENGTH COND J, V38, P33, DOI 10.1519/SSC.0000000000000265; MacDonald CJ, 2012, J STRENGTH COND RES, V26, P422, DOI 10.1519/JSC.0b013e318220df79; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Markovic G, 2010, SPORTS MED, V40, P859, DOI 10.2165/11318370-000000000-00000; Matthews M, 2009, J STRENGTH COND RES, V23, P1988, DOI 10.1519/JSC.0b013e3181b3e076; McInnes S. E., 1995, Journal of Sports Sciences, V13, P387, DOI 10.1080/02640419508732254; McMaster D., 2014, J AUST STRENGTH COND, V22, P17; Mihalik JP, 2008, J STRENGTH COND RES, V22, P47, DOI 10.1519/JSC.0b013e31815eee9e; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Ostojic S.M., 2004, RES SPORTS MED, V12, P143, DOI [10.1080/15438620490460495, DOI 10.1080/15438620490460495]; Randell AD, 2010, STRENGTH COND J, V32, P100, DOI 10.1519/SSC.0b013e3181e91eec; Rumpf MC, 2016, J STRENGTH COND RES, V30, P1767, DOI 10.1519/JSC.0000000000001245; de Villarreal ES, 2013, J SCI MED SPORT, V16, P146, DOI 10.1016/j.jsams.2012.05.007; Sale DG, 2002, EXERC SPORT SCI REV, V30, P138, DOI 10.1097/00003677-200207000-00008; Santos EJAM, 2008, J STRENGTH COND RES, V22, P903, DOI 10.1519/JSC.0b013e31816a59f2; Seitz LB, 2016, SPORTS MED, V46, P231, DOI 10.1007/s40279-015-0415-7; Seitz LB, 2014, SPORTS MED, V44, P1693, DOI 10.1007/s40279-014-0227-1; Sheppard JM, 2009, J STRENGTH COND RES, V23, P1858, DOI 10.1519/JSC.0b013e3181b45c6a; Sperlich PF, 2015, J SPORTS MED PHYS FI; Stasinaki AN, 2015, J STRENGTH COND RES, V29, P2559, DOI 10.1519/JSC.0000000000000917; Tan B, 1999, J STRENGTH COND RES, V13, P289, DOI 10.1519/00124278-199908000-00019; Tillin NA, 2009, SPORTS MED, V39, P147, DOI 10.2165/00007256-200939020-00004; Alves JMVM, 2010, J STRENGTH COND RES, V24, P936, DOI 10.1519/JSC.0b013e3181c7c5fd; Watts DG., 2012, J AUST STRENGTH COND, V20, P12; Wilson JM, 2013, J STRENGTH COND RES, V27, P854, DOI 10.1519/JSC.0b013e31825c2bdb; Young WB, 1998, J STRENGTH COND RES, V12, P82, DOI 10.1519/1533-4287(1998)012<0082:AEOPPF>2.3.CO;2	66	35	35	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180223	10.1371/journal.pone.0180223	http://dx.doi.org/10.1371/journal.pone.0180223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662108	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300128
J	Hingston, P; Chen, J; Allen, K; Hansen, LT; Wang, S				Hingston, Patricia; Chen, Jessica; Allen, Kevin; Hansen, Lisbeth Truelstrup; Wang, Siyun			Strand specific RNA-sequencing and membrane lipid profiling reveals growth phase-dependent cold stress response mechanisms in Listeria monocytogenes	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ALTERNATIVE SIGMA-FACTORS; CELL-WALL SYNTHESIS; DNA-POLYMERASE-X; BACILLUS-SUBTILIS; HEAT-SHOCK; ESCHERICHIA-COLI; STATIONARY-PHASE; GLYCINE BETAINE; GENE-EXPRESSION	The human pathogen Listeria monocytogenes continues to pose a challenge in the food industry, where it is known to contaminate ready-to-eat foods and grow during refrigerated storage. Increased knowledge of the cold-stress response of this pathogen will enhance the ability to control it in the food-supply-chain. This study utilized strand-specific RNA sequencing and whole cell fatty acid (FA) profiling to characterize the bacterium's cold stress response. RNA and FAs were extracted from a cold-tolerant strain at five time points between early lag phase and late stationary-phase, both at 4(circle)C and 20(circle)C. Overall, more genes (1.3x) were suppressed than induced at 4(circle)C. Late stationary-phase cells exhibited the greatest number (n = 1,431) and magnitude (>1,000-fold) of differentially expressed genes (>2-fold, p<0.05) in response to cold. A core set of 22 genes was upregulated at all growth phases, including nine genes required for branched-chain fatty acid (BCFA) synthesis, the osmolyte transporter genes opuCBCD, and the internalin A and D genes. Genes suppressed at 4(circle)C were largely associated with cobalamin (B12) biosynthesis or the production/export of cell wall components. Antisense transcription accounted for up to 1.6% of total mapped reads with higher levels (2.5x) observed at 4(circle)C than 20(circle)C. The greatest number of upregulated antisense transcripts at 4 C occurred in early lag phase, however, at both temperatures, antisense expression levels were highest in late stationary-phase cells. Cold induced FA membrane changes included a 15% increase in the proportion of BCFAs and a 15% transient increase in unsaturated FAs between lag and exponential phase. These increases probably reduced the membrane phase transition temperature until optimal levels of BCFAs could be produced. Collectively, this research provides new information regarding cold-induced membrane composition changes in L. monocytogenes, the growth-phase dependency of its cold-stress regulon, and the active roles of antisense transcripts in regulating its cold stress response.	[Hingston, Patricia; Chen, Jessica; Allen, Kevin; Wang, Siyun] Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada; [Hansen, Lisbeth Truelstrup] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Chen, Jessica] IHRC Inc, Atlanta, GA USA	University of British Columbia; Technical University of Denmark	Wang, S (corresponding author), Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada.	siyun.wang@ubc.ca		Wang, Siyun/0000-0003-2468-2483; Hansen, Lisbeth Truelstrup/0000-0003-0485-5252	Alberta Innovates Bio Solutions; University of British Columbia [FSC-12-030]; Alexander Graham Bell Canada Graduate Scholarships-Doctoral Program	Alberta Innovates Bio Solutions; University of British Columbia; Alexander Graham Bell Canada Graduate Scholarships-Doctoral Program	This work was funded by an investment agreement between Alberta Innovates Bio Solutions and the University of British Columbia (FSC-12-030, http://bio.albertainnovates.ca.). P. Hingston was funded by an Alexander Graham Bell Canada Graduate Scholarships-Doctoral Program Scholarship (http//www.nserc-crog.gc.ca/ Students Etudiants/PG-CS/BellandPostgrad- BelletSuperieures_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 1998, J BACTERIOL, V180, P2194, DOI 10.1128/JB.180.8.2194-2200.1998; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Akanuma G, 2012, J BACTERIOL, V194, P6282, DOI 10.1128/JB.01544-12; Ake FMD, 2011, MOL MICROBIOL, V81, P274, DOI 10.1111/j.1365-2958.2011.07692.x; Andrews S., 2010, FASTQC QUALITY CONTR; Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P7492, DOI 10.1128/AEM.69.12.7492-7498.2003; Angelidis AS, 2002, APPL ENVIRON MICROB, V68, P2644, DOI 10.1128/AEM.68.6.2644-2650.2002; Annous BA, 1997, APPL ENVIRON MICROB, V63, P3887, DOI 10.1128/AEM.63.10.3887-3894.1997; Antelmann H, 2001, GENOME RES, V11, P1484, DOI 10.1101/gr.182801; Arguedas-Villa C, 2010, FOOD MICROBIOL, V27, P653, DOI 10.1016/j.fm.2010.02.009; Arous S, 2004, MICROBIOL-SGM, V150, P1581, DOI 10.1099/mic.0.26860-0; Balachandran P, 2012, United States patent, Patent No. [US20120009575, 20120009575]; Ballesteros M, 2001, EMBO J, V20, P5280, DOI 10.1093/emboj/20.18.5280; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Baranyi J, 2004, J FOOD PROTECT, V67, P1967, DOI 10.4315/0362-028X-67.9.1967; Bayles DO, 2000, LETT APPL MICROBIOL, V30, P23, DOI 10.1046/j.1472-765X.2000.00646.x; Becker LA, 2000, J BACTERIOL, V182, P7083, DOI 10.1128/JB.182.24.7083-7087.2000; Becker LA, 1998, J BACTERIOL, V180, P4547, DOI 10.1128/JB.180.17.4547-4554.1998; Behrens S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083979; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; BEUMER RR, 1994, APPL ENVIRON MICROB, V60, P1359, DOI 10.1128/AEM.60.4.1359-1363.1994; Bisbiroulas P, 2011, LETT APPL MICROBIOL, V52, P275, DOI 10.1111/j.1472-765X.2010.02995.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borezee E, 2000, INFECT IMMUN, V68, P7069, DOI 10.1128/IAI.68.12.7069-7077.2000; Bowman JP, 2008, MICROBIOL-SGM, V154, P462, DOI 10.1099/mic.0.2007/010314-0; BOYLAN SA, 1993, J BACTERIOL, V175, P3957, DOI 10.1128/JB.175.13.3957-3963.1993; Buchanan RL, 1997, J FOOD PROTECT, V60, P918, DOI 10.4315/0362-028X-60.8.918; Cabedo L, 2008, J FOOD PROTECT, V71, P855, DOI 10.4315/0362-028X-71.4.855; Cacace G, 2010, J PROTEOMICS, V73, P2021, DOI 10.1016/j.jprot.2010.06.011; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Chan YC, 2008, J FOOD PROTECT, V71, P420, DOI 10.4315/0362-028X-71.2.420; Chan YC, 2007, APPL ENVIRON MICROB, V73, P6019, DOI 10.1128/AEM.00714-07; Chan YC, 2007, APPL ENVIRON MICROB, V73, P6484, DOI 10.1128/AEM.00897-07; Chang C, 1998, PLANT PHYSIOL, V117, P723, DOI 10.1104/pp.117.3.723; Chassaing D, 2007, FEMS MICROBIOL LETT, V275, P31, DOI 10.1111/j.1574-6968.2007.00840.x; Chaturongakul S, 2011, APPL ENVIRON MICROB, V77, P187, DOI 10.1128/AEM.00952-10; Chen YH, 2003, J FOOD PROTECT, V66, P570, DOI 10.4315/0362-028X-66.4.570; Cordero N, 2016, FRONT MICROBIOL, P7; Csonka L. N., 1996, ESCHERICHIA COLI SAL, P1210; DAMMEL CS, 1995, GENE DEV, V9, P626, DOI 10.1101/gad.9.5.626; DeMaio J, 1996, P NATL ACAD SCI USA, V93, P2790, DOI 10.1073/pnas.93.7.2790; Diaz-Acosta A, 2006, ARCH MICROBIOL, V185, P429, DOI 10.1007/s00203-006-0113-9; Diomande SE, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw174; Doyle ME, 2001, J FOOD PROTECT, V64, P410, DOI 10.4315/0362-028X-64.3.410; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Durack J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073603; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; Dussurget O, 2005, FEMS MICROBIOL LETT, V250, P253, DOI 10.1016/j.femsle.2005.07.015; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fenlon DR, 1996, J APPL BACTERIOL, V81, P641; Ferreira A, 2001, APPL ENVIRON MICROB, V67, P4454, DOI 10.1128/AEM.67.10.4454-4457.2001; Fraser KR, 2003, APPL ENVIRON MICROB, V69, P2015, DOI 10.1128/AEM.69.4.2015-2022.2003; Fredriksson A, 2006, CURR OPIN MICROBIOL, V9, P612, DOI 10.1016/j.mib.2006.10.010; Gardan R, 2003, APPL ENVIRON MICROB, V69, P154, DOI 10.1128/AEM.69.1.154-161.2003; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; GARWIN JL, 1980, J BACTERIOL, V141, P1457, DOI 10.1128/JB.141.3.1457-1459.1980; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gerhardt PNM, 2000, J BACTERIOL, V182, P2544, DOI 10.1128/JB.182.9.2544-2550.2000; Gianotti A, 2008, INT J FOOD MICROBIOL, V123, P9, DOI 10.1016/j.ijfoodmicro.2007.11.039; Glaser P, 2001, SCIENCE, V294, P849; Gounot AM, 1999, PHYSL COLD ADAPTED M, P33; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Gueriri I, 2008, MICROBIOL-SGM, V154, P2251, DOI 10.1099/mic.0.2008/017590-0; Hanawa T, 2000, CELL STRESS CHAPERON, V5, P21, DOI 10.1379/1466-1268(2000)005<0021:CSATAO>2.0.CO;2; Hebraud M, 2000, FEMS MICROBIOL LETT, V190, P29, DOI 10.1016/S0378-1097(00)00310-4; Hecker M, 1998, MOL MICROBIOL, V29, P1129, DOI 10.1046/j.1365-2958.1998.00977.x; Hingston P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00369; Howell A, 2003, MOL MICROBIOL, V49, P1639, DOI 10.1046/j.1365-2958.2003.03661.x; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7981, DOI 10.1128/AEM.01281-07; Hunger K, 2006, J BACTERIOL, V188, P240, DOI 10.1128/JB.188.1.240-248.2006; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Ivy RA, 2012, APPL ENVIRON MICROB, V78, P3824, DOI 10.1128/AEM.00051-12; Izar B, 2011, INT J MOL SCI, V12, P5070, DOI 10.3390/ijms12085070; JETER RM, 1990, J GEN MICROBIOL, V136, P887, DOI 10.1099/00221287-136-5-887; JETER RM, 1984, J BACTERIOL, V159, P206, DOI 10.1128/JB.159.1.206-213.1984; Jiang WN, 1997, J BIOL CHEM, V272, P196; Jones PG, 1996, MOL MICROBIOL, V21, P1207, DOI 10.1111/j.1365-2958.1996.tb02582.x; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Joseph B, 2008, J BACTERIOL; Joseph B, 2007, MICROBES INFECT, V9, P1188, DOI 10.1016/j.micinf.2007.05.006; Juneja V. K., 1993, J RAPID METH AUT MIC, V2, P73, DOI [10.1111/j.1745-4581.1993.tb00338.x, DOI 10.1111/J.1745-4581.1993.TB00338.X]; JUNEJA VK, 1993, J FOOD PROTECT, V56, P302, DOI 10.4315/0362-028X-56.4.302; Juneja VK, 1998, J FOOD PROTECT, V61, P683, DOI 10.4315/0362-028X-61.6.683; Jung K, 1997, J BIOL CHEM, V272, P10847; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Karatzas KAG, 2003, MOL MICROBIOL, V49, P1227, DOI 10.1046/j.1365-2958.2003.03636.x; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kilstrup M, 1997, APPL ENVIRON MICROB, V63, P1826, DOI 10.1128/AEM.63.5.1826-1837.1997; Knothe G, 2009, J AM OIL CHEM SOC, V86, P843, DOI 10.1007/s11746-009-1423-2; Knudsen GM, 2004, FEMS MICROBIOL LETT, V240, P171, DOI 10.1016/j.femsle.2004.09.039; KO R, 1994, J BACTERIOL, V176, P426, DOI 10.1128/JB.176.2.426-431.1994; Ko R, 1999, APPL ENVIRON MICROB, V65, P4040; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kovacevic J, 2013, APPL ENVIRON MICROB, V79, P1915, DOI 10.1128/AEM.03341-12; Kozak J, 1996, FOOD CONTROL, V7, P215, DOI 10.1016/S0956-7135(96)00042-4; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kullik I, 1997, ARCH MICROBIOL, V167, P151, DOI 10.1007/s002030050428; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Landolfo S, 2010, INT J FOOD MICROBIOL, V141, P229, DOI 10.1016/j.ijfoodmicro.2010.05.020; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasa I, 2012, RNA BIOL, V9, P1039, DOI 10.4161/rna.21167; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Lei Y, 2013, J BACTERIOL, V195, P1697, DOI 10.1128/JB.02201-12; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu SQ, 2006, APPL ENVIRON MICROB, V72, P3955, DOI 10.1128/AEM.02607-05; Liu SQ, 2002, APPL ENVIRON MICROB, V68, P1697, DOI 10.1128/AEM.68.4.1697-1705.2002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Markkula A, 2012, ENVIRON MICROBIOL, V14, P2223, DOI 10.1111/j.1462-2920.2012.02761.x; Mastronicolis SK, 2005, FOOD MICROBIOL, V22, P213, DOI 10.1016/j.fm.2004.08.002; Mastronicolis SK, 2010, ANTON LEEUW INT J G, V98, P307, DOI 10.1007/s10482-010-9439-z; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; Mattila M, 2012, FOOD MICROBIOL, V32, P152, DOI 10.1016/j.fm.2012.05.005; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Mellin JR, 2012, RNA BIOL, V9, P372, DOI 10.4161/rna.19235; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; METZGER R, 1994, GENE, V151, P161, DOI 10.1016/0378-1119(94)90649-1; Miladi H, 2013, J FOOD BIOCHEM, V37, P136, DOI 10.1111/j.1745-4514.2011.00607.x; Mohedano ML, 2005, J BACTERIOL, V187, P2357, DOI 10.1128/JB.187.7.2357-2367.2005; Moorhead SM, 2004, INT J FOOD MICROBIOL, V91, P63, DOI 10.1016/S0168-1605(03)00332-5; Moorman MA, 2008, J FOOD PROTECT, V71, P182, DOI 10.4315/0362-028X-71.1.182; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Nair S, 2000, MOL MICROBIOL, V35, P800, DOI 10.1046/j.1365-2958.2000.01752.x; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Nickel M, 2004, MOL GENET GENOMICS, V272, P98, DOI 10.1007/s00438-004-1038-0; Okada Y, 2006, FEMS MICROBIOL LETT, V263, P54, DOI 10.1111/j.1574-6968.2006.00405.x; Olsen KN, 2005, MICROBIOL-SGM, V151, P925, DOI 10.1099/mic.0.27552-0; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Passalacqua KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043350; PEEL M, 1988, J GEN MICROBIOL, V134, P2171; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Phan-Thanh L, 1999, ELECTROPHORESIS, V20, P2214, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2214::AID-ELPS2214>3.0.CO;2-G; Pieta L, 2014, ANN MICROBIOL, V64, P1707, DOI 10.1007/s13213-014-0814-2; Polidoro M, 2002, GENE, V296, P121, DOI 10.1016/S0378-1119(02)00839-9; Pontinen A, 2015, APPL ENVIRON MICROB, V81, P3994, DOI 10.1128/AEM.00626-15; Raimann E, 2009, FOODBORNE PATHOG DIS, V6, P583, DOI 10.1089/fpd.2008.0248; RAINES LJ, 1968, J BACTERIOL, V96, P2175, DOI 10.1128/JB.96.6.2175-2177.1968; Ramadan K, 2004, NAT REV MOL CELL BIO, V5, P1038, DOI 10.1038/nrm1530; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Rea RB, 2004, INFECT IMMUN, V72, P717, DOI 10.1128/IAI.72.2.717-727.2004; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Sakamoto T, 2002, CURR OPIN MICROBIOL, V5, P206, DOI 10.1016/S1369-5274(02)00306-5; SALOTRA P, 1995, FEMS MICROBIOL LETT, V131, P57, DOI 10.1111/j.1574-6968.1995.tb07754.x; SATO N, 1980, BIOCHIM BIOPHYS ACTA, V619, P353, DOI 10.1016/0005-2760(80)90083-1; Schmalisch M, 2002, J MOL MICROB BIOTECH, V4, P495; Schmid B, 2009, APPL ENVIRON MICROB, V75, P1621, DOI 10.1128/AEM.02154-08; Schulze-Gahmen U, 2003, PROTEINS, V50, P526, DOI 10.1002/prot.10305; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shoji S, 2011, J MOL BIOL, V413, P751, DOI 10.1016/j.jmb.2011.09.004; Showalter AK, 2001, NAT STRUCT BIOL, V8, P942, DOI 10.1038/nsb1101-942; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stoll R, 2008, MICROBIOL-SGM, V154, P3856, DOI 10.1099/mic.0.2008/018283-0; SUUTARI M, 1992, BIOCHIM BIOPHYS ACTA, V1126, P119, DOI 10.1016/0005-2760(92)90281-Y; Team RC, 2015, R LANG ENV STAT COMP; Thieringer HA, 1998, BIOESSAYS, V20, P49; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; TOONE WM, 1991, J BACTERIOL, V173, P3291, DOI 10.1128/jb.173.11.3291-3302.1991; Tramonti A, 2008, MOL MICROBIOL, V70, P965, DOI 10.1111/j.1365-2958.2008.06458.x; Vadyvaloo V, 2002, APPL ENVIRON MICROB, V68, P5223, DOI 10.1128/AEM.68.11.5223-5230.2002; van der Veen S, 2007, MICROBIOL-SGM, V153, P3593, DOI 10.1099/mic.0.2007/006361-0; Verheul A, 1997, APPL ENVIRON MICROB, V63, P3451, DOI 10.1128/AEM.63.9.3451-3457.1997; Voigt K, 2014, ISME J, V8, P2056, DOI 10.1038/ismej.2014.57; VOLKER U, 1994, MICROBIOL-UK, V140, P741, DOI 10.1099/00221287-140-4-741; Way SS, 2004, CELL MICROBIOL, V6, P235, DOI 10.1046/j.1462-5822.2004.00360.x; Weber MHW, 2001, MOL MICROBIOL, V39, P1321, DOI 10.1046/j.1365-2958.2001.02322.x; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; Wehner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108639; Wemekamp-Kamphuis HH, 2004, APPL ENVIRON MICROB, V70, P2912, DOI 10.1128/AEM.70.5.2912-2918.2004; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998; Williams T, 2005, FEMS MICROBIOL LETT, V252, P287, DOI 10.1016/j.femsle.2005.09.011; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11; Zhang CM, 2005, J BACTERIOL, V187, P7243, DOI 10.1128/JB.187.21.7243-7253.2005; ZHENG W, 1995, APPL ENVIRON MICROB, V61, P4310, DOI 10.1128/AEM.61.12.4310-4314.1995; ZHENG W, 1994, FEMS MICROBIOL LETT, V121, P287, DOI 10.1111/j.1574-6968.1994.tb07114.x; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x; Zhu K, 2005, APPL ENVIRON MICROB, V71, P8002, DOI 10.1128/AEM.71.12.8002-8007.2005; Zhu K, 2005, MICROBIOL-SGM, V151, P615, DOI 10.1099/mic.0.27634-0; Zimmermann RA, 2003, CELL, V115, P130, DOI 10.1016/S0092-8674(03)00804-3	189	25	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180123	10.1371/journal.pone.0180123	http://dx.doi.org/10.1371/journal.pone.0180123			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662112	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300107
J	Lowe, R; Norman, P; Sheeran, P				Lowe, Rob; Norman, Paul; Sheeran, Paschal			Milieu matters: Evidence that ongoing lifestyle activities influence health behaviors	PLOS ONE			English	Article							PLANNED BEHAVIOR; IMPLEMENTATION INTENTIONS; PHYSICAL-ACTIVITY; GOAL CONFLICT; SELF-EFFICACY; FACILITATION; DEPLETION; MOTIVES; NORMS; POWER	Health behaviors occur within a milieu of lifestyle activities that could conflict with health actions. We examined whether cognitions about, and performance of, other lifestyle activities augment the prediction of health behaviors, and whether these lifestyle factors are especially influential among individuals with low health behavior engagement. Participants (N = 211) completed measures of past behavior and cognitions relating to five health behaviors (e.g., smoking, getting drunk) and 23 lifestyle activities (e.g., reading, socializing), as well as personality variables. All behaviors were measured again at two weeks. Data were analyzed using neural network and cluster analyses. The neural network accurately predicted health behaviors at follow-up (R-2 = .71). As hypothesized, lifestyle cognitions and activities independently predicted health behaviors over and above behavior-specific cognitions and previous behavior. Additionally, lifestyle activities and poor self-regulatory capability were more influential among people exhibiting unhealthy behaviors. Considering ongoing lifestyle activities can enhance prediction and understanding of health behaviors and offer new targets for health behavior interventions.	[Lowe, Rob] Swansea Univ, Swansea, W Glam, Wales; [Norman, Paul] Univ Sheffield, Sheffield, S Yorkshire, England; [Sheeran, Paschal] Univ North Carolina Chapel Hill, Chapel Hill, NC 27599 USA	Swansea University; University of Sheffield; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sheeran, P (corresponding author), Univ North Carolina Chapel Hill, Chapel Hill, NC 27599 USA.	psheeran@unc.edu	Sheeran, Paschal/Y-3370-2019	Sheeran, Paschal/0000-0001-7449-4590	John Templeton Foundation [23145]	John Templeton Foundation	This research was made possible by grant#23145 from the John Templeton Foundation (https://www.templeton.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. the views expressed are those of the authors and do not necessarily reflect the views of the funder.	Abraham C, 2003, CURR PSYCHOL, V22, P264, DOI 10.1007/s12144-003-1021-7; Abraham C, 2003, BRIT J SOC PSYCHOL, V42, P495, DOI 10.1348/014466603322595248; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Armitage CJ, 2010, PSYCHOL HEALTH, V25, P1129, DOI 10.1080/08870440903121638; Atkinson J.W., 1970, DYNAMICS ACTION; Bagozzi RP, 2003, J APPL PSYCHOL, V88, P915, DOI 10.1037/0021-9010.88.5.915; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; BECKER MH, 1977, J HEALTH SOC BEHAV, V18, P348, DOI 10.2307/2955344; Burns H., 2010, HLTH SCOTLAND 2010 A; Cavallo J.V., 2012, GOAL DIRECTED BEHAV, P267; CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201; Clatworthy J, 2007, PSYCHOL HEALTH, V22, P123, DOI 10.1080/14768320600774496; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conner M, 1998, J APPL SOC PSYCHOL, V28, P1429, DOI 10.1111/j.1559-1816.1998.tb01685.x; Conner M., 2005, PREDICTING HLTH BEHA, P324; Conner M., 2015, PREDICTING CHANGING, V3rd; Conner M, 2005, PREDICTING HLTH BEHA; Dodge K. A., 1989, RES MOTIVATION ED PP, V3, P107; Ferguson E, 2013, HEALTH PSYCHOL REV, V7, pS32, DOI 10.1080/17437199.2010.547985; Fishbach A, 2003, J PERS SOC PSYCHOL, V84, P296, DOI 10.1037/0022-3514.84.2.296; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Jewell T., 2010, CHIEF MED OFFICER WA; Kuhl J., 1994, VOLITION PERSONALITY, P47; Kuhl J., 1994, VOLITION PERSONALITY, P9; Lee T. W., 1989, GOAL CONCEPTS PERSON, P291; Lefcourt H.M., 2013, RES LOCUS CONTROL CO; Li KK, 2008, J SPORT EXERCISE PSY, V30, P39, DOI 10.1123/jsep.30.1.39; Lowe R, 2003, HEALTH PSYCHOL, V22, P464, DOI 10.1037/0278-6133.22.5.464; Luszczynska A, 2007, J PSYCHOSOM RES, V63, P491, DOI 10.1016/j.jpsychores.2007.06.014; Massey EK, 2008, DEV REV, V28, P421, DOI 10.1016/j.dr.2008.03.002; McEachan RRC, 2011, HEALTH PSYCHOL REV, V5, P97, DOI 10.1080/17437199.2010.521684; MILLIGAN GW, 1980, PSYCHOMETRIKA, V45, P325, DOI 10.1007/BF02293907; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Orbell S, 1997, PERS SOC PSYCHOL B, V23, P945, DOI 10.1177/0146167297239004; Presseau J, 2013, HEALTH PSYCHOL, V32, P1179, DOI 10.1037/a0029430; Presseau J, 2010, BRIT J HEALTH PSYCH, V15, P905, DOI 10.1348/135910710X494105; Rhodes RE, 2008, PSYCHOL HEALTH, V23, P789, DOI 10.1080/08870440701421578; Riediger M, 2005, J GERONTOL B-PSYCHOL, V60, pP84, DOI 10.1093/geronb/60.2.P84; Riediger M, 2004, PERS SOC PSYCHOL B, V30, P1511, DOI 10.1177/0146167204271184; Rise J, 2010, J APPL SOC PSYCHOL, V40, P1085, DOI 10.1111/j.1559-1816.2010.00611.x; Rivis A, 2003, CURR PSYCHOL, V22, P218, DOI 10.1007/s12144-003-1018-2; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Rosenberg M., 1965, SOC ADOLESCENT SELF, P37; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Shah JY, 2002, J PERS SOC PSYCHOL, V83, P1261, DOI 10.1037//0022-3514.83.6.1261; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [10.1080/14792772143000003, DOI 10.1080/14792772143000003]; Sheeran P, 2017, ANNU REV PSYCHOL, V68, P573, DOI 10.1146/annurev-psych-010416-044007; Sheeran P, 2016, HEALTH PSYCHOL, V35, P1178, DOI 10.1037/hea0000387; Sniehotta FF, 2014, HEALTH PSYCHOL REV, V8, P1, DOI 10.1080/17437199.2013.869710; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Walker I, 2005, BEHAV RES METHODS, V37, P23, DOI 10.3758/BF03206395	56	7	7	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179699	10.1371/journal.pone.0179699	http://dx.doi.org/10.1371/journal.pone.0179699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662120	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300042
J	Ricoldi, MST; Furlaneto, FAC; Oliveira, LFF; Teixeira, GC; Pischiotini, JP; Moreira, ALG; Ervolino, E; de Oliveira, MN; Bogsan, CSB; Salvador, SL; Messora, MR				Ricoldi, Milla S. T.; Furlaneto, Flavia A. C.; Oliveira, Luiz F. F.; Teixeira, Gustavo C.; Pischiotini, Jessica P.; Moreira, Andre L. G.; Ervolino, Edilson; de Oliveira, Marice N.; Bogsan, Cristina S. B.; Salvador, Sergio L.; Messora, Michel R.			Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats	PLOS ONE			English	Article							SALIVARY MUTANS STREPTOCOCCI; LACTOBACILLUS-RHAMNOSUS; ICE-CREAM; MICROBIOTA; LOZENGES; INFLAMMATION; MECHANISMS; ADHESION; THERAPY; STRAINS	Lactobacillus probiotics have been investigated in periodontitis. However, the effects of the genus Bifidobacterium on periodontitis are hardly known. This study evaluated the effects of the probiotic (PROB) Bifidobacterium animalis subsp. lactis (B. lactis) HN019 as an adjunct to scaling and root planing (SRP) in rats with experimental periodontitis (EP). At baseline, 32 rats were assigned to 4 groups: C (control), PROB, EP-SRP and EP-SRP-PROB. In groups EP-SRP and EP-SRP-PROB, the mandibular first molars of the animals received a ligature. At day 14, the ligatures were removed and SRP was performed. Animals of groups PROB and EP-SRP-PROB were orally administered with 10 mL/day of 10(9) colony forming units of B. lactis HNO19 for 15 days, starting at day 14. Animals were euthanized at day 29. Histomorphometric, microtomographic and immunohistochemical analyses were performed. Microbiological effects of B. lactis on biofilm were also evaluated. Data were statistically analyzed (ANOVA, Tukey; Kruskal-Wallis, Dunn's; Two-tailed t-test; p<0.05). Group EP-SRP-PROB presented reduced alveolar bone resorption and attachment loss when compared with Group EP-SRP (p<0.05). Group EP-SRP-PROB showed significantly fewer osteoclasts, increased expression of anti-inflammatory cytokines and reduced expression of proinflammatory cytokines compared with Group EP-SRP (p<0.05). B. lactis promoted a higher ratio between aerobic and anaerobic bacteria in biofilm samples (p<0.05). B. lactis HNO19 may have a role in the treatment of EP in rats, as an adjunct to SRP.	[Ricoldi, Milla S. T.; Furlaneto, Flavia A. C.; Oliveira, Luiz F. F.; Teixeira, Gustavo C.; Pischiotini, Jessica P.; Messora, Michel R.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, Ribeirao Preto, SP, Brazil; [Ervolino, Edilson] UNESP Univ Estadual Paulista, Dent Sch Aracatuba, Div Histol, Dept Basic Sci, Aracatuba, SP, Brazil; [de Oliveira, Marice N.; Bogsan, Cristina S. B.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Sao Paulo, SP, Brazil; [Salvador, Sergio L.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Anal, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo	Messora, MR (corresponding author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, Ribeirao Preto, SP, Brazil.	m.messora@forp.usp.br	Ervolino, Edilson/D-1500-2018; Bogsan, Cristina S. B./E-7911-2011; Salvador, Sergio/G-1015-2019; Furlaneto, Flavia/C-4171-2013; Messora, Michel/F-3480-2012	Bogsan, Cristina S. B./0000-0003-1778-4043; Furlaneto, Flavia/0000-0002-8072-3983; ervolino, edilson/0000-0003-4859-0583; Salvador, Sergio Luiz/0000-0002-4867-7294; Messora, Michel/0000-0001-8485-9645	Sao Paulo Research Foundation (FAPESP) [2012/18313-2, 2012/18785-1]; Sao Paulo Research Foundation (FAPESP scholarship)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation (FAPESP scholarship)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP) - www.fapesp.br; Scholarship to GCT (#2012/18313-2); Scholarship to JPP (#2012/18785-1).; The authors thank Sao Paulo Research Foundation (FAPESP scholarship to GCT and JPP). The authors also thank Marina Del Arco (Laboratory Assistant, Department Clinical Analyses, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo USP, Ribeirao Preto / SP, Brazil) for technical support during the microbiological procedures.	Araya M, 2002, JOINT FAO WHO WORK G; Biavati B, 2000, ANN MICROBIOL, V50, P117; Caglar E, 2008, ACTA ODONTOL SCAND, V66, P154, DOI 10.1080/00016350802089467; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dereka XE, 2006, GROWTH FACTORS, V24, P260, DOI 10.1080/08977190601060990; Furlaneto FAC, 2014, J PERIODONTOL, V85, P1291, DOI 10.1902/jop.2014.130581; Gill HS, 2000, BRIT J NUTR, V83, P167, DOI 10.1017/S0007114500000210; Grossner-Schreiber B, 2006, J CLIN PERIODONTOL, V33, P478, DOI 10.1111/j.1600-051X.2006.00942.x; Haukioja A, 2006, ORAL MICROBIOL IMMUN, V21, P326, DOI 10.1111/j.1399-302X.2006.00299.x; Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294; Hoffman FA, 2008, CLIN INFECT DIS, V46, pS53, DOI 10.1086/523342; Ince G, 2015, J PERIODONTOL, V86, P746, DOI 10.1902/jop.2015.140612; Lisboa MRP, 2015, J PERIODONTOL, V86, P801, DOI 10.1902/jop.2015.140630; Liu C, 2010, WORLD J GASTROENTERO, V16, P2283, DOI 10.3748/wjg.v16.i18.2283; Maekawa T, 2014, J PERIODONTAL RES, V49, P785, DOI 10.1111/jre.12164; Martins AKS, 2010, ARCH MICROBIOL, V192, P995, DOI 10.1007/s00203-010-0626-0; Messora MR, 2016, ARCH ORAL BIOL, V66, P108, DOI 10.1016/j.archoralbio.2016.02.014; Messora MR, 2013, J PERIODONTOL, V84, P1818, DOI 10.1902/jop.2013.120644; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nissen L, 2014, ANN MICROBIOL, V64, P611, DOI 10.1007/s13213-013-0694-x; Oliveira LFF, 2016, J PERIODONTOL, V23, P1; Ouwehand AC, 2008, FEMS IMMUNOL MED MIC, V53, P18, DOI 10.1111/j.1574-695X.2008.00392.x; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Prasad J, 1998, INT DAIRY J, V8, P993, DOI 10.1016/S0958-6946(99)00024-2; Prescott SL, 2008, CLIN EXP ALLERGY, V38, P1606, DOI 10.1111/j.1365-2222.2008.03061.x; Shah MP, 2013, J CLIN DIAGN RES, V7, P595, DOI 10.7860/JCDR/2013/5225.2834; Singh R, 2011, ACTA ODONTOL SCAND, V69, P389, DOI 10.3109/00016357.2011.572289; Tekce M, 2015, J CLIN PERIODONTOL, V42, P363, DOI 10.1111/jcpe.12387; Teles RP, 2010, J CLIN PERIODONTOL, V37, P313, DOI 10.1111/j.1600-051X.2010.01534.x; Teughels W, 2013, J CLIN PERIODONTOL, V40, P1025, DOI 10.1111/jcpe.12155; Teughels W, 2011, J CLIN PERIODONTOL, V38, P159, DOI 10.1111/j.1600-051X.2010.01665.x; Toiviainen A, 2015, CLIN ORAL INVEST, V19, P77, DOI 10.1007/s00784-014-1221-6; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Vivekananda M R, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5344; Zhang Y, 2015, J PERIODONTAL RES, V50, P141, DOI 10.1111/jre.12193	35	35	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179946	10.1371/journal.pone.0179946	http://dx.doi.org/10.1371/journal.pone.0179946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662142	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300079
J	Yunus, RM; Wazid, SW; Hairi, NN; Choo, WY; Hairi, FM; Sooryanarayana, R; Ahmad, SN; Razak, IA; Peramalah, D; Aziz, SA; Mohamad, ZL; Mohamad, R; Ali, ZM; Mahmud, ABA				Yunus, Raudah Mohd; Wazid, Syeda Wasfeea; Hairi, Noran N.; Choo, Wan Yuen; Hairi, Farizah M.; Sooryanarayana, Rajini; Ahmad, Sharifah N.; Razak, Inayah A.; Peramalah, Devi; Aziz, Suriyati A.; Mohamad, Zaiton L.; Mohamad, Rosmala; Ali, Zainudin M.; Mahmud, Awang B. Awang			Association between elder abuse and poor sleep: A cross-sectional study among rural older Malaysians	PLOS ONE			English	Article							QUALITY INDEX PSQI; CHICAGO HEALTH; MORTALITY RISK; VERBAL ABUSE; SCALE ESS; ADULTS; NEGLECT; PREVALENCE; VALIDATION; DEPRESSION	Objectives To examine the association between elder abuse and poor sleep using a Malay validated version of Pittsburgh Sleep Quality Index (PSQI). Design This study was divided into two phases. Phase I tested the construct validity and reliability of the Malay version of PSQI. Phase II was a population-based, cross-sectional study with a multi-stage cluster sampling method. Home-based interviews were conducted by trained personnel using a structured questionnaire, to determine exposure and outcome. Setting Kuala Pilah, a district in Negeri Sembilan which is one of the fourteen states in Malaysia. Participants 1648 community-dwelling older Malaysians. Results The Malay version of PSQI had significant test re-test reliability with intra-class correlation coefficients of 0.62. Confirmatory factor analyses revealed that one factor PSQI scale with three components (subjective sleep quality, sleep latency, and sleep disturbances) was most suitable. Cronbach's Alpha was 0.60 and composite reliability was 0.63. PSQI scores were highest among neglect (4.11), followed by physical (4.10), psychological (3.96) and financial abuse (3.60). There was a dose-response relationship between clustering of abuse and PSQI scores; 3.41, 3.50 and 3.84 for "no abuse", "1 type of abuse" and "2 types or more". Generalized linear models revealed six variables as significant determinants of sleep quality-abuse, co-morbidities, self-rated health, income, social support and gait speed. Among abuse subtypes, only neglect was significantly associated with poor sleep. Conclusion The Malay PSQI was valid and reliable. Abuse was significantly associated with poor sleep. As sleep is essential for health and is a good predictor for mortality among older adults, management of abuse victims should entail sleep assessment. Interventions or treatment modalities which focus on improving sleep quality among abuse victims should be designed.	[Yunus, Raudah Mohd; Wazid, Syeda Wasfeea; Hairi, Noran N.; Choo, Wan Yuen; Hairi, Farizah M.; Sooryanarayana, Rajini; Peramalah, Devi; Mahmud, Awang B. Awang] Univ Malaya, Dept Social & Prevent Med, JCUM, Kuala Lumpur, Malaysia; [Yunus, Raudah Mohd] Univ Teknol MARA, Dept Populat Hlth & Prevent Med, Sungai Buloh, Selangor, Malaysia; [Ahmad, Sharifah N.; Razak, Inayah A.; Aziz, Suriyati A.; Mohamad, Zaiton L.; Mohamad, Rosmala; Ali, Zainudin M.] Negeri Sembilan State Hlth Dept JKNNS, Negeri Sembilan, Malaysia	Universiti Malaya; Universiti Teknologi MARA	Yunus, RM (corresponding author), Univ Malaya, Dept Social & Prevent Med, JCUM, Kuala Lumpur, Malaysia.; Yunus, RM (corresponding author), Univ Teknol MARA, Dept Populat Hlth & Prevent Med, Sungai Buloh, Selangor, Malaysia.	raudah.yunus@gmail.com	devi@ummc.edu.my, devi@ummc.edu.my/GYU-6462-2022; CHOO, WAN YUEN/B-8399-2010; Choo, Wan Yuen/ABH-3055-2021; HAIRI, NORAN/B-9339-2010; Bulgiba, Awang/B-8271-2010; Hairi, Farizah MOHD/B-8497-2010; Wazid, Syeda Wasfeea/AAH-3802-2021	Choo, Wan Yuen/0000-0002-2644-6073; HAIRI, NORAN/0000-0002-2692-9016; Bulgiba, Awang/0000-0002-5313-0445; Hairi, Farizah MOHD/0000-0002-2582-3121; Wazid, Syeda Wasfeea/0000-0001-9524-4128	University of Malaya Grand Challenge on Preventing Elder Abuse and Neglect Initiative (PEACE) [GC001D-14 HTM]; Postgraduate Research Grant [PG1042 014A]	University of Malaya Grand Challenge on Preventing Elder Abuse and Neglect Initiative (PEACE); Postgraduate Research Grant	This study was funded by the University of Malaya Grand Challenge on Preventing Elder Abuse and Neglect Initiative (PEACE) (GC001D-14 HTM) and Postgraduate Research Grant (PG1042 014A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2006, SCAND J WORK ENV HEA, V32, P493, DOI 10.5271/sjweh.1054; Aloba OO, 2007, SLEEP MED, V8, P266, DOI 10.1016/j.sleep.2006.08.003; Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; Anetzberger G., 2012, CLIN MANAGEMENT ELDE; Baker MW, 2009, J AM GERIATR SOC, V57, P1799, DOI 10.1111/j.1532-5415.2009.02429.x; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; Chapman DP, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-3; Choo WY, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011057; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Curcio G, 2013, NEUROL SCI, V34, P511, DOI 10.1007/s10072-012-1085-y; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Dam TTL, 2008, J AM GERIATR SOC, V56, P1665, DOI 10.1111/j.1532-5415.2008.01846.x; Dew MA, 2003, PSYCHOSOM MED, V65, P63, DOI 10.1097/01.PSY.0000039756.23250.7C; Dillon G., 2013, INT J FAMILY MED, DOI 10.1155/2013/313909; Dong XQ, 2015, GERONTOLOGY, V61, P389, DOI 10.1159/000368577; Dong XQ, 2013, JAMA INTERN MED, V173, P911, DOI 10.1001/jamainternmed.2013.238; Dong XQ, 2013, AM J EMERG MED, V31, P693, DOI 10.1016/j.ajem.2012.12.028; Dong XQ, 2008, J ELDER ABUSE NEGL, V20, P25, DOI 10.1300/J084v20n01_02; Dong XQ, 2009, JAMA-J AM MED ASSOC, V302, P517, DOI 10.1001/jama.2009.1109; Drake CL, 2014, SLEEP, V37, P1295, DOI 10.5665/sleep.3916; Fisher BS, 2006, GERONTOLOGIST, V46, P200, DOI 10.1093/geront/46.2.200; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; GEORGE LK, 1989, BRIT J PSYCHIAT, V154, P478, DOI 10.1192/bjp.154.4.478; Goldman SE, 2007, SLEEP, V30, P1317, DOI 10.1093/sleep/30.10.1317; Guo SR, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01126; Johannesen M, 2013, AGE AGEING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; kerstedt AA, 2006, SCAND J WORK ENV HEA, P493; Kirmayer LJ, 2007, PSYCHOSOM MED, V69, P832, DOI 10.1097/PSY.0b013e31815b002c; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Laumann EO, 2008, J GERONTOL B-PSYCHOL, V63, pS248, DOI 10.1093/geronb/63.4.S248; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Maniam R, 2014, SINGAP MED J, V55, P476, DOI 10.11622/smedj.2014119; Mouton CP, 2010, ANN FAM MED, V8, P206, DOI 10.1370/afm.1095; Naughton C, 2011, AGE AGEING; Nazatul SM, 2008, JUMMEC, V11, P66, DOI DOI 10.22452/jummec.vol11no2.5; Newman AB, 1997, J AM GERIATR SOC, V45, P1; O'Donnell D, 2009, J SLEEP RES, V18, P254, DOI 10.1111/j.1365-2869.2008.00719.x; Olofsson N, 2012, PUBLIC HEALTH, V126, P358, DOI 10.1016/j.puhe.2012.01.015; Omachi TA, 2011, ARTHRIT CARE RES, V63, pS287, DOI 10.1002/acr.20544; Patel NP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-475; Patel SR, 2008, INT J OBESITY, V32, P1825, DOI 10.1038/ijo.2008.198; Phillips B, 2001, SLEEP MED, V2, P99, DOI 10.1016/S1389-9457(00)00083-6; Pillemer K, 2016, GERONTOLOGIST, V56, pS194, DOI 10.1093/geront/gnw004; Pollak C P, 1990, J Community Health, V15, P123, DOI 10.1007/BF01321316; Potvin O, 2014, INT J GERIATR PSYCH, V29, P1262, DOI 10.1002/gps.4106; Razali R, 2016, NEUROLOGY ASIA, V21; Rose, 2000, HDB PSYCHIAT MEASURE, P544; Shochat T, 2007, ISR MED ASSOC J, V9, P853; Smagula SF, 2016, SLEEP MED REV, V25, P21, DOI 10.1016/j.smrv.2015.01.003; Sooryanarayana R, 2015, J AM GERIATR SOC, V63, P180, DOI 10.1111/jgs.13217; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; SPSS I, 2011, IBM SPSS STAT WIND V, V440; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Suleiman KH, 2010, WESTERN J NURS RES, V32, P250, DOI 10.1177/0193945909348230; Tomfohr LM, 2013, J CLIN SLEEP MED, V9, P61, DOI 10.5664/jcsm.2342; Troxel WM, 2010, J PSYCHOSOM RES, V69, P459, DOI 10.1016/j.jpsychores.2010.04.003; Yan E, 2001, J INTERPERS VIOLENCE, V16, P1158, DOI 10.1177/088626001016011004; Yao Ke-Wu, 2008, J Nurs Res, V16, P131; Yunus RM, 2017, J ELDER ABUSE NEGL, V29, P59, DOI 10.1080/08946566.2016.1260083; Zahari Z, 2015, PEERJ, V3, DOI 10.7717/peerj.839	64	19	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180222	10.1371/journal.pone.0180222	http://dx.doi.org/10.1371/journal.pone.0180222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686603	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100042
J	Elvstam, O; Medstrand, P; Yilmaz, A; Isberg, PE; Gisslen, M; Bjorkman, P				Elvstam, Olof; Medstrand, Patrik; Yilmaz, Aylin; Isberg, Per-Erik; Gisslen, Magnus; Bjorkman, Per			Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; DRUG-RESISTANCE; RALTEGRAVIR INTENSIFICATION; COPY-YEARS; THERAPY; INFLAMMATION; RISK; DETERMINANTS; INTERMITTENT	Objective Although most HIV-infected individuals achieve undetectable viremia during antiretroviral therapy (ART), a subset have low-level viremia (LLV) of varying duration and magnitude. The impact of LLV on treatment outcomes is unclear. We investigated the association between LLV and virological failure and/or all-cause mortality among Swedish patients receiving ART. Methods HIV-infected patients from two Swedish HIV centers were identified from the nationwide register InfCare HIV. Subjects aged >= 15 years with triple agent ART were included at 12 months after treatment initiation if >= 2 following viral load measurements were available. Patients with 2 consecutive HIV RNA values >= 1000 copies/mL at this time point were excluded. Participants were stratified into four categories depending on viremia profiles: permanently suppressed viremia (<50 copies/mL), LLV 50-199 copies/mL, LLV 200-999 copies/mL and viremia >= 1000 copies/mL. Association between all four viremia categories and all-cause death was calculated using survival analysis with viremia as a time-varying covariate, so that patients could change viremia category during follow-up. Association between the three lower categories and virological failure >= 2 consecutive measurements >= 1000 copies/mL) was calculated in a similar manner. Results LLV 50-199 copies/mL was recorded in 70/1015 patients (6.9%) and LLV 200-999 copies/mL in 89 (8.8%) during 7812 person-years of follow-up (median 6.5 years). LLV 200-999 copies/mL was associated with virological failure (adjusted hazard ratio 3.14 [95% confidence interval 1.41-7.03, p<0.01]), whereas LLV 50-199 copies/mL was not (1.01 [0.34-4.31, p = 0.99]; median follow-up 4.5 years). LLV 200-999 copies/mL had an adjusted mortality hazard ratio of 2.29 (0.98-5.32, p = 0.05) and LLV 50-199 copies/mL of 2.19 (0.90-5.37, p = 0.09). Conclusions In this Swedish cohort followed during ART for a median of 4.5 years, LLV 200-999 copies/mL was independently associated with virological failure. Patients with LLV had higher rates of all-cause mortality, although not statistically significant in multivariate analysis.	[Elvstam, Olof; Bjorkman, Per] Lund Univ, Dept Translat Med, Clin Infect Med Unit, Malmo, Sweden; [Medstrand, Patrik] Lund Univ, Dept Translat Med, Clin Virol, Malmo, Sweden; [Yilmaz, Aylin; Gisslen, Magnus] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Isberg, Per-Erik] Lund Univ, Dept Stat, Lund, Sweden	Lund University; Lund University; University of Gothenburg; Lund University	Elvstam, O (corresponding author), Lund Univ, Dept Translat Med, Clin Infect Med Unit, Malmo, Sweden.	olof.elvstam@gmail.com	Elvstam, Olof/AAH-6991-2020; Gisslen, Magnus/D-7454-2015	Elvstam, Olof/0000-0003-3799-9869; Gisslen, Magnus/0000-0002-2357-1020	Sahlgrenska University Hospital [ALFGBG-430271]	Sahlgrenska University Hospital	The study was supported by the Sahlgrenska University Hospital (ALFGBG-430271, https://www.sahlgrenska.se). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alboukadel Kassambara MK, R PACKAGE VERSION 0; Andrade BB, 2013, J INFECT DIS, V207, P1379, DOI 10.1093/infdis/jit033; Bastard JP, 2012, ANTIVIR THER, V17, P915, DOI 10.3851/IMP2093; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Boillat-Blanco N, 2015, ANTIVIR THER, V20, P165, DOI 10.3851/IMP2815; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Eastburn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026320; Eriksen J, 2017, INFECT DIS-NOR, V49, P1, DOI 10.1080/23744235.2016.1247495; European AIDS Clinical Society, 2015, EUR GUID TREATM HIV; Garcia-Gasco P, 2008, J ANTIMICROB CHEMOTH, V61, P699, DOI 10.1093/jac/dkm516; Geretti AM, 2008, ANTIVIR THER, V13, P927; Gisslen M, 2017, HIV MED, V18, P305, DOI 10.1111/hiv.12431; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; GUNTHARD HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI DOI 10.1001/JAMA.2016.8900; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Hermankova M, JAMA; Hofstra LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110749; Hsue PY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000422; Huffpost, 2015, HUFFPOST; Karlsson AC, 2004, AIDS, V18, P981, DOI 10.1097/00002030-200404300-00005; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Laprise C, 2013, CLIN INFECT DIS, V57, P1489, DOI 10.1093/cid/cit529; Lima V., 2010, PERSISTENT LOW LEVEL; Llibre JM, 2012, ANTIVIR THER, V17, P355, DOI 10.3851/IMP1917; Mackie NE, 2010, J INFECT DIS, V201, P1303, DOI 10.1086/651618; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Murray M, 2012, HIV MED, V13, P89, DOI 10.1111/j.1468-1293.2011.00940.x; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Quiros-Roldan E, 2016, J ANTIMICROB CHEMOTH; Silva J, 2014, J INT AIDS SOC, V17, P117, DOI 10.7448/IAS.17.4.19668; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; Sungkanuparph S, 2006, HIV MED, V7, P437, DOI 10.1111/j.1468-1293.2006.00403.x; Swenson LC, 2014, J CLIN MICROBIOL, V52, P517, DOI 10.1128/JCM.02461-13; Taiwo B, 2011, J INFECT DIS, V204, P515, DOI 10.1093/infdis/jir353; Teira R, 2017, HIV MED, V18, P196, DOI 10.1111/hiv.12413; Therneau T, PACKAGE SURVIVAL ANA; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Vancoillie L, 2015, ANTIVIR THER, V20, P789, DOI 10.3851/IMP2966; Vandenhende MA, 2015, ANTIVIR THER, V20, P655, DOI 10.3851/IMP2949; Vandenhende MA, 2015, AIDS, V29, P373, DOI 10.1097/QAD.0000000000000544; Walsh C., 2007, HIERPART PACKAGE VER; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2015, CONS GUID US ANT DRU; Wright ST, 2014, JAIDS-J ACQ IMM DEF, V66, P55, DOI 10.1097/QAI.0000000000000125; Yilmaz A, 2010, JAIDS-J ACQ IMM DEF, V55, P590, DOI 10.1097/QAI.0b013e3181f5b3d1; Zhang S, 2010, ANTIVIR THER, V15, P555, DOI 10.3851/IMP1564; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	51	32	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180761	10.1371/journal.pone.0180761	http://dx.doi.org/10.1371/journal.pone.0180761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683128	gold, Green Published, Green Submitted			2022-12-27	WOS:000405335200066
J	Hondorp, DW; Bennion, DH; Roseman, EF; Holbrook, CM; Boase, JC; Chiotti, JA; Thomas, MV; Wills, TC; Drouin, RG; Kessel, ST; Krueger, CC				Hondorp, Darryl W.; Bennion, David H.; Roseman, Edward F.; Holbrook, Christopher M.; Boase, James C.; Chiotti, Justin A.; Thomas, Michael V.; Wills, Todd C.; Drouin, Richard G.; Kessel, Steven T.; Krueger, Charles C.			Use of navigation channels by Lake Sturgeon: Does channelization increase vulnerability of fish to ship strikes?	PLOS ONE			English	Article							TIDAL STREAM TRANSPORT; ACIPENSER-FULVESCENS; ATLANTIC STURGEON; ROUTE SELECTION; LARGE RIVER; ST-CLAIR; UPPER MISSISSIPPI; CHINOOK SALMON; SPAWNING-SITE; LOWLAND RIVER	Channelization for navigation and flood control has altered the hydrology and bathymetry of many large rivers with unknown consequences for fish species that undergo riverine migrations. In this study, we investigated whether altered flow distributions and bathymetry associated with channelization attracted migrating Lake Sturgeon (Acipenser fulvescens) into commercial navigation channels, potentially increasing their exposure to ship strikes. To address this question, we quantified and compared Lake Sturgeon selection for navigation channels vs. alternative pathways in two multi-channel rivers differentially affected by channelization, but free of barriers to sturgeon movement. Acoustic telemetry was used to quantify Lake Sturgeon movements. Under the assumption that Lake Sturgeon navigate by following primary flow paths, acoustic-tagged Lake Sturgeon in the more-channelized lower Detroit River were expected to choose navigation channels over alternative pathways and to exhibit greater selection for navigation channels than conspecifics in the less-channelized lower St. Clair River. Consistent with these predictions, acoustic-tagged Lake Sturgeon in the more-channelized lower Detroit River selected the higher-flow and deeper navigation channels over alternative migration pathways, whereas in the less-channelized lower St. Clair River, individuals primarily used pathways alternative to navigation channels. Lake Sturgeon selection for navigation channels as migratory pathways also was significantly higher in the more-channelized lower Detroit River than in the less-channelized lower St. Clair River. We speculated that use of navigation channels over alternative pathways would increase the spatial overlap of commercial vessels and migrating Lake Sturgeon, potentially enhancing their vulnerability to ship strikes. Results of our study thus demonstrated an association between channelization and the path use of migrating Lake Sturgeon that could prove important for predicting sturgeon-vessel interactions in navigable rivers as well as for understanding how fish interact with their habitat in landscapes altered by human activity.	[Hondorp, Darryl W.; Bennion, David H.; Roseman, Edward F.] US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI 48105 USA; [Holbrook, Christopher M.] US Geol Survey, Great Lakes Sci Ctr, Hammond Bay Biol Stn, Millersburg, MI USA; [Boase, James C.; Chiotti, Justin A.] US Fish & Wildlife Serv, Alpena Fish & Wildlife Conservat Off, Waterford Substn, Waterford, MI USA; [Thomas, Michael V.; Wills, Todd C.] Michigan Dept Nat Resources, Lake St Clair Fisheries Res Stn, Harrison Township, MI USA; [Drouin, Richard G.] Ontario Minist Nat Resources & Forestry, Lake Erie Management Unit, London, ON, Canada; [Kessel, Steven T.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Krueger, Charles C.] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; Ministry of Natural Resources & Forestry; Michigan State University; Michigan State University	Hondorp, DW (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI 48105 USA.	dhondorp@usgs.gov		Hondorp, Darryl/0000-0002-5182-1963; Roseman, Edward/0000-0002-5315-9838	Great Lakes Fishery Trust [2011.1200]; Great Lakes Restoration Initiative [GL0 0E23010-3]; U. S.Geological Survey via Great Lakes Restoration Initiative Template (Fish Habitat Enhancement Strategies for the Huron Erie Corridors) [70]	Great Lakes Fishery Trust; Great Lakes Restoration Initiative; U. S.Geological Survey via Great Lakes Restoration Initiative Template (Fish Habitat Enhancement Strategies for the Huron Erie Corridors)	This work was funded by grant 2011.1200 of the Great Lakes Fishery Trust (https://www.glft.org/) to DWH and CCK; by Great Lakes Restoration Initiative appropriation GL0 0E23010-3 to the Great Lakes Fishery Commission (http://www.glfc.org/); and by the U. S.Geological Survey via Great Lakes Restoration Initiative Template 70 (Fish Habitat Enhancement Strategies for the Huron Erie Corridors).The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, ANIM BIOTELEM; [Anonymous], [No title captured]; Balazik MT, 2015, N AM J FISH MANAGE, V35, P398, DOI 10.1080/02755947.2015.1011358; Balazik MT, 2012, N AM J FISH MANAGE, V32, P1062, DOI 10.1080/02755947.2012.716016; Boase JC, 2011, J APPL ICHTHYOL, V27, P58, DOI 10.1111/j.1439-0426.2011.01827.x; Briggs AS, 2016, J FRESHWATER ECOL, V31, P477, DOI 10.1080/02705060.2016.1152321; BROOKER MP, 1985, GEOGR J, V151, P63, DOI 10.2307/633280; Brown JJ, 2010, FISHERIES, V35, P72, DOI 10.1577/1548-8446-35.2.72; Caswell NM, 2004, J APPL ICHTHYOL, V20, P1, DOI 10.1111/j.1439-0426.2004.00499.x; Cooke SJ, 2011, REV FISH BIOL FISHER, V21, P127, DOI 10.1007/s11160-010-9193-3; Dittman AH, 1996, J EXP BIOL, V199, P83; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Forsythe PS, 2012, J FISH BIOL, V81, P35, DOI 10.1111/j.1095-8649.2012.03308.x; Goodwin RA, 2014, P NATL ACAD SCI USA, V111, P5277, DOI 10.1073/pnas.1311874111; Goodyear CD, ATLAS SPAWNING NURSE; GORE JA, 1995, BIOSCIENCE, V45, P142, DOI 10.2307/1312553; Gutreuter S, 2003, T AM FISH SOC, V132, P646, DOI 10.1577/T01-098; Gutreuter S, 2006, CAN J FISH AQUAT SCI, V63, P2418, DOI 10.1139/F06-129; Guttridge TL, 2013, ANIM COGN, V16, P55, DOI 10.1007/s10071-012-0550-6; Holtschlag DJ, 2002, J GREAT LAKES RES, V28, P379, DOI 10.1016/S0380-1330(02)70592-3; Jansen HM, 2007, ICES J MAR SCI, V64, P1437, DOI 10.1093/icesjms/fsm132; JURAJDA P, 1995, REGUL RIVER, V10, P207, DOI 10.1002/rrr.3450100215; Keefer ML, 2006, CAN J FISH AQUAT SCI, V63, P1752, DOI 10.1139/F06-068; Killgore KJ, 2011, T AM FISH SOC, V140, P570, DOI 10.1080/00028487.2011.581977; LEVY DA, 1995, CAN J FISH AQUAT SCI, V52, P1, DOI 10.1139/f95-001; Miranda LE, 2013, J APPL ICHTHYOL, V29, P316, DOI 10.1111/jai.12132; Montgomery J, 2000, PHILOS T ROY SOC B, V355, P1325, DOI 10.1098/rstb.2000.0693; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nichols SJ, 2003, J GREAT LAKES RES, V29, P383; NIELSEN L A, 1986, Polskie Archiwum Hydrobiologii, V33, P277; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Northcote T.G., 1984, NATO Conference Series IV Marine Sciences, V14, P317; OGOWER AK, 1995, MAR FRESHWATER RES, V46, P861, DOI 10.1071/MF9950861; Oscoz J, 2005, HYDROBIOLOGIA, V543, P191, DOI 10.1007/s10750-004-7422-2; Parker SJ, 1997, J MAR BIOL ASSOC UK, V77, P871, DOI 10.1017/S0025315400036237; Peake S, 1997, CAN J FISH AQUAT SCI, V54, P1361, DOI 10.1139/cjfas-54-6-1361; Peterson DL, 2007, REV FISH BIOL FISHER, V17, P59, DOI 10.1007/s11160-006-9018-6; Pilcher MW, 2004, BIOLOGIA, V59, P669; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rusak JA, 1997, CAN J ZOOL, V75, P383, DOI 10.1139/z97-048; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Scott WB., 1973, FRESHWATER FISHES CA; Steel AE, 2013, ENVIRON BIOL FISH, V96, P215, DOI 10.1007/s10641-012-9992-6; SWALES S, 1982, FISH MANAGE, V13, P105; Thomas MV, 2002, J APPL ICHTHYOL, V18, P495, DOI 10.1046/j.1439-0426.2002.00387.x; Use of Fishes in Research Committees of the American Fisheries Society and the American Society of Ichthyologists and Herpetologists, 2014, GUIDELINES USE FISHE; Wagner GN, 2011, REV FISH BIOL FISHER, V21, P71, DOI 10.1007/s11160-010-9191-5; Watanabe YY, 2013, ENVIRON BIOL FISH, V96, P123, DOI 10.1007/s10641-012-0019-0; Wohl E., 2004, DISCONNECTED RIVERS	49	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179791	10.1371/journal.pone.0179791	http://dx.doi.org/10.1371/journal.pone.0179791			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678798	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200028
J	Reisberg, S; Iljasenko, T; Lall, K; Fischer, K; Vilo, J				Reisberg, Sulev; Iljasenko, Tatjana; Lall, Kristi; Fischer, Krista; Vilo, Jaak			Comparing distributions of polygenic risk scores of type 2 diabetes and coronary heart disease within different populations	PLOS ONE			English	Article							GENETIC RISK; EVENTS	Polygenic risk scores are gaining more and more attention for estimating genetic risks for liabilities, especially for noncommunicable diseases. They are now calculated using thousands of DNA markers. In this paper, we compare the score distributions of two previously published very large risk score models within different populations. We show that the risk score model together with its risk stratification thresholds, built upon the data of one population, cannot be applied to another population without taking into account the target population's structure. We also show that if an individual is classified to the wrong population, his/her disease risk can be systematically incorrectly estimated.	[Reisberg, Sulev; Iljasenko, Tatjana; Vilo, Jaak] Univ Tartu, Inst Comp Sci, Tartu, Estonia; [Reisberg, Sulev; Vilo, Jaak] Software Technol & Applicat Competence Ctr, Tartu, Estonia; [Reisberg, Sulev; Vilo, Jaak] Quretec Ltd, Tartu, Estonia; [Lall, Kristi] Univ Tartu, Inst Math & Stat, Tartu, Estonia; [Lall, Kristi; Fischer, Krista] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu	Reisberg, S (corresponding author), Univ Tartu, Inst Comp Sci, Tartu, Estonia.; Reisberg, S (corresponding author), Software Technol & Applicat Competence Ctr, Tartu, Estonia.; Reisberg, S (corresponding author), Quretec Ltd, Tartu, Estonia.	sulevreisberg@gmail.com	Vilo, Jaak/AAK-2228-2020; Vilo, Jaak/A-7183-2008	Vilo, Jaak/0000-0001-5604-4107; Vilo, Jaak/0000-0001-5604-4107	European Regional Development Funds for the Center of Excellence of Estonian ICT research EXCITE and Estonian Research Council [IUT34-4]	European Regional Development Funds for the Center of Excellence of Estonian ICT research EXCITE and Estonian Research Council	This work was supported by the following: European Regional Development Funds for the Center of Excellence of Estonian ICT research EXCITE and Estonian Research Council grant IUT34-4: These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors JV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Quretec Ltd.: The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors JV and SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Software Technology and Applications Competence Centre: The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors JV and SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; Agerbo E, 2015, JAMA PSYCHIAT, V72, P635, DOI 10.1001/jamapsychiatry.2015.0346; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Belsky DW, 2014, BIODEMOGR SOC BIOL, V60, P137, DOI 10.1080/19485565.2014.946591; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Chikowore T, 2016, DIABETES RES CLIN PR, V122, P1, DOI 10.1016/j.diabres.2016.09.019; Krapohl E, 2016, MOL PSYCHIATR, V21, P437, DOI 10.1038/mp.2015.2; Lall K, 2016, GENETICS MED; Leitsalu L, 2014, INT J EPIDEMIOL; Lu Dongsheng, 2013, Frontiers in Genetics, V4, P127, DOI 10.3389/fgene.2013.00127; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Martin AR, 2017, AM J HUMAN GENETICS; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Musliner KL, 2015, PSYCHOL MED, V45, P1709, DOI 10.1017/S0033291714002839; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smith Jennifer A, 2015, Curr Epidemiol Rep, V2, P180; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2016, GLOB REP DIAB 2016; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	21	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179238	10.1371/journal.pone.0179238	http://dx.doi.org/10.1371/journal.pone.0179238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678847	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200009
J	Dos Santos, PC; Panero, J; Stanganelli, C; Nagore, VP; Stella, F; Bezares, R; Slavutsky, I				Carolina Dos Santos, Patricia; Panero, Julieta; Stanganelli, Carmen; Palau Nagore, Virginia; Stella, Flavia; Bezares, Raimundo; Slavutsky, Irma			Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia	PLOS ONE			English	Article							TELOMERE-ASSOCIATED GENES; PROTEIN COMPLEX; MUTATION STATUS; EXPRESSION; SURVIVAL; LENGTH; SUBGROUPS; MAINTENANCE; ABERRATIONS; PROGNOSIS	Telomeres are protective repeats of TTAGGG sequences located at the end of human chromosomes. They are essential to maintain chromosomal integrity and genome stability. Telomerase is a ribonucleoprotein complex containing an internal RNA template (hTR) and a catalytic subunit (hTERT). The human hTR gene consists of three major domains; among them the H/ACA domain is essential for telomere biogenesis. H/ACA ribonucleoprotein (RNP) complex is composed of four evolutionary conserved proteins, including dyskerin (encoded by DKC1 gene), NOP10, NHP2 and GAR1. In this study, we have evaluated the expression profile of the H/ACA RNP complex genes: DKC1, NOP10, NHP2 and GAR1, as well as hTERT and hTR mRNA levels, in patients with chronic lymphocytic leukemia (CLL). Results were correlated with the number and type of genetic alteration detected by conventional cytogenetics and FISH (fluorescence in situ hybridization), IGHV (immunoglobulin heavy chain variable region) mutational status, telomere length (TL) and clinico-pathological characteristics of patients. Our results showed significant decreased expression of GAR1, NOP10, DKC1 and hTR, as well as increased mRNA levels of hTERT in patients compared to controls (p <= 0.04). A positive correlation between the expression of GAR1-NHP2, GAR1NOP10, and NOP10-NHP2 (p<0.0001), were observed. The analysis taking into account prognostic factors showed a significant increased expression of hTERT gene in unmutated-IGHV cases compared to mutated-CLL patients (p = 0.0185). The comparisons among FISH groups exhibited increased expression of DKC1 in cases with two or more alterations with respect to no abnormalities, trisomy 12 and del13q14, and of NHP2 and NOP10 compared to those with del13q14 (p = 0.03). The analysis according to TL showed a significant increased expression of hTERT (p = 0.0074) and DKC1 (p = 0.0036) in patients with short telomeres compared to those with long TL. No association between gene expression and clinical parameters was found. Our results suggest a role for these telomere associated genes in genomic instability and telomere dysfunction in CLL.	[Carolina Dos Santos, Patricia; Panero, Julieta; Palau Nagore, Virginia; Stella, Flavia; Slavutsky, Irma] Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, Inst Med Expt, Lab Genet Neoplasias Linfoides, Buenos Aires, DF, Argentina; [Stanganelli, Carmen] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Patol Mol, Buenos Aires, DF, Argentina; [Bezares, Raimundo] Hosp Teodoro Alvarez, Serv Hematol, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas	Slavutsky, I (corresponding author), Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, Inst Med Expt, Lab Genet Neoplasias Linfoides, Buenos Aires, DF, Argentina.	islavutsky@hematologia.anm.edu.ar		Dos Santos, Patricia Carolina/0000-0002-6607-7620	National Agency of Scientific and Technical Promotion (ANPCyT) [PICT-2014-1566]; National Cancer Institute of Argentina	National Agency of Scientific and Technical Promotion (ANPCyT)(ANPCyT); National Cancer Institute of Argentina	This work was supported by grants of the National Agency of Scientific and Technical Promotion (ANPCyT) PICT-2014-1566 and the National Cancer Institute of Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisani A, 2014, BIOL CHEM, V395, P593, DOI 10.1515/hsz-2013-0287; Bachand F, 2001, NUCLEIC ACIDS RES, V29, P3385, DOI 10.1093/nar/29.16.3385; Bechter OE, 1998, CANCER RES, V58, P4918; Bieche I, 2000, CLIN CANCER RES, V6, P452; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Chiodi I, 2013, BBA-MOL CELL RES, V1833, P1885, DOI 10.1016/j.bbamcr.2013.03.030; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Damle RN, 2004, BLOOD, V103, P375, DOI 10.1182/blood-2003-04-1345; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de la Guardia RD, 2012, J CELL MOL MED, V16, P3009, DOI 10.1111/j.1582-4934.2012.01628.x; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dos Santos P, 2015, TUMOR BIOL, V36, P8317, DOI 10.1007/s13277-015-3556-2; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Fernandez-Garcia I, 2013, INTEGR BIOL-UK, V5, P402, DOI 10.1039/c2ib20219k; Ferri CA, 2015, EUR J HAEMATOL, V94, P270, DOI 10.1111/ejh.12358; Folini M, 2005, EUR J CANCER, V41, P624, DOI 10.1016/j.ejca.2004.12.002; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hoxha M, 2014, GENE CHROMOSOME CANC, V53, P612, DOI 10.1002/gcc.22171; Lin P, 2015, HISTOCHEM CELL BIOL, V144, P543, DOI 10.1007/s00418-015-1359-6; Mansouri L, 2013, AM J HEMATOL, V88, P647, DOI 10.1002/ajh.23466; Mason PJ, 2011, CANCER GENET-NY, V204, P635, DOI 10.1016/j.cancergen.2011.11.002; Meier UT, 2006, TRENDS BIOCHEM SCI, V31, P311, DOI 10.1016/j.tibs.2006.04.002; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Panero J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137972; Panero J, 2015, MOL BIOTECHNOL, V57, P155, DOI 10.1007/s12033-014-9811-8; Panero J, 2010, MOL MED, V16, P471, DOI 10.2119/molmed.2010.00057; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rampazzo E, 2012, HAEMATOL-HEMATOL J, V97, P56, DOI 10.3324/haematol.2011.049874; Roos G, 2008, BLOOD, V111, P2246, DOI 10.1182/blood-2007-05-092759; Sbarrato T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.148; Sellmann L, 2011, INT J HEMATOL, V93, P74, DOI 10.1007/s12185-010-0750-2; Stanganelli C, 2013, CL LYMPH MYELOM LEUK, V13, P447, DOI 10.1016/j.clml.2013.02.019; Tchirkov A, 2004, ANN ONCOL, V15, P1476, DOI 10.1093/annonc/mdh389; Terrin L, 2007, LEUKEMIA, V21, P965, DOI 10.1038/sj.leu.2404607; Travella A, 2013, HEMATOL ONCOL, V31, P339, DOI 10.1002/hon.2025; Ulaner GA, 2004, AM J MED, V117, P262, DOI 10.1016/j.amjmed.2004.02.048; von Stedingk K, 2013, TRANSL ONCOL, V6, P447, DOI 10.1593/tlo.13112; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179883	10.1371/journal.pone.0179883	http://dx.doi.org/10.1371/journal.pone.0179883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666010	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700043
J	von Stemann, JH; Rigas, AS; Thorner, LW; Rasmussen, DGK; Pedersen, OB; Rostgaard, K; Erikstrup, C; Ullum, H; Hansen, MB				von Stemann, Jakob Hjorth; Rigas, Andreas Stribolt; Thorner, Lise Wegner; Rasmussen, Daniel Guldager Kring; Pedersen, Ole Birger; Rostgaard, Klaus; Erikstrup, Christian; Ullum, Henrik; Hansen, Morten Bagge			Prevalence and correlation of cytokine-specific autoantibodies with epidemiological factors and C-reactive protein in 8,972 healthy individuals: Results from the Danish Blood Donor Study	PLOS ONE			English	Article							PULMONARY ALVEOLAR PROTEINOSIS; IGG AUTOANTIBODIES; NEUTRALIZING AUTOANTIBODIES; ANTIBODY; PLASMA; IL-6; INTERLEUKIN-1-ALPHA; INTERFERON; AIRE; AGE	Natural cytokine-specific autoantibodies (c-aAb) have been measured in healthy and diseased individuals, and have been considered as both endogenous immune-regulators and pathogenic factors. Overall, the etiology and potential pathology of c-aAb are still undefined. To further characterize the sero-prevalence, predictors and consequences of high c-aAb levels, we performed the largest population-based study of c-aAb to date, using participants and epidemiological data from the Danish Blood Donor Study. Using a validated beadbased multiplex assay we assessed plasma levels of IL-1 alpha, IL-6, IL-10, IFN alpha and GM-CSFspecific c-aAb in 8,972 healthy blood donors. Trace levels of at least one of the investigated c-aAb could be measured in 86% of the participants. The presence of high levels of potentially inhibitory c-aAb was generally associated with increasing age and male or female sex, depending on the c-aAb in question. A negative correlation between high levels of IL-6-specific c-aAb and plasma levels of C-reactive protein was observed, indicating cytokineneutralizing levels of c-aAb in healthy blood donors. There was no substantial correlation between high levels of the five individual c-aAb investigated in this study. These data suggest that autoimmunity against endogenous cytokines is a relatively common phenomenon in healthy individuals, and that predictive factors for high, potentially neutralizing c-aAb levels vary depending on the cytokine in question, and may differ from predictors of general c-aAb presence.	[von Stemann, Jakob Hjorth; Rigas, Andreas Stribolt; Thorner, Lise Wegner; Rasmussen, Daniel Guldager Kring; Ullum, Henrik; Hansen, Morten Bagge] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark; [Pedersen, Ole Birger] Naestved Sygehus, Dept Clin Immunol, Naestved, Denmark; [Rostgaard, Klaus] Statens Serum Inst, Epidemiol Res, Copenhagen, Denmark; [Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark	Rigshospitalet; University of Copenhagen; Naestved Hospital; Statens Serum Institut; Aarhus University	von Stemann, JH (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark.	jakob.hjorth.von.stemann@regionh.dk	Pedersen, Ole Birger/W-8679-2019	Pedersen, Ole Birger/0000-0003-2312-5976; Ullum, Henrik/0000-0001-7306-9058; Thorner, Lise Wegner/0000-0003-4391-4956; Erikstrup, Christian/0000-0001-6551-6647; Rostgaard, Klaus/0000-0001-6220-9414	Danish Council for Independent Research-medical sciences [09-069412]; Danish Administrative Regions; Bloddonorernes Forskningsfond; Fonden til Laevidenskabens Fremme; Danish Bio and Genome Bank; Rigshospitalet Research Foundation	Danish Council for Independent Research-medical sciences(Det Frie Forskningsrad (DFF)); Danish Administrative Regions; Bloddonorernes Forskningsfond; Fonden til Laevidenskabens Fremme; Danish Bio and Genome Bank; Rigshospitalet Research Foundation	The Danish Blood Donor Study was funded by: The Danish Council for Independent Research-medical sciences (http://ufm.dk/en/research-and-innovation/councils-and-commission/the-danish-council-for-independent-research, grant number: 09-069412); The Danish Administrative Regions (http://www.regioner.dk); Bloddonorernes Forskningsfond (https://forening. bloddonor.dk/om-bloddonorerne-idanmark/fonde); Fonden til Laevidenskabens Fremme (https://www.apmollerfonde.dk/ansoegning/laegefonden.aspx); The Danish Bio and Genome Bank (http:// www.regioner.dk/rbgben). The first author was funded by Rigshospitalet Research Foundation (https://www.forskningspuljer-rh.dk). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Ben-Dov I, 2014, AUTOIMMUN REV, V13, P513, DOI 10.1016/j.autrev.2014.01.046; Browne SK, 2014, ANNU REV IMMUNOL, V32, P635, DOI 10.1146/annurev-immunol-032713-120222; Browne SK, 2010, IMMUNOL CELL BIOL, V88, P614, DOI 10.1038/icb.2010.72; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Calabrese LH, 2014, NAT REV RHEUMATOL, V10, P720, DOI 10.1038/nrrheum.2014.127; Cappellano G, 2012, AM J CLIN EXP IMMUNO, V1, P136; Ferretti A, 2016, J IMMUNOL; Fosgerau K, 2010, J ENDOCRINOL, V204, P265, DOI 10.1677/JOE-09-0413; Galle P, 2004, EUR J IMMUNOL, V34, P3267, DOI 10.1002/eji.200425268; Galle P, 2004, EUR J IMMUNOL, V34, P291, DOI 10.1002/eji.200324338; Galle P, 2007, INT IMMUNOPHARMACOL, V7, P1704, DOI 10.1016/j.intimp.2007.08.026; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Graudal NA, 2002, ANN RHEUM DIS, V61, P598, DOI 10.1136/ard.61.7.598; Guldager DKR, 2015, J IMMUNOL METHODS, V425, P62, DOI 10.1016/j.jim.2015.06.010; Gupta S, 2016, ARTHRITIS RHEUMATOL, V68, P1677, DOI 10.1002/art.39607; Hansen MB, 2007, VOX SANG, V92, P213, DOI 10.1111/j.1423-0410.2006.00881.x; HANSEN MB, 1994, EUR J CLIN INVEST, V24, P212, DOI 10.1111/j.1365-2362.1994.tb00991.x; HANSEN MB, 1991, IMMUNOL LETT, V30, P133, DOI 10.1016/0165-2478(91)90102-G; Homann C, 1996, SCAND J IMMUNOL, V44, P623, DOI 10.1046/j.1365-3083.1996.d01-344.x; Jouvenne P, 1997, SCAND J IMMUNOL, V46, P413, DOI 10.1046/j.1365-3083.1997.d01-139.x; Kaspersen KA, 2015, EPIDEMIOLOGY, V26, P580, DOI 10.1097/EDE.0000000000000301; Kildey K, 2014, HUM IMMUNOL, V75, P973, DOI 10.1016/j.humimm.2014.08.200; KIRCHNER H, 1991, CANCER, V67, P1862, DOI 10.1002/1097-0142(19910401)67:7<1862::AID-CNCR2820670708>3.0.CO;2-R; Kisand K, 2008, BLOOD, V112, P2657, DOI 10.1182/blood-2008-03-144634; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; Maniwa K, 2000, Respirology, V5, P315, DOI 10.1046/j.1440-1843.2000.00269.x; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; MenetrierCaux C, 1996, CLIN EXP IMMUNOL, V104, P173, DOI 10.1046/j.1365-2249.1996.d01-646.x; Nanki T, 2013, ANN RHEUM DIS, V72, P1100, DOI 10.1136/annrheumdis-2012-202768; Ndongo-Thiam N, 2016, ANN RHEUM DIS, V75, P1420, DOI 10.1136/annrheumdis-2016-209149; Pedersen OB, 2012, VOX SANG, V102, P271, DOI 10.1111/j.1423-0410.2011.01553.x; Perricone C, 2016, AUTOIMMUN REV, V15, P354, DOI 10.1016/j.autrev.2016.01.001; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Rieper CD, 2010, CYTOKINE, V51, P286, DOI 10.1016/j.cyto.2010.06.009; Rieper CD, 2009, CYTOKINE GROWTH F R, V20, P61, DOI 10.1016/j.cytogfr.2009.01.003; Rigas AS, 2014, TRANSFUSION, V54, P789, DOI 10.1111/trf.12518; Rosenberg JM, 2016, J ALLERGY CLIN IMMUN, V137, P204, DOI 10.1016/j.jaci.2015.07.032; Ross C, 1997, BLOOD, V90, P2376; ROSS C, 1995, J CLIN INVEST, V95, P1974, DOI 10.1172/JCI117881; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Sorensen CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088196; Strobel P, 2007, J PATHOL, V211, P563, DOI 10.1002/path.2141; SUZUKI H, 1991, CLIN EXP IMMUNOL, V85, P407; Svenson M, 1998, BLOOD, V91, P2054, DOI 10.1182/blood.V91.6.2054.2054_2054_2061; SVENSON M, 1991, CYTOKINE, V3, P125, DOI 10.1016/1043-4666(91)90032-9; SVENSON M, 1989, SCAND J IMMUNOL, V29, P489, DOI 10.1111/j.1365-3083.1989.tb01149.x; Svenson M, 2000, J IMMUNOL METHODS, V236, P1, DOI 10.1016/S0022-1759(99)00232-X; van Rooijen M, 2006, J THROMB HAEMOST, V4, P77, DOI 10.1111/j.1538-7836.2005.01690.x; VANDELOO AAJ, 1995, AM J PATHOL, V146, P239; Versini M, 2014, AUTOIMMUN REV, V13, P981, DOI 10.1016/j.autrev.2014.07.001; Vincent T, 2015, AUTOIMMUN REV, V14, P528, DOI 10.1016/j.autrev.2015.01.015	56	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179981	10.1371/journal.pone.0179981	http://dx.doi.org/10.1371/journal.pone.0179981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665954	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608700048
J	Wang, QZ; Liu, HC; Wang, Q; Zhou, FH; Liu, YX; Zhang, YW; Ding, HY; Yuan, M; Li, FJ; Chen, YC				Wang, Qiaozhen; Liu, Huancai; Wang, Qing; Zhou, Fenghua; Liu, Yongxin; Zhang, Yawen; Ding, Haoyu; Yuan, Meng; Li, Fengjie; Chen, Yanchun			ocr v56 Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9	PLOS ONE			English	Article							SIGNALING PATHWAY; PROTEIN	Osteosarcoma (OS) is an aggressive bone tumor, and proto-oncogene c-Fos is involved in this lethal disease. However, the role and molecular mechanism of c-Fos in the development and progression of OS remain enigmatic. As one of the Wnt family members, Wnt2 is closely associated with the development of several malignant tumors. In the present study, the expression of c-Fos, Wnt2, and its receptor Fzd9 in human OS tissues, MG63 OS cell line, and human osteoblast hFOB 1.19 cell line was detected by Western blot analysis, immunohistochemical staining, or reverse transcription-polymerase chain reaction. The role of c-Fos in the OS was clarified by treating MG63 cells with small interfering RNA to knockdown c-Fos. Then, cell migration and invasion were assayed by transwell assays and wound healing assay; cell proliferation was assayed by MTS method and 5-ethynyl-2'-deoxyuridine DNA proliferation in vitro detection; cell apoptosis was assayed by flow cytometric method. Co-immunoprecipitation kit was used to confirm the relationship between c-Fos and Wnt2/Fzd9. We found that the expression of c-Fos, Wnt2, and Fzd9 protein was distinctly higher in human OS tissues than that in the adjacent non-cancerous tissues, and their expression in the MG63 OS cell line was markedly increased compared with that in the human osteoblast hFOB 1.19 cell line. Knockdown of c-Fos inhibited the proliferation, migration, and invasion of MG63 cells, and promoted the apoptosis of MG63 cells. Moreover, knockdown of c-Fos inhibited the expression of Wnt2 and Fzd9 mRNA and protein. Our data enforced the evidence that knockdown of c-Fos inhibited cell proliferation, migration, and invasion, and promoted the apoptosis of OS cells accompanied by altered expression of Wnt2 and Fzd9. These findings offer new clues for OS development and progression, and c-Fos may be a potential therapeutic target for OS.	[Wang, Qiaozhen; Wang, Qing] Weifang Med Univ, Dept Human Anat, Weifang, Shandong, Peoples R China; [Liu, Huancai] Weifang Med Univ, Affiliated Hosp, Weifang, Shandong, Peoples R China; [Zhou, Fenghua] Weifang Med Univ, Dept Pathol, Weifang, Shandong, Peoples R China; [Liu, Yongxin; Zhang, Yawen; Ding, Haoyu; Yuan, Meng; Li, Fengjie; Chen, Yanchun] Weifang Med Univ, Dept Histol & Embryol, Weifang, Shandong, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University	Chen, YC (corresponding author), Weifang Med Univ, Dept Histol & Embryol, Weifang, Shandong, Peoples R China.	cyc7907@163.com	Liu, Yong/GWQ-6163-2022		National Natural Science Foundation of China [81401066]; Shandong Province Natural Science Foundation of China [ZR2016HM60, ZR2012HQ021, ZR2016HL20]; Shandong Medical and Health Science and Technology Development Program [2016WS0691, 2016WS0666]; Shandong Provincial Education Department [J11LF16]; Science and Technology Development Program of Weifang in China [201301074]; Technology Innovation Fund of Weifang Medical University [KX2016009, KX2016015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation of China; Shandong Medical and Health Science and Technology Development Program; Shandong Provincial Education Department; Science and Technology Development Program of Weifang in China; Technology Innovation Fund of Weifang Medical University	This study was supported by National Natural Science Foundation of China (81401066), the Shandong Province Natural Science Foundation of China (ZR2016HM60; ZR2012HQ021; ZR2016HL20), Shandong Medical and Health Science and Technology Development Program (2016WS0691; 2016WS0666), Shandong Provincial Education Department (J11LF16), the Science and Technology Development Program of Weifang in China (201301074), Technology Innovation Fund of Weifang Medical University (KX2016009; KX2016015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CSX, 2017, PROSTATE, V77, P72, DOI 10.1002/pros.23250; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Cai Y, 2014, J CELL BIOCHEM, V115, P625, DOI 10.1002/jcb.24708; Chen X, 2013, CELL PHYSIOL BIOCHEM, V32, P1083, DOI 10.1159/000354508; Chen YC, 2015, AM J TRANSL RES, V7, P1574; Chen YC, 2012, BIOCHEM BIOPH RES CO, V420, P397, DOI 10.1016/j.bbrc.2012.03.006; Dale TC, 1996, CANCER RES, V56, P4320; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Fan Q, 2013, CELL BIOCHEM FUNCT, V31, P319, DOI 10.1002/cbf.2902; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; He HT, 2014, ONCOL LETT, V7, P1352, DOI 10.3892/ol.2014.1935; He JP, 2014, ASIAN PAC J CANCER P, V15, P5967, DOI 10.7314/APJCP.2014.15.15.5967; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Huang CB, 2015, AM J CANCER RES, V5, P1032; Jung YS, 2015, ONCOTARGET, V6, P37257, DOI 10.18632/oncotarget.6133; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Kim Mijin, 2016, J Menopausal Med, V22, P6, DOI 10.6118/jmm.2016.22.1.6; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105506; Liu ZG, 2016, ONCOTARGET, V7, P65946, DOI 10.18632/oncotarget.11779; Marino-Enriquez Adrian, 2016, Surg Pathol Clin, V9, P457, DOI 10.1016/j.path.2016.04.009; Nouri H, 2015, J BONE ONCOL, V4, P115, DOI 10.1016/j.jbo.2015.07.002; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; VANDENBERG S, 1993, CARCINOGENESIS, V14, P925, DOI 10.1093/carcin/14.5.925; Wang W, 2010, CANCER INVEST, V28, P230, DOI 10.3109/07357900903095698; Weekes D, 2016, ONCOGENE, V35, P2948, DOI 10.1038/onc.2015.420; Wu CH, 2013, ADV MECH ENG, DOI 10.1155/2013/627124; Xiao Q, 2016, TUMOR BIOL, V37, P6315, DOI 10.1007/s13277-015-4466-z; Yang J., 2016, ELIFE, V5, P5, DOI DOI 10.1155/2016/1690896; Zhao YH, 2016, J BIOL CHEM, V291, P6831, DOI 10.1074/jbc.M115.704361	30	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180558	10.1371/journal.pone.0180558	http://dx.doi.org/10.1371/journal.pone.0180558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665975	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700017
J	Chan, J; Mack, DR; Manuel, DG; Mojaverian, N; de Nanassy, J; Benchimol, EI				Chan, Jason; Mack, David R.; Manuel, Douglas G.; Mojaverian, Nassim; de Nanassy, Joseph; Benchimol, Eric I.			Validation of an algorithm to identify children with biopsy-proven celiac disease from within health administrative data: An assessment of health services utilization patterns in Ontario, Canada	PLOS ONE			English	Article							PEDIATRIC-GASTROENTEROLOGY; CLINICAL PRESENTATION; CONFIDENCE-INTERVALS; PREVALENCE; DIAGNOSIS; GLUTEN	Importance Celiac disease (CD) is a common pediatric illness, and awareness of gluten-related disorders including CD is growing. Health administrative data represents a unique opportunity to conduct population-based surveillance of this chronic condition and assess the impact of caring for children with CD on the health system. Objective The objective of the study was to validate an algorithm based on health administrative data diagnostic codes to accurately identify children with biopsy-proven CD. We also evaluated trends over time in the use of health services related to CD by children in Ontario, Canada. Study design and setting We conducted a retrospective cohort study and validation study of population-based health administrative data in Ontario, Canada. All cases of biopsy-proven CD diagnosed 2005-2011 in Ottawa were identified through chart review from a large pediatric health care center, and linked to the Ontario health administrative data to serve as positive reference standard. All other children living within Ottawa served as the negative reference standard. Case-identifying algorithms based on outpatient physician visits with associated ICD-9 code for CD plus endoscopy billing code were constructed and tested. Sensitivity, specificity, PPV and NPV were tested for each algorithm (with 95% CI). Poisson regression, adjusting for sex and age at diagnosis, was used to explore the trend in outpatient visits associated with a CD diagnostic code from 1995-2011. Results The best algorithm to identify CD consisted of an endoscopy billing claim follow by 1 or more adult or pediatric gastroenterologist encounters after the endoscopic procedure. The sensitivity, specificity, PPV, and NPV for the algorithm were: 70.4% (95% CI 61.1-78.4%), >99.9% (95% CI >99.9->99.9%), 53.3% (95% CI 45.1-61.4%) and >99.9% (95% CI >99.9>99.9%) respectively. It identified 1289 suspected CD cases from Ontario-wide administrative data. There was a 9% annual increase in the use of this combination of CD-associated diagnostic codes in physician billing data (RR 1.09, 95% CI 1.07-1.10, P<0.001). Conclusions With its current structure and variables Ontario health administrative data is not suitable in identifying incident pediatric CD cases. The tested algorithms suffer from poor sensitivity and/or poor PPV, which increase the risk of case misclassification that could lead to biased estimation of CD incidence rate. This study reinforced the importance of validating the codes used to identify cohorts or outcomes when conducting research using health administrative data.	[Chan, Jason; Benchimol, Eric I.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Mack, David R.; Benchimol, Eric I.] Childrens Hosp Eastern Ontario, Div Gastroenterol Hepatol & Nutr, Ottawa, ON, Canada; [Mack, David R.; Benchimol, Eric I.] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada; [Manuel, Douglas G.; Mojaverian, Nassim] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Manuel, Douglas G.; Mojaverian, Nassim] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [de Nanassy, Joseph] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Benchimol, EI (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.; Benchimol, EI (corresponding author), Childrens Hosp Eastern Ontario, Div Gastroenterol Hepatol & Nutr, Ottawa, ON, Canada.; Benchimol, EI (corresponding author), Univ Ottawa, Dept Pediat, Ottawa, ON, Canada.	ebenchimol@cheo.on.ca	Benchimol, Eric Ian/A-7711-2010; Manuel, Doug/D-7100-2014	Benchimol, Eric Ian/0000-0001-8855-3598; Manuel, Doug/0000-0003-0912-0845	CHEO Research Institute; ICES Research Grant; Ontario Graduate Scholarship; Canadian Child Health Clinician Scientist Program; Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Crohn's; Colitis Canada	CHEO Research Institute; ICES Research Grant; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Child Health Clinician Scientist Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology; Crohn's; Colitis Canada	This study was funded by the CHEO Research Institute(cheori.org) ICES Research Grant. Jason Chan was supported by an Ontario Graduate Scholarship (www.uottawa.ca/graduates tudies/students/awards/ontario-graduates scholarship). EricBenchimol was supported by a Career Development Award from the Canadian Child Health Clinician Scientist Program(cchcsp.ca), and a New Investigator Award from the Canadian Institutes of Health Research (cihr.ca), the Canadian Association of Gastroenterology(caga cg.org) and Crohn's and Colitis Canada (crohnsandcolitis.ca).	Benchimol EI, 2014, J CLIN EPIDEMIOL, V67, P887, DOI 10.1016/j.jclinepi.2014.02.019; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Cohen D, 2014, J ECON AGEING, V3, P44, DOI 10.1016/j.jeoa.2014.05.002; Ducharme R, 2013, J PEDIATR-US, V163, P1073, DOI 10.1016/j.jpeds.2013.05.034; Dydensborg S, 2012, ACTA PAEDIATR, V101, P179, DOI 10.1111/j.1651-2227.2011.02392.x; Fay MP, 1997, STAT MED, V16, P791; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Hurley JJ, 2012, EUR J GASTROEN HEPAT, V24, P482, DOI 10.1097/MEG.0b013e328350f888; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Cilleruelo ML, 2014, J PEDIATR GASTR NUTR, V59, P522, DOI 10.1097/MPG.0000000000000446; Mansueto P, 2014, J AM COLL NUTR, V33, P39, DOI 10.1080/07315724.2014.869996; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mattila E, 2013, J PEDIATR GASTR NUTR, V57, P53, DOI 10.1097/MPG.0b013e31828ee55d; Morinville V, 2007, CAN J GASTROENTEROL, V21, P653, DOI 10.1155/2007/292054; Mullen KA, 2014, TOBACCO CONTROL; Namatovu F, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-59; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Ravikumara M, 2007, J PEDIATR GASTR NUTR, V45, P497, DOI 10.1097/MPG.0b013e31812e5710; Ress K, 2012, EUR J PEDIATR, V171, P1823, DOI 10.1007/s00431-012-1835-0; Rewers M, 2005, GASTROENTEROLOGY, V128, pS47, DOI 10.1053/j.gastro.2005.02.030; Roma E, 2009, DIGESTION, V80, P185, DOI 10.1159/000227275; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; West J, 2014, AM J GASTROENTEROL, V109, P757, DOI 10.1038/ajg.2014.55; White LE, 2013, ARCH DIS CHILD, V98, P52, DOI 10.1136/archdischild-2012-302056	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180338	10.1371/journal.pone.0180338	http://dx.doi.org/10.1371/journal.pone.0180338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662204	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608300142
J	Duplaga, M				Duplaga, Mariusz			Digital divide among people with disabilities: Analysis of data from a nationwide study for determinants of Internet use and activities performed online	PLOS ONE			English	Article							HEALTH INFORMATION; ACCESS	Introduction The Internet is both an opportunity as well as a challenge for people with disabilities. However, this segment of the population is usually indicated among social groups experiencing digital divide. The study is focused on the analysis of factors determining Internet usage and undertaking specific activities online among people with disabilities based on a nationwide study performed in 2013 in Poland. Methods Secondary analysis was performed on the data of persons who declared disability status in 2013 "Social Diagnosis" study. Multivariate logistic regression models were developed for the use of the Internet and performing three types of activities online. Results Among 3,556 respondents with disability 51.02% were females, 25.19% 65 years of age and over and 33.05% were Internet users. The predictors of Internet usage included the degree of disability, place of residence, level of education, marital status, occupational status, net income, use of health care service and the use of mobile phone. The odds ratio that a person with disability belonging to the oldest category will use the Internet was only 0.04 (95% CI 0.02-0.09), when compared to the youngest category. The odds that a person with disability from the highest category of education will use the Internet were 18 times higher than in the case of persons with only basic education (OR 18.17, 95% CI 11.70-28.21). Common predictors of online activities (accessing websites of public institutions, checking and sending emails, publishing own content on the Internet) included age category and net income. Conclusions People with disabilities in Poland are facing a significant digital divide. The factors determining the use of the Internet in this group are similar to those of the general population. On the other hand, people with disabilities who are active online, access diversified types of services including presentation of their own content online.	[Duplaga, Mariusz] Jagiellonian Univ, Inst Publ Hlth, Med Coll, Fac Hlth Sci,Dept Hlth Promot, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Duplaga, M (corresponding author), Jagiellonian Univ, Inst Publ Hlth, Med Coll, Fac Hlth Sci,Dept Hlth Promot, Krakow, Poland.	mmduplag@cyfronet.pl	Duplaga, Mariusz/HHZ-9721-2022	Duplaga, Mariusz/0000-0001-6963-8414	Department of Health Promotion, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland [K/ZDS/006112]	Department of Health Promotion, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland	The study was performed in the framework of statutory project No K/ZDS/006112 carried out in the Department of Health Promotion, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg P, 2005, DISABIL SOC, V20, P719, DOI 10.1080/09687590500335733; Atkinson NL, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1035; Batorski D., 2013, CONT EC, V7, P335; Baxter S, 2012, INT J LANG COMM DIS, V47, P115, DOI 10.1111/j.1460-6984.2011.00090.x; Beck F, 2014, J MED INTERNET RES, V16, P193, DOI 10.2196/jmir.2934; Beckjord EB, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e20; Buntrock S, 2007, SCAND J UROL NEPHROL, V41, P367, DOI 10.1080/00365590701303827; Central Statistical Office in Poland, INF PORT; Chadwick D, 2013, FUTURE INTERNET, V5, P376, DOI 10.3390/fi5030376; Choi NG, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2333; Consumer Expert Group, 2009, CONS EXP GROUP REP U; Cook JA, 2005, DISABIL STUD Q, V25; D'Aubin A, 2007, INFORM SOC, V23, P193, DOI 10.1080/01972240701323622; Disability Finkelstein V., 1993, DISABLING BARRIERS E, P34; Dobransky K., 2006, Information Communication & Society, V9, P313, DOI 10.1080/13691180600751298; Duplaga M, 2012, J MED INTERNET RES, V14, P393, DOI 10.2196/jmir.2358; Dutton HW, OXFORD INTERNET SUR; European Commission, EUR DAT POP AG GROUP; European Commission, EUR DAT INT LEV ACC; European Commission, EUR DAT PREV DIS SOU; Fox S., 2011, AM LIVING DISABILITY; Gracia E, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1311; Guo BR, 2005, DISABIL SOC, V20, P49, DOI 10.1080/0968759042000283638; Henshaw H, 2012, J MED INTERNET RES, V14, P211, DOI 10.2196/jmir.2036; Hollier SE, 2007, THESIS; IAB Polska: TV+ WWW = Together better. (Polish), 2014, TOG BETT; Internet Society, 2012, INT ACC INT US PERS; Kaye H. S., 2000, 13 US DEP ED NAT I D; Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117; Lancioni G, 2013, ASSIST TECHNOL, P41; Ofcom Disabled consumers' use of communications services, 2015, CONS EXP RE; Office of Communications (Ofcom), 2013, CONS EXP REP; Office of the Government Plenipotentiary for Disabled People, ASS I ASS PROC MOD R; Panek T., 2013, CONT EC, P33; Vicente MR, 2010, INFORM SOC, V26, P48, DOI 10.1080/01615440903423245; Seybert H, 2013, 3 Q EUROPEANS USED I; Shakespeare T, 2006, DISABILITY STUDIES R, DOI DOI 10.2307/20141862; Siliquini R, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-21; Sindhu BS, 2003, P RESNA 26 INT ANN C; Smith PK, 2016, NZ DISABILITIES THEI; Special Eurobarometer 396, 2013, E COMM HOUS SURV REP; Takahashi Y, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1796; UNESCO Institute for Statistics, 2012, ISCED 2011, DOI DOI 10.15220/978-92-9189-123-8-EN; Union of the Physically Impaired Against Segregation and The Disability Alliance, 1975, FUND PRINC DIAB; University of Finance and Management, SOC DIAGN 2000 2013; US Department of Commerce, 2000, FALL NET DIG INCL RE; van de Poll-Franse LV, 2008, SUPPORT CARE CANCER, V16, P1189, DOI 10.1007/s00520-008-0419-z; van Uden-Kraan CF, 2009, INFORM HEALTH SOC CA, V34, P18, DOI 10.1080/17538150902773272; W3CWeb Accessibility Initiative (WAI), INTR WEB ACC; Wang JY, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1534; World Health Organization, 2013, US ICF PRACT MAN US; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization The World Bank, 2011, EORLD BANK WORLD REP	53	51	51	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179825	10.1371/journal.pone.0179825	http://dx.doi.org/10.1371/journal.pone.0179825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662125	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300053
J	Fernandez-Nino, M; Giraldo, D; Gomez-Porras, JL; Dreyer, I; Barrios, AFG; Arevalo-Ferro, C				Fernandez-Nino, Miguel; Giraldo, Daniel; Lucia Gomez-Porras, Judith; Dreyer, Ingo; Gonzalez Barrios, Andres Fernando; Arevalo-Ferro, Catalina			A synthetic multi-cellular network of coupled self-sustained oscillators	PLOS ONE			English	Article							ESCHERICHIA-COLI; SUPRACHIASMATIC NUCLEUS; MAMMALIAN-CELLS; GENE-EXPRESSION; TOGGLE SWITCH; QUORUM; SYNCHRONIZATION; CONSTRUCTION; CLOCKS; POPULATIONS	Engineering artificial networks from modular components is a major challenge in synthetic biology. In the past years, single units, such as switches and oscillators, were successfully constructed and implemented. The effective integration of these parts into functional artificial self-regulated networks is currently on the verge of breakthrough. Here, we describe the design of a modular higher-order synthetic genetic network assembled from two independent self-sustained synthetic units: repressilators coupled via a modified quorum-sensing circuit. The isolated communication circuit and the network of coupled oscillators were analysed in mathematical modelling and experimental approaches. We monitored clustering of cells in groups of various sizes. Within each cluster of cells, cells oscillate synchronously, whereas the theoretical modelling predicts complete synchronization of the whole cellular population to be obtained approximately after 30 days. Our data suggest that self-regulated synchronization in biological systems can occur through an intermediate, long term clustering phase. The proposed artificial multicellular network provides a system framework for exploring how a given network generates a specific behaviour.	[Fernandez-Nino, Miguel; Arevalo-Ferro, Catalina] Univ Nacl Colombia, Dept Biol, Bogota, Colombia; [Giraldo, Daniel; Gonzalez Barrios, Andres Fernando] Univ Los Andes, Dept Ingn Quim, Grp Diseno Prod & Proc GDPP, Bogota, Colombia; [Lucia Gomez-Porras, Judith; Dreyer, Ingo] Univ Talca, Ctr Bioinformat & Simulac Mol CBSM, Talca, Chile; [Dreyer, Ingo] Univ Potsdam, Heisenberg Grp BPMPB, Potsdam, Germany	Universidad Nacional de Colombia; Universidad de los Andes (Colombia); Universidad de Talca; University of Potsdam	Arevalo-Ferro, C (corresponding author), Univ Nacl Colombia, Dept Biol, Bogota, Colombia.	carevalof@unal.edu.co	Dreyer, Ingo/N-4747-2014	Dreyer, Ingo/0000-0002-2781-0359; Gonzalez Barrios, Andres Fernando/0000-0003-2517-2020; Fernandez-Nino, Miguel/0000-0002-8231-7989	DAAD (German Academic Exchange Service); PROCOL [340/2009 (201010013775)]	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); PROCOL	We thank DAAD (German Academic Exchange Service) and the program PROCOL (Interchange of researchers in the framework of joint research projects) grant No. 340/2009 (201010013775) for the financial support.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Carlier A, 2003, APPL ENVIRON MICROB, V69, P4989, DOI 10.1128/AEM.69.8.4989-4993.2003; Chen BS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-136; Chen Y, 2015, SCIENCE, V349, P986, DOI 10.1126/science.aaa3794; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dockery JD, 2001, B MATH BIOL, V63, P95, DOI 10.1006/bulm.2000.0205; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Honma S, 2012, PROG BRAIN RES, V199, P129, DOI 10.1016/B978-0-444-59427-3.00029-0; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Mina P, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0612; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; NJUS D, 1981, CELL BIOPHYS, V3, P223, DOI 10.1007/BF02782625; Pikovsky A, 2003, CAMBRIDGE NONLINEAR, V432; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Ryback BM, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-26; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	33	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180155	10.1371/journal.pone.0180155	http://dx.doi.org/10.1371/journal.pone.0180155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662174	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300114
J	Fung, RSK; Bai, J; Yuen, KWY; Wong, AOL				Fung, Roger S. K.; Bai, Jin; Yuen, Karen W. Y.; Wong, Anderson O. L.			Activin/follistatin system in grass carp pituitary cells: - Regulation by local release of growth hormone and luteinizing hormone and its functional role in growth hormone synthesis and secretion	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; RIBONUCLEIC-ACID LEVELS; BETA-PROMOTER ACTIVITY; GENE-EXPRESSION; ACTIVIN-A; SIGNAL-TRANSDUCTION; MESSENGER-RNA; FEEDBACK LOOP; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-2	Gonadotrophin regulation by activin/follistatin system is well-documented, but the corresponding effect on growth hormone (GH) has not been fully characterized and with little information available in lower vertebrates, especially in fish models. In grass carp, local interactions of GH and luteinizing hormone (LH) can induce GH release and gene expression at pituitary level via autocrine/paracrine mechanisms. To shed light on the role of activin/follistatin system in GH regulation by local actions of GH and LH, grass carp activin beta A and beta B were cloned, shown to be single-copy genes expressed in the pituitary, and confirmed to encode activin proteins capable of transactivating promoter with activin-responsive elements. In grass carp pituitary cells, activin A and B were effective in reducing GH secretion and GH cell content with concurrent drop in GH mRNA level whereas the opposite was true for follistatin, the activin-binding protein known to neutralize the effects of endogenous activin. Treatment with activin A and B not only could suppress basal but also inhibit GH mRNA expression induced by GH and human chorionic gonadotropin (hCG), a functional analogue of LH in fish model. Apparently, down-regulation of GH mRNA by activin was mediated by reducing GH transcript stability with concurrent inhibition on GH promoter activity via the SMAD pathway. In reciprocal experiments, GH treatment was found to up-regulate activin beta A, activin beta B and follistatin mRNA levels in carp pituitary cells but the opposite was noted by removing endogenous GH with GH antiserum. Interestingly, parallel treatment with hCG could also inhibit basal as well as GH-induced activin beta A, activin beta B and follistatin gene expression. These results, as a whole, indicate that the pituitary activin/follistatin system can serve as a regulatory target for local interactions of GH and LH and contribute to GH regulation by autocrine/paracrine mechanisms in the carp pituitary.	[Fung, Roger S. K.; Bai, Jin; Yuen, Karen W. Y.; Wong, Anderson O. L.] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Wong, AOL (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	olwong@hku.hk	Bai, Jin/AAO-3960-2021; Wong, Anderson O L/S-1667-2017	Bai, Jin/0000-0002-4241-8814; Wong, Anderson O L/0000-0003-4224-4110	GRF [780312, 781113, 17128215, 17117716]; NSFC/RGC Research Grant Council, Hong Kong [N_HKU732/12]; School of Biological Sciences,University of Hong Kong	GRF; NSFC/RGC Research Grant Council, Hong Kong; School of Biological Sciences,University of Hong Kong(University of Hong Kong)	The project was supported by GRF grants (780312, 781113, 17128215 and 17117716) and NSFC/RGC Joint Grant (N_HKU732/12) from Research Grant Council,Hong Kong (toAOLW). Financial support from the School of Biological Sciences,University of Hong Kong,in theform of postgraduate studentship (toRSKF&JB) is also acknowledged.The funders had no role in study design, data collection and analysis, decisionto publish, or preparation of the manuscript	Abe Y, 2004, GROWTH FACTORS, V22, P105, DOI 10.1080/08977190410001704688; Aroua S, 2012, GEN COMP ENDOCR, V175, P82, DOI 10.1016/j.ygcen.2011.10.002; Beyersmann D, 2000, EXS, V89, P11; BILEZIKJIAN LM, 1990, ENDOCRINOLOGY, V126, P2369, DOI 10.1210/endo-126-5-2369; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bilezikjian LM, 2003, ENDOCRINOLOGY, V144, P732, DOI 10.1210/en.2002-220703; Bilezikjian LM, 2012, MOL CELL ENDOCRINOL, V359, P43, DOI 10.1016/j.mce.2012.01.025; BILLESTRUP N, 1990, MOL ENDOCRINOL, V4, P356, DOI 10.1210/mend-4-2-356; Cheng GFY, 2007, J ENDOCRINOL, V195, P373, DOI 10.1677/JOE-07-0265; Choi SC, 2011, VITAM HORM, V85, P79, DOI 10.1016/B978-0-12-385961-7.00005-6; Coss D, 2005, MOL ENDOCRINOL, V19, P2610, DOI 10.1210/me.2005-0047; DANIELS M, 1993, J ENDOCRINOL, V137, P329, DOI 10.1677/joe.0.1370329; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; DiMuccio T, 2005, GEN COMP ENDOCR, V143, P287, DOI 10.1016/j.ygcen.2005.04.003; ERAMAA M, 1994, J CLIN ENDOCR METAB, V79, P1670, DOI 10.1210/jc.79.6.1670; Fortin J, 2015, MOL ENDOCRINOL, V29, P963, DOI 10.1210/me.2015-1004; Ge W, 2005, MOL CELL ENDOCRINOL, V237, P1, DOI 10.1016/j.mce.2005.03.012; Ge W, 1997, J MOL ENDOCRINOL, V19, P37, DOI 10.1677/jme.0.0190037; GE W, 1994, GEN COMP ENDOCR, V95, P213, DOI 10.1006/gcen.1994.1118; GE W, 1992, ENDOCRINOLOGY, V131, P1922, DOI 10.1210/en.131.4.1922; Gong Feng-Ying, 2010, Shengli Xuebao, V62, P49; Graham Heather, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P45; Gregory SJ, 2004, SEMIN REPROD MED, V 22, P253, DOI 10.1055/s-2004-831901; HADDAD G, 1994, J CLIN ENDOCR METAB, V79, P1399, DOI 10.1210/jc.79.5.1399; Hedger MP, 2012, MOL CELL ENDOCRINOL, V359, P30, DOI 10.1016/j.mce.2011.09.031; Hedger MP, 2011, VITAM HORM, V85, P255, DOI 10.1016/B978-0-12-385961-7.00013-5; HO WKK, 1991, BIOCHIM BIOPHYS ACTA, V1090, P245, DOI 10.1016/0167-4781(91)90110-8; Hu GF, 2014, ENDOCRINOLOGY, V155, P3582, DOI 10.1210/en.2014-1105; Huo LF, 2005, ENDOCRINOLOGY, V146, P3821, DOI 10.1210/en.2004-1508; Jiang Q, 2013, AM J PHYSIOL-ENDOC M, V304, pE176, DOI 10.1152/ajpendo.00455.2012; Jiang X, 2016, J ENDOCRINOL, V229, P171, DOI 10.1530/JOE-15-0423; Kanamaru C, 2002, HEPATOL RES, V23, P211, DOI 10.1016/S1386-6346(01)00175-9; Kang HY, 2011, VITAM HORM, V85, P129, DOI 10.1016/B978-0-12-385961-7.00007-X; Knight PG, 2012, MOL CELL ENDOCRINOL, V359, P53, DOI 10.1016/j.mce.2011.04.024; LAPOLT PS, 1990, ENDOCRINOLOGY, V127, P823, DOI 10.1210/endo-127-2-823; Lau MT, 2005, GEN COMP ENDOCR, V141, P22, DOI 10.1016/j.ygcen.2004.10.019; Li YN, 2017, J BIOL CHEM, V292, P2301, DOI 10.1074/jbc.M116.759167; Lin CY, 2015, MOL CELL ENDOCRINOL, V399, P267, DOI 10.1016/j.mce.2014.10.010; Lin SW, 2009, GEN COMP ENDOCR, V160, P183, DOI 10.1016/j.ygcen.2008.11.020; LING N, 1986, BIOCHEM BIOPH RES CO, V138, P1129, DOI 10.1016/S0006-291X(86)80400-4; Loomans HA, 2016, AM J CANCER RES, V6, P2431; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; Makanji Y, 2011, VITAM HORM, V85, P299, DOI 10.1016/B978-0-12-385961-7.00014-7; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; Munz B, 2001, MOL CELL ENDOCRINOL, V180, P169, DOI 10.1016/S0303-7207(01)00514-7; NIELSEN DA, 1990, MOL ENDOCRINOL, V4, P953, DOI 10.1210/mend-4-7-953; ODA S, 1995, BIOCHEM BIOPH RES CO, V210, P581, DOI 10.1006/bbrc.1995.1699; Reindl KM, 2011, AM J PHYSIOL-REG I, V301, pR236, DOI 10.1152/ajpregu.00414.2010; Rejon CA, 2013, CELL SIGNAL, V25, P2717, DOI 10.1016/j.cellsig.2013.09.002; ROBERTS V, 1989, ENDOCRINOLOGY, V124, P552, DOI 10.1210/endo-124-1-552; ROBERTS VJ, 1992, NEUROENDOCRINOLOGY, V56, P214, DOI 10.1159/000126231; Robertson DM, 2012, MOL CELL ENDOCRINOL, V359, P78, DOI 10.1016/j.mce.2011.05.016; Rodriguez-Martinez G, 2012, CNS NEUROL DISORD-DR, V11, P844, DOI 10.2174/1871527311201070844; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Tada T, 1998, MOL MAR BIOL BIOTECH, V7, P72; Tamura N, 2000, EUR J ENDOCRINOL, V142, P506, DOI 10.1530/eje.0.1420506; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vejda S, 2002, J MOL ENDOCRINOL, V28, P137, DOI 10.1677/jme.0.0280137; Vejda S, 2003, CARCINOGENESIS, V24, P1801, DOI 10.1093/carcin/bgg154; Wang Y, 2008, ENDOCRINOLOGY, V149, P5577, DOI 10.1210/en.2008-0220; Wang YJ, 2003, GEN COMP ENDOCR, V134, P308, DOI 10.1016/S0016-6480(03)00275-2; Wang YJ, 2003, ENDOCRINOLOGY, V144, P491, DOI 10.1210/en.2002-220734; Wijayarathna R, 2016, ACTIVINS REPROD BIOL, P22; Winters SJ, 2004, REPRODUCTION, V128, P13, DOI 10.1530/rep.1.00195; Wong AOL, 2006, COMP BIOCHEM PHYS A, V144, P284, DOI 10.1016/j.cbpa.2005.11.021; Wong AOL, 1998, GEN COMP ENDOCR, V110, P29, DOI 10.1006/gcen.1997.7045; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yam KM, 1999, GEN COMP ENDOCR, V116, P81, DOI 10.1006/gcen.1999.7339; Yuen CW, 2004, GEN COMP ENDOCR, V135, P108, DOI 10.1016/j.ygcen.2003.08.012; Zhou H, 2005, J MOL ENDOCRINOL, V34, P415, DOI 10.1677/jme.1.01629; Zhou H, 2004, ENDOCRINOLOGY, V145, P5548, DOI 10.1210/en.2004-0362; Zhou H, 2004, ENDOCRINOLOGY, V145, P4615, DOI 10.1210/en.2004-0163	74	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179789	10.1371/journal.pone.0179789	http://dx.doi.org/10.1371/journal.pone.0179789			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662143	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300048
J	Hofmann, L; Karl, F; Sommer, C; Uceyler, N				Hofmann, Lukas; Karl, Franziska; Sommer, Claudia; Ueceyler, Nurcan			Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; ANIMAL-MODELS; ANXIETY; MICE; INFLAMMATION; GENE; GLOBOTRIAOSYLCERAMIDE; DEPRESSION; MALES; PAIN	Fabry disease is an X-linked inherited lysosomal storage disorder with intracellular accumulation of globotriaosylceramide (Gb3) due to alpha-galactosidase A (alpha-Gal A) deficiency. Fabry patients frequently report of anxiety, depression, and impaired cognitive function. We characterized affective and cognitive phenotype of male mice with alpha-Gal A deficiency ( Fabry KO) and compared results with those of age-matched male wildtype (WT) littermates. Young (3 months) and old (>= 18 months) mice were tested in the naive state and after i.pl. injection of complete Freund's adjuvant (CFA) as an inflammatory pain model. We used the elevated plus maze (EPM), the light-dark box (LDB) and the open field test (OF) to investigate anxiety-like behavior. The forced swim test (FST) and Morris water maze (MWM) were applied to assess depressive-like and learning behavior. The EPM test revealed no inter-group difference for anxiety-like behavior in naive young and old Fabry KO mice compared to WT littermates, except for longer time spent in open arms of the EPM for young WT mice compared to young Fabry KO mice (p<0.05). After CFA injection, young Fabry KO mice showed increased anxiety-like behavior compared to young WT littermates (p<0.05) and naive young Fabry KO mice (p<0.05) in the EPM as reflected by shorter time spent in EPM open arms. There were no relevant differences in the LDB and the OF test, except for longer time spent in the center zone of the OF by young WT mice compared to young Fabry KO mice (p<0.05). Complementary to this, depression-like and learning behavior were not different between genotypes and age-groups, except for the expectedly lower memory performance in older age-groups compared to young mice. Our results indicate that genetic influences on affective and cognitive symptoms in FD may be of subordinate relevance, drawing attention to potential influences of environmental and epigenetic factors.	[Hofmann, Lukas; Karl, Franziska; Sommer, Claudia; Ueceyler, Nurcan] Univ Wurzburg, Dept Neurol, Wurzburg, Germany	University of Wurzburg	Hofmann, L (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.	Hofmann_L3@ukw.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002	University of Wurzburg [N-260]; European Union [602133]	University of Wurzburg; European Union(European Commission)	The study was financially supported by research funds of the Interdisciplinary Center for Clinical Research (Interdisziplinares Zentrum fur Klinische Forschung, IZKF, http://www.izkf.ukw.de/) of the University of Wurzburg (N.UE.: N-260). N.UE. and C.S. are funded by the European Union's Seventh Framework Programme 2013-2017 ("ncRNAPain", grant agreement number 602133, http://www.ncrna-pain.eu/). The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Allen AL, 2003, BRAIN RES, V961, P147, DOI 10.1016/S0006-8993(02)03948-3; Balwani M, 2009, GENET MED, V11, P722, DOI 10.1097/GIM.0b013e3181b182c3; Bangari DS, 2015, AM J PATHOL, V185, P651, DOI 10.1016/j.ajpath.2014.11.004; Bolsover FE, 2014, J INHERIT METAB DIS, V37, P177, DOI 10.1007/s10545-013-9643-x; Bugescu N, 2015, AM J MED GENET B, V168, P204, DOI 10.1002/ajmg.b.32297; Chen Y, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-13; Cole AL, 2007, J INHERIT METAB DIS, V30, P943, DOI 10.1007/s10545-007-0708-6; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; De Francesco PN, 2013, MOL GENET METAB, V109, P93, DOI 10.1016/j.ymgme.2013.02.003; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007/s10545-007-0521-2; Finn DA, 2003, NEUROGENETICS, V4, P109, DOI 10.1007/s10048-003-0143-2; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Glass JM, 2008, J CLIN PSYCHIAT, V69, P20; Hopkin RJ, 2008, PEDIATR RES, V64, P550, DOI 10.1203/PDR.0b013e318183f132; ISHII S, 1993, BIOCHEM BIOPH RES CO, V197, P1585, DOI 10.1006/bbrc.1993.2659; Lakoma J, 2016, MOL PAIN, V12, DOI 10.1177/1744806916663729; Laney DA, 2015, GENET MED, V17, P323, DOI 10.1038/gim.2014.120; Laney DA, 2010, J INHERIT METAB DIS, V33, pS73, DOI 10.1007/s10545-009-9025-6; Lelieveld IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137603; Lohle M, 2015, NEUROLOGY, V84, P1454, DOI 10.1212/WNL.0000000000001450; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; Miners AH, 2002, QUAL LIFE RES, V11, P127, DOI 10.1023/A:1015009210639; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller N, 2013, PSYCHIAT DANUB, V25, P292; Nekovarova T, 2014, FRONTIERS BEHAV NEUR, V8; Ohshima T, 1995, GENE, V166, P277, DOI 10.1016/0378-1119(95)00592-7; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Povedano M, 2007, J PAIN SYMPTOM MANAG, V33, P78, DOI 10.1016/j.jpainsymman.2006.07.012; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Refsgaard LK, 2016, J NEUROSCI METH, V262, P85, DOI 10.1016/j.jneumeth.2016.01.019; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; SAKURABA H, 1990, AM J HUM GENET, V47, P784; Schermuly I, 2011, EUR J NEUROL, V18, P347, DOI 10.1111/j.1468-1331.2010.03155.x; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Shiozuka C, 2011, J BIOCHEM, V149, P161, DOI 10.1093/jb/mvq125; Sigmundsdottir L, 2014, ARCH CLIN NEUROPSYCH, V29, P642, DOI 10.1093/arclin/acu047; STEIN C, 1988, PHARMACOL BIOCHEM BE, V31, P445, DOI 10.1016/0091-3057(88)90372-3; Taguchi A, 2013, BIOCHEM J, V456, P373, DOI 10.1042/BJ20130825; Uceyler N, 2016, MOL PAIN, V12, DOI 10.1177/1744806916646379; Uceyler N, 2014, CLIN J PAIN, V30, P915, DOI 10.1097/AJP.0000000000000041; Yang X.H., 2009, CHINESE BUSINESS, V9, P5, DOI DOI 10.1016/J.PAIN.2009.04.005; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	49	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180601	10.1371/journal.pone.0180601	http://dx.doi.org/10.1371/journal.pone.0180601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662189	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300170
J	Mehta, JH; Williams, GW; Harvey, BC; Grewal, NK; George, EE				Mehta, Jaideep H.; Williams, George W., II; Harvey, Brian C.; Grewal, Navneet K.; George, Edward E.			The relationship between minute ventilation and end tidal CO2 in intubated and spontaneously breathing patients undergoing procedural sedation	PLOS ONE			English	Article							RESPIRATORY VOLUME MONITOR; MODERATE SEDATION; CONTROLLED-TRIAL; CARBON-DIOXIDE; PULSE OXIMETRY; CAPNOGRAPHY; SURGERY; MODEL	Background Monitoring respiratory status using end tidal CO2 (EtCO2), which reliably reflects arterial PaCO2 in intubated patients under general anesthesia, has often proven both inaccurate and inadequate when monitoring non-intubated and spontaneously breathing patients. This is particularly important in patients undergoing procedural sedation (e.g., endoscopy, colonoscopy). This can be undertaken in the operating theater, but is also often delivered outside the operating room by non-anesthesia providers. In this study we evaluated the ability for conventional EtCO2 monitoring to reflect changes in ventilation in non-intubated surgical patients undergoing monitored anesthesia care and compared and contrasted these findings to both intubated patients under general anesthesia and spontaneously breathing volunteers. Methods M1winute Ventilation (MV), tidal volume (TV), and respiratory rate (RR) were continuously collected from an impedance-based Respiratory Volume Monitor (RVM) simultaneously with capnography data in 160 patients from three patient groups: non-intubated surgical patients managed using spinal anesthesia and Procedural Sedation (n = 58); intubated surgical patients under General Anesthesia (n = 54); and spontaneously breathing Awake Volunteers (n = 48). EtCO2 instrument sensitivity was calculated for each patient as the slope of a Deming regression between corresponding measurements of EtCO2 and MV and expressed as angle from the x-axis (theta). All data are presented as mean +/- SD unless otherwise indicated. Results While, as expected, EtCO2 and MV measurements were negatively correlated in most patients, we found gross systematic differences across the three cohorts. In the General Anesthesia patients, small changes in MV resulted in large changes in EtCO2 (high sensitivity, theta = -83.6 +/- 9.9 degrees). In contrast, in the Awake Volunteers patients, large changes in MV resulted in insignificant changes in EtCO2 (low sensitivity, theta = -24.7 +/- 19.7 degrees, p < 0.0001 vs General Anesthesia). In the Procedural Sedation patients, EtCO2 sensitivity showed a bimodal distribution, with an approximately even split between patients showing high EtCO2 instrument sensitivity, similar to those under General Anesthesia, and patients with low EtCO2 instrument sensitivity, similar to the Awake Volunteers. Conclusions When monitoring non-intubated patients undergoing procedural sedation, EtCO2 often provides inadequate instrument sensitivity when detecting changes in ventilation. This suggests that augmenting standard patient care with EtCO2 monitoring is a less than optimal solution for detecting changes in respiratory status in non-intubated patients. Instead, adding direct monitoring of MV with an RVM may be preferable for continuous assessment of adequacy of ventilation in non-intubated patients.	[Mehta, Jaideep H.; Williams, George W., II; Grewal, Navneet K.] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX 77030 USA; [Harvey, Brian C.] Resp Motion Inc, Waltham, MA USA; [George, Edward E.] Massachusetts Gen Hosp, Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	University of Texas System; University of Texas Health Science Center Houston; Harvard University; Massachusetts General Hospital	Mehta, JH (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX 77030 USA.	Jaideep.H.Mehta@uth.tmc.edu		Mehta, Jaideep/0000-0001-9274-7010	Respiratory Motion, Inc	Respiratory Motion, Inc	Respiratory Motion, Inc. (www.respiratorymotion.com) provided the respiratory volume monitors used for data collection in this study. BCH, an employee of Respiratory Motion, Inc., collaborated with co-authors on data analysis and manuscript preparation. Respiratory Motion, Inc. provided support for author BCH in the form of salary, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Respiratory Care Protocol Committee, 2003, AD MECH VENT PROT; American Heart Association, 2005, CIRCULATION, V112, pIV; American Society of Anesthesiologists, 2010, STAND BAS AN MON; Belenkiy S, 2013, SHOCK, V39, P495, DOI 10.1097/SHK.0b013e318292c331; Castro LNG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172750; Covidien, 2014, CAPN 20 PORT BEDS CA; Delorio NM, 2005, EMERG MED J, V22, P490, DOI 10.1136/emj.2004.015818; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Ebert TJ, 2017, J CLIN MONIT COMPUT, V31, P53, DOI 10.1007/s10877-015-9809-1; ECRI Institute, 2016, EXC HLTH DEV; Galvagno SM, 2016, J TRAUMA ACUTE CARE; Heines SJH, 2013, J EMERG MED, V45, P130, DOI 10.1016/j.jemermed.2012.11.019; Holley K, 2014, OPEN J ANESTHESIOL, V4, P281, DOI DOI 10.4236/OJANES.2014.411041; Holley K, 2016, J CLIN MONIT COMPUT, V30, P33, DOI 10.1007/s10877-015-9674-y; Jabre P, 2009, AM J EMERG MED, V27, P1056, DOI 10.1016/j.ajem.2008.08.017; Kerr ME, 1996, CRIT CARE MED, V24, P785, DOI 10.1097/00003246-199605000-00010; Kodali B -S, 1992, CAN J ANAESTH, V39, P617; Lightdale JR, 2006, PEDIATRICS, V117, pE1170, DOI 10.1542/peds.2005-1709; Lumb AB, 2017, NUNNS APPL RESP PHYS, VEighth, DOI [10.2307/20024538, DOI 10.2307/20024538]; Medical D, 2005, AP OP INSTR MAN; Mehta JH, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0352-0; Mehta PP, 2016, AM J GASTROENTEROL, V111, P395, DOI 10.1038/ajg.2015.437; Miner JR, 2002, ACAD EMERG MED, V9, P275, DOI 10.1197/aemj.9.4.275; Ortega Rafael, 2012, N Engl J Med, V367, pe27, DOI 10.1056/NEJMvcm1105237; Parrillo JE, 2014, CRITICAL CARE MED PR; Pavlin EG, 2011, ANESTHESIA CONTROL V; Poirier MP, 1998, AM J EMERG MED, V16, P350, DOI 10.1016/S0735-6757(98)90125-5; Razi E, 2012, ARCH TRAUMA RES, V1, P58, DOI 10.5812/atr.6444; van Loon K, 2014, ANESTH ANALG, V119, P49, DOI 10.1213/ANE.0b013e3182a1f0a2; Vargo JJ, 2002, GASTROINTEST ENDOSC, V55, P826, DOI 10.1067/mge.2002.124208; Voscopoulos C, 2013, ANESTH ANALG, V117, P91, DOI 10.1213/ANE.0b013e3182918098; Voscopoulos CJ, 2015, J CLIN MONIT COMPUT, V29, P223, DOI 10.1007/s10877-014-9596-0; Wahba RWM, 1996, CAN J ANAESTH, V43, P862, DOI 10.1007/BF03013040; Waugh JB, 2011, J CLIN ANESTH, V23, P189, DOI 10.1016/j.jclinane.2010.08.012; Williams GW, 2017, ANESTH ANALG, V124, P120, DOI 10.1213/ANE.0000000000001395	35	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180187	10.1371/journal.pone.0180187	http://dx.doi.org/10.1371/journal.pone.0180187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662195	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300121
J	Wani, TA; Pandith, SA; Gupta, AP; Chandra, S; Sharma, N; Lattoo, SK				Wani, Tareq A.; Pandith, Shahzad A.; Gupta, Ajai P.; Chandra, Suresh; Sharma, Namrata; Lattoo, Surrinder K.			Molecular and functional characterization of two isoforms of chalcone synthase and their expression analysis in relation to flavonoid constituents in Grewia asiatica L	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; TARGETED MUTAGENESIS; MULTIGENE FAMILY; GENE-EXPRESSION; EVOLUTION; CLONING; POLLEN; DUPLICATION; GENOME; FLOWER	Chalcone synthase constitutes a functionally diverse gene family producing wide range of flavonoids by catalyzing the initial step of the phenylpropanoid pathway. There is a pivotal role of flavonoids in pollen function as they are imperative for pollen maturation and pollen tube growth during sexual reproduction in flowering plants. Here we focused on medicinally important fruit-bearing shrub Grewia asiatica. It is a rich repository of flavonoids. The fruits are highly acclaimed for various putative health benefits. Despite its importance, full commercial exploitation is hampered due to two drawbacks which include short shelf life of its fruits and larger seed volume. To circumvent these constraints, seed abortion is one of the viable options. Molecular interventions tested in a number of economic crops have been to impair male reproductive function by disrupting the chalcone synthase (CHS) gene activity. Against this backdrop the aim of the present study included cloning and characterization of two full-length cDNA clones of GaCHS isoforms from the CHS multigene family. These included GaCHS1 (NCBI acc. KX129910) and GaCHS2 (NCBI acc. KX129911) with an ORF of 1176 and 1170 bp, respectively. GaCHSs were heterologously expressed and purified in E. coli to validate their functionality. Functionality of CHS isoforms was also characterized via enzyme kinetic studies using five different substrates. We observed differential substrate specificities in terms of their Km and Vmax values. Accumulation of flavonoid constituents naringenin and quercetin were also quantified and their relative concentrations corroborated well with the expression levels of GaCHSs. Further, our results demonstrate that GaCHS isoforms show differential expression patterns at different reproductive phenological stages. Transcript levels of GaCHS2 were more than its isoform GaCHS1 at the anthesis stage of flower development pointing towards its probable role in male reproductive maturity.	[Wani, Tareq A.; Chandra, Suresh] CSIR, Indian Inst Integrat Med, Genet Resources & Agrotechnol Div, Jammu, India; [Pandith, Shahzad A.; Lattoo, Surrinder K.] CSIR, Indian Inst Integrat Med, Plant Biotechnol Div, Jammu, India; [Gupta, Ajai P.] CSIR, Indian Inst Integrat Med, Qual Control & Qual Assurance Div, Jammu, India; [Sharma, Namrata] Univ Jammu, Dept Bot, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); University of Jammu	Lattoo, SK (corresponding author), CSIR, Indian Inst Integrat Med, Plant Biotechnol Div, Jammu, India.	sklattoo@iiim.ac.in	Sharma, Namrata/AAU-4833-2021; GUPTA, AJAI/AAJ-1171-2021; Pandith, Shahzad/AAX-7067-2020	Pandith, Shahzad/0000-0002-0849-9745	Council of Scientific and Industrial Research, Government of India, New Delhi [BSC0110]; Institutional Major Laboratory [MLP3012]; UGC	Council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Institutional Major Laboratory; UGC(University Grants Commission, India)	We gratefully acknowledge the financial grant from the Council of Scientific and Industrial Research, Government of India, New Delhi under Network Project BSC0110 and Institutional Major Laboratory Project MLP3012. SAP is thankful to UGC for providing Senior Research Fellowship.	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Aiswarya G, 2016, PLANT CELL REP, V35, P2077, DOI 10.1007/s00299-016-2020-0; Ashkenazy H, 2010, CONSURF 2010 CALCULA; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Barbacar N, 1997, PLANT J, V12, P805, DOI 10.1046/j.1365-313X.1997.12040805.x; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Clark MS, 2013, PLANT MOL BIOL A LAB; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Deng XB, 2014, NEW PHYTOL, V201, P1469, DOI 10.1111/nph.12610; Ding LP, 2016, EVOLUTIONARY DYNAMIC; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Durbin ML, 2003, MOL PHYLOGENET EVOL, V29, P507, DOI 10.1016/S1055-7903(03)00196-9; Durbin ML, 2000, PLANT MOL BIOL, V42, P79, DOI 10.1023/A:1006375904820; Farzad M, 2003, PLANT SCI, V165, P1333, DOI 10.1016/j.plantsci.2003.08.001; Fenske MP, 2015, P NATL ACAD SCI USA, V112, P9775, DOI 10.1073/pnas.1422875112; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Han YY, 2006, GENETICA, V128, P429, DOI 10.1007/s10709-006-7668-x; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HELARIUTTA Y, 1993, PLANT MOL BIOL, V22, P183, DOI 10.1007/BF00014927; Helariutta Y, 1996, P NATL ACAD SCI USA, V93, P9033, DOI 10.1073/pnas.93.17.9033; Hihara Y, 1996, PLANT MOL BIOL, V30, P1181, DOI 10.1007/BF00019551; Ito M, 1997, MOL GEN GENET, V255, P28, DOI 10.1007/s004380050471; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jones B, 2016, NATURE REV GENETICS; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim SS, 2010, PLANT CELL, V22, P4045, DOI 10.1105/tpc.110.080028; KOES RE, 1989, GENE, V81, P245, DOI 10.1016/0378-1119(89)90185-6; KOES RE, 1989, PLANT MOL BIOL, V12, P213, DOI 10.1007/BF00020506; Lang D, 2016, ADV BOT RES, V78, P97, DOI 10.1016/bs.abr.2016.01.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei W, 2010, GENET MOL BIOL, V33, P285, DOI 10.1590/S1415-47572010005000031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matousek J, 2005, J AGR FOOD CHEM, V53, P4793, DOI 10.1021/jf050175y; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; MCKHANN HI, 1994, PLANT MOL BIOL, V24, P767, DOI 10.1007/BF00029858; Meng XC, 2004, PLANT GROWTH REGUL, V44, P243, DOI 10.1007/s10725-004-4454-6; Nakatsuka A, 2003, PLANT SCI, V165, P759, DOI 10.1016/S0168-9452(03)00254-1; Nakatsuka A, 2009, SCI HORTIC-AMSTERDAM, V121, P84, DOI 10.1016/j.scienta.2009.01.008; Napoli CA, 1999, PLANT PHYSIOL, V120, P615, DOI 10.1104/pp.120.2.615; Pandith SA, 2016, PLANT PHYSIOL; Pietiainen M, 2016, PLANT J; REIMOLD U, 1983, EMBO J, V2, P1801, DOI 10.1002/j.1460-2075.1983.tb01661.x; Saito R, 2006, PLANT SCI, V170, P828, DOI 10.1016/j.plantsci.2005.12.003; Samappito S, 2002, PLANTA, V216, P64, DOI 10.1007/s00425-002-0872-8; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Sun W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119054; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson A, 2016, GENETICS, V202, P765, DOI 10.1534/genetics.115.178137; Treacy BK, 1998, MOL CHARACTERIZATION; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Uddin G, 2013, NAT PROD RES, V27, P215, DOI 10.1080/14786419.2012.666749; Wang SL, 2015, PLANT CELL REP, V34, P1459, DOI 10.1007/s00299-015-1800-2; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang YC, 2011, APPL MICROBIOL BIOT, V91, P949, DOI 10.1007/s00253-011-3449-2; Wani T, 2016, J PLANT BIOCHEMPHYSI, V4, P167; Wani TA, 2015, FLORA, V211, P62, DOI 10.1016/j.flora.2014.11.002; Wass MN, 2010, 3DLIGANDSITE PREDICT; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; WINKEL BSJ, 2006, BIOSYNTHESIS FLAVONO, P71; WOLLENWEBER E, 1979, Z NATURFORSCH C, V34, P1289; Yadav A.K., 1999, PERSPECTIVES NEW CRO, P348; Yang J, 2006, CHINESE SCI BULL, V51, P505, DOI 10.1007/s11434-006-0505-x; Yi JX, 2010, PLANT J, V62, P1019, DOI 10.1111/j.1365-313X.2010.04214.x; YLSTRA B, 1992, PLANT PHYSIOL, V100, P902, DOI 10.1104/pp.100.2.902	75	15	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179155	10.1371/journal.pone.0179155	http://dx.doi.org/10.1371/journal.pone.0179155			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662128	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608300016
J	Lee, AF; Chen, MC; Chen, CJ; Yang, CJ; Huang, MS; Liu, YP				Lee, An-Fu; Chen, Man-Chin; Chen, Chao-Ju; Yang, Chih-Jen; Huang, Ming-Shyang; Liu, Yu-Peng			Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells	PLOS ONE			English	Article							PROGNOSTIC BIOMARKER; CISPLATIN RESISTANCE; EMT; METASTASIS; ADENOCARCINOMA; SLUG; ACQUISITION; EXPRESSION; PLASTICITY; PHENOTYPE	Tyrosine kinase inhibitors (TKIs) are currently the first-line treatment for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations. These patients receive platinum-based chemotherapy as the second-line treatment after they develop resistance to TKIs. Many patients regain sensitivity to the TKIs used in the first-line treatment after the failure of chemotherapy. However, the molecular mechanism for the regain of TKI sensitivity is largely unknown. In this study, we established gefitinib-resistant PC9 and HCC827 cell lines, which did not harbor the EGFR T790M mutation and MET amplification but exhibited the epithelial-mesenchymal transition (EMT) phenotype. Overexpression of EMT inducers, Snail or Slug, in the parental lines promoted their resistance to gefitinib. The gefitinib-resistant cell lines regained their sensitivity to gefitinib and displayed reverse EMT phenotypes after long-term culture in gefitinib-free culture medium. Blockage of reverse EMT by stable expression of Snail or Slug prevented the regain of TKI sensitivity. In conclusion, reverse EMT is one of the major mechanisms for the regain of TKI sensitivity in TKI-resistant NSCLC cells, suggesting that the development of small molecules targeting the EMT process may prolong the efficacy of TKIs in NSCLC patients with EGFR mutations.	[Lee, An-Fu] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Chen, Man-Chin; Yang, Chih-Jen; Huang, Ming-Shyang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Chao-Ju; Liu, Yu-Peng] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Chao-Ju] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Yang, Chih-Jen] Kaohsiung Med Univ, Sch Med, Dept Internal Med, Coll Med, Kaohsiung, Taiwan; [Yang, Chih-Jen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Ming-Shyang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Geriatr & Gerontol, Dept Internal Med, Kaohsiung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yang, CJ; Huang, MS (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.; Yang, CJ (corresponding author), Kaohsiung Med Univ, Sch Med, Dept Internal Med, Coll Med, Kaohsiung, Taiwan.; Yang, CJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Huang, MS (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Geriatr & Gerontol, Dept Internal Med, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.	chjeya@cc.kmu.edu.tw; shyang@kmu.edu.tw; ypliu@kmu.edu.tw		Liu, Yu-Peng/0000-0002-2716-0050	Ministry of Science and Technology of Taiwan [NSC102-2320-B-037-036, MOST 103-2320B-037-027-MY3, MOST 103-2314-B-037-050-MY3, MOST 105-2314-B-037-048]; Kaohsiung Medical University [KMU-TP103E04, KMU-TP104E05, KMU-TP105E05]; New faculty grant [KMU-Q103008]; Kaohsiung Municipal Ta-ung Hospital, Kaohsiung, Taiwan [KMTTH-104-021, KMTTH-105-044]; Kaohsiung Medical University Hospital,Kaohsiung,Taiwan [KMUH104-4F03]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; New faculty grant; Kaohsiung Municipal Ta-ung Hospital, Kaohsiung, Taiwan; Kaohsiung Medical University Hospital,Kaohsiung,Taiwan	This study is financially supported by the Ministry of Science and Technology of Taiwan (NSC102-2320-B-037-036-, and MOST 103-2320B-037-027-MY3, MOST 103-2314-B-037-050-MY3, and MOST 105-2314-B-037-048-). This study is supported partially by Kaohsiung Medical University "Aim for the Top Universities Grant, grant No. KMU-TP103E04, KMU-TP104E05, and KMU-TP105E05, and "New faculty grant, grant No. KMU-Q103008".This study is also supported by KMTTH-104-021 and KMTTH-105-044 in Kaohsiung Municipal Ta-ung Hospital, Kaohsiung, Taiwan, and by a grant (KMUH104-4F03) from the Kaohsiung Medical University Hospital,Kaohsiung,Taiwan	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; [Anonymous], 2017, CANC DISCOV; Bai XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149370; Beerling E, 2016, CELL REP, V14, P2281, DOI 10.1016/j.celrep.2016.02.034; Bidarra SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27072; Chang GC, 2017, LUNG CANCER, V104, P58, DOI 10.1016/j.lungcan.2016.12.002; Chang TH, 2011, AM J RESP CRIT CARE, V183, P1071, DOI 10.1164/rccm.201009-1440OC; Chen T., 2017, J CELL PHYSL; Chen Y, 2016, ONCOTARGET, V7, P71341, DOI 10.18632/oncotarget.11217; Chen YM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2917-6; Chiu LY, 2017, ONCOGENE, V36, P242, DOI 10.1038/onc.2016.195; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Chung JH, 2011, LUNG CANCER, V73, P176, DOI 10.1016/j.lungcan.2010.11.011; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Hsu CY, 2016, AM J RESP CRIT CARE, V193, P869, DOI 10.1164/rccm.201412-2226OC; Huang JY, 2015, ONCOTARGET, V6, P18613, DOI 10.18632/oncotarget.4317; Jia RJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.422; Jiang L, 2015, ONCOGENE, V34, P3908, DOI 10.1038/onc.2014.321; Kim SH, 2012, HISTOL HISTOPATHOL, V27, P581, DOI 10.14670/HH-27.581; Kuiper JL, 2015, CLIN LUNG CANCER, V16, P60, DOI 10.1016/j.cllc.2014.07.008; Kurimoto R, 2016, INT J ONCOL, V48, P1825, DOI 10.3892/ijo.2016.3419; Kurokawa M, 2013, CANCER SCI, V104, P904, DOI 10.1111/cas.12171; Lee CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084597; Lee YH, 2016, ONCOTARGET, V7, P46959, DOI 10.18632/oncotarget.10506; Liu YP, 2013, CANCER RES, V73, P406, DOI 10.1158/0008-5472.CAN-12-1733; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Pallier K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029954; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sesumi Y, 2017, LUNG CANCER, V104, P85, DOI 10.1016/j.lungcan.2016.12.012; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi L, 2016, ONCOGENE; Shi YL, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-89; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Soucheray M, 2015, CANCER RES, V75, P4372, DOI 10.1158/0008-5472.CAN-15-0377; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tong YL, 2016, ONCOTARGET, V7, P31413, DOI 10.18632/oncotarget.8920; Wang H, 2014, EUR J PHARMACOL, V723, P156, DOI 10.1016/j.ejphar.2013.12.004; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yang CJ, 2016, ONCOTARGETS THER, V9, P1579, DOI 10.2147/OTT.S100164; Yang CJ, 2016, ONCOTARGETS THER, V9, P1511, DOI 10.2147/OTT.S100169; Ye ZQ, 2016, ONCOTARGET, V7, P37524, DOI 10.18632/oncotarget.6852; Yoo SB, 2013, ANN SURG ONCOL, V20, pS545, DOI 10.1245/s10434-013-2970-1; Yoshida T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147344; Yu JS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-121	45	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180383	10.1371/journal.pone.0180383	http://dx.doi.org/10.1371/journal.pone.0180383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683123	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200030
J	Scheiermann, J; Klinman, DM				Scheiermann, Julia; Klinman, Dennis M.			Three distinct pneumotypes characterize the microbiome of the lung in BALB/cJ mice	PLOS ONE			English	Article							RESPIRATORY-TRACT; INFLAMMATION; BACTERIA; DISEASES; DATABASE; SEARCH; DNA	Bacteria can rarely be isolated from normal healthy lungs using conventional culture techniques, supporting the traditional belief that the lungs are sterile. Yet recent studies using next generation sequencing report that bacterial DNA commonly found in the upper respiratory tract (URT) is present at lower levels in the lungs. Interpretation of that finding is complicated by the technical limitations and potential for contamination introduced when dealing with low biomass samples. The current work sought to overcome those limitations to clarify the number, type and source of bacteria present in the lungs of normal mice. Results showed that the oral microbiome is diverse and highly conserved whereas murine lung samples fall into three distinct patterns. 33% of the samples were sterile, as they lacked culturable bacteria and their bacterial DNA content did not differ from background. 9% of samples contained comparatively higher amounts of bacterial DNA whose composition mimicked that detected in the URT. A final group (58%) contained smaller amounts of microbial DNA whose composition was correlating to that of rodent chow and cage bedding, likely acquired by inspiration of food and bedding fragments. By analyzing each sample independently rather than working with group averages, this work eliminated the bias introduced by aspiration-contaminated samples to establish that three distinct microbiome pneumotypes are present in normal murine lungs.	[Scheiermann, Julia; Klinman, Dennis M.] NCI, Canc & Inflammat Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Klinman, DM (corresponding author), NCI, Canc & Inflammat Program, Frederick, MD 21701 USA.	klinmand@mail.nih.gov			NIH, NCI	NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript was supported by the Intramural Research Program of the NIH, NCI. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products,or organizations imply endorsement by the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, PATHOG, V10; Barfod Kenneth Klingenberg, 2015, Open Microbiol J, V9, P167, DOI 10.2174/1874285801509010167; Barfod KK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-303; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Belizario JE, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.01050, 10.1186/1476-069X-6-20, 10.3389/fmicb.2015.1050]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chiba H, 2006, RESPIROLOGY, V11, pS2, DOI 10.1111/j.1440-1843.2006.00797.x; Chuquimia OD, 2013, INFECT IMMUN, V81, P381, DOI 10.1128/IAI.00950-12; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Cox MJ, 2015, AM J RESP CRIT CARE, V192, P403, DOI 10.1164/rccm.201506-1138ED; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dickson RP, 2015, AM J PHYSIOL-LUNG C, V309, pL1047, DOI 10.1152/ajplung.00279.2015; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gao Zhancheng, 2014, Genomics Proteomics & Bioinformatics, V12, P144, DOI 10.1016/j.gpb.2014.06.001; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Huffnagle GB, 2015, CLIN IMMUNOL, V159, P177, DOI 10.1016/j.clim.2015.05.022; Kearney SC, 2015, ANN ALLERG ASTHMA IM, V114, P364, DOI 10.1016/j.anai.2015.02.008; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nguyen M, 2016, ISME J, V10, P2978, DOI 10.1038/ismej.2016.76; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pallmann P, 2012, MOL ECOL RESOUR, V12, P1068, DOI 10.1111/1755-0998.12004; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pezzulo AA, 2013, APPL ENVIRON MICROB, V79, P5936, DOI 10.1128/AEM.01752-13; Poroyko V, 2015, AM J PHYSIOL-LUNG C, V309, pL76, DOI 10.1152/ajplung.00061.2014; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Rudkjobing VB, 2011, J CLIN MICROBIOL, V49, P4352, DOI 10.1128/JCM.06092-11; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Samuelson DR, 2015, FRONT MICROBIOL, V6, DOI [10.5389/fmicb.2015.01085, 10.3389/fmicb.2015.01085]; Scheiermann J, 2014, VACCINE, V32, P6377, DOI 10.1016/j.vaccine.2014.06.065; Segal Leopoldo N, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS21, DOI 10.1513/AnnalsATS.201306-189MG; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; WEST JB, 1978, CHEST, V74, P426, DOI 10.1378/chest.74.4.426; Willis AL, 2016, AM J RHINOL ALLERGY, V30, P94, DOI 10.2500/ajra.2016.30.4278; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097289	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180561	10.1371/journal.pone.0180561	http://dx.doi.org/10.1371/journal.pone.0180561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683098	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200047
J	Zheng, K; Gong, MC; Qin, Y; Song, HM; Shi, XM; Wu, YA; Li, F; Li, X				Zheng, Ke; Gong, Mengchun; Qin, Yan; Song, Hongmei; Shi, Ximin; Wu, Yuan; Li, Fang; Li, Xuemei			Validation of glomerular filtration rate-estimating equations in Chinese children	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CYSTATIN C; GFR; FORMULA; GUIDELINES; CREATININE; HEIGHT; MARKER	Background Glomerular filtration rate (GFR) is essential for renal function evaluation and classification of chronic kidney disease (CKD), while the reference method in children are cumbersome. In the Chinese children, there was no data about GFR measured through plasma or renal clearance of the exogenous markers, and therefore no validated GFR-estimating tools in this population. Methods We measured GFR with double-sample plasma clearance of Tc-99m-DTPA (mGFR) in 87 hospitalized children with renal injury. Using mGFR as the golden standard, we evaluate the efficiency of four different GFR estimation equations (the original and update Schwartz equation, the Filler equation, the CKiD equation) by statistical parameters of correlation, precision and accuracy. Results In our population, mGFR was 97.0 +/- 31.9 mL/min/1.73m(2). The updated Schwartz equation, the Filler equation and the CKiD equation, produced eGFR with strong correlation with mGFR, strong explanation capacity of variance in mGFR, small bias, satisfactory performance in Bland-Altman analysis, high intra-class correlation coefficients, high ratio of eGFR within mGFR +/- 10% and eGFR within mGFR +/- 30%, good agreement in CKD staging between eGFR and mGFR. The original Schwartz equation produced eGFR with large bias, poor precision and accuracy. Conclusion The validated equations to estimate GFR in our patients are the updated Schwartz equation, which is simple for bedside use, the Filler equation and the CKiD equation, which provide more accurate eGFR. The original Schwartz equation should not be applied to estimate GFR in Chinese children with kidney injuries.	[Zheng, Ke; Gong, Mengchun; Qin, Yan; Wu, Yuan; Li, Xuemei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China; [Song, Hongmei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pediat, Beijing, Peoples R China; [Shi, Ximin; Li, Fang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, X (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China.	Iixmpumch@126.com	Gong, Mengchun/ABC-8370-2021; Gong, Mengchun/GYQ-8802-2022	Gong, Mengchun/0000-0001-8197-6643	Beijing Municipal Science and Technology Commission Foundation [D131100004713007, D09050704310901]; Peking Union Medical College Hospital	Beijing Municipal Science and Technology Commission Foundation; Peking Union Medical College Hospital	This work is supported by grants from Beijing Municipal Science and Technology Commission Foundation (D131100004713007 for Yan Qin and D09050704310901 for Xuemei Li), Young Scholar Research Funding of Peking Union Medical College Hospital (for Mengchun Gong).	Andersen TB, 2013, PEDIATR NEPHROL, V28, P83, DOI 10.1007/s00467-012-2268-8; Andersen TB, 2009, PEDIATR NEPHROL, V24, P929, DOI 10.1007/s00467-008-0991-y; Bokenkamp A, 1998, PEDIATRICS, V101, P875, DOI 10.1542/peds.101.5.875; Chehade H, 2014, CLIN J AM SOC NEPHRO, V9, P54, DOI 10.2215/CJN.00940113; De Souza VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053439; Dubourg L, 2006, PEDIATR NEPHROL, P1526; Filler G, 2005, KIDNEY INT, V67, P2321, DOI 10.1111/j.1523-1755.2005.00336.x; Gretz N, 2007, PEDIATR NEPHROL, V22, P167, DOI 10.1007/s00467-006-0379-9; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hogg RJ, 2003, PEDIATRICS, V111, P1416, DOI 10.1542/peds.111.6.1416; Hsu CY, 2011, J AM SOC NEPHROL, V22, P1931, DOI 10.1681/ASN.2010101077; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Piepsz A, 2005, NUCL MED COMMUN, V26, P175, DOI 10.1097/00006231-200502000-00016; Piepsz A, 1999, SEMIN NUCL MED, V29, P160, DOI 10.1016/S0001-2998(99)80006-3; Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385; Schwartz GJ, 2009, CLIN J AM SOC NEPHRO, V4, P1832, DOI 10.2215/CJN.01640309; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Sharma AP, 2009, NEPHROL DIAL TRANSPL, V24, P470, DOI 10.1093/ndt/gfn505; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Uemura O, 2013, CLIN EXPT NEPHROLOGY; Wang Fang, 2010, Zhonghua Er Ke Za Zhi, V48, P855; White CA, 2009, KIDNEY INT, V76, P784, DOI 10.1038/ki.2009.262; Ylinen EA, 1999, PEDIATR NEPHROL, V13, P506, DOI 10.1007/s004670050647	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180565	10.1371/journal.pone.0180565	http://dx.doi.org/10.1371/journal.pone.0180565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683079	gold, Green Published, Green Submitted			2022-12-27	WOS:000405335200048
J	Bogacka, I; Paukszto, L; Jastrzebski, JP; Czerwinska, J; Chojnowska, K; Kaminska, B; Kurzynska, A; Smolinska, N; Gizejewski, Z; Kaminski, T				Bogacka, Iwona; Paukszto, Lukasz; Jastrzebski, Jan P.; Czerwinska, Joanna; Chojnowska, Katarzyna; Kaminska, Barbara; Kurzynska, Aleksandra; Smolinska, Nina; Gizejewski, Zygmunt; Kaminski, Tadeusz			Seasonal differences in the testicular transcriptome profile of free-living European beavers (Castor fiber L.) determined by the RNA-Seq method	PLOS ONE			English	Article							GENE-EXPRESSION; BASEMENT-MEMBRANE; DIFFERENT PERIODS; K+-CHANNEL; TESTIS; RAT; ANNOTATION; MOUSE; MICE; SPERMATOGENESIS	The European beaver (Castor fiber L.) is an important free-living rodent that inhabits Eurasian temperate forests. Beavers are often referred to as ecosystem engineers because they create or change existing habitats, enhance biodiversity and prepare the environment for diverse plant and animal species. Beavers are protected in most European Union countries, but their genomic background remains unknown. In this study, gene expression patterns in beaver testes and the variations in genetic expression in breeding and non-breeding seasons were determined by high-throughput transcriptome sequencing. Paired-end sequencing in the Illumina HiSeq 2000 sequencer produced a total of 373.06 million of high-quality reads. De novo assembly of contigs yielded 130,741 unigenes with an average length of 1,369.3 nt, N50 value of 1,734, and average GC content of 46.51%. A comprehensive analysis of the testicular transcriptome revealed more than 26,000 highly expressed unigenes which exhibited the highest homology with Rattus norvegicus and Ictidomys tridecemlineatus genomes. More than 8,000 highly expressed genes were found to be involved in fundamental biological processes, cellular components or molecular pathways. The study also revealed 42 genes whose regulation differed between breeding and non-breeding seasons. During the non-breeding period, the expression of 37 genes was up-regulated, and the expression of 5 genes was down-regulated relative to the breeding season. The identified genes encode molecules which are involved in signaling transduction, DNA repair, stress responses, inflammatory processes, metabolism and steroidogenesis. Our results pave the way for further research into season-dependent variations in beaver testes.	[Bogacka, Iwona; Czerwinska, Joanna; Chojnowska, Katarzyna; Kaminska, Barbara; Kurzynska, Aleksandra; Smolinska, Nina; Kaminski, Tadeusz] Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Anim Physiol, Oczapowskiego 1A, Olsztyn, Poland; [Paukszto, Lukasz; Jastrzebski, Jan P.] Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Plant Physiol & Biotechnol, Oczapowskiego 1A, Olsztyn, Poland; [Gizejewski, Zygmunt] Polish Acad Sci, Inst Anim Reprod & Food Res, Bydgoska 7, Olsztyn, Poland	University of Warmia & Mazury; University of Warmia & Mazury; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Bogacka, I (corresponding author), Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Anim Physiol, Oczapowskiego 1A, Olsztyn, Poland.	iwonab@uwn.edu.pl	Kurzyńska, Aleksandra/HHM-4122-2022; Kamińska, Barbara/AHB-2794-2022; Paukszto, Lukasz/AAV-8585-2021; Jastrzebski, Jan/C-3714-2015; Jastrzębski, Jan Paweł/J-3626-2019; Bogacka, Iwona/GYU-5963-2022; Giżejewski, Zygmunt/H-7174-2017; Jastrzębski, Jan Paweł/D-6423-2014	Kamińska, Barbara/0000-0002-1429-114X; Paukszto, Lukasz/0000-0002-3618-1064; Jastrzebski, Jan/0000-0001-8699-7742; Jastrzębski, Jan Paweł/0000-0001-8699-7742; Giżejewski, Zygmunt/0000-0001-7627-3222; Kurzynska, Aleksandra Hanna/0000-0001-7081-6409; Smolinska, Nina/0000-0001-5364-1387; Kaminski, Tadeusz/0000-0003-1643-026X; Bogacka, Iwona/0000-0003-3054-0123	Polish National Science Centre [2012/07/B/NZ9/01335]	Polish National Science Centre	This study was supported by the Polish National Science Centre (project No.2012/07/B/NZ9/01335).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Barakat B, 2012, MOL CELL ENDOCRINOL, V359, P66, DOI 10.1016/j.mce.2012.02.018; Cerec V, 2007, BIOL REPROD, V76, P241, DOI 10.1095/biolreprod.106.056168; Chen YR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/183624; Chojnowska K, 2015, EUR J WILDLIFE RES, V61, P807, DOI 10.1007/s10344-015-0955-z; Chojnowska K, 2017, THERIOGENOLOGY, V87, P266, DOI 10.1016/j.theriogenology.2016.09.001; Ciechanowski M, 2011, EUR J WILDLIFE RES, V57, P737, DOI 10.1007/s10344-010-0481-y; Collen P, 2001, REV FISH BIOL FISHER, V10, P439; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conner JR, 2008, J EXP MED, V205, P305, DOI 10.1084/jem.20071499; Conner JR, 2010, P NATL ACAD SCI USA, V107, P11477, DOI 10.1073/pnas.1006894107; Criscuolo A, 2013, GENOMICS, V102, P500, DOI 10.1016/j.ygeno.2013.07.011; Czerwinska J, 2017, GEN COMP ENDOCR, V240, P103, DOI 10.1016/j.ygcen.2016.09.013; Czerwinska J, 2015, FOLIA BIOL-KRAKOW, V63, P229, DOI 10.3409/fb63_4.229; Deng TX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147132; DZAU VJ, 1987, ENDOCRINOLOGY, V120, P2334, DOI 10.1210/endo-120-6-2334; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Glattauer V, 2007, REPROD FERT DEVELOP, V19, P473, DOI 10.1071/RD06013; Glover T.D., 1990, P213; Gong XD, 2002, BIOL REPROD, V67, P46, DOI 10.1095/biolreprod67.1.46; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063259; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Itman C, 2008, DEV DYNAM, V237, P97, DOI 10.1002/dvdy.21401; JOHNSON L, 1983, BIOL REPROD, V29, P777, DOI 10.1095/biolreprod29.3.777; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Q, 2015, EUR J HISTOCHEM, V59, P9, DOI 10.4081/ejh.2015.2456; Liu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077062; Loveland K, 1998, BIOL REPROD, V58, P1123, DOI 10.1095/biolreprod58.5.1123; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matzkin ME, 2013, MOL CELL ENDOCRINOL, V367, P41, DOI 10.1016/j.mce.2012.12.015; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; Moghadam HK, 2013, MOL ECOL RESOUR, V13, P696, DOI 10.1111/1755-0998.12096; Naillat F, 2014, MOL ENDOCRINOL, V28, P1534, DOI 10.1210/me.2013-1244; NAIMAN RJ, 1988, BIOSCIENCE, V38, P753, DOI 10.2307/1310784; Nie QH, 2011, DNA RES, V18, P343, DOI 10.1093/dnares/dsr021; Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9; Obidzinski A, 2011, POL J ECOL, V59, P63; Petrusz P, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-70; Prendergast BJ, 2005, HORM BEHAV, V48, P503, DOI 10.1016/j.yhbeh.2005.05.013; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosell F, 2005, MAMMAL REV, V35, P248, DOI 10.1111/j.1365-2907.2005.00067.x; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P422, DOI 10.1210/me.2003-0188; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; SCHLATT S, 1995, BIOL REPROD, V53, P1169, DOI 10.1095/biolreprod53.5.1169; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Tacken PJ, 2001, TRANSGENIC RES, V10, P211, DOI 10.1023/A:1016682520887; Wilsson L, 1971, VILTREVY, V8, P115; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu WL, 1998, BBA-BIOMEMBRANES, V1373, P360, DOI 10.1016/S0005-2736(98)00119-9; Zamiri MJ, 2010, SMALL RUMINANT RES, V94, P132, DOI 10.1016/j.smallrumres.2010.07.013; ZUROWSKI W, 1992, ACTA THERIOL, V37, P403	56	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180323	10.1371/journal.pone.0180323	http://dx.doi.org/10.1371/journal.pone.0180323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678806	gold, Green Submitted, Green Published			2022-12-27	WOS:000405272200052
J	Das, AJ; Murmann, DC; Cohrn, K; Raskar, R				Das, Anshuman J.; Murmann, Denise C.; Cohrn, Kenneth; Raskar, Ramesh			A method for rapid 3D scanning and replication of large paleontological specimens	PLOS ONE			English	Article							KINECT SENSOR; PHOTOGRAPHY; TECHNOLOGY; TOOL	We demonstrate a fast and cost-effective technique to perform three dimensional (3D) scanning and replication of large paleontological specimens, in this case the entire skull of a Tyrannosaurus rex (T.rex) with a volume in the range of 2 m(3). The technique involves timeof-flight (TOF) depth sensing using the Kinect scanning module commonly used in gesture recognition in gaming. Raw data from the Kinect sensor was captured using open source software and the reconstruction was done rapidly making this a viable method that can be adopted by museums and researchers in paleontology. The current method has the advantage of being low-cost as compared to industrial scanners and photogrammetric methods but also of accurately scanning a substantial volume range which is well suited for large specimens. The depth resolution from the Kinect sensor was measured to be around 0.6 mm which is ideal for scanning large specimens with reasonable structural detail. We demonstrate the efficacy of this method on the skull of FMNH PR 2081, also known as SUE, a near complete T.rex at the Field Museum of Natural History.	[Das, Anshuman J.; Raskar, Ramesh] MIT, MIT Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Murmann, Denise C.] Murmann Dent Hlth, Naperville, IL USA; [Cohrn, Kenneth] KFCForensics, 422 Teague Trail, Lady Lake, FL USA	Massachusetts Institute of Technology (MIT)	Das, AJ (corresponding author), MIT, MIT Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ajdas@mit.edu			MIT Media Lab Consortia	MIT Media Lab Consortia	MIT Media Lab Consortia Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for one of the authors (KFC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Bennett MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21916; Bimber O, 2002, COMPUTER, V35, P25, DOI 10.1109/MC.2002.1033024; Brink KS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12338; Brochu CA, 2003, J VERTEBR PALEONTOL, V22; Cnudde V, 2006, APPL GEOCHEM, V21, P826, DOI 10.1016/j.apgeochem.2006.02.010; Crabb P, 2001, PALAEONTOLOGY, V44, P659, DOI 10.1111/1475-4983.00196; Cunningham JA, 2014, TRENDS ECOL EVOL, V29, P347, DOI 10.1016/j.tree.2014.04.004; Daanen HAM, 2013, DISPLAYS, V34, P270, DOI 10.1016/j.displa.2013.08.011; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; FALKINGHAM PL, 2013, J PALEONTOL TECHN, V11, P1; Feigin M, 2016, IEEE SENS J, V16, P3419, DOI 10.1109/JSEN.2015.2421360; Fortuny J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30387; Grosman L, 2008, J ARCHAEOL SCI, V35, P3101, DOI 10.1016/j.jas.2008.06.011; GUTSCHICK RC, 1960, J PALEONTOL, V34, P756; Karasik A, 2008, J ARCHAEOL SCI, V35, P1148, DOI 10.1016/j.jas.2007.08.008; Kerp H, 2011, REV PALAEOBOT PALYNO, V166, P117, DOI 10.1016/j.revpalbo.2011.05.001; Kolb A, 2010, COMPUT GRAPH FORUM, V29, P141, DOI 10.1111/j.1467-8659.2009.01583.x; Lautenschlager S, 2014, J PALEONTOL, V88, P727, DOI 10.1666/13-085; Metallo A., 2011, CURATOR, V54, P63, DOI DOI 10.1111/J.2151-6952.2010.00067.X; Murmann DC, 2006, J FORENSIC SCI, V51, P846, DOI 10.1111/j.1556-4029.2006.00166.x; Niven L, 2009, J ARCHAEOL SCI, V36, P2018, DOI 10.1016/j.jas.2009.05.021; Peterson JE, 2009, PALAIOS, V24, P780, DOI 10.2110/palo.2009.p09-056r; Ren Z, 2013, IEEE T MULTIMEDIA, V15, P1110, DOI 10.1109/TMM.2013.2246148; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; TAUBIN G, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P852, DOI 10.1109/ICCV.1995.466848; Tong J, 2012, IEEE T VIS COMPUT GR, V18, P643, DOI 10.1109/TVCG.2012.56; Tschopp E, 2012, J PALEONTOL TECHN, V10, P1; Wang C, 2015, SCI REP-UK, P5; Wolff EDS, 2009, PLOS ONE, V4; Yang L, 2015, IEEE SENS J, V15, P4275, DOI 10.1109/JSEN.2015.2416651; Yao Y, 2014, IEEE T CIRC SYST VID, V24, P1935, DOI 10.1109/TCSVT.2014.2302538	33	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179264	10.1371/journal.pone.0179264	http://dx.doi.org/10.1371/journal.pone.0179264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678817	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200012
J	Wolf, L; Herr, C; Niederstrasser, J; Beisswenger, C; Bals, R				Wolf, Lisa; Herr, Christian; Niederstrasser, Julia; Beisswenger, Christoph; Bals, Robert			Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; GLYCOSYLATION END-PRODUCTS; TOBACCO-SMOKE; ANTIMICROBIAL PEPTIDE; PROGRESSION FACTOR; INDUCED EMPHYSEMA; SURFACE RECEPTOR; TIGHT JUNCTIONS; KNOCKOUT MICE; IN-VITRO	The receptor for advanced glycation endproducts (RAGE) is highly expressed in the lung but its physiological functions in this organ is still not completely understood. To determine the contribution of RAGE to physiological functions of the lung, we analyzed pulmonary mechanics and structure of wildtype and RAGE deficient (RAGE (-/-)) mice. RAGE deficiency spontaneously resulted in a loss of lung structure shown by an increased mean chord length, increased respiratory system compliance, decreased respiratory system elastance and increased concentrations of serum protein albumin in bronchoalveolar lavage fluids. Pulmonary expression of RAGE was mainly localized on alveolar epithelial cells and alveolar macrophages. Primary murine alveolar epithelial cells isolated from RAGE -/-mice revealed an altered differentiation and defective barrier formation under in vitro conditions. Stimulation of interferone-y (IFNy)-activated alveolar macrophages deficient for RAGE with Toll-like receptor (TLR) ligands resulted in significantly decreased release of proinflammatory cytokines and chemokines. Exposure to chronic cigarette smoke did not affect emphysema- like changes in lung parenchyma in RAGE (-/)-mice. Acute cigarette smoke exposure revealed a modified inflammatory response in RAGE (-/)-mice that was characterized by an influx of macrophages and a decreased keratinocyte-derived chemokine (KC) release. Our data suggest that RAGE regulates the differentiation of alveolar epithelial cells and impacts on the development and maintenance of pulmonary structure. In cigarette smoke-induced lung pathology, RAGE mediates inflammation that contributes to lung damage.	[Wolf, Lisa; Herr, Christian; Niederstrasser, Julia; Beisswenger, Christoph; Bals, Robert] Saarland Univ, Dept Internal Med Pulmonol Allergol & Crit Care M, Homburg, Germany	Universitatsklinikum des Saarlandes	Bals, R (corresponding author), Saarland Univ, Dept Internal Med Pulmonol Allergol & Crit Care M, Homburg, Germany.	robet.bals@uks.eu	Herr, Christian/AAH-5291-2021; Beisswenger, Christoph/GRO-6580-2022	Herr, Christian/0000-0001-9422-6569	Saarland University HOMFOR, DFG [BE 4813/1-1]	Saarland University HOMFOR, DFG	This work was supported by Saarland University HOMFOR2014, DFG BE 4813/1-1.	Al-Robaiy S, 2013, AM J PHYSIOL-LUNG C, V305, pL491, DOI 10.1152/ajplung.00090.2013; Barnes PJ, 2000, CHEST, V117, P10; Beisswenger C, 2004, RESPIRATION, V71, P402, DOI 10.1159/000079647; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Chen L, 2014, LUNG, V192, P267, DOI 10.1007/s00408-014-9561-1; Daum N, 2012, METHODS MOL BIOL, V806, P31, DOI 10.1007/978-1-61779-367-7_3; DeMaio L, 2009, AM J PHYSIOL-LUNG C, V296, pL1051, DOI 10.1152/ajplung.00021.2009; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009; Herr C, 2015, EXP TOXICOL PATHOL, V67, P261, DOI 10.1016/j.etp.2015.01.002; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Jungnickel C, 2015, AM J PHYSIOL-LUNG C, V309, pL605, DOI 10.1152/ajplung.00116.2015; Kang R, 2016, J IMMUNOL; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; LaFemina MJ, 2014, AM J RESP CELL MOL, V51, P550, DOI 10.1165/rcmb.2013-0456OC; LaFemina MJ, 2010, AM J PHYSIOL-LUNG C, V299, pL724, DOI 10.1152/ajplung.00233.2010; Li D, 2014, ONCOGENE, V33, P2709, DOI 10.1038/onc.2013.248; Li D., 2013, ONCOGENE; Li GL, 2014, AM J RESP CELL MOL, V51, P210, DOI 10.1165/rcmb.2013-0353OC; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Mosser DM, 2008, CURRENT PROTOCOLS IM; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pouwels SD, 2013, DAMPS ACTIVATING INN; Reynolds PR, 2010, AM J RESP CELL MOL, V42, P545, DOI 10.1165/rcmb.2008-0265OC; Rinaldi M, 2012, DIS MODEL MECH, V5, P333, DOI 10.1242/dmm.008508; Robinson AB, 2012, AM J PHYSIOL-LUNG C, V302, pL1192, DOI 10.1152/ajplung.00099.2012; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Sambamurthy N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118979; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Smith DJ, 2011, EUR RESPIR J, V37, P516, DOI 10.1183/09031936.00029310; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Sukkar M, 2012, BRIT J PHARMACOL; Sukkar MB, 2011, EUR RESP J; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Voss M, 2015, AM J PHYSIOL-LUNG C, V309, pL188, DOI 10.1152/ajplung.00388.2014; Waseda K, 2014, AM J RESP CELL MOL B; Williams AE, 2015, AM J PHYSIOL-LUNG C, V308, pL539, DOI 10.1152/ajplung.00141.2014; Wonnenberg B, 2014, INT J MED MICROBIOL, V304, P725, DOI 10.1016/j.ijmm.2014.05.002; Wood TT, 2014, AM J PHYSL LUNG CELL; Wood TT, 2014, AM J PHYSIOL-LUNG C, V307, pL758, DOI 10.1152/ajplung.00185.2014; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Wu XJ, 2013, MOL CELL BIOCHEM, V380, P249, DOI 10.1007/s11010-013-1680-0; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009	60	34	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180092	10.1371/journal.pone.0180092	http://dx.doi.org/10.1371/journal.pone.0180092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678851	gold, Green Submitted, Green Published			2022-12-27	WOS:000405272200037
J	Jang, YR; Shin, Y; Jin, CE; Koo, B; Park, SY; Kim, MC; Kim, T; Chong, YP; Lee, SO; Choi, SH; Kim, YS; Woo, JH; Kim, SH; Yu, E				Jang, Young-Rock; Shin, Yong; Jin, Choong Eun; Koo, Bonhan; Park, Se Yoon; Kim, Min-Chul; Kim, Taeeun; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han; Yu, Eunsil			Molecular detection of Coxiella burnetii from the formalin-fixed tissues of Q fever patients with acute hepatitis	PLOS ONE			English	Article							LONG-TERM PERSISTENCE; DIAGNOSIS; INFECTION; ORIGIN	Background Serologic diagnosis is one of the most widely used diagnostic methods for Q fever, but the window period in antibody response of 2 to 3 weeks after symptom onset results in significant diagnostic delay. We investigated the diagnostic utility of Q fever PCR from formalinfixed liver tissues in Q fever patients with acute hepatitis. Methods We reviewed the clinical and laboratory data in patients with Q fever hepatitis who underwent liver biopsy during a 17-year period, and whose biopsied tissues were available. We also selected patients who revealed granuloma in liver biopsy and with no Q fever diagnosis within the last 3 years as control. Acute Q fever hepatitis was diagnosed if two or more of the following clinical, serologic, or histopathologic criteria were met: (1) an infectious hepatitislike clinical feature such as fever (>= 38 degrees C) with elevated hepatic transaminase levels; (2) exhibition of a phase II immunoglobulin G (IgG) antibodies titer by IFA of >= 1:128 in single determination, or a four-fold or greater rise between two separate samples obtained two or more weeks apart; (3) histologic finding of biopsy tissue showing characteristic fibrin ring granuloma. Results A total of 11 patients with acute Q fever hepatitis were selected and analyzed. Of the 11 patients, 3 (27%) had exposure to zoonotic risk factors and 7 (63%) met the serologic criteria. Granulomas with either circumferential or radiating fibrin deposition were observed in 10 cases on liver biopsy and in 1 case on bone marrow biopsy. 8 (73%) revealed positive Coxiella burnetii PCR from their formalin-fixed liver tissues. In contrast, none of 10 patients with alternative diagnosis who had hepatic granuloma revealed positive C. burnetii PCR from their formalin-fixed liver tissues. Conclusions Q fever PCR from formalin-fixed liver tissues appears to be a useful adjunct for diagnosing Q fever hepatitis.	[Jang, Young-Rock; Park, Se Yoon; Kim, Min-Chul; Kim, Taeeun; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Jang, Young-Rock] Gachon Univ, Coll Med, Div Infect Dis, Dept Internal Med,Gil Med Ctr, Incheon, South Korea; [Shin, Yong; Jin, Choong Eun; Koo, Bonhan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea; [Park, Se Yoon] Soonchunhyang Univ, Coll Med, Div Infect Dis, Dept Internal Med,Seoul Hosp, Seoul, South Korea; [Yu, Eunsil] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; Gachon University; University of Ulsan; Asan Medical Center; Soonchunhyang University; University of Ulsan	Kim, SH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.; Yu, E (corresponding author), Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea.	kimsunghanmd@hotmail.com; esyu@amc.seoul.kr	Chong, Yong Pil/AAB-2623-2021; Lee, Sang-Oh/AGV-5413-2022	Lee, Sang-Oh/0000-0003-1381-8787; Kim, Sung-Han/0000-0002-6596-8253; Jin, Choong Eun/0000-0002-4462-2333; JANG, YOUNG ROCK/0000-0003-1080-7839	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0272]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI16C0272).	Anderson A, 2013, MMWR RECOMM REP, V62, P1; DUPONT HL, 1971, ANN INTERN MED, V74, P198, DOI 10.7326/0003-4819-74-2-198; Fenollar F, 2004, J CLIN MICROBIOL, V42, P4919, DOI 10.1128/JCM.42.11.4919-4924.2004; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Harris RJ, 2000, EPIDEMIOL INFECT, V124, P543, DOI 10.1017/S0950268899003763; HIGGINS D, 1990, ANN NY ACAD SCI, V590, P271, DOI 10.1111/j.1749-6632.1990.tb42231.x; HOFMANN CE, 1982, GASTROENTEROLOGY, V83, P474; KAZANJIAN PH, 1992, CLIN INFECT DIS, V15, P968, DOI 10.1093/clind/15.6.968; LARSON EB, 1982, MEDICINE, V61, P269, DOI 10.1097/00005792-198209000-00001; Lorenz H, 1998, APPL ENVIRON MICROB, V64, P4234; Marmion BP, 2005, QJM-INT J MED, V98, P7, DOI 10.1093/qjmed/hci009; MUSSO D, 1995, J CLIN MICROBIOL, V33, P3129, DOI 10.1128/JCM.33.12.3129-3132.1995; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; TRAVIS LB, 1986, ARCH PATHOL LAB MED, V110, P1017; van Wijk MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-6; WEIR WRC, 1984, J INFECTION, V8, P56, DOI 10.1016/S0163-4453(84)93354-1	16	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180237	10.1371/journal.pone.0180237	http://dx.doi.org/10.1371/journal.pone.0180237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672014	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500032
J	Xu, YY; Liu, ZX; Zhao, JC; Su, CW				Xu, Yingying; Liu, Zhixin; Zhao, Jichang; Su, Chiwei			Weibo sentiments and stock return: A time-frequency view	PLOS ONE			English	Article							INFORMATION-CONTENT; CROSS-SECTION; MARKET; COHERENCE; INVESTOR; BEHAVIOR; TRADES; NOISE; NEWS; BIAS	This study provides new insights into the relationships between social media sentiments and the stock market in China. Based on machine learning, we classify microblogs posted on Sina Weibo, a Twitter's variant in China into five detailed sentiments of anger, disgust, fear, joy, and sadness. Using wavelet analysis, we find close positive linkages between sentiments and the stock return, which have both frequency and time-varying features. Five detailed sentiments are positively related to the stock return for certain periods, particularly since October 2014 at medium to high frequencies of less than ten trading days, when the stock return is undergoing significant fluctuations. Sadness appears to have a closer relationship with the stock return than the other four sentiments. As to the lead-lag relationships, the stock return causes Weibo sentiments rather than reverse for most of the periods with significant linkages. Compared with polarity sentiments (negative vs. positive), detailed sentiments provide more information regarding relationships between Weibo sentiments and the stock market. The stock market exerts positive effects on bullishness and agreement of microblogs. Meanwhile, agreement leads the stock return in-phase at the frequency of approximately 40 trading days, indicating that less disagreement improves certainty about the stock market.	[Xu, Yingying; Liu, Zhixin; Zhao, Jichang] Beihang Univ, Sch Econ & Management, Beijing, Peoples R China; [Su, Chiwei] Ocean Univ China, Dept Finance, Qingdao, Shandong, Peoples R China	Beihang University; Ocean University of China	Xu, YY (corresponding author), Beihang Univ, Sch Econ & Management, Beijing, Peoples R China.	xuying1221@126.com	Su, Chi Wei/ABE-4976-2021	Zhao, Jichang/0000-0002-5319-8060				[Anonymous], 2012, P WORKSHOP INFORM EX; [Anonymous], 2007, J BEHAV FINANC; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Baker M, 2006, J FINANC, V61, P1645, DOI 10.1111/j.1540-6261.2006.00885.x; Bloomfield DS, 2004, ASTROPHYS J, V617, P623, DOI 10.1086/425300; Bouktif Salah, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P837; Brown G. W., 2004, J EMPIR FINANC, V11, P1, DOI [10.1016/j.jempfin.2002.12.001, DOI 10.1016/J.JEMPFIN.2002.12.001]; Celov D, 2013, RES EC BUS CENTRAL E, V2, P37; Chen GM, 2007, J BEHAV DECIS MAKING, V20, P425, DOI 10.1002/bdm.561; Chen WH, 2014, INFORM COMMUN SOC, V17, P1, DOI 10.1080/1369118X.2013.857425; Cheng A, 2009, INSIDE TWITTER IN DE; Cheng WY, 2013, J MANAGE, V5; Das S, 2005, FINANC MANAGE, V34, P103, DOI 10.1111/j.1755-053X.2005.tb00112.x; DeMarzo PM, 2003, Q J ECON, V118, P909, DOI 10.1162/00335530360698469; Dewally M, 2003, FINANC ANAL J, V59, P65, DOI 10.2469/faj.v59.n4.2546; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Dong YH, 2015, INT J EMBED SYST, V7, P148, DOI 10.1504/IJES.2015.069987; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; FAMA EF, 1991, J FINANC, V46, P1575, DOI 10.2307/2328565; Fan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110184; Garcia D, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds3; Go A, 2009, TWITTER SENTIMENT CL; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gou YT, 2013, SOC BEHAV PERSONAL, V41, P625, DOI 10.2224/sbp.2013.41.4.625; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Guille A, 2016, P 21 INT C WORLD WID, P1145, DOI 10.1145/21187980.2188254; HARRIS M, 1993, REV FINANC STUD, V6, P473, DOI 10.1093/rfs/6.3.473; Herwig U, 2007, NEUROIMAGE, V34, P848, DOI 10.1016/j.neuroimage.2006.09.035; Hirshleifer D, 2003, J ACCOUNT ECON, V36, P337, DOI 10.1016/j.jacceco.2003.10.002; Hong H, 2005, J FINANC, V60, P2801, DOI 10.1111/j.1540-6261.2005.00817.x; HUDGINS L, 1993, PHYS REV LETT, V71, P3279, DOI 10.1103/PhysRevLett.71.3279; Jin X, 2016, PHYSICA A, V452, P151, DOI 10.1016/j.physa.2016.02.052; Jones A. L, 2006, INFO, V8, P67, DOI [DOI 10.1108/14636690610688105, DOI 10.1108/]; Kristoufek L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123923; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Li XD, 2014, KNOWL-BASED SYST, V69, P14, DOI 10.1016/j.knosys.2014.04.022; Lin S, 2016, PHYSICA A, V451, P305, DOI 10.1016/j.physa.2016.01.095; Liu B, 2010, CH CRC MACH LEARN PA, P627; Lux T, 2011, EMPIR ECON, V41, P663, DOI 10.1007/s00181-010-0397-0; McDermott R, 2008, J POLIT, V70, P335, DOI 10.1017/S0022381608080341; MILGROM P, 1982, J ECON THEORY, V26, P17, DOI 10.1016/0022-0531(82)90046-1; Mizrach B, 2009, J ECON BEHAV ORGAN, V70, P266, DOI 10.1016/j.jebo.2009.02.001; Ng L, 2010, FINANC MANAGE, V39, P807, DOI 10.1111/j.1755-053X.2010.01093.x; Nofsinger J, 2005, J BEHAV FINANC, V6, P144, DOI 10.1207/s15427579jpfm0603_4; Oh C., 2011, ICIS, P1; Oliveira N, 2013, LECT NOTES ARTIF INT, V8154, P355, DOI 10.1007/978-3-642-40669-0_31; Pak A, 2010, LREC, V10, P1320, DOI DOI 10.17148/IJARCCE.2016.51274; Qian B, 2007, APPL INTELL, V26, P25, DOI 10.1007/s10489-006-0001-7; Ranco G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138441; Rao T, 2012, P 2012 INT C ADV SOC, P119, DOI DOI 10.1109/ASONAM.2012.30; Rechenthin M, 2013, ALGORITHMIC FINANC, V2, P169, DOI 10.3233/AF-13025; Sheu H.-J., 2009, INT J BUS FINANCE RE, V4, P159; Si J., 2014, P 2014 C EMP METH NA, P1139; Smailovic Jasmina, 2013, Human-Computer Interaction and Knowledge Discovery in Complex, Unstructured, Big Data. Third International Workshop, HCI-KDD 2013. Held at SouthCHI 2013. Proceedings: LNCS 7947, P77, DOI 10.1007/978-3-642-39146-0_8; Sprenger TO, 2014, EUR FINANC MANAG, V20, P926, DOI 10.1111/j.1468-036X.2013.12007.x; Sul HK, 2014, P ANN HICSS, P806, DOI 10.1109/HICSS.2014.107; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Tumarkin R, 2001, FINANC ANAL J, V57, P41, DOI 10.2469/faj.v57.n3.2449; Van Bommel J, 2003, J FINANC, V58, P1499, DOI 10.1111/1540-6261.00575; Wang YN, 2007, GLOB FINANC J, V17, P335, DOI 10.1016/j.gfj.2006.05.007; Wu DD, 2014, IEEE T SYST MAN CY-S, V44, P1077, DOI 10.1109/TSMC.2013.2295353; Wysocki P.D., 1998, 98025 U MICH BUS SCH; Xu T, 2015, 2015 INT C ART INT I; Zhang T., 2004, CHIN EC, V37, P17; Zhao J., 2012, P 18 ACM SIGKDD INT, P1528, DOI DOI 10.1145/2339530.2339772	66	14	14	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180723	10.1371/journal.pone.0180723	http://dx.doi.org/10.1371/journal.pone.0180723			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672026	Green Submitted, gold, Green Published			2022-12-27	WOS:000405268500083
J	Zhao, CC; Hu, SE; Huo, X; Zhang, Y				Zhao, Chengchen; Hu, Sheng'en; Huo, Xiao; Zhang, Yong			Dr. seq2: A quality control and analysis pipeline for parallel single cell transcriptome and epigenome data	PLOS ONE			English	Article							RNA-SEQUENCING DATA; EXPRESSION ANALYSIS; HETEROGENEITY; SUBPOPULATIONS	An increasing number of single cell transcriptome and epigenome technologies, including single cell ATAC-seq (scATAC-seq), have been recently developed as powerful tools to analyze the features of many individual cells simultaneously. However, the methods and software were designed for one certain data type and only for single cell transcriptome data. A systematic approach for epigenome data and multiple types of transcriptome data is needed to control data quality and to perform cell-to-cell heterogeneity analysis on these ultra-high-dimensional transcriptome and epigenome datasets. Here we developed Dr. seq2, a Quality Control (QC) and analysis pipeline for multiple types of single cell transcriptome and epigenome data, including scATAC-seq and Drop-ChIP data. Application of this pipeline provides four groups of QC measurements and different analyses, including cell heterogeneity analysis. Dr. seq2 produced reliable results on published single cell transcriptome and epigenome datasets. Overall, Dr. seq2 is a systematic and comprehensive QC and analysis pipeline designed for parallel single cell transcriptome and epigenome data.	[Zhang, Yong] Tongji Univ, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China; Tongji Univ, Inst Regenerat Med, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol,Shanghai East Hosp, Shanghai, Peoples R China	Tongji University; Tongji University	Zhang, Y (corresponding author), Tongji Univ, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China.	yzhang@tongji.edu.cn	Zhao, Chengchen/AAH-4166-2019; Zhang, Yong/B-4838-2011	Zhang, Yong/0000-0001-6316-2734; Zhao, Chengchen/0000-0002-8454-6347	National Natural Science Foundation of China [31571365, 31322031, 31371288]; National Key Research and Development Programof China [2016YFA0100400]; Specialized Research Fund for the Doctoral Program of Higher Education [20130072110032]; Program of Shanghai Academic Research Leader [17XD1403600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Programof China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program of Shanghai Academic Research Leader	This work was supported by National Natural Science Foundation of China (31571365, 31322031 and 31371288), National Key Research and Development Programof China (2016YFA0100400), Specialized Research Fund for the Doctoral Program of Higher Education (20130072110032), and Program of Shanghai Academic Research Leader (17XD1403600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; duVerle,DA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1175-6; Fan HC, 2015, SCIENCE, V347, DOI 10.1126/science.1258367; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Gardeux V., 2016, BIORXIV; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guo MZ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004575; Huo X, 2016, BIOINFORMATICS, V32, P2221, DOI 10.1093/bioinformatics/btw174; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jiang P, 2016, BIOINFORMATICS, V32, P2514, DOI 10.1093/bioinformatics/btw176; Julia M, 2015, BIOINFORMATICS, V31, P3377, DOI 10.1093/bioinformatics/btv368; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Korthauer KD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1077-y; Leng N, 2016, BIOINFORMATICS, V32, P1408, DOI 10.1093/bioinformatics/btw004; Leng N, 2015, NAT METHODS, V12, P947, DOI [10.1038/NMETH.3549, 10.1038/nmeth.3549]; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Marco E, 2014, P NATL ACAD SCI USA, V111, pE5643, DOI 10.1073/pnas.1408993111; Pierson E, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0805-z; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vallejos CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004333; Wang B, 2017, NAT METHODS, V14, P414, DOI 10.1038/nmeth.4207; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Xu C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/bioinformatics/btv088; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	36	21	22	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180583	10.1371/journal.pone.0180583	http://dx.doi.org/10.1371/journal.pone.0180583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671995	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500074
J	Ding, LY; Dong, DM; Jiao, LZ; Zheng, WG				Ding, Luyu; Dong, Daming; Jiao, Leizi; Zheng, Wengang			Potential using of infrared thermal imaging to detect volatile compounds released from decayed grapes	PLOS ONE			English	Article							INDICATORS	Previous studies have demonstrated variations in volatile compound content during fruit spoilage. Infrared spectroscopy was proposed as an alternative method to discriminate the various states of decayed fruit through the makeup of their volatile compounds. Based on the infrared spectra of volatile compounds obtained from decayed grapes, this study simplified the extraction of their feature spectra and visualized their gas plumes by using a commercial infrared thermal camera equipped with a custom-made wavelength filter. As a function of volatilization gradients, accumulated gray value and imaging area were proposed as indicators for semi-quantitative analysis in a volatilization range similar to that of ethanol solutions ranging from 10% to 70%. Fresh, seriously decayed, and slightly or moderately decayed grapes were rapidly discriminated through their alcoholic volatiles by thermal images with correct classification ratings of 100%, 93.3%, and 90%, respectively.	[Ding, Luyu; Dong, Daming; Jiao, Leizi; Zheng, Wengang] Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Informat Technol Agr, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Dong, DM (corresponding author), Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Informat Technol Agr, Beijing, Peoples R China.	damingdong@hotmail.com		Dong, Daming/0000-0003-1684-3072	NSFC [31622040]	NSFC(National Natural Science Foundation of China (NSFC))	This study was funded by NSFC (31622040). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogo H, 2012, PROG COLL POL SCI S, V139, P1, DOI 10.1007/978-3-642-28974-3_1; Castillo S, 2010, POSTHARVEST BIOL TEC, V57, P183, DOI 10.1016/j.postharvbio.2010.04.006; Dong D, 2016, FOOD CHEM, V194, P95, DOI 10.1016/j.foodchem.2015.08.005; Dong D, 2014, ANALYST, V139, P5028, DOI [10.1039/c4an00586d, 10.1039/C4AN00586D]; Dong D, 2014, FOOD CHEM, V155, P45, DOI 10.1016/j.foodchem.2014.01.025; Dong DM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02585; Furry D, 2005, INFRAMATION 2005 P; Graff DL, 2016, REAL TIME VIDEO IMAG, V9761; Hui GH, 2012, FOOD CONTROL, V28, P25, DOI 10.1016/j.foodcont.2012.04.025; Kalua CM, 2009, J AGR FOOD CHEM, V57, P3818, DOI 10.1021/jf803471n; Li CY, 2011, LWT-FOOD SCI TECHNOL, V44, P1019, DOI 10.1016/j.lwt.2010.11.036; Liger-Belair G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030628; Love SP, 2013, J MICRO-NANOLITH MEM, V8618, P1214; Polychroniadou E, 2003, BIORESOURCE TECHNOL, V87, P337, DOI 10.1016/S0960-8524(02)00237-7; Sanchez-Palomo E, 2005, TALANTA, V66, P1152, DOI 10.1016/j.talanta.2005.01.015; Saraiva C, 2015, J FOOD SCI TECH MYS, V52, P3887, DOI 10.1007/s13197-014-1447-y; Schnurer J, 1999, FUNGAL GENET BIOL, V27, P209, DOI 10.1006/fgbi.1999.1139; Ueno H, 2010, BUNSEKI KAGAKU, V59, P293, DOI 10.2116/bunsekikagaku.59.293; Vollmer M, 2010, INFRARED THERMAL IMA, P397; Yang CX, 2011, FOOD CHEM, V128, P823, DOI 10.1016/j.foodchem.2010.11.029; Yang CX, 2009, FOOD CHEM, V114, P1106, DOI 10.1016/j.foodchem.2008.10.061	21	12	12	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180649	10.1371/journal.pone.0180649	http://dx.doi.org/10.1371/journal.pone.0180649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665984	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608700022
J	Ho, CH; Fan, CK; Yu, HJ; Wu, CC; Chen, KC; Liu, SP; Cheng, PC				Ho, Chen-Hsun; Fan, Chia-Kwung; Yu, Hong-Jeng; Wu, Chia-Chang; Chen, Kuan-Chou; Liu, Shih-Ping; Cheng, Po-Ching			Testosterone suppresses uropathogenic Escherichia coli invasion and colonization within prostate cells and inhibits inflammatory responses through JAK/STAT-1 signaling pathway	PLOS ONE			English	Article							ANDROGEN RECEPTOR ACTIVATION; IMMUNE-RESPONSES; BACTERIAL; MACROPHAGES	Prostatitis is a common condition in adult men of all ages. Uropathogenic Escherichia coli (UPEC) are most frequent pathogen involved in bacterial prostatitis by refluxing the infected urine into prostatic ducts and resulting in an ascending urethral infection. However, the study about the mechanisms of UPEC to invade, replicate and persist in normal prostate epithelial cell is only few. Given the fact that UPEC is pathogen most frequently involved in prostatitis and that testosterone has been demonstrated to attenuate prostate inflammation caused by other etiologies. In this study we investigated whether the testosterone reduces the prostatitis and related mechanism by regulating IFN-Upsilon/STAT1 signaling pathway. In the current study aimed to clarify whether testosterone influences the process of UPEC-induced prostate inflammation and invasion into the prostate epithelial cells. In addition, we set up a normal prostate cell model for UPEC infection to evaluate the ability to invade the urothelial cells as well as the colonization of intercellular bacterial communities in vitro. By using the model, we examine the effects of testosterone to suppress effectively the invasion and survival of UPEC in the prostate cells, and inhibit LPS-induced inflammatory responses through the JAK/STAT1 pathway have also been indicated. Our results demonstrated testosterone not only suppressed the invasion and colonization of UPEC, but also inhibited the expression of pro-inflammatory IL-1 beta, IL-6 and IL-8 cytokines expression induced by UPEC in a dose-dependent manner. We found the effective dose of testosterone to suppress UPEC infect prostate cells may be appropriate under 40 mu g/ml. Our data also revealed 20 mu g/ml testosterone treated PZ-HPV-7 cells significantly suppressed the LPS-induced JAK/STAT1 pathway and inflammatory responses, and reached to maximal effects at 40 mu g/ml treatment. These results indicate that testosterone plays an anti-inflammatory role in LPS-induced prostate cell inflammation by down-regulating JAK/STAT1 signaling pathway.	[Ho, Chen-Hsun; Wu, Chia-Chang; Chen, Kuan-Chou] Taipei Med Univ, Sch Med, Dept Urol, Taipei, Taiwan; [Ho, Chen-Hsun; Wu, Chia-Chang; Chen, Kuan-Chou] Taipei Med Univ, Shuang Ho Hosp, Dept Urol, Taipei, Taiwan; [Fan, Chia-Kwung; Cheng, Po-Ching] Taipei Med Univ, Sch Med, Dept Mol Parasitol & Trop Dis, Taipei, Taiwan; [Fan, Chia-Kwung; Cheng, Po-Ching] Taipei Med Univ, Sch Med, Ctr Int Trop Med, Taipei, Taiwan; [Yu, Hong-Jeng; Liu, Shih-Ping] Natl Taiwan Univ Hosp & Coll Med, Dept Urol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital	Cheng, PC (corresponding author), Taipei Med Univ, Sch Med, Dept Mol Parasitol & Trop Dis, Taipei, Taiwan.; Cheng, PC (corresponding author), Taipei Med Univ, Sch Med, Ctr Int Trop Med, Taipei, Taiwan.; Liu, SP (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Urol, Taipei, Taiwan.	spliu@ntuh.gov.tw; bonjovi@tmu.edu.tw		Cheng, Po-Ching/0000-0002-1172-2485; LIU, SHIH-PING/0000-0002-8015-0695; YU, HONG-JENG/0000-0003-3287-5736; Ho, Chen-Hsun/0000-0002-8706-7464	Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan [104 TMU-SHH-19]	Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan	This study was supported by a grant 104 TMU-SHH-19 from Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan.	Abraham SN, 2015, NAT REV IMMUNOL, V15, P655, DOI 10.1038/nri3887; Alexander RB, 1998, UROLOGY, V52, P744, DOI 10.1016/S0090-4295(98)00390-2; Badger TM, 2003, ENDOCRINOLOGY, V144, P3969, DOI 10.1210/en.2002-0163; Baune BT, 2008, NEUROBIOL AGING, V29, P937, DOI 10.1016/j.neurobiolaging.2006.12.003; Berry RE, 2009, INFECT IMMUN, V77, P2762, DOI 10.1128/IAI.00323-09; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Boehm BJ, 2012, PROSTATE, V72, P307, DOI 10.1002/pros.21433; Breser ML, 2013, J IMMUNOL, V190, P3121, DOI 10.4049/jimmunol.1202482; de Souza JAC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/650812; Condorelli RA, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/915752; Conte MP, 2016, INFECT IMMUN, V84, P3105, DOI 10.1128/IAI.00438-16; Dhabhar FS, 2005, AM J PHYSIOL-REG I, V289, pR738, DOI 10.1152/ajpregu.00145.2005; Entezari M, 2012, MOL MED, V18, P477, DOI 10.2119/molmed.2012.00024; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Hanafi LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099211; Jia YL, 2015, INT UROL NEPHROL, V47, P39, DOI 10.1007/s11255-014-0845-4; La Vignera S, 2016, ANDROLOGIA; Lee JH, 2016, J SEX MED, V13, P1047, DOI 10.1016/j.jsxm.2016.04.070; Leimgruber C, 2013, J CELL PHYSIOL, V228, P1551, DOI 10.1002/jcp.24314; Leimgruber C, 2011, PROSTATE, V71, P1097, DOI 10.1002/pros.21322; Letourneau J, 2011, JOVE; Liao PW, 2016, J SEX MED, V13, P1872, DOI 10.1016/j.jsxm.2016.10.002; Lipsky BA, 2010, CLIN INFECT DIS, V50, P1641, DOI 10.1086/652861; Liu L, 2014, J MOL CELL CARDIOL, V76, P15, DOI 10.1016/j.yjmcc.2014.07.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longhi C, 2016, NEW MICROBIOL, V39, P146; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; NASLUND MJ, 1988, J UROLOGY, V140, P1049, DOI 10.1016/S0022-5347(17)41924-0; Qi ZL, 2013, INFLAMM RES, V62, P845, DOI 10.1007/s00011-013-0639-7; Qiu X, 2016, PLOS ONE, V11; Rudick CN, 2011, INFECT IMMUN, V79, P628, DOI 10.1128/IAI.00910-10; Saldana Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101200; Song J, 2008, CURR OPIN MICROBIOL, V11, P66, DOI 10.1016/j.mib.2007.12.001; Takahashi A, 2011, LIFE SCI, V89, P337, DOI 10.1016/j.lfs.2011.06.027; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Vignozzi L, 2013, PROSTATE, V73, P789, DOI 10.1002/pros.22623; Vignozzi L, 2012, J ENDOCRINOL, V214, P31, DOI 10.1530/JOE-12-0142; Wang YC, 2014, J IMMUNOL, V193, P4149, DOI 10.4049/jimmunol.1400594; Weichhart T, 2008, EUR J CLIN INVEST, V38, P29, DOI 10.1111/j.1365-2362.2008.02006.x; Wilson GS, 2013, CANCER LETT, V341, P224, DOI 10.1016/j.canlet.2013.08.009; Zeng KW, 2015, J CELL BIOCHEM, V116, P1286, DOI 10.1002/jcb.25084	43	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180244	10.1371/journal.pone.0180244	http://dx.doi.org/10.1371/journal.pone.0180244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665978	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700077
J	Hu, TX; Sun, L; Hu, HQ; Guo, FT				Hu, Tongxin; Sun, Long; Hu, Haiqing; Guo, Futao			Effects of fire disturbance on soil respiration in the non-growing season in a Larix gmelinii forest in the Daxing'an Mountains, China	PLOS ONE			English	Article							SURFACE CO2 FLUX; SNOW WATER EQUIVALENT; CARBON-DIOXIDE; ROOT RESPIRATION; ARCTIC TUNDRA; 3 SITES; EFFLUX; TEMPERATURE; WINTER; ECOSYSTEM	In boreal forests, fire is an important part of the ecosystem that greatly influences soil respiration, which in turn affects the carbon balance. Wildfire can have a significant effect on soil respiration and it depends on the fire severity and environmental factors (soil temperature and snow water equivalent) after fire disturbance. In this study, we quantified post-fire soil respiration during the non-growing season (from November to April) in a Larix gmelinii forest in Daxing'an Mountains of China. Soil respiration was measured in the snow-covered and snow-free conditions with varying degrees of natural burn severity forests. We found that soil respiration decreases as burn severity increases. The estimated annual C efflux also decreased with increased burn severity. Soil respiration during the non-growing season approximately accounted for 4%-5% of the annual C efflux in all site types. Soil temperature (at 5 cm depth) was the predominant determinant of non-growing season soil respiration change in this area. Soil temperature and snow water equivalent could explain 73%-79% of the soil respiration variability in winter snow-covering period (November to March). Mean spring freeze-thaw cycle (FTC) period (April) soil respiration contributed 63% of the non-growing season C efflux. Our finding is key for understanding and predicting the potential change in the response of boreal forest ecosystems to fire disturbance under future climate change.	[Hu, Tongxin; Sun, Long; Hu, Haiqing] Northeast Forestry Univ, Coll Forestry, Harbin, Peoples R China; [Guo, Futao] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Peoples R China	Northeast Forestry University - China; Fujian Agriculture & Forestry University	Sun, L; Hu, HQ (corresponding author), Northeast Forestry Univ, Coll Forestry, Harbin, Peoples R China.	sunlong365@126.com; hhq@nefu.edu.cn	Hu, Tongxin/J-9582-2019		Fundamental Research Funds for the Central Universities [2572015DA01]; National Natural Science Foundation [31070544, 31470657]; Chinese Forest Ecosystem Research Network and Gene (CFERN & GENE) Award Funds on Ecological paper	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Forest Ecosystem Research Network and Gene (CFERN & GENE) Award Funds on Ecological paper	This research was financially supported by the Fundamental Research Funds for the Central Universities (No. 2572015DA01), National Natural Science Foundation (No. 31070544, 31470657), and the Chinese Forest Ecosystem Research Network and Gene (CFERN & GENE) Award Funds on Ecological paper.; This research was financially supported by the Fundamental Research Funds for the Central Universities (No. 2572015DA01), National Natural Science Foundation (No. 31070544, 31470657), and the Chinese Forest Ecosystem Research Network and Gene (CFERN & GENE) Award Funds on Ecological paper. We also greatly appreciate the field assistance provided by the Nanweng River Forest Ecological Research Station.	Baker DG, 1971, BULLETIN, V37, P24; Bodi MB, 2014, EARTH-SCI REV, V130, P103, DOI 10.1016/j.earscirev.2013.12.007; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Borken W, 2002, GLOBAL CHANGE BIOL, V8, P1205, DOI 10.1046/j.1365-2486.2002.00547.x; Brooks PD, 2011, GEOGR COMPASS, V5, DOI 10.1111/j.1749-8198.2011.00420.x; Brooks PD, 2005, GLOBAL CHANGE BIOL, V11, P231, DOI 10.1111/j.1365-2486.2004.00877.x; Brooks PD, 1997, OECOLOGIA, V110, P403, DOI 10.1007/s004420050175; Brown RD, 2003, ATMOS OCEAN, V41, P1, DOI 10.3137/ao.410101; Campbell JL, 2005, FRONT ECOL ENVIRON, V3, P314, DOI 10.2307/3868565; Chen AJ, 2011, DESERT OASIS METEORO, V5, P5, DOI DOI 10.1088/0957-4484/22/31/315712; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Czimczik CI, 2006, GLOBAL CHANGE BIOL, V12, P957, DOI 10.1111/j.1365-2486.2006.01107.x; Dore S, 2014, FOREST ECOL MANAG, V319, P150, DOI 10.1016/j.foreco.2014.02.012; Edwards KA, 2006, SOIL BIOL BIOCHEM, V38, P2843, DOI 10.1016/j.soilbio.2006.04.042; Elberling B, 2007, SOIL BIOL BIOCHEM, V39, P646, DOI 10.1016/j.soilbio.2006.09.017; Fahnestock JT, 1998, J GEOPHYS RES-ATMOS, V103, P29023, DOI 10.1029/98JD00805; Granier A, 2000, FUNCT ECOL, V14, P312, DOI 10.1046/j.1365-2435.2000.00434.x; Grogan P, 2004, SOIL BIOL BIOCHEM, V36, P641, DOI 10.1016/j.soilbio.2003.12.007; Grogan P, 2001, CLIMATIC CHANGE, V50, P129, DOI 10.1023/A:1010610131277; Grogan P, 2006, GLOBAL CHANGE BIOL, V12, P1479, DOI 10.1111/j.1365-2486.2006.01184.x; Haei M, 2011, SOIL BIOL BIOCHEM, V43, P2069, DOI 10.1016/j.soilbio.2011.06.005; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Harpold A, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011949; Hashimoto S., 2011, PLOS ONE, V7; Hicke JA, 2003, GLOBAL CHANGE BIOL, V9, P1145, DOI 10.1046/j.1365-2486.2003.00658.x; Hu Hai-Qing, 2012, Chinese Journal of Plant Ecology, V36, P629, DOI 10.3724/SP.J.1258.2012.00629; Hubbard RM, 2005, BIOGEOCHEMISTRY, V73, P93, DOI 10.1007/s10533-004-1990-0; Jonas T, 2009, J HYDROL, V378, P161, DOI 10.1016/j.jhydrol.2009.09.021; Joo Seung Jin, 2011, Journal of Ecology and Field Biology, V34, P95, DOI 10.5141/JEFB.2011.012; Kasischke ES, 2000, ECOL STU AN, V138, P19; KASISCHKE ES, 1995, ECOL APPL, V5, P437, DOI 10.2307/1942034; Kasischke ES, 2000, ECOL STU AN, V138, P173; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Kelsey KC, 2012, ARCT ANTARCT ALP RES, V44, P457, DOI 10.1657/1938-4246-44.4.457; Kelting DL, 1998, SOIL BIOL BIOCHEM, V30, P961, DOI 10.1016/S0038-0717(97)00186-7; Lai LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048011; Landsberg J.J, 1997, APPL PHYSL ECOLOGY F; Laternser M, 2003, INT J CLIMATOL, V23, P733, DOI 10.1002/joc.912; Liang NS, 2004, AGR FOREST METEOROL, V123, P97, DOI 10.1016/j.agrformet.2003.10.002; Lin GH, 1999, GLOB CHANGE BIOL, V5, P157, DOI 10.1046/j.1365-2486.1999.00211.x; Liptzin D, 2009, BIOGEOCHEMISTRY, V95, P151, DOI 10.1007/s10533-009-9303-2; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Ma YC, 2014, AGR FOREST METEOROL, V184, P179, DOI 10.1016/j.agrformet.2013.10.008; Maranon-Jimenez S, 2011, FOREST ECOL MANAG, V261, P1436, DOI 10.1016/j.foreco.2011.01.030; Matzner E, 2008, EUR J SOIL SCI, V59, P274, DOI 10.1111/j.1365-2389.2007.00992.x; McDowell NG, 2000, TREE PHYSIOL, V20, P745; McGuire AD, 2003, LAND CHANGE SCI, V6, P139; Merbold L, 2012, BIOGEOCHEMISTRY, V111, P287, DOI 10.1007/s10533-011-9647-2; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Monson RK, 2005, OECOLOGIA, V146, P130, DOI 10.1007/s00442-005-0169-2; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Munoz-Rojas M, 2016, SCI TOTAL ENVIRON, V572, P1385, DOI 10.1016/j.scitotenv.2016.02.086; Nakane K, 1996, ECOL RES, V11, P111, DOI 10.1007/BF02347678; Ngao J, 2012, AGR FOREST METEOROL, V154, P136, DOI 10.1016/j.agrformet.2011.11.003; Niinisto SM, 2011, BIOGEOSCIENCES, V8, P3169, DOI 10.5194/bg-8-3169-2011; O'Neill KP, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000443; ONeill KP, CANADIAN J FOREST RE, V200, P1525; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rastogi M, 2002, CURR SCI INDIA, V82, P510; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Richter DD, 2000, POSTFIRE STIMULATION; Rodriguez A, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008092; Santin C, 2012, EUR J FOREST RES, V131, P1245, DOI 10.1007/s10342-012-0595-8; Schimel JP, 2006, ARCT ANTARCT ALP RES, V38, P249, DOI 10.1657/1523-0430(2006)38[249:CPOCIA]2.0.CO;2; Schimel JP, 2005, SOIL BIOL BIOCHEM, V37, P1411, DOI 10.1016/j.soilbio.2004.12.011; Schlesinger WH., 1998, BIOGEOCHEMISTRY ANAL, V73, P353, DOI 10.1016/0016-7037(92)90106-s; Smith DR, 2010, BIOGEOSCIENCES, V7, P1375, DOI 10.5194/bg-7-1375-2010; Sommerfeld RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P473, DOI 10.1029/96GB01610; SOMMERFELD RA, 1993, NATURE, V361, P140, DOI 10.1038/361140a0; Sun L, 2014, J FORESTRY RES, V25, P613, DOI 10.1007/s11676-014-0499-1; Suzuki S, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006595; Takakai F, 2008, SOIL SCI PLANT NUTR, V54, P938, DOI 10.1111/j.1747-0765.2008.00309.x; Tang XL, 2006, J INTEGR PLANT BIOL, V48, P654, DOI 10.1111/j.1744-7909.2006.00263.x; Tedeschi V, 2006, GLOBAL CHANGE BIOL, V12, P110, DOI 10.1111/j.1365-2486.2005.01081.x; Thornley JHM, 2001, ANN BOT-LONDON, V87, P591, DOI 10.1006/anbo.2001.1372; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wang C, 2013, AGR FOREST METEOROL, V177, P83, DOI 10.1016/j.agrformet.2013.04.008; [王庆丰 WANG QingFeng], 2008, [生态学报, Acta Ecologica Sinica], V28, P1883; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; WEBER MG, 1990, FOREST ECOL MANAG, V31, P1, DOI 10.1016/0378-1127(90)90107-M; Welker JM, 2000, CLIMATIC CHANGE, V44, P139, DOI 10.1023/A:1005555012742; Widen B, 2001, CAN J FOREST RES, V31, P786, DOI 10.1139/cjfr-31-5-786; Xu HC, 1998, XINGAN MOUNTAINS FOR; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yang Jin-Yan, 2006, Zhiwu Shengtai Xuebao, V30, P286; [杨阔 Yang Kuo], 2010, [生态学报, Acta Ecologica Sinica], V30, P3155; You WZ, 2013, TREES-STRUCT FUNCT, V27, P1417, DOI 10.1007/s00468-013-0889-6; Zhang YJ, 2015, ECOL ENG, V74, P196, DOI 10.1016/j.ecoleng.2014.10.003	92	8	9	10	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180214	10.1371/journal.pone.0180214	http://dx.doi.org/10.1371/journal.pone.0180214			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665958	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700072
J	Jiao, W; Blackmore, NJ; Nazmi, AR; Parker, EJ				Jiao, Wanting; Blackmore, Nicola J.; Nazmi, Ali Reza; Parker, Emily J.			Quaternary structure is an essential component that contributes to the sophisticated allosteric regulation mechanism in a key enzyme from Mycobacterium tuberculosis	PLOS ONE			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; SIZE-DISTRIBUTION ANALYSIS; AMINO-ACID BIOSYNTHESIS; SYNERGISTIC ALLOSTERY; SHIKIMATE PATHWAY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CATALYTIC MECHANISM; MOLECULAR-DYNAMICS; PROTEINS	The first enzyme of the shikimate pathway, 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS), adopts a range of distinct allosteric regulation mechanisms in different organisms, related to different quaternary assemblies. DAH7PS from Mycobacterium tuberculosis (MtuDAH7PS) is a homotetramer, with the allosteric sites in close proximity to the interfaces. Here we examine the importance of the quaternary structure on catalysis and regulation, by amino acid substitution targeting the tetramer interface of MtuDAH7PS. Using only single amino acid substitutions either in, or remote from the interface, two dimeric variants of MtuDAH7PS (MtuDAH7PS(F227D) and MtuDAH7PS(G232P)) were successfully generated. Both dimeric variants maintained activity due to the distance between the sites of amino acid substitution and the active sites, but attenuated catalytic efficiency was observed. Both dimeric variants showed significantly disrupted allosteric regulation with greatly impaired binding affinity for one of the allosteric ligands. Molecular dynamics simulations revealed changes in protein dynamics and average conformations in the dimeric variant caused by amino acid substitution remote to the tetramer interface (MtuDAH7PS(G232P)), which are consistent with the observed reduction in catalytic efficiency and loss of allosteric response.	[Jiao, Wanting; Blackmore, Nicola J.; Nazmi, Ali Reza; Parker, Emily J.] Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Biomol Interact Ctr, Christchurch, New Zealand; [Jiao, Wanting; Blackmore, Nicola J.; Nazmi, Ali Reza; Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch, New Zealand; [Jiao, Wanting; Parker, Emily J.] Victoria Univ Wellington, Ferrier Res Inst, Wellington, New Zealand; [Nazmi, Ali Reza] Scion, Rotorua, New Zealand	University of Canterbury; University of Canterbury; Victoria University Wellington; Scion	Parker, EJ (corresponding author), Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Biomol Interact Ctr, Christchurch, New Zealand.; Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Christchurch, New Zealand.; Parker, EJ (corresponding author), Victoria Univ Wellington, Ferrier Res Inst, Wellington, New Zealand.	emily.parker@vuw.ac.nz	Jiao, Wanting/I-3159-2019	Jiao, Wanting/0000-0002-0234-7206; Parker, Emily/0000-0002-9571-9987; Nazmi, Ali Reza/0000-0003-1262-5078	Maurice Wilkins Centre for Molecular Biodiscovery New Zealand Marsden fund [U0C1105]; Biomolecular Interaction Centre	Maurice Wilkins Centre for Molecular Biodiscovery New Zealand Marsden fund; Biomolecular Interaction Centre	This work was supported by the Maurice Wilkins Centre for Molecular Biodiscovery New Zealand Marsden fund (U0C1105) and the Biomolecular Interaction Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Devenish SRA, 2009, ORG BIOMOL CHEM, V7, P833, DOI 10.1039/b818251p; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P67, DOI 10.1016/j.coph.2009.10.002; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lang EJM, 2016, J AM CHEM SOC, V138, P2036, DOI 10.1021/jacs.5b13134; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Munack S, 2016, J MOL BIOL, V428, P1237, DOI 10.1016/j.jmb.2016.01.001; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reichau S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.211649; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Richie-Jannetta R, 2003, J BIOL CHEM, V278, P50070, DOI 10.1074/jbc.M306796200; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schnappauf G, 1998, ARCH MICROBIOL, V169, P517, DOI 10.1007/s002030050605; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Segura-Pena D, 2007, STRUCTURE, V15, P1555, DOI 10.1016/j.str.2007.09.025; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; Wagner T, 2000, J MOL BIOL, V301, P389, DOI 10.1006/jmbi.2000.3957; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; WALLACE BJ, 1967, J BACTERIOL, V93, P237, DOI 10.1128/JB.93.1.237-244.1967; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, BIOCHEM J, V390, P223, DOI 10.1042/BJ20050259; Xu XL, 2014, BIOCHEMISTRY-US, V53, P4239, DOI 10.1021/bi500469d	42	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180052	10.1371/journal.pone.0180052	http://dx.doi.org/10.1371/journal.pone.0180052			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665948	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700058
J	Pergantas, P; Tsatsaris, A; Malesios, C; Kriparakou, G; Demiris, N; Tselentis, Y				Pergantas, Panagiotis; Tsatsaris, Andreas; Malesios, Chrisovalantis; Kriparakou, Georgia; Demiris, Nikolaos; Tselentis, Yiannis			A spatial predictive model for malaria resurgence in central Greece integrating entomological, environmental and social data	PLOS ONE			English	Article							CLIMATE-CHANGE; TRANSMISSION; TEMPERATURE; AFRICA	Malaria constitutes an important cause of human mortality. After 2009 Greece experienced a resurgence of malaria. Here, we develop a model-based framework that integrates entomological, geographical, social and environmental evidence in order to guide the mosquito control efforts and apply this framework to data from an entomological survey study conducted in Central Greece. Our results indicate that malaria transmission risk in Greece is potentially substantial. In addition, specific districts such as seaside, lakeside and rice field regions appear to represent potential malaria hotspots in Central Greece. We found that appropriate maps depicting the basic reproduction number, R-0, are useful tools for informing policy makers on the risk of malaria resurgence and can serve as a guide to inform recommendations regarding control measures.	[Pergantas, Panagiotis; Kriparakou, Georgia] Bioapplicat Ltd, Levadeia, Greece; [Tsatsaris, Andreas] Technol Educ Inst Athens, Dept Dept Civil Surveying & Geoinformat Engn, Athens, Greece; [Malesios, Chrisovalantis] Democritus Univ Thrace, Dept Rural Dev, Orestiada, Greece; [Demiris, Nikolaos] Athens Univ Econ & Business, Dept Stat, Athens, Greece; [Tselentis, Yiannis] Univ Crete, Reg Publ Hlth Lab, Fac Med, Iraklion, Greece	University of West Attica; Democritus University of Thrace; Athens University of Economics & Business; University of Crete	Malesios, C (corresponding author), Democritus Univ Thrace, Dept Rural Dev, Orestiada, Greece.	malesios@agro.duth.gr	Malesios, Chrisovalantis/C-6659-2018; TSATSARIS, ANDREAS/R-6973-2018	Malesios, Chrisovalantis/0000-0003-0378-3939; TSATSARIS, ANDREAS/0000-0003-3509-6551	Continental Greece Region	Continental Greece Region	The entomological survey was financed by the Continental Greece Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bioapplications Ltd, a commercial company, provided support in the form of salary for authors PP and GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions'.	Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113; Craig MH, 2004, TROP MED INT HEALTH, V9, P1247, DOI 10.1111/j.1365-3156.2004.01340.x; Danis K, 2013, TRAVEL MED INFECT DI, V11, P8, DOI 10.1016/j.tmaid.2013.01.001; Gomes E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164788; Hardy A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0652-5; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hellenic Center for Disease Control and Prevention (HCDCP), 2015, EP DAT MAL GREEC; Hellenic Center for Disease Control and Prevention (HCDCP), 2012, EP DAT MAL GREEC; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Kampen H, 2003, PARASITOL RES, V89, P252, DOI 10.1007/s00436-002-0746-9; Leedale J, 2016, GEOSPATIAL HEALTH, V11, P102, DOI 10.4081/gh.2016.393; Lindsay S.W., 2001, GLOB CHANGE HUM HLTH, V2, P80, DOI DOI 10.1023/A:1011995115713; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Paaijmans KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055777; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; Piperaki ET, 2016, CLIN MICROBIOL INFEC, V22, P487, DOI 10.1016/j.cmi.2016.04.023; R Core Team, 2018, R LANG ENV STAT COMP; Smith C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-307; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Starzengruber P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-16; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; Tseroni M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004215; Waltmann A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003758; World Health Organization, 2015, WORLD MAL REP 2015	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178836	10.1371/journal.pone.0178836	http://dx.doi.org/10.1371/journal.pone.0178836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662158	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000404608300009
J	Coste, C; Neirinckx, V; Sharma, A; Agirman, G; Rogister, B; Foguenne, J; Lallemend, F; Gothot, A; Wislet, S				Coste, Cecile; Neirinckx, Virginie; Sharma, Anil; Agirman, Gulistan; Rogister, Bernard; Foguenne, Jacques; Lallemend, Francois; Gothot, Andre; Wislet, Sabine			Human bone marrow harbors cells with neural crest-associated characteristics like human adipose and dermis tissues	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; SKIN-DERIVED PRECURSORS; STEM-CELLS; PERIODONTAL-LIGAMENT; PROGENITOR CELLS; DIFFERENTIATION; MELANOCYTES; GENERATION; ONTOGENY; TRUNK	Adult neural crest stem-derived cells (NCSC) are of extraordinary high plasticity and promising candidates for use in regenerative medicine. Several locations such as skin, adipose tissue, dental pulp or bone marrow have been described in rodent, as sources of NCSC. However, very little information is available concerning their correspondence in human tissues, and more precisely for human bone marrow. The main objective of this study was therefore to characterize NCSC from adult human bone marrow. In this purpose, we compared human bone marrow stromal cells to human adipose tissue and dermis, already described for containing NCSC. We performed comparative analyses in terms of gene and protein expression as well as functional characterizations. It appeared that human bone marrow, similarly to adipose tissue and dermis, contains NESTIN+ /SOX9(+) /TWIST+ /SLUG(+) /P75(NTR+) /BRN3A(+)/MSI1(+)/SNAIL1(+) cells and were able to differentiate into melanocytes, Schwann cells and neurons. Moreover, when injected into chicken embryos, all those cells were able to migrate and follow endogenous neural crest migration pathways. Altogether, the phenotypic characterization and migration abilities strongly suggest the presence of neural crest-derived cells in human adult bone marrow.	[Coste, Cecile; Neirinckx, Virginie; Agirman, Gulistan; Rogister, Bernard; Wislet, Sabine] Univ Liege, GIGA Neurosci, Liege, Belgium; [Sharma, Anil; Agirman, Gulistan; Lallemend, Francois] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Rogister, Bernard] Univ Liege, GIGA Dev Stem Cells & Regenerat Med, Liege, Belgium; [Rogister, Bernard] Univ Liege, Dept Neurol, Liege, Belgium; [Foguenne, Jacques; Gothot, Andre] CHU Liege, Dept Lab Hematol & Immunol, Liege, Belgium; [Gothot, Andre] Univ Liege, GIGA I3, Hematol Res Unit, Liege, Belgium	University of Liege; Karolinska Institutet; University of Liege; University of Liege; University of Liege; University of Liege	Wislet, S (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	s.wislet@ulg.ac.be	Rogister, Bernard/AAJ-9591-2020	Agirman, Gulistan/0000-0003-3379-9632; Sharma, Anil/0000-0002-7442-8494	TeAleAvie-FondsNational de la Recherche Scientifique (FNRS) of Belgium; Fonds Speaciaux of the University of Liege, Belgium; Leon Fredericq Foundation; Swedish Medical Research Council; Karolinska Institute; Ragnar So Ederberg foundation; Knut and Alice Wallenberg Foundation; AkeWiberg foundation; Swedish Brain Foundation	TeAleAvie-FondsNational de la Recherche Scientifique (FNRS) of Belgium; Fonds Speaciaux of the University of Liege, Belgium; Leon Fredericq Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institute(Karolinska Institutet); Ragnar So Ederberg foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); AkeWiberg foundation; Swedish Brain Foundation	This work was supported by a grant from the TeAleAvie-FondsNational de la Recherche Scientifique (FNRS) of Belgium, by a grant of the Fonds Speaciaux of the University of Liege, Belgium, and by a grant of Leon Fredericq Foundation. Francois Lallemend is supported by the Swedish Medical Research Council, Karolinska Institute, Ragnar So Ederberg foundation, Knut and Alice Wallenberg Foundation, AkeWiberg foundation and the Swedish Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe S, 2016, STEM CELL TRANSL MED, V5, P117, DOI 10.5966/sctm.2015-0111; Abe S, 2012, CELL BIOL INT, V36, P927, DOI 10.1042/CBI20110506; Abzhanov A, 2003, DEVELOPMENT, V130, P4567, DOI 10.1242/dev.00673; Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; Biernaskie J, 2010, J INVEST DERMATOL, V130, P1202, DOI 10.1038/jid.2009.449; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Briquet A, 2010, HAEMATOL-HEMATOL J, V95, P47, DOI 10.3324/haematol.2009.008524; Bueno C, 2013, CELL TRANSPLANT, V22, P2017, DOI 10.3727/096368912X657305; Clewes O, 2011, STEM CELL REV REP, V7, P799, DOI 10.1007/s12015-011-9255-5; Cordeiro IR, 2015, CHICK EMBRYO XENOGRA, P1; Coura GS, 2008, J PERIODONTAL RES, V43, P531, DOI 10.1111/j.1600-0765.2007.01065.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dupin E, 2006, ADV EXP MED BIOL, V589, P96; Dupin E, 2013, CYTOM PART A, V83A, P38, DOI 10.1002/cyto.a.22098; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fournier BP, 2016, EUR CELLS MATER, V31, P40, DOI 10.22203/eCM.v031a04; Gho CG, 2015, CYTOTECHNOLOGY; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hara S, 2014, STEM CELLS DEV, V23, P2190, DOI 10.1089/scd.2013.0387; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Hill RP, 2012, PLOS ONE, V7; Hu YF, 2006, STEM CELLS, V24, P2692, DOI 10.1634/stemcells.2006-0233; Isern J, 2014, ELIFE, V3, DOI 10.7554/eLife.03696; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kalcheim C, 2005, INT J DEV BIOL, V49, P105, DOI 10.1387/ijdb.041949ck; Kaltschmidt B, 2012, STEM CELL REV REP, V8, P658, DOI 10.1007/s12015-011-9340-9; Krejci E, 2010, FOLIA BIOL-PRAGUE, V56, P149; Le Douarin NM, 1999, NEURAL CREST, V2; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Lechanteur C, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0892-y; Li L, 2010, J CELL SCI, V123, P853, DOI 10.1242/jcs.061598; Li X, 2011, PLOS ONE, V6; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Neirinckx V, 2014, STEM CELLS, V32, P829, DOI 10.1002/stem.1579; Ohta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016182; Pelaez D, 2013, STEM CELLS DEV, V22, P1; Pierret C, 2006, STEM CELLS DEV, V15, P286, DOI 10.1089/scd.2006.15.286; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RICHARDSON MK, 1993, DEV BIOL, V157, P348, DOI 10.1006/dbio.1993.1140; Serbedzija GN, 1989, VITAL DYE ANAL TIMIN, V816, P809; Shakhova O, 2010, NEURAL CREST DERIVED; Shakhova O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004877; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Sowa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084206; Stevens A, 2008, STEM CELLS DEV, V17, P1175, DOI 10.1089/scd.2008.0012; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Trainor PA, 2014, NEURAL CREST CELLS E; Waddington RJ, 2009, CELLS TISSUES ORGANS, V189, P268, DOI 10.1159/000151447; White PM, 1999, DEVELOPMENT, V126, P4351; Wislet-Gendebien S, 2012, CELL MOL LIFE SCI, V69, P2593, DOI 10.1007/s00018-012-0937-1; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156	67	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0177962	10.1371/journal.pone.0177962	http://dx.doi.org/10.1371/journal.pone.0177962			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683107	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200002
J	Maltsev, AV; Parsons, SP; Kim, MS; Tsutsui, K; Stern, MD; Lakatta, EG; Maltsev, VA; Monfredi, O				Maltsev, Alexander V.; Parsons, Sean P.; Kim, Mary S.; Tsutsui, Kenta; Stern, Michael D.; Lakatta, Edward G.; Maltsev, Victor A.; Monfredi, Oliver			Computer algorithms for automated detection and analysis of local Ca2+ releases in spontaneously beating cardiac pacemaker cells	PLOS ONE			English	Article							RYANODINE RECEPTOR; DIASTOLIC DEPOLARIZATION; SPARKS; SYSTEM; CLOCK; WAVES	Local Ca2+ Releases (LCRs) are crucial events involved in cardiac pacemaker cell function. However, specific algorithms for automatic LCR detection and analysis have not been developed in live, spontaneously beating pacemaker cells. In the present study we measured LCRs using a high-speed 2D-camera in spontaneously contracting sinoatrial (SA) node cells isolated from rabbit and guinea pig and developed a new algorithm capable of detecting and analyzing the LCRs spatially in two-dimensions, and in time. Our algorithm tracks points along the midline of the contracting cell. It uses these points as a coordinate system for affine transform, producing a transformed image series where the cell does not contract. Action potential-induced Ca2+ transients and LCRs were thereafter isolated from recording noise by applying a series of spatial filters. The LCR birth and death events were detected by a differential (frame-to-frame) sensitivity algorithm applied to each pixel (cell location). An LCR was detected when its signal changes sufficiently quickly within a sufficiently large area. The LCR is considered to have died when its amplitude decays substantially, or when it merges into the rising whole cell Ca2+ transient. Ultimately, our algorithm provides major LCR parameters such as period, signal mass, duration, and propagation path area. As the LCRs propagate within live cells, the algorithm identifies splitting and merging behaviors, indicating the importance of locally propagating Ca2+-induced-Ca2+-release for the fate of LCRs and for generating a powerful ensemble Ca2+ signal. Thus, our new computer algorithms eliminate motion artifacts and detect 2D local spatiotemporal events from recording noise and global signals. While the algorithms were developed to detect LCRs in sinoatrial nodal cells, they have the potential to be used in other applications in biophysics and cell physiology, for example, to detect Ca2+ wavelets (abortive waves), sparks and embers in muscle cells and Ca2+ puffs and syntillas in neurons.	[Maltsev, Alexander V.; Kim, Mary S.; Tsutsui, Kenta; Stern, Michael D.; Lakatta, Edward G.; Maltsev, Victor A.; Monfredi, Oliver] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA; [Parsons, Sean P.] McMaster Univ, Farncombe Inst, Hamilton, ON, Canada; [Monfredi, Oliver] Univ Manchester, Div Cardiovasc Sci, Manchester, Lancs, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); McMaster University; University of Manchester	Monfredi, O (corresponding author), NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA.; Monfredi, O (corresponding author), Univ Manchester, Div Cardiovasc Sci, Manchester, Lancs, England.	oliver.monfredi2@nih.gov	Tsutsui, Kenta/K-5411-2013; Lakatta, Edward G/AAL-1447-2020; Monfredi, Oliver/AAH-9507-2021; Maltsev, Victor/AAY-9460-2020	Tsutsui, Kenta/0000-0002-5121-6974; Maltsev, Victor/0000-0002-3832-791X; Monfredi, Oliver/0000-0003-1292-2902; Lakatta, Edward/0000-0002-4772-0035; Maltsev, Alexander/0000-0002-2219-1114; Stern, Michael/0000-0003-4476-7425	Intramural Research Program of the National Institute on Aging; National Institute of Health; Canadian Institutes of Heath Research [MOP12984]; Natural Sciences and Engineering Research Council [286877]; NATIONAL INSTITUTE ON AGING [ZIAAG000844] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Heath Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the Intramural Research Program of the National Institute on Aging, National Institute of Health. SP was supported by the Canadian Institutes of Heath Research (MOP12984) and the Natural Sciences and Engineering Research Council (286877).The funders had no role in study design, data collection	Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Chen BY, 2009, J MOL CELL CARDIOL, V47, P706, DOI 10.1016/j.yjmcc.2009.07.007; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lyashkov AE, 2009, AM J PHYSIOL-HEART C, V297, pH949, DOI 10.1152/ajpheart.01340.2008; Maltsev AV, 2013, CIRC RES, V113, pE94, DOI 10.1161/CIRCRESAHA.113.302465; Maltsev VA, 2009, AM J PHYSIOL-HEART C, V296, pH594, DOI 10.1152/ajpheart.01118.2008; Monfredi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067247; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Ross WN, 2012, NAT REV NEUROSCI, V13, P157, DOI 10.1038/nrn3168; Sirenko S, 2014, J MOL CELL CARDIOL, V66, P106, DOI 10.1016/j.yjmcc.2013.11.011; Sirenko S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003391; Steele EM, 2014, BIOPHYS J, V106, P566, DOI 10.1016/j.bpj.2013.12.040; STEINIER J, 1972, ANAL CHEM, V44, P1906, DOI 10.1021/ac60319a045; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; Stern MD, 2014, J GEN PHYSIOL, V143, P577, DOI 10.1085/jgp.201311123; Stuyvers BD, 2005, CIRC RES, V97, P35, DOI 10.1161/01.RES.0000173375.26489.fe; Torrente AG, 2016, CARDIOVASC RES, V109, P451, DOI 10.1093/cvr/cvw006; Vinogradova TM, 2000, CIRC RES, V87, P760, DOI 10.1161/01.RES.87.9.760; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vinogradova TM, 2004, CIRC RES, V94, P802, DOI 10.1161/01.RES.0000122045.55331.0F; Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271	25	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179419	10.1371/journal.pone.0179419	http://dx.doi.org/10.1371/journal.pone.0179419			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683095	gold, Green Submitted, Green Published			2022-12-27	WOS:000405335200004
J	Whitman, JC; Zhao, JY; Todd, RM				Whitman, Jennifer C.; Zhao, Jiaying; Todd, Rebecca M.			Alternation between different types of evidence attenuates judgments of severity	PLOS ONE			English	Article							REGULARITIES; TASK; BIAS	Most real-world judgments and decisions require the consideration of multiple types of evidence. For example, judging the severity of environmental damage, medical illness, or negative economic trends often involves tracking and integrating evidence from multiple sources (i.e. different natural disasters, physical symptoms, or financial indicators). We hypothesized that the requirement to track and integrate across distinct types of evidence would affect severity judgments of multifaceted problems, compared to simpler problems. To test this, we used scenarios depicting crop damage. Each scenario involved either two event types (i.e. mold damage and insect damage), or one event type. Participants judged the quality of the crop following each scenario. In Experiments 1 and 2, subjective judgments were attenuated if the scenario depicted multiple event types, relative to scenarios depicting single event types. This was evident as a shallower slope of subjective severity ratings, as a function of objectively quantifiable severity, for scenarios with multiple event types. In Experiment 3, we asked whether alternation between event types might contribute to this attenuation. Each scenario contained two event types, and the sequence of events either alternated frequently between types or was organized into two sequential groups. Subjective judgments were attenuated for scenarios with frequently alternating sequences. The results demonstrate that alternation between distinct event types attenuates subjective judgments of severity. This suggests that a requirement to integrate evidence across multiple sources places extra demands on the cognitive system, which reduces the perceived evidence strength.	[Whitman, Jennifer C.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Whitman, Jennifer C.; Zhao, Jiaying; Todd, Rebecca M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Zhao, Jiaying] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada	Northwestern University; University of British Columbia; University of British Columbia	Whitman, JC (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.; Whitman, JC (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jennifer.whitman@northwestern.edu			National Science and Engineering Research Council (NSERC) Discovery; Canadian Foundation for Innovation (FAS) [F13-03917, RGPIN-2014-04202]; Canada Research Chairs program; Social Sciences and Humanities Research Council Postdoctoral Fellowship; SSHR Insight Development [430-2016-00031]	National Science and Engineering Research Council (NSERC) Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (FAS); Canada Research Chairs program(Canada Research Chairs); Social Sciences and Humanities Research Council Postdoctoral Fellowship; SSHR Insight Development	This research was supported by a National Science and Engineering Research Council (NSERC) Discovery grant to R. M. Todd, by the Leaders Opportunity Fund from the Canadian Foundation for Innovation (FAS #: F13-03917) to R. M. Todd (RGPIN-2014-04202), the Canada Research Chairs program (to J. Zhao), a Social Sciences and Humanities Research Council Postdoctoral Fellowship award (to J. C. Whitman), and by a SSHR Insight Development Grant (430-2016-00031) awarded to R.M. Todd, J. Zhao, and J.C. Whitman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almashat S, 2008, PATIENT EDUC COUNS, V71, P102, DOI 10.1016/j.pec.2007.11.004; BEACH LR, 1968, J EXP PSYCHOL, V77, P57, DOI 10.1037/h0025800; Carver CS, 2014, TRENDS COGN SCI, V18, P293, DOI 10.1016/j.tics.2014.02.003; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; De Pascalis V, 2013, BIOL PSYCHOL, V94, P198, DOI 10.1016/j.biopsycho.2013.05.016; FISCHHOFF B, 1983, PSYCHOL REV, V90, P239, DOI 10.1037/0033-295X.90.3.239; Gale M, 2006, Q J EXP PSYCHOL, V59, P873, DOI 10.1080/02724980543000051; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; GINSBURG N, 1994, PERCEPT MOTOR SKILL, V79, P1059, DOI 10.2466/pms.1994.79.3.1059; GINSBURG N, 1978, AM J PSYCHOL, V91, P267, DOI 10.2307/1421536; Igou ER, 2007, J BEHAV DECIS MAKING, V20, P125, DOI [10.1002/bdm.543, 10.1002/bdm.543.]; Kidd C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036399; Kuzmanovic B, 2015, J BEHAV DECIS MAKING, V28, P281, DOI 10.1002/bdm.1849; Speechley WJ, 2010, J PSYCHIATR NEUROSCI, V35, P7, DOI 10.1503/jpn.090025; TAKEMURA K, 1994, J PSYCHOL, V128, P33, DOI 10.1080/00223980.1994.9712709; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WASON PC, 1960, Q J EXP PSYCHOL, V12, P129, DOI 10.1080/17470216008416717; Whitman JC, 2011, PSYCHON B REV, V18, P1156, DOI 10.3758/s13423-011-0141-6; Worthy DA, 2013, PSYCHON B REV, V20, P364, DOI 10.3758/s13423-012-0324-9; Yu RQ, 2015, ATTEN PERCEPT PSYCHO, V77, P2217, DOI 10.3758/s13414-015-0930-5; Zhao JY, 2016, COGNITION, V146, P217, DOI 10.1016/j.cognition.2015.09.018; Zhao JY, 2014, J EXP PSYCHOL HUMAN, V40, P1358, DOI 10.1037/a0036816; Zhao JY, 2014, THINK REASONING, V20, P1, DOI 10.1080/13546783.2013.795916; Zhao JY, 2013, PSYCHOL SCI, V24, P667, DOI 10.1177/0956797612460407; Zhao JY, 2012, COGNITION, V124, P373, DOI 10.1016/j.cognition.2012.05.001; Zhao JY, 2010, THINK REASONING, V16, P288, DOI 10.1080/13546783.2010.521695; Zhao JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085054, 10.1371/journal.pone.0108005]	28	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180585	10.1371/journal.pone.0180585	http://dx.doi.org/10.1371/journal.pone.0180585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683151	Green Submitted, Green Published, gold			2022-12-27	WOS:000405335200049
J	Khalil, MR; Uldbjerg, N; Thorsen, PB; Moller, JK				Khalil, Mohammed Rohi; Uldbjerg, Niels; Thorsen, Poul Bak; Moller, Jens Kjolseth			Intrapartum PCR assay versus antepartum culture for assessment of vaginal carriage of group B streptococci in a Danish cohort at birth	PLOS ONE			English	Article							CHAIN-REACTION ASSAY; PREGNANT-WOMEN; AGALACTIAE COLONIZATION; NEONATAL SEPSIS; UNITED-STATES; RISK-FACTORS; DISEASE; EPIDEMIOLOGY; INFANTS; POPULATION	The aim of this study was to compare the performances of two strategies for predicting intrapartum vaginal carriage of group B streptococci (GBS). One strategy was based on an antepartum culture and the other on an intrapartum polymerase chain reaction (PCR). We conducted a prospective observational study enrolling 902 pregnant women offered GBS screening before delivery by two strategies. The Culture-strategy was based on vaginal and rectal cultures at 35-37 weeks' gestation, whereas the PCR-strategy was based on PCR assay on intrapartum vaginal swab samples. An intrapartum vaginal culture for GBS was used as the reference standard from which the performances of the 2 strategies were evaluated. The reference standard showed a GBS-prevalence of 12%. The culture-strategy performed with a sensitivity of 82%, specificity of 91%, positive predictive value (PPV) of 55%, negative predictive value (NPV) of 98%, and Likelihood ratio (LH+) of 9.2. The PCR-strategy showed corresponding values as sensitivity of 83%, specificity of 97%, PPV of 78%, NPV of 98%, and LH+ of 27.5. We conclude that in a Danish population with a low rate of earlyonset neonatal infection with GBS, the intrapartum PCR assay performs better than the antepartum culture for identification of GBS vaginal carriers during labor.	[Khalil, Mohammed Rohi] Lillebaelt Hosp, Dept Gynecol & Obstet, Kolding, Denmark; [Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynecol, Skejby, Denmark; [Thorsen, Poul Bak] Univ Southern Denmark, Dept Clin Res, Res Unit Gynecol & Obstet, Odense, Denmark; [Moller, Jens Kjolseth] Lillebaelt Hosp, Dept Clin Microbiol, Vejle, Denmark	Aarhus University; University of Southern Denmark	Khalil, MR (corresponding author), Lillebaelt Hosp, Dept Gynecol & Obstet, Kolding, Denmark.	mohammed.khalil@rsyd.dk	Khalil, Mohammed Rohi/X-2671-2019; Uldbjerg, Niels/O-2038-2016	Uldbjerg, Niels/0000-0002-6449-6426; Moller, Jens Kjolseth/0000-0002-5547-5498; Khalil, Mohammed Rohi/0000-0002-5102-9976				Apostol M., 2009, Morbidity and Mortality Weekly Report, V58, P109; Benitz WE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e77; Bergeron MG, 2000, NEW ENGL J MED, V343, P175, DOI 10.1056/NEJM200007203430303; Brimil N, 2006, INT J MED MICROBIOL, V296, P39, DOI 10.1016/j.ijmm.2005.11.001; Davies HD, 2004, CLIN INFECT DIS, V39, P1129, DOI 10.1086/424518; de Tejada BM, 2011, CLIN MICROBIOL INFEC, V17, P1786, DOI 10.1111/j.1469-0691.2010.03378.x; Edwards RK, 2008, OBSTET GYNECOL, V111, P1335, DOI 10.1097/AOG.0b013e31817710ee; Ekelund K, 2004, EPIDEMIOL INFECT, V132, P1083, DOI 10.1017/S0950268804002808; El Aila NA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-285; El Helali N, 2009, CLIN INFECT DIS, V49, P417, DOI 10.1086/600303; Gavino M, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.016; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Keski-Nisula L, 2013, ACTA PAEDIATR, V102, P480, DOI 10.1111/apa.12186; Langhendries JP, 2006, ARCH PEDIATRIE, V13, P1526, DOI 10.1016/j.arcped.2006.09.018; Lyytikainen O, 2003, EMERG INFECT DIS, V9, P469, DOI 10.3201/eid0904.020481; MERCER BM, 1995, AM J OBSTET GYNECOL, V173, P1325, DOI 10.1016/0002-9378(95)91380-7; Money D, 2008, J OBSTET GYNAECOL CA, V30, P770, DOI 10.1016/S1701-2163(16)32805-5; Mueller M, 2014, EUR J OBSTET GYN R B, V176, P137, DOI 10.1016/j.ejogrb.2014.02.039; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Piccinelli G, 2015, INFECT GENET EVOL, V34, P1, DOI 10.1016/j.meegid.2015.07.001; Price D, 2006, J OBSTET GYNAECOL CA, V28, P1083, DOI 10.1016/S1701-2163(16)32337-4; Pulver LS, 2009, J PERINATOL, V29, P20, DOI 10.1038/jp.2008.115; Puopolo KM, 2005, PEDIATRICS, V115, P1240, DOI 10.1542/peds.2004-2275; Rallu F, 2006, J CLIN MICROBIOL, V44, P725, DOI 10.1128/JCM.44.3.725-728.2006; REGAN JA, 1991, OBSTET GYNECOL, V77, P604; Rodriguez-Granger J, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv089; Romero R, 2013, AM J OBSTET GYNECOL, V208, P243, DOI 10.1016/j.ajog.2012.12.026; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Schuchat A, 2000, PEDIATRICS, V105, P21, DOI 10.1542/peds.105.1.21; Silbert S, 2016, J CLIN MICROBIOL, V54, P1660, DOI 10.1128/JCM.00445-16; Stoll BJ, 1998, PEDIATR INFECT DIS J, V17, P499, DOI 10.1097/00006454-199806000-00013; Towers CV, 2010, AM J PERINAT, V27, P785, DOI 10.1055/s-0030-1254237; Valkenburg-van den Berg AW, 2006, EUR J OBSTET GYN R B, V124, P178, DOI 10.1016/j.ejogrb.2005.06.007; Van Dyke MK, 2009, NEW ENGL J MED, V360, P2626, DOI 10.1056/NEJMoa0806820; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Verani JR, 2010, CLIN PERINATOL, V37, P375, DOI 10.1016/j.clp.2010.02.002; Werawatakul Yuthapong, 2001, Journal of the Medical Association of Thailand, V84, P1422; WILKINSON HW, 1973, INFECT IMMUN, V8, P228, DOI 10.1128/IAI.8.2.228-235.1973; Yancey M K, 1996, Infect Dis Obstet Gynecol, V4, P36; Young BC, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.087	41	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180262	10.1371/journal.pone.0180262	http://dx.doi.org/10.1371/journal.pone.0180262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678829	gold, Green Published			2022-12-27	WOS:000405272200044
J	Wang, LJ; Zheng, H; Zhao, H; Robinson, BE				Wang, Lijuan; Zheng, Hua; Zhao, He; Robinson, Brian E.			Nitrogen balance dynamics during 2000-2010 in the Yangtze River Basin croplands, with special reference to the relative contributions of cropland area and synthetic fertilizer N application rate changes	PLOS ONE			English	Article							BUDGETS; INPUTS; AGROECOSYSTEMS; TRANSFORMATION; MANAGEMENT; HYPOXIA; NITRATE; TRENDS; MAIZE; YIELD	With the increases of cropland area and fertilizer nitrogen (N) application rate, general N balance characteristics in regional agroecosystems have been widely documented. However, few studies have quantitatively analyzed the drivers of spatial changes in the N budget. We constructed a mass balance model of the N budget at the soil surface using a database of county-level agricultural statistics to analyze N input, output, and proportional contribution of various factors to the overall N input changes in croplands during 2000-2010 in the Yangtze River Basin, the largest basin and the main agricultural production region in China. Over the period investigated, N input increased by 9%. Of this 87% was from fertilizer N input. In the upper and middle reaches of the basin, the increased synthetic fertilizer N application rate accounted for 84% and 76% of the N input increase, respectively, mainly due to increased N input in the cropland that previously had low synthetic fertilizer N application rate. In lower reaches of the basin, mainly due to urbanization, the decrease in cropland area and synthetic fertilizer N application rate nearly equally contributed to decreases in N input. Quantifying spatial N inputs can provide critical managerial information needed to optimize synthetic fertilizer N application rate and monitor the impacts of urbanization on agricultural production, helping to decrease agricultural environment risk and maintain sustainable agricultural production in different areas.	[Wang, Lijuan; Zheng, Hua; Zhao, He] Univ Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Wang, Lijuan; Zheng, Hua; Zhao, He] Univ Chinese Acad Sci, Beijing, Peoples R China; [Robinson, Brian E.] McGill Univ, Dept Geog, Montreal, PQ, Canada	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; McGill University	Zheng, H (corresponding author), Univ Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.; Zheng, H (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhenghua@rcees.ac.cn	Robinson, Brian E/AAC-4173-2020	Robinson, Brian E/0000-0002-8972-8318; Zheng, Hua/0000-0002-2301-1744	National Key Research and Development Program of China [2016YFC0503401]; Science and Technology Service Network Initiative of Chinese Academy of Sciences (KFJ-STS-ZDTP); Social Science and Humanities Research Council of Canada [53-2014-00861]	National Key Research and Development Program of China; Science and Technology Service Network Initiative of Chinese Academy of Sciences (KFJ-STS-ZDTP); Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the National Key Research and Development Program of China (No.2016YFC0503401), the Science and Technology Service Network Initiative of Chinese Academy of Sciences (KFJ-STS-ZDTP) and the Social Science and Humanities Research Council of Canada. Grant (53-2014-00861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Bao X, 2006, SCI TOTAL ENVIRON, V363, P136, DOI 10.1016/j.scitotenv.2005.06.029; Bo S, 2008, SURFACE N BALANCES A, V18, P304; Bouwman A, 2005, GLOBAL BIOGEOCHEMICA, V19, P4; Bouwman AF, 2017, SCI REP-UK, V7, DOI 10.1038/srep40366; Burkart MR, 1999, J ENVIRON QUAL, V28, P850, DOI 10.2134/jeq1999.00472425002800030016x; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Change IPOC, 2006, IPCC GUIDELINES NATL; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Chen NW, 2008, BIOGEOCHEMISTRY, V87, P169, DOI 10.1007/s10533-007-9175-2; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Editorial Committee of Chinese Yearbook of Agriculture, 2009, CHIN AGR YB; Ewing PM, 2015, ECOL SOC, V20, DOI 10.5751/ES-06767-200118; Fang JY, 2014, GLOBAL CHANGE BIOL, V20, P2019, DOI 10.1111/gcb.12512; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Giles J, 2005, NITROGEN STUDY FERTI, P791; Gu BJ, 2015, P NATL ACAD SCI USA, V112, P8792, DOI 10.1073/pnas.1510211112; Han YG, 2014, GEODERMA, V213, P87, DOI 10.1016/j.geoderma.2013.07.019; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Jin X.C, 1995, LAKES CHINA RES THEI; Li ShuTian, 2011, Scientia Agricultura Sinica, V44, P4207; Liu C, 2009, BIOGEOCHEMISTRY, V94, P175, DOI 10.1007/s10533-009-9317-9; [刘晓利 Liu Xiaoli], 2005, [河北农业大学学报, Journal of Agricultural University of Hebei], V28, P27; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Liu YS, 2010, J ENVIRON MANAGE, V91, P646, DOI 10.1016/j.jenvman.2009.09.028; Ma GuangWen, 2009, Research of Environmental Sciences, V22, P132; Ma L, 2013, ENVIRON SCI TECHNOL, V47, P7260, DOI 10.1021/es400456u; Meng QF, 2013, FIELD CROP RES, V143, P91, DOI 10.1016/j.fcr.2012.09.023; Mueller ND, 2017, GLOBAL BIOGEOCHEM CY, V31, P245, DOI 10.1002/2016GB005515; OECD, 2008, EUROCHOICES, V12, P30; Powlson DS, 2008, J ENVIRON QUAL, V37, P291, DOI 10.2134/jeq2007.0177; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Shindo J, 2012, NUTR CYCL AGROECOSYS, V94, P47, DOI 10.1007/s10705-012-9525-x; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; [孙志梅 SUN Zhimei], 2006, [土壤通报, Journal of Soil Science], V37, P782; Ti CP, 2012, BIOGEOCHEMISTRY, V108, P381, DOI 10.1007/s10533-011-9606-y; Van Breemen N, 2002, BIOGEOCHEMISTRY, V57, P267, DOI 10.1023/A:1015775225913; Varshney RK, 2012, NAT BIOTECHNOL, V30, P1172, DOI 10.1038/nbt.2440; Wang A, 2016, SCI CHINA EARTH SCI, P1; Wang QX, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/115005; Wu YM, 2006, CHINESE GEOGR SCI, V16, P289, DOI 10.1007/s11769-006-0289-6; Xiong ZQ, 2008, NUTR CYCL AGROECOSYS, V80, P189, DOI 10.1007/s10705-007-9132-4; Xu XP, 2017, FIELD CROP RES, V203, P8, DOI 10.1016/j.fcr.2016.11.013; Yan W., 2001, ACTA GEOGRAPHICA SIN, V68, P505, DOI [10.11821/xb200105001, DOI 10.3321/J.ISSN:0375-5444.2001.05.001]; Yan WJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002029; Yan WJ, 1999, BIOGEOCHEMISTRY, V45, P1; [张欢 Zhang Huan], 2014, [土壤通报, Chinese Journal of Soil Science], V45, P1119; Zheng MM, 2015, J ENVIRON SCI, V28, P195, DOI 10.1016/j.jes.2014.05.053	52	10	12	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180613	10.1371/journal.pone.0180613	http://dx.doi.org/10.1371/journal.pone.0180613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678841	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200076
J	Humayun, MZ; Zhang, Z; Butcher, AM; Moshayedi, A; Saier, MH				Humayun, M. Zafri; Zhang, Zhongge; Butcher, Anna M.; Moshayedi, Aref; Saier, Milton H., Jr.			Hopping into a hot seat: Role of DNA structural features on IS5-mediated gene activation and inactivation under stress	PLOS ONE			English	Article							COLI-BGL OPERON; ESCHERICHIA-COLI; DUPLEX DESTABILIZATION; NUCLEOTIDE-SEQUENCE; BINDING PROTEINS; FUCPIK OPERON; TRANSPOSITION; EXPRESSION; FLHDC; TRANSCRIPTION	Insertion sequence elements (IS elements) are proposed to play major roles in shaping the genetic and phenotypic landscapes of prokaryotic cells. Recent evidence has raised the possibility that environmental stress conditions increase IS hopping into new sites, and often such hopping has the phenotypic effect of relieving the stress. Although stressinduced targeted mutations have been reported for a number of E. coli genes, the glpFK (glycerol utilization) and the cryptic bglGFB (beta-glucoside utilization) systems are among the best characterized where the effects of IS insertion-mediated gene activation are well-characterized at the molecular level. In the glpFK system, starvation of cells incapable of utilizing glycerol leads to an IS5 insertion event that activates the glpFK operon, and enables glycerol utilization. In the case of the cryptic bglGFB operon, insertion of IS5 (and other IS elements) into a specific region in the bglG upstream sequence has the effect of activating the operon in both growing cells, and in starving cells. However, a major unanswered question in the glpFK system, the bgl system, as well as other examples, has been why the insertion events are promoted at specific locations, and how the specific stress condition (glycerol starvation for example) can be mechanistically linked to enhanced insertion at a specific locus. In this paper, we show that a specific DNA structural feature (superhelical stressinduced duplex destabilization, SIDD) is associated with "stress-induced" IS5 insertion in the glpFK, bglGFB, flhDC, fucAO and nfsB systems. We propose a speculative mechanistic model that links specific environmental conditions to the unmasking of an insertional hotspot in the glpFK system. We demonstrate that experimentally altering the predicted stability of a SIDD element in the nfsB gene significantly impacts IS5 insertion at its hotspot.	[Humayun, M. Zafri] Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Zhang, Zhongge; Butcher, Anna M.; Moshayedi, Aref; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Diego	Humayun, MZ (corresponding author), Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA.; Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	humayun@njms.rutgers.edu; msaier@ucsd.edu		Saier, Milton/0000-0001-5530-0017; Humayun, M. Zafri/0000-0001-5294-0852	National Institutes of Health [GM077402, GM109895]; NIH [GM077402, GM109895]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402, R01GM109895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MZH wishes to acknowledge a sabbatical leave of absence from Rutgers University that enabled him to initiate this work. This work was supported by National Institutes of Health grants GM077402 and GM109895 to MHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MZH wishes to acknowledge a sabbatical leave of absence from Rutgers University that enabled him to initiate this work. This work was supported by NIH grants GM077402 and GM109895 to MHS.	Ak P, 2005, PLOS COMPUT BIOL, V1, P41, DOI 10.1371/journal.pcbi.0010007; Andersson DI, 2011, ECOSAL PLUS, V4; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; BARTLETT DH, 1989, J BACTERIOL, V171, P1763, DOI 10.1128/jb.171.3.1763-1766.1989; BAUER W, 1968, J MOL BIOL, V33, P141, DOI 10.1016/0022-2836(68)90286-6; Benham C, 1997, J MOL BIOL, V274, P181, DOI 10.1006/jmbi.1997.1385; BENHAM CJ, 1993, P NATL ACAD SCI USA, V90, P2999, DOI 10.1073/pnas.90.7.2999; Benham CJ, 1996, J MOL BIOL, V255, P425, DOI 10.1006/jmbi.1996.0035; Benham CJ, 2004, J COMPUT BIOL, V11, P519, DOI 10.1089/cmb.2004.11.519; CHEN YM, 1989, J BACTERIOL, V171, P6097, DOI 10.1128/jb.171.11.6097-6105.1989; Choi J, 2011, CHEM SOC REV, V40, P5893, DOI 10.1039/c1cs15153c; CONN EE, 1991, PLANTA MED, V57, pS1, DOI 10.1055/s-2006-960222; Copeland MF, 2009, SOFT MATTER, V5, P1174, DOI 10.1039/b812146j; Craig NL, 1997, ANNU REV BIOCHEM, V66, P437, DOI 10.1146/annurev.biochem.66.1.437; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deweese JE, 2009, BIOCHEM MOL BIOL EDU, V37, P2, DOI 10.1002/bmb.20244; Du XJ, 2013, NUCLEIC ACIDS RES, V41, P5965, DOI 10.1093/nar/gkt308; EZE MO, 1981, J GEN MICROBIOL, V124, P299; Fahrner KA, 2015, J BACTERIOL, V197, P3087, DOI 10.1128/JB.00455-15; Fricker AD, 2014, ANNU REV GENET, V48, P167, DOI 10.1146/annurev-genet-120213-092046; Gilbert N, 2014, CURR OPIN GENET DEV, V25, P15, DOI 10.1016/j.gde.2013.10.013; Gleadow RM, 2014, ANNU REV PLANT BIOL, V65, P155, DOI 10.1146/annurev-arplant-050213-040027; Hall BG, 1999, J BACTERIOL, V181, P1149, DOI 10.1128/JB.181.4.1149-1155.1999; Hall BG, 1998, MOL BIOL EVOL, V15, P1; HALL BG, 1992, MOL BIOL EVOL, V9, P688; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Harshey RM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0007-2014; Hatfield GW, 2002, ANNU REV GENET, V36, P175, DOI 10.1146/annurev.genet.36.032902.111815; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Maisnier-Patin S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018176; Manna D, 2004, P NATL ACAD SCI USA, V101, P9780, DOI 10.1073/pnas.0400745101; MCCALLA DR, 1978, J BACTERIOL, V133, P10, DOI 10.1128/JB.133.1.10-16.1978; Navarre WW, 2016, ADV MICROB PHYSIOL, V69, P157, DOI 10.1016/bs.ampbs.2016.07.004; PARKER LL, 1990, GENETICS, V124, P473; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Peters JE, 2014, TN7 MICROBIOL SPECTR, V2; Race PR, 2005, J BIOL CHEM, V280, P13256, DOI 10.1074/jbc.M409652200; REYNOLDS AE, 1981, NATURE, V293, P625, DOI 10.1038/293625a0; Saier MH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00390; Sankar TS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000405; SCHNETZ K, 1992, P NATL ACAD SCI USA, V89, P1244, DOI 10.1073/pnas.89.4.1244; SCHNETZ K, 1995, EMBO J, V14, P2545, DOI 10.1002/j.1460-2075.1995.tb07252.x; Siguier P, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0030-2014; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; SINGH J, 1995, MOL MICROBIOL, V17, P1085, DOI 10.1111/j.1365-2958.1995.mmi_17061085.x; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Staib L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01116; Swingle B, 2004, MOL MICROBIOL, V52, P1055, DOI 10.1111/j.1365-2958.2004.04051.x; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vandecraen J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00359; Venkatesh GR, 2010, J BACTERIOL, V192, P6456, DOI 10.1128/JB.00807-10; Wang HQ, 2004, GENOME RES, V14, P1575, DOI 10.1101/gr.2080004; Wang XX, 2011, ISME J, V5, P1517, DOI 10.1038/ismej.2011.27; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Wiebe H, 2015, J BACTERIOL, V197, P2713, DOI 10.1128/JB.00263-15; Yona-Nadler C, 2003, MICROBIOL-SGM, V149, P877, DOI 10.1099/mic.0.25970-0; Zhabinskaya D, 2015, BIOINFORMATICS, V31, P421, DOI 10.1093/bioinformatics/btu657; Zhang Z, 2017, MICROBIOLOGY; Zhang ZG, 2017, MICROBIOL-SGM, V163, P554, DOI 10.1099/mic.0.000426; Zhang ZG, 2016, MUTAT RES-FUND MOL M, V793, P22, DOI 10.1016/j.mrfmmm.2016.10.003; Zhang ZG, 2010, J BACTERIOL, V192, P2013, DOI 10.1128/JB.01085-09; Zhang ZG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000689; Zhang ZG, 2009, MOL MICROBIOL, V74, P29, DOI 10.1111/j.1365-2958.2009.06831.x	66	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180156	10.1371/journal.pone.0180156	http://dx.doi.org/10.1371/journal.pone.0180156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666002	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608700066
J	Wang, P; Li, XP; Cao, LH; Huang, SH; Li, HY; Zhang, Y; Yang, T; Jiang, JR; Shi, DS				Wang, Ping; Li, Xiangping; Cao, Lihua; Huang, Shihai; Li, Haiyan; Zhang, Yan; Yang, Ting; Jiang, Jianrong; Shi, Deshun			MicroRNA-148a overexpression improves the early development of porcine somatic cell nuclear transfer embryos	PLOS ONE			English	Article							DNA METHYLTRANSFERASE 1; CLONED EMBRYOS; METHYLATION PATTERNS; DONOR CELLS; IN-VITRO; 5-AZA-2'-DEOXYCYTIDINE; HYPOMETHYLATION; COMPETENCE; EXPRESSION; INHIBITOR	Incomplete epigenetic reprogramming of donor cell nuclei is one of the main contributors to the low efficiency of somatic cell nuclear transfer (SCNT). To improve the success of SCNT, somatic cell DNA methylation levels must be reduced to those levels found in totipotent embryonic cells. Recent studies have demonstrated that miR-148a can affect DNA methylation via DNMT1 modulation in various cancers. Therefore, the focus of this study was to examine the influence of miR-148a on DNA methylation in donor cells and in SCNT embryo development. Thus, a stable cell line overexpressing miR-148a was established and used to produce SCNT embryos. Upon examination, DNMT1 was found to be a miR-148a target in porcine fetal fibroblasts (PFF). Furthermore, miR-148a overexpression in PFFs significantly decreased DNMT1 expression and global DNA methylation levels (P < 0.05). Moreover, miRNA-148a expression levels in SCNT embryos were significantly lower at the 2-cell and 4-cell stages when compared to IVF and parthenogenetic embryos. The group overexpressing miRNA-148a also showed a significant increase in blastocyst formation and total cell numbers (P < 0.05). Additionally, miR-148a overexpression altered the immunofluorescence signal of 5-mC and H3K9ac, and enhanced pluripotent gene (Oct4 and Nanog) expression levels during embryo development. These results indicate that miR-148a overexpression enhances the developmental potential of SCNT embryos and modifies epigenetic status.	[Wang, Ping; Li, Xiangping; Cao, Lihua; Li, Haiyan; Zhang, Yan; Yang, Ting; Jiang, Jianrong; Shi, Deshun] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi Zhuang, Peoples R China; [Huang, Shihai] Guangxi Univ, Coll Life Sci & Technol, Nanning, Guangxi Zhuang, Peoples R China	Guangxi University; Guangxi University	Li, XP; Shi, DS (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi Zhuang, Peoples R China.	xiangpingli@163.com; adrsshi@gxu.edu.cn			National Transgenic Project [2014ZX08007-001]; National Natural Science funding [31560632]; Guangxi Natural Science funding [2016GXNSFDA380030, 2014GXNSFAA118084, 2014GXNSFAA118099]; Innovation Project of Guangxi Graduate Education [YCBZ2014013]	National Transgenic Project; National Natural Science funding(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science funding; Innovation Project of Guangxi Graduate Education	This work was supported by the National Transgenic Project (2014ZX08007-001). National Natural Science funding (31560632); Guangxi Natural Science funding (2016GXNSFDA380030, 2014GXNSFAA118084, 2014GXNSFAA118099) and the Innovation Project of Guangxi Graduate Education (YCBZ2014013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2005, MOL REPROD DEV, V72, P311, DOI 10.1002/mrd.20357; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Chung YG, 2003, BIOL REPROD, V69, P146, DOI 10.1095/biolreprod.102.014076; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Gomez MC, 2012, REPROD DOMEST ANIM, V47, P130, DOI 10.1111/rda.12027; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129803; Huan YJ, 2015, CELL REPROGRAM, V17, P191, DOI 10.1089/cell.2014.0103; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Ji Huili, 2014, Yichuan, V36, P1211, DOI 10.3724/SP.J.1005.2014.1211; Jones KL, 2001, MOL REPROD DEV, V60, P208, DOI 10.1002/mrd.1079; Kavalali ET, 2011, J NEURODEV DISORD, V3, P250, DOI 10.1007/s11689-011-9078-3; Kumar BM, 2006, CELL TISSUE RES, V325, P445, DOI 10.1007/s00441-006-0201-9; Lopez-Bertoni H, 2015, ONCOGENE, V34, P3994, DOI 10.1038/onc.2014.334; Meister G, 2004, MECHANISMS GENE SILE, V16, P431; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Sun HL, 2015, CELL REPROGRAM, V17, P404, DOI 10.1089/cell.2014.0084; Teng Y, 2016, CELL PHYSIOL BIOCHEM, V39, P2341, DOI 10.1159/000447926; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Whitworth KM, 2010, MOL REPROD DEV, V77, P1001, DOI 10.1002/mrd.21242; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xu Q., 2013, ADV METEOROL, V2013, P1, DOI DOI 10.1093/JMCB/MJS049; Xu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064705; Yamanaka K, 2011, J REPROD DEVELOP, V57, P393, DOI 10.1262/jrd.10-181A; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Zhan Q, 2015, CANCER INVEST, V33, P267, DOI 10.3109/07357907.2015.1025794; Zhang XX, 2015, MOL MED REP, V12, P6672, DOI 10.3892/mmr.2015.4246; Zhou Y, 2013, REPROD DOMEST ANIM, V48, P112, DOI 10.1111/j.1439-0531.2012.02040.x; Zhu A, 2012, MED ONCOL, V29, P2701, DOI 10.1007/s12032-011-0134-3; Zuo JB, 2013, MOL CELLS, V35, P313, DOI 10.1007/s10059-013-2314-9	35	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180535	10.1371/journal.pone.0180535	http://dx.doi.org/10.1371/journal.pone.0180535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665977	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608700015
J	Yang, DD; Zhang, ZF; Liang, SS; Yang, QK; Wang, YR; Qin, ZK				Yang, Dandan; Zhang, Zhifeng; Liang, Shaoshuai; Yang, Qiankun; Wang, Yingrui; Qin, Zhenkui			A novel role of Kruppel-like factor 4 in Zhikong scallop Chlamys farreri during spermatogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; SEX DETERMINATION; GERM-CELL; EXPRESSION; KRUPPEL-LIKE-FACTOR-4; DIFFERENTIATION; GAMETOGENESIS; REVEALS; GONAD; FOXL2	Kruppel-like factor 4 (KLF4) is a kind of zinc finger transcription factor, which is involved in terminal differentiation of epithelial cells and reprogramming of somatic cells to induced pluripotent stem (iPS) cells in mammals. In the present study, we identified a full-length cDNA of Klf4 in Zhikong scallop Chamys farreri (Cf-Klf4) and found that Cf-Klf4 presented a sexual dimorphic expression characteristic in C. farreri gonads. Cf-Klf4 expression was significantly higher in testes than in ovaries from growing stage to mature stage detected by quantitative real-time PCR, and was located in male gametes, except for spermatozoa during spermatogenesis through in situ hybridization and immunohistochemistry, while no positive signal was visible in female gametes during oogenesis. Furthermore, the knockdown of Cf-Klf4 in testes by means of in vivo RNA interference led to an obviously developmental retardance, lower gonadosomatic index, less male gametes and more apoptotic spermatocytes. Interestingly, we found that two out of eight scallops showed a hermaphroditic phenotype characteristic of male-to-female sex reversal when the Klf4 mRNA and protein levels were knocked down in males. These results verified that Klf4 plays an important role in testis functional maintenance and is necessary in spermatogenesis of C. farreri.	[Yang, Dandan; Zhang, Zhifeng; Liang, Shaoshuai; Yang, Qiankun; Wang, Yingrui; Qin, Zhenkui] Ocean Univ China, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Zhang, Zhifeng] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Qin, ZK (corresponding author), Ocean Univ China, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	qinzk@ouc.edu.cn	YANG, Dan/HHD-2733-2022	Qin, Zhenkui/0000-0002-8717-1210	National Natural Science Foundation of China [31602139]; Laboratory for Marine Fisheries and Aquaculture, Qingdao National Laboratory for Marine Science and Technology [2015ASKJ02]; National High Technology Research and Development Program of China [2012AA10A402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Laboratory for Marine Fisheries and Aquaculture, Qingdao National Laboratory for Marine Science and Technology; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China received by ZQ (grant number: 31602139), http://www.nsfc.gov.cn/, the Scientific and Technological Innovation Project from Laboratory for Marine Fisheries and Aquaculture, Qingdao National Laboratory for Marine Science and Technology received by ZZ (grant number: 2015ASKJ02), http://www.qnlm.ac/ index, and the National High Technology Research and Development Program of China received by ZZ (grant number: 2012AA10A402), http//program. most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Behr R, 2007, MOL HUM REPROD, V13, P815, DOI 10.1093/molehr/gam064; Behr R, 2002, MECH DEVELOP, V115, P167, DOI 10.1016/S0925-4773(02)00127-2; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Boulanger L, 2014, CURR BIOL, V24, P404, DOI 10.1016/j.cub.2013.12.039; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; Dang T, 2000, BIOCH CELL BIOL, V32, P1103; Feng ZF, 2011, AQUACULTURE, V314, P202, DOI 10.1016/j.aquaculture.2011.02.017; [冯政夫 Feng Zhengfu], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P930; Godmann M, 2009, MOL HUM REPROD, V15, P479, DOI 10.1093/molehr/gap040; Godmann M, 2008, DEV BIOL, V315, P552, DOI 10.1016/j.ydbio.2007.12.018; Godmann M, 2009, MECH DEVELOP, V126, P650, DOI 10.1016/j.mod.2009.06.1081; Hodgkin J., 1985, TRENDS GENET, V1, P85; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Katz JP, 2002, DEVELOPMENT, V129, P2619; Li HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115917; Li Y., 2016, COMP MATH MATH PHYS, V2016, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.1109/TSG.2015.2508923; Liao C.Y., 1983, J FISH CHINA, V7, P1; Lin C, 2012, FASEB J, V26, P944; Liu J, 2014, CAN J ZOOL, V92, P195, DOI 10.1139/cjz-2013-0202; Liu JG, 2014, J STEROID BIOCHEM, V141, P77, DOI 10.1016/j.jsbmb.2014.01.008; Liu XL, 2012, DEV GENES EVOL, V222, P279, DOI 10.1007/s00427-012-0410-z; Ma YB, 2011, MAR BIOTECHNOL, V13, P93, DOI 10.1007/s10126-010-9273-3; Masuyama H, 2012, CHROMOSOME RES, V20, P163, DOI 10.1007/s10577-011-9264-x; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; [吴洪流 Wu Hongliu], 2002, [海洋科学, Marine Sciences], V26, P5; Yet F, 1998, BIOL CHEM, V273, P10747; Yu FF, 2011, J SHELLFISH RES, V30, P247, DOI 10.2983/035.030.0208; Yu T, 2015, CELL DEATH DIFFER; Zhang N, 2014, G3-GENES GENOM GENET, V4, P2207, DOI 10.1534/g3.114.013904; Zhou Z, 2012, FISH SHELLFISH IMMUN, V33, P67, DOI 10.1016/j.fsi.2012.04.002	40	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180351	10.1371/journal.pone.0180351	http://dx.doi.org/10.1371/journal.pone.0180351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665994	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700087
J	Fenwick, EK; Xie, J; Man, REK; Sabanayagam, C; Lim, L; Rees, G; Wong, TY; Lamoureux, EL				Fenwick, Eva K.; Xie, Jing; Man, Ryan E. K.; Sabanayagam, Charumathi; Lim, Lyndell; Rees, Gwyn; Wong, Tien Y.; Lamoureux, Ecosse L.			Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; HEART-DISEASE; MANAGEMENT; METHODOLOGY; POPULATION; ADULTS; CARE; EYE	Purpose To examine the association of individual and combined indicators of diabetes control with diabetic retinopathy and diabetic macular edema. Materials and methods In this clinical, cross-sectional study, 613 adults with type 2 diabetes (372 any diabetic retinopathy; 183 any diabetic macular edema) were examined. Diabetic retinopathy was assessed from fundus photographs; diabetic macular edema from Ocular Coherence Tomography scans; and HbA1c and serum lipid values from fasting blood samples. Poor glucose control was defined as HbA1c >= 7%; poor blood pressure control as SBP >= 130/DBP >= 80; and poor lipid control as total cholesterol: HDL ratio >= 4.0. The association of poor glucose control, poor blood pressure control and poor lipid control alone and in combination (poor glucose & blood pressure control; poor glucose & lipid control; poor blood pressure & lipid control; and poor glucose, blood pressure & lipid control) with diabetic retinopathy/diabetic macular edema was examined using multiple logistic regression models. Results Patients' mean +/- standard deviation age was 64.9 +/- 11.6 years (57% male). In adjusted models, compared to those with good control of all indicators (n = 99, 18.3%), the odds ratio (95% Confidence Interval) of having any diabetic retinopathy was 2.44 (1.34 +/- 4.46), 3.75 (1.75 +/- 8.07), 4.64 (2.13 +/- 10.12) and 2.28 (1.01 +/- 5.16) for poor glucose control only; poor glucose & blood pressure control; poor glucose & lipid control; and poor glucose, blood pressure & lipid control, respectively. Correspondingly for diabetic macular edema, they were 3.19 (1.55 +/- 6.59); 3.60 (1.58 +/- 8.22); 2.76 (1.18 +/- 6.44); and 3.01 (1.18 +/- 7.67), respectively. Odds were not significantly increased for other indicators. Discussion Compared to individual indicators of poor diabetes control, risk of diabetic retinopathy and diabetic macular edema increased three to fourfold with a combination of these indicators. Targeting combined diabetes control indicators is important to reduce risk of diabetic retinopathy/ diabetic macular edema.	[Fenwick, Eva K.; Xie, Jing; Lim, Lyndell; Rees, Gwyn; Lamoureux, Ecosse L.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Fenwick, Eva K.; Man, Ryan E. K.; Sabanayagam, Charumathi; Wong, Tien Y.; Lamoureux, Ecosse L.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Fenwick, Eva K.; Sabanayagam, Charumathi; Wong, Tien Y.; Lamoureux, Ecosse L.] Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; National University of Singapore; Singapore National Eye Center; National University of Singapore	Lamoureux, EL (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.; Lamoureux, EL (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.; Lamoureux, EL (corresponding author), Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore.	ecosse.lamoureux@seri.com.sg	Sabanayagam, Charumathi/C-1294-2011; xie, jing/GRY-1689-2022; Wong, Tien Yin/AAC-9724-2020; Lamoureux, Ecosse/Z-5482-2019	Sabanayagam, Charumathi/0000-0002-4042-4719; Wong, Tien Yin/0000-0002-8448-1264; /0000-0001-6694-3587; Man, Ryan/0000-0001-5028-605X; Lamoureux, Ecosse/0000-0001-8674-5705; Lim, Lyndell/0000-0003-2491-685X	National Health and Medical Research Council Centre for Clinical Research Excellence (CCRE) - Translational Clinical Research in Major Eye Diseases [529923]; CCRE Diabetes; Australian Research Council [LP0884108]; Royal Victorian Eye and Ear Hospital; Victorian Government; National Health and Medical Research Council Early Career Fellowship [1072987, 1109330, 1061801]	National Health and Medical Research Council Centre for Clinical Research Excellence (CCRE) - Translational Clinical Research in Major Eye Diseases(National Health and Medical Research Council (NHMRC) of Australia); CCRE Diabetes; Australian Research Council(Australian Research Council); Royal Victorian Eye and Ear Hospital; Victorian Government; National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Financial support came from the National Health and Medical Research Council (www. nhmrc.gov.au) Centre for Clinical Research Excellence (CCRE) #529923-Translational Clinical Research in Major Eye Diseases; CCRE Diabetes; Australian Research Council (www.arc.gov.au) Grant LP0884108; Royal Victorian Eye and Ear Hospital (www.eyeandear.org.au); Operational Infrastructure Support from the Victorian Government. Dr Eva Fenwick is funded by National Health and Medical Research Council (www. nhmrc.gov.au) Early Career Fellowship (#1072987). A/Prof Lyndell Lim is funded by National Health and Medical Research Council (www.nhmrc.gov.au) Early Career Fellowship (#1109330). Dr Reesis funded by a National Health and Medical Research Council (www. nhmrc.gov.au) Career Development Award (#1061801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athyros VG, 2010, CURR VASC PHARMACOL, V8, P1; Beaton SJ, 2004, DIABETES CARE, V27, P694, DOI 10.2337/diacare.27.3.694; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Budescu D, 1993, PSYCHOL BULL; Buse J, 2007, CIRCULATION; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chew EY, 2014, OPHTHALMOLOGY, V121, P2443, DOI 10.1016/j.ophtha.2014.07.019; Chew EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P1079, DOI 10.1001/archopht.1996.01100140281004; Das R, 2015, OPHTHALMOLOGY, V122, P1820, DOI 10.1016/j.ophtha.2015.05.011; Elis A, 2008, QJM-INT J MED, V101, P275, DOI 10.1093/qjmed/hcm150; Fenwick EK, 2011, BRIT J OPHTHALMOL, V95, P774, DOI 10.1136/bjo.2010.191312; Foo V, 2016, J DIABETES; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gupta A, 2004, AM J OPHTHALMOL; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Huang OS, 2010, ARCH OPHTHALMOL-CHIC, V128, P1185, DOI 10.1001/archophthalmol.2010.168; International Council of Ophthalmology, 2014, ICO GUID DIAB EYE CA; Kemp TM, 2005, DIABETES CARE, V28, P1490, DOI 10.2337/diacare.28.6.1490; Lamoureux E, 2015, ASS RES VIS OPHTH AR; Lamoureux EL, 2012, CLIN EXP OPHTHALMOL, V40, P73, DOI 10.1111/j.1442-9071.2011.02697.x; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Mitchell P., 2008, GUIDELINES MANAGEMEN; Mohamed Q, 2007, JAMA-J AM MED ASSOC; Raman R, 2010, OPHTHALMOLOGY; Raman R, 2012, CURR EYE RES, V37, P513, DOI 10.3109/02713683.2012.669005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; Stratton I, 2001, DIABETOLOGIA, P44156; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wong T, 2008, EPIDEMIOLOGY DIABETE, P475, DOI DOI 10.1002/9780470779750.CH30; Wong TY, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.12; World Health Organization, 2005, PREV BLINDN DIAB MEL; World Health Organization, 2007, VIS 2020 RIGHT SIGHT; Yu TC, 2015, CLINICOECON OUTCOMES, P737; Zoungas S, 2009, DIABETES CARE, V32, P2068, DOI 10.2337/dc09-0959	37	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180252	10.1371/journal.pone.0180252	http://dx.doi.org/10.1371/journal.pone.0180252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662119	Green Published, gold			2022-12-27	WOS:000404608300133
J	Kong, P; McDowell, JM; Hong, CX				Kong, Ping; McDowell, John M.; Hong, Chuanxue			Zoospore exudates from Phytophthora nicotianae affect immune responses in Arabidopsis	PLOS ONE			English	Article							PLANT DEFENSIN GENE; SALICYLIC-ACID; SIGNALING PATHWAYS; PERONOSPORA-PARASITICA; MICROBE INTERACTIONS; NONHOST RESISTANCE; JASMONATE; THALIANA; EDS1; NPR1	Zoospore exudates play important roles in promoting zoospore communication, homing and germination during plant infection by Phytophthora. However, it is not clear whether exudates affect plant immunity. Zoospore-free fluid (ZFF) and zoospores of P. nicotianae were investigated comparatively for effects on resistance of Arabidopsis thaliana Col-0 and mutants that affect signaling mediated by salicylic acid (SA) and jasmonic acid (JA): eds16 ( enhanced disease susceptibility16), pad4 (phytoalexin deficient4), and npr1 (nonexpressor of pathogenesis-related genes1). Col-0 attracted more zoospores and had severe tissue damage when flooded with a zoospore suspension in ZFF. Mutants treated with ZFF alone developed disease symptoms similar to those inoculated with zoospores and requirements of EDS16 and PAD4 for plant responses to zoospores and the exudates was apparent. Zoospore and ZFFs also induced expression of the PR1 and PDF1.2 marker genes for defense regulated by SA and JA, respectively. However, ZFF affected more JA defense signaling, down regulating PR1 when SA signaling or synthesis is deficient, which may be responsible for Arabidopsis mutant plants more susceptible to infection by high concentration of P. nicotianae zoospores. These results suggest that zoospore exudates can function as virulence factors and inducers of plant immune responses during plant infection by Phytophthora.	[Kong, Ping; Hong, Chuanxue] Virginia Tech, Hampton Rd Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA; [McDowell, John M.; Hong, Chuanxue] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Kong, P (corresponding author), Virginia Tech, Hampton Rd Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA.	pkong@vt.edu		McDowell, John/0000-0002-9070-4874	Specialty Crop Research Initiative (SCRI) [201051181-21140]; United States USDA National Institute of Food and Agriculture; Virginia Agricultural Experiment Station	Specialty Crop Research Initiative (SCRI); United States USDA National Institute of Food and Agriculture; Virginia Agricultural Experiment Station	This study was supported in part by the Specialty Crop Research Initiative (SCRI, Agreement#: 201051181-21140) and the Hatch Program of the United States USDA National Institute of Food and Agriculture, and the Virginia Agricultural Experiment Station to CH. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Attard A, 2010, NEW PHYTOL, V187, P449, DOI 10.1111/j.1469-8137.2010.03272.x; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Eulgem T, 2004, PLANT PHYSIOL, V135, P1129, DOI 10.1104/pp.104.040444; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 1997, GENETICS, V146, P381; Huitema E, 2003, MOL PLANT PATHOL, V4, P487, DOI [10.1046/j.1364-3703.2003.00195.x, 10.1046/J.1364-3703.2003.00195.X]; Jiang H, 2014, PHYTOPATHOLOGY S3, V104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 1999, TRENDS PLANT SCI, V4, P196, DOI 10.1016/S1360-1385(99)01404-1; Kamoun S, 2015, MOL PLANT PATHOL; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Kemen E, 2014, CURR OPIN PLANT BIOL, V20, P75, DOI 10.1016/j.pbi.2014.04.005; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; Kong P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33239; Kong P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-313; Kong P, 2010, PHYTOPATHOLOGY, V100, P632, DOI 10.1094/PHYTO-100-7-0632; Kong P, 2010, FEMS MICROBIOL LETT, V303, P55, DOI 10.1111/j.1574-6968.2009.01861.x; McDowell JM, 2005, MOL PLANT MICROBE IN, V18, P1226, DOI 10.1094/MPMI-18-1226; McDowell JM, 2000, PLANT J, V22, P523, DOI 10.1046/j.1365-313x.2000.00771.x; McDowell JM, 2011, METHODS MOL BIOL, V712, P137, DOI 10.1007/978-1-61737-998-7_12; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Raftoyannis Y, 2006, MICROBIOL RES, V161, P1, DOI 10.1016/j.micres.2005.04.003; Rairdan GJ, 2002, GENETICS, V161, P803; Rairdan GJ, 2001, MOL PLANT MICROBE IN, V14, P1235, DOI 10.1094/MPMI.2001.14.10.1235; Robinson LH, 2003, AUSTRALAS PLANT PATH, V32, P53, DOI 10.1071/AP02064; Roetschi A, 2001, PLANT J, V28, P293, DOI 10.1046/j.1365-313X.2001.01148.x; Rookes JE, 2008, PHYSIOL MOL PLANT P, V72, P151, DOI 10.1016/j.pmpp.2008.08.005; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; Si-Ammour A, 2003, MOL PLANT PATHOL, V4, P237, DOI 10.1046/J.1364-3703.2003.00168.X; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Staswick PE, 1998, PLANT J, V15, P747, DOI 10.1046/j.1365-313X.1998.00265.x; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008	50	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							0180523	10.1371/journal.pone.0180523	http://dx.doi.org/10.1371/journal.pone.0180523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662148	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300163
J	Liu, ZH; Li, SY; Liu, YM; Guo, W; Bai, O				Liu, Zhihe; Li, Siyun; Liu, Yingmin; Guo, Wei; Bai, Ou			PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; PREVALENCE; TUMOR; RISK; PD-1	Objective The purpose of this study was to determine the association between PD1 expression and the clinical prognosis of diffuse large B-cell lymphoma (DLBCL) co-occurring with hepatitis B virus (HBV) infection. Methods A total of 165 patients presented with newly diagnosed and untreated DLBCL at the First Hospital of Jilin University, Changchun, China, between 2011.01 and 2014.12. Complete clinical information was available for 152 of these 165 patients. We retrospectively reviewed the results of HBV serum marker assays and the clinical information of these 152 DLBCL patients from our hospital database; eventually, only 51 patients were enrolled in this study, and these 51 patients received the PD1 test item. Results. (1) The incidence of HBsAg prevalence was 13.2% (20/152) in this study;. (2)The incidence of PD1 expression in the HBsAg(+) group was 4.3-fold higher than that in the HBsAg(-) group (40.0% vs 9.4%; P = 0.010);. (3) The clinical information, including sex, age, clinical stage, IPI, molecular subtype and chemotherapy status, was analyzed between the HBsAg(+) and HBsAg(-) groups, but there were no significant differences between the two groups;. (4) The median OS and PFS of the patients in the HBsAg(+) group were 36.5 months and 12 months, respectively; however, the median OS and PFS of patients in the HBsAg(+) group were not reached (P = 0.033) and 32 months (P = 0.049), respectively; and. (5) The median OS and PFS of PD1-positive patients in the HBsAg(+) group were the worst (24 months and 9 months, respectively), whereas the median OS and PFS of PD1-negative patients in the HBsAg(-) group were the best (not reached and 32 months, respectively). Conclusions Compared with patients in the HBsAg(-) group, the incidence of PD1 expression was significantly higher in the HBsAg(+) group, and the median OS and PFS times were the worst in PD1-positive patients in the HBsAg(+) group. These results indicated that the dismal	[Liu, Zhihe; Liu, Yingmin; Guo, Wei; Bai, Ou] Jilin Univ, Hosp 1, Dept Hematol, Changchun, Peoples R China; [Li, Siyun] Qingdao Univ, Sch Med, Affiliated Women & Children Hosp, Dept Pediat, Qingdao, Peoples R China	Jilin University; Qingdao University	Bai, O (corresponding author), Jilin Univ, Hosp 1, Dept Hematol, Changchun, Peoples R China.	oubai16@163.com	liu, zhihe/J-5319-2012	liu, zhihe/0000-0002-9264-094X	Jilin Province Science and Technology Department [20160101010JC]; Jilin Province Development; Reform Commission [2014Y090]	Jilin Province Science and Technology Department; Jilin Province Development; Reform Commission	This study was funded by Jilin Province Science and Technology Department (20160101010JC) and Jilin Province Development and Reform Commission (2014Y090). The owner of the two funding was OB.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Chen X, 2015, PLOS ONE, V10; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007; Dalia S, 2013, LEUKEMIA RES, V37, P1107, DOI 10.1016/j.leukres.2013.06.007; Deng LJ, 2015, ONCOTARGET, V6, P25061, DOI 10.18632/oncotarget.4677; Engels EA, 2010, LANCET ONCOL, V11, P827, DOI 10.1016/S1470-2045(10)70167-4; Fwu CW, 2011, HEPATOLOGY, V53, P1217, DOI 10.1002/hep.24150; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Guo W, 2015, J NANOMATER, V2015, DOI 10.1155/2015/897142; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Kim JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082870; Kuchroo VK, 2014, CURR OPIN HIV AIDS, V9, P439, DOI 10.1097/COH.0000000000000088; Ma SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005642; Muenst S, 2010, DIS MARKERS, V29, P47, DOI [10.1155/2010/404069, 10.3233/DMA-2010-0725]; Nath A, 2010, INTERN MED J, V40, P633, DOI 10.1111/j.1445-5994.2009.02060.x; Ott JJ, 2017, J HEPATOL, V66, P48, DOI 10.1016/j.jhep.2016.08.013; Routh JC, 2008, J UROLOGY, V179, P1954, DOI 10.1016/j.juro.2008.01.056; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Stein H, 2008, DIFFUSE LARGE B CELL, P233; Taborelli M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0073-x; Tajima K, 2016, J MED VIROL, V88, P2206, DOI 10.1002/jmv.24584; Tzeng HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039179; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Yang ZZ, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.1	26	5	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180390	10.1371/journal.pone.0180390	http://dx.doi.org/10.1371/journal.pone.0180390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662185	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300149
J	Miyagi, M; Miyatani, M; Nakao, T				Miyagi, Madoka; Miyatani, Makoto; Nakao, Takashi			Relation between choice-induced preference change and depression	PLOS ONE			English	Article							GUIDED DECISION-MAKING; COGNITIVE-DISSONANCE; FRONTAL LOBES; NEGATIVE FEEDBACK; MAJOR DEPRESSION; POWER PREDICTS; REWARD; DISORDER; CONFLICT; PROCRASTINATION	Most experimental studies of depressive symptom effects on decision-makinghave examined situations in which a single correct answer exists based on external circumstances (externally guided decision-making, e.g., gambling task). In addition to such decision making, for decision-making of other types, no correct answer exists based on external circumstances (internally guided decision-making, e.g., preference judgment). For internally guided decision-making, a phenomenon is known by which preference for the chosen item increases and preference for the rejected item is decreased after choosing between two equally preferred items which is designated as choice-induced preference change. Recent reports suggest that this phenomenon is explainable by reinforcement learning theory just as it is with externally guided decision-making. Although many earlier studies have revealed the effects of depression in externally guided decision-making, the relation between depressive symptoms and choice-induced preference change remains unclear. This study investigated the relation between depressive symptoms and choice-induced preference change using the blind choice paradigm. Results show that depressive symptoms are correlated with change in preference of rejected items (Spearman's r=.28, p=.04): depressed individuals tend to show less decreased preference of rejected items. These results indicate that individual differences of depressive symptoms affect choice-induced preference change. We discuss the mechanisms underlying the relation between depression and choice induced preference change.	[Miyagi, Madoka] Hiroshima Univ, Grad Sch Educ, Hiroshima, Japan; [Miyatani, Makoto; Nakao, Takashi] Hiroshima Univ, Dept Psychol, Hiroshima, Japan	Hiroshima University; Hiroshima University	Miyagi, M (corresponding author), Hiroshima Univ, Grad Sch Educ, Hiroshima, Japan.	madmiyagi@gmail.com	nakao, takashi/U-7188-2017	nakao, takashi/0000-0002-2227-4526	JSPS KAKENHI [26285168, 25870467]; Center of Innovation Program of the Japan Science and Technology Agency (JST)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Center of Innovation Program of the Japan Science and Technology Agency (JST)	This work was supported by JSPS KAKENHI Grants (26285168), JSPS KAKENHI Grants (25870467), and the Center of Innovation Program of the Japan Science and Technology Agency (JST).	Akaishi R, 2014, NEURON, V81, P195, DOI 10.1016/j.neuron.2013.10.018; BEM DJ, 1965, J EXP SOC PSYCHOL, V1, P199, DOI 10.1016/0022-1031(65)90026-0; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; Caspers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018451; Chase HW, 2010, PSYCHOL MED, V40, P433, DOI 10.1017/S0033291709990468; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; Cockburn J, 2014, NEURON, V83, P551, DOI 10.1016/j.neuron.2014.06.035; de Greck M, 2008, NEUROIMAGE, V39, P2066, DOI 10.1016/j.neuroimage.2007.11.006; Di Schiena R, 2013, COGNITIVE THER RES, V37, P713, DOI 10.1007/s10608-012-9517-9; EFFERT BR, 1989, J SOC BEHAV PERS, V4, P151; Egan LC, 2010, J EXP SOC PSYCHOL, V46, P204, DOI 10.1016/j.jesp.2009.08.014; Enzi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008429; Festinger L, 1957, A THEORY OF COGNITIV; GERARD HB, 1983, PERS SOC PSYCHOL B, V9, P365, DOI 10.1177/0146167283093006; Goldberg E, 1999, CONSCIOUS COGN, V8, P364, DOI 10.1006/ccog.1999.0395; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Grimm S, 2011, WORLD J BIOL PSYCHIA, V12, P627, DOI 10.3109/15622975.2010.545145; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Henriques JB, 2000, COGNITION EMOTION, V14, P711, DOI 10.1080/02699930050117684; Izuma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00041; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Jarcho JM, 2011, SOC COGN AFFECT NEUR, V6, P460, DOI 10.1093/scan/nsq054; Johnson SC, 2005, J COGNITIVE NEUROSCI, V17, P1897, DOI 10.1162/089892905775008607; Kahane G, 2012, SOC COGN AFFECT NEUR, V7, P393, DOI 10.1093/scan/nsr005; Kitayama S, 2013, NEUROIMAGE, V69, P206, DOI 10.1016/j.neuroimage.2012.11.034; Kleiner M, 2007, PERCEPTION, V36, P14; Knutson B, 2008, NEURON, V58, P814, DOI 10.1016/j.neuron.2008.05.018; Konkle T, 2010, PSYCHOL SCI, V21, P1551, DOI 10.1177/0956797610385359; Kumar P, 2008, BRAIN, V131, P2084, DOI 10.1093/brain/awn136; Kunisato Y, 2012, J BEHAV THER EXP PSY, V43, P1088, DOI 10.1016/j.jbtep.2012.05.007; Lieberman M. D., 2005, BUILDING DEFENDING R, P77; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; Maddox WT, 2012, COGNITION, V125, P118, DOI 10.1016/j.cognition.2012.06.011; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Miyagi M, JAPANESE J PHYSL PSY; Mograbi Gabriel Jose Corre, 2011, Mens Sana Monogr, V9, P251, DOI 10.4103/0973-1229.77441; Moll J, 2006, P NATL ACAD SCI USA, V103, P14; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Murphy FC, 2003, PSYCHOL MED, V33, P455, DOI 10.1017/S0033291702007018; Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072071; Nakao T., 2010, JPN J PHYSL PSYCHOL, P45, DOI DOI 10.5674/JJPPP.28.45; Nakao T, 2016, SCI REP-UK, V6, DOI 10.1038/srep32477; Nakao T, 2013, NEUROIMAGE, V66, P9, DOI 10.1016/j.neuroimage.2012.10.034; Nakao T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00031; Nakao T, 2010, PERS SOC PSYCHOL B, V36, P455, DOI 10.1177/0146167210363403; Nakao T, 2009, PSYCHOLOGIA, V52, P93, DOI 10.2117/psysoc.2009.93; Nakao T, 2009, NEUROSCI LETT, V459, P30, DOI 10.1016/j.neulet.2009.04.056; Niv Y, 2015, TRENDS COGN SCI, V19, P4, DOI 10.1016/j.tics.2014.09.005; Northoff G, 2011, BIOL PSYCHIAT, V69, P1019, DOI 10.1016/j.biopsych.2010.12.014; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Santesso DL, 2008, NEUROREPORT, V19, P1045, DOI 10.1097/WNR.0b013e3283036e73; Sharot T, 2010, PSYCHOL SCI, V21, P1231, DOI 10.1177/0956797610379235; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Shima S., 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Sommer M, 2010, NEUROPSYCHOLOGIA, V48, P2018, DOI 10.1016/j.neuropsychologia.2010.03.023; STEELE CM, 1993, J PERS SOC PSYCHOL, V64, P885, DOI 10.1037/0022-3514.64.6.885; Tice DM, 1997, PSYCHOL SCI, V8, P454, DOI 10.1111/j.1467-9280.1997.tb00460.x; Tucker DM, 2003, J ABNORM PSYCHOL, V112, P667, DOI 10.1037/0021-843X.112.4.667; Volz KG, 2006, CURR OPIN NEUROL, V19, P401, DOI 10.1097/01.wco.0000236621.83872.71; World Health Organization, 2012, DEPR COMM ILLN PEOPL	72	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180041	10.1371/journal.pone.0180041	http://dx.doi.org/10.1371/journal.pone.0180041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662126	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300091
J	Molladavoodi, S; Robichaud, M; Wulff, D; Gorbet, M				Molladavoodi, Sara; Robichaud, Matthew; Wulff, David; Gorbet, Maud			Corneal epithelial cells exposed to shear stress show altered cytoskeleton and migratory behaviour	PLOS ONE			English	Article							MEDIATED ENDOTHELIAL MECHANOTRANSDUCTION; ADHESION MOLECULE-1 ICAM-1; ACTIVATED PROTEIN-KINASES; NANOSCALE TOPOGRAPHY; SIGNALING PATHWAYS; ELECTRIC-FIELDS; ACTIN; EXPRESSION; MOVEMENT; RHO	Cells that form the corneal epithelium, the outermost layer of the cornea, are exposed to shear stress through blinking during waking hours. In this in vitro study, the effect of fluid shear stress on human corneal epithelial cells (HCECs) was investigated. Following exposure to shear stresses of 4 and 8 dyn/cm(2), HCECs showed cytoskeletal rearrangement with more prominent, organized and elongated filamentous actin. Cytoskeletal changes were time-dependent, and were most significant after 24 hours of shear stress. Higher rates of migration and proliferation, as evaluated by a scratch assay, were also observed following 24 hours of low shear stress exposure (4 dyn/cm(2)). This result contrasted the poor migration observed in samples scratched before shear exposure, indicating that shear-induced cytoskeletal changes played a key role in improved wound healing and must therefore precede any damage to the cell layer. HCEC cytoskeletal changes were accompanied by an upregulation in integrin beta(1) and downregulation of ICAM-1. These results demonstrate that HCECs respond favourably to flow-induced shear stress, impacting their proliferation and migration properties as well as phenotype.	[Molladavoodi, Sara; Robichaud, Matthew; Gorbet, Maud] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada; [Wulff, David] Univ Waterloo, Dept Chem Engn, Waterloo, ON, Canada	University of Waterloo; University of Waterloo	Gorbet, M (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada.	mgorbet@uwaterloo.ca	Wulff, David/ABC-9184-2020	Wulff, David/0000-0002-2873-1214	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funded by Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Barar J, 2008, EXPERT OPIN DRUG DEL, V5, P567, DOI 10.1517/17425247.5.5.567 ; Bin Geng, 2015, Biochem Biophys Res Commun, V466, P117, DOI 10.1016/j.bbrc.2015.08.117; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Cheng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067675; Chiu JJ, 2004, J BIOMECH, V37, P531, DOI 10.1016/j.jbiomech.2003.08.012; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Chou SF, 2016, COLLOID SURFACE B, V142, P105, DOI 10.1016/j.colsurfb.2016.02.051; Dalton BA, 2001, EXP EYE RES, V73, P797, DOI 10.1006/exer.2001.1090; Danjo Y, 1998, J CELL SCI, V111, P3323; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Davies PF, 1997, ANNU REV PHYSIOL, V59, P527, DOI 10.1146/annurev.physiol.59.1.527; Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Etienne S, 1998, J IMMUNOL, V161, P5755; Evans ND, 2009, EUR CELLS MATER, V18, P1; FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Fukuda S, 2000, CIRC RES, V86, pE13, DOI 10.1161/01.RES.86.1.e13; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020; Jilkova ZM, 2014, BIOL OPEN, V3, P1228, DOI 10.1242/bio.201410132; Jones MB, 2008, B MATH BIOL, V70, P323, DOI 10.1007/s11538-007-9252-7; Justine C., 2016, COAL OP C, P1; Karuri NW, 2008, SCANNING, V30, P405, DOI 10.1002/sca.20123; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Koo S, 2014, ACTA BIOMATER, V10, P1975, DOI 10.1016/j.actbio.2014.01.015; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Leonard EK, 2012, BIOTECHNOL BIOENG, V109, P3189, DOI 10.1002/bit.24587; Li DQ, 2005, EXP EYE RES, V80, P581, DOI 10.1016/j.exer.2004.11.011; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; MATHERS WD, 1992, CURR EYE RES, V11, P517, DOI 10.3109/02713689209001807; Mitchell MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015008; Moazzam F, 1997, P NATL ACAD SCI USA, V94, P5338, DOI 10.1073/pnas.94.10.5338; Molladavoodi S, 2015, ACTA BIOMATER, V11, P324, DOI 10.1016/j.actbio.2014.10.005; MORIGI M, 1995, BLOOD, V85, P1696, DOI 10.1182/blood.V85.7.1696.bloodjournal8571696; Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022; Pereira HA, 2004, INVEST OPHTH VIS SCI, V45, P4284, DOI 10.1167/iovs.03-1052; Petroll WM, 2015, J FUNCT BIOMATER, V6, P222, DOI 10.3390/jfb6020222; Pretor S, 2015, MOL PHARMACEUT, V12, P34, DOI 10.1021/mp500401t; Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015; Ren HW, 1997, ACTA OPHTHALMOL SCAN, V75, P383; Rennier Keith, 2015, BMC Res Notes, V8, P85, DOI 10.1186/s13104-015-1037-8; Rennier K, 2012, J CELL PHYSIOL, V227, P2398, DOI 10.1002/jcp.22975; Risca VI, 2012, P NATL ACAD SCI USA, V109, P2913, DOI 10.1073/pnas.1114292109; Saha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084227; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Srinivas SP, 2002, ADV EXP MED BIOL, V506, P677; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Sugihara-Seki M, 2003, J BIOMECH ENG-T ASME, V125, P628, DOI 10.1115/1.1611515; Utsunomiya T, 2016, INVEST OPHTH VIS SCI, V57, P6382, DOI 10.1167/iovs.16-20638; Wang C, 2012, J BIOMECH, V45, P1212, DOI 10.1016/j.jbiomech.2012.01.045; Xia L, 2011, HUM CELL, V24, P127, DOI 10.1007/s13577-011-0031-2; Yamamoto K, 2002, CORNEA, V21, P85, DOI 10.1097/00003226-200201000-00018; Yannariello-Brown J, 1998, EXP EYE RES, V67, P383, DOI 10.1006/exer.1998.0514; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Yin J, 2008, INVEST OPHTH VIS SCI, V49, P900, DOI 10.1167/iovs.07-1122; Zhao M, 1996, J CELL SCI, V109, P1405	69	29	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178981	10.1371/journal.pone.0178981	http://dx.doi.org/10.1371/journal.pone.0178981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662184	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300012
J	Moodley, B; Tempia, S; Frean, JA				Moodley, Bhavani; Tempia, Stefano; Frean, John Andrew			Comparison of quantitative real-time PCR and direct immunofluorescence for the detection of Pneumocystis jirovecii	PLOS ONE			English	Article							IMMUNOCOMPROMISED PATIENTS; PNEUMONIA; DIAGNOSIS; CARINII; COLONIZATION; ASSAY	Background Pneumocystis pneumonia (PCP) is a serious risk for HIV-positive patients. Asymptomatic infection or colonisation with P. jirovecii has been shown to occur frequently. PCR assays frequently identify such cases, due to their high sensitivity. Quantitative real-time PCR (qPCR) gene copy number cut-off values have been suggested to differentiate colonisation and infection; these need to be standardised for routine use. We compared the results of qPCR with an immunofluorescence assay (IFA) to determine a specific cut-off value. Methods From March 2005 through June 2009, induced sputum specimens were collected from adult patients who were clinically suspected of having PCP, at the Chris Hani Baragwanath Hospital in Gauteng, South Africa. Laboratory diagnosis of PCP was done by a conventional direct IFA and a qPCR assay. A receiver operating characteristic (ROC) analysis was performed to determine a suitable copy number cut-off value. Results P. jirovecii was identified in 51% (156/305) and 67% (204/305) of specimens using IFA and qPCR, respectively. The cut-off value for the qPCR that best predicted the IFA results was 78 copies/5 mu l (area under ROC curve 0.92). The sensitivity and specificity of qPCR using this cut-off was 94.6% and 89.1%, respectively, compared with the IFA. Discussion The results of the ROC curve analysis indicate an excellent predictive value of the qPCR using the proposed cut-off. However, the IFA test is an imperfect gold standard and so this cut-off should not be used in isolation; clinical data should also contribute to the interpretation of the qPCR result.	[Moodley, Bhavani; Frean, John Andrew] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Program, Pretoria, South Africa; [Tempia, Stefano] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Frean, John Andrew] Univ Witwatersrand, Wits Res Inst Malaria, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Moodley, B (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa.	bhavanim@nicd.ac.za	Frean, John/AAF-6024-2020		National Institute for Communicable Diseases, as division of the National Health Laboratory Service	National Institute for Communicable Diseases, as division of the National Health Laboratory Service	This study was funded by the National Institute for Communicable Diseases, as division of the National Health Laboratory Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2010, CLIN MICROBIOL INFEC, P10; Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI [10.1586/eri.10.42, 10.1586/eri.10.11, 10.1586/ERI.10.42]; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Davis JL, 2008, THORAX, V63, P329, DOI 10.1136/thx.2007.088104; Dini L, 2010, J CLIN MICROBIOL, V48, P2016, DOI 10.1128/JCM.02004-09; Fauchier T, 2016, J CLIN MICROBIOL, V54, P1487, DOI 10.1128/JCM.03174-15; Fillaux J, 2008, J MICROBIOL METH, V75, P258, DOI 10.1016/j.mimet.2008.06.009; Fujisawa T, 2009, RESPIROLOGY, V14, P203, DOI 10.1111/j.1440-1843.2008.01457.x; Helweg-Larsen J, 2003, LANCET, V361, P1237, DOI 10.1016/S0140-6736(03)13027-9; Huang L, 2003, J EUKARYOT MICROBIOL, V50, P616, DOI 10.1111/j.1550-7408.2003.tb00651.x; Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; Khan MA, 1999, J INFECTION, V39, P77, DOI 10.1016/S0163-4453(99)90106-8; Larsen HH, 2002, J CLIN MICROBIOL, V40, P490, DOI 10.1128/JCM.40.2.490-494.2002; Maillet M, 2014, EUR J CLIN MICROBIOL, V33, P331, DOI 10.1007/s10096-013-1960-3; Medrano FJ, 2005, EMERG INFECT DIS, V11, P245, DOI 10.3201/eid1102.040487; Muhlethaler K, 2012, EUR RESPIR J, V39, P971, DOI 10.1183/09031936.00095811; Procop GW, 2004, J CLIN MICROBIOL, V42, P3333, DOI 10.1128/JCM.42.7.3333-3335.2004; Robberts FJL, 2007, DIAGN MICR INFEC DIS, V58, P385, DOI 10.1016/j.diagmicrobio.2007.02.014; Robert-Gangneux F, 2014, J CLIN MICROBIOL, V52, P3370, DOI 10.1128/JCM.01480-14; Sing A, 2000, J CLIN MICROBIOL, V38, P1461, DOI 10.1128/JCM.38.4.1461-1467.2000; Takahashi T, 2002, J MED MICROBIOL, V51, P611, DOI 10.1099/0022-1317-51-7-611; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621	23	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180589	10.1371/journal.pone.0180589	http://dx.doi.org/10.1371/journal.pone.0180589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683092	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200050
J	Yan, P; Chen, K; Wang, Q; Yang, DC; Li, D; Yang, YJ				Yan, Peng; Chen, Ken; Wang, Qiang; Yang, Dachun; Li, De; Yang, Yongjian			UCP-2 is involved in angiotensin-II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 OVEREXPRESSION; NITRIC-OXIDE; OXIDATIVE STRESS; ACCELERATED ATHEROSCLEROSIS; CELLS; PROGRESSION; DEFICIENCY; MECHANISMS; DISEASE; FAMILY	UCP-2 shows an important role in modulating of mitochondrial membrane potential and cell apoptosis. Whether or not UCP-2 could been a critical factor in preventing AAA formation is not known. We report that UCP-2 protein and mRNA expression were significantly higher in Ang-II-induced AAA of mice. The incident rate of AAA in UCP-2(-/-)ApoE(-/-) mice after Ang-Iltreatment was higher than the rate in the UCP-2(+/+)ApoE(-/-) mice. The abdominal aorta from UCP-2(-/-)ApoE4- mice showed the medial hypertrophy, fragmentation of elastic lamellas and depletion of alpha-SMA. The NADPH oxidase activity and level of MDA was significantly higher in UCP-2-/-ApoE4- mice than UCP-2(+/+)ApoE(-/-) or WT mice. Besides, the SOD activity is increased in UCP-2(+/+)ApoE4- mice as compared with WT mice, whereas deficiency of UCP2 decreased the increasing SOD activity in Ang-II treated ApoE(-/-) mice. UCP-2 knockout up regulated the MMP2 and MMP9 expression in aortic aneurysm. Ang-II induced apoptosis of VSMCs was increased in UCP-24-ApoE(-/-) mice. And the expression of eNOS in vascular tissue from UCP-2(-/-)ApoE(-/-) mice is lower than WT and UCP-2(+/+)ApoE(-/-) mice. This study provides a mechanism by which UCP-2, via anti -oxidants and anti-apoptosis, participates in the preventing of AAA formation.	[Yan, Peng; Chen, Ken; Wang, Qiang; Yang, Dachun; Li, De; Yang, Yongjian] Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China		Yang, YJ (corresponding author), Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China.	yangyongiian38@sna.com		Chen, Ken/0000-0002-8958-1088; Yang, Yongjian/0000-0003-1268-166X	National Natural Science Foundation of China [81500224, 81670419, 81470396]; China Postdoctoral Science Foundation [2016M593044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	These studies were supported in part by grants from National Natural Science Foundation of China (no. 81500224; 81670419; 81470396), China Postdoctoral Science Foundation funded project (no. 2016M593044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bouillaud F, 2016, BBA-MOL CELL RES, V1863, P2443, DOI 10.1016/j.bbamcr.2016.04.013; Cardoso S, 2015, J BIOENERG BIOMEMBR, V47, P119, DOI 10.1007/s10863-014-9580-x; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; Coughlan MT, 2007, ANTIOXID REDOX SIGN, V9, P331, DOI 10.1089/ars.2006.1469; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Derdak Z, 2009, METHODS MOL BIOL, V559, P205, DOI 10.1007/978-1-60327-017-5_15; Dromparis P, 2013, CIRC RES, V113, P126, DOI 10.1161/CIRCRESAHA.112.300699; Durdu S, 2012, CARDIOVASC THER, V30, P308, DOI 10.1111/1755-5922.12007; Emeto TI, 2014, CURR DRUG TARGETS, V15, P860; Emeto TI, 2014, CLIN SCI, V126, P517, DOI 10.1042/CS20130425; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Ge HS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/323246; GILLUM RF, 1995, J CLIN EPIDEMIOL, V48, P1289, DOI 10.1016/0895-4356(95)00045-3; Gomez-Hernandez A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0108-9; Grabacka M, 2008, PPAR RES, V2008, DOI 10.1155/2008/930705; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Humphrey JD, 2012, J BIOMECH, V45, P805, DOI 10.1016/j.jbiomech.2011.11.021; Kim HS, 2007, DIABETES RES CLIN PR, V77, pS46, DOI 10.1016/j.diabres.2007.01.032; Kniemeyer HW, 2000, EUR J VASC ENDOVASC, V19, P190, DOI 10.1053/ejvs.1999.0980; Krishna SM, 2012, AM J PATHOL, V181, P706, DOI 10.1016/j.ajpath.2012.04.015; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Lee KU, 2005, CIRC RES, V96, P1200, DOI 10.1161/01.RES.0000170075.73039.5b; Lizarbe TR, 2009, AM J PATHOL, V175, P1421, DOI 10.2353/ajpath.2009.080845; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Michelakis ED, 2002, CIRC RES, V90, P1307, DOI 10.1161/01.RES.0000024689.07590.C2; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Qin YW, 2012, CARDIOVASC RES, V96, P401, DOI 10.1093/cvr/cvs263; Raaz U, 2015, CIRCULATION, V131, P1783, DOI 10.1161/CIRCULATIONAHA.114.012377; Raaz U, 2014, ANTIOXID REDOX SIGN, V20, P914, DOI 10.1089/ars.2013.5507; Ruiz-Ramirez A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9340654; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Sawada H, 2015, ARTERIOSCL THROM VAS, V35, P1507, DOI 10.1161/ATVBAHA.115.305586; Siu KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088899; Sun J, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-69; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Toral M, 2016, BIOCHEM PHARMACOL, V110, P25, DOI 10.1016/j.bcp.2016.05.004; Yang QF, 2007, J MOL MED-JMM, V85, P697, DOI 10.1007/s00109-007-0170-9; Zhang H, 1999, CARDIOVASC RES, V44, P215, DOI 10.1016/S0008-6363(99)00183-2	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179743	10.1371/journal.pone.0179743	http://dx.doi.org/10.1371/journal.pone.0179743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683125	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200013
J	de Braganca, AC; Moreau, RLM; de Brito, T; Shimizu, MHM; Canale, D; de Jesus, DA; Silva, AMG; Gois, PH; Seguro, AC; Magaldi, AJ				de Braganca, Ana C.; Moreau, Regina L. M.; de Brito, Thales; Shimizu, Maria H. M.; Canale, Daniele; de Jesus, Denise A.; Silva, Ana M. G.; Gois, Pedro H.; Seguro, Antonio C.; Magaldi, Antonio J.			Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage	PLOS ONE			English	Article							MDMA ECSTASY; IN-VITRO; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; HYPONATREMIA; TEMPERATURE; VASOPRESSIN; DYSFUNCTION	Background Ecstasy (Ec) use produces hyperthermia, excessive sweating, intense thirst, an inappropriate antidiuretic hormone secretion (SIADH) and a multisystemic toxicity due to oxidative stress (OS). Intense thirst induces high intake of pure water, which associated with SIADH, usually develops into acute hyponatremia (Hn). As Hn is induced rapidly, experiments to check if Ec acted directly on the Inner Medullary Collecting Ducts (IMCD) of rats were conducted. Rhabdomyolysis and OS were also studied because Ec is known to induce Reactive Oxygen Species (ROS) and tissue damage. To decrease OS, the antioxidant inhibitors N-acetylcysteine (NAC) and Allopurinol (Allo) were used. Methods Rats were maintained on a lithium (Li) diet to block the Vasopressin action before Ec innoculation. AQP2 (Aquaporin 2), ENaC (Epitheliun Sodium Channel) and NKCC2 (Sodium, Potassium, 2 Chloride) expression were determined by Western Blot in isolated IMCDs. The TBARS (thiobarbituric acid reactive substances) and GSH (reduced form of Glutathione) were determined in the Ec group (6 rats injected with Ec-10mg/kg), in Ec+NAC groups (NAC 100mg/Kg/bw i.p.) and in Allo+Ec groups (Allo 50mg/Kg/i.p.). Results Enhanced AQP2 expression revealed that Ec increased water transporter expression, decreased by Li diet, but the expression of the tubular transporters did not change. The Ec, Ec+NAC and Allo+Ec results showed that Ec increased TBARS and decreased GSH, showing evidence of ROS occurrence, which was protected by NAC and Allo. Rhabdomyolysis was only protected by Allo. Conclusion Results showed that Ec induced an increase in AQP2 expression, evidencing another mechanism that might contribute to cause rapid hyponatremia. In addition, they showed that NAC and Allo protected against OS, but only Allo decreased rhabdomyolysis and hyperthermia.	[de Braganca, Ana C.; Gois, Pedro H.; Seguro, Antonio C.; Magaldi, Antonio J.] Univ Sao Paulo, Basic Res Lab LIM12, Dept Nephrol, Clin Hosp,Sch Med, Sao Paulo, SP, Brazil; [Moreau, Regina L. M.] Univ Sao Paulo, Dept Clin & Toxicol Anal, Sch Pharmaceut Sci, Sao Paulo, SP, Brazil; [de Brito, Thales; Silva, Ana M. G.] Univ Sao Paulo, Dept Pathol, Sch Med, Inst Trop Med, Sao Paulo, SP, Brazil; [Shimizu, Maria H. M.; Canale, Daniele; de Jesus, Denise A.] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Magaldi, AJ (corresponding author), Univ Sao Paulo, Basic Res Lab LIM12, Dept Nephrol, Clin Hosp,Sch Med, Sao Paulo, SP, Brazil.	biomag@usp.br	Shimizu, Maria/B-7887-2013; Canale, Daniele/E-8922-2014; da Silva, Ana Maria Gonçalves/ABD-3920-2020; de Braganca, Ana Carolina/E-7892-2014; Franca Gois, Pedro Henrique/F-3645-2014	Canale, Daniele/0000-0001-8609-683X; Silva, Ana Maria/0000-0001-7554-0894; de Braganca, Ana Carolina/0000-0002-1398-2512; Magaldi, Antonio J/0000-0003-3648-920X; Franca Gois, Pedro Henrique/0000-0002-3520-3225				Asl SS, 2015, METAB BRAIN DIS, V30, P171, DOI 10.1007/s11011-014-9598-0; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Budisavljevic MN, 2003, AM J MED SCI, V326, P89, DOI 10.1097/00000441-200308000-00006; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Campbell GA, 2008, CLIN J AM SOC NEPHRO, V3, P1852, DOI 10.2215/CJN.02080508; Carvalho M, 2002, ARCH TOXICOL, V76, P581, DOI 10.1007/s00204-002-0381-3; Carvalho M, 2012, ARCH TOXICOL, V86, P1167, DOI 10.1007/s00204-012-0815-5; da Silva DD, 2014, J APPL TOXICOL, V34, P637, DOI 10.1002/jat.2889; de Paula VF, 2009, NEUROIMMUNOMODULAT, V16, P191, DOI 10.1159/000204233; DIAZ PT, 1994, J APPL PHYSIOL, V77, P2434, DOI 10.1152/jappl.1994.77.5.2434; Eede HV, 2009, J EMERGENCY MED, V42, P655; El-Bassossy HM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0445-9; Fiaschi AI, 2010, CURR PHARM BIOTECHNO, V11, P444; Ghatol A, 2012, J EMERGENCY MED, V42, P137; Gois PHF, 2016, FREE RADICAL BIO MED, V101, P176, DOI 10.1016/j.freeradbiomed.2016.10.012; Gomez-Cabrera MC, 2003, JAMA-J AM MED ASSOC, V289, P2503, DOI 10.1001/jama.289.19.2503-b; Halpern P, 2011, HUM EXP TOXICOL, V30, P259, DOI 10.1177/0960327110370984; Henry JA, 1998, LANCET, V351, P1784, DOI 10.1016/S0140-6736(05)78744-4; Hoo GWS, 2012, J INTENSIVE CARE MED, V28, P259; Kaandorp JJ, 2014, ARCH DIS CHILD-FETAL, V99, pF144, DOI 10.1136/archdischild-2013-304876; Kalantar-Zadeh K, 2006, NAT CLIN PRACT NEPHR, V2, P283, DOI 10.1038/ncpneph0167; Katz A, 2014, PFLUG ARCH EUR J PHY, V466, P577, DOI 10.1007/s00424-013-1331-z; Keltz Eran, 2013, Muscles Ligaments Tendons J, V3, P303; Kunsdorf-Wnuk Anna, 2005, Pol Merkur Lekarski, V18, P436; Kwon C, 2003, PEDIATR NEPHROL, V18, P820, DOI 10.1007/s00467-003-1164-7; Lin PY, 2011, PEDIATR CRIT CARE ME, V12, pE424, DOI 10.1097/PCC.0b013e3182192c8d; Lourenco TC, 2013, J PHARMACEUT BIOMED, V73, P13, DOI 10.1016/j.jpba.2012.01.025; Matthai SM, 1996, BRIT MED J, V312, P1359, DOI 10.1136/bmj.312.7042.1359b; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Parrott AC, 2012, DRUG ALCOHOL DEPEN, V121, P1, DOI 10.1016/j.drugalcdep.2011.08.012; Pendergraft WF, 2014, CLIN J AM SOC NEPHRO, V9, P1996, DOI 10.2215/CJN.00360114; Ramaley C, 2014, J ANAL TOXICOL, V38, P249, DOI 10.1093/jat/bku023; SCREATON GR, 1992, LANCET, V339, P677, DOI 10.1016/0140-6736(92)90834-P; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Song BJ, 2010, CURR PHARM BIOTECHNO, V11, P434, DOI 10.2174/138920110791591436; Sprague JE, 2005, CRIT CARE MED, V33, P1311, DOI 10.1097/01.CCM.0000165969.29002.70; Torres PA, 2015, OCHSNER J, V15, P58; Traub SJ, 2002, J URBAN HEALTH, V79, P549, DOI 10.1093/jurban/79.4.549; Vogt BL, 2007, BIOCHEM PHARMACOL, V73, P1613, DOI 10.1016/j.bcp.2007.01.033; Wolff K, 2006, J PSYCHOPHARMACOL, V20, P400, DOI 10.1177/0269881106061514	42	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179199	10.1371/journal.pone.0179199	http://dx.doi.org/10.1371/journal.pone.0179199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678861	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200008
J	Jung, JL; Simon, G; Alfonsi, E; Thoraval, D; Kervarec, N; Ben Salem, D; Hassani, S; Domergue, F				Jung, Jean-Luc; Simon, Gaelle; Alfonsi, Eric; Thoraval, Didier; Kervarec, Nelly; Ben Salem, Douraied; Hassani, Sami; Domergue, Frederic			Qualitative and quantitative study of the highly specialized lipid tissues of cetaceans using HR-MAS NMR and classical GC	PLOS ONE			English	Article							BOTTLE-NOSED-DOLPHIN; PORPOISES PHOCOENA-PHOCOENA; FATTY-ACIDS; TURSIOPS-TRUNCATUS; ISOVALERIC ACID; PILOT WHALE; WAX ESTERS; BLUBBER; MELON; BIOSYNTHESIS	Cetacean adipose tissues contain an extremely very wide variety of acyl-chains present in triacylglycerols and / or wax esters. In addition, changes in the lipid composition across organs suggest fine stratification. It therefore remains technically challenging to describe precisely the lipid organization of these tissues. In the present study, we used in parallel HR-MAS NMR (High Resolution Magic Angle Spinning Nuclear Magnetic Resonance) and GC (gas-chromatography) to characterize and quantify the lipids and fatty acyl-chains from the blubber and melon of two odontocete species. Both methods generated very similar compositions, but each presented clear advantages. While GC underestimated the amount of short branched fatty acyl-chains, which are specific to cetacean adipose tissues and most probably of primary importance for their functioning, HR-MAS NMR allowed for their exact quantification. Conversely, when HR-MAS NMR could only discriminate a few types of fatty acyl-chain families, GC unambiguously identified and quantified most of them. In addition, this technique allowed for the determination of the wax esters molecular species. Our results further suggest that the stratification of these adipose tissues relies on changes in the triacylglycerol to wax ester ratio and in the fatty acyl composition of triacylglycerols, but not on changes in the wax esters composition. Altogether, our data show that the complementarities of these two approaches result in lipid analyses of unprecedented precision, paving the way for the detailed description of the fatty acyl composition of cetacean adipose tissues and the understanding of their functioning.	[Jung, Jean-Luc; Alfonsi, Eric] Univ Brest, BioGeMME, UFR Sci & Tech, Brest, France; [Simon, Gaelle; Kervarec, Nelly] Univ Brest, Plateforme Technol Resonance Magnet Nucl Resonanc, Brest, France; [Alfonsi, Eric; Hassani, Sami] Port Plaisance Moulin Blanc, Oceanopolis, Brest, France; [Thoraval, Didier; Domergue, Frederic] Univ Bordeaux, CNRS, UMR 5200, Lab Biogenese Membranaire, Villenave Dornon, France; [Ben Salem, Douraied] Univ Hosp Brest, NSERM, UMR 1101, Unit Forens Imaging,LaTIM, Blvd Tanguy Prigent, Brest, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale	Domergue, F (corresponding author), Univ Bordeaux, CNRS, UMR 5200, Lab Biogenese Membranaire, Villenave Dornon, France.	frederic.domergue@u-bordeaux.fr	Jung, Jean-Luc/H-5108-2011	Jung, Jean-Luc/0000-0002-8795-8056; Domergue, Frederic/0000-0002-0183-7000; BEN SALEM, DOURAIED/0000-0001-5532-2208	CNRS "Exomod"; University of Brest in the frame of its ERCS ("Equipes Reconnues par le Conseil Scientifique") program; Metabo [HUB-ANR-11-INBS-0010]	CNRS "Exomod"; University of Brest in the frame of its ERCS ("Equipes Reconnues par le Conseil Scientifique") program; Metabo	This work was supported by a CNRS "Exomod 2014" grant, by the University of Brestin the frame of its ERCS ("Equipes Reconnues par le Conseil Scientifique") program, and by grant no. Metabo HUB-ANR-11-INBS-0010 to the Functional Genomic Center of the Bordeaux-Metabolome/ Lipidome platform.	ACKMAN RG, 1973, LIPIDS, V8, P661, DOI 10.1007/BF02531831; Ames AL, 2002, COMP BIOCHEM PHYS B, V132, P625, DOI 10.1016/S1096-4959(02)00082-9; Arribart M, 2016, ANAT HISTOL EMBRYOL; Bagge LE, 2012, J EXP BIOL, V215, P4330, DOI 10.1242/jeb.071530; Blomberg J, 1978, Prog Chem Fats Other Lipids, V16, P257, DOI 10.1016/0079-6832(78)90047-2; Cranford TW, 1996, J MORPHOL, V228, P223; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Duggan ZPZ, 2009, J COMP PHYSIOL B, V179, P783, DOI 10.1007/s00360-009-0360-6; Gardner SC, 2003, NATURWISSENSCHAFTEN, V90, P528, DOI 10.1007/s00114-003-0472-x; Jung JL, 2009, J MAR BIOL ASSOC UK, V89, P1045, DOI 10.1017/S0025315409000307; Koopman HN, 2008, P ROY SOC B-BIOL SCI, V275, P2327, DOI 10.1098/rspb.2008.0457; Koopman HN, 2007, MAR BIOL, V151, P277, DOI 10.1007/s00227-006-0489-8; Koopman HN, 2006, IEEE J OCEANIC ENG, V31, P95, DOI 10.1109/JOE.2006.872205; Koopman HN, 2003, J COMP PHYSIOL B, V173, P247, DOI 10.1007/s00360-003-0329-9; Koopman HN, 2002, PHYSIOL BIOCHEM ZOOL, V75, P498, DOI 10.1086/342799; Koopman HN, 1996, J COMP PHYSIOL B, V165, P628, DOI 10.1007/BF00301131; LITCHFIELD C, 1973, MAR BIOL, V23, P165, DOI 10.1007/BF00389480; LITCHFIELD C, 1975, COMP BIOCHEM PHYS B, V50, P591, DOI 10.1016/0305-0491(75)90095-4; Lovern JA, 1934, BIOCHEM J, V28, P394, DOI 10.1042/bj0280394; MALINS DC, 1972, BIOCHEM BIOPH RES CO, V48, P314, DOI 10.1016/S0006-291X(72)80052-4; Maxia C, 2007, ANAT REC, V290, P913, DOI 10.1002/ar.20560; McLellan WA, 2002, J ZOOL, V257, P457, DOI 10.1017/S0952836902001061; MORII H, 1982, COMP BIOCHEM PHYS B, V71, P357, DOI 10.1016/0305-0491(82)90395-9; Pond C.M., 1998, FATS LIFE; Samuel AM, 2004, CAN J ZOOL, V82, P1933, DOI 10.1139/Z05-001; Sargent J.R., 1976, CHEM BIOCH NATURAL W, P49; Scano P, 2006, LIPIDS, V41, P1039, DOI 10.1007/s11745-006-5054-1; Scano P, 2005, CHEM PHYS LIPIDS, V134, P21, DOI 10.1016/j.chemphyslip.2004.10.001; Swaim Zachary T., 2009, Endangered Species Research, V6, P259, DOI 10.3354/esr00163; TANAKA K, 1966, P NATL ACAD SCI USA, V56, P236, DOI 10.1073/pnas.56.1.236; VARANASI U, 1971, BIOCHIM BIOPHYS ACTA, V231, P415, DOI 10.1016/0005-2760(71)90158-5; WEDMID Y, 1973, BIOCHIM BIOPHYS ACTA, V326, P439, DOI 10.1016/0005-2760(73)90144-6	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180597	10.1371/journal.pone.0180597	http://dx.doi.org/10.1371/journal.pone.0180597			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678824	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200075
J	Wamser, AF; Cecilio, AB; Nowaki, RHD; Mendoza-Cortez, JW; Urrestarazu, M				Wamser, Anderson Fernando; Cecilio Filho, Arthur Bemardes; Dalmazzo Nowaki, Rodrigo Hiyoshi; Mendoza-Cortez, Juan Waldir; Urrestarazu, Miguel			Influence of drainage and nutrient-solution nitrogen and potassium concentrations on the agronomic behavior of bell-pepper plants cultivated in a substrate	PLOS ONE			English	Article							SWEET-PEPPER; GROWTH; SALINITY; DECREASE; YIELD	The interactive effects of N (6, 9, 12 and 15 mmol L-1) and K (3, 5, 7, and 9 mmol L-1) concentrations in nutrient solutions were evaluated on bell pepper grown in a coconut-coir substrate and fertilized without drainage. An additional treatment with drainage was evaluated using N and K concentrations of 12 and 7 mmol L-1, respectively. The hybrid Eppo cultivar of yellow bell pepper was cultivated for 252 days beginning 9 November 2012. Electrical conductivity (EC), the N and K concentrations in the substrate solution, marketable fruit yield, total dry weight and macronutrient concentrations in shoots were periodically evaluated. Fruit production was lower in the system without drainage, regardless of the N and K concentrations, compared to the recommended 10-20% drainage of the volume of nutrient solution applied. Higher K concentrations in the nutrient solution did not affect plant production in the system without drainage for the substrate with an initial K concentration of 331.3 mg L-1. Fruit yield was higher without drainage at a nutrient-solution N concentration of 10.7 mmol L-1. The upper EC limit of the substrate solution in the system without drainage was exceeded 181 days after planting. Either lower nutrient concentrations in the nutrient solution or a drainage system could thus control the EC in the substrate solution.	[Wamser, Anderson Fernando] Empresa Pesquisa Agr & Extensao Rural Santa Catar, Estacao Expt Cacador, Cacador, SC, Brazil; [Cecilio Filho, Arthur Bemardes; Dalmazzo Nowaki, Rodrigo Hiyoshi] Univ Estadual Paulista, Dept Prod Vegetal, Fac Ciencias Agr & Vet, Sao Paulo, Brazil; [Mendoza-Cortez, Juan Waldir] Univ Nacl Agr La Molina, Fac Agron, Dept Fitotecnia, Lima, Peru; [Urrestarazu, Miguel] Univ Almeria, Dept Agron, Escuela Super Ingn, Almeria, Spain	Universidade Estadual Paulista; University Nacional Agraria La Molina; Universidad de Almeria	Cecilio, AB (corresponding author), Univ Estadual Paulista, Dept Prod Vegetal, Fac Ciencias Agr & Vet, Sao Paulo, Brazil.	rutra@fcay.unesp.br	Cecilio Filho, Arthur Bernardes/AGR-7901-2022; URRESTARAZU, MIGUEL/N-1927-2013; Cecílio Filho, Arthur/D-7237-2012	Cecilio Filho, Arthur Bernardes/0000-0002-6706-5496; URRESTARAZU, MIGUEL/0000-0003-4340-2184; Cecílio Filho, Arthur/0000-0002-6706-5496; Mendoza-Cortez, Juan Waldir/0000-0002-2158-0943	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/17524-7]; Brazilian Agricultural Research Corporation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Agricultural Research Corporation(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - process 2011/17524-7 corresponding to source of funding that have supported this work, which beneficiary was ABCF author. AFW was supported in the form of scholarship by the Brazilian Agricultural Research Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2002, BIORESOURCE TECHNOL, V82, P241, DOI 10.1016/S0960-8524(01)00189-4; ALMEIDA O. A., 2010, QUALIDADE AGUA IRRIG; Aminifard MH, 2012, J PLANT NUTR, V35, P235, DOI 10.1080/01904167.2012.636126; [Anonymous], 2006, AGR SALINITY DRAINAG; Baixauli Soria C., 2002, CULTIVO SIN SUELO HO; Bataglia O. C., 1983, METODOS ANALISE QUIM; Bres W, 2009, POL J ENVIRON STUD, V18, P341; Calbo AG, 2005, SISTEMA IRRIGAS MANE; Campos VB, 2008, REV BIOL CIENCIAS TE, V8, P72; Castellane P. D., 1994, CULTIVO SEM SOLO HID; Charlo HCD, 2012, HORTIC BRAS, V30, P125, DOI 10.1590/S0102-05362012000100021; Chartzoulakis K, 2000, SCI HORTIC-AMSTERDAM, V86, P247, DOI 10.1016/S0304-4238(00)00151-5; Choi EY, 2014, J PLANT NUTR, V37, P748, DOI 10.1080/01904167.2013.868479; Ferreira EB, 2010, C POSGRADUACAO U FED, V19; Gratieri Luiz Augusto, 2013, ScientificWorldJournal, V2013, P546594, DOI 10.1155/2013/546594; Healy MJR., 1956, J AGR SCI, V47, P205; Henz GP, 2007, REV CULTIVAR HF, V42, P2; Johnson CD, 1996, HORTSCIENCE, V31, P1119, DOI 10.21273/HORTSCI.31.7.1119; Lozano MG, 2005, ACTA HORTIC, P543; Massa D, 2010, AGR WATER MANAGE, V97, P971, DOI 10.1016/j.agwat.2010.01.029; Miranda FR, 2011, PRODUCAO TOMATE SUBS; Munoz P, 2008, AGRON SUSTAIN DEV, V28, P489, DOI 10.1051/agro:2008024; Pardossi A., 2011, FERTIGATION SUBSTRAT; Rubio JS, 2010, EUR J HORTIC SCI, V75, P33; Rubio JS, 2010, SPAN J AGRIC RES, V8, P170, DOI 10.5424/sjar/2010081-1156; Rubio JS, 2011, HORTIC BRAS, V29, P275, DOI 10.1590/S0102-05362011000300003; Sanjuan MCS, 2004, TRATADO CULTIVO SIN, P161; SONNEVELD C, 1994, COMMUN SOIL SCI PLAN, V25, P3199, DOI 10.1080/00103629409369258; SONNEVELD C, 2004, TRATADO CULTIVO SIN, P305; Thompson RB, 2013, SCI HORTIC-AMSTERDAM, V150, P387, DOI 10.1016/j.scienta.2012.11.018; Urrestarazu M, 2015, HORTSCIENCE, V50, P819, DOI 10.21273/HORTSCI.50.6.819	31	3	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180529	10.1371/journal.pone.0180529	http://dx.doi.org/10.1371/journal.pone.0180529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678884	gold, Green Published, Green Submitted			2022-12-27	WOS:000405272200070
J	Zou, K; Xiao, FK; Li, HY; Zhou, Q; Ban, L; Yang, M; Kuo, CF; Zhang, WY				Zou, Kun; Xiao, Fu-Kun; Li, Hong-Ying; Zhou, Qiao; Ban, Lu; Yang, Min; Kuo, Chang-Fu; Zhang, Weiya			Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: A cross-sectional study based on hospital medical records in 10 years	PLOS ONE			English	Article							OSTEOARTHRITIS; MORTALITY; POPULATION; PREVALENCE	Objective Though the risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA) has been established in Western population, little is known about the risk in Chinese people with RA. Our objective was to estimate the risk of CVD in Chinese people with RA using hospital medical records data. Methods The inpatients medical record database 2005-2015 of Sichuan provincial people's hospital was examined. All individuals with a primary diagnosis of RA were included as cases, and those of osteoarthritis (OA) were included as controls, which consisted of the unmatched dataset. Then, RA cases and OA controls were matched by sex and age at 1: 1 ratio, forming the matched dataset. The morbidity of CVD (including ischemia heart disease (IHD), congestive heart failure (CHF), et al), stroke and arthrosclerosis were extracted from the database, so as the demographic data and comorbidities related to CVD. Multiple logistic regression analysis was used to estimate the risk of CVD in RA adjusted for demographics and comorbidities using the unmatched dataset. Sensitivity analysis was conducted 1) considering interaction terms between RA and comorbidities, and 2) using multivariable conditional logistic regression for the matched dataset. Results The unmatched dataset comprised of 1824RA cases and 1995 OA controls and the matched dataset comprised of 1022 pairs of sex and age matched RA and OA patients. RA exhibited increased odds of prevalent CVD compared with OA, and the adjusted ORs (95% CIs) for CVD, stroke, IHD, CHF, and atherosclerosis were1.86(1.42-2.43), 1.11(0.71-1.74), 1.47(0.97-2.24), 2.09(1.03-4.22), and 2.49 (1.97-3.13), respectively, and was 2.26 (1.29-3.96) for IHD further adjusted for interaction term. The matched dataset analysis found similar results. Conclusions Chinese people with RA were approximated 2 times more likely to have CVD, IHD, CHF and atherosclerosis compared with those with OA. The findings justified the need of further longitudinal study to establish the causal-relationship between RA and CVD and to estimate the precise risk in this population.	[Zou, Kun; Xiao, Fu-Kun; Li, Hong-Ying] Univ Elect Sci & Technol, Sichuan Acad Med Sci, Dept Med Records & Stat, Chengdu, Peoples R China; [Zou, Kun; Xiao, Fu-Kun; Li, Hong-Ying; Zhou, Qiao] Univ Elect Sci & Technol, Affiliate Hosp, Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Zou, Kun; Ban, Lu; Kuo, Chang-Fu; Zhang, Weiya] Univ Nottingham, Sch Med, Div Rheumatol Orthoped & Dermatol, Nottingham, England; [Zhou, Qiao] Univ Elect Sci & Technol, Sichuan Acad Med Sci, Dept Rheumatol & Immunol, Chengdu, Peoples R China; [Ban, Lu] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England; [Yang, Min] Sichuan Univ, West China Sch Publ Hlth, West China Res Ctr Rural Hlth Dev, Chengdu, Peoples R China; [Kuo, Chang-Fu] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan	Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; University of Nottingham; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; University of Nottingham; Sichuan University; Chang Gung Memorial Hospital	Zou, K (corresponding author), Univ Elect Sci & Technol, Sichuan Acad Med Sci, Dept Med Records & Stat, Chengdu, Peoples R China.; Zou, K (corresponding author), Univ Elect Sci & Technol, Affiliate Hosp, Sichuan Prov Peoples Hosp, Chengdu, Peoples R China.; Zou, K (corresponding author), Univ Nottingham, Sch Med, Div Rheumatol Orthoped & Dermatol, Nottingham, England.	zoukun.jy@outlook.com	Zhang, Weiya/X-9481-2019	Zhang, Weiya/0000-0003-1142-1460; Ban, Lu/0000-0001-9388-9141	Cooperation Innovation Research - University of Electronic Science and Technology, China	Cooperation Innovation Research - University of Electronic Science and Technology, China	QZ was supported by the Cooperation Innovation Research Grant from the University of Electronic Science and Technology, China. The funder had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Chung WS, 2013, INT J CARDIOL, V168, P4750, DOI 10.1016/j.ijcard.2013.07.233; Hall AJ, 2016, EUR J PREV CARDIOL, V23, P938, DOI 10.1177/2047487315610663; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; National Institute for Health and Care Excellence (NICE), 2015, RHEUM ARTHR MAN RHEU; NICE, 2014, NICE GUID OST CAR MA; Nielen MMJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-150; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raftery AE., 1995, SOCIOLOGICAL METHODO, V25; Rahman MM, 2013, ARTHRIT CARE RES, V65, P1951, DOI 10.1002/acr.22092; Semb AG, 2010, ANN RHEUM DIS, V69, P1996, DOI 10.1136/ard.2009.126128; Sihvonen S, 2004, SCAND J RHEUMATOL, V33, P221, DOI 10.1080/03009740410005845; Skeoch S, 2015, NAT REV RHEUMATOL, V11, P390, DOI 10.1038/nrrheum.2015.40; Ungprasert P, 2016, JOINT BONE SPINE, V83, P290, DOI 10.1016/j.jbspin.2015.05.016; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; Watson DJ, 2003, J RHEUMATOL, V30, P1196; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253; [曾小峰 Zeng Xiaofeng], 2013, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V13, P300	22	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180376	10.1371/journal.pone.0180376	http://dx.doi.org/10.1371/journal.pone.0180376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678807	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000405272200060
J	Bienholz, A; Walter, B; Pless-Petig, G; Guberina, H; Kribben, A; Witzke, O; Rauen, U				Bienholz, Anja; Walter, Bjoern; Pless-Petig, Gesine; Guberina, Hana; Kribben, Andreas; Witzke, Oliver; Rauen, Ursula			Characterization of injury in isolated rat proximal tubules during cold incubation and rewarming	PLOS ONE			English	Article							LIVER ENDOTHELIAL-CELLS; HYPOTHERMIC MACHINE PERFUSION; DONOR KIDNEY-TRANSPLANTATION; PRESERVATION SOLUTION; ORGAN PRESERVATION; INDUCED APOPTOSIS; MITOCHONDRIAL DYSFUNCTION; CHELATABLE IRON; GRAFT FUNCTION; STORAGE	Organ shortage leads to an increased utilization of marginal organs which are particularly sensitive to storage-associated damage. Cold incubation and rewarming-induced injury is iron-dependent in many cell types. In addition, a chloride-dependent component of injury has been described. This work examines the injury induced by cold incubation and rewarm-ing in isolated rat renal proximal tubules. The tissue storage solution TiProtec (R) and a chloride-poor modification, each with and without iron chelators, were used for cold incubation. Incubation was performed 4 degrees C for up to 168 h, followed by rewarming in an extracellular buffer (3 h at 37 degrees C). After 48, 120 and 168 h of cold incubation LDH release was lower in solutions containing iron chelators. After rewarming, injury increased especially after cold incubation in chelator-free solutions. Without addition of iron chelators LDH release showed a tendency to be higher in chloride-poor solutions. Following rewarming after 48 h of cold incubation lipid peroxidation was significantly decreased and metabolic activity was tendentially better in tubules incubated with iron chelators. Morphological alterations included mitochondrial swelling and fragmentation being partially reversible during rewarming. ATP content was better preserved in chloride-rich solutions. During rewarming, there was a further decline of ATP content in the so far best conditions and minor alterations under the other conditions, while oxygen consumption was not significantly different compared to non-stored control tubules. Results show an iron-dependent component of preservation injury during cold incubation and rewarming in rat proximal renal tubules and reveal a benefit of chloride for the maintenance of tubular energy state during cold incubation.	[Bienholz, Anja; Kribben, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Walter, Bjoern; Pless-Petig, Gesine; Rauen, Ursula] Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol Chem, Essen, Germany; [Guberina, Hana; Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Infect Dis, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Bienholz, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany.	anja.bienholz@uk-essen.de	Pless-Petig, Gesine/F-3639-2010	Pless-Petig, Gesine/0000-0001-8843-6607	Dr. Werner Jackstadt-Foundation	Dr. Werner Jackstadt-Foundation	AB and UR received support from the Dr. Werner Jackstadt-Foundation.	Arnau A, 2012, TRANSPL P, V44, P2555, DOI 10.1016/j.transproceed.2012.09.061; Bartels-Stringer M, 2003, CRYOBIOLOGY, V47, P82, DOI 10.1016/S0011-2240(03)00071-3; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Bienholz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094584; ERHARD J, 1994, TRANSPLANT INT, V7, P177, DOI 10.1111/j.1432-2277.1994.tb01287.x; Feldkamp T, 2009, NEPHROL DIAL TRANSPL, V24, P43, DOI 10.1093/ndt/gfn436; Fingas CD, 2011, LIVER TRANSPLANT, V17, P650, DOI 10.1002/lt.22275; Fuckert O, 2000, TRANSPLANTATION, V70, P723, DOI 10.1097/00007890-200009150-00003; Gallinat A, 2013, CRYOBIOLOGY, V66, P131, DOI 10.1016/j.cryobiol.2012.12.007; Garbe S, 2011, J VASC SURG, V53, P1063, DOI 10.1016/j.jvs.2010.10.093; Gizewski ER, 1997, BIOCHEM J, V322, P693, DOI 10.1042/bj3220693; Heuer N, 2010, EUR J MED RES, V15, P31, DOI 10.1186/2047-783X-15-1-31; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Kerkweg U, 2003, TRANSPLANTATION, V76, P501, DOI 10.1097/01.TP.0000069830.78758.1C; Kyllonen LEJ, 2000, TRANSPLANT INT, V13, P122, DOI 10.1111/j.1432-2277.2000.tb01051.x; Lam VWT, 2013, J SURG RES, V180, P176, DOI 10.1016/j.jss.2012.10.055; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Minor T, 2015, TRANSPL INT, V28, P1102, DOI 10.1111/tri.12593; Moers C, 2012, NEW ENGL J MED, V366, P770, DOI 10.1056/NEJMc1111038; NOLL T, 1987, ARCH BIOCHEM BIOPHYS, V252, P284, DOI 10.1016/0003-9861(87)90033-6; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Peters SMA, 1998, TRANSPLANTATION, V65, P625, DOI 10.1097/00007890-199803150-00005; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Pless G, 2012, CELL TRANSPLANT, V21, P23, DOI 10.3727/096368911X580509; Pless-Petig G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040444; Quiroga I, 2006, NEPHROL DIAL TRANSPL, V21, P1689, DOI 10.1093/ndt/gfl042; Rauen U, 2007, CELL MOL LIFE SCI, V64, P192, DOI 10.1007/s00018-006-6456-1; Rauen U, 2004, J INVEST MED, V52, P299, DOI 10.1136/jim-52-05-29; Rauen U, 2003, FREE RADICAL BIO MED, V35, P1664, DOI 10.1016/j.freeradbiomed.2003.09.018; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Rauen U, 2007, CRYOBIOLOGY, V54, P77, DOI 10.1016/j.cryobiol.2006.11.008; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; Salahudeen AK, 2004, AM J PHYSIOL-RENAL, V287, pF181, DOI 10.1152/ajprenal.00098.2004; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Salahudeen AK, 2000, TRANSPLANTATION, V70, P1424, DOI 10.1097/00007890-200011270-00005; Tomaskova Z, 2010, FEBS LETT, V584, P2085, DOI 10.1016/j.febslet.2010.01.035; Vaziri N, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-15; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Wille T, 2008, J VASC SURG, V47, P422, DOI 10.1016/j.jvs.2007.09.048; WIRTHENSOHN G, 1990, METHOD ENZYMOL, V191, P325	42	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180553	10.1371/journal.pone.0180553	http://dx.doi.org/10.1371/journal.pone.0180553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672023	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500064
J	Cuenca, P; Echeverria, C				Cuenca, Pablo; Echeverria, Cristian			How do protected landscapes associated with high biodiversity and population levels change?	PLOS ONE			English	Article							LAND-USE; TROPICAL DEFORESTATION; HABITAT LOSS; FOREST LOSS; AREAS; FRAGMENTATION; CONSERVATION; ECUADOR; COVER; PARKS	Most protected areas (PA) try to limit logging of forests by means of restrictions on access and use, especially in areas where local communities coexist with the forests and depend on resources derived from PAs. In such contexts, achieving full or effective protection of the forests is almost impossible. This fact has led to researching beyond PAs boundaries in order to examine large surrounding landscapes with multiple forms of properties and restriction on forests use. The present study assessed the change in forest cover and fragmentation between 1990 and 2014, in addition to the drivers that explain such changes in a landscape with the presence of PAs and high-density population belonging to the Choco-Darien bio-diversity hotspot. Results indicated differences in the extent and spatial patterns of change in forest cover of PAs and their surrounding landscapes. Two PAs exhibited a tendency to increase fragmentation and lose their forests in comparison with the stable protection of the forests in other PAs during this period. However, the greatest change in forest cover and fragmentation was observed in the surrounding landscapes, where the best connection to markets and transport networks were the dominating deforestation drivers. Our findings corroborated that the PAs were a shield against the deforestation of the tropical Andean forest, especially in landscapes with high-density population. However, the fragmentation of the forest cannot be avoided around the PAs limits. It is expected that, if this tendency continues in the future, the biodiversity in the Choco-Darien hotspot will be seriously affected.	[Cuenca, Pablo] Univ Reg Amazon IKIAM, Tena, Ecuador; [Echeverria, Cristian] Univ Concepcion, Fac Ciencias Forestales, Lab Ecol Paisaje, Concepcion, Chile	Universidad de Concepcion	Cuenca, P (corresponding author), Univ Reg Amazon IKIAM, Tena, Ecuador.	pablo.cuenca@ikiam.edu.ec	Echeverria, Cristian/ABD-7286-2020		CONICYT (Comisio An Nacional de Investigacion Cientifica y Tecnologica) of Chile; SENESCYT (Secretaria de Educacion Superior, Ciencia, Tecnologia e innovacion) of Ecuador	CONICYT (Comisio An Nacional de Investigacion Cientifica y Tecnologica) of Chile; SENESCYT (Secretaria de Educacion Superior, Ciencia, Tecnologia e innovacion) of Ecuador	P. Cuenca acknowledges support from CONICYT (Comisio An Nacional de Investigacion Cientifica y Tecnologica) of Chile and SENESCYT (Secretaria de Educacion Superior, Ciencia, Tecnologia e innovacion) of Ecuador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; [Anonymous], 2010, GEOGR BULL; Armenteras D, 2003, BIOL CONSERV, V113, P245, DOI 10.1016/S0006-3207(02)00359-2; Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Bennett DL, 2006, LINKAGES LANDSCAPES; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Casto M, 2013, ZONAS PROCESOS HOMOG; Cernea MM, 2006, WORLD DEV, V34, P1808, DOI 10.1016/j.worlddev.2006.02.008; Chapin M., 2004, CHALLENGE CONSERVATI, VNovember/December, P17, DOI DOI 10.1146/ANNUREV.ANTHR0.34.081804.120429; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Cuenca P, 2016, ENVIRON SCI POLICY, V56, P56, DOI 10.1016/j.envsci.2015.10.014; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; DODSON CH, 1991, ANN MO BOT GARD, V78, P273, DOI 10.2307/2399563; Echeverria C, 2008, ECOL MODEL, V212, P439, DOI 10.1016/j.ecolmodel.2007.10.045; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Echeverria C, 2012, APPL GEOGR, V32, P822, DOI 10.1016/j.apgeog.2011.08.014; Ecuador MdAd, 2006, POL PLAN ESTR SIST N; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Tapia-Armijos MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133701; Fox J., 2018, R COMPANION APPL REG, VThird; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Gentry AH, 1986, FLORISTIC INVENTORY; Green JMH, 2013, BIOL CONSERV, V164, P62, DOI 10.1016/j.biocon.2013.04.016; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Holland MB, 2013, WORLD DEV; Jokisch BD, 2002, GEOGR REV, V92, P235, DOI 10.2307/4140972; Jones DA, 2009, REMOTE SENS ENVIRON, V113, P1346, DOI 10.1016/j.rse.2008.08.018; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Jorgensen P. M., 1999, CATALOGUE VASCULAR P; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Larrea C, 2009, ENERGY SUSTAIN DEV, V13, P219, DOI 10.1016/j.esd.2009.08.003; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leon-Yanez S, 2011, LIBRO ROJO PLANTAS E, P957; Loaiza T, 2015, APPL GEOGR, V62, P225, DOI 10.1016/j.apgeog.2015.04.020; MAE, 2005, PLAN MAN GEST PART R; MAE, 2007, PLAN MAN RES EC COT; MAE, 2012, LIN BAS DEF EC CONT; MAE, 1999, EST COMPL TEN TIERR; MAE (Ministerio del Ambiente del Ecuador), 2006, POL PLAN ESTR SIST N; Marquette CM, 1998, HUM ECOL, V26, P573, DOI 10.1023/A:1018797325069; Mateo RG, 2013, BIOL CONSERV, V160, P150, DOI 10.1016/j.biocon.2013.01.014; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Mena CF, 2008, PHOTOGRAMM ENG REM S, V74, P737, DOI 10.14358/PERS.74.6.737; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1986, TACKLING MASS EXTINC; Nagendra H, 2004, AGR ECOSYST ENVIRON, V101, P111, DOI 10.1016/j.agee.2003.09.003; Nagendra H, 2006, APPL GEOGR, V26, P96, DOI 10.1016/j.apgeog.2005.11.002; Nagendra H, 2009, ENVIRON MANAGE, V44, P853, DOI 10.1007/s00267-009-9374-9; Nahuelhual L, 2012, LANDSCAPE URBAN PLAN, V107, P12, DOI 10.1016/j.landurbplan.2012.04.006; Newton A, 2007, BIODIVERSITY LOSS AND CONSERVATION IN FRAGMENTED FOREST LANDSCAPES: THE FORESTS OF MONTANE MEXICO AND TEMPERATE SOUTH AMERICA, pXIII, DOI 10.1079/9781845932619.0000; Nolte C, 2015, ORYX, P1; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Plant RE, 2012, SPAT DAT AN EC AGR U; Robbins AST, 2012, RESTOR ECOL, V20, P10, DOI 10.1111/j.1526-100X.2011.00838.x; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Sierra R, 2001, ECOL ECON, V36, P327, DOI 10.1016/S0921-8009(00)00233-0; Sierra R., 2013, ECUADOR FOREST TREND; Sloep Peter BA, 2005, ENV POLICY INT CONTE; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; SOUTHGATE D, 1991, WORLD DEV, V19, P1145, DOI 10.1016/0305-750X(91)90063-N; Southgate DD, 1990, I ORIGINS DEFORESTAT; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; UNEP-WCMC, 2008, STAT WORLDS PROT AR; Vina A, 2004, AMBIO, V33, P118, DOI 10.1639/0044-7447(2004)033[0118:SCDAOD]2.0.CO;2; Wilson K, 2005, BIOL CONSERV, V122, P9, DOI 10.1016/j.biocon.2004.06.015; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wunder S, 2000, EC DEFORESTATION EXA; Wyman MS, 2010, APPL GEOGR, V30, P329, DOI 10.1016/j.apgeog.2009.10.001	78	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180537	10.1371/journal.pone.0180537	http://dx.doi.org/10.1371/journal.pone.0180537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672002	gold, Green Published			2022-12-27	WOS:000405268500061
J	Pando, MA; Dolezal, C; Marone, RO; Barreda, V; Carballo-Dieguez, A; Avila, MM; Balan, IC				Pando, Maria A.; Dolezal, Curtis; Marone, Ruben O.; Barreda, Victoria; Carballo-Dieguez, Alex; Avila, Maria M.; Balan, Ivan C.			High acceptability of rapid HIV self-testing among a diverse sample of MSM from Buenos Aires, Argentina	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SEX; MEN; INFECTION; COLLECTION; FEASIBILITY; POPULATIONS; ZIMBABWE; BRAZIL; BLOOD	Introduction The objective of this study was to explore the acceptability of rapid HIV self-testing (RHST) among men who have sex with men (MSM). Methods During 2006-2009, a sample of 500 MSM was recruited through Respondent Driven Sampling for an HIV prevalence/incidence study. Attitude toward RHST was explored among HIV negative MSM. Data were weighted prior to analyses. Results Participants reported they were likely to buy RHST (74%), test themselves more frequently than they currently do (77%), and that the procedure would simplify testing (70%). Furthermore, 71% reported they would probably use it alone, 66% would use it with a steady partner, and 56% with a friend/partner. While a majority acknowledged that RHST use would deprive them of receiving counseling (61%), 74% declared they would go for help if they tested positive; 57% would use an RHST in order to avoid condoms. Probability of use surpassed 70% among gay and non-gay identified MSM as well as those with and without a previous HIV test. Those likely to buy RHST were older (p = 0.025) and more likely to identify as gay (p = 0.036). A total of 17% said they would think about killing themselves and 9% would attempt suicide if they tested positive. These MSM were more likely to be younger (p<0.001), with lower mood level (p<0.001) and greater feelings of loneliness (p = 0.026). Conclusions The high acceptability of RHST found among MSM should encourage the authorities to consider the possibility of offering it for self-testing, as it can improve early diagnosis and prevention of future transmissions. However, further research is needed to understand how to	[Pando, Maria A.; Avila, Maria M.] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina; [Dolezal, Curtis; Carballo-Dieguez, Alex; Balan, Ivan C.] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA; [Dolezal, Curtis; Carballo-Dieguez, Alex; Balan, Ivan C.] Columbia Univ, New York, NY USA; [Marone, Ruben O.; Barreda, Victoria] Nexo Asociac Civil, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; New York State Psychiatry Institute; Columbia University	Pando, MA (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina.	mpando@fmed.uba.ar			US National Institute of Mental Health (NIMH) at the New York State Psychiatric Institute and Columbia University [R01 MH073410]; NIMH at New York State Psychiatric Institute and Columbia University [P30 MH43520]	US National Institute of Mental Health (NIMH) at the New York State Psychiatric Institute and Columbia University; NIMH at New York State Psychiatric Institute and Columbia University	This work was supported with funds from the US National Institute of Mental Health (NIMH) to the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University (R01 MH073410; Principal Investigator: Alex Carballo D ieguez, Ph.D.).Additional funds came from a grant from NIMH to the HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute and Columbia University (P30 MH43520; Principal Investigator: Robert H. Remien and P30 MH43520; Principal Investigator: Anke A. Ehrhardt, Ph.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIMH or the NIH	[Anonymous], 2013, B OFICIAL REPUBLICA; Appiah LT, 2009, AIDS PATIENT CARE ST, V23, P365, DOI 10.1089/apc.2008.0224; Balan Ivan C, 2011, Actual SIDA, V19, P26; Belza MJ, 2012, SEX TRANSM INFECT, V88, P218, DOI 10.1136/sextrans-2011-050131; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Branson BM, 1998, JAMA-J AM MED ASSOC, V280, P1699, DOI 10.1001/jama.280.19.1699; Brito AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130445; Carballo-Dieguez A, 2014, AIDS CARE, V26, P33, DOI 10.1080/09540121.2013.793277; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Carballo-Dieguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027447; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1233; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Fisher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120810; Flowers P, 2017, SEX HLTH; Frith L, 2007, LANCET, V369, P243, DOI 10.1016/S0140-6736(07)60113-5; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Greacen T, 2012, SEX TRANSM INFECT, V88, P368, DOI 10.1136/sextrans-2011-050405; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Bustamante MJ, 2017, INT J STD AIDS, V28, P133, DOI 10.1177/0956462416630674; Katz DA, 2015, 8 INT AIDS SOC C HIV; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Lane T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111063; Lippman S.A., 2015, 8 INT AIDS SOC C HIV; Lippman SA, 2014, CAD SAUDE PUBLICA, V30, P724, DOI 10.1590/0102-311X00008913; Ma QQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2591-7; Ministerio de Salud Presidencia de la Nacio, 2016, B VIH SID ARG, V33; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Montlahuc C, 2013, JAIDS-J ACQ IMM DEF, V64, P197, DOI 10.1097/QAI.0b013e31829cfbfa; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Osmond DH, 2000, J ACQ IMMUN DEF SYND, V24, P363; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Paz-Bailey G, 2013, AIDS BEHAV, V17, P3081, DOI 10.1007/s10461-013-0589-7; Roberts KJ, 2007, AIDS PATIENT CARE ST, V21, P621, DOI 10.1089/apc.2006.0196; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Sharma A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-109; Smith LV, 2006, AIDS PATIENT CARE ST, V20, P693, DOI 10.1089/apc.2006.20.693; U. S. Food and Drug Administration, 2012, FDA APPR 1 OV THE CO; Volk JE, 2016, INT J STD AIDS, V27, P531, DOI 10.1177/0956462415586676; Volz E, 2008, J OFF STAT, V24, P79; Wurcel A, 2005, AIDS PATIENT CARE ST, V19, P499, DOI 10.1089/apc.2005.19.499	51	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180361	10.1371/journal.pone.0180361	http://dx.doi.org/10.1371/journal.pone.0180361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672037	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500046
J	Song, F; Wang, P; Chen, SX; Wang, ZD; Fan, GR				Song, Fei; Wang, Peng; Chen, Shangxing; Wang, Zongde; Fan, Guorong			Ordered lamellar supermicroporous titania templating by rosin-derived quaternary ammonium salt	PLOS ONE			English	Article							MESOPOROUS MOLECULAR-SIEVES; MESOSTRUCTURED LAMELLAR; TEMPERATURE SYNTHESIS; POROUS SILICA; SURFACTANT; TIO2; LIQUID; COPOLYMER; PHASES; OXIDES	By using dehydroabietyltrimethyl ammonium bromine (DTAB), a novel rosin-derived quaternary ammonium salt, as template and peroxotitanium acid as precursor, ordered lamellar supermicroporous titania has been synthesized via a hydrothermal process. The template agent: titanium source molar ratio in the synthesis system and the hydrothermal temperature have great impact on the microstructure characteristics of the samples. The increase of DTAB: TiO2 molar ratio from 0.04:1 to 0.10:1 is favorable to the increase of regularity of pore structures, but has no significant effects on the crystalline structures. The increase of the hydrothermal temperature from 343 to 393 K can induce an increase in crystallinity of the samples. However, the exorbitant hydrothermal temperature will reduce the regularity of pore structures. When the mole ratio of DTAB: TiO2 is 0.10:1 and the hydrothermal temperature is 373 K, the as-synthesized sample possesses pore structure with the highest level of long-range order, as well as pore wall with semicrystallized anatase phase. The pore size and the pore wall thickness are about 2.0 nm and 1.0 nm, respectively.	[Song, Fei; Wang, Peng; Chen, Shangxing; Wang, Zongde; Fan, Guorong] Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University	Wang, P (corresponding author), Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China.	pengwang1981@126.com		Wang, Peng/0000-0001-8350-691X	National Natural Science Foundation of China [31500484]; Natural Science Foundation of Jiangxi Province, China [20151BAB214019, 20161BAB204186)]; Open Foundation of Guangxi Key Laboratory of Chemistry and Engineering of Forest Products [GXFC14-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province, China(Natural Science Foundation of Jiangxi Province); Open Foundation of Guangxi Key Laboratory of Chemistry and Engineering of Forest Products	This work was supported by the National Natural Science Foundation of China (grant No. 31500484), the Natural Science Foundation of Jiangxi Province, China (grant No. 20151BAB214019 and 20161BAB204186) and the Open Foundation of Guangxi Key Laboratory of Chemistry and Engineering of Forest Products (grant no. GXFC14-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (grant No. 31500484), the Natural Science Foundation of Jiangxi Province, China (grant No. 20151BAB214019 and 20161BAB204186) and the Open Foundation of Guangxi Key Laboratory of Chemistry and Engineering of Forest Products (grant no. GXFC14-05).	ANTONELLI DM, 1995, ANGEW CHEM INT EDIT, V34, P2014, DOI 10.1002/anie.199520141; BAGSHAW SA, 1995, SCIENCE, V269, P1242, DOI 10.1126/science.269.5228.1242; Bagshaw SA, 2001, MICROPOR MESOPOR MAT, V44, P81, DOI 10.1016/S1387-1811(01)00171-8; Bagshaw SA, 2001, ADV MATER, V13, P1011, DOI 10.1002/1521-4095(200107)13:12/13<1011::AID-ADMA1011>3.0.CO;2-T; Bastakoti BP, 2014, ACS APPL MATER INTER, V6, P854, DOI 10.1021/am4039954; BECK JS, 1994, CHEM MATER, V6, P1816, DOI 10.1021/cm00046a040; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Chandra D, 2008, MICROPOR MESOPOR MAT, V112, P533, DOI 10.1016/j.micromeso.2007.10.035; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Di Y, 2006, LANGMUIR, V22, P3068, DOI 10.1021/la0521342; Fukasawa Y, 2010, CHEM LETT, V39, P236, DOI 10.1246/cl.2010.236; Gu D, 2014, CHEM SOC REV, V43, P313, DOI 10.1039/c3cs60155b; Huang YY, 1997, CHEM COMMUN, P1181, DOI 10.1039/a700974g; Huo QS, 1996, CHEM MATER, V8, P1147, DOI 10.1021/cm960137h; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kruk M, 1997, J PHYS CHEM B, V101, P583, DOI 10.1021/jp962000k; Lin YS, 2004, MICROPOR MESOPOR MAT, V76, P203, DOI 10.1016/j.micromeso.2004.08.015; Liu G, 2012, ENERG ENVIRON SCI, V5, P9603, DOI 10.1039/c2ee22930g; Liu H, 2015, J AM CHEM SOC, V137, P13161, DOI 10.1021/jacs.5b08743; Liu XY, 2002, ANGEW CHEM INT EDIT, V41, P3876, DOI 10.1002/1521-3773(20021018)41:20<3876::AID-ANIE3876>3.0.CO;2-R; Mori K, 2016, ACS CATAL, V6, P3128, DOI 10.1021/acscatal.6b00715; On DT, 1999, LANGMUIR, V15, P8561, DOI 10.1021/la9905463; Ryoo R, 2001, J AM CHEM SOC, V123, P1650, DOI 10.1021/ja0038326; Serrano DP, 2000, CHEM COMMUN, P2041, DOI 10.1039/b006186g; Shibata H, 2005, J AM CHEM SOC, V127, P16396, DOI 10.1021/ja0552601; Song K, 2009, APPL SURF SCI, V255, P5843, DOI 10.1016/j.apsusc.2009.01.016; TANEV PT, 1995, SCIENCE, V267, P865, DOI 10.1126/science.267.5199.865; VARTULI JC, 1994, CHEM MATER, V6, P2317, DOI 10.1021/cm00048a018; Wang P, 2015, RSC ADV, V5, P11223, DOI 10.1039/c4ra12113a; Wang RL, 2013, J COLLOID INTERF SCI, V407, P128, DOI 10.1016/j.jcis.2013.06.033; Wang RL, 2007, J PHYS CHEM C, V111, P10955, DOI 10.1021/jp0716029; Yang PD, 1998, NATURE, V396, P152; Yu CZ, 2000, CHEM COMMUN, P575, DOI 10.1039/b000603n; Yu CZ, 2002, J AM CHEM SOC, V124, P4556, DOI 10.1021/ja025548f; Zhang JY, 2011, ADV ENERGY MATER, V1, P241, DOI 10.1002/aenm.201000004; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Zhao XS, 1999, CHEM COMMUN, P1391; Zhou Y, 2004, CHEM MATER, V16, P544, DOI 10.1021/cm034442w; Zhou Y, 2003, ADV MATER, V15, P1452, DOI 10.1002/adma.200305265; Zhu YM, 2014, CHEM LETT, V43, P1170, DOI 10.1246/cl.140327	41	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180178	10.1371/journal.pone.0180178	http://dx.doi.org/10.1371/journal.pone.0180178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666012	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700068
J	Dorn, ES; Tress, B; Suchodolski, JS; Nisar, T; Ravindran, P; Weber, K; Hartmann, K; Schulz, BS				Dorn, Elisabeth S.; Tress, Barbara; Suchodolski, Jan S.; Nisar, Tariq; Ravindran, Prajesh; Weber, Karin; Hartmann, Katrin; Schulz, Bianka S.			Bacterial microbiome in the nose of healthy cats and in cats with nasal disease	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; NASOPHARYNGEAL MICROBIOTA; BRADYRHIZOBIUM-ENTERICA; PATHOGENIC BACTERIA; INCREASED RISK; EARLY-LIFE; COMMUNITIES; ASTHMA; INFECTION; COLITIS	Background Traditionally, changes in the microbial population of the nose have been assessed using conventional culture techniques. Sequencing of bacterial 16S rRNA genes demonstrated that the human nose is inhabited by a rich and diverse bacterial microbiome that cannot be detected using culture-based methods. The goal of this study was to describe the nasal microbiome of healthy cats, cats with nasal neoplasia, and cats with feline upper respiratory tract disease (FURTD). Methodology/Principal findings DNA was extracted from nasal swabs of healthy cats (n = 28), cats with nasal neoplasia (n = 16), and cats with FURTD (n = 15), and 16S rRNA genes were sequenced. High species richness was observed in all samples. Rarefaction analysis revealed that healthy cats living indoors had greater species richness (observed species p = 0.042) and Shannon diversity (p = 0.003) compared with healthy cats living outdoors. Higher species richness (observed species p = 0.001) and Shannon diversity (p<0.001) were found in middle-aged cats in comparison to healthy cats in different age groups. Principal coordinate analysis revealed separate clustering based on similarities in bacterial molecular phylogenetic trees of 16S rRNA genes for indoor and outdoor cats. In all groups examined, the most abundant phyla identified were Proteobacteria, Firmicutes, and Bacteroidetes. At the genus level, 375 operational taxonomic units (OTUs) were identified. In healthy cats and cats with FURTD, Moraxella spp. was the most common genus, while it was unclassified Bradyrhizobiaceae in cats with nasal neoplasia. High individual variability was observed. Conclusion This study demonstrates that the nose of cats is inhabited by much more variable and diverse microbial communities than previously shown. Future research in this field might help to develop new diagnostic tools to easily identify nasal microbial changes, relate them to certain disease processes, and help clinicians in the decision process of antibiotic selection for individual patients.	[Dorn, Elisabeth S.; Tress, Barbara; Weber, Karin; Hartmann, Katrin; Schulz, Bianka S.] LMU Univ Munich, Clin Small Anim Med, Munich, Germany; [Suchodolski, Jan S.; Nisar, Tariq; Ravindran, Prajesh] Texas A&M Univ, Coll Vet Med & Biomed Sci, Gastrointestinal Lab, Dept Small Anim Clin Sci, College Stn, TX USA	University of Munich; Texas A&M University System; Texas A&M University College Station	Schulz, BS (corresponding author), LMU Univ Munich, Clin Small Anim Med, Munich, Germany.	B.Schulz@medizinische-kleintierklinik.de	Weber, Karin/A-6034-2016	Weber, Karin/0000-0002-0541-4355; Dorn, Elisabeth/0000-0002-8052-7026	sdw-Stiftung der Deutschen Wirtschaft	sdw-Stiftung der Deutschen Wirtschaft	This work was supported by sdw-Stiftung der Deutschen Wirtschaft (30,000 epsilon, https://www.sdw.org/home) (ESD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Alho OP, 2003, ALLERGY, V58, P767, DOI 10.1034/j.1398-9995.2003.00252.x; Allen EK, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-22; Autio TJ, 2015, LARYNGOSCOPE, V125, pE1, DOI 10.1002/lary.24862; Bassiouni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123216; Berger A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0595-2; Bhatt AS, 2013, NEW ENGL J MED, V369, P1867, DOI 10.1056/NEJMc1311318; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P298, DOI 10.1164/rccm.201401-0073OC; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Biswas K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00134; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Boutin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116029; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Choi CH, 2014, AM J RHINOL ALLERGY, V28, P281, DOI 10.2500/ajra.2014.28.4050; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Deusch O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144881; Dickey AM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0316-2; Dolieslager SMJ, 2011, VET MICROBIOL, V148, P93, DOI 10.1016/j.vetmic.2010.08.002; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154646; Feazel LM, 2011, INT FORUM ALLERGY RH, V1, P451, DOI 10.1002/alr.20071; Folsgaard NV, 2013, AM J RESP CRIT CARE, V187, P589, DOI 10.1164/rccm.201207-1297OC; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Goldstein EJC, 2012, ANTIMICROB AGENTS CH, V56, P6319, DOI 10.1128/AAC.01794-12; Gourkow N, 2013, CAN VET J, V54, P132; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hariharan H, 2011, COMP IMMUNOL MICROB, V34, P129, DOI 10.1016/j.cimid.2010.05.001; Harris S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136986; Hasegawa K, 2015, EXPERT REV CLIN IMMU, V11, P789, DOI 10.1586/1744666X.2015.1045417; Hauser LJ, 2016, INT FORUM ALLERGY RH, V6, P34, DOI 10.1002/alr.21630; Hilty M, 2012, J INFECT DIS, V205, P1048, DOI 10.1093/infdis/jis024; Holst BS, 2010, J FELINE MED SURG, V12, P783, DOI 10.1016/j.jfms.2010.06.002; Johnson LR, 2009, J FELINE MED SURG, V11, P645, DOI 10.1016/j.jfms.2008.12.004; Johnson RC, 2015, INFECT IMMUN, V83, P802, DOI 10.1128/IAI.02664-14; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Kil DY, 2011, J ANIM SCI, V89, P1498, DOI 10.2527/jas.2010-3498; Kim RJT, 2015, INT FORUM ALLERGY RH, V5, P877, DOI 10.1002/alr.21600; Kizilova A K, 2014, Mikrobiologiia, V83, P366; Kloepfer KM, 2014, J ALLERGY CLIN IMMUN, V133, P1301, DOI 10.1016/j.jaci.2014.02.030; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Liu C M, 1992, J Formos Med Assoc, V91, P252; Lo SC, 2015, INT J CLIN EXP PATHO, V8, P13834; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076142; McDonald R, 2015, ISME J, V9, P2712, DOI 10.1038/ismej.2015.65; McManus CM, 2014, VET J, V201, P196, DOI 10.1016/j.tvjl.2014.05.015; Mika M, 2015, J ALLERGY CLIN IMMUN, V135, P905, DOI 10.1016/j.jaci.2014.12.1909; Mizgerd JP, 2014, AM J RESP CRIT CARE, V190, P1206, DOI 10.1164/rccm.201410-1919ED; NIH Human Microbiome Project, 2011, COR MICR SAMPL PROT; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Park HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109479; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Peterson SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152493; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; PUGH GW, 1986, AM J VET RES, V47, P2343; Redinbo MR, 2014, J MOL BIOL, V426, P3877, DOI 10.1016/j.jmb.2014.09.011; Rutten NBMM, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0519-0; Sakwinska O, 2014, J CLIN MICROBIOL, V52, P1590, DOI 10.1128/JCM.03280-13; Schulz BS, 2014, J FELINE MED SURG, V16, P943, DOI 10.1177/1098612X14524969; Schulz BS, 2006, VET REC, V158, P269, DOI 10.1136/vr.158.8.269; Schulz C, 2015, J FELINE MED SURG; Sellart-Altisent Maite, 2007, Revista Iberoamericana de Micologia, V24, P125; Slifierz MJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0512-7; Sturgeon A, 2014, VET J, V201, P223, DOI 10.1016/j.tvjl.2014.01.024; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Ungaro R, 2014, AM J GASTROENTEROL, V109, P1728, DOI 10.1038/ajg.2014.246; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; Vazquez-Baeza Y, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.177, 10.1038/nmicrobiol.2016.177]; Veir JK, 2008, J FELINE MED SURG, V10, P551, DOI 10.1016/j.jfms.2008.04.002; Vientos-Plotts AI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173818; Vingataramin L, 2015, BIOTECHNIQUES, V58, P120, DOI 10.2144/000114263; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Wanke I, 2011, J INVEST DERMATOL, V131, P382, DOI 10.1038/jid.2010.328; Whelan Fiona J, 2014, Ann Am Thorac Soc, V11, P513, DOI 10.1513/AnnalsATS.201310-351OC; Wilson MT, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0485-x; Wu SG, 2012, WORLD J MICROB BIOT, V28, P2165, DOI 10.1007/s11274-012-1022-5; Yi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0583-3; Zariwala M. A., 2007, GENEREVIEWS	89	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180299	10.1371/journal.pone.0180299	http://dx.doi.org/10.1371/journal.pone.0180299			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662139	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300139
J	Jang, HD; Hong, JY; Han, K; Lee, JC; Shin, BJ; Choi, SW; Suh, SW; Yang, JH; Park, SY; Bang, C				Jang, Hae-Dong; Hong, Jae-Young; Han, Kyungdo; Lee, Jae Chul; Shin, Byung-Joon; Choi, Sung-Woo; Suh, Seung-Woo; Yang, Jae-Hyuk; Park, Si-Young; Bang, Chungwon			Relationship between bone mineral density and alcohol intake: A nationwide health survey analysis of postmenopausal women	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; NUTRITION EXAMINATION SURVEY; MEN; ASSOCIATION; CONSUMPTION; METABOLISM; TOOL	Objectives Among a variety of relevant factors of osteoporosis, the association between alcohol intake and postmenopausal women's bone mineral density (BMD) by using data from the Korean National Health and Nutrition Examination Survey was evaluated in this study. Materials and methods Among a total of 31,596 subjects, males, premenopausal women, participants without BMD data were excluded. Finally, a total number of subjects in the study was 3,312. The frequency and amount of alcohol intake were determined by self-reported questionnaires, and BMD was measured by dual-energy x-ray absorptiometry. Results Mean femoral BMD for light drinkers was statistically significantly greater than that for heavy drinkers and non-drinkers. We observed the characteristic trends for BMD by drinking frequency; the mean BMD gradually increased from non-drinkers to the participants who drank 2-3 times per week; these participants exhibited the highest BMD. Participants who drank alcohol greater than 4 times per week showed a lower BMD. In the risk factor analysis, the adjusted odds ratio for osteoporosis (at femoral neck) was 1.68 in non-drinkers and 1.70 in heavy drinkers compared with light drinkers. Conclusions Light alcohol intake (2-3 times per week and 1-2 or 5-6 glasses per occasion) in South Korean postmenopausal women was related to high femoral BMD. Non-drinkers and heavy drinkers had approximately a 1.7-times greater risk for osteoporosis than light drinkers.	[Jang, Hae-Dong; Lee, Jae Chul; Shin, Byung-Joon; Choi, Sung-Woo] Soonchunhyang Univ Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Hong, Jae-Young] Univ Korea Hosp, Dept Orthoped, Ansan, South Korea; [Han, Kyungdo] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Suh, Seung-Woo; Yang, Jae-Hyuk] Korea Univ, Coll Med, Guro Hosp, Scoliosis Res Inst,Dept Orthoped, Seoul, South Korea; [Park, Si-Young] Korea Univ, Coll Med, Anam Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Bang, Chungwon] Soonchunhyang Univ, Cheonan Hosp, Dept Orthopaed Surg, Chungcheongnam Do, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Soonchunhyang University	Hong, JY (corresponding author), Univ Korea Hosp, Dept Orthoped, Ansan, South Korea.	osspine@korea.ac.kr						Aalto M, 2009, DRUG ALCOHOL DEPEN, V103, P25, DOI 10.1016/j.drugalcdep.2009.02.013; Adewuya AO, 2005, ALCOHOL ALCOHOLISM, V40, P575, DOI 10.1093/alcalc/agh197; Al-Saeed O, 2013, ASIAN SPINE J, V7, P104, DOI 10.4184/asj.2013.7.2.104; Cousins JM, 2010, BONE, V47, P205, DOI 10.1016/j.bone.2010.05.003; de Jonge E.A., 2016, EUR J NUTR; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Ganry O, 2000, AM J EPIDEMIOL, V151, P773, DOI 10.1093/oxfordjournals.aje.a010277; Gong GM, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8076796; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Hirata H, 2016, TOHOKU J EXP MED, V239, P95, DOI 10.1620/tjem.239.95; Hyeon JH, 2016, ASIA PAC J CLIN NUTR, V25, P308, DOI 10.6133/apjcn.2016.25.2.17; Jugdaohsingh R, 2006, P NUTR SOC, V65, P291, DOI 10.1079/PNS2006508; Kim BH, 2009, ASIAN SPINE J, V3, P1, DOI 10.4184/asj.2009.3.1.1; Kim Mi Jin, 2003, Korean J Intern Med, V18, P174; Kizilgul M, 2016, INDIAN J GASTROENTER, V35, P253, DOI 10.1007/s12664-016-0652-1; LAITINEN K, 1991, BONE MINER, V13, P139, DOI 10.1016/0169-6009(91)90081-A; Lee J, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3514-5; Lin JT, 2004, CLIN ORTHOP RELAT R, P126, DOI 10.1097/01.blo.0000132404.30139.f2; Maurel DB, 2012, OSTEOPOROSIS INT, V23, P1, DOI 10.1007/s00198-011-1787-7; Rapuri PB, 2000, AM J CLIN NUTR, V72, P1206; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seo S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007914; Tucker KL, 2009, AM J CLIN NUTR, V89, P1188, DOI 10.3945/ajcn.2008.26765; Ulhoi MP, 2017, J FORENSIC SCI, V62, P131, DOI 10.1111/1556-4029.13256; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wosje KS, 2007, OSTEOPOROSIS INT, V18, P391, DOI 10.1007/s00198-006-0249-0	27	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180132	10.1371/journal.pone.0180132	http://dx.doi.org/10.1371/journal.pone.0180132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662191	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300110
J	Matusu, R; Senol, B; Pekar, L				Matusu, Radek; Senol, Bilal; Pekar, Libor			Robust stability of fractional order polynomials with complicated uncertainty structure	PLOS ONE			English	Article							CONTROLLER-DESIGN; SYSTEMS; STABILIZATION; BOUNDS	The main aim of this article is to present a graphical approach to robust stability analysis for families of fractional order (quasi-) polynomials with complicated uncertainty structure. More specifically, the work emphasizes the multilinear, polynomial and general structures of uncertainty and, moreover, the retarded quasi-polynomials with parametric uncertainty are studied. Since the families with these complex uncertainty structures suffer from the lack of analytical tools, their robust stability is investigated by numerical calculation and depiction of the value sets and subsequent application of the zero exclusion condition.	[Matusu, Radek] Tomas Bata Univ Zlin, Fac Appl Informat, Ctr Secur Informat & Adv Technol CEBIA Tech, Zlin, Czech Republic; [Senol, Bilal] Inonu Univ, Dept Comp Engn, Fac Engn, Malatya, Turkey; [Pekar, Libor] Tomas Bata Univ Zlin, Fac Appl Informat, Dept Automat & Control Engn, Zlin, Czech Republic	Tomas Bata University Zlin; Inonu University; Tomas Bata University Zlin	Matusu, R (corresponding author), Tomas Bata Univ Zlin, Fac Appl Informat, Ctr Secur Informat & Adv Technol CEBIA Tech, Zlin, Czech Republic.	rmatusu@fai.utb.cz	SENOL, Bilal/Y-5328-2018; Pekar, Libor/H-6373-2012; Matušů, Radek/H-6355-2012	SENOL, Bilal/0000-0002-3734-8807; Pekar, Libor/0000-0002-2401-5886; 	European Regional Development Fund under the project CEBIA-Tech Instrumentation [CZ.1.05/ 2.1.00/19.0376]; Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme [LO1303, MSMT-7778/2014]	European Regional Development Fund under the project CEBIA-Tech Instrumentation; Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme	This work was supported by the European Regional Development Fund under the project CEBIA-Tech Instrumentation No. CZ.1.05/ 2.1.00/19.0376 and by the Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme project No. LO1303 (MSMT-7778/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson K, 2005, MECH TIME-DEPEND MAT, V9, P15, DOI 10.1007/s11043-005-3442-1; Ahmed BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166150; Ahn HS, 2007, APPL MATH COMPUT, V187, P27, DOI 10.1016/j.amc.2006.08.099; Ahn HS, 2008, AUTOMATICA, V44, P2985, DOI 10.1016/j.automatica.2008.07.003; [Anonymous], 2004, UNSOLVED PROBLEMS MA; [Anonymous], 1974, MATH SCI ENG; [Anonymous], IEEE INT C EM TECHN; Atangana A, 2016, CHAOS SOLITON FRACT, V89, P447, DOI 10.1016/j.chaos.2016.02.012; Barmish BR, 1994, NEW TOOLS ROBUSTNESS; Bhattacharyya SP, 2009, AUTOM CONTROL ENG SE, V33, pXVII; Bhattacharyya SP., 1995, ROBUST CONTROL PARAM; Chang XH, 2016, APPL MATH COMPUT, V291, P213, DOI 10.1016/j.amc.2016.07.001; Chen Y, 2009, P 2009 AM CONTR C ST; Chen Y., 2005, P IEEE INT C MECH AU; Das S, 2012, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-642-23117-9; Delavari H, 2013, ASIAN J CONTROL, V15, P783, DOI 10.1002/asjc.677; Dorcak L, 2007, ACTA MONTAN SLOVACA, V12, P231; Doyle JC, 1992, FEEDBACK CONTROL THE; Dzielinski A, 2010, B POL ACAD SCI-TECH, V58, P583, DOI 10.2478/v10175-010-0059-6; Gu K., 2003, STABILITY TIME DELAY; Gutierrez RE, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/375858; Heymans N, 2008, J VIB CONTROL, V14, P1587, DOI 10.1177/1077546307087428; Hilfer R., 2000, APPL FRACTIONAL CALC; Jiao Z, 2012, COMPUT MATH APPL, V64, P3258, DOI 10.1016/j.camwa.2012.03.011; Kasnakoglu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165017; Krishna BT, 2008, ACT PASSIV ELECTRON, V2008, DOI 10.1155/2008/369421; Li CG, 2004, CHAOS SOLITON FRACT, V22, P549, DOI 10.1016/j.chaos.2004.02.035; Li C, 2012, J FRANKLIN I, V349, P2406, DOI 10.1016/j.jfranklin.2012.05.006; Liao Z, 2011, J FRANKLIN I, V348, P1101, DOI 10.1016/j.jfranklin.2011.04.012; Lima MFM, 2007, J ADV COMPUT INTELL, V11, P1079, DOI 10.20965/jaciii.2007.p1079; Liu S, 2016, APPL MATH LETT, V51, P13, DOI 10.1016/j.aml.2015.06.018; Lu JG, 2013, FRACT CALC APPL ANAL, V16, P142, DOI 10.2478/s13540-013-0010-2; Lu JG, 2010, IEEE T AUTOMAT CONTR, V55, P152, DOI 10.1109/TAC.2009.2033738; Lu JG, 2009, IEEE T AUTOMAT CONTR, V54, P1294, DOI 10.1109/TAC.2009.2013056; Lu JG, 2013, J FRANKLIN I, V350, P3365, DOI 10.1016/j.jfranklin.2013.07.014; Luo Y, 2012, AUTOMATICA, V48, P2159, DOI 10.1016/j.automatica.2012.05.072; Ma YD, 2014, FRACT CALC APPL ANAL, V17, P136, DOI 10.2478/s13540-014-0159-3; Machado JT, 2011, COMMUN NONLINEAR SCI, V16, P1140, DOI 10.1016/j.cnsns.2010.05.027; Magin RL, 2008, J VIB CONTROL, V14, P1431, DOI 10.1177/1077546307087439; Magin R.-L., 2006, FRACTIONAL CALCULUS; Magin RL, 2012, P 13 INT CARP CONTR; Matuat R, 2015, MATH PROBLEMS ENG; Matusu Radek, 2016, International Journal of Circuits, Systems and Signal Processing, V10, P326; Matusu R, 2017, APPL THERMAL E UNPUB; Matusu R, 2011, T I MEAS CONTROL, V33, P274, DOI 10.1177/0142331210361409; Matuu R., 2013, INT J CIRCUITS SYSTE, V7, P26; Miller K.S., 1993, INTRO FRACTIONAL CAL; Moornani KA, 2010, IET CONTROL THEORY A, V4, P2097, DOI 10.1049/iet-cta.2009.0485; Ostalczyk P, 2009, IFAC P VOLUMES, V42, P268; Perdikaris P, 2014, ANN BIOMED ENG, V42, P1012, DOI 10.1007/s10439-014-0970-3; Petras I., 2009, FRACT CALC APPL ANAL, V12, P269; Petras I, 2002, P INT CARP CONTR C M; Petras I, 2005, P INT C COMP CYB VIE; Podlubny I, 1999, IEEE T AUTOMAT CONTR, V44, P208, DOI 10.1109/9.739144; Podlubny I., 1999, FRACTIONAL DIFFERENT; Radwan AG, 2014, J ADV RES, V5, P125, DOI 10.1016/j.jare.2013.01.003; Sabatier J., 2007, ADV FRACTIONAL CALCU; Senol B, 2012, P 5 IFAC WORKSH FRAC; Senol B., 2012, P 2012 IEEE INT C CO; Senol B, 2014, ISA T, V53, P189, DOI 10.1016/j.isatra.2013.09.004; Senol B, 2013, J FRANKLIN I, V350, P1908, DOI 10.1016/j.jfranklin.2013.05.010; Sheng H, 2012, FRACTIONAL PROCESSES AND FRACTIONAL-ORDER SIGNAL PROCESSING: TECHNIQUES AND APPLICATIONS, P1, DOI 10.1007/978-1-4471-2233-3; Silva MF, 2004, NONLINEAR DYNAM, V38, P417, DOI 10.1007/s11071-004-3770-8; Skogestad S., 2005, MULTIVARIABLE FEEDBA; Tan N, 2009, ISA T, V48, P166, DOI 10.1016/j.isatra.2009.01.002; Yeroglu C, 2013, SYST CONTROL LETT, V62, P845, DOI 10.1016/j.sysconle.2013.06.005; Yeroglu C, 2011, ISA T, V50, P461, DOI 10.1016/j.isatra.2011.03.004; Yeroglu C, 2010, INT J CONTROL AUTOM, V8, P1009, DOI 10.1007/s12555-010-0510-3; Yin C, 2015, APPL MATH COMPUT, V269, P351, DOI 10.1016/j.amc.2015.07.059; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066	70	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180274	10.1371/journal.pone.0180274	http://dx.doi.org/10.1371/journal.pone.0180274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662173	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300136
J	Case, A; Brisson, BK; Durham, AC; Rosen, S; Monslow, J; Buza, E; Salah, P; Gillem, J; Ruthel, G; Veluvolu, S; Kristiansen, V; Pure, E; Brown, DC; Sorenmo, KU; Volk, SW				Case, Ashley; Brisson, Becky K.; Durham, Amy C.; Rosen, Suzanne; Monslow, James; Buza, Elizabeth; Salah, Pascale; Gillem, Julie; Ruthel, Gordon; Veluvolu, Sridhar; Kristiansen, Veronica; Pure, Ellen; Brown, Dorothy C.; Sorenmo, Karin U.; Volk, Susan W.			Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma	PLOS ONE			English	Article							INCIDENCE RATES; IN-SITU; DOGS; TUMORS; POPULATION; EXPRESSION; PROGRESSION; PARAMETERS; NEOPLASMS; SURVIVAL	Increasing evidence indicates that the tumor microenvironment plays a critical role in regulating the biologic behavior of breast cancer. In veterinary oncology, there is a need for improved prognostic markers to accurately identify dogs at risk for local and distant (metastatic) recurrence of mammary gland carcinoma and therefore would benefit from adjuvant therapy. Collagen density and fiber organization have been shown to regulate tumor progression in both mouse and human mammary tumors, with certain collagen signatures predicting poor outcomes in women with breast cancer. We hypothesized that collagen signatures in canine mammary tumor biopsies can serve as prognostic biomarkers and potential targets for treatment. We used second harmonic generation imaging to evaluate fibrillar collagen density, the presence of a tumor-stromal boundary, tumor associated collagen signatures (TACS) and individual collagen fiber characteristics (width, length and straightness) in grade I/II and grade III canine mammary tumors. Collagen density, as well as fiber width, length and straightness, were inversely correlated with patient overall survival time. Notably, grade III cases were less likely to have a tumor-stromal boundary and the lack of a boundary predicted poor outcome. Importantly, a lack of a defined tumor-stromal boundary and an increased collagen fiber width were associated with decreased survival even when tumor grade, patient stage, ovariohysterectomy status at the time of mammary tumor excision, and histologic evidence of lymphovascular invasion were considered in a multivariable model, indicating that these parameters could augment current methods to identify patients at high risk for local or metastatic progression/recurrence. Furthermore, these data, which identify for the first time, prognostic collagen biomarkers in naturally occurring mammary gland neoplasia in the dog, support the use of the dog as a translational model for tumor-stromal interactions in breast cancer.	[Case, Ashley; Brisson, Becky K.; Rosen, Suzanne; Salah, Pascale; Gillem, Julie; Veluvolu, Sridhar; Brown, Dorothy C.; Volk, Susan W.] Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA; [Durham, Amy C.; Buza, Elizabeth; Ruthel, Gordon] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Monslow, James; Pure, Ellen; Sorenmo, Karin U.; Volk, Susan W.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Kristiansen, Veronica] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci Vet Med & Biosci, Oslo, Norway	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Norwegian University of Life Sciences	Volk, SW (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA.; Sorenmo, KU; Volk, SW (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA.	karins@vetupenn.edu; strevolk@vet.upenn.edu		Ruthel, Gordon/0000-0001-9193-5589	Greatergood org; Petco Foundation; Blue Buffalo Foundation; National Institutes of Health [510RR027128, 1S100D021633]; Morris Animal Foundation; University of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER	Greatergood org; Petco Foundation; Blue Buffalo Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morris Animal Foundation; University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from Greatergood org (to KS and SWV), the Petco Foundation, the Blue Buffalo Foundation (to KS) and a kind gift from the Jack and Mina Ebrahimi Foundation (to SWV). National Institutes of Health grants 510RR027128 and 1S100D021633 provided funding for instrumentation in the Penn Vet Imaging Core facility. Mammary tumor samples and clinical outcome data for dogs treated at the Norwegian University of Life Sciences were in part sponsored by funds from the Morris Animal Foundation (morrisanimalfoundation.org), while funds for the University of Pennsylvania cases enrolled in the prospective study were provided to the Penn Vet Shelter Canine Mammary Tumor Program (to KS).	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; American Cancer Society, 2011, GLOB CANC FACTS FIG; Benjamin SA, 1999, VET PATHOL, V36, P423, DOI 10.1354/vp.36-5-423; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Bredfeldt Jeremy S, 2014, J Pathol Inform, V5, P28, DOI 10.4103/2153-3539.139707; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Brisson BK, 2015, AM J PATHOL, V185, P1471, DOI 10.1016/j.ajpath.2015.01.029; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; Burke K, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031106; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Drifka CR, 2015, MODERN PATHOL, V28, P1470, DOI 10.1038/modpathol.2015.97; Egenvall A, 2005, PREV VET MED, V69, P109, DOI 10.1016/j.prevetmed.2005.01.014; Elston C W, 2002, Histopathology, V41, P154; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Hanley CJ, 2016, ONCOTARGET, V7, P6159, DOI 10.18632/oncotarget.6740; Heller DA, 2005, VET PATHOL, V42, P776, DOI 10.1354/vp.42-6-776; Kahn LH, 2008, AM J MED, V121, P169, DOI 10.1016/j.amjmed.2007.09.023; Kakkad Samata M, 2012, J Biomed Opt, V17, P116017, DOI 10.1117/1.JBO.17.11.116017; Karayannopoulou M, 2005, J COMP PATHOL, V133, P246, DOI 10.1016/j.jcpa.2005.05.003; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kristiansen VM, 2016, J VET INTERN MED, V30, P230, DOI 10.1111/jvim.13812; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lo A, 2015, CANCER RES, V75, P2800, DOI 10.1158/0008-5472.CAN-14-3041; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Maller O, 2013, J CELL SCI; Marshall EM, 2016, BREAST J; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Misdorp W, 2002, VET QUART, V24, P1; Moe L, 2001, J REP FER S, P439; Munson Linda, 2007, Breast Dis, V28, P7; Pena L, 2013, VET PATHOL, V50, P94, DOI 10.1177/0300985812447830; Pointer KB, 2016, J NEUROSURG, P1; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Rasotto R, 2012, VET PATHOL, V49, P330, DOI 10.1177/0300985811409253; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Rutteman G, 2001, SMALL ANIMAL CLIN ON; Santos M, 2015, ANTICANCER RES, V35, P4219; Santos M, 2014, VET J, V200, P426, DOI 10.1016/j.tvjl.2014.03.019; Sapudom J, 2015, BIOMATERIALS, V52, P367, DOI 10.1016/j.biomaterials.2015.02.022; SCHNEIDER R, 1970, CANCER-AM CANCER SOC, V26, P419, DOI 10.1002/1097-0142(197008)26:2&lt;419::AID-CNCR2820260225&gt;3.0.CO;2-U; Sorenmo KU, 2011, VET PATHOL, V48, P85, DOI 10.1177/0300985810389480; Sorenmo KU, 2009, VET COMP ONCOL, V7, P162, DOI 10.1111/j.1476-5829.2009.00184.x; Takai K, 2016, ONCOTARGET; Tchou J, 2013, HUM PATHOL, V44, P2549, DOI 10.1016/j.humpath.2013.06.016; Tran CM, 2016, VET COMP ONCOL, V14, P252, DOI 10.1111/vco.12092; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Xiong GF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-1; Yoshimura H, 2011, VET PATHOL, V48, P313, DOI 10.1177/0300985810369901; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743	55	26	26	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180448	10.1371/journal.pone.0180448	http://dx.doi.org/10.1371/journal.pone.0180448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683102	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200037
J	Han, BF; Zhang, S; Zeng, FR; Mao, JJ				Han, Benfeng; Zhang, Shen; Zeng, Fanrong; Mao, Jianjun			Nutritional and reproductive signaling revealed by comparative gene expression analysis in Chrysopa pallens (Rambur) at different nutritional statuses	PLOS ONE			English	Article							INSULIN-LIKE PEPTIDES; MOLECULAR CHARACTERIZATION; LIFE-SPAN; FOXO; VITELLOGENIN; MOSQUITO; NEUROPTERA; GROWTH; DOWNSTREAM; METABOLISM	Background The green lacewing, Chrysopa pallens Rambur, is one of the most important natural predators because of its extensive spectrum of prey and wide distribution. However, what we know about the nutritional and reproductive physiology of this species is very scarce. Results By cDNA amplification and Illumina short-read sequencing, we analyzed transcriptomes of C. pallens female adult under starved and fed conditions. In total, 71236 unigenes were obtained with an average length of 833 bp. Four vitellogenins, three insulin-like peptides and two insulin receptors were annotated. Comparison of gene expression profiles suggested that totally 1501 genes were differentially expressed between the two nutritional statuses. KEGG orthology classification showed that these differentially expression genes (DEGs) were mapped to 241 pathways. In turn, the top 4 are ribosome, protein processing in endoplasmic reticulum, biosynthesis of amino acids and carbon metabolism, indicating a distinct difference in nutritional and reproductive signaling between the two feeding conditions. Conclusions Our study yielded large-scale molecular information relevant to C. pallens nutritional and reproductive signaling, which will contribute to mass rearing and commercial use of this predaceous insect species.	[Han, Benfeng; Zhang, Shen; Zeng, Fanrong; Mao, Jianjun] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Biol Plant Dis & Insect Pests, Minist Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Mao, JJ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Biol Plant Dis & Insect Pests, Minist Agr, Beijing, Peoples R China.	maojianjun0615@126.com			National Basic Research Program of China [2013CB127602]; NSFC [31201570]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was sponsored by National Basic Research Program of China (973Program) (2013CB127602) and NSFC (31201570).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Brooks S.J., 1990, Bulletin of the British Museum (Natural History) Entomology, V59, P117; Brooks SJ, 1997, DEUT ENTOMOL Z, V44, P267, DOI 10.1002/mmnd.19970440212; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Krieger MJB, 2004, INSECT MOL BIOL, V13, P305, DOI 10.1111/j.0962-1075.2004.00489.x; Li ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067151; Liu C, 2015, J ECON ENTOMOL, V108, P2779, DOI 10.1093/jee/tov229; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masumura M, 2000, GEN COMP ENDOCR, V118, P393, DOI 10.1006/gcen.1999.7438; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Sheng ZT, 2011, J BIOL CHEM, V286, P41924, DOI 10.1074/jbc.M111.269845; Shu YH, 2009, J INSECT PHYSIOL, V55, P608, DOI 10.1016/j.jinsphys.2009.03.005; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Suren-Castillo S, 2012, INSECT BIOCHEM MOLEC, V42, P491, DOI 10.1016/j.ibmb.2012.03.006; Tauber Maurice J., 2000, American Entomologist, V46, P26; Tufail M, 2014, ENTOMOLOLY SCI, V17, P69; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Winterton S, 2006, AUST J ENTOMOL, V45, P235, DOI 10.1111/j.1440-6055.2006.00537.x; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Xu HJ, 2015, NATURE, V519, P464, DOI 10.1038/nature14286; Zhang TT, 2017, B ENTOMOL RES, V107, P148, DOI 10.1017/S0007485316000742; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; Zou D, 2013, PLOS ONE, V4	42	5	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180373	10.1371/journal.pone.0180373	http://dx.doi.org/10.1371/journal.pone.0180373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683101	Green Submitted, Green Published, gold			2022-12-27	WOS:000405335200028
J	Kong, ZH; Zou, Y; Liu, T				Kong, Zehui; Zou, Yuan; Liu, Teng			Implementation of real-time energy management strategy based on reinforcement learning for hybrid electric vehicles and simulation validation	PLOS ONE			English	Article							POWER MANAGEMENT; SYSTEM	To further improve the fuel economy of series hybrid electric tracked vehicles, a reinforcement learning (RL)-based real-time energy management strategy is developed in this paper. In order to utilize the statistical characteristics of online driving schedule effectively, a recursive algorithm for the transition probability matrix (TPM) of power-request is derived. The reinforcement learning (RL) is applied to calculate and update the control policy at regular time, adapting to the varying driving conditions. A facing-forward powertrain model is built in detail, including the engine-generator model, battery model and vehicle dynamical model. The robustness and adaptability of real-time energy management strategy are validated through the comparison with the stationary control strategy based on initial transition probability matrix (TPM) generated from a long naturalistic driving cycle in the simulation. Results indicate that proposed method has better fuel economy than stationary one and is more effective in real-time control.	[Kong, Zehui; Zou, Yuan; Liu, Teng] Inst Technol, Sch Mech Engn, Natl Engn Lab Elect Vehicles, Beijing, Peoples R China		Zou, Y (corresponding author), Inst Technol, Sch Mech Engn, Natl Engn Lab Elect Vehicles, Beijing, Peoples R China.	zouyuan@bit.edu.cn			National Nature Science Foundation of China [51375044]; University Talent Introduction 111 Project [B12022]; Defense Basic Research Project [B20132010]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Talent Introduction 111 Project; Defense Basic Research Project	This work was supported by the National Nature Science Foundation of China (Grant 51375044), University Talent Introduction 111 Project (B12022), and Defense Basic Research Project (B20132010).	Barillas JK, 2015, APPL ENERG, V155, P455, DOI 10.1016/j.apenergy.2015.05.102; Bassam AM, 2016, INT J HYDROGEN ENERG, V41, P22453, DOI 10.1016/j.ijhydene.2016.08.049; Castaings A, 2016, APPL ENERG, V163, P190, DOI 10.1016/j.apenergy.2015.11.020; Delprat S, 2004, IEEE T VEH TECHNOL, V53, P872, DOI 10.1109/TVT.2004.827161; Feng TH, 2015, IEEE T VEH TECHNOL, V64, P1691, DOI 10.1109/TVT.2014.2336378; Filev DP, 2014, IEEE T FUZZY SYST, V22, P983, DOI 10.1109/TFUZZ.2013.2279535; Hemi H, 2014, IEEE EL POW EN C EPE, P1; Hou C, 2014, APPL ENERG, V115, P174, DOI 10.1016/j.apenergy.2013.11.002; Hu XS, 2017, MECH SYST SIGNAL PR, V87, P4, DOI 10.1016/j.ymssp.2016.03.004; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Hu XS, 2016, IEEE T CONTR SYST T, V24, P1036, DOI 10.1109/TCST.2015.2476799; Hu XS, 2015, IEEE T IND ELECTRON, V62, P7847, DOI 10.1109/TIE.2015.2463770; Jalil N, 1997, P AMER CONTR CONF, P689, DOI 10.1109/ACC.1997.611889; Li L, 2016, IEEE T VEH TECHNOL, V65, P4459, DOI 10.1109/TVT.2015.2496975; Lin CC, 2003, IEEE T CONTR SYST T, V11, P839, DOI 10.1109/TCST.2003.815606; Lin X, 2014, ICCAD-IEEE ACM INT, P32; Liu C, 2014, INTERNATIONAL CONFERENCE ON ELECTRONIC AND ELECTRICAL ENGINEERING (CEEE 2014), P1; Liu T, 2015, IEEE T IND ELECTRON, V62, P7837, DOI 10.1109/TIE.2015.2475419; Martinez JS, 2012, INFORM SCIENCES, V190, P192, DOI 10.1016/j.ins.2011.12.013; Panday A., 2014, INT J VEHIC TECH, V2014, P1, DOI [10.1155/2014/160510, DOI 10.1155/2014/160510]; Plett GL, 2004, J POWER SOURCES, V134, P262, DOI 10.1016/j.jpowsour.2004.02.032; Qi XW, 2015, IEEE INT C INTELL TR, P1002, DOI 10.1109/ITSC.2015.167; Ryan MJ, 2002, IEEE IND APPL SOC, V4, P2376; Trovao JP, 2013, APPL ENERG, V105, P304, DOI 10.1016/j.apenergy.2012.12.081; Wang Y, 2012, P AMER CONTR CONF, P553; Xiang C. L., 2017, SCI CHINA TECHNOL SC, P1; Yin H, 2016, IEEE T IND ELECTRON, V63, P4266, DOI 10.1109/TIE.2016.2539245; Yuedong Fang, 2015, 2015 27th Chinese Control and Decision Conference (CCDC), P4973, DOI 10.1109/CCDC.2015.7162814; Zeng XR, 2015, IEEE T CONTR SYST T, V23, P2416, DOI 10.1109/TCST.2015.2409235; Zhang P, 2015, RENEW SUST ENERG REV, V48, P88, DOI 10.1016/j.rser.2015.03.093	30	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180491	10.1371/journal.pone.0180491	http://dx.doi.org/10.1371/journal.pone.0180491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671967	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500057
J	Lee, HU; Blasiak, A; Agrawal, DR; Loong, DTB; Thakor, NV; All, AH; Ho, JS; Yang, IH				Lee, Hae Ung; Blasiak, Agata; Agrawal, Devansh R.; Loong, Daniel Teh Boon; Thakor, Nitish V.; All, Angelo H.; Ho, John S.; Yang, In Hong			Subcellular electrical stimulation of neurons enhances the myelination of axons by oligodendrocytes	PLOS ONE			English	Article							DIRECTIONAL MIGRATION; IN-VIVO; DIFFERENTIATION; PRECURSORS; PLATFORM; SYSTEM; CELLS	Myelin formation has been identified as a modulator of neural plasticity. New tools are required to investigate the mechanisms by which environmental inputs and neural activity regulate myelination patterns. In this study, we demonstrate a microfluidic compartmentalized culture system with integrated electrical stimulation capabilities that can induce neural activity by whole cell and focal stimulation. A set of electric field simulations was performed to confirm spatial restriction of the electrical input in the compartmentalized culture system. We further demonstrate that electrode localization is a key consideration for generating uniform the stimulation of neuron and oligodendrocytes within the compartments. Using three configurations of the electrodes we tested the effects of subcellular activation of neural activity on distal axon myelination with oligodendrocytes. We further investigated if oligodendrocytes have to be exposed to the electrical field to induce axon myelination. An isolated stimulation of cell bodies and proximal axons had the same effect as an isolated stimulation of distal axons co-cultured with oligodendrocytes, and the two modes had a non-different result than whole cell stimulation. Our platform enabled the demonstration that electrical stimulation enhances oligodendrocyte maturation and myelin formation independent of the input localization and oligodendrocyte exposure to the electrical field.	[Lee, Hae Ung; Blasiak, Agata; Agrawal, Devansh R.; Loong, Daniel Teh Boon; Thakor, Nitish V.; All, Angelo H.; Ho, John S.; Yang, In Hong] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore; [Thakor, Nitish V.; All, Angelo H.; Yang, In Hong] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [All, Angelo H.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Ho, John S.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore	National University of Singapore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; National University of Singapore	Yang, IH (corresponding author), Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore.; Yang, IH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	iyang3@jhmi.edu	Thakor, Nitish V/A-5878-2008; Loong, Daniel Teh Boon/AAF-6660-2019	Loong, Daniel Teh Boon/0000-0002-4560-8568; Agrawal, Devansh/0000-0002-0236-9077; Ho, John/0000-0002-9458-9033; Blasiak, Agata/0000-0003-0727-7611; Yang, In Hong/0000-0002-1020-0538	Singapore Institute for Neurotechnology Seed Fund [R-175-000-121-733]	Singapore Institute for Neurotechnology Seed Fund	All authors and consumables were funded by R-175-000-121-733 Singapore Institute for Neurotechnology Seed Fund.	All AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047645; [Anonymous], 1956, J RES NBS, V56; [Anonymous], 1992, PRACTICAL ELECTROPHY, P67; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Biasiak A, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00298; Chang KJ, 2016, NAT NEUROSCI, V19, P190, DOI 10.1038/nn.4200; Charvet G, 2010, IEEE ENG MED BIO, P1804, DOI 10.1109/IEMBS.2010.5626403; de Hoz L, 2015, BIOESSAYS, V37, P60, DOI 10.1002/bies.201400127; FITZGERALD M, 1987, NATURE, V326, P603, DOI 10.1038/326603a0; Fumagalli M, 2011, J BIOL CHEM, V286, P10593, DOI 10.1074/jbc.M110.162867; Gadani DH, 2012, INDIAN J PURE AP PHY, V50, P405; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kerman BE, 2015, DEVELOPMENT, V142, P2213, DOI 10.1242/dev.116517; Lee HU, 2016, ACS CHEM NEUROSCI, V7, P1317, DOI 10.1021/acschemneuro.6b00157; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Li Q, 2010, NEUROSCI LETT, V479, P128, DOI 10.1016/j.neulet.2010.05.043; Li YC, 2015, AM J PHYSIOL-CELL PH, V309, pC532, DOI 10.1152/ajpcell.00175.2015; Li YC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0042-0; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Malone M, 2013, GLIA, V61, P843, DOI 10.1002/glia.22476; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Park HS, 2013, IEEE ENG MED BIO, P2833, DOI 10.1109/EMBC.2013.6610130; Park J, 2009, BIOMED MICRODEVICES, V11, P1145, DOI 10.1007/s10544-009-9331-7; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Walczak P, 2011, GLIA, V59, P499, DOI 10.1002/glia.21119; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Yang IH, 2012, NEUROMOL MED, V14, P112, DOI 10.1007/s12017-012-8170-5; Yang IH, 2009, EXP NEUROL, V218, P124, DOI 10.1016/j.expneurol.2009.04.017; 1999, POLYM DATA HDB	35	24	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179642	10.1371/journal.pone.0179642	http://dx.doi.org/10.1371/journal.pone.0179642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671962	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500004
J	Longato, E; Garrido, M; Saccardo, D; Guevara, CM; Mani, AR; Bolognesi, M; Amodio, P; Facchinetti, A; Sparacino, G; Montagnese, S				Longato, Enrico; Garrido, Maria; Saccardo, Desy; Guevara, Camila Montesinos; Mani, Ali R.; Bolognesi, Massimo; Amodio, Piero; Facchinetti, Andrea; Sparacino, Giovanni; Montagnese, Sara			Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin	PLOS ONE			English	Article							BODY-TEMPERATURE; SURFACE-TEMPERATURE; CONTACT THERMOMETRY; CIRCADIAN-RHYTHMS; SLEEP; CALORIMETRY; MELATONIN; FORMULAS; SYSTEM; ONSET	A popular method to estimate proximal/distal temperature (T-PROX and T-DIST) consists in calculating a weighted average of nine wireless sensors placed on pre-defined skin locations. Specifically, T-PROX is derived from five sensors placed on the infra-clavicular and mid-thigh area (left and right) and abdomen, and T-DIST from four sensors located on the hands and feet. In clinical practice, the loss/removal of one or more sensors is a common occurrence, but limited information is available on how this affects the accuracy of temperature estimates. The aim of this study was to determine the accuracy of temperature estimates in relation to number/position of sensors removed. Thirteen healthy subjects wore all nine sensors for 24 hours and reference T-PROX and T-DIST time-courses were calculated using all sensors. Then, all possible combinations of reduced subsets of sensors were simulated and suitable weights for each sensor calculated. The accuracy of T-PROX and T-DIST estimates resulting from the reduced subsets of sensors, compared to reference values, was assessed by the mean squared error, the mean absolute error (MAE), the cross-validation error and the 25 th and 75 th percentiles of the reconstruction error. Tables of the accuracy and sensor weights for all possible combinations of sensors are provided. For instance, in relation to T-PROX, a subset of three sensors placed in any combination of three non-homologous areas (abdominal, right or left infra-clavicular, right or left mid-thigh) produced an error of 0.13 degrees C MAE, while the loss/removal of the abdominal sensor resulted in an error of 0.25 degrees C MAE, with the greater impact on the quality of the reconstruction. This information may help researchers/clinicians: i) evaluate the expected goodness of their T-PROX and T-DIST estimates based on the number of available sensors; ii) select the most appropriate subset of sensors, depending on goals and operational constraints.	[Longato, Enrico; Facchinetti, Andrea; Sparacino, Giovanni] Univ Padua, Dept Informat Engn, Padua, Italy; [Garrido, Maria; Saccardo, Desy; Guevara, Camila Montesinos; Bolognesi, Massimo; Amodio, Piero; Montagnese, Sara] Univ Padua, Dept Med, Padua, Italy; [Guevara, Camila Montesinos; Mani, Ali R.] UCL, Div Med, London, England	University of Padua; University of Padua; University of London; University College London	Montagnese, S (corresponding author), Univ Padua, Dept Med, Padua, Italy.	sara.montagnese@unipd.it	Garrido, Maria/AAG-7793-2020; Mani, Alireza/H-3236-2015; BOLOGNESI, MASSIMO/G-4742-2012	Garrido, Maria/0000-0002-6987-1950; Mani, Alireza/0000-0003-0830-2022; Simancas-Racines, Daniel/0000-0002-3641-1501; Amodio, Piero/0000-0002-2395-7599; BOLOGNESI, MASSIMO/0000-0002-9715-5572; Longato, Enrico/0000-0001-5940-645X; Montesinos-Guevara, Camila/0000-0001-6763-3644	Italian Ministry of Health [2009-1604309]; Gobierno de Extremadura [European Regional Development Fund (ERDF)] [P014013]	Italian Ministry of Health(Ministry of Health, Italy); Gobierno de Extremadura [European Regional Development Fund (ERDF)]	The work was partly funded by a grant from The Italian Ministry of Health to S.M. (Giovani Ricercatori 2009-1604309); M.G. holds a research post-doctoral fellowship from Gobierno de Extremadura [jointly financed by the European Regional Development Fund (ERDF); ref. P014013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach AJE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117907; Batinga H, 2015, AGE, V37, DOI 10.1007/s11357-015-9768-y; Buono MJ, 2007, PHYSIOL MEAS, V28, P855, DOI 10.1088/0967-3334/28/8/008; Burton AC, 1935, J NUTR, V9, P261, DOI 10.1093/jn/9.3.261; Choi JK, 1997, INT J BIOMETEOROL, V41, P68, DOI 10.1007/s004840050056; CRAWSHAW LI, 1975, PFLUG ARCH EUR J PHY, V354, P19, DOI 10.1007/BF00584500; Gagge A.P., 2010, COMPREHENSIVE PHYSL, P69, DOI DOI 10.1002/CPHY.CP090105; Hardy JD, 1938, J NUTR, V15, P461, DOI 10.1093/jn/15.5.461; Hasselberg MJ, 2013, SLEEP MED, V14, P5, DOI 10.1016/j.sleep.2010.12.011; Jones H, 2014, CHRONOBIOL INT, V31, P157, DOI 10.3109/07420528.2013.833516; Jutte LS, 2001, ARCH PHYS MED REHAB, V82, P845, DOI 10.1053/apmr.2001.23195; Krauchi K, 1997, AM J PHYSIOL-REG I, V272, pR1178, DOI 10.1152/ajpregu.1997.272.4.R1178; Krauchi K, 1999, NATURE, V401, P36, DOI 10.1038/43366; Krauchi K, 1999, SLEEP, V22, pS285; Antunez JM, 2016, CHRONOBIOL INT, V33, P1410, DOI 10.1080/07420528.2016.1223092; Martinez-Nicolas A, 2015, PHYSIOL BEHAV, V149, P203, DOI 10.1016/j.physbeh.2015.06.014; MITCHELL D, 1969, J APPL PHYSIOL, V26, P616, DOI 10.1152/jappl.1969.26.5.616; NADEL ER, 1973, PFLUG ARCH EUR J PHY, V340, P71, DOI 10.1007/BF00592198; Ortiz-Tudela E, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2319-9; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Raymann RJEM, 2005, AM J PHYSIOL-REG I, V288, pR1589, DOI 10.1152/ajpregu.00492.2004; Rutkove SB, 2007, PHYSIOL MEAS, V28, P1421, DOI 10.1088/0967-3334/28/11/008; Rutrove SB, 2009, DIABETES CARE, V32, P671, DOI 10.2337/dc08-1844; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; TEICHNER WH, 1958, J APPL PHYSIOL, V12, P169, DOI 10.1152/jappl.1958.12.2.169; Tyler CJ, 2011, PHYSIOL MEAS, V32, P1541, DOI 10.1088/0967-3334/32/10/003; van den Heuvel CJ, 2003, PHYSIOL MEAS, V24, P717, DOI 10.1088/0967-3334/24/3/308; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Winslow CEA, 1936, AM J PHYSIOL, V116, P641; Zornoza-Moreno M, 2011, CHRONOBIOL INT, V28, P330, DOI 10.3109/07420528.2011.565895	30	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180315	10.1371/journal.pone.0180315	http://dx.doi.org/10.1371/journal.pone.0180315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666029	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608700084
J	Lee, JC; Chuang, KS; Chen, YW; Hsu, FY; Chou, FI; Yen, SH; Wu, YH				Lee, Jia-Cheng; Chuang, Keh-Shih; Chen, Yi-Wei; Hsu, Fang-Yuh; Chou, Fong-In; Yen, Sang-Hue; Wu, Yuan-Hung			Preliminary dosimetric study on feasibility of multi-beam boron neutron capture therapy in patients with diffuse intrinsic pontine glioma without craniotomy	PLOS ONE			English	Article							BNCT; BEAM; THOR; RADIATION; CHILDREN; TRIAL	Diffuse intrinsic pontine glioma is a very frustrating disease. Since the tumor infiltrates the brain stem, surgical removal is often impossible. For conventional radiotherapy, the dose constraint of the brain stem impedes attempts at further dose escalation. Boron neutron capture therapy (BNCT), a targeted radiotherapy, carries the potential to selectively irradiate tumors with an adequate dose while sparing adjacent normal tissue. In this study, 12 consecutive patients treated with conventional radiotherapy in our institute were reviewed to evaluate the feasibility of BNCT. NCTPIan Ver. 1.1.44 was used for dose calculations. Compared with two and three fields, the average maximal dose to the normal brain may be lowered to 7.35 +/- 0.72 Gy-Eq by four-field irradiation. The mean ratio of minimal dose to clinical target volume and maximal dose to normal tissue was 2.41 +/- 0.26 by four-field irradiation. A therapeutic benefit may be expected with multi-field boron neutron capture therapy to treat diffuse intrinsic pontine glioma without craniotomy, while the maximal dose to the normal brain would be minimized by using the four-field setting.	[Lee, Jia-Cheng; Chen, Yi-Wei; Yen, Sang-Hue; Wu, Yuan-Hung] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Lee, Jia-Cheng; Chuang, Keh-Shih] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Chen, Yi-Wei; Wu, Yuan-Hung] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hsu, Fang-Yuh; Chou, Fong-In] Natl Tsing Hua Univ, Nucl Sci & Technol Dev Ctr, Hsinchu, Taiwan; [Wu, Yuan-Hung] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Wu, Yuan-Hung] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan	Taipei Veterans General Hospital; National Tsing Hua University; National Yang Ming Chiao Tung University; National Tsing Hua University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wu, YH (corresponding author), Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan.; Wu, YH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Wu, YH (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Wu, YH (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.	yuanhung@gmail.com	Chen, Yi/HIR-2608-2022	wu, yuanhung/0000-0003-2908-7704	Taipei Veterans General Hospital [V105A-046, V105A-013, V106A-007, V106A-016]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by the Taipei Veterans General Hospital (www.vghtpe.gov,tw) No: V105A-046(JCL), V105A-013(YHW), V106A-007(YHW), V106A-016 (JCL), Taipei Veterans General Hospital-National Yang Ming University Excellent Physician Scientists Cultivation Program (www.vghtpe.gov.tw) No. 105-V-B-107(YHW). The funders had no role in study design, data collection	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aoyama H, 2006, INT J RADIAT ONCOL, V64, P962, DOI 10.1016/j.ijrobp.2005.11.005; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Gonzalez S, 2003, NCTPLAN NEW PC VERSI; Hsu FY, 2009, APPL RADIAT ISOTOPES, V67, pS130, DOI 10.1016/j.apradiso.2009.03.033; ICRU, 1992, PHOT EL PROT NEUTR I; Kawabata S, 2011, APPL RADIAT ISOTOPES, V69, P1796, DOI 10.1016/j.apradiso.2011.03.014; Kiger W III, 2002, VERIFICATION VALIDAT, P613; Liu YH, 2009, APPL RADIAT ISOTOPES, V67, pS137, DOI 10.1016/j.apradiso.2009.03.088; Marcus KJ, 2003, INT J RADIAT ONCOL, V55, P1182, DOI 10.1016/S0360-3016(02)04391-2; Morgan-Fletcher S.L., 2001, BRIT J RADIOL, V74, P294, DOI [10.1259/bjr.74.879.740294, DOI 10.1259/bjr.74.879.740294, DOI 10.1259/BJR.74.879.740294]; Nakagawa Y, 2009, APPL RADIAT ISOTOPES, V67, pS27, DOI 10.1016/j.apradiso.2009.03.090; Pelowitz D.B., 2011, 0LACP1100438 LOS AL; Rasband W., 2006, IMAGEJ; ROGUS RD, 1994, MED PHYS, V21, P1611, DOI 10.1118/1.597267; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenenko VA, 2008, MED PHYS, V35, P5851, DOI 10.1118/1.3013556; Skold K, 2014, BRIT J RADIOLOGY; Tung CJ, 2004, APPL RADIAT ISOTOPES, V61, P861, DOI 10.1016/j.apradiso.2004.05.066; Wang LW, 2016, INT J RADIAT ONCOL, V95, P396, DOI 10.1016/j.ijrobp.2016.02.028; Wang LW, 2014, APPL RADIAT ISOTOPES, V88, P23, DOI 10.1016/j.apradiso.2013.11.134; Zamenhof R., 2001, NEUTRON CAPTURE THER, P216	22	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180461	10.1371/journal.pone.0180461	http://dx.doi.org/10.1371/journal.pone.0180461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662135	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300158
J	Liao, K; Chen, WB; Zhang, RT; Zhou, HB; Xu, JL; Zhou, CX; Yan, XJ				Liao, Kai; Chen, Wenbi; Zhang, Runtao; Zhou, Haibo; Xu, Jilin; Zhou, Chengxu; Yan, Xiaojun			qPCR analysis of bivalve larvae feeding preferences when grazing on mixed microalgal diets	PLOS ONE			English	Article							OYSTER CRASSOSTREA-VIRGINICA; SCALLOP PLACOPECTEN-MAGELLANICUS; PARTICLE SELECTION; RAZOR CLAM; SURFACE-PROPERTIES; GROWTH; SURVIVAL; ABSORPTION; SUSPENSION; SEA	Characterization of the feeding preferences of bivalve larvae would help improving the bivalve aquaculture and hatchery by providing appropriate microalgal diets. However, inaccurate and laborious identification and counting of microalgal species have challenged the selective feeding of bivalves. In the present study, we developed a highly specific and sensitive assay using quantitative polymerase chain reaction (qPCR) to assess the selective feeding of bivalve larvae based on species-specific primers targeting to microalgal 18S rDNA sequences. The assay exhibited good specificity. The detection limits of the qPCR assay were 769, 71, 781 and 21 18S rDNA copies for Chaetoceros calcitrans, Isochrysis galbana, Platymonas helgolandica and Nannochloropsis oculata, respectively. Using such assay, we found that C. calcitrans and I. galbana were preferentially ingested, whereas N. oculata was preferentially rejected in biodeposits of four bivalve species, Tegillarca gransa, Cyclina sinensis, Scapharca subcrenata and Sinonovacula constricta. Furthermore, our growth experiments revealed that C. calcitrans and I. galbana could significantly promote the shell growth, whereas feeding of N. oculata resulted in poorer growth of four bivalve species. These data indicated that qPCR might be useful in screening of efficient and reliable microalgal species for each bivalve species, leading to improved bivalve aquaculture and hatchery.	[Liao, Kai; Zhang, Runtao; Zhou, Haibo; Xu, Jilin] Ningbo Univ, Key Lab Appl Marine Biotechnol, Chinese Minist Educ, Ningbo, Zhejiang, Peoples R China; [Chen, Wenbi; Zhou, Chengxu; Yan, Xiaojun] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Xu, JL (corresponding author), Ningbo Univ, Key Lab Appl Marine Biotechnol, Chinese Minist Educ, Ningbo, Zhejiang, Peoples R China.; Yan, XJ (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China.	xujilin@nbu.edu.cn; yanxiaojun@nbu.edu.cn	ZHOU, Haibo/M-7373-2017	Yan, Xiaojun/0000-0003-0257-0157	Zhejiang Natural Science Foundation, China [LY15C190004]; Project of Ministry of Education, China [20133305130001]; Ningbo Science and Technology Research Projects, China [2017C110003]; Ningbo Marine Algae Biotechnology Team, China [2011B81007]; Earmarked Fund for Modern Agro-industry Technology Research System, China [CARS-48]; Li DakSum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; K.C. Wong Magna Fund in Ningbo University; Fujian Baozhi Aquatic Science and Technology Ltd.	Zhejiang Natural Science Foundation, China(Natural Science Foundation of Zhejiang Province); Project of Ministry of Education, China(Ministry of Education, China); Ningbo Science and Technology Research Projects, China; Ningbo Marine Algae Biotechnology Team, China; Earmarked Fund for Modern Agro-industry Technology Research System, China; Li DakSum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; K.C. Wong Magna Fund in Ningbo University; Fujian Baozhi Aquatic Science and Technology Ltd.	This research was supported by Zhejiang Natural Science Foundation, China (LY15C190004); Project of Ministry of Education, China (20133305130001); Ningbo Science and Technology Research Projects, China (2017C110003); Ningbo Marine Algae Biotechnology Team, China (2011B81007); the Earmarked Fund for Modern Agro-industry Technology Research System, China (CARS-48); Li DakSum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; and partly sponsored by K.C. Wong Magna Fund in Ningbo University. HZ received support in the form of salary from Fujian Baozhi Aquatic Science and Technology Ltd. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript .The specific roles of these authors are articulated in the 'author contributions' section	[Anonymous], 1916, SCIENCE, V44, P178, DOI 10.1126/science.44.1127.178; Bernardo V, 2013, ANAL BIOCHEM, V432, P131, DOI 10.1016/j.ab.2012.09.029; Brillant MGS, 2002, MAR BIOL, V141, P457, DOI 10.1007/s00227-002-0845-2; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; China Fishery Statistical Yearbook, 2015, CHI FISH STAT YB; Dunphy BJ, 2006, AQUACULTURE, V261, P594, DOI 10.1016/j.aquaculture.2006.08.015; Durbin EG, 2008, MAR BIOL, V153, P699, DOI 10.1007/s00227-007-0843-5; Durbin EG, 2012, J PLANKTON RES, V34, P72, DOI 10.1093/plankt/fbr082; Espinosa E. P., 2016, MAR BIOL, V163, P1; Espinosa EP, 2008, ESTUAR COAST SHELF S, V79, P1, DOI 10.1016/j.ecss.2008.02.022; Gouda R, 2006, AQUACULTURE, V259, P169, DOI 10.1016/j.aquaculture.2006.03.050; HAVEN DS, 1970, BIOL BULL, V139, P248, DOI 10.2307/1540081; Fernandez-Reiriz MJ, 2015, AQUACULTURE, V446, P42, DOI 10.1016/j.aquaculture.2015.04.025; MAMAT NZ, 2014, INT AQUAT RES, V6, pNIL33, DOI DOI 10.1007/s40071-014-0057-7; Marshall R, 2010, REV AQUACULT, V2, P33, DOI 10.1111/j.1753-5131.2010.01022.x; Martinez-Fernandez E, 2006, AQUACULTURE, V257, P491, DOI 10.1016/j.aquaculture.2006.03.022; Navarro E, 2016, MAR ENVIRON RES, V120, P111, DOI 10.1016/j.marenvres.2016.07.013; Nejstgaard JC, 2003, LIMNOL OCEANOGR-METH, V1, P29, DOI 10.4319/lom.2003.1.29; Rosa M, 2017, J EXP MAR BIOL ECOL, V486, P59, DOI 10.1016/j.jembe.2016.09.007; Rosa M, 2013, J EXP MAR BIOL ECOL, V446, P320, DOI 10.1016/j.jembe.2013.05.011; Sanchez-Lazo C, 2014, AQUACULTURE, V426, P138, DOI 10.1016/j.aquaculture.2014.01.032; Shen HD, 2013, AQUAC RES, V44, P1524, DOI 10.1111/j.1365-2109.2012.03159.x; SHUMWAY SE, 1985, J EXP MAR BIOL ECOL, V91, P77, DOI 10.1016/0022-0981(85)90222-9; SIERSZEN ME, 1992, ARCH HYDROBIOL, V123, P257; Velasco LA, 2007, AQUACULTURE, V270, P299, DOI 10.1016/j.aquaculture.2007.04.005; Villanueva PA, 2016, MAR FRESHW BEHAV PHY, V49, P291, DOI 10.1080/10236244.2016.1193952; Wang Hui, 2008, Marine Fisheries, V30, P92; Ward JE, 2004, J EXP MAR BIOL ECOL, V300, P83, DOI 10.1016/j.jembe.2004.03.002; Xu JL, 2012, J AGR FOOD CHEM, V60, P3973, DOI 10.1021/jf300620e; Yang F, 2016, AQUACULT NUTR, V22, P846, DOI 10.1111/anu.12310	30	7	7	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180730	10.1371/journal.pone.0180730	http://dx.doi.org/10.1371/journal.pone.0180730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662212	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300174
J	Ogawa, C; Tsuchiya, K; Tomosugi, N; Kanda, F; Maeda, K; Maeda, T				Ogawa, Chie; Tsuchiya, Ken; Tomosugi, Naohisa; Kanda, Fumiyoshi; Maeda, Kunimi; Maeda, Teiryo			Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; HEPCIDIN LEVELS; THERAPY; MANAGEMENT; RISK; ERYTHROPOIETIN; INFLAMMATION; DIALYSIS	Background Optimal iron levels in patients on hemodialysis are currently unknown, and a higher level than that for the healthy population is usually set for such patients considering the use of erythropoiesis-stimulating agents or the occurrence of chronic inflammation. However, excessive iron causes oxidative stress and impairment of its utilization by cells. Therefore we investigated the relationship between hemoglobin (Hb) level and iron status in hemodialysis patients to identify the optimal iron levels for patients undergoing hemodialysis. Methods A total of 208 outpatients on maintenance hemodialysis were followed up between July 2006 and June 2007. Men accounted for 64.9% cases [mean age, 59.3 +/- 13.1 years and median dialysis history, 7.7 (3.6-13.2) years], and diabetic nephropathy accounted for 25.0% cases. Hemoglobin level was measured twice a month and serum ferritin, serum iron, and total iron-binding capacity were measured once a month. The doses of recombinant human erythropoietin and low-dose iron supplement were adjusted to maintain a hemoglobin level of 10-11 g/dL, according to the guidelines of the Japanese Society for Dialysis Therapy. Hepcidin was measured at baseline. Using the mean values for 1-year period, the relationships among hemoglobin, serum ferritin levels, and transferrin saturation levels were investigated based on a receiver operating characteristic curve and a logistic regression model. In addition, the correlations among serum ferritin, transferrin saturation, and hepcidin levels were analyzed by Pearson product-moment correlation coefficient and linear regression model. Results By receiver operating characteristic curve, the cutoff point of serum ferritin and transferrin saturation levels with a hemoglobin >= 10 g/dL showed <90 ng/mL (sensitivity: 69.1%, specificity: 72.1%, p < 0.001) and >= 20% (sensitivity: 77.6%, specificity: 48.8%, p = 0.302). Upon logistic regression model analysis with a hemoglobin >= 10 g/dL as the endpoint, the analysis of odds ratios relative to a group with serum ferritin >= 90 ng/mL and transferrin saturation <20% revealed that the group with serum ferritin <90 ng/mL and transferrin saturation >= 20% had the highest ratio: 46.75 (95% confidence interval: 10.89-200.70, p < 0.001). In Pearson product-moment correlation coefficient, hepcidin showed a strong positive correlation with serum ferritin [r = 0.78 (95% confidence interval: 0.72-0.83, p < 0.001)] and a weak positive correlation with transferrin saturation [r = 0.18 (95% confidence interval: 0.04-0.31, p = 0.010)]. In the multivariable analyses of the linear regression model, a positive relationship was shown between hepcidin and serum ferritin [beta-coefficient of 0.30 (95% confidence interval: 0.27-0.34, p < 0.001)]; however, no relationship was shown with transferrin saturation [beta-coefficient of 0.09 (95% confidence interval: -0.31-0.49, p = 0.660)]. Conclusions In this study, the iron status of serum ferritin <90 ng/mL and transferrin saturation >= 20% was optimal in hemodialysis patients receiving recombinant human erythropoietin for anemia therapy. This result indicates that the threshold values for the optimal iron status may be lower than those currently recommended in iron-level management guideline.	[Ogawa, Chie; Kanda, Fumiyoshi; Maeda, Kunimi; Maeda, Teiryo] Maeda Inst Renal Res, Kawasaki, Kanagawa, Japan; [Ogawa, Chie; Tsuchiya, Ken; Tomosugi, Naohisa; Maeda, Kunimi; Maeda, Teiryo] INC, Biomarker Soc, Kawasaki, Kanagawa, Japan; [Tsuchiya, Ken] Tokyo Womens Med Univ, Dept Blood Purificat, Tokyo, Japan; [Tomosugi, Naohisa] Kanazawa Med Univ, Med Res Inst, Project Res Ctr, Div Syst Biosci Drug Discovery, Uchinada, Ishikawa, Japan	Tokyo Women's Medical University; Kanazawa Medical University	Ogawa, C (corresponding author), Maeda Inst Renal Res, Kawasaki, Kanagawa, Japan.; Ogawa, C (corresponding author), INC, Biomarker Soc, Kawasaki, Kanagawa, Japan.	tato.ogawa@gmail.com						Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; ALI MAM, 1978, CAN MED ASSOC J, V118, P945; [Anonymous], 2011, KIDNEY INT S, V4, P292; [Anonymous], 2006, AM J KIDNEY DIS S, V47, pS11; Anraku M, 2008, CLIN BIOCHEM, V41, P1168, DOI 10.1016/j.clinbiochem.2008.07.007; Bregman DB, 2013, AM J HEMATOL, V88, P97, DOI 10.1002/ajh.23354; Brookhart MA, 2013, J AM SOC NEPHROL, V24, P1151, DOI 10.1681/ASN.2012121164; Bross R, 2009, AM J NEPHROL, V29, P571, DOI 10.1159/000191470; Cristol JP, 1997, NEPHROL DIAL TRANSPL, V12, P2312, DOI 10.1093/ndt/12.11.2312; Drueke T, 2002, CIRCULATION, V106, P2212, DOI 10.1161/01.CIR.0000035250.66458.67; ESCHBACH JW, 1977, ANN INTERN MED, V87, P710, DOI 10.7326/0003-4819-87-6-710; Ferrucci L, 2010, BLOOD, V115, P3810, DOI 10.1182/blood-2009-02-201087; FLYNN TP, 1983, J CLIN INVEST, V71, P1215, DOI 10.1172/JCI110870; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Hamano T, 2015, KIDNEY INT SUPPL, V5, P23, DOI 10.1038/kisup.2015.6; Kato J, 2007, J GASTROENTEROL, V42, P830, DOI 10.1007/s00535-007-2095-z; Kiechl S, 1997, CIRCULATION, V96, P3300; Kliger SA, AM J KIDNEY DIS, V62, P849; Kuragano T, 2010, AM J NEPHROL, V31, P534, DOI 10.1159/000312381; Locatelli F, 2009, NEPHROL DIAL TRANSPL, V24, P348, DOI 10.1093/ndt/gfn653; Maruyama Y, 2007, NEPHROL DIAL TRANSPL, V22, P1407, DOI 10.1093/ndt/gfl789; Nakanishi T, 2012, CLIN EXP NEPHROL, V16, P819, DOI 10.1007/s10157-012-0694-3; Nakanishi T, 2010, AM J NEPHROL, V32, P439, DOI 10.1159/000320733; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pasricha SRS, 2010, MED J AUSTRALIA, V193, P525, DOI 10.5694/j.1326-5377.2010.tb04038.x; Reis KA, 2005, INT HEART J, V46, P255, DOI 10.1536/ihj.46.255; Rubab Z, 2015, SAUDI J KIDNEY DIS T, V26, P19; Sargent JA, 2004, BLOOD PURIFICAT, V22, P112, DOI 10.1159/000074931; Takasawa K, 2015, NUTRIENTS, V7, P103, DOI 10.3390/nu7010103; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Tsukamoto T, 2016, AM J NEPHROL, V43, P32, DOI 10.1159/000444335; Turenne MN, 2015, J AM SOC NEPHROL, V26, P754, DOI 10.1681/ASN.2013111232; Usberti M, 2002, J NEPHROL, V15, P558; Weiss G, 2009, EUR J CLIN INVEST, V39, P883, DOI 10.1111/j.1365-2362.2009.02182.x; Wish JB, 2006, CLIN J AM SOC NEPHRO, V1, pS4, DOI 10.2215/CJN.01490506	39	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179608	10.1371/journal.pone.0179608	http://dx.doi.org/10.1371/journal.pone.0179608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662118	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300038
J	Yamasaki, K; Hyodo, S; Taguchi, K; Nishi, K; Yamaotsu, N; Hirono, S; Chuang, VTG; Seo, H; Maruyama, T; Otagiri, M				Yamasaki, Keishi; Hyodo, Saya; Taguchi, Kazuaki; Nishi, Koji; Yamaotsu, Noriyuki; Hirono, Shuichi; Chuang, Victor Tuan Giam; Seo, Hakaru; Maruyama, Toru; Otagiri, Masaki			Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin	PLOS ONE			English	Article							N-B TRANSITION; NUCLEAR-MAGNETIC-RESONANCE; TO-BASE TRANSITION; PROTEIN COMPLEXES; WARFARIN-BINDING; CRYSTALLOGRAPHIC ANALYSIS; CIRCULAR-DICHROISM; FLUFENAMIC ACID; DIAZEPAM; PLASMA	A wide variety of drugs bind to human serum albumin (HSA) at its two principal sites, namely site I and site II. A number of reports indicate that drug binding to these two binding sites are not completely independent, and that interactions between ligands of these two discrete sites can play a role. In this study, the effect of the binding of long-chain fatty acids on the interactive binding between dansyl-L-asparagine (DNSA; site I ligand) and ibuprofen (site II ligand) at pH6.5 was examined. Binding experiments showed that the binding of sodium oleate (Ole) to HSA induces conformational changes in the molecule, which, in turn, changes the individual binding of DNSA and ibuprofen, as well as the mode of interaction between these two ligands from a 'competitive-like' allosteric interaction in the case of the defatted HSA conformer to a 'nearly independent' binding in the case of non-defatted HSA conformer. Circular dichroism measurements indicated that ibuprofen and Ole are likely to modify the spatial orientation of DNSA at its binding site. Docking simulations suggest that the long-distance electric repulsion between DNSA and ibuprofen on defatted HSA contributes to a 'competitive-like' allosteric interaction, whereas extending the distance between ligands and/or increasing the flexibility or size of the DNSA binding site in fatted HSA evokes a change in the interaction mode to 'nearly independent' binding. The present findings provide further insights into the structural dynamics of HSA upon the binding of fatty acids, and its effects on drug binding and drug-drug interactions that occur on HSA.	[Yamasaki, Keishi; Hyodo, Saya; Taguchi, Kazuaki; Seo, Hakaru; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan; [Yamasaki, Keishi; Seo, Hakaru; Otagiri, Masaki] Sojo Univ, DDS Res Inst, Kumamoto, Japan; [Nishi, Koji] Yokohama Univ Pharm, Dept Clin Pharm, Yokohama, Kanagawa, Japan; [Yamaotsu, Noriyuki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Tokyo, Japan; [Chuang, Victor Tuan Giam] Curtin Univ, Sch Pharm, Fac Hlth Sci, Perth, WA, Australia; [Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto, Japan	Sojo University; Sojo University; Kitasato University; Curtin University; Kumamoto University	Yamasaki, K; Otagiri, M (corresponding author), Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan.; Yamasaki, K; Otagiri, M (corresponding author), Sojo Univ, DDS Res Inst, Kumamoto, Japan.	kcyama@ph.sojo-u.ac.jp; otagirim@ph.sojo-u.ac.jp	Chuang, Victor/A-3644-2011; Yamaotsu, Noriyuki/AAW-2545-2020	Chuang, Victor/0000-0002-2141-630X; Yamaotsu, Noriyuki/0000-0002-4302-1085; Yamasaki, Keishi/0000-0003-0537-2367	Japan Society for the Promotion of Science (JSPS) [KAKENHI 21590054]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in part, by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) (KAKENHI 21590054 to KY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour N, 2016, EUR J DRUG METAB PH, V41, P705, DOI 10.1007/s13318-015-0297-y; Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Ascenzi P, 2005, BIOCHEM BIOPH RES CO, V334, P481, DOI 10.1016/j.bbrc.2005.06.127; BAHR R, 1991, ACTA PHYSIOL SCAND, V143, P105, DOI 10.1111/j.1748-1716.1991.tb09205.x; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bocedi A, 2005, FEBS J, V272, P6287, DOI 10.1111/j.1742-4658.2005.05015.x; BOS OJM, 1989, J BIOL CHEM, V264, P953; BREE F, 1990, EUR J DRUG METAB PH, V15, P303, DOI 10.1007/BF03190219; BREE F, 1993, J PHARM PHARMACOL, V45, P1050, DOI 10.1111/j.2042-7158.1993.tb07179.x; BRODERSEN R, 1990, EUR J BIOCHEM, V189, P343, DOI 10.1111/j.1432-1033.1990.tb15495.x; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CHAKRABARTI SK, 1978, BIOCHEM PHARMACOL, V27, P739, DOI 10.1016/0006-2952(78)90513-0; CHIGNELL CF, 1969, MOL PHARMACOL, V5, P455; CHIGNELL CF, 1971, MOL PHARMACOL, V7, P229; CHIGNELL CF, 1970, MOL PHARMACOL, V6, P1; CHIGNELL CF, 1969, MOL PHARMACOL, V5, P244; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Curry S, 2009, DRUG METAB PHARMACOK, V24, P342, DOI 10.2133/dmpk.24.342; di Masi A, 2011, FEBS J, V278, P654, DOI 10.1111/j.1742-4658.2010.07986.x; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; DROGE JHM, 1985, BIOCHIM BIOPHYS ACTA, V827, P396, DOI 10.1016/0167-4838(85)90224-9; DROGE JHM, 1982, BIOCHEM PHARMACOL, V31, P3781, DOI 10.1016/0006-2952(82)90293-3; ERA S, 1990, INT J PEPT PROT RES, V35, P1; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; FREDRICKSON DS, 1958, J CLIN INVEST, V37, P1504, DOI 10.1172/JCI103742; GIACOMINI KM, 1984, PHARMACEUT RES, P179, DOI 10.1023/A:1016352725805; KASAIMORITA S, 1987, BIOCHIM BIOPHYS ACTA, V915, P277, DOI 10.1016/0167-4838(87)90310-4; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; KRAGHHANSEN U, 1988, MOL PHARMACOL, V34, P160; Krenzel ES, 2013, BIOCHEMISTRY-US, V52, P1559, DOI 10.1021/bi301458b; KURIEN V A, 1971, Progress in Cardiovascular Diseases, V13, P361, DOI 10.1016/S0033-0620(71)80012-9; MANGROO D, 1995, BIOCHEM CELL BIOL, V73, P223, DOI 10.1139/o95-027; MCNAMARA PJ, 1990, BIOCHEM PHARMACOL, V40, P1247, DOI 10.1016/0006-2952(90)90390-7; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; Moosavi-Movahedi Z, 2006, PROTEIN J, V25, P193, DOI 10.1007/s10930-006-9002-y; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Ryan AJ, 2011, J STRUCT BIOL, V174, P84, DOI 10.1016/j.jsb.2010.10.004; Sakai T, 2001, PHARMACEUT RES, V18, P520, DOI 10.1023/A:1011014629551; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; SJODIN T, 1977, BIOCHEM PHARMACOL, V26, P2157, DOI 10.1016/0006-2952(77)90268-4; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; WANWIMOLRUK S, 1982, BIOCHIM BIOPHYS ACTA, V709, P247, DOI 10.1016/0167-4838(82)90467-8; WILDING G, 1977, BIOCHEM PHARMACOL, V26, P1143, DOI 10.1016/0006-2952(77)90058-2; WILTING J, 1980, J BIOL CHEM, V255, P3032; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9; Yamasaki K, 2013, BBA-GEN SUBJECTS, V1830, P5435, DOI 10.1016/j.bbagen.2013.05.005; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	52	34	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180404	10.1371/journal.pone.0180404	http://dx.doi.org/10.1371/journal.pone.0180404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662200	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300152
J	Pezeshkpoori, B; Schreck, U; Biswas, A; Driesen, J; Berkemeier, AC; Pavlov, A; Muller, J; Oldenburg, J				Pezeshkpoori, Behnaz; Schreck, Ursula; Biswas, Arijit; Driesen, Julia; Berkemeier, Ann-Cristin; Pavlov, Anna; Mueller, Jens; Oldenburg, Johannes			An in silico and in vitro approach to elucidate the impact of residues flanking the cleavage scissile bonds of FVIII	PLOS ONE			English	Article							HEMOPHILIA-A MUTATIONS; FACTOR-VIII ACTIVITY; ONE-STAGE; SUBSTRATE-SPECIFICITY; FACTOR XA; CHROMOGENIC ASSAYS; THROMBIN; ACTIVATION; DISCREPANCY; ENZYME	Coagulation Factor VIII is activated by an ordered limited thrombin proteolysis with different catalytic efficiency at three P1 Arginine residues: Arg(759)> Arg(108)>Arg(391), indicating the flanking residues of the latter to be less optimal. This study aimed to investigate, in silico and in vitro, the impact of possessing hypothetically optimized residues at these three catalytic cleavage sites. The structural impact of the residues flanking Arginine cleavage sites was studied by in silico analysis through comparing the cleavage cleft of the native site with a hypothetically optimized sequence at each site. Moreover, recombinant FVIII proteins were prepared by replacing the sequences flanking native thrombin cleavage sites with the proposed cleavage-optimized sequence. FVIII specific activity was determined by assessing the FVIII activity levels in relation to FVIII antigen levels. We further investigated whether thrombin generation could reflect the haemostatic potential of the variants. Our in silico results show the impact of the residues directly in the cleavage bond, and their neighboring residues on the insertion efficiency of the loop into the thrombin cleavage cleft. Moreover, the in vitro analysis shows that the sequences flanking the Arg(1708) cleavage site seem to be the most close to optimal residues for achieving the maximal proteolytic activation and pro factor activity of FVIII. The residues flanking the scissile bonds of FVIIII affect the cleavage rates and modulate the profactor activation. We were able to provide insights into the mechanisms of the specificity of thrombin for the P1 cleavage sites of FVIII. Thus, the P4-P2' residues surrounding Arg(1708) of FVIII have the highest impact on rates of thrombin proteolysis which contributes to thrombin activation of the profactor and eventually to the thrombin generation potential.	[Pezeshkpoori, Behnaz; Schreck, Ursula; Biswas, Arijit; Driesen, Julia; Berkemeier, Ann-Cristin; Pavlov, Anna; Mueller, Jens; Oldenburg, Johannes] Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany; [Pezeshkpoori, Behnaz; Schreck, Ursula; Biswas, Arijit; Berkemeier, Ann-Cristin; Pavlov, Anna; Mueller, Jens; Oldenburg, Johannes] Univ Clin Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany	University of Bonn; University of Bonn	Oldenburg, J (corresponding author), Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany.; Oldenburg, J (corresponding author), Univ Clin Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany.	Johannes.Oldenburg@ukbonn.de	Biswas, A./B-9673-2011; Müller, Jens/A-8264-2012; Oldenburg, Johannes/ABB-7817-2020; Pezeshkpoor, Behnaz/ABB-3194-2020	Müller, Jens/0000-0001-7713-9631; Pezeshkpoor, Behnaz/0000-0002-4796-3424; Oldenburg, Johannes/0000-0002-1585-4100; Biswas, Arijit/0000-0002-4103-5854				Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Chahal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129511; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; EATON DL, 1986, PROG HEMOST THROMB, V8, P47; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; Lippi G, 2009, BLOOD COAGUL FIBRIN, V20, P1, DOI 10.1097/MBC.0b013e32831bc324; LOLLAR P, 1991, MAYO CLIN PROC, V66, P524, DOI 10.1016/S0025-6196(12)62395-7; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Newell JL, 2007, J BIOL CHEM, V282, P25367, DOI 10.1074/jbc.M703433200; Newell JL, 2009, J BIOL CHEM, V284, P11080, DOI 10.1074/jbc.M900234200; Newell-Caito JL, 2012, BIOCHEMISTRY-US, V51, P3451, DOI 10.1021/bi300070z; Pahl S, 2014, THROMB HAEMOSTASIS, V111, P58, DOI 10.1160/TH13-01-0028; Parker ET, 1997, BIOCHEMISTRY-US, V36, P9365, DOI 10.1021/bi970599o; Pavlova A, 2010, HAEMOPHILIA, V16, P44; Pavlova A, 2014, THROMB HAEMOSTASIS, V111, P851, DOI 10.1160/TH13-08-0690; Petrassi HM, 2005, BIOORG MED CHEM LETT, V15, P3162, DOI 10.1016/j.bmcl.2005.04.019; Peyvandi F, 2016, J THROMB HAEMOST, V14, P248, DOI 10.1111/jth.13215; PIETERS J, 1989, BLOOD, V74, P1021; Pipe SW, 2001, BLOOD, V97, P685, DOI 10.1182/blood.V97.3.685; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; Sadasivan C, 2000, J BIOL CHEM, V275, P36942, DOI 10.1074/jbc.M006076200; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180456	10.1371/journal.pone.0180456	http://dx.doi.org/10.1371/journal.pone.0180456			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683085	Green Submitted, Green Published, gold			2022-12-27	WOS:000405335200039
J	Burnham, JP; Micek, ST; Kollef, MH				Burnham, Jason P.; Micek, Scott T.; Kollef, Marin H.			Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; GLOMERULAR-FILTRATION-RATE; PLASMA CREATININE CONCENTRATIONS; INTENSIVE-CARE-UNIT; CLASSIFICATION; VANCOMYCIN; EQUATION; THERAPY; DISEASE	The main objective of the study was to assess whether augmented renal clearance was a risk factor for mortality in a cohort of patients with Enterobacteriaceae sepsis, severe sepsis, or septic shock that all received appropriate antimicrobial therapy within 12 hours. Using a retrospective cohort from Barnes-Jewish Hospital, a 1,250-bed teaching hospital, we collected data on individuals with Enterobacteriaceae sepsis, severe sepsis, and septic shock who received appropriate initial antimicrobial therapy between June 2009 and December 2013. Clinical outcomes were compared according to renal clearance, as assessed by Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formulas, sepsis classification, demographics, severity of illness, and comorbidities. We identified 510 patients with Enterobacteriaceae bacteremia and sepsis, severe sepsis, or septic shock. Sixty-seven patients (13.1%) were nonsurvivors. Augmented renal clearance was uncommon (5.1% of patients by MDRD and 3.0% by CKD-EPI) and was not associated with increased mortality. Our results are limited by the absence of prospective determination of augmented renal clearance. However, in this small cohort, augmented renal clearance as assessed by MDRD and CKD-EPI does not seem to be a risk factor for mortality in patients with Enterobacteriaceae sepsis. Future studies should assess this finding prospectively.	[Burnham, Jason P.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Micek, Scott T.] St Louis Coll Pharm, St Louis, MO USA; [Kollef, Marin H.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Burnham, JP (corresponding author), Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA.	kollefm@wustl.edu	Burnham, Jason/S-1770-2019	Burnham, Jason/0000-0002-4777-3006	Washington University Institute of Clinical and Translational Sciences - National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1TR000448]	Washington University Institute of Clinical and Translational Sciences - National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Burnham reports that the research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH).The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnan S, 2014, ANAESTH INTENS CARE, V42, P715, DOI 10.1177/0310057X1404200606; Baptista JP, 2014, J NEPHROL, V27, P403, DOI 10.1007/s40620-013-0036-x; Baptista JP, 2012, INT J ANTIMICROB AG, V39, P420, DOI 10.1016/j.ijantimicag.2011.12.011; Barletta JF, 2016, J TRAUMA ACUTE CARE, V81, P1115, DOI 10.1097/TA.0000000000001211; Bragadottir G, 2013, CRIT CARE, V17, DOI 10.1186/cc12777; Burnham JP, 2015, CRIT CARE MED, V43, P1580, DOI 10.1097/CCM.0000000000001013; Claus BOM, 2013, J CRIT CARE, V28, P695, DOI 10.1016/j.jcrc.2013.03.003; De Waele JJ, 2015, MINERVA ANESTESIOL, V81, P1079; Hirai K, 2016, THER DRUG MONIT, V38, P706, DOI 10.1097/FTD.0000000000000346; Huttner A, 2015, INT J ANTIMICROB AG, V45, P385, DOI 10.1016/j.ijantimicag.2014.12.017; Jones RN, 2005, DIAGN MICR INFEC DIS, V52, P235, DOI 10.1016/j.diagmicrobio.2005.02.006; Kawano Y, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0187-7; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luc. M, 2015, COMP DISC DIFFUSION; May CC, 2015, NEUROCRIT CARE, V23, P374, DOI 10.1007/s12028-015-0127-8; Patel J.B., 2015, PERFORMANCE STANDARD; Roberts JA, 2014, CLIN INFECT DIS, V58, P1072, DOI 10.1093/cid/ciu027; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Udy AA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-250; Udy AA, 2013, CRIT CARE, V17, DOI 10.1186/cc12544; Udy AA, 2012, CHEST, V142, P30, DOI 10.1378/chest.11-1671	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180247	10.1371/journal.pone.0180247	http://dx.doi.org/10.1371/journal.pone.0180247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678812	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200042
J	Deng, JL; Wang, LZ; Zhang, YF; Chang, XY; Ma, XJ				Deng, Jiali; Wang, Lizhong; Zhang, Yinfa; Chang, Xiangyang; Ma, Xingjie			Insertion of an intrathecal catheter in parturients reduces the risk of post-dural puncture headache: A retrospective study and meta-analysis	PLOS ONE			English	Article							ACCIDENTAL DURAL PUNCTURE; OBSTETRIC PATIENTS; EPIDURAL ANALGESIA; MANAGEMENT; LABOR; COMPLICATIONS; EXPERIENCE; BIAS	This study aimed to determine whether insertion of an intrathecal catheter following accidental dural puncture (ADP) in obstetric patients can reduce the incidence of post-dural puncture headache (PDPH) and the requirement of a therapeutic epidural blood patch (TEBP). This was also compared with relocating the epidural catheter at a different vertebral interspace. A retrospective study was performed, as well as a meta-analysis of the literature to further validate our findings. We reviewed the records of 86 obstetric patients who suffered from ADP during epidural anesthesia or combined spinal-epidural anesthesia from October 2015 to November 2016 at our institution. Although, there was no significant decrease in the incidence of PDPH (P = 0.08), the requirement for a TEBP (P = 0.025) was significantly reduced in the intrathecal catheter group compared with the relocated group. In the metaanalysis, 13 eligible studies including 1044 obstetric patients were finally identified. To estimate the pooled risk ratios (RRs), fixed or random effect models were used depending on the heterogeneity. We initially found that an intrathecal catheter significantly reduced the incidence of PDPH (pooled RR = 0.823; 95% CI = 0.700-0.967; P = 0.018) and the requirement of a TEBP (pooled RR = 0.616; 95% CI = 0.443-0.855; P = 0.004). Our study shows that insertion of an intrathecal catheter following ADP might be an effective and dependable method for reducing the risk of a PDPH and requirement for a TEBP in obstetric patients.	[Deng, Jiali; Wang, Lizhong; Zhang, Yinfa; Chang, Xiangyang] Jiaxing Univ, Sch Med, Jiaxing Matern & Child Hlth Hosp, Dept Anesthesia, Jiaxing, Zhejiang, Peoples R China; [Ma, Xingjie] Jiaxing Univ, Sch Med, Hosp Jiaxing 1, Dept Cardiothorac Surg, Jiaxing, Zhejiang, Peoples R China	Jiaxing University; Jiaxing University	Ma, XJ (corresponding author), Jiaxing Univ, Sch Med, Hosp Jiaxing 1, Dept Cardiothorac Surg, Jiaxing, Zhejiang, Peoples R China.	dr_maixngjie@163.com			Jiaxing Science and Technology Bureau in Zhengjiang Province, China [2013AY21050-2]	Jiaxing Science and Technology Bureau in Zhengjiang Province, China	This study was supported by the grant from Jiaxing Science and Technology Bureau in Zhengjiang Province, China (no. 2013AY21050-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MV, 2016, ACTA MEDICA PORT, V29, P268, DOI 10.20344/amp.6815; Apfel CC, 2010, BRIT J ANAESTH, V105, P255, DOI 10.1093/bja/aeq191; Ayad S, 2003, REGION ANESTH PAIN M, V28, P512, DOI 10.1016/S1098-7339(03)00393-6; Baraz R, 2005, ANAESTHESIA, V60, P673, DOI 10.1111/j.1365-2044.2005.04222.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bolden N, 2016, REGION ANESTH PAIN M, V41, P169, DOI 10.1097/AAP.0000000000000339; COHEN S, 1994, ACTA ANAESTH SCAND, V38, P716, DOI 10.1111/j.1399-6576.1994.tb03983.x; de Velde MV, 2008, INT J OBSTET ANESTH, V17, P329, DOI 10.1016/j.ijoa.2007.04.009; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Heesen M, 2013, INT J OBSTET ANESTH, V22, P26, DOI 10.1016/j.ijoa.2012.10.004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jagannathan DK, 2016, INT J OBSTET ANESTH, V25, P23, DOI 10.1016/j.ijoa.2015.09.002; Kaddoum R, 2014, J ANESTH, V28, P628, DOI 10.1007/s00540-013-1761-y; NORRIS MC, 1990, REGION ANESTH, V15, P285; Paech M, 2001, INT J OBSTET ANESTH, V10, P162, DOI 10.1054/ijoa.2000.0825; Russell IF, 2012, INT J OBSTET ANESTH, V21, P7, DOI 10.1016/j.ijoa.2011.10.005; Rutter SV, 2001, INT J OBSTET ANESTH, V10, P177, DOI 10.1054/ijoa.2001.0854; Tien M, 2016, CURR MED RES OPIN, V32, P841, DOI 10.1185/03007995.2016.1146665; Verstraete S, 2014, ACTA ANAESTH SCAND, V58, P1233, DOI 10.1111/aas.12394	20	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180504	10.1371/journal.pone.0180504	http://dx.doi.org/10.1371/journal.pone.0180504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678882	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200068
J	Filipovic, A; Ghasemian, E; Inic-Kanada, A; Lukic, I; Stein, E; Marinkovic, E; Djokic, R; Kosanovic, D; Schuerer, N; Chalabi, H; Belij-Rammerstorfer, S; Stojanovic, M; Barisani-Asenbauer, T				Filipovic, Ana; Ghasemian, Ehsan; Inic-Kanada, Aleksandra; Lukic, Ivana; Stein, Elisabeth; Marinkovic, Emilija; Djokic, Radmila; Kosanovic, Dejana; Schuerer, Nadine; Chalabi, Hadeel; Belij-Rammerstorfer, Sandra; Stojanovic, Marijana; Barisani-Asenbauer, Talin			The effect of infectious dose on humoral and cellular immune responses in Chlamydophila caviae primary ocular infection	PLOS ONE			English	Article							PIG INCLUSION CONJUNCTIVITIS; CHLAMYDIAL GENITAL-INFECTION; OUTER-MEMBRANE PROTEIN; FEMALE GUINEA-PIGS; CD8(+) T-CELLS; PROTECTIVE MONOCLONAL-ANTIBODIES; ACTIVE TRACHOMA; TRACT INFECTION; IFN-GAMMA; B-CELLS	Following infection, the balance between protective immunity and immunopathology often depends on the initial infectious load. Several studies have investigated the effect of infectious dose; however, the mechanism by which infectious dose affects disease outcomes and the development of a protective immune response is not known. The aim of this study was to investigate how the infectious dose modulates the local and systemic humoral and the cellular immune responses during primary ocular chlamydial infection in the guinea pig animal model. Guinea pigs were infected by ocular instillation of a Chlamydophila caviae-containing eye solution in the conjunctival sac in three different doses: 1x10(2), 1x10(4), and 1x10(6) inclusion forming units (IFUs). Ocular pathology, chlamydial clearance, local and systemic C. caviae-specific humoral and cellular immune responses were assessed. All inocula of C. caviae significantly enhanced the local production of C. caviae-specific IgA in tears, but only guinea pigs infected with the higher doses showed significant changes in C. caviae-specific IgA levels in vaginal washes and serum. On complete resolution of infection, the low dose of C. caviae did not alter the ratio of CD4(+) and CD8(+) cells within guinea pigs' submandibular lymph node (SMLN) lymphocytes while the higher doses increased the percentages of CD4(+) and CD8(+) cells within the SMLN lymphocytes. A significant negative correlation between pathology intensity and the percentage of CD4(+) and CD8(+) cells within SMLN lymphocyte pool at selected time points post-infection was recorded for both 1x10(4), and 1x10(6) IFU infected guinea pigs. The relevance of the observed dose-dependent differences on the immune response should be further investigated in repeated ocular chlamydial infections.	[Filipovic, Ana; Lukic, Ivana; Marinkovic, Emilija; Djokic, Radmila; Kosanovic, Dejana; Stojanovic, Marijana] Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia; [Ghasemian, Ehsan; Inic-Kanada, Aleksandra; Stein, Elisabeth; Schuerer, Nadine; Chalabi, Hadeel; Belij-Rammerstorfer, Sandra; Barisani-Asenbauer, Talin] Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Centres Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria	Medical University of Vienna	Stojanovic, M (corresponding author), Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia.; Barisani-Asenbauer, T (corresponding author), Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Centres Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	mstojanovic@torlak.rs; talin.barisani@meduniwien.ac.at	Belij-Rammerstorfer, Sandra/B-8243-2018	Ghasemian, Ehsan/0000-0003-1019-6572; Belij-Rammerstorfer, Sandra/0000-0002-8637-3785; Lukic, Ivana/0000-0002-6330-471X; Stein, Elisabeth/0000-0002-1240-506X; Stojanovic, Marijana/0000-0002-8204-4183; Barisani-Asenbauer, Talin/0000-0002-8661-9183; Inic-Kanada, Aleksandra/0000-0001-7854-3812	"Laura Bassi Centers of Expertise" program of Austrian Federal Ministry of Economy through Austrian Research Promotion Agency (FFG) [822768]; Ministry of Education, Science, and Technological Development of the Republic of Serbia [172049, 451-03-01039/2015-09/04]; OeAD - die osterreichische Agentur fur internationale Mobilitat und Kooperation in Bildung, Wissenschaft und Forschung [SRB 15/2016]	"Laura Bassi Centers of Expertise" program of Austrian Federal Ministry of Economy through Austrian Research Promotion Agency (FFG); Ministry of Education, Science, and Technological Development of the Republic of Serbia; OeAD - die osterreichische Agentur fur internationale Mobilitat und Kooperation in Bildung, Wissenschaft und Forschung	This research was funded by the "Laura Bassi Centers of Expertise'' program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG project number 822768) (https://www.ffg.at/en); the Ministry of Education, Science, and Technological Development of the Republic of Serbia (grant numbers 172049 and 451-03-01039/2015-09/04) (http://www.mpn.gov.rs/) and OeAD - die osterreichische Agentur fur internationale Mobilitat und Kooperation in Bildung, Wissenschaft und Forschung (grant number SRB 15/2016) (https://oead.at).	Belij-Rammerstorfer S, 2015, MICROBES INFECT I PA; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; BRUNHAM RC, 1983, INFECT IMMUN, V39, P1491, DOI 10.1128/IAI.39.3.1491-1494.1983; Burton MJ, 2011, INFECT IMMUN, V79, P4977, DOI 10.1128/IAI.05718-11; Burton MJ, 2004, INFECT IMMUN, V72, P7352, DOI 10.1128/IAI.72.12.7352-7356.2004; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; de Jonge MI, 2011, VACCINE, V29, P5994, DOI 10.1016/j.vaccine.2011.06.037; Holland MJ, 1997, CLIN EXP IMMUNOL, V107, P44, DOI 10.1046/j.1365-2249.1997.2511129.x; Holland MJ, 2006, INFECT IMMUN, V74, P1565, DOI 10.1128/IAI.74.3.1565-1572.2006; Holland MJ, 1996, CLIN EXP IMMUNOL, V105, P429, DOI 10.1046/j.1365-2249.1996.d01-792.x; Igietseme Joseph U., 1993, Regional Immunology, V5, P317; Inic-Kanada A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144380; Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764; Lacy HM, 2011, INFECT IMMUN, V79, P1889, DOI 10.1128/IAI.01257-10; LEVITT D, 1988, J IMMUNOL, V140, P273; Longbottom D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057950; Mabey DCW, 2014, VACCINE, V32, P1572, DOI 10.1016/j.vaccine.2013.10.016; Mahdi OSM, 2001, CLIN EXP IMMUNOL, V123, P68, DOI 10.1046/j.1365-2249.2001.01416.x; MALATY R, 1981, INVEST OPHTH VIS SCI, V21, P833; Maxion HK, 2004, INFECT IMMUN, V72, P6330, DOI 10.1128/IAI.72.11.6330-6340.2004; MEGRAN DW, 1988, J INFECT DIS, V158, P661, DOI 10.1093/infdis/158.3.661; MONNICKENDAM MA, 1980, BRIT J OPHTHALMOL, V64, P279, DOI 10.1136/bjo.64.4.279; MONNICKENDAM MA, 1980, BRIT J OPHTHALMOL, V64, P284, DOI 10.1136/bjo.64.4.284; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; MURRAY ES, 1967, AM J OPHTHALMOL, V63, P1263, DOI 10.1016/0002-9394(67)94108-6; MURRAY ES, 1964, J INFECT DIS, V114, P1, DOI 10.1093/infdis/114.1.1; Nogueira CV, 2015, J IMMUNOL, V194, P2319, DOI 10.4049/jimmunol.1402675; Olivares-Zavaleta N, 2014, J IMMUNOL, V192, P4648, DOI 10.4049/jimmunol.1400120; PEDERSEN KB, 1973, ACTA PATH MICRO IM B, V81, P245; Perry LL, 1999, J IMMUNOL, V162, P3541; PETERSON EM, 1991, INFECT IMMUN, V59, P4147, DOI 10.1128/IAI.59.11.4147-4153.1991; Peterson EM, 1998, INFECT IMMUN, V66, P3848, DOI 10.1128/IAI.66.8.3848-3855.1998; Phillips TE, 2010, INVEST OPHTH VIS SCI, V51, P1533, DOI 10.1167/iovs.09-4491; RAMSEY KH, 1988, INFECT IMMUN, V56, P1320, DOI 10.1128/IAI.56.5.1320-1325.1988; Ramsey KH, 2009, INFECT IMMUN, V77, P3284, DOI 10.1128/IAI.00147-09; RANK RG, 1983, INFECT IMMUN, V39, P463, DOI 10.1128/IAI.39.1.463-465.1983; RANK RG, 1988, INFECT IMMUN, V56, P2243, DOI 10.1128/IAI.56.9.2243-2249.1988; Rank RG, 2003, INFECT IMMUN, V71, P6148, DOI 10.1128/IAI.71.11.6148-6154.2003; RANK RG, 1994, METHOD ENZYMOL, V235, P69; RANK RG, 1979, INFECT IMMUN, V26, P573, DOI 10.1128/IAI.26.2.573-579.1979; Rank RG, 2012, VIVO CHLAMYDIAL INFE; Rank RG, 2008, FEMS IMMUNOL MED MIC, V54, P104, DOI 10.1111/j.1574-695X.2008.00459.x; Reinhold P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030125; Roan NR, 2008, CELL MICROBIOL, V10, P9, DOI 10.1111/j.1462-5822.2007.01069.x; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Taylor H. R., 2008, TRACHOMA BLINDING SC; Trama AM, 2014, CELL HOST MICROBE, V16, P215, DOI 10.1016/j.chom.2014.07.003; Van Nerom A, 1998, AVIAN DIS, V42, P53, DOI 10.2307/1592576; Wali S, 2017, IMMUNOLOGY CELL BIOL; Wali S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114261; WHITTUMHUDSON JA, 1986, INVEST OPHTH VIS SCI, V27, P64; WHITTUMHUDSON JA, 1995, INVEST OPHTH VIS SCI, V36, P1976; WHO, 2014, 39 WHO; Wilson DP, 2009, J INFECT DIS, V199, P1780, DOI 10.1086/599093; World Health Organization, 2016, TRACH FACT SHEET; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052; YOUNG E, 1984, J INFECT DIS, V150, P745, DOI 10.1093/infdis/150.5.745; ZHANG YX, 1987, J IMMUNOL, V138, P575; ZHANG YX, 1989, INFECT IMMUN, V57, P636, DOI 10.1128/IAI.57.2.636-638.1989	61	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180551	10.1371/journal.pone.0180551	http://dx.doi.org/10.1371/journal.pone.0180551			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678871	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200073
J	Ma, QG; Qian, D; Hu, LF; Wang, L				Ma, Qingguo; Qian, Da; Hu, Linfeng; Wang, Lei			Hello handsome! Male's facial attractiveness gives rise to female's fairness bias in Ultimatum Game scenarios-An ERP study	PLOS ONE			English	Article							MEDIAL FRONTAL NEGATIVITY; EVENT-RELATED POTENTIALS; PHYSICAL ATTRACTIVENESS; BRAIN POTENTIALS; DECISION-MAKING; ORBITOFRONTAL CORTEX; GENDER-DIFFERENCES; NEURAL BASIS; BEAUTY; RESPONSES	The current study delineated how male proposers' facial attractiveness affect female responders' fairness considerations and their subsequent decision outcome during the Ultimatum Game (UG). Event Related Potentials (ERPs) were recorded from 17 female subjects, who played the role as responders and had to decide whether to accept offers from either attractive or unattractive male proposers. Behavioral data (Acceptance Ratio and Response time) revealed that, more offers were accepted from attractive-face conditions; subjects typically responded quicker to unfair offers from unattractive proposers as compared with slower to unfair offers from attractive proposers. The ERP data demonstrated similar N2 amplitudes elicited by both attractive and unattractive faces, and a larger early frontal LPP elicited by the attractive faces compared with unattractive ones, but no significant differences of both late posterior LPP and typical parietal LPP amplitudes were observed between these two face conditions, which was different from our previous study with similar paradigm but male participants. The results suggest that, in comparison to males, females might not experience the potential attention bias towards unattractive opposite-sex faces and are less likely to possess an enhanced processing and evaluation of those faces. This phenomenon might be explained by endogenous gender differences in mate preference. The feedback-related negativity (FRN) and P300 responses during an offer presentation were further measured in both attractive-face and unattractive-face conditions and the results demonstrated that the amplitudes elicited by fair and unfair offers were not statistically different in the former condition, but were different in the latter condition. More specifically, unfair offers generated larger FRN and smaller P300 than fair ones in the unattractive-face condition. Findings suggest that, although females tend to possess less salient evaluation of male's facial attractiveness, the attractiveness of male proposers would still attenuate female responders' fairness consideration during the UG.	[Ma, Qingguo; Qian, Da; Hu, Linfeng; Wang, Lei] Zhejiang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China; [Ma, Qingguo; Qian, Da; Hu, Linfeng; Wang, Lei] Zhejiang Univ, Neuromanagement Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, L (corresponding author), Zhejiang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China.; Wang, L (corresponding author), Zhejiang Univ, Neuromanagement Lab, Hangzhou, Zhejiang, Peoples R China.	wang_lei@zju.edu.cn		Qian, Da/0000-0003-0467-1285; Wang, Lei/0000-0001-6383-0624	Chinese Association of Higher Education [11ZD0028]; Ministry of Education of People's Republic of China [09JZD0006]; National Natural Science Foundation of China [71371167, 71471163]	Chinese Association of Higher Education; Ministry of Education of People's Republic of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Association of Higher Education, Grant number: 11ZD0028. QGM was supported by the Ministry of Education of People's Republic of China (Grant No. 09JZD0006) as a key project and the National Natural Science Foundation of China (Grant No. 71371167). Lei Wang was supported by the National Natural Science Foundation of China (Grant No. 71471163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Boksem MAS, 2010, SOC NEUROSCI-UK, V5, P118, DOI 10.1080/17470910903202666; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cameron L, 2013, SCIENCE, V339, P953, DOI 10.1126/science.1230221; Chen J, 2012, NEUROSCI LETT, V517, P65, DOI 10.1016/j.neulet.2012.02.082; Clark CR, 2004, CLIN EEG NEUROSCI, V35, pVI; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Dolan RI, 1999, NAT NEUROSCI, V2, P927, DOI 10.1038/14707; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Eckel CC, 2011, AM ECON REV, V101, P1497, DOI 10.1257/aer.101.4.1497; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; Fugere MA, 2017, EVOLUTIONARY PSYCHOL, P1; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gibbons JL, 2010, PSYCHOL WOMEN QUART, V34, P127, DOI 10.1111/j.1471-6402.2009.01549.x; Guo XY, 2014, SOC COGN AFFECT NEUR, V9, P1498, DOI 10.1093/scan/nst131; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; JACKSON LA, 1995, SOC PSYCHOL QUART, V58, P108, DOI 10.2307/2787149; Jin J, 2017, NEUROSCI LETT, V640, P130, DOI 10.1016/j.neulet.2017.01.037; Johnston VS, 1997, J SEX RES, V34, P188, DOI 10.1080/00224499709551884; Krupp DB, 2011, EVOL HUM BEHAV, V32, P198, DOI 10.1016/j.evolhumbehav.2010.10.001; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lee DY, 2006, CURR OPIN NEUROBIOL, V16, P191, DOI 10.1016/j.conb.2006.02.001; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Luo Y, 2014, PSYCHOPHYSIOLOGY, V51, P834, DOI 10.1111/psyp.12235; Ma Q, 2015, PLOS ONE, V10; Ma QG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00077; Martin RS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00304; Marzi T, 2010, BIOL PSYCHOL, V84, P192, DOI 10.1016/j.biopsycho.2010.01.013; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moser A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00031; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Oliver-Rodriguez JC, 1999, PSYCHOPHYSIOLOGY, V36, P176; Olson IR, 2005, EMOTION, V5, P498, DOI 10.1037/1528-3542.5.4.498; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Qu C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00505; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schacht A, 2008, COGN AFFECT BEHAV NE, V8, P132, DOI 10.3758/CABN.8.2.132; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shackelford TK, 2005, PERS INDIV DIFFER, V39, P447, DOI 10.1016/j.paid.2005.01.023; Shackelford TK, 1999, EVOL HUM BEHAV, V20, P71, DOI 10.1016/S1090-5138(98)00036-1; Shen H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35905; Smith FG, 2009, EVOL HUM BEHAV, V30, P393, DOI 10.1016/j.evolhumbehav.2009.06.003; SNYDER M, 1985, J PERS SOC PSYCHOL, V48, P1427, DOI 10.1037/0022-3514.48.6.1427; Solnick SJ, 1999, ORGAN BEHAV HUM DEC, V79, P199, DOI 10.1006/obhd.1999.2843; SPRECHER S, 1994, J PERS SOC PSYCHOL, V66, P1074, DOI 10.1037/0022-3514.66.6.1074; Turner JH, 2006, ANNU REV SOCIOL, V32, P25, DOI 10.1146/annurev.soc.32.061604.123130; Van der Veen FM, 2011, COGN AFFECT BEHAV NE, V11, P516, DOI 10.3758/s13415-011-0050-1; van Hooff JC, 2011, SOC COGN AFFECT NEUR, V6, P477, DOI 10.1093/scan/nsq066; Werheid K, 2007, BIOL PSYCHOL, V76, P100, DOI 10.1016/j.biopsycho.2007.06.008; Wiese H, 2014, NEUROPSYCHOLOGIA, V56, P26, DOI 10.1016/j.neuropsychologia.2013.12.023; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039627; Wu Y, 2011, BIOL PSYCHOL, V88, P253, DOI 10.1016/j.biopsycho.2011.08.009; Xu Q, 2011, NEUROSCI LETT, V505, P200, DOI 10.1016/j.neulet.2011.10.024; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Zeng J, 2012, PLOS ONE, V7, P1; Zhang Y, 2011, J NEUROSCI RES, V89, P1887, DOI 10.1002/jnr.22724	78	18	20	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180459	10.1371/journal.pone.0180459	http://dx.doi.org/10.1371/journal.pone.0180459			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678888	Green Submitted, gold, Green Published			2022-12-27	WOS:000405272200066
J	Mahavadi, S; Sriwai, W; Manion, O; Grider, JR; Murthy, KS				Mahavadi, Sunila; Sriwai, Wimolpak; Manion, Olivia; Grider, John R.; Murthy, Karnam S.			Diabetes-induced oxidative stress mediates upregulation of RhoA/Rho kinase pathway and hypercontractility of gastric smooth muscle	PLOS ONE			English	Article							DOUBLE-EDGED-SWORD; INTERSTITIAL-CELLS; NOX ENZYMES; REACTIVE OXYGEN; POLYOL PATHWAY; HIGH-GLUCOSE; RHO-KINASE; PHOSPHORYLATION; EXPRESSION; CAJAL	The pathogenesis of diabetes-associated motility disorders are multifactorial and attributed to abnormalities in extrinsic and intrinsic innervation, and a decrease in the number of interstitial cells of Cajal, and nNOS expression and activity. Here we studied the effect of hyperglycemia on smooth muscle function. Using smooth muscles from the fundus of ob/ob mice and of wild type (WT) mice treated with 30 mM glucose (HG), we identified the molecular mechanism by which hyperglycemia upregulates RhoA/Rho kinase pathway and muscle contraction. RhoA expression, Rho kinase activity and muscle contraction were increased, while miR-133a expression was decreased in smooth muscle of ob/ob mice and in smooth muscle treated with HG. Intraperitoneal injections of pre-miR-133a decreased RhoA expression in WT mice and reversed the increase in RhoA expression in ob/ob mice. Intraperitoneal injections of antagomiR-133a increased RhoA expression in WT mice and augmented the increase in RhoA expression in ob/ob mice. The effect of pre-miR-133a or antagomiR-133a in vitro in smooth muscle treated with HG was similar to that obtained in vivo, suggesting that the expression of RhoA is negatively regulated by miR-133a and a decrease in miR-133a expression in diabetes causes an increase in RhoA expression. Oxidative stress (levels of reactive oxygen species and hydrogen peroxide, and expression of superoxide dismutase 1 and NADPH oxidase 4) was increased in smooth muscle of ob/ob mice and in HG-treated smooth muscle. Treatment of ob/ob mice with N-acetylcysteine (NAC) in vivo or addition of NAC in vitro to HG-treated smooth muscle reversed the effect of glucose on the expression of miR-133a and RhoA, Rho kinase activity and muscle contraction. NAC treatment also reversed the decrease in gastric emptying in ob/ob mice. We conclude that oxidative stress in diabetes causes a decrease in miR-133a expression leading to an increase in RhoA/Rho kinase pathway and muscle contraction.	[Mahavadi, Sunila; Sriwai, Wimolpak; Manion, Olivia; Grider, John R.; Murthy, Karnam S.] Virginia Commonwealth Univ, Dept Physiol & Biophys, VCU Program Enter Neuromuscular Sci, Richmond, VA 23284 USA	Virginia Commonwealth University	Mahavadi, S (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, VCU Program Enter Neuromuscular Sci, Richmond, VA 23284 USA.	sunila.mahavadi@vchealth.org			 [NIDDKD-DK28300]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028300] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by funds from NIDDKD-DK28300.	Abd-Elrahman KS, 2015, CAN J PHYSIOL PHARM, V93, P177, DOI 10.1139/cjpp-2014-0437; [Anonymous], 2003, PHYSIOL REV, V83, P1325; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Araki E, 2010, J DIABETES INVEST, V1, P90, DOI 10.1111/j.2040-1124.2010.00013.x; Asakawa A, 2003, J DIABETES COMPLICAT, V17, P27, DOI 10.1016/S1056-8727(02)00198-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharya S, 2013, AM J PHYSIOL-CELL PH, V305, pC334, DOI 10.1152/ajpcell.00334.2012; Bhetwal BP, 2013, J MUSCLE RES CELL M, V34, P137, DOI 10.1007/s10974-013-9341-1; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cellek S, 2004, CURR PHARM DESIGN, V10, P3683, DOI 10.2174/1381612043382792; Chandran Manju, 2003, Curr Diab Rep, V3, P43, DOI 10.1007/s11892-003-0052-7; Chiba Y, 2010, J PHARMACOL SCI, V114, P264, DOI 10.1254/jphs.10R10FM; Chiba Y, 2010, J PHARMACOL SCI, V114, P239, DOI 10.1254/jphs.10R03CR; Chiba Y, 2009, AM J RESP CRIT CARE, V180, P713, DOI 10.1164/rccm.200903-0325OC; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; de Godoy MAF, 2011, TRENDS PHARMACOL SCI, V32, P384, DOI 10.1016/j.tips.2011.03.005; Descorbeth M, 2010, FREE RADICAL BIO MED, V49, P1395, DOI 10.1016/j.freeradbiomed.2010.07.023; Drel VR, 2006, DIABETES, V55, P3335, DOI 10.2337/db06-0885; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Fu YB, 2010, AM J NEPHROL, V32, P581, DOI 10.1159/000322105; Gangula PRR, 2007, AM J PHYSIOL-GASTR L, V292, pG725, DOI 10.1152/ajpgi.00406.2006; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Georgiev T, 2017, PHYSIOL RES, V66, P125, DOI 10.33549/physiolres.933373; Gopinath C, 2013, CYTOTHERAPY, V15, P869, DOI 10.1016/j.jcyt.2013.02.015; Goto K, 2010, PHARMACOL RES, V61, P466, DOI 10.1016/j.phrs.2009.12.001; Hagiwara SJ, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/173783; Hu WH, 2007, AM J PHYSIOL-CELL PH, V293, pC1991, DOI 10.1152/ajpcell.00300.2007; Huang J, 2005, AM J PHYSIOL-GASTR L, V288, pG23, DOI 10.1152/ajpgi.00305.2004; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Kakehi T, 2008, SEMIN IMMUNOPATHOL, V30, P301, DOI 10.1007/s00281-008-0122-7; Kashyap PC, 2010, AM J PHYSIOL-GASTR L, V298, pG1013, DOI 10.1152/ajpgi.00069.2010; Kato M, 2013, FREE RADICAL BIO MED, V64, P85, DOI 10.1016/j.freeradbiomed.2013.06.009; KUNISAKI M, 1994, DIABETES, V43, P1372, DOI 10.2337/diabetes.43.11.1372; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Magenta A, 2013, INT J MOL SCI, V14, P17319, DOI 10.3390/ijms140917319; McMurray F, 2011, MAMM GENOME, V22, P390, DOI 10.1007/s00335-011-9345-3; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Ohmasa F, 2011, J SEX MED, V8, P1638, DOI 10.1111/j.1743-6109.2011.02238.x; Ohtsuka M, 2015, J CLIN MED, V4, P1651, DOI 10.3390/jcm4081651; Pinho JF, 2010, BRIT J PHARMACOL, V161, P1458, DOI 10.1111/j.1476-5381.2010.00955.x; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; Singh J, 2016, AM J PHYSIOL-GASTR L, V311, pG964, DOI 10.1152/ajpgi.00290.2016; Southwell BR, 2008, J GASTROEN HEPATOL, V23, P505, DOI 10.1111/j.1440-1746.2008.05363.x; Srivastava KK, 2015, INDIAN J CLIN BIOCHE, V30, P3, DOI 10.1007/s12291-014-0441-5; Sriwai W, 2008, BIOCHEM J, V411, P543, DOI [10.1042/BJ20071299, 10.1042/bj20071299]; Takahashi T, 1996, AM J PHYSIOL-GASTR L, V270, pG411, DOI 10.1152/ajpgi.1996.270.3.G411; Tang WH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00087; Touw K, 2012, AM J PHYSIOL-GASTR L, V302, pG66, DOI 10.1152/ajpgi.00183.2011; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Varga ZV, 2013, J MOL CELL CARDIOL, V62, P111, DOI 10.1016/j.yjmcc.2013.05.009; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177; Wang XY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01336.x; Watkins CC, 2000, J CLIN INVEST, V106, P373, DOI 10.1172/JCI8273; Wrzos HF, 1997, DIGEST DIS SCI, V42, P2106, DOI 10.1023/A:1018830820537; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Yamamoto T, 2008, J GASTROEN HEPATOL, V23, P660, DOI 10.1111/j.1440-1746.2008.05326.x; Yan LJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/137919; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911	70	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178574	10.1371/journal.pone.0178574	http://dx.doi.org/10.1371/journal.pone.0178574			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678840	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200005
J	Shevelev, OB; Illarionova, NB; Petrovski, DV; Sarapultsev, AP; Chupakhin, ON; Moshkin, MP				Shevelev, O. B.; Illarionova, N. B.; Petrovski, D. V.; Sarapultsev, A. P.; Chupakhin, O. N.; Moshkin, M. P.			Effects of a compound from the group of substituted thiadiazines with hypothermia inducing properties on brain metabolism in rats, a study in vivo and in vitro	PLOS ONE			English	Article							MAGNETIC-RESONANCE; 1,3,4-THIADIAZINE DERIVATIVES; MODERATE HYPOTHERMIA; SPECTROSCOPY; MECHANISMS; PROTECTION; RECEPTORS; MARKER; INJURY	The aim of the present study was to examine how administration of a compound of 1,3,4-thiadiazine class 2-morpholino-5-phenyl-6H-1,3,4-thiadiazine, hydrobromide (L-17) with hypothermia inducing properties affects the brain metabolism. The mechanism by which L-17 induces hypothermia is unknown; it may involve hypothalamic central thermoregulation as well as act via inhibition of energy metabolism. We tested the hypothesis that L-17 may induce hypothermia by directly inhibiting energy metabolism. The study in vivo was carried out on Sprague-Dawley adult rats. Two doses of L-17 were administered (190 mg/kg and 760 mg/kg). Brain metabolites were analyzed in control and treated groups using magnetic resonance spectroscopy, along with blood flow rate measurements in carotid arteries and body temperature measurements. Further in vitro studies on primary cultures from rat hippocampus were carried out to perform a mitochondria function test of L-17 preincubation (100 mu M, 30 min). Analysis of brain metabolites showed no significant changes in 190 mg/kg treated group along with a significant reduction in body temperature by 1.5 degrees C. However, administration of L-17 in higher dose 760 mg/kg provoked changes in brain metabolites indicative of neurotoxicity as well as reduction in carotid arteries flow rate. In addition, a balance change of excitatory and inhibitory neurotransmitters was observed. The L-17 pre-incubation with cell primary cultures from rat brain showed no significant changes in mitochondrial function. The results obtained in the study indicate that acute administration of L-17 190 mg/kg in rats induces mild hypothermia with no adverse effects onto brain metabolism.	[Shevelev, O. B.; Illarionova, N. B.; Petrovski, D. V.; Moshkin, M. P.] Russian Acad Sci, Fed Res Ctr, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia; [Sarapultsev, A. P.] Russian Acad Sci, Inst Immunol & Physiol, Ural Branch, Ekaterinburg, Russia; [Sarapultsev, A. P.; Chupakhin, O. N.] Ural Fed Univ, Fed State Autonomous Educ Inst Higher Profess Edu, Ekaterinburg, Russia; [Chupakhin, O. N.] Russian Acad Sci, Inst Organ Synth, Ural Div, Ekaterinburg, Russia; [Moshkin, M. P.] Tomsk State Univ, Dept Vertebrate Zool, Tomsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Institute of Immunology & Physiology UB RAS; Russian Academy of Sciences; Ural Federal University; Russian Academy of Sciences; Postovsky Institute of Organic Synthesis, Ural Branch of Russian Academy of Sciences; Tomsk State University	Shevelev, OB (corresponding author), Russian Acad Sci, Fed Res Ctr, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia.	shevelev.oleg.nsk@gmail.com	Illarionova, Nina/AAO-3434-2020; Sarapultsev, Alexey P./K-7220-2012; Moshkin, Mikhail P./N-7620-2014; Chupakhin, Oleg/M-7633-2019; Shevelev, Oleg B/U-9436-2017	Sarapultsev, Alexey P./0000-0003-3101-9655; Chupakhin, Oleg/0000-0002-1672-2476; Shevelev, Oleg B/0000-0003-3200-958X	Russian Science Foundation [14-14-00221]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by the Russian Science Foundation (grant No 14-14-00221) http://www.rscf.ru/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisultanova N, 2014, IZV SAMAR NAUCHNOG 4, V16, P1205; Allen GI, 2013, STAT ANAL DATA MIN, V6, P302, DOI 10.1002/sam.11169; Arranz ME, 1999, BIOORGAN MED CHEM, V7, P2811, DOI 10.1016/S0968-0896(99)00221-7; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Blier P, 2002, NEUROPSYCHOPHARMACOL, V27, P301, DOI 10.1016/S0893-133X(02)00318-4; Carlin JL, 2016, J PHARMACOL EXP THER, V356, P474, DOI 10.1124/jpet.115.229872; Chaperon F, 2003, NEUROPHARMACOLOGY, V44, P1047, DOI 10.1016/S0028-3908(03)00113-8; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; EBISU T, 1994, J CEREBR BLOOD F MET, V14, P373, DOI 10.1038/jcbfm.1994.48; FREINKEL N, 1972, NEW ENGL J MED, V287, P841, DOI 10.1056/NEJM197210262871702; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gonzalez-Ibarra Fernando Pavel, 2011, Front Neurol, V2, P4, DOI 10.3389/fneur.2011.00004; Gordon CJ, 2008, TOXICOLOGY, V244, P87, DOI 10.1016/j.tox.2007.10.030; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Logvinova Y. S., 2010, Eksperimental'naya i Klinicheskaya Farmakologiya, V73, P21; Moshkin MP, 2014, NMR BIOMED, V27, P399, DOI 10.1002/nbm.3074; Novikova A.P., 1991, CHEM HETEROCYC COMPO, V27, P1159, DOI [10.1007/BF00471738, DOI 10.1007/BF00471738]; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rantsev MA, 2013, MED ALMANAC, V5, P92; Rawls Scott M, 2011, Front Biosci (Schol Ed), V3, P822; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V270, pR693, DOI 10.1152/ajpregu.1996.270.4.R693; Sahu JK, 2014, J ADV PHARM TECHNOL, V5, P90, DOI 10.4103/2231-4040.133434; Sarapultsev AP, 2014, CURR PHARM DESIGN, V20, P1980, DOI 10.2174/13816128113199990492; Sarapultsev AP, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9020027; Sarapultsev P, 2012, INT J EXP PATHOL, V93, P18, DOI 10.1111/j.1365-2613.2011.00794.x; Tuskova R, 2015, BEHAV BRAIN RES, V284, P257, DOI 10.1016/j.bbr.2015.02.016; Vasil'eva T. M., 2009, Eksperimental'naya i Klinicheskaya Farmakologiya, V72, P27; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Yang YJ, 2011, CHEM PHARM BULL, V59, P1016, DOI 10.1248/cpb.59.1016; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180739	10.1371/journal.pone.0180739	http://dx.doi.org/10.1371/journal.pone.0180739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678857	gold, Green Published			2022-12-27	WOS:000405272200089
J	Wan, X; Bovornchutichai, P; Cui, ZF; O'Neill, E; Ye, H				Wan, Xiao; Bovornchutichai, Phurit; Cui, Zhanfeng; O'Neill, Eric; Ye, Hua			Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: An oncogenic angiogenesis assay	PLOS ONE			English	Article							GROWTH	Antiangiogenic therapy for cancer is a strategy targeted at tumour vasculature, often in combination with conventional cytotoxicity treatments. Animal testing is still the most common method used for evaluating the efficacy of new drugs but tissue-engineered in vitro models are becoming more acceptable for replacing and reducing the use of animals in anti-cancer drug screening. In this study, a 3D co-culture model of human endothelial cells and ovarian cancer cells was developed. This model has the potential to mimic the interactions between endothelial cells and ovarian cancer cells. The feasibility of applying this model in drug testing was explored here. The complex morphology of the co-culture system, which features development of both endothelial tubule-like structures and tumour structures, was analysed quantitatively by an image analysis method. The co-culture morphology integrity was maintained for 10 days and the potential of the model for anti-cancer drug testing was evaluated using Paclitaxel and Cisplatin, two common anti-tumour drugs with different mechanisms of action. Both traditional cell viability assays and quantitative morphological analyses were applied in the drug testing. Cisplatin proved a good example showing the advantages of morphological analysis of the co-culture model when compared with mono-culture of endothelial cells, which did not reveal an inhibitory effect of Cisplatin on the tubule-like endothelial structures. Thus, the tubule areas of the co-culture reflected the anti-angiogenesis potential of Cisplatin. In summary, in vitro cancer models can be developed using a tissue engineering approach to more closely mimic the characteristics of tumours in vivo. Combined with the image analysis technique, this developed 3D co-culture angiogenesis model will provide more reproducible and reliably quantified results and reveal further information of the drug's effects on both tumour cell growth and tumour angiogenesis.	[Wan, Xiao; Bovornchutichai, Phurit; O'Neill, Eric] Univ Oxford, Med Sci Div, Dept Oncol, CRUK MRC Oxford Inst Radiat Oncol, Oxford, Oxon, England; [Bovornchutichai, Phurit; Cui, Zhanfeng; Ye, Hua] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Math Phys & Life Sci Div, Oxford, Oxon, England	University of Oxford; University of Oxford	O'Neill, E (corresponding author), Univ Oxford, Med Sci Div, Dept Oncol, CRUK MRC Oxford Inst Radiat Oncol, Oxford, Oxon, England.; Ye, H (corresponding author), Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Math Phys & Life Sci Div, Oxford, Oxon, England.	eric.oneill@oncology.ox.ac.uk; hua.ye@eng.ox.ac.uk	Ye, Hua/L-5408-2019	Ye, Hua/0000-0001-7613-6041; Wan, Xiao/0000-0003-3600-7928; Cui, Zhanfeng/0000-0002-9251-9752	Anandamahidol Foundation; National Centre of the Replacement, Refinement & Reduction of Animals in Research; China-Oxford-Scholarship-Fund - Cancer Research UK [A19277]; Cancer Research UK [19277] Funding Source: researchfish	Anandamahidol Foundation; National Centre of the Replacement, Refinement & Reduction of Animals in Research; China-Oxford-Scholarship-Fund - Cancer Research UK; Cancer Research UK(Cancer Research UK)	P.Bovornchutichai is funded by Anandamahidol Foundation. URL:http://www.ananda mahidolfoundation.org/en. Dr Xiao Wan is a Training Fellow funded by the National Centre of the Replacement, Refinement & Reduction of Animals in Research, and this study was partially funded by the China-Oxford-Scholarship-Fund URL: http://chinaoxford.org/Professor Eric O'Neill is funded by Cancer Research UK. URL: http://www.cancerresearchuk.org/ grant number A19277. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Arbelaez P, 2011, IEEE T PATTERN ANAL, V33, P898, DOI 10.1109/TPAMI.2010.161; Barber PR, 2003, J MICROSC-OXFORD, V211, P54, DOI 10.1046/j.1365-2818.2003.01205.x; Benton G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123312; Buess M, 2009, NEOPLASIA, V11, P987, DOI 10.1593/neo.09670; Chen Y, PLOS ONE, V7; Delibasis KK, 2010, COMPUT METH PROG BIO, V100, P108, DOI 10.1016/j.cmpb.2010.03.004; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Ingthorsson Saevar, 2010, BMC Res Notes, V3, P184, DOI 10.1186/1756-0500-3-184; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; L'Azou B, 2005, CELL BIOL TOXICOL, V21, P127, DOI 10.1007/s10565-005-0172-8; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Logan DJ, 2016, METHODS, V96, P6, DOI 10.1016/j.ymeth.2015.12.002; Reynolds PM, 2013, NANO LETT, V13, P570, DOI 10.1021/nl304097p; Russ J. C., 2011, IMAGE PROCESSING HDB, P235; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Seaman ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020807; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Vacca A, 2002, J HEMATOTH STEM CELL, V11, P103, DOI 10.1089/152581602753448577; Wan X, 2016, BIOTECHNOL LETT, V38, P1389, DOI 10.1007/s10529-016-2035-1; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569	25	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180296	10.1371/journal.pone.0180296	http://dx.doi.org/10.1371/journal.pone.0180296			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671994	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500040
J	Wang, F; Zhang, T; Kang, YW; He, JL; Li, SM; Li, SW				Wang, Feng; Zhang, Tao; Kang, Yan Wei; He, Jing Liang; Li, Shi-Ming; Li, Shao-Wei			Endothelial keratoplasty versus repeat penetrating keratoplasty after failed penetrating keratoplasty: A systematic review and meta-analysis	PLOS ONE			English	Review							GRAFT-REJECTION; OUTCOMES; RISK; EYES; SURVIVAL; REGRESSION; QUALITY; FAILURE; TRIALS	Objective This study sought to compare graft survival, graft rejection and the visual acuity outcome of endothelial keratoplasty (EK) with repeat penetrating keratoplasty (PK) after failed PK. Methods A systematic literature search with subsequent screening of the identified articles was conducted to obtain potentially eligible randomized clinical trials (RCTs) and comparative cohort studies. To assess the methodological quality of the included studies, the Jadad Scale or Newcastle-Ottawa Scale (NOS) was used based on the study design. To calculate the pooled odds ratios (ORs) for graft survival, graft rejection and the visual acuity outcome with 95% confidential intervals (CIs), a fixed-or random-effects model was applied based on the heterogeneity across studies. Results Four comparative cohort studies (n = 649 eyes) comparing the outcome of EK with repeat PK after failed PK were included in this review. These studies were considered high quality, with NOS scores ranging from 6 to 9. The EK group showed a significantly lower risk of graft rejection than the repeat PK group [0.43 (95% CI: 0.23-0.80, P = 0.007)]. In addition, no significant differences were observed in a comparison of graft survival and visual acuity (P values ranged from 0.81 to 0.97 using the Der-Simonian and Laird random-effects model). Conclusions As an alternative to repeat PK, EK after failed PK allows for potential reduction of the risk of graft rejection; however, it does not appear to confer a significant advantage in graft survival or visual acuity.	[Wang, Feng; Zhang, Tao; Kang, Yan Wei; He, Jing Liang; Li, Shao-Wei] Cent South Univ, Aier Sch Ophthalmol, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Li, Shi-Ming] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing Ophthalmol Visual Sci Key Lab, Beijing, Peoples R China	Central South University; Capital Medical University	Li, SW (corresponding author), Cent South Univ, Aier Sch Ophthalmol, Dept Ophthalmol, Changsha, Hunan, Peoples R China.; Li, SM (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing Ophthalmol Visual Sci Key Lab, Beijing, Peoples R China.	lishiming81@163.com; lishaowei@csu.edu.cn	Wang, Feng/AAT-9232-2021	Wang, Feng/0000-0002-0364-718X; Li, Shaowei/0000-0002-3108-3684	Aier Eye Hospital Group Scientific Research Project [AFI44D11]; Hunan Provincial Natural Science Foundation of China [2017JJ2001]	Aier Eye Hospital Group Scientific Research Project; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This work was supported by the Aier Eye Hospital Group Scientific Research Project Grant (No. AFI44D11) as well as Hunan Provincial Natural Science Foundation of China (No. 2017JJ2001).	Al-Mezaine H, 2006, BRIT J OPHTHALMOL, V90, P324, DOI 10.1136/bjo.2005.079624; Al-Yousuf N, 2004, BRIT J OPHTHALMOL, V88, P998, DOI 10.1136/bjo.2003.031948; Allan BDS, 2007, CORNEA, V26, P1039, DOI 10.1097/ICO.0b013e31812f66e5; Ang M, 2014, AM J OPHTHALMOL, V158, P1221, DOI 10.1016/j.ajo.2014.08.024; Anshu A, 2012, OPHTHALMOLOGY, V119, P536, DOI 10.1016/j.ophtha.2011.09.019; Anshu A, 2011, OPHTHALMOLOGY, V118, P2155, DOI 10.1016/j.ophtha.2011.04.032; Anshu A, 2011, AM J OPHTHALMOL, V151, P442, DOI 10.1016/j.ajo.2010.09.002; Atkinson Kayla M, 2015, Res Synth Methods, V6, P87, DOI 10.1002/jrsm.1127; Berkey CS, 1998, STAT MED, V17, P2537, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2537::AID-SIM953>3.0.CO;2-C; Bersudsky V, 2001, OPHTHALMOLOGY, V108, P461, DOI 10.1016/S0161-6420(00)00544-3; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Chaurasia S, 2014, ACTA OPHTHALMOL, V92, P167, DOI [10.1111/aos.12033, 10.1111/aos.12229]; Claesson M, 2013, CORNEA, V32, P1026, DOI 10.1097/ICO.0b013e31828a2810; Clark HD, 1999, CONTROL CLIN TRIALS, V20, P448, DOI 10.1016/S0197-2456(99)00026-4; Covert DJ, 2007, CORNEA, V26, P692, DOI 10.1097/ICO.0b013e31805fc38f; de Paula FH, 2012, CORNEA, V31, P645, DOI 10.1097/ICO.0b013e31823f8c59; Ezon I, 2013, OPHTHALMOLOGY, V120, P1360, DOI 10.1016/j.ophtha.2012.12.036; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z; Keane MC, 2016, BRIT J OPHTHALMOL, V100, P1569, DOI 10.1136/bjophthalmol-2015-307792; Kelly TL, 2011, OPHTHALMOLOGY, V118, P1538, DOI 10.1016/j.ophtha.2011.01.002; KITZMANN A, 2012, INT OPHTHALMOL, V32, P15, DOI DOI 10.1007/S10792-012-9518-4; Lee BS, 2011, CLIN EXP OPHTHALMOL, V39, P195, DOI 10.1111/j.1442-9071.2010.02461.x; Lee WB, 2009, OPHTHALMOLOGY, V116, P1818, DOI 10.1016/j.ophtha.2009.06.021; Mitry D, 2014, JAMA OPHTHALMOL, V132, P742, DOI 10.1001/jamaophthalmol.2014.352; Nottage JM, 2012, BRIT J OPHTHALMOL, V96, P24, DOI 10.1136/bjo.2010.199794; Patel NP, 2000, OPHTHALMOLOGY, V107, P719, DOI 10.1016/S0161-6420(00)00003-8; Price FW, 2011, AM J OPHTHALMOL, V151, P187, DOI 10.1016/j.ajo.2010.09.033; Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078; Price MO, 2009, BRIT J OPHTHALMOL, V93, P391, DOI 10.1136/bjo.2008.140038; Price MO, 2007, CURR OPIN OPHTHALMOL, V18, P290, DOI 10.1097/ICU.0b013e3281a4775b; Price MO, 2006, OPHTHALMOLOGY, V113, P1936, DOI 10.1016/j.ophtha.2006.05.034; Ramamurthy S, 2016, AM J OPHTHALMOL, V162, P83, DOI 10.1016/j.ajo.2015.11.004; Rao SK, 2008, AM J OPHTHALMOL, V145, P991, DOI 10.1016/j.ajo.2008.01.017; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Terry MA, 2008, OPHTHALMOLOGY, V115, P1179, DOI 10.1016/j.ophtha.2007.09.005; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Weisbrod DJ, 2003, CORNEA, V22, P429, DOI 10.1097/00003226-200307000-00008	39	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180468	10.1371/journal.pone.0180468	http://dx.doi.org/10.1371/journal.pone.0180468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671976	gold, Green Submitted, Green Published			2022-12-27	WOS:000405268500056
J	Carlino, E; De Caro, L; Giannini, C; Fanti, G				Carlino, Elvio; De Caro, Liberato; Giannini, Cinzia; Fanti, Giulio			Atomic resolution studies detect new biologic evidences on the Turin Shroud	PLOS ONE			English	Article							OF-TURIN; ELECTRON NANODIFFRACTION; NANOPARTICLES; FERRITIN; MATTER	We performed reproducible atomic resolution Transmission Electron Microscopy and Wide Angle X-ray Scanning Microscopy experiments studying for the first time the nanoscale properties of a pristine fiber taken from the Turin Shroud. We found evidence of biologic nanoparticles of creatinine bounded with small nanoparticles of iron oxide. The kind, size and distribution of the iron oxide nanoparticles cannot be dye for painting but are ferrihydrate cores of ferritin. The consistent bound of ferritin iron to creatinine occurs in human organism in case of a severe polytrauma. Our results point out that at the nanoscale a scenario of violence is recorded in the funeral fabric and suggest an explanation for some contradictory results so far published.	[Carlino, Elvio] CNR, Lab Tecnol Avanzate Superfici & Catalisi, Ist Officina Mat, Area Sci Pk Basovizza, Trieste, Italy; [De Caro, Liberato; Giannini, Cinzia] CNR, Ist Cristallog, Bari, Italy; [Fanti, Giulio] Univ Padua, Dept Ind Engn, Padua, Italy; [Carlino, Elvio] CNR, Ist Microelettron & Microsistemi, Sez Lecce, Campus Univ,Via Monteroni, Lecce, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Microelettronica e Microsistemi (IMM-CNR)	Carlino, E (corresponding author), CNR, Lab Tecnol Avanzate Superfici & Catalisi, Ist Officina Mat, Area Sci Pk Basovizza, Trieste, Italy.; Carlino, E (corresponding author), CNR, Ist Microelettron & Microsistemi, Sez Lecce, Campus Univ,Via Monteroni, Lecce, Italy.	carlino@iom.cnr.it	Carlino, Elvio/C-3607-2015	Carlino, Elvio/0000-0003-0285-7297; GIANNINI, CINZIA/0000-0003-0983-2885; DECARO, LIBERATO/0000-0002-7927-6178	Progetto Premiale MIUR USCEF [DFM.AD006.077.001]	Progetto Premiale MIUR USCEF(Ministry of Education, Universities and Research (MIUR))	The work was funded by Progetto Premiale MIUR 2013 USCEF DFM.AD006.077.001. There was no additional external funding received for this study.	Altamura D, 2012, J APPL CRYSTALLOGR, V45, P869, DOI 10.1107/S0021889812025733; Baalousha M, 2009, SCI TOTAL ENVIRON, V407, P2093, DOI 10.1016/j.scitotenv.2008.11.022; Baima P. Bollone, 1981, SINDON, V30, P5; Banerji B, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1452-2; Chen LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119427; DAMON PE, 1989, NATURE, V337, P611, DOI 10.1038/337611a0; de Abreu KLS, 2010, INDIAN J CRIT CARE M, V14, P121, DOI 10.4103/0972-5229.74170; de Oliveira LFC, 2002, ANALYST, V127, P536, DOI 10.1039/b111473p; Fanti G, 2011, J IMAGING SCI TECHN, V55, DOI 10.2352/J.ImagingSci.Technol.2011.55.6.060507; Fanti G, 2010, J IMAGING SCI TECHN, V54, DOI 10.2352/J.ImagingSci.Technol.2010.54.4.040201; Fanti G, 2017, J CULTURAL HERITAGE; Fanti G., 2014, ATSI 2014 WORKSH ADV; Fanti G, 2015, SHROUD TURIN 1 CENTU, DOI [10.1201/b18627-11, DOI 10.1201/b18627-11]; Fanti G, 2015, MATEC WEB CONF, V36, DOI 10.1051/matecconf/20153601001; Frache G., 1977, OSSERVAZIONI PERIZIE, P49; Franceschi E., 2014, OPEN ACCESS LIB J, V1, pe437; Glaeser RM, 2011, BIOPHYS J, V100, P2331, DOI 10.1016/j.bpj.2011.04.018; HARRISON PM, 1967, NATURE, V216, P1188, DOI 10.1038/2161188a0; Harrison PM, 1986, BIOCHEM EDUC, V14, P4; Hasa D, 2016, CRYST GROWTH DES, V16, P1772, DOI 10.1021/acs.cgd.6b00084; Hasa D, 2013, MOL PHARMACEUT, V10, P211, DOI 10.1021/mp300371f; Heller J. H., 1981, CANADIAN SOC FORENSI, V14, P81, DOI DOI 10.1080/00085030.1981.10756882; HELLER JH, 1980, APPL OPTICS, V19, P2742, DOI 10.1364/AO.19.002742; Hirsch PB, 1977, ELECT MICROSCOPY THI; Janney DE, 2000, AM MINERAL, V85, P1180, DOI 10.2138/am-2000-8-910; Jumper E. J., 1984, ACS ADV CHEM, V205, DOI DOI 10.1021/ADVANCES; Klepper MJ, 2010, DRUG SAFETY DATA, P83; Konz T, 2014, ANALYST, V139, P5451, DOI 10.1039/c4an01187b; MCCRONE WC, 1980, MICROSCOPE, V28, P105; Pan YH, 2009, J STRUCT BIOL, V166, P22, DOI 10.1016/j.jsb.2008.12.001; PENNYCOOK SJ, 1990, PHYS REV LETT, V64, P938, DOI 10.1103/PhysRevLett.64.938; Quintana C, 2004, J STRUCT BIOL, V147, P166, DOI 10.1016/j.jsb.2004.03.001; Reimer L., 1984, TRANSMISSION ELECT M; Riani M, 2012, J STAT COMPUTING; Richter GW, 1958, J BIOPHYSIC CYTOL, V4, P1; Rogers RN, 2005, THERMOCHIM ACTA, V425, P189, DOI 10.1016/j.tca.2004.09.029; SCHWALBE LA, 1982, ANAL CHIM ACTA, V135, P3, DOI 10.1016/S0003-2670(01)85263-6; SCHWARTZ JG, 1988, CLIN CHEM, V34, P898; Schwortz BM, 1982, IEEE 1982 P INT C CY, P538; Sibillano T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06985; TOWE KM, 1967, J COLLOID INTERF SCI, V24, P384, DOI 10.1016/0021-9797(67)90266-4; Wilson I., 1986, MYSTERIOUS SHROUD	42	4	4	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180487	10.1371/journal.pone.0180487	http://dx.doi.org/10.1371/journal.pone.0180487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666007	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700012
J	Ingelbeen, B; Bah, EI; Decroo, T; Balde, I; Nordenstedt, H; van Griensven, J; De Weggheleire, A				Ingelbeen, Brecht; Bah, Elhadj Ibrahima; Decroo, Tom; Balde, Idrissa; Nordenstedt, Helena; van Griensven, Johan; De Weggheleire, Anja			Mortality among PCR negative admitted Ebola suspects during the 2014/15 outbreak in Conakry, Guinea: A retrospective cohort study	PLOS ONE			English	Article							VIRUS DISEASE; SIERRA-LEONE	Non-cases are suspect Ebola Virus Disease (EVD) cases testing negative by EVD RT-PCR after admission to an Ebola Treatment Centre (ETC). Admitting non-cases to an ETC prompts concerns on case-and workload in the ETC, risk for nosocomial EVD infection, and delays in diagnosis and disease-specific treatment. We retrospectively analysed characteristics, outcomes and determinants of death of EVD cases and non-cases admitted to the Conakry ETC in Guinea between 03/2014 and 09/2015. Of the 2362 admitted suspects who underwent full confirmatory PCR testing, 1540 (65.2%) were non-cases; among them 727 needed repeated confirmatory PCR testing resulting in 2.5 days (average) in the ETC isolation ward. Twenty-one patients tested positive on the repeat test, most in a period of flawed sampling for the initial test and none after introduction of PCR confirmation with geneXpert. No readmissions following nosocomial EVD infection were recorded. No combination of symptoms yielded acceptable sensitivity and specificity to allow differentiating confirmed from non-cases. Symptoms as ocular bleeding/redness have high specificity, but limited usefulness as not common. Admission delay and age distribution were not different for both groups. In total, 98 (20.6%) of 475 deaths in the ETC were non-cases. Most died within 24 hours after admission. Living in Conakry (aOR 1.78 (1.08-2.96)) was the strongest risk factor for death. Weeks with higher admission load had lower case fatality among non-cases, probably because more acute (and treatable) illnesses of contacts of known cases were admitted. These findings show high numbers of potentially critically ill non-cases need to be considered when setting up triage and referral of EVD suspect cases. Symptoms and risk factors alone do not allow differentiating the non-cases. Integration of highly-sensitive EVD diagnostic methods with short turnaround time in the triage of peripheral hospitals and dropping the systematic 2nd PCR for symptomatic early presenters could limit delays in access to adapted care of cases and seriously ill non-cases. Whether feasible without compromising outbreak control, and under which conditions, should be further assessed.	[Ingelbeen, Brecht; Bah, Elhadj Ibrahima; Balde, Idrissa; Nordenstedt, Helena] Operat Ctr Brussels, Med Sans Frontieres, Conakry, Guinea; [Bah, Elhadj Ibrahima; Balde, Idrissa] Ctr Hosp Univ Donka, Conakry, Guinea; [Decroo, Tom] Operat Ctr Brussels, Operat Res Unit, Med Sans Frontieres, Brussels, Belgium; [Nordenstedt, Helena] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [van Griensven, Johan; De Weggheleire, Anja] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium	Doctors Without Borders; Karolinska Institutet; Institute of Tropical Medicine (ITM)	Ingelbeen, B (corresponding author), Operat Ctr Brussels, Med Sans Frontieres, Conakry, Guinea.	brechtingelbeen@gmail.com	Decroo, Tom/AAV-7208-2020; De Weggheleire, Anja/C-7345-2018	Decroo, Tom/0000-0002-1205-1484; De Weggheleire, Anja/0000-0001-9377-4766; Ingelbeen, Brecht/0000-0002-2214-6858	Medecins Sans Frontieres. Medecins Sans Frontieres	Medecins Sans Frontieres. Medecins Sans Frontieres	This research received no specific funding. It was carried out during and following patient management at the Conakry Ebola treatment centre supported by Medecins Sans Frontieres. Medecins Sans Frontieres provided funding for the publication fee.	Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Brolin Ribacke KJ, 2016, FRONT PUBLIC HEAL, V4, P1; Cheng X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145422; Edwards Justin D., 2015, INTRO TECHNOLOGIES G, P1; Farge E., 2014, EXCLUSIVE GUINEA SAY; Fitzpatrick G, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.40.20924; Fitzpatrick G, 2015, J INFECT DIS; Lado M, 2015, LANCET INFECT DIS, V15, P1024, DOI 10.1016/S1473-3099(15)00137-1; Levine AC, 2015, ANN EMERG MED, V66, P285, DOI 10.1016/j.annemergmed.2015.03.011; Li WG, 2016, ONCOTARGET, V7, P27910, DOI 10.18632/oncotarget.8558; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Semper AE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001980; Van den Bergh R, 2016, EMERG INFECT DIS J, V22; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; van Vuren PJ, 2016, J CLIN MICROBIOL, V54, P359, DOI 10.1128/JCM.02724-15; WHO CDC, 2014, TECHN GUID INT DIS S; World Health Organization, 2016, SIT EP MIOL HEBD EP	17	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180070	10.1371/journal.pone.0180070	http://dx.doi.org/10.1371/journal.pone.0180070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665950	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700059
J	Talsma, DT; Katta, K; Boersema, M; Adepu, S; Naggi, A; Torri, G; Stegeman, C; Navis, G; van Goor, H; Hillebrands, JL; Yazdani, S; van den Born, J				Talsma, Ditmer T.; Katta, Kirankumar; Boersema, Miriam; Adepu, Saritha; Naggi, Annamaria; Torri, Giangiacomo; Stegeman, Coen; Navis, Gerjan; van Goor, Harry; Hillebrands, Jan-Luuk; Yazdani, Saleh; van den Born, Jacob			Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin	PLOS ONE			English	Article							DENDRITIC CELLS; ALLOGRAFT-REJECTION; ENDOTHELIAL-CELLS; INFLAMMATION; LYMPHANGIOGENESIS; SULFATE; SKIN; RAT; DIFFERENTIATION; PROTEOGLYCANS	Background Chronic renal transplant dysfunction is characterized by loss of renal function and tissue remodeling, including chronic inflammation and lymph vessel formation. Proteoglycans are known for their chemokine presenting capacity. We hypothesize that interruption of the lymphatic chemokine-proteoglycan interaction interferes with the lymphatic outflow of leukocytes from the renal graft and might decrease the anti-graft allo-immune response. Methods In a rat renal chronic transplant dysfunction model (female Dark-Agouti to male Wistar Furth), chemokines were profiled by qRT-PCR in microdissected tubulo-interstitial tissue. Disruption of lymphatic chemokine-proteoglycan interaction was studied by (non-anticoagulant) heparin-derived polysaccharides in vitro and in renal allografts. The renal allograft function was assessed by rise in plasma creatinine and urea. Results Within newly-formed lymph vessels of transplanted kidneys, numerous CD45(+) leukocytes were found, mainly MHCII+, ED-1(-), IDO-, HIS14(-), CD103(-) antigen presenting cells, most likely representing a subset of dendritic cells. Treatment of transplanted rats with regular heparin and two different (non-)anticoagulant heparin derivatives revealed worsening of kidney function only in the glycol-split heparin treated group despite a two-fold reduction of tubulo-interstitial leukocytes (p<0.02). Quantitative digital image analysis however revealed increased numbers of intra-lymphatic antigen-presenting cells only in the glycol-split heparin group (p<0.01). The number of intra-lymphatic leukocytes significantly correlates with plasma creatinine and urea, and inversely with creatinine clearance. Conclusions Treatment of transplanted rats with glycol-split heparin significantly increases the number of intra-lymphatic antigen presenting cells, by increased renal diffusion of lymphatic chemokines, thereby increasing the activation and recruitment of antigen presenting cells towards the lymph vessel. This effect is unwanted in the transplantation setting, but might be advantageous in e.g., dendritic cell vaccination.	[Talsma, Ditmer T.; Katta, Kirankumar; Adepu, Saritha; Stegeman, Coen; Navis, Gerjan; Yazdani, Saleh; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Boersema, Miriam; van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Naggi, Annamaria; Torri, Giangiacomo] Ronzoni Inst, Milan, Italy	University of Groningen; University of Groningen	Talsma, DT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.	d.t.talsma@umcg.nl	van+Goor, Harry/AAS-7712-2020	van Goor, Harry/0000-0002-6670-1577; Stegeman, Coen/0000-0002-0224-0927; Torri, Giangiacomo/0000-0002-2077-1203; Adepu, Saritha/0000-0002-8617-9421; Hillebrands, Jan-Luuk/0000-0003-3135-3274	graduate school of Medical Sciences of the University Medical Center of Groningen	graduate school of Medical Sciences of the University Medical Center of Groningen	The graduate school of Medical Sciences of the University Medical Center of Groningen provided financial support to DT, KK, MB, SA, SY in the form of PhD stipends. The authors received no specific funding for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was financially supported by the graduate school of Medical Sciences of the University Medical Center of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Pramod Agarwal, Peter Zwiers, Marian Bulthuis, Andre A Zandvoort, Michel Weij, Annemieke Smit-van Oosten and Melinda Sammary for their excellent technical assistance.	Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Asgeirsdottir SA, 2002, ANN NY ACAD SCI, V973, P586, DOI 10.1111/j.1749-6632.2002.tb04704.x; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Boersema M, 2012, AM J TRANSPLANT, V12, P1429, DOI 10.1111/j.1600-6143.2012.04001.x; Braun C, 2001, TRANSPLANTATION, V72, P209, DOI 10.1097/00007890-200107270-00007; Casu B, 2004, J MED CHEM, V47, P838, DOI 10.1021/jm030893g; Casu B, 2002, SEMIN THROMB HEMOST, V28, P335, DOI 10.1055/s-2002-34302; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; Cui Y, 2015, J CLIN INVEST, V125, P4255, DOI 10.1172/JCI79693; Dias-Baruffi M, 1998, GLYCOCONJUGATE J, V15, P523, DOI 10.1023/A:1006995222189; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Ezzelarab M, 2011, SEMIN IMMUNOL, V23, P252, DOI 10.1016/j.smim.2011.06.007; Frank RD, 2005, J THROMB HAEMOST, V3, P531, DOI 10.1111/j.1538-7836.2005.01188.x; Frank RD, 2006, THROMB HAEMOSTASIS, V96, P802, DOI 10.1160/TH06-07-0418; Gottmann U, 2007, TRANSPL INT, V20, P542, DOI 10.1111/j.1432-2277.2007.00471.x; Hansson M, 2006, MICROBES INFECT, V8, P841, DOI 10.1016/j.micinf.2005.10.007; Huber S, 2007, KIDNEY INT, V71, P771, DOI 10.1038/sj.ki.5002112; Ingulli E, 2010, PEDIATR NEPHROL, V25, P61, DOI 10.1007/s00467-008-1020-x; Johns SC, 2016, CIRC RES, V119, P210, DOI 10.1161/CIRCRESAHA.116.308504; Johnson LA, 2014, ANGIOGENESIS, V17, P335, DOI 10.1007/s10456-013-9407-0; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; KROESE FGM, 1987, EUR J IMMUNOL, V17, P921, DOI 10.1002/eji.1830170705; Kusyk T, 2005, TRANSPL P, V37, P1026, DOI 10.1016/j.transproceed.2005.02.018; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353; Nykanen AI, 2010, CIRCULATION, V121, P1413, DOI 10.1161/CIRCULATIONAHA.109.910703; Rienstra H, 2009, AM J TRANSPLANT, V9, P463, DOI 10.1111/j.1600-6143.2008.02534.x; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Saeki H, 1999, J IMMUNOL, V162, P2472; Shapira OM, 1999, J SURG RES, V85, P83, DOI 10.1006/jsre.1999.5667; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Solez K, 2007, AM J TRANSPLANT, V7, P2834, DOI 10.1111/j.1600-6143.2007.02001.x; Spirig R, 2008, MOL IMMUNOL, V45, P4084, DOI 10.1016/j.molimm.2008.07.024; Tan SM, 2013, CYTOTHERAPY, V15, P492, DOI 10.1016/j.jcyt.2012.12.002; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Yazdani S, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.18; Yin X, 2014, J IMMUNOL, V192, P2133, DOI 10.4049/jimmunol.1301286; Zheng YX, 2011, MOL VIS, V17, P1694	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180206	10.1371/journal.pone.0180206	http://dx.doi.org/10.1371/journal.pone.0180206			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665959	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608700071
J	Treves, A; Rabenhorst, MF				Treves, Adrian; Rabenhorst, Mark F.			Risk map for wolf threats to livestock still predictive 5 years after construction	PLOS ONE			English	Article							HUMAN-CARNIVORE CONFLICT; SPATIAL MODEL; PREDATION	Risk maps are spatial models of environmental hazards such as predation on livestock. We tested the long-term validity of a published risk map built from locations where Wisconsin wolves attacked livestock from 1999-2006. Using data collected after model construction, we verified the predictive accuracy of the risk map exceeded 91% for the period 2007-2011. Predictive power lasting 5 years or more substantiates the claim that risk maps are both valid and verified tools for anticipating spatial hazards. Classification errors coincided with verifier uncertainty about which wolves might be responsible. Perceived threats by wolves to domestic animals were not as well predicted (82%) as verified attacks had been and errors in classification coincided with incidents involved domestic animals other than bovids and verifier uncertainty about which wolves were involved. We recommend risk maps be used to target interventions selectively at high-risk sites.	[Treves, Adrian] Univ Wisconsin Madison, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Rabenhorst, Mark F.] Carnivore Coexistence Lab, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Treves, A (corresponding author), Univ Wisconsin Madison, Nelson Inst Environm Studies, Madison, WI 53706 USA.	atreves@wisc.edu	Treves, Adrian/P-3707-2018	Treves, Adrian/0000-0002-3052-4708				Edge JL, 2011, WILDLIFE BIOL, V17, P1, DOI 10.2981/10-043; Miller JRB, 2016, WILDLIFE SOC B, V40, P806, DOI 10.1002/wsb.720; Miller JRB, 2015, BIODIVERS CONSERV, V24, P2887, DOI 10.1007/s10531-015-0993-6; Miller JRB, 2015, ECOL EVOL, V5, P1354, DOI 10.1002/ece3.1440; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2002, WILDLIFE SOC B, V30, P231; Treves A., 2015, DATA ARCH; Treves A, 2016, FRONT ECOL ENVIRON, V14, P380, DOI 10.1002/fee.1312; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5	10	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180043	10.1371/journal.pone.0180043	http://dx.doi.org/10.1371/journal.pone.0180043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665979	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608700057
J	Abade, E; Sampaio, J; Goncalves, B; Baptista, J; Alves, A; Viana, J				Abade, Eduardo; Sampaio, Jaime; Goncalves, Bruno; Baptista, Jorge; Alves, Alberto; Viana, Joao			Effects of different re-warm up activities in football players' performance	PLOS ONE			English	Article							POST-ACTIVATION POTENTIATION; POSTACTIVATION POTENTIATION; SOCCER PLAYERS; PLYOMETRIC EXERCISE; ECCENTRIC EXERCISE; INJURY PREVENTION; SPORTS-MEDICINE; REPEATED-SPRINT; UP STRATEGIES; VERTICAL JUMP	Warm up routines are commonly used to optimize football performance and prevent injuries. Yet, official pre-match protocols may require players to passively rest for approximately 10 to 15 minutes between the warm up and the beginning of the match. Therefore, the aim of this study was to explore the effect of different re-warm up activities on the physical performance of football players. Twenty-Two Portuguese elite under-19 football players participated in the study conducted during the competitive season. Different re-warm up protocols were performed 6 minutes after the same standardized warm up in 4 consecutive days in a crossover controlled approach: without, eccentric, plyometric and repeated changes of direction. Vertical jump and Sprint performances were tested immediately after warm up and 12 minutes after warm up. Results showed that repeated changes of direction and plyometrics presented beneficial effects to jump and sprint. Different practical implications may be taken from the eccentric protocol since a vertical jump impairment was observed, suggesting a possibly harmful effect. The absence of re-warm up activities may be detrimental to players' physical performance. However, the inclusion of re-warm up prior to match is a complex issue, since the manipulation of volume, intensity and recovery may positively or negatively affect the subsequent performance. In fact, this exploratory study shows that eccentric exercise may be harmful for physical performance when performed prior a football match. However, plyometric and repeated changes of direction exercises seem to be simple, quick and efficient activities to attenuate losses in vertical jump and sprint capacity after warm up. Coaches should aim to develop individual optimal exercise modes in order to optimize physical performance after re warm activities.	[Abade, Eduardo; Sampaio, Jaime; Goncalves, Bruno; Baptista, Jorge; Alves, Alberto; Viana, Joao] Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, Evora, Portugal; [Abade, Eduardo; Baptista, Jorge; Alves, Alberto; Viana, Joao] Univ Inst Maia, ISMAI, Maia, Portugal; [Sampaio, Jaime; Goncalves, Bruno] Univ Tras Os Montes & Alto Douro, UTAD, Vila Real, Portugal	Instituto Universitario da Maia (ISMAI); University of Tras-os-Montes & Alto Douro	Abade, E (corresponding author), Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, Evora, Portugal.; Abade, E (corresponding author), Univ Inst Maia, ISMAI, Maia, Portugal.	eduardoabade@gmail.com	Sampaio, Jaime/B-7392-2008; Viana, João L/V-8946-2017; Gonçalves, Bruno/M-5361-2013	Sampaio, Jaime/0000-0003-2335-9991; Viana, João L/0000-0002-9147-7781; Gonçalves, Bruno/0000-0001-7874-4104; Alves, Alberto/0000-0001-9484-7349; Abade, Eduardo Andre de Azevedo/0000-0002-4766-896X	Portuguese Foundation for Science and Technology [UID/DTP/04045/2013]; European Regional Development Fund, through COMPETE 2020 [POCI-01-0145-FEDER-006969]; European Regional Development Fund [NORTE-01-0145-FEDER-000016]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Regional Development Fund, through COMPETE 2020; European Regional Development Fund(European Commission)	CIDESD is a research unit supported by the Portuguese Foundation for Science and Technology, (UID/DTP/04045/2013) and by the European Regional Development Fund, through COMPETE 2020 (POCI-01-0145-FEDER-006969). This research is part of NanoSTIMA: Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics, funded by the European Regional Development Fund, through NORTE 2020 (NORTE-01-0145-FEDER-000016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banister EW, 1999, EUR J APPL PHYSIOL O, V79, P182, DOI 10.1007/s004210050493; Barengo NC, 2014, INT J ENV RES PUB HE, V11, P11986, DOI 10.3390/ijerph111111986; Bishop D, 2003, SPORTS MED, V33, P483, DOI 10.2165/00007256-200333070-00002; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Brandenburg JP, 2005, J STRENGTH COND RES, V19, P427; Brockett CL, 2001, MED SCI SPORT EXER, V33, P783; Byrne PJ, 2014, J STRENGTH COND RES, V28, P610, DOI 10.1519/JSC.0b013e3182a0d8c1; Chiu LZF, 2003, J STRENGTH COND RES, V17, P671, DOI 10.1519/1533-4287(2003)017<0671:PPRIAA>2.0.CO;2; Dellal A, 2010, J STRENGTH COND RES, V24, P3219, DOI 10.1519/JSC.0b013e3181b94a63; Dello Iacono A, 2016, J STRENGTH COND RES, V30, P3122, DOI 10.1519/JSC.0000000000001393; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Edholm P, 2015, SCAND J MED SCI SPOR, V25, pE40, DOI 10.1111/sms.12236; Fatouros IG, 2000, J STRENGTH COND RES, V14, P470; Fauth ML, 2010, J STRENGTH COND RES, V24, P1131, DOI 10.1519/JSC.0b013e3181cc2353; Fredrick GA, 2001, STRENGTH COND J, V23, P21, DOI 10.1519/1533-4295(2001)023<0021:BPIDF>2.0.CO;2; Hader K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149839; Hodgson M, 2005, SPORTS MED, V35, P585, DOI 10.2165/00007256-200535070-00004; Hoff J, 2004, SPORTS MED, V34, P165, DOI 10.2165/00007256-200434030-00003; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kilduff LP, 2013, J SCI MED SPORT, V16, P482, DOI 10.1016/j.jsams.2012.11.889; Masamoto N, 2003, J STRENGTH COND RES, V17, P68; McGowan CJ, 2015, SPORTS MED, V45, P1523, DOI 10.1007/s40279-015-0376-x; Mjolsnes R, 2004, SCAND J MED SCI SPOR, V14, P311, DOI 10.1046/j.1600-0838.2003.367.x; Opar DA, 2012, SPORTS MED, V42, P209, DOI 10.2165/11594800-000000000-00000; Proske U, 2005, EXERC SPORT SCI REV, V33, P98, DOI 10.1097/00003677-200504000-00007; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; Quagliarella L, 2010, J STRENGTH COND RES, V24, P1229, DOI 10.1519/JSC.0b013e3181cb281a; Russell M, 2015, SPORTS MED, V45, P353, DOI 10.1007/s40279-014-0297-0; Sale D, 2004, BRIT J SPORT MED, V38, P386, DOI 10.1136/bjsm.2002.003392; SARGEANT AJ, 1987, EUR J APPL PHYSIOL, V56, P693, DOI 10.1007/BF00424812; Sayers A, 2008, STRENGTH COND J, V30, P56, DOI 10.1519/SSC.0b013e31817f985d; SCHOT P, 1995, J ORTHOP SPORT PHYS, V22, P254, DOI 10.2519/jospt.1995.22.6.254; Sotiropoulos K, 2010, J SPORT SCI MED, V9, P326; Stolen T, 2005, SPORTS MED, V35, P501; Tillin NA, 2009, SPORTS MED, V39, P147, DOI 10.2165/00007256-200939020-00004; Towlson C, 2013, J SPORT SCI, V31, P1393, DOI 10.1080/02640414.2013.792946; Wilson JM, 2013, J STRENGTH COND RES, V27, P854, DOI 10.1519/JSC.0b013e31825c2bdb; Wong DP, 2012, J STRENGTH COND RES, V26, P2324, DOI 10.1519/JSC.0b013e31823daeab	40	8	8	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180152	10.1371/journal.pone.0180152	http://dx.doi.org/10.1371/journal.pone.0180152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662123	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300113
J	Kang, HM; Kim, GH; Jeon, HK; Kim, DH; Jeon, TY; Park, DY; Jeong, H; Chun, WJ; Kim, MH; Park, J; Lim, M; Kim, TH; Cho, YK				Kang, Hwa Mi; Kim, Gwang Ha; Jeon, Hye Kyung; Kim, Dae Hwan; Jeon, Tae Yong; Park, Do Youn; Jeong, Hyunjin; Chun, Won Joo; Kim, Mi-Hyun; Park, Juhee; Lim, Minji; Kim, Tae-Hyeong; Cho, Yoon-Kyung			Circulating tumor cells detected by lab-on-adisc: Role in early diagnosis of gastric cancer	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; MICROFLUIDIC DEVICE; PERIPHERAL-BLOOD; CLINICAL-SIGNIFICANCE; MOLECULAR-DETECTION; MUCIN EXPRESSION; HIGH-PURITY; ENRICHMENT; METASTASIS; CARCINOMAS	Background The use of circulating tumor cells (CTCs) as an early diagnostic biomarker and prognostic indicator after surgery or chemotherapy has been suggested for various cancers. This study aimed to evaluate CTCs in patients who underwent gastrectomy for gastric cancer and to explore their clinical usefulness in the early diagnosis of gastric cancer. Methods A total of 116 patients with gastric cancer who underwent gastrectomy and 31 healthy volunteers were prospectively included between 2014 and 2015. Peripheral blood samples were collected before gastrectomy, and CTCs were examined using a centrifugal microfluidic system with a new fluid-assisted separation technique. Results After creating a receiver operating characteristic curve to identify the discriminative CTC value needed differentiate patients with gastric cancer from healthy volunteers, sensitivity and specificity were nearly optimized at a CTC threshold of 2 per 7.5 mL of blood. Of the 102 persons with a CTC level >= 2 per 7.5 mL of blood, 99 (97.1%) had gastric cancer, and of the 45 persons with a CTC level <2 per 7.5 mL of blood, 28 (62.2%) were healthy controls. Accordingly, the sensitivity and specificity for the differentiation of patients with gastric cancer from healthy controls were 85.3% and 90.3%, respectively. However, the presence of CTCs was not associated with any clinicopathologic features such as staging, histologic type, or mucin phenotype. Conclusion Although we could not prove the clinical feasibility of CTCs for gastric cancer staging, our results suggest a potential role of CTCs as an early diagnostic biomarker of gastric cancer.	[Kang, Hwa Mi; Kim, Gwang Ha; Jeon, Hye Kyung; Jeong, Hyunjin; Chun, Won Joo; Kim, Mi-Hyun] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Kang, Hwa Mi; Kim, Gwang Ha; Jeon, Hye Kyung; Jeong, Hyunjin; Chun, Won Joo; Kim, Mi-Hyun] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Kim, Dae Hwan; Jeon, Tae Yong] Pusan Natl Univ, Dept Surg, Sch Med, Busan, South Korea; [Park, Do Youn] Pusan Natl Univ, Dept Pathol, Sch Med, Busan, South Korea; [Park, Juhee; Kim, Tae-Hyeong; Cho, Yoon-Kyung] IBS, Ctr Soft & Living Matter, Ulsan, South Korea; [Lim, Minji; Cho, Yoon-Kyung] UNIST, Sch Life Sci, Dept Biomed Engn, Ulsan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST)	Kim, GH (corresponding author), Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea.; Kim, GH (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.	doc0224@pusan.ac.kr	Kim, Gwang Ha/ABF-3932-2021; Kim, Tae-Hyeong/X-8784-2019; Kim, Tae-Hyeong/AAO-8275-2020; Cho, Yoon-Kyoung/E-9082-2010; Cho, Yoon-Kyoung/ABF-9355-2021; Park, Juhee/P-5219-2017	Kim, Gwang Ha/0000-0001-9721-5734; Kim, Tae-Hyeong/0000-0002-1959-4705; Kim, Tae-Hyeong/0000-0002-1959-4705; Cho, Yoon-Kyoung/0000-0001-6423-1834; Cho, Yoon-Kyoung/0000-0001-6423-1834; Park, Juhee/0000-0002-8109-6387	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C1845]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C1845). The funders had no role in study design, data collection and analysis, decisionto publish, or preparation of the manuscript.	Adams DL, 2014, RSC ADV, V4, P4334, DOI 10.1039/c3ra46839a; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Beeharry MK, 2016, WORLD J GASTROENTERO, V22, P1202, DOI 10.3748/wjg.v22.i3.1202; Bertazza L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-111; Correia M, 2009, HELICOBACTER, V14, P36, DOI 10.1111/j.1523-5378.2009.00696.x; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061774; Digklia A, 2016, WORLD J GASTROENTERO, V22, P2403, DOI 10.3748/wjg.v22.i8.2403; Edge S, 2010, AJCC CANC STAGING HD; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ghossein RA, 1999, CLIN CANCER RES, V5, P1950; Hiraiwa K, 2008, ANN SURG ONCOL, V15, P3092, DOI 10.1245/s10434-008-0122-9; Hosokawa M, 2013, ANAL CHEM, V85, P5692, DOI 10.1021/ac400167x; Huang XZ, 2015, INT J CANCER, V136, P21, DOI 10.1002/ijc.28954; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Joosse SA, 2013, CANCER RES, V73, P8, DOI 10.1158/0008-5472.CAN-12-3422; Kim DH, 2013, ARCH PATHOL LAB MED, V137, P1047, DOI 10.5858/arpa.2012-0193-OA; Kim GH, 2006, SCAND J GASTROENTERO, V41, P880, DOI 10.1080/00365520500497140; Kim TH, 2017, ANAL CHEM, V89, P1155, DOI 10.1021/acs.analchem.6b03534; Kubisch I, 2015, ONCOLOGY-BASEL, V89, P294, DOI 10.1159/000437373; Lee A, 2014, ANAL CHEM, V86, P11349, DOI 10.1021/ac5035049; Lee HJ, 2015, WORLD J GASTROENTERO, V21, P3944, DOI 10.3748/wjg.v21.i13.3944; Li M, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/981261; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mimori K, 2008, CLIN CANCER RES, V14, P2609, DOI 10.1158/1078-0432.CCR-07-4354; Mimori K, 2008, ANN SURG ONCOL, V15, P2934, DOI 10.1245/s10434-008-9916-z; Park DY, 2008, AM J SURG PATHOL, V32, P524, DOI 10.1097/PAS.0b013e31815b890e; Sarioglu AF, 2015, NAT METHODS, V12, P685, DOI [10.1038/NMETH.3404, 10.1038/nmeth.3404]; Tang YD, 2014, SCI REP-UK, V4, DOI 10.1038/srep06052; Uenosono Y, 2013, CANCER-AM CANCER SOC, V119, P3984, DOI 10.1002/cncr.28309; Witzig TE, 2002, CLIN CANCER RES, V8, P1085; Wu CH, 2006, DIS MARKERS, V22, P103, DOI 10.1155/2006/281315; Yeh KH, 1998, ANTICANCER RES, V18, P1283; Zhou MD, 2014, SCI REP-UK, V4, DOI 10.1038/srep07392	35	39	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180251	10.1371/journal.pone.0180251	http://dx.doi.org/10.1371/journal.pone.0180251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662130	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300132
J	Liang, B; Zhao, JY; Wang, X				Liang, Bin; Zhao, Jianying; Wang, Xuan			A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis	PLOS ONE			English	Article							MICRORNA EXPRESSION SIGNATURES; CARCINOMA-CELLS; BLADDER-CANCER; PROLIFERATION; INVASION; APOPTOSIS; SURVIVAL; TUMORIGENESIS; METASTASIS; MIGRATION	Accumulating evidence has demonstrated that some specific miRNAs were aberrantly expressed in renal clear cell carcinoma and participated in many biological processes. The aim of this study was to investigate a panel of miRNA signature for diagnosis and prognosis of renal clear cell carcinoma (KIRC). Here, we performed a comprehensive analysis for miRNA expression profiles and corresponding clinical information of 516 KIRC patients from The Cancer Genome Atlas (TCGA). In the study, a total of 63 differentially expressed miRNAs were identified, of which 34 were up-regulated and 29 were down-regulated. We constructed a panel of three-miRNA that were significantly associated with KIRC diagnosis and KIRC patients' prognosis. The three-miRNA signature reached a sensitivity of 98.3% and a specificity of 97.2% in the diagnosis of KIRC. Using the three-miRNA signature, we classified the KIRC patients into high-risk group and low-risk group. The Kaplan-Meier curves showed that KIRC patients with high risk scores had significantly worsen overall survival (OS) and disease free survival (DFS) than KIRC patients with low risk scores. In the univariate and multivariate Cox regression analysis, three-miRNA signature was an independent prognostic factor in OS. In conclusion, the three-miRNA signature could be used as a diagnostic and prognostic biomarker in KIRC, and therefore, may help to provide significant clinical implication for the treatment of KIRC.	[Liang, Bin] China Med Univ, Dept Bioinformat, Key Lab Cell Biol, Minist Publ Hlth,Coll Basic Med Sci, Shenyang, Peoples R China; [Liang, Bin] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Coll Basic Med Sci, Shenyang, Peoples R China; [Zhao, Jianying] PLA, Dept Clin Lab, Hosp 202, Shenyang, Peoples R China; [Zhao, Jianying] Jinzhou Med Univ, Grad Sch, Jinzhou, Peoples R China; [Wang, Xuan] Dalian Med Univ, Grad Sch, Dalian, Peoples R China	China Medical University; China Medical University; Jinzhou Medical University; Dalian Medical University	Liang, B (corresponding author), China Med Univ, Dept Bioinformat, Key Lab Cell Biol, Minist Publ Hlth,Coll Basic Med Sci, Shenyang, Peoples R China.; Liang, B (corresponding author), China Med Univ, Key Lab Med Cell Biol, Minist Educ, Coll Basic Med Sci, Shenyang, Peoples R China.	bliang@cmu.edu.cn						Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Chen JJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-169; Christinat Y, 2015, ONCOTARGET, V6, P10521, DOI 10.18632/oncotarget.3294; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Feng YH, 2016, BIOMED REP, V5, P395, DOI 10.3892/br.2016.747; Gao Y, 2016, ONCOTARGET, V7, P20324, DOI 10.18632/oncotarget.7951; Gowrishankar B, 2014, CANCER BIOL THER, V15, P329, DOI 10.4161/cbt.27314; Han ZB, 2012, J CANCER RES CLIN, V138, P153, DOI 10.1007/s00432-011-1076-z; He HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125672; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Ji S., 2012, ADV DIFFER EQU, V2012, P1, DOI DOI 10.1016/J.CAGE0.2012.01.004; Kaucsar T, 2010, ADV DRUG DELIVER REV, V62, P1390, DOI 10.1016/j.addr.2010.10.003; Kong W, 2016, J BIOL CHEM, V291, P22855, DOI 10.1074/jbc.A110.101055; Kurozumi A, 2017, J HUM GENET, V62, P49, DOI 10.1038/jhg.2016.84; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Li YF, 2016, MOL MED REP, V14, P560, DOI 10.3892/mmr.2016.5251; Liang T, 2016, ONCOL RES, V24, P371, DOI 10.3727/096504016X14685034103356; Liao LL, 2015, CANCER GENET-NY, V208, P206, DOI 10.1016/j.cancergen.2015.02.008; Liep J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157801; Liu F, 2016, BIOCHEM BIOPH RES CO, V480, P87, DOI 10.1016/j.bbrc.2016.10.004; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma Q, 2016, INT J ONCOL, V49, P2589, DOI 10.3892/ijo.2016.3746; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mlcochova H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31852; Ramanathan R, 2017, BREAST CANC RES TREA; Schmidt LS, 2016, SEMIN ONCOL, V43, P566, DOI 10.1053/j.seminoncol.2016.09.001; Shinmei S, 2013, INT J UROL, V20, P468, DOI 10.1111/j.1442-2042.2012.03182.x; Shu X, 2017, BRIT J CANCER, V116, P77, DOI 10.1038/bjc.2016.392; Sohn W, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.68; Szabo Z, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.06.011; Trevisani F, 2016, BRIT J CANCER, V115, P1343, DOI 10.1038/bjc.2016.329; Tusong H, 2016, CANC BIOMARK; Ueno K, 2011, BRIT J CANCER, V104, P308, DOI 10.1038/sj.bjc.6606028; Velazquez KT, 2016, AM J PHYSIOL-GASTR L, V310, pG347, DOI 10.1152/ajpgi.00326.2015; Wang H, 2015, LABMEDICINE, V46, P118, DOI 10.1309/LMWR9CEA2K2XVSOX; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zeng FC, 2016, ONCOTARGETS THER, V9, P2131, DOI 10.2147/OTT.S98002; Zhao JJ, 2016, ARCH MED SCI, V12, P473, DOI 10.5114/aoms.2016.59918; ZHU J, 2016, TUMOUR BIOL	42	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180660	10.1371/journal.pone.0180660	http://dx.doi.org/10.1371/journal.pone.0180660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662155	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300173
J	Mosepele, M; Hemphill, LC; Moloi, W; Moyo, S; Nkele, I; Makhema, J; Bennett, K; Triant, VA; Lockman, S				Mosepele, Mosepele; Hemphill, Linda C.; Moloi, Walter; Moyo, Sikhulile; Nkele, Isaac; Makhema, Joseph; Bennett, Kara; Triant, Virginia A.; Lockman, Shahin			Pre-clinical carotid atherosclerosis and sCD1 63 among virally suppressed HIV patients in Botswana compared with uninfected controls	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INTIMA-MEDIA THICKNESS; SOLUBLE CD163; SUBCLINICAL ATHEROSCLEROSIS; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; IMMUNE ACTIVATION	Objectives Human immune deficiency virus (HIV) is associated with increased cardiovascular disease (CVD) risk, yet the relationship between HIV and carotid atherosclerosis / monocyte activation among virally suppressed HIV-infected patients in sub-Saharan Africa is not well understood. Methods We measured traditional CVD risk factors, bilateral distal common carotid intima media thickness (cIMT), presence of carotid plaque and plasma sCD163 levels among virally suppressed HIV-infected adults and HIV-uninfected controls, in a cross-sectional study in Gaborone, Botswana. The associations between HIV status, traditional CVD risk factors, sCD163 and outcome of cIMT were assessed in univariate and multivariate linear regression models. Results We enrolled 208 HIV -infected adults (55% Female, mean age 39 years) who had undetectable HIV-1 RNA on antiretroviral therapy and 224 HIV-uninfected controls (47% Female, mean age 37 years). There was no difference in cIMT between study groups, with mean cIMT 0.607mm and 0.599mm in HIV-infected and HIV-uninfected, respectively (p = 0.37). Plasma sCD163 was significantly higher in HIV-infected versus HIV -uninfected persons (1917ng/mlys 1593ng/ml, p = 0.003), but was not associated with cIMT (p = 0.43 among all, p = 0.72 for HIV -infected only). In the final multivariate model, increased cIMT was associated with older age, being treated for hypertension, and higher non-HDL cholesterol among all (p<0.001, p = 0.03, p<0.001 respectively), and with older age and waist -hip ratio in HIV-infected participants (p = 0.02 & p = 0.02 respectively). Carotid plaque was present in a significantly higher proportion of HIV-infected adults (RR 2.15, 95% CI 1.22, 3.81). Conclusions HIV-infected participants aged 30-50 years who have achieved viral suppression did not have increased cIMT when compared to HIV-uninfected controls in Botswana. However, well -controlled HIV was associated with excess monocyte activation. Future work should explore the impact of subclinical atherosclerosis on CVD events among HIV-infected and-uninfected adults in Botswana.	[Mosepele, Mosepele; Moloi, Walter] Univ Botswana, Fac Med, Dept Med, Gaborone, Botswana; [Mosepele, Mosepele; Moyo, Sikhulile; Nkele, Isaac; Makhema, Joseph; Lockman, Shahin] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Hemphill, Linda C.; Triant, Virginia A.] Harvard Med Sch, Boston, MA USA; [Hemphill, Linda C.; Triant, Virginia A.] Massachusetts Gen Hosp, Div Cardiol, LCH, Boston, MA 02114 USA; [Hemphill, Linda C.; Triant, Virginia A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Hemphill, Linda C.; Triant, Virginia A.] Massachusetts Gen Hosp, Div Gen Internal Med, VAT, Boston, MA 02114 USA; [Bennett, Kara] Bennett Stat Consulting Inc, Ballston Lake, NY USA; [Lockman, Shahin] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Lockman, Shahin] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA	University of Botswana; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Mosepele, M (corresponding author), Univ Botswana, Fac Med, Dept Med, Gaborone, Botswana.; Mosepele, M (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.	mosepelemosepele@gmail.com	Moyo, Sikhulile/E-1464-2015	Moyo, Sikhulile/0000-0003-3821-4592	National Institute of Health; Harvard University Center for AIDS Research (CFAR)-National Institute of Allergy and Infectious Diseases-NIH/NIAID [5P30A1060354-0]; Harvard Global Health Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132786, R56HL125029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI131928] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Center for AIDS Research (CFAR)-National Institute of Allergy and Infectious Diseases-NIH/NIAID; Harvard Global Health Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by The National Institute of Health and the Harvard University Center for AIDS Research (CFAR)-National Institute of Allergy and Infectious Diseases-NIH/NIAID 5P30A1060354-0. Funds from the Harvard Global Health Institute were used to purchase the ultrasound used in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzinger JJ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/569819; Beltran LM, 2015, VASC HEALTH RISK MAN, V11, P35, DOI 10.2147/VHRM.S65885; Beltran LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090541; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Calza L, 2013, AIDS RES HUM RETROV, V29, P547, DOI 10.1089/aid.2012.0015; Currier JS, 2007, AIDS, V21, P1137, DOI 10.1097/QAD.0b013e32811ebf79; Currier JS, 2014, ANN INTERN MED, V160, P509, DOI 10.7326/M14-0378; De Socio GV, 2016, INFECTION, V44, P589, DOI 10.1007/s15010-016-0893-z; Desvarieux M, 2013, AIDS, V27, P2603, DOI 10.1097/QAD.0b013e3283634819; Fitch KV, 2013, J INFECT DIS, V208, P1737, DOI 10.1093/infdis/jit508; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Freitas P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-348; Gaolathe T, 2016, LANCET HIV, V3, pE221, DOI 10.1016/S2352-3018(16)00037-0; Gast KB, 2015, ATHEROSCLEROSIS, V241, P547, DOI 10.1016/j.atherosclerosis.2015.05.026; Gepner AD, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002262; Gleason RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117125; Albuquerque VMG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-274; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Hanna DB, 2015, CLIN INFECT DIS, V61, P640, DOI 10.1093/cid/civ325; Hemkens LG, 2014, EUR HEART J, V35, P1373, DOI 10.1093/eurheartj/eht528; Hulten E, 2009, HEART, V95, P1826, DOI 10.1136/hrt.2009.177774; Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044; Kim SY, 2014, CLIN MED INSIGHTS-EN, V7, P41, DOI [10.4137/CMED.S19202, 10.4137/CMEDED.S19202]; Knudsen A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-230; Knudsen TB, 2016, J INFECT DIS, V214, P1198, DOI 10.1093/infdis/jiw263; Longenecker CT, 2016, AIDS, V30, P2195, DOI 10.1097/QAD.0000000000001167; Longenecker CT, 2012, TRANSL RES, V159, P127, DOI 10.1016/j.trsl.2011.10.007; Lucas GM, 2016, ARTERIOSCL THROM VAS, V36, P2100, DOI 10.1161/ATVBAHA.116.307985; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Mukai N, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0247-7; Nambi V, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000180; O'Halloran JA, 2015, HIV MED, V16, P608, DOI 10.1111/hiv.12270; Schoffelen AF, 2015, CLIN INFECT DIS, V61, P1606, DOI 10.1093/cid/civ586; Shahbaz S, 2015, WORLD J CARDIOL, V7, P633, DOI 10.4330/wjc.v7.i10.633; Siedner M. J., 2015, J INFECT DIS; Ssinabulya I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089537; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Stein JH, 2014, JACC-CARDIOVASC IMAG, V7, P515, DOI 10.1016/j.jcmg.2013.08.019; Stein JH, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001396; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Suchindran S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu076; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Vos AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147484; Westhorpe CLV, 2014, IMMUNOL CELL BIOL, V92, P133, DOI 10.1038/icb.2013.84; Yuk HB, 2015, KOREAN CIRC J, V45, P28, DOI 10.4070/kcj.2015.45.1.28	46	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179994	10.1371/journal.pone.0179994	http://dx.doi.org/10.1371/journal.pone.0179994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662159	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300085
J	Paul, AL; Sng, NJ; Zupanska, AK; Krishnamurthy, A; Schultz, ER; Ferl, RJ				Paul, Anna-Lisa; Sng, Natasha J.; Zupanska, Agata K.; Krishnamurthy, Aparna; Schultz, Eric R.; Ferl, Robert J.			Genetic dissection of the Arabidopsis spaceflight transcriptome: Are some responses dispensable for the physiological adaptation of plants to spaceflight?	PLOS ONE			English	Article							EXPRESSION ANALYSIS; PHYTOCHROME D; SPACE; THALIANA; ROOTS; GRAVITY; GROWTH; HEAT; GRAVITROPISM; TOLERANCE	Experimentation on the International Space Station has reached the stage where repeated and nuanced transcriptome studies are beginning to illuminate the structural and metabolic differences between plants grown in space compared to plants on the Earth. Genes that are important in establishing the spaceflight responses are being identified, their roles in spaceflight physiological adaptation are increasingly understood, and the fact that different genotypes adapt differently is recognized. However, the basic question of whether these spaceflight responses are actually required for survival has yet to be posed, and the fundamental notion that spaceflight responses may be non-adaptive has yet to be explored. Therefore the experiments presented here were designed to ask if portions of the plant spaceflight response can be genetically removed without causing loss of spaceflight survival and without causing increased stress responses. The CARA experiment compared the spaceflight transcriptome responses in the root tips of two Arabidopsis ecotypes, Col-0 and WS, as well as that of a PhyD mutant of Col-0. When grown with the ambient light of the ISS, phyD plants displayed a significantly reduced spaceflight transcriptome response compared to Col-0, suggesting that altering the activity of a single gene can actually improve spaceflight adaptation by reducing the transcriptome cost of physiological adaptation. The WS genotype showed an even simpler spaceflight transcriptome response in the ambient light of the ISS, more broadly indicating that the plant genotype can be manipulated to reduce the cost of spaceflight adaptation, as measured by transcriptional response. These differential genotypic responses suggest that genetic manipulation could further reduce, or perhaps eliminate the metabolic cost of spaceflight adaptation. When plants were germinated and then left in the dark on the ISS, the WS genotype actually mounted a larger transcriptome response than Col-0, suggesting that the in-space light environment affects physiological adaptation, which implies that manipulating the local habitat can also substantially impact the metabolic cost of spaceflight adaptation.	[Paul, Anna-Lisa; Sng, Natasha J.; Zupanska, Agata K.; Krishnamurthy, Aparna; Schultz, Eric R.; Ferl, Robert J.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Ferl, Robert J.] Univ Florida, Interdisciplinary Ctr Biotechnol & Res, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ferl, RJ (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.; Ferl, RJ (corresponding author), Univ Florida, Interdisciplinary Ctr Biotechnol & Res, Gainesville, FL 32611 USA.	robferl@ufl.edu	Zupanska, Agata/AAE-6817-2020	Ferl, Robert/0000-0003-4178-764X; Haveman, Natasha/0000-0001-7083-5925; Paul, Anna-Lisa/0000-0003-2211-2604	Center for Advancement of Science in Space (CASIS) [GA-2013-104]	Center for Advancement of Science in Space (CASIS)	The work was supported by grant number GA-2013-104, Center for Advancement of Science in Space (CASIS), URL:http://www.isscasis.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; [Anonymous], 2015, PROTEOMICS TRANSCRIP; [Anonymous], 2015, COMP SPACEFLIGHT TRA; Aoki Y, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv165; Aubert Y, 2010, PLANT CELL PHYSIOL, V51, P1975, DOI 10.1093/pcp/pcq155; Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bargmann BOR, 2009, PLANT CELL PHYSIOL, V50, P78, DOI 10.1093/pcp/pcn173; Bernsdorff F, 2016, PLANT CELL, V28, P102, DOI 10.1105/tpc.15.00496; Boonsirichai K, 2002, ANNU REV PLANT BIOL, V53, P421, DOI 10.1146/annurev.arplant.53.100301.135158; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Chan ZL, 2013, PLANT PHYSIOL BIOCH, V73, P189, DOI 10.1016/j.plaphy.2013.09.013; Correll MJ, 2013, PLANTA, V238, P519, DOI 10.1007/s00425-013-1909-x; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; Des Marais DL, 2012, PLANT CELL, V24, P893, DOI 10.1105/tpc.112.096180; Devlin PF, 1999, PLANT PHYSIOL, V119, P909, DOI 10.1104/pp.119.3.909; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fengler S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/547495; Ferl RJ, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2015.23; Ferl RJ, 2015, ASTROBIOLOGY, V15, P32, DOI 10.1089/ast.2014.1210; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Guo M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00114; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Kiss JZ, 2015, METHODS MOL BIOL, V1309, P255, DOI 10.1007/978-1-4939-2697-8_19; Kiss JZ, 2012, PLANTA, V236, P635, DOI 10.1007/s00425-012-1633-y; Kittang AI, 2014, PLANT BIOLOGY, V16, P528, DOI 10.1111/plb.12132; Klingseisen B, 2013, PREV VET MED, V110, P159, DOI 10.1016/j.prevetmed.2012.12.001; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kwon T, 2015, AM J BOT, V102, P21, DOI 10.3732/ajb.1400458; Langsrud Y, 2003, STAT COMPUT, V13, P163, DOI 10.1023/A:1023260610025; Li HT, 2009, BIOCHEM BIOPH RES CO, V382, P637, DOI 10.1016/j.bbrc.2009.03.091; Liu HC, 2011, PLANT CELL ENVIRON, V34, P738, DOI 10.1111/j.1365-3040.2011.02278.x; Mazars C, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29637; Mazars C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091814; Millar KDL, 2011, ASTROBIOLOGY, V11, P787, DOI 10.1089/ast.2011.0699; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Nakashima J, 2014, PLANT BIOLOGY, V16, P142, DOI 10.1111/plb.12062; Nakashima J, 2014, PLANT BIOL, V16; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Oliva M, 2007, NEW PHYTOL, V176, P37, DOI 10.1111/j.1469-8137.2007.02184.x; Paez-Garcia Ana, 2015, Plants-Basel, V4, P334, DOI 10.3390/plants4020334; Passardi F, 2007, J PLANT PHYSIOL, V164, P980, DOI 10.1016/j.jplph.2006.06.008; Paul AL, 2005, ADV SPACE RES-SERIES, V36, P1175, DOI 10.1016/j.asr.2005.03.066; Paul AL, 2015, METHODS MOL BIOL, V1309, P285, DOI 10.1007/978-1-4939-2697-8_20; Paul AL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-112; Paul AL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-232; Paul AL, 2012, ASTROBIOLOGY, V12, P40, DOI 10.1089/ast.2011.0696; Poulet L, 2016, BOT LETT, V163, P337, DOI 10.1080/23818107.2016.1194228; Ruyters G, 2014, PLANT BIOLOGY, V16, P4, DOI 10.1111/plb.12127; Salmi ML, 2008, PLANTA, V229, P151, DOI 10.1007/s00425-008-0817-y; Sato EM, 2015, J EXP BOT, V66, P2155, DOI [10.1093/jxb/eru515, 10.1093/jxb/er]; Schuler O, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.01776, 10.3389/fpls.2015.01176]; Schultz ER, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0975-9; Schultz ER, 2016, MICROGRAVITY SCI TEC, V28, P621, DOI 10.1007/s12217-016-9514-9; Sng N, 2014, GRAVITATIONAL SPACE, V2, P81; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Sugimoto M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-4; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; Thatcher LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126978; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vandenbrink JP, 2016, PLANTA, V244, P1201, DOI 10.1007/s00425-016-2581-8; Vandenbrink JP, 2016, PLANT SCI, V243, P115, DOI 10.1016/j.plantsci.2015.11.004; Vandenbrink JP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00563; Vanholme B, 2014, PLANT PHYSIOL, V165, P290, DOI 10.1104/pp.113.233742; Yong WD, 2005, PLANTA, V221, P747, DOI 10.1007/s00425-005-1563-z; Zhang Y, 2015, PLANTA, V241, P475, DOI 10.1007/s00425-014-2196-x; Zupanska AK, 2013, AM J BOT, V100, P235, DOI 10.3732/ajb.1200343	68	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180186	10.1371/journal.pone.0180186	http://dx.doi.org/10.1371/journal.pone.0180186			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662188	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300120
J	Piotrowska, I; Isalan, M; Mielcarek, M				Piotrowska, Izabela; Isalan, Mark; Mielcarek, Michal			Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy	PLOS ONE			English	Article							INDUCED HEART-FAILURE; CARDIAC-HYPERTROPHY; ANTHRACYCLINE CARDIOTOXICITY; MOLECULAR-MECHANISMS; HDAC INHIBITION; MICE; REPRESSION; INFUSION; THERAPY; DISEASE	Doxorubicin is a potent chemotherapeutic agent that is widely-used to treat a variety of cancers but causes acute and chronic cardiac injury, severely limiting its use. Clinically, the acute side effects of doxorubicin are mostly manageable, whereas the delayed consequences can lead to life-threatening heart failure, even decades after cancer treatment. The cardiotoxicity of doxorubicin is subject to a critical cumulative dose and so dosage limitation is considered to be the best way to reduce these effects. Hence, a number of studies have defined a "safe dose" of the drug, both in animal models and clinical settings, with the aim of avoiding long-term cardiac effects. Here we show that a dose generally considered as safe in a mouse model can induce harmful changes in the myocardium, as early as 2 weeks after infusion. The adverse changes include the development of fibrotic lesions, disarray of cardiomyocytes and a major transcription dysregulation. Importantly, low-dose doxorubicin caused specific changes in the transcriptional profile of several histone deacetylases (HDACs) which are epigenetic regulators of cardiac remodelling. This suggests that cardioprotective therapies, aimed at modulating HDACs during doxorubicin treatment, deserve further exploration.	[Piotrowska, Izabela] UCL, Hatter Cardiovasc Inst, London, England; [Isalan, Mark; Mielcarek, Michal] Imperial Coll London, Dept Life Sci, London, England; [Mielcarek, Michal] Univ Med Sci, Dept Epidemiol Rare Dis & Neuroepidemiol, Poznan, Poland	University of London; University College London; Imperial College London	Mielcarek, M (corresponding author), Imperial Coll London, Dept Life Sci, London, England.; Mielcarek, M (corresponding author), Univ Med Sci, Dept Epidemiol Rare Dis & Neuroepidemiol, Poznan, Poland.	m.mielcarek@imperial.ac.uk	Mielcarek, Michal/M-6302-2018	Mielcarek, Michal/0000-0002-9874-6753; Isalan, Mark/0000-0002-4652-0365	European Research Council [H2020E-RC-2014-PoC641232-Fingers4Cure]; MRC [MC_PC_15028] Funding Source: UKRI; Medical Research Council [MC_PC_15028] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the funding from European Research Council grant H2020E-RC-2014-PoC641232-Fingers4Cure. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustin-Pavon C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0128-x; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Berry JM, 2008, EXPERT OPIN DRUG SAF, V7, P53, DOI [10.1517/14740338.7.1.53, 10.1517/14740338.7.1.53 ]; Bush EW, 2009, EXPERT OPIN THER TAR, V13, P767, DOI 10.1517/14728220902939161; Cardinale JP, 2010, HYPERTENSION, V56, P437, DOI 10.1161/HYPERTENSIONAHA.110.154567; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Chen MC, 2011, HEPATOLOGY, V53, P148, DOI 10.1002/hep.23964; Colussi C, 2010, PHARMACOL RES, V62, P3, DOI 10.1016/j.phrs.2010.02.014; Delgado RM, 2004, CIRCULATION, V109, P1428, DOI 10.1161/01.CIR.0000121354.34067.48; Desai VG, 2013, TOXICOL APPL PHARM, V266, P109, DOI 10.1016/j.taap.2012.10.025; Dirkx E, 2013, BBA-MOL BASIS DIS, V1832, P2414, DOI 10.1016/j.bbadis.2013.07.023; Fulgenzi G, 2015, J CELL BIOL, V210, P1003, DOI 10.1083/jcb.201502100; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Horan PG, 2006, EUR HEART J, V27, P1137, DOI 10.1093/eurheartj/ehi702; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lee TM, 2007, AM J PHYSIOL-HEART C, V293, pH968, DOI 10.1152/ajpheart.00891.2006; Lehmann LH, 2014, CELL MOL LIFE SCI, V71, P1673, DOI 10.1007/s00018-013-1516-9; Lipshultz SE, 2012, PEDIATRICS, V130, P1003, DOI 10.1542/peds.2012-0727; Liu XJ, 2012, ACTA CARDIOL SIN, V28, P236; Lotrionte M, 2013, AM J CARDIOL, V112, P1980, DOI 10.1016/j.amjcard.2013.08.026; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; McGowan JV, 2017, CARDIOVASC DRUG THER, V31, P63, DOI 10.1007/s10557-016-6711-0; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; McLendon PM, 2014, P NATL ACAD SCI USA, V111, pE5178, DOI 10.1073/pnas.1415589111; Mielcarek M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00042; Mielcarek M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108961; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717; Mielcarek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080849; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Mitry MA, 2016, IJC HEART VASC, V10, P17, DOI 10.1016/j.ijcha.2015.11.004; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Rafehi H, 2014, GENOME RES, V24, P1271, DOI 10.1101/gr.168781.113; Rahman AM, 2007, INT J NANOMED, V2, P567; Raj Shashi, 2014, Curr Treat Options Cardiovasc Med, V16, P315, DOI 10.1007/s11936-014-0315-4; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	44	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180571	10.1371/journal.pone.0180571	http://dx.doi.org/10.1371/journal.pone.0180571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662206	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300167
J	Ott, L; Hacker, E; Kunert, T; Karrington, I; Etschel, P; Lang, R; Wiesmann, V; Wittenberg, T; Singh, A; Varela, C; Bhatt, A; Sangal, V; Burkovski, A				Ott, Lisa; Hacker, Elena; Kunert, Timo; Karrington, Ian; Etschel, Philipp; Lang, Roland; Wiesmann, Veit; Wittenberg, Thomas; Singh, Albel; Varela, Cristian; Bhatt, Apoorva; Sangal, Vartul; Burkovski, Andreas			Analysis of Corynebacterium diphtheriae macrophage interaction: Dispensability of corynomycolic acids for inhibition of phagolysosome maturation and identification of a new gene involved in synthesis of the corynomycolic acid layer	PLOS ONE			English	Article							MYCOLIC ACIDS; CORD FACTOR; FATTY-ACID; CELL-WALL; IN-VIVO; MYCOBACTERIAL GROWTH; GAS-CHROMATOGRAPHY; COA HYDRATASE; BIOSYNTHESIS; TUBERCULOSIS	Corynebacterium diphtheriae is the causative agent of diphtheria, a toxin mediated disease of upper respiratory tract, which can be fatal. As a member of the CMNR group, C. diphtheriae is closely related to members of the genera Mycobacterium, Nocardia and Rhodococcus. Almost all members of these genera comprise an outer membrane layer of mycolic acids, which is assumed to influence host-pathogen interactions. In this study, three different C. diphtheriae strains were investigated in respect to their interaction with phagocytic murine and human cells and the invertebrate infection model Caenorhabditis elegans. Our results indicate that C. diphtheriae is able to delay phagolysosome maturation after internalization in murine and human cell lines. This effect is independent of the presence of mycolic acids, as one of the strains lacked corynomycolates. In addition, analyses of NF-kBinduction revealed a mycolate- independent mechanism and hint to detrimental effects of the different strains tested on the phagocytic cells. Bioinformatics analyses carried out to elucidate the reason for the lack of mycolates in one of the strains led to the identification of a new gene involved in mycomembrane formation in C. diphtheriae.	[Ott, Lisa; Hacker, Elena; Kunert, Timo; Karrington, Ian; Etschel, Philipp; Burkovski, Andreas] Friedrich Alexander Univ Erlangen Nurnberg, Mikrobiol, Erlangen, Germany; [Etschel, Philipp; Lang, Roland] Friedrich Alexander Univ Erlangen Nurnberg, Mikrobiol Inst, Univ Klinikum Erlangen, Erlangen, Germany; [Wiesmann, Veit; Wittenberg, Thomas] Fraunhofer Inst Integrierte Schaltungen IIS, Erlangen, Germany; [Singh, Albel; Varela, Cristian; Bhatt, Apoorva] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Singh, Albel; Varela, Cristian; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Sangal, Vartul] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Fraunhofer Gesellschaft; University of Birmingham; University of Birmingham; Northumbria University	Burkovski, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Mikrobiol, Erlangen, Germany.	andreas.burkovski@fau.de	Sangal, Vartul/AAB-5426-2020; Wittenberg, Thomas/AAD-6340-2019	Sangal, Vartul/0000-0002-7405-8446; Wittenberg, Thomas/0000-0003-0840-8695; Burkovski, Andreas/0000-0003-1896-4521; Lang, Roland/0000-0003-0502-3677; Ott, Lisa/0000-0002-9779-9052	Deutsche Forschungsgemeinschaft [SFB796]; Fulbright program; Medical Research Foundation; Anniversary Research Fellowship; Higher Education Innovation Funding (HEIF) from Northumbria University, Newcastle upon Tyne, UK	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fulbright program; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anniversary Research Fellowship; Higher Education Innovation Funding (HEIF) from Northumbria University, Newcastle upon Tyne, UK	The project was supported by the Deutsche Forschungsgemeinschaft in frame of SFB796 (A4, B6 and MGK) and the Fulbright program (fellowship to I. A. Kline). A. Bhatt acknowledges equipment funding from the Medical Research Foundation. V. Sangal was supported by an Anniversary Research Fellowship and the Higher Education Innovation Funding (HEIF) from Northumbria University, Newcastle upon Tyne, UK.	ABE S, 1967, J GEN APPL MICROBIOL, V13, P279, DOI 10.2323/jgam.13.279; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Ang MLT, 2014, INFECT IMMUN, V82, P1850, DOI 10.1128/IAI.01332-13; Antunes CA, 2015, MICROBIOL-SGM, V161, P639, DOI 10.1099/mic.0.000020; ATHALYE M, 1984, J GEN MICROBIOL, V130, P513; Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Burkovski A, 2013, ISRN MICROBIOL, V2013, P935736, DOI 10.1155/2013/935736; Burkovski A, 2015, CORYNEBACTERIUM GLUTAMICUM: FROM SYSTEMS BIOLOGY TO BIOTECHNOLOGICAL APPLICATIONS, P1; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Collins MD, 1998, INT J SYST BACTERIOL, V48, P1449, DOI 10.1099/00207713-48-4-1449; COLLINS MD, 1988, FEMS MICROBIOL LETT, V49, P349; Cox JAG, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.6, 10.1038/nmicrobiol.2015.6]; Daffe A M, 2005, CELL ENVELOPE CORYNE; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; dos Santos LS, 2015, MEM I OSWALDO CRUZ, V110, P662, DOI 10.1590/0074-02760140479; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Fiani ML, 1998, J LEUKOCYTE BIOL, V64, P85, DOI 10.1002/jlb.64.1.85; GAILLY C, 1982, EUR J BIOCHEM, V125, P83, DOI 10.1111/j.1432-1033.1982.tb06654.x; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gande R, 2007, J BACTERIOL, V189, P5257, DOI 10.1128/JB.00254-07; Gebhardt H, 2007, MICROBIOL-SGM, V153, P1424, DOI 10.1099/mic.0.2006/003541-0; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hacker E, 2016, VIRULENCE, V7, P45, DOI 10.1080/21505594.2015.1125068; HARD GC, 1975, INFECT IMMUN, V12, P1439, DOI 10.1128/IAI.12.6.1439-1449.1975; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Knoppova M, 2007, CURR MICROBIOL, V55, P234, DOI 10.1007/s00284-007-0106-1; Lang R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00005; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Marrakchi H, 2002, J BIOL CHEM, V277, P44809, DOI 10.1074/jbc.M208920200; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Nakao H, 1996, J CLIN MICROBIOL, V34, P1711, DOI 10.1128/JCM.34.7.1711-1716.1996; Nataraj V, 2015, MOL MICROBIOL, V98, P7, DOI 10.1111/mmi.13101; Niederweis M, 2010, TRENDS MICROBIOL, V18, P109, DOI 10.1016/j.tim.2009.12.005; Ott L, 2013, MICROBIOL-SGM, V159, P126, DOI 10.1099/mic.0.061879-0; Ott L, 2012, FEMS IMMUNOL MED MIC, V65, P413, DOI 10.1111/j.1574-695X.2012.00963.x; Ott L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-257; Ott L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-2; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Portevin D, 2014, MICROBIOLOGYOPEN, V3, P823, DOI 10.1002/mbo3.193; Radmacher E, 2005, MICROBIOL-SGM, V151, P2421, DOI 10.1099/mic.0.28012-0; Rheinlaender J, 2012, EUR BIOPHYS J BIOPHY, V41, P561, DOI 10.1007/s00249-012-0818-4; Riegel P, 2004, INT J MED MICROBIOL, V294, P413, DOI 10.1016/j.ijmm.2004.07.013; Sabbadini PS, 2012, MICROB PATHOGENESIS, V52, P165, DOI 10.1016/j.micpath.2011.12.003; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sangal V, 2016, INFECT GENET EVOL, V43, P364, DOI 10.1016/j.meegid.2016.06.024; Sangal V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1980-8; Sangal V, 2014, INFECT GENET EVOL, V21, P54, DOI 10.1016/j.meegid.2013.10.019; Sangal V, 2012, J BACTERIOL, V194, P4738, DOI 10.1128/JB.00939-12; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Sydor T, 2013, CELL MICROBIOL, V15, P458, DOI 10.1111/cmi.12050; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Tauch A, 2014, THE PROKARYOTES; Tauch A, 2008, J BIOTECHNOL, V136, P22, DOI 10.1016/j.jbiotec.2008.03.004; Tippelt A, 2014, GENOME ANOUNC, V2, P1; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x	72	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180105	10.1371/journal.pone.0180105	http://dx.doi.org/10.1371/journal.pone.0180105			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686600	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100035
J	Wang, XY; Wang, LH; Zhang, WS; Zhao, H; Li, F				Wang, Xiaoye; Wang, Lihua; Zhang, Weisheng; Zhao, Hong; Li, Feng			Can we differentiate minimally invasive adenocarcinoma and non-invasive neoplasms based on high-resolution computed tomography features of pure ground glass nodules?	PLOS ONE			English	Article							LUNG ADENOCARCINOMA; OPACITY NODULES; PULMONARY NODULES; CT FINDINGS; HELICAL CT; CLASSIFICATION; MANAGEMENT; RESECTION; CANCER; HISTOPATHOLOGY	Objective The purpose of our study was to assess the differentially diagnostic value of radiographic characteristics of pure ground glass nodules (GGNs) between minimally invasive adenocarcinoma and non-invasive neoplasm. Methods Sixty-seven pure GGNs (28 minimally invasive adenocarcinomas (MIA) and 39 pre-invasive lesions) were analyzed from June 2012 to June 2015. Pre-invasive lesions consisted of 15 atypical adenomatous hyperplasia (AAH) and 24 adenocarcinomas in situ (AIS). High-resolution computed tomography (HRCT) features and volume of MIA and pre-invasive lesions were assessed. Fisher exact test, independent sample t test, Mann-Whitney U test and receiver operating characteristic (ROC) curve analysis were performed. Results Inter-observer agreement indexes for the diameter, mean HRCT attenuations and volume of pure GGNs were all high (ICC>0.75). Univariate analyses showed that lesion diameter, mean HRCT attenuation, and volume value differed significantly between two groups. Among HRCT findings, GGN shape as round or oval (F = 13.456, P = 0.002) and lesion borders as smooth or notched (F = 15.742, P = 0.001) frequently appeared in pre-invasive lesions in comparison with MIA. Type II and type III of the relationship between blood vessels and pure GGNs suggested higher possibility of malignancy than type I. Conclusions HRCT features of pure GGNs can help to differentiate MIA from non-invasive neoplasms.	[Wang, Xiaoye; Zhang, Weisheng] Dalian Med Univ, Affiliated Hosp 1, Dept Radiol, Dalian, Peoples R China; [Wang, Xiaoye; Zhao, Hong; Li, Feng] Second Peoples Hosp Zhuhai, Dept Radiol, Zhuhai, Peoples R China; [Wang, Lihua] Qingdao Women & Childrens Hosp, Dept Med Imaging, Qingdao, Peoples R China	Dalian Medical University	Zhang, WS (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Radiol, Dalian, Peoples R China.	11111210027@fudan.edu.cn			Dalian Municipal Science and Technology Plan Project [2015E12SF163]; Liaoning Science and Technology Project [201602245]	Dalian Municipal Science and Technology Plan Project; Liaoning Science and Technology Project	This study was supported by the Dalian Municipal Science and Technology Plan Project (grant number 2015E12SF163), (http://kjjh.dlinfo.gov.cn/index.shtml); and the Liaoning Science and Technology Project (grant number 201602245),(http://kjjh.lninfo.gov.cn/).The funders had no role in study design, data collection and analys, decision to publish, or preparation of the manuscript	Cho S, 2013, ANN THORAC SURG, V96, P1190, DOI 10.1016/j.athoracsur.2013.05.062; Eguchi T, 2014, LUNG CANCER, V84, P242, DOI 10.1016/j.lungcan.2014.03.009; Farooqi AO, 2012, AM J ROENTGENOL, V199, P781, DOI 10.2214/AJR.11.7812; Gao F, 2013, EUR RADIOL, V23, P3271, DOI 10.1007/s00330-013-2954-3; Godoy MCB, 2012, J THORAC IMAG, V27, P240, DOI 10.1097/RTI.0b013e31825d515b; Haro A, 2012, LUNG CANCER, V76, P56, DOI 10.1016/j.lungcan.2011.09.002; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Honda T, 2013, CLIN RADIOL, V68, pE21, DOI 10.1016/j.crad.2012.09.002; Ikeda K, 2007, CHEST, V132, P984, DOI 10.1378/chest.07-0793; Jeong YJ, 2008, RADIOLOGIA-MADRID, V50, P183, DOI 10.1016/S0033-8338(08)71964-7; Koo CW, 2012, EUR J RADIOL, V81, P139, DOI 10.1016/j.ejrad.2010.07.001; Lee HY, 2014, AM J ROENTGENOL, V202, pW224, DOI 10.2214/AJR.13.11819; Lee HY, 2011, J THORAC IMAG, V26, P106, DOI 10.1097/RTI.0b013e3181fbaa64; Lee HJ, 2009, EUR RADIOL, V19, P552, DOI 10.1007/s00330-008-1188-2; Lee SM, 2013, RADIOLOGY, V268, P265, DOI 10.1148/radiol.13120949; Lee SW, 2013, RESP MED, V107, P904, DOI 10.1016/j.rmed.2013.02.014; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Nakata M, 2003, ANN THORAC SURG, V75, P1601, DOI 10.1016/S0003-4975(02)04815-4; Noguchi M, 2010, CANCER METAST REV, V29, P15, DOI 10.1007/s10555-010-9210-y; Oda S, 2008, AM J ROENTGENOL, V190, P1363, DOI 10.2214/AJR.07.3101; Raso MG, 2009, CLIN CANCER RES, V15, P5359, DOI 10.1158/1078-0432.CCR-09-0033; Takashima S, 2003, AM J ROENTGENOL, V180, P817, DOI 10.2214/ajr.180.3.1800817; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Yang ZG, 2001, AM J ROENTGENOL, V176, P1399, DOI 10.2214/ajr.176.6.1761399; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232	25	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180502	10.1371/journal.pone.0180502	http://dx.doi.org/10.1371/journal.pone.0180502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683126	Green Submitted, Green Published, gold			2022-12-27	WOS:000405335200042
J	Kao, KC; Chang, CH; Hung, CY; Chiu, LC; Huang, CC; Hu, HC				Kao, Kuo-Chin; Chang, Chih-Hao; Hung, Chen-Yiu; Chiu, Li-Chung; Huang, Chung-Chi; Hu, Han-Chung			Survival predictor in patients with acute respiratory distress syndrome and diffuse alveolar damage undergoing open lung biopsy	PLOS ONE			English	Article							CORTICOSTEROIDS; ARDS; CLASSIFICATION; MORTALITY; SEVERITY; STAGE	Background Diffuse alveolar damage (DAD) is a typical pathological finding of open lung biopsies in patients with acute respiratory distress syndrome (ARDS). Patients with ARDS and DAD have been reported to have a poorer prognosis than those without DAD. The aim of this study was to investigate the survival predictors in patients with ARDS and DAD. Methods We retrospectively reviewed all ARDS patients who underwent an open lung biopsy which showed evidence of DAD from January 2006 to June 2015 at Chang Gung Memorial Hospital. Clinical data including baseline characteristics, medication, and survival outcomes were analyzed. Results A total of 64 ARDS patients with DAD were eligible for analysis and divided into known etiology (n = 17, 26.6%) and unknown etiology groups (n = 47, 73.4%). There was no significant difference in hospital mortality rate between the two groups (71.9% vs. 70.6%, p = 0.890). Univariate logistic regression analysis revealed that sequential organ failure assessment (SOFA) score at the time of a diagnosis of ARDS, and SOFA score, PaO2/ FiO(2) ratio, and positive end expiratory pressure level when the biopsy was performed were associated with hospital mortality. Multivariate analysis showed that the SOFA score on the day of the biopsy was an independent predictor of hospital mortality (odds ratio 1.413, 95% confidence interval 1.127 - 1.772; p = 0.03). There were no significant differences in the use, dose, duration and timing from ARDS to glucocorticoid therapy between the survivors and nonsurvivors. Conclusion For selected ARDS patients who underwent an open lung biopsy with pathological DAD, SOFA score was an independent predictor of hospital mortality.	[Kao, Kuo-Chin; Chang, Chih-Hao; Hung, Chen-Yiu; Chiu, Li-Chung; Huang, Chung-Chi; Hu, Han-Chung] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan; [Kao, Kuo-Chin; Huang, Chung-Chi; Hu, Han-Chung] Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Hu, HC (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan.; Hu, HC (corresponding author), Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan.	h3226@cgmh.org.tw						American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Avnon LS, 2009, ANESTH ANALG, V108, P232, DOI 10.1213/ane.0b013e318188af7a; Bouros D, 2000, EUR RESPIR J, V15, P412, DOI 10.1034/j.1399-3003.2000.15b31.x; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Cardinal-Fernandez P, 2016, J CRIT CARE, V34, P31, DOI 10.1016/j.jcrc.2016.03.015; Cardinal-Fernandez P, 2016, CHEST, V149, P1155, DOI 10.1016/j.chest.2016.02.635; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Guerin C, 2015, INTENS CARE MED, V41, P222, DOI 10.1007/s00134-014-3583-2; Horita N, 2015, INTERNAL MED, V54, P1473, DOI 10.2169/internalmedicine.54.4015; Kao KC, 2006, CRIT CARE, V10, DOI 10.1186/cc4981; Kao KC, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0949-y; KATZENSTEIN ALA, 1976, AM J PATHOL, V85, P210; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Libby LJ, 2014, ANN THORAC SURG, V98, P1254, DOI 10.1016/j.athoracsur.2014.05.029; Lorente JA, 2015, INTENS CARE MED, V41, P1921, DOI 10.1007/s00134-015-4046-0; Mac Sweeney R, 2016, LANCET, V388, P2416, DOI 10.1016/S0140-6736(16)00578-X; Meduri GU, 2016, INTENS CARE MED, V42, P829, DOI 10.1007/s00134-015-4095-4; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Papazian L, 1998, ANESTHESIOLOGY, V88, P935, DOI 10.1097/00000542-199804000-00013; Patel SR, 2004, CHEST, V125, P197, DOI 10.1378/chest.125.1.197; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ruan SY, 2014, CRIT CARE, V18, DOI 10.1186/cc13819; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Suh GY, 2006, CHEST, V129, P753, DOI 10.1378/chest.129.3.753; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507; Thille AW, 2013, AM J RESP CRIT CARE, V187, P761, DOI 10.1164/rccm.201211-1981OC; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Tomassetti S, 2016, AM J RESP CRIT CARE, V193, P745, DOI 10.1164/rccm.201504-0711OC; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vourlekis JS, 2000, MEDICINE, V79, P369, DOI 10.1097/00005792-200011000-00003; Zhao JN, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0194-4	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180018	10.1371/journal.pone.0180018	http://dx.doi.org/10.1371/journal.pone.0180018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678876	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200034
J	Jazayeri, FS; Amininasab, M; Hosseinkhani, S				Jazayeri, Fatemeh S.; Amininasab, Mehriar; Hosseinkhani, Saman			Structural and dynamical insight into thermally induced functional inactivation of firefly luciferase	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; PROTEIN DYNAMICS; PROPOSED MODEL; AMINO-ACIDS; BIOLUMINESCENCE; THERMOSTABILITY; SIMULATIONS; SUPERFAMILY	Luciferase is the key component of light production in bioluminescence process. Extensive and advantageous application of this enzyme in biotechnology is restricted due to its low thermal stability. Here we report the effect of heating up above T-m on the structure and dynamical properties of luciferase enzyme compared to temperature at 298 K. In this way we demonstrate that the number of hydrogen bonds between N-and C-domain is increased for the free enzyme at 325 K. Increased inter domain hydrogen bonds by three at 325 K suggests that inter domain contact is strengthened. The appearance of simultaneous strong salt bridge and hydrogen bond between K529 and D422 and increased existence probability between R533 and E389 could mechanistically explain stronger contact between N-and C-domain. Mutagenesis studies demonstrated the importance of K529 and D422 experimentally. Also the significant reduction in SASA for experimentally important residues K529, D422 and T343 which are involved in active site region was observed. Principle component analysis (PCA) in our study shows that the dynamical behavior of the enzyme is changed upon heating up which mainly originated from the change of motion modes and associated extent of those motions with respect to 298 K. These findings could explain why heating up of the enzyme or thermal fluctuation of protein conformation reduces luciferase activity in course of time as a possible mechanism of thermal functional inactivation. According to these results we proposed two strategies to improve thermal stability of functional luciferase.	[Jazayeri, Fatemeh S.; Amininasab, Mehriar] Univ Tehran, Sch Biol, Dept Cell & Mol Biol, Coll Sci, Tehran, Iran; [Hosseinkhani, Saman] Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran	University of Tehran; Tarbiat Modares University	Amininasab, M (corresponding author), Univ Tehran, Sch Biol, Dept Cell & Mol Biol, Coll Sci, Tehran, Iran.; Hosseinkhani, S (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran.	amininasab@khayam.ut.ac.ir; saman_h@modares.ac.ir		Hosseinkhani, Saman/0000-0002-0345-7909				Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Azad T, 2014, ANAL BIOANAL CHEM, V406, P5541, DOI 10.1007/s00216-014-7980-8; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; BEKKER H, 1993, PHYSICS COMPUTING '92, P252; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Branchini BR, 1998, BIOCHEMISTRY-US, V37, P15311, DOI 10.1021/bi981150d; Branchini BR, 2005, BIOCHEMISTRY-US, V44, P1385, DOI 10.1021/bi047903f; Branchini BR, 2003, BIOCHEMISTRY-US, V42, P10429, DOI 10.1021/bi030099x; Branchini BR, 1999, BIOCHEMISTRY-US, V38, P13223, DOI 10.1021/bi991181o; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLuca M., 1978, Methods in Enzymology, V37, P3; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Fraga H, 2008, PHOTOCH PHOTOBIO SCI, V7, P146, DOI 10.1039/b719181b; Grottesi A, 2002, PROTEINS, V46, P287, DOI 10.1002/prot.10045; HASTINGS JW, 1953, J CELL COMPAR PHYSL, V42, P137, DOI 10.1002/jcp.1030420109; HASTINGS JW, 1983, J MOL EVOL, V19, P309, DOI 10.1007/BF02101634; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hosseinkhani S, 2011, CELL MOL LIFE SCI, V68, P1167, DOI 10.1007/s00018-010-0607-0; Imani M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1167, DOI 10.1039/c0pp00105h; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAJIYAMA N, 1993, BIOCHEMISTRY-US, V32, P13795, DOI 10.1021/bi00213a007; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Koksharov MI, 2011, PHOTOCH PHOTOBIO SCI, V10, P931, DOI 10.1039/c0pp00318b; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law GHE, 2006, BIOCHEM J, V397, P305, DOI 10.1042/BJ20051847; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McGeagh JD, 2011, BBA-PROTEINS PROTEOM, V1814, P1077, DOI 10.1016/j.bbapap.2010.12.002; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Niwa K, 2010, PHOTOCHEM PHOTOBIOL, V86, P1046, DOI 10.1111/j.1751-1097.2010.00777.x; Pikkemaat MG, 2002, PROTEIN ENG, V15, P185, DOI 10.1093/protein/15.3.185; Polyansky AA, 2004, RUSS J BIOORG CHEM+, V30, P421, DOI 10.1023/B:RUBI.0000043784.51859.41; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; Rycroft CH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021306; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott D, 2011, ANNU REV ANAL CHEM, V4, P297, DOI 10.1146/annurev-anchem-061010-113855; SELIGER HH, 1964, J GEN PHYSIOL, V48, P95, DOI 10.1085/jgp.48.1.95; Shimomura O, 2012, BIOLUMINESCENCE CHEM; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Tisi LC, 2002, ANAL CHIM ACTA, V457, P115, DOI 10.1016/S0003-2670(01)01496-9; White PJ, 1996, BIOCHEM J, V319, P343, DOI 10.1042/bj3190343; Wintrode PL, 2003, J MOL BIOL, V327, P745, DOI 10.1016/S0022-2836(03)00147-5; Yu HR, 2015, BBA-PROTEINS PROTEOM, V1854, P65, DOI 10.1016/j.bbapap.2014.10.017	54	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180667	10.1371/journal.pone.0180667	http://dx.doi.org/10.1371/journal.pone.0180667			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672033	gold, Green Published, Green Submitted			2022-12-27	WOS:000405268500077
J	Nabi, R; Moldoveanu, Z; Wei, Q; Golub, ET; Durkin, HG; Greenblatt, RM; Herold, BC; Nowicki, MJ; Kassaye, S; Cho, MW; Pinter, A; Landay, AL; Mestecky, J; Kozlowski, PA				Nabi, Rafiq; Moldoveanu, Zina; Wei, Qing; Golub, Elizabeth T.; Durkin, Helen G.; Greenblatt, Ruth M.; Herold, Betsy C.; Nowicki, Marek J.; Kassaye, Seble; Cho, Michael W.; Pinter, Abraham; Landay, Alan L.; Mestecky, Jiri; Kozlowski, Pamela A.			Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DEPENDENT CELLULAR CYTOTOXICITY; CD4(+) T-CELLS; VAGINAL SHIV CHALLENGE; HELPER TYPE 17; IMMUNE-RESPONSES; NONNEUTRALIZING ANTIBODIES; 1-INFECTED INDIVIDUALS; NEUTRALIZING ANTIBODY; INFECTED INDIVIDUALS	Mechanisms responsible for natural control of human immunodeficiency type 1 (HIV) replication in elite controllers (EC) remain incompletely defined. To determine if EC generate high quality HIV-specific IgA responses, we used Western blotting to compare the specificities and frequencies of IgA to HIV antigens in serum of gender-, age-and race-matched EC and aviremic controllers (HC) and viremic noncontrollers (HN) on highly active antiretroviral therapy (HAART). Concentrations and avidity of IgA to HIV antigens were measured using ELISA or multiplex assays. Measurements for IgG were performed in parallel. EC were found to have stronger p24-and V1V2-specific IgG responses than HN, but there were no IgG differences for EC and HC. In contrast, IgA in EC serum bound more frequently to gp160 and gag proteins than IgA in HC or HN. The avidity of anti-gp41 IgA was also greater in EC, and these subjects had stronger IgA responses to the gp41 heptad repeat region 1 (HR1), a reported target of anti-bacterial RNA polymerase antibodies that cross react with gp41. However, EC did not demonstrate greater IgA responses to E. coli RNA polymerase or to peptides containing the shared LRAI sequence, suggesting that most of their HR1-specific IgA antibodies were not induced by intestinal microbiota. In both EC and HAART recipients, the concentrations of HIV-specific IgG were greater than HIV-specific IgA, but their avidities were comparable, implying that they could compete for antigen. Exceptions were C1 peptides and V1V2 loops. IgG and IgA responses to these antigens were discordant, with IgG reacting to V1V2, and IgA reacting to C1, especially in EC. Interestingly, EC with IgG hypergammaglobulinemia had greater HIV-specific IgA and IgG responses than EC with normal total IgG levels. Heterogeneity in EC antibody responses may therefore be due to a more focused HIV-specific B cell response in some of these individuals. Overall, these data suggest that development of HIV-specific IgA responses and affinity maturation of antigp41 IgA antibodies occurs to a greater extent in EC than in subjects on HAART. Future studies will be required to determine if IgA antibodies in EC may contribute in control of viral replication.	[Nabi, Rafiq; Kozlowski, Pamela A.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70803 USA; [Moldoveanu, Zina; Wei, Qing; Mestecky, Jiri] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL USA; [Golub, Elizabeth T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Durkin, Helen G.] SUNY Downstate, Dept Pathol, Brooklyn, NY USA; [Durkin, Helen G.] SUNY Downstate, Dept Med, Brooklyn, NY USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Epidemiol Biostastist, San Francisco, CA USA; [Herold, Betsy C.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Nowicki, Marek J.] Univ Southern Calif, Dept Pediat, Los Angeles, CA USA; [Kassaye, Seble] Georgetown Univ, Dept Med, Washington, DC USA; [Cho, Michael W.] Iowa State Univ, Dept Biomed Sci, Ames, IA USA; [Pinter, Abraham] Rutgers New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ USA; [Landay, Alan L.] Rush Univ, Med Ctr, Dept Immun & Emerging Pathogens, Chicago, IL 60612 USA; [Mestecky, Jiri] Charles Univ Prague, Inst Immunol & Microbiol, Fac Med 1, Prague, Czech Republic; [Nowicki, Marek J.] Mendez Natl Inst Transplantat Fdn, Los Angeles, CA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; University of Southern California; Georgetown University; Iowa State University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rush University; Charles University Prague	Kozlowski, PA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70803 USA.	pkozlo@lsuhsc.edu		Herold, Betsy/0000-0001-9974-0786; Cho, Michael/0000-0003-0522-345X	National Institutes of Health [PO1 AI074286, U19 AI091031, AI102718]; Louisiana Vaccine Center - Louisiana Board of Regents; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, KL2TR001432, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034989, U01AI034993, U01AI031834, U01AI035004, U01AI034994, P30AI027763, U01AI042590, R01AI046283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Vaccine Center - Louisiana Board of Regents; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health grants PO1 AI074286 (MWC), U19 AI091031 (MWC) and AI102718 (AP) and by the Louisiana Vaccine Center funded by the Louisiana Board of Regents (PAK).	Ackerman ME, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005315; Adnan S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006104; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Black KP, 1996, CLIN IMMUNOL IMMUNOP, V81, P182, DOI 10.1006/clin.1996.0175; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Broadbent AJ, 2015, MUCOSAL IMMUNOLOGY, p1129 ~70; Brombin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058768; BROWN TA, 1985, J CLIN MICROBIOL, V22, P259, DOI 10.1128/JCM.22.2.259-264.1985; BURNETT PR, 1994, J IMMUNOL, V152, P4642; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Cao AT, 2015, MUCOSAL IMMUNOL, V8, P1072, DOI 10.1038/mi.2014.134; Chamcha V, 2016, OPEN FORUM IN PRESS; Christensen D, 2016, MUCOSAL IMMUNOL; Ciccone EJ, 2011, J VIROL, V85, P5880, DOI 10.1128/JVI.02643-10; Collins AM, 2013, VACCINE, V31, P3469, DOI 10.1016/j.vaccine.2013.04.062; COOGAN MM, 1994, INFECT IMMUN, V62, P892, DOI 10.1128/IAI.62.3.892-896.1994; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Ferre AL, 2010, J VIROL, V84, P10354, DOI 10.1128/JVI.00803-10; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Fink E, 2016, AIDS RES HUM RETROV, V32, P1187, DOI 10.1089/aid.2016.0182; Gaardbo JC, 2014, JAIDS-J ACQ IMM DEF, V65, P10, DOI 10.1097/QAI.0b013e3182a7c932; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Granados-Gonzalez V, 2008, AIDS RES HUM RETROV, V24, P289, DOI 10.1089/aid.2007.0187; Guillot-Delost M, 2012, J IMMUNOL, V188, P981, DOI 10.4049/jimmunol.1101592; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hel Z, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006087; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Iyer SS, 2016, J VIROL, V90, P8842, DOI 10.1128/JVI.01163-16; Jaffar Z, 2009, EUR J IMMUNOL, V39, P3307, DOI 10.1002/eji.200939498; Kato LM, 2014, IMMUNOL CELL BIOL, V92, P49, DOI 10.1038/icb.2013.54; Kaushik K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-179; Kovacs A, 2001, LANCET, V358, P1593, DOI 10.1016/S0140-6736(01)06653-3; KOZLOWSKI PA, 1992, AIDS RES HUM RETROV, V8, P1773, DOI 10.1089/aid.1992.8.1773; KOZLOWSKI PA, 1994, AIDS RES HUM RETROV, V10, P813, DOI 10.1089/aid.1994.10.813; Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297; Lai JI, 2014, J VIROL, V88, P2799, DOI 10.1128/JVI.03130-13; Lai L, 2007, VIROLOGY, V369, P153, DOI 10.1016/j.virol.2007.07.017; Lai LL, 2012, VACCINE, V30, P1737, DOI 10.1016/j.vaccine.2011.12.026; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Li D, 2011, CLIN EXP IMMUNOL, V165, P363, DOI 10.1111/j.1365-2249.2011.04435.x; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Marthas ML, 2011, VACCINE, V29, P3124, DOI 10.1016/j.vaccine.2011.02.051; Masson L, 2015, IMMUNOLOGY, V146, P557, DOI 10.1111/imm.12527; McKinnon LR, 2015, JAIDS-J ACQ IMM DEF, V68, P6, DOI 10.1097/QAI.0000000000000389; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Mestecky J, 2011, AIDS RES HUM RETROV, V27, P469, DOI 10.1089/aid.2010.0169; Montefiori D. C., 2005, CURR PROTOC IMMUNOL; Moog C, 2014, MUCOSAL IMMUNOL, V7, P46, DOI 10.1038/mi.2013.23; Murphy BR, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P799, DOI 10.1016/B978-012491543-5/50047-4; OGRA PL, 1968, NEW ENGL J MED, V279, P893, DOI 10.1056/NEJM196810242791701; Okulicz JF, 2011, CURR OPIN HIV AIDS, V6, P163, DOI 10.1097/COH.0b013e328344f35e; Ostrowski SR, 2008, SCAND J IMMUNOL, V68, P652, DOI 10.1111/j.1365-3083.2008.02184.x; Pastori C, 2000, J BIOL REG HOMEOS AG, V14, P15; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; REZZA G, 1992, J BIOL REG HOMEOS AG, V6, P15; Ruiz MJ, 2016, J VIROL, V90, P670, DOI 10.1128/JVI.02363-15; Santra S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005042; Schafer F, 2002, GUT, V50, P608, DOI 10.1136/gut.50.5.608; Tay MZ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005817; Theze J, 2011, CLIN IMMUNOL, V141, P15, DOI 10.1016/j.clim.2011.07.007; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trama AM, 2014, CELL HOST MICROBE, V16, P215, DOI 10.1016/j.chom.2014.07.003; TYLER DS, 1990, J IMMUNOL, V145, P3276; Velu V, 2016, J IMMUNOL, V197, P1832, DOI 10.4049/jimmunol.1600143; Vingert B, 2012, J VIROL, V86, P10661, DOI 10.1128/JVI.00056-12; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498; Wei Qing, 2012, Open AIDS J, V6, P293, DOI 10.2174/1874613601206010293; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yamada T, 2004, J IMMUNOL, V172, P2401, DOI 10.4049/jimmunol.172.4.2401; Yates NL, 2013, MUCOSAL IMMUNOL, V6, P692, DOI 10.1038/mi.2012.107; Yu XY, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-52; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629	90	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180245	10.1371/journal.pone.0180245	http://dx.doi.org/10.1371/journal.pone.0180245			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671952	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500033
J	Broussard, MA; Mas, F; Howlett, B; Pattemore, D; Tylianakis, JM				Broussard, Melissa Ann; Mas, Flore; Howlett, Brad; Pattemore, David; Tylianakis, Jason M.			Possible mechanisms of pollination failure in hybrid carrot seed and implications for industry in a changing climate	PLOS ONE			English	Article							POLLEN VIABILITY; TEMPERATURE STRESS; APIS-MELLIFERA; BRASSICA-NAPUS; FRUIT-SET; WILD; YIELD; OLIGOSACCHARIDES; PERFORMANCE; NECTAR	Approximately one-third of our food globally comes from insect-pollinated crops. The dependence on pollinators has been linked to yield instability, which could potentially become worse in a changing climate. Insect-pollinated crops produced via hybrid breeding (20% of fruit and vegetable production globally) are especially at risk as they are even more reliant on pollinators than open-pollinated plants. We already observe a wide range of fruit and seed yields between different cultivars of the same crop species, and it is unknown how existing variation will be affected in a changing climate. In this study, we examined how three hybrid carrot varieties with differential performance in the field responded to three temperature regimes (cooler than the historical average, average, and warmer that the historical average). We tested how temperature affected the plants' ability to set seed (seed set, pollen viability) as well as attract pollinators (nectar composition, floral volatiles). We found that there were significant intrinsic differences in nectar phenolics, pollen viability, and seed set between the carrot varieties, and that higher temperatures did not exaggerate those differences. However, elevated temperature did negatively affect several characteristics relating to the attraction and reward of pollinators (lower volatile production and higher nectar sugar concentration) across all varieties, which may decrease the attractiveness of this already pollinator-limited crop. Given existing predictions of lower pollinator populations in a warmer climate, reduced attractiveness would add yet another challenge to future food production.	[Broussard, Melissa Ann; Tylianakis, Jason M.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Mas, Flore; Howlett, Brad] Christchurch Mail Ctr, New Zealand Inst Plant & Food Res, Christchurch, New Zealand; [Pattemore, David] Waikato Mail Ctr, New Zealand Inst Plant & Food Res, Hamilton, New Zealand; [Tylianakis, Jason M.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England	University of Canterbury; New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; Imperial College London	Broussard, MA (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.	melissa.a.broussard@gmail.com	Broussard, Melissa/F-5357-2018; Mas, Flore/N-6656-2019; Pattemore, David/G-1269-2018; Howlett, Brad/F-1150-2018	Broussard, Melissa/0000-0002-0177-3393; Mas, Flore/0000-0002-0348-2936; Pattemore, David/0000-0003-4609-2660; Howlett, Brad/0000-0002-0694-135X	New Zealand Ministry for Business, Employment & Innovation under "Bee minus to Bee plus and Beyond: Higher Yields from Smarter, Growth-focused Pollination Systems" [C11X1309]	New Zealand Ministry for Business, Employment & Innovation under "Bee minus to Bee plus and Beyond: Higher Yields from Smarter, Growth-focused Pollination Systems"	This project was funded by the New Zealand Ministry for Business, Employment & Innovation (www.mbie.govt.nz/) under grant no. C11X1309, "Bee minus to Bee plus and Beyond: Higher Yields from Smarter, Growth-focused Pollination Systems". The granting agency had no role in the research process apart from approving the initial proposal and granting funding.	ABDULBAKI AA, 1995, HORTSCIENCE, V30, P115, DOI 10.21273/HORTSCI.30.1.115; AHMAD M, 2002, J RES SCI, V13, P31; [Anonymous], 2010, PRINCIPLES PRACTICES; ARNASON JT, 1992, J STORED PROD RES, V28, P119, DOI 10.1016/0022-474X(92)90019-M; Barton K., 2014, MUMIN MULTIMODEL INT; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bohart GE, 1960, INSECT POLLINATORS C; Bolker B, 2014, GETTING STARTED GLMM; Bradeen JM, 2002, J AM SOC HORTIC SCI, V127, P383, DOI 10.21273/JASHS.127.3.383; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Burnham K. P., 1998, MODEL SELECTION INFE; Cakmak I, 2010, J INSECT BEHAV, V23, P100, DOI 10.1007/s10905-009-9199-7; Cao YH, 2004, CHROMATOGRAPHIA, V59, P135, DOI 10.1365/s10337-003-0138-z; Davidson MM, 2010, NEW ZEAL J CROP HORT, V38, P113, DOI 10.1080/01140671003781736; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; DOWKER BD, 1981, J AGR SCI, V97, P25, DOI 10.1017/S0021859600035802; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Erickson E, 1979, JOURNAL; FAOSTAT F, 2009, STAT DAT; Gaffney A., 2011, THESIS; Galuszka H., 1989, Biuletyn Warzywniczy, V33, P35; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Geard A, 2006, 27 INT HORT C EXH, P42; GONZALEZ JL, 1994, AGRON J, V86, P1070, DOI 10.2134/agronj1994.00021962008600060070x; Goodwin M., 2012, POLLINATION CROPS AU; Gracie A., 2011, IMPROVING RELIABILIT; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; HAGLER JR, 1990, ENVIRON ENTOMOL, V19, P327, DOI 10.1093/ee/19.2.327; HAGLER JR, 1993, J KANSAS ENTOMOL SOC, V66, P223; Hampton J. G., 2012, Agronomy New Zealand, V42, P129; Hanna WW, 1995, PLANT BREEDING REV, V13, P179; Hart JM, 2004, HYBRID SEED CARROT C; Hauser TP, 2001, GENET RESOUR CROP EV, V48, P499, DOI 10.1023/A:1012051731933; HAWTHORN L. R., 1956, PROC AMER SOC HORT SCI, V67, P384; Hedhly A, 2011, ENVIRON EXP BOT, V74, P9, DOI 10.1016/j.envexpbot.2011.03.016; HESLOPHARRISON J, 1970, STAIN TECHNOL, V45, P115, DOI 10.3109/10520297009085351; &HLARR, 1985, CRYOPRESERVATION PLA, P171; Holzschuh A, 2011, P ROY SOC B-BIOL SCI, V278, P3444, DOI 10.1098/rspb.2011.0268; Howlett B, 2013, IMPACT CLIMATE CHANG; Howlett B. G., 2015, New Zealand Plant Protection, V68, P373; Howlett BG, 2012, J APPL ENTOMOL, V136, P421, DOI 10.1111/j.1439-0418.2011.01665.x; Howlett B. G., 2011, New Zealand Plant Protection, V64, P25; Juroszek P, 2011, PLANT PATHOL, V60, P100, DOI 10.1111/j.1365-3059.2010.02410.x; Kearns C. A., 1993, TECHNIQUES POLLINATI; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; KNUDSEN IM, 1986, J SCI FOOD AGR, V37, P560, DOI 10.1002/jsfa.2740370609; KNUDSEN KEB, 1991, J AGR FOOD CHEM, V39, P689, DOI 10.1021/jf00004a013; KOUL P, 1989, NEW PHYTOL, V112, P437, DOI 10.1111/j.1469-8137.1989.tb00335.x; Krontal Y, 2000, J HORTIC SCI BIOTECH, V75, P35, DOI 10.1080/14620316.2000.11511197; Kuznetsova A, 2020, PACKAGE IMERTEST; Mahli SS, 2007, CAN J PLANT SCI, V87, P449, DOI 10.4141/P05-180; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Niemela T, 2006, CAN J PLANT SCI, V86, P693, DOI 10.4141/P05-189; OCKENDON DJ, 1976, NEW PHYTOL, V76, P511, DOI 10.1111/j.1469-8137.1976.tb01487.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pacini E, 2003, PLANT SYST EVOL, V238, P7, DOI 10.1007/s00606-002-0277-y; PARKER FD, 1982, J KANSAS ENTOMOL SOC, V55, P171; PATTERSON DT, 1995, WEED SCI, V43, P685, DOI 10.1017/S0043174500081832; Perez-Banon C, 2007, PLANT ECOL, V192, P133, DOI 10.1007/s11258-006-9233-1; Petanidou T, 1996, NEW PHYTOL, V133, P513, DOI 10.1111/j.1469-8137.1996.tb01919.x; Potts SG, 2016, NATURE, V540, P220, DOI 10.1038/nature20588; Proctor M., 1996, The natural history of pollination.; R Core Team, 2021, R LANGUAGE ENV STAT; Rogers MA, 2012, HORTTECHNOLOGY, V22, P452, DOI 10.21273/HORTTECH.22.4.452; Rubatzky V.E., 1999, CARROTS RELATED VEGE; Ruperez P, 1998, Z LEBENSM UNTERS F A, V206, P130, DOI 10.1007/s002170050228; Sagae M, 2008, BIOSCI BIOTECH BIOCH, V72, P110, DOI 10.1271/bbb.70490; SMALL E, 1984, PLANT BIOSYSTEMATICS, P195; Song H-x, 2010, J SHANXI AGR SCI, V4; Spurr C., 2003, THESIS U TASMANIA; Steffan-Dewenter I, 2003, APIDOLOGIE, V34, P227, DOI [10.1051/apdio:2003015, 10.1051/apido:2003015]; STEIN M, 1995, PLANT BREEDING, V114, P1, DOI 10.1111/j.1439-0523.1995.tb00750.x; Sugimoto A, 2012, PLANT GENETIC RESOUR, V11; Tay D., 2002, P INT SEED SEM TRAD, P128; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Verdial M. F., 2001, Scientia Agricola, V58, P533, DOI 10.1590/S0103-90162001000300015; WALLER GD, 1972, ANN ENTOMOL SOC AM, V65, P857, DOI 10.1093/aesa/65.4.857; Willis J. C., 1895, Ann Botany, Vxxxiv, P227; Willis JC, 1903, ANN BOT-LONDON, V17, P313, DOI 10.1093/oxfordjournals.aob.a088919; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Wolf S, 1999, HORTSCIENCE, V34, P860, DOI 10.21273/HORTSCI.34.5.860; Wood S, 2009, GAMM4 GENERALIZED AD; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038; Ziska LH, 2004, WEED SCI, V52, P584, DOI 10.1614/WS-03-161R; Ziska LH, 2000, AUST J PLANT PHYSIOL, V27, P159; Zuur Alain F., 2009, P1	89	15	15	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180215	10.1371/journal.pone.0180215	http://dx.doi.org/10.1371/journal.pone.0180215			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665949	Green Published, gold			2022-12-27	WOS:000404608700073
J	Carvalho, JTG; Schneider, M; Cuppari, L; Grabulosa, CC; Aoike, DT; Redublo, BMQ; Batista, MC; Cendoroglo, M; Moyses, RM; Dalboni, MA				Carvalho, Jose Tarcisio G.; Schneider, Marion; Cuppari, Lilian; Grabulosa, Caren C.; Aoike, Danilo T.; Redublo, Beata Marie Q.; Batista, Marcelo C.; Cendoroglo, Miguel; Moyses, Rosa Maria; Dalboni, Maria Aparecida			Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial	PLOS ONE			English	Article							STAGE RENAL-DISEASE; TOLL-LIKE RECEPTORS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; CYTOKINE RESPONSE; KAPPA-B; EXPRESSION; FIBROBLAST-GROWTH-FACTOR-23; MONOCYTES; METABOLISM; FGF23	It has been reported that vitamin D regulates the immune system. However, whether vitamin D repletion modulates inflammatory responses in lymphocytes from dialysis patients is unclear. In the clinical trial, thirty-two (32) dialysis patients with 25 vitamin D <= 20ng/mL were randomized to receive either supplementation of cholecalciferol 100,000 UI/week/3 months (16 patients) or placebo (16 patients). In the in vitro study, B and T lymphocytes from 12 healthy volunteers (HV) were incubated with or without uremic serum in the presence or absence of 25 or 1,25 vitamin D. We evaluated the intracellular expression of IL-6, IFN-. TLR7, TLR9, VDR, CYP27b1 and CYP24a1 by flow cytometry. We observed a reduction in the expression of TLR7, TLR9, INF-gamma and CYP24a1 and an increase in VDR and CYP27b1 expression in patients which were supplemented with cholecalciferol, whereas no differences were found in the placebo group. Uremic serum increased the intracellular expression of IL-6, IFN-gamma, TLR7, TLR9, VDR, CYP27b1 and CYP24a1. Treatment with 25 or 1,25 vitamin D decreased IL-6 and TLR9. CYP24a1 silencing plus treatment with 25 and/or 1,25 vitamin D had an additional reduction effect on IL-6, IFN-gamma, TLR7 and TLR9 expression. This is the first study showing that cholecalciferol repletion has an anti-inflammatory effect and improves vitamin D intracellular regulatory enzymes on lymphocytes from dialysis patients.	[Carvalho, Jose Tarcisio G.; Schneider, Marion; Cuppari, Lilian; Grabulosa, Caren C.; Aoike, Danilo T.; Redublo, Beata Marie Q.; Batista, Marcelo C.; Cendoroglo, Miguel; Dalboni, Maria Aparecida] Univ Fed Sao Paulo, UNIFESP, Div Nephrol, Sao Paulo, SP, Brazil; [Moyses, Rosa Maria; Dalboni, Maria Aparecida] Univ Nove de Julho UNINOVE, Postgrad Program Med, Sao Paulo, SP, Brazil; [Batista, Marcelo C.; Cendoroglo, Miguel] Hosp Israelite Albert Einstein, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Nove de Julho; Hospital Israelita Albert Einstein	Carvalho, JTG (corresponding author), Univ Fed Sao Paulo, UNIFESP, Div Nephrol, Sao Paulo, SP, Brazil.	tarcisiogiffoni@hotmail.com	Cuppari, Lilian/C-3394-2012; Dalboni, Maria Aparecida/V-6749-2019; Moyses, Rosa M A/F-8268-2012	Cuppari, Lilian/0000-0002-5927-9179; Dalboni, Maria Aparecida/0000-0002-9282-7181; Moyses, Rosa M A/0000-0002-7902-2127; giffoni de carvalho, jose tarcisio/0000-0001-7897-8218	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP [2012/19314-2, 2012/21345-3]; Sao Paulo Research Foundation (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP: 2012/19314-2 and 2012/21345-3. This study was supported by grants from the Sao Paulo Research Foundation (FAPESP)'s Doctoral fellowship for Jose Tarcisio Giffoni Carvalho.	Alvarez JA, 2012, DERM-ENDOCRINOL, V4, P118, DOI 10.4161/derm.20014; Ando M, 2006, KIDNEY INT, V70, P358, DOI 10.1038/sj.ki.5001548; Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Bai XY, 2016, J CLIN INVEST, V126, P667, DOI 10.1172/JCI81928; Cohen G, 1997, KIDNEY INT, V52, pS79; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Cohen-Lahav M, 2007, J STEROID BIOCHEM, V103, P558, DOI 10.1016/j.jsbmb.2006.12.093; Dickie LJ, 2010, RHEUMATOLOGY, V49, P1466, DOI 10.1093/rheumatology/keq124; Dusso A, 2011, BEST PRACT RES CL EN, V25, P647, DOI 10.1016/j.beem.2011.05.005; Ebert R, 2004, MOL ENDOCRINOL, V18, P2440, DOI 10.1210/me.2002-0441; Fernandez-Fresnedo G, 2000, NEPHROL DIAL TRANSPL, V15, P502, DOI 10.1093/ndt/15.4.502; Galesanu C, 2015, MED-SURG J, V119, P310; Girndt M, 2001, KIDNEY INT, V59, pS206, DOI 10.1046/j.1523-1755.2001.59780206.x; Gollapudi P, 2010, AM J NEPHROL, V31, P247, DOI 10.1159/000276764; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Kaisho T, 2001, ACTA ODONTOL SCAND, V59, P124, DOI 10.1080/000163501750266701; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Khoo AL, 2011, CYTOKINE, V55, P294, DOI 10.1016/j.cyto.2011.04.016; Koshikawa M, 2010, CLIN EXP NEPHROL, V14, P233, DOI 10.1007/s10157-010-0264-5; Kuroki Y, 2007, INT J MOL MED, V19, P783; Lehmann B, 2001, J INVEST DERMATOL, V117, P1179, DOI 10.1046/j.0022-202x.2001.01538.x; Lehmann B, 2007, J STEROID BIOCHEM, V103, P682, DOI 10.1016/j.jsbmb.2006.12.033; Lehmann B, 2010, DERMATOL THER, V23, P2, DOI 10.1111/j.1529-8019.2009.01286.x; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Meireles MS, 2016, CLIN NUTR, V35, P1251, DOI 10.1016/j.clnu.2016.04.014; Pahl MV, 2010, NEPHROL DIAL TRANSPL, V25, P205, DOI 10.1093/ndt/gfp397; Petkovich M, 2011, CURR OPIN NEPHROL HY, V20, P337, DOI 10.1097/MNH.0b013e3283477a7b; Posner GH, 2010, J STEROID BIOCHEM, V121, P13, DOI 10.1016/j.jsbmb.2010.03.065; Quarles LD, 2012, EXP CELL RES, V318, P1040, DOI 10.1016/j.yexcr.2012.02.027; Robson MG, 2009, NEPHRON EXP NEPHROL, V113, pE1, DOI 10.1159/000228077; Spustova V, 2004, Vnitr Lek, V50, P537; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x; Stubbs JR, 2010, J AM SOC NEPHROL, V21, P353, DOI 10.1681/ASN.2009040451; Vaziri ND, 2012, J RENAL NUTR, V22, P149, DOI 10.1053/j.jrn.2011.10.020; Weber TJ, 2003, J BONE MINER RES, V18, P1227, DOI 10.1359/jbmr.2003.18.7.1227	38	39	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179540	10.1371/journal.pone.0179540	http://dx.doi.org/10.1371/journal.pone.0179540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665937	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700034
J	Cebron, D; Viroulet, S; Vidal, J; Masson, JP; Viroulet, P				Cebron, David; Viroulet, Sylvain; Vidal, Jeremie; Masson, Jean-Paul; Viroulet, Philippe			Experimental and theoretical study of magnetohydrodynamic ship models	PLOS ONE			English	Article							PROPULSION; MHD; SEAWATER; FLOW; MAGNET; FORCE	Magnetohydrodynamic (MHD) ships represent a clear demonstration of the Lorentz force in fluids, which explains the number of students practicals or exercises described on the web. However, the related literature is rather specific and no complete comparison between theory and typical small scale experiments is currently available. This work provides, in a self-consistent framework, a detailed presentation of the relevant theoretical equations for small MHD ships and experimental measurements for future benchmarks. Theoretical results of the literature are adapted to these simple battery/magnets powered ships moving on salt water. Comparison between theory and experiments are performed to validate each theoretical step such as the Tafel and the Kohlrausch laws, or the predicted ship speed. A successful agreement is obtained without any adjustable parameter. Finally, based on these results, an optimal design is then deduced from the theory. Therefore this work provides a solid theoretical and experimental ground for small scale MHD ships, by presenting in detail several approximations and how they affect the boat efficiency. Moreover, the theory is general enough to be adapted to other contexts, such as large scale ships or industrial flow measurement techniques.	[Cebron, David; Vidal, Jeremie; Masson, Jean-Paul] Univ Grenoble Alpes, CNRS, ISTerre, F-38000 Grenoble, France; [Viroulet, Sylvain] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England; [Viroulet, Sylvain] Univ Manchester, Manchester Ctr Nonlinear Dynam, Manchester M13 9PL, Lancs, England	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; University of Manchester; University of Manchester	Cebron, D (corresponding author), Univ Grenoble Alpes, CNRS, ISTerre, F-38000 Grenoble, France.	david.cebron@univ-grenoble-alpes.fr	Viroulet, Sylvain/M-2408-2017; Cebron, David/A-9625-2014; Vidal, Jérémie/M-6382-2019	Viroulet, Sylvain/0000-0002-8204-1425; Cebron, David/0000-0002-3579-8281; Vidal, Jérémie/0000-0002-3654-6633				BAUMGARTL J, 1993, PHYS FLUIDS A-FLUID, V5, P3280, DOI 10.1063/1.858685; Bennett JE, 1978, AICHE S SERIES, V74; Boissonneau P, 1999, ENERG CONVERS MANAGE, V40, P1783, DOI 10.1016/S0196-8904(99)00072-2; Boissonneau P, 1999, J PHYS D APPL PHYS, V32, P2387, DOI 10.1088/0022-3727/32/18/310; Brown SH, 1990, PROPULSIVE EFFICIENC; Camacho J. M., 2013, Rev. mex. fís. E, V59, P8; Clancy T., 1998, HUNT RED OCOTBER; Convert D., 1995, Magnetohydrodynamics, V31, P290; Convert D., 1995, PROPULSION MAGNETOHY; Davidson PA, 1992, ROLE PRESSURE FORCES, V104, P39; Doragh RA., 1963, SNAME T, V71, P370; DOSS E, 1991, J PROPUL POWER, V7, P635, DOI 10.2514/3.23372; Doss E, 1990, NEED SUPERCONDUCTING; Doss ED, 1992, SAE TECHNICAL PAPER; Engel-Herbert R, 2005, J APPL PHYS, V97, DOI 10.1063/1.1883308; Font GI, 2004, PHYS TEACH, V42, P410; Friauf JB., 1961, J AM SOC NAVAL ENG, V73, P139; Gilbert JB, 1991, STUDIES MHD PROPULSI; Han J, 2002, 17 INT C MAGN LEV SY; Hoerner S. F, 1965, FLUID DYNAMIC DRAG; Huebscher R.G., 1948, ASHVE T, V54, P101; Iwata A, 1980, P ICEC 8 GEN, V8, P775; Khonichev V. I., 1980, Journal of Applied Mechanics and Technical Physics, V21, P77, DOI 10.1007/BF00910143; Khonichev V. I., 1978, Journal of Applied Mechanics and Technical Physics, V19, P760, DOI 10.1007/BF01201553; Khonichev VI, 1981, PMTF ZH PRIKLADNOI M, V21, P109; Leroy R, 1978, P S WAT EL, V78, P4; Leus V., 2004, ETR20042 TECHN ISR I; LIN TF, 1995, J PROPUL POWER, V11, P1349, DOI 10.2514/3.23978; LIN TF, 1991, J PROPUL POWER, V7, P1081, DOI 10.2514/3.23433; Mitchell D. L., 1988, Journal of Superconductivity, V1, P349, DOI 10.1007/BF00618593; Motora S, 1994, INT C EN TRANSF MHD, P501; Muller U, 2002, CISM COUR L, P1; Nishigaki K, 2000, CRYOGENICS, V40, P353, DOI 10.1016/S0011-2275(00)00049-7; Paula J.D., 2006, ATKINS PHYS CHEM, P77; Petrick M, 1992, RESULTS LARGE SCALE; Phillips O.M., 1962, J SHIP RES, V43, P43; POHJAVIRTA A, 1991, IEEE T MAGN, V27, P3735, DOI 10.1109/20.102945; Priede J, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/5/055402; Rice WA, 1961, PROPULSION SYSTEM; Robinson RA, 1937, J CHEM SOC, P574, DOI 10.1039/jr9370000574; Saji Y, 1988, REV KOBE U MERCANT 2, V36; Saji Y, 1978, ADV CRYO ENG, P159; Sasakawa Y, 1995, SUPERCONDUCTING MHD; Schlichting H., 1968, BOUNDARY LAYER THEOR; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shatrov V. I., 1985, Journal of Applied Mechanics and Technical Physics, V26, P19, DOI 10.1007/BF00919618; Shatrov V. I., 1981, Journal of Applied Mechanics and Technical Physics, V22, P817, DOI 10.1007/BF00906112; SWALLOM DW, 1991, NAV ENG J, V103, P141, DOI 10.1111/j.1559-3584.1991.tb00945.x; Takezawa S, 1995, B MESJ, V23, P46; Tempelmeyer KE, 1990, DTIC DOCUMENT; Thess A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.164501; Thibault J., 1994, 2 INT C EN TRANSF MH; TUCK EO, 1966, J FLUID MECH, V26, P81, DOI 10.1017/S0022112066001101; Tuck EO, 2002, 24 S NAV HYDR FUK JA, V813; Van den Berg Thomas H, 2005, PHYS REV LETT, V94; Way S., 1968, ELECTROMAGNETIC PROP, V2, P49; Weier T, 2007, FLUID MECH APPL, V80, P295; Wright M.R., 2007, INTRO AQUEOUS ELECTR; Yakovlev V. I., 1980, Journal of Applied Mechanics and Technical Physics, V21, P376, DOI 10.1007/BF00920776; Yan LG, 2000, IEEE T APPL SUPERCON, V10, P955, DOI 10.1109/77.828390; Yan LG, 2000, IEEE T APPL SUPERCON, V10, P951, DOI 10.1109/77.828389; YANG ZJ, 1990, SUPERCOND SCI TECH, V3, P591, DOI 10.1088/0953-2048/3/12/004	62	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0178599	10.1371/journal.pone.0178599	http://dx.doi.org/10.1371/journal.pone.0178599			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665941	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608700027
J	Ferrara, S; Falcone, M; Macchi, R; Bragonzi, A; Girelli, D; Cariani, L; Cigana, C; Bertoni, G				Ferrara, Silvia; Falcone, Marilena; Macchi, Raffaella; Bragonzi, Alessandra; Girelli, Daniela; Cariani, Lisa; Cigana, Cristina; Bertoni, Giovanni			The PAPI-1 pathogenicity island-encoded small RNA PesA influences Pseudomonas aeruginosa virulence and modulates pyocin S3 production	PLOS ONE			English	Article							FIBROSIS LUNG INFECTION; FUNCTIONAL-ANALYSIS; IDENTIFICATION; GENES; PAO1; BACTERIA; RECEPTOR; TARGETS; STRAIN; GROWTH	Small non-coding RNAs (sRNAs) are post-transcriptional regulators of gene expression that have been recognized as key contributors to bacterial virulence and pathogenic mechanisms. In this study, we characterized the sRNA PesA of the opportunistic human pathogen Pseudomonas aeruginosa. We show that PesA, which is transcribed within the pathogenicity island PAPI-1 of P. aeruginosa strain PA14, contributes to P. aeruginosa PA14 virulence. In fact, pesA gene deletion resulted in a less pathogenic strain, showing higher survival of cystic fibrosis human bronchial epithelial cells after infection. Moreover, we show that PesA influences positively the expression of pyocin S3 whose genetic locus comprises two structural genes, pyoS3A and pyoS3I, encoding the killing S3A and the immunity S3I proteins, respectively. Interestingly, the deletion of pesA gene results in increased sensitivity to UV irradiation and to the fluoroquinolone antibiotic ciprofloxacin. The degree of UV sensitivity displayed by the PA14 strain lacking PesA is comparable to that of a strain deleted for pyoS3A-I. These results suggest an involvement of pyocin S3 in DNA damage repair and a regulatory role of PesA on this function.	[Ferrara, Silvia; Falcone, Marilena; Macchi, Raffaella; Bertoni, Giovanni] Univ Milan, Dept Biosci, Milan, Italy; [Bragonzi, Alessandra; Cigana, Cristina] IRCCS San Raffaele Sci Inst, Infect & Cyst Fibrosis Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Girelli, Daniela; Cariani, Lisa] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Cyst Fibrosis Microbiol Lab, Milan, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico	Ferrara, S; Bertoni, G (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	silvia.ferrara@unimi.it; giovanni.bertoni@unimi.it	BERTONI, GIOVANNI/J-3437-2012; FERRARA, SILVIA/ABB-8803-2020; Bragonzi, Alessandra/AAC-6751-2022; Ferrara, Silvia/AAR-4497-2020; Cigana, Cristina/D-2883-2016	BERTONI, GIOVANNI/0000-0001-5761-9494; FERRARA, SILVIA/0000-0002-8024-7147; Cigana, Cristina/0000-0003-0436-9721; Falcone, Marilena/0000-0001-7838-7258	European Commission [NABATIVI-223670]; Italian Cystic Fibrosis Research Foundation (FFC) [13/2015]; Universita degli Studi di Milano	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Cystic Fibrosis Research Foundation (FFC)(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Universita degli Studi di Milano	This work has been supported by the following grants to GB: European Commission (NABATIVI-223670, EU-FP7-HEALTH-2007-B) and Italian Cystic Fibrosis Research Foundation (FFC#13/2015) with the contribution of Gruppo di Sostegno FFC di Sassari Castelsardo and Delegazione FFC di Boschi Sant'Anna Minerbe and (FFC#14/2016) with the contribution of Delegazione FFC di Reggio Calabria and Gruppo di Sostegno FFC di Vigevano. SF was the recipient of a Postdoctoral Fellowship of the Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi-Ali A, 2004, CAN J MICROBIOL, V50, P375, DOI 10.1139/W04-019; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Baysse C, 1999, J BACTERIOL, V181, P3849, DOI 10.1128/JB.181.12.3849-3851.1999; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Caldelari I, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010298; Choi JY, 2002, J BACTERIOL, V184, P952, DOI 10.1128/jb.184.4.952-961.2002; Cigana C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21465; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Corcoran CP, 2012, MOL MICROBIOL, V84, P428, DOI 10.1111/j.1365-2958.2012.08031.x; Delvillani F, 2014, RNA, V20, P1963, DOI 10.1261/rna.044354.114; Dingemans J, 2016, MICROBIOLOGYOPEN, V5, P413, DOI 10.1002/mbo3.339; DUPORT C, 1995, J BIOL CHEM, V270, P8920, DOI 10.1074/jbc.270.15.8920; Elfarash A, 2012, MICROBIOLOGYOPEN, V1, P268, DOI 10.1002/mbo3.27; Ferrara S, 2015, ENVIRON MICROBIOL, V17, P199, DOI 10.1111/1462-2920.12590; Ferrara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036553; FYFE JAM, 1984, J CLIN MICROBIOL, V20, P47, DOI 10.1128/JCM.20.1.47-50.1984; Gomez-Lozano M, 2012, ENVIRON MICROBIOL, V14, P2006, DOI 10.1111/j.1462-2920.2012.02759.x; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Hoe CH, 2013, INT J MED MICROBIOL, V303, P217, DOI 10.1016/j.ijmm.2013.04.002; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Ling H, 2010, FEBS LETT, V584, P3354, DOI 10.1016/j.febslet.2010.06.021; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Popat R, 2012, P ROY SOC B-BIOL SCI, V279, P4765, DOI 10.1098/rspb.2012.1976; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; SANO Y, 1993, J BACTERIOL, V175, P2907, DOI 10.1128/JB.175.10.2907-2916.1993; SANO Y, 1993, MOL GEN GENET, V237, P161, DOI 10.1007/BF00282797; SANO Y, 1993, J BACTERIOL, V175, P6179, DOI 10.1128/JB.175.19.6179-6185.1993; SEO YH, 1990, BIOCHEM BIOPH RES CO, V172, P455, DOI 10.1016/0006-291X(90)90694-I; Sonnleitner E, 2008, MICROBIOL-SGM, V154, P3175, DOI 10.1099/mic.0.2008/019703-0; Sonnleitner E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004440; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tjaden B., 2008, NUCLEIC ACIDS RES, P36; Wagner Victoria E., 2008, P129; Wenner N, 2014, ENVIRON MICROBIOL, V16, P1053, DOI 10.1111/1462-2920.12272; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wright PR, 2014, NUCLEIC ACIDS RES, P42; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945	46	10	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180386	10.1371/journal.pone.0180386	http://dx.doi.org/10.1371/journal.pone.0180386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665976	Green Published, gold			2022-12-27	WOS:000404608700004
J	Ghazanfar, S; Vuocolo, T; Morrison, JL; Nicholas, LM; McMillen, IC; Yang, JYH; Buckley, MJ; Tellam, RL				Ghazanfar, Shila; Vuocolo, Tony; Morrison, Janna L.; Nicholas, Lisa M.; McMillen, Isabella C.; Yang, Jean Y. H.; Buckley, Michael J.; Tellam, Ross L.			Gene expression allelic imbalance in ovine brown adipose tissue impacts energy homeostasis	PLOS ONE			English	Article							INTEGRATIVE ANALYSIS; EARLY-LIFE; DISCOVERY; DIVERGENCE; FRAMEWORK; POWERFUL; DATABASE; PROGRESS; REVEALS; TOOL	Heritable trait variation within a population of organisms is largely governed by DNA variations that impact gene transcription and protein function. Identifying genetic variants that affect complex functional traits is a primary aim of population genetics studies, especially in the context of human disease and agricultural production traits. The identification of alleles directly altering mRNA expression and thereby biological function is challenging due to difficulty in isolating direct effects of cis-acting genetic variations from indirect trans-acting genetic effects. Allele specific gene expression or allelic imbalance in gene expression (AI) occurring at heterozygous loci provides an opportunity to identify genes directly impacted by cis-acting genetic variants as indirect trans-acting effects equally impact the expression of both alleles. However, the identification of genes showing AI in the context of the expression of all genes remains a challenge due to a variety of technical and statistical issues. The current study focuses on the discovery of genes showing AI using single nucleotide polymorphisms as allelic reporters. By developing a computational and statistical process that addressed multiple analytical challenges, we ranked 5,809 genes for evidence of AI using RNA-Seq data derived from brown adipose tissue samples from a cohort of late gestation fetal lambs and then identified a conservative subgroup of 1,293 genes. Thus, AI was extensive, representing approximately 25% of the tested genes. Genes associated with AI were enriched for multiple Gene Ontology (GO) terms relating to lipid metabolism, mitochondrial function and the extracellular matrix. These functions suggest that cis-acting genetic variations causing AI in the population are preferentially impacting genes involved in energy homeostasis and tissue remodelling. These functions may contribute to production traits likely to be under genetic selection in the population.	[Ghazanfar, Shila; Buckley, Michael J.] CSIRO, Data61, N Ryde, NSW, Australia; [Ghazanfar, Shila; Yang, Jean Y. H.] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Vuocolo, Tony; Tellam, Ross L.] CSIRO Agr, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Morrison, Janna L.; Nicholas, Lisa M.; McMillen, Isabella C.] Univ South Australia, Early Origins Adult Hlth Res Grp, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of South Australia	Ghazanfar, S (corresponding author), CSIRO, Data61, N Ryde, NSW, Australia.; Ghazanfar, S (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia.; Tellam, RL (corresponding author), CSIRO Agr, Queensland Biosci Precinct, St Lucia, Qld, Australia.	shila.ghazanfar@sydney.edu.au; Ross.Tellam@gmail.com	McMillen, Isabella Caroline/N-5540-2019; Morrison, Janna/B-8308-2009; Tellam, Ross/T-2423-2019; Yang, Jean YH/D-2920-2015; Tellam, Ross/H-2798-2013	Morrison, Janna/0000-0002-8602-8519; Yang, Jean YH/0000-0002-5271-2603; Tellam, Ross/0000-0003-2353-1640; Ghazanfar, Shila/0000-0001-7861-6997	CSIRO OCE Top-Up Scholarship; Australian Postgraduate Award; Science and Industry Endowment Fund [RP03-064]; Australian Research Council Future Fellowship Grant [FT0991918]; Australian Research Council DP Grant [130100488]; National Health and Medical Research Council [APP1066916]	CSIRO OCE Top-Up Scholarship; Australian Postgraduate Award(Australian Government); Science and Industry Endowment Fund; Australian Research Council Future Fellowship Grant(Australian Research Council); Australian Research Council DP Grant(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funded by SG: CSIRO OCE Top-Up Scholarship, SG: Australian Postgraduate Award, RT, MJB, JLM, ICM: Science and Industry Endowment Fund (RP03-064), JYHY: Australian Research Council Future Fellowship Grant (FT0991918), JYHY: Australian Research Council DP Grant (130100488), JLM: National Health and Medical Research Council (APP1066916). Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Aldermann G, 1975, FISHERIES FOOD TECHN, P33; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Asada R, 2015, SCI REP-UK, V5, DOI 10.1038/srep16580; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bell GDM, 2013, GENOME BIOL EVOL, V5, P1309, DOI 10.1093/gbe/evt072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Byrne K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-378; Chamberlain AJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2174-0; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; ENCODE, GUID EXP; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutter B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-116; Iizuka K, 2013, ENDOCR J, V60, P1145, DOI 10.1507/endocrj.EJ13-0079; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nag A, 2015, G3-GENES GENOM GENET, V5, P1713, DOI 10.1534/g3.115.018853; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; Obenchain V, 2014, BIOINFORMATICS, V30, P2076, DOI 10.1093/bioinformatics/btu168; Pandey RV, 2013, MOL ECOL RESOUR, V13, P740, DOI 10.1111/1755-0998.12110; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Romanoski CE, 2015, NATURE, V518, P314, DOI 10.1038/518314a; Savova V, 2016, NUCLEIC ACIDS RES, V44, pD753, DOI 10.1093/nar/gkv1106; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Symonds ME, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/305763; Symonds ME, 2012, P NUTR SOC, V71, P363, DOI 10.1017/S0029665112000584; Symonds ME, 2011, PROG BIOPHYS MOL BIO, V106, P300, DOI 10.1016/j.pbiomolbio.2010.11.008; Verdeguer F, 2016, MOL CELL BIOL, V36, P184, DOI 10.1128/MCB.00722-15; Yao X, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-35; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180378	10.1371/journal.pone.0180378	http://dx.doi.org/10.1371/journal.pone.0180378			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665992	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000404608700003
J	Joly, P; Schaus, T; Sass, A; Dienelt, A; Cheung, AS; Duda, GN; Mooney, DJ				Joly, Pascal; Schaus, Thomas; Sass, Andrea; Dienelt, Anke; Cheung, Alexander S.; Duda, Georg N.; Mooney, David J.			Biophysical induction of cell release for minimally manipulative cell enrichment strategies	PLOS ONE			English	Article							ISCHEMIC VASCULAR-DISEASE; CD31(+) CELLS; TRANSPLANTATION; ADHESION; LEUKOCYTES; SURFACES; APTAMER; MARROW	The use of autologous cells harvested and subsequently transplanted in an intraoperative environment constitutes a new approach to promote regeneration. Usually cells are isolated by selection methods such as fluorescence- or magnetic-activated cell sorting with residual binding of the antibodies or beads. Thus, cell-based therapies would benefit from the development of new devices for cell isolation that minimally manipulate the target cell population. In the clinic, 5 to 10 percent of fractures do not heal properly and CD31+ cells have been identified as promising candidates to support bone regeneration. The aim of this project was to develop and prototype a simple system to facilitate the enrichment of CD31+ cells from whole blood. After validating the specificity of a commercially available aptamer for CD31, we combined this aptamer with traditional magnetic bead strategies, which led to enrichment of CD31+ cells with a purity of 91 +/- 10%. Subsequently, the aptamer was attached to agarose beads (empty set = 100-165 um) that were incorporated into a column-based system to enable capture and subsequent release of the CD31+ enriched cells. Different parameters were investigated to allow a biophysical-based cell release from beads, and a simple mixing was found sufficient to release initially bound cells from the optimized column without the need for any chemicals that promote disassociation. The system led to a significant enrichment of CD31+ cells (initial population: 63 +/- 9%, released: 87 +/- 3%) with excellent cell viability (released: 97 +/- 1%). The composition of the released CD31+ fraction indicated an enrichment of the monocyte population. The angiogenic and osteogenic potential of the released cell population were confirmed in vitro. These results and the simplicity of this system highlight the potential of such approach to enable cell enrichment strategies in intraoperative settings.	[Joly, Pascal; Schaus, Thomas; Cheung, Alexander S.; Duda, Georg N.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Joly, Pascal; Sass, Andrea; Dienelt, Anke; Duda, Georg N.] Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany; [Joly, Pascal; Sass, Andrea; Dienelt, Anke; Duda, Georg N.] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany; [Sass, Andrea; Dienelt, Anke; Duda, Georg N.] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Cheung, Alexander S.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University	Duda, GN; Mooney, DJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Duda, GN (corresponding author), Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany.; Duda, GN (corresponding author), Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany.; Duda, GN (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.; Mooney, DJ (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	georg.duda@charite.de; mooneyd@seas.harvard.edu	Sass, Andrea F/M-6962-2017; Duda, Georg N/H-2085-2016	Sass, Andrea F/0000-0001-6098-3609; Duda, Georg N/0000-0001-7605-3908; Mooney, David/0000-0001-6299-1194; Cheung, Alexander/0000-0002-7139-1665	Wyss Institute; Berlin-Brandenburg Center for Regenerative Therapies (BCRT) through German Federal Ministry of Education and Research (BMBF)	Wyss Institute; Berlin-Brandenburg Center for Regenerative Therapies (BCRT) through German Federal Ministry of Education and Research (BMBF)	This work has been funded by the Wyss Institute, the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) through funding by the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt V, 2009, INJURY, V40, P1269, DOI 10.1016/j.injury.2009.02.007; Ashrafuzzaman M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/697923; Assmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101449; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Burkardt O, 2015, ANN ANAT, P1; Caralla T, 2013, TISSUE ENG PT A, V19, P125, DOI 10.1089/ten.tea.2011.0622; Dahabreh Z, 2007, INJURY, V38, P371, DOI 10.1016/j.injury.2006.08.055; Dong L, 2013, TRENDS BIOTECHNOL, V31, P342, DOI 10.1016/j.tibtech.2013.04.001; DOWNEY GP, 1990, J APPL PHYSIOL, V69, P1767, DOI 10.1152/jappl.1990.69.5.1767; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Guo K- T, 2008, CELL SELEX NOVEL PER, P1; Guo KT, 2008, INT J MOL SCI, V9, P668, DOI 10.3390/ijms9040668; HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8; HAMMER DA, 1992, BIOPHYS J, V63, P35, DOI 10.1016/S0006-3495(92)81577-1; Hammer DA, 2014, J BIOMECHANICAL ENG; Kawamoto A, 2009, STEM CELLS, V27, P2857, DOI 10.1002/stem.207; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kim S- W, 2010, SCIENCEDIRECT; Kuroda R, 2014, STEM CELL TRANSL MED, V3, P128, DOI 10.5966/sctm.2013-0106; Kushner EJ, 2009, SCIENCEDIRECT, V44, P74; Lee Wu N, 2013, ORTHOPEDIA RES REV; Li TGF, 2015, SPRINGER THESES-RECO, pCP5, DOI 10.1007/978-3-319-19273-4; Lin Q, 2014, IET NANOBIOTECHNOLOG, V8; Mills LA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002276; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nilsson C, 2008, CLIN VACCINE IMMUNOL, V15, P585, DOI 10.1128/CVI.00161-07; Ozkan MC, 2015, TRANSFUS APHER SCI; Pierzchalski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074745; Reinke S, 2013, SCI TRANSLATIONAL ME, V5; Riis S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.10; Sass FA, 2016, J BONE MINER R UNPUB; SCHMIDSCHONBEIN GW, 1980, BLOOD, V56, P866; Shen QL, 2013, ADV MATER, V25, P2368, DOI 10.1002/adma.201300082; Simari RD, 2010, J AM COLL CARDIOL, V56, P608, DOI 10.1016/j.jacc.2010.01.069; Soltan M, 2012, MONOCYTES SUPER CELL, V21; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Yoon JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131785; Zhu J, 2012, LAB CHIP RSC	38	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180568	10.1371/journal.pone.0180568	http://dx.doi.org/10.1371/journal.pone.0180568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665971	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700018
J	Burgerhout, E; Mommens, M; Johnsen, H; Aunsmo, A; Santi, N; Andersen, O				Burgerhout, Erik; Mommens, Maren; Johnsen, Hanne; Aunsmo, Arnfinn; Santi, Nina; Andersen, Oivind			Genetic background and embryonic temperature affect DNA methylation and expression of myogenin and muscle development in Atlantic salmon (Salmo solar)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; SKELETAL-MUSCLE; SALAR L; INCUBATION-TEMPERATURE; EPIGENETIC CONTROL; TELEOST FISH; GROWTH; CELLULARITY; CELLS	The development of ectothermic embryos is strongly affected by incubation temperature, and thermal imprinting of body growth and muscle phenotype has been reported in various teleost fishes. The complex epigenetic regulation of muscle development in vertebrates involves DNA methylation of the myogenin promoter. Body growth is a heritable and highly variable trait among fish populations that allows for local adaptations, but also for selective breeding. Here we studied the epigenetic effects of embryonic temperature and genetic background on body growth, muscle cellularity and myogenin expression in farmed Atlantic salmon (Salmo salar). Eggs from salmon families with either high or low estimated breeding values for body growth, referred to as Fast and Slow genotypes, were incubated at 8(circle)C or 4(circle)C until the embryonic 'eyed-stage' followed by rearing at the production temperature of 8(circle)C. Rearing temperature strongly affected the growth rates, and the 8(circle)C fish were about twice as heavy as the 4(circle)C fish in the order Fast8>Slow8>Fast4>Slow4 prior to seawater transfer. Fast8 was the largest fish also at harvest despite strong growth compensation in the low temperature groups. Larval myogenin expression was approximately 4-6 fold higher in the Fast8 group than in the other groups and was associated with relative low DNA methylation levels, but was positively correlated with the expression levels of the DNA methyltransferase genes dnmt1, dnmt3a and dnmt3b. Juvenile Fast8 fish displayed thicker white muscle fibres than Fast4 fish, while Slow 8 and Slow 4 showed no difference in muscle cellularity. The impact of genetic background on the thermal imprinting of body growth and muscle development in Atlantic salmon suggests that epigenetic variation might play a significant role in the local adaptation to fluctuating temperatures over short evolutionary time.	[Burgerhout, Erik; Johnsen, Hanne] Nofima AS, Tromso, Norway; [Mommens, Maren; Aunsmo, Arnfinn; Santi, Nina] AquaGen AS, Trondheim, Norway; [Andersen, Oivind] Nofima AS, As, Norway; [Andersen, Oivind] Norwegian Univ Life Sci, Dept Anim & Aquaculture Sci, As, Norway	Nofima; Nofima; Norwegian University of Life Sciences	Andersen, O (corresponding author), Nofima AS, As, Norway.; Andersen, O (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquaculture Sci, As, Norway.	oivind.andersen@nofima.no	Burgerhout, Erik/AAI-4527-2020		Norwegian Research Council Project [221734/030]	Norwegian Research Council Project(Research Council of Norway)	The authors received funding from Norwegian Research Council Project No. 221734/030. Nofima AS provided support in the form of salaries for authors [EB, HJ, OA] and AquaGen AS provided support in the form of salaries for authors [MM, AA, NS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albokhadaim I, 2007, J EXP BIOL, V210, P1735, DOI 10.1242/jeb.003194; Aunsmo A, 2014, AQUACULTURE, P249; Aunsmo A, 2008, AQUACULTURE, V284, P19, DOI 10.1016/j.aquaculture.2008.07.028; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bizuayehu TT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1503-7; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Campos C, 2013, EPIGENETICS-US, V8, P389, DOI 10.4161/epi.24178; CHO CY, 1992, AQUACULTURE, V100, P107, DOI 10.1016/0044-8486(92)90353-M; DuRant SE, 2012, FUNCT ECOL, V26, P416, DOI 10.1111/j.1365-2435.2011.01945.x; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fuso A, 2010, CELL CYCLE, V9, P3965, DOI 10.4161/cc.9.19.13193; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Harvey AC, 2016, EVOL APPL, V9, P435, DOI 10.1111/eva.12346; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hupkes M, 2011, FASEB J, V25, P3861, DOI 10.1096/fj.11-186122; Jimenez AG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3150; Johansen KA, 2005, MAR BIOTECHNOL, V7, P576, DOI 10.1007/s10126-004-5133-3; Johnston IA, 1997, CAN J ZOOL, V75, P64, DOI 10.1139/z97-008; Johnston IA, 2000, J EXP BIOL, V203, P2539; Johnston IA, 2001, MAR ECOL PROG SER, V213, P285, DOI 10.3354/meps213285; Johnston IA, 2004, J EXP BIOL, V207, P4343, DOI 10.1242/jeb.01292; Johnston IA, 2012, P ROY SOC B-BIOL SCI, V279, P2255, DOI 10.1098/rspb.2011.2536; Julin K, 2009, J VIROL METHODS, V162, P30, DOI 10.1016/j.jviromet.2009.07.003; Laker RC, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5725927; Lighten J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160299; Macqueen DJ, 2008, BIOL LETTERS, V4, P294, DOI 10.1098/rsbl.2007.0620; Macqueen DJ, 2007, J EXP BIOL, V210, P2781, DOI 10.1242/jeb.006981; Maltby V, 2004, BRIT POULTRY SCI, V45, P491, DOI 10.1080/00071660412331286190; MATSCHAK TW, 1995, EXPERIENTIA, V51, P260, DOI 10.1007/BF01931109; Moresi V, 2015, BBA-GENE REGUL MECH, V1849, P309, DOI 10.1016/j.bbagrm.2015.01.002; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nakatsuka R, 2010, ARCH ORAL BIOL, V55, P350, DOI 10.1016/j.archoralbio.2010.03.003; NATHANAILIDES C, 1995, CAN J FISH AQUAT SCI, V52, P675, DOI 10.1139/f95-068; O'Steen S, 1998, J EXP BIOL, V201, P439; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rescan PY, 2005, GEN COMP ENDOCR, V142, P111, DOI 10.1016/j.ygcen.2004.12.016; Schnurr ME, 2014, J EXP BIOL, V217, P1370, DOI 10.1242/jeb.094037; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; Seiliez I, 2015, CELL TISSUE RES, V359, P715, DOI 10.1007/s00441-014-2060-0; Shima A, 2008, ZOOL SCI, V25, P1066, DOI 10.2108/zsj.25.1066; Skinner MK, 2014, GENOME BIOL EVOL, V6, P1972, DOI 10.1093/gbe/evu158; Steinbacher P, 2006, DEV DYNAM, V235, P3132, DOI 10.1002/dvdy.20950; Steinbacher P, 2011, J EXP BIOL, V214, P1791, DOI 10.1242/jeb.050096; STICKLAND NC, 1988, ANAT EMBRYOL, V178, P253, DOI 10.1007/BF00318228; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Tsai HY, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0215-y; USHER ML, 1994, J FISH BIOL, V44, P953, DOI 10.1006/jfbi.1994.1088; Valente LMP, 1999, J FISH BIOL, V55, P675, DOI 10.1111/j.1095-8649.1999.tb00710.x; VEGGETTI A, 1993, ANAT EMBRYOL, V187, P353; Watkins TB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P140, DOI 10.1086/498182; WEATHERLEY AH, 1988, J FISH BIOL, V33, P851, DOI 10.1111/j.1095-8649.1988.tb05532.x; Wilkes D, 2001, J EXP BIOL, V204, P2763; Xie SQ, 2001, DIFFERENTIATION, V68, P106, DOI 10.1046/j.1432-0436.2001.680204.x	59	42	43	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179918	10.1371/journal.pone.0179918	http://dx.doi.org/10.1371/journal.pone.0179918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662198	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000404608300070
J	Dugovich, BS; Peel, MJ; Palmer, AL; Zielke, RA; Sikora, AE; Beechler, BR; Jolles, AE; Epps, CW; Dolan, BP				Dugovich, Brian S.; Peel, Melanie J.; Palmer, Amy L.; Zielke, Ryszard A.; Sikora, Aleksandra E.; Beechler, Brianna R.; Jolles, Anna E.; Epps, Clinton W.; Dolan, Brian P.			Detection of bacterial-reactive natural IgM antibodies in desert bighorn sheep populations	PLOS ONE			English	Article							KEYHOLE LIMPET HEMOCYANIN; VIBRIO-CORALLIILYTICUS; INFLUENZA-VIRUS; MOUNTAIN SHEEP; CELLS; PATHOGEN; DISEASE; INHIBITION; DIVERSITY; IMMUNITY	Ecoimmunology is a burgeoning field of ecology which studies immune responses in wildlife by utilizing general immune assays such as the detection of natural antibody. Unlike adaptive antibodies, natural antibodies are important in innate immune responses and often recognized conserved epitopes present in pathogens. Here, we describe a procedure for measuring natural antibodies reactive to bacterial antigens that may be applicable to a variety of organisms. IgM from desert bighorn sheep plasma samples was tested for reactivity to outer membrane proteins from Vibrio coralliilyticus, a marine bacterium to which sheep would have not been exposed. Immunoblotting demonstrated bighorn sheep IgM could bind to a variety of bacterial cell envelope proteins while ELISA analysis allowed for rapid determination of natural antibody levels in hundreds of individual animals. Natural antibody levels were correlated with the ability of plasma to kill laboratory strains of E. coli bacteria. Finally, we demonstrate that natural antibody levels varied in two distinct populations of desert bighorn sheep. These data demonstrate a novel and specific measure of natural antibody function and show that this varies in ecologically relevant ways.	[Dugovich, Brian S.; Peel, Melanie J.; Palmer, Amy L.; Beechler, Brianna R.; Jolles, Anna E.; Dolan, Brian P.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Zielke, Ryszard A.; Sikora, Aleksandra E.] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Epps, Clinton W.] Oregon State Univ, Dept Fisheries & Wildlife, Coll Agr Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Dolan, BP (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Brian.Dolan@oregonstate.edu	Sikora, Aleksandra E/HGD-6641-2022; Beechler, Brianna R/H-7972-2019; Epps, Clinton/AAX-3971-2021	Beechler, Brianna R/0000-0002-9711-4340; Epps, Clinton/0000-0001-6577-1840; Jolles, Anna/0000-0003-3074-9912	California Department of Fish and Wildlife (CDFW); National Park Service (NPS); California Chapter of the Wild Sheep Foundation; Oregon State University; NPS	California Department of Fish and Wildlife (CDFW); National Park Service (NPS); California Chapter of the Wild Sheep Foundation; Oregon State University; NPS	Bighorn samples were provided from research funded by the California Department of Fish and Wildlife (CDFW), the National Park Service (NPS), and the California Chapter of the Wild Sheep Foundation. Funding for analyses was provided by Oregon State University and NPS. Bighorn sheep captures within the Mojave National Preserve were conducted under NPS research permit MOJA-2013-SCI-0030. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Baxendale HE, 2008, CLIN EXP IMMUNOL, V151, P51, DOI 10.1111/j.1365-2249.2007.03535.x; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Brock PM, 2014, INTEGR COMP BIOL, V54, P353, DOI 10.1093/icb/icu046; Buchalski MR, 2016, J MAMMAL, V97, P823, DOI 10.1093/jmammal/gyw011; BUDZKO DB, 1981, J CLIN MICROBIOL, V13, P818, DOI 10.1128/JCM.13.5.818-823.1981; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; COWAN IAN McTAGGART, 1940, AMER MIDLAND NAT, V24, P505, DOI 10.2307/2420858; Creech TG, 2016, J ARID ENVIRON, V127, P160, DOI 10.1016/j.jaridenv.2015.11.011; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; ELLIOT LF, 1994, J WILDLIFE DIS, V30, P315, DOI 10.7589/0090-3558-30.3.315; Elston RA, 2008, DIS AQUAT ORGAN, V82, P119, DOI 10.3354/dao01982; Epps CW, 2006, MOL ECOL, V15, P4295, DOI 10.1111/j.1365-294X.2006.03103.x; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Epps CW, 2004, CONSERV BIOL, V18, P102, DOI 10.1111/j.1523-1739.2004.00023.x; Epps CW, 2016, MOJAVE NATL PRESERVE, V2016, P1; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7; Herget S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-35; Hunter KW, 2008, J MICROBIOL METH, V75, P464, DOI 10.1016/j.mimet.2008.07.022; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Jessup DA, 1985, T DESERT BIGHORN COU, V29, P29; Kantor AB, 1997, J IMMUNOL, V158, P1175; Kearney JF, 2015, ANNU REV IMMUNOL, V33, P475, DOI 10.1146/annurev-immunol-032713-120140; Lobo PI, 2008, J IMMUNOL, V180, P1769, DOI 10.4049/jimmunol.180.3.1769; LUDEWIG S, 1949, J BIOL CHEM, V179, P271; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin LB, 2007, AM J PHYSIOL-REG I, V292, pR316, DOI 10.1152/ajpregu.00386.2006; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Mayasari N, 2016, PREV VET MED, V127, P1, DOI 10.1016/j.prevetmed.2016.03.001; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Nguyen TTT, 2015, J IMMUNOL, V194, P1489, DOI 10.4049/jimmunol.1401880; Notley CA, 2011, J IMMUNOL, V186, P4967, DOI 10.4049/jimmunol.1003021; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Quartier P, 2005, EUR J IMMUNOL, V35, P252, DOI 10.1002/eji.200425497; Richards GP, 2015, APPL ENVIRON MICROB, V81, P292, DOI 10.1128/AEM.02930-14; Sandmeier FC, 2012, BIOL OPEN, V1, P1078, DOI 10.1242/bio.20122527; Savage HP, 2015, ANN NY ACAD SCI, V1362, P132, DOI 10.1111/nyas.12799; SEITANID.B, 1969, J CLIN PATHOL, V22, P321, DOI 10.1136/jcp.22.3.321; van der Klein SAS, 2015, POULTRY SCI, V94, P875, DOI 10.3382/ps/pev052; van Knegsel ATM, 2007, J DAIRY SCI, V90, P5490, DOI 10.3168/jds.2007-0289; Wang CG, 2013, INT IMMUNOL, V25, P575, DOI 10.1093/intimm/dxt022; Wehausen J. D., 1993, DESERT BIGHORN COUNC, V37, P1; Wehausen JD, 2011, CALIF FISH GAME, V97, P7; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083; Zielke RA, 2014, CURR PROTOC MICROBIO, V34	53	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180415	10.1371/journal.pone.0180415	http://dx.doi.org/10.1371/journal.pone.0180415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662203	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300153
J	Jiang, JW; Min, Y; Chang, J; Ge, Y				Jiang, Jinwei; Min, Yong; Chang, Jie; Ge, Ying			Biological interactions and cooperative management of multiple species	PLOS ONE			English	Article							ECOLOGICAL SYSTEMS; FISHERIES; MODEL; CAPABILITIES; RESOURCES; DYNAMICS; ECOPATH; ECOSIM	Coordinated decision making and actions have become the primary solution for the overexploitation of interacting resources within ecosystems. However, the success of coordinated management is highly sensitive to biological, economic, and social conditions. Here, using a game theoretic framework and a 2-species model that considers various biological relationships (competition, predation, and mutualism), we compute cooperative (or joint) and noncooperative (or separate) management equilibrium outcomes of the model and investigate the effects of the type and strength of the relationships. We find that cooperation does not always show superiority to non-cooperation in all biological interactions: (1) if and only if resources are involved in high-intensity predation relationships, cooperation can achieve a win-win scenario for ecosystem services and resource diversity; (2) for competitive resources, cooperation realizes higher ecosystem services by sacrificing resource diversity; and (3) for mutual resources, cooperation has no obvious advantage for either ecosystem services or resource evenness but can slightly improve resource abundance. Furthermore, by using a fishery model of the North California Current Marine Ecosystem with 63 species and seven fleets, we demonstrate that the theoretical results can be reproduced in real ecosystems. Therefore, effective ecosystem management should consider the interconnection between stakeholders' social relationship and resources' biological relationships.	[Jiang, Jinwei; Min, Yong] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Min, Yong; Chang, Jie; Ge, Ying] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Min, Yong] Univ Quebec Montreal, Dept Biol Sci, Inst Environm Sci, Montreal, PQ, Canada	Zhejiang University of Technology; Zhejiang University; University of Quebec; University of Quebec Montreal	Min, Y (corresponding author), Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China.; Min, Y (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.; Min, Y (corresponding author), Univ Quebec Montreal, Dept Biol Sci, Inst Environm Sci, Montreal, PQ, Canada.	myong@zjut.edu.cn			The National Natural Science Foundation of China [71303217, 31370354, 31470463]; Zhejiang Provincial Natural Science Foundation of China [LY17G030030]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The National Natural Science Foundation of China (Grant Nos. 71303217, 31370354 and 31470463) and the Zhejiang Provincial Natural Science Foundation of China (Grant No. LY17G030030).	ANDERSON LG, 1975, J FISH RES BOARD CAN, V32, P1825, DOI 10.1139/f75-217; Audet C, 2003, SIAM J OPTIMIZ, V13, P889, DOI 10.1137/S1052623400378742; Chen XJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04161; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Field JC, 2006, PROG OCEANOGR, V68, P238, DOI 10.1016/j.pocean.2006.02.010; Field JC, 2004, APPL ECOSYSTEM BASED, P408; Garcia-Algarra J, 2014, J THEOR BIOL, V363, P332, DOI 10.1016/j.jtbi.2014.08.039; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; HANNESSON R, 1983, J ENVIRON ECON MANAG, V10, P329, DOI 10.1016/0095-0696(83)90003-7; Hannesson R, 2011, ANNU REV RESOUR ECON, V3, P181, DOI 10.1146/annurev-resource-083110-120107; LIDICKER WZ, 1979, BIOSCIENCE, V29, P475, DOI 10.2307/1307540; May R., 2007, THEORETICAL ECOLOGY, V3rd; MAY RM, 1979, SCIENCE, V205, P267, DOI 10.1126/science.205.4403.267; Min Y, 2011, ECOL MODEL, V222, P3277, DOI 10.1016/j.ecolmodel.2011.06.013; MUNRO GR, 1979, CAN J ECON, V12, P355, DOI 10.2307/134727; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Steenbeek J, 2016, ECOL MODEL, V319, P178, DOI 10.1016/j.ecolmodel.2015.06.031; Sumaila U.R., 2013, GAME THEORY FISHERIE; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; Weitz JS, 2016, P NATL ACAD SCI USA, V113, pE7518, DOI 10.1073/pnas.1604096113; White C, 2008, ECOL LETT, V11, P370, DOI 10.1111/j.1461-0248.2007.01151.x; White C, 2012, ECOL LETT, V15, P509, DOI 10.1111/j.1461-0248.2012.01773.x; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003; Yang W, 2013, P NATL ACAD SCI USA, V110, P10916, DOI 10.1073/pnas.1301733110	28	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180189	10.1371/journal.pone.0180189	http://dx.doi.org/10.1371/journal.pone.0180189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662140	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300123
J	Dong, ZY; Yang, YS; Zhang, KP; Li, YW; Wang, JJ; Wang, ZJ; Liu, X; Qin, HJ; Wang, DW				Dong, Zhenying; Yang, Yushuang; Zhang, Kunpu; Li, Yiwen; Wang, Junjun; Wang, Zhaojun; Liu, Xin; Qin, Huanju; Wang, Daowen			Development of a new set of molecular markers for examining Glu-A1 variants in common wheat and ancestral species	PLOS ONE			English	Article							WEIGHT GLUTENIN SUBUNITS; BREAD-MAKING QUALITY; GENETIC DIVERSITY; STORAGE PROTEINS; GENOME EVOLUTION; SEQUENCE; LINES; INSERTION; ALLELES; REGIONS	In common wheat (Triticum aestivum L.), allelic variations of Glu-A1 locus have important influences on grain end-use quality. Among the three Glu-A1 alleles, Glu-A1a and -A1b encode the high-molecular-weight glutenin subunits (HMW-GSs) 1Ax1 and 1Ax2*, respectively, whereas Glu-A1c does not specify any subunit. Here, we detected a total of 11 GluA1 locus haplotypes (H1 to H11) in three wheat species, by developing and using a new set of DNA markers (Xrj5, Xid3, Xrj6, Xid4 and Xrj7). The main haplotypes found in the diploid wheat T. urartu were H1, H4, H5 and H6, with H1 and H4 expressing both 1Ax and 1Ay subunits. The major haplotypes revealed for tetraploid wheat (T. turgidum) were H1, H8 and H9, with the lines expressing both 1Ax and 1Ay belonging to H1, H4 or H7. Four major haplotypes (H1, H9, H10 and H11) were discovered in common wheat, with Glu-A1a associated with H1 and H8, Glu-A1b with H10 or H11, and Glu-A1c with H9. The Glu-A1 locus haplotypes and the new set of DNA markers have potential to be used for more effectively studying and utilizing the molecular variations of Glu-A1 to improve the end-use quality of common wheat are discussed.	[Dong, Zhenying; Yang, Yushuang; Zhang, Kunpu; Li, Yiwen; Wang, Junjun; Wang, Zhaojun; Liu, Xin; Qin, Huanju; Wang, Daowen] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosomal Engn, Beijing, Peoples R China; [Yang, Yushuang] Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou, Peoples R China; [Wang, Junjun; Wang, Zhaojun; Wang, Daowen] Grad Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Daowen] Henan Agr Univ, Collaborat Innovat Ctr Grain Crops, Zhengzhou, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Henan Agricultural University	Dong, ZY; Wang, DW (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosomal Engn, Beijing, Peoples R China.; Wang, DW (corresponding author), Grad Univ Chinese Acad Sci, Beijing, Peoples R China.; Wang, DW (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Grain Crops, Zhengzhou, Peoples R China.	zhydong@genetics.ac.cn; dwwang@genetics.ac.cn		wang, dao wen/0000-0002-6230-8735	National Natural Science Foundation of China [31300280]; Ministry of Science and Technology of China [2016YFD0100500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This project was supported by grants from the National Natural Science Foundation of China (31300280) and the Ministry of Science and Technology of China (2016YFD0100500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of themanuscript	Alvarez JB, 2009, CEREAL RES COMMUN, V37, P243, DOI 10.1556/CRC.37.2009.2.11; Anderson OD, 2011, J CEREAL SCI, V54, P280, DOI 10.1016/j.jcs.2011.04.005; Bai JR, 2004, ACTA BOT SIN, V46, P463; Belton PS, 1999, J CEREAL SCI, V29, P103, DOI 10.1006/jcrs.1998.0227; Branlard G, 2001, EUPHYTICA, V119, P59, DOI 10.1023/A:1017586220359; Charmet G, 2011, CR BIOL, V334, P212, DOI 10.1016/j.crvi.2010.12.013; CIAFFI M, 1995, CEREAL CHEM, V72, P465; Dixon J, 2009, WHEAT FACTS FUTURES; Dong LL, 2012, MOL GENET GENOMICS, V287, P855, DOI 10.1007/s00438-012-0721-9; Dong ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083263; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Feldman M., 1995, EVOLUTION CROP PLANT, V2nd, P184; Feldman M, 2012, GENETICS, V192, P763, DOI 10.1534/genetics.112.146316; Feng B, 2011, MOL BREEDING, V28, P163, DOI 10.1007/s11032-010-9470-9; FORDE J, 1985, NUCLEIC ACIDS RES, V13, P6817, DOI 10.1093/nar/13.19.6817; Groos C, 2007, THEOR APPL GENET, V115, P313, DOI 10.1007/s00122-007-0563-8; Gu YQ, 2006, GENETICS, V174, P1493, DOI 10.1534/genetics.106.060756; Gu YQ, 2004, PLANT PHYSIOL, V135, P459, DOI 10.1104/pp.103.038083; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HALFORD NG, 1989, PLANT SCI, V62, P207, DOI 10.1016/0168-9452(89)90083-6; HARBERD NP, 1987, MOL GEN GENET, V209, P326, DOI 10.1007/BF00329661; Hu XG, 2012, GENET RESOUR CROP EV, V59, P491, DOI 10.1007/s10722-011-9698-1; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jiang QT, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-16; LAFIANDRA D, 1993, J CEREAL SCI, V18, P197, DOI 10.1006/jcrs.1993.1046; Li W, 2004, THEOR APPL GENET, V109, P1093, DOI 10.1007/s00122-004-1726-5; Li YW, 2015, MOL PLANT, V8, P332, DOI 10.1016/j.molp.2014.10.002; Liu YN, 2012, THEOR APPL GENET, V125, P1, DOI 10.1007/s00122-012-1829-3; Pang BS, 2008, J INTEGR PLANT BIOL, V50, P329, DOI 10.1111/j.1744-7909.2007.00573.x; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Payne P. I., 1983, Cereal Research Communications, V11, P29; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1981, THEOR APPL GENET, V60, P229, DOI 10.1007/BF02342544; Prescott-Allen R, 2013, GENES WILD USING WIL; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Rogers WJ, 1997, EUPHYTICA, V93, P19, DOI 10.1023/A:1002991206350; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry Peter R, 2003, Adv Food Nutr Res, V45, P219; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; WAINES JG, 1987, THEOR APPL GENET, V74, P71, DOI 10.1007/BF00290086; Wan Y, 2000, THEOR APPL GENET, V101, P879, DOI 10.1007/s001220051556; Wang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058947; Wanjugi H, 2009, GENOME, V52, P576, DOI [10.1139/G09-033, 10.1139/g09-033]; Wrigley CW, 2009, WHEAT SCI TRADE, P470; Xu LL, 2009, GENET RESOUR CROP EV, V56, P377, DOI 10.1007/s10722-008-9373-3; Yue SJ, 2008, J CEREAL SCI, V47, P153, DOI 10.1016/j.jcs.2007.03.006; [张平平 ZHANG Ping-Ping], 2009, [作物学报, Acta Agronomica Sinica], V35, P1606	52	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180766	10.1371/journal.pone.0180766	http://dx.doi.org/10.1371/journal.pone.0180766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683152	Green Published, gold, Green Submitted			2022-12-27	WOS:000405335200067
J	Ribeiro, AA; Azcarate-Peril, MA; Cadenas, MB; Butz, N; Paster, BJ; Chen, T; Bair, E; Arnold, RR				Ribeiro, Apoena Aguiar; Azcarate-Peril, Maria Andrea; Cadenas, Maria Belen; Butz, Natasha; Paster, Bruce J.; Chen, Tsute; Bair, Eric; Arnold, Roland R.			The oral bacterial microbiome of occlusal surfaces in children and its association with diet and caries	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; DENTAL-CARIES; STREPTOCOCCUS-MUTANS; IN-VITRO; COMMUNITIES; PLAQUE; LACTOBACILLI; DIVERSITY; HEALTH; CAVITY	Dental caries is the most prevalent disease in humans globally. Efforts to control it have been invigorated by an increasing knowledge of the oral microbiome composition. This study aimed to evaluate the bacterial diversity in occlusal biofilms and its relationship with clinical surface diagnosis and dietary habits. Anamneses were recorded from thirteen 12-year-old children. Biofilm samples collected from occlusal surfaces of 46 permanent second molars were analyzed by 16S rRNA amplicon sequencing combined with the BLASTN-based search algorithm for species identification. The overall mean decayed, missing and filled surfaces modified index [DMFSm Index, including active white spot lesions (AWSL)] value was 8.77 +/- 7.47. Biofilm communities were highly polymicrobial collectively, representing 10 bacterial phyla, 25 classes, 29 orders, 58 families, 107 genera, 723 species. Streptococcus sp_Oral_Taxon_065, Corynebacterium matruchotii, Actinomyces viscosus, Actinomyces sp_Oral_Taxon_175, Actinomyces sp_Oral_Taxon_178, Actinomyces sp_Oral_Taxon_877, Prevotella nigrescens, Dialister micraerophilus, Eubacterium_XI G 1 infirmum were more abundant among surfaces with AWSL, and Streptococcus gordonii, Streptococcus sp._Oral_Taxon_058, Enterobacter sp._str._638 Streptococcus australis, Yersinia mollaretii, Enterobacter cloacae, Streptococcus sp._Oral_Taxon_71, Streptococcus sp._Oral_Taxon_F11, Centipeda sp._Oral_Taxon_D18 were more abundant among sound surfaces. Streptococcus mutans was detected on all surfaces in all patients, while Streptococcus sobrinus was detected only in three patients (mean relative abundances 7.1% and 0.6%, respectively). Neither species differentiated healthy from diseased sites. Diets of nine of the subjects were scored as high in fermentable carbohydrates (>= 2X/day between meals). A direct association between relative abundances of bacteria and carbohydrate consumption was observed among 18 species. High consumption of fermentable carbohydrates and sound surfaces were associated with a reduction in bacterial diversity. PCoA plots displayed differences in bacterial community profiles between sound and diseased surfaces. Our study showed that, in addition to mutans streptococci, other species may be associated with the initiation of dental caries on occlusal surfaces, and that biofilm diversity of tooth surfaces is influenced by carbohydrate consumption and a surface's health status.	[Ribeiro, Apoena Aguiar] Fluminense Fed Univ, Dept Pediat Dent & Cariol, Sch Dent, Nova Friburgo, Brazil; [Ribeiro, Apoena Aguiar; Arnold, Roland R.] Univ N Carolina, Dept Diagnost Sci, Sch Dent, Chapel Hill, NC 27515 USA; [Azcarate-Peril, Maria Andrea] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Azcarate-Peril, Maria Andrea; Cadenas, Maria Belen; Butz, Natasha] Univ N Carolina, Sch Med, Microbiome Core Facil, Chapel Hill, NC USA; [Paster, Bruce J.; Chen, Tsute] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Paster, Bruce J.] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA USA; [Bair, Eric] Univ N Carolina, Sch Dent, Dept Endodont & Biostat, Chapel Hill, NC USA	Universidade Federal Fluminense; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; University of North Carolina; University of North Carolina Chapel Hill	Ribeiro, AA (corresponding author), Fluminense Fed Univ, Dept Pediat Dent & Cariol, Sch Dent, Nova Friburgo, Brazil.; Ribeiro, AA (corresponding author), Univ N Carolina, Dept Diagnost Sci, Sch Dent, Chapel Hill, NC 27515 USA.	apoenaribeiro@hotmail.com	Azcarate-Peril, M. Andrea/ABH-5508-2020; Core, UNC Microbiome/AAB-3304-2022; Ribeiro, Apoena/AAZ-8478-2021; Paster, Bruce J/AAP-8559-2021; Chen, Tsute/ABC-2676-2020; Azcarate-Peril, M. Andrea/AFO-7157-2022; Azcarate-Peril, M. Andrea/AAA-9056-2022	Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; de Aguiar Ribeiro, Apoena/0000-0001-7702-6178	Science without Borders Scholarship (Coordenacao de AperfeicEoamento de Pessoal de NoAvel Superior) Brazil [8729/13-1]; National Institute of Diabetes and Digestive and Kidney Diseases NIH [P30DK34987]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE016937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	Science without Borders Scholarship (Coordenacao de AperfeicEoamento de Pessoal de NoAvel Superior) Brazil; National Institute of Diabetes and Digestive and Kidney Diseases NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AAR was funded by the Science without Borders Scholarship (Coordenacao de AperfeicEoamento de Pessoal de NoAvel Superior www.capes.gov.br)#8729/13-1; Brazil. The Microbiome Core Facility is funded in part by the National Institute of Diabetes and Digestive and Kidney Diseases NIH grant P30DK34987.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Al-Hebshi NN, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.28934; Allali I, 2015, GUT MICROBES, V6, P161, DOI 10.1080/19490976.2015.1039223; Arcella D, 2002, PUBLIC HEALTH NUTR, V5, P553, DOI 10.1079/PHN2001319; Bagramian RA, 2009, AM J DENT, V22, P3; Beighton D, 1996, ARCH ORAL BIOL, V41, P271, DOI 10.1016/0003-9969(96)84555-9; Belstrom D, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.30170; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Bourgeois DM, 2014, INT DENT J, V64, P27, DOI 10.1111/idj.12129; BRADSHAW DJ, 1989, J DENT RES, V68, P1298, DOI 10.1177/00220345890680090101; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Bradshawa DJ, 2002, CARIES RES, V36, P81, DOI 10.1159/000057864; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fejerskov O., 2015, DENT CARIES DIS ITS, V4th, P5; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; FITZGERALD RJ, 1981, J DENT RES, V60, P919, DOI 10.1177/00220345810600051201; Georgios A, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.26197; GUGGENHEIM B, 1968, Caries Research, V2, P147; HARPER DS, 1984, ARCH ORAL BIOL, V29, P843, DOI 10.1016/0003-9969(84)90015-3; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Johansson I, 2016, J DENT RES, V95, P80, DOI 10.1177/0022034515609554; Lang N P, 1987, Oral Microbiol Immunol, V2, P39, DOI 10.1111/j.1399-302X.1987.tb00268.x; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1979, INFECT IMMUN, V26, P498, DOI 10.1128/IAI.26.2.498-507.1979; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marsh P D, 1994, Adv Dent Res, V8, P263; MEURMAN JH, 1987, SCAND J DENT RES, V95, P32; NCHS, 2010, HLTH US 2009 SPEC FE; Nyvad B, 1999, CARIES RES, V33, P252, DOI 10.1159/000016526; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Nyvad B, 2013, CARIES RES, V47, P89, DOI 10.1159/000345367; Ogaard B, 2012, J ORAL MICROBIOL, V4; Palmer CA, 2010, J DENT RES, V89, P1224, DOI 10.1177/0022034510376543; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Peterson SN, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00108; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; Pinto AC, 2011, GENET MOL RES, V10, P1707, DOI 10.4238/vol10-3gmr1554; Ribeiro AD, 2013, INT J PAEDIATR DENT, V23, P359, DOI 10.1111/ipd.12008; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Simon-Soro A, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.25443; Slater B, 2003, EUR J CLIN NUTR, V57, P629, DOI 10.1038/sj.ejcn.1601588; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Tanzer J M, 2001, J Dent Educ, V65, P1028; Tenuta LMA, 2006, CARIES RES, V40, P546, DOI 10.1159/000095656; Thompson AL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00003; Thylstrup A, 1998, QUINTESSENCE INT, V29, P594; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269; Zaura E, 2012, Adv Dent Res, V24, P81, DOI 10.1177/0022034512449466; Zaura E, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00039; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	57	36	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180621	10.1371/journal.pone.0180621	http://dx.doi.org/10.1371/journal.pone.0180621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678838	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200077
J	Roy, A; Ramalinga, M; Kim, OJ; Chijioke, J; Lynch, S; Byers, S; Kumar, D				Roy, Arpita; Ramalinga, Malathi; Kim, Okjin J.; Chijioke, Juliet; Lynch, Solomon; Byers, Stephen; Kumar, Deepak			Multiple roles of RARRES1 in prostate cancer: Autophagy induction and angiogenesis inhibition	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FOXO TRANSCRIPTION FACTORS; PROMOTER HYPERMETHYLATION; GENE-EXPRESSION; DNA METHYLATION; STEM-CELLS; SIRT1; PROTEIN; TIG1; PHOSPHORYLATION	Background Prostate cancer (PCa) poses a major health concern in men worldwide. Retinoic Acid Receptor Responder (RARRES1)/Tazarotene-induced gene-1 (TIG-1) is a putative tumor suppressor gene that exerts its tumor suppressor function via unknown mechanisms. Epigenetic silencing of RARRES1 leads to its loss in several types of cancer, including PCa. Determining the molecular mechanisms that mediate the tumor suppressor role of RARRES1 in PCa is the focus of our study. Findings Our data indicates that RARRES1 over expression in PCa cell lines represses mitogen-activated protein kinase (MAPK) activation. RARRES1 expression induces the levels of autophagy- related genes, beclin, ATG3 and increases LC3B-II conversion. A significant induction of SIRT1 along with mTOR inhibition is noted on RARRES1 expression. Furthermore, RARRES1 over expression elevates the levels of the antioxidant enzyme, catalase. Our results also indicate that RARRES1 expression inhibits angiogenesis in endothelial cells. Conclusions In summary, the data presented here indicate that forced expression of RARRES1 in PCa cells (a) induces ER stress and autophagic response; (b) increases SIRT1 levels; and (c) higher levels of anti-oxidant enzymes. Our study also implicates the role of RARRES1 as a novel anti-angiogenic molecule. Overall this study reports the molecular players that RARRES1 modulates to serve as a tumor suppressor molecule. Future studies will help determine the in vivo mechanisms by which RARRES1 may serve as a target for therapeutic intervention both in cancer and in angiogenesis-related disorders.	[Roy, Arpita; Ramalinga, Malathi; Kim, Okjin J.; Chijioke, Juliet; Lynch, Solomon; Kumar, Deepak] Univ Dist Columbia, Canc Res Lab, Washington, DC 20008 USA; [Byers, Stephen; Kumar, Deepak] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Kumar, Deepak] North Carolina Cent Univ, JLC BBRI Nutr Res Lab, Kannapolis, NC 28081 USA; [Kumar, Deepak] North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA	University of the District of Columbia; Georgetown University; University of North Carolina; North Carolina Central University; University of North Carolina; North Carolina Central University	Kumar, D (corresponding author), Univ Dist Columbia, Canc Res Lab, Washington, DC 20008 USA.; Kumar, D (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.; Kumar, D (corresponding author), North Carolina Cent Univ, JLC BBRI Nutr Res Lab, Kannapolis, NC 28081 USA.; Kumar, D (corresponding author), North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA.	dkumar@nccu.edu			Synergistic Idea Award [W81XWH-12-1-0425]; Department of Defense Prostate Cancer Research Program; National Cancer Institute's [CA141935, CA194730, CA162264]; NATIONAL CANCER INSTITUTE [R21CA162264, U01CA194730] Funding Source: NIH RePORTER	Synergistic Idea Award; Department of Defense Prostate Cancer Research Program(United States Department of Defense); National Cancer Institute's(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Synergistic Idea Award (W81XWH-12-1-0425) to DK and SB from the Department of Defense Prostate Cancer Research Program. Financial support by National Cancer Institute's grants CA141935, CA194730 and CA162264 is also gratefully acknowledged. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dieterich S, 2000, CIRCULATION, V101, P33, DOI 10.1161/01.CIR.101.1.33; Ellinger J, 2008, UROLOGY, V71, P161, DOI 10.1016/j.urology.2007.09.056; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Glorieux C, 2011, BIOCHEM PHARMACOL, V82, P1384, DOI 10.1016/j.bcp.2011.06.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Khodayari S, 2013, J GASTROEN HEPATOL, V28, P819, DOI 10.1111/jgh.12141; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim SH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/904142; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kwong J, 2005, INT J CANCER, V113, P386, DOI 10.1002/ijc.20593; Leonhardt H, 2000, J CELL BIOCHEM, P78; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mizuiri H, 2005, CANCER SCI, V96, P571, DOI 10.1111/j.1349-7006.2005.00082.x; Nagpal S, 1996, J INVEST DERMATOL, V106, P269, DOI 10.1111/1523-1747.ep12340668; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ou X, 2014, STEM CELLS, V32, P1183, DOI 10.1002/stem.1641; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rodriguez-Berriguete Gonzalo, 2012, J Signal Transduct, V2012, P169170, DOI 10.1155/2012/169170; Roudier E, 2013, ANGIOGENESIS, V16, P759, DOI 10.1007/s10456-013-9353-x; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; Shah MH, 2015, BREAST CANC RES TREA; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh K, 2012, AUTOPHAGY, V8, P236, DOI 10.4161/auto.8.2.18600; Su ZY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0321-5; Takai N, 2005, MOL CANCER RES, V3, P261, DOI 10.1158/1541-7786.MCR-04-0110; Wang F, 2015, DRUG DES DEV THER, V9, P575, DOI 10.2147/DDDT.S75221; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu JC, 2013, CELL RES, V23, P691, DOI 10.1038/cr.2013.36; Wu YY, 2015, METHODS MOL BIOL, V1238, P425, DOI 10.1007/978-1-4939-1804-1_23; Yanatatsaneejit P, 2008, ORAL ONCOL, V44, P400, DOI 10.1016/j.oraloncology.2007.05.008; Yang Hui, 2015, Critical Reviews in Oncogenesis, V20, P49; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhang X, 2011, CURR DRUG TARGETS, V12, P1267, DOI 10.2174/138945011796150325; Zhi Xiaoyong, 2015, F1000Prime Rep, V7, P18, DOI 10.12703/P7-18	48	12	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180344	10.1371/journal.pone.0180344	http://dx.doi.org/10.1371/journal.pone.0180344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678839	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200057
J	Seawright, JW; Samman, Y; Sridharan, V; Mao, XW; Cao, MH; Singh, P; Meinyk, S; Koturbash, I; Nelson, GA; Hauer-Jensen, M; Boerma, M				Seawright, John W.; Samman, Yusra; Sridharan, Vijayalakshmi; Mao, Xiao Wen; Cao, Maohua; Singh, Preeti; Meinyk, Stepan; Koturbash, Igor; Nelson, Gregory A.; Hauer-Jensen, Martin; Boerma, Marjan			Effects of low-dose rate gamma-irradiation combined with simulated microgravity on markers of oxidative stress, DNA methylation potential, and remodeling in the mouse heart	PLOS ONE			English	Article							RADIATION-INDUCED CHANGES; LONG-TERM SURVIVORS; CARDIAC-FUNCTION; SPACE-FLIGHT; BREAST-CANCER; CARDIOVASCULAR-DISEASE; IONIZING-RADIATION; HUMAN-LYMPHOCYTES; MORTALITY; DAMAGE	Purpose Space travel is associated with an exposure to low-dose rate ionizing radiation and the microgravity environment, both of which may lead to impairments in cardiac function. We used a mouse model to determine short-and long-term cardiac effects to simulated microgravity (hindlimb unloading; HU), continuous low-dose rate.-irradiation, or a combination of HU and low-dose rate.-irradiation. Methods Cardiac tissue was obtained from female, C57BL/6J mice 7 days, 1 month, 4 months, and 9 months following the completion of a 21 day exposure to HU or a 21 day exposure to low-dose rate.-irradiation (average dose rate of 0.01 cGy/h to a total of 0.04 Gy), or a 21 day simultaneous exposure to HU and low-dose rate.-irradiation. Immunoblot analysis, rt-PCR, high-performance liquid chromatography, and histology were used to assess inflammatory cell infiltration, cardiac remodeling, oxidative stress, and the methylation potential of cardiac tissue in 3 to 6 animals per group. Results The combination of HU and.-irradiation demonstrated the strongest increase in reduced to oxidized glutathione ratios 7 days and 1 month after treatment, but a difference was no longer apparent after 9 months. On the other hand, no significant changes in 4-hydroxynonenal adducts was seen in any of the groups, at the measured endpoints. While manganese superoxide dismutase protein levels decreased 9 months after low-dose.-radiation, no changes were observed in expression of catalase or Nrf2, a transcription factor that determines the expression of several antioxidant enzymes, at the measured endpoints. Inflammatory marker, CD-2 protein content was significantly decreased in all groups 4 months after treatment. No significant differences were observed in alpha-smooth muscle cell actin protein content, collagen type III protein content or% total collagen. Conclusions This study has provided the first and relatively broad analysis of small molecule and protein markers of oxidative stress, T-lymphocyte infiltration, and cardiac remodeling in response to HU with simultaneous exposure to low-dose rate gamma-radiation. Results from the late observation time points suggest that the hearts had mostly recovered from these two experimental conditions. However, further research is needed with larger numbers of animals for a more robust statistical power to fully characterize the early and late effects of simulated micro-gravity combined with exposure to low-dose rate ionizing radiation on the heart.	[Seawright, John W.; Samman, Yusra; Sridharan, Vijayalakshmi; Cao, Maohua; Singh, Preeti; Hauer-Jensen, Martin; Boerma, Marjan] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Mao, Xiao Wen; Nelson, Gregory A.] Loma Linda Univ, Dept Basic Sci & Radiat Med, Loma Linda, CA 92350 USA; [Meinyk, Stepan] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Koturbash, Igor] Univ Arkansas Med Sci, Dept Environm & Occupat Hlth, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; Loma Linda University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Seawright, JW (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.	JWSeawright@uams.edu		Singh, Preeti/0000-0003-3481-2771	National Space Biomedical Research Institute [RE03701, NCC9-58]; National Aeronautics and Space Administration (NAS Agrantnumber) [NNX13AL97G]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM109005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109005] Funding Source: NIH RePORTER	National Space Biomedical Research Institute; National Aeronautics and Space Administration (NAS Agrantnumber); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Space Biomedical Research Institute (www.nsbri. org) (RE03701) through NCC9-58, the National Aeronautics and Space Administration (www.nasa. gov) (NAS Agrantnumber NNX13AL97G), and through an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (www. nigms.nih.gov) under grant number P20 GM109005.The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Azimzadeh O, 2017, ONCOTARGET, V8, P9067, DOI 10.18632/oncotarget.10424; Barger LK, 1995, RES SPORTS MED INT J, V5, P293, DOI DOI 10.1080/15438629509512026; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Bellone JA, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.19; Boerma M, 2005, CANCER RES, V65, P3100, DOI 10.1158/0008-5472.CAN-04-4333; Boerma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070479; Casciati A, 2016, ONCOTARGET, V7, P28040, DOI 10.18632/oncotarget.8575; Chancellor Jeffery C., 2014, Life-Basel, V4, P491, DOI 10.3390/life4030491; Chowdhury B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147514; Chowdhury P, 2008, OPEN CLIN CHEM J, V1, P47, DOI DOI 10.2174/1874241600801010047; Constine LS, 1997, INT J RADIAT ONCOL, V39, P897, DOI 10.1016/S0360-3016(97)00467-7; CUZICK J, 1994, J CLIN ONCOL, V12, P447, DOI 10.1200/JCO.1994.12.3.447; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; De Luca C, 2009, TOXICOL IND HEALTH, V25, P259, DOI 10.1177/0748233709103032; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; Gridley DS, 2008, RADIAT RES, V169, P280, DOI 10.1667/RR1155.1; Gridley DS, 2010, TECHNOL CANCER RES T, V9, P637, DOI 10.1177/153303461000900612; Gridley DS, 2009, J RADIAT RES, V50, P139, DOI 10.1269/jrr.08095; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Heidenreich PA, 2005, AM HEART J, V150, P977, DOI 10.1016/j.ahj.2004.12.026; Hollander J, 1998, FREE RADICAL BIO MED, V24, P385, DOI 10.1016/S0891-5849(97)00278-5; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kang JH, 2001, LAB INVEST, V81, P573, DOI 10.1038/labinvest.3780266; Kempf SJ, 2016, ONCOTARGET, V7, P71817, DOI 10.18632/oncotarget.12376; Kimzey SL, 1975, TECHNICAL REPORT; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Koturbash I, 2016, MUTAT RES-FUND MOL M, V787, P43, DOI 10.1016/j.mrfmmm.2016.02.009; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2; Lee DH, 2009, ENVIRON HEALTH PERSP, P1799; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Mansour HH, 2012, EUR J PHARMACOL, V692, P46, DOI 10.1016/j.ejphar.2012.06.037; Mao XW, 2016, RADIAT RES, V185, P647, DOI 10.1667/RR14267.1; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Musacchia XJ, 1984, PHYSIOLOGIST S, V28, pS237; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Paneni F, 2013, ATHEROSCLEROSIS, V230, P191, DOI 10.1016/j.atherosclerosis.2013.07.003; Patties I, 2015, STRAHLENTHER ONKOL, V191, P172, DOI 10.1007/s00066-014-0745-7; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Qin FZ, 2003, AM J PHYSIOL-HEART C, V285, pH822, DOI 10.1152/ajpheart.00015.2003; Ramadan SS, 2016, LIFE SCI SPACE RES, V8, P8, DOI 10.1016/j.lssr.2015.12.001; Rizzo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032361; Sanzari JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071757; Seemann I, 2012, RADIOTHER ONCOL, V103, P143, DOI 10.1016/j.radonc.2011.10.011; Simonetto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096309; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Sonnenfeld G, 1998, INT J SPORTS MED, V19, pS195, DOI 10.1055/s-2007-971992; Soucy KG, 2007, RADIAT ENVIRON BIOPH, V46, P179, DOI 10.1007/s00411-006-0090-z; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Sridharan V, 2015, RADIAT RES, V183, P357, DOI 10.1667/RR13915.1; Sridharan V, 2014, RADIAT RES, V181, P324, DOI 10.1667/RR13452.1; Sridharan V, 2014, INT J RADIAT ONCOL, V88, P167, DOI 10.1016/j.ijrobp.2013.10.014; Subramanian V, 2017, J PROTEOME RES, V16, P307, DOI 10.1021/acs.jproteome.6b00795; TAYLOR GR, 1992, J LEUKOCYTE BIOL, V51, P129, DOI 10.1002/jlb.51.2.129; Tipton CM, 1996, MED SCI SPORT EXER, V28, P988, DOI 10.1097/00005768-199608000-00009; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; Westby CM, 2016, J APPL PHYSIOL, V120, P956, DOI 10.1152/japplphysiol.00676.2015; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zimmermann O, 2009, BASIC RES CARDIOL, V104, P591, DOI 10.1007/s00395-009-0026-2	66	16	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180594	10.1371/journal.pone.0180594	http://dx.doi.org/10.1371/journal.pone.0180594			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678877	Green Submitted, gold, Green Published			2022-12-27	WOS:000405272200074
J	Weiss, J; Maurer, M; Ketelsen, D; Notohamiprodjo, M; Zinsser, D; Wichmann, JL; Nikolaou, K; Bamberg, F; Othman, AE				Weiss, Jakob; Maurer, Michael; Ketelsen, Dominik; Notohamiprodjo, Mike; Zinsser, Dominik; Wichmann, Julian L.; Nikolaou, Konstantin; Bamberg, Fabian; Othman, Ahmed E.			Effect of reduced z-axis scan coverage on diagnostic performance and radiation dose of neck computed tomography in patients with suspected cervical abscess	PLOS ONE			English	Article							ITERATIVE RECONSTRUCTION; PERITONSILLAR ABSCESS; IMAGE QUALITY; CT; REDUCTION; RISK; HEAD; AGE	Purpose To evaluate the effect of reduced z-axis scan coverage on diagnostic performance and radiation dose of neck CT in patients with suspected cervical abscess. Methods Fifty-one patients with suspected cervical abscess were included and underwent contrast-enhanced neck CT on a 2nd or 3rd generation dual-source CT system. Image acquisition ranged from the aortic arch to the upper roof of the frontal sinuses (CTstd). Subsequently, series with reduced z-axis coverage (CTred) were reconstructed starting at the aortic arch up to the orbital floor. CTstd and CTred were independently assessed by two radiologists for the presence/absence of cervical abscesses and for incidental and alternative findings. In addition, diagnostic accuracy for the depiction of the cervical abscesses was calculated for both readers. Furthermore, DLP (dose-length-product), effective dose (ED) and organ doses were calculated and compared for CTred and CTstd, using a commercially available dose management platform. Results A total of 41 abscesses and 3 incidental/alternative findings were identified in CTstd. All abscesses and incidental/alternative findings could also be detected on CTred resulting in a sensitivity and specificity of 1.0 for both readers. DLP, ED and organ doses of the brain, the eye lenses, the red bone marrow and the salivary glands of CTred were significantly lower than for CTstd (p<0.001). Conclusions Reducing z-axis coverage of neck CT allows for a significant reduction of effective dose and organ doses at similar diagnostic performance as compared to CTstd.	[Weiss, Jakob; Maurer, Michael; Ketelsen, Dominik; Notohamiprodjo, Mike; Zinsser, Dominik; Nikolaou, Konstantin; Bamberg, Fabian; Othman, Ahmed E.] Eberhard Karls Univ Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Wichmann, Julian L.] Univ Hosp Frankfurt, Dept Diagnost & Intervent Radiol, Frankfurt, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Notohamiprodjo, M (corresponding author), Eberhard Karls Univ Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany.	Mike.Notohamiprodjo@uni.tuebingen..de	Ketelsen, Dominik/A-1143-2012	Ketelsen, Dominik/0000-0002-7333-8024; Othman, Ahmed/0000-0002-3827-8695; othman, ahmed mohamed abdel ghany/0000-0002-0405-8918	Siemens Healthineers	Siemens Healthineers	This study was funded by an unrestricted research grant from Siemens Healthineers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bovo R, 2016, EUR ARCH OTO-RHINO-L, V273, P225, DOI 10.1007/s00405-014-3454-z; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brito TP, 2016, BRAZ J OTORHINOLARYN; Campbell J, 2005, AM J ROENTGENOL, V185, P1525, DOI 10.2214/AJR.04.1512; Celakovsky P, 2014, EUR ARCH OTO-RHINO-L, V271, P1679, DOI 10.1007/s00405-013-2651-5; Christner JA, 2012, RADIOLOGY, V265, P841, DOI 10.1148/radiol.12112365; Christner JA, 2010, AM J ROENTGENOL, V194, P881, DOI 10.2214/AJR.09.3462; Corwin MT, 2015, ABDOM IMAGING, V40, P1177, DOI 10.1007/s00261-014-0280-0; Corwin MT, 2014, J COMPUT ASSIST TOMO, V38, P404, DOI 10.1097/RCT.0b013e3182ab5f35; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Gaddikeri S, 2015, AM J NEURORADIOL, V36, P391, DOI 10.3174/ajnr.A4123; Kallen JA, 2010, EMERG RADIOL, V17, P31, DOI 10.1007/s10140-009-0818-6; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Kalra MK, 2004, RADIOLOGY, V232, P409, DOI 10.1148/radiol.2322031151; Lepelletier D, 2016, EUR J CLIN MICROBIOL, V35, P867, DOI 10.1007/s10096-016-2609-9; Lin YY, 2012, EUR ARCH OTO-RHINO-L, V269, P585, DOI 10.1007/s00405-011-1622-y; Mayo-Smith WW, 2014, RADIOLOGY, V273, P657, DOI 10.1148/radiol.14132328; McCollough CH, 2011, RADIOLOGY, V259, P311, DOI 10.1148/radiol.11101800; Mukherj SK, 2014, ACR ASNR SPR PRACTIC; Risberg S, 2008, SCAND J INFECT DIS, V40, P792, DOI 10.1080/00365540802195226; Samei E, 2014, PEDIATR RADIOL, V44, P460, DOI 10.1007/s00247-014-3117-7; Schlattl H, 2010, PHYS MED BIOL, V55, P6243, DOI 10.1088/0031-9155/55/20/013; Scholtz JE, 2015, CLIN RADIOL, V70, pE67, DOI 10.1016/j.crad.2015.04.009; Scholtz JE, 2015, EUR RADIOL; Sinclair L, 2015, RADIOLOGY, V277, P471, DOI 10.1148/radiol.2015140971; Vachha B, 2013, EUR J RADIOL, V82, P2222, DOI 10.1016/j.ejrad.2013.08.014; Wang B, 2014, ACTA RADIOL, V55, P945, DOI 10.1177/0284185113509093; Wippold FJ, 2007, J MAGN RESON IMAGING, V25, P453, DOI 10.1002/jmri.20838; Yuan MK, 2013, AM J ROENTGENOL, V201, P626, DOI 10.2214/AJR.12.9652	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180671	10.1371/journal.pone.0180671	http://dx.doi.org/10.1371/journal.pone.0180671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678820	Green Submitted, Green Published, gold			2022-12-27	WOS:000405272200084
J	Bray, TJP; Singh, S; Latifoltojar, A; Rajesparan, K; Rahman, F; Narayanan, P; Naaseri, S; Lopes, A; Bainbridge, A; Punwani, S; Hall-Craggs, MA				Bray, Timothy J. P.; Singh, Saurabh; Latifoltojar, Arash; Rajesparan, Kannan; Rahman, Farzana; Narayanan, Priya; Naaseri, Sahar; Lopes, Andre; Bainbridge, Alan; Punwani, Shonit; Hall-Craggs, Margaret A.			Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study	PLOS ONE			English	Article							BONE-MARROW; WORKING GROUP; PROGNOSTIC-SIGNIFICANCE; IMAGING TECHNIQUES; QUANTIFICATION; GUIDELINES; MANAGEMENT; CONSENSUS; CRITERIA; TESLA	Objective To determine which of four Dixon image types [in-phase (IP), out-of-phase (OP), fat only (FO) and water-only (WO)] is most sensitive for detecting multiple myeloma (MM) focal lesions on whole body MRI (WB-MRI) images. MethodsThirty patients with clinically-suspected MM underwent WB-MRI at 3 Tesla. Unenhanced IP, OP, FO and WO Dixon images were generated and read by four radiologists. On each image type, each radiologist identified and labelled all visible myeloma lesions in the bony pelvis. Each identified lesion was compared with a reference standard consisting of pre- and post-contrast Dixon and diffusion weighted imaging (read by a further consultant radiologist) to determine whether the lesion was truly positive. Lesion count, true positives, sensitivity, and positive predictive value were compared across the four Dixon image types. Results Lesion count, true positives, sensitivity and confidence scores were all significantly higher on FO images than on IP images (p>0.05). Discussion FO images are more sensitive than other Dixon image types for MM focal lesions, and should be preferentially read by radiologists to improve diagnostic accuracy and reporting efficiency.	[Bray, Timothy J. P.; Singh, Saurabh; Latifoltojar, Arash; Rajesparan, Kannan; Rahman, Farzana; Narayanan, Priya; Naaseri, Sahar; Punwani, Shonit; Hall-Craggs, Margaret A.] UCL, Ctr Med Imaging, London, England; [Lopes, Andre] Canc Res UK & UCL Clin Trials Ctr, London, England; [Bainbridge, Alan] Univ Coll London Hosp, Dept Med Phys, London, England	University of London; University College London; Cancer Research UK; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Bray, TJP (corresponding author), UCL, Ctr Med Imaging, London, England.	t.bray@ucl.ac.uk		Lopes, Andre/0000-0002-1405-7337; Bray, Timothy/0000-0001-8886-5356	Department of Health's the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme; NIHR University College London Hospitals BRC; Arthritis Research UK Grant [21369]; CRUK/EPSRC KCL/ UCL Comprehensive Cancer Imaging Centre; Cancer Research UK [15953] Funding Source: researchfish; National Institute for Health Research [CL-2007-18-015] Funding Source: researchfish	Department of Health's the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme; NIHR University College London Hospitals BRC; Arthritis Research UK Grant(Versus Arthritis); CRUK/EPSRC KCL/ UCL Comprehensive Cancer Imaging Centre; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was under taken at UCLH/UCL, which receives funding from the Department of Health's the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health. MHC, SP, TJPB and ALa are supported by the NIHR University College London Hospitals BRC. TJPB is also supported by Arthritis Research UK Grant 21369. This work was supported by CRUK/EPSRC KCL/ UCL Comprehensive Cancer Imaging Centre.	[Anonymous], 2016, EXCELLENCE NI H C MY; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Costelloe CM, 2013, MAGN RESON IMAGING, V31, P669, DOI 10.1016/j.mri.2012.10.017; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Dimopoulos M, 2011, INT MYELOMA WORKSHOP, V3, P4701, DOI DOI 10.1182/BL00D-2010-10-299529; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; DOnofrio G, 2015, MORPHOLOGY OF BLOOD DISORDERS, 2ND EDITION, P1; Durie Brian G M, 2003, Hematol J, V4, P379; Eggers H, DUAL ECHO DIXON IMAG; Giles SL, 2014, RADIOLOGY, V271, P785, DOI 10.1148/radiol.13131529; Hillengass J, 2014, LEUKEMIA, V28, P174, DOI 10.1038/leu.2013.244; Karampinos DC, 2014, MAGN RESON MED, V71, P1158, DOI 10.1002/mrm.24775; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lecouvet FE, 1998, RADIOLOGY, V209, P653, DOI 10.1148/radiology.209.3.9844655; Lecouvet FE, 2016, RADIOLOGY, V279, P345, DOI 10.1148/radiol.2016142084; Li XJ, 2011, J MAGN RESON IMAGING, V33, P974, DOI 10.1002/jmri.22489; Liney GP, 2007, J MAGN RESON IMAGING, V26, P787, DOI 10.1002/jmri.21072; Messiou C, 2011, EUR RADIOL, V21, P1713, DOI 10.1007/s00330-011-2116-4; Moulopoulos LA, 2005, ANN ONCOL, V16, P1824, DOI 10.1093/annonc/mdi362; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Smith D, 2015, BRIT J HAEMATOL, V171, P881, DOI 10.1111/bjh.13446; Sonneveld P, 2016, BLOOD, V127, P2955, DOI 10.1182/blood-2016-01-631200; Takasu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116842; Takasu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085931; Takasu M, 2012, EUR RADIOL, V22, P1114, DOI 10.1007/s00330-011-2351-8; Walker R, 2007, J CLIN ONCOL, V25, P1121, DOI 10.1200/JCO.2006.08.5803; Weckbach S, 2010, EUR RADIOL, V20, P2907, DOI 10.1007/s00330-010-1865-9; Zamagni E, 2012, BRIT J HAEMATOL, V159, P499, DOI 10.1111/bjh.12007	28	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180562	10.1371/journal.pone.0180562	http://dx.doi.org/10.1371/journal.pone.0180562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672007	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500067
J	Charalampopoulos, D; Hesketh, KR; Amin, R; Paes, VM; Viner, RM; Stephenson, T				Charalampopoulos, Dimitrios; Hesketh, Kathryn R.; Amin, Rakesh; Paes, Veena Mazarello; Viner, Russell M.; Stephenson, Terence			Psycho-educational interventions for children and young people with Type 1 Diabetes in the UK: How effective are they? A systematic review and meta-analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; GLYCEMIC CONTROL; TEAMWORK INTERVENTION; STRUCTURED EDUCATION; INTENSIVE THERAPY; METABOLIC-CONTROL; ADOLESCENTS; MANAGEMENT; YOUTH; CARE	Aims To synthesise evidence from UK-based randomised trials of psycho-educational interventions in children and young people (CYP) with Type 1 Diabetes (T1D) to inform the evidence- base for adoption of such interventions into the NHS. Methods We searched Medline, Embase, Cochrane, PsycINFO, CINAHL, and Web of Science up to March 2016. Two reviewers independently selected UK-based randomised trials comparing psycho-educational interventions for improving management of T1D for CYP with a control group of usual care or attention control. The main outcome was glycaemic control measured by percentage of glycated haemoglobin (HbA1c); secondary outcomes included psychosocial functioning, diabetes knowledge, adverse and other clinical outcomes. A narrative synthesis and meta-analysis were conducted. Pooled effect sizes of standardised mean difference (SMD) were calculated. Results Ten eligible trials of three educational and seven psycho-educational interventions were identified. Most interventions were delivered by non-psychologists and targeted adolescents with more than one year duration of diabetes. Meta-analysis of nine of these trials (N = 1,838 participants) showed a non-significant reduction in HbA(1c) attributable to the intervention (pooled SMD = -0.06, 95% CI: -0.21 to 0.09). Psycho-educational interventions aiming to increase children's self-efficacy had a moderate, beneficial effect (SMD = 0.50, 95% CI: 0.13 to 0.87). No benefits on diabetes knowledge and other indicators of psychosocial functioning were identified. Conclusions There is insufficient evidence to recommend the use of particular psycho-educational programme for CYP with T1D in the UK. Further trials with sufficient power and reporting standards are needed. Future trials could consider active involvement of psychological specialists in the delivery of psychologically informed interventions and implementation of psycho-educational interventions earlier in the course of the disease. Systematic review registration PROSPERO CRD42015010701	[Charalampopoulos, Dimitrios; Hesketh, Kathryn R.; Amin, Rakesh; Paes, Veena Mazarello; Viner, Russell M.; Stephenson, Terence] UCL, Great Ormond St Inst Child Hlth, London, England	University of London; University College London	Charalampopoulos, D (corresponding author), UCL, Great Ormond St Inst Child Hlth, London, England.	d.charalampopoulos@ucl.ac.uk	Viner, Russell/A-1441-2009	Viner, Russell/0000-0003-3047-2247; Stephenson, Terence/0000-0001-8871-7847; Charalampopoulos, Dimitrios/0000-0002-3763-3130	Children's Policy Research Unit (CPRU), UCL [10090001]; Department of Health Policy Research Programme; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London	Children's Policy Research Unit (CPRU), UCL; Department of Health Policy Research Programme; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London	This is an independent study commissioned and funded by the Children's Policy Research Unit (CPRU), UCL (funding reference 10090001), which is funded by the Department of Health Policy Research Programme and supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. The views expressed are not necessarily those of the Department of Health.	Alam R, 2009, PATIENT EDUC COUNS, V75, P25, DOI 10.1016/j.pec.2008.08.026; Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; ANDERSON BJ, 1989, DIABETES CARE, V12, P179, DOI 10.2337/diacare.12.3.179; [Anonymous], 2016, NAT PAED DIAB AUD RE; Armour TA, 2005, DIABETIC MED, V22, P1295, DOI 10.1111/j.1464-5491.2005.01618.x; Ayling K, 2015, PSYCHOL HEALTH, V30, P85, DOI 10.1080/08870446.2014.953528; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; BLOOMFIELD S, 1990, DIABETIC MED, V7, P137, DOI 10.1111/j.1464-5491.1990.tb01348.x; Borenstein M, 2009, MULTIPLE OUTCOMES TI, P225, DOI DOI 10.1002/9780470743386.CH25; Centre for Reviews and Dissemination UoY, 2009, SYST REV CRDSGUID UN; Channon SJ, 2007, DIABETES CARE, V30, P1390, DOI 10.2337/dc06-2260; Christie D, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18200; Coates V, 2013, J DIABETES METABOLIS, V4, P2155; Cohen J.E., 1988, STAT POWER ANAL BEHA; DELAMATER AM, 1990, DIABETES CARE, V13, P492, DOI 10.2337/diacare.13.5.492; Department of Health, 2005, STRUCT PAT ED DIAB R; Department of Health, 2003, NAT SERV FRAM DIAB D; Department of Health Diabetes Policy Team, 2007, MAK EV YOUNG PERS DI; Diabetes UK, 2008, MIND GAP PROV PSYCH; Doherty FM, 2013, J PEDIATR PSYCHOL, V38, P846, DOI 10.1093/jpepsy/jst046; DUNN SM, 1984, DIABETES CARE, V7, P36, DOI 10.2337/diacare.7.1.36; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Franklin VL, 2006, DIABETIC MED, V23, P1332, DOI 10.1111/j.1464-5491.2006.01989.x; Grey M, 1998, DIABETES CARE, V21, P902, DOI 10.2337/diacare.21.6.902; Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568; GROSSMAN HY, 1987, DIABETES CARE, V10, P324, DOI 10.2337/diacare.10.3.324; Hampson S E, 2001, Health Technol Assess, V5, P1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Howells L, 2002, DIABETIC MED, V19, P643, DOI 10.1046/j.1464-5491.2002.00791.x; *INT DIAB FED, 2014, DIABETES ATLAS; Kanavos P, 2012, DIABETES EXPENDITURE; Kaufman Francine Ratner, 2002, Pediatr Diabetes, V3, P179, DOI 10.1034/j.1399-5448.2002.30402.x; Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mendez FJ, 1997, DIABETES CARE, V20, P1370, DOI 10.2337/diacare.20.9.1370; Murphy HR, 2007, DIABETIC MED, V24, P1261, DOI 10.1111/j.1464-5491.2007.02229.x; Murphy HR, 2006, DIABETIC MED, V23, P935, DOI 10.1111/j.1464-5491.2006.01816.x; Murphy HR, 2012, DIABETIC MED, V29, pE249, DOI 10.1111/j.1464-5491.2012.03683.x; Nathan DM, 2013, DIABETES, V62, P3976, DOI 10.2337/db13-1093; NICE clinical quideline, 2015, DIAB TYP 1 YP 2 CHIL; Owen Claire, 2012, Br J Nurs, V21, P226; Price KJ, 2016, DIABETIC MED, V33, P192, DOI 10.1111/dme.12881; Robling M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2359; SATIN W, 1989, J PEDIATR PSYCHOL, V14, P259, DOI 10.1093/jpepsy/14.2.259; Scottish Diabetes Survey 2013, 2014, NHS SCOTL; Winkley K, 2006, BMJ-BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55; Wysocki T, 2003, DIABETES CARE, V26, P2043, DOI 10.2337/diacare.26.7.2043	50	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179685	10.1371/journal.pone.0179685	http://dx.doi.org/10.1371/journal.pone.0179685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665946	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700039
J	Grapow, M; Haug, M; Tschung, C; Winkler, B; Banerjee, P; Heinisch, PP; Fassl, J; Reuthebuch, O; Eckstein, F				Grapow, Martin; Haug, Martin; Tschung, Chistopher; Winkler, Bernhard; Banerjee, Prerana; Heinisch, Paul Philipp; Fassl, Jens; Reuthebuch, Oliver; Eckstein, Friedrich			Therapy options in deep sternal wound infection: Sternal plating versus muscle flap	PLOS ONE			English	Article							RISK-FACTOR-ANALYSIS; OPEN-HEART-SURGERY; CARDIAC-SURGERY; MEDIASTINITIS; MANAGEMENT; FIXATION; CLOSURE; EXPERIENCE; RECONSTRUCTION; PREVALENCE	Background Management of deep sternal wound infection (DSWI) in cardiac surgical patients still remains challenging. A variety of treatment strategies has been described. Aim of this cohort study was to analyse two different treatment strategies for DSWI: titanium sternal plating system (TSFS) and muscle flap coverage (MFC). Methods Between January 2007 and December 2011, from 3122 patients undergoing cardiac surgery 42 were identified with DSWI and treated with one of the above mentioned strategies. In-hospital data were collected, follow-up performed by telephone and assessment of Quality of Life (QoL) using the SF-12 Health Survey Questionnaire. Results 20 patients with deep sternal wound infection were stabilized with TSFS and 22 patients treated with MFC. Preoperative demographics and risk factors did not reveal any significant differences. Patients treated with TSFS had a significantly shorter operation time (p<0.05) and shorter hospitalization (p<0.05). A tendency towards lower mortality rate (p = n.s.) and less re-interventions were also noted (plating 0.6 vs. flap 1.17 per patient, n.s.). Quality of Life in the TSFS group for the physical-summary-score was significantly elevated compared to the MFC group (p<0.05). Relating to chest stability and cosmetic result the treatment with TSFS showed superior results, but the usage of MFC gave the patients more freedom in breathing and less chest pain. Conclusion Our results demonstrate that the use of TSFS is a feasible and safe alternative in DSWI. However, MFC remains an absolutely essential option for complicated DSWI since the amount of perfused tissue can be the key for infection control.	[Grapow, Martin; Tschung, Chistopher; Winkler, Bernhard; Banerjee, Prerana; Reuthebuch, Oliver; Eckstein, Friedrich] Univ Hosp, Dept Cardiac Surg, Basel, Switzerland; [Haug, Martin] Univ Hosp, Dept Plast Reconstruct Aesthet & Hand Surg, Basel, Switzerland; [Winkler, Bernhard; Heinisch, Paul Philipp] Univ Hosp, Dept Cardiovasc Surg, Inselspital, Bern, Switzerland; [Fassl, Jens] Univ Hosp, Dept Anaesthesiol, Basel, Switzerland	University of Bern; University Hospital of Bern	Winkler, B (corresponding author), Univ Hosp, Dept Cardiac Surg, Basel, Switzerland.; Winkler, B (corresponding author), Univ Hosp, Dept Cardiovasc Surg, Inselspital, Bern, Switzerland.	publications.medic@gmail.com	Fassl, Jens/P-7901-2018; Reuthebuch, Oliver/AAC-3164-2022; ECKSTEIN, FRIEDRICH/AAB-5232-2022	Reuthebuch, Oliver/0000-0003-1386-0686; , Paul/0000-0003-2606-0557				Ariyaratnam P, 2010, INTERACT CARDIOV TH, V11, P543, DOI 10.1510/icvts.2010.237883; Baillot R, 2010, EUR J CARDIO-THORAC, V37, P880, DOI 10.1016/j.ejcts.2009.09.023; Bastuji-Garin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064733; Bitkover CY, 1998, ANN THORAC SURG, V65, P36, DOI 10.1016/S0003-4975(97)01003-5; Braxton John H, 2004, Semin Thorac Cardiovasc Surg, V16, P70; Centofanti P, 2007, J CARDIOVASC SURG, V48, P641; Cicilioni OJ, 2005, PLAST RECONSTR SURG, V115, P1297, DOI 10.1097/01.PRS.0000156918.15595.85; Cowan KN, 2005, ANN THORAC SURG, V80, P2205, DOI 10.1016/j.athoracsur.2005.04.005; Dalton ML, 1992, JULIANS REINTRODUCTI, V53; Ennker IC, 2009, J PLAST RECONSTR AES, V62, P1479, DOI 10.1016/j.bjps.2008.05.017; Fawzy H, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-63; Floros P, 2011, HEART LUNG CIRC, V20, P712, DOI 10.1016/j.hlc.2011.08.001; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gaudreau G, 2010, EUR J CARDIO-THORAC, V37, P888, DOI 10.1016/j.ejcts.2009.07.043; Graeber G M, 1999, Semin Thorac Cardiovasc Surg, V11, P251; Gummert JF, 2002, THORAC CARDIOV SURG, V50, P87, DOI 10.1055/s-2002-26691; Hallock GG, 2007, ANN PLAS SURG, V59, P655, DOI 10.1097/SAP.0b013e318049e6d5; Jones G, 1997, ANN SURG, V225, P766, DOI 10.1097/00000658-199706000-00014; Jonkers D, 2003, EUR J CARDIO-THORAC, V23, P97, DOI 10.1016/S1010-7940(02)00662-0; Juhl AA, 2012, SCAND CARDIOVASC J, V46, P254, DOI 10.3109/14017431.2012.674549; JURKIEWICZ MJ, 1980, ANN SURG, V191, P738, DOI 10.1097/00000658-198006000-00012; Karra R, 2006, J THORAC CARDIOV SUR, V132, P537, DOI 10.1016/j.jtcvs.2006.04.037; Lee JC, 2010, PLAST RECONSTR SURG, V125, P1720, DOI 10.1097/PRS.0b013e3181d51292; Li EN, 2004, ANN PLAS SURG, V53, P334, DOI 10.1097/01.sap.0000120684.64559.49; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mauermann WJ, 2008, BEST PRACT RES-CLIN, V22, P423, DOI 10.1016/j.bpa.2008.04.003; MILANO CA, 1995, CIRCULATION, V92, P2245, DOI 10.1161/01.CIR.92.8.2245; Plass A, 2011, THORAC CARDIOV SURG, V59, P30, DOI 10.1055/s-0030-1250390; Raja Shahzad G, 2007, Interact Cardiovasc Thorac Surg, V6, P523, DOI 10.1510/icvts.2007.157370; ROBICSEK F, 1977, J THORAC CARDIOV SUR, V73, P267; Schols RM, 2011, EUR J PLAST SURG, V34, P487, DOI 10.1007/s00238-011-0573-2; Singh Kimberly, 2011, Semin Plast Surg, V25, P25, DOI 10.1055/s-0031-1275168; Upton Arlo, 2005, N Z Med J, V118, pU1316; van Wingerden JJ, 2011, INTERACT CARDIOV TH, V13, P179, DOI 10.1510/icvts.2011.270652; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180024	10.1371/journal.pone.0180024	http://dx.doi.org/10.1371/journal.pone.0180024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665964	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608700055
J	Liu, DQ; Wu, ZQ; Wang, YX; Guo, Q; Liu, JG				Liu, Dan-Qing; Wu, Zhen-Qiang; Wang, Yu-Xin; Guo, Qiang; Liu, Jian-Guo			Optimal teaching strategy in periodic impulsive knowledge dissemination system	PLOS ONE			English	Article							SCIENCE BASIC RESEARCH; NETWORK PROPERTIES; MEMORY; MODEL; RECOGNITION; DIFFUSION; EDUCATION; TRACE	Accurately describing the knowledge dissemination process is significant to enhance the performance of personalized education. In this study, considering the effect of periodic teaching activities on the learning process, we propose a periodic impulsive knowledge dissemination system to regenerate the knowledge dissemination process. Meanwhile, we put forward learning effectiveness which is an outcome of a trade-off between the benefits and costs raised by knowledge dissemination as objective function. Further, we investigate the optimal teaching strategy which can maximize learning effectiveness, to obtain the optimal effect of knowledge dissemination affected by the teaching activities. We solve this dynamic optimization problem by optimal control theory and get the optimization system. At last we numerically solve this system in several practical examples to make the conclusions intuitive and specific. The optimal teaching strategy proposed in this paper can be applied widely in the optimization problem of personal education and beneficial for enhancing the effect of knowledge dissemination.	[Liu, Dan-Qing; Wu, Zhen-Qiang] Shaanxi Normal Univ, Sch Comp Sci, Xian, Peoples R China; [Liu, Dan-Qing] Qinghai Normal Univ, Sch Comp, Xining, Peoples R China; [Liu, Dan-Qing; Wu, Zhen-Qiang] Minist Educ, Key Lab Modern Teaching Technol, Xian, Peoples R China; [Wang, Yu-Xin] Sichuan Inst Educ Res, Chengdu, Peoples R China; [Guo, Qiang; Liu, Jian-Guo] Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China; [Liu, Jian-Guo] Shanghai Univ Finance & Econ, Data Sci & Cloud Serv Res Ctr, Shanghai, Peoples R China	Shaanxi Normal University; Qinghai Normal University; University of Shanghai for Science & Technology; Shanghai University of Finance & Economics	Liu, JG (corresponding author), Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China.; Liu, JG (corresponding author), Shanghai Univ Finance & Econ, Data Sci & Cloud Serv Res Ctr, Shanghai, Peoples R China.	liujg004@ustc.edu.cn	Guo, Qiang/B-2635-2014; Liu, Jianguo/B-4492-2012	Liu, Jianguo/0000-0002-5641-0266	Fundamental Research Funds for the Central Universities [GK201501008, GK261001236]; National Natural Science Foundation of China [61261047, 61363080, 71371125, 61374177]; Project of Basic Research of Qinghai Province [2016-ZJ-920Q]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Basic Research of Qinghai Province	The authors would like to thank Professors San-Yi Tang and Jia-Wei Dou for fruitful discussions and guidelines. This work is supported by the Fundamental Research Funds for the Central Universities (Nos. GK201501008 and GK261001236), the National Natural Science Foundation of China (Nos. 61261047, 61363080, 71371125 and 61374177) and the Project of Basic Research of Qinghai Province (No. 2016-ZJ-920Q). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso F, 2005, BRIT J EDUC TECHNOL, V36, P217, DOI 10.1111/j.1467-8535.2005.00454.x; ANDERSON OR, 1983, J RES SCI TEACH, V20, P603, DOI 10.1002/tea.3660200702; [Anonymous], 2004, EDU PSY, V24, P419; Benfenati Fabio, 2007, Acta Biomed, V78 Suppl 1, P58; Camison C, 2010, J BUS RES, V63, P707, DOI 10.1016/j.jbusres.2009.04.022; CHAPPELL M, 1994, PSYCHOL REV, V101, P103, DOI 10.1037/0033-295X.101.1.103; Clark C.W., 2010, MATH BIOECONOMICS, V3rd; Cowan R, 2004, J ECON DYN CONTROL, V28, P1557, DOI 10.1016/j.jedc.2003.04.002; Dabbagh N, 2012, INTERNET HIGH EDUC, V15, P3, DOI 10.1016/j.iheduc.2011.06.002; Dong LZ, 2007, NONLINEAR ANAL-REAL, V8, P572, DOI 10.1016/j.nonrwa.2006.01.001; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Gosen J., 2004, Simulation & Gaming, V35, P270, DOI 10.1177/1046878104263544; Guo HY, 2014, J SHAANXI U SCI TEC, V32, P169; Haas MR, 2007, STRATEG MANAGE J, V28, P1133, DOI 10.1002/smj.631; HICKLIN WJ, 1976, J MATH PSYCHOL, V13, P79, DOI 10.1016/0022-2496(76)90035-3; HINTZMAN DL, 1988, PSYCHOL REV, V95, P528, DOI 10.1037/0033-295X.95.4.528; HUMPHREYS MS, 1989, PSYCHOL REV, V96, P208, DOI 10.1037/0033-295X.96.2.208; Lakshmikantham V., 1989, SERIES MODERN APPIED, DOI DOI 10.1142/0906; Liu JG, 2007, PHYSICA A, V377, P302, DOI 10.1016/j.physa.2006.11.011; Liu JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089746; Liu JG, 2006, PHYSICA A, V366, P578, DOI 10.1016/j.physa.2005.10.036; METCALFE J, 1991, PSYCHOL REV, V98, P529, DOI 10.1037/0033-295X.98.4.529; Murre JMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120644; Roy S, 2010, PSYCHOLOGY, V1, P252; Sikstrom S, 2002, COGNITIVE PSYCHOL, V45, P95, DOI 10.1016/S0010-0285(02)00012-9; Simeonov PS., 1993, IMPULSIVE DIFFERENTI; Smolen P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000445; Waldeck JH, 2007, COMMUN EDUC, V56, P409, DOI 10.1080/03634520701400090; Xiao Y, 2006, SYST CONTROL LETT, V55, P558, DOI 10.1016/j.sysconle.2005.12.003; Yang GY, 2015, PHYSICA A, V419, P429, DOI 10.1016/j.physa.2014.10.012	30	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0178024	10.1371/journal.pone.0178024	http://dx.doi.org/10.1371/journal.pone.0178024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665961	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700026
J	Hao, M; Zhang, PP; Li, BS; Liu, X; Zhao, Y; Tan, HL; Sun, CY; Wang, XC; Wang, XR; Qiu, HY; Wang, DC; Diao, BW; Jing, HQ; Yang, RF; Kan, BA; Zhou, L				Hao, Min; Zhang, Pingping; Li, Baisheng; Liu, Xiao; Zhao, Yong; Tan, Hailing; Sun, Chongyun; Wang, Xiaochen; Wang, Xinrui; Qiu, Haiyan; Wang, Duochun; Diao, Baowei; Jing, Huaiqi; Yang, Ruifu; Kan, Biao; Zhou, Lei			Development and evaluation of an up-converting phosphor technology-based lateral flow assay for the rapid, simultaneous detection of Vibrio cholerae serogroups 01 and 0139	PLOS ONE			English	Article							ENVIRONMENTAL WATER SAMPLES; GOLD NANOPARTICLE; YERSINIA-PESTIS; O139 BENGAL; BANGLADESH; EPIDEMIC; PCR; COAGGLUTINATION; BIOSENSOR; SEAFOOD	Vibrio cholerae serogroups 01 and 0139 are etiological agents of cholera, a serious and acute diarrheal disease, and rapid detection of V. cholerae is a key method for preventing and controlling cholera epidemics. Here, a point of care testing (POCT) method called Vch-UPT-LF, which is an up-converting phosphor technology-based lateral flow (UPT-LF) assay with a dual-target detection mode, was developed to detect V. cholerae 01 and 0139 simultaneously from one sample loading. Although applying an independent reaction pair made both detection results for the two Vch-UPT-LF detection channels more stable, the sensitivity slightly declined from 10(4) to 10(5) colony-forming units (CFU) mL(-1) compared with that of the single-target assay, while the quantification ranges covering four orders of magnitude were maintained. The strip showed excellent specificity for seven Vibrio species that are highly related genetically, and nine food-borne species whose transmission routes are similar to those of V. cholerae. The legitimate arrangement of the two adjacent test lines lessened the mutual impact of the quantitation results between the two targets, and the quantification values did not differ by more than one order of magnitude when the samples contained high concentrations of both V. cholerae 01 and 0139. Under pre-incubation conditions, 1x10(1) CFU mL(-1) of V. cholerae 01 or 0139 could be detected in fewer than 7 h, while the Vch-UPT-LF assay exhibited sensitivity as high as a real-time fluorescent polymerase chain reaction with fewer false-positive results. Therefore, successful development of Vch-UPT-LF as a dual-target assay for quantitative detection makes this assay a good candidate POCT method for the detection and surveillance of epidemic cholera.	[Hao, Min; Qiu, Haiyan; Wang, Duochun; Diao, Baowei; Jing, Huaiqi; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Hao, Min] Beijing Chaoyang Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Pingping; Liu, Xiao; Zhao, Yong; Sun, Chongyun; Wang, Xiaochen; Wang, Xinrui; Yang, Ruifu; Zhou, Lei] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Lab Analyt Microbiol, Beijing, Peoples R China; [Zhang, Pingping; Liu, Xiao; Zhao, Yong; Sun, Chongyun; Wang, Xiaochen; Wang, Xinrui; Yang, Ruifu; Zhou, Lei] Beijing Key Lab POCT Bioemergency & Clin BZ0329, Beijing, Peoples R China; [Li, Baisheng; Tan, Hailing] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Liu, Xiao] Chongqing Entry Exit Inspect & Quarantine Bur, Chongqing, Peoples R China; [Sun, Chongyun] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Lab, Beijing, Peoples R China; [Wang, Xiaochen] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Wang, Xinrui] Inst Plague Prevent & Control Hebei Prov, Zhangjiakou, Hebei, Peoples R China; [Kan, Biao] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Zhou, Lei] Northwest Univ, Coll Life Sci, Xian, Shanxi, Peoples R China; [Zhou, Lei] Northwest Univ, Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Shanxi, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese People's Liberation Army General Hospital; Jilin Agricultural University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Northwest University Xi'an; Northwest University Xi'an	Kan, BA (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Yang, RF; Zhou, L (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Lab Analyt Microbiol, Beijing, Peoples R China.; Yang, RF; Zhou, L (corresponding author), Beijing Key Lab POCT Bioemergency & Clin BZ0329, Beijing, Peoples R China.; Kan, BA (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.; Zhou, L (corresponding author), Northwest Univ, Coll Life Sci, Xian, Shanxi, Peoples R China.; Zhou, L (corresponding author), Northwest Univ, Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Shanxi, Peoples R China.	ruifuyang@gmail.com; Kanbiao@icdc.cn; ammszhoulei@aliyun.com			National High Technology Research and Development Program of China [2013AA032205]; Beijing Nova Program [Z151100000315086]; National Key Research and Development Program [2016YFC1202502]; Science and Technology Program of Guangzhou, China [2014Y2-00090]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Nova Program(Beijing Municipal Science & Technology Commission); National Key Research and Development Program; Science and Technology Program of Guangzhou, China	This study was supported by the National High Technology Research and Development Program of China (grant no. 2013AA032205), the Beijing Nova Program (grant no. Z151100000315086), National Key Research and Development Program (grant no. 2016YFC1202502), and Science and Technology Program of Guangzhou, China (2014Y2-00090). The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.	AGARWAL V, 1995, INDIAN J MED RES, V101, P55; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; ARYA SC, 1995, J CLIN MICROBIOL, V33, P509, DOI 10.1128/JCM.33.2.509-510.1995; Bhattacharya T, 2006, ENVIRON MICROBIOL, V8, P526, DOI 10.1111/j.1462-2920.2005.00932.x; Chomvarin C, 2007, J GEN APPL MICROBIOL, V53, P229, DOI 10.2323/jgam.53.229; COLWELL RR, 1992, FEMS MICROBIOL LETT, V97, P215, DOI 10.1016/0378-1097(92)90339-P; Durrheim D, 2004, LANCET, V363, P897, DOI 10.1016/S0140-6736(04)15748-6; Faruque SM, 2003, EMERG INFECT DIS, V9, P1116; FINELLI L, 1992, J INFECT DIS, V166, P1433, DOI 10.1093/infdis/166.6.1433; Fykse EM, 2012, MAR POLLUT BULL, V64, P200, DOI 10.1016/j.marpolbul.2011.12.007; Harris JB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000221; Hill VR, 2011, EMERG INFECT DIS, V17, P2147, DOI 10.3201/eid1711.110748; Hong WY, 2010, J MICROBIOL METH, V83, P133, DOI 10.1016/j.mimet.2010.08.005; Hua F, 2015, SCI REP-UK, V5, DOI 10.1038/srep17178; HUQ A, 1995, LANCET, V345, P1249, DOI 10.1016/S0140-6736(95)92038-2; Huq A, 2012, CURR PROTOC MICROBIO; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kumar P, 2010, VISUAL INFORMATION COMMUNICATION, P41, DOI 10.1007/978-1-4419-0312-9_3; Maggi P, 1997, EUR J EPIDEMIOL, V13, P95, DOI 10.1023/A:1007329700125; Pengsuk C, 2013, BIOSENS BIOELECTRON, V42, P229, DOI 10.1016/j.bios.2012.10.011; Rawlings TK, 2007, APPL ENVIRON MICROB, V73, P7926, DOI 10.1128/AEM.01238-07; REHNSTAM AS, 1989, APPL ENVIRON MICROB, V55, P1907, DOI 10.1128/AEM.55.8.1907-1910.1989; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SRIVASTAVA R, 1985, GENE, V40, P267, DOI 10.1016/0378-1119(85)90049-6; Theron J, 2000, J APPL MICROBIOL, V89, P539, DOI 10.1046/j.1365-2672.2000.01140.x; Vora GJ, 2005, P NATL ACAD SCI USA, V102, P19109, DOI 10.1073/pnas.0505033102; Wang DC, 2010, APPL ENVIRON MICROB, V76, P5520, DOI 10.1128/AEM.02559-09; Wang Xiao-Mei, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P768; Yan ZQ, 2006, SENSOR ACTUAT B-CHEM, V119, P656, DOI 10.1016/j.snb.2006.01.029; Yang L, 2008, BIOTECHNOL ADV, V26, P135, DOI 10.1016/j.biotechadv.2007.10.003; Yu CY, 2011, J MICROBIOL METH, V86, P277, DOI 10.1016/j.mimet.2011.04.020; Zhang PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105305; Zhao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21342	33	16	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179937	10.1371/journal.pone.0179937	http://dx.doi.org/10.1371/journal.pone.0179937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662147	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300074
J	Hsu, TH; Gwo, JC				Hsu, Te-Hua; Gwo, Jin-Chywan			Genetic diversity and stock identification of small abalone (Haliotis diversicolor) in Taiwan and Japan	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; FRAGMENT-LENGTH POLYMORPHISM; POPULATION-STRUCTURE; SPECIES DELIMITATION; MITOCHONDRIAL-DNA; TIDELAND SNAILS; SAGAMI BAY; SUPERTEXTA; DISCUS; SURVIVAL	Small abalone (Haliotis diversicolor) is a commercially valuable species for both fisheries and aquaculture. The production of annual farmed small abalone in Taiwan, once the highest in the world, has dramatically decreased in the past 15 years, and currently, the industry is close to collapse. Understanding the genetic diversity of small abalone and developing stock identification methods will be useful for genetic breeding, restoring collapsed stocks, managing stocks, and preventing illegal trade. We investigated 307 cultured and wild individuals from Taiwan, Japan, and Bali Island (Indonesia) by using the mitochondrial cytochrome c oxidase subunit I (COI) gene. Network analysis of mtDNA COI gene sequences revealed that the individuals collected from Taiwan, Japan, and Indonesia could be identified, and showed significant genetic divergence. In addition, the Indonesian population (Haliotis diversicolor squamata) was significantly different from the other populations and might need to be considered a separate species. We discovered a single nucleotide polymorphism marker in the mtDNA COI gene that can be used to distinguish the Taiwan population from the Japan population. We also developed a polymerase chain reactionrestriction fragment length polymorphism method for rapid detection. Furthermore, we could identify the cultured stocks, wild population, and hybrid stocks by using 6 microsatellites and amplified fragment length polymorphism. This study contributes useful tools for stock identification and the production of high-disease resistant small abalone strains (Japan x Taiwan or Taiwan x Japan). Efforts should be made to avoid unintentional random genetic mixing of the Taiwan population with the Japan population and subsequent breakdown of population differentiation, which impair local adaptation of the Taiwan wild population. Molecular markers revealed a split between the Taiwan and Japan populations, and the existence of a possible barrier to the free dispersal of small abalone is discussed.	[Hsu, Te-Hua] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Gwo, Jin-Chywan] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Gwo, JC (corresponding author), Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan.	gwojc@hotmail.com	HSU, Te-Hua/A-8294-2011	HSU, Te-Hua/0000-0001-7819-4122	Ministry of Science and Technology, Taiwan (MST) [98-2311-B-019-003-MY3]	Ministry of Science and Technology, Taiwan (MST)	This work was funded by the Ministry of Science and Technology, Taiwan (MST) under project number 98-2311-B-019-003-MY3 to J.-C. Gwo.	An HS, 2013, GENET MOL RES, V12, P6309, DOI 10.4238/2013.December.4.18; An HS, 2005, MAR BIOTECHNOL, V7, P373, DOI 10.1007/s10126-004-4405-2; An HS, 2013, BIOCHEM SYST ECOL, V48, P76, DOI 10.1016/j.bse.2012.11.010; An HS, 2012, INT J MOL SCI, V13, P10750, DOI 10.3390/ijms130910750; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Chang PH, 2005, DIS AQUAT ORGAN, V65, P23, DOI 10.3354/dao065023; CHEN HC, 1984, AQUACULTURE, V39, P11, DOI 10.1016/0044-8486(84)90256-4; Cook PA., 2014, MOD EC, V5, P1181, DOI DOI 10.4236/ME.2014.513110; Degnan SA, 2006, MOL PHYLOGENET EVOL, V41, P249, DOI 10.1016/j.ympev.2006.06.023; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estes JA, 2005, PALEOBIOLOGY, V31, P591, DOI 10.1666/04059.1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans B, 2004, AQUACULTURE, V233, P109, DOI 10.1016/j.aquaculture.2003.09.037; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; *FAO, 2000, FISHSTAT PLUS UN SOF; Gamfeldt L, 2007, OIKOS, V116, P700, DOI 10.1111/j.2007.0030-1299.15382.x; Geiger DL, 2000, B MALACOLOGICO, V35, P57; Gonzalez EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125743; Gwo JC, 2002, THERIOGENOLOGY, V58, P1563, DOI 10.1016/S0093-691X(02)01055-5; Hamasaki K, 2008, FISH FISH, V9, P243, DOI 10.1111/j.1467-2979.2008.00280.x; Hara M, 2007, MAR BIOTECHNOL, V9, P74, DOI 10.1007/s10126-006-6060-2; Hsu TH, 2010, AQUAC RES, V41, pe316, DOI 10.1111/j.1365-2109.2010.02533.x; Hsu TeHua, 2015, Endangered Species Research, V27, P277; Hsu TH, 2011, J NAT TAIWAN MUSEUM, V65, P29; Huang CY, 2001, Z NATURFORSCH C, V56, P898; Huang WB, 2010, FISHERIES SCI, V76, P131, DOI 10.1007/s12562-009-0190-1; Jiang L, 1995, MOL MAR BIOL BIOTECH, V4, P353; Kitada S, 2006, FISH RES, V80, P101, DOI 10.1016/j.fishres.2006.03.019; Kojima S, 2006, MAR BIOL, V149, P525, DOI 10.1007/s00227-005-0183-2; Kojima S, 2003, ZOOL SCI, V20, P1423, DOI 10.2108/zsj.20.1423; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; de la Cruz FL, 2011, REV AQUACULT, V3, P74, DOI 10.1111/j.1753-5131.2011.01045.x; Launey S, 2001, GENETICS, V159, P255; Lemay MA, 2009, AQUACULTURE, V295, P22, DOI 10.1016/j.aquaculture.2009.06.029; Li Q, 2004, AQUACULTURE, V235, P207, DOI 10.1016/j.aquaculture.2003.12.018; Liang WD, 2003, DEEP-SEA RES PT II, V50, P1085, DOI 10.1016/S0967-0645(03)00011-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindberg DR, 1992, ABALONE OF THE WORLD, P318; Liu JY, 2011, AFR J BIOTECHNOL, V10, P19267, DOI 10.5897/AJB10.2344; Luo XA, 2010, AQUAC RES, V41, P1827, DOI 10.1111/j.1365-2109.2010.02568.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Nie ZQ, 2004, J SHELLFISH RES, V23, P941; Onitsuka T, 2008, J SHELLFISH RES, V27, P843, DOI 10.2983/0730-8000(2008)27[843:SGAROA]2.0.CO;2; Onitsuka T, 2007, MAR ECOL PROG SER, V351, P129, DOI 10.3354/meps07150; Onitsuka T, 2007, FISHERIES SCI, V73, P995, DOI 10.1111/j.1444-2906.2007.01428.x; Onitsuka T, 2007, FISHERIES SCI, V73, P295, DOI 10.1111/j.1444-2906.2007.01335.x; Park CJ, 2012, BIOCHEM SYST ECOL, V44, P86, DOI 10.1016/j.bse.2012.04.006; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rambaut A., 2007, TRACER V1 4; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Ren P, 2008, MOL ECOL RESOUR, V8, P1390, DOI 10.1111/j.1755-0998.2008.02329.x; Ren P, 2016, AQUACULTURE, V454, P163, DOI 10.1016/j.aquaculture.2015.12.026; Roodt-Wilding R, 2007, AQUAC RES, V38, P1229, DOI 10.1111/j.1365-2109.2007.01801.x; Somarakis S, 2013, AQUACULT ENV INTERAC, V3, P135, DOI 10.3354/aei00057; Takeshima H, 2016, MOL ECOL, V25, P3048, DOI 10.1111/mec.13650; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ting YY, 2003, SEEDLING PRODUCTION; Tomiyama T, 1980, FISHERIES JAPAN ABAL; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang ZY, 2004, J SHELLFISH RES, V23, P1143; Will M, 2015, GENETICA, V143, P487, DOI 10.1007/s10709-015-9847-0; Will M, 2011, MAR BIOL, V158, P1417, DOI 10.1007/s00227-011-1659-x; Yang H.-S., 1986, Bulletin of Taiwan Fisheries Research Institute, P195; Yang HS, 1989, LAND BASED CULTURE S; You Wei-wei, 2005, Journal of Xiamen University Natural Science, V44, P701; You WW, 2009, AQUAC RES, V40, P1474, DOI 10.1111/j.1365-2109.2009.02247.x; Zhan X, 2009, CONSERV GENET, V10, P1185, DOI 10.1007/s10592-008-9740-9; Zhang GF, 2004, J SHELLFISH RES, V23, P947; [周晶 ZHOU Jing], 2006, [海洋湖沼通报, Transactions of Oceanology and Limnology], V0, P54	71	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179818	10.1371/journal.pone.0179818	http://dx.doi.org/10.1371/journal.pone.0179818			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662122	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300051
J	Manceur, AP; Zou, W; Marcil, A; Paquet, E; Gadoury, C; Jaentschke, B; Li, XG; Petiot, E; Durocher, Y; Baardsnes, J; Rosa-Calatrava, M; Ansorge, S; Kamen, AA				Manceur, Aziza P.; Zou, Wei; Marcil, Anne; Paquet, Eric; Gadoury, Christine; Jaentschke, Bozena; Li, Xuguang; Petiot, Emma; Durocher, Yves; Baardsnes, Jason; Rosa-Calatrava, Manuel; Ansorge, Sven; Kamen, Amine A.			Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza	PLOS ONE			English	Article							A VIRAL HEMAGGLUTININS; VIRUS-LIKE PARTICLES; NEUTRALIZING EPITOPE; UNIVERSAL ANTIBODIES; MDCK CELLS; VACCINES; CULTURE; CANDIDATE; SUBTYPES; GROWTH	Vaccination is the most effective course of action to prevent influenza. About 150 million doses of influenza vaccines were distributed for the 2015-2016 season in the USA alone according to the Centers for Disease Control and Prevention. Vaccine dosage is calculated based on the concentration of hemagglutinin (HA), the main surface glycoprotein expressed by influenza which varies from strain to strain. Therefore yearly-updated strain-specific antibodies and calibrating antigens are required. Preparing these quantification reagents can take up to three months and significantly slows down the release of new vaccine lots. Therefore, to circumvent the need for strain-specific sera, two anti-HA monoclonal antibodies (mAbs) against a highly conserved sequence have been produced by immunizing mice with a novel peptide-conjugate. Immunoblots demonstrate that 40 strains of influenza encompassing HA subtypes H1 to H13, as well as B strains from the Yamagata and Victoria lineage were detected when the two mAbs are combined to from a pan-HA mAb cocktail. Quantification using this pan-HA mAbs cocktail was achieved in a dot blot assay and results correlated with concentrations measured in a hemagglutination assay with a coefficient of correlation of 0.80. A competitive ELISA was also optimised with purified viral-like particles. Regardless of the quantification method used, pan-HA antibodies can be employed to accelerate process development when strain-specific antibodies are not available, and represent a valuable tool in case of pandemics. These antibodies were also expressed in CHO cells to facilitate large-scale production using bioreactor technologies which might be required to meet industrial needs for quantification reagents. Finally, a simulation model was created to predict the binding affinity of the two anti-HA antibodies to the amino acids composing the highly conserved epitope; different probabilities of interaction between a given amino acid and the antibodies might explain the affinity of each antibody against different influenza strains.	[Manceur, Aziza P.; Zou, Wei; Marcil, Anne; Paquet, Eric; Gadoury, Christine; Durocher, Yves; Baardsnes, Jason; Ansorge, Sven; Kamen, Amine A.] Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada; [Jaentschke, Bozena; Li, Xuguang] Hlth Canada, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON, Canada; [Petiot, Emma; Rosa-Calatrava, Manuel] Univ Claude Bernard Lyon 1, Lab Virol & Pathol Humaine, Int Ctr Infect Dis Res, VirPath Team,ENS Lyon,CNRS,UMR5308,Inserm,U1111, Villeurbanne, France; [Kamen, Amine A.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada	National Research Council Canada; Health Canada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; McGill University	Manceur, AP (corresponding author), Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada.	Aziza.Manceur@cnrc-nrc.gc.ca	Durocher, Yves/K-8709-2019	Marcil, Anne/0000-0002-4111-1781; Rosa-calatrava, Manuel/0000-0002-7559-9527; PETIOT, Emma/0000-0002-1989-4695	National Research Council Canada	National Research Council Canada	Funded by the National Research Council Canada.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Chen JE, 2015, BIOINFORMATICS, V31, P1484, DOI 10.1093/bioinformatics/btu841; Chon JH, 2011, NEW BIOTECHNOL, V28, P458, DOI 10.1016/j.nbt.2011.03.015; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Gaillet B, 2010, BIOTECHNOL BIOENG, V106, P203, DOI 10.1002/bit.22698; Genzel Y, 2004, VACCINE, V22, P2202, DOI 10.1016/j.vaccine.2003.11.041; Gorr TA, 2015, PROTEOM CLIN APPL, V9, P396, DOI 10.1002/prca.201400118; Kalbfuss B, 2007, BIOTECHNOL BIOENG, V96, P932, DOI 10.1002/bit.21109; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Le Mauff F, 2014, PLANT BIOTECHNOL J, DOI 10.1111/pbi.12301; Ru A, 2010, VACCINE, V28, P3661, DOI 10.1016/j.vaccine.2010.03.029; Li CG, 2010, NAT PROTOC, V5, P14, DOI 10.1038/nprot.2009.200; Li GL, 2012, P NATL ACAD SCI USA, V109, P20774, DOI 10.1073/pnas.1219604110; Maiti R, 2005, NUCLEIC ACIDS RES, V33, pW358, DOI 10.1093/nar/gki485; Manceur AP, 2015, VACCINE, V33, P5913, DOI 10.1016/j.vaccine.2015.07.104; Milian E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504831; Montomoli E, 2012, EXPERT REV VACCINES, V11, P587, DOI [10.1586/ERV.12.24, 10.1586/erv.12.24]; Moules V, 2011, VIROLOGY, V414, P51, DOI 10.1016/j.virol.2011.03.011; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9; Reperant Leslie A, 2014, F1000Prime Rep, V6, P47, DOI 10.12703/P6-47; Rose PW, NUCL ACIDS RES, V43, pD345; Schuind A, 2015, J INFECT DIS; Shriver Z, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00315; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun Y, MBIO, V7; Thompson CM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-141; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Venereo-Sanchez A, 2016, VACCINE, V34, P3371, DOI 10.1016/j.vaccine.2016.04.089; Voeten JTM, 1999, VACCINE, V17, P1942, DOI 10.1016/S0264-410X(98)00464-2; Wen YX, 2016, VACCINE, V34, P3388, DOI 10.1016/j.vaccine.2016.04.091; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; Yagami H, 2013, PHARM PAT ANAL, V2, P249, DOI [10.4155/PPA.13.2, 10.4155/ppa.13.2]; Ye J, BIOTECHNOL PROG, V26, P1431; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yusibov V., 2014, EXPERT REV VACCINES, V9, P1; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207	44	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180317	10.1371/journal.pone.0180314	http://dx.doi.org/10.1371/journal.pone.0180314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662134	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300141
J	Ming, LS; Li, Z; Wu, F; Du, RF; Feng, Y				Ming, Liangshan; Li, Zhe; Wu, Fei; Du, Ruofei; Feng, Yi			A two-step approach for fluidized bed granulation in pharmaceutical processing: Assessing different models for design and control	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; RESPONSE-SURFACE METHODOLOGY; WET GRANULATION; PROCESS PARAMETERS; HIGH-SHEAR; MAGNESIUM STEARATE; QUALITY ATTRIBUTES; MELT GRANULATION; OPTIMIZATION; NUCLEATION	Various modeling techniques were used to understand fluidized bed granulation using a two-step approach. First, Plackett-Burman design (PBD) was used to identify the high-risk factors. Then, Box-Behnken design (BBD) was used to analyze and optimize those high-risk factors. The relationship between the high-risk input variables (inlet air temperature X-1, binder solution rate X-3, and binder-to-powder ratio X-5) and quality attributes (flowability Y-1, temperature Y-2, moisture content Y-3, aggregation index Y-4, and compactability Y-5) of the process was investigated using response surface model (RSM), partial least squares method (PLS) and artificial neural network of multilayer perceptron (MLP). The morphological study of the granules was also investigated using a scanning electron microscope. The results showed that X-1, X-3, and X-5 significantly affected the properties of granule. The RSM, PLS and MLP models were found to be useful statistical analysis tools for a better mechanistic understanding of granulation. The statistical analysis results showed that the RSM model had a better ability to fit the quality attributes of granules compared to the PLS and MLP models. Understanding the effect of process parameters on granule properties provides the basis for modulating the granulation parameters and optimizing the product performance at the early development stage of pharmaceutical products.	[Ming, Liangshan; Wu, Fei; Du, Ruofei; Feng, Yi] Shanghai Univ Tradit Chinese Med, Engn Res Ctr Modern Preparat TCM, Minist Educ, Shanghai, Peoples R China; [Li, Zhe; Wu, Fei] Shanghai Univ Tradit Chinese Med, Coll Chinese Mat Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Du, RF; Feng, Y (corresponding author), Shanghai Univ Tradit Chinese Med, Engn Res Ctr Modern Preparat TCM, Minist Educ, Shanghai, Peoples R China.	drf790101@163.com; fyi5117@163.com	Li, Zhe/AAE-1872-2019	Ming, Liangshan/0000-0003-2971-822X; Li, Zhe/0000-0001-7798-8983	National Natural Science Foundation of China [81403110]; Shanghai Municipal Commission of Health and Family Planning [ZY3-CCCX-3-5001]; Science and Technology Commission of Shanghai Municipality [15DZ2292000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from: 1. National Natural Science Foundation of China [grant number 81403110], URL: http://sci-hub.io/http://www.nsfc.gov.cn/; 2. Shanghai Municipal Commission of Health and Family Planning [grant number ZY3-CCCX-3-5001], URL: http://sci-hub.io/http://www.wsjsw.gov.cn/wsj/; 3. Science and Technology Commission of Shanghai Municipality [grant number 15DZ2292000], URL: http://sci-hub.io/http://www.stcsm.gov.cn/.	Abdelbary AA, 2015, INT J PHARMACEUT, V485, P235, DOI 10.1016/j.ijpharm.2015.03.020; Aleksic I, 2015, INT J PHARMACEUT, V496, P627, DOI 10.1016/j.ijpharm.2015.11.001; Aleksic I, 2014, INT J PHARMACEUT, V466, P21, DOI 10.1016/j.ijpharm.2014.02.045; Amasya G, 2016, EUR J PHARM SCI, V84, P92, DOI 10.1016/j.ejps.2016.01.003; Aviles-Aviles C, 2015, POWDER TECHNOL, V270, P445, DOI 10.1016/j.powtec.2014.03.026; Badawy SIF, 2012, INT J PHARMACEUT, V439, P324, DOI 10.1016/j.ijpharm.2012.09.011; Ban SVD, 2016, POWDER TECHNOL, V295, P43; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Chen YH, 2009, POWDER TECHNOL, V191, P206, DOI 10.1016/j.powtec.2008.10.010; Dacanal GC, 2010, POWDER TECHNOL, V203, P565, DOI 10.1016/j.powtec.2010.06.023; Djuris J, 2013, J PHARM SCI-US, V102, P1869, DOI 10.1002/jps.23530; Dumarey M, 2015, INT J PHARMACEUT, V486, P112, DOI 10.1016/j.ijpharm.2015.03.040; Emery E, 2009, POWDER TECHNOL, V189, P409, DOI 10.1016/j.powtec.2008.06.017; Faulhammer E, 2016, DRUG DEV IND PHARM, V42, P221, DOI 10.3109/03639045.2015.1040416; Fujiwara M, 2014, ADV POWDER TECHNOL, V25, P704, DOI 10.1016/j.apt.2013.10.013; Gabbott IP, 2016, EUR J PHARM BIOPHARM, V106, P70, DOI 10.1016/j.ejpb.2016.03.022; Mir VG, 2011, CARBOHYD POLYM, V86, P477, DOI 10.1016/j.carbpol.2011.04.065; Godhe A, 2003, AQUAT MICROB ECOL, V32, P185, DOI 10.3354/ame032185; Gong XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128236; Gong XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114300; Haware RV, 2016, EUR J PHARM SCI, V89, P115, DOI 10.1016/j.ejps.2016.04.019; Haware RV, 2014, J PHARM SCI-US, V103, P1466, DOI 10.1002/jps.23920; Iveson SM, 2001, POWDER TECHNOL, V117, P3, DOI 10.1016/S0032-5910(01)00313-8; Kariuki WIJ, 2013, CHEM ENG SCI, V92, P134, DOI 10.1016/j.ces.2013.01.010; Li WY, 2007, J PHARM SCI-US, V96, P3470, DOI 10.1002/jps.20974; [廖正根 Liao Zhenggen], 2014, [中国药学杂志, Chinese Pharmaceutical Journal], V49, P572; Liu HL, 2014, INT J PHARMACEUT, V475, P256, DOI 10.1016/j.ijpharm.2014.08.057; Liu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090646; Lourenco V, 2011, EUR J PHARM BIOPHARM, V78, P513, DOI 10.1016/j.ejpb.2011.02.008; Mamidi AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141674; Maran JP, 2015, ULTRASON SONOCHEM, V23, P192, DOI 10.1016/j.ultsonch.2014.10.019; Medarevic DP, 2016, DRUG DEV IND PHARM, V42, P389, DOI 10.3109/03639045.2015.1054831; Mei B, 2015, EUR J PHARM BIOPHARM, V89, P208, DOI 10.1016/j.ejpb.2014.12.007; Meng W, 2016, INT J PHARMACEUT, V513, P357, DOI 10.1016/j.ijpharm.2016.09.041; Mitra B, 2015, ADV POWDER TECHNOL, V26, P553, DOI 10.1016/j.apt.2015.01.004; Morin G, 2014, AAPS PHARMSCITECH, V15, P1039, DOI 10.1208/s12249-014-0134-7; Nalawade P, 2015, ARCH PHARM RES, P1; Narvanen T, 2009, AAPS PHARMSCITECH, V10, P1268, DOI 10.1208/s12249-009-9310-6; Parikh DM, 2011, PHARM PROCESS SCALE, P288; Park SJ, 2013, ARCH PHARM RES, V36, P593, DOI 10.1007/s12272-013-0064-z; Patel AD, 2014, EUR J PHARM BIOPHARM, V86, P404, DOI 10.1016/j.ejpb.2013.10.014; Patel AD, 2013, J PHARM SCI-US, V102, P1847, DOI 10.1002/jps.23526; Podczeck F, 2010, EUR J PHARM SCI, V41, P483, DOI 10.1016/j.ejps.2010.08.002; Rajniak P, 2007, INT J PHARM, V334, P92, DOI 10.1016/j.ijpharm.2006.10.040; Rivera EC, 2010, J CHEM TECHNOL BIOT, V85, P983, DOI 10.1002/jctb.2391; Saleh MF, 2015, INT J PHARMACEUT, V487, P124, DOI 10.1016/j.ijpharm.2015.04.017; Singh P, 2013, BIORESOURCE TECHNOL, V137, P261, DOI 10.1016/j.biortech.2013.03.086; Soppela I, 2014, EUR J PHARM BIOPHARM, V88, P879, DOI 10.1016/j.ejpb.2014.08.009; Souihi N, 2015, INT J PHARMACEUT, V483, P200, DOI 10.1016/j.ijpharm.2015.02.006; Sovany T, 2016, EUR J PHARM BIOPHARM, V106, P79, DOI 10.1016/j.ejpb.2016.05.009; Takasaki H, 2016, POWDER TECHNOL, V294, P113, DOI 10.1016/j.powtec.2016.02.013; Vanhoorne V, 2016, INT J PHARMACEUT, V506, P13, DOI 10.1016/j.ijpharm.2016.04.025; Vercruysse J, 2014, EUR J PHARM  BIOPHAR, V89, pc39	53	12	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180209	10.1371/journal.pone.0180209	http://dx.doi.org/10.1371/journal.pone.0180209			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662115	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300127
J	Read, SA; Alonso-Caneiro, D; Vincent, SJ				Read, Scott A.; Alonso-Caneiro, David; Vincent, Stephen J.			Longitudinal changes in macular retinal layer thickness in pediatric populations: Myopic vs non-myopic eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; HUMAN FOVEAL DEVELOPMENT; CHOROIDAL THICKNESS; CHILDREN; CHILDHOOD; RETINOBLASTOMA; TOPOGRAPHY; MORPHOLOGY; ETIOLOGY	Knowledge of the normal in vivo thickness of the retina, and its individual layers in pediatric populations is important for diagnosing and monitoring retinal disorders, and for understanding the eye's normal development and the impact of eye growth and refractive error such as myopia (short-sightedness) upon retinal morphology. In this prospective, observational longitudinal study, total retinal thickness (and individual retinal layer thickness) and the changes in retinal morphology occurring over an 18-month period were examined in 101 children with a range of refractive errors. In childhood, the presence of myopia was associated with subtle but statistically significant (p<0.05) changes in the topographical thickness distribution of macular retinal thickness (and retinal layer thickness), characterised by a thinning of the parafoveal retina (and parafoveal or perifoveal thinning in most outer and inner retinal layers). The parafoveal retina was on average 6 pm thinner in myopic children. However, over 18 months, longitudinal changes in retinal thickness and individual layers were of small magnitude (average changes of less than 2 pm over 18 months), indicative of a high degree of stability in retinal morphology in healthy adolescent eyes, despite significant eye growth over this same period of time. This provides the first detailed longitudinal assessment of macula retinal layer morphology in adolescence, and delivers new normative data on expected changes in retinal structure over time and associated with myopia during this period of childhood development.	[Read, Scott A.; Alonso-Caneiro, David; Vincent, Stephen J.] Queensland Univ Technol, Contact Lens & Visual Opt Lab, Sch Optometry & Vis Sci, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Read, SA (corresponding author), Queensland Univ Technol, Contact Lens & Visual Opt Lab, Sch Optometry & Vis Sci, Brisbane, Qld, Australia.	sa.read@qut.edu.au	Vincent, Stephen J/H-6548-2019	Vincent, Stephen J/0000-0002-5998-1320; Read, Scott/0000-0002-1595-673X; Alonso-Caneiro, David/0000-0002-7754-6592	Australian Research Council Discovery Early Career Research Award [DE120101434]	Australian Research Council Discovery Early Career Research Award(Australian Research Council)	This work was funded by an Australian Research Council Discovery Early Career Research Award (DE120101434) to SAR. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrio-Barrio J, 2013, ACTA OPHTHALMOL, V91, pe56, DOI 10.1111/j.1755-3768.2012.02562.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cao C, 2014, J PEDIAT OPHTH STRAB, V51, P230, DOI 10.3928/01913913-20140603-01; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Chen S, 2014, INVEST OPHTH VIS SCI, V55, P7410, DOI 10.1167/iovs.14-13894; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Ctori I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129005; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dubis AM, 2012, ARCH OPHTHALMOL-CHIC, V130, P1291, DOI 10.1001/archophthalmol.2012.2270; FitzGibbon T, 1996, J COMP NEUROL, V375, P238; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Gerth C, 2008, ARCH OPHTHALMOL-CHIC, V126, P807, DOI 10.1001/archopht.126.6.807; Harb E, 2012, OPTOMETRY VISION SCI, V89, P620, DOI 10.1097/OPX.0b013e318251293a; Henry CR, 2015, J AAPOS, V19, P541, DOI 10.1016/j.jaapos.2015.09.006; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Jin PY, 2016, AM J OPHTHALMOL, V168, P164, DOI 10.1016/j.ajo.2016.05.008; Lee H, 2016, INVEST OPHTH VIS SCI, V57, pOCT69, DOI 10.1167/iovs.15-18825; Lee H, 2015, OPHTHALMOLOGY, V122, P2145, DOI 10.1016/j.ophtha.2015.03.033; Lee H, 2015, INVEST OPHTH VIS SCI, V56, P4537, DOI 10.1167/iovs.15-16542; Li T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158948; Liu XT, 2015, AM J OPHTHALMOL, V160, P53, DOI 10.1016/j.ajo.2015.03.012; Maldonado RS, 2013, CLIN PERINATOL, V40, P271, DOI 10.1016/j.clp.2013.02.007; Maldonado RS, 2011, OPHTHALMOLOGY, V118, P2315, DOI 10.1016/j.ophtha.2011.05.028; McCafferty BK, 2015, J PEDIAT OPHTH STRAB, V52, P167, DOI 10.3928/01913913-20150427-06; Park S, 2013, DOC OPHTHALMOL, V126, P199, DOI 10.1007/s10633-013-9375-0; Park SY, 2013, AM J OPHTHALMOL, V156, P557, DOI 10.1016/j.ajo.2013.04.027; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P6779, DOI 10.1167/iovs.14-15978; Read SA, 2015, RETINA-J RET VIT DIS, V35, P1223, DOI 10.1097/IAE.0000000000000464; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P3103, DOI 10.1167/iovs.15-16446; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P7578, DOI 10.1167/iovs.13-12772; Read SA, 2012, OPTOMETRY VISION SCI, V89, P611, DOI 10.1097/OPX.0b013e3182501917; Rudnicka AR, 2016, BRIT J OPHTHALMOL, V100, P882, DOI 10.1136/bjophthalmol-2015-307724; Samara WA, 2015, J AAPOS, V19, P368, DOI 10.1016/j.jaapos.2015.02.019; Shen L, 2016, OPHTHALMOLOGY, V123, P92, DOI 10.1016/j.ophtha.2015.07.002; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Turk A, 2012, AM J OPHTHALMOL, V153, P552, DOI 10.1016/j.ajo.2011.08.026; Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Yanni SE, 2013, AM J OPHTHALMOL, V155, P354, DOI 10.1016/j.ajo.2012.08.010	40	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180462	10.1371/journal.pone.0180462	http://dx.doi.org/10.1371/journal.pone.0180462			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662138	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300159
J	Khafif, M; Balague, C; Huard-Chauveau, C; Roby, D				Khafif, Mehdi; Balague, Claudine; Huard-Chauveau, Carine; Roby, Dominique			An essential role for the VASt domain of the Arabidopsis VAD1 protein in the regulation of defense and cell death in response to pathogens	PLOS ONE			English	Article							PLANT IMMUNE-SYSTEM; GRAM DOMAIN; MOLECULAR CHARACTERIZATION; DISEASE RESISTANCE; ACTIVATION; CERAMIDE; GENE; TRANSFORMATION; INTERACTS; MEMBRANE	Several regulators of programmed cell death (PCD) have been identified in plants which encode proteins with putative lipid -binding domains. Among them, VAD1 (Vascular Associated Death) contains a novel protein domain called VASt (VAD1 analog StAR-related lipid transfer) still uncharacterized. The Arabidopsis mutant vadl-1 has been shown to exhibit a lesion mimic phenotype with light-conditional appearance of propagative hypersensitive response -like lesions along the vascular system, associated with defense gene expression and increased resistance to Pseudomonas strains. To test the potential of ectopic expression of VAD1 to influence HR cell death and to elucidate the role of the VASt domain in this function, we performed a structure -function analysis of VAD1 by transient over -expression in Nicotiana benthamiana and by complementation of the mutant vadl-1. We found that (i) overexpression of VAD1 controls negatively the HR cell death and defense expression either transiently in Nicotiana benthamania or in Arabidopsis plants in response to avirulent strains of Pseudomonas syringae, (ii) VAD1 is expressed in multiple subcellular compartments, including the nucleus, and (iii) while the GRAM domain does not modify neither the subcellular localization of VAD1 nor its immunorepressor activity, the domain VASt plays an essential role in both processes. In conclusion, VAD1 acts as a negative regulator of cell death associated with the plant immune response and the VASt domain of this unknown protein plays an essential role in this function, opening the way for the functional analysis of VASt-containing proteins and the characterization of novel mechanisms regulating PCD.	[Khafif, Mehdi; Balague, Claudine; Huard-Chauveau, Carine; Roby, Dominique] Univ Toulouse, CNRS, INRA, LIPM, Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Roby, D (corresponding author), Univ Toulouse, CNRS, INRA, LIPM, Castanet Tolosan, France.	dominique.roby@toulouse.inra.fr			French Laboratory of Excellence project "TULIP' [ANR-10-LABX-41, ANR-11-IDEX-0002-02]	French Laboratory of Excellence project "TULIP'	This work was supported by the French Laboratory of Excellence project "TULIP' (ANR-10-LABX-41; ANR-11-IDEX-0002-02).	Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; Babaeizad V, 2009, THEOR APPL GENET, V118, P455, DOI 10.1007/s00122-008-0912-2; Balague C, 2003, PLANT CELL, V15, P365, DOI 10.1105/tpc.006999; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Bi FC, 2014, PLANT CELL, V26, P3449, DOI 10.1105/tpc.114.127050; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Bouchez O, 2007, PLANT PHYSIOL, V145, P465, DOI 10.1104/pp.107.106302; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Bruggeman Q, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00024; BUELL CR, 1995, MOL PLANT MICROBE IN, V8, P435, DOI 10.1094/MPMI-8-0435; Canonne J, 2011, PLANT CELL, V23, P3498, DOI 10.1105/tpc.111.088815; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Chisholm ST, 2003, MOL MICROBIOL, V49, P1537; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Gao X, 2008, J STAT PLAN INFER, V138, P3674, DOI 10.1016/j.jspi.2007.11.019; Gatta AT, 2015, ELIFE, V4, DOI 10.7554/eLife.07253; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khafif M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-222; Kohler C, 1999, PLANT J, V20, P695; La Camera S, 2009, MOL PLANT MICROBE IN, V22, P469, DOI 10.1094/MPMI-22-4-0469; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lefebvre B, 2004, PLANT CELL, V16, P1772, DOI 10.1105/tpc.022277; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Li YR, 2016, PLANT CELL, V28, P233, DOI 10.1105/tpc.15.00626; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Lorrain S, 2004, PLANT CELL, V16, P2217, DOI 10.1105/tpc.104.022038; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Mudgett MB, 1998, CURR OPIN MICROBIOL, V1, P109, DOI 10.1016/S1369-5274(98)80150-1; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; Rodriguez E, 2016, FEBS J, V283, P1385, DOI 10.1111/febs.13613; RONALD PC, 1992, J BACTERIOL, V174, P1604, DOI 10.1128/jb.174.5.1604-1611.1992; Saito C, 2002, PLANT J, V29, P245, DOI 10.1046/j.0960-7412.2001.01189.x; Simanshu DK, 2014, CELL REP, V6, P388, DOI 10.1016/j.celrep.2013.12.023; Sokolov S, 2006, BBA-BIOENERGETICS, V1757, P1366, DOI 10.1016/j.bbabio.2006.07.005; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Ternes P, 2011, NEW PHYTOL, V192, P841, DOI 10.1111/j.1469-8137.2011.03852.x; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Van Durme M, 2016, CURR OPIN PLANT BIOL, V29, P29, DOI 10.1016/j.pbi.2015.10.013; Vorwerk S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-35; Watanabe N, 2009, INT J MOL SCI, V10, P3149, DOI 10.3390/ijms10073149; Williams B, 2008, MOL PLANT PATHOL, V9, P531, DOI [10.1111/j.1364-3703.2008.00473.x, 10.1111/J.1364-3703.2008.00473.X]; Yang HJ, 2007, PLANT PHYSIOL, V145, P135, DOI 10.1104/pp.107.100800	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179782	10.1371/journal.pone.0179782	http://dx.doi.org/10.1371/journal.pone.0179782			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683084	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200015
J	Perrin, G; Korb-Savoldelli, V; Karras, A; Danchin, N; Durieux, P; Sabatier, B				Perrin, Germain; Korb-Savoldelli, Virginie; Karras, Alexandre; Danchin, Nicolas; Durieux, Pierre; Sabatier, Brigitte			Cardiovascular risk associated with high sodium-containing drugs: A systematic review	PLOS ONE			English	Review							BLOOD-PRESSURE; SALT SENSITIVITY; DOUBLE-BLIND; HYPERTENSION; EFFERVESCENT; REDUCTION; COCHRANE; TRIAL	Background Excess dietary sodium is associated with increased blood pressure (BP). Some drugs are associated with high sodium intake (in particular effervescent tablets), but the cardiovascular risk associated with such high sodium-containing drugs (HSCD) is largely underevaluated. Objectives To summarize the evidence for a potential cardiovascular risk associated with exposure to HSCD, and to highlight possible risk factors associated with this iatrogenic issue; in general and/or specific populations. Methods We conducted a systematic review, by searching electronic databases including MEDLINE, EMBASE, Web of Science, CENTRAL and grey literature between 1960 and 2015. We included studies that reported modification of cardiovascular parameters or incidence/prevalence of cardiovascular outcomes, between a group of subjects exposed to HSCD relative to a non-exposed group. The threshold used to identify HSCD was 391 mg/day. We did not consider studies evaluating exposure to sodium as an active ingredient or those focusing on dialysis solutions or enteral/parenteral nutrition. Study quality was assessed using the EPHPP tool. Results A total of eight studies met our inclusion criteria. Four reported results for short-term exposure to HSCD (<= 7 days) on BP fluctuations. One study reported an elevation of BP (associated sodium intake: 1,656 mg/day). Four studies evaluated a long- term exposure (<= 2 years or discontinuation of a chronic treatment). Two studies reported iatrogenic risk. For these studies, drug associated sodium intake was high (> 1,500 mg/day) in patients with comorbidities (in particular, diabetes mellitus and hypertension). Conclusion Despite numerous study limitations, this systematic review suggests three potential synergistic risk factors for cardiovascular complications after exposure to HSCD: a high sodium intake (>= 1,500 mg/day), a long duration of exposure, and the presence of comorbidities. Further studies are required to characterize this iatrogenic risk.	[Perrin, Germain; Korb-Savoldelli, Virginie; Sabatier, Brigitte] Georges Pompidou European Hosp, Dept Pharm, Paris, France; [Perrin, Germain; Durieux, Pierre; Sabatier, Brigitte] Paris Descartes Univ, Team Informat Sci Support Personalized Med 22, INSERM, UMR 1138, Paris, France; [Korb-Savoldelli, Virginie] Paris Saclay Univ, Clin Pharm Dept, Fac Pharm, Chatenay Malabry, France; [Karras, Alexandre] Georges Pompidou European Hosp, Dept Nephrol, Paris, France; [Karras, Alexandre; Danchin, Nicolas] Paris Descartes Univ, Paris, France; [Danchin, Nicolas] Georges Pompidou European Hosp, Dept Cardiol, Paris, France; [Durieux, Pierre] Georges Pompidou European Hosp, Dept Biomed Informat & Publ Hlth, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Perrin, G (corresponding author), Georges Pompidou European Hosp, Dept Pharm, Paris, France.; Perrin, G (corresponding author), Paris Descartes Univ, Team Informat Sci Support Personalized Med 22, INSERM, UMR 1138, Paris, France.	germain.perrin@aphp.fr	Korb-Savoldelli, Virginie/D-2134-2012; Perrin, Germain/AAK-6550-2021; Korb-Savoldelli, Virginie/AAW-7011-2021; Danchin, Nicolas/AAN-8291-2020	Korb-Savoldelli, Virginie/0000-0003-3496-6244; Perrin, Germain/0000-0002-5330-1777; Sabatier, Brigitte/0000-0003-1643-2070	University of Paris Descartes	University of Paris Descartes	The authors would like to acknowledge Sophie Guiquerro from the University of Paris Descartes for her support developing the literature search strategy.	Basile C, 2016, NEPHROL DIAL TRANSPL, V31, P548, DOI 10.1093/ndt/gfv084; Benitez-Camps M, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0161-7; Bruehl S, 2005, CLIN J PAIN, V21, P147, DOI 10.1097/00002508-200503000-00006; Burnier M, 2007, SODIUM HLTH DIS; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dawson J, 2013, J HYPERTENS, V31, P1485, DOI 10.1097/HJH.0b013e328360f6f8; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Elijovich F, 2016, HYPERTENSION, V68, pE7, DOI 10.1161/HYP.0000000000000047; European Medicines Agency, 2015, REV GUID EXC LAB PAC; George J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6954; Goodacre S, 2015, EMERG MED J, V32, P507, DOI 10.1136/emermed-2015-204761; Granberry MC, 1995, ANN PHARMACOTHER, V29, P1232, DOI 10.1177/106002809502901208; Graudal N, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0522-0; Graudal NA, 2012, AM J HYPERTENS, V25, P1, DOI 10.1038/ajh.2011.210; Grossman A, 2015, EUR J PHARMACOL, V763, P15, DOI 10.1016/j.ejphar.2015.06.027; Hall JE, 2016, CIRCULATION, V133, P894, DOI 10.1161/CIRCULATIONAHA.115.018526; He F. J., 2013, BMJ, V346; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; HUSTED FC, 1975, J CLIN INVEST, V56, P414, DOI 10.1172/JCI108107; KURTZ TW, 1987, NEW ENGL J MED, V317, P1043, DOI 10.1056/NEJM198710223171702; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Mahajan A, 2010, KIDNEY INT, V78, P303, DOI 10.1038/ki.2010.129; MARK NH, 1993, CRIT CARE MED, V21, P659, DOI 10.1097/00003246-199305000-00007; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Passfall J, 1997, CLIN NEPHROL, V47, P92; RADACK KL, 1987, ANN INTERN MED, V107, P628, DOI 10.7326/0003-4819-107-5-628; Schmidlin O, 2007, HYPERTENSION, V50, P1085, DOI 10.1161/HYPERTENSIONAHA.107.091694; SHARMA AM, 1992, HYPERTENSION, V19, P541, DOI 10.1161/01.HYP.19.6.541; SHORE AC, 1988, J HYPERTENS, V6, P613, DOI 10.1097/00004872-198808000-00003; Sudano I, 2010, CIRCULATION, V122, P1789, DOI 10.1161/CIRCULATIONAHA.110.956490; Adler Alma J, 2014, Cochrane Database Syst Rev, pCD009217, DOI [10.1002/14651858.CD009217, 10.1002/14651858.CD009217.pub3]; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Thomas E, 2014, ALIMENT PHARM THER, V39, P595, DOI 10.1111/apt.12640; TURNBERG L A, 1970, Journal of Clinical Investigation, V49, P557, DOI 10.1172/JCI106266; Ubeda A, 2009, PHARMACOEPIDEM DR S, V18, P417, DOI 10.1002/pds.1701; Union Re A gionale des Caisses d'Assurance Maladie, 2005, PRESCR MED SOD CHEZ; Uzoigwe OF, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1404; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; WHO, 2012, GUID SOD INT AD CHIL	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180634	10.1371/journal.pone.0180634	http://dx.doi.org/10.1371/journal.pone.0180634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683120	gold, Green Submitted, Green Published			2022-12-27	WOS:000405335200056
J	Nagler, C; Hornig, MK; Haug, JT; Noever, C; Hoeg, JT; Glenner, H				Nagler, Christina; Hoernig, Marie K.; Haug, Joachim T.; Noever, Christoph; Hoeg, Jens T.; Glenner, Henrik			The bigger, the better? Volume measurements of parasites and hosts: Parasitic barnacles (Cirripedia, Rhizocephala) and their decapod hosts	PLOS ONE			English	Article							BRIAROSACCUS-CALLOSUS BOSCHMA; HERMIT-CRAB; LIFE-CYCLE; REPRODUCTIVE OUTPUT; BODY-SIZE; EGG SIZE; PELTOGASTRIDAE CRUSTACEA; COMPARATIVE MORPHOLOGY; R-SELECTION; KING CRAB	Rhizocephala, a group of parasitic castrators of other crustaceans, shows remarkable morphological adaptations to their lifestyle. The adult female parasite consists of a body that can be differentiated into two distinct regions: a sac-like structure containing the reproductive organs (the externa), and a trophic, root like system situated inside the hosts body (the interna). Parasitism results in the castration of their hosts, achieved by absorbing the entire reproductive energy of the host. Thus, the ratio of the host and parasite sizes is crucial for the understanding of the parasite's energetic cost. Using advanced imaging methods (micro-CT in conjunction with 3D modeling), we measured the volume of parasitic structures (externa, interna, egg mass, egg number, visceral mass) and the volume of the entire host. Our results show positive correlations between the volume of (1) entire rhizocephalan (externa + interna) and host body, (2) rhizocephalan externa and host body, (3) rhizocephalan visceral mass and rhizocephalan body, (4) egg mass and rhizocephalan externa, (5) rhizocephalan egg mass and their egg number. Comparing the rhizocephalan Sylon hippolytes, a parasite of caridean shrimps, and representatives of Peltogaster, parasites of hermit crabs, we could match their different traits on a reconstructed relationship. With this study we add new and significant information to our global understanding of the evolution of parasitic castrators, of interactions between a parasitic castrator and its host and of different parasitic strategies within parasitic castrators exemplified by rhizocephalans.	[Nagler, Christina; Haug, Joachim T.] Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany; [Hoernig, Marie K.] Ernst Moritz Arndt Univ Greifswald, Cytol & Evolutionary Biol, Greifswald, Germany; [Haug, Joachim T.] Ludwig Maximilians Univ Munchen, GeoBioctr, Munich, Germany; [Noever, Christoph; Glenner, Henrik] Univ Bergen, Dept Marine Biol, Bergen, Norway; [Hoeg, Jens T.] Univ Copenhagen, Marine Biol Sect, Dept Biol, Copenhagen, Denmark	University of Munich; Ernst Moritz Arndt Universitat Greifswald; University of Munich; University of Bergen; University of Copenhagen	Nagler, C (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany.	christina.nagler@palaeo-evo-clevo.info	Hoeg, Jens Thorvald/D-5784-2015	Hoeg, Jens Thorvald/0000-0002-3596-1691; Noever, Christoph/0000-0002-1455-4966; Nagler, Christina/0000-0003-2876-6342; Hornig, Marie K./0000-0002-0401-2282	Studienstiftung des deutschen Volkes; German Research Foundation (DFG) [Ha 6300/3-1]; Carlsberg Foundation [2008_01_0491, 2013_01_0130]; Danish Agency for Science, Technology and Innovation [4070001486]; Norwegian Biodiversity Information Centre (NBIC); The University of Bergen (Norway); NBIC; The University of Greifswald (Germany); DFG [INST 292/119-1 FUGG, INST 292/120-1 FUGG]	Studienstiftung des deutschen Volkes; German Research Foundation (DFG)(German Research Foundation (DFG)); Carlsberg Foundation(Carlsberg Foundation); Danish Agency for Science, Technology and Innovation; Norwegian Biodiversity Information Centre (NBIC); The University of Bergen (Norway); NBIC; The University of Greifswald (Germany); DFG(German Research Foundation (DFG))	CN and MKH are grateful to be funded by the Studienstiftung des deutschen Volkes with a PhD fellowship. CN is furthermore grateful to be funded by the Studienstiftung des deutschen Volkes with a grant fora six month research stay in Bergen, Norway. JTH is kindly funded by the German Research Foundation (DFG) under Ha 6300/3-1. JT Hoeg is grateful to be funded by the Carlsberg Foundation under 2008_01_0491 and 2013_01_0130 and by the Danish Agency for Science, Technology and Innovation under 4070001486. C Noever and HG were financed by the Norwegian Biodiversity Information Centre (NBIC). HG was furthermore financed by the Carlsberg Foundation under 2008_01_0491. The University of Bergen (Norway) and the NBIC financed the sampling cruise. The University of Greifswald (Germany) financed the micro CT scans with a DFG grant under INST 292/119-1 FUGG and INST 292/120-1 FUGG.	ALLEN J. A., 1966, P45; Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Anger K, 1998, J CRUSTACEAN BIOL, V18, P823, DOI 10.2307/1549156; Barnes M., 1989, OCEANOGR MAR BIOL AN, P27; Battoni GM, 1948, I PUBBL STN ZOOL NAP, V21, P236; BAUDOIN M, 1975, EVOLUTION, V29, P335, DOI [10.2307/2407221, 10.1111/j.1558-5646.1975.tb00213.x]; BISHOP RK, 1979, J FISH DIS, V2, P131, DOI 10.1111/j.1365-2761.1979.tb00150.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P13, DOI DOI 10.1111/J.1365-2818.2006.01706.X; Boschma H., 1962, Discovery Reports, V33, P55; BOSCHMA H., 1930, PROC U S NATION MUS, V76, P1; BOWER SM, 1990, PATHOLOGY IN MARINE SCIENCE, P267; Bresciani J, 2001, J MORPHOL, V249, P9, DOI 10.1002/jmor.1039; Bush SE, 2009, FUNCT ECOL, V23, P578, DOI 10.1111/j.1365-2435.2008.01535.x; Castillo-Neyra R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003433; Cavaleiro FI, 2014, INT J PARASITOL, V44, P173, DOI 10.1016/j.ijpara.2013.10.009; CEDHAGEN T, 1995, CRUSTACEANA, V68, P659, DOI 10.1163/156854095X00926; CLARKE A, 1991, FUNCT ECOL, V5, P724, DOI 10.2307/2389534; Costa S, 2013, CRUSTACEANA, V86, P34, DOI 10.1163/15685403-00003150; Fernando CH, 1970, PERCA FLUVIATILIS, V19, P1; GALIL BSA, 1995, J CRUSTACEAN BIOL, V15, P659, DOI 10.2307/1548815; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GLENNER H, 1995, NATURE, V377, P147, DOI 10.1038/377147a0; Glenner H, 2000, MAR BIOL, V136, P249, DOI 10.1007/s002270050683; Glenner H, 2002, MODERN APPROACHES TO THE STUDY OF CRUSTACEA, P301; Glenner H, 2006, MOL PHYLOGENET EVOL, V41, P528, DOI 10.1016/j.ympev.2006.06.004; Glenner H, 2010, EXP PARASITOL, V125, P3, DOI 10.1016/j.exppara.2009.09.019; GOTTO R. V., 1960, ANN AND MAG NAT HIST, V3, P211; Guha Arun, 2013, Journal of Parasitic Diseases, V37', P118, DOI 10.1007/s12639-012-0144-x; Harrison L., 1915, Parasitology Cambridge, V8, DOI 10.1017/S0031182000010428; HARVEY PH, 1991, PHILOS T R SOC B, V332, P31, DOI 10.1098/rstb.1991.0030; Haug C, 2013, PALAEONTOL ELECTRON, V16; Haug Carolin, 2011, International Journal of Zoology, V2011, P1; Haug C, 2012, DEV GENES EVOL, V222, P253, DOI 10.1007/s00427-012-0407-7; HAWKES CR, 1985, P BIOL SOC WASH, V98, P935; Hoeg J. T., 1985, MARINE INVERTEBRATES, V6; HOEG JT, 1990, J CRUSTACEAN BIOL, V10, P37, DOI 10.2307/1548668; HOEG JT, 1985, J EXP MAR BIOL ECOL, V89, P221, DOI 10.1016/0022-0981(85)90128-5; HOEG JT, 1982, J EXP MAR BIOL ECOL, V58, P87, DOI 10.1016/0022-0981(82)90099-5; Hoeg JT, 1995, OCEANOGR MAR BIOL, V33, P427; HOEG JT, 1995, J MAR BIOL ASSOC UK, V75, P517, DOI 10.1017/S0025315400038996; HOEG JT, 1993, ZOOL SCR, V22, P363, DOI 10.1111/j.1463-6409.1993.tb00365.x; Hornig MK, 2016, PALAEONTOL ELECTRON, V19; Johnson KP, 2005, EVOLUTION, V59, P1744, DOI 10.1111/j.0014-3820.2005.tb01823.x; Kashenko SD, 2003, RUSS J MAR BIOL+, V29, P150; KIRK WDJ, 1991, ECOL ENTOMOL, V16, P351, DOI 10.1111/j.1365-2311.1991.tb00227.x; KURIS AM, 1974, Q REV BIOL, V49, P129, DOI 10.1086/408018; Kuris AM, 2000, DEV AN VET, V32, P9; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; Lajeunesse MJ, 2002, P ROY SOC B-BIOL SCI, V269, P703, DOI 10.1098/rspb.2001.1943; Llodra ER, 2000, J MAR BIOL ASSOC UK, V80, P473, DOI 10.1017/S0025315400002174; LUTZEN J, 1981, J EXP MAR BIOL ECOL, V50, P231, DOI 10.1016/0022-0981(81)90052-6; LUTZEN J, 1987, J CRUSTACEAN BIOL, V7, P493, DOI 10.2307/1548297; Lutzen J, 1996, ZOOL SCR, V25, P171, DOI 10.1111/j.1463-6409.1996.tb00157.x; Lutzen Jorgen, 1992, Bulletin of the National Science Museum Series A (Zoology), V18, P117; MAC ARTHUR ROBERT H., 1967; MACDIARMID AB, 1989, J EXP MAR BIOL ECOL, V127, P229, DOI 10.1016/0022-0981(89)90076-2; Martin J. W., 2009, DECAPOD CRUSTACEAN P, V18, P197; McDermott JJ, 2010, J EXP MAR BIOL ECOL, V394, P2, DOI 10.1016/j.jembe.2010.06.022; MCLAIN DK, 1991, OIKOS, V60, P263, DOI 10.2307/3544875; McMurrich J. P., 1917, T ROY SOC CAN SECT 3, V11, P47; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Morand S, 2000, BIOL J LINN SOC, V70, P239, DOI 10.1111/j.1095-8312.2000.tb00209.x; Nilsson-Cantell CA, 1921, ZOOL BIDR UPPS, V7, P75; Noever C, 2016, J SEA RES, V113, P58, DOI 10.1016/j.seares.2015.08.002; Noever C, 2016, ZOOL J LINN SOC-LOND, V176, P3, DOI 10.1111/zoj.12304; Oh CW, 1999, J CRUSTACEAN BIOL, V19, P252, DOI 10.2307/1549231; PARRY GD, 1981, OECOLOGIA, V48, P260, DOI 10.1007/BF00347974; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; PIKE R. B., 1960, JOUR LINN SOC LONDON ZOOL, V44, P239; Poulin R, 1997, ACTA OECOL, V18, P621, DOI 10.1016/S1146-609X(97)80047-1; Poulin R, 2011, ADV PARASIT, V74, P1, DOI 10.1016/B978-0-12-385897-9.00001-X; Reinhard Edward G., 1946, JOUR WASHINGTON ACAD SCI, V36, P127; Reinhard EG, 1942, J MORPHOL, V70, P69, DOI 10.1002/jmor.1050700105; Ritchie G., 1993, P153; ROSS DM, 1971, NATURE, V230, P401, DOI 10.1038/230401a0; ROTHLISBERG PC, 1976, FISH B-NOAA, V74, P994; Samuelsen TJ, 1970, BIOL 6 SPECIES ANOMU, V45, P25; Santos S, 1997, INTERCIENCIA, V22, P259; Sasal P, 1999, J ANIM ECOL, V68, P437, DOI 10.1046/j.1365-2656.1999.00313.x; SCHOLTZ G, 1995, ZOOL J LINN SOC-LOND, V113, P289, DOI 10.1006/zjls.1995.0011; Sibly R. M., 1986, PHYSL ECOLOGY ANIMAL; SLOAN NA, 1984, J EXP MAR BIOL ECOL, V84, P111, DOI 10.1016/0022-0981(84)90205-3; Sombke A, 2015, J COMP NEUROL, V523, P1281, DOI 10.1002/cne.23741; THESSALOULEGAKI M, 1992, ESTUAR COAST SHELF S, V35, P593, DOI 10.1016/S0272-7714(05)80041-1; Thompson S. N., 1993, P125; Timi JT, 2005, PARASITOL RES, V95, P1, DOI 10.1007/s00436-004-1242-1; VANDAMME PA, 1993, J FISH BIOL, V42, P395, DOI 10.1006/jfbi.1993.1042; VARADARAJAN S, 1982, MAR ECOL PROG SER, V8, P197, DOI 10.3354/meps008197; Walker G, 2001, J MORPHOL, V249, P1; WALKER SE, 1988, PALAEOGEOGR PALAEOCL, V63, P45, DOI 10.1016/0031-0182(88)90090-9; WENNER EL, 1979, CRUSTACEANA, V37, P293, DOI 10.1163/156854079X00618; Yoshida R, 2016, ZOOTAXA, V4139, P209, DOI 10.11646/zootaxa.4139.2.5; Yoshida R, 2014, J CRUSTACEAN BIOL, V34, P467, DOI 10.1163/1937240X-00002246; Yoshida R, 2011, ZOOL SCI, V28, P853, DOI 10.2108/zsj.28.853	95	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179958	10.1371/journal.pone.0179958	http://dx.doi.org/10.1371/journal.pone.0179958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678878	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200033
J	Pusceddu, M; Floris, I; Buffa, F; Salaris, E; Satta, A				Pusceddu, Michelins; Floris, Ignazio; Buffa, Franco; Salaris, Emanuele; Satta, Alberto			Agonistic interactions between the honeybee (Apis mellifera ligustica) and the European wasp (Vespula germanica) reveal context-dependent defense strategies	PLOS ONE			English	Article							COLONY DEFENSE; BEHAVIOR; BEES; HYMENOPTERA; PREDATOR; COMPETITION; AGGRESSION; VESPIDAE; VELUTINA; HORNETS	Predator-prey relationships between sympatric species allow the evolution of defense behaviors, such as honeybee colonies defending their nests against predatory wasps. We investigated the predator-prey relationship between the honeybee (Apis mellifera ligustica) and the European wasp (Vespula germanica) by evaluating the effectiveness of attack and defense behaviors, which have coevolved in these sympatric species, as well as the actual damage and disturbance caused to the colonies under attack. Attack and defense behaviors were recorded in front of the hive to observe attacks at the hive entrance (68 attacks in 279 h) and at ground level on isolated and weakened honeybees close to the hive (465 attacks in 32 h). We found that V. germanica attacked the hive entrance infrequently due to the low success rate of this strategy and instead preferred a specialized attack method targeting adult honeybees at ground level, demonstrating opportunistic scavenger behavior. Individual honeybees usually responded effectively to an attack by recruiting an average of two nestmates, causing the wasp to flee, whereas collective balling behavior was only observed on four occasions. V. germanica does not appear to disrupt the foraging activity of the colonies under attack. We found that agonistic events supported by other nestmates were typically the most intense ones, involving physical combat and prolonged attacks at the entrance to the hive. These observations support the hypothesis that A. mellifera ligustica can adapt its behavior to match the severity of the threat and the context of the attack.	[Pusceddu, Michelins; Floris, Ignazio; Buffa, Franco; Salaris, Emanuele; Satta, Alberto] Univ Sassari, Dipartimento Agr, Sez Patol Vegetate & Entomol, Sassari, Italy	University of Sassari	Satta, A (corresponding author), Univ Sassari, Dipartimento Agr, Sez Patol Vegetate & Entomol, Sassari, Italy.	albsatta@uniss.it	Satta, Alberto/K-8597-2015	Satta, Alberto/0000-0003-1296-3835	Italian Ministry of Education, University and Research (MIUR; Research Project PRIN); Social immunity in honeybee: behavioural, chemical and microbiological aspects [2012RCEZWH]; National Institute of Social providence (INPS, Italy)	Italian Ministry of Education, University and Research (MIUR; Research Project PRIN)(Ministry of Education, Universities and Research (MIUR)); Social immunity in honeybee: behavioural, chemical and microbiological aspects; National Institute of Social providence (INPS, Italy)	This study was financially supported by the Italian Ministry of Education, University and Research (MIUR; Research Project PRIN 2012), Social immunity in honeybee: behavioural, chemical and microbiological aspects. prot. 2012RCEZWH. The National Institute of Social providence (INPS, Italy) which provide the PhD scholarship granted to Michelina Pusceddu.	Abrol Dharam Pal, 2006, Journal of Apicultural Science, V50, P39; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arca M, 2014, BEHAV PROCESS, V106, P122, DOI 10.1016/j.beproc.2014.05.002; Baracchi D, 2010, ETHOL ECOL EVOL, V22, P281, DOI 10.1080/03949370.2010.502323; BREED MD, 1978, INSECT SOC, V25, P351, DOI 10.1007/BF02224299; BREED MD, 1992, ANN ENTOMOL SOC AM, V85, P633, DOI 10.1093/aesa/85.5.633; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BREED MD, 1990, BEHAV ECOL SOCIOBIOL, V27, P395, DOI 10.1007/BF00164065; COELHO JR, 1995, FUNCT ECOL, V9, P171, DOI 10.2307/2390561; COLLINS AM, 1982, SCIENCE, V218, P72, DOI 10.1126/science.218.4567.72; D'Adamo P, 2003, NEW ZEAL J ZOOL, V30, P171, DOI 10.1080/03014223.2003.9518336; De Wroey C, 1978, INSECTES SOC PARIS, V25; DeGrandi-Hoffman G, 1998, J INSECT BEHAV, V11, P37, DOI 10.1023/A:1020862432087; Denis D, 2008, ANIM BEHAV, V75, P791, DOI 10.1016/j.anbehav.2007.06.016; FREE JB, 1970, INSECT SOC, V17, P11, DOI 10.1007/BF02223769; Futuyama D. J., 1986, EVOLUTIONARY BIOL, P482; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Hermann H.R., 1984, P1; JOHNSON LK, 1974, ECOLOGY, V55, P120, DOI 10.2307/1934624; Kasper ML, 2008, INSECT SOC, V55, P288, DOI 10.1007/s00040-008-1004-7; Kastberger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036736; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Kastberger G, 2009, J INSECT BEHAV, V22, P65, DOI 10.1007/s10905-008-9155-y; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; MARKWELL TJ, 1993, NEW ZEAL J ECOL, V17, P85; Matsuura M., 1991, P232; Matsuura M., 1973, HUSCAP J, V19, P125; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Monceau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066492; Nieh JC, 2005, INSECT SOC, V52, P147, DOI 10.1007/s00040-004-0785-6; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Papachristoforou A, 2007, CURR BIOL, V17, pR795, DOI 10.1016/j.cub.2007.07.033; Papachristoforou A, 2011, BEHAV PROCESS, V86, P236, DOI 10.1016/j.beproc.2010.12.012; Pappas N., 1988, P85; Ruttner H., 1972, P PAAR SEL HON INT S, P112; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; Shorter JR, 2012, INSECT SOC, V59, P1, DOI 10.1007/s00040-011-0210-x; Sokal R. R, 1981, BIOMETRY; Sugahara M, 2009, NATURWISSENSCHAFTEN, V96, P1133, DOI 10.1007/s00114-009-0575-0; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002423; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Tan K, 2012, APIDOLOGIE, V43, P195, DOI 10.1007/s13592-011-0098-5; Turillazzi S., 2003, SOC VESPE, P55; WHITFORD WG, 1979, ECOLOGY, V60, P686, DOI 10.2307/1936605; Wilson E.O., 1975, P1; Wood MJ, 2004, APIDOLOGIE, V35, P461, DOI 10.1051/apido:2004040; Zakour MK, 2013, J APIC SCI, V57, P137, DOI 10.2478/JAS-2013-0024	49	8	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180278	10.1371/journal.pone.0180278	http://dx.doi.org/10.1371/journal.pone.0180278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678826	gold, Green Published, Green Submitted			2022-12-27	WOS:000405272200045
J	Sauter-Louis, C; Jones, BA; Henning, J; Stoll, A; Nielen, M; Van Schaik, G; Smolenaars, A; Schouten, M; den Uijl, I; Fourichon, C; Guatteo, R; Madouasse, A; Nusinovici, S; Deprez, P; De Vliegher, S; Laureyns, J; Booth, R; Cardwell, JM; Pfeiffer, DU				Sauter-Louis, Carole; Jones, Bryony A.; Henning, Jorg; Stoll, Alexander; Nielen, Mirjam; Van Schaik, Gerdien; Smolenaars, Anja; Schouten, Matthijs; den Uijl, Ingrid; Fourichon, Christine; Guatteo, Raphael; Madouasse, Aurelien; Nusinovici, Simon; Deprez, Piet; De Vliegher, Sarne; Laureyns, Jozef; Booth, Richard; Cardwell, Jacqueline M.; Pfeiffer, Dirk U.			Herd-level animal management factors associated with the occurrence of bovine neonatal pancytopenia in calves in a multi-country study	PLOS ONE			English	Article							HEMORRHAGIC DIATHESIS; CLASS-I; BNP; COLOSTRUM; ALLOANTIBODIES	Since 2007, mortality associated with a previously unreported haemorrhagic disease has been observed in young calves in several European countries. The syndrome, which has been named 'bovine neonatal pancytopenia' (BNP), is characterised by thrombocytopenia, leukocytopenia and a panmyelophthisis. A herd-level case-control study was conducted in four BNP affected countries (Belgium, France, Germany and the Netherlands) to identify herd management risk factors for BNP occurrence. Data were collected using structured face-to-face and telephone interviews of farm managers and their local veterinarians. In total, 363 case farms and 887 control farms were included in a matched multivariable conditional logistic regression analysis. Case-control status was strongly associated with the odds of herd level use of the vaccine PregSure r BVD (PregSure, Pfizer Animal Health) (matched adjusted odds ratio (OR) 107.2; 95% CI: 41.0-280.1). This was also the case for the practices of feeding calves colostrum from the calf's own dam (OR 2.0; 95% CI: 1.1-3.4) or feeding pooled colostrum (OR 4.1; 95% CI: 1.9-8.8). Given that the study had relatively high statistical power and represented a variety of cattle production and husbandry systems, it can be concluded with some confidence that no other herd level management factors are competent causes for a sufficient cause of BNP occurrence on herd level. It is suggested that genetic characteristics of the dams and BNP calves should be the focus of further investigations aimed at identifying the currently missing component causes that together with PregSure vaccination and colostrum feeding represent a sufficient cause for occurrence of BNP in calves.	[Sauter-Louis, Carole; Stoll, Alexander] Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Clin Ruminants Ambulatory & Herd Hlth Serv, Oberschleissheim, Germany; [Sauter-Louis, Carole; Jones, Bryony A.; Cardwell, Jacqueline M.; Pfeiffer, Dirk U.] Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Grp, Hawkshead Lane, N Mymms, Herts, England; [Sauter-Louis, Carole] Friedrich Loeffler Inst, Inst Epidemiol, Suedufer 10, Greifswald, Germany; [Henning, Jorg] Univ Queensland, Sch Vet Sci, Gatton, Australia; [Nielen, Mirjam; Schouten, Matthijs] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Yalelaan 7, Utrecht, Netherlands; [Van Schaik, Gerdien; Smolenaars, Anja; den Uijl, Ingrid] GD Anim Hlth, Arnsbergstr 7, Deventer, Netherlands; [Fourichon, Christine; Guatteo, Raphael; Madouasse, Aurelien; Nusinovici, Simon] LUNAM Univ Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, Nantes, France; [Deprez, Piet] Univ Ghent, Fac Vet Med, Dept Internal Med & Clin Biol Large Anim, Salisburylaan 133, Merelbeke, Belgium; [De Vliegher, Sarne; Laureyns, Jozef] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, Salisburylaan 133, Merelbeke, Belgium; [Booth, Richard] Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, N Mymms, Herts, England; [Pfeiffer, Dirk U.] City Univ Hong Kong, Sch Vet Med, Hong Kong, Hong Kong, Peoples R China	University of Munich; University of London; University of London Royal Veterinary College; Friedrich Loeffler Institute; University of Queensland; Utrecht University; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ghent University; Ghent University; University of London; University of London Royal Veterinary College; City University of Hong Kong	Sauter-Louis, C (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Clin Ruminants Ambulatory & Herd Hlth Serv, Oberschleissheim, Germany.; Sauter-Louis, C (corresponding author), Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Grp, Hawkshead Lane, N Mymms, Herts, England.; Sauter-Louis, C (corresponding author), Friedrich Loeffler Inst, Inst Epidemiol, Suedufer 10, Greifswald, Germany.	carola@sauter-louis.de	Cardwell, Jacqueline Martina/I-3273-2014; De Vliegher, Sarne/J-9491-2012; Pfeiffer, Dirk U/C-5002-2009; van Schaik, Gerdien/AAD-7771-2020; Fourichon, Christine/B-1265-2010; De Vliegher, Sarne/N-7712-2019; Madouasse, Aurélien/AAC-2814-2019; Henning, Joerg/G-8662-2017	De Vliegher, Sarne/0000-0001-6330-9062; Pfeiffer, Dirk U/0000-0001-7000-0530; Fourichon, Christine/0000-0002-7079-0955; De Vliegher, Sarne/0000-0001-6330-9062; Madouasse, Aurélien/0000-0002-9254-5707; van Schaik, Gerdien/0000-0002-0460-2629; Jones, Bryony/0000-0003-4383-2504; Henning, Joerg/0000-0002-0282-1318	Zoetis (formerly Pfizer Animal Health)	Zoetis (formerly Pfizer Animal Health)	The study was funded by Zoetis (formerly Pfizer Animal Health) which produced the vaccine PregSure, one of the risk factors investigated here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Surveillance (Wellington), V39, P14; Armengol R, 2010, B ANEMBE, V85, P28; Assad A, 2012, VET IMMUNOL IMMUNOP, V147, P25, DOI 10.1016/j.vetimm.2012.04.012; BANKS KL, 1982, J AM VET MED ASSOC, V181, P1053; Bastian M, 2011, VACCINE, V29, P5267, DOI 10.1016/j.vaccine.2011.05.012; Bednarski M, 2011, MED WETER, V67, P283; Bell CR, 2013, VET IMMUNOL IMMUNOP, V151, P303, DOI 10.1016/j.vetimm.2012.12.002; Benedictus L, 2014, VET RES, V45, DOI 10.1186/s13567-014-0129-0; Bridger PS, 2011, VET IMMUNOL IMMUNOP, V141, P1, DOI 10.1016/j.vetimm.2011.01.001; Buck BC, 2011, BERL MUNCH TIERARZTL, V124, P329, DOI 10.2376/0005-9366-124-329; Carlin A, 2011, EPIDEMIOLOGISCHE UNT; Demasius W, 2014, RES VET SCI, V96, P537, DOI 10.1016/j.rvsc.2014.03.019; Deutskens F, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-97; DEVERYPOCIUS JE, 1983, J DAIRY SCI, V66, P221, DOI 10.3168/jds.S0022-0302(83)81780-9; Ellis-Iversen J, 2009, P SAT S HAEM DIAT CA; Euler KN, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-18; Foucras G, 2009, P SAT S HAEM DIATH C; Foucras G, 2011, J IMMUNOL, V187, P6564, DOI 10.4049/jimmunol.1102533; Friedrich A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-10; Friedrich A, 2009, TIERAERZTL UMSCHAU, V64, P423; Gentile A, 2009, P SAT S HAEM DIATH C; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jones BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080619; Kappe EC, 2010, BERL MUNCH TIERARZTL, V123, P31, DOI 10.2376/0005-9366-123-31; Kasonta R, 2012, VACCINE, V30, P6649, DOI 10.1016/j.vaccine.2012.08.069; Lambton SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034183; Pardon B, 2010, TRANSBOUND EMERG DIS, V57, P135, DOI 10.1111/j.1865-1682.2010.01098.x; Pardon B, 2009, P  SAT S HAEM DIATH; Pardon B, 2011, VET IMMUNOL IMMUNOP, V141, P293, DOI 10.1016/j.vetimm.2011.02.017; Paul-Ehrlich-Institut, 2011, DTSCH TIERARZTEBLATT, V12, P1662; Paul-Ehrlich-Institut, 2013, FALL BOV NEON PANZ B; Reichmann F, 2012, FALL KONTROLL STUDIE; Sanchez-Miguel C, 2010, VET REC, V166, P664, DOI 10.1136/vr.c2690; Sauter-Louis C, 2012, PREV VET MED, V105, P49, DOI 10.1016/j.prevetmed.2012.02.008; Schroter P, 2012, BERL MUNCH TIERARZTL, V125, P476, DOI 10.2376/0005-9366-125-476; Schroter P, 2011, BERL MUNCH TIERARZTL, V124, P390, DOI 10.2376/0005-9366-124-390; Smolenaars AJG., 2009, P SAT S HAEM DIATH C; TODD AG, 1995, AUST VET J, V72, P415, DOI 10.1111/j.1751-0813.1995.tb06191.x; Wolf C., 2006, NUTZTIERPRAXIS AKTEL, P26	39	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e4179878	10.1371/journal.pone.0179878	http://dx.doi.org/10.1371/journal.pone.0179878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678850	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000405272200030
J	Doi, L; Jepson, R; Hardie, S				Doi, Lawrence; Jepson, Ruth; Hardie, Samantha			Realist evaluation of an enhanced health visiting programme	PLOS ONE			English	Article							FAMILY HEALTH; SERVICES	Background The health visitors' role in many countries is changing. In Scotland, the role has undergone substantial changes through the introduction of an enhanced health visiting programme, which includes increased, structured home visits. This evaluation was conducted within NHS Ayrshire and Arran, one of the 14 Scottish Health Boards. Our aim was to understand and explain how, and why, the programme could contribute to improving health and wellbeing outcomes for children and families. Methods We used a realist evaluation approach, conducted in three phases. In phase one, eight managerial staff involved in developing and implementing the programme provided data, which were used to develop initial programme theories. In phase two, the programme theories were tested using qualitative data from 25 health visitors and 22 parents. The programme theories were refined through analyses and interpretation of data in phase three. Results The home visiting context provided by the programme interacted with the mechanisms of the programme and produced outcomes such as early identification of health and wellbeing issues amongst families who needed more support, leading to referral and engagement with sources of additional help. The home visits facilitated development of parent-health visitor relationships, and parents considered health visitors as their first point of contact on children's wellbeing and developmental-related issues. Moreover, the programme provided more clarity to health visitors' role, which in turn enhanced partnership working. However, there were aspects of the programme that may require further development. For instance, both parents and health visitors were concerned about the wide gaps between some home visits. Conclusions The enhanced health visiting programme increased opportunities for monitoring and early identification of health and wellbeing concerns. It created structures for a more efficient partnership working and ensured that the needs of children and families were supported. These benefits need to be evaluated further in an effectiveness study.	[Doi, Lawrence; Jepson, Ruth] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Scottish Collaborat Publ Hlth Res & Policy, Edinburgh, Midlothian, Scotland; [Hardie, Samantha] Glasgow Caledonian, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland	University of Edinburgh; Glasgow Caledonian University	Doi, L (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Scottish Collaborat Publ Hlth Res & Policy, Edinburgh, Midlothian, Scotland.	larry.doi@ed.ac.uk		Doi, Lawrence/0000-0001-6853-5050	Medical Research Council [MR/KO023209/1]; Chief Scientist Office; Scottish Government Chief Nurse'sOffice; MRC [MR/K023209/1] Funding Source: UKRI; Medical Research Council [MR/K023209/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; Scottish Government Chief Nurse'sOffice; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Scottish Collaboration for Public Health Research and Policy is funded by the Medical Research Council (MR/KO023209/1) and the Chief Scientist Office. The evaluation was funded by a grant from the Scottish Government Chief Nurse'sOffice. The views expressed in this publication are those of the authors and not necessarily those of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ONLINE J ISSUES NURS; [Anonymous], 2011, HLTH VIS IMPL PLAN 2; Barlow J., 2003, INT J MENT HEALTH PR, V12, P172, DOI DOI 10.1080/14623730.2005.9721953; Barlow J., 2003, CHILD ABUSE REV, V12, P172, DOI DOI 10.1002/CAR.796; Blair M, 2006, ARCH DIS CHILD, V91, P730, DOI 10.1136/adc.2004.065003; Byng R, 2011, FAM MED, V43, P112; Cowley S, 2013, WHY HLTH VIS REV LIT; Cowley S, 2015, INT J NURS STUD, V52, P465, DOI 10.1016/j.ijnurstu.2014.07.013; DELACUESTA C, 1994, INT J NURS STUD, V31, P451, DOI 10.1016/0020-7489(94)90015-9; Doi L, 2015, MIDWIFERY, V31, P965, DOI 10.1016/j.midw.2015.06.007; Donetto S, 2013, HLTH VISITING VOICE; Funnell S., 2011, PURPOSEFUL PROGRAM T; Greenhalgh T, 2009, MILBANK Q, V87, P391, DOI 10.1111/j.1468-0009.2009.00562.x; ISD Scotland:, 2014, MAT BIRTHS; Lamont T, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i154; Lefroy J, 2015, MED EDUC, V49, P307, DOI 10.1111/medu.12659; Marchal B, 2012, EVALUATION-US, V18, P192, DOI 10.1177/1356389012442444; Marmot M, 2010, FAIR SOC HLTH LIVES; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mathie A., 2003, DEV PRACT, V13, P474, DOI DOI 10.1080/0961452032000125857; NHS Scotland, 2001, NURS HLTH REV CONTR; Pawson R., 2006, EVIDENCE BASED POLIC, DOI DOI 10.4135/9781849209120; Pawson R., 1997, REALISTIC EVALUATION; Psaila K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-151; Punton M., 2016, REFLECTIONS REALIST; QSR International, 2014, NVIVO QUAL DAT AN SO; Roberts H, 2012, WHAT WORKS REDUCING; Scottish Executive, 2005, HLTH ALL CHILDR; Scottish Government, 2015, UN HLTH VIS PATHW SC; Scottish Government, 2016, PLAN SCOTL SCOTT GOV; Scottish Government, 2012, SCOTT CHILD HLTH PRO; Sharpe PA, 2000, PUBLIC HEALTH REP, V115, P205, DOI 10.1093/phr/115.2.205; Wand T, 2010, NURS INQ, V17, P231, DOI 10.1111/j.1440-1800.2010.00488.x; Westhorp G., 2014, REALIST IMPACT EVALU; Wiggins M, 2004, HEALTH TECHNOL ASSES, V8, P1; Williams L, 2016, NURSING PHILOS	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180569	10.1371/journal.pone.0180569	http://dx.doi.org/10.1371/journal.pone.0180569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672013	Green Published, gold, Green Submitted			2022-12-27	WOS:000405268500069
J	Kong, E; Chun, KA; Cho, IH				Kong, Eunjung; Chun, Kyung Ah; Cho, Ihn Ho			Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; WEIGHTED MRI; LIVER; LESIONS; PET/CT; CHOLANGIOCARCINOMA; EXPRESSION; GRADE	Purpose Metabolism and water diffusion may have a relationship or an effect on each other in the same tumor. Knowledge of their relationship could expand the understanding of tumor biology and serve the field of oncologic imaging. This study aimed to evaluate the relationship between metabolism and water diffusivity in hepatic tumors using a simultaneous positron emission tomography/magnetic resonance imaging (PET/MRI) system with F-18 fluorodeoxyglucose (FDG) and to reveal the metabolic and diffusional characteristics of each type of hepatic tumor. Methods Forty-one patients (mean age 63 +/- 13 years, 31 male) with hepatic tumors (18 hepatocellular carcinoma [HCC], six cholangiocarcinoma [CCC], 10 metastatic tumors, one neuroendocrine malignancy, and six benign lesions) underwent FDG PET/MRI before treatment. Maximum standard uptake (SUVmax) values from FDG PET and the apparent diffusion coefficient (ADC) from the diffusion-weighted images were obtained for the tumor and their relationships were examined. We also investigated the difference in SUVmax and ADC for each type of tumor. Results SUVmax showed a negative correlation with ADC (r = -0.404, p = 0.009). The median of SUVmax was 3.22 in HCC, 6.99 in CCC, 6.30 in metastatic tumors, and 1.82 in benign lesions. The median of ADC was 1.039 x 10(-3) mm/s(2) in HCC, 1.148 x 10(-3) mm/s(2) in CCC, 0.876 x 10(-3) mm/s (2) in metastatic tumors, and 1.323 x 10(-3) mm/s (2) in benign lesions. SUVmax was higher in metastatic tumors than in benign lesions (p = 0.023). Metastatic tumors had a lower ADC than CCC (p = 0.039) and benign lesions (p = 0.004). HCC had a lower ADC than benign lesions, with a suggestive trend (p = 0.06). Conclusion Our results indicate that SUVmax is negatively correlated with ADC in hepatic tumors, and each group of tumors has different metabolic and water diffusivity characteristics. Evaluation of hepatic tumors by PET/MRI could be helpful in understanding tumor characteristics.	[Kong, Eunjung; Chun, Kyung Ah; Cho, Ihn Ho] Yeungnam Univ, Dept Nucl Med, Med Sch & Hosp, Daegu, South Korea	Yeungnam University	Kong, E (corresponding author), Yeungnam Univ, Dept Nucl Med, Med Sch & Hosp, Daegu, South Korea.	kongej@yu.ac.kr	Kong, Eunjung/J-9231-2018		Yeungnam University	Yeungnam University	This research was supported by a research grant from Yeungnam University (2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071571; Assy N, 2009, WORLD J GASTROENTERO, V15, P3217, DOI 10.3748/wjg.15.3217; Boussouar S, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0062-8; Brandmaier P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141684; Conrad R, 2013, J GASTROINTEST ONCOL, V4, P53, DOI 10.3978/j.issn.2078-6891.2012.020; Czernin J, 2007, J NUCL MED, V48, p78S; Di Costanzo A, 2006, NEURORADIOLOGY, V48, P622, DOI 10.1007/s00234-006-0102-3; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; Gambhir SS, 2001, J NUCL MED, V42, p1S; Gu J, 2011, MOL IMAGING BIOL, V13, P1020, DOI 10.1007/s11307-010-0433-7; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Hayashida Y, 2006, AM J NEURORADIOL, V27, P1419; HERHOLZ K, 1993, J NEUROSURG, V79, P853, DOI 10.3171/jns.1993.79.6.0853; Higashi K, 2000, J NUCL MED, V41, P85; Higashi T, 2002, J NUCL MED, V43, P173; Kong E, 2016, Q J NUCL ME IN PRESS; Kumar V A A, 2015, AJ ROBBINS COTRAN PA, P870; Lee JD, 2005, J NUCL MED, V46, P1753; Mannelli L, 2009, AM J ROENTGENOL, V193, P1044, DOI 10.2214/AJR.08.1461; Naganawa S, 2005, EUR RADIOL, V15, P71, DOI 10.1007/s00330-004-2529-4; Rakheja R, 2012, AM J ROENTGENOL, V198, P1409, DOI 10.2214/AJR.11.7560; Regier M, 2012, EUR J RADIOL, V81, P2913, DOI 10.1016/j.ejrad.2011.11.050; Roh MS, 2004, HEPATO-GASTROENTEROL, V51, P1315; Rubesova E, 2006, J MAGN RESON IMAGING, V24, P319, DOI 10.1002/jmri.20643; Schoder H, 2005, J CLIN ONCOL, V23, P4643, DOI 10.1200/JCO.2005.12.072; Schwenzer NF, 2014, J MAGN RESON IMAGING, V40, P1121, DOI 10.1002/jmri.24497; Wang JC, 2001, RADIOLOGY, V220, P621, DOI 10.1148/radiol.2202010063; Zimmerman RL, 2002, ONCOL REP, V9, P689	28	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180184	10.1371/journal.pone.0180184	http://dx.doi.org/10.1371/journal.pone.0180184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672016	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500023
J	Tsai, CS; Chen, VCH; Yang, YH; Hung, TH; Lu, ML; Huang, KY; Gossop, M				Tsai, Ching-Shu; Chen, Vincent Chin-Hung; Yang, Yao-Hsu; Hung, Tai-Hsin; Lu, Mong-Liang; Huang, Kuo-You; Gossop, Michael			The association between Mycoplasma pneumoniae infection and speech and language impairment: A nationwide population-based study in Taiwan	PLOS ONE			English	Article							NERVOUS-SYSTEM COMPLICATIONS; OTITIS-MEDIA; RISK-FACTORS; CHILDREN; MANIFESTATIONS; DISORDERS; COMMUNITY; DISEASE; DELAY; EPIDEMIOLOGY	Manifestations of Mycoplasma pneumoniae infection can range from self- limiting upper respiratory symptoms to various neurological complications, including speech and language impairment. But an association between Mycoplasma pneumoniae infection and speech and language impairment has not been sufficiently explored. In this study, we aim to investigate the association between Mycoplasma pneumoniae infection and subsequent speech and language impairment in a nationwide population- based sample using Taiwan's National Health Insurance Research Database. We identified 5,406 children with Mycoplasma pneumoniae infection (International Classification of Disease, Revision 9, Clinical Modification code 4830) and compared to 21,624 age-, sex-, urban- and incomematched controls on subsequent speech and language impairment. The mean follow- up interval for all subjects was 6.44 years (standard deviation = 2.42 years); the mean latency period between the initial Mycoplasma pneumoniae infection and presence of speech and language impairment was 1.96 years (standard deviation = 1.64 years). The results showed that Mycoplasma pneumoniae infection was significantly associated with greater incidence of speech and language impairment [hazard ratio (HR) = 1.49, 95% CI: 1.23-1.80]. In addition, significantly increased hazard ratio of subsequent speech and language impairment in the groups younger than 6 years old and no significant difference in the groups over the age of 6 years were found (HR = 1.43, 95% CI: 1.09-1.88 for age 0-3 years group; HR = 1.67, 95% CI: 1.25-2.23 for age 4-5 years group; HR = 1.14, 95% CI: 0.54-2.39 for age 6-7 years group; and HR = 0.83, 95% CI: 0.23-2.92 for age 8-18 years group). In conclusion, Mycoplasma pneumoniae infection is temporally associated with incident speech and language impairment.	[Tsai, Ching-Shu; Chen, Vincent Chin-Hung; Hung, Tai-Hsin] Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan; [Tsai, Ching-Shu; Chen, Vincent Chin-Hung; Hung, Tai-Hsin] Univ Chiayi, Chiayi, Taiwan; [Tsai, Ching-Shu; Chen, Vincent Chin-Hung; Hung, Tai-Hsin] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Tsai, Ching-Shu; Hung, Tai-Hsin] Chang Gung Inst Technol, Taoyuan, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Yang, Yao-Hsu] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Dept Psychiat, Wan Fang Hosp, Taipei, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Huang, Kuo-You] Chung Shan Med Univ & Hosp, Dept Speech Language Pathol & Audiol, Taichung, Taiwan; [Gossop, Michael] Kings Coll London, Natl Addict Ctr, London, England	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Taiwan University; Chang Gung University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; University of London; King's College London	Huang, KY (corresponding author), Chung Shan Med Univ & Hosp, Dept Speech Language Pathol & Audiol, Taichung, Taiwan.	huangkuoyou@yahoo.com.tw	楊, 曜旭/A-3450-2019	楊, 曜旭/0000-0002-8080-0504; Lu, Mong-Liang/0000-0003-3184-6554	Chang Gung Memorial Hospital, Chiayi Branch [CMRPG6F0281]	Chang Gung Memorial Hospital, Chiayi Branch	The present study is supported by a grant from Chang Gung Memorial Hospital, Chiayi Branch (CMRPG6F0281). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtekar CS, 2003, DEV MED CHILD NEUROL, V45, P634, DOI 10.1017/S0012162203001154; Bebear CM, 2008, ARCH PEDIATRIE, V15, P1253, DOI 10.1016/j.arcped.2008.02.010; BEHAN PO, 1986, ACTA NEUROL SCAND, V74, P314; BIBERFELD G, 1971, CLIN EXP IMMUNOL, V8, P319; Bitnun A, 2001, CLIN INFECT DIS, V32, P1674, DOI 10.1086/320748; Buschmann A, 2008, DEV MED CHILD NEUROL, V50, P223, DOI 10.1111/j.1469-8749.2008.02034.x; Chaudhry R, 2016, INDIAN J MED MICROBI, V34, P7, DOI 10.4103/0255-0857.174112; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; CIMOLAI N, 1994, ARCH DIS CHILD, V71, P281, DOI 10.1136/adc.71.3.281; Dollaghan CA, 1999, J SPEECH LANG HEAR R, V42, P1432, DOI 10.1044/jslhr.4206.1432; FERNALD GW, 1975, PEDIATRICS, V55, P327; FERNANDEZ CV, 1993, J CHILD NEUROL, V8, P27, DOI 10.1177/088307389300800104; Fox AV, 2002, INT J LANG COMM DIS, V37, P117, DOI 10.1080/13682820110116776; FOY HM, 1970, J AMER MED ASSOC, V214, P1666, DOI 10.1001/jama.214.9.1666; FOY HM, 1979, J INFECT DIS, V139, P681, DOI 10.1093/infdis/139.6.681; Fu M, 1998, J NEUROL SCI, V157, P113, DOI 10.1016/S0022-510X(98)00074-4; GOERTZEN SM, 1957, AM J MENT DEF, V62, P244; Guleria R, 2005, J LAB CLIN MED, V146, P55, DOI 10.1016/j.lab.2005.04.006; Gurgel LG, 2014, CODAS, V26, P350, DOI 10.1590/2317-1782/20142014070; Harrison LJ, 2010, J SPEECH LANG HEAR R, V53, P508, DOI 10.1044/1092-4388(2009/08-0086); Hauner KKY, 2005, J SPEECH LANG HEAR R, V48, P635, DOI 10.1044/1092-4388(2005/044); Horwitz SM, 2003, J AM ACAD CHILD PSY, V42, P932, DOI 10.1097/01.CHI.0000046889.27264.5E; Kammer J, 2016, NEUROPEDIATRICS, V47, P308, DOI 10.1055/s-0036-1584325; Korrel H, 2017, J CHILD PSYCHOL PSYC, V58, P640, DOI 10.1111/jcpp.12688; KOSKINIEMI M, 1993, CLIN INFECT DIS, V17, pS52, DOI 10.1093/clinids/17.Supplement_1.S52; Lin Wen-Chuan, 2002, Journal of Microbiology Immunology and Infection, V35, P173; LIND K, 1983, YALE J BIOL MED, V56, P461; LIND K, 1988, INFECT IMMUN, V56, P714, DOI 10.1128/IAI.56.3.714-715.1988; Ma YJ, 2015, J MICROBIOL IMMUNOL, V48, P632, DOI 10.1016/j.jmii.2014.08.003; MANSEL JK, 1989, CHEST, V95, P639, DOI 10.1378/chest.95.3.639; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Mody M, 1999, J SPEECH LANG HEAR R, V42, P1069, DOI 10.1044/jslhr.4205.1069; MULDER LJMM, 1987, NEUROLOGY, V37, P1430, DOI 10.1212/WNL.37.8.1430; Nishimura M, 1996, J NEUROL SCI, V140, P91, DOI 10.1016/0022-510X(96)00106-2; Nordberg A, 2014, INT J SPEECH-LANG PA, V16, P386, DOI 10.3109/17549507.2014.917440; Paradise JL, 2000, PEDIATRICS, V105, P1119, DOI 10.1542/peds.105.5.1119; Prathanee B, 2007, CLIN PEDIATR, V46, P22, DOI 10.1177/0009922806297153; Reilly S, 2007, PEDIATRICS, V120, pE1441, DOI 10.1542/peds.2007-0045; Reilly S, 2006, J PAEDIATR CHILD H, V42, P764, DOI 10.1111/j.1440-1754.2006.00974.x; Rice ML, 1998, J SPEECH LANG HEAR R, V41, P419, DOI 10.1044/jslhr.4102.419; Roses-Noguer F, 2006, REV NEUROLOGIA, V42, P466, DOI 10.33588/rn.4208.2005429; Socan M, 2001, CLIN INFECT DIS, V32, pE31, DOI 10.1086/318446; Spitz RV, 1997, J SPEECH LANG HEAR R, V40, P990, DOI 10.1044/jslhr.4005.990; Stanton-Chapman TL, 2002, RES DEV DISABIL, V23, P390, DOI 10.1016/S0891-4222(02)00141-5; Tsai CJ, 2012, NEPHROLOGY, V17, P390, DOI 10.1111/j.1440-1797.2012.01571.x; Tsiodras S, 2005, J INFECTION, V51, P343, DOI 10.1016/j.jinf.2005.07.005; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites KB, 2003, PEDIATR PULM, V36, P267, DOI 10.1002/ppul.10346; Weindrich D, 2000, EUR CHILD ADOLES PSY, V9, P186, DOI 10.1007/s007870070042; Yeh JJ, 2015, J ALLERGY CLIN IMMUN; YEOH C, 1993, BRIT MED J, V306, P972, DOI 10.1136/bmj.306.6883.972; Yimenicioglu S, 2014, IRAN J PEDIATR, V24, P647; Zubrick SR, 2007, J SPEECH LANG HEAR R, V50, P1562, DOI 10.1044/1092-4388(2007/106)	53	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180402	10.1371/journal.pone.0180402	http://dx.doi.org/10.1371/journal.pone.0180402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672017	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500050
J	Huang, WS; Hung, HN; Hamasaki, T; Hsiao, CF				Huang, Wong-Shian; Hung, Hui-Nien; Hamasaki, Toshimitsu; Hsiao, Chin-Fu			Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints	PLOS ONE			English	Article							CONSISTENCY	Recently, multi-regional clinical trials (MRCTs), which incorporate subjects from many countries/ regions around the world under the same protocol, have been widely conducted by many global pharmaceutical companies. The objective of such trials is to accelerate the development process for a drug and shorten the drug's approval time in key markets. Several statistical methods have been purposed for the design and evaluation of MRCTs, as well as for assessing the consistency of treatment effects across all regions with one primary endpoint. However, in some therapeutic areas (e.g., Alzheimer's disease), the clinical efficacy of a new treatment may be characterized by a set of possibly correlated endpoints, known as multiple co-primary endpoints. In this paper, we focus on a specific region and establish three statistical criteria for evaluating consistency between the specific region and overall results in MRCTs with multiple co-primary endpoints. More specifically, two of those criteria are used to assess whether the treatment effect in the region of interest is as large as that of the other regions or of the regions overall, while the other criterion is used to assess the consistency of the treatment effect of the specific region achieving a pre-specified threshold. The sample size required for the region of interest can also be evaluated based on these three criteria.	[Huang, Wong-Shian; Hung, Hui-Nien; Hsiao, Chin-Fu] Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan; [Huang, Wong-Shian; Hsiao, Chin-Fu] Natl Hlth Res Inst, Inst Populat Sci, Zhunan, Miaoli County, Taiwan; [Hamasaki, Toshimitsu] Natl Cerebral & Cardiovasc Ctr, Osaka, Japan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Cerebral & Cardiovascular Center - Japan	Hsiao, CF (corresponding author), Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan.; Hsiao, CF (corresponding author), Natl Hlth Res Inst, Inst Populat Sci, Zhunan, Miaoli County, Taiwan.	chinfu@nhri.org.tw	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160; Hsiao, Chin-Fu/0000-0003-1284-7260	Ministry of Science and Technology, Taiwan [MOST 103-2118-M-400-004-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The work in this paper was supported by the grant MOST 103-2118-M-400-004- from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CT, 2012, J BIOPHARM STAT, V22, P1037, DOI 10.1080/10543406.2012.701585; Committee for Medicinal Products for Human Use (CHMP), 2008, CPMPEWP55395REV; Dmitrienko A, 2010, CH CRC BIOSTAT SER, V33, P1; Food and Drug Administration. Guidance for Industry, 2013, ALZH DIS DEV DRUGS T; Hamasaki T, 2013, PHARM STAT, V12, P28, DOI 10.1002/pst.1545; Huang YF, 2013, PHARM STAT, V12, P59, DOI 10.1002/pst.1553; Hung HMJ, 2009, J BIOPHARM STAT, V19, P1, DOI 10.1080/10543400802541693; Ikeda K, 2010, PHARM STAT, V9, P207, DOI 10.1002/pst.455; International Conference on Harmonization, 2006, INT C HARM TECHN REQ; International Conference on Harmonization, 2016, INT C HARM TECHN REQ; Kawai N, 2008, DRUG INF J, V42, P139, DOI 10.1177/009286150804200206; Ko FS, 2010, J BIOPHARM STAT, V20, P870, DOI 10.1080/10543401003618900; Ministry of Health, 2007, LAB WEALTH JAP BAS P; Offen W, 2007, DRUG INF J, V41, P31, DOI 10.1177/009286150704100105; Quan H, 2010, PHARM STAT, V9, P100, DOI 10.1002/pst.380; Senn S, 2007, PHARM STAT, V6, P161, DOI 10.1002/pst.301; Sozu T, 2015, SPRINGERBRIEF STAT, P1, DOI 10.1007/978-3-319-22005-5; Sozu T, 2006, JAPANESE J BIOMETRIC, V27, P83, DOI [DOI 10.5691/JJB.27.83, 10.5691/jjb.27.83]; Sozu T, 2011, J BIOPHARM STAT, V21, P650, DOI 10.1080/10543406.2011.551329; Sugimoto T, 2012, PHARM STAT, V11, P118, DOI 10.1002/pst.505; Tsou HH, 2012, PHARM STAT, V11, P295, DOI 10.1002/pst.1512; Tsou HH, 2011, STAT MED, V30, P2171, DOI 10.1002/sim.4251; Uesaka H, 2009, J BIOPHARM STAT, V19, P580, DOI 10.1080/10543400902963185; Westfall PH, 2011, MULTIPLE COMP MULTIP	24	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180405	10.1371/journal.pone.0180405	http://dx.doi.org/10.1371/journal.pone.0180405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665972	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608700005
J	Jonas, SF; Mbogning, C; Hassler, S; Broet, P				Jonas, Sarah Flora; Mbogning, Cyprien; Hassler, Signe; Broet, Philippe			A score test for comparing cross-sectional survival data with a fraction of non-susceptible patients and its application in clinical immunology	PLOS ONE			English	Article							PROPORTIONAL HAZARDS MODEL; FAILURE TIME DATA; MIXTURE-MODELS	Objectives In cross-sectional studies of time-to-event data collected by patient examinations at a single random point in time, a fraction of them will not experience the event regardless of the length of the follow-up time. This is the case in clinical immunology studies that include a mixed population, with both immune-reactive and immune-tolerant (or non-susceptible) patients. In these cases, classical tests of current status data may perform poorly. New methods for testing these data are needed. Methods In the two-sample comparison setting, we propose a score test for testing the null hypothesis that survival does not differ in either the non-susceptible fraction or the time-to-event distribution among the susceptible fraction. Results In a wide range of scenarios, simulation results show interesting improvements in power for the proposed score test compared to the logrank-type test in most of the configurations we investigated. In a cross-sectional study of drug immunogenicity among treated multiple sclerosis patients, the proposed score test reveals that gender is associated with the immunogenicity of interferon.	[Jonas, Sarah Flora; Mbogning, Cyprien; Hassler, Signe; Broet, Philippe] Univ Paris Saclay, Univ Paris Sud, UVSQ, CESP,INSERM, Villejuif, France; [Mbogning, Cyprien; Hassler, Signe; Broet, Philippe] Abirisk Consortium WP4, 14-16 Ave Paul Vaillant Couturier, Villejuif, France; [Broet, Philippe] Hop Paul Brousse, AP HP, 14-16 Ave Paul Vaillant Couturier, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Jonas, SF (corresponding author), Univ Paris Saclay, Univ Paris Sud, UVSQ, CESP,INSERM, Villejuif, France.	sarahflora.jonas@hotmail.fr	Jonas, Sarah Flora/K-2496-2019; Mbogning, Cyprien/AAI-1788-2020	Jonas, Sarah Flora/0000-0002-4346-1806; Mbogning, Cyprien/0000-0002-6619-3883; BROET, PHILIPPE/0000-0001-9122-2810	University Paris-Saclay; Innovative Medicines Initiative [115303]; European Union's Seventh Framework Programme; EFPIA; University Paris-Saclay (France)	University Paris-Saclay; Innovative Medicines Initiative; European Union's Seventh Framework Programme; EFPIA; University Paris-Saclay (France)	This work was supported by University Paris-Saclay (Miss Sarah Flora Jonas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge ABIRISK (Dr. Signe Hassler, Dr. Cyprien Mbogning). The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no [115303], resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution.; The research of the first author was supported by a grant from University Paris-Saclay (France).	ABIRISK, 2017, ANT BIOPH IMM PRED S; Bachelet D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162752; Cook RJ, 2008, STAT MED, V27, P2715, DOI 10.1002/sim.3102; Cooner F, 2007, J AM STAT ASSOC, V102, P560, DOI 10.1198/016214507000000112; Fay MP, 2010, J STAT SOFTW, V36, P1; Fay MP, 1996, BIOMETRICS, V52, P811, DOI 10.2307/2533044; FINKELSTEIN DM, 1986, BIOMETRICS, V42, P845, DOI 10.2307/2530698; Fleming T.R., 1991, COUNTING PROCESSES S; Gomez G., 2008, HARVARD U BIOSTATIST; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Kalbfleisch J. D., 1980, WILEY SERIES PROBABI; Leeuw Jd, 2009, J STAT SOFTWARE, V32; Maller RA, 1995, BIOMETRICS, V51, P1197, DOI 10.2307/2533253; Oller R, 2015, FHTEST TESTS RIGHT I; Peng Y, 2013, HDB SURVIVAL ANAL CH, P113; Rup B, 2015, CLIN EXP IMMUNOL, V181, P385, DOI 10.1111/cei.12652; Sun J., 2006, STAT BIOL HLTH; Sun JG, 2005, SCAND J STAT, V32, P49, DOI 10.1111/j.1467-9469.2005.00414.x; TAYLOR JMG, 1995, BIOMETRICS, V51, P899, DOI 10.2307/2532991; Tsodikov A, 1998, BIOMETRICS, V54, P1508, DOI 10.2307/2533675; Tsodikov AD, 2003, J AM STAT ASSOC, V98, P1063, DOI 10.1198/01622145030000001007; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; Yakovlev AY, 1996, SERIES MATH BIOLOGY, V1; Zhao Q, 2015, GLRT GENERALIZED LOG	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179896	10.1371/journal.pone.0179896	http://dx.doi.org/10.1371/journal.pone.0179896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665947	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608700044
J	An, JY; Park, BB; Chun, JH; Osawa, A				An, Ji Young; Park, Byung Bae; Chun, Jung Hwa; Osawa, Akira			Litterfall production and fine root dynamics in cool-temperate forests	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; GROUND CARBON ALLOCATION; SCOTS PINE STANDS; NORTHERN HARDWOOD; NITROGEN AVAILABILITY; DOUGLAS-FIR; BIOMASS; TURNOVER; SOIL; ECOSYSTEMS	Current understanding of litterfall and fine root dynamics in temperate forests is limited, even though these are the major contributors to carbon and nutrient cycling in the ecosystems. In this study, we investigated litterfall and fine root biomass and production in five deciduous and four coniferous forests at the Gwangneung Experimental Forest in Korea. We used ingrowth cores to measure fine root production and root turnover rate. The litterfall was separated into leaves, twigs, and others, and then leaves were further separated according to species. Annual litterfall mass was not significantly different between the years, 360 to 651 g m(-2) in 2011 and 300 to 656 g m(-2) in 2012. Annual fine root (<5 mm) production was significantly higher in 2012 (421 to 1342 g m(-2)) than in 2011 (99 to 872 g m(-2)). Annual litterfall mass was significantly different among the stands, while fine root production did not statistically differ among the stands. The average fine root turnover rate, calculated by dividing the annual fine root production by the maximum standing fine root biomass, was 1.65 for deciduous forests and 1.97 for coniferous forests. Fine root production constituted 18-44% of NPP, where NPP was the sum of woody biomass production, litterfall production, and fine root production. Belowground production was a greater fraction of NPP in more productive forests suggesting their greater carbon allocation belowground.	[An, Ji Young; Park, Byung Bae; Chun, Jung Hwa] Korea Forest Res Inst, Div Forest Ecol, Seoul, South Korea; [An, Ji Young; Osawa, Akira] Kyoto Univ, Div Forest & Biomat Sci, Kyoto, Japan; [Park, Byung Bae] Chungnam Natl Univ, Dept Environm & Forest Resources, Daejeon, South Korea	Korea Forest Research Institute (KFRI); Kyoto University; Chungnam National University	Park, BB (corresponding author), Korea Forest Res Inst, Div Forest Ecol, Seoul, South Korea.; Park, BB (corresponding author), Chungnam Natl Univ, Dept Environm & Forest Resources, Daejeon, South Korea.	bbpark@cnu.ac.kr		Park, Byung Bae/0000-0002-0620-7374; An, Ji Young/0000-0001-8573-0456	'R&D Program for Forest Science Technology [FTIS2014068E10-1719-AA01]; Korea Forest Service (Korea Forestry Promotion Institute)	'R&D Program for Forest Science Technology; Korea Forest Service (Korea Forestry Promotion Institute)(Korea Forest ServiceKorea Forestry Promotion Institute (KOFPI))	This study was partially carried out with the support of 'R&D Program for Forest Science Technology (Project No. FTIS2014068E10-1719-AA01)' provided by Korea Forest Service (Korea Forestry Promotion Institute), http://english.forest.go.kr/newkfsweb/eng/idx/Index.do?mn=ENG_01.	ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; Alvarez-Uria P, 2007, FUNCT ECOL, V21, P211, DOI 10.1111/j.1365-2435.2007.01231.x; [Anonymous], THESIS; Bremner J. M., 1996, Methods of soil analysis. Part 3 - chemical methods., P1085; BURKE MK, 1994, PLANT SOIL, V162, P135, DOI 10.1007/BF01416099; Chae N, 2011, J PLANT BIOL, V54, P101, DOI 10.1007/s12374-011-9148-9; Chen WJ, 2004, PLANT SOIL, V265, P31, DOI 10.1007/s11104-005-8503-3; Cho YC, 2007, J PLANT BIOL, V50, P615, DOI 10.1007/BF03030604; Chun Jung Hwa, 2007, Journal of Korean Forestry Society, V96, P591; Cox MS, 2001, SOIL SCI, V166, P484, DOI 10.1097/00010694-200107000-00006; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Fairley R. I., 1985, Ecological interactions in soil: plants, microbes and animals, P37; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; GOWER ST, 1987, BIOTROPICA, V19, P171, DOI 10.2307/2388741; GOWER ST, 1992, ECOL MONOGR, V62, P43, DOI 10.2307/2937170; Helmisaari HS, 2002, FOREST ECOL MANAG, V165, P317, DOI 10.1016/S0378-1127(01)00648-X; HENDRICK RL, 1993, CAN J FOREST RES, V23, P2507, DOI 10.1139/x93-312; Hendricks JJ, 2006, J ECOL, V94, P40, DOI 10.1111/j.1365-2745.2005.01067.x; Hishi T., 2015, Plant Root, V9, P85, DOI 10.3117/plantroot.9.85; Hwang J, 2007, J PLANT NUTR, V30, P1821, DOI 10.1080/01904160701628940; Im J-N, 2000, METHODS SOIL PLANT, P1; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Janssens IA, 2002, FOREST ECOL MANAG, V168, P231, DOI 10.1016/S0378-1127(01)00755-1; KEYES MR, 1981, CAN J FOREST RES, V11, P599, DOI 10.1139/x81-082; Kim J, 2006, ECOL RES, V21, P881, DOI 10.1007/s11284-006-0055-3; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Lee Dongho, 2007, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V9, P149; Leppalammi-Kujansuu J, 2014, FOREST ECOL MANAG, V326, P79, DOI 10.1016/j.foreco.2014.03.039; Li Z, 2003, CAN J FOREST RES, V33, P126, DOI 10.1139/X02-165; Lim J. H., 2003, KOREAN J AGR FOREST, V5, P101; Makkonen K, 2001, TREE PHYSIOL, V21, P193, DOI 10.1093/treephys/21.2-3.193; Makkonen K, 1999, PLANT SOIL, V210, P43, DOI 10.1023/A:1004629212604; McCormack ML, 2015, ECOL MODEL, V297, P107, DOI 10.1016/j.ecolmodel.2014.11.013; McCormack ML, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00205; Messier C., 1993, Silva Fennica, V27, P209; Nadelhoffer KJ, 2000, NEW PHYTOL, V147, P131, DOI 10.1046/j.1469-8137.2000.00677.x; NADELHOFFER KJ, 1985, ECOLOGY, V66, P1377, DOI 10.2307/1939190; NADELHOFFER KJ, 1992, ECOLOGY, V73, P1139, DOI 10.2307/1940664; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Newman GS, 2006, ECOSYSTEMS, V9, P317, DOI 10.1007/s10021-006-0015-3; Noguchi K, 2007, J FOREST RES-JPN, V12, P83, DOI 10.1007/s10310-006-0262-3; Park BB, 2008, ECOSYSTEMS, V11, P325, DOI 10.1007/s10021-008-9126-3; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Ruess RW, 1996, CAN J FOREST RES, V26, P1326, DOI 10.1139/x26-148; SANTANTONIO D, 1987, CAN J FOREST RES, V17, P900, DOI 10.1139/x87-141; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Sierra CA, 2003, J TROP ECOL, V19, P599, DOI 10.1017/S0266467403003663; Smithwick EAH, 2014, ECOL MODEL, V291, P193, DOI 10.1016/j.ecolmodel.2014.07.023; Son Y, 2003, ECOL RES, V18, P339, DOI 10.1046/j.1440-1703.2003.00559.x; Sparks DL, 1996, SSSA BOOK SER; Steele SJ, 1997, TREE PHYSIOL, V17, P577; Sumner M. E., 1996, Methods of soil analysis. Part 3 - chemical methods., P1201; Tateno R, 2004, FOREST ECOL MANAG, V193, P297, DOI 10.1016/j.foreco.2003.11.011; Van Do T, 2015, ECOL RES, V30, P921, DOI 10.1007/s11284-015-1295-x; Trumbore SE, 2003, SCIENCE, V302, P1344, DOI 10.1126/science.1091841; VanDo T, 2015, TREES; VOGT K, 1991, TREE PHYSIOL, V9, P69, DOI 10.1093/treephys/9.1-2.69; Vogt K.A., 1991, TECHNIQUES APPROACHE, P477; Vogt KA, 1996, PLANT SOIL, V187, P159, DOI 10.1007/BF00017088; Vogt KA, 1998, DEV PLANT SOIL SCI, V82, P687; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; YIN XW, 1989, FOREST ECOL MANAG, V27, P159, DOI 10.1016/0378-1127(89)90105-9; Yuan ZY, 2013, ACTA OECOL, V48, P54, DOI 10.1016/j.actao.2013.01.009; Zak DR, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P372; Zhang HC, 2014, ECOL COMPLEX, V20, P240, DOI 10.1016/j.ecocom.2014.01.003; Zhou Y, 2014, PLANT SOIL, V374, P19, DOI 10.1007/s11104-013-1816-8	69	14	15	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180126	10.1371/journal.pone.0180126	http://dx.doi.org/10.1371/journal.pone.0180126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662215	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300108
J	Jeong, J; Park, S; An, HT; Kang, M; Ko, J				Jeong, Juyeon; Park, Sodam; An, Hyoung-Tae; Kang, Minsoo; Ko, Jesang			Small leucine zipper protein functions as a negative regulator of estrogen receptor a in breast cancer	PLOS ONE			English	Article							NUCLEAR RECEPTOR; CO-REPRESSOR; SUPERFAMILY; BINDING; SLZIP; GENE; TRANSCRIPTION; COACTIVATORS; COREGULATORS; INVOLVEMENT	The nuclear transcription factor estrogen receptor alpha (ER alpha) plays a critical role in breast cancer progression. ER alpha acts as an important growth stimulatory protein in breast cancer and the expression level of ER alpha is tightly related to the prognosis and treatment of patients. Small leucine zipper protein (sLZIP) functions as a transcriptional cofactor by binding to various nuclear receptors, including glucocorticoid receptor, androgen receptor, and peroxisome proliferator-activated receptor gamma. However, the role of sLZIP in the regulation of ER alpha and its involvement in breast cancer progression is unknown. We found that sLZIP binds to ER alpha and represses the transcriptional activity of ERa in ER alpha-positive breast cancer cells. sLZIP also suppressed the expression of ER alpha target genes. sLZIP disrupted the binding of ER alpha to the estrogen response element of the target gene promoter, resulting in suppression of cell proliferation. sLZIP is a novel co-repressor of ER alpha, and plays a negative role in ER alpha-mediated cell proliferation in breast cancer.	[Jeong, Juyeon; Park, Sodam; An, Hyoung-Tae; Kang, Minsoo; Ko, Jesang] Korea Univ, Div Life Sci, Seoul, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Div Life Sci, Seoul, South Korea.	jesangko@korea.ac.kr		An, Hyoung-Tae/0000-0002-0732-2083	Tunneling Nanotube Research Center through National Research Foundation of Korea (NRF) [NRF-2015R1A5A1009024]; Korea government (MSIP)	Tunneling Nanotube Research Center through National Research Foundation of Korea (NRF); Korea government (MSIP)	This work was supported by Tunneling Nanotube Research Center (NRF-2015R1A5A1009024) through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP).	CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Giguere V, 1998, STEROIDS, V63, P335, DOI 10.1016/S0039-128X(98)00024-5; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hanstein B, 2004, EUR J ENDOCRINOL, V150, P243, DOI 10.1530/eje.0.1500243; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HENDERSON BE, 1988, CANCER RES, V48, P246; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Kang H, 2009, MOL ENDOCRINOL, V23, P1746, DOI 10.1210/me.2009-0009; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kim J, 2014, CELL DEATH DIFFER, V21, P1642, DOI 10.1038/cdd.2014.80; Kim J, 2014, FASEB J, V28, P5010, DOI 10.1096/fj.14-259218; Kim Y, 2015, ONCOGENE, V34, P226, DOI 10.1038/onc.2013.538; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Lu DS, 2001, CANCER RES, V61, P6755; Luciano RL, 2000, P NATL ACAD SCI USA, V97, P10757, DOI 10.1073/pnas.190062797; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; RIBEIRO RCJ, 1995, ANNU REV MED, V46, P443, DOI 10.1146/annurev.med.46.1.443; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sun JM, 2001, J BIOL CHEM, V276, P49435, DOI 10.1074/jbc.M108364200; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Xue H, 2016, INT J ONCOL, V49, P519, DOI 10.3892/ijo.2016.3576	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180197	10.1371/journal.pone.0180197	http://dx.doi.org/10.1371/journal.pone.0180197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662179	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608300124
J	Liu, YL; Lardi, M; Pedrioli, A; Eberl, L; Pessi, G				Liu, Yilei; Lardi, Martina; Pedrioli, Alessandro; Eberl, Leo; Pessi, Gabriella			NtrC-dependent control of exopolysaccharide synthesis and motility in Burkholderia cenocepacia H111	PLOS ONE			English	Article							ENHANCER-BINDING PROTEIN; ESCHERICHIA-COLI; BIOFILM FORMATION; SWARMING MOTILITY; PSEUDOMONAS-AERUGINOSA; CEPACIA COMPLEX; SIGMA-FACTOR; NITROGEN ASSIMILATION; BIOSYNTHESIS; SYSTEM	Burkholderia cenocepacia is a versatile opportunistic pathogen that survives in a wide variety of environments, which can be limited in nutrients such as nitrogen. We have previously shown that the sigma factor sigma(54) is involved in the control of nitrogen assimilation and virulence in B. cenocepacia H111. In this work, we investigated the role of the sigma(54) enhancer binding protein NtrC in response to nitrogen limitation and in the pathogenicity of H111. Of 95 alternative nitrogen sources tested the ntrC showed defects in the utilisation of nitrate, urea, L-citrulline, acetamide, DL-lactamide, allantoin and parabanic acid. RNA-Seq and phenotypic analyses of an ntrC mutant strain showed that NtrC positively regulates two important phenotypic traits: exopolysaccharide (EPS) production and motility. However, the ntrC mutant was not attenuated in C. elegans virulence.	[Liu, Yilei; Lardi, Martina; Pedrioli, Alessandro; Eberl, Leo; Pessi, Gabriella] Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland	University of Zurich	Eberl, L; Pessi, G (corresponding author), Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland.	leberl@botinst.uzh.ch; gabriella.pessi@botinst.uzh.ch	Eberl, Leo/AAE-8165-2019; Pessi, Gabriella/AGW-2342-2022; Eberl, Leo/A-8380-2012	Eberl, Leo/0000-0002-7241-0864; Pessi, Gabriella/0000-0002-8138-5541	Swiss National Science Foundation [31003A-169307/1, LEand31003A_153374]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (31003A-169307/1 to LEand31003A_153374 to GP).	Agnoli K, 2012, MOL MICROBIOL, V83, P362, DOI 10.1111/j.1365-2958.2011.07937.x; Ahn SJ, 2016, APPL ENVIRON MICROB, V82, P6189, DOI 10.1128/AEM.01499-16; AMES GFL, 1985, EMBO J, V4, P539, DOI 10.1002/j.1460-2075.1985.tb03662.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baker AE, 2016, J BACTERIOL, V198, P1837, DOI 10.1128/JB.00196-16; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Carlier A, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00298-14; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004; Cuzzi B, 2012, INNATE IMMUN-LONDON, V18, P661, DOI 10.1177/1753425911435954; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Deng YY, 2012, P NATL ACAD SCI USA, V109, P15479, DOI 10.1073/pnas.1205037109; Eberl L, 1996, J BACTERIOL, V178, P554, DOI 10.1128/jb.178.2.554-559.1996; Ferreira AS, 2007, APPL ENVIRON MICROB, V73, P524, DOI 10.1128/AEM.01450-06; Ferreira AS, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00016; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; Francke C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-385; Hervas AB, 2008, J BACTERIOL, V190, P416, DOI 10.1128/JB.01230-07; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; HIRSCHMAN J, 1985, P NATL ACAD SCI USA, V82, P7525, DOI 10.1073/pnas.82.22.7525; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Kim HS, 2009, MOL MICROBIOL, V74, P436, DOI 10.1111/j.1365-2958.2009.06875.x; Kuchma SL, 2015, J BACTERIOL, V197, P420, DOI 10.1128/JB.02130-14; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lardi M, 2015, APPL ENVIRON MICROB, V81, P4077, DOI 10.1128/AEM.00694-15; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; Moreira LM, 2003, BIOCHEM BIOPH RES CO, V312, P323, DOI 10.1016/j.bbrc.2003.10.118; MORETT E, 1989, J MOL BIOL, V210, P65, DOI 10.1016/0022-2836(89)90291-X; MORRIS L, 1994, J BIOL CHEM, V269, P11563; Nickzad A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01215; Nickzad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128509; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Pessi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072939; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pioszak AA, 2000, BIOCHEMISTRY-US, V39, P13450, DOI 10.1021/bi000795m; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; REITZER LJ, 1986, CELL, V45, P785, DOI 10.1016/0092-8674(86)90553-2; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Richau JA, 2000, J CLIN MICROBIOL, V38, P1651, DOI 10.1128/JCM.38.4.1651-1655.2000; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; Ruffing AM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-17; Saldias MS, 2008, INFECT IMMUN, V76, P1059, DOI 10.1128/IAI.01167-07; Shastri S, 2017, PLASMID, V89, P49, DOI 10.1016/j.plasmid.2016.11.002; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Wang D, 2013, APPL ENVIRON MICROB, V79, P7150, DOI 10.1128/AEM.02225-13; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658; Yang Y, 2015, SCIENCE, V349, P882, DOI 10.1126/science.aab1478; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	63	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180362	10.1371/journal.pone.0180362	http://dx.doi.org/10.1371/journal.pone.0180362			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662146	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300145
J	Liu, YZ; Sharp, JS; Do, DHT; Kahn, RA; Schwalbe, H; Buhr, F; Prestegard, JH				Liu, Yizhou; Sharp, Joshua S.; Do, Duc H-T.; Kahn, Richard A.; Schwalbe, Harald; Buhr, Florian; Prestegard, James H.			Mistakes in translation: Reflections on mechanism	PLOS ONE			English	Article							RARE ARGININE CODON; ESCHERICHIA-COLI; MESSENGER-RNA; ACID MISINCORPORATION; PROTEIN EXPRESSION; RIBOSOME; CONTEXT; LEVEL; GENE; DYNAMICS	Mistakes in translation of messenger RNA into protein are clearly a detriment to the recombinant production of pure proteins for biophysical study or the biopharmaceutical market. However, they may also provide insight into mechanistic details of the translation process. Mistakes often involve the substitution of an amino acid having an abundant codon for one having a rare codon, differing by substitution of a G base by an A base, as in the case of substitution of a lysine (AAA) for arginine (AGA). In these cases one expects the substitution frequency to depend on the relative abundances of the respective tRNAs, and thus, one might expect frequencies to be similar for all sites having the same rare codon. Here we demonstrate that, for the ADP-ribosylation factor from yeast expressed in E. coli, lysine for arginine substitutions frequencies are not the same at the 9 sites containing a rare arginine codon; mis-incorporation frequencies instead vary from less than 1 to 16%. We suggest that the context in which the codons occur (clustering of rare sites) may be responsible for the variation. The method employed to determine the frequency of mis-incorporation involves a novel mass spectrometric analysis of the products from the parallel expression of wild type and codon-optimized genes in N-15 and N-14 enriched media, respectively. The high sensitivity and low material requirements of the method make this a promising technology for the collection of data relevant to other mis-incorporations. The additional data could be of value in refining models for the ribosomal translation elongation process.	[Liu, Yizhou; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Sharp, Joshua S.] Univ Mississippi, Dept BioMol Sci, Oxford, MS USA; [Do, Duc H-T.] Univ Georgia, Dept Food Sci & Technol, Athens, GA 30602 USA; [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Schwalbe, Harald; Buhr, Florian] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt, Germany; [Liu, Yizhou] Merck & Co Inc, Proc & Analyt Res & Dev, NMR Struct Elucidat Grp, Rahway, NJ 07065 USA; [Buhr, Florian] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge, England	University System of Georgia; University of Georgia; University of Mississippi; University System of Georgia; University of Georgia; Emory University; Goethe University Frankfurt; Merck & Company; University of Cambridge	Prestegard, JH (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	jpresteg@ccrc.uga.edu	Kahn, Richard/ABD-2666-2020; Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010	Kahn, Richard/0000-0002-0259-0601; Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909; Prestegard, James/0000-0002-1602-4790	National Institute of General Medical Sciences [GM061268]; EU; state of Hesse, Germany; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122568] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EU(European Commission); state of Hesse, Germany; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially funded by a grant from the National Institute of General Medical Sciences to JHP, GM061268. FB was funded by EU Programme iNEXT. Work supervised by HS was funded by the state of Hesse, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021035; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; Chen CL, 2013, NAT STRUCT MOL BIOL, V20, P582, DOI 10.1038/nsmb.2544; Chen J, 2016, Q REV BIOPHYS, V49, DOI 10.1017/S0033583516000056; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Fagan CE, 2013, P NATL ACAD SCI USA, V110, P9716, DOI 10.1073/pnas.1301585110; Forman MD, 1998, PROTEIN SCI, V7, P500; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Harris RP, 2014, CURR OPIN BIOTECH, V30, P45, DOI 10.1016/j.copbio.2014.05.003; Huang YP, 2012, PROTEIN SCI, V21, P625, DOI 10.1002/pro.2046; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Kerrigan JJ, 2008, PROTEIN EXPRES PURIF, V60, P110, DOI 10.1016/j.pep.2008.02.016; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ogle JM, ANN REV BIOCH, P129; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pasa-Tolic L, 1999, J AM CHEM SOC, V121, P7949, DOI 10.1021/ja991063o; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Rodnina MV, 2016, PROTEIN SCI, V25, P1390, DOI 10.1002/pro.2950; Rudorf S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134994; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; SEETHARAM R, 1988, BIOCHEM BIOPH RES CO, V155, P518, DOI 10.1016/S0006-291X(88)81117-3; SIEMION IZ, 1994, BIOSYSTEMS, V33, P139, DOI 10.1016/0303-2647(94)90053-1; Vieira JP, 2016, BIOPHYS J, V110, P2120, DOI 10.1016/j.bpj.2016.04.004; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Wilson DN, 2016, CURR OPIN STRUC BIOL, V37, P123, DOI 10.1016/j.sbi.2016.01.008; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Xie T, 1998, FEBS LETT, V434, P93; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhang JJ, 2015, P NATL ACAD SCI USA, V112, P9602, DOI 10.1073/pnas.1506823112; Zouridis H, 2008, BIOPHYS J, V95, P1018, DOI 10.1529/biophysj.107.126128	35	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180566	10.1371/journal.pone.0180566	http://dx.doi.org/10.1371/journal.pone.0180566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662217	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300166
J	Loiselle, JJ; Roy, JG; Sutherland, LC				Loiselle, Julie J.; Roy, Justin G.; Sutherland, Leslie C.			RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR GENE; OXIDATIVE-PHOSPHORYLATION; DIFFERENTIAL EXPRESSION; SPLICING REGULATION; PARKINSONS-DISEASE; BREAST-CANCER; SIGNATURES; 3P21.3; ADENOCARCINOMA	Lung cancers are the leading cause of cancer-related deaths worldwide, with small cell lung cancer (SCLC) being the most aggressive type. At the time of diagnosis, SCLC has usually already metastasized, and an astonishing 95% of patients eventually succumb to the disease. This highlights the need for more effective SCLC screening and treatment options. Interestingly, the earliest and most frequent genetic alteration associated with lung cancers involves a lesion in the region to which the RNA binding protein RBM5 maps. We have recently shown that a decrease in RBM5 expression may be a key step in SCLC development, as RBM5 regulated many transformation-associated processes in SCLC cells. RBM5 is structurally and functionally similar to another RNA binding protein, RBM10. Both proteins have tumor-suppressor properties in a variety of cancer cell lines, and it has been suggested that RBM5 expression can influence RBM10. Due to their similarities, and the recent evidence that RBM10 is mutated in up to 21% of lung cancers, we hypothesized that RBM10 would share RBM5' s tumor-suppressor properties in SCLC. Using transcriptome analysis and functional assays, we show, however, that RBM10' s function was opposite to what we hypothesized; in the endogenously RBM5-null GLC20 SCLC cell line, RBM10 actually promoted cell proliferation and other transformation-associated processes. Using RNA immunoprecipitation followed by next generation sequencing (RIP-Seq) and Western blotting, we demonstrate that RBM5 post-transcriptionally regulated RBM10 expression via direct interaction with specific RBM10 splice variants. We propose a working model describing the impact of this interaction on cellular processes. Our results provide evidence that RBM10 expression, in RBM5-null tumors, may contribute to tumor growth and metastasis. Measurement of both RBM10 and RBM5 expression in clinical samples may therefore hold prognostic and/or potentially predictive value.	[Loiselle, Julie J.; Sutherland, Leslie C.] Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada; [Roy, Justin G.; Sutherland, Leslie C.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada; [Sutherland, Leslie C.] HSNRI, Sudbury, ON, Canada	Laurentian University; Laurentian University; Health Sciences North	Loiselle, JJ (corresponding author), Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada.	jloiselle@hsnri.ca			Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC); Natural Sciences and Engineering Research Council of Canada (NSERC) [9043429]	Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC) (JJL) (http://www.nserc-crsng.gc.ca/Students- Etudiants/PG-CS/BellandPostgradB elletSuperieures_eng.asp). Discovery Grant #9043429 from the Natural Sciences and Engineering Research Council of Canada (NSERC) (LCS) (http://www.nserc-crsng.gc.ca/ProfessorsP rofesseurs/Grants-Subs/DGIGP-PSIGP_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Biffi A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.141; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chute JP, 1999, J CLIN ONCOL, V17, P1794, DOI 10.1200/JCO.1999.17.6.1794; D'Andrea D, 2013, NUCLEIC ACIDS RES, V41, pW84, DOI 10.1093/nar/gkt516; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Del Fabbro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085024; Dey D, 2013, LUPUS, V22, P919, DOI 10.1177/0961203313497118; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Finsterer J, 2001, NEURORADIOLOGY, V43, P997, DOI 10.1007/s002340100618; Forsyth CB, 2010, ALCOHOL CLIN EXP RES, V34, P19, DOI 10.1111/j.1530-0277.2009.01061.x; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Garrisi VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112025; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GORLIN RJ, 1970, AM J DIS CHILD, V119, P176, DOI 10.1001/archpedi.1970.02100050178020; Gu Shuo, 2010, Silence, V1, P11, DOI 10.1186/1758-907X-1-11; Hernandez J, 2016, RNA BIOL, V13, P466, DOI 10.1080/15476286.2016.1144004; HUNG J, 1995, JAMA-J AM MED ASSOC, V273, P1908; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inoue A, 2014, FEBS LETT, V588, P942, DOI 10.1016/j.febslet.2014.01.052; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jackson TC, 2015, J CEREBR BLOOD F MET, V35, P655, DOI 10.1038/jcbfm.2014.242; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; James CG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-205; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-576; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kurpinski KT, 2003, AM J MED GENET A, V120A, P1, DOI 10.1002/ajmg.a.10201; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lerman MI, 2000, CANCER RES, V60, P6116; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Loiselle JJ, 2015, IN VITRO CELL DEV BI; Loiselle JJ, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00204; Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147; Martinez-Arribas F, 2006, J CELL BIOCHEM, V97, P1275, DOI 10.1002/jcb.20725; Miller G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-62; Mueller CFH, 2009, ARCH BIOCHEM BIOPHYS, V488, P76, DOI 10.1016/j.abb.2009.06.002; Oh JJ, 2002, CANCER RES, V62, P3207; Ozuemba B, 2016, GENE, V580, P26, DOI 10.1016/j.gene.2015.12.070; Peng J, 2013, ONCOL LETT, V5, P1000, DOI 10.3892/ol.2012.1080; Qiu TH, 2004, CANCER RES, V64, P5973, DOI 10.1158/0008-5472.CAN-04-0242; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; ROBIN ED, 1984, J CELL PHYSIOL, V118, P287, DOI 10.1002/jcp.1041180311; Rodor J, 2017, RNA BIOL, V14, P45, DOI 10.1080/15476286.2016.1247148; SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304; SMIT EF, 1992, INT J CANCER, V51, P72, DOI 10.1002/ijc.2910510115; Smith KS, 2015, NUCLEIC ACIDS RES, V43, P5307, DOI 10.1093/nar/gkv419; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Tessier Sarah J, 2015, BMC Res Notes, V8, P46, DOI 10.1186/s13104-015-0983-5; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vinayanuwattikun C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31628; Wang Ke, 2012, J Cell Death, V5, P1, DOI 10.4137/JCD.S9073; Wang YB, 2013, EMBO MOL MED, V5, P1431, DOI 10.1002/emmm.201302663; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Welling DB, 2002, OTOL NEUROTOL, V23, P736, DOI 10.1097/00129492-200209000-00022; Wistuba II, 2000, CANCER RES, V60, P1949; Xiong Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep06347; Yamada H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146593; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhao JW, 2017, SCI REP-UK, V7, DOI 10.1038/srep40488; Zhao LJ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-247; Zheng SK, 2013, GENOME RES, V23, P998, DOI 10.1101/gr.147546.112; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	76	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180258	10.1371/journal.pone.0180258	http://dx.doi.org/10.1371/journal.pone.0180258			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662214	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300134
J	Hegazi, NA; Sarhan, MS; Fayez, M; Patz, S; Murphy, BR; Ruppel, S				Hegazi, Nabil A.; Sarhan, Mohamed S.; Fayez, Mohamed; Patz, Sascha; Murphy, Brian R.; Ruppel, Silke			Plant-fed versus chemicals-fed rhizobacteria of Lucerne: Plant-only teabags culture media not only increase culturability of rhizobacteria but also recover a previously uncultured Lysobacter sp., Novosphingobium sp and Pedobacter sp	PLOS ONE			English	Article							GEL-ELECTROPHORESIS ANALYSIS; MEDICAGO-SATIVA; BACTERIAL COMMUNITIES; SOIL BACTERIA; GROWTH-MEDIUM; DIVERSITY; CULTIVATION; ACIDOBACTERIA; POPULATIONS; SIZE	In an effort to axenically culture the previously uncultivable populations of the rhizobacteria of Lucerne (Medicago sativa L.), we propose plant-only teabags culture media to mimic the nutritional matrix available in the rhizosphere. Here, we show that culture media prepared from Lucerne powder teabags substantially increased the cultivability of Lucerne rhizobacteria compared with a standard nutrient agar, where we found that the cultivable populations significantly increased by up to 60% of the total bacterial numbers as estimated by Quantitative Real-time Polymerase Chain Reaction (qRT-PCR). Cluster analysis of 16S rDNA Polymerase Chain Reaction-Denaturing Gradient Gel Electrophoresis (PCR-DGGE) of cultivable Colony-Forming Units (CFUs) revealed a more distinct composition and separation of bacterial populations recovered on the plant-only teabags culture media than those developed on a standard nutrient agar. Further, the new plant medium gave preference to the micro-symbiont Sinorhizobium meliloti, and succeeded in isolating a number of not-yet-cultured bacteria, most closely matched to Novosphingobium sp., Lysobacter sp. and Pedobacter sp. The present study may encourage other researchers to consider moving from the well-established standard culture media to the challenging new plant-only culture media. Such a move may reveal previously hidden members of rhizobacteria, and help to further explore their potential environmental impacts.	[Hegazi, Nabil A.; Sarhan, Mohamed S.; Fayez, Mohamed] Cairo Univ, Environm Studies & Res Unit, Dept Microbiol, Fac Agr, Giza, Egypt; [Patz, Sascha; Ruppel, Silke] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Grossbeeren, Germany; [Murphy, Brian R.] Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin, Ireland	Egyptian Knowledge Bank (EKB); Cairo University; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Trinity College Dublin	Hegazi, NA (corresponding author), Cairo Univ, Environm Studies & Res Unit, Dept Microbiol, Fac Agr, Giza, Egypt.	hegazinabil8@gmail.com	Sarhan, Mohamed/ABA-2586-2021; Sarhan, Mohamed S./AAI-6492-2020	Sarhan, Mohamed/0000-0003-0904-976X; Patz, Sascha/0000-0002-3385-8922; Murphy, Brian R./0000-0002-3771-5283	Cairo University; Alexandervon Humboldt Stiftung; Leibniz institut fur gemuse und zierpflanzenbau	Cairo University(Cairo University); Alexandervon Humboldt Stiftung(Alexander von Humboldt Foundation); Leibniz institut fur gemuse und zierpflanzenbau	This study was supported by Cairo University, Alexandervon Humboldt Stiftung, and Leibniz institut fur gemuse und zierpflanzenbau.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annicchiarico P, 2015, CRIT REV PLANT SCI, V34, P327, DOI 10.1080/07352689.2014.898462; Atlas R. M., 2004, Handbook of microbiological media; Bai Y, 2015, NATURE, V528, P364, DOI 10.1038/nature16192; Carelli M, 2000, APPL ENV MICROBIOL, V66; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; Choi EJ, 2015, CHEM BIOL, V22, P1270, DOI 10.1016/j.chembiol.2015.07.014; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Dunbar J, 1999, APPL ENVIRON MICROB, V65, P1662; El Khalloufi F, 2016, SCI TOTAL ENVIRON, V539, P135, DOI 10.1016/j.scitotenv.2015.08.127; George IF, 2011, APPL ENVIRON MICROB, V77, P8184, DOI 10.1128/AEM.05956-11; Hegazi NA, 1998, DEV PLANT SOIL SCI, V79, P247; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Katsaveli K, 2012, EXTREMOPHILES, V16, P285, DOI 10.1007/s00792-012-0429-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; LEDERBERG J, 1952, J BACTERIOL, V63, P399, DOI 10.1128/JB.63.3.399-406.1952; Mielmann A, 2017, S AFR J BOT, V108, P8, DOI 10.1016/j.sajb.2016.09.006; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Muurholm S, 2007, INT J SYST EVOL MICR, V57, P2221, DOI 10.1099/ijs.0.65166-0; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nour EH, 2012, J ADV RES, V3, P35, DOI 10.1016/j.jare.2011.03.002; OLSEN RA, 1987, MICROB ECOL, V13, P59, DOI 10.1007/BF02014963; Ong M, 2016, PREP BIOCHEM BIOTECH, V46, P657, DOI 10.1080/10826068.2015.1135447; Peakall R, 2005, BIOINFORMATICS, V502, P1; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; Pini F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-78; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Sarhan MS, 2016, PHYSIOL PLANTARUM, V157, P403, DOI 10.1111/ppl.12469; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Schoenborn L, 2004, APPL ENVIRON MICROB, V70, P4363, DOI 10.1128/AEM.70.7.4363-4366.2004; Schwieger F, 2000, APPL ENVIRON MICROB, V66, P3556, DOI 10.1128/AEM.66.8.3556-3565.2000; Sharma AR, 2003, CHARACTERIZATION ROO; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Nunez EV, 2012, APPL SOIL ECOL, V61, P113, DOI 10.1016/j.apsoil.2012.04.005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watson RJ, 2001, APPL ENVIRON MICROB, V67, P3767, DOI 10.1128/AEM.67.8.3767-3770.2001; Yin H., 2010, THESIS; Youssef HH, 2016, J ADV RES, V7, P305, DOI 10.1016/j.jare.2015.07.005; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999	42	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180424	10.1371/journal.pone.0180424	http://dx.doi.org/10.1371/journal.pone.0180424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686606	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100063
J	Bernabe, B; Gonzalez-Rivera, MD; Campos-Izquierdo, A				Bernabe, Beatriz; Dolores Gonzalez-Rivera, Maria; Campos-Izquierdo, Antonio			The evaluation and planning method of Spanish sport and physical activity instructors: A comparative study across gender, age, level of studies and work experience	PLOS ONE			English	Article							ELITE COACHES; KNOWLEDGE	The purpose of this study is to investigate the planning and the evaluation of Spanish sport and physical activity instructors as well as to analyze and compare the two variables in terms of their gender, age, level of studies and work experience. This research falls inside the quantitative type methodology of descriptive cut through standardized interview using the standardized questionnaire: "Human resources of sport and physical activity". It analyses the situation and performance of people working in functions of sport and physical activity. The questionnaire was completed by 600 sport and physical activity instructors from Spain. Key results revealed that 48.0% of them plan their classes and 58.17% assess. The study also found male university graduates between the ages of 60 and 70, with 10 years of experience or more spend the most time on planning and assessment. Daily classroom observation was the tool which physical activity and sport instructors used the most, followed by execution tests. The lesser used tools were theoretical knowledge exams, diaries and the personally created tests, across all of the variables.	[Bernabe, Beatriz; Campos-Izquierdo, Antonio] Tech Univ Madrid, Fac Sport & Phys Activ Sci INEF, Madrid, Spain; [Dolores Gonzalez-Rivera, Maria] Univ Alcala De Henares, Fac Med & Hlth Sci, Madrid, Spain	Universidad Politecnica de Madrid; Facultad de Ciencias de la Actividad Fisica del Deporte (INEF); Universidad de Alcala	Bernabe, B (corresponding author), Tech Univ Madrid, Fac Sport & Phys Activ Sci INEF, Madrid, Spain.	beatriz_bm2@hotmail.com	González-Rivera, María Dolores/ABC-9619-2021		Ministry of Science and Innovation of Spain;  [I+D+i DEP2009-12828]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	The research presented here is part of the fundamental research project: I+D+i DEP2009-12828. The project was funded by the Ministry of Science and Innovation of Spain. The authors gratefully acknowledge them and all the sport and physical activity instructors who have agreed to answer the survey.	Bernabe B, 2016, S AFR J RES SPORT PH, V38, P1; Blazquez D., 1990, EVALUAR EDUCACION FI; Bryman A., 2013, SOCIAL RES METHODS; Buceta JM, 2004, ESTRATEGIAS PSICOLOG; Campos-Izquierdo A., 2004, THESIS; Campos-Izquierdo A, 2011, ACTIVIDAD FISICA DEP, V15, P53; Campos-Izquierdo A, 2016, EUR SPORT MANAG Q, V16, P106, DOI 10.1080/16184742.2015.1108990; Carreras JC, 2010, NUEVAS TENDENCIAS ED; Cea MA, 2010, METHODOS ENCUESTA TE; Cregan K, 2007, RES Q EXERCISE SPORT, V78, P339; Cushion CJ, 2013, PHYS EDUC SPORT PEDA, V11, P83; Di Cola G., 2006, SCOREBOARD YOUTH EMP; Diaz J., 2005, EVALUACION FORMATIVA; Dorgo S, 2009, INT J SPORTS SCI COA, V4, P17, DOI 10.1260/1747-9541.4.1.17; Fink A., 1995, SAMPLE SURVEYS; Franks I. M., 1988, J TEACH PHYS EDUC, V8, P23; Garcia M., 2002, ANALISIS REALIDAD SO, P167; Gilbert WD, 2001, J TEACH PHYS EDUC, V21, P16, DOI 10.1123/jtpe.21.1.16; Gonzalez MD, 2010, REV PSICODIDACT, V15, P101; Kidman L, 2011, COACHING PROCESS: A PRACTICAL GUIDE TO BECOMING AN EFFECTIVE SPORTS COACH, 3RD EDITION, P1; Kravitz L, 2010, STRENGTH COND J, V32, P87, DOI 10.1519/SSC.0b013e3181def3d1; Kwon HH, 2010, J TEACH PHYS EDUC, V29, P131, DOI 10.1123/jtpe.29.2.131; Le Roux N, 1999, SPORT EMPLOYMENT EUR; Martinez G., 2007, THESIS; Moya SJ, 2007, REV PSICOL DEPORTE, V16, P185; Nash CS, 2011, RES Q EXERCISE SPORT, V82, P229; Nash CS, 2008, INT J SPORTS SCI COA, V3, P539, DOI 10.1260/174795408787186495; Olusoga P, 2012, J SPORT SCI, V30, P229, DOI 10.1080/02640414.2011.639384; Perez MC, 2002, REV PSICOL DEPORTE, V11, P9; Thomas J.R., 2011, RES METHODS PHYS ACT, Vsixth; Vallee CN, 2005, J APPL SPORT PSYCHOL, V17, P179, DOI 10.1080/10413200591010021; Viciana J., 1999, LECT EDUCACION FISIC, V4, P1; Viciana J., 2002, PLANIFICAR EDUCACION; Wright C, 2012, INT J PERF ANAL SPOR, V12, P436, DOI 10.1080/24748668.2012.11868609	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180228	10.1371/journal.pone.0180228	http://dx.doi.org/10.1371/journal.pone.0180228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683081	gold, Green Submitted, Green Published			2022-12-27	WOS:000405335200020
J	Lebani, K; Jones, ML; Watterson, D; Ranzoni, A; Traves, RJ; Young, PR; Mahler, SM				Lebani, Kebaneilwe; Jones, Martina L.; Watterson, Daniel; Ranzoni, Andrea; Traves, Renee J.; Young, Paul R.; Mahler, Stephen M.			Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay	PLOS ONE			English	Article							ANTIGEN CAPTURE IMMUNOASSAY; MONOCLONAL-ANTIBODIES; NS1; DIAGNOSIS; SENSITIVITY; LIBRARY; TESTS; BLOOD; SERUM	The multidimensional nature of dengue virus (DENV) infections, which can be caused by four distinct serotypes of the virus, complicates the sensitivity of assays designed for the diagnosis of infection. Different viral markers can be optimally detected at different stages of infection. Of particular clinical importance is the early identification of infection, which is pivotal for disease management and the development of blood screening assays. Nonstructural protein 1 ( NS1) is an early surrogate marker of infection and its detection in serum coincides with detectable viraemia. The aim of this work was to isolate and characterise serotype-specific monoclonal antibodies that bind to NS1 for each of the four DENV serotypes. This was achieved using phage display and a subtractive biopanning strategy to direct the antibody selection towards serotype-specific epitopes. This antibody isolation strategy has advantages over immunisation techniques where it is difficult to avoid antibody responses to cross-reactive, immunodominant epitopes. Serotype specificity to recombinant antigen for each of the antibodies was confirmed by Enzyme Linked Immunosorbent Assay ( ELISA) and Surface Plasmon Resonance. Confirmation of binding to native DENV NS1 was achieved using ELISA and immunofluorescence assay on DENV infected Vero cells. No cross-reactivity with Zika or Kunjin viruses was observed. A previously isolated pan-reactive antibody that binds to an immunodominant epitope was able to pair with each of the serotype-specific antibodies in a sandwich ELISA, indicating that the serotype specific antibodies bind to epitopes which are all spatially distinct from the immunodominant epitope. These antibodies were suitable for use in a multiplexed assay for simultaneous detection and serotyping of DENV NS1 in human serum. This work demonstrates that phage display coupled with novel biopanning strategies is a valuable in vitro methodology for isolation of binders that can discern amongst antigens with high homology for diagnostic applicability.	[Lebani, Kebaneilwe; Jones, Martina L.; Mahler, Stephen M.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Jones, Martina L.; Young, Paul R.; Mahler, Stephen M.] Univ Queensland, ARC Training Ctr Biopharmaceut Innovat, Brisbane, Qld, Australia; [Watterson, Daniel; Traves, Renee J.; Young, Paul R.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Watterson, Daniel; Young, Paul R.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Ranzoni, Andrea] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Lebani, Kebaneilwe] Botswana Int Univ Sci & Technol, Dept Biol & Biotechnol Sci, Palapye, Botswana	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Queensland	Jones, ML (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.; Jones, ML (corresponding author), Univ Queensland, ARC Training Ctr Biopharmaceut Innovat, Brisbane, Qld, Australia.	martina.jones@uq.edu.au	Young, Paul R/A-6176-2010	Young, Paul R/0000-0002-2040-5190; mahler, stephen/0000-0003-2403-1437; Jones, Martina/0000-0002-5154-6017; Traves, Renee Joycelyn/0000-0003-4291-8699; Watterson, Daniel/0000-0001-5957-2853; Lebani, Kebaneilwe/0000-0001-8927-091X	Australian Research Council Linkage Grant; Australian Red Cross Blood Service	Australian Research Council Linkage Grant(Australian Research Council); Australian Red Cross Blood Service	This work was supported by an Australian Research Council Linkage Grant with project partner Australian Red Cross Blood Service. The Blood Service. The funders had no role in study design, data colloction and analysis,decision to publish, or preparation of the manuscript.	Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749; Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Bessoff K, 2010, CLIN VACCINE IMMUNOL, V17, P949, DOI 10.1128/CVI.00041-10; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Bock G., 2006, NEW TREATMENT STRATE; Cabezas S, 2008, J VIROL METHODS, V147, P235, DOI 10.1016/j.jviromet.2007.09.001; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Codamo J, 2011, J CHEM TECHNOL BIOT, V86, P923, DOI 10.1002/jctb.2572; Das S, 2008, J CLIN MICROBIOL, V46, P3276, DOI 10.1128/JCM.00163-08; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Ding XX, 2011, CLIN VACCINE IMMUNOL, V18, P430, DOI 10.1128/CVI.00462-10; FALCONAR AKI, 1991, J GEN VIROL, V72, P961, DOI 10.1099/0022-1317-72-4-961; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; Halstead S. B, 2008, DENGUE; Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Jones ML, 2017, MOLECULES, V22, DOI 10.3390/molecules22040607; Jones ML, 2010, J IMMUNOL METHODS, V354, P85, DOI 10.1016/j.jim.2010.02.001; Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183; Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08; Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738; Ranzoni A, 2015, ANAL CHEM, V87, P6150, DOI 10.1021/acs.analchem.5b00762; Rathakrishnan Anusyah, 2013, Expert Opin Med Diagn, V7, P99, DOI 10.1517/17530059.2012.718759; Sanjaya KC, 2015, BIOSENS BIOELECTRON, V67, P769, DOI 10.1016/j.bios.2014.09.048; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461; Tezuka K, 2016, TRANSFUSION, V56, P3094, DOI 10.1111/trf.13875; Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000	37	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180669	10.1371/journal.pone.0180669	http://dx.doi.org/10.1371/journal.pone.0180669			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683141	Green Published, Green Submitted, gold			2022-12-27	WOS:000405335200059
J	Gupta, P; Martin, R; Knolker, HJ; Nihalani, D; Sinha, DK				Gupta, Prabuddha; Martin, Rene; Knoelker, Hans-Joachim; Nihalani, Deepak; Sinha, Deepak Kumar			Myosin-1 inhibition by PClP affects membrane shape, cortical actin distribution and lipid droplet dynamics in early Zebrafish embryos	PLOS ONE			English	Article							BLEBBISTATIN INHIBITION; XENOPUS-LAEVIS; CELL; CYTOSKELETON; CYTOKINESIS; PENTACHLOROPSEUDILIN; LOCALIZATION; TRAFFICKING; SPECIFICITY; EXOCYTOSIS	Myosin-1 (Myo1) represents a mechanical link between the membrane and actin-cytoskeleton in animal cells. We have studied the effect of Myo1 inhibitor PClP in 1-8 cell Zebrafish embryos. Our results indicate a unique involvement of Myo1 in early development of Zebrafish embryos. Inhibition of Myo1 (by PClP) and Myo2 (by Blebbistatin) lead to arrest in cell division. While Myo1 isoforms appears to be important for both the formation and the maintenance of cleavage furrows, Myo2 is required only for the formation of furrows. We found that the blastodisc of the embryo, which contains a thick actin cortex (similar to 13 mu m), is loaded with cortical Myo1. Myo1 appears to be crucial for maintaining the blastodisc morphology and the actin cortex thickness. In addition to cell division and furrow formation, inhibition of Myo1 has a drastic effect on the dynamics and distribution of lipid droplets (LDs) in the blastodisc near the cleavage furrow. All these results above are effects of Myo1 inhibition exclusively; Myo2 inhibition by blebbistatin does not show such phenotypes. Therefore, our results demonstrate a potential role for Myo1 in the maintenance and formation of furrow, blastodisc morphology, cell-division and LD organization within the blastodisc during early embryogenesis.	[Gupta, Prabuddha; Sinha, Deepak Kumar] IACS, Dept Biol Chem, Kolkata, India; [Martin, Rene; Knoelker, Hans-Joachim] Tech Univ Dresden, Dept Chem, Dresden, Germany; [Nihalani, Deepak] Med Univ South Carolina, Dept Med, Charleston, SC USA; [Gupta, Prabuddha] Amity Univ Kolkata, Kolkata, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; Technische Universitat Dresden; Medical University of South Carolina	Sinha, DK (corresponding author), IACS, Dept Biol Chem, Kolkata, India.	bcdks@iacs.res.in	Knölker, Hans-Joachim/I-4954-2019; nihalani, deepak/AAK-9453-2020	Knölker, Hans-Joachim/0000-0002-9631-5239; Gupta, Prabuddha/0000-0003-1009-2781	CSIR poolship [13 (8655-A)/2013-pool]; Department of Science and Technology, India [SB/S0/BB-101/2013]; Ramanujan fellowship [SR/S2/RJN-114/2011]; Department of Biotechnology, India [BT/PR6995/BRB/10/1140/2012]; Wellcome Trust-DBT of Dr B Sinha, IISER Kolkata [IA/I/13/1/500885]; National Institutes of Health, NIDDK [RO1 2R01DK087956-06A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956] Funding Source: NIH RePORTER	CSIR poolship; Department of Science and Technology, India(Department of Science & Technology (India)); Ramanujan fellowship(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Wellcome Trust-DBT of Dr B Sinha, IISER Kolkata; National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PG Acknowledge CSIR poolship 13 (8655-A)/2013-pool, also Drs Probhatand Pradip Kr Mallick memorial. DKS acknowledge Grant No SB/S0/BB-101/2013 (Department of Science and Technology, India), SR/S2/RJN-114/2011 (Ramanujan fellowship), BT/PR6995/BRB/10/1140/2012 (Department of Biotechnology, India). TIRF microscopy is funded by Grant no-IA/I/13/1/500885 (Wellcome Trust-DBT) of Dr B Sinha, IISER Kolkata. National Institutes of Health, NIDDK, grants RO1 2R01DK087956-06A1 to D.N. is duly acknowledged.	Alberts B, 2008, MOL BIOL CELL; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Arif E, 2013, KIDNEY INT, V84, P1154, DOI 10.1038/ki.2013.201; BLUEMINK JG, 1973, J CELL BIOL, V59, P89, DOI 10.1083/jcb.59.1.89; Brandstaetter H, 2014, AUTOPHAGY, V10, P2310, DOI 10.4161/15548627.2014.984272; Brandstaetter H, 2012, J CELL SCI, V125, P1991, DOI 10.1242/jcs.097212; Cheng J, 2012, MOL BIOL CELL, V23, P2891, DOI 10.1091/mbc.E11-04-0383; Chinthalapudi K, 2011, J BIOL CHEM, V286, P29700, DOI 10.1074/jbc.M111.239210; Coudrier Evelyne, 2011, Bioarchitecture, V1, P230; Danilchik MV, 2003, J CELL SCI, V116, P273, DOI 10.1242/jcs.00217; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Dutta A, 2015, SCI REPORTS, V5; Dzijak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030529; Eliyahu E, 2005, REPRODUCTION, V129, P161, DOI 10.1530/rep.1.00424; Field CM, 2011, J CELL SCI, V124, P2086, DOI 10.1242/jcs.082263; Fleming A, 2007, ZEBRAFISH ALTERNATIV; Gomez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031658; Greenberg MJ, 2015, P NATL ACAD SCI USA, V112, pE3337, DOI 10.1073/pnas.1506633112; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gupta Prabuddha, 2013, Biol Open, V2, P1288, DOI 10.1242/bio.20135827; Hart NH, 1995, CURR TOP DEV BIOL, V31, P343; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Ikegami R, 1999, DEV BIOL, V209, P409, DOI 10.1006/dbio.1999.9243; Joensuu M, 2014, MOL BIOL CELL, V25, P1111, DOI 10.1091/mbc.E13-12-0712; Kane DA, 2009, ESSENTIAL ZEBRAFISH, P11; Kittelberger N, 2016, J CELL SCI, V129, P1685, DOI 10.1242/jcs.181313; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Langley AR, 2014, DEVELOPMENT, V141, P3834, DOI 10.1242/dev.102368; Lee KW, 2003, INT J DEV BIOL, V47, P411; Li WM, 2008, DEV BIOL, V316, P228, DOI 10.1016/j.ydbio.2008.01.027; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Logue JS, 2015, ELIFE, V4, DOI 10.7554/eLife.08314; Marlow F., 2010, MAT CONTROL DEV VERT; Martin R, 2009, ANGEW CHEM INT EDIT, V48, P8042, DOI 10.1002/anie.200903743; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; McIntosh BB, 2016, J CELL SCI, V129, P2689, DOI 10.1242/jcs.186403; Mehta IS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r5; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Nair S, 2013, DEV DYNAM, V242, P44, DOI 10.1002/dvdy.23894; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Peterson Samuel M, 2009, J Vis Exp, DOI 10.3791/1470; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Prosperi MT, 2015, J CELL BIOL, V210, P347, DOI 10.1083/jcb.201501018; Rozbicki E, 2015, NAT CELL BIOL, V17, P397, DOI 10.1038/ncb3138; RUPPERT C, 1995, J CELL SCI, V108, P3775; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; SINGAL PK, 1974, CELL TISSUE RES, V154, P189; Sittaramane V, 2008, GENE EXPR PATTERNS, V8, P161, DOI 10.1016/j.gep.2007.10.010; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Topczewski J, 2009, ESSENTIAL ZEBRAFIS A, P133; Urven LE, 2006, J CELL SCI, V119, P4342, DOI 10.1242/jcs.03197; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wuhr M, 2011, METHOD CELL BIOL, V101, P1, DOI 10.1016/B978-0-12-387036-0.00001-3; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011	63	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180301	10.1371/journal.pone.0180301	http://dx.doi.org/10.1371/journal.pone.0180301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678859	Green Published, gold, Green Submitted			2022-12-27	WOS:000405272200049
J	Jiang, ZH; Hu, Y; Jiang, HY; Tong, JH				Jiang, Zhuohua; Hu, Yang; Jiang, Huanyu; Tong, Junhua			Design and force analysis of end-effector for plug seedling transplanter	PLOS ONE			English	Article								Automatic transplanters have been very important in greenhouses since the popularization of seedling nurseries. End-effector development is a key technology for transplanting plug seedlings. Most existing end-effectors have problems with holding root plugs or releasing plugs. An efficient end-effector driven by a linear pneumatic cylinder was designed in this study, which could hold root plugs firmly and release plugs easily. This end-effector with four needles could clamp the plug simultaneously while the needles penetrate into the substrate. The depth and verticality of the needles could be adjusted conveniently for different seedling trays. The effectiveness of this end-effector was tested by a combinational trial examining three seedling nursery factors (the moisture content of the substrate, substrate bulk density and the volume proportion of substrate ingredients). Results showed that the total transplanting success rate for the end-effector was 100%, and the root plug harm rate was below 17%. A force measure system with tension and pressure transducers was installed on the designed end-effector. The adhesive force FL between the root plug and the cell of seedling trays and the extrusion force FK on the root plug were measured and analyzed. The results showed that all three variable factors and their interactions had significant effects on the extrusion force. Each factor had a significant effect on adhesive force. Additionally, it was found that the end-effector did not perform very well when the value of FK/FL was beyond the range of 5.99 similar to 8.67. This could provide a scientific basis for end-effector application in transplanting.	[Jiang, Zhuohua; Hu, Yang; Jiang, Huanyu] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China; [Jiang, Huanyu] Minist Agr, Key Lab Equipment & Informatizat Environm Control, Hangzhou, Zhejiang, Peoples R China; [Tong, Junhua] Zhejiang Sci Tech Univ, Fac Mech Engn & Automat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang Sci-Tech University	Jiang, HY (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.; Jiang, HY (corresponding author), Minist Agr, Key Lab Equipment & Informatizat Environm Control, Hangzhou, Zhejiang, Peoples R China.	hyjiang@zju.edu.cn			National Nature Science Foundation of China [51275475]; Ministry of Agriculture of Chinas Introduction of Advanced International Agricultural Science and Technology [2011-G32]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of Chinas Introduction of Advanced International Agricultural Science and Technology	This work was supported by National Nature Science Foundation of China (51275475), URL: http://www.nsfc.gov.cn/, and The Ministry of Agriculture of Chinas Introduction of Advanced International Agricultural Science and Technology Project (2011-G32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beam SM, 1991, ASAE ANN INT M ST JO; Boudreault S, 2014, VADOSE ZONE J, P1; Chen J, 2004, ADV HORTICULTURE, V6, P410; Choi JM, 2012, HORTICULTURE ENV BIO, V53; Feng QingChun, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P21; Gao GuoHua, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P16; Han LuHua, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P24; Hu MinJuan, 2011, Acta Agriculturae Zhejiangensis, V23, P154; Idris M, 2004, FOREST ECOL MANAG, V195, P399, DOI 10.1016/j.foreco.2004.03.005; Jiang HuanYu, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P127; Jiang ZH, 2015, COMPUT ELECTRON AGR, V113, P225, DOI 10.1016/j.compag.2015.02.011; Kim K.D., 1995, P ARBIP, V95, P157; KUTZ LJ, 1987, T ASAE, V30, P586; Ryu KH, 2001, J AGR ENG RES, V78, P141, DOI 10.1006/jaer.2000.0656; SIMONTON W, 1991, T ASAE, V34, P2615, DOI 10.13031/2013.31914; Sun GuoXiang, 2010, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V41, P48; TAI YW, 1994, T ASAE, V37, P661, DOI 10.13031/2013.28127; TING KC, 1990, T ASAE, V33, P1013, DOI 10.13031/2013.31431; TING KC, 1992, IN VITRO CELL DEV-PL, V28P, P5; Tong JunHua, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P8; Wang Qiao, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P32; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; [周婷 ZHOU Ting], 2009, [机械设计与研究, Machine Design and Research], V25, P121	23	11	15	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180229	10.1371/journal.pone.0180229	http://dx.doi.org/10.1371/journal.pone.0180229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678858	gold, Green Submitted, Green Published			2022-12-27	WOS:000405272200041
J	Negi, S; Singh, H; Mukhopadhyay, A				Negi, Sapna; Singh, Harpreet; Mukhopadhyay, Anirban			Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In-silico study	PLOS ONE			English	Article							IGM ANTIBODIES; MICROBIOTA; PREDICTION; BARRIER	Recent evidences suggest that human gut microbiota with major component as bacteria can induce immunity. It is also known that gut lining depletes with ageing and that there is increased risk of autoimmune and inflammatory disorders with ageing. It is therefore likely that both may be correlated as depletion of gut lining exposes the gut bacterial antigens to host immune mechanisms, which may induce immunity to certain bacterial proteins, but at the same time such immunity may also be auto-immunogenic to host. This autoimmunity may make a protein molecule nonfunctional and thereby may be involved in late onset metabolic, autoimmune and inflammatory disorders such as, Diabetes, Rheumatoid Arthritis, Hyperlipidemias and Cancer. In this in-silico study we found a large number of peptides identical between human and gut bacteria which were binding to HLA-II alleles, and hence, likely to be auto-immunogenic. Further we observed that such autoimmune candidates were enriched in bacterial species belonging to Firmicutes and Proteobacteria phyla, which lead us to conclude that these phyla may have higher disease impact in genetically predisposed individuals. Functional annotation of human proteins homologous to candidate gut-bacterial peptides showed significant enrichment in metabolic processes and pathways. Cognitive trait, Ageing, Alzheimer, Type 2 diabetes, Chronic Kidney Failure (CKF), Chronic Obstructive Pulmonary Disease (COPD) and various Cancers were the major diseases represented in the dataset. This dataset provides us with gut bacterial autoimmune candidates which can be studied for their clinical significance in late onset diseases.	[Negi, Sapna] Natl Inst Pathol ICMR, Safdarjung Hosp Campus, New Delhi, India; [Singh, Harpreet] Indian Council Med Res ICMR Headquarter, Biomed Informat Ctr, New Delhi, India; [Mukhopadhyay, Anirban] Univ Delhi, Dept Genet, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); University of Delhi	Negi, S (corresponding author), Natl Inst Pathol ICMR, Safdarjung Hosp Campus, New Delhi, India.; Singh, H (corresponding author), Indian Council Med Res ICMR Headquarter, Biomed Informat Ctr, New Delhi, India.	negisapna@yahoo.com; hsingh@bmi.icmr.org.in	Negi, Sapna/HGA-5265-2022; Mukhopadhyay, Anirban/H-3220-2012	Singh, Harpreet/0000-0002-5838-1884				Bar F, 2013, CLIN EXP IMMUNOL, V172, P280, DOI 10.1111/cei.12047; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; D'Souza AL, 2007, POSTGRAD MED J, V83, P44, DOI 10.1136/pgmj.2006.049361; Dambroise E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23523; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Harmsen HJM, 2012, CLIN VACCINE IMMUNOL, V19, P515, DOI 10.1128/CVI.05517-11; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Lopez P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24072; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Man AL, 2014, CELL IMMUNOL, V289, P112, DOI 10.1016/j.cellimm.2014.04.001; Merchant HA, 2016, INT J PHARMACEUT, V512, P382, DOI 10.1016/j.ijpharm.2016.04.024; Morohoshi K, 2012, EXP MOL PATHOL, V92, P64, DOI 10.1016/j.yexmp.2011.09.017; Mrozinska S, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3876764; Newkirk MM, 2005, RHEUMATOLOGY, V44, P1433, DOI 10.1093/rheumatology/kei036; Packard TA, 2013, IMMUNOL RES, V55, P48, DOI 10.1007/s12026-012-8347-x; Paschke A, 2013, POL ARCH MED WEWN, V123, P401, DOI 10.20452/pamw.1831; Percival RS, 1996, FEMS IMMUNOL MED MIC, V15, P35, DOI 10.1111/j.1574-695X.1996.tb00356.x; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rigoni R, 2016, GUT MICROBES, V7, P503, DOI 10.1080/19490976.2016.1228517; Rogier R, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/527696; Saraswat A, J VACCINES VACCIN, V3, P141; Shamriz O, 2016, AUTOIMMUN REV, V15, P859, DOI 10.1016/j.autrev.2016.07.012; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Shiota S, 2010, FUTURE MICROBIOL, V5, P1885, DOI 10.2217/FMB.10.135; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Somers K, 2011, J AUTOIMMUN, V36, P33, DOI 10.1016/j.jaut.2010.10.003; Van Niel G, 2003, GUT, V52, P1690, DOI 10.1136/gut.52.12.1690; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Wu XH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030431; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914	38	24	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180518	10.1371/journal.pone.0180518	http://dx.doi.org/10.1371/journal.pone.0180518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678867	Green Published, Green Submitted, gold			2022-12-27	WOS:000405272200069
J	Chen, S; Zhu, YQ; Wayland, R				Chen, Si; Zhu, Yiqing; Wayland, Ratree			Effects of stimulus duration and vowel quality in cross-linguistic categorical perception of pitch directions	PLOS ONE			English	Article							SPEECH-PERCEPTION; LANGUAGE EXPERIENCE; LEXICAL TONES; ONSET TIME; DISCRIMINATION; IDENTIFICATION; MANDARIN; INTONATION; CONSONANTS; FREQUENCY	We investigated categorical perception of rising and falling pitch contours by tonal and nontonal listeners. Specifically, we determined minimum durations needed to perceive both contours and compared to those of production, how stimuli duration affects their perception, whether there is an intrinsic F0 effect, and how first language background, duration, directions of pitch and vowel quality interact with each other. Continua of fundamental frequency on different vowels with 9 duration values were created for identification and discrimination tasks. Less time is generally needed to effectively perceive a pitch direction than to produce it. Overall, tonal listeners' perception is more categorical than non-tonal listeners. Stimuli duration plays a critical role for both groups, but tonal listeners showed a stronger duration effect, and may benefit more from the extra time in longer stimuli for context-coding, consistent with the multistore model of categorical perception. Within a certain range of semitones, tonal listeners also required shorter stimulus duration to perceive pitch direction changes than non-tonal listeners. Finally, vowel quality plays a limited role and only interacts with duration in perceiving falling pitch directions. These findings further our understanding on models of categorical perception, the relationship between speech perception and production, and the interaction between the perception of tones and vowel quality.	[Chen, Si] Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Hong Kong, Peoples R China; [Zhu, Yiqing; Wayland, Ratree] Univ Florida, Dept Linguist, Gainesville, FL USA	Hong Kong Polytechnic University; State University System of Florida; University of Florida	Chen, S (corresponding author), Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Hong Kong, Peoples R China.	sarah.chen@polyu.edu.hk	Chen, Si/B-8601-2015	Chen, Si/0000-0003-3581-9561	Research Grants Council of the Hong Kong Special Administrative Region; Early Career Scheme [25602816]; Fund for ECS Project Rated 3.5 CRG Grant of Faculty of Humanities [G-YBGK]; Hong Kong Polytechnic University [1-ZVHJ]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Early Career Scheme; Fund for ECS Project Rated 3.5 CRG Grant of Faculty of Humanities; Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work was supported by the Research Grants Council of the Hong Kong Special Administrative Region; Funding scheme: Early Career Scheme (grant number: 25602816) (http:// www.ugc.edu.hk/eng/rgc/about/term/rgc.htm) and Fund for ECS Project Rated 3.5 CRG (grant number: G-YBGK) Grant of Faculty of Humanities, the Hong Kong Polytechnic University (grant number: 1-ZVHJ) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON AS, 1977, J ACOUST SOC AM, V61, pS66, DOI 10.1121/1.2015837; AINSWORTH WA, 1981, J PHONETICS, V9, P333, DOI 10.1016/S0095-4470(19)30976-3; Altmann CF, 2014, NEUROPSYCHOLOGIA, V64, P13, DOI 10.1016/j.neuropsychologia.2014.09.006; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bidelman GM, 2015, NEUROIMAGE, V120, P191, DOI 10.1016/j.neuroimage.2015.06.087; Burnham D, 2002, P 9 INT C SPEECH SCI; Casserly ED, 2010, WIRES COGN SCI, V1, P629, DOI 10.1002/wcs.63; DiCanio CT, 2012, J PHONETICS, V40, P672, DOI 10.1016/j.wocn.2012.05.003; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; DURLACH NI, 1969, J ACOUST SOC AM, V46, P372, DOI 10.1121/1.1911699; Eerola O, 2012, J PHONETICS, V40, P315, DOI 10.1016/j.wocn.2011.12.003; EIMAS PD, 1963, LANG SPEECH, V6, P206, DOI 10.1177/002383096300600403; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; Francis AL, 2003, PERCEPT PSYCHOPHYS, V65, P1029, DOI 10.3758/BF03194832; Francis AL, 2008, J PHONETICS, V36, P268, DOI 10.1016/j.wocn.2007.06.005; FRY DB, 1962, LANG SPEECH, V5, P171, DOI 10.1177/002383096200500401; Fujisaki H., 1970, Annual Report of the Engineering Research Institute, Faculty of Engineering, University of Tokyo, V29, P207; Fujisaki H., 1971, Annual Report of the Engineering Research Institute, Faculty of Engineering, University of Tokyo, V30, P59; Fujisaki H., 1969, Annual Report of the Engineering Research Institute, Faculty of Engineering, University of Tokyo, V28, P67; GANDOUR J, 1977, PHONETICA, V34, P54, DOI 10.1159/000259869; GANDOUR J, 1983, J PHONETICS, V11, P149, DOI 10.1016/S0095-4470(19)30813-7; Gandour J, 2000, J COGNITIVE NEUROSCI, V12, P207, DOI 10.1162/089892900561841; Gandour JT., 1984, THESIS; Halle A P, 2004, J PHONETICS, V32, P395; Hao YC, 2012, J PHONETICS, V40, P269, DOI 10.1016/j.wocn.2011.11.001; HOWARD D, 1992, MUSIC PERCEPT, V10, P205; Janse E, 2003, PRODUCTION PERCEPTIO; Jongman A, 2016, J ACOUST SOC AM, V140, P3225, DOI DOI 10.1121/1.4970184; Kaan E, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-53; Krishnan A, 2004, HEARING RES, V189, P1, DOI 10.1016/S0378-5955(03)00402-7; Kronrod Y, 2012, P 34 ANN C COGN SCI, P629; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; Kutner M., 2005, APPL LINEAR STAT MOD; Lehiste L., 1976, J PHONETICS, V4, P113, DOI DOI 10.1016/S0095-4470(19)31231-8; Lehnert-LeHouillier H., 2013, ORIGINS SOUND CHANGE, P98, DOI [10.1093/acprof:oso/9780199573745.003.0004, DOI 10.1093/ACPROF:OSO/9780199573745.003.0004]; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; LIBERMAN AM, 1996, SPEECH SPECIAL CODE; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; Liu L, 2017, LANGUAGE LINGUISTICS, V18; Macmillan NA, 2005, DETECTION THEORY USE; McMurray B, 2002, COGNITION, V86, pB33, DOI 10.1016/S0010-0277(02)00157-9; Meister E, 2009, LINGUIST URAL, V45, P161, DOI 10.3176/lu.2009.3.01; MOULINES E, 1995, SPEECH COMMUN, V16, P175, DOI 10.1016/0167-6393(94)00054-E; Niebuhr O., 2004, P INT C SPEECH PROS; Ohman S., 1979, FRONTIERS SPEECH COM, P127; Ortega-Llebaria M, 2017, BILING-LANG COGN, V20, P367, DOI 10.1017/S1366728915000723; Peng G, 2010, J PHONETICS, V38, P616, DOI 10.1016/j.wocn.2010.09.003; PISONI DB, 1973, PERCEPT PSYCHOPHYS, V13, P253, DOI 10.3758/BF03214136; PISONI DB, 1975, MEM COGNITION, V3, P7, DOI 10.3758/BF03198202; PISONI DB, 1977, J ACOUST SOC AM, V61, P1352, DOI 10.1121/1.381409; PISONI DB, 1976, J ACOUST SOC AM, V59, pS39, DOI 10.1121/1.2002669; Pisoni DB, 1971, THESIS; POLLACK I, 1971, PSYCHON SCI, V24, P299; Prom-on S, 2009, J ACOUST SOC AM, V125, P405, DOI 10.1121/1.3037222; Reetz H., 2009, PHONETICS TRANSCRIPT; Repp B., 1984, SPEECH LANGUAGE ADV, V10, P243, DOI [10.1016/B978-0-12-608610-2.50012-1, DOI 10.1016/B978-0-12-608610-2.50012-1]; REPP BH, 1979, J EXP PSYCHOL HUMAN, V5, P129, DOI 10.1037/0096-1523.5.1.129; SCHOUTEN MEH, 1992, J ACOUST SOC AM, V92, P1841, DOI 10.1121/1.403841; Sharma A, 1999, J ACOUST SOC AM, V106, P1078, DOI 10.1121/1.428048; So CK, 2010, LANG SPEECH, V53, P273, DOI 10.1177/0023830909357156; STAGRAY JR, 1993, J CHINESE LINGUIST, V21, P143; Stevens K.N., 1981, ADV PSYCHOL, DOI [10.1016/S0166-4115(08)60179-X, DOI 10.1016/S0166-4115(08)60179-X]; STOLL G, 1984, SPEECH COMMUN, V3, P137, DOI 10.1016/0167-6393(84)90035-9; STUDDERTKENNEDY M, 1970, PSYCHOL REV, V77, P234, DOI 10.1037/h0029078; TANNER WP, 1964, J ACOUST SOC AM, V36, P1465, DOI 10.1121/1.1919226; TREISMAN M, 1995, Q J EXP PSYCHOL-A, V48, P334, DOI 10.1080/14640749508401394; van Hessen AJ, 1999, PHONETICA, V56, P56, DOI 10.1159/000028441; Venables WN., 2002, MODERN APPL STAT S, V4; WANG WSY, 1976, ANN NY ACAD SCI, V280, P61, DOI 10.1111/j.1749-6632.1976.tb25472.x; WANG WSY, 1976, J ACOUST SOC AM, V60, pS92, DOI 10.1121/1.2003607; Wayland R, 2015, SCOTTISH CONSORTIUM; Wayland RP, 2004, LANG LEARN, V54, P681, DOI 10.1111/j.1467-9922.2004.00283.x; WERKER JF, 1985, PERCEPT PSYCHOPHYS, V37, P35, DOI 10.3758/BF03207136; WHALEN DH, 1995, J PHONETICS, V23, P349, DOI 10.1016/S0095-4470(95)80165-0; Wu H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00436; Xu Y, 2002, J ACOUST SOC AM, V111, P1399, DOI 10.1121/1.1445789; Xu Y, 2009, LINGUA, V119, P906, DOI 10.1016/j.lingua.2007.09.015; Xu YS, 2006, J ACOUST SOC AM, V120, P1063, DOI 10.1121/1.2213572; Yu A. C. L., 2010, LABORABORY PHONOLOGY, V10, P151, DOI DOI 10.1515/9783110224917.2.151; Yu AC, 2014, 4 INT S TON ASP LANG; Zhang C., 2013, EASTWARD FLOWS GREAT, P256, DOI DOI 10.1007/S10831-007-9016-2; Zhang CC, 2015, J NEUROLINGUIST, V33, P149, DOI 10.1016/j.jneuroling.2014.07.002	82	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180656	10.1371/journal.pone.0180656	http://dx.doi.org/10.1371/journal.pone.0180656			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA2JX	28671991	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500076
J	Guisier, F; Bohn, P; Patout, M; Piton, N; Farah, I; Vera, P; Thiberville, L; Salaun, M				Guisier, Florian; Bohn, Pierre; Patout, Maxime; Piton, Nicolas; Farah, Insaf; Vera, Pierre; Thiberville, Luc; Salaun, Mathieu			In-and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TYROSINE KINASE INHIBITORS; FLUORESCENCE MICROSCOPY; PULMONARY ASPERGILLOSIS; 1ST-LINE TREATMENT; OPEN-LABEL; ADENOCARCINOMA; CHEMOTHERAPY; ERLOTINIB; MUTATION	Background Prediction of treatment outcome of non-small cell lung cancer (NSCLC) with EGFR inhibitors on the basis of the genetic analysis of the tumor can be incorrect in case of rare or complex mutations, bypass molecular activation pathways, or pharmacodynamic variations. The aim of this study was to develop an ex vivo and in vivo real-time quantitative imaging test for EGFR inhibitors sensitivity assessment. Methods Erlotinib resistant (A549, H460, H1975), insensitive (H1650) and hypersensitive (HCC827) cell lines were injected subcutaneously in Nude mice. Tumor xenografts from mice treated with Erlotinib were imaged ex vivo and in vivo using probe-based confocal laser endomicroscopy (pCLE) and NucView 488 Caspase 3 substrate, a fluorescent probe specific for the activated caspase 3. Results Assessment of apoptosis at 24h post treatment, both ex vivo in explanted tumor xenografts and in vivo, showed a significant difference between resistant cell lines (A549, H460 and H1975) and insensitive (H1650) or hypersensitive (HCC827) ones (p< 0.05 for ex vivo imaging, p <= 0.02 for in vivo imaging). There was also a significant difference between insensitive and hypersensitive cell lines, both ex vivo (p< 0.05) and in vivo (p = 0.01). Conclusion Real-time in vivo and ex vivo assessment of apoptosis using pCLE differentiates resistant from sensitive NSCLC xenografts to Erlotinib.	[Guisier, Florian; Thiberville, Luc; Salaun, Mathieu] Rouen Univ Hosp, Dept Pulmonol Thorac Oncol & Resp Intens Care, Rouen, France; [Guisier, Florian; Thiberville, Luc; Salaun, Mathieu] Rouen Univ Hosp, CIC INSERM U1404, Rouen, France; [Guisier, Florian; Bohn, Pierre; Patout, Maxime; Farah, Insaf; Vera, Pierre; Thiberville, Luc; Salaun, Mathieu] Normandie Univ, UNIROUEN, LITIS, Quant IF EA 4108, Rouen, France; [Bohn, Pierre; Vera, Pierre] Henri Becquerel Canc Ctr, Nucl Med Dept, Rouen, France; [Bohn, Pierre; Vera, Pierre] Rouen Univ Hosp, Rouen, France; [Piton, Nicolas] Rouen Univ Hosp, Cytol & Pathol Dept, Rouen, France	CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Henri Becquerel; CHU de Rouen; CHU de Rouen	Salaun, M (corresponding author), Rouen Univ Hosp, Dept Pulmonol Thorac Oncol & Resp Intens Care, Rouen, France.; Salaun, M (corresponding author), Rouen Univ Hosp, CIC INSERM U1404, Rouen, France.; Salaun, M (corresponding author), Normandie Univ, UNIROUEN, LITIS, Quant IF EA 4108, Rouen, France.	mathieu.salaun@univ-rouen.fr	Patout, Maxime/AAH-9001-2019; Bohn, Pierre/AAO-8549-2020; SALAUN, Mathieu/M-3914-2019	Patout, Maxime/0000-0002-1366-8726; Bohn, Pierre/0000-0001-8972-9022; SALAUN, Mathieu/0000-0003-1430-6396; Piton, Nicolas/0000-0001-8779-586X; Guisier, Florian/0000-0002-8166-7303	ADIR Association and LaLigue Contrele Cancer	ADIR Association and LaLigue Contrele Cancer	This study was funded by ADIR Association and LaLigue Contrele Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2012, EUR J NUCL MED MOL I, V39, P1400, DOI 10.1007/s00259-012-2150-8; Aukema TS, 2010, J NUCL MED, V51, P1344, DOI 10.2967/jnumed.110.076224; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Becker S, 2015, NUCL MED BIOL, V42, P923, DOI 10.1016/j.nucmedbio.2015.08.002; Besse B, 2014, ANN ONCOL, V25, P1475, DOI 10.1093/annonc/mdu123; Blankenberg FG, 2012, J NUCL MED, V53, P1659, DOI 10.2967/jnumed.112.108944; Challapalli A, 2013, J NUCL MED, V54, P1551, DOI 10.2967/jnumed.112.118760; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lee JK, 2014, JAMA-J AM MED ASSOC, V311, P1430, DOI 10.1001/jama.2014.3314; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mohapatra PR, 2012, EUR RESPIR J, V39, P1550, DOI 10.1183/09031936.00022112; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morisse H, 2013, MED MYCOL, V51, P352, DOI 10.3109/13693786.2012.729138; Morisse H, 2012, MED MYCOL, V50, P386, DOI 10.3109/13693786.2011.617788; National Comprehensive Cancer Network (NCCN), 2015, NCCN CLIN PRACT GUID; Obstoy B, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0020-4; Pal A, 2006, MOL IMAGING BIOL, V8, P262, DOI 10.1007/s11307-006-0049-0; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Salaun M, 2010, EUR RESPIR J, V36, P451, DOI 10.1183/09031936.00194509; Salaun M, 2013, EUR RESPIR J, V42, P1646, DOI 10.1183/09031936.00191911; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sohn HJ, 2008, CLIN CANCER RES, V14, P7423, DOI 10.1158/1078-0432.CCR-08-0312; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; Thiberville L, 2010, EUR RESPIR J, V36, P451; Thiberville L, 2007, AM J RESP CRIT CARE, V175, P22, DOI 10.1164/rccm.200605-684OC; Thiberville Luc, 2009, Proc Am Thorac Soc, V6, P444, DOI 10.1513/pats.200902-009AW; Wu YL, 2013, J CLIN ONCOL, V31; Wu YL, 2015, ANN ONCOL; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yeh HH, 2011, P NATL ACAD SCI USA, V108, P1603, DOI 10.1073/pnas.1010744108; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	35	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180576	10.1371/journal.pone.0180576	http://dx.doi.org/10.1371/journal.pone.0180576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671975	gold, Green Published, Green Submitted			2022-12-27	WOS:000405268500071
J	Tang, L; Li, XT; Gao, Y; Chen, LY; Gu, LY; Chen, JW; Lyu, XJ; Zhang, Y; Zhang, X				Tang, Lu; Li, Xintao; Gao, Yu; Chen, Luyao; Gu, Liangyou; Chen, Jianwen; Lyu, Xiangjun; Zhang, Yu; Zhang, Xu			Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis	PLOS ONE			English	Review							TUMOR-SUPPRESSOR PROTEIN; PROGNOSTIC-SIGNIFICANCE; MAMMALIAN TARGET; CANCER; HETEROZYGOSITY; ACTIVATION; MUTATIONS; SURVIVAL; PATHWAY; PREDICT	The phosphatase and tensin homolog (PTEN) gene is suggested to be a dormant tumor suppressor. However, the prognostic value of the loss of PTEN expression in renal cell carcinoma (RCC) remains controversial. Therefore, we conducted a meta-analysis to evaluate the association of PTEN expression with the clinicopathological presentations and outcomes of patients with RCC through immunohistochemistry staining analysis. We systematically searched for relevant studies in PubMed, Web of Science, and Embase until March 2016. Data regarding clinical stage, pathological type, Fuhrman grade, overall survival (OS), progression-free survival (PFS), and disease-specific survival (DSS) was analyzed in the present study. In total, there were 12 studies with 2,368 patients included in this metaanalysis. The low PTEN expression in RCC was significantly associated with unfavorable DSS (HR = 1.568, 95% CI 1.015-2.242) in a random-effects model but not with OS (HR = 1.046, 95% CI 0.93-1.176) and PFS (HR = 1.244, 95% CI 0.907-1.704). Other results indicated that PTEN expression was not correlated with clinical stage, pathological type, and Fuhrman grade. This meta-analysis suggests that PTEN expression is of limited value in predicting the prognosis of patients with RCC for OS and PFS via immunohistochemistry staining analysis; and that for DSS, low PTEN expression is significantly associated with an unfavorable outcome.	[Tang, Lu; Li, Xintao; Gao, Yu; Chen, Luyao; Gu, Liangyou; Chen, Jianwen; Lyu, Xiangjun; Zhang, Yu; Zhang, Xu] Chinese PLA Med Acad, Dept Urol, State Key Lab Kidney Dis, Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Zhang, X (corresponding author), Chinese PLA Med Acad, Dept Urol, State Key Lab Kidney Dis, Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China.	xzhang@tjh.tjmu.edu.cn						Bose S, 2002, HUM PATHOL, V33, P405, DOI 10.1053/hupa.2002.124721; Brenner W, 2002, INT J CANCER, V99, P53, DOI 10.1002/ijc.10303; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chaux A, 2013, HUM PATHOL, V44, P2323, DOI 10.1016/j.humpath.2013.05.014; Chaux A, 2012, HUM PATHOL, V43, P2129, DOI 10.1016/j.humpath.2012.01.009; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Campos Eurico Cleto Ribeiro de, 2013, Rev. Col. Bras. Cir., V40, P471; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Downes CP, 2001, BIOCHEM SOC T, V29, P846, DOI 10.1042/BST0290846; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Hager M, 2007, PATHOLOGY, V39, P482, DOI 10.1080/00313020701570012; Hara S, 2005, ANN ONCOL, V16, P928, DOI 10.1093/annonc/mdi182; Kechagioglou P, 2014, ANTICANCER RES, V34, P1387; Kim HL, 2005, J UROLOGY, V173, P1496, DOI 10.1097/01.ju.0000154351.37249.f0; Kim HL, 2004, CLIN CANCER RES, V10, P5464, DOI 10.1158/1078-0432.CCR-04-0488; Lee HJ, 2014, J UROLOGY, V192, P940, DOI 10.1016/j.juro.2014.03.097; Lee JI, 2001, ARCH OTOLARYNGOL, V127, P1441, DOI 10.1001/archotol.127.12.1441; Lee JS, 2003, J SURG ONCOL, V84, P166, DOI 10.1002/jso.10302; Li YL, 2005, WORLD J GASTROENTERO, V11, P285, DOI 10.3748/wjg.v11.i2.285; Merseburger AS, 2008, UROL INT, V80, P372, DOI 10.1159/000132694; Minami A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00318; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Lopez CM, 2012, CLIN GENITOURIN CANC, V10, P262, DOI 10.1016/j.clgc.2012.06.005; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nishikawa M., 2014, UROL ONCOL, V32, DOI DOI 10.1016/J.UR0L0NC.2013.07.014; Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pantuck AJ, 2007, CANCER-AM CANCER SOC, V109, P2257, DOI 10.1002/cncr.22677; Park I, 2016, TUMOR BIOL, V37, P4919, DOI 10.1007/s13277-015-4339-5; Rasheed BKA, 1997, CANCER RES, V57, P4187; Salvesen HB, 2002, CANCER-AM CANCER SOC, V94, P2185, DOI 10.1002/cncr.10434; Schneider E, 2011, INT J ONCOL, V38, P823, DOI 10.3892/ijo.2010.893; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sun LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098851; Tachibana M, 2002, CANCER-AM CANCER SOC, V94, P1955, DOI 10.1002/cncr.0678; Tan MH, 2012, CLIN CANCER RES, V18, P400, DOI 10.1158/1078-0432.CCR-11-2283; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Velickovic M, 2002, MODERN PATHOL, V15, P479, DOI 10.1038/modpathol.3880551; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Wells GA, 2014, NEWCASTLEOTTAWA SCAL; Weng LP, 1999, CANCER RES, V59, P5808; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhu CY, 2015, INT J CLIN EXP PATHO, V8, P12668; Znaor A, 2015, EUR UROL, V67, P519, DOI 10.1016/j.eururo.2014.10.002	47	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179437	10.1371/journal.pone.0179437	http://dx.doi.org/10.1371/journal.pone.0179437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672019	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500002
J	Yaya, S; Bishwajit, G; Ekholuenetale, M; Shah, V; Kadio, B; Udenigwe, O				Yaya, Sanni; Bishwajit, Ghose; Ekholuenetale, Michael; Shah, Vaibhav; Kadio, Bernard; Udenigwe, Ogochukwu			Knowledge of prevention, cause, symptom and practices of malaria among women in Burkina Faso	PLOS ONE			English	Article							HOUSEHOLDS; BARRIERS; BEHAVIOR; CHILDREN; NETS	Background Malaria remains a major public health issue in most southern African countries as the disease remains hyper endemic. Burkina Faso continues to face challenges in the treatment of malaria, as the utilization of preventive measures remains low on a national scale. While it has been acknowledged that understanding women's health-seeking behaviours, perception of malaria and its preventive measures will aid in the control of malaria, there is paucity of information on Knowledge, Attitudes and Practices among women in the reproductive age of 15-49 years in Burkina Faso. This study investigated women's knowledge of malaria, attitudes towards malaria, and practices of malaria control in order to create a synergy between community efforts and governmental/non-governmental malaria control interventions in Burkina Faso. Methods The analysis used data from the 2014 Burkina Faso Malaria Indicator Survey (MIS). In total 8111 women aged between 15-49 years were included in the present study. We assessed women's knowledge about 1) preventive measures, 2) causes and 3) symptoms of malaria, as well as malaria prevention practices for their children and during pregnancy. The socio-demographic characteristics were considered for Age, Religion, Education, Wealth index, Number of household members, Sex of household head, Household possession of radio, TV and Received antenatal care. Data were analyzed using STATA, version 14. Associations between variables were tested using a Chi-square and logistic regression, with the level of statistical significance set at 95%. Results A preponderant proportion of respondents were aged 15-29 years (mean age was 28.63 +/- 9.41). About three-quarters of the respondents had no formal education. An estimated two-third of the participants were of Islamic faith, while access to media and behavioural communication were generally poor. The level of knowledge was 53% for rural women and 68.2% for urban dwellers. In sum, there was 56.1% level of accurate knowledge of malaria among women in Burkina Faso. In the multivariable logistic regression, women in rural location had 40% reduction in the odds of having accurate knowledge of malaria when compared to urban women (aOR = 0.60; 95%CI: 0.52-0.68). The educational level was a key factor in the knowledge of malaria. The odds of having accurate knowledge of malaria increased as the educational level increased, hence, women with secondary and higher education had 29% and 93% increase in the odds of having accurate knowledge of malaria when compared to the women without formal education. Results indicate that antenatal care (ANC) services were major sources of information on malaria. Women who reportedly received ANC were 3.9 times more likely to have accurate knowledge of malaria when compared to those who did not utilize skilled ANC services (aOR = 3.90; 95%CI = 3.34-4.56). Conclusion The overall knowledge of malaria prevention practices among a large proportion of women was found to be low, which implies that the knowledge about the prevention of malaria should be improved upon by both urban and rural dwellers. There is need for concerted behavioural communication intervention to improve the knowledge of malaria especially for rural dwellers regarding malaria prevention measures, causes and symptoms. Consistent efforts at providing relevant information by health organizations are needed to reduce and control incidences of malaria in the general public.	[Yaya, Sanni; Udenigwe, Ogochukwu] Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada; [Bishwajit, Ghose] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Ekholuenetale, Michael] Womens Hlth & Act Res Ctr, Benin, Nigeria; [Shah, Vaibhav; Kadio, Bernard] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada	University of Ottawa; Huazhong University of Science & Technology; University of Ottawa	Yaya, S (corresponding author), Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada.	sanni.yaya@uOttawa.ca	Yaya, Sanni/C-1079-2019; Ekholuenetale, Michael/AAL-3655-2021	Yaya, Sanni/0000-0002-4876-6043; Ekholuenetale, Michael/0000-0002-2372-3020; Udenigwe, Ogochukwu/0000-0001-6844-8854				Astatkie A., 2011, ETHIOPIAN J HLTH SCI, V20; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Bocoum FY, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0108-0; Borgella S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080624; Chuma J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-137; Deressa W, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-259; Dhawan G, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-303; Diboulo E, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1282-x; Diiro GM, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1039-y; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Forero DA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-165; Garley A, 2012, AM J TROP MED HYG, V87, P117; Hien AS, 2017, J TROP MED-US, V2017, P1, DOI 10.1155/2017/1507829; Institut National de la Statistique et de la De A mographie, 2014, ENQ IND PAL EIPBF; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Jenkins R, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0781-5; Kidima WB., 2015, SYNCYTIOTROPHOBLAST, V2015; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Louis VR, 2015, B WORLD HEALTH ORGAN, V93, P750, DOI 10.2471/BLT.14.147702; Maslove DM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-26; Maternal and Child Health Integrated Program, 2013, DOC MAL PROGR IMPL B, V54; Mathania MM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1332-4; Mutegeki E, 2016, ACTA TROP ELSEVIER B; Obasy E, 2010, MALARIA RES TREATMEN, V2010, P1; Okiro EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062214; Okwundu C, 2013, COCHRANE DATABASE SY; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Singh Rupashree, 2014, J Family Med Prim Care, V3, P39, DOI 10.4103/2249-4863.130271; Tipke M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-95; Tusting LS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002234; WHO, 2016, WORLD MALARIA REPORT; WHO WHO, 2015, MAL IS NO LONG LEAD; World Health Organization, 2007, HLTH POLICY, V52, P267; Yamamoto SS, 2010, J TROP PEDIATRICS, V56, P414, DOI 10.1093/tropej/fmq016; Zhou G, 2011, PLOS ONE, V6	35	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180508	10.1371/journal.pone.0180508	http://dx.doi.org/10.1371/journal.pone.0180508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671987	Green Submitted, Green Published, gold			2022-12-27	WOS:000405268500060
J	Zhou, X; Zhou, SQ; Feng, XB				Zhou, Xiao; Zhou, Shaoqi; Feng, Xinbin			Optimization of the photoelectrocatalytic oxidation of landfill leachate using copper and nitrate co-doped TiO2 (Ti) by response surface methodology	PLOS ONE			English	Article							PHOTOCATALYTIC DEGRADATION; RSM; DECOLORIZATION; WASTEWATERS; DESIGN	In this paper, a statistically-based experimental design with response surface methodology (RSM) was employed to examine the effects of functional conditions on the photoelectrocatalytic oxidation of landfill leachate using a Cu/N co-doped TiO2 (Ti) electrode. The experimental design method was applied to response surface modeling and the optimization of the operational parameters of the photoelectro-catalytic degradation of landfill leachate using TiO2 as a photo-anode. The variables considered were the initial chemical oxygen demand (COD) concentration, pH and the potential bias. Two dependent parameters were either directly measured or calculated as responses: chemical oxygen demand (COD) removal and total organic carbon (TOC) removal. The results of this investigation reveal that the optimum conditions are an initial pH of 10.0, 4377.98mgL(-1) initial COD concentration and 25.0 V of potential bias. The model predictions and the test data were in satisfactory agreement. COD and TOC removals of 67% and 82.5%, respectively, were demonstrated. Under the optimal conditions, GC/MS showed 73 organic micro-pollutants in the raw landfill leachate which included hydrocarbons, aromatic compounds and esters. After the landfill leachate treatment processes, 38 organic micro-pollutants disappeared completely in the photoelectrocatalytic process.	[Zhou, Xiao] Guangdong Univ Technol, Guangzhou Higher Educ Mega Ctr, Coll Environm Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Zhou, Xiao; Zhou, Shaoqi] Guizhou Acad Sci, Inst Biol, Guiyang, Peoples R China; [Zhou, Xiao; Zhou, Shaoqi] South China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou, Guangdong, Peoples R China; [Zhou, Xiao; Feng, Xinbin] Chinese Acad Sci, Inst Geochem, Guiyang, Peoples R China; [Zhou, Shaoqi] South China Univ Technol, Coll Environm & Energy, Guangzhou Higher Educ Mega Ctr, Guangzhou, Guangdong, Peoples R China; [Zhou, Shaoqi] South China Univ Technol, Key Lab Environm Protect & Ecoremediat, Guangzhou Higher Educ Mega Ctr, Guangdong Regular Higher Educ Inst, Guangzhou, Guangdong, Peoples R China	Guangdong University of Technology; South China University of Technology; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; South China University of Technology; South China University of Technology	Zhou, SQ (corresponding author), Guizhou Acad Sci, Inst Biol, Guiyang, Peoples R China.; Zhou, SQ (corresponding author), South China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou, Guangdong, Peoples R China.; Zhou, SQ (corresponding author), South China Univ Technol, Coll Environm & Energy, Guangzhou Higher Educ Mega Ctr, Guangzhou, Guangdong, Peoples R China.; Zhou, SQ (corresponding author), South China Univ Technol, Key Lab Environm Protect & Ecoremediat, Guangzhou Higher Educ Mega Ctr, Guangdong Regular Higher Educ Inst, Guangzhou, Guangdong, Peoples R China.	fesqzhou@scut.edu.cn	Feng, Xinbin/F-4512-2011	Feng, Xinbin/0000-0002-7462-8998; ZHOU, XIAO/0000-0002-7229-9473	National Key Research and Development Plan [2016YFC0400702, 2016YFC0400705]; Department of Guangdong Education and Science and Technology Bureau; State Key Laboratory of Subtropical Building Science [2013ZC03, 2014ZB04, 2016ZB24]; Environmental Protection Bureau [201203]; Guizhou Province Scientific Technology Foundation [20152056]; Guizhou Academy of Sciences Foundation for Young Scientists [019]; Guizhou province major science and technology projects [J[2015]2001]	National Key Research and Development Plan; Department of Guangdong Education and Science and Technology Bureau; State Key Laboratory of Subtropical Building Science; Environmental Protection Bureau; Guizhou Province Scientific Technology Foundation; Guizhou Academy of Sciences Foundation for Young Scientists; Guizhou province major science and technology projects	Funded by National Key Research and Development Plan (2016YFC0400702, 2016YFC0400705), the Department of Guangdong Education and Science and Technology Bureau (2010), the State Key Laboratory of Subtropical Building Science (2013ZC03,2014ZB04, 2016ZB24),the Environmental Protection Bureau (201203), the Guizhou Province Scientific Technology Foundation (20152056), the Guizhou Academy of Sciences Foundation for Young Scientists (019) and the Guizhou province major science and technology projects (J[2015]2001)	Anderson-Cook C.M., 2016, RESPONSE SURFACE MET; Arslan-Alaton I, 2010, APPL CATAL B-ENVIRON, V96, P208, DOI 10.1016/j.apcatb.2010.02.023; Beg QK, 2003, PROCESS BIOCHEM, V39, P203, DOI 10.1016/S0032-9592(03)00064-5; Benatti CT, 2006, J ENVIRON MANAGE, V80, P66, DOI 10.1016/j.jenvman.2005.08.014; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Castillo M, 2001, ANAL CHIM ACTA, V426, P253, DOI 10.1016/S0003-2670(00)00828-X; Cho IH, 2007, DYES PIGMENTS, V75, P533, DOI 10.1016/j.dyepig.2006.06.041; Fang CR, 2009, BIORESOURCE TECHNOL, V100, P5664, DOI 10.1016/j.biortech.2009.06.039; Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0; Ghafari S, 2009, J HAZARD MATER, V163, P650, DOI 10.1016/j.jhazmat.2008.07.090; Gunst RF., 2002, TECHNOMETRICS, V38, P284; Haaland PD, 1989, EXPT DESIGN BIOTECHN; JOGLEKAR AM, 1987, CEREAL FOOD WORLD, V32, P857; Korbahti BK, 2009, J HAZARD MATER, V161, P281, DOI 10.1016/j.jhazmat.2008.03.118; Li MC, 2006, J SOLID STATE ELECTR, V10, P980, DOI 10.1007/s10008-005-0043-5; Liu HL, 2005, CHEM ENG J, V112, P173, DOI 10.1016/j.cej.2005.07.012; Mason R.L., 2003, STAT DESIGN ANAL EXP; Moraes PB, 2005, CHEMOSPHERE, V58, P41, DOI 10.1016/j.chemosphere.2004.09.026; Olmez-Hanci T, 2011, J HAZARD MATER, V185, P193, DOI 10.1016/j.jhazmat.2010.09.018; Palominos RA, 2009, CATAL TODAY, V144, P100, DOI 10.1016/j.cattod.2008.12.031; Parilti NB, 2011, J PHOTOCH PHOTOBIO A, V225, P26, DOI 10.1016/j.jphotochem.2011.09.021; Ray S, 2009, CHEM ENG J, V150, P15, DOI 10.1016/j.cej.2008.11.039; Sakkas VA, 2010, J HAZARD MATER, V175, P33, DOI 10.1016/j.jhazmat.2009.10.050; Secula MS, 2008, CHEM ENG J, V141, P18, DOI 10.1016/j.cej.2007.10.003; Tatsi AA, 2003, CHEMOSPHERE, V53, P737, DOI 10.1016/S0045-6535(03)00513-7; Tauchert E, 2006, CHEMOSPHERE, V64, P1458, DOI 10.1016/j.chemosphere.2005.12.064; WANG XIAOJUN, 2009, FENTON OXIDATION BIO, V29, P1354, DOI DOI 10.1016/J.WASMAN.2008.10.006; Wang ZP, 2002, J HAZARD MATER, V95, P153, DOI 10.1016/S0304-3894(02)00116-4; WARD MD, 1982, J PHYS CHEM-US, V86, P3599, DOI 10.1021/j100215a021; Wu JJ, 2004, CHEMOSPHERE, V54, P997, DOI 10.1016/j.chemosphere.2003.10.006; Xu YL, 2013, CHEM ENG J, V225, P138, DOI 10.1016/j.cej.2013.03.085; Zhang JW, 2010, J ENVIRON SCI, V22, P1281, DOI 10.1016/S1001-0742(09)60251-5	32	13	13	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0171234	10.1371/journal.pone.0171234	http://dx.doi.org/10.1371/journal.pone.0171234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671943	Green Published, Green Submitted, gold			2022-12-27	WOS:000405268500001
J	De Palma, GD; Colavita, I; Zambrano, G; Giglio, MC; Maione, F; Luglio, G; Sarnelli, G; Rispo, A; Schettino, P; D'Armiento, FP; De Palma, FDE; D'Argenio, V; Salvatore, F				De Palma, Giovanni Domenico; Colavita, Irene; Zambrano, Gerardo; Giglio, Mariano Cesare; Maione, Francesco; Luglio, Gaetano; Sarnelli, Giovanni; Rispo, Antonio; Schettino, Pietro; D'Armiento, Francesco Paolo; De Palma, Fatima Domenica Elisa; D'Argenio, Valeria; Salvatore, Francesco			Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; INTRAEPITHELIAL NEOPLASIA; INSTABILITY PATHWAY; DIAGNOSTIC YIELD; SURVEILLANCE; MANAGEMENT; CHROMOENDOSCOPY; CONSENSUS	Aim Targeted molecular probes have been used to detect sporadic colonic dysplasia during confocal laser endomicroscopy (CLE) with promising results. This is a feasibility pilot study aiming to assess the potential role of CLE combined with a fluorescent-labeled peptide to stain and detect dysplasia associated with Ulcerative Colitis. Method A phage-derived heptapeptide with predicted high binding affinity for dysplastic tissue, was synthesized and labeled with fluorescein. Eleven lesions with suspected dysplasia at endoscopy were excised from nine patients with long-standing ulcerative colitis. Specimens were sprayed with the peptide and examined by CLE. The CLE images were then compared to the corresponding histological sections. Results At definitive histology, 4 lesions were diagnosed as inflammatory polyps, 6 as dysplastic lesions and one as invasive cancer. In inflammatory polyps, the fluorescence signal came from peri-cryptal spaces and crypt lumen due to passive accumulation of the peptide in these areas. Dysplasia was associated with active binding of the peptide to dysplastic colonocytes. Conclusion Ex vivo staining of ulcerative colitis-associated dysplasia using a fluorescent labeled molecular probe and CLE is feasible. In vivo studies on larger populations are required to evaluate the safety and the effective contribution of molecular probes in cancer surveillance of ulcerative colitis.	[De Palma, Giovanni Domenico; Giglio, Mariano Cesare; Maione, Francesco; Luglio, Gaetano; Sarnelli, Giovanni; Rispo, Antonio; Schettino, Pietro] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Colavita, Irene; Zambrano, Gerardo; De Palma, Fatima Domenica Elisa; D'Argenio, Valeria; Salvatore, Francesco] CEINGE Biotecnol Avanzate, Naples, Italy; [Zambrano, Gerardo; De Palma, Fatima Domenica Elisa; D'Argenio, Valeria; Salvatore, Francesco] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [D'Armiento, Francesco Paolo] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II	De Palma, GD (corresponding author), Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy.	giovanni.depalma@unina.it	D'Argenio, Valeria/K-9345-2016; De Palma, Giovanni D/G-6895-2012; Sarnelli, Giovanni/AAB-4050-2019; Giglio, Mariano Cesare/L-6550-2017	D'Argenio, Valeria/0000-0001-9273-3698; Sarnelli, Giovanni/0000-0002-1467-1134; Giglio, Mariano Cesare/0000-0002-9222-5885; Maione, Francesco/0000-0001-7043-9295; De Palma, Fatima/0000-0002-6109-2768; Zambrano, Gerardo/0000-0002-4284-2172; De Palma, Giovanni Domenico/0000-0001-7474-7180; Luglio, Gaetano/0000-0002-5931-9599; Rispo, Antonio/0000-0002-1454-2412	(Campania - Bioscience) from the Italian Ministry of University and Research [PON03PE_00060_2, PON03PE_00060_7]	(Campania - Bioscience) from the Italian Ministry of University and Research	This study was supported by grant PON03PE_00060_2 and PON03PE_00060_7 (Campania - Bioscience) from the Italian Ministry of University and Research (to Francesco Salvatore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROSTROM O, 1986, GUT, V27, P1408, DOI 10.1136/gut.27.12.1408; De Palma GD, 2010, DIGEST LIVER DIS, V42, P791, DOI 10.1016/j.dld.2010.03.009; Dlugosz A, 2016, ENDOSC INT OPEN, V4, pE901, DOI 10.1055/s-0042-111203; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.035, 10.1053/j.gastro.2009.12.037]; Fujiwara I, 2008, DIS COLON RECTUM, V51, P1387, DOI 10.1007/s10350-008-9212-9; Goetz M, 2013, ENDOSCOPY, V45, P469, DOI 10.1055/s-0032-1326361; Goetz M, 2010, GASTROENTEROLOGY, V138, P435, DOI 10.1053/j.gastro.2009.10.032; GruionuLG A, 2012, PLOS ONE, V7; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Hurlstone DP, 2006, ENDOSCOPY, V38, P1213, DOI 10.1055/s-2006-944732; Karstensen JG, 2014, WORLD J GASTROENTERO, V20, P7794, DOI 10.3748/wjg.v20.i24.7794; Kiesslich R, 2003, GASTROENTEROLOGY, V124, P880, DOI 10.1053/gast.2003.50146; Kiesslich R, 2007, GASTROENTEROLOGY, V132, P874, DOI 10.1053/j.gastro.2007.01.048; Laine L, 2015, GASTROINTEST ENDOSC, V81, P489, DOI 10.1016/j.gie.2014.12.009; Liu J, 2013, CANCER LETT, V330, P200, DOI 10.1016/j.canlet.2012.11.044; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Paramsothy S, 2010, NAT REV GASTRO HEPAT, V7, P366, DOI 10.1038/nrgastro.2010.83; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Rispo A, 2012, WORLD J GASTRO ENDOS, V4, P414, DOI 10.4253/wjge.v4.i9.414; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Shergill AK, 2015, GASTROINTEST ENDOSC, V81, P1101, DOI 10.1016/j.gie.2014.10.030; Sturm MB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004733; Thorlacius H, 2007, INFLAMM BOWEL DIS, V13, P911, DOI 10.1002/ibd.20118; Van Assche G, 2013, J CROHNS COLITIS, V7, P1, DOI 10.1016/j.crohns.2012.09.005; Wallace MB, 2010, ALIMENT PHARM THER, V31, P548, DOI 10.1111/j.1365-2036.2009.04207.x; Wanders LK, 2016, GASTROINTEST ENDOSC, V83, P966, DOI 10.1016/j.gie.2015.09.001	27	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180509	10.1371/journal.pone.0180509	http://dx.doi.org/10.1371/journal.pone.0180509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666016	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608700013
J	Suzuki, K; Yamada, K; Fukuhara, Y; Tsuji, A; Shibata, K; Wakamatsu, N				Suzuki, Kaoru; Yamada, Kenichiro; Fukuhara, Yayoi; Tsuji, Ai; Shibata, Katsumi; Wakamatsu, Nobuaki			High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice	PLOS ONE			English	Article							BASAL GANGLIA DISEASE; EXPERIMENTAL WERNICKES ENCEPHALOPATHY; EXOME SEQUENCING REVEALS; EXTRACELLULAR GLUTAMATE; OXIDATIVE-METABOLISM; SLC19A3 MUTATIONS; PHOSPHATE-ESTERS; DEFICIENCY; MOUSE; PYRITHIAMINE	SLC19A3 deficiency, also called thiamine metabolism dysfunction syndrome-2 (THMD2; OMIM 607483), is an autosomal recessive neurodegenerative disorder caused by mutations in SLC19A3, the gene encoding thiamine transporter 2. To investigate the molecular mechanisms of neurodegeneration in SLC19A3 deficiency and whether administration of high-dose thiamine prevents neurodegeneration, we generated homozygous Slc19a3 E314Q knock-in (KI) mice harboring the mutation corresponding to the human SLC19A3 E320Q, which is associated with the severe form of THMD2. Homozygous KI mice and previously reported homozygous Slc19a3 knock-out (KO) mice fed a thiamine-restricted diet (thiamine: 0.60 mg/100 g food) died within 30 and 12 days, respectively, with dramatically decreased thiamine concentration in the blood and brain, acute neurodegeneration, and astrogliosis in the submedial nucleus of the thalamus and ventral anterior-lateral complex of the thalamus. These findings may bear some features of thiamine-deficient mice generated by pyrithiamine injection and a thiamine-deficient diet, suggesting that the primary cause of THMD2 could be thiamine pyrophosphate (TPP) deficiency. Next, we analyzed the therapeutic effects of high-dose thiamine treatment. When the diet was reverted to a conventional diet (thiamine: 1.71 mg/100 g food) after thiamine restriction, all homozygous KO mice died. In contrast, when the diet was changed to a high-thiamine diet (thiamine: 8.50 mg/100 g food) after thiamine restriction, more than half of homozygous KO mice survived, without progression of brain lesions. Unexpectedly, when the high-thiamine diet of recovered mice was reverted to a conventional diet, some homozygous KO mice died. These results showed that acute neurodegeneration caused by thiamine deficiency is preventable in most parts, and prompt high-dose thiamine administration is critical for the treatment of THMD2. However, reduction of thiamine should be performed carefully to prevent recurrence after recovery of the disease.	[Suzuki, Kaoru; Yamada, Kenichiro; Fukuhara, Yayoi; Wakamatsu, Nobuaki] Aichi Human Serv Ctr, Inst Dev Res, Dept Genet, Kasugai, Aichi, Japan; [Tsuji, Ai; Shibata, Katsumi] Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, Hikone, Shiga, Japan	University Shiga Prefecture	Wakamatsu, N (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Genet, Kasugai, Aichi, Japan.	nwaka@inst-hsc.jp	Suzuki, Kaoru/AHC-0437-2022	Tsuji, Ai/0000-0003-1619-7592; Nobuaki, Wakamatsu/0000-0003-1956-8977; Yamada, Kenichiro/0000-0003-0486-284X; Suzuki, Kaoru/0000-0002-5168-9018; Wakamatsu, Nobuaki/0000-0001-5693-2227	Takeda Science Foundation [10]; Ministry of Education, Culture, Sports, Science and Technology of Japan [26462225, 15K09610]; Grants-in-Aid for Scientific Research [15K09610] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Takeda Science Foundation (No.10 in 2009, to NW), http://www.takeda-sci.or.jp; Ministry of Education, Culture, Sports, Science and Technology of Japan (26462225 to NW, 15K09610 to KY, http://www.mext.go.jp.	Abdou E, 2015, NEUROCHEM RES, V40, P353, DOI 10.1007/s11064-014-1430-z; Allen PG., 2006, ALLEN BRAIN ATLAS; ANDERSON SH, 1986, LANCET, V2, P85; Ashokkumar B, 2006, AM J PHYSIOL-RENAL, V291, pF796, DOI 10.1152/ajprenal.00078.2006; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Berdanier CD., 1998, ADV NUTR MICRONUTRIE, P73; BETTENDORFF L, 1994, BBA-MOL CELL RES, V1222, P7, DOI 10.1016/0167-4889(94)90019-1; BETTENDORFF L, 1993, J NEUROCHEM, V60, P423, DOI 10.1111/j.1471-4159.1993.tb03168.x; CALINGASAN NY, 1995, EXP NEUROL, V134, P64, DOI 10.1006/exnr.1995.1037; Calingasan NY, 2000, J NEUROPATH EXP NEUR, V59, P207, DOI 10.1093/jnen/59.3.207; Debs R, 2010, ARCH NEUROL-CHICAGO, V67, P126, DOI 10.1001/archneurol.2009.293; Diaz GA, 1999, NAT GENET, V22, P309, DOI 10.1038/10385; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Gerards M, 2013, BRAIN, V136, P882, DOI 10.1093/brain/awt013; GIBSON GE, 1984, NEUROCHEM RES, V9, P803, DOI 10.1007/BF00965667; HARATA N, 1995, METAB BRAIN DIS, V10, P159, DOI 10.1007/BF01991863; HAYASHI K, 1981, BIOCHIM BIOPHYS ACTA, V641, P106, DOI 10.1016/0005-2736(81)90573-3; Hazell AS, 2010, GLIA, V58, P148, DOI 10.1002/glia.20908; HAZELL AS, 1993, J NEUROCHEM, V61, P1155, DOI 10.1111/j.1471-4159.1993.tb03635.x; Hazell AS, 1998, METAB BRAIN DIS, V13, P97, DOI 10.1023/A:1020657129593; Hazell AS, 2001, J NEUROCHEM, V78, P560, DOI 10.1046/j.1471-4159.2001.00436.x; HEROUX M, 1995, NEUROCHEM RES, V20, P87, DOI 10.1007/BF00995157; IWATA H, 1988, J CHROMATOGR, V450, P317, DOI 10.1016/S0021-9673(01)83586-X; Kato K, 2014, PHARM RES-DORDR, V31, P136, DOI 10.1007/s11095-013-1144-y; Ke ZJ, 2005, NEUROCHEM INT, V47, P204, DOI 10.1016/j.neuint.2005.03.002; Ke ZJ, 2003, J NEUROPATH EXP NEUR, V62, P195, DOI 10.1093/jnen/62.2.195; Kevelam SH, 2013, BRAIN, V136, P1534, DOI 10.1093/brain/awt054; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; Kono S, 2009, NEW ENGL J MED, V360, P1792, DOI 10.1056/NEJMc0809100; LANGLAIS PJ, 1993, J NEUROCHEM, V61, P2175, DOI 10.1111/j.1471-4159.1993.tb07457.x; Losa R, 2005, J PHARMACEUT BIOMED, V37, P1025, DOI 10.1016/j.jpba.2004.08.038; McCormick DB, 1988, MODERN NUTRITION HLT, P355; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Nosaka K, 2001, BBA-GENE STRUCT EXPR, V1517, P293, DOI 10.1016/S0167-4781(00)00247-5; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reidling JC, 2010, GASTROENTEROLOGY, V138, P1802, DOI 10.1053/j.gastro.2009.10.042; RINDI G, 1961, BIOCHEM J, V80, P214, DOI 10.1042/bj0800214; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Said HM, 1999, AM J PHYSIOL-CELL PH, V277, pC645, DOI 10.1152/ajpcell.1999.277.4.C645; Said HM, 2004, AM J PHYSIOL-GASTR L, V286, pG491, DOI 10.1152/ajpgi.00361.2003; Schmuck G, 2009, ARCH TOXICOL, V83, P397, DOI 10.1007/s00204-008-0360-4; Tabarki B, 2015, EUR J PAEDIATR NEURO, V19, P547, DOI 10.1016/j.ejpn.2015.05.008; TALLAKSEN CME, 1993, ALCOHOL CLIN EXP RES, V17, P712, DOI 10.1111/j.1530-0277.1993.tb00825.x; Todd KG, 1999, GLIA, V25, P190, DOI 10.1002/(SICI)1098-1136(19990115)25:2<190::AID-GLIA9>3.0.CO;2-B; WATANABE I, 1978, EXP MOL PATHOL, V28, P381, DOI 10.1016/0014-4800(78)90012-6; WOOLLEY DW, 1951, J BIOL CHEM, V191, P43; Yamada K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-171; Zeng WQ, 2005, AM J HUM GENET, V77, P16, DOI 10.1086/431216; ZHANG SX, 1995, J NEUROPATH EXP NEUR, V54, P255, DOI 10.1097/00005072-199503000-00012; Zhao RB, 2001, BBA-GENE STRUCT EXPR, V1517, P320, DOI 10.1016/S0167-4781(00)00264-5; Zhao RB, 2013, MOL ASPECTS MED, V34, P373, DOI 10.1016/j.mam.2012.07.006	52	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180279	10.1371/journal.pone.0180279	http://dx.doi.org/10.1371/journal.pone.0180279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665968	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608700080
J	Fett, D; Trompeter, K; Platen, P				Fett, Daniela; Trompeter, Katharina; Platen, Petra			Back pain in elite sports: A cross-sectional study on 1114 athletes	PLOS ONE			English	Article							INTERVERTEBRAL-DISK DEGENERATION; PHYSICAL-ACTIVITY; COUNTRY SKIERS; OVERUSE INJURIES; SPINAL POSTURE; RISK-FACTORS; NECK PAIN; PREVALENCE; ADOLESCENTS; STRENGTH	Objectives To establish the prevalence of back pain in German elite athletes; examine the influence of age, sex, sports discipline and training volume; and compare elite athletes with a physically active control group. Methods A standardized and validated online back pain questionnaire was sent by the German Olympic Sports Confederation to approximately 4,000 German national and international elite athletes, and a control group of 253 physically active but non-elite sports students. Results We received responses from 1,114 elite athletes (46.5% male and 53.1% female, mean age 20.9 years +/- 4.8 years, mean height 176.5 +/- 11.5 cm, mean weight 71.0 +/- 10.3 kg) and 166 physically active sports students (74.7% male and 24.1 female, mean age 21.2 +/- 2.0 years, mean height 180.0 +/- 8.0 cm, mean weight 74.0 +/- 14.5 kg). In elite athletes, the lifetime prevalence of back pain was 88.5%, the 12-month prevalence was 81.1%, the 3-month prevalence was 68.3% and the point prevalence was 49.0%, compared with 80.7%, 69.9%, 59.0% and 42.8%, respectively in the control group. The lifetime, 12-month and 3-month prevalences in elite athletes were significantly higher than in the control group. Regarding the individual sports disciplines, the prevalence of back pain was significantly higher in elite rowers, dancers, fencers, gymnasts, track and field athletes, figure skaters and marksmen, and those who play underwater rugby, water polo, basketball, hockey and ice hockey compared with the control group. The prevalence of back pain was significantly lower in elite triathletes. Conclusions Back pain is a common complaint in German elite athletes. Low back pain seems to be a problem in both elite athletes and physically active controls. A high training volume in elite athletes and a low training volume in physically active individuals might increase prevalence rates. Our findings indicate the necessity for specific prevention programs, especially in high-risk sports. Further research should investigate the optimal dose-effect relationship of sporting activity for the general population to prevent back pain.	[Fett, Daniela; Trompeter, Katharina; Platen, Petra] Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany	Ruhr University Bochum	Fett, D; Trompeter, K (corresponding author), Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany.	daniela.fett@rub.de; katharina.trompeter@rub.de		Platen, Petra/0000-0002-3440-8245	German Federal Institute of Sport Science; project RAN Rucken [ZMVI1-080102N11-18]	German Federal Institute of Sport Science; project RAN Rucken	The present study was funded by the German Federal Institute of Sport Science (http://www.bisp.de). The research was realized within the project RAN Rucken (ZMVI1-080102N11-18). Funding were received by PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alricsson M, 2005, J SPORT MED PHYS FIT, V45, P547; Bahr R, 2004, SPINE, V29, P449, DOI 10.1097/01.BRS.0000096176.92881.37; Bahr R, 2009, BRIT J SPORT MED, V43, P966, DOI 10.1136/bjsm.2009.066936; Balague F, 1999, EUR SPINE J, V8, P429, DOI 10.1007/s005860050201; Belavy DL, 2016, SPORTS MED, V46, P473, DOI 10.1007/s40279-015-0444-2; Bergstrom KA, 2004, KNEE SURG SPORT TR A, V12, P80, DOI 10.1007/s00167-003-0389-0; Burnett AF, 2004, MANUAL THER, V9, P211, DOI 10.1016/j.math.2004.06.002; Cabri J, 2003, SPORTVERLETZ SPORTSC, V17, P61; Campello M, 1996, SCAND J MED SCI SPOR, V6, P63, DOI 10.1111/j.1600-0838.1996.tb00073.x; Cholewicki J, 2005, SPINE, V30, P2614, DOI 10.1097/01.brs.0000188273.27463.bc; Clarsen B, 2010, AM J SPORT MED, V38, P2494, DOI 10.1177/0363546510376816; Close C, 2016, MIDWIFERY, V37, P1, DOI 10.1016/j.midw.2016.03.013; Dalichau S, 2002, DEUT Z SPORTMED, V53, P12; Dankaerts W, 2006, SPINE, V31, P2017, DOI 10.1097/01.brs.0000228728.11076.82; Dubravcic-Simunjak S, 2003, AM J SPORT MED, V31, P511, DOI 10.1177/03635465030310040601; Eriksson K, 1996, SCAND J MED SCI SPOR, V6, P31; Filler TJ, 2004, TRAUMATOLOGY, V20, P13; Greene HS, 2001, AM J SPORT MED, V29, P795, DOI 10.1177/03635465010290062001; Hangai M, 2009, AM J SPORT MED, V37, P149, DOI 10.1177/0363546508323252; Haydt R, 2012, INT J SPORTS PHYS TH, V7, P296; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; HOWELL DW, 1984, AM J SPORT MED, V12, P278, DOI 10.1177/036354658401200407; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hutchinson MR, 1999, MED SCI SPORT EXER, V31, P1686, DOI 10.1097/00005768-199911000-00027; Iwamoto J, 2005, SCAND J MED SCI SPOR, V15, P163, DOI 10.1111/j.1600-0838.2004.00414.x; Kaneoka K, 2007, AM J SPORT MED, V35, P1341, DOI 10.1177/0363546507300259; Kernahan M, 1979, NOVA SCOTIA MED B, V58, P167; Kujala UM, 1997, AM J SPORT MED, V25, P363, DOI 10.1177/036354659702500316; Kujala UM, 1996, MED SCI SPORT EXER, V28, P165, DOI 10.1097/00005768-199602000-00002; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Legault EP, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0681-4; Ng L, 2014, J SCI MED SPORT, V17, P266, DOI 10.1016/j.jsams.2013.08.003; Lindgren S, 1988, Aust J Physiother, V34, P123, DOI 10.1016/S0004-9514(14)60604-8; Lively Mathew W, 2002, W V Med J, V98, P202; Manninen JSO, 1996, BRIT J SPORT MED, V30, P134, DOI 10.1136/bjsm.30.2.134; Mikkelsson LO, 2006, BRIT J SPORT MED, V40, P107, DOI 10.1136/bjsm.2004.017350; Mitchell T, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-152; Mortazavi J, 2015, ASIAN J SPORTS MED; Muller J, 2016, SCAND J MED SCI SPOR; Murtaugh K, 2001, MED SCI SPORT EXER, V33, P201; Newcomer K, 1996, ACTA PAEDIATR, V85, P1433, DOI 10.1111/j.1651-2227.1996.tb13948.x; Newlands C, 2015, BR J SPORTS MED; Noll M, 2016, PLOS ONE; Oksuz E, 2006, SPINE, V31, pE968, DOI 10.1097/01.brs.0000247787.25382.3c; Perich D, 2011, KNEE SURG SPORT TR A, V19, P20, DOI 10.1007/s00167-010-1173-6; Rees CS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-382; ROY SH, 1990, MED SCI SPORT EXER, V22, P463; SALMINEN JJ, 1993, INT J SPORTS MED, V14, P406, DOI 10.1055/s-2007-1021200; Sato T, 2011, EUR SPINE J, V20, P94, DOI 10.1007/s00586-010-1485-8; Schulz SS, 2016, EUR SPINE J, V25, P1204, DOI 10.1007/s00586-015-4210-9; Shakeri H, 2013, J CHIROPR MED, V12, P160, DOI 10.1016/j.jcm.2013.08.005; Shan Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078109; Shehab DK, 2005, J ADOLESCENT HEALTH, V36, P32, DOI 10.1016/j.jadohealth.2003.12.011; Sitthipornvorakul E, 2011, EUR SPINE J, V20, P677, DOI 10.1007/s00586-010-1630-4; SWARD L, 1990, SPINE, V15, P124; Taimela S, 1997, SPINE, V22, P1132, DOI 10.1097/00007632-199705150-00013; Triki M, 2015, LIBYAN J MED, V10, DOI 10.3402/ljm.v10.26802; Trompeter K, 2016, SPORTS MED IN PRESS; Tunas P, 2014, KNEE SURG SPORTS TRA; Villavicencio Alan T, 2006, Neurosurg Focus, V21, pE7; Villavicencio AT, 2007, J NEUROSURG-SPINE, V7, P408, DOI 10.3171/SPI-07/10/408; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Vuori IM, 2001, MED SCI SPORT EXER, V33, pS551, DOI 10.1097/00005768-200106001-00026; Wade M, 2012, J APPL BIOMECH, V28, P677, DOI 10.1123/jab.28.6.677; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003	66	67	67	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180130	10.1371/journal.pone.0180130	http://dx.doi.org/10.1371/journal.pone.0180130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662110	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300109
J	Kolb, M; Kurz, S; Schafer, A; Huse, K; Dietz, A; Wichmann, G; Birkenmeier, G				Kolb, Marlen; Kurz, Susanne; Schaefer, Angelika; Huse, Klaus; Dietz, Andreas; Wichmann, Gunnar; Birkenmeier, Gerd			Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant	PLOS ONE			English	Article							PROSTATE-CANCER; GENE-EXPRESSION; BREAST-CANCER; NECK-CANCER; IDENTIFICATION; LRP; HYPERCHOLESTEROLEMIA; POLYMORPHISMS; PREDICTION; BIOMARKER	Background Low density lipoprotein (LDL) receptor-related protein 1 (LRP1) is a ubiquitously expressed multi-ligand endocytosis receptor implicated in a wide range of signalling, among others in tumour biology. Tumour-associated genomic mutations of the LRP1 gene are described, but nothing is known about cancer-associated expression of LRP1 splice variants Therefore, the focus of this study was on an annotated truncated LRP1 splice variant (BC072015.1; NCBI GenBank), referred to as smLRP1, which was initially identified in prostate and lung carcinoma. Methods Using PCR and quantitative PCR, the expression of LRP1 and smLRP1 in different human tissues and tumour cell lines was screened and compared on tumour biopsies of head and neck squamous cell carcinoma (HNSCC). Using a recently developed anti-smLRP1 antibody, the expression of the putative LRP1 protein isoform in tumour cell lines in Western blot and immunofluorescence staining was further investigated. Results The alternative transcript smLRP1 is ubiquitously expressed in 12 human cell lines of different origin and 22 tissues which is similar to LRP1. A shift in expression of smLRP1 relative to LRP1 towards smLRP1 was observed in most tumour cell lines compared to healthy tissue. The expression of LRP1 as well as smLRP1 is decreased in HNSCC cell lines in comparison to healthy mucosa. In vitro results were checked using primary HNSCC. Furthermore, the expression of the protein isoform smLRP1 (32 kDa) was confirmed in human tumour cell lines. Conclusions Similar to LRP1, the truncated splice variant smLRP1 is ubiquitously expressed in healthy human tissues, but altered in tumours pointing to a potential role of smLRP1 in cancer. Comparative results suggest a shift in expression in favour of smLRP1 in tumour cells that warrant further evaluation. The protein isoform is suggested to be secreted.	[Kolb, Marlen; Dietz, Andreas; Wichmann, Gunnar] Univ Hosp Leipzig, Clin Otorhinolaryngol Head & Neck Surg, Leipzig, Germany; [Kurz, Susanne] Fraunhofer Inst Ceram Technol & Syst IKTS, Bio & Nanotechnol, Leipzig, Germany; [Schaefer, Angelika; Birkenmeier, Gerd] Univ Leipzig, Rudolf Schonheimer Inst Biochem, Leipzig, Germany; [Huse, Klaus] FLI, Leibniz Inst Aging, Jena, Germany	Leipzig University; Fraunhofer Gesellschaft; Leipzig University; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Kolb, M (corresponding author), Univ Hosp Leipzig, Clin Otorhinolaryngol Head & Neck Surg, Leipzig, Germany.	marlen.kolb@medizin.uni-leipzig.de	Wichmann, Gunnar/AGW-9592-2022	Wichmann, Gunnar/0000-0001-6191-2095; Kolb, Marlen/0000-0002-8397-8295	European Social Fund [100098250]; GB; German Research Foundation (DFG) and University of Leipzig	European Social Fund(European Social Fund (ESF)); GB; German Research Foundation (DFG) and University of Leipzig	This work was supported by the European Social Fund (URLhttp://www.esf.de/ portal/DE/Startseite/inhalt.html); grant number 100098250. Funding was granted to GB.We also acknowledge support from the German Research Foundation (DFG) and University of Leipzig within the program of Open Access Publishing.The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Aledo R, 2012, REV ESP CARDIOL, V65, P807, DOI [10.1016/j.recesp.2012.03.013, 10.1016/j.rec.2012.03.012]; Andl T, 1998, CANCER RES, V58, P5; [Anonymous], 2004, PREDICTION N GLYCOSY; Baum L, 1998, NEUROSCI LETT, V256, P5, DOI 10.1016/S0304-3940(98)00734-4; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Benes P, 2003, BREAST CANCER RES, V5, pR77, DOI 10.1186/bcr591; BIRKENMEIER G, 1993, J IMMUNOL METHODS, V162, P59, DOI 10.1016/0022-1759(93)90407-X; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Cheng C-F, MOL CELLULAR BIOL, V28, P3344; de Gonzalo-Calvo D, 2015, INT J CARDIOL, V201, P20, DOI 10.1016/j.ijcard.2015.07.085; Gatta G, 2015, EUROPEAN J CANC; Gilardoni MB, 2003, J HISTOCHEM CYTOCHEM, V51, P1575, DOI 10.1177/002215540305101201; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gopal U, PLOS ONE, V6; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Jang JH, 2002, BIOCHEM BIOPH RES CO, V292, P378, DOI 10.1006/bbrc.2002.6668; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Jung- H, 2015, NAT GENET, V47, P1242, DOI 10.1038/ng.3414; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laatsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029385; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Laskowski RA, NUCL ACIDS RES, V33, pW89; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li YH, 1998, ANTICANCER RES, V18, P1197; Li Yonghe, 1998, Invasion and Metastasis, V18, P240, DOI 10.1159/000024517; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu Q, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-17; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MACFARLANE GJ, 1995, ORAL ONCOL, V31B, P181; Martinez-Ledesma E, 2015, SCI REP-UK, V5, DOI 10.1038/srep11966; Martinez-Poveda B, 2013, BIOPROTOCOL, V3; Meng H, 2011, CLIN CANCER RES, V17, P2426, DOI 10.1158/1078-0432.CCR-10-2385; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Mucchielli-Giorgi MHM, 2002, PROTEINS, V46, P243, DOI 10.1002/prot.10047; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Obermeyer K, 2007, ONCOL REP, V17, P361; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; Sobin L, 2009, TNM CLASSIFICATION M; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Suh Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.548; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Van Leuven F, 1998, GENOMICS, V52, P138, DOI 10.1006/geno.1998.5408; VANLEUVEN F, 1994, GENOMICS, V24, P78, DOI 10.1006/geno.1994.1584; Wichmann G, 2015, INT J CANCER, V137, P2846, DOI 10.1002/ijc.29649; Xing P, 2016, CHIN J CANCER, V35, P4119	55	4	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180354	10.1371/journal.pone.0180354	http://dx.doi.org/10.1371/journal.pone.0180354			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662213	Green Published, gold			2022-12-27	WOS:000404608300143
J	Tovote, KA; Schroevers, MJ; Snippe, E; Emmelkamp, PMG; Links, TP; Sanderman, R; Fleer, J				Tovote, K. Annika; Schroevers, Maya J.; Snippe, Evelien; Emmelkamp, Paul M. G.; Links, Thera P.; Sanderman, Robbert; Fleer, Joke			What works best for whom? Cognitive Behavior Therapy and Mindfulness-Based Cognitive Therapy for depressive symptoms in patients with diabetes	PLOS ONE			English	Article							MAJOR DEPRESSION; PREDICTORS; MODERATORS; PERSONALITY; ANXIETY; PHARMACOTHERAPY; PREVENTION; DISORDERS; SEVERITY; INTERNET	Objective Cognitive Behavior Therapy (CBT) and Mindfulness-Based Cognitive Therapy (MBCT) have shown to be effective interventions for treating depressive symptoms in patients with diabetes. However, little is known about which intervention works best for whom (i.e., moderators of efficacy). The aim of this study was to identify variables that differentially predicted response to either CBT or MBCT (i.e., prescriptive predictors). Methods The sample consisted of 91 adult outpatients with type 1 or type 2 diabetes and comorbid depressive symptoms (i.e., BDI-II >= 14) who were randomized to either individual 8-week CBT (n = 45) or individual 8-week MBCT (n = 46). Patients were followed for a year and depressive symptoms were measured at pre-treatment, post-treatment, and at 9-months follow-up. The predictive effect of demographics, depression related characteristics, and disease specific characteristics on change in depressive symptoms was assessed by means of hierarchical regression analyses. Results Analyses showed that education was the only factor that differentially predicted a decrease in depressive symptoms directly after the interventions. At post-treatment, individuals with higher educational attainment responded better to MBCT, as compared to CBT. Yet, this effect was not apparent at 9-months follow-up. Conclusions This study did not identify variables that robustly differentially predicted treatment effectiveness of CBT and MBCT, indicating that both CBT and MBCT are accessible interventions that are effective for treating depressive symptoms in broad populations with diabetes. More research is needed to guide patient-treatment matching in clinical practice.	[Tovote, K. Annika; Schroevers, Maya J.; Sanderman, Robbert; Fleer, Joke] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands; [Snippe, Evelien] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Emmelkamp, Paul M. G.] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Emmelkamp, Paul M. G.] HSK Grp, Woerden, Netherlands; [Links, Thera P.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Sanderman, Robbert] Univ Twente, Dept Psychol Hlth & Technol, Enschede, Netherlands	University of Groningen; University of Groningen; University of Amsterdam; University of Groningen; University of Twente	Tovote, KA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands.	K.A.Tovote@umcg.nl		Snippe, Evelien/0000-0002-3003-7475; Fleer, Joke/0000-0002-9116-9404	University of Groningen and University Medical Center Groningen	University of Groningen and University Medical Center Groningen	No specific funding was obtained; the study was financed by the University of Groningen and University Medical Center Groningen. Therefore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Andersson G, 2004, VERHALTENSTHERAPIE, V14, P185, DOI 10.1159/000080914; Arch JJ, 2013, BEHAV RES THER, V51, P185, DOI 10.1016/j.brat.2013.01.003; Bagby RM, 2008, CAN J PSYCHIAT, V53, P361, DOI 10.1177/070674370805300605; Beck A.T., 1979, COGNITIVE THERAPY EM; Beck AT, 2005, ARCH GEN PSYCHIAT, V62, P953, DOI 10.1001/archpsyc.62.9.953; Beck AT., 1996, MANUAL BECK DEPRESSI; Beltman MW, 2010, BRIT J PSYCHIAT, V197, P11, DOI 10.1192/bjp.bp.109.064675; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Carter JD, 2011, J AFFECT DISORDERS, V128, P252, DOI 10.1016/j.jad.2010.07.002; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Cohen J., 1977, J BEHAV MED; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Cohen J, 2013, METHODOLOGICAL ISSUE, P427; Cuijpers P, 2014, DEPRESS ANXIETY, V31, P941, DOI 10.1002/da.22328; de Vibe M, 2015, MINDFULNESS, V6, P281, DOI 10.1007/s12671-013-0258-y; DeRubeis RJ, 1999, AM J PSYCHIAT, V156, P1007; DeRubeis RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083875; Driessen E, 2010, PSYCHIAT CLIN N AM, V33, P537, DOI 10.1016/j.psc.2010.04.005; Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024; First M. B., 1997, STRUCTURED CLIN INTE; Fournier JC, 2009, J CONSULT CLIN PSYCH, V77, P775, DOI 10.1037/a0015401; Geschwind N, 2012, BRIT J PSYCHIAT, V201, P320, DOI 10.1192/bjp.bp.111.104851; Hamilton KE, 2002, CLIN PSYCHOL REV, V22, P875, DOI 10.1016/S0272-7358(02)00106-X; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Huibers MJH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140771; Huibers MJH, 2014, J AFFECT DISORDERS, V152, P146, DOI 10.1016/j.jad.2013.08.027; JARRETT RB, 1991, PSYCHIAT RES, V37, P245, DOI 10.1016/0165-1781(91)90061-S; Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kraemer HC, 2006, JAMA-J AM MED ASSOC, V296, P1286, DOI 10.1001/jama.296.10.1286; Kuyken W, 2010, BEHAV RES THER, V48, P1105, DOI 10.1016/j.brat.2010.08.003; Lustman PJ, 1998, GEN HOSP PSYCHIAT, V20, P302, DOI 10.1016/S0163-8343(98)00039-5; Ma SH, 2004, J CONSULT CLIN PSYCH, V72, P31, DOI 10.1037/0022-006X.72.1.31; Manicavasgar V, 2011, J AFFECT DISORDERS, V130, P138, DOI 10.1016/j.jad.2010.09.027; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; Mulder RT, 2002, AM J PSYCHIAT, V159, P359, DOI 10.1176/appi.ajp.159.3.359; Nyklicek I, 2016, J PSYCHOSOM RES, V91, P40, DOI 10.1016/j.jpsychores.2016.10.009; Piet J, 2010, SCAND J PSYCHOL, V51, P403, DOI 10.1111/j.1467-9450.2009.00801.x; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Quilty LC, 2008, J AFFECT DISORDERS, V108, P241, DOI 10.1016/j.jad.2007.10.022; Schroevers MJ, 2015, MINDFULNESS, V6, P99, DOI 10.1007/s12671-013-0235-5; Segal Z. V., 2002, MINDFULNESS BASED CO; SHAPIRO DA, 1994, J CONSULT CLIN PSYCH, V62, P522, DOI 10.1037/0022-006X.62.3.522; Spek V, 2008, J AFFECT DISORDERS, V105, P137, DOI 10.1016/j.jad.2007.05.001; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Tovote KA, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000375453; Tovote K Annika, 2013, BMC Psychol, V1, P17, DOI 10.1186/2050-7283-1-17; Tovote KA, 2014, DIABETES CARE, V37, P2427, DOI 10.2337/dc13-2918; Watanabe N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-81; Weitz ES, 2015, JAMA PSYCHIAT, V72, P1102, DOI 10.1001/jamapsychiatry.2015.1516; Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760; Zautra AJ, 2008, J CONSULT CLIN PSYCH, V76, P408, DOI 10.1037/0022-006X.76.3.408	54	17	18	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179941	10.1371/journal.pone.0179941	http://dx.doi.org/10.1371/journal.pone.0179941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662208	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300076
J	Wang, LL; Wang, SW; Chen, W; Li, HB; Deng, XP				Wang, Linlin; Wang, Shiwen; Chen, Wei; Li, Hongbing; Deng, Xiping			Physiological mechanisms contributing to increased water-use efficiency in winter wheat under organic fertilization	PLOS ONE			English	Article							GRAIN-YIELD; DRY-MATTER; SOIL-WATER; SPRING WHEAT; DURUM-WHEAT; BIOCHEMICAL RESPONSES; NITROGEN ACCUMULATION; LIPID-PEROXIDATION; OXIDATIVE STRESS; LEAF SENESCENCE	Improving the efficiency of resource utilization has received increasing research attention in recent years. In this study, we explored the potential physiological mechanisms underlying improved grain yield and water-use efficiency of winter wheat (Triticum aestivum L.) following organic fertilizer application. Two wheat cultivars, ChangHan58 (CH58) and XiNong9871 (XN9871), were grown under the same nitrogen (N) fertilizer rate (urea-N, CK; and manure plus urea-N, M) and under two watering regimes (WW, well-watered; and WS, water stress) imposed after anthesis. The M fertilizer treatment had a higher P-n and lower g(s) and T-r than CK under both water conditions, in particular, it significantly increased WRC and psi(w), and decreased EWLR and MDA under WS. Also, the M treatment increased post-anthesis N uptake by 81.4 and 16.4% under WS and WW, thus increasing post-anthesis photosynthetic capacity and delaying leaf senescence. Consequently, the M treatment increased post-anthesis DM accumulation under WS and WW by 51.5 and 29.6%, WUEB by 44.5 and 50.9%, grain number per plant by 11.5 and 12.2% and 1000-grain weight by 7.3 and 3.6%, respectively, compared with CK. The grain yield under M treatment increased by 23 and 15%, and water use efficiency (WUEg) by 25 and 23%, respectively. The increased WUE under organic fertilizer treatment was due to elevated photosynthesis and decreased Tr and gs. Our results suggest that the organic fertilizer treatment enabled plants to use water more efficiently under drought stress.	[Wang, Linlin; Wang, Shiwen; Li, Hongbing; Deng, Xiping] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Wang, Linlin] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Chen, Wei] Baoji Univ Arts & Sci, Key Lab Disaster Monitoring & Mech Simulating Sha, Baoji, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Baoji University of Arts & Sciences	Deng, XP (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	dengxp@ms.iswc.ac.cn	Wang, Shiwen/AAA-9751-2019	Wang, Shiwen/0000-0003-3195-5531; deng, xi ping/0000-0003-4577-9217; Wang, Linlin/0000-0001-5981-8833	National Basic Research Program of China [2015CB150402]; Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China [51479189]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2015CB150402); Ministry of Science and Technology of the People's Republic of China, http://sci-hub.io/http://www.most.gov.cn/eng/, XPD; National Natural Science Foundation of China (No. 51479189), http://sci-hub.io/http://www.nsfc.gov.cn/publish/portal1/, XPD.	Ahmadi A., 2005, International Journal of Agriculture and Biology, V7, P807; Altenbach SB, 2003, J CEREAL SCI, V37, P9, DOI 10.1006/jcrs.2002.0483; Arduini I, 2006, EUR J AGRON, V25, P309, DOI 10.1016/j.eja.2006.06.009; Bai LP, 2006, PEDOSPHERE, V16, P326, DOI 10.1016/S1002-0160(06)60059-3; Bancal MO, 2008, ANN BOT-LONDON, V102, P579, DOI 10.1093/aob/mcn124; Blum A, 1998, EUPHYTICA, V100, P77, DOI 10.1023/A:1018303922482; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Bremner J. M., 1996, Methods of soil analysis. Part 3 - chemical methods., P1085; Chen CC, 2011, AGRON J, V103, P786, DOI 10.2134/agronj2010.0424; Chen D, 2015, INT J BREAST CANC, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0137026; Chen W, 2015, J PLANT NUTR, V38, P13, DOI 10.1080/01904167.2014.892989; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Chen YL, 2015, FIELD CROP RES, V172, P53, DOI 10.1016/j.fcr.2014.11.016; Demiral T, 2005, ENVIRON EXP BOT, V53, P247, DOI 10.1016/j.envexpbot.2004.03.017; Dordas C, 2009, EUR J AGRON, V30, P129, DOI 10.1016/j.eja.2008.09.001; Dordas CA, 2009, FIELD CROP RES, V110, P35, DOI 10.1016/j.fcr.2008.06.011; Du TS, 2008, AGR WATER MANAGE, V95, P659, DOI 10.1016/j.agwat.2008.01.017; Ehdaie B, 2006, CROP SCI, V46, P2093, DOI 10.2135/cropsci2006.01.0013; Abreu ME, 2008, ENVIRON EXP BOT, V64, P105, DOI 10.1016/j.envexpbot.2007.12.016; Ercoli L, 2008, EUR J AGRON, V28, P138, DOI 10.1016/j.eja.2007.06.002; Esch A, 1998, CHEMOSPHERE, V36, P645, DOI 10.1016/S0045-6535(97)10101-1; Estrada-Campuzano G, 2012, FIELD CROP RES, V128, P167, DOI 10.1016/j.fcr.2012.01.003; Fan TL, 2005, AGR ECOSYST ENVIRON, V106, P313, DOI 10.1016/j.agee.2004.09.003; Fang Y, 2010, CROP PASTURE SCI, V61, P899, DOI 10.1071/CP10125; Ferrante A, 2012, FIELD CROP RES, V136, P52, DOI 10.1016/j.fcr.2012.07.015; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Fuertes-Mendizabal T, 2010, J PLANT NUTR SOIL SC, V173, P907, DOI 10.1002/jpln.200900262; Gaju O, 2014, FIELD CROP RES, V155, P213, DOI 10.1016/j.fcr.2013.09.003; Guan XK, 2015, J AGRON CROP SCI, V201, P253, DOI 10.1111/jac.12103; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guttieri MJ, 2001, CROP SCI, V41, P327, DOI 10.2135/cropsci2001.412327x; He FF, 2009, ENVIRON POLLUT, V157, P1666, DOI 10.1016/j.envpol.2008.12.017; Hu CL, 2015, FIELD CROP RES, V179, P6, DOI 10.1016/j.fcr.2015.03.026; Kato Y, 2011, FIELD CROP RES, V120, P387, DOI 10.1016/j.fcr.2010.11.015; KOBATA T, 1992, CROP SCI, V32, P1238, DOI 10.2135/cropsci1992.0011183X003200050035x; Koutroubas SD, 2012, FIELD CROP RES, V127, P1, DOI 10.1016/j.fcr.2011.10.011; Li FS, 2010, AGR WATER MANAGE, V97, P1156, DOI 10.1016/j.agwat.2010.01.024; Li HB, 2014, PLANT PHYSIOL BIOCH, V85, P31, DOI 10.1016/j.plaphy.2014.10.010; Li Hui, 2013, Fire Control and Command Control, V38, P48; Liu CA, 2013, AGR WATER MANAGE, V117, P123, DOI 10.1016/j.agwat.2012.11.002; Liu P, 2014, J EXPT BOT; Ma SC, 2008, FIELD CROP RES, V105, P56, DOI 10.1016/j.fcr.2007.07.005; Ma SC, 2010, FIELD CROP RES, V115, P158, DOI 10.1016/j.fcr.2009.10.017; Martinez DE, 2008, PLANT J, V56, P196, DOI 10.1111/j.1365-313X.2008.03585.x; Martinez DE, 2007, J EXP BOT, V58, P1099, DOI 10.1093/jxb/erl270; Monneveux P, 2003, J PLANT PHYSIOL, V160, P657, DOI 10.1078/0176-1617-00772; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Oscarson P, 2000, J EXP BOT, V51, P1921, DOI 10.1093/jexbot/51.352.1921; PALTA JA, 1994, CROP SCI, V34, P118, DOI 10.2135/cropsci1994.0011183X003400010021x; Puckette MC, 2007, PLANT PHYSIOL BIOCH, V45, P70, DOI 10.1016/j.plaphy.2006.12.004; Qi Wei, 2008, Yingyong Shengtai Xuebao, V19, P306; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rieux CM, 2013, CROP SCI, V53, P1139, DOI 10.2135/cropsci2012.07.0448; Shi CH, 2014, CROP SCI, V54, P2745, DOI 10.2135/cropsci2013.11.0732; Thorup-Kristensen K, 2012, EUR J AGRON, V37, P66, DOI 10.1016/j.eja.2011.11.004; TIESSEN H, 1994, NATURE, V371, P783, DOI 10.1038/371783a0; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Wang J, 2001, ACTA BOT BOREALI-OCC, V22, P285; Wang J, 2013, AGRON J, V105, P143, DOI 10.2134/agronj2012.0067; Wang J, 2011, PLANT SOIL, V347, P41, DOI 10.1007/s11104-011-0764-4; Wang WB, 2009, PLANT PHYSIOL BIOCH, V47, P570, DOI 10.1016/j.plaphy.2009.02.009; Xu WZ, 2014, ACTA PHYSIOL PLANT, V36, P1033, DOI 10.1007/s11738-013-1481-9; Xue QW, 2006, J PLANT PHYSIOL, V163, P154, DOI 10.1016/j.jplph.2005.04.026; Yang JC, 2001, FIELD CROP RES, V71, P47, DOI 10.1016/S0378-4290(01)00147-2; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang SL, 2011, SOIL TILL RES, V112, P92, DOI 10.1016/j.still.2010.11.006; Zhao YC, 2009, EUR J AGRON, V31, P36, DOI 10.1016/j.eja.2009.03.001; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	70	16	17	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180205	10.1371/journal.pone.0180205	http://dx.doi.org/10.1371/journal.pone.0180205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662113	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300126
